https://www.pharmasources.com/industryinsights/allergan-gedeon-richter-receive-fda-appr-311872.html 0.6 2026-06-22T05:33:28+08:00 daily https://www.pharmasources.com/industryinsights/allergan-and-gedeon-richter-receive-us-f-311873.html 0.6 2026-08-09T03:34:24+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-zolgensma-onasemnogene-abep-311874.html 0.6 2026-08-12T10:58:56+08:00 daily https://www.pharmasources.com/industryinsights/biomarin-announces-valoctocogene-roxapar-311875.html 0.6 2026-08-09T02:18:54+08:00 daily https://www.pharmasources.com/industryinsights/amgen-joins-with-community-oncology-netw-311876.html 0.6 2026-08-07T10:52:57+08:00 daily https://www.pharmasources.com/industryinsights/cancer-cells-are-quick-change-artists-ad-311877.html 0.6 2026-08-07T06:07:15+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-announces-top-line-results-from-p-311878.html 0.6 2026-08-08T08:30:06+08:00 daily https://www.pharmasources.com/industryinsights/aggressive-uterine-cancer-on-the-rise-es-311879.html 0.6 2026-08-07T04:04:07+08:00 daily https://www.pharmasources.com/industryinsights/cmfri-develops-nutraceutical-product-to--311880.html 0.6 2026-08-07T02:37:08+08:00 daily https://www.pharmasources.com/industryinsights/china-india-pharmaceutical-business-conv-311881.html 0.6 2026-08-07T02:30:37+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-receives-anda-approval-for-dipy-311882.html 0.6 2026-08-06T19:59:57+08:00 daily https://www.pharmasources.com/industryinsights/dil-reports-a-115-per-cent-hike-in-pat-r-311883.html 0.6 2026-08-06T19:23:13+08:00 daily https://www.pharmasources.com/industryinsights/clariant-launches-eqius-a-brand-of-humid-311884.html 0.6 2026-08-06T20:01:12+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-jakafi-ruxolitinib-for-the--311885.html 0.6 2026-08-06T23:57:09+08:00 daily https://www.pharmasources.com/industryinsights/do-you-have-the-fainting-gene-311886.html 0.6 2026-08-07T00:02:46+08:00 daily https://www.pharmasources.com/industryinsights/china-approves-gsks-shingles-vaccine-shi-311887.html 0.6 2026-07-24T04:08:39+08:00 daily https://www.pharmasources.com/industryinsights/armas-micro-labs-enter-injectables-colla-311888.html 0.6 2026-08-07T00:40:47+08:00 daily https://www.pharmasources.com/industryinsights/almac-appoints-sheryl-foster-vp-of-quali-311889.html 0.6 2026-08-11T00:44:18+08:00 daily https://www.pharmasources.com/industryinsights/particle-sciences-expands-controlled-sub-311890.html 0.6 2026-06-21T14:54:21+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-gene-therapy-for-paed-311891.html 0.6 2026-06-21T07:00:06+08:00 daily https://www.pharmasources.com/industryinsights/85-million-settlement-agreed-for-opioid--311892.html 0.6 2026-07-04T23:23:58+08:00 daily https://www.pharmasources.com/industryinsights/first-pi3k-inhibitor-for-breast-cancer-a-311893.html 0.6 2026-08-02T16:43:15+08:00 daily https://www.pharmasources.com/industryinsights/labvolution-paving-the-way-for-the-lab-o-311894.html 0.6 2026-06-21T04:03:51+08:00 daily https://www.pharmasources.com/industryinsights/retail-prices-on-several-anti-cancer-med-311895.html 0.6 2026-06-21T22:58:40+08:00 daily https://www.pharmasources.com/industryinsights/transgender-no-longer-classified-as-ment-311896.html 0.6 2026-07-15T18:49:47+08:00 daily https://www.pharmasources.com/industryinsights/daratumumab-cuts-risk-for-progression-in-311897.html 0.6 2026-06-21T18:46:29+08:00 daily https://www.pharmasources.com/industryinsights/recent-plateauing-seen-in-prevalence-of--311898.html 0.6 2026-06-20T17:07:27+08:00 daily https://www.pharmasources.com/industryinsights/remote-ischemic-preconditioning-may-have-311899.html 0.6 2026-06-24T16:16:36+08:00 daily https://www.pharmasources.com/industryinsights/long-term-survival-similar-for-endovascu-311900.html 0.6 2026-06-21T09:00:01+08:00 daily https://www.pharmasources.com/industryinsights/face-transplants-improve-lives-years-lat-311901.html 0.6 2026-06-21T10:18:28+08:00 daily https://www.pharmasources.com/industryinsights/alex-trebek-says-his-pancreatic-cancer-i-311902.html 0.6 2026-07-02T15:25:49+08:00 daily https://www.pharmasources.com/industryinsights/colon-cancer-striking-more-under-50-and--311903.html 0.6 2026-06-21T13:06:27+08:00 daily https://www.pharmasources.com/industryinsights/blood-test-could-spot-multiple-cancer-ty-311904.html 0.6 2026-06-07T07:23:24+08:00 daily https://www.pharmasources.com/industryinsights/sermonix-receives-fda-fast-track-designa-311905.html 0.6 2026-08-12T12:45:58+08:00 daily https://www.pharmasources.com/industryinsights/iovance-biotherapeutics-announces-breakt-311906.html 0.6 2026-06-22T01:36:45+08:00 daily https://www.pharmasources.com/industryinsights/lillys-mirikizumab-met-primary-endpoint--311907.html 0.6 2026-06-21T07:16:18+08:00 daily https://www.pharmasources.com/industryinsights/imara-announces-fda-fast-track-designati-311908.html 0.6 2026-06-20T23:15:57+08:00 daily https://www.pharmasources.com/industryinsights/do-you-really-need-10000-steps-a-day-311909.html 0.6 2026-07-24T02:23:46+08:00 daily https://www.pharmasources.com/industryinsights/rejenevie-therapeutics-announces-start-o-311910.html 0.6 2026-08-05T22:55:16+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-lenalidomide-for-follicular-311911.html 0.6 2026-06-20T17:17:35+08:00 daily https://www.pharmasources.com/industryinsights/akero-therapeutics-initiates-akr-001-pha-311912.html 0.6 2026-08-12T11:19:47+08:00 daily https://www.pharmasources.com/industryinsights/energy-drinks-may-take-a-toll-on-the-hea-311913.html 0.6 2026-06-20T14:51:06+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-ind-application-to-initiate-311914.html 0.6 2026-08-07T02:31:21+08:00 daily https://www.pharmasources.com/industryinsights/heritage-pharmaceuticals-issues-recall-o-311915.html 0.6 2026-06-21T01:08:53+08:00 daily https://www.pharmasources.com/industryinsights/british-columbia-in-canada-switches-pati-311916.html 0.6 2026-06-21T20:56:37+08:00 daily https://www.pharmasources.com/industryinsights/uk-researchers-develop-compound-to-kill--311917.html 0.6 2026-08-07T00:42:43+08:00 daily https://www.pharmasources.com/industryinsights/lilly-licenses-non-opioid-pain-therapeut-311918.html 0.6 2026-08-07T00:40:08+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-celgenes-r2-for-two-types-o-311919.html 0.6 2026-08-07T00:01:44+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-novartis-piqray-as-the-firs-311920.html 0.6 2026-08-06T23:55:46+08:00 daily https://www.pharmasources.com/industryinsights/bayer-receives-us-fda-breakthrough-thera-311921.html 0.6 2026-08-06T23:45:16+08:00 daily https://www.pharmasources.com/industryinsights/fermenta-biotechs-dahej-facilitys-de-bot-311922.html 0.6 2026-08-06T20:07:33+08:00 daily https://www.pharmasources.com/industryinsights/lupin-wins-india-packaging-award-for-cor-311923.html 0.6 2026-08-06T23:56:37+08:00 daily https://www.pharmasources.com/industryinsights/addressable-market-for-e-pharmacies-in-i-311924.html 0.6 2026-08-07T00:03:23+08:00 daily https://www.pharmasources.com/industryinsights/cadila-healthcare-posts-q4-net-profit-of-311925.html 0.6 2026-08-07T13:19:32+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-announces-q4fy19-financial-re-311926.html 0.6 2026-06-22T05:58:40+08:00 daily https://www.pharmasources.com/industryinsights/health-canada-approves-biocon-and-mylans-311927.html 0.6 2026-06-20T19:18:22+08:00 daily https://www.pharmasources.com/industryinsights/low-cost-method-to-store-transport-life--311928.html 0.6 2026-06-20T21:40:15+08:00 daily https://www.pharmasources.com/industryinsights/lupin-launches-budesonide-inhalation-sus-311929.html 0.6 2026-08-11T18:35:58+08:00 daily https://www.pharmasources.com/industryinsights/scientists-develop-an-antibiotic-alterna-311930.html 0.6 2026-08-06T18:07:25+08:00 daily https://www.pharmasources.com/industryinsights/breathe-easier-new-york-city-clean-air-t-311931.html 0.6 2026-07-31T05:52:42+08:00 daily https://www.pharmasources.com/industryinsights/its-never-too-late-for-new-brain-cells-311932.html 0.6 2026-06-21T08:02:06+08:00 daily https://www.pharmasources.com/industryinsights/could-you-have-a-sensitive-gut-311933.html 0.6 2026-06-20T19:50:26+08:00 daily https://www.pharmasources.com/industryinsights/high-ldl-cholesterol-tied-to-early-onset-311934.html 0.6 2026-07-08T14:56:15+08:00 daily https://www.pharmasources.com/industryinsights/more-than-1-in-4-middle-aged-men-women-h-311935.html 0.6 2026-07-02T10:57:23+08:00 daily https://www.pharmasources.com/industryinsights/hip-fracture-linked-to-increased-risk-fo-311936.html 0.6 2026-06-25T12:22:00+08:00 daily https://www.pharmasources.com/industryinsights/eczema-related-school-absences-higher-am-311937.html 0.6 2026-06-21T11:53:34+08:00 daily https://www.pharmasources.com/industryinsights/evolving-world-of-pharma-navigating-the--311938.html 0.6 2026-08-07T13:19:36+08:00 daily https://www.pharmasources.com/industryinsights/mammogram-benefits-seen-as-more-importan-311939.html 0.6 2026-06-21T17:38:21+08:00 daily https://www.pharmasources.com/industryinsights/experts-develop-standardized-tool-for-de-311940.html 0.6 2026-06-29T05:24:10+08:00 daily https://www.pharmasources.com/industryinsights/many-immunosuppressed-persons-join-in-hu-311941.html 0.6 2026-06-30T17:09:49+08:00 daily https://www.pharmasources.com/industryinsights/many-feel-frozen-when-heart-attack-strik-311942.html 0.6 2026-07-12T13:27:22+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-test-for-zika-in-huma-311943.html 0.6 2026-06-21T23:56:40+08:00 daily https://www.pharmasources.com/industryinsights/pediatric-nurse-practitioner-shortage-lo-311944.html 0.6 2026-06-21T01:10:52+08:00 daily https://www.pharmasources.com/industryinsights/nursing-moms-who-eat-right-have-slimmer--311945.html 0.6 2026-06-21T11:08:15+08:00 daily https://www.pharmasources.com/industryinsights/us-measles-cases-for-2019-already-exceed-311946.html 0.6 2026-06-21T22:55:50+08:00 daily https://www.pharmasources.com/industryinsights/a-new-way-to-fight-a-previously-inoperab-311947.html 0.6 2026-06-29T06:16:20+08:00 daily https://www.pharmasources.com/industryinsights/controlled-burns-better-for-kids-health--311948.html 0.6 2026-07-04T03:51:32+08:00 daily https://www.pharmasources.com/industryinsights/ampersand-to-acquire-vibalogics-311949.html 0.6 2026-06-20T15:12:18+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-opens-life-science-office-in-ma-311950.html 0.6 2026-06-20T21:00:39+08:00 daily https://www.pharmasources.com/industryinsights/api-markets-to-grow-68-percent-by-2026-311951.html 0.6 2026-08-08T01:38:39+08:00 daily https://www.pharmasources.com/industryinsights/proteomics-research-advanced-by-use-of-a-311952.html 0.6 2026-06-20T18:56:34+08:00 daily https://www.pharmasources.com/industryinsights/british-columbia-first-province-to-switc-311953.html 0.6 2026-06-23T17:12:52+08:00 daily https://www.pharmasources.com/industryinsights/cphi-china-opens-with-analysis-pointing--311954.html 0.6 2026-06-25T06:06:51+08:00 daily https://www.pharmasources.com/industryinsights/bpog-extractables-testing-of-advantapure-311955.html 0.6 2026-06-21T13:02:32+08:00 daily https://www.pharmasources.com/industryinsights/teasing-kids-about-weight-linked-to-more-311956.html 0.6 2026-06-20T15:12:16+08:00 daily https://www.pharmasources.com/industryinsights/forget-fasting-before-that-cholesterol-t-311957.html 0.6 2025-12-28T09:05:46+08:00 daily https://www.pharmasources.com/industryinsights/highly-processed-diets-tied-to-heart-dis-311958.html 0.6 2026-06-21T15:50:18+08:00 daily https://www.pharmasources.com/industryinsights/us-cancer-cases-deaths-continue-to-fall-311959.html 0.6 2026-06-21T01:09:54+08:00 daily https://www.pharmasources.com/industryinsights/a-less-invasive-fix-works-well-for-abdom-311960.html 0.6 2026-08-11T05:29:13+08:00 daily https://www.pharmasources.com/industryinsights/ibrutinib-venetoclax-active-in-high-risk-311961.html 0.6 2026-08-14T07:21:04+08:00 daily https://www.pharmasources.com/industryinsights/scynexis-completes-chronic-nonclinical-t-311962.html 0.6 2026-06-21T00:04:42+08:00 daily https://www.pharmasources.com/industryinsights/audentes-therapeutics-announces-changes--311963.html 0.6 2026-06-20T18:50:30+08:00 daily https://www.pharmasources.com/industryinsights/stepped-tx-for-alcohol-use-disorder-stud-311964.html 0.6 2025-12-19T03:44:19+08:00 daily https://www.pharmasources.com/industryinsights/inhibrx-announces-agreement-for-inbrx-10-311965.html 0.6 2026-07-22T23:19:45+08:00 daily https://www.pharmasources.com/industryinsights/abitec-improves-solubility-of-topical-tr-311966.html 0.6 2026-06-20T23:05:44+08:00 daily https://www.pharmasources.com/industryinsights/gt-biopharma-provides-gtb-1550-clinical--311967.html 0.6 2026-07-05T17:26:35+08:00 daily https://www.pharmasources.com/industryinsights/us-dentists-prescribe-opioids-more-often-311968.html 0.6 2026-08-11T19:26:29+08:00 daily https://www.pharmasources.com/industryinsights/neurorx-reports-phase-2-efficacy-for-nrx-311969.html 0.6 2026-06-21T05:05:45+08:00 daily https://www.pharmasources.com/industryinsights/fda-releases-statement-on-fixed-quantity-311970.html 0.6 2026-06-21T10:56:06+08:00 daily https://www.pharmasources.com/industryinsights/who-adopts-resolution-on-drug-pricing-tr-311971.html 0.6 2026-02-12T09:50:58+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-allergan-gedeons-vraylar-to-311972.html 0.6 2026-06-21T03:48:39+08:00 daily https://www.pharmasources.com/industryinsights/amicus-therapeutics-expands-gene-therapy-311973.html 0.6 2026-06-22T00:53:45+08:00 daily https://www.pharmasources.com/industryinsights/merck-pioneers-new-effort-to-see-ms-from-311974.html 0.6 2026-06-20T21:47:12+08:00 daily https://www.pharmasources.com/industryinsights/natco-pharma-settles-patent-litigation-w-311975.html 0.6 2026-06-21T04:07:15+08:00 daily https://www.pharmasources.com/industryinsights/indoco-remedies-reports-q4fy19-revenue-a-311976.html 0.6 2026-06-21T18:59:41+08:00 daily https://www.pharmasources.com/industryinsights/biocon-academy-introduces-experiential-l-311977.html 0.6 2026-06-20T21:00:44+08:00 daily https://www.pharmasources.com/industryinsights/glenmarks-consolidated-revenue-rises-124-311978.html 0.6 2026-06-22T02:48:34+08:00 daily https://www.pharmasources.com/industryinsights/syncope-in-pregnancy-may-up-risk-for-adv-311979.html 0.6 2026-06-20T18:12:45+08:00 daily https://www.pharmasources.com/industryinsights/lupin-wins-packaging-award-for-lupin-sah-311980.html 0.6 2026-07-10T14:26:12+08:00 daily https://www.pharmasources.com/industryinsights/no-subfascial-intramuscular-injection-re-311981.html 0.6 2026-06-20T23:06:47+08:00 daily https://www.pharmasources.com/industryinsights/many-middle-aged-men-may-have-signs-of-t-311982.html 0.6 2026-06-20T21:55:34+08:00 daily https://www.pharmasources.com/industryinsights/cancer-patients-vaping-in-growing-number-311983.html 0.6 2026-06-22T12:47:07+08:00 daily https://www.pharmasources.com/industryinsights/health-highlights-may-30-2019-311984.html 0.6 2026-06-22T01:54:31+08:00 daily https://www.pharmasources.com/industryinsights/weight-based-teasing-linked-to-gain-in-b-311985.html 0.6 2026-06-20T21:15:59+08:00 daily https://www.pharmasources.com/industryinsights/high-costs-associated-with-physician-bur-311986.html 0.6 2026-06-23T13:00:53+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-piqray-alpelisib-as-first-p-311987.html 0.6 2026-07-27T07:16:24+08:00 daily https://www.pharmasources.com/industryinsights/could-2-prostate-cancer-drugs-fight-dise-311988.html 0.6 2026-06-20T22:17:04+08:00 daily https://www.pharmasources.com/industryinsights/newer-drug-extends-lives-of-young-breast-311989.html 0.6 2026-07-09T08:43:25+08:00 daily https://www.pharmasources.com/industryinsights/zolgensma-first-gene-therapy-for-pediatr-311990.html 0.6 2026-06-21T11:06:16+08:00 daily https://www.pharmasources.com/industryinsights/novartis-piqray-approved-as-first-pi3k-i-311991.html 0.6 2026-07-15T15:45:10+08:00 daily https://www.pharmasources.com/industryinsights/fda-clears-nayzilam-as-first-nasal-spray-311992.html 0.6 2026-07-20T20:01:07+08:00 daily https://www.pharmasources.com/industryinsights/ruzurgi-approved-for-pediatric-lambert-e-311993.html 0.6 2026-06-21T06:11:49+08:00 daily https://www.pharmasources.com/industryinsights/2007-to-2017-saw-decline-in-number-of-us-311994.html 0.6 2026-06-20T15:10:21+08:00 daily https://www.pharmasources.com/industryinsights/nonfasting-lipid-levels-adequate-for-ass-311995.html 0.6 2026-07-31T12:12:26+08:00 daily https://www.pharmasources.com/industryinsights/providers-peers-influence-aspirin-use-am-311996.html 0.6 2026-06-20T22:54:41+08:00 daily https://www.pharmasources.com/industryinsights/fda-takes-hard-look-at-cbd-311997.html 0.6 2026-08-05T19:15:59+08:00 daily https://www.pharmasources.com/industryinsights/cdc-warns-again-of-salmonella-from-pet-h-311998.html 0.6 2026-06-21T06:18:13+08:00 daily https://www.pharmasources.com/industryinsights/financial-disaster-may-prompt-self-destr-311999.html 0.6 2026-03-05T14:18:09+08:00 daily https://www.pharmasources.com/industryinsights/patients-who-read-doctors-notes-more-lik-312000.html 0.6 2026-07-05T21:19:18+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-is-it-fatigue-or-a-stroke-women-312001.html 0.6 2026-08-09T05:41:22+08:00 daily https://www.pharmasources.com/industryinsights/many-heart-failure-patients-might-safely-312002.html 0.6 2026-08-13T16:53:01+08:00 daily https://www.pharmasources.com/industryinsights/why-some-kids-with-eczema-are-at-higher--312003.html 0.6 2026-08-09T00:10:12+08:00 daily https://www.pharmasources.com/industryinsights/how-much-coffee-is-too-much-312004.html 0.6 2026-08-09T22:16:53+08:00 daily https://www.pharmasources.com/industryinsights/impaired-vision-tied-to-perceived-discri-312005.html 0.6 2026-08-06T22:43:54+08:00 daily https://www.pharmasources.com/industryinsights/who-announces-support-for-drug-pricing-t-312006.html 0.6 2026-08-06T22:50:07+08:00 daily https://www.pharmasources.com/industryinsights/sotios-dcvacluca-significantly-improves--312007.html 0.6 2026-08-06T23:32:06+08:00 daily https://www.pharmasources.com/industryinsights/blueprint-identifies-genomic-subtypes-fo-312008.html 0.6 2026-08-06T23:37:01+08:00 daily https://www.pharmasources.com/industryinsights/cdc-reported-measles-cases-reach-971-312009.html 0.6 2026-08-06T23:45:37+08:00 daily https://www.pharmasources.com/industryinsights/noncompliance-common-in-teens-prescribed-312010.html 0.6 2026-08-06T23:48:55+08:00 daily https://www.pharmasources.com/industryinsights/excess-cause-specific-mortality-tied-to--312011.html 0.6 2026-08-10T15:21:45+08:00 daily https://www.pharmasources.com/industryinsights/esketamine-nasal-spray-may-improve-refra-312012.html 0.6 2026-06-21T21:49:43+08:00 daily https://www.pharmasources.com/industryinsights/guidelines-updated-for-radiotherapy-afte-312013.html 0.6 2026-06-20T14:35:51+08:00 daily https://www.pharmasources.com/industryinsights/higher-ldl-c-levels-linked-to-early-onse-312014.html 0.6 2026-06-21T01:12:55+08:00 daily https://www.pharmasources.com/industryinsights/recommendations-developed-for-pediatric--312015.html 0.6 2026-06-21T13:02:30+08:00 daily https://www.pharmasources.com/industryinsights/novis-pr-llc-issues-voluntary-nationwide-312016.html 0.6 2026-06-20T14:51:06+08:00 daily https://www.pharmasources.com/industryinsights/fda-oks-vyndaqel-and-vyndamax-as-first-t-312017.html 0.6 2026-06-21T00:55:43+08:00 daily https://www.pharmasources.com/industryinsights/janssen-presents-positive-darzalex-resul-312018.html 0.6 2026-06-20T21:57:47+08:00 daily https://www.pharmasources.com/industryinsights/novartis-kisqali-hits-endpoints-in-phase-312019.html 0.6 2026-06-20T21:04:45+08:00 daily https://www.pharmasources.com/industryinsights/unprecedented-results-in-az-late-stage-l-312020.html 0.6 2026-06-21T10:00:09+08:00 daily https://www.pharmasources.com/industryinsights/gp-surgery-closures-hit-all-time-high-la-312021.html 0.6 2026-07-04T11:52:36+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommendation-for-msds-prevymis-af-312022.html 0.6 2026-06-20T16:01:16+08:00 daily https://www.pharmasources.com/industryinsights/novartis-hits-targets-in-late-stage-qmf1-312023.html 0.6 2026-06-22T11:02:54+08:00 daily https://www.pharmasources.com/industryinsights/bmj-study-shows-correlation-between-proc-312024.html 0.6 2026-01-15T09:13:05+08:00 daily https://www.pharmasources.com/industryinsights/clinical-trials-verification-of-cinepazi-312025.html 0.6 2026-06-28T18:31:42+08:00 daily https://www.pharmasources.com/industryinsights/personalised-digital-wellness-services-a-312026.html 0.6 2026-02-09T07:11:39+08:00 daily https://www.pharmasources.com/industryinsights/saluda-medical-announces-clinical-study--312027.html 0.6 2026-07-01T04:36:23+08:00 daily https://www.pharmasources.com/industryinsights/obp-launches-cordless-surgical-retractor-312028.html 0.6 2026-06-21T12:56:33+08:00 daily https://www.pharmasources.com/industryinsights/great-bay-bio-launches-platform-for-inno-312029.html 0.6 2026-08-12T22:21:16+08:00 daily https://www.pharmasources.com/industryinsights/benchmark-zhejiang-yatai-pharma-to-explo-312030.html 0.6 2026-06-21T11:31:40+08:00 daily https://www.pharmasources.com/industryinsights/wat-medical-receives-approval-for-migrai-312031.html 0.6 2026-08-08T03:15:10+08:00 daily https://www.pharmasources.com/industryinsights/cstone-submits-new-drug-application-for--312032.html 0.6 2026-08-10T14:46:27+08:00 daily https://www.pharmasources.com/industryinsights/milliporesigma-awards-grants-to-biotech--312033.html 0.6 2026-06-21T01:05:51+08:00 daily https://www.pharmasources.com/industryinsights/beam-therapeutics-bio-palette-to-develop-312034.html 0.6 2026-08-12T13:30:40+08:00 daily https://www.pharmasources.com/industryinsights/aslan-pharmaceuticals-amends-license-agr-312035.html 0.6 2026-06-20T14:55:04+08:00 daily https://www.pharmasources.com/industryinsights/worlds-first-digital-nicotine-dependent--312036.html 0.6 2026-06-21T08:05:04+08:00 daily https://www.pharmasources.com/industryinsights/vaccine-hesitancy-will-hinder-growth-in--312037.html 0.6 2026-08-07T21:50:31+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-zerbaxa-ceftolozane-and-taz-312038.html 0.6 2026-07-20T00:02:08+08:00 daily https://www.pharmasources.com/industryinsights/many-buprenorphine-prescribers-not-offer-312039.html 0.6 2026-06-24T13:23:56+08:00 daily https://www.pharmasources.com/industryinsights/most-older-adults-would-have-to-liquidat-312040.html 0.6 2026-06-22T08:07:20+08:00 daily https://www.pharmasources.com/industryinsights/functional-limitations-persist-one-year--312041.html 0.6 2026-06-21T14:58:23+08:00 daily https://www.pharmasources.com/industryinsights/peripherally-inserted-central-catheters--312042.html 0.6 2026-06-21T10:17:26+08:00 daily https://www.pharmasources.com/industryinsights/acp-issues-position-on-response-to-physi-312043.html 0.6 2026-06-21T08:20:22+08:00 daily https://www.pharmasources.com/industryinsights/lesbian-gay-youth-at-higher-risk-for-sel-312044.html 0.6 2026-06-21T14:25:11+08:00 daily https://www.pharmasources.com/industryinsights/even-25-cups-of-coffee-a-day-may-be-ok-f-312045.html 0.6 2026-06-21T05:56:51+08:00 daily https://www.pharmasources.com/industryinsights/immigrants-make-up-1-in-4-us-health-care-312046.html 0.6 2026-06-20T22:15:59+08:00 daily https://www.pharmasources.com/industryinsights/many-patients-dont-need-opioids-after-su-312047.html 0.6 2026-07-02T21:06:34+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-expanded-use-of-vraylar-car-312048.html 0.6 2026-03-03T02:39:20+08:00 daily https://www.pharmasources.com/industryinsights/younger-gout-patients-have-higher-odds-f-312049.html 0.6 2026-02-28T18:19:15+08:00 daily https://www.pharmasources.com/industryinsights/your-gut-bacteria-could-affect-your-resp-312050.html 0.6 2026-06-21T00:53:45+08:00 daily https://www.pharmasources.com/industryinsights/hiv-patients-more-likely-to-have-heart-t-312051.html 0.6 2026-06-22T12:16:15+08:00 daily https://www.pharmasources.com/industryinsights/sleep-deprived-teens-more-prone-to-unsaf-312052.html 0.6 2026-07-28T06:36:12+08:00 daily https://www.pharmasources.com/industryinsights/health-tip-avoid-mouth-injuries-in-child-312053.html 0.6 2026-06-21T08:19:15+08:00 daily https://www.pharmasources.com/industryinsights/guidelines-issued-for-addressing-heart-d-312054.html 0.6 2026-06-07T11:09:57+08:00 daily https://www.pharmasources.com/industryinsights/asco-low-dose-chemo-benefits-advanced-ga-312055.html 0.6 2026-06-20T17:58:33+08:00 daily https://www.pharmasources.com/industryinsights/gout-linked-to-increased-risk-for-venous-312056.html 0.6 2026-06-20T20:57:38+08:00 daily https://www.pharmasources.com/industryinsights/higher-surgical-volume-may-improve-outco-312057.html 0.6 2026-06-21T03:16:57+08:00 daily https://www.pharmasources.com/industryinsights/current-strategies-for-measles-vaccinati-312058.html 0.6 2026-07-03T22:24:10+08:00 daily https://www.pharmasources.com/industryinsights/pressure-injuries-at-time-of-icu-admissi-312059.html 0.6 2026-06-14T06:42:08+08:00 daily https://www.pharmasources.com/industryinsights/asco-pembrolizumab-noninferior-to-chemo--312060.html 0.6 2026-06-21T17:04:26+08:00 daily https://www.pharmasources.com/industryinsights/decline-in-nontraumatic-lower-extremity--312061.html 0.6 2026-06-20T22:06:40+08:00 daily https://www.pharmasources.com/industryinsights/ptc-therapeutics-appoints-cfo-312062.html 0.6 2026-06-22T20:23:49+08:00 daily https://www.pharmasources.com/industryinsights/lonza-to-spin-out-specialty-ingredients--312063.html 0.6 2026-08-05T22:01:44+08:00 daily https://www.pharmasources.com/industryinsights/avadel-pharma-appoints-ceo-312064.html 0.6 2026-06-23T04:32:36+08:00 daily https://www.pharmasources.com/industryinsights/aldevron-to-build-14-acre-gene-therapy-m-312065.html 0.6 2026-06-20T18:18:02+08:00 daily https://www.pharmasources.com/industryinsights/ibio-launches-sterile-fill-finish-servic-312066.html 0.6 2026-06-21T08:57:10+08:00 daily https://www.pharmasources.com/industryinsights/cure-hepatitis-c-in-8-weeks-maviret-the--312067.html 0.6 2026-07-29T09:56:49+08:00 daily https://www.pharmasources.com/industryinsights/promising-early-results-for-bms-investig-312068.html 0.6 2026-06-21T15:57:14+08:00 daily https://www.pharmasources.com/industryinsights/thousands-more-gp-staff-recruited-across-312069.html 0.6 2026-03-27T20:54:40+08:00 daily https://www.pharmasources.com/industryinsights/bluebird-bags-eu-conditional-marketing-a-312070.html 0.6 2026-06-21T13:39:39+08:00 daily https://www.pharmasources.com/industryinsights/new-late-stage-prostate-cancer-technolog-312071.html 0.6 2026-06-23T20:36:10+08:00 daily https://www.pharmasources.com/industryinsights/categories-available-for-all-experience--312072.html 0.6 2026-06-21T21:55:36+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-gubra-collaborate-f-312073.html 0.6 2026-06-20T14:55:09+08:00 daily https://www.pharmasources.com/industryinsights/biotage-and-yingsheng-collaborates-to-de-312074.html 0.6 2026-04-01T02:25:14+08:00 daily https://www.pharmasources.com/industryinsights/johns-hopkins-licensed-technology-receiv-312075.html 0.6 2026-06-30T06:39:12+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-receives-reimbursement-cov-312076.html 0.6 2026-08-06T19:37:16+08:00 daily https://www.pharmasources.com/industryinsights/genecare-jupiter-chain-to-release-secure-312077.html 0.6 2026-08-08T03:36:40+08:00 daily https://www.pharmasources.com/industryinsights/personalised-digital-wellness-services-a-312078.html 0.6 2026-06-24T02:40:37+08:00 daily https://www.pharmasources.com/industryinsights/thbi-to-philadelphia-for-2019-annual-bio-312079.html 0.6 2026-06-21T06:11:52+08:00 daily https://www.pharmasources.com/industryinsights/intervenn-biosciences-enrolls-first-pati-312080.html 0.6 2026-06-22T13:32:06+08:00 daily https://www.pharmasources.com/industryinsights/international-medical-innovation-and-coo-312081.html 0.6 2026-07-20T00:01:30+08:00 daily https://www.pharmasources.com/industryinsights/clinical-trials-verification-of-cinepazi-312082.html 0.6 2026-07-20T10:02:50+08:00 daily https://www.pharmasources.com/industryinsights/asco-soundbites-vol-3-real-time-approval-312083.html 0.6 2026-07-01T17:01:06+08:00 daily https://www.pharmasources.com/industryinsights/years-after-cubist-buyout-merck-scores-a-312084.html 0.6 2026-08-05T19:25:48+08:00 daily https://www.pharmasources.com/industryinsights/how-patient-adherence-and-engagement-sol-312085.html 0.6 2026-06-21T05:09:54+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-regeneron-dive-deep-on-asthma-in--312086.html 0.6 2026-06-21T04:18:12+08:00 daily https://www.pharmasources.com/industryinsights/jury-smacks-jj-with-325m-talc-verdict-af-312087.html 0.6 2026-06-21T10:16:33+08:00 daily https://www.pharmasources.com/industryinsights/asco-survival-up-with-ribociclib-in-adva-312088.html 0.6 2026-06-08T18:34:15+08:00 daily https://www.pharmasources.com/industryinsights/2000-to-2016-saw-mortality-from-falls-in-312089.html 0.6 2026-06-21T10:54:25+08:00 daily https://www.pharmasources.com/industryinsights/common-supplement-ingredient-could-harm--312090.html 0.6 2026-08-03T16:47:38+08:00 daily https://www.pharmasources.com/industryinsights/asco-combo-regimen-effective-in-cll-with-312091.html 0.6 2026-08-13T20:41:27+08:00 daily https://www.pharmasources.com/industryinsights/asco-olaparib-beats-placebo-for-brca-rel-312092.html 0.6 2026-08-07T19:44:17+08:00 daily https://www.pharmasources.com/industryinsights/chicken-no-better-than-beef-for-your-cho-312093.html 0.6 2026-06-27T15:49:40+08:00 daily https://www.pharmasources.com/industryinsights/testicular-cancer-treatment-unlikely-to--312094.html 0.6 2026-08-14T20:38:03+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-for-lgbtq-patients-discriminati-312095.html 0.6 2026-07-01T16:32:48+08:00 daily https://www.pharmasources.com/industryinsights/another-use-for-beta-blockers-curbing-a--312096.html 0.6 2026-06-22T03:15:10+08:00 daily https://www.pharmasources.com/industryinsights/is-mri-screening-worth-it-for-breast-can-312097.html 0.6 2026-06-20T20:02:37+08:00 daily https://www.pharmasources.com/industryinsights/secret-shopper-study-finds-many-who-need-312098.html 0.6 2026-03-31T21:29:45+08:00 daily https://www.pharmasources.com/industryinsights/a-5-minute-recipe-for-stress-relief-312099.html 0.6 2026-06-20T14:53:10+08:00 daily https://www.pharmasources.com/industryinsights/caffeine-nicotine-withdrawal-can-cause-p-312100.html 0.6 2026-06-23T16:36:59+08:00 daily https://www.pharmasources.com/industryinsights/patient-catches-on-fire-during-heart-sur-312101.html 0.6 2026-06-22T02:54:41+08:00 daily https://www.pharmasources.com/industryinsights/instagram-self-harm-posts-give-rise-to-c-312102.html 0.6 2026-06-21T08:09:05+08:00 daily https://www.pharmasources.com/industryinsights/health-tip-over-the-counter-drugs-that-d-312103.html 0.6 2026-06-20T20:59:34+08:00 daily https://www.pharmasources.com/industryinsights/health-tip-understanding-liver-spots-312104.html 0.6 2026-06-20T17:10:30+08:00 daily https://www.pharmasources.com/industryinsights/ai-model-based-on-deep-learning-detects--312105.html 0.6 2026-06-21T11:43:13+08:00 daily https://www.pharmasources.com/industryinsights/allo-hct-with-unrelated-donor-tied-to-be-312106.html 0.6 2026-06-20T20:58:35+08:00 daily https://www.pharmasources.com/industryinsights/immunizations-up-in-california-after-rep-312107.html 0.6 2026-06-20T22:15:55+08:00 daily https://www.pharmasources.com/industryinsights/the-pea-needed-by-love-from-the-perspect-312108.html 0.6 2026-07-31T07:55:29+08:00 daily https://www.pharmasources.com/industryinsights/zerbaxa-approved-for-hospital-acquired-b-312109.html 0.6 2026-06-21T19:49:38+08:00 daily https://www.pharmasources.com/industryinsights/staphylococcus-aureus-linked-to-food-sen-312110.html 0.6 2026-07-01T11:15:28+08:00 daily https://www.pharmasources.com/industryinsights/costs-complications-up-for-minorities-in-312111.html 0.6 2026-06-20T18:01:27+08:00 daily https://www.pharmasources.com/industryinsights/nonsuicidal-self-injury-rate-up-in-sexua-312112.html 0.6 2026-06-22T06:56:45+08:00 daily https://www.pharmasources.com/industryinsights/pci-expands-clinical-operations-312113.html 0.6 2026-06-20T16:52:05+08:00 daily https://www.pharmasources.com/industryinsights/cambrex-completes-new-process-and-analyt-312114.html 0.6 2026-08-03T13:36:47+08:00 daily https://www.pharmasources.com/industryinsights/sterlings-pilot-plant-facility-expansion-312115.html 0.6 2026-06-21T16:08:33+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-prevymis-on-the-nhs-afte-312116.html 0.6 2026-06-21T14:51:21+08:00 daily https://www.pharmasources.com/industryinsights/new-partnership-established-to-track-dru-312117.html 0.6 2026-06-20T18:01:24+08:00 daily https://www.pharmasources.com/industryinsights/more-effective-safe-drugs-drive-biobette-312118.html 0.6 2026-06-21T07:22:15+08:00 daily https://www.pharmasources.com/industryinsights/fda-opens-call-centre-to-streamline-pati-312119.html 0.6 2026-06-20T17:15:26+08:00 daily https://www.pharmasources.com/industryinsights/pembrolizumab-trumps-chemotherapy-in-rec-312120.html 0.6 2026-03-28T09:21:09+08:00 daily https://www.pharmasources.com/industryinsights/lilly-and-atomwise-partner-to-use-ai-for-312121.html 0.6 2026-06-20T19:48:36+08:00 daily https://www.pharmasources.com/industryinsights/merck-secures-fda-expanded-indication-fo-312122.html 0.6 2026-06-21T03:55:48+08:00 daily https://www.pharmasources.com/industryinsights/ec-grants-conditional-approval-for-blueb-312123.html 0.6 2026-06-21T23:59:42+08:00 daily https://www.pharmasources.com/industryinsights/berkeley-scientists-discover-chinese-cri-312124.html 0.6 2026-06-23T19:59:08+08:00 daily https://www.pharmasources.com/industryinsights/lynparza-reduces-pfs-in-germline-brca-mu-312125.html 0.6 2026-06-21T09:03:07+08:00 daily https://www.pharmasources.com/industryinsights/aslan-pharmaceuticals-acquires-rights-to-312126.html 0.6 2026-06-20T20:12:42+08:00 daily https://www.pharmasources.com/industryinsights/chinas-regulator-agrees-to-review-beigen-312127.html 0.6 2026-06-21T23:53:38+08:00 daily https://www.pharmasources.com/industryinsights/beam-therapeutics-licenses-bio-palettes--312128.html 0.6 2026-06-21T18:59:40+08:00 daily https://www.pharmasources.com/industryinsights/death-risk-from-sepsis-lasts-up-to-five--312129.html 0.6 2026-06-20T22:53:32+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-roche-present-positive-venclyxto--312130.html 0.6 2026-06-21T16:56:51+08:00 daily https://www.pharmasources.com/industryinsights/lynparza-asco-success-continues-with-pos-312131.html 0.6 2026-08-11T17:31:38+08:00 daily https://www.pharmasources.com/industryinsights/fda-yes-for-emgality-in-cluster-headache-312132.html 0.6 2026-06-21T10:19:22+08:00 daily https://www.pharmasources.com/industryinsights/janssen-presents-positive-darzalex-resul-312133.html 0.6 2026-06-22T05:57:35+08:00 daily https://www.pharmasources.com/industryinsights/gp-surgery-closures-hit-all-time-high-la-312134.html 0.6 2026-06-20T20:56:39+08:00 daily https://www.pharmasources.com/industryinsights/unprecedented-results-in-az-late-stage-l-312135.html 0.6 2026-06-18T19:51:02+08:00 daily https://www.pharmasources.com/industryinsights/novartis-hits-targets-in-late-stage-qmf1-312136.html 0.6 2026-06-22T06:01:56+08:00 daily https://www.pharmasources.com/industryinsights/lpixel-announces-initiation-of-ai-system-312137.html 0.6 2026-06-21T03:59:43+08:00 daily https://www.pharmasources.com/industryinsights/japans-pmda-completes-inspection-of-lupi-312138.html 0.6 2026-06-21T01:39:17+08:00 daily https://www.pharmasources.com/industryinsights/japans-pmda-completes-inspection-of-lupi-312139.html 0.6 2026-08-04T03:55:08+08:00 daily https://www.pharmasources.com/industryinsights/leo-pharma-appoints-catherine-mazzacco-a-312140.html 0.6 2026-07-20T22:02:02+08:00 daily https://www.pharmasources.com/industryinsights/dupont-reveals-cutting-edge-solutions-fo-312141.html 0.6 2026-03-13T14:34:14+08:00 daily https://www.pharmasources.com/industryinsights/few-oncologists-refer-patients-to-weight-312142.html 0.6 2026-06-17T17:26:02+08:00 daily https://www.pharmasources.com/industryinsights/app-helps-pediatric-asthma-patients-pare-312143.html 0.6 2026-06-15T03:27:01+08:00 daily https://www.pharmasources.com/industryinsights/increase-in-cv-mortality-smaller-with-me-312144.html 0.6 2026-06-21T10:02:10+08:00 daily https://www.pharmasources.com/industryinsights/fragmentation-profiles-of-cell-free-dna--312145.html 0.6 2026-08-11T05:15:07+08:00 daily https://www.pharmasources.com/industryinsights/no-evidence-of-legacy-effect-seen-for-in-312146.html 0.6 2026-06-20T17:03:18+08:00 daily https://www.pharmasources.com/industryinsights/tight-diabetes-control-alone-may-not-ben-312147.html 0.6 2026-06-21T06:10:55+08:00 daily https://www.pharmasources.com/industryinsights/for-some-trouble-tracking-finances-could-312148.html 0.6 2026-06-20T21:58:43+08:00 daily https://www.pharmasources.com/industryinsights/human-endurance-may-have-its-limits-stud-312149.html 0.6 2025-11-28T10:50:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-emgality-galcanezumab-gnlm--312150.html 0.6 2026-07-20T09:03:08+08:00 daily https://www.pharmasources.com/industryinsights/acas-medicaid-expansion-may-have-lowered-312151.html 0.6 2026-06-22T22:53:50+08:00 daily https://www.pharmasources.com/industryinsights/few-prostate-cancer-patients-are-getting-312152.html 0.6 2026-02-21T07:47:09+08:00 daily https://www.pharmasources.com/industryinsights/american-soldiers-hearts-in-worse-shape--312153.html 0.6 2026-06-20T23:00:44+08:00 daily https://www.pharmasources.com/industryinsights/average-american-ingests-70000-bits-of-m-312154.html 0.6 2026-06-22T01:01:50+08:00 daily https://www.pharmasources.com/industryinsights/dentists-prescribe-antibiotics-far-too-o-312155.html 0.6 2026-04-18T17:39:36+08:00 daily https://www.pharmasources.com/industryinsights/the-lifelong-health-benefits-of-intimacy-312156.html 0.6 2026-06-20T22:14:15+08:00 daily https://www.pharmasources.com/industryinsights/many-dietary-supplements-dangerous-for-t-312157.html 0.6 2026-06-11T21:59:44+08:00 daily https://www.pharmasources.com/industryinsights/health-tip-nasal-spray-safety-312158.html 0.6 2026-06-30T03:51:37+08:00 daily https://www.pharmasources.com/industryinsights/health-tip-causes-of-hair-loss-312159.html 0.6 2026-08-12T11:10:02+08:00 daily https://www.pharmasources.com/industryinsights/workplace-exposures-contribute-to-burden-312160.html 0.6 2026-06-21T01:53:36+08:00 daily https://www.pharmasources.com/industryinsights/asco-enzalutamide-beneficial-in-metastat-312161.html 0.6 2026-06-20T15:14:22+08:00 daily https://www.pharmasources.com/industryinsights/lowering-cholesterol-levels-may-worsen-n-312162.html 0.6 2026-06-21T05:01:46+08:00 daily https://www.pharmasources.com/industryinsights/cholecystectomy-reduces-risk-for-stroke--312163.html 0.6 2026-07-02T22:05:35+08:00 daily https://www.pharmasources.com/industryinsights/burden-of-new-onset-a-fib-considerable-a-312164.html 0.6 2026-02-28T19:36:07+08:00 daily https://www.pharmasources.com/industryinsights/surveillance-breast-mri-ups-biopsy-cance-312165.html 0.6 2026-07-17T20:01:51+08:00 daily https://www.pharmasources.com/industryinsights/dietary-supplements-may-up-risk-for-seve-312166.html 0.6 2026-06-21T04:00:45+08:00 daily https://www.pharmasources.com/industryinsights/carotid-atherosclerosis-predicts-cv-even-312167.html 0.6 2026-06-20T14:52:08+08:00 daily https://www.pharmasources.com/industryinsights/postop-delirium-may-briefly-up-risk-for--312168.html 0.6 2026-06-20T19:59:32+08:00 daily https://www.pharmasources.com/industryinsights/arivis-presents-the-new-vision4d-31-rele-312169.html 0.6 2026-06-21T12:02:15+08:00 daily https://www.pharmasources.com/industryinsights/strategic-collaboration-between-biotage--312170.html 0.6 2026-07-28T10:44:24+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-drug-for-episodic-clu-312171.html 0.6 2026-06-22T08:00:47+08:00 daily https://www.pharmasources.com/industryinsights/gsk-gets-positive-opinion-for-nucala-sel-312172.html 0.6 2026-08-05T14:52:29+08:00 daily https://www.pharmasources.com/industryinsights/vaccitech-universal-flu-vaccine-passes-p-312173.html 0.6 2026-06-21T01:36:24+08:00 daily https://www.pharmasources.com/industryinsights/lannett-initiates-human-clinical-trial-o-312174.html 0.6 2026-07-22T14:59:02+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-treatment-for-episodi-312175.html 0.6 2026-06-21T09:04:10+08:00 daily https://www.pharmasources.com/industryinsights/cellenkos-initiates-ck0801-trial-for-bon-312176.html 0.6 2026-07-03T15:46:53+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-nda-for-triple-combination-t-312177.html 0.6 2026-07-27T15:30:11+08:00 daily https://www.pharmasources.com/industryinsights/windtree-eleison-announce-study-results--312178.html 0.6 2026-07-06T20:19:33+08:00 daily https://www.pharmasources.com/industryinsights/proteostasis-therapeutics-receives-orpha-312179.html 0.6 2026-08-13T19:24:18+08:00 daily https://www.pharmasources.com/industryinsights/biosight-receives-orphan-drug-designatio-312180.html 0.6 2026-08-12T11:00:33+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-treatment-for-hospital-acqu-312181.html 0.6 2026-06-20T22:53:40+08:00 daily https://www.pharmasources.com/industryinsights/starpharma-signs-second-oncology-agreeme-312182.html 0.6 2026-06-21T10:19:23+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-laboratories-announces-re-laun-312183.html 0.6 2026-06-21T22:52:50+08:00 daily https://www.pharmasources.com/industryinsights/fda-announces-project-for-doctors-to-acc-312184.html 0.6 2026-06-21T08:59:05+08:00 daily https://www.pharmasources.com/industryinsights/prescription-drug-costs-steadily-soar-ye-312185.html 0.6 2026-08-02T16:34:00+08:00 daily https://www.pharmasources.com/industryinsights/cholesterol-in-eggs-tied-to-cardiac-dise-312186.html 0.6 2026-08-02T17:36:23+08:00 daily https://www.pharmasources.com/industryinsights/fda-announces-project-facilitate-to-assi-312187.html 0.6 2026-06-22T06:05:45+08:00 daily https://www.pharmasources.com/industryinsights/novartis-kisqali-significantly-extends-l-312188.html 0.6 2026-06-21T02:55:42+08:00 daily https://www.pharmasources.com/industryinsights/usfda-concludes-inspection-of-indocos-st-312189.html 0.6 2026-06-21T07:08:02+08:00 daily https://www.pharmasources.com/industryinsights/aurobindo-pharma-gets-10-observations-fr-312190.html 0.6 2026-06-21T09:58:42+08:00 daily https://www.pharmasources.com/industryinsights/first-treatment-for-cluster-headaches-ap-312191.html 0.6 2026-06-21T05:05:50+08:00 daily https://www.pharmasources.com/industryinsights/new-initiative-launched-to-boost-norther-312192.html 0.6 2026-06-22T03:49:56+08:00 daily https://www.pharmasources.com/industryinsights/ten-big-pharma-companies-collaborate-on--312193.html 0.6 2026-06-21T08:05:59+08:00 daily https://www.pharmasources.com/industryinsights/global-contraceptive-pill-market-to-grow-312194.html 0.6 2025-12-09T14:13:30+08:00 daily https://www.pharmasources.com/industryinsights/influenza-a-vaccine-enters-phase-iib-tri-312195.html 0.6 2026-06-20T21:06:51+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-intermediates-market-to-s-312196.html 0.6 2026-06-20T16:03:14+08:00 daily https://www.pharmasources.com/industryinsights/nucala-mepolizumab-gains-fda-approval-fo-312197.html 0.6 2026-06-21T02:01:37+08:00 daily https://www.pharmasources.com/industryinsights/jeff-settleman-phd-joins-pfizer-to-lead--312198.html 0.6 2026-06-23T04:23:36+08:00 daily https://www.pharmasources.com/industryinsights/cleveland-researchers-test-novel-gene-th-312199.html 0.6 2026-06-23T10:13:55+08:00 daily https://www.pharmasources.com/industryinsights/long-term-survival-benefit-shown-for-met-312200.html 0.6 2026-06-25T04:56:40+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-announces-post-clos-312201.html 0.6 2026-06-20T17:15:30+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-names-new-ceo-312202.html 0.6 2026-06-22T00:53:54+08:00 daily https://www.pharmasources.com/industryinsights/phoenix-molecular-wuxi-sta-reach-drug-su-312203.html 0.6 2026-08-13T08:57:05+08:00 daily https://www.pharmasources.com/industryinsights/ogt-opens-new-cambridge-rd-site-312204.html 0.6 2026-06-28T21:06:04+08:00 daily https://www.pharmasources.com/industryinsights/biogen-completes-800m-nightstar-acquisit-312205.html 0.6 2026-06-21T01:58:40+08:00 daily https://www.pharmasources.com/industryinsights/symbiosis-boosts-business-development-te-312206.html 0.6 2026-06-21T13:03:30+08:00 daily https://www.pharmasources.com/industryinsights/contract-pharmacal-corp-acquires-florida-312207.html 0.6 2026-06-21T01:01:44+08:00 daily https://www.pharmasources.com/industryinsights/apceth-bluebird-bio-enter-mfg-tie-up-312208.html 0.6 2026-06-21T09:04:21+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-to-invest-10m-in-continuous-pro-312209.html 0.6 2026-06-21T05:59:46+08:00 daily https://www.pharmasources.com/industryinsights/evotec-celgene-expand-strategic-alliance-312210.html 0.6 2026-07-08T06:27:33+08:00 daily https://www.pharmasources.com/industryinsights/servier-selects-yposkesi-for-car-t-gmp-m-312211.html 0.6 2026-07-06T12:16:42+08:00 daily https://www.pharmasources.com/industryinsights/frontage-holdings-completes-ipo-312212.html 0.6 2026-06-20T21:07:43+08:00 daily https://www.pharmasources.com/industryinsights/sugary-sodas-still-popular-but-warnings--312213.html 0.6 2026-08-10T11:03:10+08:00 daily https://www.pharmasources.com/industryinsights/what-and-how-you-eat-affects-your-odds-f-312214.html 0.6 2026-08-07T00:02:30+08:00 daily https://www.pharmasources.com/industryinsights/antibiotic-prophylaxis-before-dental-wor-312215.html 0.6 2026-08-06T23:57:06+08:00 daily https://www.pharmasources.com/industryinsights/ada-vitamin-d-supplementation-does-not-l-312216.html 0.6 2025-11-28T11:04:13+08:00 daily https://www.pharmasources.com/industryinsights/naloxone-available-in-one-in-three-phila-312217.html 0.6 2026-08-06T23:48:47+08:00 daily https://www.pharmasources.com/industryinsights/irritable-bowel-symptoms-tied-to-intesti-312218.html 0.6 2026-08-07T13:19:14+08:00 daily https://www.pharmasources.com/industryinsights/how-your-marital-status-affects-your-odd-312219.html 0.6 2026-08-08T05:09:01+08:00 daily https://www.pharmasources.com/industryinsights/pharm-d-solutions-llc-issues-voluntary-n-312220.html 0.6 2026-08-09T06:59:39+08:00 daily https://www.pharmasources.com/industryinsights/calliditas-therapeutics-signs-agreement--312221.html 0.6 2026-06-24T11:16:59+08:00 daily https://www.pharmasources.com/industryinsights/dulaglutide-reduces-cardiovascular-disea-312222.html 0.6 2026-07-01T22:32:54+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-scientific-acquires-highch-312223.html 0.6 2026-07-17T01:24:50+08:00 daily https://www.pharmasources.com/industryinsights/thermo-scientific-launches-rheometer-ser-312224.html 0.6 2026-06-21T04:56:43+08:00 daily https://www.pharmasources.com/industryinsights/labcorp-qiagen-announce-companion-diagno-312225.html 0.6 2026-04-13T05:19:13+08:00 daily https://www.pharmasources.com/industryinsights/ptc-gets-fda-nod-for-the-expansion-of-th-312226.html 0.6 2026-07-08T20:32:09+08:00 daily https://www.pharmasources.com/industryinsights/otsuka-chemical-acquires-cefixime-busine-312227.html 0.6 2026-06-21T21:15:03+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-announces-positive-topline-res-312228.html 0.6 2026-06-21T09:00:59+08:00 daily https://www.pharmasources.com/industryinsights/cstone-and-bayer-to-evaluate-pd-l1-monoc-312229.html 0.6 2026-06-27T07:54:31+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-genentechs-polivy-polatuzumab-312230.html 0.6 2026-07-02T12:01:48+08:00 daily https://www.pharmasources.com/industryinsights/data-insufficient-for-safety-of-lithium--312231.html 0.6 2026-07-14T03:08:55+08:00 daily https://www.pharmasources.com/industryinsights/high-blood-pressure-at-doctors-office-ma-312232.html 0.6 2026-08-08T23:52:12+08:00 daily https://www.pharmasources.com/industryinsights/chemoimmunotherapy-regimen-approved-to-t-312233.html 0.6 2026-06-20T15:12:17+08:00 daily https://www.pharmasources.com/industryinsights/marketing-okd-for-device-to-help-reduce--312234.html 0.6 2026-07-04T06:45:32+08:00 daily https://www.pharmasources.com/industryinsights/targeting-barriers-to-self-care-benefits-312235.html 0.6 2026-06-20T15:10:24+08:00 daily https://www.pharmasources.com/industryinsights/untreated-white-coat-htn-may-increase-ca-312236.html 0.6 2026-06-21T07:02:57+08:00 daily https://www.pharmasources.com/industryinsights/legalizing-medical-pot-wont-ease-opioid--312237.html 0.6 2026-06-21T11:01:15+08:00 daily https://www.pharmasources.com/industryinsights/few-days-of-formula-feeding-after-delive-312238.html 0.6 2026-07-08T03:18:06+08:00 daily https://www.pharmasources.com/industryinsights/ptc-therapeutics-receives-fda-approval-f-312239.html 0.6 2026-06-22T04:54:51+08:00 daily https://www.pharmasources.com/industryinsights/exeltis-usa-inc-announces-the-approval-o-312240.html 0.6 2026-08-14T11:10:26+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-and-ema-accept-applications-for-o-312241.html 0.6 2026-08-07T20:40:29+08:00 daily https://www.pharmasources.com/industryinsights/celgene-corporation-and-acceleron-pharma-312242.html 0.6 2026-07-26T04:12:03+08:00 daily https://www.pharmasources.com/industryinsights/investigational-drug-teplizumab-may-help-312243.html 0.6 2026-06-21T09:06:20+08:00 daily https://www.pharmasources.com/industryinsights/bedroom-light-at-night-might-boost-women-312244.html 0.6 2026-06-22T10:06:51+08:00 daily https://www.pharmasources.com/industryinsights/whooping-cough-vaccine-effectiveness-fad-312245.html 0.6 2026-06-21T12:07:17+08:00 daily https://www.pharmasources.com/industryinsights/chickenpox-vaccine-shields-kids-from-shi-312246.html 0.6 2026-07-10T16:33:27+08:00 daily https://www.pharmasources.com/industryinsights/vitamin-d-supplements-dont-prevent-type--312247.html 0.6 2026-08-03T05:50:30+08:00 daily https://www.pharmasources.com/industryinsights/hyperglycemia-in-pregnancy-may-up-risk-f-312248.html 0.6 2026-08-07T02:06:02+08:00 daily https://www.pharmasources.com/industryinsights/irregular-sleep-patterns-may-increase-ri-312249.html 0.6 2026-06-29T00:33:11+08:00 daily https://www.pharmasources.com/industryinsights/fewer-new-t2dm-cases-seen-in-adults-on-p-312250.html 0.6 2026-04-11T12:38:07+08:00 daily https://www.pharmasources.com/industryinsights/rapid-fluid-removal-may-up-mortality-in--312251.html 0.6 2026-06-21T02:57:47+08:00 daily https://www.pharmasources.com/industryinsights/access-to-health-care-has-little-impact--312252.html 0.6 2026-06-21T05:11:53+08:00 daily https://www.pharmasources.com/industryinsights/cough-sound-analyzer-helps-differentiate-312253.html 0.6 2026-06-22T11:55:56+08:00 daily https://www.pharmasources.com/industryinsights/2003-to-2014-saw-incidence-of-herpes-zos-312254.html 0.6 2026-06-21T01:41:38+08:00 daily https://www.pharmasources.com/industryinsights/mouth-rinse-for-hpv-dna-may-be-biomarker-312255.html 0.6 2026-06-21T19:09:41+08:00 daily https://www.pharmasources.com/industryinsights/location-of-body-fat-linked-to-advanced--312256.html 0.6 2026-04-05T11:16:12+08:00 daily https://www.pharmasources.com/industryinsights/rabies-vaccines-shortage-puts-delhi-on-b-312257.html 0.6 2026-06-22T00:56:47+08:00 daily https://www.pharmasources.com/industryinsights/amyloidosis-treatment-discontinued-from--312258.html 0.6 2026-06-21T11:05:21+08:00 daily https://www.pharmasources.com/industryinsights/three-more-us-states-announce-lawsuits-a-312259.html 0.6 2026-06-11T21:48:26+08:00 daily https://www.pharmasources.com/industryinsights/taurx-gets-recognition-as-a-technology-i-312260.html 0.6 2026-08-13T09:21:29+08:00 daily https://www.pharmasources.com/industryinsights/calliditas-therapeutics-to-commercialize-312261.html 0.6 2026-06-23T04:20:58+08:00 daily https://www.pharmasources.com/industryinsights/labcorp-qiagen-announce-companion-diagno-312262.html 0.6 2026-06-20T19:11:27+08:00 daily https://www.pharmasources.com/industryinsights/hamamatsu-photonics-develops-novel-3d-fl-312263.html 0.6 2026-06-21T10:05:13+08:00 daily https://www.pharmasources.com/industryinsights/fedex-express-launches-industry-leading--312264.html 0.6 2026-06-27T10:41:50+08:00 daily https://www.pharmasources.com/industryinsights/proteona-launches-novel-assay-for-cart-c-312265.html 0.6 2026-06-21T01:10:57+08:00 daily https://www.pharmasources.com/industryinsights/imfinzi-opdivo-among-latest-smc-decision-312266.html 0.6 2026-06-20T23:59:36+08:00 daily https://www.pharmasources.com/industryinsights/proventions-prv-031-found-to-delay-type--312267.html 0.6 2026-06-21T07:11:07+08:00 daily https://www.pharmasources.com/industryinsights/mayo-clinic-oxford-uni-announce-team-of--312268.html 0.6 2026-08-09T21:30:22+08:00 daily https://www.pharmasources.com/industryinsights/az-new-headquarters-double-in-price-312269.html 0.6 2026-08-07T18:45:17+08:00 daily https://www.pharmasources.com/industryinsights/jj-announce-first-of-its-kind-portopulmo-312270.html 0.6 2026-08-09T19:36:23+08:00 daily https://www.pharmasources.com/industryinsights/roche-launches-first-in-vitro-lung-cance-312271.html 0.6 2026-06-20T19:03:45+08:00 daily https://www.pharmasources.com/industryinsights/positive-results-for-novos-xultophy-312272.html 0.6 2026-06-20T23:12:54+08:00 daily https://www.pharmasources.com/industryinsights/sosei-heptares-to-get-3m-pfizer-mileston-312273.html 0.6 2026-06-22T09:53:12+08:00 daily https://www.pharmasources.com/industryinsights/novartis-iscalimab-results-hint-at-exten-312274.html 0.6 2026-06-20T17:16:33+08:00 daily https://www.pharmasources.com/industryinsights/just-44-of-uk-health-sector-would-trust--312275.html 0.6 2026-06-21T11:58:15+08:00 daily https://www.pharmasources.com/industryinsights/biogen-completes-nightstar-acquisition-312276.html 0.6 2026-08-09T07:56:37+08:00 daily https://www.pharmasources.com/industryinsights/fda-oks-new-administration-options-for-g-312277.html 0.6 2026-08-08T18:23:30+08:00 daily https://www.pharmasources.com/industryinsights/merck-rigaku-to-form-molecular-structure-312278.html 0.6 2026-08-08T00:49:25+08:00 daily https://www.pharmasources.com/industryinsights/coeliac-uk-innovate-uk-announce-180k-res-312279.html 0.6 2026-08-09T14:00:40+08:00 daily https://www.pharmasources.com/industryinsights/az-calquence-hits-endpoints-in-late-stag-312280.html 0.6 2026-06-21T00:00:35+08:00 daily https://www.pharmasources.com/industryinsights/rcgp-responds-to-new-nice-quality-standa-312281.html 0.6 2026-06-22T10:18:59+08:00 daily https://www.pharmasources.com/industryinsights/takeda-ditches-late-stage-ninlaro-trial-312282.html 0.6 2026-06-21T15:51:42+08:00 daily https://www.pharmasources.com/industryinsights/new-nhs-innovations-to-benefit-750000-312283.html 0.6 2026-06-21T12:04:17+08:00 daily https://www.pharmasources.com/industryinsights/sales-awards-finalists-give-their-though-312284.html 0.6 2026-06-22T09:55:48+08:00 daily https://www.pharmasources.com/industryinsights/death-risk-from-sepsis-lasts-up-to-five--312285.html 0.6 2026-06-20T14:56:08+08:00 daily https://www.pharmasources.com/industryinsights/cytodyn-evaluates-leronlimab-for-triple--312286.html 0.6 2026-06-20T16:13:53+08:00 daily https://www.pharmasources.com/industryinsights/mg-america-appoints-processing-division--312287.html 0.6 2026-06-20T17:15:51+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-roches-venclexta-for-cll-312288.html 0.6 2026-06-21T00:49:50+08:00 daily https://www.pharmasources.com/industryinsights/trividia-manufacturing-solutions-expands-312289.html 0.6 2026-06-10T00:32:29+08:00 daily https://www.pharmasources.com/industryinsights/uhlmann-appoints-southwestern-sales-lead-312290.html 0.6 2026-06-21T06:02:49+08:00 daily https://www.pharmasources.com/industryinsights/evotec-receives-238m-tb-grant-312291.html 0.6 2026-04-05T13:03:50+08:00 daily https://www.pharmasources.com/industryinsights/lonza-launches-engine-equipment-portfoli-312292.html 0.6 2026-06-21T05:32:13+08:00 daily https://www.pharmasources.com/industryinsights/agc-biologics-appoints-new-chief-technic-312293.html 0.6 2026-06-27T00:46:23+08:00 daily https://www.pharmasources.com/industryinsights/fda-inspection-of-asymchem-dunhua-1-api--312294.html 0.6 2026-08-06T19:44:19+08:00 daily https://www.pharmasources.com/industryinsights/enable-injections-enters-into-partnershi-312295.html 0.6 2026-07-26T10:31:51+08:00 daily https://www.pharmasources.com/industryinsights/abzena-bolsters-development-timeline-cap-312296.html 0.6 2026-08-14T02:01:47+08:00 daily https://www.pharmasources.com/industryinsights/adial-tedor-enter-manufacturing-collabor-312297.html 0.6 2026-08-11T02:36:23+08:00 daily https://www.pharmasources.com/industryinsights/saga-raises-40-million-sek-37-million-to-312298.html 0.6 2026-06-22T08:46:36+08:00 daily https://www.pharmasources.com/industryinsights/vitamin-k-can-up-anticoagulation-stabili-312299.html 0.6 2026-06-20T22:52:38+08:00 daily https://www.pharmasources.com/industryinsights/prescription-opioid-use-up-among-binge-d-312300.html 0.6 2026-04-12T00:17:55+08:00 daily https://www.pharmasources.com/industryinsights/uspstf-issues-recommendations-on-hiv-scr-312301.html 0.6 2026-06-20T15:52:30+08:00 daily https://www.pharmasources.com/industryinsights/ada-dulaglutide-tied-to-decline-in-cardi-312302.html 0.6 2026-06-20T20:56:50+08:00 daily https://www.pharmasources.com/industryinsights/mortality-no-different-with-tavr-for-bic-312303.html 0.6 2026-06-22T13:51:54+08:00 daily https://www.pharmasources.com/industryinsights/marketing-okd-for-device-to-help-reduce--312304.html 0.6 2025-12-13T13:21:55+08:00 daily https://www.pharmasources.com/industryinsights/polivy-chemoimmunotherapy-regimen-approv-312305.html 0.6 2026-06-22T03:52:54+08:00 daily https://www.pharmasources.com/industryinsights/can-playing-a-sport-foster-better-adjust-312306.html 0.6 2026-06-22T23:53:52+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-keytruda-pembrolizumab-for--312307.html 0.6 2026-08-13T14:21:51+08:00 daily https://www.pharmasources.com/industryinsights/teva-pharmaceuticals-usa-inc-expands-vol-312308.html 0.6 2026-06-21T05:05:50+08:00 daily https://www.pharmasources.com/industryinsights/cancer-survivors-predicted-to-top-22-mil-312309.html 0.6 2026-08-11T21:50:31+08:00 daily https://www.pharmasources.com/industryinsights/study-refutes-notion-that-people-on-warf-312310.html 0.6 2026-06-20T18:57:05+08:00 daily https://www.pharmasources.com/industryinsights/blood-from-previously-pregnant-women-is--312311.html 0.6 2026-08-10T00:20:54+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-how-to-have-a-heart-healthy-pre-312312.html 0.6 2026-08-07T02:26:39+08:00 daily https://www.pharmasources.com/industryinsights/gene-test-might-someday-gauge-your-heart-312313.html 0.6 2026-06-12T18:03:24+08:00 daily https://www.pharmasources.com/industryinsights/why-humans-respond-to-music-and-monkeys--312314.html 0.6 2026-06-23T08:14:11+08:00 daily https://www.pharmasources.com/industryinsights/communications-team-of-the-year-chair-ex-312315.html 0.6 2026-06-20T15:11:17+08:00 daily https://www.pharmasources.com/industryinsights/eli-lillys-taltz-touts-long-term-clear-s-312316.html 0.6 2026-08-11T02:41:50+08:00 daily https://www.pharmasources.com/industryinsights/ada-lilly-boehringers-dpp-4-drug-tradjen-312317.html 0.6 2026-06-22T00:50:46+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-pads-humira-follow-up-skyrizis-bl-312318.html 0.6 2026-06-20T14:45:04+08:00 daily https://www.pharmasources.com/industryinsights/professional-training-a-worthwhile-inves-312319.html 0.6 2026-08-05T18:54:06+08:00 daily https://www.pharmasources.com/industryinsights/how-to-correct-opioid-misinformation-spe-312320.html 0.6 2026-06-20T22:57:44+08:00 daily https://www.pharmasources.com/industryinsights/amgen-connects-chicago-artists-social-me-312321.html 0.6 2026-08-07T16:54:01+08:00 daily https://www.pharmasources.com/industryinsights/cornings-disruptive-continuous-flow-reac-312322.html 0.6 2026-08-09T21:58:15+08:00 daily https://www.pharmasources.com/industryinsights/abbott-launches-digital-health-service-p-312323.html 0.6 2026-07-07T01:16:58+08:00 daily https://www.pharmasources.com/industryinsights/the-healthcare-of-tomorrow-boehringer-in-312324.html 0.6 2026-06-22T13:05:06+08:00 daily https://www.pharmasources.com/industryinsights/new-thinking-on-longstanding-asthma-trea-312325.html 0.6 2026-06-21T08:59:59+08:00 daily https://www.pharmasources.com/industryinsights/pediatric-car-t-cell-immunotherapy-trial-312326.html 0.6 2026-06-20T15:51:28+08:00 daily https://www.pharmasources.com/industryinsights/aimmune-therapeutics-discusses-ar101s-co-312327.html 0.6 2026-06-21T05:00:41+08:00 daily https://www.pharmasources.com/industryinsights/novel-agent-reactivates-an-immune-call-b-312328.html 0.6 2026-06-20T15:54:26+08:00 daily https://www.pharmasources.com/industryinsights/phrma-statement-on-florida-importation-p-312329.html 0.6 2026-03-25T16:26:23+08:00 daily https://www.pharmasources.com/industryinsights/expert-witness-johnson-johnsons-role-in--312330.html 0.6 2026-06-21T10:04:08+08:00 daily https://www.pharmasources.com/industryinsights/regulus-announces-new-additions-to-board-312331.html 0.6 2026-06-21T06:10:54+08:00 daily https://www.pharmasources.com/industryinsights/deep-learning-algorithm-predicts-sleep-q-312332.html 0.6 2026-08-07T15:40:58+08:00 daily https://www.pharmasources.com/industryinsights/nebula-genomics-signs-agreement-for-pilo-312333.html 0.6 2026-06-21T22:52:45+08:00 daily https://www.pharmasources.com/industryinsights/pqe-launches-the-new-digital-governance--312334.html 0.6 2026-06-26T01:41:33+08:00 daily https://www.pharmasources.com/industryinsights/air-cargo-carrier-unveils-purpose-built--312335.html 0.6 2026-06-21T00:57:51+08:00 daily https://www.pharmasources.com/industryinsights/cdc-wildlife-rabies-especially-in-bats-p-312336.html 0.6 2026-07-04T11:30:25+08:00 daily https://www.pharmasources.com/industryinsights/study-confirms-teratogenicity-of-valproi-312337.html 0.6 2026-06-21T10:38:47+08:00 daily https://www.pharmasources.com/industryinsights/chemoradiation-does-not-up-survival-in-e-312338.html 0.6 2026-06-22T12:43:02+08:00 daily https://www.pharmasources.com/industryinsights/next-gen-sequencing-of-csf-improves-diag-312339.html 0.6 2026-02-20T06:42:12+08:00 daily https://www.pharmasources.com/industryinsights/most-providers-unaware-of-online-feedbac-312340.html 0.6 2026-06-21T04:13:55+08:00 daily https://www.pharmasources.com/industryinsights/scared-safe-pics-of-suns-damage-to-face--312341.html 0.6 2026-08-07T13:19:30+08:00 daily https://www.pharmasources.com/industryinsights/no-needle-prick-laser-based-test-hunts-s-312342.html 0.6 2026-08-07T00:42:59+08:00 daily https://www.pharmasources.com/industryinsights/strobes-at-concerts-may-cause-epileptic--312343.html 0.6 2026-08-07T00:40:13+08:00 daily https://www.pharmasources.com/industryinsights/tg-therapeutics-confirms-registration-pa-312344.html 0.6 2026-08-07T00:59:21+08:00 daily https://www.pharmasources.com/industryinsights/epizyme-submits-new-drug-application-to--312345.html 0.6 2026-08-07T05:37:00+08:00 daily https://www.pharmasources.com/industryinsights/lillys-tirzepatide-demonstrates-benefits-312346.html 0.6 2026-08-07T05:39:43+08:00 daily https://www.pharmasources.com/industryinsights/novartis-presents-first-of-its-kind-hist-312347.html 0.6 2026-06-21T05:09:48+08:00 daily https://www.pharmasources.com/industryinsights/motif-bio-announces-path-forward-for-icl-312348.html 0.6 2026-08-07T01:19:16+08:00 daily https://www.pharmasources.com/industryinsights/astex-pharmaceuticals-and-otsuka-announc-312349.html 0.6 2026-08-07T00:40:52+08:00 daily https://www.pharmasources.com/industryinsights/nearly-1-in-4-home-care-aides-faces-verb-312350.html 0.6 2026-08-07T00:02:40+08:00 daily https://www.pharmasources.com/industryinsights/your-drinking-water-may-harbor-cancer-ca-312351.html 0.6 2026-08-06T23:55:32+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-when-dancer-kept-fainting-an-ek-312352.html 0.6 2026-08-06T23:47:44+08:00 daily https://www.pharmasources.com/industryinsights/1-in-5-people-living-in-conflict-areas-h-312353.html 0.6 2026-08-11T01:51:49+08:00 daily https://www.pharmasources.com/industryinsights/obesity-could-worsen-ms-disability-312354.html 0.6 2026-08-07T00:04:14+08:00 daily https://www.pharmasources.com/industryinsights/surprising-ways-owning-a-dog-is-good-for-312355.html 0.6 2026-08-07T05:06:13+08:00 daily https://www.pharmasources.com/industryinsights/which-foods-are-the-best-sources-of-diet-312356.html 0.6 2026-06-20T14:58:19+08:00 daily https://www.pharmasources.com/industryinsights/health-tip-drinking-and-boating-dont-mix-312357.html 0.6 2026-07-09T04:55:54+08:00 daily https://www.pharmasources.com/industryinsights/weight-loss-surgery-may-not-relieve-acid-312358.html 0.6 2026-06-20T16:01:14+08:00 daily https://www.pharmasources.com/industryinsights/hot-water-therapy-aids-patients-with-per-312359.html 0.6 2026-06-20T14:50:14+08:00 daily https://www.pharmasources.com/industryinsights/virtual-reality-ids-navigation-issues-in-312360.html 0.6 2026-07-04T11:48:42+08:00 daily https://www.pharmasources.com/industryinsights/microbes-tied-to-pedicle-screw-loosening-312361.html 0.6 2026-06-21T03:01:44+08:00 daily https://www.pharmasources.com/industryinsights/pde5i-use-linked-to-post-lvad-right-hear-312362.html 0.6 2026-06-21T03:56:42+08:00 daily https://www.pharmasources.com/industryinsights/exposure-to-air-pollution-may-impact-chi-312363.html 0.6 2026-08-06T01:32:16+08:00 daily https://www.pharmasources.com/industryinsights/bolder-biotechnology-announces-fda-orpha-312364.html 0.6 2026-06-20T23:09:52+08:00 daily https://www.pharmasources.com/industryinsights/tolero-announces-first-patient-dosed-wit-312365.html 0.6 2026-08-08T23:35:58+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-priority-review-to-rituxan-in-312366.html 0.6 2026-08-07T13:42:54+08:00 daily https://www.pharmasources.com/industryinsights/cutispharma-announces-acquisition-of-sil-312367.html 0.6 2026-08-08T20:34:20+08:00 daily https://www.pharmasources.com/industryinsights/catalyst-pharmaceuticals-files-federal-l-312368.html 0.6 2026-06-22T01:08:52+08:00 daily https://www.pharmasources.com/industryinsights/achieve-life-sciences-announces-positive-312369.html 0.6 2026-06-21T04:17:02+08:00 daily https://www.pharmasources.com/industryinsights/lcrf-awards-300000-in-research-grants-312370.html 0.6 2026-08-07T02:25:11+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-scientific-launches-new-ge-312371.html 0.6 2026-08-09T00:10:58+08:00 daily https://www.pharmasources.com/industryinsights/hoth-therapeutics-to-begin-production-of-312372.html 0.6 2026-06-21T08:07:06+08:00 daily https://www.pharmasources.com/industryinsights/metvital-announces-fda-clearance-aeo-tes-312373.html 0.6 2026-08-09T18:08:04+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-pembrolizumab-for-first-lin-312374.html 0.6 2026-07-31T17:28:26+08:00 daily https://www.pharmasources.com/industryinsights/sesen-bio-announces-successful-pre-bla-m-312375.html 0.6 2026-06-22T11:07:28+08:00 daily https://www.pharmasources.com/industryinsights/study-shows-dapagliflozin-reduces-kidney-312376.html 0.6 2026-06-27T00:21:59+08:00 daily https://www.pharmasources.com/industryinsights/deciphera-licenses-cancer-drug-ripretini-312377.html 0.6 2026-08-05T14:52:25+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-expands-protac-drugs-partners-312378.html 0.6 2026-06-21T16:47:28+08:00 daily https://www.pharmasources.com/industryinsights/exscientia-and-gt-apeiron-form-ai-drug-d-312379.html 0.6 2026-07-28T15:06:44+08:00 daily https://www.pharmasources.com/industryinsights/bms-opdivo-plus-yervoy-for-rcc-to-be-ava-312380.html 0.6 2026-06-21T21:50:33+08:00 daily https://www.pharmasources.com/industryinsights/merck-to-acquire-tilos-therapeutics-for--312381.html 0.6 2026-08-13T23:55:09+08:00 daily https://www.pharmasources.com/industryinsights/regulators-demand-more-details-on-roches-312382.html 0.6 2026-06-21T12:08:19+08:00 daily https://www.pharmasources.com/industryinsights/genentech-receives-fda-approval-for-poli-312383.html 0.6 2026-06-20T20:00:37+08:00 daily https://www.pharmasources.com/industryinsights/new-vaping-to-quit-smoking-website-launc-312384.html 0.6 2026-06-21T09:05:10+08:00 daily https://www.pharmasources.com/industryinsights/schott-ag-to-acquire-australian-microflu-312385.html 0.6 2026-06-21T11:02:10+08:00 daily https://www.pharmasources.com/industryinsights/proteona-launches-novel-assay-for-cart-c-312386.html 0.6 2026-06-21T05:15:01+08:00 daily https://www.pharmasources.com/industryinsights/biomx-licenses-novel-targets-for-phage-t-312387.html 0.6 2026-08-10T15:13:20+08:00 daily https://www.pharmasources.com/industryinsights/merck-buys-tilos-therapeutics-in-a-773m--312388.html 0.6 2026-06-20T14:58:07+08:00 daily https://www.pharmasources.com/industryinsights/fedex-express-launches-industry-leading--312389.html 0.6 2026-08-06T23:54:52+08:00 daily https://www.pharmasources.com/industryinsights/acucela-gets-ema-approval-for-emixustat--312390.html 0.6 2026-08-06T23:47:22+08:00 daily https://www.pharmasources.com/industryinsights/strive-for-success-in-the-2019-medical-s-312391.html 0.6 2026-08-06T23:36:33+08:00 daily https://www.pharmasources.com/industryinsights/icu-care-for-stemi-associated-with-impro-312392.html 0.6 2026-08-06T23:33:05+08:00 daily https://www.pharmasources.com/industryinsights/cdc-prevalence-of-meeting-exercise-guide-312393.html 0.6 2026-08-06T20:07:11+08:00 daily https://www.pharmasources.com/industryinsights/cdc-opens-emergency-operations-center-fo-312394.html 0.6 2026-08-07T13:14:57+08:00 daily https://www.pharmasources.com/industryinsights/drug-alcohol-and-suicide-deaths-up-among-312395.html 0.6 2026-08-07T13:56:10+08:00 daily https://www.pharmasources.com/industryinsights/depression-symptoms-greater-in-mothers-w-312396.html 0.6 2026-06-21T07:23:28+08:00 daily https://www.pharmasources.com/industryinsights/50-years-after-ban-canadian-lakes-still--312397.html 0.6 2026-06-21T19:00:40+08:00 daily https://www.pharmasources.com/industryinsights/type-1-diabetes-might-affect-young-kids--312398.html 0.6 2026-06-21T11:57:14+08:00 daily https://www.pharmasources.com/industryinsights/2-hoursweek-in-nature-your-prescription--312399.html 0.6 2026-08-02T23:01:43+08:00 daily https://www.pharmasources.com/industryinsights/xeris-pharmaceuticals-receives-notificat-312400.html 0.6 2026-06-22T22:57:56+08:00 daily https://www.pharmasources.com/industryinsights/exercise-rates-rising-for-urban-rural-am-312401.html 0.6 2026-06-06T02:36:25+08:00 daily https://www.pharmasources.com/industryinsights/epilepsy-drug-pregabalin-lyrica-tied-to--312402.html 0.6 2026-07-20T01:09:47+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-study-provides-rare-look-at-str-312403.html 0.6 2026-06-21T00:03:40+08:00 daily https://www.pharmasources.com/industryinsights/male-victims-of-domestic-violence-often--312404.html 0.6 2026-06-20T20:11:44+08:00 daily https://www.pharmasources.com/industryinsights/drug-ods-suicides-soaring-among-millenni-312405.html 0.6 2026-06-21T09:06:06+08:00 daily https://www.pharmasources.com/industryinsights/double-edged-sword-lung-cancer-radiation-312406.html 0.6 2026-06-21T08:51:28+08:00 daily https://www.pharmasources.com/industryinsights/workouts-a-prescription-to-ease-severe-c-312407.html 0.6 2026-06-21T14:41:24+08:00 daily https://www.pharmasources.com/industryinsights/eating-more-red-meat-may-shorten-your-li-312408.html 0.6 2026-06-20T21:56:37+08:00 daily https://www.pharmasources.com/industryinsights/gabapentinoids-linked-to-increased-risk--312409.html 0.6 2026-06-21T00:06:39+08:00 daily https://www.pharmasources.com/industryinsights/vitamin-d-estradiol-deficiency-have-syne-312410.html 0.6 2025-12-13T12:11:48+08:00 daily https://www.pharmasources.com/industryinsights/hpv16-antibodies-can-develop-long-before-312411.html 0.6 2026-06-21T06:02:52+08:00 daily https://www.pharmasources.com/industryinsights/hiv-risk-does-not-differ-with-three-cont-312412.html 0.6 2026-06-21T03:53:48+08:00 daily https://www.pharmasources.com/industryinsights/figo-2018-staging-ups-discrimination-of--312413.html 0.6 2026-06-21T08:04:02+08:00 daily https://www.pharmasources.com/industryinsights/ada-teplizumab-can-delay-t1dm-progressio-312414.html 0.6 2026-06-20T21:43:23+08:00 daily https://www.pharmasources.com/industryinsights/long-term-opioid-prescribing-up-among-ol-312415.html 0.6 2026-06-22T05:56:05+08:00 daily https://www.pharmasources.com/industryinsights/fda-dermatology-advisors-found-to-accept-312416.html 0.6 2026-07-27T14:53:41+08:00 daily https://www.pharmasources.com/industryinsights/more-countries-added-to-the-eu-us-mutual-312417.html 0.6 2026-08-07T16:52:27+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-roches-kadcyla-for-her2-pos-312418.html 0.6 2026-03-20T17:31:18+08:00 daily https://www.pharmasources.com/industryinsights/aclaris-therapeutics-submits-ind-for-ra--312419.html 0.6 2026-06-21T18:14:38+08:00 daily https://www.pharmasources.com/industryinsights/avexis-zolgensma-aproved-for-pediatric-p-312420.html 0.6 2026-08-12T10:58:56+08:00 daily https://www.pharmasources.com/industryinsights/new-leader-of-pharmaceuticals-bu-for-nov-312421.html 0.6 2026-07-02T11:28:17+08:00 daily https://www.pharmasources.com/industryinsights/cordyceps-militaris-and-cordycepin-extra-312422.html 0.6 2026-08-05T15:50:26+08:00 daily https://www.pharmasources.com/industryinsights/ibm-kpmg-merck-walmart-collaborate-to-ev-312423.html 0.6 2026-08-10T06:10:53+08:00 daily https://www.pharmasources.com/industryinsights/effrx-signs-agreement-with-pharmaxis-for-312424.html 0.6 2026-06-20T17:41:25+08:00 daily https://www.pharmasources.com/industryinsights/terns-pharmaceuticals-initiates-phase-1--312425.html 0.6 2026-06-23T00:37:30+08:00 daily https://www.pharmasources.com/industryinsights/ionis-announces-board-of-directors-appoi-312426.html 0.6 2026-06-22T11:42:28+08:00 daily https://www.pharmasources.com/industryinsights/resolve-announces-rslv-132-sjgrens-syndr-312427.html 0.6 2026-08-07T19:15:28+08:00 daily https://www.pharmasources.com/industryinsights/impala-phase-3-study-of-molgradex-does-n-312428.html 0.6 2026-07-12T12:02:30+08:00 daily https://www.pharmasources.com/industryinsights/dassault-to-enhance-clinical-tech-with-5-312429.html 0.6 2026-08-05T12:55:33+08:00 daily https://www.pharmasources.com/industryinsights/genmab-and-janssen-biotech-to-develop-cd-312430.html 0.6 2026-07-10T11:29:16+08:00 daily https://www.pharmasources.com/industryinsights/mercks-keytruda-secures-expanded-indicat-312431.html 0.6 2026-07-05T16:40:04+08:00 daily https://www.pharmasources.com/industryinsights/sobi-to-acquire-emapalumab-drug-from-nov-312432.html 0.6 2026-07-01T20:34:11+08:00 daily https://www.pharmasources.com/industryinsights/drl-to-sell-neurology-branded-products-t-312433.html 0.6 2026-07-02T11:11:38+08:00 daily https://www.pharmasources.com/industryinsights/wockhardts-bioequivalence-centre-at-aura-312434.html 0.6 2026-07-02T13:19:44+08:00 daily https://www.pharmasources.com/industryinsights/sobi-buys-rare-disease-drug-emapalumab-z-312435.html 0.6 2026-07-13T13:17:28+08:00 daily https://www.pharmasources.com/industryinsights/catalyst-pharma-sues-fda-over-approval-o-312436.html 0.6 2026-06-22T04:14:51+08:00 daily https://www.pharmasources.com/industryinsights/oral-novo-nordisk-diabetes-drug-poses-no-312437.html 0.6 2026-08-14T04:04:16+08:00 daily https://www.pharmasources.com/industryinsights/new-psoriasis-drug-study-yields-positive-312438.html 0.6 2026-08-08T15:49:50+08:00 daily https://www.pharmasources.com/industryinsights/alembic-pharmas-approves-ncds-up-to-rs-3-312439.html 0.6 2026-08-08T14:03:26+08:00 daily https://www.pharmasources.com/industryinsights/dr-vatsal-shah-to-lead-siro-clinpharms-u-312440.html 0.6 2026-08-08T12:18:32+08:00 daily https://www.pharmasources.com/industryinsights/aptar-acquires-nanopharm-and-gateway-ana-312441.html 0.6 2026-08-08T10:11:02+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-finds-zero-483-observations-and-g-312442.html 0.6 2026-08-08T07:42:00+08:00 daily https://www.pharmasources.com/industryinsights/gsk-uni-of-california-pair-up-to-advance-312443.html 0.6 2026-08-07T13:58:52+08:00 daily https://www.pharmasources.com/industryinsights/outdated-technology-systems-still-limiti-312444.html 0.6 2026-06-20T22:55:59+08:00 daily https://www.pharmasources.com/industryinsights/rituxan-hits-endpoints-in-late-stage-ski-312445.html 0.6 2026-08-05T21:14:05+08:00 daily https://www.pharmasources.com/industryinsights/gilead-abcellera-team-up-against-infecti-312446.html 0.6 2026-07-02T02:42:38+08:00 daily https://www.pharmasources.com/industryinsights/inaugural-global-health-forum-of-boao-fo-312447.html 0.6 2026-08-04T14:47:46+08:00 daily https://www.pharmasources.com/industryinsights/abpi-publishes-new-guidelines-on-pharma--312448.html 0.6 2026-08-06T19:23:23+08:00 daily https://www.pharmasources.com/industryinsights/ibm-kpmg-merck-and-walmart-to-evaluate-t-312449.html 0.6 2026-08-06T20:08:16+08:00 daily https://www.pharmasources.com/industryinsights/terns-pharmaceuticals-and-shanghai-tuosh-312450.html 0.6 2026-08-09T14:59:48+08:00 daily https://www.pharmasources.com/industryinsights/111-partners-with-tong-ren-tang-technolo-312451.html 0.6 2026-08-14T18:18:29+08:00 daily https://www.pharmasources.com/industryinsights/biocon-biologics-receive-eu-gmp-certific-312453.html 0.6 2026-06-20T18:20:24+08:00 daily https://www.pharmasources.com/industryinsights/lumosa-to-initiate-phase-2-human-clinica-312454.html 0.6 2026-08-05T10:01:17+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharmas-ilumya-improves-joint-and-sk-312455.html 0.6 2026-06-21T10:16:34+08:00 daily https://www.pharmasources.com/industryinsights/allmed-healthcare-management-joins-fight-312456.html 0.6 2025-12-15T05:19:34+08:00 daily https://www.pharmasources.com/industryinsights/gsk-to-advance-genomic-research-and-impr-312457.html 0.6 2026-06-21T07:00:54+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-enters-into-a-definitive-agree-312458.html 0.6 2026-03-17T19:57:56+08:00 daily https://www.pharmasources.com/industryinsights/novartis-continues-to-innovate-in-cml-312459.html 0.6 2026-08-10T11:31:34+08:00 daily https://www.pharmasources.com/industryinsights/blackstone-therapeutics-closes-76-m-seri-312460.html 0.6 2026-06-21T06:01:45+08:00 daily https://www.pharmasources.com/industryinsights/head-injuries-tied-to-motorized-scooters-312461.html 0.6 2026-06-20T22:03:41+08:00 daily https://www.pharmasources.com/industryinsights/a-healthy-baby-starts-with-a-healthy-mom-312462.html 0.6 2026-06-20T20:15:06+08:00 daily https://www.pharmasources.com/industryinsights/federal-officials-seize-adulterated-diet-312463.html 0.6 2026-06-22T00:53:50+08:00 daily https://www.pharmasources.com/industryinsights/two-hour-weekly-dose-of-nature-may-aid-h-312464.html 0.6 2026-06-20T16:47:24+08:00 daily https://www.pharmasources.com/industryinsights/fda-warns-of-infections-from-fecal-trans-312465.html 0.6 2026-06-20T16:21:03+08:00 daily https://www.pharmasources.com/industryinsights/new-york-state-halts-religious-vaccine-e-312466.html 0.6 2026-04-06T23:41:34+08:00 daily https://www.pharmasources.com/industryinsights/overweight-kids-are-at-risk-for-high-blo-312467.html 0.6 2026-06-21T21:00:48+08:00 daily https://www.pharmasources.com/industryinsights/best-gift-from-dad-for-kids-more-time-to-312468.html 0.6 2026-06-21T11:09:14+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-kanjinti-trastuzumab-anns-a-312469.html 0.6 2026-08-15T00:57:49+08:00 daily https://www.pharmasources.com/industryinsights/education-intelligence-might-protect-you-312470.html 0.6 2026-06-21T04:11:52+08:00 daily https://www.pharmasources.com/industryinsights/hot-water-soak-may-help-ease-poor-leg-ci-312471.html 0.6 2026-08-08T09:25:04+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-are-transgender-men-and-women-w-312472.html 0.6 2026-06-21T09:12:12+08:00 daily https://www.pharmasources.com/industryinsights/daddy-do-overs-men-increasingly-getting--312473.html 0.6 2026-06-20T14:36:06+08:00 daily https://www.pharmasources.com/industryinsights/common-infant-rotavirus-vaccine-may-also-312474.html 0.6 2026-06-22T02:59:42+08:00 daily https://www.pharmasources.com/industryinsights/maine-legalizes-assisted-suicide-312475.html 0.6 2026-08-13T04:01:17+08:00 daily https://www.pharmasources.com/industryinsights/rotavirus-vaccination-tied-to-lower-risk-312476.html 0.6 2026-06-20T20:18:55+08:00 daily https://www.pharmasources.com/industryinsights/infliximab-introduction-has-not-cut-ibd--312477.html 0.6 2026-06-22T01:56:32+08:00 daily https://www.pharmasources.com/industryinsights/more-aggressive-statin-tx-needed-after-h-312478.html 0.6 2026-06-22T02:57:48+08:00 daily https://www.pharmasources.com/industryinsights/drug--and-alcohol-related-deaths-higher--312479.html 0.6 2026-06-21T07:16:12+08:00 daily https://www.pharmasources.com/industryinsights/opioid-sparing-strategy-still-provides-g-312480.html 0.6 2026-06-21T10:04:12+08:00 daily https://www.pharmasources.com/industryinsights/undetected-dysglycemia-linked-to-mi-peri-312481.html 0.6 2026-06-21T13:01:42+08:00 daily https://www.pharmasources.com/industryinsights/ada-combo-injectable-controls-blood-gluc-312482.html 0.6 2025-12-27T13:00:37+08:00 daily https://www.pharmasources.com/industryinsights/cardiac-radiation-dose-in-nsclc-predicts-312483.html 0.6 2026-06-22T09:01:44+08:00 daily https://www.pharmasources.com/industryinsights/prenatal-antiepileptic-rx-exposure-ups-r-312484.html 0.6 2026-06-21T11:51:05+08:00 daily https://www.pharmasources.com/industryinsights/penicillamine-capsules-usp-250-mg-312485.html 0.6 2026-08-08T20:28:24+08:00 daily https://www.pharmasources.com/industryinsights/mesalamine-delayed-release-capsules-400--312486.html 0.6 2026-07-20T12:04:56+08:00 daily https://www.pharmasources.com/industryinsights/sapropterin-dihydrochloride-tablets-100--312487.html 0.6 2026-06-29T17:39:03+08:00 daily https://www.pharmasources.com/industryinsights/whitepaper-vivapur-mcg-a-powerful-stabil-312488.html 0.6 2026-06-21T02:53:47+08:00 daily https://www.pharmasources.com/industryinsights/eurofins-biopharma-product-testing-312489.html 0.6 2026-06-24T00:12:50+08:00 daily https://www.pharmasources.com/industryinsights/blueprint-medicines-submits-new-drug-app-312490.html 0.6 2026-08-06T21:06:19+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-victoza-liraglutide-for-the-312491.html 0.6 2026-07-20T01:02:47+08:00 daily https://www.pharmasources.com/industryinsights/who-congo-ebola-outbreak-still-not-globa-312492.html 0.6 2026-06-21T05:16:00+08:00 daily https://www.pharmasources.com/industryinsights/cdc-us-measles-cases-reach-1044-312493.html 0.6 2026-07-24T11:40:32+08:00 daily https://www.pharmasources.com/industryinsights/cognitive-decline-faster-after-incident--312494.html 0.6 2026-06-20T18:19:56+08:00 daily https://www.pharmasources.com/industryinsights/drug-makers-challenge-new-rule-requiring-312495.html 0.6 2026-08-07T04:53:13+08:00 daily https://www.pharmasources.com/industryinsights/opioids-prescribed-in-hospital-often-tie-312496.html 0.6 2026-08-07T04:18:58+08:00 daily https://www.pharmasources.com/industryinsights/did-puppy-dog-eyes-evolve-to-please-huma-312497.html 0.6 2026-08-07T04:04:15+08:00 daily https://www.pharmasources.com/industryinsights/ailing-heart-can-speed-the-brains-declin-312498.html 0.6 2026-08-07T03:48:58+08:00 daily https://www.pharmasources.com/industryinsights/another-reason-breast-is-best-for-fragil-312499.html 0.6 2026-08-07T03:24:56+08:00 daily https://www.pharmasources.com/industryinsights/teen-sexting-can-be-warning-sign-of-othe-312500.html 0.6 2026-08-07T03:12:42+08:00 daily https://www.pharmasources.com/industryinsights/blood-pressure-medication-nilvadipine-mi-312501.html 0.6 2026-08-07T03:33:31+08:00 daily https://www.pharmasources.com/industryinsights/how-much-fat-do-you-really-need-312502.html 0.6 2026-08-07T03:54:58+08:00 daily https://www.pharmasources.com/industryinsights/how-to-recognize-early-learning-challeng-312503.html 0.6 2026-08-07T04:07:52+08:00 daily https://www.pharmasources.com/industryinsights/high-soy-intake-may-cut-fracture-risk-in-312504.html 0.6 2026-08-07T04:18:13+08:00 daily https://www.pharmasources.com/industryinsights/study-examines-use-of-electronic-consult-312505.html 0.6 2026-08-07T04:28:37+08:00 daily https://www.pharmasources.com/industryinsights/glucocorticoid-tapering-feasible-for-rhe-312506.html 0.6 2026-08-07T04:52:51+08:00 daily https://www.pharmasources.com/industryinsights/us-travelers-should-be-aware-of-measles--312507.html 0.6 2026-08-07T12:12:00+08:00 daily https://www.pharmasources.com/industryinsights/review-suggests-more-sleep-may-lower-car-312508.html 0.6 2026-08-07T13:18:08+08:00 daily https://www.pharmasources.com/industryinsights/nilvadipine-increases-cerebral-blood-flo-312509.html 0.6 2026-08-07T00:59:29+08:00 daily https://www.pharmasources.com/industryinsights/feelings-of-powerlessness-tied-to-delays-312510.html 0.6 2026-08-07T00:42:46+08:00 daily https://www.pharmasources.com/industryinsights/ppi-use-for-up-to-three-years-safe-durin-312511.html 0.6 2026-08-07T00:40:13+08:00 daily https://www.pharmasources.com/industryinsights/avomeen-appoints-head-of-elemental-analy-312512.html 0.6 2026-08-07T00:15:28+08:00 daily https://www.pharmasources.com/industryinsights/lsne-acquires-sterile-injectables-mfg-fa-312513.html 0.6 2026-08-07T00:01:28+08:00 daily https://www.pharmasources.com/industryinsights/catalent-biologics-iveric-bio-ink-mfg-pa-312514.html 0.6 2026-08-07T02:40:29+08:00 daily https://www.pharmasources.com/industryinsights/casi-acquires-anti-cd19-t-cell-therapy-f-312515.html 0.6 2026-08-14T08:44:25+08:00 daily https://www.pharmasources.com/industryinsights/voyager-therapeutics-sanofi-genzyme-rest-312516.html 0.6 2026-06-20T17:08:19+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-to-acquire-array-biopharma-for-11-312517.html 0.6 2026-08-07T03:30:52+08:00 daily https://www.pharmasources.com/industryinsights/cytel-and-axio-research-merge-312518.html 0.6 2026-08-07T03:54:52+08:00 daily https://www.pharmasources.com/industryinsights/bellwyck-pharma-services-on-growth-path-312519.html 0.6 2026-08-07T04:04:01+08:00 daily https://www.pharmasources.com/industryinsights/lonza-to-expand-hpapi-development-and-ma-312520.html 0.6 2026-08-13T00:09:53+08:00 daily https://www.pharmasources.com/industryinsights/modified-vaccinia-virus-shows-potential--312521.html 0.6 2026-08-07T04:30:51+08:00 daily https://www.pharmasources.com/industryinsights/positive-results-for-az-lokelma-in-hyper-312522.html 0.6 2026-08-07T04:57:11+08:00 daily https://www.pharmasources.com/industryinsights/nhs-long-term-plan-stunted-by-lack-of-wo-312523.html 0.6 2026-08-07T05:27:49+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-google-link-up-for-new-healthcare-312524.html 0.6 2026-06-21T06:15:58+08:00 daily https://www.pharmasources.com/industryinsights/rcgp-plea-to-avoid-no-deal-brexit-312525.html 0.6 2026-06-21T13:04:52+08:00 daily https://www.pharmasources.com/industryinsights/venue-announced-for-the-2019-marketer-of-312526.html 0.6 2026-06-21T08:53:31+08:00 daily https://www.pharmasources.com/industryinsights/owlstone-medical-explores-breath-based-t-312527.html 0.6 2026-08-07T06:16:08+08:00 daily https://www.pharmasources.com/industryinsights/greater-manchester-joins-cities-changing-312528.html 0.6 2026-06-22T09:14:06+08:00 daily https://www.pharmasources.com/industryinsights/az-calquence-shows-pfs-benefit-in-cll-pa-312529.html 0.6 2026-03-18T13:05:59+08:00 daily https://www.pharmasources.com/industryinsights/medicrea-secures-several-new-patents-to--312530.html 0.6 2026-06-21T01:03:50+08:00 daily https://www.pharmasources.com/industryinsights/zydus-nesher-pharma-gets-final-usfda-nod-312531.html 0.6 2026-03-09T09:54:25+08:00 daily https://www.pharmasources.com/industryinsights/need-better-collaboration-to-eliminate-m-312532.html 0.6 2026-06-20T17:48:24+08:00 daily https://www.pharmasources.com/industryinsights/bi-lilly-announces-results-of-new-post-h-312533.html 0.6 2026-06-21T12:17:30+08:00 daily https://www.pharmasources.com/industryinsights/85-shares-voted-to-date-to-support-merge-312534.html 0.6 2026-06-21T04:18:22+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-cochlear-implant-with-e-312535.html 0.6 2026-06-27T03:27:18+08:00 daily https://www.pharmasources.com/industryinsights/experts-underline-need-for-harm-reductio-312536.html 0.6 2026-06-22T17:49:03+08:00 daily https://www.pharmasources.com/industryinsights/speedx-receives-fda-breakthrough-designa-312537.html 0.6 2026-06-21T04:00:50+08:00 daily https://www.pharmasources.com/industryinsights/catalys-pacific-to-advance-early-stage-l-312538.html 0.6 2026-06-21T05:00:41+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-to-acquire-array-biopharma-in-a-1-312539.html 0.6 2026-06-20T15:58:26+08:00 daily https://www.pharmasources.com/industryinsights/ntu-researchers-reveal-inconsistency-in--312540.html 0.6 2026-08-05T12:58:59+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-keytruda-pembrolizumab-for--312541.html 0.6 2026-06-21T03:08:51+08:00 daily https://www.pharmasources.com/industryinsights/recommendations-issued-for-imaging-use-i-312542.html 0.6 2026-06-22T05:46:27+08:00 daily https://www.pharmasources.com/industryinsights/uspstf-addresses-screening-for-abdominal-312543.html 0.6 2026-02-28T15:04:42+08:00 daily https://www.pharmasources.com/industryinsights/one-in-five-have-mental-health-issues-in-312544.html 0.6 2026-07-15T17:11:41+08:00 daily https://www.pharmasources.com/industryinsights/a-fib-can-raise-dementia-risk-even-in-ab-312545.html 0.6 2026-03-27T01:23:11+08:00 daily https://www.pharmasources.com/industryinsights/yogurt-might-help-men-avoid-colon-cancer-312546.html 0.6 2026-06-21T08:12:14+08:00 daily https://www.pharmasources.com/industryinsights/rheumatoid-arthritis-remission-cuts-risk-312547.html 0.6 2026-06-22T02:48:44+08:00 daily https://www.pharmasources.com/industryinsights/help-for-impotence-starts-with-frank-tal-312548.html 0.6 2026-08-13T12:16:57+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-and-ose-immunothera-312549.html 0.6 2026-06-22T01:51:33+08:00 daily https://www.pharmasources.com/industryinsights/sunesis-pharmaceuticals-announces-presen-312550.html 0.6 2026-07-06T13:28:53+08:00 daily https://www.pharmasources.com/industryinsights/new-long-term-data-from-upadacitinib-pha-312551.html 0.6 2026-06-21T01:55:53+08:00 daily https://www.pharmasources.com/industryinsights/gbt-announces-updated-24-week-efficacy-d-312552.html 0.6 2026-07-08T16:23:09+08:00 daily https://www.pharmasources.com/industryinsights/perfect-teeth-wont-guarantee-a-perfect-l-312553.html 0.6 2026-07-01T17:36:49+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-victoza-injection-for-child-312554.html 0.6 2026-08-13T22:57:07+08:00 daily https://www.pharmasources.com/industryinsights/us-youth-suicide-rate-reaches-20-year-hi-312555.html 0.6 2026-06-26T20:49:10+08:00 daily https://www.pharmasources.com/industryinsights/japan-first-to-approve-roches-rozlytrek-312556.html 0.6 2026-08-09T15:10:26+08:00 daily https://www.pharmasources.com/industryinsights/genoceas-gen-009-vaccine-achieves-positi-312557.html 0.6 2026-06-20T22:51:37+08:00 daily https://www.pharmasources.com/industryinsights/ziopharm-oncology-achieves-positive-resu-312558.html 0.6 2026-06-28T00:30:59+08:00 daily https://www.pharmasources.com/industryinsights/bionure-reports-successful-phase-1-data--312559.html 0.6 2026-06-21T12:24:46+08:00 daily https://www.pharmasources.com/industryinsights/gsk-partners-with-university-of-californ-312560.html 0.6 2026-06-22T03:59:39+08:00 daily https://www.pharmasources.com/industryinsights/colorcon-inc-introduces-one-step-opadry--312561.html 0.6 2026-06-21T16:03:25+08:00 daily https://www.pharmasources.com/industryinsights/gemini-adds-to-executive-leadership-team-312562.html 0.6 2026-06-20T19:47:21+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-google-to-develop-innovation--312563.html 0.6 2026-06-21T22:49:53+08:00 daily https://www.pharmasources.com/industryinsights/genesis-aquires-nexuspharma-312564.html 0.6 2026-06-21T06:21:39+08:00 daily https://www.pharmasources.com/industryinsights/hoth-signs-contract-service-pacts-for-bi-312565.html 0.6 2026-06-22T13:11:18+08:00 daily https://www.pharmasources.com/industryinsights/cdmo-great-bay-bio-founded-312566.html 0.6 2026-06-21T15:44:02+08:00 daily https://www.pharmasources.com/industryinsights/otsuka-chemical-enters-api-business-312567.html 0.6 2026-06-20T22:55:51+08:00 daily https://www.pharmasources.com/industryinsights/cognizant-to-acquire-zenith-technologies-312568.html 0.6 2026-06-20T20:49:00+08:00 daily https://www.pharmasources.com/industryinsights/ani-pharmaceuticals-expands-generic-pipe-312569.html 0.6 2026-06-22T01:55:36+08:00 daily https://www.pharmasources.com/industryinsights/researchers-discover-how-to-identify-exh-312570.html 0.6 2026-06-21T08:57:05+08:00 daily https://www.pharmasources.com/industryinsights/mycovia-and-jaingsu-to-commercialise-vt--312571.html 0.6 2026-08-03T11:49:33+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-to-acquire-us-company-array-bioph-312572.html 0.6 2026-06-20T18:01:23+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-google-partner-to-set-up-heal-312573.html 0.6 2026-06-21T09:01:58+08:00 daily https://www.pharmasources.com/industryinsights/janssens-tremfya-shows-promise-in-two-ph-312574.html 0.6 2026-06-26T18:35:18+08:00 daily https://www.pharmasources.com/industryinsights/theravance-and-mylan-expand-agreement-fo-312575.html 0.6 2026-06-21T11:10:18+08:00 daily https://www.pharmasources.com/industryinsights/upsher-smith-to-buy-migraine-drugs-from--312576.html 0.6 2026-08-08T12:14:11+08:00 daily https://www.pharmasources.com/industryinsights/amgen-and-allergan-secure-us-fda-approva-312577.html 0.6 2026-08-11T07:43:18+08:00 daily https://www.pharmasources.com/industryinsights/fda-chooses-ibm-kmpg-merck-and-walmart-f-312578.html 0.6 2026-08-04T21:08:23+08:00 daily https://www.pharmasources.com/industryinsights/egis-pharmaceuticals-to-launch-mundiphar-312579.html 0.6 2026-07-17T22:52:50+08:00 daily https://www.pharmasources.com/industryinsights/gsk-and-university-of-california-team-up-312580.html 0.6 2026-06-21T07:21:12+08:00 daily https://www.pharmasources.com/industryinsights/many-young-children-treated-in-ed-for-in-312581.html 0.6 2026-06-20T18:56:52+08:00 daily https://www.pharmasources.com/industryinsights/is-interval-training-the-fountain-of-you-312582.html 0.6 2026-06-30T10:48:13+08:00 daily https://www.pharmasources.com/industryinsights/nice-nod-for-blincyto-312583.html 0.6 2026-04-02T01:23:57+08:00 daily https://www.pharmasources.com/industryinsights/poor-oral-health-linked-to-75-increased--312584.html 0.6 2026-06-21T01:50:54+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-uni-of-dundee-extend-anti-can-312585.html 0.6 2026-06-22T01:01:51+08:00 daily https://www.pharmasources.com/industryinsights/millions-in-uk-living-with-undiagnosed-c-312586.html 0.6 2026-06-22T05:54:33+08:00 daily https://www.pharmasources.com/industryinsights/lynparza-bags-eu-approval-for-rca-mutate-312587.html 0.6 2026-06-20T15:07:24+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-announces-results-from-xeljanz-xr-312588.html 0.6 2026-06-21T07:09:01+08:00 daily https://www.pharmasources.com/industryinsights/shandong-cancer-hospital-joins-flashforw-312589.html 0.6 2026-07-21T16:51:05+08:00 daily https://www.pharmasources.com/industryinsights/varian-expands-cancer-care-solutions-por-312590.html 0.6 2026-08-11T18:40:15+08:00 daily https://www.pharmasources.com/industryinsights/seegene-establishes-brazilian-subsidiary-312591.html 0.6 2026-06-20T18:19:57+08:00 daily https://www.pharmasources.com/industryinsights/japan-the-first-to-approve-roches-person-312592.html 0.6 2026-06-20T22:58:39+08:00 daily https://www.pharmasources.com/industryinsights/sierras-momelotinib-granted-fda-fast-tra-312593.html 0.6 2026-06-21T23:00:42+08:00 daily https://www.pharmasources.com/industryinsights/sellas-achieves-immune-response-data-in--312594.html 0.6 2026-08-01T08:02:28+08:00 daily https://www.pharmasources.com/industryinsights/concept-life-sciences-opens-new-facility-312595.html 0.6 2026-06-20T18:59:31+08:00 daily https://www.pharmasources.com/industryinsights/parexel-to-collaborate-with-cluepoints-312596.html 0.6 2026-06-21T05:07:47+08:00 daily https://www.pharmasources.com/industryinsights/gamida-cell-and-lonza-to-manufacture-omi-312597.html 0.6 2026-06-21T01:45:32+08:00 daily https://www.pharmasources.com/industryinsights/pacira-appoints-max-reinhardt-as-preside-312598.html 0.6 2026-06-23T17:12:40+08:00 daily https://www.pharmasources.com/industryinsights/ibio-inks-first-fill-finish-services-agr-312599.html 0.6 2026-06-21T05:12:57+08:00 daily https://www.pharmasources.com/industryinsights/catalent-to-purchase-bms-mfg-facility-in-312600.html 0.6 2026-07-18T07:30:15+08:00 daily https://www.pharmasources.com/industryinsights/armas-micro-labs-collaborate-for-generic-312601.html 0.6 2026-06-20T17:58:15+08:00 daily https://www.pharmasources.com/industryinsights/camargo-to-acquire-insymbiosis-312602.html 0.6 2026-08-03T17:01:50+08:00 daily https://www.pharmasources.com/industryinsights/quanticate-expands-presence-in-north-ame-312603.html 0.6 2026-08-07T10:37:46+08:00 daily https://www.pharmasources.com/industryinsights/alvogen-inks-agreement-with-exeltis-312604.html 0.6 2026-08-14T04:26:40+08:00 daily https://www.pharmasources.com/industryinsights/genmab-janssen-partner-for-next-gen-cd38-312605.html 0.6 2026-08-13T14:10:59+08:00 daily https://www.pharmasources.com/industryinsights/cytovance-completes-second-fda-pai-of-ok-312606.html 0.6 2026-06-21T01:58:42+08:00 daily https://www.pharmasources.com/industryinsights/vitamin-d-may-not-help-your-heart-312607.html 0.6 2026-06-22T09:51:40+08:00 daily https://www.pharmasources.com/industryinsights/japan-becomes-the-first-country-to-appro-312608.html 0.6 2026-08-09T15:10:26+08:00 daily https://www.pharmasources.com/industryinsights/researchers-identify-enzyme-that-suppres-312609.html 0.6 2026-06-20T19:07:52+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-amgen-and-allergans-kanjint-312610.html 0.6 2026-08-05T08:02:26+08:00 daily https://www.pharmasources.com/industryinsights/making-it-personal-how-genetic-technolog-312611.html 0.6 2026-06-21T14:53:20+08:00 daily https://www.pharmasources.com/industryinsights/weighing-risks-and-benefits-of-drug-trea-312612.html 0.6 2026-08-11T11:54:10+08:00 daily https://www.pharmasources.com/industryinsights/full-data-from-carolina-outcome-trial-su-312613.html 0.6 2026-06-21T11:33:46+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-chemoimmunotherapy-re-312614.html 0.6 2026-06-23T14:34:15+08:00 daily https://www.pharmasources.com/industryinsights/phase-2-trial-shows-efficacy-of-cytuvaxs-312615.html 0.6 2026-08-06T20:02:32+08:00 daily https://www.pharmasources.com/industryinsights/osteolabs-gmbh-successfully-closes-seed--312616.html 0.6 2026-06-21T18:57:53+08:00 daily https://www.pharmasources.com/industryinsights/type-2-diabetes-treatment-approved-for-c-312617.html 0.6 2026-06-21T05:49:43+08:00 daily https://www.pharmasources.com/industryinsights/biopharmaceutical-contract-manufacturing-312618.html 0.6 2026-06-20T19:13:51+08:00 daily https://www.pharmasources.com/industryinsights/mhra-issues-recall-of-paracetamol-tablet-312619.html 0.6 2026-06-21T08:34:40+08:00 daily https://www.pharmasources.com/industryinsights/us-food-and-drug-administration-sued-ove-312620.html 0.6 2026-06-20T18:37:12+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-packaginglabelling-market-312621.html 0.6 2026-06-18T00:35:30+08:00 daily https://www.pharmasources.com/industryinsights/india-to-introduce-mandatory-barcoding-o-312622.html 0.6 2026-06-21T08:53:51+08:00 daily https://www.pharmasources.com/industryinsights/researchers-discover-antibody-that-inter-312623.html 0.6 2026-06-21T22:53:56+08:00 daily https://www.pharmasources.com/industryinsights/lynparza-approved-in-eu-and-japan-for-br-312624.html 0.6 2026-06-21T20:10:55+08:00 daily https://www.pharmasources.com/industryinsights/japan-first-to-approve-roches-tumour-agn-312625.html 0.6 2026-06-22T11:59:43+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-novo-nordisks-type-2-diabet-312626.html 0.6 2026-07-01T02:28:43+08:00 daily https://www.pharmasources.com/industryinsights/atox-bio-announces-exercise-by-barda-of--312627.html 0.6 2026-06-22T00:52:56+08:00 daily https://www.pharmasources.com/industryinsights/kleo-announces-cd38-arm-as-first-clinica-312628.html 0.6 2026-06-21T12:10:19+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-fast-track-designation-for-fi-312629.html 0.6 2026-06-21T04:10:49+08:00 daily https://www.pharmasources.com/industryinsights/vanflyta-receives-approval-in-japan-312630.html 0.6 2026-06-21T09:12:33+08:00 daily https://www.pharmasources.com/industryinsights/premier-pharmacy-labs-issues-recall-of-a-312631.html 0.6 2026-07-04T02:46:08+08:00 daily https://www.pharmasources.com/industryinsights/gilead-nurix-announce-collaboration-to-d-312632.html 0.6 2026-06-21T09:14:13+08:00 daily https://www.pharmasources.com/industryinsights/patent-covering-manufacturing-process-of-312633.html 0.6 2026-08-13T19:03:07+08:00 daily https://www.pharmasources.com/industryinsights/therapix-biosciences-announces-interim-r-312634.html 0.6 2026-06-22T05:11:55+08:00 daily https://www.pharmasources.com/industryinsights/mill-creek-life-sciences-receives-grant--312635.html 0.6 2026-06-21T08:15:17+08:00 daily https://www.pharmasources.com/industryinsights/cellular-biomedicine-announces-first-pat-312636.html 0.6 2026-03-24T21:54:25+08:00 daily https://www.pharmasources.com/industryinsights/janssen-reports-top-line-phase-3-results-312637.html 0.6 2026-08-11T20:45:14+08:00 daily https://www.pharmasources.com/industryinsights/arena-announces-first-subject-dosed-in-e-312638.html 0.6 2026-08-12T08:36:35+08:00 daily https://www.pharmasources.com/industryinsights/neurana-announces-completion-of-tolperis-312639.html 0.6 2026-06-21T02:02:48+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-treatment-for-pediatric-312640.html 0.6 2026-06-08T07:55:50+08:00 daily https://www.pharmasources.com/industryinsights/theravance-mylan-expand-yupelri-developm-312641.html 0.6 2026-07-29T12:09:38+08:00 daily https://www.pharmasources.com/industryinsights/blueprint-medicines-submits-nda-for-avap-312642.html 0.6 2026-06-21T11:58:11+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-announces-data-showing-potent-312643.html 0.6 2026-04-14T00:16:50+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-kanjinti-312644.html 0.6 2026-06-21T06:57:54+08:00 daily https://www.pharmasources.com/industryinsights/reistone-announces-first-patient-dosed-i-312645.html 0.6 2026-08-06T16:03:45+08:00 daily https://www.pharmasources.com/industryinsights/four-pharmaceutical-companies-accused-of-312646.html 0.6 2026-06-26T18:28:43+08:00 daily https://www.pharmasources.com/industryinsights/study-reveals-the-risk-inactive-ingredie-312647.html 0.6 2026-06-21T03:07:45+08:00 daily https://www.pharmasources.com/industryinsights/agendia-announces-publication-of-study-v-312648.html 0.6 2026-08-11T18:18:15+08:00 daily https://www.pharmasources.com/industryinsights/amgen-and-ipd-partner-for-drug-research-312649.html 0.6 2026-04-21T10:06:23+08:00 daily https://www.pharmasources.com/industryinsights/gilead-and-nurix-to-collaborate-on-novel-312650.html 0.6 2026-08-07T13:55:57+08:00 daily https://www.pharmasources.com/industryinsights/pelican-biothermal-launches-dublin-netwo-312651.html 0.6 2026-08-10T12:11:49+08:00 daily https://www.pharmasources.com/industryinsights/rssl-opens-new-microbiology-lab-312652.html 0.6 2026-08-13T13:52:27+08:00 daily https://www.pharmasources.com/industryinsights/cymabay-therapeutics-reports-results-for-312653.html 0.6 2026-07-04T07:00:56+08:00 daily https://www.pharmasources.com/industryinsights/aptinyxs-nyx-2925-demonstrates-positive--312654.html 0.6 2026-06-09T04:55:47+08:00 daily https://www.pharmasources.com/industryinsights/axovant-yposkesi-ink-gene-therapy-pact-312655.html 0.6 2026-08-08T15:51:57+08:00 daily https://www.pharmasources.com/industryinsights/seqens-unveils-innovation-and-developmen-312656.html 0.6 2026-08-08T17:53:41+08:00 daily https://www.pharmasources.com/industryinsights/telix-eczacba-monrol-sign-manufacturing--312657.html 0.6 2026-08-08T19:41:45+08:00 daily https://www.pharmasources.com/industryinsights/tergus-to-build-commercial-manufacturing-312658.html 0.6 2026-08-09T04:32:04+08:00 daily https://www.pharmasources.com/industryinsights/new-england-journal-of-medicine-picks-ne-312659.html 0.6 2026-06-21T10:05:10+08:00 daily https://www.pharmasources.com/industryinsights/restricting-blood-transfusions-ok-in-car-312660.html 0.6 2026-06-21T20:18:54+08:00 daily https://www.pharmasources.com/industryinsights/2018-to-2019-influenza-season-in-us-was--312661.html 0.6 2026-06-21T20:54:45+08:00 daily https://www.pharmasources.com/industryinsights/meta-analysis-does-not-link-vitamin-d-su-312662.html 0.6 2026-08-08T00:58:29+08:00 daily https://www.pharmasources.com/industryinsights/most-women-unaware-alcohol-poses-breast--312663.html 0.6 2026-06-20T08:00:56+08:00 daily https://www.pharmasources.com/industryinsights/us-cases-of-infant-gut-illness-plummet-a-312664.html 0.6 2026-06-21T05:55:43+08:00 daily https://www.pharmasources.com/industryinsights/cell-mapping-provides-new-insights-about-312665.html 0.6 2026-08-07T09:49:16+08:00 daily https://www.pharmasources.com/industryinsights/how-do-birth-defects-affect-childhood-ca-312666.html 0.6 2026-06-21T11:02:12+08:00 daily https://www.pharmasources.com/industryinsights/unprofessional-surgeons-hurt-patient-out-312667.html 0.6 2026-06-21T07:09:33+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-this-faulty-gene-may-help-predi-312668.html 0.6 2026-08-05T11:04:31+08:00 daily https://www.pharmasources.com/industryinsights/more-than-5-million-us-cancer-survivors--312669.html 0.6 2026-06-20T21:54:35+08:00 daily https://www.pharmasources.com/industryinsights/the-safer-way-to-ease-post-surgical-pain-312670.html 0.6 2026-06-20T17:03:15+08:00 daily https://www.pharmasources.com/industryinsights/how-to-pack-more-plant-protein-into-your-312671.html 0.6 2026-06-21T02:39:36+08:00 daily https://www.pharmasources.com/industryinsights/global-efforts-to-cut-smoking-show-mixed-312672.html 0.6 2026-07-04T06:58:21+08:00 daily https://www.pharmasources.com/industryinsights/many-health-care-workers-with-flu-colds--312673.html 0.6 2026-06-22T09:11:53+08:00 daily https://www.pharmasources.com/industryinsights/sudden-death-can-occur-even-in-well-cont-312674.html 0.6 2026-06-21T04:59:14+08:00 daily https://www.pharmasources.com/industryinsights/risk-factors-idd-for-atrial-fibrillation-312675.html 0.6 2026-08-13T17:02:12+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-to-improve-paediatric-medicines-m-312676.html 0.6 2025-12-04T13:55:24+08:00 daily https://www.pharmasources.com/industryinsights/nurix-and-gilead-partner-on-developing-p-312677.html 0.6 2026-06-22T03:02:43+08:00 daily https://www.pharmasources.com/industryinsights/amgen-and-university-of-washington-partn-312678.html 0.6 2026-06-20T21:57:32+08:00 daily https://www.pharmasources.com/industryinsights/ricoh-and-elixirgen-to-develop-biomedica-312679.html 0.6 2026-06-21T02:59:57+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-victoza-for-type-2-diabetes-312680.html 0.6 2026-06-21T11:02:08+08:00 daily https://www.pharmasources.com/industryinsights/servier-breaks-ground-on-paris-saclay-re-312681.html 0.6 2026-06-20T19:01:36+08:00 daily https://www.pharmasources.com/industryinsights/sophiris-bio-receives-positive-feedback--312682.html 0.6 2026-06-21T08:12:21+08:00 daily https://www.pharmasources.com/industryinsights/rxq-compounding-issues-recall-of-all-ste-312683.html 0.6 2026-06-21T03:18:55+08:00 daily https://www.pharmasources.com/industryinsights/denovo-biopharma-receives-global-rights--312684.html 0.6 2026-07-12T18:33:36+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-pharma-gets-tentative-nod-from--312685.html 0.6 2026-06-22T07:49:54+08:00 daily https://www.pharmasources.com/industryinsights/piramal-pharma-invests-10-million-to-exp-312686.html 0.6 2026-06-21T03:53:46+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-for-voluntary-action-by-cadila-he-312687.html 0.6 2026-06-20T14:51:05+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-lynparza-gets-eu-nod-as-fir-312688.html 0.6 2026-07-01T03:34:13+08:00 daily https://www.pharmasources.com/industryinsights/roche-wins-japan-approval-for-personalis-312689.html 0.6 2026-08-11T09:02:01+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-google-to-use-data-tech-for-innov-312690.html 0.6 2026-06-20T17:47:16+08:00 daily https://www.pharmasources.com/industryinsights/biocon-board-approves-sale-of-branded-fo-312691.html 0.6 2026-06-20T20:16:48+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-to-buy-array-biopharma-for-1064-b-312692.html 0.6 2026-08-03T16:24:45+08:00 daily https://www.pharmasources.com/industryinsights/conception-awarded-grant-to-conduct-rese-312693.html 0.6 2026-07-06T22:05:52+08:00 daily https://www.pharmasources.com/industryinsights/laurus-labs-finishes-usfda-inspection-of-312694.html 0.6 2026-07-02T15:28:14+08:00 daily https://www.pharmasources.com/industryinsights/brinton-pharmaceuticals-receives-series--312695.html 0.6 2026-08-12T03:55:31+08:00 daily https://www.pharmasources.com/industryinsights/lupin-recalls-over-18000-bottles-of-anti-312696.html 0.6 2026-08-08T21:07:28+08:00 daily https://www.pharmasources.com/industryinsights/novartis-india-appoints-sanjay-murdeshwa-312697.html 0.6 2026-08-07T02:48:04+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-drug-showed-reduced-chronic-312698.html 0.6 2026-06-21T15:13:42+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-makes-2-observations-for-caplins--312699.html 0.6 2026-06-21T05:07:51+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-restructures-rd-group-312700.html 0.6 2026-06-21T12:48:17+08:00 daily https://www.pharmasources.com/industryinsights/zosano-pharma-completes-site-qualificati-312701.html 0.6 2026-06-21T04:12:52+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-plans-to-further-expand-n-312702.html 0.6 2026-06-21T00:00:34+08:00 daily https://www.pharmasources.com/industryinsights/piramal-invests-10-million-in-riverview--312703.html 0.6 2026-06-21T12:25:21+08:00 daily https://www.pharmasources.com/industryinsights/regorafenib-to-be-tested-in-brain-cancer-312704.html 0.6 2026-08-03T07:20:24+08:00 daily https://www.pharmasources.com/industryinsights/human-on-a-chip-model-tests-cancer-drug--312705.html 0.6 2026-07-30T05:37:47+08:00 daily https://www.pharmasources.com/industryinsights/breztri-aerosphere-pt010-approved-in-jap-312706.html 0.6 2026-08-14T08:17:05+08:00 daily https://www.pharmasources.com/industryinsights/manufacturing-of-paediatric-medicines-se-312707.html 0.6 2026-08-09T21:22:21+08:00 daily https://www.pharmasources.com/industryinsights/us150-million-invested-to-expand-us-phar-312708.html 0.6 2026-06-21T23:32:42+08:00 daily https://www.pharmasources.com/industryinsights/premier-pharmacy-labs-recalls-products-a-312709.html 0.6 2026-08-07T13:15:26+08:00 daily https://www.pharmasources.com/industryinsights/fda-announces-new-data-points-to-aid-gen-312710.html 0.6 2026-08-07T12:27:06+08:00 daily https://www.pharmasources.com/industryinsights/lynparza-has-been-approved-for-brca-muta-312711.html 0.6 2026-08-07T11:55:12+08:00 daily https://www.pharmasources.com/industryinsights/fda-joins-blockchain-system-for-drug-saf-312712.html 0.6 2026-08-07T11:22:56+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-to-expand-integrated-biol-312713.html 0.6 2026-08-07T10:52:59+08:00 daily https://www.pharmasources.com/industryinsights/four-pharmaceutical-companies-accused-of-312714.html 0.6 2026-08-07T01:18:53+08:00 daily https://www.pharmasources.com/industryinsights/ocean-swimming-causes-skin-changes-study-312715.html 0.6 2026-08-07T01:14:01+08:00 daily https://www.pharmasources.com/industryinsights/amag-pharmaceuticals-announces-fda-appro-312716.html 0.6 2026-08-07T00:53:12+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-symdeko-tezacaftorivacaftor-312717.html 0.6 2026-08-07T00:40:43+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-second-drug-vyleesi-to-help-312718.html 0.6 2026-08-07T01:08:29+08:00 daily https://www.pharmasources.com/industryinsights/seniors-who-develop-cancer-have-better-m-312719.html 0.6 2026-08-07T13:15:56+08:00 daily https://www.pharmasources.com/industryinsights/poor-oral-health-not-linked-to-gastroint-312720.html 0.6 2026-08-08T07:41:41+08:00 daily https://www.pharmasources.com/industryinsights/fda-expands-cystic-fibrosis-treatment-ap-312721.html 0.6 2026-08-08T18:23:12+08:00 daily https://www.pharmasources.com/industryinsights/new-experimental-drug-vosoritide-combats-312722.html 0.6 2026-08-09T06:59:28+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-botox-onabotulinumtoxina-fo-312723.html 0.6 2026-08-05T05:37:24+08:00 daily https://www.pharmasources.com/industryinsights/biomarin-announces-new-england-journal-o-312724.html 0.6 2026-06-21T02:49:04+08:00 daily https://www.pharmasources.com/industryinsights/heart-disease-is-lasting-threat-to-breas-312725.html 0.6 2026-06-22T05:00:42+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-what-migraine-sufferers-need-to-312726.html 0.6 2026-02-09T16:05:24+08:00 daily https://www.pharmasources.com/industryinsights/better-treatments-needed-to-boost-brain--312727.html 0.6 2025-11-11T09:17:24+08:00 daily https://www.pharmasources.com/industryinsights/how-does-your-diet-stack-up-312728.html 0.6 2026-06-20T20:01:38+08:00 daily https://www.pharmasources.com/industryinsights/geographic-patterns-of-copd-similar-for--312729.html 0.6 2026-06-21T07:19:29+08:00 daily https://www.pharmasources.com/industryinsights/gracell-data-on-multi-center-investigati-312730.html 0.6 2026-07-28T18:42:21+08:00 daily https://www.pharmasources.com/industryinsights/prestige-biopharma-reports-positive-top--312731.html 0.6 2026-06-30T13:29:32+08:00 daily https://www.pharmasources.com/industryinsights/definiens-targos-innovation-ai-powered-m-312732.html 0.6 2026-08-12T03:47:02+08:00 daily https://www.pharmasources.com/industryinsights/clinigen-broadens-partnership-with-accor-312733.html 0.6 2026-08-07T16:02:26+08:00 daily https://www.pharmasources.com/industryinsights/syneos-health-launches-new-fsp-model-312734.html 0.6 2026-06-21T10:06:10+08:00 daily https://www.pharmasources.com/industryinsights/celldex-therapeutics-appoints-cmo-312735.html 0.6 2026-06-21T09:06:02+08:00 daily https://www.pharmasources.com/industryinsights/phastar-to-expand-asia-pac-and-us-footpr-312736.html 0.6 2026-06-20T14:46:19+08:00 daily https://www.pharmasources.com/industryinsights/loxo-oncology-enters-strategic-pact-with-312737.html 0.6 2026-06-20T21:48:40+08:00 daily https://www.pharmasources.com/industryinsights/death-from-specific-causes-up-for-vetera-312738.html 0.6 2026-08-10T15:47:12+08:00 daily https://www.pharmasources.com/industryinsights/older-americans-generally-current-with-e-312739.html 0.6 2026-06-22T00:58:50+08:00 daily https://www.pharmasources.com/industryinsights/adrenal-incidentalomas-rarely-grow-chang-312740.html 0.6 2026-06-21T04:18:12+08:00 daily https://www.pharmasources.com/industryinsights/colonoscopy-quality-not-affected-by-seda-312741.html 0.6 2026-06-21T11:08:17+08:00 daily https://www.pharmasources.com/industryinsights/vets-with-ptsd-face-higher-odds-for-earl-312742.html 0.6 2026-01-14T08:53:18+08:00 daily https://www.pharmasources.com/industryinsights/coffee-might-be-your-go-to-brew-for-weig-312743.html 0.6 2026-06-14T11:59:57+08:00 daily https://www.pharmasources.com/industryinsights/the-right-gut-bacteria-may-give-athletes-312744.html 0.6 2026-06-25T01:03:05+08:00 daily https://www.pharmasources.com/industryinsights/med-students-smartphones-loaded-with-sta-312745.html 0.6 2026-06-21T04:03:48+08:00 daily https://www.pharmasources.com/industryinsights/ocular-therapeutix-announces-fda-approva-312746.html 0.6 2026-06-21T15:16:40+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-provides-update-on-fda-re-312747.html 0.6 2026-06-20T22:55:47+08:00 daily https://www.pharmasources.com/industryinsights/young-female-smokers-at-especially-high--312748.html 0.6 2026-06-20T18:12:32+08:00 daily https://www.pharmasources.com/industryinsights/widely-prescribed-anticholinergics-might-312749.html 0.6 2026-06-21T07:13:06+08:00 daily https://www.pharmasources.com/industryinsights/could-3-d-mammograms-soon-be-the-standar-312750.html 0.6 2026-04-16T06:06:59+08:00 daily https://www.pharmasources.com/industryinsights/thanks-for-the-stinky-memories-scientist-312751.html 0.6 2026-06-21T04:09:55+08:00 daily https://www.pharmasources.com/industryinsights/secret-shopper-study-shows-how-easily-te-312752.html 0.6 2026-06-22T23:53:56+08:00 daily https://www.pharmasources.com/industryinsights/fda-expands-cystic-fibrosis-treatment-ap-312753.html 0.6 2026-06-21T04:08:49+08:00 daily https://www.pharmasources.com/industryinsights/is-green-tea-a-fad-or-a-real-health-boos-312754.html 0.6 2026-06-21T15:38:01+08:00 daily https://www.pharmasources.com/industryinsights/seafood-offers-vital-nutrient-for-expect-312755.html 0.6 2026-06-21T13:14:39+08:00 daily https://www.pharmasources.com/industryinsights/just-how-harmful-is-tv-for-your-health-312756.html 0.6 2026-06-30T15:48:52+08:00 daily https://www.pharmasources.com/industryinsights/suicide-risk-seen-among-older-adults-liv-312757.html 0.6 2026-06-19T21:46:11+08:00 daily https://www.pharmasources.com/industryinsights/drug-combo-slows-progression-in-advanced-312758.html 0.6 2026-06-22T08:00:50+08:00 daily https://www.pharmasources.com/industryinsights/oral-steroids-increase-infection-risk-in-312759.html 0.6 2026-06-21T11:01:14+08:00 daily https://www.pharmasources.com/industryinsights/greater-long-term-decline-in-stroke-seen-312760.html 0.6 2026-08-09T07:59:42+08:00 daily https://www.pharmasources.com/industryinsights/transfusion-dose-density-affects-myelody-312761.html 0.6 2026-08-08T03:45:48+08:00 daily https://www.pharmasources.com/industryinsights/rotavirus-vaccine-led-to-reduced-disease-312762.html 0.6 2026-08-07T20:13:19+08:00 daily https://www.pharmasources.com/industryinsights/anxiety-with-type-2-diabetes-tied-to-hig-312763.html 0.6 2026-08-07T13:18:02+08:00 daily https://www.pharmasources.com/industryinsights/evolving-world-of-pharma-addressing-real-312764.html 0.6 2026-06-17T05:58:05+08:00 daily https://www.pharmasources.com/industryinsights/3p-biopharmaceuticals-and-nordic-nanovec-312765.html 0.6 2026-08-07T13:17:15+08:00 daily https://www.pharmasources.com/industryinsights/rafael-pharma-signs-license-agreement-wi-312766.html 0.6 2026-08-08T10:38:36+08:00 daily https://www.pharmasources.com/industryinsights/cobra-biologics-and-symbiosis-complete-v-312767.html 0.6 2026-08-08T12:36:19+08:00 daily https://www.pharmasources.com/industryinsights/phoremost-and-c4x-discovery-announce-col-312768.html 0.6 2026-08-10T12:36:41+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-to-buy-allergan-for-63b-312769.html 0.6 2026-06-21T11:58:12+08:00 daily https://www.pharmasources.com/industryinsights/global-diabetes-drug-market-expected-to--312770.html 0.6 2026-08-08T01:00:12+08:00 daily https://www.pharmasources.com/industryinsights/china-announces-generic-drug-list-to-red-312771.html 0.6 2026-06-22T06:57:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-treatment-for-sexual-dysfun-312772.html 0.6 2026-02-16T14:41:51+08:00 daily https://www.pharmasources.com/industryinsights/fda-plans-to-institutionalise-drug-compo-312773.html 0.6 2026-06-21T08:55:59+08:00 daily https://www.pharmasources.com/industryinsights/job-cuts-limit-cardiovascular-and-diabet-312774.html 0.6 2026-06-21T02:40:23+08:00 daily https://www.pharmasources.com/industryinsights/exposure-to-anticholinergics-may-increas-312775.html 0.6 2026-06-20T20:12:42+08:00 daily https://www.pharmasources.com/industryinsights/mortality-not-higher-with-transfusions-f-312776.html 0.6 2026-06-21T12:00:15+08:00 daily https://www.pharmasources.com/industryinsights/uspstf-urges-interventions-to-prevent-to-312777.html 0.6 2026-06-20T18:59:36+08:00 daily https://www.pharmasources.com/industryinsights/nutrient-intake-inadequate-in-many-pregn-312778.html 0.6 2026-07-31T14:39:32+08:00 daily https://www.pharmasources.com/industryinsights/childhood-brain-tumor-survivors-face-mor-312779.html 0.6 2026-06-20T21:02:38+08:00 daily https://www.pharmasources.com/industryinsights/many-young-men-putting-health-at-risk-to-312780.html 0.6 2026-06-20T20:01:36+08:00 daily https://www.pharmasources.com/industryinsights/buyer-beware-many-stem-cell-clinics-lack-312781.html 0.6 2026-04-07T17:47:31+08:00 daily https://www.pharmasources.com/industryinsights/correvio-resubmits-brinavess-vernakalant-312782.html 0.6 2026-06-30T17:37:29+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-genetics-may-help-predict-the-r-312783.html 0.6 2026-06-23T08:17:27+08:00 daily https://www.pharmasources.com/industryinsights/more-education-could-mean-less-heart-dis-312784.html 0.6 2026-08-06T11:43:19+08:00 daily https://www.pharmasources.com/industryinsights/could-antibacterial-triclosan-weaken-wom-312785.html 0.6 2026-07-01T15:50:09+08:00 daily https://www.pharmasources.com/industryinsights/experts-want-doctors-to-add-vaping-to-yo-312786.html 0.6 2026-06-21T01:54:35+08:00 daily https://www.pharmasources.com/industryinsights/money-worries-around-food-may-spur-migra-312787.html 0.6 2025-10-25T07:59:27+08:00 daily https://www.pharmasources.com/industryinsights/is-your-child-depressed-or-suicidal-here-312788.html 0.6 2026-06-20T18:21:56+08:00 daily https://www.pharmasources.com/industryinsights/healthy-work-lunches-are-hard-to-come-by-312789.html 0.6 2026-06-20T20:47:21+08:00 daily https://www.pharmasources.com/industryinsights/diabetes-outcomes-similar-regardless-of--312790.html 0.6 2026-06-21T06:12:09+08:00 daily https://www.pharmasources.com/industryinsights/changing-ehr-systems-may-up-operating-ti-312791.html 0.6 2026-04-05T20:09:10+08:00 daily https://www.pharmasources.com/industryinsights/cancer-survivors-have-high-prevalence-of-312792.html 0.6 2026-04-01T11:05:55+08:00 daily https://www.pharmasources.com/industryinsights/iron-intake-may-not-improve-pregnancy-ch-312793.html 0.6 2026-06-21T06:09:49+08:00 daily https://www.pharmasources.com/industryinsights/voxelotor-improves-hemoglobin-levels-in--312794.html 0.6 2026-07-28T09:06:05+08:00 daily https://www.pharmasources.com/industryinsights/bms-opdivo-fails-to-reach-primary-endpoi-312795.html 0.6 2026-06-20T18:22:08+08:00 daily https://www.pharmasources.com/industryinsights/mlnlycke-and-zuellig-to-offer-wound-care-312796.html 0.6 2026-08-06T09:58:37+08:00 daily https://www.pharmasources.com/industryinsights/study-shows-human-sperm-keeps-viability--312797.html 0.6 2026-06-21T09:11:32+08:00 daily https://www.pharmasources.com/industryinsights/bms-to-divest-otezla-for-approval-of-74b-312798.html 0.6 2026-06-24T10:30:57+08:00 daily https://www.pharmasources.com/industryinsights/fda-expands-label-of-vertexs-cf-drug-sym-312799.html 0.6 2026-03-12T17:58:38+08:00 daily https://www.pharmasources.com/industryinsights/shionogi-agrees-to-license-out-lusutromb-312800.html 0.6 2026-07-27T13:40:17+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-allergans-botox-for-upper-l-312801.html 0.6 2026-06-22T01:04:58+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-secures-ec-approval-for-oral-parp-312802.html 0.6 2026-06-22T04:59:38+08:00 daily https://www.pharmasources.com/industryinsights/fda-issues-complete-response-letter-for--312803.html 0.6 2026-06-20T21:07:42+08:00 daily https://www.pharmasources.com/industryinsights/biopharmx-announces-positive-topline-res-312804.html 0.6 2026-06-21T07:55:07+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-announces-dosing-of-first-patient--312805.html 0.6 2026-07-04T06:24:35+08:00 daily https://www.pharmasources.com/industryinsights/hanwell-acquired-by-ellab-312806.html 0.6 2026-07-05T07:46:51+08:00 daily https://www.pharmasources.com/industryinsights/domp-announces-first-patient-enrollment--312807.html 0.6 2026-06-20T18:28:47+08:00 daily https://www.pharmasources.com/industryinsights/sound-pharmaceuticals-announces-positive-312808.html 0.6 2026-08-01T22:12:45+08:00 daily https://www.pharmasources.com/industryinsights/shionogi-concludes-licensing-agreements--312809.html 0.6 2026-07-27T13:40:25+08:00 daily https://www.pharmasources.com/industryinsights/infusion-options-issues-recall-of-all-lo-312810.html 0.6 2026-06-22T08:11:05+08:00 daily https://www.pharmasources.com/industryinsights/fda-lifts-partial-clinical-hold-on-phase-312811.html 0.6 2026-07-15T17:13:10+08:00 daily https://www.pharmasources.com/industryinsights/epygenix-submits-ind-application-for-epx-312812.html 0.6 2026-06-21T01:59:54+08:00 daily https://www.pharmasources.com/industryinsights/emmaus-life-sciences-announces-study-pro-312813.html 0.6 2026-06-21T22:53:50+08:00 daily https://www.pharmasources.com/industryinsights/fda-expands-approval-of-cystic-fibrosis--312814.html 0.6 2026-06-21T13:02:28+08:00 daily https://www.pharmasources.com/industryinsights/powder-flow-the-influence-of-storage-and-312815.html 0.6 2026-06-29T22:43:11+08:00 daily https://www.pharmasources.com/industryinsights/oxford-bio-receives-boehringer-milestone-312816.html 0.6 2025-11-25T09:46:03+08:00 daily https://www.pharmasources.com/industryinsights/akorn-receives-warning-letter-from-fda-312817.html 0.6 2026-08-09T07:56:29+08:00 daily https://www.pharmasources.com/industryinsights/abeona-therapeutics-appoints-new-svp-of--312818.html 0.6 2026-08-08T00:49:21+08:00 daily https://www.pharmasources.com/industryinsights/registration-is-open-for-the-uks-only-la-312819.html 0.6 2026-08-07T22:09:27+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-orphan-drug-designation-for-n-312820.html 0.6 2026-08-07T14:34:59+08:00 daily https://www.pharmasources.com/industryinsights/gsk-reported-to-have-started-the-sale-of-312821.html 0.6 2026-08-07T13:15:44+08:00 daily https://www.pharmasources.com/industryinsights/new-partnership-established-to-develop-a-312822.html 0.6 2026-08-07T05:45:50+08:00 daily https://www.pharmasources.com/industryinsights/mammaprint-becomes-only-molecular-diagno-312823.html 0.6 2026-08-07T05:38:11+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-dupixent-dupilumab-for-chro-312824.html 0.6 2026-08-07T06:04:24+08:00 daily https://www.pharmasources.com/industryinsights/hpv-vaccine-making-headway-against-cance-312825.html 0.6 2026-08-10T17:34:43+08:00 daily https://www.pharmasources.com/industryinsights/mssp-acos-may-not-improve-spending-quali-312826.html 0.6 2026-08-07T23:10:31+08:00 daily https://www.pharmasources.com/industryinsights/eeg-may-detect-brain-activation-in-some--312827.html 0.6 2026-08-10T01:00:55+08:00 daily https://www.pharmasources.com/industryinsights/educational-attainment-positively-linked-312828.html 0.6 2026-06-21T00:03:36+08:00 daily https://www.pharmasources.com/industryinsights/dupixent-approved-for-chronic-rhinosinus-312829.html 0.6 2026-06-22T18:20:51+08:00 daily https://www.pharmasources.com/industryinsights/combination-therapy-for-rosacea-shows-im-312830.html 0.6 2026-06-21T18:19:50+08:00 daily https://www.pharmasources.com/industryinsights/could-heavier-folks-be-at-lower-risk-for-312831.html 0.6 2026-06-20T17:07:27+08:00 daily https://www.pharmasources.com/industryinsights/when-traditional-rx-fails-psoriasis-pati-312832.html 0.6 2025-11-06T20:10:19+08:00 daily https://www.pharmasources.com/industryinsights/americans-aware-of-antibiotic-resistance-312833.html 0.6 2026-07-28T16:00:56+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-adjusting-bmi-eliminates-lead-a-312834.html 0.6 2026-05-10T06:15:29+08:00 daily https://www.pharmasources.com/industryinsights/new-urine-test-might-show-whether-prosta-312835.html 0.6 2026-07-09T23:21:07+08:00 daily https://www.pharmasources.com/industryinsights/whats-the-most-effective-way-to-tone-you-312836.html 0.6 2026-06-21T19:17:59+08:00 daily https://www.pharmasources.com/industryinsights/tv-watching-may-be-most-unhealthy-type-o-312837.html 0.6 2026-06-24T02:04:51+08:00 daily https://www.pharmasources.com/industryinsights/big-decline-seen-in-use-of-annual-pelvic-312838.html 0.6 2026-07-09T11:42:06+08:00 daily https://www.pharmasources.com/industryinsights/americans-concerned-about-clinician-burn-312839.html 0.6 2026-06-20T17:03:15+08:00 daily https://www.pharmasources.com/industryinsights/physicians-unaware-of-breast-density-law-312840.html 0.6 2026-07-28T10:43:33+08:00 daily https://www.pharmasources.com/industryinsights/triclosan-exposure-may-lower-bone-minera-312841.html 0.6 2026-06-20T17:38:08+08:00 daily https://www.pharmasources.com/industryinsights/downward-trend-seen-in-pelvic-exams-amon-312842.html 0.6 2026-06-21T09:02:01+08:00 daily https://www.pharmasources.com/industryinsights/micronutrient-deficiencies-often-found-w-312843.html 0.6 2026-06-21T09:04:01+08:00 daily https://www.pharmasources.com/industryinsights/combination-biopsy-strategy-may-identify-312844.html 0.6 2026-06-20T16:36:55+08:00 daily https://www.pharmasources.com/industryinsights/prevention-bundle-may-cut-cardiac-device-312845.html 0.6 2026-06-22T22:37:40+08:00 daily https://www.pharmasources.com/industryinsights/terns-to-commercialise-genfits-elafibran-312846.html 0.6 2026-06-20T20:08:44+08:00 daily https://www.pharmasources.com/industryinsights/oxb-and-santen-to-develop-gene-therapy-p-312847.html 0.6 2026-06-23T01:00:08+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-signs-agreement-to-acquire-irish--312848.html 0.6 2026-07-05T11:08:08+08:00 daily https://www.pharmasources.com/industryinsights/evolving-world-of-pharma-uniting-pharma--312849.html 0.6 2026-07-04T11:45:56+08:00 daily https://www.pharmasources.com/industryinsights/taris-announces-positive-results-of-tar--312850.html 0.6 2026-06-21T00:15:51+08:00 daily https://www.pharmasources.com/industryinsights/uspto-allows-patent-claims-for-cbm-bioph-312851.html 0.6 2026-06-21T02:14:51+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-dupixent-for-chronic-rhinos-312852.html 0.6 2026-07-08T20:17:49+08:00 daily https://www.pharmasources.com/industryinsights/fda-releases-statement-on-stem-cell-clin-312853.html 0.6 2026-06-21T14:47:19+08:00 daily https://www.pharmasources.com/industryinsights/lillys-trial-studying-higher-doses-of-tr-312854.html 0.6 2026-08-07T05:06:22+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-looks-beyond-humira-with-63-billi-312855.html 0.6 2026-08-07T00:01:48+08:00 daily https://www.pharmasources.com/industryinsights/nclt-approves-dhanukas-resolution-plan-f-312856.html 0.6 2026-08-06T23:54:43+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-launches-tobramycin-inhalation-312857.html 0.6 2026-08-06T23:48:05+08:00 daily https://www.pharmasources.com/industryinsights/ipa-releases-vision-2030-for-indian-phar-312858.html 0.6 2026-08-06T23:45:15+08:00 daily https://www.pharmasources.com/industryinsights/alembic-pharma-gets-us-fda-nod-for-oselt-312859.html 0.6 2026-06-21T05:16:57+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-pharma-says-us-fda-has-issued-c-312860.html 0.6 2026-04-05T21:25:50+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-to-partner-with-novartis-to-mar-312861.html 0.6 2026-08-08T01:07:16+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-launches-in-phytonadione-injec-312862.html 0.6 2026-07-04T19:04:07+08:00 daily https://www.pharmasources.com/industryinsights/fogsi-and-bayer-launch-care-guidelines-o-312863.html 0.6 2026-06-21T05:57:46+08:00 daily https://www.pharmasources.com/industryinsights/us-group-says-novartis-ms-drug-price-out-312864.html 0.6 2026-08-07T14:35:42+08:00 daily https://www.pharmasources.com/industryinsights/fda-alerts-consumers-not-to-use-kratom-n-312865.html 0.6 2026-03-25T00:29:48+08:00 daily https://www.pharmasources.com/industryinsights/fda-warns-two-kratom-marketers-about-fal-312866.html 0.6 2026-03-28T07:33:29+08:00 daily https://www.pharmasources.com/industryinsights/target-health-and-dmed-biopharmaceutical-312867.html 0.6 2026-06-21T09:06:04+08:00 daily https://www.pharmasources.com/industryinsights/fda-seeks-public-feedback-on-new-drug-ap-312868.html 0.6 2026-07-31T01:27:43+08:00 daily https://www.pharmasources.com/industryinsights/pathogen-engineered-to-self-destruct-und-312869.html 0.6 2026-07-09T23:34:13+08:00 daily https://www.pharmasources.com/industryinsights/medtech-nears-its-golden-age-focusing-on-312870.html 0.6 2026-06-22T09:59:39+08:00 daily https://www.pharmasources.com/industryinsights/inovio-completes-enrollment-of-vgx-3100--312871.html 0.6 2026-07-14T15:32:01+08:00 daily https://www.pharmasources.com/industryinsights/ewib-partners-with-bio-to-promote-gender-312872.html 0.6 2026-08-09T01:03:57+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-launches-cancer-can-give-mov-312873.html 0.6 2026-08-13T00:23:20+08:00 daily https://www.pharmasources.com/industryinsights/fresenius-medical-care-opens-a-new-dialy-312874.html 0.6 2026-08-08T19:55:40+08:00 daily https://www.pharmasources.com/industryinsights/yisheng-biopharma-receives-ind-clearance-312875.html 0.6 2026-06-21T00:52:40+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-treatment-for-chronic-312876.html 0.6 2026-06-20T14:26:36+08:00 daily https://www.pharmasources.com/industryinsights/nmpa-accepts-nda-for-biosimilar-product--312877.html 0.6 2026-06-04T13:44:09+08:00 daily https://www.pharmasources.com/industryinsights/microport-orthopedics-unveils-new-knee-r-312878.html 0.6 2026-06-21T05:14:57+08:00 daily https://www.pharmasources.com/industryinsights/nih-launches-large-tb-prevention-trial-312879.html 0.6 2026-06-20T15:50:27+08:00 daily https://www.pharmasources.com/industryinsights/merck-builds-first-mobile-lab-to-conduct-312880.html 0.6 2026-06-20T19:49:46+08:00 daily https://www.pharmasources.com/industryinsights/experimental-drug-development-centre-edd-312881.html 0.6 2026-06-20T23:16:55+08:00 daily https://www.pharmasources.com/industryinsights/takeda-selects-new-partnerships-for-annu-312882.html 0.6 2026-08-12T15:49:54+08:00 daily https://www.pharmasources.com/industryinsights/indias-piramal-adds-capacity-to-us-high--312883.html 0.6 2026-08-07T21:40:12+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-regenerons-dupixent-scores-3r-312884.html 0.6 2026-06-23T03:13:33+08:00 daily https://www.pharmasources.com/industryinsights/analysts-rip-into-abbvie-allergans-63b-d-312885.html 0.6 2026-06-21T06:09:11+08:00 daily https://www.pharmasources.com/industryinsights/fda-fast-tracks-bi-lillys-jardiance-in-c-312886.html 0.6 2026-06-21T06:11:52+08:00 daily https://www.pharmasources.com/industryinsights/novartis-manufacturing-agreement-cited-i-312887.html 0.6 2026-08-13T04:43:18+08:00 daily https://www.pharmasources.com/industryinsights/whos-the-next-big-pharma-takeout-target--312888.html 0.6 2026-08-03T13:03:00+08:00 daily https://www.pharmasources.com/industryinsights/after-roche-bms-surprises-what-does-abbv-312889.html 0.6 2026-08-03T13:02:57+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-keeps-may-tv-focus-on-humira-whil-312890.html 0.6 2026-07-01T01:29:41+08:00 daily https://www.pharmasources.com/industryinsights/acadia-teams-up-with-michael-j-fox-found-312891.html 0.6 2026-08-08T04:21:51+08:00 daily https://www.pharmasources.com/industryinsights/former-pfizer-site-in-puerto-rico-picked-312892.html 0.6 2026-06-21T02:48:38+08:00 daily https://www.pharmasources.com/industryinsights/lilly-enlists-patients-to-raise-cluster--312893.html 0.6 2026-06-21T17:59:32+08:00 daily https://www.pharmasources.com/industryinsights/novartis-gilenya-staves-off-generic-chal-312894.html 0.6 2026-06-21T10:02:09+08:00 daily https://www.pharmasources.com/industryinsights/teetering-akorn-hit-with-another-fda-war-312895.html 0.6 2026-06-21T12:21:42+08:00 daily https://www.pharmasources.com/industryinsights/horizon-bulks-up-sales-force-ahead-of-75-312896.html 0.6 2026-06-20T19:46:21+08:00 daily https://www.pharmasources.com/industryinsights/horizon-bulks-up-sales-force-ahead-of-75-312897.html 0.6 2026-06-21T18:14:38+08:00 daily https://www.pharmasources.com/industryinsights/pharmas-got-its-chief-digital-officers-n-312898.html 0.6 2026-06-20T23:00:42+08:00 daily https://www.pharmasources.com/industryinsights/novartis-sells-colorado-site-to-maker-of-312899.html 0.6 2026-06-22T06:50:58+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-nearing-the-end-of-humiras-histor-312900.html 0.6 2026-08-08T01:48:55+08:00 daily https://www.pharmasources.com/industryinsights/gsk-wins-speedy-fda-zejula-review-in-ova-312901.html 0.6 2026-06-20T14:23:42+08:00 daily https://www.pharmasources.com/industryinsights/jj-depression-drug-spravato-gets-half-he-312902.html 0.6 2026-06-21T16:58:22+08:00 daily https://www.pharmasources.com/industryinsights/fda-lifts-hold-on-abbvie-roches-venclext-312903.html 0.6 2026-06-21T10:06:15+08:00 daily https://www.pharmasources.com/industryinsights/cytovance-biologics-inc-appoints-chief-t-312904.html 0.6 2025-12-13T09:43:50+08:00 daily https://www.pharmasources.com/industryinsights/contravir-pharmaceuticals-submits-ind-fo-312905.html 0.6 2026-06-20T19:18:51+08:00 daily https://www.pharmasources.com/industryinsights/genfit-terns-pharmaceuticals-to-commerci-312906.html 0.6 2026-07-02T19:45:55+08:00 daily https://www.pharmasources.com/industryinsights/sungen-pharma-athenex-pharma-partner-for-312907.html 0.6 2026-06-20T18:07:30+08:00 daily https://www.pharmasources.com/industryinsights/neomed-labs-and-public-health-england-pa-312908.html 0.6 2026-06-20T20:56:40+08:00 daily https://www.pharmasources.com/industryinsights/velabs-therapeutics-announces-3-million--312909.html 0.6 2026-08-09T18:41:27+08:00 daily https://www.pharmasources.com/industryinsights/new-ambr-250-modular-bioreactor-vessel-l-312910.html 0.6 2026-06-21T18:18:06+08:00 daily https://www.pharmasources.com/industryinsights/revealed-structure-of-glucagon-fibrils-c-312911.html 0.6 2026-07-01T05:51:04+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-is-to-acquire-allergan-in-a-trans-312912.html 0.6 2026-08-07T06:48:08+08:00 daily https://www.pharmasources.com/industryinsights/new-stable-nanoemulsions-could-change-dr-312913.html 0.6 2026-06-21T02:17:56+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-google-to-develop-new-healthc-312914.html 0.6 2026-03-28T01:03:49+08:00 daily https://www.pharmasources.com/industryinsights/dova-pharmaceuticals-announces-fda-appro-312915.html 0.6 2026-08-01T23:11:35+08:00 daily https://www.pharmasources.com/industryinsights/alexion-receives-fda-approval-of-soliris-312916.html 0.6 2026-06-20T20:18:06+08:00 daily https://www.pharmasources.com/industryinsights/acip-men-as-old-as-26-should-get-hpv-vac-312917.html 0.6 2026-06-23T14:47:23+08:00 daily https://www.pharmasources.com/industryinsights/less-than-40-percent-of-all-us-adults-ha-312918.html 0.6 2026-06-20T20:10:43+08:00 daily https://www.pharmasources.com/industryinsights/three-interventions-could-cut-cardiovasc-312919.html 0.6 2026-04-01T07:53:31+08:00 daily https://www.pharmasources.com/industryinsights/womens-exposure-to-solvents-at-work-tied-312920.html 0.6 2026-06-21T18:13:41+08:00 daily https://www.pharmasources.com/industryinsights/uspstf-lung-cancer-screening-too-conserv-312921.html 0.6 2026-04-21T08:18:36+08:00 daily https://www.pharmasources.com/industryinsights/fda-updates-cases-of-food-related-heart--312922.html 0.6 2026-06-21T07:09:03+08:00 daily https://www.pharmasources.com/industryinsights/selfie-craze-has-young-americans-viewing-312923.html 0.6 2026-06-20T19:16:59+08:00 daily https://www.pharmasources.com/industryinsights/air-pollution-bad-news-for-your-blood-pr-312924.html 0.6 2026-08-08T00:51:21+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-drug-for-sinusitis-wi-312925.html 0.6 2026-06-21T12:50:21+08:00 daily https://www.pharmasources.com/industryinsights/infections-especially-utis-may-be-trigge-312926.html 0.6 2026-08-10T06:25:45+08:00 daily https://www.pharmasources.com/industryinsights/early-risers-may-be-a-little-less-likely-312927.html 0.6 2026-04-25T07:36:27+08:00 daily https://www.pharmasources.com/industryinsights/even-slightly-elevated-blood-pressure-ea-312928.html 0.6 2026-06-21T00:02:41+08:00 daily https://www.pharmasources.com/industryinsights/alzheimers-genes-might-show-effects-in-y-312929.html 0.6 2026-06-20T14:36:12+08:00 daily https://www.pharmasources.com/industryinsights/outcomes-improved-after-acl-repair-with--312930.html 0.6 2026-08-09T06:59:35+08:00 daily https://www.pharmasources.com/industryinsights/high-bmi-weight-gain-linked-to-lasting-d-312931.html 0.6 2026-08-09T01:20:38+08:00 daily https://www.pharmasources.com/industryinsights/psoriasis-patients-often-use-cams-when-t-312932.html 0.6 2026-08-08T23:30:18+08:00 daily https://www.pharmasources.com/industryinsights/ct-use-to-evaluate-suspected-urolithiasi-312933.html 0.6 2026-08-08T21:48:21+08:00 daily https://www.pharmasources.com/industryinsights/study-reveals-impressive-success-of-wide-312934.html 0.6 2026-08-08T20:04:39+08:00 daily https://www.pharmasources.com/industryinsights/almirall-secures-eib-grant-to-support-re-312935.html 0.6 2026-08-08T18:13:55+08:00 daily https://www.pharmasources.com/industryinsights/clinigen-obtains-marketing-authorisation-312936.html 0.6 2026-08-08T10:10:42+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-regenerons-antibody-dupixen-312937.html 0.6 2026-08-11T09:28:20+08:00 daily https://www.pharmasources.com/industryinsights/cara-therapeutics-initiates-second-pruri-312938.html 0.6 2026-08-09T15:04:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-fast-track-designation-to-emp-312939.html 0.6 2026-06-21T12:22:48+08:00 daily https://www.pharmasources.com/industryinsights/aridis-pharmaceuticals-receives-orphan-d-312940.html 0.6 2026-06-22T11:47:54+08:00 daily https://www.pharmasources.com/industryinsights/imfinzi-improves-os-at-interim-analysis--312941.html 0.6 2026-08-01T12:02:19+08:00 daily https://www.pharmasources.com/industryinsights/precigen-announces-first-patient-dosed-i-312942.html 0.6 2026-06-21T22:56:42+08:00 daily https://www.pharmasources.com/industryinsights/lillys-trial-studying-higher-doses-of-tr-312943.html 0.6 2026-06-20T18:01:24+08:00 daily https://www.pharmasources.com/industryinsights/cadila-encompasses-a-major-coup-with-the-312944.html 0.6 2026-06-21T06:46:42+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-pharma-gets-us-fda-nod-for-chol-312945.html 0.6 2026-06-20T16:11:23+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-and-cms-enter-into-a-license--312946.html 0.6 2026-07-28T02:57:37+08:00 daily https://www.pharmasources.com/industryinsights/new-non-invasive-test-for-bowel-diseases-312947.html 0.6 2026-06-21T22:11:52+08:00 daily https://www.pharmasources.com/industryinsights/gsk-and-regional-centre-for-biotechnolog-312948.html 0.6 2026-06-23T14:35:32+08:00 daily https://www.pharmasources.com/industryinsights/what-are-the-most-dangerous-food-groups-312949.html 0.6 2026-06-21T04:19:01+08:00 daily https://www.pharmasources.com/industryinsights/forget-the-past-get-moving-now-and-live--312950.html 0.6 2026-06-21T10:17:28+08:00 daily https://www.pharmasources.com/industryinsights/will-video-games-make-your-kid-obese-may-312951.html 0.6 2026-08-09T00:06:22+08:00 daily https://www.pharmasources.com/industryinsights/krystal-biotech-announces-positive-resul-312952.html 0.6 2026-06-22T01:52:31+08:00 daily https://www.pharmasources.com/industryinsights/tricida-announces-publication-of-positiv-312953.html 0.6 2026-06-20T14:33:36+08:00 daily https://www.pharmasources.com/industryinsights/new-biotage-vacmaster-disk---vacuum-extr-312954.html 0.6 2026-06-22T04:12:48+08:00 daily https://www.pharmasources.com/industryinsights/artificial-dna-can-control-release-of-ac-312955.html 0.6 2026-06-21T07:00:01+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-treatment-for-neuromy-312956.html 0.6 2026-06-20T17:05:16+08:00 daily https://www.pharmasources.com/industryinsights/cryo-electron-microscope-market-predicte-312957.html 0.6 2026-06-22T10:10:56+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-company-combats-counterfe-312958.html 0.6 2026-06-20T14:51:08+08:00 daily https://www.pharmasources.com/industryinsights/new-drug-delivery-implant-could-treat-pa-312959.html 0.6 2026-06-21T20:13:49+08:00 daily https://www.pharmasources.com/industryinsights/medical-journals-found-to-restrict-acces-312960.html 0.6 2026-08-12T19:20:19+08:00 daily https://www.pharmasources.com/industryinsights/cambrex-makes-senior-appointments-312961.html 0.6 2026-06-21T23:57:42+08:00 daily https://www.pharmasources.com/industryinsights/draper-bms-sign-toxicity-testing-pact-312962.html 0.6 2026-06-21T10:15:22+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-jjs-darzalex-in-multiple-my-312963.html 0.6 2026-07-04T15:50:26+08:00 daily https://www.pharmasources.com/industryinsights/eye-injuries-from-fireworks-in-us-have-n-312964.html 0.6 2026-06-21T06:07:56+08:00 daily https://www.pharmasources.com/industryinsights/five-year-survival-less-than-40-percent--312965.html 0.6 2026-08-09T14:00:01+08:00 daily https://www.pharmasources.com/industryinsights/medicare-advantage-patients-have-higher--312966.html 0.6 2025-12-13T23:15:58+08:00 daily https://www.pharmasources.com/industryinsights/medtronic-recalls-some-insulin-pumps-ove-312967.html 0.6 2026-07-16T07:57:52+08:00 daily https://www.pharmasources.com/industryinsights/overall-survival-worse-with-multiple-pri-312968.html 0.6 2026-06-22T07:00:49+08:00 daily https://www.pharmasources.com/industryinsights/connected-teens-become-healthier-adults-312969.html 0.6 2026-03-17T19:47:54+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-zirabev-bevacizumab-bvzr-a--312970.html 0.6 2026-06-20T22:15:52+08:00 daily https://www.pharmasources.com/industryinsights/soliris-eculizumab-injection-approved-to-312971.html 0.6 2026-08-09T03:34:16+08:00 daily https://www.pharmasources.com/industryinsights/prenatal-opioid-exposure-could-bring-lon-312972.html 0.6 2026-08-09T01:20:40+08:00 daily https://www.pharmasources.com/industryinsights/broccoli-you-are-sure-to-love-312973.html 0.6 2026-08-09T00:37:46+08:00 daily https://www.pharmasources.com/industryinsights/infections-tied-to-subsequent-risk-for-a-312974.html 0.6 2026-08-08T21:35:06+08:00 daily https://www.pharmasources.com/industryinsights/increase-seen-in-cryptosporidiosis-outbr-312975.html 0.6 2026-08-10T10:53:56+08:00 daily https://www.pharmasources.com/industryinsights/global-patients-whining-about-the-produc-312976.html 0.6 2026-08-08T15:12:04+08:00 daily https://www.pharmasources.com/industryinsights/is-your-county-an-opioid-overdose-hotspo-312977.html 0.6 2026-08-09T07:59:40+08:00 daily https://www.pharmasources.com/industryinsights/most-americans-have-never-had-an-hiv-tes-312978.html 0.6 2026-03-09T07:28:56+08:00 daily https://www.pharmasources.com/industryinsights/medtronic-recalls-some-insulin-pumps-as--312979.html 0.6 2026-06-22T01:05:20+08:00 daily https://www.pharmasources.com/industryinsights/when-it-comes-to-treating-infertility-ra-312980.html 0.6 2026-06-22T15:53:43+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-whos-helping-smokers-quit-proba-312981.html 0.6 2026-07-26T12:54:37+08:00 daily https://www.pharmasources.com/industryinsights/how-do-kids-learn-to-turn-off-troublesom-312982.html 0.6 2026-06-22T03:04:08+08:00 daily https://www.pharmasources.com/industryinsights/myocardial-perfusion-pet-predicts-cardia-312983.html 0.6 2026-06-21T02:08:14+08:00 daily https://www.pharmasources.com/industryinsights/review-hpv-vaccination-program-has-consi-312984.html 0.6 2026-07-15T18:07:03+08:00 daily https://www.pharmasources.com/industryinsights/lannett-enters-into-distribution-agreeme-312985.html 0.6 2026-06-20T17:15:53+08:00 daily https://www.pharmasources.com/industryinsights/just-biotherapeutics-teva-enter-agreemen-312986.html 0.6 2026-06-10T10:07:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-warns-of-potential-cybersecurity-con-312987.html 0.6 2026-06-21T06:02:58+08:00 daily https://www.pharmasources.com/industryinsights/ptc-provides-update-on-translarna-applic-312988.html 0.6 2026-06-20T14:43:12+08:00 daily https://www.pharmasources.com/industryinsights/amgen-ucb-receives-negative-opinion-on-e-312989.html 0.6 2026-06-21T20:59:36+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-alexions-soliris-as-first-t-312990.html 0.6 2026-04-17T11:34:52+08:00 daily https://www.pharmasources.com/industryinsights/vivus-amends-agreement-with-nordmark-for-312991.html 0.6 2026-08-11T18:07:59+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-and-cms-to-commercialise-csa--312992.html 0.6 2026-08-05T14:59:17+08:00 daily https://www.pharmasources.com/industryinsights/springworks-and-gsk-sign-clinical-trial--312993.html 0.6 2025-12-13T22:46:59+08:00 daily https://www.pharmasources.com/industryinsights/ministry-of-ayush-integrates-ayush-syste-312994.html 0.6 2026-07-17T07:43:43+08:00 daily https://www.pharmasources.com/industryinsights/netmedscom-partners-with-zee5-312995.html 0.6 2026-03-25T09:04:18+08:00 daily https://www.pharmasources.com/industryinsights/lupin-receives-tentative-us-fda-approval-312996.html 0.6 2026-06-20T13:59:25+08:00 daily https://www.pharmasources.com/industryinsights/fda-warns-patients-and-health-care-profe-312997.html 0.6 2026-06-21T05:55:51+08:00 daily https://www.pharmasources.com/industryinsights/meet-huggable-the-robot-bear-whos-helpin-312998.html 0.6 2026-06-21T15:45:15+08:00 daily https://www.pharmasources.com/industryinsights/sour-note-marching-band-members-at-risk--312999.html 0.6 2026-08-09T02:27:33+08:00 daily https://www.pharmasources.com/industryinsights/unnecessary-ambulance-calls-in-nyc-spike-313000.html 0.6 2026-08-07T16:03:51+08:00 daily https://www.pharmasources.com/industryinsights/mammaprint-becomes-only-molecular-diagno-313001.html 0.6 2026-08-09T00:32:01+08:00 daily https://www.pharmasources.com/industryinsights/stewardship-intervention-can-cut-inappro-313002.html 0.6 2026-06-21T17:53:32+08:00 daily https://www.pharmasources.com/industryinsights/metformin-may-cut-mortality-risk-in-post-313003.html 0.6 2026-06-30T13:50:05+08:00 daily https://www.pharmasources.com/industryinsights/high-sensitivity-troponin-levels-can-pre-313004.html 0.6 2026-05-03T09:54:48+08:00 daily https://www.pharmasources.com/industryinsights/amicus-brammer-bio-enter-gene-therapy-de-313005.html 0.6 2026-07-05T02:47:13+08:00 daily https://www.pharmasources.com/industryinsights/lonza-to-acquire-sterile-fill-and-finish-313006.html 0.6 2025-12-30T07:04:08+08:00 daily https://www.pharmasources.com/industryinsights/jet-lag-medication-approved-by-mhra-313007.html 0.6 2026-06-21T14:37:11+08:00 daily https://www.pharmasources.com/industryinsights/ai-model-better-predicts-cv-risk-mortali-313008.html 0.6 2026-06-21T13:03:30+08:00 daily https://www.pharmasources.com/industryinsights/calculated-tumor-area-has-prognostic-val-313009.html 0.6 2026-06-22T12:53:01+08:00 daily https://www.pharmasources.com/industryinsights/abuse-injury-more-likely-when-child-is-w-313010.html 0.6 2026-06-20T21:19:14+08:00 daily https://www.pharmasources.com/industryinsights/soys-heart-benefits-hold-steady-over-tim-313011.html 0.6 2026-06-20T13:58:02+08:00 daily https://www.pharmasources.com/industryinsights/cancer-risk-rises-after-iodine-rx-for-ov-313012.html 0.6 2026-06-20T22:44:40+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-summer-heat-brings-special-heal-313013.html 0.6 2026-06-21T09:00:02+08:00 daily https://www.pharmasources.com/industryinsights/gut-bacteria-supplements-might-boost-obe-313014.html 0.6 2026-07-05T01:54:52+08:00 daily https://www.pharmasources.com/industryinsights/ms-linked-to-higher-cancer-risk-313015.html 0.6 2026-07-07T17:39:48+08:00 daily https://www.pharmasources.com/industryinsights/can-stem-cells-be-the-cure-for-baldness-313016.html 0.6 2026-06-20T20:45:18+08:00 daily https://www.pharmasources.com/industryinsights/how-to-foster-your-childs-imagination-313017.html 0.6 2026-06-20T20:01:34+08:00 daily https://www.pharmasources.com/industryinsights/low-vitamin-d-at-birth-linked-to-kids-hi-313018.html 0.6 2026-08-06T13:47:07+08:00 daily https://www.pharmasources.com/industryinsights/sino-biopharmaceuticals-rd-investment-gr-313019.html 0.6 2026-07-20T17:59:06+08:00 daily https://www.pharmasources.com/industryinsights/where-a-womans-fat-lies-hints-at-future--313020.html 0.6 2026-06-21T17:00:24+08:00 daily https://www.pharmasources.com/industryinsights/leisure-time-physical-activity-linked-to-313021.html 0.6 2026-06-23T08:58:08+08:00 daily https://www.pharmasources.com/industryinsights/multiple-first-generics-of-the-hard-to-i-313022.html 0.6 2026-06-22T21:49:44+08:00 daily https://www.pharmasources.com/industryinsights/core-components-of-teen-mental-health-in-313023.html 0.6 2026-06-22T00:56:49+08:00 daily https://www.pharmasources.com/industryinsights/most-grandparents-store-meds-in-containe-313024.html 0.6 2026-06-21T02:06:43+08:00 daily https://www.pharmasources.com/industryinsights/romosozumab-increases-bone-formation-cut-313025.html 0.6 2026-06-22T07:50:50+08:00 daily https://www.pharmasources.com/industryinsights/most-women-do-not-regret-genetic-testing-313026.html 0.6 2026-06-21T22:51:44+08:00 daily https://www.pharmasources.com/industryinsights/better-uti-monitoring-needed-after-hospi-313027.html 0.6 2026-02-28T15:30:37+08:00 daily https://www.pharmasources.com/industryinsights/model-can-predict-lung-cancer-in-patient-313028.html 0.6 2026-06-20T19:00:34+08:00 daily https://www.pharmasources.com/industryinsights/nutrition-focused-program-at-home-health-313029.html 0.6 2026-06-21T12:49:21+08:00 daily https://www.pharmasources.com/industryinsights/novartis-successfully-completes-acquisit-313030.html 0.6 2026-07-23T04:34:41+08:00 daily https://www.pharmasources.com/industryinsights/longevity-benefits-for-adults-becoming-m-313031.html 0.6 2026-06-20T22:17:00+08:00 daily https://www.pharmasources.com/industryinsights/generic-drug-faqs-313032.html 0.6 2026-06-20T17:13:04+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-apptec-named-one-of-mit-technology--313033.html 0.6 2026-08-12T23:56:38+08:00 daily https://www.pharmasources.com/industryinsights/becoming-contracted-authors-of-pharmasou-313034.html 0.6 2026-08-12T04:39:22+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-irvine-scientific-to-construct--313035.html 0.6 2026-08-07T13:55:23+08:00 daily https://www.pharmasources.com/industryinsights/oncovita-signs-licensing-agreement-with--313036.html 0.6 2026-06-22T06:13:50+08:00 daily https://www.pharmasources.com/industryinsights/ptc-therapeutics-odylia-therapeutics-ent-313037.html 0.6 2026-06-22T10:56:51+08:00 daily https://www.pharmasources.com/industryinsights/trakcel-appoints-senior-director-313038.html 0.6 2026-03-28T17:10:28+08:00 daily https://www.pharmasources.com/industryinsights/pii-appoints-business-executives-313039.html 0.6 2026-06-21T03:06:44+08:00 daily https://www.pharmasources.com/industryinsights/amicus-catalent-biologics-enter-gene-the-313040.html 0.6 2026-03-20T01:16:33+08:00 daily https://www.pharmasources.com/industryinsights/a-review-of-progress-of-immunotherapy-dr-313041.html 0.6 2026-07-22T14:39:27+08:00 daily https://www.pharmasources.com/industryinsights/vermont-places-92-percent-tax-on-e-cigar-313042.html 0.6 2026-06-21T19:01:40+08:00 daily https://www.pharmasources.com/industryinsights/anti-vaccine-movement-a-man-made-health--313043.html 0.6 2026-08-11T13:15:01+08:00 daily https://www.pharmasources.com/industryinsights/adverse-outcomes-up-for-pregnant-women-w-313044.html 0.6 2025-12-23T03:33:34+08:00 daily https://www.pharmasources.com/industryinsights/ping-an-wins-top-ranking-in-global-artif-313045.html 0.6 2026-07-23T17:33:13+08:00 daily https://www.pharmasources.com/industryinsights/integrated-operating-rooms-to-grow-expon-313046.html 0.6 2026-06-27T08:03:34+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-acquires-rare-disease-biotech-the-313047.html 0.6 2026-06-21T03:13:53+08:00 daily https://www.pharmasources.com/industryinsights/taisho-pharmaceutical-concludes-acquisit-313048.html 0.6 2026-07-09T01:21:37+08:00 daily https://www.pharmasources.com/industryinsights/cancer-research-uk-forms-alliance-for-on-313049.html 0.6 2026-06-21T20:49:08+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-partners-with-yuhan-for-liver-313050.html 0.6 2026-05-02T07:08:03+08:00 daily https://www.pharmasources.com/industryinsights/zirabev-gets-fda-approval-to-treat-five--313051.html 0.6 2026-06-22T00:42:36+08:00 daily https://www.pharmasources.com/industryinsights/imbruvica-receives-positive-opinion-from-313052.html 0.6 2026-01-14T10:23:24+08:00 daily https://www.pharmasources.com/industryinsights/sensorions-pip-is-ema-approved-for-two-i-313053.html 0.6 2026-02-28T17:43:33+08:00 daily https://www.pharmasources.com/industryinsights/fda-warns-repackers-distributing-pharmac-313054.html 0.6 2026-08-04T08:42:01+08:00 daily https://www.pharmasources.com/industryinsights/biohaven-enrolls-first-patient-in-rimege-313055.html 0.6 2025-12-13T22:29:48+08:00 daily https://www.pharmasources.com/industryinsights/appili-signs-grant-contract-with-dod-to--313056.html 0.6 2026-06-22T00:55:14+08:00 daily https://www.pharmasources.com/industryinsights/asieris-photocure-enter-into-license-agr-313057.html 0.6 2026-06-21T06:00:48+08:00 daily https://www.pharmasources.com/industryinsights/compugen-announces-board-of-directors-ap-313058.html 0.6 2026-06-21T08:58:56+08:00 daily https://www.pharmasources.com/industryinsights/leo-pharma-completes-acquisition-of-baye-313059.html 0.6 2026-07-21T09:07:26+08:00 daily https://www.pharmasources.com/industryinsights/enesi-pharma-adds-to-scientific-advisory-313060.html 0.6 2026-04-29T00:45:31+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-completes-acquisition-of-theracho-313061.html 0.6 2026-06-22T02:33:17+08:00 daily https://www.pharmasources.com/industryinsights/actobio-therapeutics-progresses-diabetes-313062.html 0.6 2026-08-04T17:53:03+08:00 daily https://www.pharmasources.com/industryinsights/takeda-completes-sale-of-xiidra-to-novar-313063.html 0.6 2026-06-21T03:01:44+08:00 daily https://www.pharmasources.com/industryinsights/teva-launches-1-sodium-hyaluronate-in-us-313064.html 0.6 2026-06-23T11:56:37+08:00 daily https://www.pharmasources.com/industryinsights/confo-therapeutics-and-dynabind-announce-313065.html 0.6 2026-07-05T05:58:33+08:00 daily https://www.pharmasources.com/industryinsights/leo-pharma-completes-the-acquisition-of--313066.html 0.6 2026-08-06T08:59:18+08:00 daily https://www.pharmasources.com/industryinsights/warren-blasts-gottliebs-jump-to-pfizer-b-313067.html 0.6 2026-06-21T03:00:38+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-regenerons-libtayo-hits-hot-strea-313068.html 0.6 2026-07-03T04:27:35+08:00 daily https://www.pharmasources.com/industryinsights/gsk-taps-nascar-favorite-to-drive-awaren-313069.html 0.6 2026-07-04T15:43:47+08:00 daily https://www.pharmasources.com/industryinsights/in-a-crowded-psoriasis-field-who-could-n-313070.html 0.6 2026-07-21T16:47:43+08:00 daily https://www.pharmasources.com/industryinsights/amarin-plots-salesforce-hiring-binge-to--313071.html 0.6 2026-06-29T11:23:37+08:00 daily https://www.pharmasources.com/industryinsights/in-cybersquatting-lawsuit-adamis-says-ri-313072.html 0.6 2026-07-03T23:36:52+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-and-catalent-to-manufactur-313073.html 0.6 2026-07-08T15:53:56+08:00 daily https://www.pharmasources.com/industryinsights/array-played-with-pfizers-eagerness-to-l-313074.html 0.6 2026-07-13T12:21:55+08:00 daily https://www.pharmasources.com/industryinsights/array-ceo-squarers-set-to-reap-210m-in-p-313075.html 0.6 2025-12-13T22:50:13+08:00 daily https://www.pharmasources.com/industryinsights/mylan-investors-favor-expanding-exec-pay-313076.html 0.6 2026-06-30T13:54:43+08:00 daily https://www.pharmasources.com/industryinsights/pharma-shells-out-3b-to-doctors-and-hosp-313077.html 0.6 2026-07-26T21:36:04+08:00 daily https://www.pharmasources.com/industryinsights/pelosi-aims-for-feds-to-negotiate-drug-p-313078.html 0.6 2026-06-23T09:03:42+08:00 daily https://www.pharmasources.com/industryinsights/endo-enlists-americas-favorite-penis-doc-313079.html 0.6 2026-06-20T14:56:09+08:00 daily https://www.pharmasources.com/industryinsights/novartis-unloading-sterile-production-fa-313080.html 0.6 2026-06-21T12:08:18+08:00 daily https://www.pharmasources.com/industryinsights/sage-strategy-for-postpartum-depression--313081.html 0.6 2026-06-22T08:04:50+08:00 daily https://www.pharmasources.com/industryinsights/with-remarkable-data-biogens-spinraza-sh-313082.html 0.6 2026-06-23T10:55:53+08:00 daily https://www.pharmasources.com/industryinsights/jjs-darzalex-pads-blockbuster-sales-with-313083.html 0.6 2026-06-21T01:03:48+08:00 daily https://www.pharmasources.com/industryinsights/cue-the-revolving-door-criticism-former--313084.html 0.6 2026-06-21T15:49:10+08:00 daily https://www.pharmasources.com/industryinsights/merck-pfizer-keep-high-flying-vaccine-sa-313085.html 0.6 2026-06-21T07:00:03+08:00 daily https://www.pharmasources.com/industryinsights/alexion-nabs-potential-1b-indication-for-313086.html 0.6 2026-07-02T23:12:37+08:00 daily https://www.pharmasources.com/industryinsights/pharma-back-in-hot-seat-as-2020-presiden-313087.html 0.6 2026-08-05T22:15:33+08:00 daily https://www.pharmasources.com/industryinsights/can-tiny-dova-take-on-novartis-with-its--313088.html 0.6 2026-06-21T08:58:04+08:00 daily https://www.pharmasources.com/industryinsights/catalent-snaps-up-novavax-production-sit-313089.html 0.6 2026-06-21T13:05:32+08:00 daily https://www.pharmasources.com/industryinsights/us-reps-to-gilead-did-your-donation-of-f-313090.html 0.6 2026-03-30T17:30:52+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-imfinzi-tees-up-small-cell--313091.html 0.6 2026-06-21T13:05:33+08:00 daily https://www.pharmasources.com/industryinsights/y-mabs-secures-commercial-radiolabeling--313092.html 0.6 2026-06-22T00:10:53+08:00 daily https://www.pharmasources.com/industryinsights/tilt-biotherapeutics-to-collaborate-with-313093.html 0.6 2026-06-08T11:56:39+08:00 daily https://www.pharmasources.com/industryinsights/confo-therapeutics-and-dynabind-to-colla-313094.html 0.6 2026-07-03T19:46:00+08:00 daily https://www.pharmasources.com/industryinsights/evotec-acquires-biotherapeutics-313095.html 0.6 2026-06-21T19:14:19+08:00 daily https://www.pharmasources.com/industryinsights/tekni-plex-purchases-lameplast-313096.html 0.6 2026-04-16T00:38:00+08:00 daily https://www.pharmasources.com/industryinsights/chi-meds-surufatinib-study-meets-primary-313097.html 0.6 2026-06-29T01:19:35+08:00 daily https://www.pharmasources.com/industryinsights/regis-technologies-expands-capabilities-313098.html 0.6 2026-07-04T14:57:48+08:00 daily https://www.pharmasources.com/industryinsights/just-biotherapeutics-and-teva-form-biolo-313099.html 0.6 2026-06-21T12:23:09+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-xpovio-selinexor-for-the-tr-313100.html 0.6 2026-06-21T11:18:31+08:00 daily https://www.pharmasources.com/industryinsights/most-adult-use-cannabis-customers-use-fo-313101.html 0.6 2026-06-20T19:57:39+08:00 daily https://www.pharmasources.com/industryinsights/doj-asks-congress-to-permanently-classif-313102.html 0.6 2026-06-22T09:57:40+08:00 daily https://www.pharmasources.com/industryinsights/il-6-level-may-predict-symptom-duration--313103.html 0.6 2026-06-21T09:00:00+08:00 daily https://www.pharmasources.com/industryinsights/concussion-recovery-isnt-the-same-for-ev-313104.html 0.6 2025-12-13T23:21:18+08:00 daily https://www.pharmasources.com/industryinsights/wic-changes-improve-moms-and-babies-heal-313105.html 0.6 2026-06-20T16:02:17+08:00 daily https://www.pharmasources.com/industryinsights/easing-depression-can-bring-longer-life--313106.html 0.6 2026-06-21T13:12:50+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-thiola-ec-tiopronin-for-the-313107.html 0.6 2026-08-10T12:01:01+08:00 daily https://www.pharmasources.com/industryinsights/millions-of-life-years-billions-of-dolla-313108.html 0.6 2026-08-06T23:55:43+08:00 daily https://www.pharmasources.com/industryinsights/stillbirth-risk-rises-with-prolonged-pre-313109.html 0.6 2026-08-06T23:46:56+08:00 daily https://www.pharmasources.com/industryinsights/different-clinical-layouts-of-chinese-pr-313110.html 0.6 2026-07-19T13:06:33+08:00 daily https://www.pharmasources.com/industryinsights/need-emergency-air-lift-to-hospital-it-c-313111.html 0.6 2026-08-06T23:56:26+08:00 daily https://www.pharmasources.com/industryinsights/survey-urges-grandparents-to-lock-down-t-313112.html 0.6 2026-08-07T02:41:21+08:00 daily https://www.pharmasources.com/industryinsights/image-based-model-predicts-radiation-tx--313113.html 0.6 2026-08-07T02:48:42+08:00 daily https://www.pharmasources.com/industryinsights/urine-biomarker-helps-classify-risk-leve-313114.html 0.6 2026-08-07T02:52:11+08:00 daily https://www.pharmasources.com/industryinsights/interventions-linked-to-drop-in-unvaccin-313115.html 0.6 2026-06-20T21:13:46+08:00 daily https://www.pharmasources.com/industryinsights/lack-of-evidence-for-treating-chronic-pa-313116.html 0.6 2026-06-20T23:56:38+08:00 daily https://www.pharmasources.com/industryinsights/adding-clinical-variables-aids-in-lung-a-313117.html 0.6 2026-06-20T20:43:25+08:00 daily https://www.pharmasources.com/industryinsights/libtayo-approved-for-cscc-in-the-eu-incl-313118.html 0.6 2026-08-10T11:07:37+08:00 daily https://www.pharmasources.com/industryinsights/predictors-of-recovery-after-brain-injur-313119.html 0.6 2026-06-22T00:01:45+08:00 daily https://www.pharmasources.com/industryinsights/chmp-issues-positive-opinion-for-astraze-313120.html 0.6 2026-06-21T07:09:29+08:00 daily https://www.pharmasources.com/industryinsights/century-therapeutics-secures-250m-to-dev-313121.html 0.6 2026-06-21T02:08:05+08:00 daily https://www.pharmasources.com/industryinsights/regional-fat-with-normal-bmi-affects-cvd-313122.html 0.6 2026-06-21T08:52:54+08:00 daily https://www.pharmasources.com/industryinsights/novartis-acquires-ophthalmic-drug-from-t-313123.html 0.6 2026-06-21T09:15:10+08:00 daily https://www.pharmasources.com/industryinsights/viiv-healthcare-receives-ma-in-europe-fo-313124.html 0.6 2026-06-22T00:54:51+08:00 daily https://www.pharmasources.com/industryinsights/tanezumab-improves-scores-for-pain-funct-313125.html 0.6 2026-06-20T14:41:01+08:00 daily https://www.pharmasources.com/industryinsights/neurofilament-light-chain-levels-predict-313126.html 0.6 2026-08-09T00:43:13+08:00 daily https://www.pharmasources.com/industryinsights/flesh-eating-bacteria-claims-life-of-flo-313127.html 0.6 2026-01-14T04:36:17+08:00 daily https://www.pharmasources.com/industryinsights/luminex-submits-aries-mrsa-assay-for-fda-313128.html 0.6 2025-12-13T23:44:56+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-announces-launch-of-carboprost-313129.html 0.6 2026-06-21T14:48:15+08:00 daily https://www.pharmasources.com/industryinsights/global-pharmaceutical-filler-market-set--313130.html 0.6 2026-08-04T19:37:20+08:00 daily https://www.pharmasources.com/industryinsights/fresenius-kabi-issues-recall-of-two-lots-313131.html 0.6 2026-02-27T09:26:18+08:00 daily https://www.pharmasources.com/industryinsights/fda-issues-three-warning-letters-to-api--313132.html 0.6 2026-08-03T03:28:41+08:00 daily https://www.pharmasources.com/industryinsights/boston-biomedical-discontinues-napabucas-313133.html 0.6 2026-06-30T22:39:09+08:00 daily https://www.pharmasources.com/industryinsights/akero-announces-dosing-of-first-patient--313134.html 0.6 2026-06-21T03:07:46+08:00 daily https://www.pharmasources.com/industryinsights/bioinvent-receives-ind-approval-for-phas-313135.html 0.6 2026-08-11T14:10:08+08:00 daily https://www.pharmasources.com/industryinsights/leo-pharma-completes-acquisition-of-baye-313136.html 0.6 2026-06-22T21:04:03+08:00 daily https://www.pharmasources.com/industryinsights/nosopharm-and-evotec-enter-into-collabor-313137.html 0.6 2026-06-20T22:59:39+08:00 daily https://www.pharmasources.com/industryinsights/strides-pharma-puducherry-unit-receives--313138.html 0.6 2026-06-21T10:17:28+08:00 daily https://www.pharmasources.com/industryinsights/report-suggests-process-for-vaccine-tria-313139.html 0.6 2026-06-21T01:02:50+08:00 daily https://www.pharmasources.com/industryinsights/gilead-sciences-announces-launch-of-asia-313140.html 0.6 2026-08-09T15:05:39+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-launches-generic-hemabate-inje-313141.html 0.6 2026-06-22T04:55:47+08:00 daily https://www.pharmasources.com/industryinsights/new-analysis-shows-that-3400-drug-prices-313142.html 0.6 2026-06-20T18:54:53+08:00 daily https://www.pharmasources.com/industryinsights/union-budget-2019-what-does-the-indian-p-313143.html 0.6 2026-06-21T00:03:38+08:00 daily https://www.pharmasources.com/industryinsights/esperer-bioresearch-launches-health-supp-313144.html 0.6 2026-03-31T23:29:18+08:00 daily https://www.pharmasources.com/industryinsights/saince-launches-qural-a-healthcare-commu-313145.html 0.6 2026-06-22T09:13:00+08:00 daily https://www.pharmasources.com/industryinsights/novartis-announces-26-week-gender-neutra-313146.html 0.6 2026-06-20T15:41:57+08:00 daily https://www.pharmasources.com/industryinsights/latest-technologies-to-transform-healthc-313147.html 0.6 2026-06-21T13:01:35+08:00 daily https://www.pharmasources.com/industryinsights/bridge-biotherapeutics-becomes-new-resid-313148.html 0.6 2026-06-30T13:54:39+08:00 daily https://www.pharmasources.com/industryinsights/miraca-and-7sbio-announce-strategic-inve-313149.html 0.6 2026-06-24T19:00:17+08:00 daily https://www.pharmasources.com/industryinsights/interphex-japan-puts-up-an-impressive-sh-313150.html 0.6 2026-06-22T02:58:40+08:00 daily https://www.pharmasources.com/industryinsights/chinese-red-cross-foundation-initiates-r-313151.html 0.6 2026-08-03T02:37:58+08:00 daily https://www.pharmasources.com/industryinsights/gilead-sciences-announces-launch-of-asia-313152.html 0.6 2026-06-21T04:16:12+08:00 daily https://www.pharmasources.com/industryinsights/agenda-for-the-3rd-annual-big-data-ai-le-313153.html 0.6 2026-06-22T00:54:46+08:00 daily https://www.pharmasources.com/industryinsights/ping-ans-insight-on-transformative-power-313154.html 0.6 2026-08-11T00:46:27+08:00 daily https://www.pharmasources.com/industryinsights/leo-pharma-completes-the-acquisition-of--313155.html 0.6 2026-07-06T02:04:38+08:00 daily https://www.pharmasources.com/industryinsights/omada-health-raises-73m-to-accelerate-pr-313156.html 0.6 2026-06-21T10:56:08+08:00 daily https://www.pharmasources.com/industryinsights/advent-access-receives-ce-mark-for-av-gu-313157.html 0.6 2026-07-03T03:23:37+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-inks-870m-worth-dea-313158.html 0.6 2026-06-21T06:15:59+08:00 daily https://www.pharmasources.com/industryinsights/crystallised-drug-formulation-extends-me-313159.html 0.6 2026-06-21T06:22:12+08:00 daily https://www.pharmasources.com/industryinsights/fda-releases-guidance-on-pharmaceutical--313160.html 0.6 2026-06-21T03:06:45+08:00 daily https://www.pharmasources.com/industryinsights/the-chief-executive-of-abpi-has-announce-313161.html 0.6 2026-06-25T03:05:52+08:00 daily https://www.pharmasources.com/industryinsights/clinical-trial-sponsors-called-to-publis-313162.html 0.6 2026-06-22T04:03:45+08:00 daily https://www.pharmasources.com/industryinsights/macleods-pharmaceuticals-issues-recall-d-313163.html 0.6 2026-06-20T15:55:28+08:00 daily https://www.pharmasources.com/industryinsights/fasenra-receives-positive-eu-chmp-opinio-313164.html 0.6 2026-06-22T12:10:10+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-treatment-for-rare-neurolog-313165.html 0.6 2026-06-21T11:57:13+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-successfully-completes-the-acquis-313166.html 0.6 2026-06-12T14:57:42+08:00 daily https://www.pharmasources.com/industryinsights/abpi-finds-377-million-spent-on-uk-rd-313167.html 0.6 2026-06-22T21:34:49+08:00 daily https://www.pharmasources.com/industryinsights/former-fda-commissioner-joins-pfizers-bo-313168.html 0.6 2026-06-20T16:44:01+08:00 daily https://www.pharmasources.com/industryinsights/ema-releases-medicinal-approval-recommen-313169.html 0.6 2026-08-09T04:58:16+08:00 daily https://www.pharmasources.com/industryinsights/sports-playbook-helps-doctors-predict-ca-313170.html 0.6 2026-06-20T14:59:08+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-treatment-for-refractor-313171.html 0.6 2026-06-27T13:54:00+08:00 daily https://www.pharmasources.com/industryinsights/new-study-showing-drug-prolongs-life-for-313172.html 0.6 2026-06-30T10:46:54+08:00 daily https://www.pharmasources.com/industryinsights/its-mosquito-season-heres-how-to-protect-313173.html 0.6 2026-06-22T01:01:51+08:00 daily https://www.pharmasources.com/industryinsights/dont-drink-and-drive-on-the-fourth-313174.html 0.6 2026-06-22T10:08:02+08:00 daily https://www.pharmasources.com/industryinsights/how-to-avoid-information-overload-313175.html 0.6 2026-06-20T19:19:57+08:00 daily https://www.pharmasources.com/industryinsights/health-tip-understanding-root-canal-313176.html 0.6 2025-10-28T21:20:40+08:00 daily https://www.pharmasources.com/industryinsights/health-tip-severe-thunderstorm-safety-313177.html 0.6 2026-06-22T01:51:33+08:00 daily https://www.pharmasources.com/industryinsights/male-students-affected-more-by-poor-diet-313178.html 0.6 2026-06-21T03:07:43+08:00 daily https://www.pharmasources.com/industryinsights/mental-health-service-use-up-after-campa-313179.html 0.6 2026-08-11T13:55:29+08:00 daily https://www.pharmasources.com/industryinsights/dont-let-fireworks-deafen-you-313180.html 0.6 2026-06-29T15:40:16+08:00 daily https://www.pharmasources.com/industryinsights/febuxostat-fe-bux-oh-stat-313181.html 0.6 2026-08-03T22:18:21+08:00 daily https://www.pharmasources.com/industryinsights/phenylephrine-and-ketorolac-fen-il-ef-ri-313182.html 0.6 2026-07-09T18:34:23+08:00 daily https://www.pharmasources.com/industryinsights/assessing-host-cell-protein-contaminatio-313183.html 0.6 2026-06-20T17:05:23+08:00 daily https://www.pharmasources.com/industryinsights/analytical-methods-used-in-obtaining-hig-313184.html 0.6 2026-06-30T05:01:15+08:00 daily https://www.pharmasources.com/industryinsights/capsosomes-the-revolutionary-enzyme-carr-313185.html 0.6 2026-06-21T09:15:14+08:00 daily https://www.pharmasources.com/industryinsights/digital-design-for-pharmaceutical-produc-313186.html 0.6 2026-06-20T19:09:59+08:00 daily https://www.pharmasources.com/industryinsights/the-impact-of-counterfeit-drugs-in-south-313187.html 0.6 2026-07-20T03:02:54+08:00 daily https://www.pharmasources.com/industryinsights/expert-view-eshmuno-cp-ft-resin-develope-313188.html 0.6 2026-06-21T05:59:45+08:00 daily https://www.pharmasources.com/industryinsights/implementing-global-standards-to-ensure--313189.html 0.6 2026-06-21T07:02:15+08:00 daily https://www.pharmasources.com/industryinsights/raman-spectroscopy-of-the-amorphous-phas-313190.html 0.6 2026-07-20T06:01:03+08:00 daily https://www.pharmasources.com/industryinsights/do-viability-methods-detect-all-viable-o-313191.html 0.6 2026-07-05T09:08:10+08:00 daily https://www.pharmasources.com/industryinsights/tadalafil-uksc-decision-evolution-of-the-313192.html 0.6 2026-06-21T05:54:44+08:00 daily https://www.pharmasources.com/industryinsights/researchers-model-binding-of-drug-to-mit-313193.html 0.6 2026-06-21T00:05:40+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-karyopharms-multiple-myelom-313194.html 0.6 2026-07-19T14:58:24+08:00 daily https://www.pharmasources.com/industryinsights/dundee-university-and-bukwang-to-develop-313195.html 0.6 2026-06-22T15:52:45+08:00 daily https://www.pharmasources.com/industryinsights/crispr-study-offers-hope-for-potential-h-313196.html 0.6 2026-04-15T21:47:06+08:00 daily https://www.pharmasources.com/industryinsights/indian-pharma-industry-to-grow-at-11-13--313197.html 0.6 2026-06-21T00:55:52+08:00 daily https://www.pharmasources.com/industryinsights/e-pharmacies-claim-in-hc-they-are-like-s-313198.html 0.6 2026-07-12T11:08:29+08:00 daily https://www.pharmasources.com/industryinsights/mfine-raises-rs-31-crore-in-venture-debt-313199.html 0.6 2026-08-08T22:17:01+08:00 daily https://www.pharmasources.com/industryinsights/ministry-of-ayush-signs-mou-with-ministr-313200.html 0.6 2026-08-07T04:00:47+08:00 daily https://www.pharmasources.com/industryinsights/lupin-receives-us-fda-approval-for-pheny-313201.html 0.6 2026-08-08T23:52:44+08:00 daily https://www.pharmasources.com/industryinsights/neurovive-initiates-second-part-of-its-o-313202.html 0.6 2026-06-21T09:12:18+08:00 daily https://www.pharmasources.com/industryinsights/fosun-launches-fourth-edition-of-its-acc-313203.html 0.6 2026-06-22T18:58:03+08:00 daily https://www.pharmasources.com/industryinsights/new-england-biolabs-inc-opens-eighth-sub-313204.html 0.6 2026-06-21T20:13:46+08:00 daily https://www.pharmasources.com/industryinsights/china-sxt-pharmaceuticals-inc-announces--313205.html 0.6 2026-08-13T17:56:23+08:00 daily https://www.pharmasources.com/industryinsights/a2a-pharmaceuticals-appoints-dr-sotirios-313206.html 0.6 2026-06-20T14:41:58+08:00 daily https://www.pharmasources.com/industryinsights/tsinghua-university-amgen-scholars-progr-313207.html 0.6 2026-07-28T05:50:33+08:00 daily https://www.pharmasources.com/industryinsights/dachser-india-receives-iata-ceiv-pharma--313208.html 0.6 2026-08-07T12:00:46+08:00 daily https://www.pharmasources.com/industryinsights/csl-behring-delivers-on-its-promise-to-a-313209.html 0.6 2026-08-09T02:22:09+08:00 daily https://www.pharmasources.com/industryinsights/nanologica-starts-business-within-prepar-313210.html 0.6 2026-08-14T04:58:25+08:00 daily https://www.pharmasources.com/industryinsights/cardiac-dimensions-reaches-1000-implants-313211.html 0.6 2026-08-07T01:19:36+08:00 daily https://www.pharmasources.com/industryinsights/alembic-pharma-gets-usfda-nod-for-seizur-313212.html 0.6 2026-08-07T01:27:40+08:00 daily https://www.pharmasources.com/industryinsights/drugs-on-a-coil-method-could-free-patien-313213.html 0.6 2026-08-07T01:52:09+08:00 daily https://www.pharmasources.com/industryinsights/keep-unused-meds-out-of-the-hands-of-add-313214.html 0.6 2026-08-07T02:04:46+08:00 daily https://www.pharmasources.com/industryinsights/decision-by-nice-for-the-use-of-osimerti-313215.html 0.6 2026-08-07T02:09:49+08:00 daily https://www.pharmasources.com/industryinsights/dont-forget-your-pets-in-emergency-plans-313216.html 0.6 2026-08-13T02:04:17+08:00 daily https://www.pharmasources.com/industryinsights/phase-iii-programme-for-the-use-otilimab-313217.html 0.6 2026-08-09T10:33:44+08:00 daily https://www.pharmasources.com/industryinsights/exercising-when-you-have-high-blood-pres-313218.html 0.6 2026-06-21T10:09:24+08:00 daily https://www.pharmasources.com/industryinsights/surgeons-give-13-paralyzed-adults-hand-a-313219.html 0.6 2026-06-21T00:38:31+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-grifols-xembify-for-immunod-313220.html 0.6 2026-07-04T22:52:55+08:00 daily https://www.pharmasources.com/industryinsights/how-to-create-a-diet-that-lowers-your-ch-313221.html 0.6 2026-07-20T07:59:43+08:00 daily https://www.pharmasources.com/industryinsights/how-protect-against-short--and-long-term-313222.html 0.6 2026-06-20T22:14:25+08:00 daily https://www.pharmasources.com/industryinsights/health-tip-preventing-child-burns-313223.html 0.6 2026-06-20T15:09:22+08:00 daily https://www.pharmasources.com/industryinsights/study-finds-common-cold-virus-could-help-313224.html 0.6 2026-06-26T16:15:24+08:00 daily https://www.pharmasources.com/industryinsights/nosopharm-and-evotec-to-develop-antibiot-313225.html 0.6 2026-06-20T15:12:18+08:00 daily https://www.pharmasources.com/industryinsights/biogen-secures-extended-access-agreement-313226.html 0.6 2026-06-20T18:05:19+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-xembify-20-subcutaneous-imm-313227.html 0.6 2026-06-20T20:19:49+08:00 daily https://www.pharmasources.com/industryinsights/cyxone-submits-first-application-to-star-313228.html 0.6 2026-06-21T09:06:04+08:00 daily https://www.pharmasources.com/industryinsights/altaire-issues-recall-of-multiple-ophtha-313229.html 0.6 2026-06-21T00:56:45+08:00 daily https://www.pharmasources.com/industryinsights/bioinvent-receives-tak-169-ind-applicati-313230.html 0.6 2026-06-24T05:03:23+08:00 daily https://www.pharmasources.com/industryinsights/wasdell-begins-operations-at-eu-hq-313231.html 0.6 2026-06-19T10:47:58+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-accelerated-approval-to-selin-313232.html 0.6 2026-06-20T18:01:27+08:00 daily https://www.pharmasources.com/industryinsights/price-erosion-symptoms-dr-reddys-laborat-313233.html 0.6 2026-08-07T05:06:16+08:00 daily https://www.pharmasources.com/industryinsights/budget-reactions-2019-313234.html 0.6 2026-08-07T02:40:15+08:00 daily https://www.pharmasources.com/industryinsights/isth-announces-launch-of-new-global-educ-313235.html 0.6 2026-06-24T01:08:10+08:00 daily https://www.pharmasources.com/industryinsights/prestige-biopharma-and-pharmapark-announ-313236.html 0.6 2026-08-06T23:47:27+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2019070-313237.html 0.6 2026-06-24T12:05:58+08:00 daily https://www.pharmasources.com/industryinsights/new-portable-viscometer-enables-reliable-313238.html 0.6 2026-08-06T19:23:33+08:00 daily https://www.pharmasources.com/industryinsights/gsk-opens-new-pharma-manufacturing-facil-313239.html 0.6 2026-08-14T14:37:54+08:00 daily https://www.pharmasources.com/industryinsights/cobo-technologies-sciex-partner-to-devel-313240.html 0.6 2026-08-06T20:08:03+08:00 daily https://www.pharmasources.com/industryinsights/incyte-and-zai-lab-enter-into-775m-colla-313241.html 0.6 2026-08-06T23:46:41+08:00 daily https://www.pharmasources.com/industryinsights/takeda-announces-results-from-phase-iiib-313242.html 0.6 2026-06-22T07:07:56+08:00 daily https://www.pharmasources.com/industryinsights/sangamo-pfizer-announce-updated-phase-12-313243.html 0.6 2026-08-07T05:50:58+08:00 daily https://www.pharmasources.com/industryinsights/fsd-pharma-closes-deal-and-acquires-pris-313244.html 0.6 2026-08-08T19:21:40+08:00 daily https://www.pharmasources.com/industryinsights/nmpa-grants-priority-review-to-beigenes--313245.html 0.6 2026-08-09T00:41:01+08:00 daily https://www.pharmasources.com/industryinsights/varian-inks-bead-agreement-with-boston-s-313246.html 0.6 2026-06-21T04:42:26+08:00 daily https://www.pharmasources.com/industryinsights/asia-healthtech-momentum-continues-unaba-313247.html 0.6 2026-06-21T16:21:48+08:00 daily https://www.pharmasources.com/industryinsights/fda-promo-police-spank-aclaris-for-misle-313248.html 0.6 2026-06-20T23:09:50+08:00 daily https://www.pharmasources.com/industryinsights/jazz-targets-docs-consumers-with-branded-313249.html 0.6 2026-06-22T23:09:16+08:00 daily https://www.pharmasources.com/industryinsights/karyopharms-xpovio-nabs-myeloma-nod-desp-313250.html 0.6 2026-07-06T03:57:44+08:00 daily https://www.pharmasources.com/industryinsights/trump-seeks-favored-nation-order-on-drug-313251.html 0.6 2026-02-28T15:34:55+08:00 daily https://www.pharmasources.com/industryinsights/nice-shuts-down-azs-tagrissoand-backs-pf-313252.html 0.6 2025-11-07T08:26:17+08:00 daily https://www.pharmasources.com/industryinsights/skyhawk-biogen-expand-alliance-in-neurol-313253.html 0.6 2026-06-23T02:48:47+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-yuhan-enter-nash-pact-313254.html 0.6 2026-08-11T15:11:33+08:00 daily https://www.pharmasources.com/industryinsights/optima-opens-cspe-center-313255.html 0.6 2026-06-20T19:04:38+08:00 daily https://www.pharmasources.com/industryinsights/most-supplements-offer-little-protection-313256.html 0.6 2026-07-08T09:58:49+08:00 daily https://www.pharmasources.com/industryinsights/infective-endocarditis-prevalence-26-per-313257.html 0.6 2026-07-06T14:15:12+08:00 daily https://www.pharmasources.com/industryinsights/operating-time-for-hip-knee-replacement--313258.html 0.6 2026-07-03T06:02:31+08:00 daily https://www.pharmasources.com/industryinsights/eye-drops-ointments-sold-at-walgreens-re-313259.html 0.6 2026-06-27T11:35:15+08:00 daily https://www.pharmasources.com/industryinsights/consistent-time-of-day-aids-workout-habi-313260.html 0.6 2026-08-06T22:09:38+08:00 daily https://www.pharmasources.com/industryinsights/semi-slug-is-spreading-a-lethal-parasite-313261.html 0.6 2026-07-08T18:19:37+08:00 daily https://www.pharmasources.com/industryinsights/one-downside-of-legalized-pot-poisoned-p-313262.html 0.6 2026-08-10T12:10:56+08:00 daily https://www.pharmasources.com/industryinsights/hormone-treatment-for-prostate-cancer-li-313263.html 0.6 2026-08-06T14:10:02+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-surprising-lack-of-progress-on--313264.html 0.6 2026-06-23T07:03:06+08:00 daily https://www.pharmasources.com/industryinsights/meals-on-wheels-delivers-an-extra-health-313265.html 0.6 2026-06-20T20:51:32+08:00 daily https://www.pharmasources.com/industryinsights/teens-risk-seizures-coma-when-they-use-s-313266.html 0.6 2026-08-05T13:57:18+08:00 daily https://www.pharmasources.com/industryinsights/eu-releases-guidance-for-medicine-shorta-313267.html 0.6 2026-06-21T08:04:01+08:00 daily https://www.pharmasources.com/industryinsights/nice-endorses-dacomitinib-for-treatment--313268.html 0.6 2026-06-21T09:04:04+08:00 daily https://www.pharmasources.com/industryinsights/survey-reveals-gaps-in-opioid-rx-pattern-313269.html 0.6 2026-06-21T00:10:43+08:00 daily https://www.pharmasources.com/industryinsights/45-percent-of-us-adults-have-some-doubts-313270.html 0.6 2026-06-22T05:53:34+08:00 daily https://www.pharmasources.com/industryinsights/treating-depression-may-reduce-mortality-313271.html 0.6 2026-06-20T21:53:43+08:00 daily https://www.pharmasources.com/industryinsights/early-nerve-transfer-enables-hand-functi-313272.html 0.6 2026-06-22T11:47:54+08:00 daily https://www.pharmasources.com/industryinsights/extended-follow-up-supports-low-dose-ct--313273.html 0.6 2025-12-16T18:05:38+08:00 daily https://www.pharmasources.com/industryinsights/merck-and-utah-university-find-potential-313274.html 0.6 2026-06-21T06:51:56+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-pfizers-dacomitinib-for--313275.html 0.6 2026-06-21T12:08:13+08:00 daily https://www.pharmasources.com/industryinsights/new-staffing-data-source-can-improve-nur-313276.html 0.6 2026-06-21T18:01:21+08:00 daily https://www.pharmasources.com/industryinsights/eisai-forms-protacs-research-collaborati-313277.html 0.6 2026-06-21T07:11:02+08:00 daily https://www.pharmasources.com/industryinsights/sexual-activity-may-cut-disability-in-me-313278.html 0.6 2026-08-08T03:01:37+08:00 daily https://www.pharmasources.com/industryinsights/mylan-atomo-announce-who-prequalificatio-313279.html 0.6 2026-07-28T20:08:03+08:00 daily https://www.pharmasources.com/industryinsights/hormone-treatment-for-prostate-cancer-li-313280.html 0.6 2026-06-21T05:07:53+08:00 daily https://www.pharmasources.com/industryinsights/do-you-need-vitamin-enhanced-foods-313281.html 0.6 2026-06-22T08:01:47+08:00 daily https://www.pharmasources.com/industryinsights/4d-pharma-commences-phase-iii-asthma-tri-313282.html 0.6 2026-08-12T22:16:08+08:00 daily https://www.pharmasources.com/industryinsights/first-participant-enrolled-in-second-pha-313283.html 0.6 2026-08-07T16:28:22+08:00 daily https://www.pharmasources.com/industryinsights/the-dhsc-has-announced-their-plans-for-p-313284.html 0.6 2025-12-16T17:52:25+08:00 daily https://www.pharmasources.com/industryinsights/fda-announces-public-health-emergency-pr-313285.html 0.6 2026-06-22T00:48:58+08:00 daily https://www.pharmasources.com/industryinsights/emmaus-announces-initiation-of-its-diver-313286.html 0.6 2026-06-22T02:12:49+08:00 daily https://www.pharmasources.com/industryinsights/prestige-biopharma-releases-positive-res-313287.html 0.6 2026-02-08T18:22:38+08:00 daily https://www.pharmasources.com/industryinsights/prestige-biopharma-and-pharmapark-announ-313288.html 0.6 2026-08-07T23:41:20+08:00 daily https://www.pharmasources.com/industryinsights/cellect-biotechnology-washington-univers-313289.html 0.6 2026-08-09T06:59:26+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-pharmaceuticals-receives-anda-a-313290.html 0.6 2026-08-06T20:07:55+08:00 daily https://www.pharmasources.com/industryinsights/natural-antioxidant-helps-improve-immune-313291.html 0.6 2026-08-06T23:48:21+08:00 daily https://www.pharmasources.com/industryinsights/jiva-ayurveda-to-offer-free-consultation-313292.html 0.6 2026-08-06T23:50:24+08:00 daily https://www.pharmasources.com/industryinsights/union-health-ministrys-proposal-to-class-313293.html 0.6 2026-08-06T23:56:51+08:00 daily https://www.pharmasources.com/industryinsights/new-vaccine-in-the-treatment-of-rheumato-313294.html 0.6 2026-08-10T08:39:15+08:00 daily https://www.pharmasources.com/industryinsights/sitma-finds-an-answer-for-servitization-313295.html 0.6 2026-08-12T18:59:39+08:00 daily https://www.pharmasources.com/industryinsights/asia-healthtech-momentum-continues-unaba-313296.html 0.6 2026-06-20T16:17:01+08:00 daily https://www.pharmasources.com/industryinsights/medeon-completes-investments-in-panther--313297.html 0.6 2026-08-14T13:17:34+08:00 daily https://www.pharmasources.com/industryinsights/university-of-oslo-iavi-and-thsti-to-dev-313298.html 0.6 2026-06-20T16:57:16+08:00 daily https://www.pharmasources.com/industryinsights/eisai-collaborates-with-university-of-du-313299.html 0.6 2026-06-26T03:41:08+08:00 daily https://www.pharmasources.com/industryinsights/ag-mednet-median-technologies-to-conduct-313300.html 0.6 2026-08-05T11:04:57+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-receives-anda-approval-for-rano-313301.html 0.6 2026-06-22T00:59:51+08:00 daily https://www.pharmasources.com/industryinsights/daewoong-pharmaceutical-introduced-the-e-313302.html 0.6 2026-06-21T04:01:52+08:00 daily https://www.pharmasources.com/industryinsights/new-managing-director-at-romaco-north-am-313303.html 0.6 2026-06-22T12:39:46+08:00 daily https://www.pharmasources.com/industryinsights/aicuris-and-lysando-join-forces-against--313304.html 0.6 2026-06-20T20:56:37+08:00 daily https://www.pharmasources.com/industryinsights/altimmune-signs-agreement-to-acquire-spi-313305.html 0.6 2026-06-22T19:53:03+08:00 daily https://www.pharmasources.com/industryinsights/oric-pharmaceuticals-appoints-chief-scie-313306.html 0.6 2026-06-22T10:10:10+08:00 daily https://www.pharmasources.com/industryinsights/cytomx-therapeutics-announces-second-tar-313307.html 0.6 2026-06-21T01:46:28+08:00 daily https://www.pharmasources.com/industryinsights/cellectar-receives-ftd-for-diffuse-large-313308.html 0.6 2026-08-10T23:05:37+08:00 daily https://www.pharmasources.com/industryinsights/reachbio-research-labs-offers-new-servic-313309.html 0.6 2026-06-22T00:56:49+08:00 daily https://www.pharmasources.com/industryinsights/sungen-pharma-receives-sixth-anda-approv-313310.html 0.6 2026-01-30T22:59:32+08:00 daily https://www.pharmasources.com/industryinsights/catalent-expands-global-spray-drying-ops-313311.html 0.6 2026-06-22T04:58:05+08:00 daily https://www.pharmasources.com/industryinsights/gsk-opens-two-mfg-facilities-in-singapor-313312.html 0.6 2026-07-08T05:54:12+08:00 daily https://www.pharmasources.com/industryinsights/wdsrx-warehouse-receives-vawd-accreditat-313313.html 0.6 2026-06-20T22:56:38+08:00 daily https://www.pharmasources.com/industryinsights/fewer-new-measles-cases-reported-last-we-313314.html 0.6 2026-06-20T16:57:24+08:00 daily https://www.pharmasources.com/industryinsights/ehr-system-generated-in-basket-messages--313315.html 0.6 2026-06-20T15:06:24+08:00 daily https://www.pharmasources.com/industryinsights/cdc-updates-data-on-cases-meeting-criter-313316.html 0.6 2026-08-12T05:24:46+08:00 daily https://www.pharmasources.com/industryinsights/xpovio-with-dexamethasone-approved-for-r-313317.html 0.6 2026-06-20T15:54:14+08:00 daily https://www.pharmasources.com/industryinsights/blood-donations-needed-red-cross-313318.html 0.6 2026-08-12T07:09:17+08:00 daily https://www.pharmasources.com/industryinsights/have-kids-buy-more-produce-313319.html 0.6 2026-06-21T10:58:07+08:00 daily https://www.pharmasources.com/industryinsights/in-a-us-first-baby-is-delivered-from-wom-313320.html 0.6 2026-06-21T08:02:01+08:00 daily https://www.pharmasources.com/industryinsights/cdc-warns-of-start-to-season-for-mysteri-313321.html 0.6 2026-07-06T20:20:35+08:00 daily https://www.pharmasources.com/industryinsights/more-money-more-gabapentin-313322.html 0.6 2026-06-20T22:00:42+08:00 daily https://www.pharmasources.com/industryinsights/new-predictive-software-could-aid-clinic-313323.html 0.6 2026-06-21T06:55:52+08:00 daily https://www.pharmasources.com/industryinsights/nhs-releases-guidance-to-remove-drugs-fr-313324.html 0.6 2026-06-20T22:15:55+08:00 daily https://www.pharmasources.com/industryinsights/gastrointestinal-drugs-market-set-to-rea-313325.html 0.6 2026-06-21T04:56:52+08:00 daily https://www.pharmasources.com/industryinsights/zikas-damage-continues-in-children-infec-313326.html 0.6 2026-06-21T01:36:17+08:00 daily https://www.pharmasources.com/industryinsights/addex-to-lead-mglu7-nam-focused-ptsd-con-313327.html 0.6 2026-06-21T19:50:43+08:00 daily https://www.pharmasources.com/industryinsights/evotec-spin-off-to-develop-cancer-drugs--313328.html 0.6 2026-06-22T08:17:01+08:00 daily https://www.pharmasources.com/industryinsights/us-judge-blocks-hhs-rule-to-disclose-dru-313329.html 0.6 2026-06-20T15:55:10+08:00 daily https://www.pharmasources.com/industryinsights/legalizing-marijuana-not-a-trigger-for-t-313330.html 0.6 2026-06-20T18:58:37+08:00 daily https://www.pharmasources.com/industryinsights/merck-and-skyhawk-therapeutics-sign-coll-313331.html 0.6 2026-08-08T14:52:25+08:00 daily https://www.pharmasources.com/industryinsights/competition-in-the-rmb3-billion-psoriasi-313332.html 0.6 2026-06-21T22:12:00+08:00 daily https://www.pharmasources.com/industryinsights/a-guide-to-gift-shopping-thats-good-for--313333.html 0.6 2026-07-28T11:48:50+08:00 daily https://www.pharmasources.com/industryinsights/should-you-try-allergen-immunotherapy-313334.html 0.6 2026-08-05T17:12:09+08:00 daily https://www.pharmasources.com/industryinsights/in-hospital-cardiac-arrests-may-be-a-maj-313335.html 0.6 2026-06-21T11:21:31+08:00 daily https://www.pharmasources.com/industryinsights/mainstream-psoriasis-drugs-marketed-in-t-313336.html 0.6 2026-06-30T06:53:15+08:00 daily https://www.pharmasources.com/industryinsights/dermata-therapeutics-announces-positive--313337.html 0.6 2026-02-28T13:28:56+08:00 daily https://www.pharmasources.com/industryinsights/dangerous-utis-can-follow-hospital-patie-313338.html 0.6 2026-06-23T15:26:09+08:00 daily https://www.pharmasources.com/industryinsights/leni-flap-reliable-for-nasal-defect-reco-313339.html 0.6 2026-07-04T12:31:54+08:00 daily https://www.pharmasources.com/industryinsights/the-latest-innovations-in-hpapi-manufact-313340.html 0.6 2026-07-29T13:18:05+08:00 daily https://www.pharmasources.com/industryinsights/federal-judge-blocks-rule-requiring-phar-313341.html 0.6 2026-07-09T12:56:26+08:00 daily https://www.pharmasources.com/industryinsights/eip-pharma-initiates-neflamapimod-study-313342.html 0.6 2026-06-20T15:58:36+08:00 daily https://www.pharmasources.com/industryinsights/mirum-initiates-maralixibat-phase-3-clin-313343.html 0.6 2026-06-22T12:04:50+08:00 daily https://www.pharmasources.com/industryinsights/noramco-spi-pharma-announce-availability-313344.html 0.6 2026-06-20T14:55:12+08:00 daily https://www.pharmasources.com/industryinsights/trovagene-initiates-enrollment-for-kras--313345.html 0.6 2026-06-21T08:53:20+08:00 daily https://www.pharmasources.com/industryinsights/indian-pharmacovigilance-day-2019-to-be--313346.html 0.6 2026-06-21T05:00:46+08:00 daily https://www.pharmasources.com/industryinsights/bi-announces-dabigatrans-safety-and-effi-313347.html 0.6 2026-06-21T11:50:35+08:00 daily https://www.pharmasources.com/industryinsights/neurolief-receives-ce-mark-for-relivion-313348.html 0.6 2026-06-20T17:45:10+08:00 daily https://www.pharmasources.com/industryinsights/cmic-joins-align-clinical-cro-313349.html 0.6 2026-06-16T08:45:46+08:00 daily https://www.pharmasources.com/industryinsights/imaginab-teams-up-with-roche-for-multipl-313350.html 0.6 2026-08-14T01:53:52+08:00 daily https://www.pharmasources.com/industryinsights/ocd-to-examine-labs-and-health-care-tran-313351.html 0.6 2026-06-20T21:17:57+08:00 daily https://www.pharmasources.com/industryinsights/nus-opens-new-centre-for-oral-health-313352.html 0.6 2026-06-21T14:30:06+08:00 daily https://www.pharmasources.com/industryinsights/biocon-receives-12-usfda-observations-fo-313353.html 0.6 2026-06-21T10:03:13+08:00 daily https://www.pharmasources.com/industryinsights/dtc-genetic-testing-market-size-to-excee-313354.html 0.6 2026-06-21T14:53:17+08:00 daily https://www.pharmasources.com/industryinsights/who-updates-global-guidance-on-medicines-313355.html 0.6 2026-08-14T09:39:48+08:00 daily https://www.pharmasources.com/industryinsights/cstone-announces-first-patient-dosed-in--313356.html 0.6 2026-08-08T04:34:20+08:00 daily https://www.pharmasources.com/industryinsights/3d-printing-in-apac-empowering-yet-chall-313357.html 0.6 2026-06-30T05:00:38+08:00 daily https://www.pharmasources.com/industryinsights/cellect-biotechnology-and-washington-uni-313358.html 0.6 2026-06-20T18:01:25+08:00 daily https://www.pharmasources.com/industryinsights/rockwell-automation-launches-singapores--313359.html 0.6 2026-06-21T01:47:38+08:00 daily https://www.pharmasources.com/industryinsights/mpio-appoints-chief-financial-officer-313360.html 0.6 2026-08-09T06:20:23+08:00 daily https://www.pharmasources.com/industryinsights/astellas-appoints-national-oncology-sale-313361.html 0.6 2026-08-09T03:13:28+08:00 daily https://www.pharmasources.com/industryinsights/schreiner-medipharm-introduces-product-f-313362.html 0.6 2026-08-09T01:20:43+08:00 daily https://www.pharmasources.com/industryinsights/ned-biosystems-appoints-geoffrey-ling-as-313363.html 0.6 2026-08-08T23:19:59+08:00 daily https://www.pharmasources.com/industryinsights/passage-bio-announces-new-gene-therapy-m-313364.html 0.6 2026-08-07T13:18:13+08:00 daily https://www.pharmasources.com/industryinsights/ergomed-proposes-appointment-of-former-c-313365.html 0.6 2026-08-07T12:38:45+08:00 daily https://www.pharmasources.com/industryinsights/mundipharma-acquires-rights-to-orexos-zu-313366.html 0.6 2026-08-07T12:03:15+08:00 daily https://www.pharmasources.com/industryinsights/jazz-pharma-acquires-redx-pharmas-pan-ra-313367.html 0.6 2026-08-06T23:36:42+08:00 daily https://www.pharmasources.com/industryinsights/lonza-completes-15m-tampa-site-expansion-313368.html 0.6 2026-08-06T20:05:37+08:00 daily https://www.pharmasources.com/industryinsights/fda-to-review-isatuximab-as-a-potential--313369.html 0.6 2026-08-06T19:23:21+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-katerzia-amlodipine-oral-su-313370.html 0.6 2026-08-06T18:21:27+08:00 daily https://www.pharmasources.com/industryinsights/mentally-stimulating-activities-lower-ri-313371.html 0.6 2026-08-06T19:23:13+08:00 daily https://www.pharmasources.com/industryinsights/focus-on-ovarian-cancer-surgical-volume--313372.html 0.6 2026-06-20T16:01:26+08:00 daily https://www.pharmasources.com/industryinsights/galcanezumab-can-cut-frequency-of-cluste-313373.html 0.6 2026-06-21T08:11:13+08:00 daily https://www.pharmasources.com/industryinsights/lab-tests-show-experimental-ebola-treatm-313374.html 0.6 2026-08-07T03:28:40+08:00 daily https://www.pharmasources.com/industryinsights/new-migraine-drug-rimegepant-not-yet-app-313375.html 0.6 2026-08-09T14:46:45+08:00 daily https://www.pharmasources.com/industryinsights/brain-injury-often-a-devastating-side-ef-313376.html 0.6 2026-08-07T00:02:04+08:00 daily https://www.pharmasources.com/industryinsights/could-computers-crafts-help-preserve-the-313377.html 0.6 2026-08-06T23:56:01+08:00 daily https://www.pharmasources.com/industryinsights/overview-of-the-approval-trends-of-pharm-313378.html 0.6 2026-08-06T23:50:39+08:00 daily https://www.pharmasources.com/industryinsights/acacia-pharma-plans-to-resubmit-the-barh-313379.html 0.6 2026-08-06T23:46:16+08:00 daily https://www.pharmasources.com/industryinsights/sugary-sodas-juices-tied-to-higher-cance-313380.html 0.6 2026-08-07T13:14:52+08:00 daily https://www.pharmasources.com/industryinsights/is-your-mattress-releasing-toxins-while--313381.html 0.6 2026-08-07T13:55:41+08:00 daily https://www.pharmasources.com/industryinsights/gilead-partners-with-lyndra-to-create-lo-313382.html 0.6 2026-08-08T18:42:06+08:00 daily https://www.pharmasources.com/industryinsights/uk-to-test-subscription-payment-model-fo-313383.html 0.6 2026-08-09T03:34:14+08:00 daily https://www.pharmasources.com/industryinsights/biontech-secures-325m-in-series-b-fundin-313384.html 0.6 2026-08-09T06:51:42+08:00 daily https://www.pharmasources.com/industryinsights/jazz-pharmaceuticals-buys-oncology-asset-313385.html 0.6 2026-06-21T23:53:40+08:00 daily https://www.pharmasources.com/industryinsights/sleep-the-right-prescription-for-your-he-313386.html 0.6 2026-08-09T00:16:01+08:00 daily https://www.pharmasources.com/industryinsights/household-chemicals-might-be-sparking-ri-313387.html 0.6 2026-04-18T21:42:56+08:00 daily https://www.pharmasources.com/industryinsights/addicted-to-video-games-this-treatment-m-313388.html 0.6 2025-11-30T22:14:49+08:00 daily https://www.pharmasources.com/industryinsights/mirati-announces-clinical-collaboration--313389.html 0.6 2026-06-21T07:57:58+08:00 daily https://www.pharmasources.com/industryinsights/neurorx-initiates-nrx-101-study-for-suic-313390.html 0.6 2026-03-01T06:49:40+08:00 daily https://www.pharmasources.com/industryinsights/syndax-announces-fda-clearance-of-ind-ap-313391.html 0.6 2026-08-14T12:55:40+08:00 daily https://www.pharmasources.com/industryinsights/jazz-pharmaceuticals-acquires-pre-clinic-313392.html 0.6 2026-08-07T23:20:49+08:00 daily https://www.pharmasources.com/industryinsights/high-incarceration-rates-tied-to-more-dr-313393.html 0.6 2026-06-21T18:15:39+08:00 daily https://www.pharmasources.com/industryinsights/amneal-announces-restructuring-costs-sav-313394.html 0.6 2026-08-10T01:34:30+08:00 daily https://www.pharmasources.com/industryinsights/guidance-updated-for-managing-infants-at-313395.html 0.6 2026-08-10T10:05:42+08:00 daily https://www.pharmasources.com/industryinsights/high-sodium-high-fiber-both-increase-blo-313396.html 0.6 2026-06-20T15:06:38+08:00 daily https://www.pharmasources.com/industryinsights/risk-for-cancer-higher-in-those-with-con-313397.html 0.6 2026-06-21T06:57:58+08:00 daily https://www.pharmasources.com/industryinsights/osteoporosis-undertreated-in-joint-repla-313398.html 0.6 2026-07-04T00:11:51+08:00 daily https://www.pharmasources.com/industryinsights/two-algorithms-can-id-patients-at-risk-f-313399.html 0.6 2026-08-10T04:15:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-pulls-up-aurobindo-pharma-for-repeat-313400.html 0.6 2026-06-20T16:55:09+08:00 daily https://www.pharmasources.com/industryinsights/gsks-dovato-suppresses-aids-virus-at-sam-313401.html 0.6 2026-06-21T07:03:55+08:00 daily https://www.pharmasources.com/industryinsights/strides-announces-final-closure-of-arrow-313402.html 0.6 2026-06-30T00:25:47+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-launches-anti-phlegm-otc-drug--313403.html 0.6 2026-06-20T18:01:22+08:00 daily https://www.pharmasources.com/industryinsights/govt-to-reduce-granting-environmental-cl-313404.html 0.6 2026-02-04T00:24:13+08:00 daily https://www.pharmasources.com/industryinsights/usfda-issues-12-observations-for-three-b-313405.html 0.6 2026-06-21T07:00:13+08:00 daily https://www.pharmasources.com/industryinsights/why-older-women-have-less-sex-its-not-as-313406.html 0.6 2026-06-22T07:02:46+08:00 daily https://www.pharmasources.com/industryinsights/can-a-budget-make-you-happier-313407.html 0.6 2026-07-16T12:11:46+08:00 daily https://www.pharmasources.com/industryinsights/president-to-sign-order-to-improve-kidne-313408.html 0.6 2026-06-21T11:57:10+08:00 daily https://www.pharmasources.com/industryinsights/new-migraine-drug-rimegepant-not-yet-app-313409.html 0.6 2026-06-20T16:50:13+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-xembify-immune-globulin-sub-313410.html 0.6 2026-06-21T16:30:36+08:00 daily https://www.pharmasources.com/industryinsights/nhs-to-launch-subscription-service-to-en-313411.html 0.6 2026-08-09T07:56:39+08:00 daily https://www.pharmasources.com/industryinsights/jellyfish-inspired-device-could-aid-drug-313412.html 0.6 2026-08-10T13:19:32+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-fast-track-designation-to-par-313413.html 0.6 2026-08-14T23:11:03+08:00 daily https://www.pharmasources.com/industryinsights/two-pharma-companies-collaborate-on-long-313414.html 0.6 2026-08-07T13:18:52+08:00 daily https://www.pharmasources.com/industryinsights/chinese-drug-packaging-industry-set-to-b-313415.html 0.6 2026-08-07T12:38:30+08:00 daily https://www.pharmasources.com/industryinsights/sotio-initiates-first-in-human-clinical--313416.html 0.6 2026-08-07T12:12:26+08:00 daily https://www.pharmasources.com/industryinsights/awareness-use-of-prep-on-rise-among-men--313417.html 0.6 2026-08-07T04:21:45+08:00 daily https://www.pharmasources.com/industryinsights/uncontrolled-diabetes-hypertension-rates-313418.html 0.6 2026-08-07T04:04:24+08:00 daily https://www.pharmasources.com/industryinsights/capping-work-hours-in-residency-does-not-313419.html 0.6 2026-08-07T03:55:08+08:00 daily https://www.pharmasources.com/industryinsights/negative-cognitive-bias-may-be-key-to-de-313420.html 0.6 2026-08-07T03:24:55+08:00 daily https://www.pharmasources.com/industryinsights/for-kids-with-rare-condition-restricted--313421.html 0.6 2026-06-24T04:19:42+08:00 daily https://www.pharmasources.com/industryinsights/flu-vaccine-safe-during-pregnancy-313422.html 0.6 2026-08-07T03:03:38+08:00 daily https://www.pharmasources.com/industryinsights/is-an-elusive-us-total-ban-on-asbestos-f-313423.html 0.6 2026-08-07T02:52:37+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-5-threats-to-heart-health-you-m-313424.html 0.6 2026-08-07T02:40:11+08:00 daily https://www.pharmasources.com/industryinsights/cuts-in-trainee-doctor-hours-havent-harm-313425.html 0.6 2026-08-07T01:42:41+08:00 daily https://www.pharmasources.com/industryinsights/tongue-lip-snip-surgeries-may-be-overuse-313426.html 0.6 2026-08-07T01:36:40+08:00 daily https://www.pharmasources.com/industryinsights/pe-death-not-reduced-with-early-vena-cav-313427.html 0.6 2026-08-07T01:31:43+08:00 daily https://www.pharmasources.com/industryinsights/elevated-systolic-bp-may-up-risk-for-val-313428.html 0.6 2026-08-09T02:00:04+08:00 daily https://www.pharmasources.com/industryinsights/werum-it-solutions-partners-with-blood-c-313429.html 0.6 2026-08-07T10:53:21+08:00 daily https://www.pharmasources.com/industryinsights/madrigal-pharma-appoints-president-of-rd-313430.html 0.6 2026-08-08T22:31:25+08:00 daily https://www.pharmasources.com/industryinsights/biomarck-announces-positive-results-from-313431.html 0.6 2026-08-07T02:30:44+08:00 daily https://www.pharmasources.com/industryinsights/neurorx-initiates-study-for-breakthrough-313432.html 0.6 2026-08-07T13:15:23+08:00 daily https://www.pharmasources.com/industryinsights/syndax-pharma-gets-ind-clearance-for-leu-313433.html 0.6 2026-08-08T21:48:23+08:00 daily https://www.pharmasources.com/industryinsights/cryoport-eversana-enter-supply-chain-all-313434.html 0.6 2026-08-09T00:10:20+08:00 daily https://www.pharmasources.com/industryinsights/ampio-appoints-chief-financial-officer-313435.html 0.6 2026-08-09T17:55:29+08:00 daily https://www.pharmasources.com/industryinsights/tbi-focused-vasopharm-closes-a-95m-finan-313436.html 0.6 2026-08-07T18:55:20+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-bla-of-sanofis-isatuximab-in-313437.html 0.6 2026-07-30T06:42:42+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-launches-epinephrine-injection-am-313438.html 0.6 2026-06-20T22:17:00+08:00 daily https://www.pharmasources.com/industryinsights/ec-approves-gsk-pfizer-consumer-health-j-313439.html 0.6 2026-06-21T02:58:42+08:00 daily https://www.pharmasources.com/industryinsights/neurocrine-biosciences-announces-nda-acc-313440.html 0.6 2026-07-18T13:50:44+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-dosed-with-dna-based-neoan-313441.html 0.6 2026-06-23T12:41:26+08:00 daily https://www.pharmasources.com/industryinsights/abbott-announces-fda-approval-of-alinity-313442.html 0.6 2026-08-06T21:15:36+08:00 daily https://www.pharmasources.com/industryinsights/clover-health-launches-clover-therapeuti-313443.html 0.6 2026-06-20T15:52:34+08:00 daily https://www.pharmasources.com/industryinsights/moleculin-files-for-new-patents-for-anna-313444.html 0.6 2026-06-21T03:06:47+08:00 daily https://www.pharmasources.com/industryinsights/taris-initiates-clinical-trial-of-tar-20-313445.html 0.6 2026-06-27T21:11:04+08:00 daily https://www.pharmasources.com/industryinsights/elderly-onset-rheumatoid-arthritis-ups-b-313446.html 0.6 2026-08-09T19:17:42+08:00 daily https://www.pharmasources.com/industryinsights/hospitalized-pneumonia-patients-often-ge-313447.html 0.6 2026-06-20T15:46:46+08:00 daily https://www.pharmasources.com/industryinsights/exposure-to-2009-ph1n1-vaccine-during-pr-313448.html 0.6 2026-06-20T15:27:41+08:00 daily https://www.pharmasources.com/industryinsights/high-social-stress-linked-to-greater-bon-313449.html 0.6 2026-06-21T13:03:30+08:00 daily https://www.pharmasources.com/industryinsights/gilead-snags-lilly-exec-shaw-for-kite-ce-313450.html 0.6 2026-06-21T12:09:16+08:00 daily https://www.pharmasources.com/industryinsights/emgality-maker-lilly-courts-payers-with--313451.html 0.6 2026-06-22T13:18:07+08:00 daily https://www.pharmasources.com/industryinsights/with-test-merck-takes-temperature-contro-313452.html 0.6 2026-06-30T15:18:39+08:00 daily https://www.pharmasources.com/industryinsights/amgen-ready-to-kick-pcsk9-rivals-sanofi--313453.html 0.6 2026-06-27T08:16:20+08:00 daily https://www.pharmasources.com/industryinsights/white-house-pulls-industrys-favored-reba-313454.html 0.6 2026-07-01T08:55:54+08:00 daily https://www.pharmasources.com/industryinsights/indiviors-former-parent-ponies-up-a-whop-313455.html 0.6 2026-08-07T22:10:53+08:00 daily https://www.pharmasources.com/industryinsights/biohaven-sporting-new-data-moves-closer--313456.html 0.6 2026-06-21T07:39:34+08:00 daily https://www.pharmasources.com/industryinsights/alnylam-recruits-former-shire-exec-to-re-313457.html 0.6 2026-06-22T08:49:58+08:00 daily https://www.pharmasources.com/industryinsights/sterile-drug-maker-nexus-launches-250m-u-313458.html 0.6 2026-06-22T08:04:54+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-launches-oncology-generic-gefitin-313459.html 0.6 2026-06-21T01:05:50+08:00 daily https://www.pharmasources.com/industryinsights/amgen-novartis-and-banner-discontinue-cn-313460.html 0.6 2026-08-13T11:03:21+08:00 daily https://www.pharmasources.com/industryinsights/gilead-appoints-ceo-of-kite-313461.html 0.6 2026-08-11T18:19:54+08:00 daily https://www.pharmasources.com/industryinsights/bosch-sells-packaging-technology-biz-to--313462.html 0.6 2026-08-09T19:16:57+08:00 daily https://www.pharmasources.com/industryinsights/swimming-lessons-a-must-for-everyone-313463.html 0.6 2026-06-20T18:52:29+08:00 daily https://www.pharmasources.com/industryinsights/standing-frame-program-can-up-motor-func-313464.html 0.6 2026-06-21T07:02:57+08:00 daily https://www.pharmasources.com/industryinsights/risk-for-leg-amputation-higher-with-micr-313465.html 0.6 2026-06-21T18:56:34+08:00 daily https://www.pharmasources.com/industryinsights/productivity-loss-sizable-with-menstruat-313466.html 0.6 2026-06-23T02:39:43+08:00 daily https://www.pharmasources.com/industryinsights/prenatal-opioid-exposure-harms-long-term-313467.html 0.6 2026-06-21T05:01:46+08:00 daily https://www.pharmasources.com/industryinsights/high-fiber-diets-might-shield-against-a--313468.html 0.6 2026-06-22T10:10:52+08:00 daily https://www.pharmasources.com/industryinsights/many-pneumonia-patients-get-too-many-ant-313469.html 0.6 2026-04-28T01:30:42+08:00 daily https://www.pharmasources.com/industryinsights/just-300-fewer-calories-a-day-brings-a-h-313470.html 0.6 2026-06-21T04:22:11+08:00 daily https://www.pharmasources.com/industryinsights/altaire-pharmaceuticals-inc-issues-volun-313471.html 0.6 2026-06-21T02:15:01+08:00 daily https://www.pharmasources.com/industryinsights/elbows-key-to-your-walking-efficiency-st-313472.html 0.6 2026-07-03T21:28:29+08:00 daily https://www.pharmasources.com/industryinsights/adopt-a-diet-thats-good-for-your-gut-313473.html 0.6 2026-06-20T17:19:31+08:00 daily https://www.pharmasources.com/industryinsights/8-in-10-americans-want-less-nicotine-in--313474.html 0.6 2026-06-23T12:14:54+08:00 daily https://www.pharmasources.com/industryinsights/kratom-use-associated-with-significant-t-313475.html 0.6 2026-06-22T05:06:48+08:00 daily https://www.pharmasources.com/industryinsights/state-level-variation-noted-in-economic--313476.html 0.6 2026-06-21T05:14:59+08:00 daily https://www.pharmasources.com/industryinsights/serious-misdiagnosis-related-harms-mostl-313477.html 0.6 2026-06-21T14:46:14+08:00 daily https://www.pharmasources.com/industryinsights/erectile-dysfunction-presents-large-glob-313478.html 0.6 2026-01-31T06:26:02+08:00 daily https://www.pharmasources.com/industryinsights/prescribing-fewer-tablets-can-cut-post-a-313479.html 0.6 2026-06-21T08:54:57+08:00 daily https://www.pharmasources.com/industryinsights/feeding-examination-can-avert-surgical-f-313480.html 0.6 2026-06-22T10:02:47+08:00 daily https://www.pharmasources.com/industryinsights/crp-guided-testing-cuts-antibiotic-use-i-313481.html 0.6 2026-06-21T04:03:51+08:00 daily https://www.pharmasources.com/industryinsights/us-health-economic-burden-of-uncontrolle-313482.html 0.6 2026-08-14T17:06:36+08:00 daily https://www.pharmasources.com/industryinsights/healthy-lifestyle-may-offset-genetic-ris-313483.html 0.6 2026-08-06T22:00:04+08:00 daily https://www.pharmasources.com/industryinsights/controlled-release-drug-delivery-market--313484.html 0.6 2026-08-07T02:31:08+08:00 daily https://www.pharmasources.com/industryinsights/fda-publishes-guidance-for-inactive-ingr-313485.html 0.6 2026-08-07T02:37:07+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-risankizumab-to-treat-se-313486.html 0.6 2026-08-09T22:52:45+08:00 daily https://www.pharmasources.com/industryinsights/fda-sends-warning-letter-to-sterile-inje-313487.html 0.6 2026-06-30T22:44:46+08:00 daily https://www.pharmasources.com/industryinsights/health-tip-causes-of-dry-eye-313488.html 0.6 2026-06-22T10:04:45+08:00 daily https://www.pharmasources.com/industryinsights/health-tip-treating-a-bunion-313489.html 0.6 2026-06-20T16:52:13+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2019071-313490.html 0.6 2026-08-06T19:59:42+08:00 daily https://www.pharmasources.com/industryinsights/bukwang-pharma-subsidiary-raises-3-billi-313491.html 0.6 2026-06-20T21:51:53+08:00 daily https://www.pharmasources.com/industryinsights/ntu-team-develops-probes-to-detect-acute-313492.html 0.6 2026-06-21T05:02:46+08:00 daily https://www.pharmasources.com/industryinsights/japanese-researchers-use-ai-to-design-no-313493.html 0.6 2026-06-21T02:57:44+08:00 daily https://www.pharmasources.com/industryinsights/gilead-sciences-galapagos-enter-into-dea-313494.html 0.6 2026-06-21T06:09:47+08:00 daily https://www.pharmasources.com/industryinsights/first-world-longevity-forum-and-life-sci-313495.html 0.6 2026-08-04T08:58:21+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-gets-ind-approval-for-tjc4-antibod-313496.html 0.6 2026-06-21T08:51:02+08:00 daily https://www.pharmasources.com/industryinsights/novena-global-lifecare-merges-with-xingk-313497.html 0.6 2026-06-21T05:04:44+08:00 daily https://www.pharmasources.com/industryinsights/certara-forms-new-practice-area-to-achie-313498.html 0.6 2026-07-12T11:54:58+08:00 daily https://www.pharmasources.com/industryinsights/hummingbird-bioscience-closes-extended-s-313499.html 0.6 2026-08-06T03:50:43+08:00 daily https://www.pharmasources.com/industryinsights/duke-nus-researchers-link-ageing-with-ch-313500.html 0.6 2026-06-27T13:53:37+08:00 daily https://www.pharmasources.com/industryinsights/phc-launches-medical-integrated-chart-sy-313501.html 0.6 2026-06-27T08:15:37+08:00 daily https://www.pharmasources.com/industryinsights/central-blood-bank-of-catalonia-to-use-o-313502.html 0.6 2026-06-20T18:59:39+08:00 daily https://www.pharmasources.com/industryinsights/obesity-linked-to-increased-risk-for-ped-313503.html 0.6 2026-06-21T02:15:53+08:00 daily https://www.pharmasources.com/industryinsights/increase-seen-in-foster-care-entries-due-313504.html 0.6 2026-06-21T12:11:19+08:00 daily https://www.pharmasources.com/industryinsights/company-reaches-14-billion-settlement-in-313505.html 0.6 2026-08-14T16:11:00+08:00 daily https://www.pharmasources.com/industryinsights/frequent-fried-food-intake-increases-ris-313506.html 0.6 2026-06-22T15:50:43+08:00 daily https://www.pharmasources.com/industryinsights/congo-officials-first-ebola-case-confirm-313507.html 0.6 2026-02-15T14:29:56+08:00 daily https://www.pharmasources.com/industryinsights/newer-lung-cancer-screening-saves-more-l-313508.html 0.6 2026-06-20T20:09:38+08:00 daily https://www.pharmasources.com/industryinsights/more-evidence-that-socializing-helps-pro-313509.html 0.6 2026-06-30T05:05:01+08:00 daily https://www.pharmasources.com/industryinsights/opioid-epidemic-more-than-doubled-number-313510.html 0.6 2026-06-23T10:58:03+08:00 daily https://www.pharmasources.com/industryinsights/high-blood-pressure-bad-cholesterol-risk-313511.html 0.6 2026-06-22T06:02:41+08:00 daily https://www.pharmasources.com/industryinsights/too-much-social-media-a-depression-risk--313512.html 0.6 2026-06-20T16:13:37+08:00 daily https://www.pharmasources.com/industryinsights/healthy-living-can-cut-odds-for-alzheime-313513.html 0.6 2026-07-01T09:24:21+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-pregnancy-complications-could-b-313514.html 0.6 2026-06-20T23:00:41+08:00 daily https://www.pharmasources.com/industryinsights/is-sex-good-medicine-for-parkinsons-313515.html 0.6 2026-06-20T16:04:35+08:00 daily https://www.pharmasources.com/industryinsights/race-neighborhood-impact-bystander-cpr-i-313516.html 0.6 2026-06-22T12:59:20+08:00 daily https://www.pharmasources.com/industryinsights/opioids-commonly-prescribed-in-emergency-313517.html 0.6 2026-06-20T22:55:50+08:00 daily https://www.pharmasources.com/industryinsights/risk-for-arterial-hypertension-up-with-a-313518.html 0.6 2026-06-22T19:35:40+08:00 daily https://www.pharmasources.com/industryinsights/practitioner-empathy-has-lasting-benefit-313519.html 0.6 2026-06-22T04:02:45+08:00 daily https://www.pharmasources.com/industryinsights/prepregnancy-surgery-linked-to-risk-for--313520.html 0.6 2026-07-02T16:27:59+08:00 daily https://www.pharmasources.com/industryinsights/many-perceive-lack-of-choice-in-receipt--313521.html 0.6 2026-06-11T04:46:03+08:00 daily https://www.pharmasources.com/industryinsights/tool-uses-spine-x-rays-to-assess-respons-313522.html 0.6 2026-06-21T04:07:47+08:00 daily https://www.pharmasources.com/industryinsights/etanercept-tx-for-autoimmune-disease-may-313523.html 0.6 2026-06-21T13:07:41+08:00 daily https://www.pharmasources.com/industryinsights/suspected-counterfeit-vaccines-seized-in-313524.html 0.6 2026-06-20T19:21:12+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-orphan-drug-designation-to-im-313525.html 0.6 2026-06-21T07:02:57+08:00 daily https://www.pharmasources.com/industryinsights/a-review-of-us-anda-approvals-received-b-313526.html 0.6 2026-06-29T10:17:42+08:00 daily https://www.pharmasources.com/industryinsights/amgen-wins-patent-block-on-sanofi-drug-r-313527.html 0.6 2026-06-21T02:51:47+08:00 daily https://www.pharmasources.com/industryinsights/marken-acquires-three-european-logistics-313528.html 0.6 2026-06-22T09:51:33+08:00 daily https://www.pharmasources.com/industryinsights/gilead-inks-10-year-5b-deal-with-galapag-313529.html 0.6 2026-06-09T00:22:25+08:00 daily https://www.pharmasources.com/industryinsights/adc-bios-new-state-of-the-art-cleanroom--313530.html 0.6 2026-08-08T18:18:24+08:00 daily https://www.pharmasources.com/industryinsights/colorcon-expands-excipients-business-313531.html 0.6 2026-06-21T07:07:59+08:00 daily https://www.pharmasources.com/industryinsights/catalent-breaks-ground-in-indiana-313532.html 0.6 2026-06-21T09:00:04+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-gadavist-injection-313533.html 0.6 2026-06-21T02:58:47+08:00 daily https://www.pharmasources.com/industryinsights/seqirus-is-first-to-market-with-us-20192-313534.html 0.6 2026-06-20T13:20:38+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-acquires-amal-thera-313535.html 0.6 2026-06-22T11:57:53+08:00 daily https://www.pharmasources.com/industryinsights/bla-submitted-to-fda-for-subcutaneous-fo-313536.html 0.6 2026-08-04T06:58:08+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-generic-abiraterone-313537.html 0.6 2026-06-22T00:13:07+08:00 daily https://www.pharmasources.com/industryinsights/neurotrope-concludes-data-collection-in--313538.html 0.6 2026-06-21T04:50:41+08:00 daily https://www.pharmasources.com/industryinsights/amgen-novartis-banner-alzheimers-institu-313539.html 0.6 2026-02-04T06:07:42+08:00 daily https://www.pharmasources.com/industryinsights/american-regent-announces-launch-availab-313540.html 0.6 2026-07-04T23:01:48+08:00 daily https://www.pharmasources.com/industryinsights/cdc-lab-research-shows-two-treatments-ef-313541.html 0.6 2026-06-20T17:20:03+08:00 daily https://www.pharmasources.com/industryinsights/teva-completes-facilities-purchase-in-pe-313542.html 0.6 2026-06-21T11:57:15+08:00 daily https://www.pharmasources.com/industryinsights/nus-invents-wearable-health-monitoring-d-313543.html 0.6 2026-08-07T18:14:42+08:00 daily https://www.pharmasources.com/industryinsights/gilead-sciences-renown-institute-for-hea-313544.html 0.6 2026-06-20T17:00:16+08:00 daily https://www.pharmasources.com/industryinsights/filterlex-medical-raises-3m-in-series-a--313545.html 0.6 2026-06-21T14:56:22+08:00 daily https://www.pharmasources.com/industryinsights/kaneka-launches-takeover-bid-for-100-of--313546.html 0.6 2026-06-21T00:40:29+08:00 daily https://www.pharmasources.com/industryinsights/maxq-ai-announces-tom-neufelder-as-cto-313547.html 0.6 2026-06-21T11:55:25+08:00 daily https://www.pharmasources.com/industryinsights/jj-announces-ppp-for-investigational-pro-313548.html 0.6 2026-06-22T03:02:41+08:00 daily https://www.pharmasources.com/industryinsights/michigan-scientists-develop-epipen-to-he-313549.html 0.6 2026-06-23T05:55:45+08:00 daily https://www.pharmasources.com/industryinsights/eisai-centre-for-g2d2-commences-operatio-313550.html 0.6 2026-07-01T18:05:36+08:00 daily https://www.pharmasources.com/industryinsights/cipla-eu-jiangsu-acebright-enter-into-jo-313551.html 0.6 2026-07-19T10:06:24+08:00 daily https://www.pharmasources.com/industryinsights/novotech-partners-with-skin-research-ins-313552.html 0.6 2026-06-21T10:01:06+08:00 daily https://www.pharmasources.com/industryinsights/fda-rejects-astrazenecas-farxiga-treatme-313553.html 0.6 2026-06-21T08:04:04+08:00 daily https://www.pharmasources.com/industryinsights/drone-temperature-controlled-medicine-de-313554.html 0.6 2026-06-21T18:07:32+08:00 daily https://www.pharmasources.com/industryinsights/altaire-issues-sterile-product-voluntary-313555.html 0.6 2026-06-20T14:46:17+08:00 daily https://www.pharmasources.com/industryinsights/top-five-generic-drug-makers-313556.html 0.6 2026-08-04T03:46:18+08:00 daily https://www.pharmasources.com/industryinsights/us-and-eu-enter-mutual-recognition-agree-313557.html 0.6 2026-08-07T10:12:36+08:00 daily https://www.pharmasources.com/industryinsights/partnership-with-evotec-to-advance-nosop-313558.html 0.6 2026-06-24T14:36:42+08:00 daily https://www.pharmasources.com/industryinsights/rawcliffe-to-succeed-noble-as-adaptimmun-313559.html 0.6 2026-06-21T05:05:46+08:00 daily https://www.pharmasources.com/industryinsights/skyhawk-genentech-enter-exclusive-multi--313560.html 0.6 2026-06-20T15:46:50+08:00 daily https://www.pharmasources.com/industryinsights/mereo-biopharma-appoints-head-of-pharma--313561.html 0.6 2026-06-20T14:23:53+08:00 daily https://www.pharmasources.com/industryinsights/intra-cellular-therapies-announces-posit-313562.html 0.6 2026-04-23T14:01:38+08:00 daily https://www.pharmasources.com/industryinsights/catalent-avexis-enter-long-term-strategi-313563.html 0.6 2026-04-11T23:21:03+08:00 daily https://www.pharmasources.com/industryinsights/lubrizol-acquires-bavaria-medizin-techno-313564.html 0.6 2026-06-21T03:54:46+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-redhill-biopharmas-nda-for-t-313565.html 0.6 2026-08-10T08:46:22+08:00 daily https://www.pharmasources.com/industryinsights/pistoia-alliance-backed-by-roche-az-and--313566.html 0.6 2026-06-22T01:52:31+08:00 daily https://www.pharmasources.com/industryinsights/mapi-to-establish-new-sterile-production-313567.html 0.6 2026-06-22T07:01:54+08:00 daily https://www.pharmasources.com/industryinsights/educational-handout-may-increase-receipt-313568.html 0.6 2026-06-21T07:00:15+08:00 daily https://www.pharmasources.com/industryinsights/flexible-family-visitation-policy-does-n-313569.html 0.6 2026-06-20T19:01:38+08:00 daily https://www.pharmasources.com/industryinsights/colonoscopy-rates-increased-in-those-age-313570.html 0.6 2026-02-28T20:23:03+08:00 daily https://www.pharmasources.com/industryinsights/protocolized-sepsis-care-lowers-sepsis-m-313571.html 0.6 2026-06-22T16:57:03+08:00 daily https://www.pharmasources.com/industryinsights/disinfectants-cant-stop-this-dangerous-h-313572.html 0.6 2026-06-21T01:58:40+08:00 daily https://www.pharmasources.com/industryinsights/gsk-ships-2019-20-seasonal-influenza-vac-313573.html 0.6 2026-06-13T03:29:13+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-acquires-mavupharma-313574.html 0.6 2026-06-21T11:00:18+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-airduo-digihaler-fluticason-313575.html 0.6 2026-08-04T02:11:26+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-bla-grants-priority-review-f-313576.html 0.6 2026-07-04T05:29:25+08:00 daily https://www.pharmasources.com/industryinsights/obesity-may-boost-odds-for-ms-in-kids-313577.html 0.6 2026-06-23T00:47:09+08:00 daily https://www.pharmasources.com/industryinsights/astellas-seattle-genetics-announce-bla-s-313578.html 0.6 2026-06-20T15:56:41+08:00 daily https://www.pharmasources.com/industryinsights/uspto-issues-patent-for-com701-anti-pd-1-313579.html 0.6 2026-06-21T07:15:13+08:00 daily https://www.pharmasources.com/industryinsights/sosei-heptares-genentech-announces-resea-313580.html 0.6 2026-06-22T05:46:27+08:00 daily https://www.pharmasources.com/industryinsights/altaire-issues-recall-of-multiple-ophtha-313581.html 0.6 2026-04-05T04:29:25+08:00 daily https://www.pharmasources.com/industryinsights/evolution-could-explain-why-staying-slim-313582.html 0.6 2026-07-01T02:48:53+08:00 daily https://www.pharmasources.com/industryinsights/hurricanes-can-hurt-survival-odds-among--313583.html 0.6 2026-06-20T18:52:43+08:00 daily https://www.pharmasources.com/industryinsights/how-to-protect-your-dna-for-big-health-b-313584.html 0.6 2026-08-14T12:04:59+08:00 daily https://www.pharmasources.com/industryinsights/hiv-lurking-in-spinal-fluid-linked-to-th-313585.html 0.6 2026-06-21T09:55:59+08:00 daily https://www.pharmasources.com/industryinsights/depression-at-time-of-diagnosis-may-wors-313586.html 0.6 2026-06-21T13:01:01+08:00 daily https://www.pharmasources.com/industryinsights/cvd-risk-up-in-later-life-for-young-adul-313587.html 0.6 2026-07-27T21:41:51+08:00 daily https://www.pharmasources.com/industryinsights/athira-pharma-announces-coo-appointment-313588.html 0.6 2026-06-21T19:57:36+08:00 daily https://www.pharmasources.com/industryinsights/am-pharma-raises-116m-to-support-sa-aki--313589.html 0.6 2026-06-20T19:35:07+08:00 daily https://www.pharmasources.com/industryinsights/hiv-infected-cells-persist-in-csf-in-ind-313590.html 0.6 2026-08-09T04:37:17+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-acquires-amal-therapeutics-fo-313591.html 0.6 2026-08-07T01:14:49+08:00 daily https://www.pharmasources.com/industryinsights/oklahoma-seeks-17bn-from-jj-for-opioid-c-313592.html 0.6 2026-08-07T01:18:53+08:00 daily https://www.pharmasources.com/industryinsights/recursion-secures-funds-to-support-ai-ba-313593.html 0.6 2026-08-07T02:39:51+08:00 daily https://www.pharmasources.com/industryinsights/superior-outcomes-seen-for-living-donor--313594.html 0.6 2026-08-07T01:28:39+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-acquires-sting-pathway-focused-ma-313595.html 0.6 2026-08-07T02:42:58+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-imfinzi-cancer-drug-secures-313596.html 0.6 2026-08-10T12:29:16+08:00 daily https://www.pharmasources.com/industryinsights/gilead-and-galapagos-deepen-rd-alliance--313597.html 0.6 2026-07-06T23:43:32+08:00 daily https://www.pharmasources.com/industryinsights/recordati-acquires-rights-to-signifor-an-313598.html 0.6 2026-06-23T17:03:37+08:00 daily https://www.pharmasources.com/industryinsights/amgen-and-novartis-discontinue-alzheimer-313599.html 0.6 2026-06-20T20:07:38+08:00 daily https://www.pharmasources.com/industryinsights/us-researchers-develop-epipen-to-treat-i-313600.html 0.6 2026-06-21T02:15:50+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-finds-significant-violations-at-i-313601.html 0.6 2026-06-21T07:16:15+08:00 daily https://www.pharmasources.com/industryinsights/indocos-goa-plant-i-receives-warning-let-313602.html 0.6 2026-06-21T18:09:31+08:00 daily https://www.pharmasources.com/industryinsights/powder-flow-the-influence-of-roller-comp-313603.html 0.6 2026-07-26T12:12:01+08:00 daily https://www.pharmasources.com/industryinsights/servier-australia-biocurate-to-accelerat-313604.html 0.6 2026-06-21T14:15:36+08:00 daily https://www.pharmasources.com/industryinsights/sengenics-joins-hands-with-fnih-biomarke-313605.html 0.6 2026-06-21T08:10:03+08:00 daily https://www.pharmasources.com/industryinsights/sosei-heptares-teams-up-with-genentech-f-313606.html 0.6 2026-08-09T08:05:41+08:00 daily https://www.pharmasources.com/industryinsights/abcam-acquires-edigenes-knock-out-cell-l-313607.html 0.6 2026-06-21T00:00:36+08:00 daily https://www.pharmasources.com/industryinsights/new-state-of-the-art-cleanroom-completed-313608.html 0.6 2026-06-20T22:57:47+08:00 daily https://www.pharmasources.com/industryinsights/chad-mirkin-wins-kabiller-prize-in-nanos-313609.html 0.6 2026-06-21T04:15:02+08:00 daily https://www.pharmasources.com/industryinsights/global-b-cell-nhl-market-set-to-reach-92-313610.html 0.6 2026-06-20T16:18:40+08:00 daily https://www.pharmasources.com/industryinsights/illumina-expands-genomics-accelerator-to-313611.html 0.6 2026-06-21T14:55:20+08:00 daily https://www.pharmasources.com/industryinsights/recursion-pharmaceuticals-secures-121m-i-313612.html 0.6 2026-08-03T00:43:15+08:00 daily https://www.pharmasources.com/industryinsights/convelo-genentech-to-collaborate-on-remy-313613.html 0.6 2026-06-21T21:11:48+08:00 daily https://www.pharmasources.com/industryinsights/astellas-frequency-therapeutics-enter-al-313614.html 0.6 2026-06-21T00:59:44+08:00 daily https://www.pharmasources.com/industryinsights/lonza-selects-rockwell-automation-for-di-313615.html 0.6 2026-07-03T19:54:04+08:00 daily https://www.pharmasources.com/industryinsights/idt-biologika-awarded-new-nih-task-order-313616.html 0.6 2026-06-21T16:03:23+08:00 daily https://www.pharmasources.com/industryinsights/immunotherapy-specialist-benefits-from-q-313617.html 0.6 2026-07-02T15:33:35+08:00 daily https://www.pharmasources.com/industryinsights/little-progress-shown-for-gender-diversi-313618.html 0.6 2026-06-20T18:46:34+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-recarbrio-imipenem-cilastat-313619.html 0.6 2026-07-14T23:46:41+08:00 daily https://www.pharmasources.com/industryinsights/us-drug-od-deaths-fall-for-first-time-in-313620.html 0.6 2026-06-21T00:54:42+08:00 daily https://www.pharmasources.com/industryinsights/physical-activity-linked-to-slower-a-rel-313621.html 0.6 2026-06-21T13:30:28+08:00 daily https://www.pharmasources.com/industryinsights/who-declares-congo-ebola-outbreak-global-313622.html 0.6 2026-06-23T20:47:26+08:00 daily https://www.pharmasources.com/industryinsights/recarbrio-okd-for-complicated-urinary-tr-313623.html 0.6 2026-06-23T07:43:56+08:00 daily https://www.pharmasources.com/industryinsights/mans-award-in-roundup-cancer-case-slashe-313624.html 0.6 2026-07-07T16:02:54+08:00 daily https://www.pharmasources.com/industryinsights/new-test-can-pinpoint-which-pancreatic-c-313625.html 0.6 2026-06-23T08:28:55+08:00 daily https://www.pharmasources.com/industryinsights/a-new-and-better-way-to-stage-alzheimers-313626.html 0.6 2026-06-20T19:01:35+08:00 daily https://www.pharmasources.com/industryinsights/clues-to-why-women-have-higher-odds-for--313627.html 0.6 2026-06-20T15:48:38+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-doctors-little-heart-attack-tur-313628.html 0.6 2026-07-04T02:21:26+08:00 daily https://www.pharmasources.com/industryinsights/medical-marijuana-wont-help-ease-opioid--313629.html 0.6 2026-06-20T18:07:26+08:00 daily https://www.pharmasources.com/industryinsights/can-a-broken-heart-contribute-to-cancer-313630.html 0.6 2026-07-05T02:41:57+08:00 daily https://www.pharmasources.com/industryinsights/exercises-to-head-off-a-painful-rotator--313631.html 0.6 2026-06-24T09:45:13+08:00 daily https://www.pharmasources.com/industryinsights/many-patients-with-depression-do-not-nee-313632.html 0.6 2026-06-20T20:44:55+08:00 daily https://www.pharmasources.com/industryinsights/subclinical-cardiovascular-dz-may-up-fal-313633.html 0.6 2026-06-20T19:43:15+08:00 daily https://www.pharmasources.com/industryinsights/continuous-anticoagulants-cold-snare-pol-313634.html 0.6 2026-08-13T16:33:54+08:00 daily https://www.pharmasources.com/industryinsights/early-eeg-helps-predict-cardiac-arrest-o-313635.html 0.6 2026-06-20T17:32:08+08:00 daily https://www.pharmasources.com/industryinsights/prevalence-of-malignancy-high-in-takotsu-313636.html 0.6 2026-06-21T07:15:39+08:00 daily https://www.pharmasources.com/industryinsights/intranasal-sufentanil-cuts-acute-trauma--313637.html 0.6 2026-06-22T06:57:45+08:00 daily https://www.pharmasources.com/industryinsights/rituximab-noninferior-to-cyclosporine-in-313638.html 0.6 2026-06-20T22:51:39+08:00 daily https://www.pharmasources.com/industryinsights/cvs-health-announces-clinical-trial-for--313639.html 0.6 2026-01-04T04:24:34+08:00 daily https://www.pharmasources.com/industryinsights/eton-provides-update-on-em-100-program-313640.html 0.6 2026-06-22T04:41:31+08:00 daily https://www.pharmasources.com/industryinsights/anixa-biosciences-announces-agreement-wi-313641.html 0.6 2026-06-20T18:07:28+08:00 daily https://www.pharmasources.com/industryinsights/durect-receives-posimir-crl-313642.html 0.6 2026-06-21T12:06:12+08:00 daily https://www.pharmasources.com/industryinsights/elios-announces-positive-top-line-data-e-313643.html 0.6 2026-06-22T04:00:40+08:00 daily https://www.pharmasources.com/industryinsights/gotham-and-mercachem-generate-epitranscr-313644.html 0.6 2026-06-21T04:18:04+08:00 daily https://www.pharmasources.com/industryinsights/researchers-develop-genomic-barcode-to-t-313645.html 0.6 2026-06-20T21:09:44+08:00 daily https://www.pharmasources.com/industryinsights/sosei-heptares-and-genentech-enter-gpcr--313646.html 0.6 2026-08-08T02:22:35+08:00 daily https://www.pharmasources.com/industryinsights/kite-to-open-new-manufacturing-plant-for-313647.html 0.6 2026-06-20T22:57:43+08:00 daily https://www.pharmasources.com/industryinsights/novartis-continues-to-build-healthcare-t-313648.html 0.6 2026-06-20T22:15:04+08:00 daily https://www.pharmasources.com/industryinsights/government-takes-measures-to-curtail-mis-313649.html 0.6 2026-06-20T19:03:40+08:00 daily https://www.pharmasources.com/industryinsights/lupin-aims-to-launch-new-products-across-313650.html 0.6 2026-06-21T11:00:14+08:00 daily https://www.pharmasources.com/industryinsights/jubilant-announces-10-per-cent-price-inc-313651.html 0.6 2026-07-06T21:22:29+08:00 daily https://www.pharmasources.com/industryinsights/cipla-eu-and-jiangsu-acebright-enter-int-313652.html 0.6 2026-06-20T14:55:02+08:00 daily https://www.pharmasources.com/industryinsights/vaccine-trial-launched-by-icmr-to-preven-313653.html 0.6 2026-06-21T07:21:45+08:00 daily https://www.pharmasources.com/industryinsights/pathfinder-research-and-training-foundat-313654.html 0.6 2026-06-21T03:58:46+08:00 daily https://www.pharmasources.com/industryinsights/pakistan-imported-medicines-worth-rs-136-313655.html 0.6 2026-07-18T12:39:23+08:00 daily https://www.pharmasources.com/industryinsights/usfda-inspection-at-chennai-facility-end-313656.html 0.6 2026-06-22T04:54:36+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-issues-5-observations-to-dr-reddy-313657.html 0.6 2026-06-20T23:08:48+08:00 daily https://www.pharmasources.com/industryinsights/code-prohibits-doctors-from-taking-gifts-313658.html 0.6 2026-06-22T01:47:30+08:00 daily https://www.pharmasources.com/industryinsights/how-was-the-small-molecule-apixaban-with-313659.html 0.6 2026-07-08T07:17:32+08:00 daily https://www.pharmasources.com/industryinsights/development-status-of-pilose-antler-a-tr-313660.html 0.6 2026-07-12T05:05:09+08:00 daily https://www.pharmasources.com/industryinsights/aum-biosciences-expands-pipeline-with-ne-313661.html 0.6 2026-06-21T08:20:20+08:00 daily https://www.pharmasources.com/industryinsights/janssen-korea-launches-quickfire-challen-313662.html 0.6 2026-06-21T06:56:50+08:00 daily https://www.pharmasources.com/industryinsights/fossil-remedies-to-launch-innovative-fra-313663.html 0.6 2026-04-26T08:43:27+08:00 daily https://www.pharmasources.com/industryinsights/cxa-group-sets-up-new-tech-hub-313664.html 0.6 2026-06-20T19:20:56+08:00 daily https://www.pharmasources.com/industryinsights/china-approves-anti-cancer-agent-by-eisa-313665.html 0.6 2026-08-14T04:02:19+08:00 daily https://www.pharmasources.com/industryinsights/takeda-kyoto-university-research-collabo-313666.html 0.6 2026-08-06T19:08:37+08:00 daily https://www.pharmasources.com/industryinsights/mhi-appoints-national-accounts-manager-313667.html 0.6 2026-06-20T14:37:27+08:00 daily https://www.pharmasources.com/industryinsights/catalent-appoints-svp-chief-hr-officer-313668.html 0.6 2026-07-16T17:56:27+08:00 daily https://www.pharmasources.com/industryinsights/milliporesigma-broad-institute-announce--313669.html 0.6 2026-06-21T11:21:26+08:00 daily https://www.pharmasources.com/industryinsights/tracelink-excellis-partner-to-provide-lo-313670.html 0.6 2026-06-20T23:59:38+08:00 daily https://www.pharmasources.com/industryinsights/bayer-bms-ono-to-collaborate-on-colorect-313671.html 0.6 2026-08-08T09:10:40+08:00 daily https://www.pharmasources.com/industryinsights/narrowing-seen-in-racialethnic-differenc-313672.html 0.6 2026-03-03T01:42:10+08:00 daily https://www.pharmasources.com/industryinsights/permira-funds-to-acquire-majority-stake--313673.html 0.6 2026-06-22T05:52:31+08:00 daily https://www.pharmasources.com/industryinsights/beigenes-tislelizumab-achieves-positive--313674.html 0.6 2026-06-21T09:48:11+08:00 daily https://www.pharmasources.com/industryinsights/transfers-up-for-mental-health-disorders-313675.html 0.6 2025-12-22T10:35:53+08:00 daily https://www.pharmasources.com/industryinsights/recovery-from-concussion-longer-for-athl-313676.html 0.6 2026-08-15T00:35:36+08:00 daily https://www.pharmasources.com/industryinsights/cdc-prevalence-of-smoking-quit-attempts--313677.html 0.6 2026-06-24T10:51:46+08:00 daily https://www.pharmasources.com/industryinsights/prevalence-of-suicide-ideation-46-percen-313678.html 0.6 2026-06-21T02:13:48+08:00 daily https://www.pharmasources.com/industryinsights/recarbrio-okd-for-complicated-urinary-tr-313679.html 0.6 2026-06-21T02:06:46+08:00 daily https://www.pharmasources.com/industryinsights/how-to-make-your-childs-hospital-stay-sa-313680.html 0.6 2026-08-08T03:05:08+08:00 daily https://www.pharmasources.com/industryinsights/the-bottom-blood-pressure-number-matters-313681.html 0.6 2026-07-21T10:59:05+08:00 daily https://www.pharmasources.com/industryinsights/another-study-casts-doubt-on-safety-of-h-313682.html 0.6 2026-06-21T03:11:49+08:00 daily https://www.pharmasources.com/industryinsights/health-tip-minimizing-shortness-of-breat-313683.html 0.6 2026-06-22T08:15:57+08:00 daily https://www.pharmasources.com/industryinsights/novel-test-accurately-identifies-precanc-313684.html 0.6 2026-06-20T20:17:24+08:00 daily https://www.pharmasources.com/industryinsights/safety-practice-violations-idd-in-septic-313685.html 0.6 2026-03-21T17:39:16+08:00 daily https://www.pharmasources.com/industryinsights/systolic-diastolic-htn-contribute-to-adv-313686.html 0.6 2026-06-25T03:27:26+08:00 daily https://www.pharmasources.com/industryinsights/novel-pet-staging-system-may-help-monito-313687.html 0.6 2026-06-21T07:57:08+08:00 daily https://www.pharmasources.com/industryinsights/about-one-in-20-patients-exposed-to-prev-313688.html 0.6 2026-06-21T12:07:13+08:00 daily https://www.pharmasources.com/industryinsights/air-pollution-found-to-accelerate-aging--313689.html 0.6 2026-06-21T04:14:57+08:00 daily https://www.pharmasources.com/industryinsights/medical-marijuana-laws-may-not-impact-op-313690.html 0.6 2026-06-25T09:03:38+08:00 daily https://www.pharmasources.com/industryinsights/pregnancies-in-women-taking-isotretinoin-313691.html 0.6 2026-06-22T02:07:48+08:00 daily https://www.pharmasources.com/industryinsights/cdc-assesses-burden-of-eye-disorders-in--313692.html 0.6 2026-06-21T02:15:54+08:00 daily https://www.pharmasources.com/industryinsights/people-living-with-hiv-have-higher-risk--313693.html 0.6 2026-06-21T00:02:39+08:00 daily https://www.pharmasources.com/industryinsights/bayer-bristol-myers-squibb-and-ono-pharm-313694.html 0.6 2026-07-27T16:57:25+08:00 daily https://www.pharmasources.com/industryinsights/review-evaluates-how-ai-could-boost-the--313695.html 0.6 2026-06-22T07:46:38+08:00 daily https://www.pharmasources.com/industryinsights/drc-rejects-clinical-trial-for-experimen-313696.html 0.6 2026-06-20T22:17:12+08:00 daily https://www.pharmasources.com/industryinsights/emmaus-life-sciences-completes-merger-313697.html 0.6 2026-07-26T13:48:05+08:00 daily https://www.pharmasources.com/industryinsights/bayer-bristol-myers-squibb-ono-pharmaceu-313698.html 0.6 2026-08-05T23:21:04+08:00 daily https://www.pharmasources.com/industryinsights/pear-therapeutics-announces-fda-submissi-313699.html 0.6 2026-06-21T16:03:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-treatment-for-complicated-u-313700.html 0.6 2026-06-21T20:09:54+08:00 daily https://www.pharmasources.com/industryinsights/mallinckrodt-silence-therapeutics-announ-313701.html 0.6 2026-06-21T13:16:43+08:00 daily https://www.pharmasources.com/industryinsights/cti-biopharma-to-move-to-phase-3-study-o-313702.html 0.6 2026-06-21T19:35:12+08:00 daily https://www.pharmasources.com/industryinsights/researchers-develop-trojan-horse-chemo-d-313703.html 0.6 2026-06-21T01:08:51+08:00 daily https://www.pharmasources.com/industryinsights/mercks-recarbrio-gets-fda-approval-for-t-313704.html 0.6 2026-06-21T14:18:44+08:00 daily https://www.pharmasources.com/industryinsights/astellas-licences-frequency-therapeutics-313705.html 0.6 2026-06-21T02:01:40+08:00 daily https://www.pharmasources.com/industryinsights/aum-biosciences-to-develop-inflections-c-313706.html 0.6 2026-07-28T01:43:49+08:00 daily https://www.pharmasources.com/industryinsights/cabinet-okays-rs-330-crore-loan-to-3-pha-313707.html 0.6 2026-06-20T14:50:11+08:00 daily https://www.pharmasources.com/industryinsights/amway-india-launches-nutrilite-cal-mag-d-313708.html 0.6 2026-06-20T20:04:37+08:00 daily https://www.pharmasources.com/industryinsights/zolgensma-launch-on-track-and-fully-in-l-313709.html 0.6 2026-06-21T02:00:39+08:00 daily https://www.pharmasources.com/industryinsights/novartis-aiming-to-clean-up-its-rep-sets-313710.html 0.6 2026-06-21T16:52:20+08:00 daily https://www.pharmasources.com/industryinsights/biotech-building-facility-to-make-genome-313711.html 0.6 2026-06-20T16:56:14+08:00 daily https://www.pharmasources.com/industryinsights/still-on-a-cash-raising-spree-takeda-sho-313712.html 0.6 2026-06-21T11:21:55+08:00 daily https://www.pharmasources.com/industryinsights/pharmacies-take-up-drug-disposal-effort--313713.html 0.6 2026-06-22T00:56:47+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-bayer-team-up-on-op-313714.html 0.6 2026-06-29T12:05:46+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-to-shell-out-12m-in-severanc-313715.html 0.6 2026-06-29T12:32:09+08:00 daily https://www.pharmasources.com/industryinsights/doj-indicts-2nd-opioid-distributor-for-r-313716.html 0.6 2026-06-21T14:15:34+08:00 daily https://www.pharmasources.com/industryinsights/novartis-key-multiple-sclerosis-product--313717.html 0.6 2026-08-08T07:45:04+08:00 daily https://www.pharmasources.com/industryinsights/merck-and-broad-institute-announce-crisp-313718.html 0.6 2026-06-22T07:10:53+08:00 daily https://www.pharmasources.com/industryinsights/cannabiz-invest-asia-to-gather-global-ca-313719.html 0.6 2026-06-21T01:12:52+08:00 daily https://www.pharmasources.com/industryinsights/ping-an-good-doctor-to-build-new-interne-313720.html 0.6 2026-07-02T23:01:55+08:00 daily https://www.pharmasources.com/industryinsights/celltrion-nan-fung-group-form-jv-to-mark-313721.html 0.6 2026-06-21T06:58:52+08:00 daily https://www.pharmasources.com/industryinsights/genscript-biotech-starts-operations-for--313722.html 0.6 2026-06-22T22:02:09+08:00 daily https://www.pharmasources.com/industryinsights/esc-provides-asian-doctors-with-latest-c-313723.html 0.6 2026-08-14T14:45:37+08:00 daily https://www.pharmasources.com/industryinsights/pmi-creates-intervals-an-online-communit-313724.html 0.6 2026-07-08T09:50:17+08:00 daily https://www.pharmasources.com/industryinsights/tracelink-partners-with-excellis-health--313725.html 0.6 2026-06-20T19:44:16+08:00 daily https://www.pharmasources.com/industryinsights/teva-announces-fda-approval-of-airduo-di-313726.html 0.6 2026-07-27T09:34:21+08:00 daily https://www.pharmasources.com/industryinsights/kazia-therapeutics-calls-for-greater-awa-313727.html 0.6 2026-06-21T11:09:18+08:00 daily https://www.pharmasources.com/industryinsights/downstream-processing-market-will-grow-t-313728.html 0.6 2026-06-21T10:13:17+08:00 daily https://www.pharmasources.com/industryinsights/pall-servier-enter-biomanufacturing-tie--313729.html 0.6 2026-06-20T19:58:30+08:00 daily https://www.pharmasources.com/industryinsights/celltrion-nan-fung-group-set-up-bio-cdmo-313730.html 0.6 2025-12-13T22:16:53+08:00 daily https://www.pharmasources.com/industryinsights/genscript-biotech-opens-biologics-rd-and-313731.html 0.6 2026-07-12T17:18:49+08:00 daily https://www.pharmasources.com/industryinsights/sickle-cell-drug-wins-priority-review-by-313732.html 0.6 2026-07-04T01:24:38+08:00 daily https://www.pharmasources.com/industryinsights/jet-milling-industrialisation-of-sticky--313733.html 0.6 2026-08-09T04:43:12+08:00 daily https://www.pharmasources.com/industryinsights/quotient-sciences-to-recapitalise-with-g-313734.html 0.6 2026-06-21T02:57:39+08:00 daily https://www.pharmasources.com/industryinsights/drug-manufacturer-planned-to-shred-cgmp--313735.html 0.6 2026-08-05T19:09:04+08:00 daily https://www.pharmasources.com/industryinsights/new-system-delivers-drug-straight-into-t-313736.html 0.6 2026-06-21T17:13:32+08:00 daily https://www.pharmasources.com/industryinsights/keep-sugar-substitute-away-from-fido-313737.html 0.6 2026-08-12T07:33:59+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-otezla-apremilast-for-the-t-313738.html 0.6 2026-06-21T03:56:42+08:00 daily https://www.pharmasources.com/industryinsights/frequency-of-cannabis-use-before-during--313739.html 0.6 2026-06-20T18:58:47+08:00 daily https://www.pharmasources.com/industryinsights/female-ophthalmology-residents-perform-f-313740.html 0.6 2026-06-22T03:03:43+08:00 daily https://www.pharmasources.com/industryinsights/family-support-may-improve-asthma-outcom-313741.html 0.6 2026-02-27T09:31:43+08:00 daily https://www.pharmasources.com/industryinsights/epa-will-not-ban-pesticide-linked-to-bra-313742.html 0.6 2026-06-21T16:13:41+08:00 daily https://www.pharmasources.com/industryinsights/frax-score-underestimates-risk-for-fract-313743.html 0.6 2026-06-20T18:00:21+08:00 daily https://www.pharmasources.com/industryinsights/longer-rx-for-birth-control-pills-a-smar-313744.html 0.6 2026-06-21T06:58:57+08:00 daily https://www.pharmasources.com/industryinsights/pot-use-during-early-pregnancy-on-the-ri-313745.html 0.6 2026-07-10T05:21:18+08:00 daily https://www.pharmasources.com/industryinsights/diabetes-raises-heart-failure-risk-more--313746.html 0.6 2026-06-20T15:13:25+08:00 daily https://www.pharmasources.com/industryinsights/factors-associated-with-thyroid-cancer-o-313747.html 0.6 2026-06-21T02:17:11+08:00 daily https://www.pharmasources.com/industryinsights/blueprint-medicines-announces-ema-valida-313748.html 0.6 2026-08-13T19:53:58+08:00 daily https://www.pharmasources.com/industryinsights/pmz-1620-enters-phase-iii-trial-in-patie-313749.html 0.6 2026-08-10T15:18:46+08:00 daily https://www.pharmasources.com/industryinsights/abiraterone-acetate-included-in-whos-ess-313750.html 0.6 2026-08-07T02:31:11+08:00 daily https://www.pharmasources.com/industryinsights/music-soothes-the-stressed-soul-before-s-313751.html 0.6 2026-06-23T15:47:26+08:00 daily https://www.pharmasources.com/industryinsights/aridis-receives-orphan-drug-designation--313752.html 0.6 2026-06-20T22:59:35+08:00 daily https://www.pharmasources.com/industryinsights/sosei-heptares-to-receive-milestone-paym-313753.html 0.6 2026-08-07T02:31:08+08:00 daily https://www.pharmasources.com/industryinsights/is-caffeine-fueling-your-anxieties-313754.html 0.6 2026-08-09T15:06:18+08:00 daily https://www.pharmasources.com/industryinsights/recarbrio-okd-for-complicated-urinary-tr-313755.html 0.6 2026-08-07T23:31:01+08:00 daily https://www.pharmasources.com/industryinsights/mvasi-kanjinti-now-available-in-united-s-313756.html 0.6 2026-08-09T08:00:36+08:00 daily https://www.pharmasources.com/industryinsights/key-cystic-fibrosis-pathogens-reduced-wi-313757.html 0.6 2026-06-22T12:55:20+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-forms-alliance-with-bridge-bi-313758.html 0.6 2026-06-30T17:58:14+08:00 daily https://www.pharmasources.com/industryinsights/uks-nice-backs-novartis-breast-cancer-dr-313759.html 0.6 2026-06-23T01:01:54+08:00 daily https://www.pharmasources.com/industryinsights/mallinckrodt-partners-with-silence-thera-313760.html 0.6 2026-01-23T10:39:59+08:00 daily https://www.pharmasources.com/industryinsights/higher-egfr-at-dialysis-initiation-tied--313761.html 0.6 2026-06-21T18:55:03+08:00 daily https://www.pharmasources.com/industryinsights/women-are-twice-as-likely-to-develop-pos-313762.html 0.6 2026-06-21T07:47:47+08:00 daily https://www.pharmasources.com/industryinsights/current-antibiotic-stewardship-program-p-313763.html 0.6 2026-06-21T17:44:42+08:00 daily https://www.pharmasources.com/industryinsights/recommendations-developed-for-japanese-e-313764.html 0.6 2026-06-21T04:49:40+08:00 daily https://www.pharmasources.com/industryinsights/nonprofit-funding-by-cancer-type-not-pro-313765.html 0.6 2026-06-21T10:09:11+08:00 daily https://www.pharmasources.com/industryinsights/supply-of-opioids-predicts-long-term-use-313766.html 0.6 2026-06-21T07:19:22+08:00 daily https://www.pharmasources.com/industryinsights/excess-risk-for-diabetes-linked-heart-fa-313767.html 0.6 2026-08-05T15:59:00+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2019072-313768.html 0.6 2026-07-06T21:41:16+08:00 daily https://www.pharmasources.com/industryinsights/huge-cphi-p-mec-china-a-direct-result-of-313769.html 0.6 2026-07-24T08:28:30+08:00 daily https://www.pharmasources.com/industryinsights/orum-therapeutics-raises-30m-to-advance--313770.html 0.6 2026-07-03T19:25:49+08:00 daily https://www.pharmasources.com/industryinsights/nus-scientists-develop-artificial-nervou-313771.html 0.6 2026-06-22T11:54:48+08:00 daily https://www.pharmasources.com/industryinsights/ping-an-good-doctor-to-build-new-interne-313772.html 0.6 2026-07-21T14:24:51+08:00 daily https://www.pharmasources.com/industryinsights/bayer-bms-ono-pharma-enter-into-clinical-313773.html 0.6 2026-06-21T20:49:40+08:00 daily https://www.pharmasources.com/industryinsights/volitionrx-commences-lung-cancer-clinica-313774.html 0.6 2026-06-21T03:58:49+08:00 daily https://www.pharmasources.com/industryinsights/china-set-to-begin-phase-ii-hiv-vaccine--313775.html 0.6 2026-07-18T00:45:57+08:00 daily https://www.pharmasources.com/industryinsights/ema-grants-ar-501-with-orphan-drug-desig-313776.html 0.6 2026-06-21T00:48:45+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-generics-of-lyrica-313777.html 0.6 2026-06-21T14:57:24+08:00 daily https://www.pharmasources.com/industryinsights/almost-one-in-four-adults-40-takes-aspir-313778.html 0.6 2026-06-20T15:00:12+08:00 daily https://www.pharmasources.com/industryinsights/nonprescription-antibiotic-use-seems-pre-313779.html 0.6 2026-03-17T23:24:00+08:00 daily https://www.pharmasources.com/industryinsights/smoking-has-long-term-impact-on-peripher-313780.html 0.6 2026-06-20T23:54:44+08:00 daily https://www.pharmasources.com/industryinsights/complete-response-letter-given-to-als-tr-313781.html 0.6 2026-06-21T12:56:27+08:00 daily https://www.pharmasources.com/industryinsights/plant-based-diets-inversely-linked-to-ri-313782.html 0.6 2026-08-13T16:09:43+08:00 daily https://www.pharmasources.com/industryinsights/many-americans-take-antibiotics-without--313783.html 0.6 2026-06-26T08:19:32+08:00 daily https://www.pharmasources.com/industryinsights/some-women-still-getting-pregnant-while--313784.html 0.6 2026-08-09T03:13:37+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-where-theres-wildfire-smoke-the-313785.html 0.6 2026-08-09T00:37:58+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisks-recombinant-coagulation-fa-313786.html 0.6 2026-06-30T00:10:20+08:00 daily https://www.pharmasources.com/industryinsights/plastic-surgery-pays-off-for-men-313787.html 0.6 2026-08-08T23:07:56+08:00 daily https://www.pharmasources.com/industryinsights/market-shares-of-overseas-pharma-enterpr-313788.html 0.6 2026-08-09T00:38:16+08:00 daily https://www.pharmasources.com/industryinsights/the-latest-on-caffeine-limits-313789.html 0.6 2026-06-20T23:41:42+08:00 daily https://www.pharmasources.com/industryinsights/the-great-fat-debate-how-much-is-unhealt-313790.html 0.6 2026-07-31T13:15:04+08:00 daily https://www.pharmasources.com/industryinsights/health-tip-symptoms-of-tennis-elbow-313791.html 0.6 2026-06-20T22:50:40+08:00 daily https://www.pharmasources.com/industryinsights/rates-of-anal-cancer-precursors-high-in--313792.html 0.6 2026-08-05T18:29:30+08:00 daily https://www.pharmasources.com/industryinsights/proportion-of-crc-diagnoses-increased-in-313793.html 0.6 2026-06-21T01:03:48+08:00 daily https://www.pharmasources.com/industryinsights/opioid-rx-education-insufficient-for-pla-313794.html 0.6 2026-06-20T16:59:15+08:00 daily https://www.pharmasources.com/industryinsights/sleep-disorders-up-health-care-visits-co-313795.html 0.6 2026-07-04T15:02:23+08:00 daily https://www.pharmasources.com/industryinsights/more-screen-time-ups-risk-for-depression-313796.html 0.6 2026-06-21T09:58:24+08:00 daily https://www.pharmasources.com/industryinsights/initial-sustained-remission-common-in-rh-313797.html 0.6 2026-06-21T11:00:18+08:00 daily https://www.pharmasources.com/industryinsights/pediatricians-can-play-role-in-ensuring--313798.html 0.6 2026-08-10T15:14:32+08:00 daily https://www.pharmasources.com/industryinsights/new-accaha-guidelines-detect-more-cases--313799.html 0.6 2026-08-06T22:42:23+08:00 daily https://www.pharmasources.com/industryinsights/light-therapy-may-prevent-oral-mucositis-313800.html 0.6 2026-08-09T14:57:19+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-myxredlin-insulin-for-iv-in-313801.html 0.6 2026-06-21T01:41:22+08:00 daily https://www.pharmasources.com/industryinsights/apb-102-receives-orphan-drug-designation-313802.html 0.6 2026-06-21T09:05:07+08:00 daily https://www.pharmasources.com/industryinsights/pall-corporation-chosen-as-single-source-313803.html 0.6 2026-06-20T22:59:39+08:00 daily https://www.pharmasources.com/industryinsights/vertex-submits-nda-for-triple-combinatio-313804.html 0.6 2026-08-03T06:55:03+08:00 daily https://www.pharmasources.com/industryinsights/sumitomo-dainippon-publishes-positive-re-313805.html 0.6 2026-07-19T02:30:13+08:00 daily https://www.pharmasources.com/industryinsights/biohavens-nurtec-fails-to-obtain-fda-app-313806.html 0.6 2026-07-03T15:53:35+08:00 daily https://www.pharmasources.com/industryinsights/gilead-gets-licences-to-three-antiviral--313807.html 0.6 2026-06-23T08:12:57+08:00 daily https://www.pharmasources.com/industryinsights/janssen-files-submission-for-subcutaneou-313808.html 0.6 2026-07-10T06:21:14+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-announces-closure-of-the-trans-313809.html 0.6 2026-06-21T09:10:22+08:00 daily https://www.pharmasources.com/industryinsights/laurus-labs-distribution-partner-rising--313810.html 0.6 2026-08-13T05:50:38+08:00 daily https://www.pharmasources.com/industryinsights/invagen-receives-final-approval-for-preg-313811.html 0.6 2026-06-20T22:58:46+08:00 daily https://www.pharmasources.com/industryinsights/lupins-nagpur-facility-won-enr-global-be-313812.html 0.6 2026-06-20T22:06:40+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-launches-generic-version-of-al-313813.html 0.6 2026-04-10T07:49:29+08:00 daily https://www.pharmasources.com/industryinsights/tell-chinas-drug-regulatory-stories-to-t-313814.html 0.6 2026-08-14T06:23:41+08:00 daily https://www.pharmasources.com/industryinsights/2019-china-cancer-immunotherapy-workshop-313815.html 0.6 2026-06-20T14:24:43+08:00 daily https://www.pharmasources.com/industryinsights/nmpa-carries-out-training-on-vaccine-sup-313816.html 0.6 2026-06-21T13:15:47+08:00 daily https://www.pharmasources.com/industryinsights/nmpa-head-pledges-most-rigorous-administ-313817.html 0.6 2026-06-21T09:07:03+08:00 daily https://www.pharmasources.com/industryinsights/nmpa-issued-the-announcement-on-the-requ-313818.html 0.6 2026-06-22T04:54:36+08:00 daily https://www.pharmasources.com/industryinsights/nmpa-issued-the-announcement-on-implemen-313819.html 0.6 2026-06-21T17:56:50+08:00 daily https://www.pharmasources.com/industryinsights/nmpa-issued-the-announcement-on-issues-c-313820.html 0.6 2026-07-30T22:42:54+08:00 daily https://www.pharmasources.com/industryinsights/kazia-to-use-drug-with-radiotherapy-for--313821.html 0.6 2025-12-13T21:13:45+08:00 daily https://www.pharmasources.com/industryinsights/shinsung-tk-paves-way-for-iot-healthcare-313822.html 0.6 2026-06-21T22:58:41+08:00 daily https://www.pharmasources.com/industryinsights/dermatix-launches-new-product-as-acne-sc-313823.html 0.6 2026-06-21T03:52:48+08:00 daily https://www.pharmasources.com/industryinsights/yisheng-biopharma-receives-approval-from-313824.html 0.6 2026-08-05T19:53:50+08:00 daily https://www.pharmasources.com/industryinsights/who-recommends-dolutegravir-as-preferred-313825.html 0.6 2026-06-22T22:31:29+08:00 daily https://www.pharmasources.com/industryinsights/eisai-merck-receive-breakthrough-therapy-313826.html 0.6 2026-08-08T03:27:23+08:00 daily https://www.pharmasources.com/industryinsights/yellow-wood-partners-to-acquire-dr-schol-313827.html 0.6 2026-06-20T17:46:14+08:00 daily https://www.pharmasources.com/industryinsights/fda-urges-to-submit-thorough-timely-safe-313828.html 0.6 2026-06-29T07:41:05+08:00 daily https://www.pharmasources.com/industryinsights/akebia-submits-new-drug-application-for--313829.html 0.6 2026-08-12T07:59:14+08:00 daily https://www.pharmasources.com/industryinsights/the-spines-that-prick-memories-313830.html 0.6 2026-06-21T10:55:12+08:00 daily https://www.pharmasources.com/industryinsights/huge-cphi-p-mec-china-a-direct-result-of-313831.html 0.6 2026-08-07T23:42:17+08:00 daily https://www.pharmasources.com/industryinsights/nih-publishes-largest-genomic-study-on-t-313832.html 0.6 2026-06-21T07:13:02+08:00 daily https://www.pharmasources.com/industryinsights/avalon-globocare-ge-healthcare-to-accele-313833.html 0.6 2026-06-21T21:13:52+08:00 daily https://www.pharmasources.com/industryinsights/la-jolla-pharma-receives-orphan-designat-313834.html 0.6 2026-06-20T16:52:10+08:00 daily https://www.pharmasources.com/industryinsights/cytena-establishes-subsidiary-in-taiwan--313835.html 0.6 2026-06-21T09:03:05+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-ruxience-rituximab-pvvr-a-b-313836.html 0.6 2026-06-21T08:48:50+08:00 daily https://www.pharmasources.com/industryinsights/senate-bill-would-reduce-drug-costs-for--313837.html 0.6 2026-07-01T15:35:35+08:00 daily https://www.pharmasources.com/industryinsights/medpharm-expands-relationship-with-novan-313838.html 0.6 2026-06-21T08:49:04+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-bridge-biotherapeut-313839.html 0.6 2026-06-21T12:20:48+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-sta-facilities-pass-fda-inspections-313840.html 0.6 2026-07-22T12:00:21+08:00 daily https://www.pharmasources.com/industryinsights/hikma-civica-rx-ink-generic-drug-shortag-313841.html 0.6 2026-06-21T00:15:49+08:00 daily https://www.pharmasources.com/industryinsights/abzena-completes-adc-tech-transfer-313842.html 0.6 2026-06-21T13:03:38+08:00 daily https://www.pharmasources.com/industryinsights/vgxi-geneos-establish-supply-agreement-313843.html 0.6 2026-07-02T01:16:12+08:00 daily https://www.pharmasources.com/industryinsights/yisheng-receives-gmp-certification-in-ch-313844.html 0.6 2026-08-03T22:56:04+08:00 daily https://www.pharmasources.com/industryinsights/legacy-pharmaceuticals-advances-new-russ-313845.html 0.6 2026-02-04T10:22:08+08:00 daily https://www.pharmasources.com/industryinsights/mallinckrodt-silence-therapeutics-enter--313846.html 0.6 2026-06-22T03:48:40+08:00 daily https://www.pharmasources.com/industryinsights/uspstf-reaffirms-benefit-of-hep-b-screen-313847.html 0.6 2026-04-19T23:42:13+08:00 daily https://www.pharmasources.com/industryinsights/filgotinib-bests-placebo-in-tx-of-refrac-313848.html 0.6 2026-06-21T01:36:22+08:00 daily https://www.pharmasources.com/industryinsights/2001-to-2017-saw-increase-in-suicides-in-313849.html 0.6 2026-06-28T21:50:55+08:00 daily https://www.pharmasources.com/industryinsights/nonphysican-practitioners-filling-post-a-313850.html 0.6 2026-06-20T17:52:34+08:00 daily https://www.pharmasources.com/industryinsights/mediterranean-diet-has-big-benefits-for--313851.html 0.6 2026-06-21T22:01:40+08:00 daily https://www.pharmasources.com/industryinsights/higher-cost-of-new-cholesterol-drugs-put-313852.html 0.6 2026-06-21T03:42:27+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-early-pregnancy-may-be-a-prime--313853.html 0.6 2026-06-22T11:44:54+08:00 daily https://www.pharmasources.com/industryinsights/vertex-submits-new-drug-application-to-t-313854.html 0.6 2026-06-10T13:24:22+08:00 daily https://www.pharmasources.com/industryinsights/more-clues-to-mysterious-illness-among-s-313855.html 0.6 2026-04-08T14:51:39+08:00 daily https://www.pharmasources.com/industryinsights/screen-every-pregnant-woman-for-hep-b-ta-313856.html 0.6 2025-12-13T21:33:00+08:00 daily https://www.pharmasources.com/industryinsights/extreme-eating-habits-could-be-an-early--313857.html 0.6 2026-06-21T09:58:08+08:00 daily https://www.pharmasources.com/industryinsights/testosterone-therapy-may-threaten-the-he-313858.html 0.6 2026-08-08T01:08:59+08:00 daily https://www.pharmasources.com/industryinsights/health-tip-signs-of-heat-stroke-313859.html 0.6 2025-12-19T14:16:01+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-enrolled-on-clinical-study-313860.html 0.6 2026-06-20T18:10:28+08:00 daily https://www.pharmasources.com/industryinsights/vertex-submits-nda-to-fda-for-triple-com-313861.html 0.6 2026-06-20T20:16:56+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-nine-generics-of-pfizers-ly-313862.html 0.6 2026-07-21T03:59:12+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-nine-generics-for-lyrica-dr-313863.html 0.6 2026-06-20T17:51:29+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-gains-otc-rights-to-roches-tamifl-313864.html 0.6 2026-06-21T09:03:04+08:00 daily https://www.pharmasources.com/industryinsights/t2dm-increases-gastric-cancer-risk-after-313865.html 0.6 2026-06-22T14:34:41+08:00 daily https://www.pharmasources.com/industryinsights/bayer-recalls-two-lots-of-kogenate-fs-an-313866.html 0.6 2026-08-13T23:55:32+08:00 daily https://www.pharmasources.com/industryinsights/mgus-can-progress-to-multiple-myeloma-wi-313867.html 0.6 2025-11-13T08:45:48+08:00 daily https://www.pharmasources.com/industryinsights/stero-biotechs-to-commence-phase-2a-tria-313868.html 0.6 2026-08-13T17:31:01+08:00 daily https://www.pharmasources.com/industryinsights/camurus-announces-positive-outcome-of-co-313869.html 0.6 2026-06-21T00:02:38+08:00 daily https://www.pharmasources.com/industryinsights/samus-therapeutics-launches-pu-ad-clinic-313870.html 0.6 2026-07-01T09:50:30+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-generics-of-lyrica-313871.html 0.6 2026-06-21T15:45:44+08:00 daily https://www.pharmasources.com/industryinsights/university-of-california-granted-two-new-313872.html 0.6 2026-06-22T06:05:52+08:00 daily https://www.pharmasources.com/industryinsights/samr-issued-the-measures-for-the-adminis-313873.html 0.6 2026-07-19T21:01:18+08:00 daily https://www.pharmasources.com/industryinsights/nmpa-issued-the-announcement-on-adjustin-313874.html 0.6 2026-06-21T18:06:34+08:00 daily https://www.pharmasources.com/industryinsights/a-blockbuster-to-arrive-in-the-multiple--313875.html 0.6 2026-06-21T08:02:00+08:00 daily https://www.pharmasources.com/industryinsights/a-review-of-ms-drugs-in-china-313876.html 0.6 2026-07-06T20:31:02+08:00 daily https://www.pharmasources.com/industryinsights/taf-the-strongest-hbv-drug-in-history-313877.html 0.6 2026-07-24T17:39:04+08:00 daily https://www.pharmasources.com/industryinsights/alkahest-appoints-chief-business-officer-313878.html 0.6 2026-06-22T07:56:43+08:00 daily https://www.pharmasources.com/industryinsights/pra-health-sciences-buys-out-joint-ventu-313879.html 0.6 2026-06-21T02:14:51+08:00 daily https://www.pharmasources.com/industryinsights/lonza-expands-bioconjugation-facility-an-313880.html 0.6 2026-07-31T15:26:51+08:00 daily https://www.pharmasources.com/industryinsights/ziopharm-oncology-names-chief-financial--313881.html 0.6 2026-06-20T14:59:11+08:00 daily https://www.pharmasources.com/industryinsights/contravir-pharmaceuticals-becomes-hepion-313882.html 0.6 2026-03-31T20:57:12+08:00 daily https://www.pharmasources.com/industryinsights/opiant-pharmaceuticals-sanofi-to-manufac-313883.html 0.6 2026-06-20T23:16:54+08:00 daily https://www.pharmasources.com/industryinsights/nosopharm-evotec-to-develop-novel-antibi-313884.html 0.6 2026-02-14T23:32:29+08:00 daily https://www.pharmasources.com/industryinsights/financial-report-thermo-fisher-scientifi-313885.html 0.6 2026-06-20T16:21:25+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-sta-facilities-pass-us-fda-inspecti-313886.html 0.6 2026-06-21T01:44:26+08:00 daily https://www.pharmasources.com/industryinsights/syapse-pfizer-in-oncology-precision-medi-313887.html 0.6 2026-08-02T03:05:04+08:00 daily https://www.pharmasources.com/industryinsights/two-lots-of-kogenate-recalled-due-to-mis-313888.html 0.6 2026-06-20T22:17:50+08:00 daily https://www.pharmasources.com/industryinsights/bipartisan-bill-revealed-to-lower-drug-p-313889.html 0.6 2026-06-20T17:55:17+08:00 daily https://www.pharmasources.com/industryinsights/warning-issued-to-company-for-using-unfo-313890.html 0.6 2026-06-21T06:21:23+08:00 daily https://www.pharmasources.com/industryinsights/new-model-could-be-used-to-predict-shelf-313891.html 0.6 2026-06-21T22:48:39+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-baqsimi-glucagon-nasal-powd-313892.html 0.6 2026-08-11T18:46:05+08:00 daily https://www.pharmasources.com/industryinsights/mediterranean-diet-may-reduce-gestationa-313893.html 0.6 2026-06-20T23:07:52+08:00 daily https://www.pharmasources.com/industryinsights/fda-warns-cbd-product-maker-about-false--313894.html 0.6 2026-07-04T11:26:50+08:00 daily https://www.pharmasources.com/industryinsights/allergan-recalls-textured-breast-implant-313895.html 0.6 2026-06-21T19:31:15+08:00 daily https://www.pharmasources.com/industryinsights/private-equity-stake-rising-among-dermat-313896.html 0.6 2026-06-22T17:38:43+08:00 daily https://www.pharmasources.com/industryinsights/adiposity-in-early-old-age-tied-to-mri-s-313897.html 0.6 2026-07-02T21:37:39+08:00 daily https://www.pharmasources.com/industryinsights/some-of-most-common-deadly-cancers-get-t-313898.html 0.6 2026-01-13T19:26:16+08:00 daily https://www.pharmasources.com/industryinsights/fda-advises-patients-not-to-use-herbal-d-313899.html 0.6 2026-06-21T00:00:39+08:00 daily https://www.pharmasources.com/industryinsights/lipocine-receives-fda-clearance-for-test-313900.html 0.6 2026-06-21T20:03:41+08:00 daily https://www.pharmasources.com/industryinsights/breast-implants-tied-to-rare-cancer-risk-313901.html 0.6 2026-03-20T11:16:15+08:00 daily https://www.pharmasources.com/industryinsights/bigger-waistlines-a-threat-to-womens-hea-313902.html 0.6 2026-06-23T12:57:31+08:00 daily https://www.pharmasources.com/industryinsights/samus-therapeutics-launches-pu-ad-clinic-313903.html 0.6 2026-07-05T01:43:25+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-hadlima-adalimumab-bwwd-a-b-313904.html 0.6 2026-06-21T03:06:44+08:00 daily https://www.pharmasources.com/industryinsights/regulus-therapeutics-announces-rgls4326--313905.html 0.6 2026-08-12T22:56:02+08:00 daily https://www.pharmasources.com/industryinsights/jubilant-cadista-issues-recall-of-drospi-313906.html 0.6 2026-06-21T02:04:40+08:00 daily https://www.pharmasources.com/industryinsights/immix-receives-fda-authorization-to-expa-313907.html 0.6 2026-06-22T00:58:51+08:00 daily https://www.pharmasources.com/industryinsights/former-nfl-players-have-higher-odds-for--313908.html 0.6 2026-06-21T10:01:27+08:00 daily https://www.pharmasources.com/industryinsights/pregnant-women-exposed-to-more-risky-ct--313909.html 0.6 2026-06-21T12:00:13+08:00 daily https://www.pharmasources.com/industryinsights/myovant-reports-uterine-fibroid-combinat-313910.html 0.6 2026-06-23T08:54:48+08:00 daily https://www.pharmasources.com/industryinsights/celgene-licenses-antibody-jtx-8064-from--313911.html 0.6 2026-06-20T23:15:16+08:00 daily https://www.pharmasources.com/industryinsights/us-senators-introduce-bipartisan-bill-to-313912.html 0.6 2026-08-08T02:30:50+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-exercise-caution-outdoors-in-th-313913.html 0.6 2026-06-18T10:01:22+08:00 daily https://www.pharmasources.com/industryinsights/jj-launches-research-consortium-for-new--313914.html 0.6 2026-07-06T21:17:48+08:00 daily https://www.pharmasources.com/industryinsights/periop-diabetic-ketoacidosis-seen-in-pat-313915.html 0.6 2026-06-21T10:49:20+08:00 daily https://www.pharmasources.com/industryinsights/eisai-merck-combination-therapy-gets-bre-313916.html 0.6 2026-06-24T00:18:22+08:00 daily https://www.pharmasources.com/industryinsights/international-freight-logistics-network--313917.html 0.6 2026-06-20T21:05:59+08:00 daily https://www.pharmasources.com/industryinsights/malaria-resistance-to-first-line-antimal-313918.html 0.6 2026-06-20T14:33:13+08:00 daily https://www.pharmasources.com/industryinsights/cancer-risks-examined-in-rheumatoid-arth-313919.html 0.6 2025-11-15T10:30:52+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-launches-insomnia-drug-in-t-313920.html 0.6 2026-06-28T20:03:42+08:00 daily https://www.pharmasources.com/industryinsights/lonza-expands-its-bioconjugation-facilit-313921.html 0.6 2026-06-20T17:15:55+08:00 daily https://www.pharmasources.com/industryinsights/indian-government-takes-steps-for-vaccin-313922.html 0.6 2026-06-21T05:56:03+08:00 daily https://www.pharmasources.com/industryinsights/ayush-grid-project-to-digitise-ayush-hea-313923.html 0.6 2026-06-21T06:10:54+08:00 daily https://www.pharmasources.com/industryinsights/gsk-pharmaceuticals-revenue-grows-at-sev-313924.html 0.6 2026-06-20T23:01:38+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-approvals-for-generic-lyrica-313925.html 0.6 2026-06-22T02:58:37+08:00 daily https://www.pharmasources.com/industryinsights/who-treat-all-recommendation-for-hiv-wid-313926.html 0.6 2026-06-20T20:01:33+08:00 daily https://www.pharmasources.com/industryinsights/tissue-adhesive-sterile-strips-similar-a-313927.html 0.6 2026-04-23T14:12:52+08:00 daily https://www.pharmasources.com/industryinsights/pharma-processing-and-packaging-equipmen-313928.html 0.6 2026-06-21T12:11:18+08:00 daily https://www.pharmasources.com/industryinsights/roche-confirms-cyber-attack-from-winnti--313929.html 0.6 2026-06-20T15:45:04+08:00 daily https://www.pharmasources.com/industryinsights/ruxience-biosimilar-granted-approval-fro-313930.html 0.6 2026-08-09T20:28:23+08:00 daily https://www.pharmasources.com/industryinsights/fda-posts-fy2020-gdufa-fees-313931.html 0.6 2026-06-21T15:50:54+08:00 daily https://www.pharmasources.com/industryinsights/olon-spa-expands-microbial-gmp-capabilit-313932.html 0.6 2026-08-05T13:50:20+08:00 daily https://www.pharmasources.com/industryinsights/penta-cromsource-partner-to-improve-pedi-313933.html 0.6 2026-08-08T02:04:54+08:00 daily https://www.pharmasources.com/industryinsights/zambon-acquires-sofinnova-partners-breat-313934.html 0.6 2026-06-21T04:13:58+08:00 daily https://www.pharmasources.com/industryinsights/clariant-now-producing-desiccant-packets-313935.html 0.6 2026-08-11T10:14:43+08:00 daily https://www.pharmasources.com/industryinsights/pressure-biosciences-inks-contract-servi-313936.html 0.6 2026-06-22T03:03:47+08:00 daily https://www.pharmasources.com/industryinsights/regenxbio-neurimmune-to-develop-antibodi-313937.html 0.6 2026-08-09T04:58:16+08:00 daily https://www.pharmasources.com/industryinsights/first-us-trial-using-crispr-within-the-b-313938.html 0.6 2026-06-20T19:06:56+08:00 daily https://www.pharmasources.com/industryinsights/taking-prescription-opioids-could-limit--313939.html 0.6 2026-08-05T22:54:00+08:00 daily https://www.pharmasources.com/industryinsights/testosterone-may-rejuvenate-older-womens-313940.html 0.6 2026-06-20T19:12:54+08:00 daily https://www.pharmasources.com/industryinsights/female-oncologists-attend-fewer-conferen-313941.html 0.6 2026-06-22T16:04:33+08:00 daily https://www.pharmasources.com/industryinsights/most-pediatric-in-flight-medical-events--313942.html 0.6 2026-06-20T23:00:40+08:00 daily https://www.pharmasources.com/industryinsights/bariatric-surgery-up-in-patients-with-en-313943.html 0.6 2026-06-21T12:56:30+08:00 daily https://www.pharmasources.com/industryinsights/brain-changes-noted-in-holocaust-survivo-313944.html 0.6 2026-06-21T17:01:19+08:00 daily https://www.pharmasources.com/industryinsights/for-asthmatic-kids-in-tough-neighborhood-313945.html 0.6 2026-06-20T20:48:27+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-needle-free-rescue-dr-313946.html 0.6 2026-06-21T18:49:42+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-heres-how-many-years-you-could--313947.html 0.6 2026-07-04T06:21:41+08:00 daily https://www.pharmasources.com/industryinsights/plastics-chemicals-meant-to-replace-bpa--313948.html 0.6 2026-06-22T02:14:04+08:00 daily https://www.pharmasources.com/industryinsights/plant-based-diet-helps-keep-diabetes-at--313949.html 0.6 2026-01-30T20:19:55+08:00 daily https://www.pharmasources.com/industryinsights/smog-could-land-newborns-in-intensive-ca-313950.html 0.6 2026-06-22T04:51:52+08:00 daily https://www.pharmasources.com/industryinsights/health-tip-chiropractors-and-back-pain-313951.html 0.6 2026-03-30T21:30:29+08:00 daily https://www.pharmasources.com/industryinsights/asct-may-offer-alternative-for-tx-of-hig-313952.html 0.6 2026-08-07T06:47:25+08:00 daily https://www.pharmasources.com/industryinsights/bms-opdivo-fails-to-meet-primary-endpoin-313953.html 0.6 2026-06-20T15:58:19+08:00 daily https://www.pharmasources.com/industryinsights/gemphire-to-merge-with-neurobo-pharmaceu-313954.html 0.6 2026-07-05T01:28:50+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-samsung-bioepis-humira-bios-313955.html 0.6 2026-06-20T17:36:10+08:00 daily https://www.pharmasources.com/industryinsights/valneva-secures-cepi-grant-to-develop-ch-313956.html 0.6 2026-06-29T06:56:19+08:00 daily https://www.pharmasources.com/industryinsights/minor-changes-in-bmd-seen-with-tenofovir-313957.html 0.6 2026-06-20T14:16:43+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-noninjection-glucagon-313958.html 0.6 2026-06-20T23:52:35+08:00 daily https://www.pharmasources.com/industryinsights/proteostasis-therapeutics-initiates-glob-313959.html 0.6 2026-06-21T12:14:26+08:00 daily https://www.pharmasources.com/industryinsights/fda-sending-warning-to-curaleaf-for-mark-313960.html 0.6 2026-06-22T11:47:00+08:00 daily https://www.pharmasources.com/industryinsights/opdivo-yervoy-combination-study-meets-co-313961.html 0.6 2026-08-05T09:08:36+08:00 daily https://www.pharmasources.com/industryinsights/no-indication-of-july-effect-in-context--313962.html 0.6 2026-06-21T03:37:14+08:00 daily https://www.pharmasources.com/industryinsights/epizyme-announces-nda-acceptance-priorit-313963.html 0.6 2026-08-05T13:01:58+08:00 daily https://www.pharmasources.com/industryinsights/targeted-interventions-raise-hpv-vaccine-313964.html 0.6 2026-07-04T07:13:52+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-severe-hypoglycemia-tre-313965.html 0.6 2026-06-21T01:49:31+08:00 daily https://www.pharmasources.com/industryinsights/first-subject-dosed-in-olorinab-trial-fo-313966.html 0.6 2026-07-06T22:16:38+08:00 daily https://www.pharmasources.com/industryinsights/provisions-for-supervision-of-drug-distr-313967.html 0.6 2026-07-20T10:40:39+08:00 daily https://www.pharmasources.com/industryinsights/provisions-for-medical-device-registrati-313968.html 0.6 2026-06-21T14:52:21+08:00 daily https://www.pharmasources.com/industryinsights/provisions-for-in-vitro-diagnostic-reage-313969.html 0.6 2026-07-25T18:31:04+08:00 daily https://www.pharmasources.com/industryinsights/provisions-for-drug-insert-sheets-and-la-313970.html 0.6 2026-07-16T05:29:20+08:00 daily https://www.pharmasources.com/industryinsights/5440-jaks-functional-in-india-ashwini-ku-313971.html 0.6 2026-06-21T22:40:49+08:00 daily https://www.pharmasources.com/industryinsights/huge-cphi-p-mec-china-a-direct-result-of-313972.html 0.6 2026-08-10T18:47:18+08:00 daily https://www.pharmasources.com/industryinsights/clariant-adds-pharmaceutical-desiccant-p-313973.html 0.6 2026-06-21T12:52:29+08:00 daily https://www.pharmasources.com/industryinsights/syngene-announces-q1-fy20-results-313974.html 0.6 2026-06-21T08:03:58+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-launches-insomnia-treatment-ta-313975.html 0.6 2026-06-21T11:49:29+08:00 daily https://www.pharmasources.com/industryinsights/cipla-usa-acquires-anti-infective-zemdri-313976.html 0.6 2026-06-21T16:53:28+08:00 daily https://www.pharmasources.com/industryinsights/are-you-up-to-date-with-the-new-laborato-313977.html 0.6 2026-06-20T15:55:31+08:00 daily https://www.pharmasources.com/industryinsights/gsk-appoints-jonathan-symonds-as-non-exe-313978.html 0.6 2026-07-02T16:47:25+08:00 daily https://www.pharmasources.com/industryinsights/perkinelmer-to-expand-at-home-health-ser-313979.html 0.6 2026-08-14T20:52:10+08:00 daily https://www.pharmasources.com/industryinsights/astellas-submits-biologics-license-appli-313980.html 0.6 2026-08-14T17:01:38+08:00 daily https://www.pharmasources.com/industryinsights/liscure-biosciences-completes-seed-fundi-313981.html 0.6 2026-04-03T17:22:37+08:00 daily https://www.pharmasources.com/industryinsights/aier-eye-hospital-group-objective-acuity-313982.html 0.6 2026-06-21T18:51:48+08:00 daily https://www.pharmasources.com/industryinsights/halodoc-completes-strategic-funding-roun-313983.html 0.6 2026-06-23T02:45:03+08:00 daily https://www.pharmasources.com/industryinsights/novartis-mundipharma-to-enhance-access-o-313984.html 0.6 2026-06-21T03:53:49+08:00 daily https://www.pharmasources.com/industryinsights/first-impressions-go-a-long-way-in-the-i-313985.html 0.6 2026-06-21T02:07:46+08:00 daily https://www.pharmasources.com/industryinsights/eli-lillys-baqsimi-nasal-powder-set-to-t-313986.html 0.6 2026-08-07T23:00:21+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-roxadustat-reveals-positive-313987.html 0.6 2026-06-30T15:53:49+08:00 daily https://www.pharmasources.com/industryinsights/health-catalyst-announces-pricing-of-ipo-313988.html 0.6 2026-03-28T18:43:53+08:00 daily https://www.pharmasources.com/industryinsights/ping-an-introduces-doctors-ai-assistant--313989.html 0.6 2026-04-16T02:05:36+08:00 daily https://www.pharmasources.com/industryinsights/cipla-usa-acquires-worldwide-rights-for--313990.html 0.6 2026-06-22T03:43:55+08:00 daily https://www.pharmasources.com/industryinsights/merck-to-build-gardasil-9-plant-and-add--313991.html 0.6 2026-04-21T14:47:20+08:00 daily https://www.pharmasources.com/industryinsights/key-european-committee-backs-gws-epidyol-313992.html 0.6 2026-06-08T14:10:58+08:00 daily https://www.pharmasources.com/industryinsights/parexel-launches-health-advances-asia-ex-313993.html 0.6 2026-04-20T07:44:07+08:00 daily https://www.pharmasources.com/industryinsights/gop-senators-distance-themselves-from-gr-313994.html 0.6 2026-06-20T23:14:06+08:00 daily https://www.pharmasources.com/industryinsights/can-bms-parlay-its-surprise-win-and-a-mi-313995.html 0.6 2026-06-20T19:56:03+08:00 daily https://www.pharmasources.com/industryinsights/herceptin-drops-on-contracting-ahead-of--313996.html 0.6 2026-06-22T00:46:01+08:00 daily https://www.pharmasources.com/industryinsights/bristols-celgene-buyout-more-important-g-313997.html 0.6 2026-06-21T00:08:43+08:00 daily https://www.pharmasources.com/industryinsights/alexions-beating-forecasts-with-soliris--313998.html 0.6 2026-08-05T03:23:32+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-cancer-meds-lynparza-imfinz-313999.html 0.6 2026-07-23T19:01:36+08:00 daily https://www.pharmasources.com/industryinsights/novartis-reclaims-sterile-products-plant-314000.html 0.6 2026-06-20T14:59:12+08:00 daily https://www.pharmasources.com/industryinsights/teva-claws-back-50m-from-former-execs-bo-314001.html 0.6 2026-06-20T14:48:05+08:00 daily https://www.pharmasources.com/industryinsights/vertex-joins-the-new-ceo-brigade-with-le-314002.html 0.6 2026-06-21T03:06:46+08:00 daily https://www.pharmasources.com/industryinsights/lonza-expanding-adc-production-as-pharma-314003.html 0.6 2026-06-22T12:48:29+08:00 daily https://www.pharmasources.com/industryinsights/gsk-withstands-advair-generics-thanks-to-314004.html 0.6 2026-06-20T19:59:31+08:00 daily https://www.pharmasources.com/industryinsights/biogen-keeps-its-foot-on-the-pedal-in-bi-314005.html 0.6 2026-06-23T13:50:44+08:00 daily https://www.pharmasources.com/industryinsights/another-win-for-vascepa-pricing-watchdog-314006.html 0.6 2026-06-20T18:15:44+08:00 daily https://www.pharmasources.com/industryinsights/can-new-dovato-data-jump-start-uptake-of-314007.html 0.6 2026-06-20T15:58:31+08:00 daily https://www.pharmasources.com/industryinsights/among-recent-megamergers-only-abbvie-all-314008.html 0.6 2026-08-05T22:42:35+08:00 daily https://www.pharmasources.com/industryinsights/with-pharma-consumer-split-in-its-sights-314009.html 0.6 2026-06-20T22:55:50+08:00 daily https://www.pharmasources.com/industryinsights/roche-like-bayer-was-hit-in-winnti-cyber-314010.html 0.6 2026-08-02T05:03:34+08:00 daily https://www.pharmasources.com/industryinsights/avexis-bia-ink-gene-therapy-manufacturin-314011.html 0.6 2026-06-21T02:59:40+08:00 daily https://www.pharmasources.com/industryinsights/what-you-need-to-know-before-your-next-b-314012.html 0.6 2026-06-20T23:16:09+08:00 daily https://www.pharmasources.com/industryinsights/some-meds-and-driving-a-dangerous-duo-314013.html 0.6 2026-06-20T14:51:06+08:00 daily https://www.pharmasources.com/industryinsights/testosterone-replacement-therapy-may-inc-314014.html 0.6 2026-06-29T15:25:43+08:00 daily https://www.pharmasources.com/industryinsights/outpatient-service-receipt-down-after-me-314015.html 0.6 2026-06-20T14:38:19+08:00 daily https://www.pharmasources.com/industryinsights/adherence-to-aerobic-activity-guidelines-314016.html 0.6 2026-06-21T05:58:43+08:00 daily https://www.pharmasources.com/industryinsights/fda-blood-clot-death-risk-up-with-higher-314017.html 0.6 2026-08-07T04:22:29+08:00 daily https://www.pharmasources.com/industryinsights/juul-e-cigarettes-never-meant-for-teens--314018.html 0.6 2026-08-07T04:04:00+08:00 daily https://www.pharmasources.com/industryinsights/athletes-with-adhd-may-need-more-time-to-314019.html 0.6 2026-08-07T03:56:07+08:00 daily https://www.pharmasources.com/industryinsights/janssen-reports-positive-top-line-phase--314020.html 0.6 2026-08-07T04:03:51+08:00 daily https://www.pharmasources.com/industryinsights/americans-are-spending-even-more-time-si-314021.html 0.6 2026-08-07T04:18:52+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-accrufer-ferric-maltol-for--314022.html 0.6 2026-08-07T03:02:55+08:00 daily https://www.pharmasources.com/industryinsights/surgery-not-a-relapse-risk-for-ms-patien-314023.html 0.6 2026-08-07T13:15:47+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2019072-314024.html 0.6 2026-08-07T02:55:17+08:00 daily https://www.pharmasources.com/industryinsights/many-us-women-get-opioids-after-giving-b-314025.html 0.6 2026-08-07T18:30:34+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-innovative-hub-feeds-the-need-f-314026.html 0.6 2026-08-09T04:32:22+08:00 daily https://www.pharmasources.com/industryinsights/most-airplanes-not-equipped-with-first-a-314027.html 0.6 2026-06-21T23:56:42+08:00 daily https://www.pharmasources.com/industryinsights/why-do-some-people-drink-until-they-blac-314028.html 0.6 2026-01-02T02:21:14+08:00 daily https://www.pharmasources.com/industryinsights/alexion-receives-positive-chmp-opinion-f-314029.html 0.6 2026-08-10T06:23:15+08:00 daily https://www.pharmasources.com/industryinsights/health-tip-understanding-exposure-therap-314030.html 0.6 2026-07-18T12:20:01+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-correvios-resubmitted-nda-fo-314031.html 0.6 2026-06-21T02:44:18+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-her-heart-looked-like-swiss-che-314032.html 0.6 2026-06-21T08:51:02+08:00 daily https://www.pharmasources.com/industryinsights/mortality-up-in-women-with-central-obesi-314033.html 0.6 2026-06-23T02:53:57+08:00 daily https://www.pharmasources.com/industryinsights/eurofins-alphora-announces-company-rebra-314034.html 0.6 2026-06-23T19:34:18+08:00 daily https://www.pharmasources.com/industryinsights/novadoz-gains-fda-approval-start-shippin-314035.html 0.6 2026-08-14T09:54:22+08:00 daily https://www.pharmasources.com/industryinsights/nmpa-launches-english-language-website-314036.html 0.6 2026-07-30T23:29:28+08:00 daily https://www.pharmasources.com/industryinsights/wellcomes-genomics-in-cancer-database-be-314037.html 0.6 2026-06-24T13:24:26+08:00 daily https://www.pharmasources.com/industryinsights/sofinnova-sells-breath-therapeutics-to-z-314038.html 0.6 2026-08-14T09:55:15+08:00 daily https://www.pharmasources.com/industryinsights/lillys-nasal-hypoglycaemia-therapy-recei-314039.html 0.6 2026-07-15T09:29:57+08:00 daily https://www.pharmasources.com/industryinsights/model-fails-to-predict-risk-for-maternal-314040.html 0.6 2026-08-12T20:11:06+08:00 daily https://www.pharmasources.com/industryinsights/online-symptom-self-management-telehealt-314041.html 0.6 2026-08-09T01:20:35+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-to-develop-verastems-copiktra-in--314042.html 0.6 2026-08-09T06:59:13+08:00 daily https://www.pharmasources.com/industryinsights/vitamin-d-supplementation-beneficial-for-314043.html 0.6 2026-08-08T02:37:53+08:00 daily https://www.pharmasources.com/industryinsights/roxadustat-noninferior-to-epoetin-alfa-i-314044.html 0.6 2026-08-08T01:44:15+08:00 daily https://www.pharmasources.com/industryinsights/thyroidectomy-complication-rate-down-whe-314045.html 0.6 2026-08-08T01:01:36+08:00 daily https://www.pharmasources.com/industryinsights/hyaluronic-acid-used-in-the-most-popular-314046.html 0.6 2026-08-07T13:18:31+08:00 daily https://www.pharmasources.com/industryinsights/abbvies-psoriasis-launch-skyrizi-hitting-314047.html 0.6 2026-08-07T13:57:42+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-lynparza-scores-limited-nic-314048.html 0.6 2026-08-08T05:07:29+08:00 daily https://www.pharmasources.com/industryinsights/fbi-targeted-outcome-health-and-its-co-f-314049.html 0.6 2026-08-09T07:36:45+08:00 daily https://www.pharmasources.com/industryinsights/thai-startups-to-capture-a-major-chunk-o-314050.html 0.6 2026-06-22T23:22:44+08:00 daily https://www.pharmasources.com/industryinsights/hikma-and-richter-sign-pact-to-market-ca-314051.html 0.6 2026-06-23T08:27:14+08:00 daily https://www.pharmasources.com/industryinsights/us-researchers-design-3d-printed-indiges-314052.html 0.6 2026-06-20T19:57:01+08:00 daily https://www.pharmasources.com/industryinsights/aucta-pharma-licenses-vigabatrin-for-ora-314053.html 0.6 2026-07-23T08:05:12+08:00 daily https://www.pharmasources.com/industryinsights/healthysg-taskforce-charts-healthier-pat-314054.html 0.6 2026-06-20T20:01:36+08:00 daily https://www.pharmasources.com/industryinsights/accellix-expands-leadership-team-announc-314055.html 0.6 2026-06-25T05:40:05+08:00 daily https://www.pharmasources.com/industryinsights/scientists-in-japan-develop-prosthetics--314056.html 0.6 2026-06-21T12:21:12+08:00 daily https://www.pharmasources.com/industryinsights/alvotech-cipla-gulf-to-commercialise-key-314057.html 0.6 2026-06-21T05:07:51+08:00 daily https://www.pharmasources.com/industryinsights/exposure-to-urban-tree-canopy-beneficial-314058.html 0.6 2026-06-22T04:58:39+08:00 daily https://www.pharmasources.com/industryinsights/nc-man-dies-of-brain-eating-amoeba-after-314059.html 0.6 2026-06-21T02:55:37+08:00 daily https://www.pharmasources.com/industryinsights/experts-warn-of-mosquito-borne-brain-inf-314060.html 0.6 2026-06-20T16:09:45+08:00 daily https://www.pharmasources.com/industryinsights/authors-say-lower-bp-targets-may-cut-rec-314061.html 0.6 2026-07-12T11:28:48+08:00 daily https://www.pharmasources.com/industryinsights/lifesaving-drug-for-infants-costs-21-mil-314062.html 0.6 2026-07-01T21:09:43+08:00 daily https://www.pharmasources.com/industryinsights/stress-takes-toll-in-very-complicated-bi-314063.html 0.6 2026-07-01T18:35:26+08:00 daily https://www.pharmasources.com/industryinsights/high-levels-of-estrogen-in-womb-might-ra-314064.html 0.6 2026-07-01T20:13:59+08:00 daily https://www.pharmasources.com/industryinsights/merck-to-build-650m-biomanufacturing-pla-314065.html 0.6 2026-07-05T13:10:05+08:00 daily https://www.pharmasources.com/industryinsights/cordenpharma-names-new-ceo-314066.html 0.6 2026-07-24T13:52:20+08:00 daily https://www.pharmasources.com/industryinsights/chargepoint-strengthens-presence-in-euro-314067.html 0.6 2026-06-21T00:52:38+08:00 daily https://www.pharmasources.com/industryinsights/alvotech-cipla-gulf-ink-biosimilar-deal-314068.html 0.6 2026-07-05T12:00:12+08:00 daily https://www.pharmasources.com/industryinsights/iontas-teva-enter-antibody-optimization--314069.html 0.6 2026-06-21T13:11:43+08:00 daily https://www.pharmasources.com/industryinsights/could-your-cellphone-charger-electrocute-314070.html 0.6 2026-08-10T22:04:39+08:00 daily https://www.pharmasources.com/industryinsights/ema-recommends-vitrakvi-for-eu-marketing-314071.html 0.6 2026-06-21T12:04:13+08:00 daily https://www.pharmasources.com/industryinsights/where-is-your-risk-of-dying-greatest-aft-314072.html 0.6 2026-06-21T02:07:48+08:00 daily https://www.pharmasources.com/industryinsights/living-with-repetitive-strain-injury-314073.html 0.6 2026-06-22T08:58:48+08:00 daily https://www.pharmasources.com/industryinsights/one-gene-change-2-million-years-ago-left-314074.html 0.6 2026-07-05T05:36:25+08:00 daily https://www.pharmasources.com/industryinsights/family-home-football-field-most-dangerou-314075.html 0.6 2026-06-21T07:08:01+08:00 daily https://www.pharmasources.com/industryinsights/delay-in-time-to-chemo-impacts-survival--314076.html 0.6 2026-06-20T22:59:40+08:00 daily https://www.pharmasources.com/industryinsights/substantial-costs-attributable-to-hospit-314077.html 0.6 2026-07-27T17:30:49+08:00 daily https://www.pharmasources.com/industryinsights/opioid-prescribing-new-persistent-use-do-314078.html 0.6 2026-06-25T08:20:36+08:00 daily https://www.pharmasources.com/industryinsights/ai-model-can-predict-long-term-mortality-314079.html 0.6 2026-08-07T11:19:27+08:00 daily https://www.pharmasources.com/industryinsights/previous-silent-mi-often-found-at-autops-314080.html 0.6 2026-06-21T12:07:12+08:00 daily https://www.pharmasources.com/industryinsights/serious-falls-pose-risk-to-people-living-314081.html 0.6 2026-06-20T19:10:47+08:00 daily https://www.pharmasources.com/industryinsights/random-plasma-glucose-levels-can-predict-314082.html 0.6 2026-08-12T23:41:40+08:00 daily https://www.pharmasources.com/industryinsights/neurostat-project-receives-fda-fast-trac-314083.html 0.6 2026-06-22T00:01:44+08:00 daily https://www.pharmasources.com/industryinsights/bpa-substitute-chemicals-linked-to-obesi-314084.html 0.6 2026-04-14T03:13:09+08:00 daily https://www.pharmasources.com/industryinsights/cv-event-risk-up-with-rejected-abandoned-314085.html 0.6 2026-06-21T06:46:02+08:00 daily https://www.pharmasources.com/industryinsights/keytruda-chemotherapy-combination-met-pr-314086.html 0.6 2026-08-08T19:33:22+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-boxed-warning-about-increas-314087.html 0.6 2026-06-08T18:23:38+08:00 daily https://www.pharmasources.com/industryinsights/relmada-completes-dosing-of-rel-1017-in--314088.html 0.6 2026-06-20T21:02:45+08:00 daily https://www.pharmasources.com/industryinsights/mylan-upjohn-announce-new-combined-busin-314089.html 0.6 2026-08-05T16:59:56+08:00 daily https://www.pharmasources.com/industryinsights/thermo-scientific-announces-new-general--314090.html 0.6 2026-08-07T12:29:56+08:00 daily https://www.pharmasources.com/industryinsights/chmp-issues-approval-of-13-medicines-314091.html 0.6 2026-07-03T15:46:49+08:00 daily https://www.pharmasources.com/industryinsights/stimulant-treatment-has-strong-protectiv-314092.html 0.6 2026-06-21T18:07:28+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-ovarian-cancer-drug-olapari-314093.html 0.6 2026-06-20T16:08:39+08:00 daily https://www.pharmasources.com/industryinsights/fda-adds-boxed-warning-to-pfizers-xeljan-314094.html 0.6 2026-07-17T06:12:12+08:00 daily https://www.pharmasources.com/industryinsights/usfda-clears-indocos-goa-plant-ii-and-ii-314095.html 0.6 2026-06-21T12:58:38+08:00 daily https://www.pharmasources.com/industryinsights/biocon-q1fy20-revenue-grows-by-25-per-ce-314096.html 0.6 2026-06-22T21:07:11+08:00 daily https://www.pharmasources.com/industryinsights/stempeutics-partners-with-kemwell-for-gl-314097.html 0.6 2026-06-21T21:50:45+08:00 daily https://www.pharmasources.com/industryinsights/cipla-seeks-favourable-policy-for-domest-314098.html 0.6 2026-06-21T02:59:41+08:00 daily https://www.pharmasources.com/industryinsights/alembic-pharma-gets-tentative-nod-from-u-314099.html 0.6 2026-05-30T02:49:53+08:00 daily https://www.pharmasources.com/industryinsights/alvotech-in-partnership-with-cipla-gulf-314100.html 0.6 2026-06-21T10:20:23+08:00 daily https://www.pharmasources.com/industryinsights/karnataka-govts-bisep-to-mentor-manpower-314101.html 0.6 2026-06-20T21:14:18+08:00 daily https://www.pharmasources.com/industryinsights/initiating-stroke-tx-15-minutes-earlier--314102.html 0.6 2026-06-22T03:02:38+08:00 daily https://www.pharmasources.com/industryinsights/mylan-and-upjohn-a-division-of-pfizer-to-314103.html 0.6 2026-08-14T22:09:41+08:00 daily https://www.pharmasources.com/industryinsights/compound-found-in-red-wine-opens-door-fo-314104.html 0.6 2026-06-21T14:50:19+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-treatment-for-severe--314105.html 0.6 2026-08-08T03:25:16+08:00 daily https://www.pharmasources.com/industryinsights/hiv-vaccine-nears-clinical-trial-followi-314106.html 0.6 2026-08-12T15:25:35+08:00 daily https://www.pharmasources.com/industryinsights/enbrel-and-its-patent-layout-the-period--314107.html 0.6 2026-08-07T13:17:57+08:00 daily https://www.pharmasources.com/industryinsights/nec-acquires-oncoimmunity-as-to-empower--314108.html 0.6 2026-08-08T07:56:02+08:00 daily https://www.pharmasources.com/industryinsights/strides-enters-into-jv-with-sihuan-pharm-314109.html 0.6 2026-08-08T10:11:43+08:00 daily https://www.pharmasources.com/industryinsights/watsons-joins-hands-with-prenetics-314110.html 0.6 2026-08-08T12:07:20+08:00 daily https://www.pharmasources.com/industryinsights/fda-limits-xeljanz-in-colitis-slaps-blac-314111.html 0.6 2026-08-08T13:18:16+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-big-split-is-finally-here-thanks-314112.html 0.6 2026-08-10T10:35:22+08:00 daily https://www.pharmasources.com/industryinsights/deja-vu-pharma-ad-tax-deduction-faces-th-314113.html 0.6 2026-08-08T02:28:11+08:00 daily https://www.pharmasources.com/industryinsights/mylan-ceo-bresch-set-to-exit-after-years-314114.html 0.6 2026-06-21T11:51:16+08:00 daily https://www.pharmasources.com/industryinsights/lonza-vineti-enter-cell-and-gene-therapy-314115.html 0.6 2026-06-20T14:35:28+08:00 daily https://www.pharmasources.com/industryinsights/kodiak-sciences-receives-positive-phase--314116.html 0.6 2026-06-08T22:28:38+08:00 daily https://www.pharmasources.com/industryinsights/cambrex-expands-process-development-at-e-314117.html 0.6 2026-06-20T23:51:43+08:00 daily https://www.pharmasources.com/industryinsights/canbridge-appoints-svp-rare-disease-comm-314118.html 0.6 2026-06-21T01:53:39+08:00 daily https://www.pharmasources.com/industryinsights/g1-therapeutics-appoints-chief-business--314119.html 0.6 2026-06-21T08:15:12+08:00 daily https://www.pharmasources.com/industryinsights/tyme-technologies-nyu-langone-to-advance-314120.html 0.6 2026-06-20T15:46:50+08:00 daily https://www.pharmasources.com/industryinsights/prometrika-comprehend-partner-on-clinica-314121.html 0.6 2026-06-20T20:51:42+08:00 daily https://www.pharmasources.com/industryinsights/mustang-bios-aml-treatment-receives-orph-314122.html 0.6 2026-08-12T05:46:13+08:00 daily https://www.pharmasources.com/industryinsights/legionnaires-disease-outbreak-linked-to--314123.html 0.6 2026-06-22T08:52:04+08:00 daily https://www.pharmasources.com/industryinsights/oil-gas-well-exposure-may-up-risk-for-co-314124.html 0.6 2026-07-04T10:39:53+08:00 daily https://www.pharmasources.com/industryinsights/new-opioid-rx-rules-coming-for-us-employ-314125.html 0.6 2026-06-21T04:57:54+08:00 daily https://www.pharmasources.com/industryinsights/biologics-or-small-molecule-drugs-for-ra-314126.html 0.6 2026-06-21T12:58:40+08:00 daily https://www.pharmasources.com/industryinsights/70-million-settlement-reached-in-generic-314127.html 0.6 2026-06-20T15:07:34+08:00 daily https://www.pharmasources.com/industryinsights/cdc-general-fertility-rate-teen-birth-ra-314128.html 0.6 2026-06-22T19:06:17+08:00 daily https://www.pharmasources.com/industryinsights/twins-deaths-in-hot-car-highlight-a-prev-314129.html 0.6 2026-06-20T21:09:43+08:00 daily https://www.pharmasources.com/industryinsights/are-too-many-kids-prescribed-antihistami-314130.html 0.6 2026-06-22T07:01:48+08:00 daily https://www.pharmasources.com/industryinsights/smoking-may-interfere-with-embolization--314131.html 0.6 2026-06-20T17:20:50+08:00 daily https://www.pharmasources.com/industryinsights/middle-age-now-a-high-risk-time-for-bad--314132.html 0.6 2026-06-21T02:09:44+08:00 daily https://www.pharmasources.com/industryinsights/heartburn-drugs-might-bring-allergy-woes-314133.html 0.6 2026-06-21T03:02:51+08:00 daily https://www.pharmasources.com/industryinsights/clogged-leg-arteries-may-not-require-inv-314134.html 0.6 2026-06-20T23:00:42+08:00 daily https://www.pharmasources.com/industryinsights/childhood-cancer-steals-over-11-million--314135.html 0.6 2026-07-01T01:13:26+08:00 daily https://www.pharmasources.com/industryinsights/eurofins-alphora-and-eurofins-amatsigrou-314136.html 0.6 2026-06-22T08:44:52+08:00 daily https://www.pharmasources.com/industryinsights/alkermes-announces-settlement-with-amnea-314137.html 0.6 2026-06-24T00:35:11+08:00 daily https://www.pharmasources.com/industryinsights/fda-clears-new-indications-for-existing--314138.html 0.6 2026-06-21T20:05:44+08:00 daily https://www.pharmasources.com/industryinsights/mylan-to-merge-with-pfizers-off-patent-d-314139.html 0.6 2026-06-21T13:08:38+08:00 daily https://www.pharmasources.com/industryinsights/hearing-loss-takes-mental-social-physica-314140.html 0.6 2026-06-21T05:58:52+08:00 daily https://www.pharmasources.com/industryinsights/global-burden-of-childhood-cancers-exami-314141.html 0.6 2026-08-09T07:56:23+08:00 daily https://www.pharmasources.com/industryinsights/first-surgery-for-ischemic-leg-ulcer-may-314142.html 0.6 2026-08-08T07:43:46+08:00 daily https://www.pharmasources.com/industryinsights/viiv-and-janssen-seek-european-approval--314143.html 0.6 2026-06-21T12:05:16+08:00 daily https://www.pharmasources.com/industryinsights/lyndra-therapeutics-to-create-long-actin-314144.html 0.6 2026-08-08T04:35:05+08:00 daily https://www.pharmasources.com/industryinsights/cied-complication-rates-vary-considerabl-314145.html 0.6 2026-08-08T03:25:21+08:00 daily https://www.pharmasources.com/industryinsights/national-norms-developed-for-assessing-m-314146.html 0.6 2026-08-07T11:55:30+08:00 daily https://www.pharmasources.com/industryinsights/poll-patients-want-to-talk-to-physicians-314147.html 0.6 2026-08-07T11:28:19+08:00 daily https://www.pharmasources.com/industryinsights/strides-inks-jv-pact-with-chinas-sihuan--314148.html 0.6 2026-08-07T13:18:07+08:00 daily https://www.pharmasources.com/industryinsights/sglt-2-inhibitor-use-not-linked-to-incre-314149.html 0.6 2026-08-06T22:53:12+08:00 daily https://www.pharmasources.com/industryinsights/alembic-reports-a-37-per-cent-hike-in-ne-314150.html 0.6 2026-08-06T22:08:35+08:00 daily https://www.pharmasources.com/industryinsights/changes-in-radial-pulse-during-menopause-314151.html 0.6 2026-08-07T22:41:35+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-and-novartis-set-to-lose-out-314152.html 0.6 2026-08-07T14:35:34+08:00 daily https://www.pharmasources.com/industryinsights/newer-technology-will-disrupt-the-pharma-314153.html 0.6 2026-08-06T20:08:08+08:00 daily https://www.pharmasources.com/industryinsights/nppa-to-hire-12-consultants-for-differen-314154.html 0.6 2026-08-06T23:45:03+08:00 daily https://www.pharmasources.com/industryinsights/romaco-opens-new-sales-service-centre-in-314155.html 0.6 2026-08-06T23:47:58+08:00 daily https://www.pharmasources.com/industryinsights/omeros-lonza-enter-commercial-manufactur-314156.html 0.6 2026-08-07T13:16:27+08:00 daily https://www.pharmasources.com/industryinsights/lsne-expands-controlled-temperature-stor-314157.html 0.6 2026-08-07T00:15:41+08:00 daily https://www.pharmasources.com/industryinsights/eurofins-amatsigroup-rebrands-to-eurofin-314158.html 0.6 2026-08-07T00:01:56+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-and-ucb-sign-third-dru-314159.html 0.6 2026-08-06T23:57:03+08:00 daily https://www.pharmasources.com/industryinsights/antares-vision-offers-traceability-solut-314160.html 0.6 2026-08-06T23:46:35+08:00 daily https://www.pharmasources.com/industryinsights/neogenomics-opens-new-lab-in-singapore-314161.html 0.6 2026-08-07T06:06:55+08:00 daily https://www.pharmasources.com/industryinsights/nephron-rapid-micro-announce-automated-m-314162.html 0.6 2026-06-22T02:55:37+08:00 daily https://www.pharmasources.com/industryinsights/trial-tests-crispr-gene-editing-to-treat-314163.html 0.6 2026-08-03T07:58:33+08:00 daily https://www.pharmasources.com/industryinsights/u-shaped-association-found-for-hemoglobi-314164.html 0.6 2026-06-20T17:50:21+08:00 daily https://www.pharmasources.com/industryinsights/biologic-tx-for-psoriasis-may-reduce-cor-314165.html 0.6 2026-06-20T16:03:10+08:00 daily https://www.pharmasources.com/industryinsights/106-percent-of-seniors-estimated-as-curr-314166.html 0.6 2026-07-19T05:20:30+08:00 daily https://www.pharmasources.com/industryinsights/drug-duo-may-be-an-advance-against-a-com-314167.html 0.6 2026-06-20T20:06:37+08:00 daily https://www.pharmasources.com/industryinsights/anemia-linked-to-higher-odds-for-dementi-314168.html 0.6 2026-06-21T11:23:29+08:00 daily https://www.pharmasources.com/industryinsights/overweight-men-may-feel-stigmatized-too-314169.html 0.6 2026-06-29T16:27:55+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-nubeqa-darolutamide-for-men-314170.html 0.6 2026-07-24T01:19:53+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-chemical-widely-used-in-medical-314171.html 0.6 2026-06-21T22:40:59+08:00 daily https://www.pharmasources.com/industryinsights/harrow-health-announces-launch-of-mayfie-314172.html 0.6 2026-06-20T13:20:43+08:00 daily https://www.pharmasources.com/industryinsights/fda-issues-draft-guidance-regarding-clin-314173.html 0.6 2026-08-08T02:42:07+08:00 daily https://www.pharmasources.com/industryinsights/sangamo-announces-executive-vp-general-c-314174.html 0.6 2026-06-21T03:14:59+08:00 daily https://www.pharmasources.com/industryinsights/indians-big-pharma-companies-finding-new-314175.html 0.6 2026-07-20T10:57:59+08:00 daily https://www.pharmasources.com/industryinsights/verzenio-demonstrates-significant-improv-314176.html 0.6 2026-08-03T09:05:42+08:00 daily https://www.pharmasources.com/industryinsights/niimbl-fda-sign-new-agreement-to-support-314177.html 0.6 2026-06-21T10:15:45+08:00 daily https://www.pharmasources.com/industryinsights/biohaven-enrolls-first-patient-in-verdip-314178.html 0.6 2026-06-21T10:17:24+08:00 daily https://www.pharmasources.com/industryinsights/delmar-achieves-two-thirds-enrollment-fo-314179.html 0.6 2026-06-23T10:14:04+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-dosed-with-the-affinity-ta-314180.html 0.6 2026-06-25T11:10:54+08:00 daily https://www.pharmasources.com/industryinsights/vitamin-a-linked-to-lower-odds-of-common-314181.html 0.6 2026-06-20T22:01:38+08:00 daily https://www.pharmasources.com/industryinsights/alligator-bioscience-regains-cancer-asse-314182.html 0.6 2026-07-20T23:30:19+08:00 daily https://www.pharmasources.com/industryinsights/teva-settles-californias-pay-for-delay-a-314183.html 0.6 2026-07-29T13:03:59+08:00 daily https://www.pharmasources.com/industryinsights/its-not-just-college-kids-many-seniors-a-314184.html 0.6 2026-06-20T17:56:53+08:00 daily https://www.pharmasources.com/industryinsights/orion-and-bayer-secure-fda-approval-for--314185.html 0.6 2026-06-21T11:10:14+08:00 daily https://www.pharmasources.com/industryinsights/mild-head-injury-can-impair-your-sense-o-314186.html 0.6 2026-06-20T14:28:36+08:00 daily https://www.pharmasources.com/industryinsights/oral-semaglutide-reduces-hba1c-weight-in-314187.html 0.6 2026-08-07T02:27:17+08:00 daily https://www.pharmasources.com/industryinsights/results-of-the-pivotal-phase-3-study-of--314188.html 0.6 2026-06-21T05:56:41+08:00 daily https://www.pharmasources.com/industryinsights/drive-for-generics-sees-korea-increasing-314189.html 0.6 2026-06-21T06:50:12+08:00 daily https://www.pharmasources.com/industryinsights/china-mulls-regulations-for-e-cigarettes-314190.html 0.6 2026-06-21T04:56:42+08:00 daily https://www.pharmasources.com/industryinsights/biocon-mylan-launch-first-trastuzumab-bi-314191.html 0.6 2026-06-20T19:00:37+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-announces-regulatory-filing-o-314192.html 0.6 2026-06-22T09:56:44+08:00 daily https://www.pharmasources.com/industryinsights/therapix-biosciences-announces-canadian--314193.html 0.6 2026-07-16T17:18:08+08:00 daily https://www.pharmasources.com/industryinsights/single-lead-ecg-wristband-gets-cfda-cert-314194.html 0.6 2026-06-22T06:58:50+08:00 daily https://www.pharmasources.com/industryinsights/fda-new-drug-approvals-up-11-in-2018-314195.html 0.6 2026-06-20T18:04:24+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-inks-6m-deal-with-genome-c-314196.html 0.6 2026-06-20T20:44:23+08:00 daily https://www.pharmasources.com/industryinsights/medibeacon-enters-into-30-m-partnership--314197.html 0.6 2026-06-20T14:29:09+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-ucb-sign-third-drug-ma-314198.html 0.6 2026-06-21T11:19:35+08:00 daily https://www.pharmasources.com/industryinsights/nus-medicine-researcher-wins-gabbay-awar-314199.html 0.6 2026-07-08T09:30:50+08:00 daily https://www.pharmasources.com/industryinsights/amgen-sales-slide-as-copies-dig-into-sen-314200.html 0.6 2026-06-20T16:10:41+08:00 daily https://www.pharmasources.com/industryinsights/gileads-exec-search-wont-hurt-its-deal-s-314201.html 0.6 2026-06-21T00:55:41+08:00 daily https://www.pharmasources.com/industryinsights/music-to-the-ear-podcasts-streaming-radi-314202.html 0.6 2026-08-07T03:54:38+08:00 daily https://www.pharmasources.com/industryinsights/megadeals-aside-pharma-ma-actually-dropp-314203.html 0.6 2026-08-09T00:58:59+08:00 daily https://www.pharmasources.com/industryinsights/mylan-which-bought-novartis-cf-drugs-cir-314204.html 0.6 2026-08-12T03:41:37+08:00 daily https://www.pharmasources.com/industryinsights/roche-extends-43b-spark-tender-offer-yet-314205.html 0.6 2026-08-08T01:22:30+08:00 daily https://www.pharmasources.com/industryinsights/chasing-pfizer-and-jj-bayers-nubeqa-nabs-314206.html 0.6 2026-08-08T00:32:16+08:00 daily https://www.pharmasources.com/industryinsights/would-trumps-new-drug-imports-plan-do-mu-314207.html 0.6 2026-08-06T13:37:43+08:00 daily https://www.pharmasources.com/industryinsights/when-it-comes-to-vascepa-expansion-we-ca-314208.html 0.6 2026-06-22T21:54:50+08:00 daily https://www.pharmasources.com/industryinsights/milliporesigma-launches-plug-play-upstre-314209.html 0.6 2026-06-21T08:16:17+08:00 daily https://www.pharmasources.com/industryinsights/pfenex-arcellx-announce-development-eval-314210.html 0.6 2026-06-21T13:00:44+08:00 daily https://www.pharmasources.com/industryinsights/endo-appoints-evp-and-cco-sterile-and-ge-314211.html 0.6 2026-06-21T09:02:10+08:00 daily https://www.pharmasources.com/industryinsights/marken-acquires-japanese-logistics-compa-314212.html 0.6 2026-06-20T15:11:19+08:00 daily https://www.pharmasources.com/industryinsights/nektar-therapeutics-bms-receive-breakthr-314213.html 0.6 2026-08-07T13:17:20+08:00 daily https://www.pharmasources.com/industryinsights/ontario-and-quebec-against-plan-to-lower-314214.html 0.6 2026-06-20T19:20:04+08:00 daily https://www.pharmasources.com/industryinsights/ftc-investigates-contracts-regarding-aut-314215.html 0.6 2026-06-21T04:13:55+08:00 daily https://www.pharmasources.com/industryinsights/many-hospitals-lack-sufficient-surgery-v-314216.html 0.6 2026-06-20T17:52:25+08:00 daily https://www.pharmasources.com/industryinsights/indian-drug-makers-looking-to-expand-in--314217.html 0.6 2026-06-22T14:51:57+08:00 daily https://www.pharmasources.com/industryinsights/niimbl-fda-to-advance-innovation-in-bio--314218.html 0.6 2026-03-24T23:48:33+08:00 daily https://www.pharmasources.com/industryinsights/transmission-risks-up-for-hiv-positive-i-314219.html 0.6 2026-06-21T13:08:35+08:00 daily https://www.pharmasources.com/industryinsights/cphi-p-mec-china-2019-celebrated-its-19t-314220.html 0.6 2026-07-08T09:07:34+08:00 daily https://www.pharmasources.com/industryinsights/first-ebola-transmission-in-congo-city-o-314221.html 0.6 2026-08-12T17:13:09+08:00 daily https://www.pharmasources.com/industryinsights/blood-test-may-spot-brain-changes-of-ear-314222.html 0.6 2026-06-20T18:21:11+08:00 daily https://www.pharmasources.com/industryinsights/cdc-renews-pledge-to-fight-ebola-outbrea-314223.html 0.6 2026-06-20T16:43:58+08:00 daily https://www.pharmasources.com/industryinsights/endo-announces-executive-vp-chief-commer-314224.html 0.6 2026-06-21T15:48:23+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-glaxosmithkline-announce-joint-ve-314225.html 0.6 2026-06-20T23:55:37+08:00 daily https://www.pharmasources.com/industryinsights/medicasafe-announces-advisory-board-appo-314226.html 0.6 2026-06-20T15:52:32+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-breakthrough-therapy-designat-314227.html 0.6 2026-07-10T05:29:59+08:00 daily https://www.pharmasources.com/industryinsights/generic-version-of-navelbine-softgel-cap-314228.html 0.6 2026-08-05T23:55:53+08:00 daily https://www.pharmasources.com/industryinsights/go-easy-on-caffeine-during-pregnancy-for-314229.html 0.6 2026-06-23T02:57:53+08:00 daily https://www.pharmasources.com/industryinsights/3-d-printers-might-someday-make-replacem-314230.html 0.6 2026-06-20T23:45:29+08:00 daily https://www.pharmasources.com/industryinsights/recommendations-decreased-for-cough-cold-314231.html 0.6 2026-06-21T20:57:40+08:00 daily https://www.pharmasources.com/industryinsights/entresto-study-misses-primary-endpoint-314232.html 0.6 2026-06-21T02:10:52+08:00 daily https://www.pharmasources.com/industryinsights/gsk-closes-consumer-healthcare-jv-transa-314233.html 0.6 2026-06-21T03:15:53+08:00 daily https://www.pharmasources.com/industryinsights/exelixis-signs-drug-licensing-deal-with--314234.html 0.6 2026-06-20T20:05:38+08:00 daily https://www.pharmasources.com/industryinsights/mylan-and-biocon-launch-first-trastuzuma-314235.html 0.6 2026-07-16T14:51:04+08:00 daily https://www.pharmasources.com/industryinsights/trivitron-and-c-camp-sign-an-mou-314236.html 0.6 2026-06-22T10:43:34+08:00 daily https://www.pharmasources.com/industryinsights/warning-letter-woes-dr-reddys-expects-fd-314237.html 0.6 2026-06-20T22:58:41+08:00 daily https://www.pharmasources.com/industryinsights/dietary-vitamin-a-intake-tied-to-reduced-314238.html 0.6 2026-06-21T05:02:45+08:00 daily https://www.pharmasources.com/industryinsights/could-exercise-in-pregnancy-boost-babys--314239.html 0.6 2026-06-22T00:59:49+08:00 daily https://www.pharmasources.com/industryinsights/dual-therapy-might-be-advance-against-ge-314240.html 0.6 2026-07-05T20:36:51+08:00 daily https://www.pharmasources.com/industryinsights/how-does-meth-trigger-heart-disease-new--314241.html 0.6 2026-06-21T03:04:43+08:00 daily https://www.pharmasources.com/industryinsights/go-easy-on-caffeine-during-pregnancy-for-314242.html 0.6 2026-06-22T05:16:53+08:00 daily https://www.pharmasources.com/industryinsights/blood-test-may-spot-brain-changes-of-ear-314243.html 0.6 2026-08-09T04:19:52+08:00 daily https://www.pharmasources.com/industryinsights/more-buyer-beware-warnings-for-unregulat-314244.html 0.6 2026-06-20T20:04:35+08:00 daily https://www.pharmasources.com/industryinsights/trump-admin-announces-plan-to-allow-drug-314245.html 0.6 2026-06-21T03:43:36+08:00 daily https://www.pharmasources.com/industryinsights/closing-the-door-breaking-new-ground-rel-314246.html 0.6 2026-06-21T07:15:09+08:00 daily https://www.pharmasources.com/industryinsights/kyowa-kirin-buys-back-tivozanib-rights-f-314247.html 0.6 2026-01-13T22:23:36+08:00 daily https://www.pharmasources.com/industryinsights/biocon-mylan-launch-ogivri-in-australia-314248.html 0.6 2026-06-20T17:08:24+08:00 daily https://www.pharmasources.com/industryinsights/marken-acquires-pcx-international-to-str-314249.html 0.6 2026-06-21T17:11:34+08:00 daily https://www.pharmasources.com/industryinsights/biosyngen-group-signs-contract-of-dalian-314250.html 0.6 2026-06-22T17:57:55+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-completes-acquisition-of-biogen-314251.html 0.6 2026-08-07T18:40:38+08:00 daily https://www.pharmasources.com/industryinsights/morimoto-pharma-reveals-new-exposure-pre-314252.html 0.6 2026-08-09T22:30:21+08:00 daily https://www.pharmasources.com/industryinsights/nucala-by-gsk-receives-eu-approval-for-p-314253.html 0.6 2026-07-15T17:15:10+08:00 daily https://www.pharmasources.com/industryinsights/gsk-completes-transaction-with-pfizer-to-314254.html 0.6 2026-06-22T07:00:49+08:00 daily https://www.pharmasources.com/industryinsights/fda-clears-oleena-first-digital-therapeu-314255.html 0.6 2026-08-13T14:37:15+08:00 daily https://www.pharmasources.com/industryinsights/sysmex-gets-japanese-manufacturing-and-m-314256.html 0.6 2026-06-21T22:56:44+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-tracon-initiate-phase-1-trial-of-t-314257.html 0.6 2026-08-09T19:12:33+08:00 daily https://www.pharmasources.com/industryinsights/bayer-gets-eu-chmp-nod-for-precision-onc-314258.html 0.6 2026-06-24T19:30:22+08:00 daily https://www.pharmasources.com/industryinsights/international-experts-convene-to-respond-314259.html 0.6 2026-06-20T14:59:09+08:00 daily https://www.pharmasources.com/industryinsights/fiercepharmaasiatakedas-cost-saving-prog-314260.html 0.6 2026-06-21T02:10:48+08:00 daily https://www.pharmasources.com/industryinsights/another-day-another-form-483-for-a-dr-re-314261.html 0.6 2026-08-09T07:59:59+08:00 daily https://www.pharmasources.com/industryinsights/chipscreen-upsizes-ipo-as-investors-floc-314262.html 0.6 2026-06-20T14:54:07+08:00 daily https://www.pharmasources.com/industryinsights/pra-buys-out-takeda-jv-cements-outpost-i-314263.html 0.6 2026-06-21T01:00:43+08:00 daily https://www.pharmasources.com/industryinsights/longtime-pharma-critic-and-democratic-ca-314264.html 0.6 2026-06-24T03:15:19+08:00 daily https://www.pharmasources.com/industryinsights/could-ftc-scrutiny-of-the-roche-spark-me-314265.html 0.6 2026-06-20T19:54:36+08:00 daily https://www.pharmasources.com/industryinsights/for-kids-with-asthma-allergies-new-schoo-314266.html 0.6 2026-08-08T17:08:23+08:00 daily https://www.pharmasources.com/industryinsights/choose-your-running-shoes-carefully-314267.html 0.6 2026-06-20T19:11:52+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-turalio-pexidartinib-for-th-314268.html 0.6 2026-06-21T08:53:22+08:00 daily https://www.pharmasources.com/industryinsights/acg-acquires-pharma-processing-equipment-314269.html 0.6 2026-08-05T20:07:28+08:00 daily https://www.pharmasources.com/industryinsights/mylan-and-upjohn-join-forces-314270.html 0.6 2026-06-22T04:00:40+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-completes-acquisition-of-biogen-314271.html 0.6 2026-07-05T00:13:27+08:00 daily https://www.pharmasources.com/industryinsights/biological-e-gvk-bio-enter-rd-partnershi-314272.html 0.6 2026-06-26T18:03:26+08:00 daily https://www.pharmasources.com/industryinsights/vetio-completes-plant-expansion-in-montr-314273.html 0.6 2026-06-22T01:50:33+08:00 daily https://www.pharmasources.com/industryinsights/risk-for-developing-frailty-high-in-olde-314274.html 0.6 2026-06-21T04:59:42+08:00 daily https://www.pharmasources.com/industryinsights/us-air-force-orders-day-off-training-to--314275.html 0.6 2026-06-22T04:00:39+08:00 daily https://www.pharmasources.com/industryinsights/049-percent-of-us-population-reports-cur-314276.html 0.6 2026-06-21T20:15:52+08:00 daily https://www.pharmasources.com/industryinsights/us-hospital-patients-receive-more-opioid-314277.html 0.6 2026-06-22T02:57:37+08:00 daily https://www.pharmasources.com/industryinsights/finances-affect-womens-choice-of-breast--314278.html 0.6 2026-06-21T03:04:43+08:00 daily https://www.pharmasources.com/industryinsights/teens-are-getting-hooked-on-leftover-pre-314279.html 0.6 2026-06-21T07:02:58+08:00 daily https://www.pharmasources.com/industryinsights/brand-brand-competition-has-not-cut-pric-314280.html 0.6 2026-06-24T02:19:37+08:00 daily https://www.pharmasources.com/industryinsights/scorching-pavement-sends-some-to-the-er--314281.html 0.6 2026-06-20T18:01:24+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-hurricane-checklist-batteries-b-314282.html 0.6 2026-06-30T19:00:27+08:00 daily https://www.pharmasources.com/industryinsights/estrogen-preps-differ-in-effects-on-hear-314283.html 0.6 2026-06-22T11:00:52+08:00 daily https://www.pharmasources.com/industryinsights/age-adjusted-drug-overdose-death-rate-hi-314284.html 0.6 2026-06-21T09:04:06+08:00 daily https://www.pharmasources.com/industryinsights/mediterranean-eating-plan-may-help-keep--314285.html 0.6 2026-06-21T09:52:18+08:00 daily https://www.pharmasources.com/industryinsights/discontinuing-statins-linked-to-cardiac--314286.html 0.6 2026-06-20T14:41:05+08:00 daily https://www.pharmasources.com/industryinsights/ai-enabled-ecg-during-normal-sinus-rhyth-314287.html 0.6 2026-06-20T19:18:06+08:00 daily https://www.pharmasources.com/industryinsights/compliance-with-meds-falters-with-age-in-314288.html 0.6 2026-06-21T23:57:43+08:00 daily https://www.pharmasources.com/industryinsights/psychologic-distress-linked-to-cervical--314289.html 0.6 2026-06-30T15:29:56+08:00 daily https://www.pharmasources.com/industryinsights/plasma-assay-promising-for-diagnosis-of--314290.html 0.6 2026-06-21T01:09:55+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-lokelma-treatment-for-hy-314291.html 0.6 2026-06-21T10:06:10+08:00 daily https://www.pharmasources.com/industryinsights/tecan-synergence-offers-comprehensive-ap-314292.html 0.6 2026-06-22T08:02:47+08:00 daily https://www.pharmasources.com/industryinsights/us-food-and-drug-administration-approves-314293.html 0.6 2026-06-21T13:01:29+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-therapy-for-rare-join-314294.html 0.6 2026-06-21T11:04:16+08:00 daily https://www.pharmasources.com/industryinsights/hair-loss-not-just-a-male-problem-314295.html 0.6 2026-06-20T15:51:34+08:00 daily https://www.pharmasources.com/industryinsights/evolving-world-of-pharma-ai-is-the-break-314296.html 0.6 2026-07-01T16:43:27+08:00 daily https://www.pharmasources.com/industryinsights/sensyne-health-and-bayer-partner-on-ai-d-314297.html 0.6 2026-07-20T13:50:52+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-breakthrough-status-to-new-co-314298.html 0.6 2026-07-01T12:07:42+08:00 daily https://www.pharmasources.com/industryinsights/acg-engineering-acquires-germanys-xertec-314299.html 0.6 2026-06-21T09:13:09+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-shuts-two-clinical-pharmacolo-314300.html 0.6 2026-06-20T13:20:34+08:00 daily https://www.pharmasources.com/industryinsights/lupin-gets-eir-from-usfda-for-aurangabad-314301.html 0.6 2026-06-21T09:57:28+08:00 daily https://www.pharmasources.com/industryinsights/space-study-seeks-treatments-for-parkins-314302.html 0.6 2026-02-28T15:03:57+08:00 daily https://www.pharmasources.com/industryinsights/sangita-reddy-to-step-down-as-independen-314303.html 0.6 2026-08-05T20:59:22+08:00 daily https://www.pharmasources.com/industryinsights/acg-acquires-pharma-processing-equipment-314304.html 0.6 2026-04-19T09:09:10+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2019080-314305.html 0.6 2026-08-07T03:07:00+08:00 daily https://www.pharmasources.com/industryinsights/exelixis-aurigene-to-develop-novel-thera-314306.html 0.6 2026-08-07T03:34:01+08:00 daily https://www.pharmasources.com/industryinsights/ntu-kwong-wai-shiu-hospital-launch-excha-314307.html 0.6 2026-08-07T03:54:49+08:00 daily https://www.pharmasources.com/industryinsights/dyaco-international-brings-philips-physi-314308.html 0.6 2026-08-07T12:03:41+08:00 daily https://www.pharmasources.com/industryinsights/botanix-receives-commitments-for-a40m-in-314309.html 0.6 2026-08-07T13:17:03+08:00 daily https://www.pharmasources.com/industryinsights/rakuten-medical-to-further-develop-its-p-314310.html 0.6 2026-08-08T17:53:00+08:00 daily https://www.pharmasources.com/industryinsights/improving-trial-efficiency-and-lowering--314311.html 0.6 2026-06-20T23:49:24+08:00 daily https://www.pharmasources.com/industryinsights/chemist-warehouse-to-provide-affordable--314312.html 0.6 2026-06-21T07:19:28+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-daiichi-sankyos-turalio-314313.html 0.6 2026-06-20T20:19:49+08:00 daily https://www.pharmasources.com/industryinsights/sosei-heptares-takeda-enter-rd-partnersh-314314.html 0.6 2026-06-20T23:16:54+08:00 daily https://www.pharmasources.com/industryinsights/ptc-therapeutics-expands-in-new-jersey-314315.html 0.6 2026-06-20T19:54:34+08:00 daily https://www.pharmasources.com/industryinsights/electric-fans-help-in-hot-humid-conditio-314316.html 0.6 2026-06-21T02:40:30+08:00 daily https://www.pharmasources.com/industryinsights/professional-coaching-can-reduce-emotion-314317.html 0.6 2026-06-22T08:05:48+08:00 daily https://www.pharmasources.com/industryinsights/risk-for-mental-health-disorders-up-for--314318.html 0.6 2026-06-22T12:49:13+08:00 daily https://www.pharmasources.com/industryinsights/vaping-likely-to-blame-for-14-hospitaliz-314319.html 0.6 2026-06-21T08:17:20+08:00 daily https://www.pharmasources.com/industryinsights/neuropathology-tied-to-dementia-idd-in-f-314320.html 0.6 2026-06-22T10:20:29+08:00 daily https://www.pharmasources.com/industryinsights/smoking-creates-long-lasting-risk-for-cl-314321.html 0.6 2026-06-21T16:00:18+08:00 daily https://www.pharmasources.com/industryinsights/football-head-trauma-linked-again-to-lon-314322.html 0.6 2026-06-20T20:03:37+08:00 daily https://www.pharmasources.com/industryinsights/keto-diet-may-help-control-type-2-diabet-314323.html 0.6 2026-06-21T09:01:07+08:00 daily https://www.pharmasources.com/industryinsights/explaining-easing-the-horror-of-mass-sho-314324.html 0.6 2026-06-23T19:09:30+08:00 daily https://www.pharmasources.com/industryinsights/overweight-obesity-may-up-early-mortalit-314325.html 0.6 2026-06-20T17:02:16+08:00 daily https://www.pharmasources.com/industryinsights/bp-waist-circumference-lipids-should-be--314326.html 0.6 2026-06-30T12:49:43+08:00 daily https://www.pharmasources.com/industryinsights/study-explores-dose-ranges-for-efpeglena-314327.html 0.6 2026-06-21T03:41:26+08:00 daily https://www.pharmasources.com/industryinsights/education-emphasized-in-guidelines-on-su-314328.html 0.6 2026-06-21T12:23:07+08:00 daily https://www.pharmasources.com/industryinsights/premature-ovarian-insufficiency-tied-to--314329.html 0.6 2026-06-20T22:38:32+08:00 daily https://www.pharmasources.com/industryinsights/more-social-contact-at-age-60-linked-to--314330.html 0.6 2026-06-21T19:49:41+08:00 daily https://www.pharmasources.com/industryinsights/machine-learning-algorithms-can-classify-314331.html 0.6 2026-08-08T17:00:48+08:00 daily https://www.pharmasources.com/industryinsights/risk-for-cardiovascular-deaths-increased-314332.html 0.6 2026-06-20T19:19:53+08:00 daily https://www.pharmasources.com/industryinsights/childhood-physical-activity-improves-lun-314333.html 0.6 2026-06-22T03:53:39+08:00 daily https://www.pharmasources.com/industryinsights/guidance-issued-for-research-use-of-card-314334.html 0.6 2026-06-21T09:11:18+08:00 daily https://www.pharmasources.com/industryinsights/turalio-pexidartinib-approved-to-treat-t-314335.html 0.6 2026-04-29T16:33:20+08:00 daily https://www.pharmasources.com/industryinsights/after-pot-legalized-colorados-teens-move-314336.html 0.6 2026-06-20T21:17:52+08:00 daily https://www.pharmasources.com/industryinsights/common-prostate-cancer-treatment-anti-an-314337.html 0.6 2026-06-21T10:20:27+08:00 daily https://www.pharmasources.com/industryinsights/some-transgender-women-may-be-able-to-ma-314338.html 0.6 2026-06-21T05:08:49+08:00 daily https://www.pharmasources.com/industryinsights/4-personal-items-you-probably-should-rep-314339.html 0.6 2026-07-26T01:12:03+08:00 daily https://www.pharmasources.com/industryinsights/new-moms-can-save-a-life-by-donating-cor-314340.html 0.6 2026-08-12T01:29:41+08:00 daily https://www.pharmasources.com/industryinsights/metastatic-melanoma-treatment-gets-break-314341.html 0.6 2026-06-22T06:53:53+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-chemical-market-to-witnes-314342.html 0.6 2026-04-25T14:27:42+08:00 daily https://www.pharmasources.com/industryinsights/verona-announces-positive-results-for-dp-314343.html 0.6 2026-06-22T04:08:47+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-secures-fda-approval-for--314344.html 0.6 2026-06-22T12:03:49+08:00 daily https://www.pharmasources.com/industryinsights/santhera-licenses-lebers-hereditary-opti-314345.html 0.6 2026-03-29T17:27:47+08:00 daily https://www.pharmasources.com/industryinsights/antikor-forms-alliance-with-essex-bio-in-314346.html 0.6 2026-06-20T18:00:17+08:00 daily https://www.pharmasources.com/industryinsights/rye-is-healthy-thanks-to-an-interplay-of-314347.html 0.6 2026-06-20T19:18:52+08:00 daily https://www.pharmasources.com/industryinsights/innovent-and-shenogen-announce-collabora-314348.html 0.6 2026-08-06T07:57:42+08:00 daily https://www.pharmasources.com/industryinsights/new-drug-for-diabetes-induced-vision-los-314349.html 0.6 2026-08-10T09:05:00+08:00 daily https://www.pharmasources.com/industryinsights/dyaco-international-launches-philips-phy-314350.html 0.6 2026-08-07T00:40:58+08:00 daily https://www.pharmasources.com/industryinsights/smithers-rapras-extractables-leachables--314351.html 0.6 2026-08-07T00:01:21+08:00 daily https://www.pharmasources.com/industryinsights/ascletis-received-ind-approval-and-manag-314352.html 0.6 2026-08-05T12:57:26+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-biopharma-and-tracon-pharmaceutica-314353.html 0.6 2026-08-07T00:53:03+08:00 daily https://www.pharmasources.com/industryinsights/marken-acquires-japanese-logistics-compa-314354.html 0.6 2026-08-10T17:34:17+08:00 daily https://www.pharmasources.com/industryinsights/medibeacon-enters-into-30-million-invest-314355.html 0.6 2026-08-09T06:20:14+08:00 daily https://www.pharmasources.com/industryinsights/single-lead-ecg-wristband-developed-by-l-314356.html 0.6 2026-08-09T18:35:02+08:00 daily https://www.pharmasources.com/industryinsights/gc-pharma-reports-q2-2019-results-314357.html 0.6 2026-08-07T13:55:41+08:00 daily https://www.pharmasources.com/industryinsights/hksh-medical-group-brings-precision-radi-314358.html 0.6 2026-08-07T13:17:27+08:00 daily https://www.pharmasources.com/industryinsights/submission-and-acceptance-of-application-314359.html 0.6 2026-08-07T04:30:52+08:00 daily https://www.pharmasources.com/industryinsights/alvotech-and-cipla-gulf-enter-into-a-par-314360.html 0.6 2026-08-07T04:22:21+08:00 daily https://www.pharmasources.com/industryinsights/neurovives-neurostat-project-receives-fd-314361.html 0.6 2026-08-07T03:55:39+08:00 daily https://www.pharmasources.com/industryinsights/china-biologic-products-to-report-second-314362.html 0.6 2026-08-14T09:57:00+08:00 daily https://www.pharmasources.com/industryinsights/novartis-mundipharma-ink-partnership-to--314363.html 0.6 2026-08-12T19:05:02+08:00 daily https://www.pharmasources.com/industryinsights/a-review-of-the-injection-varieties-of-t-314364.html 0.6 2026-08-07T03:08:00+08:00 daily https://www.pharmasources.com/industryinsights/dual-tailwinds-for-the-injection-export--314365.html 0.6 2026-08-07T02:52:20+08:00 daily https://www.pharmasources.com/industryinsights/liposomal-medicine-names-to-be-changed-t-314366.html 0.6 2026-08-07T03:33:33+08:00 daily https://www.pharmasources.com/industryinsights/us-and-china-should-collaborate-more-to--314367.html 0.6 2026-08-07T03:55:11+08:00 daily https://www.pharmasources.com/industryinsights/recent-advances-in-pharmaceutical-regula-314368.html 0.6 2026-08-07T04:06:59+08:00 daily https://www.pharmasources.com/industryinsights/swine-fever-in-china-raises-concern-over-314369.html 0.6 2026-08-07T18:13:04+08:00 daily https://www.pharmasources.com/industryinsights/surge-in-negative-verifications-of-salea-314370.html 0.6 2026-08-11T11:30:16+08:00 daily https://www.pharmasources.com/industryinsights/how-pharma-will-profit-from-a-warming-pl-314371.html 0.6 2026-03-27T01:53:16+08:00 daily https://www.pharmasources.com/industryinsights/gsk-completes-transaction-with-pfizer-to-314372.html 0.6 2026-06-20T15:47:33+08:00 daily https://www.pharmasources.com/industryinsights/cytena-gmbh-announces-that-it-has-been-e-314373.html 0.6 2026-07-18T14:32:01+08:00 daily https://www.pharmasources.com/industryinsights/astellas-appoints-svp-and-head-clinical--314374.html 0.6 2026-06-20T15:01:04+08:00 daily https://www.pharmasources.com/industryinsights/entera-bio-appoints-chief-executive-offi-314375.html 0.6 2026-06-21T01:05:51+08:00 daily https://www.pharmasources.com/industryinsights/tcr2-therapeutics-expands-leadership-tea-314376.html 0.6 2026-06-22T01:06:58+08:00 daily https://www.pharmasources.com/industryinsights/aquinox-neoleukin-therapeutics-announce--314377.html 0.6 2026-06-20T20:46:24+08:00 daily https://www.pharmasources.com/industryinsights/gsk-grants-ebola-vaccine-license-to-sabi-314378.html 0.6 2026-06-21T00:53:49+08:00 daily https://www.pharmasources.com/industryinsights/inovalon-implements-platform-initiative--314379.html 0.6 2026-06-20T21:51:46+08:00 daily https://www.pharmasources.com/industryinsights/milliporesigma-acquires-bssn-software-314380.html 0.6 2026-06-20T23:18:00+08:00 daily https://www.pharmasources.com/industryinsights/financial-report-syneos-health-314381.html 0.6 2026-07-19T02:05:28+08:00 daily https://www.pharmasources.com/industryinsights/exercise-during-pregnancy-may-boost-infa-314382.html 0.6 2026-01-12T01:28:40+08:00 daily https://www.pharmasources.com/industryinsights/altavant-sciences-initiates-study-of-rod-314383.html 0.6 2026-06-22T14:29:55+08:00 daily https://www.pharmasources.com/industryinsights/uspstf-reaffirms-recs-against-screening--314384.html 0.6 2026-06-21T04:15:56+08:00 daily https://www.pharmasources.com/industryinsights/2012-to-2018-saw-substantial-rise-in-nal-314385.html 0.6 2026-06-21T05:14:57+08:00 daily https://www.pharmasources.com/industryinsights/provention-bio-announces-breakthrough-th-314386.html 0.6 2026-08-13T15:37:02+08:00 daily https://www.pharmasources.com/industryinsights/poor-pneumonia-outcomes-tied-to-overuse--314387.html 0.6 2026-06-29T14:41:37+08:00 daily https://www.pharmasources.com/industryinsights/lilly-announces-positive-results-for-emg-314388.html 0.6 2026-07-08T06:43:42+08:00 daily https://www.pharmasources.com/industryinsights/sosei-heptares-takeda-announce-partnersh-314389.html 0.6 2026-06-20T15:09:17+08:00 daily https://www.pharmasources.com/industryinsights/bracco-diagnostics-receives-fda-approval-314390.html 0.6 2026-08-13T17:43:42+08:00 daily https://www.pharmasources.com/industryinsights/high-intensity-lipid-lowering-may-aid-ve-314391.html 0.6 2026-06-21T02:47:41+08:00 daily https://www.pharmasources.com/industryinsights/adults-need-vaccines-too-314392.html 0.6 2026-06-20T20:03:43+08:00 daily https://www.pharmasources.com/industryinsights/sanofis-dupixent-met-study-endpoints-in--314393.html 0.6 2026-06-21T08:04:00+08:00 daily https://www.pharmasources.com/industryinsights/too-few-us-opioid-users-are-getting-od-a-314394.html 0.6 2026-06-22T13:07:08+08:00 daily https://www.pharmasources.com/industryinsights/innovent-and-shenogen-study-tyvyt-sng100-314395.html 0.6 2026-06-21T02:03:41+08:00 daily https://www.pharmasources.com/industryinsights/sosei-group-and-takeda-to-develop-and-co-314396.html 0.6 2026-06-21T01:14:08+08:00 daily https://www.pharmasources.com/industryinsights/foamix-seeks-fda-approval-for-fmx103-to--314397.html 0.6 2026-08-13T13:14:43+08:00 daily https://www.pharmasources.com/industryinsights/researchers-spin-clinical-trial-findings-314398.html 0.6 2026-06-21T10:36:06+08:00 daily https://www.pharmasources.com/industryinsights/selfies-might-someday-track-your-blood-p-314399.html 0.6 2026-07-07T19:58:26+08:00 daily https://www.pharmasources.com/industryinsights/roche-says-tecentriq-prevents-disease-wo-314400.html 0.6 2026-08-04T16:11:43+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-regeneron-get-eu-approval-for-314401.html 0.6 2026-06-08T20:07:20+08:00 daily https://www.pharmasources.com/industryinsights/lifestyle-counseling-frequency-cv-outcom-314402.html 0.6 2026-06-20T14:56:15+08:00 daily https://www.pharmasources.com/industryinsights/granules-india-receives-us-fda-approval--314403.html 0.6 2026-06-22T02:12:48+08:00 daily https://www.pharmasources.com/industryinsights/lupins-mandideep-facility-inspection-com-314404.html 0.6 2026-06-29T15:21:56+08:00 daily https://www.pharmasources.com/industryinsights/bone-health-management-key-in-childhood--314405.html 0.6 2026-06-20T20:01:35+08:00 daily https://www.pharmasources.com/industryinsights/allergan-voluntarily-recalls-biocell-tex-314406.html 0.6 2026-06-24T05:39:38+08:00 daily https://www.pharmasources.com/industryinsights/111-signs-strategic-cooperation-with-har-314407.html 0.6 2026-08-04T20:53:08+08:00 daily https://www.pharmasources.com/industryinsights/infant-suffocation-deaths-in-bed-increas-314408.html 0.6 2026-06-23T14:24:00+08:00 daily https://www.pharmasources.com/industryinsights/shanghai-concord-medical-cancer-center-h-314409.html 0.6 2026-02-12T03:51:21+08:00 daily https://www.pharmasources.com/industryinsights/vaccination-does-not-up-risk-for-develop-314410.html 0.6 2026-04-08T00:28:44+08:00 daily https://www.pharmasources.com/industryinsights/dna-methylation-classifier-predicts-prog-314411.html 0.6 2026-06-22T10:43:16+08:00 daily https://www.pharmasources.com/industryinsights/transdermal-optical-imaging-shows-promis-314412.html 0.6 2026-07-22T16:28:00+08:00 daily https://www.pharmasources.com/industryinsights/ranking-for-abdominal-surgeries-not-link-314413.html 0.6 2026-06-20T16:01:30+08:00 daily https://www.pharmasources.com/industryinsights/children-with-adhd-have-differences-in-p-314414.html 0.6 2026-06-20T15:13:21+08:00 daily https://www.pharmasources.com/industryinsights/reporting-of-results-often-biased-in-psy-314415.html 0.6 2026-06-21T16:59:20+08:00 daily https://www.pharmasources.com/industryinsights/the-miracle-drug-metformin-has-no-antica-314416.html 0.6 2026-07-15T12:13:54+08:00 daily https://www.pharmasources.com/industryinsights/abbvies-63b-allergan-buyout-offer-depend-314417.html 0.6 2026-06-20T16:53:22+08:00 daily https://www.pharmasources.com/industryinsights/mallinckrodt-postpones-split-up-plan-as--314418.html 0.6 2026-06-20T22:55:39+08:00 daily https://www.pharmasources.com/industryinsights/gileads-descovy-seems-set-for-a-prep-nod-314419.html 0.6 2026-06-22T01:02:50+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-buys-out-purdue-pill-plant--314420.html 0.6 2026-06-21T06:49:46+08:00 daily https://www.pharmasources.com/industryinsights/regenerons-sanofi-deal-finally-turns-a-p-314421.html 0.6 2026-08-13T16:09:08+08:00 daily https://www.pharmasources.com/industryinsights/eating-more-plant-based-foods-may-be-lin-314422.html 0.6 2026-07-05T14:04:29+08:00 daily https://www.pharmasources.com/industryinsights/major-step-towards-candida-auris-vaccine-314423.html 0.6 2026-06-21T22:13:19+08:00 daily https://www.pharmasources.com/industryinsights/philippines-may-re-introduce-controversi-314424.html 0.6 2026-06-21T01:09:53+08:00 daily https://www.pharmasources.com/industryinsights/colorcon-trutag-technologies-partner-on--314425.html 0.6 2026-03-25T18:25:52+08:00 daily https://www.pharmasources.com/industryinsights/adc-therapeutics-sophia-genetics-partner-314426.html 0.6 2026-06-20T17:57:37+08:00 daily https://www.pharmasources.com/industryinsights/aevi-genomic-medicine-astrazeneca-enter--314427.html 0.6 2026-06-21T13:10:36+08:00 daily https://www.pharmasources.com/industryinsights/permira-funds-to-acquire-cambrex-in-24b--314428.html 0.6 2026-07-17T22:43:24+08:00 daily https://www.pharmasources.com/industryinsights/atlasciences-appoints-chief-scientific-o-314429.html 0.6 2026-06-21T04:07:48+08:00 daily https://www.pharmasources.com/industryinsights/assembly-biosciences-appoints-president--314430.html 0.6 2026-06-23T04:24:58+08:00 daily https://www.pharmasources.com/industryinsights/adaptive-biotechnologies-triples-footpri-314431.html 0.6 2026-06-21T05:00:48+08:00 daily https://www.pharmasources.com/industryinsights/goodwin-biotechnology-bolsters-quality-r-314432.html 0.6 2026-06-21T14:58:24+08:00 daily https://www.pharmasources.com/industryinsights/carbogen-amcis-api-site-passes-fda-pai-314433.html 0.6 2026-06-21T22:52:41+08:00 daily https://www.pharmasources.com/industryinsights/lilly-announces-leadership-changes-314434.html 0.6 2026-08-03T04:20:40+08:00 daily https://www.pharmasources.com/industryinsights/cstone-to-build-global-rd-headquarters-i-314435.html 0.6 2026-08-12T10:55:49+08:00 daily https://www.pharmasources.com/industryinsights/nurse-intervention-using-tech-may-improv-314436.html 0.6 2026-06-21T05:13:53+08:00 daily https://www.pharmasources.com/industryinsights/doctors-come-out-against-gay-conversion--314437.html 0.6 2026-06-22T01:51:29+08:00 daily https://www.pharmasources.com/industryinsights/patient-who-caught-legionnaires-disease--314438.html 0.6 2026-06-27T16:54:44+08:00 daily https://www.pharmasources.com/industryinsights/fda-approval-of-zolgensma-was-based-on-m-314439.html 0.6 2026-07-06T21:09:46+08:00 daily https://www.pharmasources.com/industryinsights/strong-ssri-may-be-tied-to-small-decreas-314440.html 0.6 2026-06-21T00:52:50+08:00 daily https://www.pharmasources.com/industryinsights/phone-consults-grow-mental-health-servic-314441.html 0.6 2026-02-28T15:37:13+08:00 daily https://www.pharmasources.com/industryinsights/dont-sweat-it-hyperhydrosis-can-be-treat-314442.html 0.6 2026-06-22T12:05:51+08:00 daily https://www.pharmasources.com/industryinsights/addition-of-sotagliflozin-for-t1dm-alter-314443.html 0.6 2026-06-21T06:00:49+08:00 daily https://www.pharmasources.com/industryinsights/recommendations-developed-for-obesity-hy-314444.html 0.6 2026-06-21T23:53:39+08:00 daily https://www.pharmasources.com/industryinsights/new-score-predicts-risk-for-vte-in-those-314445.html 0.6 2026-07-27T18:53:35+08:00 daily https://www.pharmasources.com/industryinsights/completion-rates-of-recommended-vaccines-314446.html 0.6 2026-06-20T16:02:24+08:00 daily https://www.pharmasources.com/industryinsights/medicare-spending-on-essential-medicines-314447.html 0.6 2026-07-05T04:33:23+08:00 daily https://www.pharmasources.com/industryinsights/common-therapy-for-obstetric-cholestasis-314448.html 0.6 2026-06-21T13:01:32+08:00 daily https://www.pharmasources.com/industryinsights/plants-on-your-plate-will-protect-your-h-314449.html 0.6 2026-06-21T01:45:25+08:00 daily https://www.pharmasources.com/industryinsights/low-specificity-limits-use-of-focused-ca-314450.html 0.6 2026-08-08T01:47:22+08:00 daily https://www.pharmasources.com/industryinsights/gsk-grants-exclusive-technology-license--314451.html 0.6 2026-06-21T03:16:56+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-therapy-for-symptomatic-ten-314452.html 0.6 2026-07-03T02:03:23+08:00 daily https://www.pharmasources.com/industryinsights/leap-announces-positive-results-for-dkn--314453.html 0.6 2026-06-20T18:59:36+08:00 daily https://www.pharmasources.com/industryinsights/dupixent-showed-positive-topline-results-314454.html 0.6 2026-08-07T15:29:32+08:00 daily https://www.pharmasources.com/industryinsights/novartis-defends-zolgensma-in-face-of-fd-314455.html 0.6 2026-06-20T14:23:51+08:00 daily https://www.pharmasources.com/industryinsights/gsk-transfers-rights-to-ebola-vaccines-d-314456.html 0.6 2026-06-20T20:55:54+08:00 daily https://www.pharmasources.com/industryinsights/permira-affiliate-to-buy-small-molecule--314457.html 0.6 2026-06-21T23:10:13+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-orphan-drug-designation-to-st-314458.html 0.6 2026-08-12T21:56:02+08:00 daily https://www.pharmasources.com/industryinsights/lupin-q1-net-profit-up-49-pc-to-rs-30305-314459.html 0.6 2026-06-20T21:20:30+08:00 daily https://www.pharmasources.com/industryinsights/meril-life-sciences-becomes-indias-first-314460.html 0.6 2026-07-30T08:51:20+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheims-latest-copd-campai-314461.html 0.6 2026-08-06T06:56:08+08:00 daily https://www.pharmasources.com/industryinsights/teva-scouts-new-cfo-as-mcclellan-steps-d-314462.html 0.6 2026-08-02T06:27:24+08:00 daily https://www.pharmasources.com/industryinsights/mccann-health-taps-north-american-exec-a-314463.html 0.6 2026-08-01T04:56:58+08:00 daily https://www.pharmasources.com/industryinsights/as-bernie-predicted-phrma-bio-and-big-ph-314464.html 0.6 2026-08-01T22:08:19+08:00 daily https://www.pharmasources.com/industryinsights/sai-life-sciences-adopts-processmap-plat-314465.html 0.6 2026-06-22T08:14:56+08:00 daily https://www.pharmasources.com/industryinsights/111-wins-2019-china-healthcare-industry--314466.html 0.6 2026-08-06T18:14:05+08:00 daily https://www.pharmasources.com/industryinsights/global-diagnostics-australia-incorporate-314467.html 0.6 2026-08-02T08:53:32+08:00 daily https://www.pharmasources.com/industryinsights/tcd-teams-up-with-tata-memorial-centre-t-314468.html 0.6 2026-08-06T18:09:24+08:00 daily https://www.pharmasources.com/industryinsights/astellas-initiates-phase-3-clinical-tria-314469.html 0.6 2026-08-10T15:41:02+08:00 daily https://www.pharmasources.com/industryinsights/south-koreas-pharma-biotech-space-to-att-314470.html 0.6 2026-06-21T20:19:03+08:00 daily https://www.pharmasources.com/industryinsights/cstone-to-build-global-rd-hq-and-industr-314471.html 0.6 2026-08-09T20:55:35+08:00 daily https://www.pharmasources.com/industryinsights/discgenics-treates-first-patients-in-jap-314472.html 0.6 2026-06-20T20:02:37+08:00 daily https://www.pharmasources.com/industryinsights/cphi-mea-expert-growing-domestic-manufac-314473.html 0.6 2026-08-03T04:06:39+08:00 daily https://www.pharmasources.com/industryinsights/ping-an-good-doctors-revenue-up-by-102yo-314474.html 0.6 2026-07-20T10:59:24+08:00 daily https://www.pharmasources.com/industryinsights/histoindex-and-ilbs-launch-centre-of-exc-314475.html 0.6 2026-08-01T11:18:14+08:00 daily https://www.pharmasources.com/industryinsights/samsung-honors-three-teams-with-the-brea-314476.html 0.6 2026-08-04T00:39:44+08:00 daily https://www.pharmasources.com/industryinsights/meiji-seika-to-launch-two-products-from--314477.html 0.6 2026-07-29T08:13:39+08:00 daily https://www.pharmasources.com/industryinsights/lupus-pipeline-sees-high-level-of-43-fir-314478.html 0.6 2026-07-31T15:38:58+08:00 daily https://www.pharmasources.com/industryinsights/bayer-acquires-bluerock-therapeutics-to--314479.html 0.6 2026-08-06T19:48:28+08:00 daily https://www.pharmasources.com/industryinsights/thermally-stable-tb-vaccine-developed-us-314480.html 0.6 2026-07-30T16:02:50+08:00 daily https://www.pharmasources.com/industryinsights/pharma-contract-placements-found-to-incr-314481.html 0.6 2026-08-09T02:30:13+08:00 daily https://www.pharmasources.com/industryinsights/novartis-could-face-legal-action-over-zo-314482.html 0.6 2026-08-09T10:16:52+08:00 daily https://www.pharmasources.com/industryinsights/kamada-takeda-discuss-glassia-manufactur-314483.html 0.6 2026-07-28T20:17:11+08:00 daily https://www.pharmasources.com/industryinsights/bioivt-acquires-keystone-biologicals-314484.html 0.6 2026-07-28T22:13:35+08:00 daily https://www.pharmasources.com/industryinsights/agenus-gilead-milestone-triggers-75m-pay-314485.html 0.6 2026-08-01T10:14:46+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-launches-new-services-for-mamm-314486.html 0.6 2026-07-29T07:19:45+08:00 daily https://www.pharmasources.com/industryinsights/codexis-names-svp-and-cfo-314487.html 0.6 2026-07-29T00:47:52+08:00 daily https://www.pharmasources.com/industryinsights/fda-reports-more-seizures-among-vapers-314488.html 0.6 2026-08-01T09:23:12+08:00 daily https://www.pharmasources.com/industryinsights/medicare-to-cover-car-t-therapy-for-leuk-314489.html 0.6 2026-08-10T17:17:34+08:00 daily https://www.pharmasources.com/industryinsights/breast-cancer-surgery-another-procedure--314490.html 0.6 2026-07-31T13:32:04+08:00 daily https://www.pharmasources.com/industryinsights/warnings-issued-to-companies-illegally-s-314491.html 0.6 2026-07-24T19:05:48+08:00 daily https://www.pharmasources.com/industryinsights/in-2018-2813-cases-of-domestic-arbovirus-314492.html 0.6 2026-08-02T06:11:18+08:00 daily https://www.pharmasources.com/industryinsights/new-study-finds-a-family-risk-for-blood--314493.html 0.6 2026-08-05T20:29:34+08:00 daily https://www.pharmasources.com/industryinsights/deaths-from-cocaine-laced-with-fentanyl--314494.html 0.6 2026-07-24T19:17:54+08:00 daily https://www.pharmasources.com/industryinsights/stroke-may-lead-to-lower-vitamin-d-314495.html 0.6 2026-07-24T19:20:49+08:00 daily https://www.pharmasources.com/industryinsights/kids-getting-too-many-opioids-after-tons-314496.html 0.6 2026-06-21T20:51:33+08:00 daily https://www.pharmasources.com/industryinsights/can-major-surgeries-cause-a-long-term-br-314497.html 0.6 2026-08-07T02:05:21+08:00 daily https://www.pharmasources.com/industryinsights/fda-update-paclitaxel-coated-balloons-pa-314498.html 0.6 2026-08-07T01:52:04+08:00 daily https://www.pharmasources.com/industryinsights/biohaven-completes-enrollment-in-phase-3-314499.html 0.6 2026-08-07T18:43:31+08:00 daily https://www.pharmasources.com/industryinsights/provention-bio-initiates-trial-evaluatin-314500.html 0.6 2026-08-07T01:42:48+08:00 daily https://www.pharmasources.com/industryinsights/89bio-initiates-trial-of-bio89-100-for-n-314501.html 0.6 2026-08-07T01:39:31+08:00 daily https://www.pharmasources.com/industryinsights/blueprint-medicines-announces-fda-accept-314502.html 0.6 2026-08-07T01:31:35+08:00 daily https://www.pharmasources.com/industryinsights/regen-biopharma-files-immuno-oncology-pa-314503.html 0.6 2026-08-08T02:19:31+08:00 daily https://www.pharmasources.com/industryinsights/nice-approves-keytruda-combination-thera-314504.html 0.6 2026-08-07T01:11:53+08:00 daily https://www.pharmasources.com/industryinsights/takeda-submits-nda-for-sc-formation-of-u-314505.html 0.6 2026-08-07T00:39:46+08:00 daily https://www.pharmasources.com/industryinsights/bayer-agrees-to-acquire-biotech-bluerock-314506.html 0.6 2026-08-07T00:33:56+08:00 daily https://www.pharmasources.com/industryinsights/personal-trainers-top-tips-314507.html 0.6 2026-08-07T01:19:26+08:00 daily https://www.pharmasources.com/industryinsights/hummingbird-and-cancer-research-uk-to-de-314508.html 0.6 2026-08-07T00:24:30+08:00 daily https://www.pharmasources.com/industryinsights/heart-healthy-habits-good-for-your-brain-314509.html 0.6 2026-08-07T00:15:42+08:00 daily https://www.pharmasources.com/industryinsights/how-much-coffee-is-too-much-for-migraine-314510.html 0.6 2026-08-07T00:02:20+08:00 daily https://www.pharmasources.com/industryinsights/unlocking-speech-for-kids-with-autism-314511.html 0.6 2026-08-06T23:55:33+08:00 daily https://www.pharmasources.com/industryinsights/new-dna-blood-test-may-help-guide-breast-314512.html 0.6 2026-06-21T16:29:52+08:00 daily https://www.pharmasources.com/industryinsights/donate-blood-safely-314513.html 0.6 2026-08-06T23:45:13+08:00 daily https://www.pharmasources.com/industryinsights/better-cv-health-in-midlife-tied-to-redu-314514.html 0.6 2026-08-06T23:36:27+08:00 daily https://www.pharmasources.com/industryinsights/major-surgery-linked-to-lasting-change-i-314515.html 0.6 2026-08-06T21:47:14+08:00 daily https://www.pharmasources.com/industryinsights/nsaids-contribute-to-increased-cvd-risk--314516.html 0.6 2026-08-06T20:05:30+08:00 daily https://www.pharmasources.com/industryinsights/fluoride-exposure-tied-to-kidney-liver-f-314517.html 0.6 2026-08-06T20:47:41+08:00 daily https://www.pharmasources.com/industryinsights/aurobindo-pharma-net-surges-395-per-cent-314518.html 0.6 2026-08-10T12:01:30+08:00 daily https://www.pharmasources.com/industryinsights/rockwell-automation-to-help-indian-manuf-314519.html 0.6 2026-06-21T00:07:41+08:00 daily https://www.pharmasources.com/industryinsights/younger-crc-patients-more-likely-to-pres-314520.html 0.6 2026-06-21T03:48:55+08:00 daily https://www.pharmasources.com/industryinsights/whoops-allergans-bid-to-shield-botox-man-314521.html 0.6 2026-06-21T13:01:27+08:00 daily https://www.pharmasources.com/industryinsights/with-importation-on-tap-grassley-urges-f-314522.html 0.6 2026-06-24T21:34:33+08:00 daily https://www.pharmasources.com/industryinsights/medicares-new-car-t-coverage-rules-could-314523.html 0.6 2026-06-20T23:00:44+08:00 daily https://www.pharmasources.com/industryinsights/bayer-elanco-could-lock-up-animal-health-314524.html 0.6 2026-07-21T14:50:06+08:00 daily https://www.pharmasources.com/industryinsights/novos-ozempic-launch-kicks-into-gear-ahe-314525.html 0.6 2026-06-23T23:11:24+08:00 daily https://www.pharmasources.com/industryinsights/lilly-evidation-health-and-apple-study-s-314526.html 0.6 2026-06-22T08:42:35+08:00 daily https://www.pharmasources.com/industryinsights/nice-releases-draft-guidance-for-using-c-314527.html 0.6 2026-07-02T16:21:44+08:00 daily https://www.pharmasources.com/industryinsights/fda-antibody-biosimilar-product-approval-314528.html 0.6 2026-08-05T21:49:49+08:00 daily https://www.pharmasources.com/industryinsights/increasing-number-of-diseases-causing-al-314529.html 0.6 2026-06-20T14:52:12+08:00 daily https://www.pharmasources.com/industryinsights/avomeen-appoints-project-director-of-bio-314530.html 0.6 2026-06-20T20:50:40+08:00 daily https://www.pharmasources.com/industryinsights/gemini-bioproducts-nordmark-biochemicals-314531.html 0.6 2026-06-21T14:52:20+08:00 daily https://www.pharmasources.com/industryinsights/biolife-solutions-aquires-savsu-technolo-314532.html 0.6 2026-06-22T12:08:52+08:00 daily https://www.pharmasources.com/industryinsights/genprex-partner-aldevron-completes-step--314533.html 0.6 2026-08-14T10:05:02+08:00 daily https://www.pharmasources.com/industryinsights/eurofins-genomics-us-expands-gene-synthe-314534.html 0.6 2026-06-22T01:58:40+08:00 daily https://www.pharmasources.com/industryinsights/blue-water-ology-ink-vaccine-mfg-deal-314535.html 0.6 2026-06-22T11:54:45+08:00 daily https://www.pharmasources.com/industryinsights/halix-completes-new-cgmp-facility-314536.html 0.6 2026-06-21T20:14:58+08:00 daily https://www.pharmasources.com/industryinsights/how-to-help-your-heart-weather-extreme-h-314537.html 0.6 2026-04-10T09:56:35+08:00 daily https://www.pharmasources.com/industryinsights/excess-caffeine-may-be-a-trigger-for-epi-314538.html 0.6 2026-06-23T11:09:43+08:00 daily https://www.pharmasources.com/industryinsights/nurse-led-quality-initiative-cuts-hypogl-314539.html 0.6 2026-08-06T02:25:09+08:00 daily https://www.pharmasources.com/industryinsights/endometriosis-tied-to-adverse-pregnancy--314540.html 0.6 2026-01-04T12:57:58+08:00 daily https://www.pharmasources.com/industryinsights/worse-cancer-outcomes-for-elderly-hiv-in-314541.html 0.6 2026-06-20T21:55:35+08:00 daily https://www.pharmasources.com/industryinsights/high-temps-may-up-admissions-deaths-in-e-314542.html 0.6 2026-06-21T16:58:28+08:00 daily https://www.pharmasources.com/industryinsights/powder-flow-particle-size-independent-va-314543.html 0.6 2026-08-06T17:48:34+08:00 daily https://www.pharmasources.com/industryinsights/health-threats-dont-end-for-some-sepsis--314544.html 0.6 2026-06-23T11:34:21+08:00 daily https://www.pharmasources.com/industryinsights/dynacure-receives-orphan-drug-designatio-314545.html 0.6 2026-06-20T22:08:42+08:00 daily https://www.pharmasources.com/industryinsights/kala-receives-crl-from-fda-for-kpi-121-0-314546.html 0.6 2026-07-12T01:48:21+08:00 daily https://www.pharmasources.com/industryinsights/sesen-bio-reports-positive-preliminary-d-314547.html 0.6 2026-06-22T01:20:28+08:00 daily https://www.pharmasources.com/industryinsights/heres-why-stroke-survivors-need-to-pay-a-314548.html 0.6 2026-06-22T21:49:44+08:00 daily https://www.pharmasources.com/industryinsights/pure-cbd-wont-make-you-fail-a-drug-test--314549.html 0.6 2026-06-22T07:03:51+08:00 daily https://www.pharmasources.com/industryinsights/glaukos-avedro-announce-acquisition-agre-314550.html 0.6 2026-07-26T08:26:25+08:00 daily https://www.pharmasources.com/industryinsights/are-you-still-putting-off-colon-cancer-s-314551.html 0.6 2026-06-21T02:12:49+08:00 daily https://www.pharmasources.com/industryinsights/tagrisso-shows-improved-overall-survival-314552.html 0.6 2026-06-20T18:59:35+08:00 daily https://www.pharmasources.com/industryinsights/health-tip-avoiding-anemia-314553.html 0.6 2026-08-13T11:16:58+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-demonstrates-tagrissos-super-314554.html 0.6 2026-08-01T12:02:17+08:00 daily https://www.pharmasources.com/industryinsights/oric-closes-funding-to-develop-glucocort-314555.html 0.6 2026-06-21T13:07:34+08:00 daily https://www.pharmasources.com/industryinsights/uf-researchers-focus-on-new-drug-candida-314556.html 0.6 2026-07-17T01:33:26+08:00 daily https://www.pharmasources.com/industryinsights/xinhua-silk-road-yili-teams-up-with-part-314557.html 0.6 2026-06-21T06:49:05+08:00 daily https://www.pharmasources.com/industryinsights/ossdsign-ab-publ-initiates-commercial-pr-314558.html 0.6 2026-06-22T01:53:30+08:00 daily https://www.pharmasources.com/industryinsights/vitamin-d-tied-to-falls-nonmotor-symptom-314559.html 0.6 2026-07-15T16:30:11+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-tagrisso-helps-lung-cancer--314560.html 0.6 2026-07-06T07:58:25+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-completes-audit-of-dr-reddys-loui-314561.html 0.6 2026-01-04T15:39:58+08:00 daily https://www.pharmasources.com/industryinsights/no-evidence-for-benefits-of-opioids-afte-314562.html 0.6 2026-07-22T12:26:02+08:00 daily https://www.pharmasources.com/industryinsights/delayedforegone-care-more-likely-for-can-314563.html 0.6 2026-06-21T10:40:56+08:00 daily https://www.pharmasources.com/industryinsights/hba1c-bmi-linked-to-stillbirth-risk-in-w-314564.html 0.6 2026-06-21T01:12:58+08:00 daily https://www.pharmasources.com/industryinsights/sleep-apnea-traits-may-predict-response--314565.html 0.6 2026-07-04T15:34:36+08:00 daily https://www.pharmasources.com/industryinsights/ulcerative-colitis-outcomes-similar-for--314566.html 0.6 2026-08-07T04:30:44+08:00 daily https://www.pharmasources.com/industryinsights/giant-cell-arteritis-occurs-at-similar-r-314567.html 0.6 2026-08-09T21:02:09+08:00 daily https://www.pharmasources.com/industryinsights/adhd-may-increase-risk-of-premature-deat-314568.html 0.6 2026-08-06T23:57:29+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2019081-314569.html 0.6 2026-08-06T23:46:32+08:00 daily https://www.pharmasources.com/industryinsights/ancient-natural-history-of-antibiotic-pr-314570.html 0.6 2026-08-06T23:54:12+08:00 daily https://www.pharmasources.com/industryinsights/us-court-rules-in-favour-of-lilly-in-ali-314571.html 0.6 2026-08-07T20:03:10+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-orphan-drug-designation-to-dy-314572.html 0.6 2026-08-07T13:16:48+08:00 daily https://www.pharmasources.com/industryinsights/clinical-trial-reporting-is-improved-by--314573.html 0.6 2026-08-09T07:15:58+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-expands-biomanufacturi-314574.html 0.6 2026-07-04T04:39:17+08:00 daily https://www.pharmasources.com/industryinsights/caladrius-cognate-ink-clinical-manufactu-314575.html 0.6 2026-06-20T19:09:45+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-stedim-biotech-launches-new-se-314576.html 0.6 2026-06-21T03:01:46+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-md-anderson-form-vi-314577.html 0.6 2026-06-22T12:59:30+08:00 daily https://www.pharmasources.com/industryinsights/epa-will-not-approve-warning-labels-for--314578.html 0.6 2026-06-21T23:14:04+08:00 daily https://www.pharmasources.com/industryinsights/use-of-technology-now-included-in-standa-314579.html 0.6 2026-08-07T20:41:25+08:00 daily https://www.pharmasources.com/industryinsights/adherence-to-surgical-guidelines-low-for-314580.html 0.6 2026-06-21T01:05:50+08:00 daily https://www.pharmasources.com/industryinsights/is-a-chlamydia-vaccine-on-the-horizon-314581.html 0.6 2026-06-22T00:44:52+08:00 daily https://www.pharmasources.com/industryinsights/new-ebola-drugs-highly-effective-might-s-314582.html 0.6 2026-06-22T14:31:47+08:00 daily https://www.pharmasources.com/industryinsights/obesity-and-spare-tire-raise-hispanics-o-314583.html 0.6 2026-06-22T08:57:43+08:00 daily https://www.pharmasources.com/industryinsights/caring-doctors-can-be-life-changing-for--314584.html 0.6 2026-06-20T20:00:37+08:00 daily https://www.pharmasources.com/industryinsights/protein-made-during-long-workouts-may-wa-314585.html 0.6 2025-11-05T15:10:33+08:00 daily https://www.pharmasources.com/industryinsights/too-much-napping-may-signal-alzheimers-314586.html 0.6 2026-08-07T02:15:58+08:00 daily https://www.pharmasources.com/industryinsights/aspirin-may-improve-liver-function-after-314587.html 0.6 2026-08-12T03:32:43+08:00 daily https://www.pharmasources.com/industryinsights/ai-tool-discerns-lung-cancer-outcomes-fr-314588.html 0.6 2026-06-21T06:12:54+08:00 daily https://www.pharmasources.com/industryinsights/unused-pharmaceuticals-common-after-cata-314589.html 0.6 2026-06-21T00:46:40+08:00 daily https://www.pharmasources.com/industryinsights/flu-vaccine-tied-to-better-long-term-out-314590.html 0.6 2026-06-21T11:02:09+08:00 daily https://www.pharmasources.com/industryinsights/perfusion-assessment-key-for-critical-li-314591.html 0.6 2026-06-20T23:03:45+08:00 daily https://www.pharmasources.com/industryinsights/adjuvant-rt-may-cut-recurrence-in-some-w-314592.html 0.6 2026-06-20T18:10:30+08:00 daily https://www.pharmasources.com/industryinsights/psychotherapy-alone-first-line-of-treatm-314593.html 0.6 2026-07-19T15:50:41+08:00 daily https://www.pharmasources.com/industryinsights/prescription-drug-misuse-common-in-high--314594.html 0.6 2026-06-23T02:21:58+08:00 daily https://www.pharmasources.com/industryinsights/depression-alzheimers-might-be-part-of-s-314595.html 0.6 2026-06-20T17:36:58+08:00 daily https://www.pharmasources.com/industryinsights/red-meat-consumption-may-up-risk-of-inva-314596.html 0.6 2026-07-01T17:29:38+08:00 daily https://www.pharmasources.com/industryinsights/hematological-malignancy-risk-up-for-fir-314597.html 0.6 2026-08-06T17:32:52+08:00 daily https://www.pharmasources.com/industryinsights/halix-starts-operational-production-with-314598.html 0.6 2026-06-21T20:05:49+08:00 daily https://www.pharmasources.com/industryinsights/new-review-suggests-normal-use-of-electr-314599.html 0.6 2026-06-20T16:58:27+08:00 daily https://www.pharmasources.com/industryinsights/independent-monitoring-board-recommends--314600.html 0.6 2026-07-15T16:37:37+08:00 daily https://www.pharmasources.com/industryinsights/appeals-court-rules-in-favor-of-lilly-in-314601.html 0.6 2026-07-03T22:50:55+08:00 daily https://www.pharmasources.com/industryinsights/oncologie-merck-to-evaluate-bavituximab--314602.html 0.6 2026-06-20T15:09:28+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-enrolled-in-primary-sclero-314604.html 0.6 2026-07-18T12:05:07+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-enrolled-in-hepatic-cirrho-314605.html 0.6 2025-11-20T06:35:47+08:00 daily https://www.pharmasources.com/industryinsights/polypid-completes-enrollment-of-trial-fo-314606.html 0.6 2026-06-23T14:03:43+08:00 daily https://www.pharmasources.com/industryinsights/explanation-found-for-high-mortality-in--314607.html 0.6 2026-06-28T15:09:16+08:00 daily https://www.pharmasources.com/industryinsights/us-court-rules-in-favour-of-amgen-in-enb-314608.html 0.6 2026-06-21T13:04:37+08:00 daily https://www.pharmasources.com/industryinsights/china-approves-gileads-hiv-1-drug-candid-314609.html 0.6 2026-07-07T06:29:23+08:00 daily https://www.pharmasources.com/industryinsights/canada-announces-changes-to-lower-medici-314610.html 0.6 2026-08-08T00:49:46+08:00 daily https://www.pharmasources.com/industryinsights/facing-headwinds-in-us-natco-pharma-look-314611.html 0.6 2026-06-23T10:58:50+08:00 daily https://www.pharmasources.com/industryinsights/cadila-pharma-bags-tiss-leapvault-clo-aw-314612.html 0.6 2026-06-22T12:52:02+08:00 daily https://www.pharmasources.com/industryinsights/bayer-wins-best-employer-in-india-2019-a-314613.html 0.6 2026-08-08T04:25:51+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-issues-six-observations-to-natco--314614.html 0.6 2026-06-22T08:05:38+08:00 daily https://www.pharmasources.com/industryinsights/unichem-laboratories-gets-us-fda-nod-for-314615.html 0.6 2026-06-21T10:09:16+08:00 daily https://www.pharmasources.com/industryinsights/philippine-officials-consider-sanofis-de-314616.html 0.6 2026-06-24T15:33:29+08:00 daily https://www.pharmasources.com/industryinsights/takeda-sosei-form-gastrointestinal-disea-314617.html 0.6 2026-06-20T14:57:10+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-pays-biogen-nearly-1b-for-denma-314618.html 0.6 2026-06-20T22:56:46+08:00 daily https://www.pharmasources.com/industryinsights/takeda-staffers-accuse-drugmaker-of-favo-314619.html 0.6 2026-06-21T10:35:30+08:00 daily https://www.pharmasources.com/industryinsights/rakuten-medical-reels-in-another-megarou-314620.html 0.6 2026-06-15T09:17:11+08:00 daily https://www.pharmasources.com/industryinsights/pentagon-eyeing-chinese-production-of-ta-314621.html 0.6 2026-08-11T18:46:05+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-wades-deeper-into-oncolog-314622.html 0.6 2026-08-07T05:52:10+08:00 daily https://www.pharmasources.com/industryinsights/faulty-manufacturing-trips-up-nektars-br-314623.html 0.6 2026-08-07T05:49:19+08:00 daily https://www.pharmasources.com/industryinsights/gsk-appeals-to-parents-with-latest-menin-314624.html 0.6 2026-08-07T05:45:31+08:00 daily https://www.pharmasources.com/industryinsights/with-enbrel-patent-victory-amgen-scores--314625.html 0.6 2026-08-07T05:39:33+08:00 daily https://www.pharmasources.com/industryinsights/natco-faces-double-whammy-falling-profit-314626.html 0.6 2026-08-07T05:37:09+08:00 daily https://www.pharmasources.com/industryinsights/humana-calls-mallinckrodts-acthar-a-bill-314627.html 0.6 2026-08-07T06:07:46+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-and-md-anderson-for-314628.html 0.6 2026-08-07T11:23:04+08:00 daily https://www.pharmasources.com/industryinsights/voluntary-recall-issued-for-lidocaine-cr-314629.html 0.6 2026-08-07T11:55:27+08:00 daily https://www.pharmasources.com/industryinsights/ebola-clinical-trial-stopped-early-due-t-314630.html 0.6 2026-08-07T12:27:12+08:00 daily https://www.pharmasources.com/industryinsights/amgen-wins-court-patent-ruling-over-sand-314631.html 0.6 2026-08-07T13:18:30+08:00 daily https://www.pharmasources.com/industryinsights/schreiner-medipharm-applied-dna-offer-fo-314632.html 0.6 2026-04-22T14:30:13+08:00 daily https://www.pharmasources.com/industryinsights/advanced-clinical-opens-new-office-in-it-314633.html 0.6 2026-06-21T05:58:48+08:00 daily https://www.pharmasources.com/industryinsights/signant-health-launches-partner-program-314634.html 0.6 2026-06-22T12:54:11+08:00 daily https://www.pharmasources.com/industryinsights/curevac-yale-collaborate-on-discovery-re-314635.html 0.6 2026-06-22T15:03:27+08:00 daily https://www.pharmasources.com/industryinsights/ac-immune-upenn-to-research-tdp-43-in-ne-314636.html 0.6 2026-06-22T08:40:28+08:00 daily https://www.pharmasources.com/industryinsights/reed-lane-opens-cold-chain-room-for-vial-314637.html 0.6 2026-06-20T15:11:18+08:00 daily https://www.pharmasources.com/industryinsights/uspstf-recommends-screening-adults-for-i-314638.html 0.6 2026-06-20T19:19:54+08:00 daily https://www.pharmasources.com/industryinsights/doctors-say-new-drugs-cured-two-ebola-pa-314639.html 0.6 2026-06-21T12:26:14+08:00 daily https://www.pharmasources.com/industryinsights/bp-from-midlife-to-late-life-tied-to-ris-314640.html 0.6 2026-07-24T13:01:08+08:00 daily https://www.pharmasources.com/industryinsights/non-hospital-based-provider-to-patient-t-314641.html 0.6 2026-03-20T19:03:05+08:00 daily https://www.pharmasources.com/industryinsights/miracle-mineral-solution-is-no-miracle-c-314642.html 0.6 2026-04-06T10:47:44+08:00 daily https://www.pharmasources.com/industryinsights/scientists-uncover-more-autism-genes-314643.html 0.6 2026-06-08T21:47:38+08:00 daily https://www.pharmasources.com/industryinsights/jazz-pharmaceuticals-announces-acquisiti-314644.html 0.6 2026-06-21T02:43:29+08:00 daily https://www.pharmasources.com/industryinsights/ctd-holdings-files-supporting-data-for-a-314645.html 0.6 2026-07-17T04:09:40+08:00 daily https://www.pharmasources.com/industryinsights/scans-reveal-smoldering-spots-in-brains--314646.html 0.6 2026-06-21T18:19:51+08:00 daily https://www.pharmasources.com/industryinsights/terns-announces-positive-interim-results-314647.html 0.6 2026-04-02T00:38:04+08:00 daily https://www.pharmasources.com/industryinsights/deciphera-announces-positive-results-fro-314648.html 0.6 2026-03-07T04:49:54+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-eylea-injection-prefilled-s-314649.html 0.6 2026-07-19T23:01:39+08:00 daily https://www.pharmasources.com/industryinsights/schrdinger-expands-drug-discovery-partne-314650.html 0.6 2026-08-04T23:38:03+08:00 daily https://www.pharmasources.com/industryinsights/lots-of-gluten-during-toddler-years-migh-314651.html 0.6 2026-06-21T03:07:45+08:00 daily https://www.pharmasources.com/industryinsights/progress-made-in-developing-first-chlamy-314652.html 0.6 2026-06-20T15:52:03+08:00 daily https://www.pharmasources.com/industryinsights/us-senator-seeks-records-linked-to-novar-314653.html 0.6 2026-07-01T09:26:29+08:00 daily https://www.pharmasources.com/industryinsights/rising-blood-pressure-puts-women-at-grea-314654.html 0.6 2026-06-22T09:46:01+08:00 daily https://www.pharmasources.com/industryinsights/adhd-medication-methylphenidate-may-alte-314655.html 0.6 2026-06-22T01:09:07+08:00 daily https://www.pharmasources.com/industryinsights/sonnet-biotherapeutics-agrees-to-buy-rel-314656.html 0.6 2026-06-22T08:07:47+08:00 daily https://www.pharmasources.com/industryinsights/nmpa-issues-notice-on-publicity-and-impl-314657.html 0.6 2026-07-16T08:35:24+08:00 daily https://www.pharmasources.com/industryinsights/methylphenidate-treatment-tied-to-brain--314658.html 0.6 2026-06-21T12:00:15+08:00 daily https://www.pharmasources.com/industryinsights/comorbid-cvd-may-up-mortality-with-adt-f-314659.html 0.6 2026-06-13T00:19:53+08:00 daily https://www.pharmasources.com/industryinsights/erectile-dysfunction-tied-to-lower-work--314660.html 0.6 2026-06-20T21:59:40+08:00 daily https://www.pharmasources.com/industryinsights/why-edaravone-of-mitsubishi-tanabe-is-ex-314661.html 0.6 2026-08-10T21:50:48+08:00 daily https://www.pharmasources.com/industryinsights/gsk-poaches-merck-kgaa-exec-to-replace-d-314662.html 0.6 2026-06-21T00:06:44+08:00 daily https://www.pharmasources.com/industryinsights/sanders-warren-join-team-of-senators-bla-314663.html 0.6 2026-06-22T20:46:50+08:00 daily https://www.pharmasources.com/industryinsights/senate-panel-launches-probe-into-novarti-314664.html 0.6 2026-06-20T20:19:00+08:00 daily https://www.pharmasources.com/industryinsights/novartis-inspection-puts-into-question-w-314665.html 0.6 2026-08-04T09:36:53+08:00 daily https://www.pharmasources.com/industryinsights/regenerons-eylea-snags-pre-filled-syring-314666.html 0.6 2026-08-10T10:58:08+08:00 daily https://www.pharmasources.com/industryinsights/sgs-life-sciences-launches-onevision-314667.html 0.6 2026-06-21T10:01:08+08:00 daily https://www.pharmasources.com/industryinsights/sp-scientific-offers-aseptic-vial-handli-314668.html 0.6 2026-06-21T06:47:48+08:00 daily https://www.pharmasources.com/industryinsights/askbio-acquires-synpromics-ltd-314669.html 0.6 2026-06-22T08:06:53+08:00 daily https://www.pharmasources.com/industryinsights/nephron-clemson-collaborate-on-syringe-f-314670.html 0.6 2026-08-08T21:46:08+08:00 daily https://www.pharmasources.com/industryinsights/cdmo-indena-improves-manufacturing-proce-314671.html 0.6 2026-08-07T06:36:22+08:00 daily https://www.pharmasources.com/industryinsights/gencure-reports-successful-first-run-of--314672.html 0.6 2026-08-10T11:59:03+08:00 daily https://www.pharmasources.com/industryinsights/frontage-clinical-expands-nj-facilities-314673.html 0.6 2026-08-07T02:51:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-pretomanid-for-highly-drug--314674.html 0.6 2026-08-13T20:24:37+08:00 daily https://www.pharmasources.com/industryinsights/postoperative-opioid-rx-size-down-after--314675.html 0.6 2026-08-06T23:32:54+08:00 daily https://www.pharmasources.com/industryinsights/israeli-flight-attendant-dies-of-measles-314676.html 0.6 2026-08-06T22:26:27+08:00 daily https://www.pharmasources.com/industryinsights/evidence-supports-meds-used-for-pain-rel-314677.html 0.6 2026-08-06T22:32:12+08:00 daily https://www.pharmasources.com/industryinsights/radial-artery-access-used-for-neuroendov-314678.html 0.6 2026-08-06T23:56:55+08:00 daily https://www.pharmasources.com/industryinsights/for-kids-born-with-hiv-taking-needed-med-314679.html 0.6 2026-08-07T00:02:38+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-announces-positive-topline-res-314680.html 0.6 2026-08-06T23:46:19+08:00 daily https://www.pharmasources.com/industryinsights/fewer-opioid-painkillers-can-still-contr-314681.html 0.6 2026-08-10T17:33:05+08:00 daily https://www.pharmasources.com/industryinsights/new-treatments-could-be-powerful-weapons-314682.html 0.6 2026-06-20T18:16:44+08:00 daily https://www.pharmasources.com/industryinsights/adult-weight-gain-likely-explains-link-b-314683.html 0.6 2026-06-21T03:05:42+08:00 daily https://www.pharmasources.com/industryinsights/tiring-easily-may-warn-of-future-heart-t-314684.html 0.6 2026-06-20T13:23:26+08:00 daily https://www.pharmasources.com/industryinsights/forge-receives-notice-of-allowance-from--314685.html 0.6 2026-06-20T19:18:00+08:00 daily https://www.pharmasources.com/industryinsights/scientists-creating-gene-map-of-human-mi-314686.html 0.6 2026-06-21T20:46:30+08:00 daily https://www.pharmasources.com/industryinsights/calquence-granted-us-breakthrough-therap-314687.html 0.6 2026-07-01T15:05:38+08:00 daily https://www.pharmasources.com/industryinsights/henry-ford-cancer-institute-enrolls-firs-314688.html 0.6 2026-06-20T17:55:44+08:00 daily https://www.pharmasources.com/industryinsights/low-muscle-mass-in-the-arms-legs-tied-to-314689.html 0.6 2026-06-20T22:51:06+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-drug-for-treatment-resistan-314690.html 0.6 2026-06-21T12:19:53+08:00 daily https://www.pharmasources.com/industryinsights/ai-assists-in-reading-of-digital-breast--314691.html 0.6 2026-06-21T01:04:47+08:00 daily https://www.pharmasources.com/industryinsights/neuropore-receives-orphan-drug-designati-314692.html 0.6 2026-08-10T13:49:04+08:00 daily https://www.pharmasources.com/industryinsights/tsh-elevated-in-6-percent-of-psychiatric-314693.html 0.6 2026-06-20T19:37:17+08:00 daily https://www.pharmasources.com/industryinsights/eli-lillys-taltz-outperforms-janssens-tr-314694.html 0.6 2026-08-07T22:05:12+08:00 daily https://www.pharmasources.com/industryinsights/curevac-and-yale-university-to-develop-m-314695.html 0.6 2026-06-21T02:56:37+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-announces-breakthrough-thera-314696.html 0.6 2026-06-21T23:55:40+08:00 daily https://www.pharmasources.com/industryinsights/gluten-intake-celiac-disease-linked-in-g-314697.html 0.6 2026-07-04T09:52:04+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-partners-with-md-anderson-on--314698.html 0.6 2026-06-12T13:47:23+08:00 daily https://www.pharmasources.com/industryinsights/internet-self-referrals-aid-in-diagnosis-314699.html 0.6 2026-06-21T03:11:52+08:00 daily https://www.pharmasources.com/industryinsights/dop-to-constitute-a-forum-of-pharma-asso-314700.html 0.6 2026-06-22T00:14:45+08:00 daily https://www.pharmasources.com/industryinsights/antiarrhythmic-drugs-may-up-fall-injurie-314701.html 0.6 2026-06-22T18:21:11+08:00 daily https://www.pharmasources.com/industryinsights/reduce-gst-form-a-separate-ministry-of-p-314702.html 0.6 2026-06-21T13:38:57+08:00 daily https://www.pharmasources.com/industryinsights/prescription-drug-use-similar-in-united--314703.html 0.6 2026-06-22T11:59:45+08:00 daily https://www.pharmasources.com/industryinsights/prices-of-knee-implants-not-to-increase--314704.html 0.6 2026-08-05T11:17:00+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-announces-licensing-agreement-314705.html 0.6 2026-06-21T03:07:45+08:00 daily https://www.pharmasources.com/industryinsights/kala-pharmaceuticals-receives-fda-comple-314706.html 0.6 2026-08-02T16:28:51+08:00 daily https://www.pharmasources.com/industryinsights/morepen-labs-net-profit-rises-by-256-per-314707.html 0.6 2026-08-07T16:13:38+08:00 daily https://www.pharmasources.com/industryinsights/wockhardt-q1-net-loss-narrows-to-rs-45-c-314708.html 0.6 2026-06-21T10:05:16+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-reports-q1fy20-results-314709.html 0.6 2026-07-17T23:32:57+08:00 daily https://www.pharmasources.com/industryinsights/indocos-cro-anacipher-clears-us-fda-insp-314710.html 0.6 2026-06-21T21:55:01+08:00 daily https://www.pharmasources.com/industryinsights/chlamydia-vaccine-passes-safety-trial-314711.html 0.6 2026-06-22T03:42:46+08:00 daily https://www.pharmasources.com/industryinsights/strides-completes-us-fda-inspection-at-i-314712.html 0.6 2026-06-21T22:11:51+08:00 daily https://www.pharmasources.com/industryinsights/at-rs-588-cr-murali-of-divis-lab-highest-314713.html 0.6 2026-06-22T12:57:11+08:00 daily https://www.pharmasources.com/industryinsights/imbruvica-granted-expanded-use-from-euro-314714.html 0.6 2026-06-21T15:53:12+08:00 daily https://www.pharmasources.com/industryinsights/fda-to-deactivate-out-of-date-drug-listi-314715.html 0.6 2026-06-26T00:04:57+08:00 daily https://www.pharmasources.com/industryinsights/letter-highlights-issues-with-us-drug-re-314716.html 0.6 2026-07-06T14:20:43+08:00 daily https://www.pharmasources.com/industryinsights/overseas-sight-the-fast-rising-south-kor-314717.html 0.6 2026-08-06T15:11:34+08:00 daily https://www.pharmasources.com/industryinsights/home-grown-companies-are-building-up-hig-314718.html 0.6 2026-08-01T16:32:40+08:00 daily https://www.pharmasources.com/industryinsights/askbio-acquires-synpromics-expands-gene--314719.html 0.6 2026-06-21T18:05:26+08:00 daily https://www.pharmasources.com/industryinsights/bdms-with-cnnic-to-spread-awareness-for--314720.html 0.6 2026-06-22T20:08:11+08:00 daily https://www.pharmasources.com/industryinsights/ping-an-good-doctor-launches-strategic-p-314721.html 0.6 2026-06-23T11:17:00+08:00 daily https://www.pharmasources.com/industryinsights/heart-on-a-chip-mimics-drug-response-see-314722.html 0.6 2026-08-05T16:17:25+08:00 daily https://www.pharmasources.com/industryinsights/biotek-gets-recognition-as-2019-vermont--314723.html 0.6 2026-06-20T22:15:09+08:00 daily https://www.pharmasources.com/industryinsights/great-bay-bio-adds-two-industry-leaders--314724.html 0.6 2026-06-20T18:10:43+08:00 daily https://www.pharmasources.com/industryinsights/ismrm-astar-hold-workshop-on-mri-of-obes-314725.html 0.6 2026-08-07T05:35:14+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-reports-q1-net-profit-at-rs13-314726.html 0.6 2026-06-22T01:55:31+08:00 daily https://www.pharmasources.com/industryinsights/empowering-asias-healthtech-innovators-314727.html 0.6 2026-06-20T16:55:14+08:00 daily https://www.pharmasources.com/industryinsights/straumann-group-to-expand-warantec-denta-314728.html 0.6 2026-02-28T17:14:28+08:00 daily https://www.pharmasources.com/industryinsights/dynosense-gets-fda-approval-for-unique-c-314729.html 0.6 2026-06-30T14:10:58+08:00 daily https://www.pharmasources.com/industryinsights/bayer-acquires-bluerock-therapeutics-to--314730.html 0.6 2026-07-02T18:05:11+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-opens-health-manage-314731.html 0.6 2026-06-24T05:40:36+08:00 daily https://www.pharmasources.com/industryinsights/allergan-ceo-saunders-lines-up-for-39m-p-314732.html 0.6 2026-06-22T04:06:49+08:00 daily https://www.pharmasources.com/industryinsights/lawmakers-to-teva-mylan-stop-stonewallin-314733.html 0.6 2026-07-03T01:54:37+08:00 daily https://www.pharmasources.com/industryinsights/does-stada-need-takedas-for-sale-europea-314734.html 0.6 2026-07-07T00:29:02+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-plots-800m-new-york-production-314735.html 0.6 2026-02-28T23:56:41+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-copaxone-nuvaring-generics-der-314736.html 0.6 2026-06-21T02:02:45+08:00 daily https://www.pharmasources.com/industryinsights/humira-tv-ad-buys-heat-up-summer-airwave-314737.html 0.6 2026-08-12T06:18:26+08:00 daily https://www.pharmasources.com/industryinsights/how-should-pharma-be-using-ai-new-series-314738.html 0.6 2026-07-05T22:00:17+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-was-allergans-only-suitor-in-63b--314739.html 0.6 2026-06-24T14:36:38+08:00 daily https://www.pharmasources.com/industryinsights/novartis-names-bulto-new-us-pharma-chief-314740.html 0.6 2026-06-28T18:32:15+08:00 daily https://www.pharmasources.com/industryinsights/eli-lillys-taltz-bests-jj-rival-tremfya--314741.html 0.6 2026-06-22T12:07:05+08:00 daily https://www.pharmasources.com/industryinsights/regenerons-eylea-snags-prefilled-syringe-314742.html 0.6 2026-06-20T22:02:39+08:00 daily https://www.pharmasources.com/industryinsights/drug-accelerates-blood-systems-recovery--314743.html 0.6 2026-06-22T11:51:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-drug-for-treatment-resi-314744.html 0.6 2026-06-20T23:03:45+08:00 daily https://www.pharmasources.com/industryinsights/lynparza-phase-iii-paola-1-trial-met-pri-314745.html 0.6 2026-06-20T15:40:23+08:00 daily https://www.pharmasources.com/industryinsights/new-drug-shows-encouraging-survival-in-p-314746.html 0.6 2026-07-05T03:50:41+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-treatment-for-drug-resi-314747.html 0.6 2026-06-20T16:20:57+08:00 daily https://www.pharmasources.com/industryinsights/phastar-appoints-head-of-statistical-res-314748.html 0.6 2026-06-20T15:12:16+08:00 daily https://www.pharmasources.com/industryinsights/syapse-fda-announce-rca-using-real-world-314749.html 0.6 2026-06-21T03:16:55+08:00 daily https://www.pharmasources.com/industryinsights/boston-analytical-continues-expansion-314750.html 0.6 2026-06-22T06:01:41+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-wakix-pitolisant-a-first-in-314751.html 0.6 2026-06-22T01:48:31+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-rozlytrek-entrectinib-for-p-314752.html 0.6 2026-06-21T09:13:17+08:00 daily https://www.pharmasources.com/industryinsights/acip-recommends-catch-up-hpv-vaccines-th-314753.html 0.6 2026-06-20T21:12:48+08:00 daily https://www.pharmasources.com/industryinsights/fda-proposes-graphic-warning-labels-on-c-314754.html 0.6 2026-07-03T12:55:26+08:00 daily https://www.pharmasources.com/industryinsights/patients-recall-few-suggestions-for-cont-314755.html 0.6 2026-06-22T10:31:21+08:00 daily https://www.pharmasources.com/industryinsights/nearly-half-of-us-patients-keep-vital-se-314756.html 0.6 2026-06-21T07:05:58+08:00 daily https://www.pharmasources.com/industryinsights/age-could-be-key-to-womens-worse-quality-314757.html 0.6 2026-08-09T02:11:23+08:00 daily https://www.pharmasources.com/industryinsights/how-to-relieve-dry-irritated-eyes-314758.html 0.6 2026-04-13T16:49:31+08:00 daily https://www.pharmasources.com/industryinsights/more-than-half-of-younger-patients-skip--314759.html 0.6 2026-08-10T08:32:11+08:00 daily https://www.pharmasources.com/industryinsights/antipsychotic-rx-patterns-in-children-wi-314760.html 0.6 2026-06-21T23:44:47+08:00 daily https://www.pharmasources.com/industryinsights/nonpersistence-low-adherence-to-bp-meds--314761.html 0.6 2026-06-22T06:03:42+08:00 daily https://www.pharmasources.com/industryinsights/renal-anomaly-on-fetal-scan-may-up-risk--314762.html 0.6 2026-06-22T19:05:17+08:00 daily https://www.pharmasources.com/industryinsights/cost-burden-of-disease-progression-high--314763.html 0.6 2026-08-07T06:10:17+08:00 daily https://www.pharmasources.com/industryinsights/model-predicts-hypoglycemia-risk-in-adul-314764.html 0.6 2026-06-21T11:05:15+08:00 daily https://www.pharmasources.com/industryinsights/agilent-introduces-real-time-cell-analyz-314765.html 0.6 2026-06-24T04:43:30+08:00 daily https://www.pharmasources.com/industryinsights/harmony-biosciences-announces-fda-approv-314766.html 0.6 2026-07-04T01:04:52+08:00 daily https://www.pharmasources.com/industryinsights/soligenix-announces-nih-small-business-i-314767.html 0.6 2026-06-23T12:05:54+08:00 daily https://www.pharmasources.com/industryinsights/2005-2016-saw-no-improvement-in-diabetes-314768.html 0.6 2026-06-21T04:58:48+08:00 daily https://www.pharmasources.com/industryinsights/half-of-physician-directors-of-nci-cance-314769.html 0.6 2026-06-21T15:45:08+08:00 daily https://www.pharmasources.com/industryinsights/pharma-bodies-confirm-signing-ndas-for-n-314770.html 0.6 2026-08-08T23:24:27+08:00 daily https://www.pharmasources.com/industryinsights/drug-supplier-aspen-to-pay-nhs-8m-after--314771.html 0.6 2026-08-07T05:55:48+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-announces-positive-topline-res-314772.html 0.6 2026-08-08T20:27:29+08:00 daily https://www.pharmasources.com/industryinsights/accellix-announces-board-of-directors-ap-314773.html 0.6 2026-07-08T03:23:00+08:00 daily https://www.pharmasources.com/industryinsights/emphycorp-fda-submission-for-rx-new-non--314774.html 0.6 2026-08-11T23:40:09+08:00 daily https://www.pharmasources.com/industryinsights/mallinckrodt-announces-top-line-results--314775.html 0.6 2026-08-07T03:03:53+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-and-mercks-lynparza-continue-314776.html 0.6 2026-08-07T02:52:18+08:00 daily https://www.pharmasources.com/industryinsights/curevac-collaborates-with-yale-for-mrna--314777.html 0.6 2026-08-07T02:51:42+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-to-develop-more-generic-produ-314778.html 0.6 2026-08-07T03:03:14+08:00 daily https://www.pharmasources.com/industryinsights/clinithink-and-healthix-harness-benefits-314779.html 0.6 2026-08-07T12:03:20+08:00 daily https://www.pharmasources.com/industryinsights/bioivt-examines-link-between-hiv-integra-314780.html 0.6 2026-08-07T13:16:04+08:00 daily https://www.pharmasources.com/industryinsights/china-nmpa-approves-biktarvy-to-treat-hi-314781.html 0.6 2026-08-07T15:24:53+08:00 daily https://www.pharmasources.com/industryinsights/johannesburg-gets-ready-for-5th-healthca-314782.html 0.6 2026-08-08T02:56:02+08:00 daily https://www.pharmasources.com/industryinsights/japanese-scientists-develop-3d-printed-p-314783.html 0.6 2026-08-08T07:55:17+08:00 daily https://www.pharmasources.com/industryinsights/xylonix-biogemex-to-co-develop-predictiv-314784.html 0.6 2026-08-08T10:11:01+08:00 daily https://www.pharmasources.com/industryinsights/v-waves-interatrial-shunt-receives-fda-b-314785.html 0.6 2026-08-10T15:14:20+08:00 daily https://www.pharmasources.com/industryinsights/111-inc-launches-video-interview-series--314786.html 0.6 2026-06-24T16:57:45+08:00 daily https://www.pharmasources.com/industryinsights/tasly-remains-chinas-2019-national-tech--314787.html 0.6 2026-07-24T03:14:31+08:00 daily https://www.pharmasources.com/industryinsights/digital-health-in-india-is-certainly-one-314788.html 0.6 2026-08-10T12:07:35+08:00 daily https://www.pharmasources.com/industryinsights/roche-gets-approval-for-oncology-drug-ro-314789.html 0.6 2026-08-06T23:45:16+08:00 daily https://www.pharmasources.com/industryinsights/bausch-may-have-shed-the-valeant-name-bu-314790.html 0.6 2026-08-06T23:37:25+08:00 daily https://www.pharmasources.com/industryinsights/investors-angry-about-insulin-woes-sue-n-314791.html 0.6 2026-06-20T14:22:03+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-copaxone-nuvaring-generics-der-314792.html 0.6 2026-08-06T23:56:41+08:00 daily https://www.pharmasources.com/industryinsights/embattled-sun-pharmas-dilip-shanghvi-wit-314793.html 0.6 2026-08-07T00:01:49+08:00 daily https://www.pharmasources.com/industryinsights/ge-healthcare-fujitsu-to-develop-ai-to-h-314794.html 0.6 2026-08-07T13:16:50+08:00 daily https://www.pharmasources.com/industryinsights/emcure-knocked-by-the-fda-for-sterility--314795.html 0.6 2026-08-09T00:10:05+08:00 daily https://www.pharmasources.com/industryinsights/roche-scores-rozlytrek-ok-to-challenge-b-314796.html 0.6 2026-07-01T06:46:16+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-defends-top-oncology-drug-with-je-314797.html 0.6 2026-08-07T09:40:02+08:00 daily https://www.pharmasources.com/industryinsights/top-10-all-star-drugs-in-2024-humiras-ca-314798.html 0.6 2026-07-21T01:49:54+08:00 daily https://www.pharmasources.com/industryinsights/teva-shares-approach-20-year-low-amid-mo-314799.html 0.6 2026-06-20T23:58:35+08:00 daily https://www.pharmasources.com/industryinsights/no-love-for-mr-mucus-rbs-mucinex-charact-314800.html 0.6 2026-06-21T06:05:45+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-recalls-migraine-med-relpax-becau-314801.html 0.6 2026-06-20T23:51:32+08:00 daily https://www.pharmasources.com/industryinsights/roches-first-fda-approved-tumour-agnosti-314802.html 0.6 2026-08-11T09:02:00+08:00 daily https://www.pharmasources.com/industryinsights/berkshire-sterile-manufacturing-expands--314803.html 0.6 2026-07-03T16:25:31+08:00 daily https://www.pharmasources.com/industryinsights/marker-therapeutics-appoints-regulatory--314804.html 0.6 2026-06-21T16:00:27+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-rinvoq-upadacitinib-an-oral-314805.html 0.6 2026-06-21T21:04:40+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-inrebic-fedratinib-for-the--314806.html 0.6 2026-08-14T06:31:55+08:00 daily https://www.pharmasources.com/industryinsights/pediatric-cannabis-exposure-up-after-med-314807.html 0.6 2026-07-28T01:57:57+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-inrebic-capsules-for-myelof-314808.html 0.6 2026-06-21T02:43:32+08:00 daily https://www.pharmasources.com/industryinsights/intensive-bp-therapy-not-beneficial-in-n-314809.html 0.6 2026-06-21T05:50:57+08:00 daily https://www.pharmasources.com/industryinsights/periop-covert-stroke-idd-in-7-percent-of-314810.html 0.6 2026-06-21T02:59:19+08:00 daily https://www.pharmasources.com/industryinsights/ai-program-may-aid-in-pathologic-evaluat-314811.html 0.6 2026-06-20T21:02:40+08:00 daily https://www.pharmasources.com/industryinsights/for-heart-patients-cpap-treatment-may-ea-314812.html 0.6 2026-06-21T00:55:49+08:00 daily https://www.pharmasources.com/industryinsights/do-you-know-your-cardiorespiratory-fitne-314813.html 0.6 2026-08-13T19:56:43+08:00 daily https://www.pharmasources.com/industryinsights/higher-risk-of-mental-health-problems-fo-314814.html 0.6 2026-01-30T20:13:08+08:00 daily https://www.pharmasources.com/industryinsights/recommendations-developed-for-management-314815.html 0.6 2026-05-30T21:49:51+08:00 daily https://www.pharmasources.com/industryinsights/diabetes-education-support-cuts-hypoglyc-314816.html 0.6 2026-06-21T23:57:47+08:00 daily https://www.pharmasources.com/industryinsights/air-pollutants-tied-to-significant-worse-314817.html 0.6 2026-06-21T01:14:53+08:00 daily https://www.pharmasources.com/industryinsights/saved-score-can-predict-risk-for-vte-in--314818.html 0.6 2026-06-21T12:51:30+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-accelerated-approval-to-rozly-314819.html 0.6 2026-06-20T13:57:11+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-issues-recall-for-2-lots-of-relpa-314820.html 0.6 2026-06-21T01:52:44+08:00 daily https://www.pharmasources.com/industryinsights/zelnorm-now-available-in-the-us-314821.html 0.6 2026-06-21T04:14:00+08:00 daily https://www.pharmasources.com/industryinsights/ema-validates-marketing-application-for--314822.html 0.6 2026-07-30T11:10:03+08:00 daily https://www.pharmasources.com/industryinsights/vaping-industry-group-sues-to-delay-fda--314823.html 0.6 2026-06-21T04:00:43+08:00 daily https://www.pharmasources.com/industryinsights/lynparza-bevacizumab-trial-meets-primary-314824.html 0.6 2026-06-21T13:05:28+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-non-controlled-substa-314825.html 0.6 2026-07-06T07:52:46+08:00 daily https://www.pharmasources.com/industryinsights/genentech-gets-fda-approval-for-tumour-a-314826.html 0.6 2026-06-21T21:13:10+08:00 daily https://www.pharmasources.com/industryinsights/uk-to-set-up-freight-service-for-medicin-314827.html 0.6 2026-06-22T12:59:08+08:00 daily https://www.pharmasources.com/industryinsights/complete-response-letter-sent-for-two-ge-314828.html 0.6 2026-06-20T16:01:21+08:00 daily https://www.pharmasources.com/industryinsights/silica-based-drug-delivery-could-improve-314829.html 0.6 2026-07-07T01:17:40+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-rozlytrek-cancer-treatment-ap-314830.html 0.6 2026-06-21T15:47:46+08:00 daily https://www.pharmasources.com/industryinsights/evolving-world-of-pharma-surging-scienti-314831.html 0.6 2026-08-07T02:36:46+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2019081-314832.html 0.6 2026-07-01T11:14:40+08:00 daily https://www.pharmasources.com/industryinsights/ibbr-seeks-rfps-for-cgmp-biologics-manuf-314833.html 0.6 2026-06-20T15:38:03+08:00 daily https://www.pharmasources.com/industryinsights/acg-capsules-introduces-acgcaps-h-capsul-314834.html 0.6 2026-06-20T21:07:46+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-opens-vr-training-center-i-314835.html 0.6 2026-06-21T03:08:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-abbvies-new-ra-drug-314836.html 0.6 2026-08-10T17:34:33+08:00 daily https://www.pharmasources.com/industryinsights/rozlytrek-approved-to-treat-tumors-with--314837.html 0.6 2026-06-20T13:53:24+08:00 daily https://www.pharmasources.com/industryinsights/new-antibiotic-xenleta-approved-for-comm-314838.html 0.6 2026-08-07T04:04:08+08:00 daily https://www.pharmasources.com/industryinsights/barostim-neo-system-implant-approved-to--314839.html 0.6 2026-08-07T03:27:34+08:00 daily https://www.pharmasources.com/industryinsights/supplement-pills-can-pose-choking-risk-f-314840.html 0.6 2026-08-07T03:24:52+08:00 daily https://www.pharmasources.com/industryinsights/mechanical-oral-antibiotic-bowel-prep-yi-314841.html 0.6 2026-08-07T03:30:50+08:00 daily https://www.pharmasources.com/industryinsights/gerd-associated-with-chronic-temporomand-314842.html 0.6 2026-08-07T03:49:00+08:00 daily https://www.pharmasources.com/industryinsights/no-quick-fix-for-a-fib-but-cardiologist--314843.html 0.6 2026-06-21T05:07:46+08:00 daily https://www.pharmasources.com/industryinsights/why-do-women-get-statins-less-frequently-314844.html 0.6 2026-08-07T04:16:23+08:00 daily https://www.pharmasources.com/industryinsights/upping-seniors-blood-pressure-meds-after-314845.html 0.6 2026-08-11T21:43:42+08:00 daily https://www.pharmasources.com/industryinsights/could-fluoride-be-bad-for-your-baby-duri-314846.html 0.6 2026-06-22T00:05:49+08:00 daily https://www.pharmasources.com/industryinsights/heart-experts-support-use-of-prescriptio-314847.html 0.6 2026-06-26T22:22:48+08:00 daily https://www.pharmasources.com/industryinsights/how-sleep-woes-may-strain-your-heart-314848.html 0.6 2026-04-21T18:14:49+08:00 daily https://www.pharmasources.com/industryinsights/dr-google-helps-some-patients-diagnose-a-314849.html 0.6 2026-06-20T18:56:43+08:00 daily https://www.pharmasources.com/industryinsights/prescription-omega-3-fatty-acids-effecti-314850.html 0.6 2026-07-23T15:32:24+08:00 daily https://www.pharmasources.com/industryinsights/alcohol-consumption-in-pregnancy-ups-mis-314851.html 0.6 2026-06-22T04:54:36+08:00 daily https://www.pharmasources.com/industryinsights/genetic-liability-to-insomnia-linked-to--314852.html 0.6 2026-06-21T04:58:49+08:00 daily https://www.pharmasources.com/industryinsights/hypoglycemia-up-with-intensive-glucose-l-314853.html 0.6 2026-08-09T00:51:36+08:00 daily https://www.pharmasources.com/industryinsights/study-finds-lack-of-racial-diversity-in--314854.html 0.6 2026-06-20T20:58:46+08:00 daily https://www.pharmasources.com/industryinsights/rinvoq-arthritis-treatment-granted-appro-314855.html 0.6 2026-06-21T11:58:20+08:00 daily https://www.pharmasources.com/industryinsights/us-appeals-court-overturns-patent-case-f-314856.html 0.6 2026-06-21T08:16:11+08:00 daily https://www.pharmasources.com/industryinsights/global-cephalosporin-drugs-market-projec-314857.html 0.6 2026-07-03T12:51:19+08:00 daily https://www.pharmasources.com/industryinsights/two-lots-of-migraine-medication-have-bee-314858.html 0.6 2026-06-21T12:58:42+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-laboratories-launches-versavo--314859.html 0.6 2026-06-20T17:07:22+08:00 daily https://www.pharmasources.com/industryinsights/genecentric-therapeutics-acquires-select-314860.html 0.6 2026-06-21T12:23:50+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-receives-approval-for-combinati-314861.html 0.6 2026-07-11T18:01:38+08:00 daily https://www.pharmasources.com/industryinsights/vanda-pharmaceuticals-receives-crl-from--314862.html 0.6 2026-07-06T21:21:08+08:00 daily https://www.pharmasources.com/industryinsights/boston-scientific-closes-acquisition-of--314863.html 0.6 2026-07-04T05:36:37+08:00 daily https://www.pharmasources.com/industryinsights/exagen-and-the-university-of-washington--314864.html 0.6 2026-08-09T08:17:25+08:00 daily https://www.pharmasources.com/industryinsights/researchers-develop-compound-to-reduce-i-314865.html 0.6 2026-06-26T23:36:07+08:00 daily https://www.pharmasources.com/industryinsights/celgenes-bone-marrow-cancer-drug-inrebic-314866.html 0.6 2026-08-09T05:11:27+08:00 daily https://www.pharmasources.com/industryinsights/juvenescence-closes-100m-series-b-round--314867.html 0.6 2026-06-30T14:17:56+08:00 daily https://www.pharmasources.com/industryinsights/upstar-against-breast-cancercdk-46-inhib-314868.html 0.6 2026-08-13T20:09:28+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-receives-fda-approval-for-rinvoq-314869.html 0.6 2026-06-21T00:47:19+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-inrebic-for-myelofibrosis-t-314870.html 0.6 2026-08-05T22:38:26+08:00 daily https://www.pharmasources.com/industryinsights/medtronic-evolut-tavr-system-receives-ex-314871.html 0.6 2026-06-22T02:51:46+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-novel-treatment-for-highly--314872.html 0.6 2026-07-11T09:36:19+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-novel-device-to-treat-idiop-314873.html 0.6 2026-07-31T16:09:55+08:00 daily https://www.pharmasources.com/industryinsights/idtechex-forecasts-61-billion-market-for-314874.html 0.6 2026-06-30T02:01:39+08:00 daily https://www.pharmasources.com/industryinsights/eppendorf-ag-with-positive-first-half-ye-314875.html 0.6 2026-06-21T01:05:48+08:00 daily https://www.pharmasources.com/industryinsights/merck-receives-7-additional-crispr-paten-314876.html 0.6 2026-06-21T04:00:56+08:00 daily https://www.pharmasources.com/industryinsights/idf-congress-to-bring-together-global-di-314877.html 0.6 2026-06-22T19:49:49+08:00 daily https://www.pharmasources.com/industryinsights/xynomic-research-institute-designs-poten-314878.html 0.6 2026-06-22T12:02:55+08:00 daily https://www.pharmasources.com/industryinsights/singapore-national-eye-centre-opens-new--314879.html 0.6 2026-08-14T15:57:05+08:00 daily https://www.pharmasources.com/industryinsights/noac-treatment-effective-against-liver-d-314880.html 0.6 2026-06-22T09:58:42+08:00 daily https://www.pharmasources.com/industryinsights/sustainable-manufacturing-practices-to-c-314881.html 0.6 2026-06-21T01:59:39+08:00 daily https://www.pharmasources.com/industryinsights/pra-close-up-enter-strategic-data-soluti-314882.html 0.6 2026-04-18T09:29:01+08:00 daily https://www.pharmasources.com/industryinsights/provention-bio-appoints-clinical-develop-314883.html 0.6 2026-06-21T07:51:50+08:00 daily https://www.pharmasources.com/industryinsights/marken-expands-services-for-home-based-c-314884.html 0.6 2026-08-11T08:05:55+08:00 daily https://www.pharmasources.com/industryinsights/emendo-biotherapeutics-achieves-takeda-m-314885.html 0.6 2026-06-21T01:55:44+08:00 daily https://www.pharmasources.com/industryinsights/takeda-ireland-implements-werums-pas-x-m-314886.html 0.6 2026-08-01T15:07:53+08:00 daily https://www.pharmasources.com/industryinsights/some-pregnant-women-exposed-to-common-mr-314887.html 0.6 2026-06-22T10:51:50+08:00 daily https://www.pharmasources.com/industryinsights/uspstf-recommends-genetic-counseling-for-314888.html 0.6 2026-04-03T08:17:31+08:00 daily https://www.pharmasources.com/industryinsights/daas-cut-deaths-in-those-treated-for-hcv-314889.html 0.6 2026-06-21T21:38:18+08:00 daily https://www.pharmasources.com/industryinsights/exposure-to-pollution-may-up-risk-for-ps-314890.html 0.6 2026-07-19T13:21:55+08:00 daily https://www.pharmasources.com/industryinsights/womens-mid-life-stress-might-have-long-t-314891.html 0.6 2026-06-21T02:12:51+08:00 daily https://www.pharmasources.com/industryinsights/when-does-heart-health-return-to-normal--314892.html 0.6 2026-06-20T22:08:50+08:00 daily https://www.pharmasources.com/industryinsights/vaping-constricts-blood-vessels-raising--314893.html 0.6 2026-06-21T00:16:54+08:00 daily https://www.pharmasources.com/industryinsights/us-task-force-updates-breast-cancer-gene-314894.html 0.6 2026-06-21T11:02:11+08:00 daily https://www.pharmasources.com/industryinsights/study-points-to-harms-from-mri-dye-in-ea-314895.html 0.6 2026-06-21T08:03:01+08:00 daily https://www.pharmasources.com/industryinsights/use-of-opioids-cannabis-tied-to-poorer-m-314896.html 0.6 2026-06-22T05:58:41+08:00 daily https://www.pharmasources.com/industryinsights/certain-dietary-supplements-tied-to-dysp-314897.html 0.6 2026-06-22T05:00:37+08:00 daily https://www.pharmasources.com/industryinsights/biogen-and-invitae-to-offer-genetic-test-314898.html 0.6 2026-04-01T16:50:24+08:00 daily https://www.pharmasources.com/industryinsights/sanfer-receives-500m-from-cdpq-to-fund-s-314899.html 0.6 2026-08-07T06:11:56+08:00 daily https://www.pharmasources.com/industryinsights/richter-launches-biosimilar-teriparatide-314900.html 0.6 2026-07-10T05:21:37+08:00 daily https://www.pharmasources.com/industryinsights/farxiga-meets-primary-endpoint-in-heart--314901.html 0.6 2026-06-20T19:55:31+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-antibiotic-to-treat-com-314902.html 0.6 2026-06-21T18:57:58+08:00 daily https://www.pharmasources.com/industryinsights/milliporesigma-granted-20-crispr-patents-314903.html 0.6 2026-04-21T10:00:42+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-diabetes-drug-farxiga-perfo-314904.html 0.6 2026-08-07T23:27:47+08:00 daily https://www.pharmasources.com/industryinsights/vaxxilon-receives-grant-to-develop-new-p-314905.html 0.6 2026-04-06T19:55:55+08:00 daily https://www.pharmasources.com/industryinsights/mateon-and-pointr-to-merge-into-ai-drive-314906.html 0.6 2026-06-20T23:00:41+08:00 daily https://www.pharmasources.com/industryinsights/nabrivas-bacterial-pneumonia-drug-gets-u-314907.html 0.6 2026-03-16T14:12:05+08:00 daily https://www.pharmasources.com/industryinsights/nmpa-issued-the-announcement-on-issues-p-314908.html 0.6 2026-06-20T23:53:31+08:00 daily https://www.pharmasources.com/industryinsights/nmpa-issued-the-notice-on-expanding-the--314909.html 0.6 2026-06-18T05:28:18+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-launches-generic-oral-anti-epi-314910.html 0.6 2026-06-21T04:07:47+08:00 daily https://www.pharmasources.com/industryinsights/roche-taps-lilly-executive-garraway-as-c-314911.html 0.6 2026-06-23T10:01:45+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-nabrivas-antibiotic-for-pne-314912.html 0.6 2026-06-23T17:19:03+08:00 daily https://www.pharmasources.com/industryinsights/workshop-on-antimicrobial-resistance-org-314913.html 0.6 2026-08-09T13:06:26+08:00 daily https://www.pharmasources.com/industryinsights/most-uk-patients-with-uti-receive-antibi-314914.html 0.6 2026-02-28T15:39:10+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-receives-approval-to-market-rem-314915.html 0.6 2026-06-21T15:45:08+08:00 daily https://www.pharmasources.com/industryinsights/factors-idd-in-pregnancy-chances-after-k-314916.html 0.6 2026-07-15T07:59:26+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-gives-commercialisation-licen-314917.html 0.6 2026-02-15T00:41:29+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-launches-roches-avastin-biosim-314918.html 0.6 2026-08-05T10:43:53+08:00 daily https://www.pharmasources.com/industryinsights/minority-low-income-individuals-less-lik-314919.html 0.6 2026-06-20T18:17:50+08:00 daily https://www.pharmasources.com/industryinsights/a-new-favorite-in-the-medical-world-epig-314920.html 0.6 2026-05-15T22:44:34+08:00 daily https://www.pharmasources.com/industryinsights/lipophilic-statins-may-cut-liver-cancer--314921.html 0.6 2026-06-21T08:03:03+08:00 daily https://www.pharmasources.com/industryinsights/childhood-onset-ibd-ups-risk-for-psychia-314922.html 0.6 2026-08-06T19:14:17+08:00 daily https://www.pharmasources.com/industryinsights/patient-preferences-explored-in-multiple-314923.html 0.6 2026-06-21T01:05:48+08:00 daily https://www.pharmasources.com/industryinsights/farxiga-met-primary-endpoint-in-landmark-314924.html 0.6 2026-07-09T14:44:59+08:00 daily https://www.pharmasources.com/industryinsights/emcure-pharmaceuticals-receives-warning--314925.html 0.6 2026-08-15T00:54:48+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-ind-application-for-coeliac-314926.html 0.6 2026-08-07T10:33:54+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-pulls-up-emcure-pharma-for-manufa-314927.html 0.6 2026-06-21T08:48:58+08:00 daily https://www.pharmasources.com/industryinsights/huixing-biotech-following-the-nature-to--314928.html 0.6 2026-08-08T11:52:38+08:00 daily https://www.pharmasources.com/industryinsights/cstone-submits-an-abstract-on-cs1001-201-314929.html 0.6 2026-07-01T22:40:38+08:00 daily https://www.pharmasources.com/industryinsights/moderna-receives-fda-fast-track-designat-314930.html 0.6 2026-08-10T19:02:02+08:00 daily https://www.pharmasources.com/industryinsights/microsoft-welcomes-new-chief-medical-off-314931.html 0.6 2026-06-20T23:19:03+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-announces-positive-results-f-314932.html 0.6 2026-07-08T16:30:08+08:00 daily https://www.pharmasources.com/industryinsights/check-cap-ge-healthcare-announce-updates-314933.html 0.6 2026-06-21T22:03:46+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-launches-vigabatrin-in-the-us-314934.html 0.6 2026-06-22T03:00:39+08:00 daily https://www.pharmasources.com/industryinsights/ntu-grows-mini-kidneys-in-lab-to-study-p-314935.html 0.6 2026-06-21T06:50:47+08:00 daily https://www.pharmasources.com/industryinsights/malaysia-to-host-biotechnology-2019-summ-314936.html 0.6 2026-06-21T01:01:46+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-antibiotic-for-community-ac-314937.html 0.6 2026-07-27T08:53:34+08:00 daily https://www.pharmasources.com/industryinsights/ibio-announces-3d-bioprinting-agreement-314938.html 0.6 2026-06-21T12:48:31+08:00 daily https://www.pharmasources.com/industryinsights/evidera-css-to-develop-patient-centered--314939.html 0.6 2026-06-22T07:55:46+08:00 daily https://www.pharmasources.com/industryinsights/eag-launches-new-laboratory-in-china-314940.html 0.6 2026-06-20T21:18:57+08:00 daily https://www.pharmasources.com/industryinsights/alligator-bioscience-biotheus-inc-enter--314941.html 0.6 2026-06-22T06:52:55+08:00 daily https://www.pharmasources.com/industryinsights/enable-injections-genentech-enter-partne-314942.html 0.6 2026-06-20T13:21:36+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-invests-500m-in-gene-therapy-faci-314943.html 0.6 2026-06-20T23:06:46+08:00 daily https://www.pharmasources.com/industryinsights/fish-oil-not-a-magic-pill-against-diabet-314944.html 0.6 2026-06-21T12:00:16+08:00 daily https://www.pharmasources.com/industryinsights/odds-of-developing-c-diff-increased-in-o-314945.html 0.6 2026-06-21T02:04:39+08:00 daily https://www.pharmasources.com/industryinsights/facial-involvement-in-primary-headaches--314946.html 0.6 2026-06-21T07:16:22+08:00 daily https://www.pharmasources.com/industryinsights/oral-antibiotic-use-linked-to-risk-for-c-314947.html 0.6 2026-06-20T22:40:31+08:00 daily https://www.pharmasources.com/industryinsights/serelaxin-does-not-lower-cv-death-in-acu-314948.html 0.6 2026-07-17T15:32:56+08:00 daily https://www.pharmasources.com/industryinsights/eiger-receives-fda-breakthrough-therapy--314949.html 0.6 2026-06-23T05:00:51+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-foundation-invests-in-20-organiza-314950.html 0.6 2026-06-21T11:08:15+08:00 daily https://www.pharmasources.com/industryinsights/emendo-biotherapeutics-achieves-collabor-314951.html 0.6 2026-06-21T10:56:14+08:00 daily https://www.pharmasources.com/industryinsights/teva-launches-generic-equivalent-of-epip-314952.html 0.6 2026-06-21T00:33:37+08:00 daily https://www.pharmasources.com/industryinsights/deep-brain-zap-restores-vivid-memories-t-314953.html 0.6 2026-06-21T00:07:42+08:00 daily https://www.pharmasources.com/industryinsights/selinexor-offers-hope-against-a-tough-to-314954.html 0.6 2026-06-20T23:58:33+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-launches-vigabatrin-powder-for-314955.html 0.6 2026-06-21T12:04:17+08:00 daily https://www.pharmasources.com/industryinsights/meth-and-heart-disease-a-deadly-crisis-t-314956.html 0.6 2026-06-20T14:37:37+08:00 daily https://www.pharmasources.com/industryinsights/aging-narrows-gender-gap-in-flu-vaccine--314957.html 0.6 2026-06-21T05:02:42+08:00 daily https://www.pharmasources.com/industryinsights/rapid-dose-therapeutics-begins-clinical--314958.html 0.6 2026-06-21T08:00:57+08:00 daily https://www.pharmasources.com/industryinsights/texas-cities-are-ripe-for-measles-outbre-314959.html 0.6 2026-06-21T01:12:55+08:00 daily https://www.pharmasources.com/industryinsights/more-antibiotics-higher-odds-for-colon-c-314960.html 0.6 2026-06-21T06:53:19+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-imfinzi-fails-to-meet-endpo-314961.html 0.6 2026-06-22T07:00:47+08:00 daily https://www.pharmasources.com/industryinsights/sarepta-fails-to-receive-fda-approval-fo-314962.html 0.6 2026-07-17T22:41:45+08:00 daily https://www.pharmasources.com/industryinsights/bayer-to-divest-animal-health-unit-for-7-314963.html 0.6 2026-06-21T00:49:42+08:00 daily https://www.pharmasources.com/industryinsights/northern-antibiotics-develops-new-drug-f-314964.html 0.6 2026-06-20T14:46:06+08:00 daily https://www.pharmasources.com/industryinsights/asian-study-finds-diabetes-heart-failure-314965.html 0.6 2026-06-21T05:12:01+08:00 daily https://www.pharmasources.com/industryinsights/women-with-diabetes-more-likely-than-men-314966.html 0.6 2026-06-22T11:13:03+08:00 daily https://www.pharmasources.com/industryinsights/depression-substance-use-increasing-in-f-314967.html 0.6 2026-04-15T17:51:46+08:00 daily https://www.pharmasources.com/industryinsights/high-increasing-bp-in-midlife-tied-to-br-314968.html 0.6 2026-08-06T01:00:59+08:00 daily https://www.pharmasources.com/industryinsights/quitting-smoking-linked-to-lower-cvd-ris-314969.html 0.6 2026-08-05T23:53:21+08:00 daily https://www.pharmasources.com/industryinsights/taking-buprenorphine-for-opioid-use-diso-314970.html 0.6 2026-07-19T12:55:09+08:00 daily https://www.pharmasources.com/industryinsights/cdphp-partners-with-valera-health-to-bre-314971.html 0.6 2026-06-21T18:08:36+08:00 daily https://www.pharmasources.com/industryinsights/virtual-reality-program-reduces-pain-in--314972.html 0.6 2025-12-14T01:51:32+08:00 daily https://www.pharmasources.com/industryinsights/family-history-of-diabetes-tied-to-highe-314973.html 0.6 2026-06-21T16:53:32+08:00 daily https://www.pharmasources.com/industryinsights/mobile-stroke-unit-speeds-access-to-intr-314974.html 0.6 2026-06-21T02:05:49+08:00 daily https://www.pharmasources.com/industryinsights/the-pfizer-foundation-invests-in-20-orga-314975.html 0.6 2026-08-07T22:25:17+08:00 daily https://www.pharmasources.com/industryinsights/atelerix-consortium-awarded-267000-innov-314976.html 0.6 2026-06-21T20:57:43+08:00 daily https://www.pharmasources.com/industryinsights/investigational-zika-vaccine-receives-fa-314977.html 0.6 2026-06-20T16:07:23+08:00 daily https://www.pharmasources.com/industryinsights/lupin-to-sell-japanese-injectable-biz-to-314978.html 0.6 2026-06-20T22:07:46+08:00 daily https://www.pharmasources.com/industryinsights/cmab-kintor-announce-comprehensive-colla-314979.html 0.6 2026-06-20T21:58:39+08:00 daily https://www.pharmasources.com/industryinsights/adherium-and-summatix-join-hands-for-dig-314980.html 0.6 2026-08-11T15:18:20+08:00 daily https://www.pharmasources.com/industryinsights/innovent-to-develop-commercialize-a-nove-314981.html 0.6 2026-08-11T15:03:39+08:00 daily https://www.pharmasources.com/industryinsights/thailand-boi-university-network-to-spur--314982.html 0.6 2026-06-24T00:46:37+08:00 daily https://www.pharmasources.com/industryinsights/alligator-bioscience-signs-antibody-agre-314983.html 0.6 2026-07-01T07:35:04+08:00 daily https://www.pharmasources.com/industryinsights/lillys-first-crowdsourced-digital-health-314984.html 0.6 2026-06-22T12:53:11+08:00 daily https://www.pharmasources.com/industryinsights/hikma-picks-up-insys-naloxone-spray-equi-314985.html 0.6 2026-06-22T12:49:01+08:00 daily https://www.pharmasources.com/industryinsights/endo-strikes-10m-opioid-settlement-with--314986.html 0.6 2026-08-09T06:59:33+08:00 daily https://www.pharmasources.com/industryinsights/ousted-avexis-cso-denies-wrongdoing-in-n-314987.html 0.6 2026-08-08T02:37:46+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-farxiga-pads-its-case-for-n-314988.html 0.6 2026-08-09T07:15:47+08:00 daily https://www.pharmasources.com/industryinsights/could-a-creative-deal-between-perrigo-am-314989.html 0.6 2026-06-21T00:53:48+08:00 daily https://www.pharmasources.com/industryinsights/heres-an-sec-lesson-courtesy-therapeutic-314990.html 0.6 2026-07-10T23:24:52+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-adds-500m-to-gene-therapy-manufac-314991.html 0.6 2026-08-07T02:12:34+08:00 daily https://www.pharmasources.com/industryinsights/just-one-pill-for-all-your-heart-health--314992.html 0.6 2026-07-10T15:27:23+08:00 daily https://www.pharmasources.com/industryinsights/who-microplastics-in-drinking-water-not--314993.html 0.6 2026-08-12T13:29:05+08:00 daily https://www.pharmasources.com/industryinsights/multidrug-resistant-salmonella-outbreak--314994.html 0.6 2026-07-10T05:24:20+08:00 daily https://www.pharmasources.com/industryinsights/online-information-about-diabetic-retino-314995.html 0.6 2026-06-21T03:15:56+08:00 daily https://www.pharmasources.com/industryinsights/opioid-addiction-treatment-used-more-in--314996.html 0.6 2026-07-26T12:37:22+08:00 daily https://www.pharmasources.com/industryinsights/coverage-with-hpv-vaccine-continuing-to--314997.html 0.6 2026-07-15T18:18:47+08:00 daily https://www.pharmasources.com/industryinsights/push-stroke-patients-harder-for-better-g-314998.html 0.6 2026-06-20T16:58:19+08:00 daily https://www.pharmasources.com/industryinsights/hpv-vaccination-rate-in-us-girls-has-sta-314999.html 0.6 2026-06-21T04:19:59+08:00 daily https://www.pharmasources.com/industryinsights/large-opioid-rx-after-heart-lung-surgery-315000.html 0.6 2026-06-21T12:12:21+08:00 daily https://www.pharmasources.com/industryinsights/mixing-marijuana-with-opioids-may-not-be-315001.html 0.6 2026-06-21T03:02:45+08:00 daily https://www.pharmasources.com/industryinsights/cbd-is-the-rage-but-more-science-needed--315002.html 0.6 2026-06-22T06:03:40+08:00 daily https://www.pharmasources.com/industryinsights/cases-of-lung-injury-tied-to-vaping-keep-315003.html 0.6 2026-06-29T09:21:16+08:00 daily https://www.pharmasources.com/industryinsights/tb-cases-drop-among-the-young-but-racial-315004.html 0.6 2026-06-29T17:03:42+08:00 daily https://www.pharmasources.com/industryinsights/risk-factors-idd-for-worse-qol-from-knee-315005.html 0.6 2026-07-03T00:05:36+08:00 daily https://www.pharmasources.com/industryinsights/rx-size-predicts-persistent-opioid-use-a-315006.html 0.6 2026-08-05T07:50:28+08:00 daily https://www.pharmasources.com/industryinsights/tuberculosis-rates-for-us-children-are-l-315007.html 0.6 2026-06-21T17:07:27+08:00 daily https://www.pharmasources.com/industryinsights/intensifying-bp-meds-at-hospital-dischar-315008.html 0.6 2026-06-22T03:09:55+08:00 daily https://www.pharmasources.com/industryinsights/type-2-diabetes-may-impact-sleep-in-midd-315009.html 0.6 2026-08-05T21:56:52+08:00 daily https://www.pharmasources.com/industryinsights/type-2-diabetes-risk-up-with-inflammator-315010.html 0.6 2026-06-20T20:59:51+08:00 daily https://www.pharmasources.com/industryinsights/some-cities-in-texas-susceptible-to-meas-315011.html 0.6 2026-06-22T12:13:28+08:00 daily https://www.pharmasources.com/industryinsights/more-physical-activity-at-any-intensity--315012.html 0.6 2026-06-21T05:03:14+08:00 daily https://www.pharmasources.com/industryinsights/preventing-tumor-metastasis-315013.html 0.6 2026-06-21T07:46:48+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-beigenes-lymphoma-treatment-p-315014.html 0.6 2026-07-19T00:10:44+08:00 daily https://www.pharmasources.com/industryinsights/amgen-and-allergan-announce-positive-top-315015.html 0.6 2026-07-22T16:26:55+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-astellaspfizers-xtandi-applic-315016.html 0.6 2026-06-20T22:07:46+08:00 daily https://www.pharmasources.com/industryinsights/perrigo-announces-patent-litigation-sett-315017.html 0.6 2026-06-22T04:47:32+08:00 daily https://www.pharmasources.com/industryinsights/otc-drug-manufacturer-receives-warning-l-315018.html 0.6 2026-06-20T20:18:49+08:00 daily https://www.pharmasources.com/industryinsights/imfinzi-combination-fails-advanced-lung--315019.html 0.6 2026-08-10T12:59:18+08:00 daily https://www.pharmasources.com/industryinsights/fda-and-ema-align-on-90-percent-of-marke-315020.html 0.6 2026-06-21T11:10:15+08:00 daily https://www.pharmasources.com/industryinsights/23m-aid-announced-for-ebola-vaccine-manu-315021.html 0.6 2026-06-20T20:20:03+08:00 daily https://www.pharmasources.com/industryinsights/biotech-conagen-acquires-production-plat-315022.html 0.6 2026-06-21T04:11:54+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-stage-iv-lung-cancer-drug-m-315023.html 0.6 2026-06-21T12:27:00+08:00 daily https://www.pharmasources.com/industryinsights/propanc-biopharma-granted-us-patent-cove-315024.html 0.6 2026-06-20T18:53:35+08:00 daily https://www.pharmasources.com/industryinsights/terrosa-osteoporosis-biosimilar-treatmen-315025.html 0.6 2026-06-20T21:51:05+08:00 daily https://www.pharmasources.com/industryinsights/nhs-england-expands-funding-of-roches-he-315026.html 0.6 2026-08-09T20:32:12+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-commits-500m-to-expand-gene-thera-315027.html 0.6 2026-08-10T00:55:10+08:00 daily https://www.pharmasources.com/industryinsights/msd-and-crick-institute-partner-on-motor-315028.html 0.6 2026-08-06T10:13:52+08:00 daily https://www.pharmasources.com/industryinsights/brand-name-drug-prices-found-to-be-risin-315029.html 0.6 2026-08-07T19:16:49+08:00 daily https://www.pharmasources.com/industryinsights/jonathan-brn-to-leave-ceo-role-at-the-br-315030.html 0.6 2026-06-22T01:50:28+08:00 daily https://www.pharmasources.com/industryinsights/interlink-marketing-consultancy-to-condu-315031.html 0.6 2026-04-13T04:11:36+08:00 daily https://www.pharmasources.com/industryinsights/biocons-malaysia-insulin-glargine-facili-315032.html 0.6 2026-04-21T04:54:47+08:00 daily https://www.pharmasources.com/industryinsights/lupin-to-sell-japanese-injectables-busin-315033.html 0.6 2026-08-08T09:22:29+08:00 daily https://www.pharmasources.com/industryinsights/merck-invites-applications-for-merck-you-315034.html 0.6 2026-06-20T15:02:16+08:00 daily https://www.pharmasources.com/industryinsights/pharmexcil-to-collect-district-wise-phar-315035.html 0.6 2026-06-22T10:52:36+08:00 daily https://www.pharmasources.com/industryinsights/biomarker-may-uncover-uncontrolled-asthm-315036.html 0.6 2026-06-21T06:08:51+08:00 daily https://www.pharmasources.com/industryinsights/boston-scientific-announces-fda-approval-315037.html 0.6 2026-06-21T19:16:42+08:00 daily https://www.pharmasources.com/industryinsights/luye-pharmas-anti-depression-drug-to-sta-315038.html 0.6 2026-06-30T02:56:06+08:00 daily https://www.pharmasources.com/industryinsights/patient-groups-top-pharma-when-it-comes--315039.html 0.6 2026-06-21T06:05:00+08:00 daily https://www.pharmasources.com/industryinsights/future-proofing-pharma-for-outcomes-base-315040.html 0.6 2026-06-20T15:58:30+08:00 daily https://www.pharmasources.com/industryinsights/a-next-generation-sequencing-ngs-approac-315041.html 0.6 2026-07-29T09:09:04+08:00 daily https://www.pharmasources.com/industryinsights/2-month-hiv-injection-could-be-on-its-wa-315042.html 0.6 2026-03-28T21:01:51+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-astellas-rocket-toward-broader-xt-315043.html 0.6 2026-08-07T14:46:31+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-and-fibrogens-roxadustat-not-315044.html 0.6 2026-07-24T09:12:01+08:00 daily https://www.pharmasources.com/industryinsights/philippines-officials-nix-sanofis-attemp-315045.html 0.6 2026-08-05T01:05:28+08:00 daily https://www.pharmasources.com/industryinsights/enough-hubbub-about-hhs-truvada-patents--315046.html 0.6 2026-06-22T06:57:48+08:00 daily https://www.pharmasources.com/industryinsights/dillon-who-shaped-nice-into-an-influenti-315047.html 0.6 2026-06-21T03:59:46+08:00 daily https://www.pharmasources.com/industryinsights/appeal-shows-trumps-hhs-isnt-giving-up-o-315048.html 0.6 2026-08-07T22:12:51+08:00 daily https://www.pharmasources.com/industryinsights/neopharma-snaps-up-lupins-sterile-inject-315049.html 0.6 2026-08-05T01:06:58+08:00 daily https://www.pharmasources.com/industryinsights/rising-to-the-challenge-of-malaria-eradi-315050.html 0.6 2026-03-25T07:26:38+08:00 daily https://www.pharmasources.com/industryinsights/chinese-startup-carevoice-closes-series--315051.html 0.6 2026-06-23T11:00:41+08:00 daily https://www.pharmasources.com/industryinsights/the-asia-pacific-cardiovascular-devices--315052.html 0.6 2026-06-21T04:01:54+08:00 daily https://www.pharmasources.com/industryinsights/fitbit-collaborates-with-singapores-heal-315053.html 0.6 2026-06-21T07:00:23+08:00 daily https://www.pharmasources.com/industryinsights/cstone-registers-for-phase-i-trial-of-cd-315054.html 0.6 2026-08-03T08:39:52+08:00 daily https://www.pharmasources.com/industryinsights/gencurixs-study-explores-geneswell-bct-a-315055.html 0.6 2026-06-22T03:13:55+08:00 daily https://www.pharmasources.com/industryinsights/merck-thermis-collaborate-to-develop-vac-315056.html 0.6 2026-06-22T10:43:34+08:00 daily https://www.pharmasources.com/industryinsights/biocon-malaysia-unit-receives-eu-gmp-cer-315057.html 0.6 2026-08-14T01:43:41+08:00 daily https://www.pharmasources.com/industryinsights/china-approves-astrazeneca-drug-to-treat-315058.html 0.6 2026-07-23T23:48:47+08:00 daily https://www.pharmasources.com/industryinsights/voronoi-selects-cdd-vault-platform-to-ma-315059.html 0.6 2026-08-10T12:16:09+08:00 daily https://www.pharmasources.com/industryinsights/australias-propanc-biopharma-gets-us-pat-315060.html 0.6 2026-08-09T00:16:02+08:00 daily https://www.pharmasources.com/industryinsights/gsk-submits-first-regulatory-application-315061.html 0.6 2026-08-09T01:20:54+08:00 daily https://www.pharmasources.com/industryinsights/grand-river-ranked-on-the-inc-5000-list--315062.html 0.6 2026-08-13T15:06:30+08:00 daily https://www.pharmasources.com/industryinsights/cmab-and-kintor-enter-mfg-tie-up-315063.html 0.6 2026-08-09T06:20:02+08:00 daily https://www.pharmasources.com/industryinsights/labvantage-solutions-awarded-isoiec-2700-315064.html 0.6 2026-08-09T18:29:45+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-names-chief-people-office-315065.html 0.6 2026-01-16T14:59:41+08:00 daily https://www.pharmasources.com/industryinsights/patient-confidentiality-rule-changes-aim-315066.html 0.6 2026-08-09T02:10:23+08:00 daily https://www.pharmasources.com/industryinsights/peds-mortality-down-for-presentation-at--315067.html 0.6 2026-08-07T03:43:11+08:00 daily https://www.pharmasources.com/industryinsights/who-malaria-eradication-not-currently-po-315068.html 0.6 2026-07-25T22:12:34+08:00 daily https://www.pharmasources.com/industryinsights/novel-therapy-treats-triple-class-refrac-315069.html 0.6 2026-07-16T15:01:18+08:00 daily https://www.pharmasources.com/industryinsights/poor-hiv-control-ups-risk-for-sudden-car-315070.html 0.6 2026-06-23T11:00:37+08:00 daily https://www.pharmasources.com/industryinsights/climate-change-hiking-danger-of-flesh-ea-315071.html 0.6 2026-06-22T08:53:43+08:00 daily https://www.pharmasources.com/industryinsights/restless-legs-syndrome-might-raise-risk--315072.html 0.6 2026-06-21T12:20:42+08:00 daily https://www.pharmasources.com/industryinsights/prurigo-nodularis-associated-with-mental-315073.html 0.6 2026-06-21T10:42:02+08:00 daily https://www.pharmasources.com/industryinsights/prevalence-of-celiac-disease-high-in-fir-315074.html 0.6 2026-06-21T03:01:42+08:00 daily https://www.pharmasources.com/industryinsights/hospitalizations-with-psych-diagnosis-co-315075.html 0.6 2026-06-22T08:08:51+08:00 daily https://www.pharmasources.com/industryinsights/most-hpv-linked-cancers-due-to-types-tar-315076.html 0.6 2026-04-13T20:16:50+08:00 daily https://www.pharmasources.com/industryinsights/antibiotic-use-tied-to-higher-risk-of-rh-315077.html 0.6 2026-06-21T10:58:14+08:00 daily https://www.pharmasources.com/industryinsights/radiologists-performing-more-paracentese-315078.html 0.6 2026-06-21T08:05:06+08:00 daily https://www.pharmasources.com/industryinsights/low-cost-fixed-dose-polypill-reduces-ris-315079.html 0.6 2026-08-07T18:08:24+08:00 daily https://www.pharmasources.com/industryinsights/reduction-in-ptsd-symptoms-linked-to-dec-315080.html 0.6 2026-06-21T01:47:44+08:00 daily https://www.pharmasources.com/industryinsights/as-needed-inhaler-use-an-option-for-chil-315081.html 0.6 2026-06-21T05:57:53+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-agrees-to-buy-us-fda-priorit-315082.html 0.6 2026-06-20T16:59:31+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2019082-315083.html 0.6 2026-06-21T14:59:25+08:00 daily https://www.pharmasources.com/industryinsights/rfxcel-to-establish-its-biz-in-middle-ea-315084.html 0.6 2026-06-22T14:57:35+08:00 daily https://www.pharmasources.com/industryinsights/lupin-launches-antidepressant-drug-315085.html 0.6 2026-06-21T20:09:55+08:00 daily https://www.pharmasources.com/industryinsights/chinese-startup-carevoice-closes-series--315086.html 0.6 2026-06-20T15:51:46+08:00 daily https://www.pharmasources.com/industryinsights/new-trial-to-evaluate-an-investigational-315087.html 0.6 2026-06-21T11:09:16+08:00 daily https://www.pharmasources.com/industryinsights/myomo-announces-technology-licensing-pro-315088.html 0.6 2026-06-21T18:11:38+08:00 daily https://www.pharmasources.com/industryinsights/fitbit-collaborates-with-singapores-heal-315089.html 0.6 2026-06-22T08:52:39+08:00 daily https://www.pharmasources.com/industryinsights/atonarp-inc-completes-33m-series-c-fundi-315090.html 0.6 2026-06-20T15:55:20+08:00 daily https://www.pharmasources.com/industryinsights/ntu-scientists-advance-organ-on-chip-tec-315091.html 0.6 2026-06-21T04:37:02+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-dosed-for-phase-iii-trial--315092.html 0.6 2026-07-27T16:06:01+08:00 daily https://www.pharmasources.com/industryinsights/gilead-galapagos-close-their-development-315093.html 0.6 2026-06-21T08:20:16+08:00 daily https://www.pharmasources.com/industryinsights/eisai-appoints-global-clinical-quality-a-315094.html 0.6 2026-06-21T15:56:18+08:00 daily https://www.pharmasources.com/industryinsights/amgen-acquires-rights-to-celgenes-otezla-315095.html 0.6 2026-06-23T11:07:44+08:00 daily https://www.pharmasources.com/industryinsights/enteris-cara-therapeutics-enter-peptelli-315096.html 0.6 2026-03-28T17:46:15+08:00 daily https://www.pharmasources.com/industryinsights/men-should-be-included-in-breast-cancer--315097.html 0.6 2026-06-22T09:08:50+08:00 daily https://www.pharmasources.com/industryinsights/oklahoma-judge-fines-johnson-johnson-572-315098.html 0.6 2026-07-03T15:12:27+08:00 daily https://www.pharmasources.com/industryinsights/rule-changes-for-donor-organs-could-incr-315099.html 0.6 2026-07-18T01:47:32+08:00 daily https://www.pharmasources.com/industryinsights/childhood-cancer-survivors-struggle-with-315100.html 0.6 2026-06-24T14:26:05+08:00 daily https://www.pharmasources.com/industryinsights/for-seniors-silent-strokes-are-common-po-315101.html 0.6 2026-06-21T06:08:48+08:00 daily https://www.pharmasources.com/industryinsights/staying-optimistic-might-lengthen-your-l-315102.html 0.6 2026-06-24T19:11:21+08:00 daily https://www.pharmasources.com/industryinsights/every-sudden-infant-death-deserves-a-clo-315103.html 0.6 2026-06-26T11:19:00+08:00 daily https://www.pharmasources.com/industryinsights/study-of-skiers-holds-surprises-about-a--315104.html 0.6 2026-07-01T06:23:42+08:00 daily https://www.pharmasources.com/industryinsights/vaping-may-trigger-lung-damage-like-that-315105.html 0.6 2026-07-03T10:25:55+08:00 daily https://www.pharmasources.com/industryinsights/rates-of-palliative-care-rising-for-inpa-315106.html 0.6 2026-06-21T07:20:22+08:00 daily https://www.pharmasources.com/industryinsights/acip-recommendations-updated-for-2019-20-315107.html 0.6 2026-07-23T20:53:15+08:00 daily https://www.pharmasources.com/industryinsights/risk-for-cardiovascular-disease-greater--315108.html 0.6 2026-06-21T05:16:55+08:00 daily https://www.pharmasources.com/industryinsights/liraglutide-ups-risk-for-gallbladder-bil-315109.html 0.6 2026-06-21T22:14:02+08:00 daily https://www.pharmasources.com/industryinsights/postrx-antimicrobial-stewardship-feasibl-315110.html 0.6 2026-06-20T14:41:18+08:00 daily https://www.pharmasources.com/industryinsights/cervical-cancer-vaccine-market-set-to-in-315111.html 0.6 2026-07-18T22:38:21+08:00 daily https://www.pharmasources.com/industryinsights/switzerland-found-to-be-most-innovative--315112.html 0.6 2026-08-10T10:29:14+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-files-lawsuit-against-mylan-315113.html 0.6 2026-07-20T16:55:13+08:00 daily https://www.pharmasources.com/industryinsights/xtandi-treatment-granted-priority-review-315114.html 0.6 2026-07-16T23:00:07+08:00 daily https://www.pharmasources.com/industryinsights/amgen-to-acquire-otezla-for-134-billion--315115.html 0.6 2026-06-20T15:56:29+08:00 daily https://www.pharmasources.com/industryinsights/denovomatrix-introduces-ready-to-use-che-315116.html 0.6 2026-06-21T09:08:13+08:00 daily https://www.pharmasources.com/industryinsights/rfxcel-will-exhibit-at-cphi-middle-east--315117.html 0.6 2026-06-22T09:37:32+08:00 daily https://www.pharmasources.com/industryinsights/novartis-ctl019-applied-for-clinical-tri-315118.html 0.6 2026-08-14T17:17:34+08:00 daily https://www.pharmasources.com/industryinsights/rentschler-fill-solutions-receives-ages--315119.html 0.6 2026-06-22T05:11:04+08:00 daily https://www.pharmasources.com/industryinsights/wcg-introduces-velos-eresearch-express-c-315120.html 0.6 2026-07-04T06:21:03+08:00 daily https://www.pharmasources.com/industryinsights/lilly-receives-fda-approval-for-ankylosi-315121.html 0.6 2026-08-10T10:07:14+08:00 daily https://www.pharmasources.com/industryinsights/harbour-biomed-ppd-to-develop-oncology-a-315122.html 0.6 2026-06-21T13:04:31+08:00 daily https://www.pharmasources.com/industryinsights/mustang-bio-csl-behring-enter-license-ag-315123.html 0.6 2026-03-27T08:32:04+08:00 daily https://www.pharmasources.com/industryinsights/orchestra-biomed-appoints-chief-medical--315124.html 0.6 2026-06-21T04:03:51+08:00 daily https://www.pharmasources.com/industryinsights/vaccitech-appoints-ceo-315125.html 0.6 2026-06-20T20:39:35+08:00 daily https://www.pharmasources.com/industryinsights/ibio-cc-pharming-expand-collaboration-in-315126.html 0.6 2026-06-20T13:19:33+08:00 daily https://www.pharmasources.com/industryinsights/viralgen-receives-cgmp-certification-fro-315127.html 0.6 2026-06-21T20:00:38+08:00 daily https://www.pharmasources.com/industryinsights/ionis-licenses-hepatitis-b-program-to-gs-315128.html 0.6 2026-08-11T16:11:14+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-nourianz-istradefylline-as--315129.html 0.6 2026-06-21T11:14:33+08:00 daily https://www.pharmasources.com/industryinsights/oxycontin-maker-offers-up-to-12-billion--315130.html 0.6 2026-08-08T16:55:34+08:00 daily https://www.pharmasources.com/industryinsights/dea-to-approve-dozens-more-growers-for-m-315131.html 0.6 2026-06-21T12:56:33+08:00 daily https://www.pharmasources.com/industryinsights/lv-hypertrophy-predicts-long-term-risk-f-315132.html 0.6 2026-06-21T05:59:48+08:00 daily https://www.pharmasources.com/industryinsights/uspstf-advises-broader-age-range-for-hep-315133.html 0.6 2026-06-21T14:52:19+08:00 daily https://www.pharmasources.com/industryinsights/decline-in-mortality-rates-for-cardiomet-315134.html 0.6 2026-08-10T15:16:37+08:00 daily https://www.pharmasources.com/industryinsights/can-breast-cancer-be-a-risk-factor-for-o-315135.html 0.6 2026-08-07T02:51:53+08:00 daily https://www.pharmasources.com/industryinsights/even-a-little-drinking-while-pregnant-up-315136.html 0.6 2026-08-07T02:39:59+08:00 daily https://www.pharmasources.com/industryinsights/rising-obesity-rates-undermining-strides-315137.html 0.6 2026-08-07T02:36:48+08:00 daily https://www.pharmasources.com/industryinsights/thousands-of-kidneys-thrown-away-by-us-t-315138.html 0.6 2026-08-07T02:31:02+08:00 daily https://www.pharmasources.com/industryinsights/test-all-us-adults-for-hepatitis-c-exper-315139.html 0.6 2026-08-06T23:55:31+08:00 daily https://www.pharmasources.com/industryinsights/why-adhd-might-raise-the-risk-of-early-d-315140.html 0.6 2026-08-06T23:46:30+08:00 daily https://www.pharmasources.com/industryinsights/polyunsaturated-fatty-acids-have-little--315141.html 0.6 2026-08-06T23:56:06+08:00 daily https://www.pharmasources.com/industryinsights/few-oncologists-suggest-health-promotion-315142.html 0.6 2026-08-07T00:01:53+08:00 daily https://www.pharmasources.com/industryinsights/combo-tx-may-improve-disease-control-for-315143.html 0.6 2026-08-07T00:39:41+08:00 daily https://www.pharmasources.com/industryinsights/prenatal-exposure-to-omt-does-not-worsen-315144.html 0.6 2026-08-07T01:13:52+08:00 daily https://www.pharmasources.com/industryinsights/prices-spike-for-drugs-used-to-treat-mul-315145.html 0.6 2026-08-07T01:18:58+08:00 daily https://www.pharmasources.com/industryinsights/smaller-larger-infarctions-may-escalate--315146.html 0.6 2026-08-14T07:05:42+08:00 daily https://www.pharmasources.com/industryinsights/psoriasis-independently-linked-to-increa-315147.html 0.6 2026-08-07T01:58:57+08:00 daily https://www.pharmasources.com/industryinsights/ct-scan-screen-for-lung-cancer-can-id-sm-315148.html 0.6 2026-08-07T02:05:14+08:00 daily https://www.pharmasources.com/industryinsights/harbour-biomed-ppd-partner-for-oncology--315149.html 0.6 2026-08-07T02:15:45+08:00 daily https://www.pharmasources.com/industryinsights/fda-fast-tracks-astrazenecas-farxiga-315150.html 0.6 2026-08-07T02:21:57+08:00 daily https://www.pharmasources.com/industryinsights/global-neurorehabilitation-devices-marke-315151.html 0.6 2026-08-07T13:15:51+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-add-on-drug-to-treat-pa-315152.html 0.6 2026-08-08T03:08:45+08:00 daily https://www.pharmasources.com/industryinsights/ascletis-receives-ind-approval-for-its-n-315153.html 0.6 2026-08-08T14:47:42+08:00 daily https://www.pharmasources.com/industryinsights/medtec-china-2019-to-inaugurate-on-septe-315154.html 0.6 2026-08-08T20:02:59+08:00 daily https://www.pharmasources.com/industryinsights/kpmg-thermo-fisher-to-work-on-gene-inter-315155.html 0.6 2026-08-08T21:34:34+08:00 daily https://www.pharmasources.com/industryinsights/hemacare-provides-human-derived-biologic-315156.html 0.6 2026-08-09T00:16:03+08:00 daily https://www.pharmasources.com/industryinsights/inex-innovate-offers-precision-healthcar-315157.html 0.6 2026-08-09T02:52:30+08:00 daily https://www.pharmasources.com/industryinsights/hand-held-device-for-predicting-heart-fa-315158.html 0.6 2026-08-09T06:59:48+08:00 daily https://www.pharmasources.com/industryinsights/agilent-completes-acquisition-of-biotek--315159.html 0.6 2026-06-22T12:06:05+08:00 daily https://www.pharmasources.com/industryinsights/abstract-on-ph2-study-of-varlitinib-gets-315160.html 0.6 2026-06-21T10:48:01+08:00 daily https://www.pharmasources.com/industryinsights/studies-shows-critically-ill-patients-us-315161.html 0.6 2026-06-21T05:59:48+08:00 daily https://www.pharmasources.com/industryinsights/adc-therapeutics-freenome-enter-biomarke-315162.html 0.6 2026-06-21T06:12:59+08:00 daily https://www.pharmasources.com/industryinsights/sterling-starts-large-scale-production-o-315163.html 0.6 2026-06-21T16:17:38+08:00 daily https://www.pharmasources.com/industryinsights/alvotech-prestige-biopharma-enter-new-ma-315164.html 0.6 2026-04-25T19:23:33+08:00 daily https://www.pharmasources.com/industryinsights/pci-strengthens-position-in-europe-with--315165.html 0.6 2026-06-20T20:01:43+08:00 daily https://www.pharmasources.com/industryinsights/fda-statement-on-the-agencys-ongoing-eff-315166.html 0.6 2026-08-07T14:44:27+08:00 daily https://www.pharmasources.com/industryinsights/guidelines-updated-for-vaccination-in-mu-315167.html 0.6 2026-06-21T19:46:31+08:00 daily https://www.pharmasources.com/industryinsights/could-red-wine-boost-your-microbiome-315168.html 0.6 2026-06-21T07:03:56+08:00 daily https://www.pharmasources.com/industryinsights/vaccine-related-searches-on-pinterest-wi-315169.html 0.6 2026-06-21T08:54:59+08:00 daily https://www.pharmasources.com/industryinsights/nourianz-approved-to-treat-off-episodes--315170.html 0.6 2026-06-20T23:03:48+08:00 daily https://www.pharmasources.com/industryinsights/regular-vaccines-advised-with-multiple-s-315171.html 0.6 2026-06-21T15:42:03+08:00 daily https://www.pharmasources.com/industryinsights/interactions-discovered-in-cells-insulat-315172.html 0.6 2026-06-21T16:08:34+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-fast-track-designation-for-fa-315173.html 0.6 2026-06-14T15:46:54+08:00 daily https://www.pharmasources.com/industryinsights/a-new-drug-could-revolutionize-the-treat-315174.html 0.6 2026-06-22T11:55:59+08:00 daily https://www.pharmasources.com/industryinsights/breztri-aerosphere-phase-iii-trial-meets-315175.html 0.6 2026-06-21T09:55:05+08:00 daily https://www.pharmasources.com/industryinsights/17-spanish-infants-develop-werewolf-synd-315176.html 0.6 2026-03-18T04:22:51+08:00 daily https://www.pharmasources.com/industryinsights/nice-to-work-with-gw-pharma-on-cannabidi-315177.html 0.6 2026-06-20T16:00:20+08:00 daily https://www.pharmasources.com/industryinsights/licence-extension-submission-accepted-fo-315178.html 0.6 2026-06-21T07:50:11+08:00 daily https://www.pharmasources.com/industryinsights/hrt-shortage-in-uk-expected-to-continue--315179.html 0.6 2026-06-20T18:58:43+08:00 daily https://www.pharmasources.com/industryinsights/drug-makers-file-complaint-for-regulatio-315180.html 0.6 2026-06-20T14:47:04+08:00 daily https://www.pharmasources.com/industryinsights/jj-ordered-to-pay-572m-to-oklahoma-over--315181.html 0.6 2026-06-21T09:04:00+08:00 daily https://www.pharmasources.com/industryinsights/significant-number-of-drugs-on-the-marke-315182.html 0.6 2026-06-21T09:11:13+08:00 daily https://www.pharmasources.com/industryinsights/china-to-relax-generic-drug-import-laws-315183.html 0.6 2026-06-21T22:07:45+08:00 daily https://www.pharmasources.com/industryinsights/transgender-conversion-therapy-common-po-315184.html 0.6 2026-06-26T01:16:20+08:00 daily https://www.pharmasources.com/industryinsights/long-term-night-shift-work-may-up-risk-f-315185.html 0.6 2026-08-14T12:00:15+08:00 daily https://www.pharmasources.com/industryinsights/treatment-guidelines-updated-for-ankylos-315186.html 0.6 2026-08-10T04:42:45+08:00 daily https://www.pharmasources.com/industryinsights/dipeptidyl-peptidase-4-inhibitors-may-up-315187.html 0.6 2026-08-11T17:04:26+08:00 daily https://www.pharmasources.com/industryinsights/salvage-therapy-does-not-up-survival-for-315188.html 0.6 2026-08-07T03:55:13+08:00 daily https://www.pharmasources.com/industryinsights/concussion-symptom-history-tied-to-low-t-315189.html 0.6 2026-08-07T03:34:03+08:00 daily https://www.pharmasources.com/industryinsights/losing-20-lb-improves-knee-replacement-o-315190.html 0.6 2026-08-12T14:20:20+08:00 daily https://www.pharmasources.com/industryinsights/central-obesity-tied-to-cad-in-postmenop-315191.html 0.6 2026-06-22T09:03:45+08:00 daily https://www.pharmasources.com/industryinsights/inex-innovate-offers-precision-healthcar-315192.html 0.6 2026-08-09T18:41:31+08:00 daily https://www.pharmasources.com/industryinsights/eisai-teams-up-with-merck-to-tackle-ntds-315193.html 0.6 2026-06-21T13:11:38+08:00 daily https://www.pharmasources.com/industryinsights/fda-fast-tracks-astrazenecas-farxiga-315194.html 0.6 2026-06-21T09:13:12+08:00 daily https://www.pharmasources.com/industryinsights/pumch-brings-hope-in-rare-diseases-and-s-315195.html 0.6 2026-06-21T08:56:59+08:00 daily https://www.pharmasources.com/industryinsights/novena-global-lifecare-becomes-taiwan-ch-315196.html 0.6 2026-07-19T15:55:47+08:00 daily https://www.pharmasources.com/industryinsights/medtronic-welcomes-new-ceo-315197.html 0.6 2026-06-22T04:54:03+08:00 daily https://www.pharmasources.com/industryinsights/aji-bio-pharma-buys-out-india-joint-vent-315198.html 0.6 2026-06-21T07:15:17+08:00 daily https://www.pharmasources.com/industryinsights/covance-launches-lab-solution-within-fsp-315199.html 0.6 2026-06-20T18:56:05+08:00 daily https://www.pharmasources.com/industryinsights/eton-receives-nda-acceptance-for-oral-li-315200.html 0.6 2026-06-20T14:39:09+08:00 daily https://www.pharmasources.com/industryinsights/esperions-bempedoic-acid-ezetimibe-table-315201.html 0.6 2026-06-21T06:17:04+08:00 daily https://www.pharmasources.com/industryinsights/roches-tecentriqabraxane-combo-for-tnbc--315202.html 0.6 2026-08-12T20:43:46+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-discontinues-rova-t-research-and--315203.html 0.6 2026-08-10T08:36:39+08:00 daily https://www.pharmasources.com/industryinsights/fda-reports-rare-cases-of-liver-injury-f-315204.html 0.6 2026-06-20T20:46:26+08:00 daily https://www.pharmasources.com/industryinsights/us-surgeon-general-warns-of-marijuanas-e-315205.html 0.6 2026-06-21T07:46:59+08:00 daily https://www.pharmasources.com/industryinsights/major-study-gives-women-more-guidance-on-315206.html 0.6 2026-06-21T07:15:22+08:00 daily https://www.pharmasources.com/industryinsights/fda-risk-from-tainted-blood-pressure-dru-315207.html 0.6 2026-06-22T04:53:35+08:00 daily https://www.pharmasources.com/industryinsights/cdc-january-to-july-2018-saw-decrease-in-315208.html 0.6 2026-06-21T20:56:40+08:00 daily https://www.pharmasources.com/industryinsights/who-dramatic-resurgence-of-measles-occur-315209.html 0.6 2026-06-20T16:16:46+08:00 daily https://www.pharmasources.com/industryinsights/there-is-no-gay-gene-major-study-conclud-315210.html 0.6 2026-06-20T21:52:06+08:00 daily https://www.pharmasources.com/industryinsights/exercise-is-good-medicine-for-advanced-c-315211.html 0.6 2026-06-21T06:02:46+08:00 daily https://www.pharmasources.com/industryinsights/for-medicare-patients-costs-of-ms-drugs--315212.html 0.6 2026-06-06T06:38:00+08:00 daily https://www.pharmasources.com/industryinsights/new-anti-cre-antibiotics-used-for-35-per-315213.html 0.6 2026-08-03T01:56:50+08:00 daily https://www.pharmasources.com/industryinsights/hormone-tx-not-tied-to-change-in-muscle--315214.html 0.6 2026-06-22T12:48:17+08:00 daily https://www.pharmasources.com/industryinsights/plasma-marker-may-help-detect-traumatic--315215.html 0.6 2026-06-20T18:17:50+08:00 daily https://www.pharmasources.com/industryinsights/cancer-survivors-face-long-term-cardiova-315216.html 0.6 2026-06-21T04:08:57+08:00 daily https://www.pharmasources.com/industryinsights/2001-to-2016-saw-large-increase-in-mohs--315217.html 0.6 2026-06-20T16:57:48+08:00 daily https://www.pharmasources.com/industryinsights/1984-to-2016-saw-increase-in-age-of-deat-315218.html 0.6 2026-07-18T08:10:20+08:00 daily https://www.pharmasources.com/industryinsights/velabs-therapeutics-enters-into-a-screen-315219.html 0.6 2026-08-08T15:12:29+08:00 daily https://www.pharmasources.com/industryinsights/rfxcel-the-global-leader-in-track-and-tr-315220.html 0.6 2026-08-08T10:02:03+08:00 daily https://www.pharmasources.com/industryinsights/biocity-invests-in-early-stage-precision-315221.html 0.6 2026-08-08T08:39:04+08:00 daily https://www.pharmasources.com/industryinsights/agilent-presents-thought-leader-award-to-315222.html 0.6 2026-08-08T07:49:51+08:00 daily https://www.pharmasources.com/industryinsights/proteona-and-ai-singapore-partner-to-imp-315223.html 0.6 2026-08-07T13:56:12+08:00 daily https://www.pharmasources.com/industryinsights/fitbit-launches-fitbit-premium-new-healt-315224.html 0.6 2026-08-07T13:18:02+08:00 daily https://www.pharmasources.com/industryinsights/invicro-appoints-hidenori-seshimo-as-vic-315225.html 0.6 2026-08-07T03:33:36+08:00 daily https://www.pharmasources.com/industryinsights/half-of-all-safety-warnings-issued-to-dr-315226.html 0.6 2026-08-07T01:19:22+08:00 daily https://www.pharmasources.com/industryinsights/belgiums-ajinomoto-bio-pharma-buys-india-315227.html 0.6 2026-08-07T01:13:56+08:00 daily https://www.pharmasources.com/industryinsights/freudenberg-medical-announces-compendium-315228.html 0.6 2026-08-07T01:19:36+08:00 daily https://www.pharmasources.com/industryinsights/got-high-blood-pressure-get-your-flu-sho-315229.html 0.6 2026-08-10T13:12:46+08:00 daily https://www.pharmasources.com/industryinsights/after-heart-attack-stenting-more-than-th-315230.html 0.6 2026-06-25T09:40:13+08:00 daily https://www.pharmasources.com/industryinsights/how-you-can-help-head-off-alzheimers-dis-315231.html 0.6 2026-06-27T15:23:06+08:00 daily https://www.pharmasources.com/industryinsights/offers-of-viable-deceased-donor-kidneys--315232.html 0.6 2026-06-22T09:59:41+08:00 daily https://www.pharmasources.com/industryinsights/as-lung-injury-cases-rise-cdc-advises-do-315233.html 0.6 2026-08-12T13:37:40+08:00 daily https://www.pharmasources.com/industryinsights/cdc-boosts-efforts-to-fight-congo-ebola--315234.html 0.6 2026-07-28T22:03:18+08:00 daily https://www.pharmasources.com/industryinsights/how-heart-health-factors-may-affect-your-315235.html 0.6 2026-06-21T11:02:13+08:00 daily https://www.pharmasources.com/industryinsights/interest-in-marijuana-cannabinoids-for-p-315236.html 0.6 2026-06-22T04:03:46+08:00 daily https://www.pharmasources.com/industryinsights/massachusetts-communities-at-critical-ri-315237.html 0.6 2026-06-23T03:40:53+08:00 daily https://www.pharmasources.com/industryinsights/netarsudil-lowers-iop-in-glaucoma-ocular-315238.html 0.6 2026-06-21T16:49:49+08:00 daily https://www.pharmasources.com/industryinsights/type-and-timing-of-menopausal-hrt-affect-315239.html 0.6 2026-06-21T06:57:51+08:00 daily https://www.pharmasources.com/industryinsights/cerebrovascular-risk-factors-may-up-risk-315240.html 0.6 2026-06-21T19:45:22+08:00 daily https://www.pharmasources.com/industryinsights/costs-of-reusable-colonoscopes-vary-base-315241.html 0.6 2026-06-30T20:43:08+08:00 daily https://www.pharmasources.com/industryinsights/study-shows-the-potential-to-deliver-imm-315242.html 0.6 2026-08-07T23:37:05+08:00 daily https://www.pharmasources.com/industryinsights/small-molecules-dominate-fda-drug-approv-315243.html 0.6 2026-06-21T10:09:10+08:00 daily https://www.pharmasources.com/industryinsights/fda-announces-expansion-of-generic-impur-315244.html 0.6 2026-08-08T22:48:20+08:00 daily https://www.pharmasources.com/industryinsights/antibody-drug-conjugates-market-to-be-wo-315245.html 0.6 2026-07-28T19:08:57+08:00 daily https://www.pharmasources.com/industryinsights/unique-hydrogel-strategy-aids-the-delive-315246.html 0.6 2026-08-07T04:49:05+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-invests-half-billion-dollars-to-a-315247.html 0.6 2026-08-07T04:36:42+08:00 daily https://www.pharmasources.com/industryinsights/anniversary-of-the-pivotal-re-ly-trial-m-315248.html 0.6 2026-08-07T04:16:08+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2019090-315249.html 0.6 2026-08-07T03:55:06+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-regeneron-score-win-against-amgen-315250.html 0.6 2026-08-07T17:07:27+08:00 daily https://www.pharmasources.com/industryinsights/as-api-production-consolidates-abroad-us-315251.html 0.6 2026-08-07T04:36:52+08:00 daily https://www.pharmasources.com/industryinsights/are-jj-endo-and-allergan-in-line-for-glo-315252.html 0.6 2026-08-07T04:52:49+08:00 daily https://www.pharmasources.com/industryinsights/ajinomoto-bio-pharma-buys-indian-api-pla-315253.html 0.6 2026-08-07T13:16:29+08:00 daily https://www.pharmasources.com/industryinsights/fda-red-flags-liver-risks-for-abbvie-mer-315254.html 0.6 2026-08-09T07:56:34+08:00 daily https://www.pharmasources.com/industryinsights/roches-tecentriq-grabs-i-os-first-europe-315255.html 0.6 2026-07-01T07:35:31+08:00 daily https://www.pharmasources.com/industryinsights/relief-for-sun-pharma-as-regulators-prob-315256.html 0.6 2026-06-21T03:18:00+08:00 daily https://www.pharmasources.com/industryinsights/bayers-market-cap-now-close-to-the-total-315257.html 0.6 2026-08-03T17:49:28+08:00 daily https://www.pharmasources.com/industryinsights/bio-campaign-gathers-pharma-partners-to--315258.html 0.6 2026-06-20T23:58:34+08:00 daily https://www.pharmasources.com/industryinsights/beset-by-lawsuits-and-criticism-in-us-op-315259.html 0.6 2026-06-21T12:15:28+08:00 daily https://www.pharmasources.com/industryinsights/greek-prosecutors-drop-another-inquiry-i-315260.html 0.6 2026-06-22T05:57:37+08:00 daily https://www.pharmasources.com/industryinsights/wham-alexion-investors-sucker-punched-as-315261.html 0.6 2026-07-05T04:01:27+08:00 daily https://www.pharmasources.com/industryinsights/for-men-living-alone-may-mean-poorer-con-315262.html 0.6 2026-06-20T17:57:26+08:00 daily https://www.pharmasources.com/industryinsights/a-prescription-for-medicating-your-child-315263.html 0.6 2026-06-21T12:13:21+08:00 daily https://www.pharmasources.com/industryinsights/lifestyle-may-matter-more-than-your-gene-315264.html 0.6 2026-06-21T05:47:43+08:00 daily https://www.pharmasources.com/industryinsights/multiple-myeloma-treatment-receives-orph-315265.html 0.6 2026-06-21T22:46:51+08:00 daily https://www.pharmasources.com/industryinsights/biologics-and-generics-reported-to-save--315266.html 0.6 2026-07-28T13:24:37+08:00 daily https://www.pharmasources.com/industryinsights/rova-t-programme-discontinued-following--315267.html 0.6 2026-06-20T20:19:12+08:00 daily https://www.pharmasources.com/industryinsights/breast-cancer-can-form-sleeper-cells-aft-315268.html 0.6 2026-06-22T07:59:49+08:00 daily https://www.pharmasources.com/industryinsights/mario-polywka-joins-orbit-discoverys-boa-315269.html 0.6 2025-11-27T05:45:37+08:00 daily https://www.pharmasources.com/industryinsights/aprecia-names-vp-of-medical-clinical-aff-315270.html 0.6 2026-06-20T21:50:36+08:00 daily https://www.pharmasources.com/industryinsights/biomatrix-announces-new-ceo-315271.html 0.6 2026-06-21T05:54:41+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-receives-anda-approval-for-pime-315272.html 0.6 2026-06-20T17:01:20+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-recalls-losartan-potassium-ezetim-315273.html 0.6 2026-06-20T17:59:17+08:00 daily https://www.pharmasources.com/industryinsights/us-district-court-invalidates-amgen-pate-315274.html 0.6 2026-06-20T18:08:22+08:00 daily https://www.pharmasources.com/industryinsights/fda-announces-director-cvm-office-of-res-315275.html 0.6 2026-06-21T06:00:48+08:00 daily https://www.pharmasources.com/industryinsights/potential-new-lupus-treatment-effectivel-315276.html 0.6 2026-08-07T05:07:40+08:00 daily https://www.pharmasources.com/industryinsights/la-jolla-receives-european-commission-ap-315277.html 0.6 2026-08-07T04:57:01+08:00 daily https://www.pharmasources.com/industryinsights/pneumagen-appoints-scientific-advisory-b-315278.html 0.6 2026-08-07T04:49:28+08:00 daily https://www.pharmasources.com/industryinsights/acurx-successfully-completes-ph1-clinica-315279.html 0.6 2026-08-07T04:22:12+08:00 daily https://www.pharmasources.com/industryinsights/aan-issues-guideline-on-vaccines-and-ms-315280.html 0.6 2026-08-07T04:22:04+08:00 daily https://www.pharmasources.com/industryinsights/fda-warns-of-liver-injury-with-mavyret-z-315281.html 0.6 2026-08-13T08:59:48+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-reports-positive-initial--315282.html 0.6 2026-08-07T05:16:16+08:00 daily https://www.pharmasources.com/industryinsights/fasenra-granted-orphan-drug-designation-315283.html 0.6 2026-06-20T18:20:59+08:00 daily https://www.pharmasources.com/industryinsights/gavi-vaccine-alliance-seeks-7-4bn-to-imm-315284.html 0.6 2026-06-27T14:28:33+08:00 daily https://www.pharmasources.com/industryinsights/researchers-find-new-drug-with-promise-f-315285.html 0.6 2026-07-23T10:03:40+08:00 daily https://www.pharmasources.com/industryinsights/springworks-receives-breakthrough-status-315286.html 0.6 2026-08-08T12:02:48+08:00 daily https://www.pharmasources.com/industryinsights/adcendo-secures-loan-to-advance-adcs-for-315287.html 0.6 2026-06-21T01:11:53+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-sle-drug-performs-well-in-p-315288.html 0.6 2026-06-21T14:52:21+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-kyowa-kirins-nourianz-drug--315289.html 0.6 2026-04-29T03:46:16+08:00 daily https://www.pharmasources.com/industryinsights/ec-approves-roches-tecentriq-combination-315290.html 0.6 2026-06-21T20:52:56+08:00 daily https://www.pharmasources.com/industryinsights/venatorx-initiates-enrollment-of-cefepim-315291.html 0.6 2026-06-30T20:31:23+08:00 daily https://www.pharmasources.com/industryinsights/full-use-of-property-amd-automated-media-315292.html 0.6 2026-08-07T03:55:31+08:00 daily https://www.pharmasources.com/industryinsights/evolving-world-of-pharma-distributors-fa-315293.html 0.6 2026-08-14T09:45:15+08:00 daily https://www.pharmasources.com/industryinsights/anti-bcma-autologous-car-t-cells-ct053-r-315294.html 0.6 2026-06-24T11:43:02+08:00 daily https://www.pharmasources.com/industryinsights/ajinomoto-bio-pharma-buys-indian-api-pla-315295.html 0.6 2026-08-06T03:36:55+08:00 daily https://www.pharmasources.com/industryinsights/quantum-leap-in-implantology-magnezix-me-315296.html 0.6 2026-06-20T22:01:47+08:00 daily https://www.pharmasources.com/industryinsights/ibi303-results-for-ankylosing-spondyliti-315297.html 0.6 2026-07-20T11:57:38+08:00 daily https://www.pharmasources.com/industryinsights/ping-an-good-doctor-develops-ai-med-tech-315298.html 0.6 2026-07-30T22:44:58+08:00 daily https://www.pharmasources.com/industryinsights/abbott-unveils-new-detection-platform-in-315299.html 0.6 2026-06-22T12:45:04+08:00 daily https://www.pharmasources.com/industryinsights/itm-dcb-sign-agreement-for-targeted-radi-315300.html 0.6 2026-08-07T14:26:38+08:00 daily https://www.pharmasources.com/industryinsights/alwaleed-philanthropies-invests-5-m-in-g-315301.html 0.6 2026-06-20T21:08:48+08:00 daily https://www.pharmasources.com/industryinsights/himss-asiapac19-to-address-paradigm-shif-315302.html 0.6 2026-06-21T21:34:29+08:00 daily https://www.pharmasources.com/industryinsights/clinigen-to-distribute-etopophos-vepesid-315303.html 0.6 2026-08-07T13:05:52+08:00 daily https://www.pharmasources.com/industryinsights/insilico-medicine-uses-ai-to-transform-d-315304.html 0.6 2026-06-21T05:00:47+08:00 daily https://www.pharmasources.com/industryinsights/nus-ntu-teams-reveal-common-deficiency-i-315305.html 0.6 2026-06-21T02:49:36+08:00 daily https://www.pharmasources.com/industryinsights/metrasens-global-mri-safety-business-get-315306.html 0.6 2026-07-21T23:51:11+08:00 daily https://www.pharmasources.com/industryinsights/celltrion-lonza-sign-contract-to-manufac-315307.html 0.6 2026-06-20T15:57:08+08:00 daily https://www.pharmasources.com/industryinsights/bora-secures-fda-approval-for-cdmo-servi-315308.html 0.6 2026-08-09T01:50:45+08:00 daily https://www.pharmasources.com/industryinsights/biomx-completes-in-house-phage-manufactu-315309.html 0.6 2026-07-29T11:29:32+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-juvderm-voluma-xc-for-mid-f-315310.html 0.6 2026-05-03T02:52:15+08:00 daily https://www.pharmasources.com/industryinsights/esc-guidelines-updated-for-supraventricu-315311.html 0.6 2026-08-13T10:53:31+08:00 daily https://www.pharmasources.com/industryinsights/in-stemi-biodegradable-polymer-sirolimus-315312.html 0.6 2026-04-18T05:26:55+08:00 daily https://www.pharmasources.com/industryinsights/higher-risk-for-noncommunicable-diseases-315313.html 0.6 2026-06-21T11:58:43+08:00 daily https://www.pharmasources.com/industryinsights/officials-say-new-york-city-measles-outb-315314.html 0.6 2026-06-21T20:53:32+08:00 daily https://www.pharmasources.com/industryinsights/uspstf-advises-meds-to-reduce-risk-for-p-315315.html 0.6 2026-06-20T14:35:21+08:00 daily https://www.pharmasources.com/industryinsights/chemotherapy-is-out-of-date-global-chemo-315316.html 0.6 2026-06-21T07:13:04+08:00 daily https://www.pharmasources.com/industryinsights/ultrasonography-helps-differentiate-arth-315317.html 0.6 2026-06-23T07:46:58+08:00 daily https://www.pharmasources.com/industryinsights/complete-revascularization-best-for-stem-315318.html 0.6 2026-06-20T14:56:36+08:00 daily https://www.pharmasources.com/industryinsights/benefit-harm-seen-for-ticagrelor-plus-as-315319.html 0.6 2026-08-08T22:13:33+08:00 daily https://www.pharmasources.com/industryinsights/adolescent-oral-contraceptive-use-tied-t-315320.html 0.6 2026-08-07T06:07:40+08:00 daily https://www.pharmasources.com/industryinsights/evidence-says-antipsychotics-do-not-prev-315321.html 0.6 2026-08-09T01:19:01+08:00 daily https://www.pharmasources.com/industryinsights/mylan-generic-of-lung-cancer-drug-alimta-315322.html 0.6 2026-08-12T12:04:09+08:00 daily https://www.pharmasources.com/industryinsights/endo-and-allergan-settle-opioid-case-ahe-315323.html 0.6 2026-06-26T11:00:16+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-issues-voluntary-recall-for-medic-315324.html 0.6 2026-06-21T17:20:21+08:00 daily https://www.pharmasources.com/industryinsights/chinas-drug-bulk-buy-programme-has-been--315325.html 0.6 2026-06-29T21:06:15+08:00 daily https://www.pharmasources.com/industryinsights/roche-and-spark-therapeutics-inc-announc-315326.html 0.6 2026-06-22T01:07:02+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-fast-tracks-inotrems-nangibotide--315327.html 0.6 2026-06-29T05:29:46+08:00 daily https://www.pharmasources.com/industryinsights/insilico-medicine-develops-new-ai-drug-d-315328.html 0.6 2026-08-12T13:03:41+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-licences-proposed-multiple-sclero-315329.html 0.6 2026-06-04T15:23:16+08:00 daily https://www.pharmasources.com/industryinsights/novartiss-heart-failure-drug-entresto-pr-315330.html 0.6 2026-06-02T18:43:12+08:00 daily https://www.pharmasources.com/industryinsights/emmaus-granted-european-patent-for-l-glu-315331.html 0.6 2026-07-18T02:06:22+08:00 daily https://www.pharmasources.com/industryinsights/sutrovax-receives-carb-x-award-to-group--315332.html 0.6 2026-06-22T07:41:32+08:00 daily https://www.pharmasources.com/industryinsights/ar-105-for-ventilator-associated-pneumon-315333.html 0.6 2026-07-19T20:06:00+08:00 daily https://www.pharmasources.com/industryinsights/merck-grant-to-support-smithsonian-futur-315334.html 0.6 2026-06-21T19:53:43+08:00 daily https://www.pharmasources.com/industryinsights/biolinerx-successfully-completes-dose-es-315335.html 0.6 2026-06-21T12:01:15+08:00 daily https://www.pharmasources.com/industryinsights/kyowa-kirin-gets-fda-nod-for-parkinsons--315336.html 0.6 2026-08-07T15:05:20+08:00 daily https://www.pharmasources.com/industryinsights/hifibio-therapeutics-closes-67-m-series--315337.html 0.6 2026-08-04T10:05:21+08:00 daily https://www.pharmasources.com/industryinsights/chinas-huimei-technology-receives-30-mil-315338.html 0.6 2026-08-04T07:57:46+08:00 daily https://www.pharmasources.com/industryinsights/syntellix-asia-chunli-to-introduce-magne-315339.html 0.6 2026-08-04T05:55:47+08:00 daily https://www.pharmasources.com/industryinsights/japan-looks-out-for-rapidly-growing-asea-315340.html 0.6 2026-06-21T08:03:04+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-apptec-to-expedite-early-drug-disco-315341.html 0.6 2026-06-23T14:55:44+08:00 daily https://www.pharmasources.com/industryinsights/medipharm-labs-forms-multiple-cannabis-s-315342.html 0.6 2026-06-22T10:02:57+08:00 daily https://www.pharmasources.com/industryinsights/mundipharma-cidara-ink-568m-deal-for-ant-315343.html 0.6 2026-06-21T03:18:03+08:00 daily https://www.pharmasources.com/industryinsights/celyad-successfully-produces-cyad-01-wit-315344.html 0.6 2026-06-23T02:58:58+08:00 daily https://www.pharmasources.com/industryinsights/rentschler-biopharma-takes-on-new-projec-315345.html 0.6 2026-06-20T22:46:32+08:00 daily https://www.pharmasources.com/industryinsights/four-pitfalls-to-avoid-when-packaging-in-315346.html 0.6 2026-08-03T08:51:55+08:00 daily https://www.pharmasources.com/industryinsights/california-bill-targets-doctors-who-sell-315347.html 0.6 2026-06-21T03:06:44+08:00 daily https://www.pharmasources.com/industryinsights/postictal-serotonin-levels-associated-wi-315348.html 0.6 2026-08-07T03:22:53+08:00 daily https://www.pharmasources.com/industryinsights/what-works-best-against-varicose-veins-315349.html 0.6 2026-06-29T20:15:27+08:00 daily https://www.pharmasources.com/industryinsights/second-possible-death-reported-in-us-fro-315350.html 0.6 2026-06-20T18:05:24+08:00 daily https://www.pharmasources.com/industryinsights/sacubitril-valsartan-does-not-impact-aor-315351.html 0.6 2026-06-20T20:45:03+08:00 daily https://www.pharmasources.com/industryinsights/esc-guidelines-updated-for-diagnosis-tre-315352.html 0.6 2026-08-11T21:54:25+08:00 daily https://www.pharmasources.com/industryinsights/experimental-drug-works-quickly-on-major-315353.html 0.6 2026-07-18T10:03:35+08:00 daily https://www.pharmasources.com/industryinsights/clues-to-why-epileptic-seizures-can-halt-315354.html 0.6 2026-06-21T10:51:11+08:00 daily https://www.pharmasources.com/industryinsights/us-opioid-prescription-rate-is-7-times-t-315355.html 0.6 2026-06-21T04:52:37+08:00 daily https://www.pharmasources.com/industryinsights/poor-circulation-in-legs-statin-meds-can-315356.html 0.6 2026-06-21T21:14:56+08:00 daily https://www.pharmasources.com/industryinsights/metabolic-surgery-may-reduce-cv-risk-in--315357.html 0.6 2026-06-20T23:18:14+08:00 daily https://www.pharmasources.com/industryinsights/cesarean-section-quality-initiative-cuts-315358.html 0.6 2026-06-21T22:56:40+08:00 daily https://www.pharmasources.com/industryinsights/pakistan-lifts-indian-import-ban-for-ess-315359.html 0.6 2026-07-07T15:35:13+08:00 daily https://www.pharmasources.com/industryinsights/brain-disease-drug-delivery-platform-dev-315360.html 0.6 2026-06-20T01:38:57+08:00 daily https://www.pharmasources.com/industryinsights/warning-issued-to-company-for-selling-un-315361.html 0.6 2026-06-21T10:57:15+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-voretigene-neparvovec-fo-315362.html 0.6 2026-08-08T21:04:21+08:00 daily https://www.pharmasources.com/industryinsights/tagrisso-approved-in-china-as-a-1st-line-315363.html 0.6 2026-08-07T08:22:32+08:00 daily https://www.pharmasources.com/industryinsights/experimental-validation-confirms-the-abi-315364.html 0.6 2026-08-09T04:00:36+08:00 daily https://www.pharmasources.com/industryinsights/impel-neuropharma-announces-last-patient-315365.html 0.6 2026-07-01T20:59:09+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-announces-new-ceo-315366.html 0.6 2026-07-12T06:29:54+08:00 daily https://www.pharmasources.com/industryinsights/amex-pharmacy-issues-voluntary-nationwid-315367.html 0.6 2026-06-21T02:56:37+08:00 daily https://www.pharmasources.com/industryinsights/citius-announces-change-to-primary-endpo-315368.html 0.6 2026-06-21T09:13:12+08:00 daily https://www.pharmasources.com/industryinsights/infinity-announces-start-of-two-ipi-549--315369.html 0.6 2026-06-26T01:36:50+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-presents-positive-results-315370.html 0.6 2026-06-21T06:12:54+08:00 daily https://www.pharmasources.com/industryinsights/vertex-to-buy-semma-therapeutics-for-950-315371.html 0.6 2026-07-27T22:31:28+08:00 daily https://www.pharmasources.com/industryinsights/personalised-cell-therapy-developer-achi-315372.html 0.6 2026-06-21T14:58:28+08:00 daily https://www.pharmasources.com/industryinsights/cidara-and-mundipharma-sign-rezafungin-d-315373.html 0.6 2026-06-23T15:19:36+08:00 daily https://www.pharmasources.com/industryinsights/duke-nus-holds-ageing-and-healthcare-con-315374.html 0.6 2026-07-05T05:29:26+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-evaluates-impact-and-prevention-o-315375.html 0.6 2026-01-17T12:16:22+08:00 daily https://www.pharmasources.com/industryinsights/berkeley-lights-opens-shanghai-location-315376.html 0.6 2026-06-13T12:06:30+08:00 daily https://www.pharmasources.com/industryinsights/eisai-to-develop-cognitive-function-test-315377.html 0.6 2026-06-21T20:50:04+08:00 daily https://www.pharmasources.com/industryinsights/schrdinger-astrazeneca-join-hands-to-acc-315378.html 0.6 2026-06-21T04:18:23+08:00 daily https://www.pharmasources.com/industryinsights/covance-launches-laboratory-data-managem-315379.html 0.6 2026-06-23T02:34:30+08:00 daily https://www.pharmasources.com/industryinsights/viralgen-receives-ema-cgmp-certification-315380.html 0.6 2026-08-12T08:35:38+08:00 daily https://www.pharmasources.com/industryinsights/kpmg-coriell-and-thermo-fisher-collabora-315381.html 0.6 2026-06-21T17:11:32+08:00 daily https://www.pharmasources.com/industryinsights/metrics-appoints-greenville-ops-vp-315382.html 0.6 2026-08-14T23:21:48+08:00 daily https://www.pharmasources.com/industryinsights/catalent-invests-9m-in-new-clinical-supp-315383.html 0.6 2026-06-20T15:12:15+08:00 daily https://www.pharmasources.com/industryinsights/psychedelic-research-center-created-at-j-315384.html 0.6 2026-06-22T01:05:11+08:00 daily https://www.pharmasources.com/industryinsights/cdc-racialethnic-disparities-reported-in-315385.html 0.6 2026-07-23T15:22:22+08:00 daily https://www.pharmasources.com/industryinsights/health-officials-close-in-on-culprit-in--315386.html 0.6 2026-06-21T00:13:59+08:00 daily https://www.pharmasources.com/industryinsights/ptsd-a-risk-factor-for-ovarian-cancer-315387.html 0.6 2026-06-20T14:31:37+08:00 daily https://www.pharmasources.com/industryinsights/colon-cancer-rates-rising-among-the-youn-315388.html 0.6 2026-06-20T23:18:22+08:00 daily https://www.pharmasources.com/industryinsights/even-small-improvements-in-cholesterol-b-315389.html 0.6 2026-06-29T22:55:50+08:00 daily https://www.pharmasources.com/industryinsights/high-post-hospital-death-rate-trails-ebo-315390.html 0.6 2026-06-21T07:51:28+08:00 daily https://www.pharmasources.com/industryinsights/respiratory-virus-vaccine-receives-break-315391.html 0.6 2026-08-04T11:26:56+08:00 daily https://www.pharmasources.com/industryinsights/purdue-pharma-prepares-for-bankruptcy-ah-315392.html 0.6 2026-08-08T23:18:35+08:00 daily https://www.pharmasources.com/industryinsights/china-grants-tagrisso-osimertinib-market-315393.html 0.6 2026-06-21T09:03:06+08:00 daily https://www.pharmasources.com/industryinsights/drug-delivery-improved-through-mesoporou-315394.html 0.6 2026-06-20T21:58:58+08:00 daily https://www.pharmasources.com/industryinsights/white-house-announces-nearly-2-billion-i-315395.html 0.6 2026-03-01T22:33:00+08:00 daily https://www.pharmasources.com/industryinsights/drinking-more-coffee-tied-to-lower-risk--315396.html 0.6 2026-06-21T00:13:53+08:00 daily https://www.pharmasources.com/industryinsights/esc-guidelines-updated-for-managing-cvd--315397.html 0.6 2026-07-31T09:24:18+08:00 daily https://www.pharmasources.com/industryinsights/underused-drug-combo-may-up-survival-in--315398.html 0.6 2026-06-22T09:40:36+08:00 daily https://www.pharmasources.com/industryinsights/decline-in-heart-failure-mortality-rates-315399.html 0.6 2026-03-24T07:51:47+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-announces-global-deal-to-commerci-315400.html 0.6 2026-08-11T18:39:33+08:00 daily https://www.pharmasources.com/industryinsights/algorithm-based-on-response-biology-guid-315401.html 0.6 2026-06-30T15:03:29+08:00 daily https://www.pharmasources.com/industryinsights/position-statement-clarifies-benefits-of-315402.html 0.6 2026-06-21T05:01:46+08:00 daily https://www.pharmasources.com/industryinsights/ocuphire-announces-completion-of-the-fir-315403.html 0.6 2026-07-21T01:51:44+08:00 daily https://www.pharmasources.com/industryinsights/inhibrx-announces-enrollment-of-first-pa-315404.html 0.6 2026-06-22T09:09:49+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-announces-opdivo-gl-315405.html 0.6 2026-08-13T19:15:59+08:00 daily https://www.pharmasources.com/industryinsights/amneal-announces-approval-of-generic-ami-315406.html 0.6 2026-06-20T13:22:38+08:00 daily https://www.pharmasources.com/industryinsights/neuraegis-scientific-founder-awarded-gra-315407.html 0.6 2026-07-30T20:41:40+08:00 daily https://www.pharmasources.com/industryinsights/understanding-biofilm-lifecycle-and-reme-315408.html 0.6 2026-08-14T03:01:05+08:00 daily https://www.pharmasources.com/industryinsights/zyversa-advances-development-of-inflamma-315409.html 0.6 2026-06-20T21:02:37+08:00 daily https://www.pharmasources.com/industryinsights/australia-develops-new-technology-for-ne-315410.html 0.6 2026-06-18T12:08:09+08:00 daily https://www.pharmasources.com/industryinsights/sumitomo-dainippon-inks-strategic-collab-315411.html 0.6 2026-07-03T16:23:18+08:00 daily https://www.pharmasources.com/industryinsights/sanyo-chemical-receives-certification-fo-315412.html 0.6 2026-06-21T14:46:14+08:00 daily https://www.pharmasources.com/industryinsights/duke-nus-holds-conference-on-ageing-and--315413.html 0.6 2026-06-21T08:51:28+08:00 daily https://www.pharmasources.com/industryinsights/beroni-group-jinshui-park-to-develop-ste-315414.html 0.6 2026-06-22T23:32:39+08:00 daily https://www.pharmasources.com/industryinsights/gvk-bio-announces-new-appointment-315415.html 0.6 2026-07-04T19:30:40+08:00 daily https://www.pharmasources.com/industryinsights/bnv-denso-establish-new-medical-iot-firm-315416.html 0.6 2026-08-07T16:02:56+08:00 daily https://www.pharmasources.com/industryinsights/david-mayo-joins-verita-healthcare-as-sa-315417.html 0.6 2026-06-20T18:06:31+08:00 daily https://www.pharmasources.com/industryinsights/hcmed-joins-wuxi-life-science-innovation-315418.html 0.6 2026-08-02T22:42:56+08:00 daily https://www.pharmasources.com/industryinsights/speedx-gets-ce-ivd-nod-for-resistanceplu-315419.html 0.6 2026-06-22T10:02:46+08:00 daily https://www.pharmasources.com/industryinsights/wontechs-holmium-laser-receives-fda-appr-315420.html 0.6 2026-06-23T19:30:51+08:00 daily https://www.pharmasources.com/industryinsights/eisai-launches-antimicrobial-wet-wipes-315421.html 0.6 2026-06-21T11:03:20+08:00 daily https://www.pharmasources.com/industryinsights/amid-zolgensma-crisis-novartis-gets-a-ge-315422.html 0.6 2026-08-05T08:41:43+08:00 daily https://www.pharmasources.com/industryinsights/is-a-soliris-patent-review-that-big-a-th-315423.html 0.6 2026-06-20T16:55:12+08:00 daily https://www.pharmasources.com/industryinsights/potential-buyers-size-up-novartis-site-a-315424.html 0.6 2026-08-03T02:22:27+08:00 daily https://www.pharmasources.com/industryinsights/amgens-aimovig-under-fire-from-lilly-los-315425.html 0.6 2026-06-21T16:02:19+08:00 daily https://www.pharmasources.com/industryinsights/bausch-loses-salix-presidentand-turnarou-315426.html 0.6 2026-06-20T19:50:32+08:00 daily https://www.pharmasources.com/industryinsights/mallinckrodt-investors-stream-for-the-ex-315427.html 0.6 2026-06-20T21:10:48+08:00 daily https://www.pharmasources.com/industryinsights/novartis-selling-manufacturing-site-to-c-315428.html 0.6 2026-07-21T15:58:37+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibbs-opdivo-fails-3rd-s-315429.html 0.6 2026-06-21T02:11:55+08:00 daily https://www.pharmasources.com/industryinsights/in-the-race-for-permanent-fda-chief-shar-315430.html 0.6 2026-02-15T09:09:22+08:00 daily https://www.pharmasources.com/industryinsights/im-quite-frankly-baffled-tevas-235m-over-315431.html 0.6 2026-08-09T21:47:53+08:00 daily https://www.pharmasources.com/industryinsights/takeda-recalls-eye-drug-natpara-but-warn-315432.html 0.6 2026-08-09T23:53:58+08:00 daily https://www.pharmasources.com/industryinsights/emergent-awarded-10-year-hhs-contract-315433.html 0.6 2026-08-07T01:06:36+08:00 daily https://www.pharmasources.com/industryinsights/velesco-pharma-set-for-clinical-manufact-315434.html 0.6 2026-08-07T00:59:08+08:00 daily https://www.pharmasources.com/industryinsights/zyversa-selexis-and-kbi-enter-devt-and-m-315435.html 0.6 2026-08-14T07:20:51+08:00 daily https://www.pharmasources.com/industryinsights/shimadzu-opens-new-mid-atlantic-facility-315436.html 0.6 2026-08-07T00:03:11+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-ofev-nintedanib-for-interst-315437.html 0.6 2026-08-07T00:41:16+08:00 daily https://www.pharmasources.com/industryinsights/world-trade-center-site-exposure-linked--315438.html 0.6 2026-08-07T01:08:31+08:00 daily https://www.pharmasources.com/industryinsights/mammos-may-not-benefit-elderly-women-wit-315439.html 0.6 2026-08-09T15:05:43+08:00 daily https://www.pharmasources.com/industryinsights/scientists-find-biological-link-between--315440.html 0.6 2026-06-21T10:39:04+08:00 daily https://www.pharmasources.com/industryinsights/vitamin-e-oil-might-be-cause-of-vaping-l-315441.html 0.6 2026-06-21T06:04:46+08:00 daily https://www.pharmasources.com/industryinsights/diabetes-control-has-stalled-across-us-315442.html 0.6 2026-06-20T20:10:54+08:00 daily https://www.pharmasources.com/industryinsights/incidence-of-colorectal-cancer-up-in-you-315443.html 0.6 2026-06-21T23:54:43+08:00 daily https://www.pharmasources.com/industryinsights/machine-learning-algorithms-promising-in-315444.html 0.6 2026-06-22T02:39:26+08:00 daily https://www.pharmasources.com/industryinsights/ats-guideline-outlines-lab-tests-for-dia-315445.html 0.6 2026-06-20T14:40:27+08:00 daily https://www.pharmasources.com/industryinsights/1971-to-2017-saw-32-drinking-water-hepat-315446.html 0.6 2026-06-21T09:54:29+08:00 daily https://www.pharmasources.com/industryinsights/psychiatric-disorders-may-up-risk-for-bi-315447.html 0.6 2026-06-20T16:04:27+08:00 daily https://www.pharmasources.com/industryinsights/fosaprepitant-and-decitabine-generics-re-315448.html 0.6 2026-08-07T23:35:48+08:00 daily https://www.pharmasources.com/industryinsights/ema-to-review-picato-after-rise-in-skin--315449.html 0.6 2026-07-05T05:56:12+08:00 daily https://www.pharmasources.com/industryinsights/ec-approves-expanded-use-of-ustekinumab--315450.html 0.6 2026-08-11T19:51:23+08:00 daily https://www.pharmasources.com/industryinsights/korean-pharma-company-alleged-to-have-co-315451.html 0.6 2026-06-21T02:57:45+08:00 daily https://www.pharmasources.com/industryinsights/novadozmsn-labs-receives-fda-clearance-f-315452.html 0.6 2026-07-02T21:19:41+08:00 daily https://www.pharmasources.com/industryinsights/cyxone-explores-orphan-drug-designation--315453.html 0.6 2026-08-07T08:01:05+08:00 daily https://www.pharmasources.com/industryinsights/cantargia-submits-request-for-pre-ind-me-315454.html 0.6 2026-06-20T14:37:43+08:00 daily https://www.pharmasources.com/industryinsights/lillys-pain-clinical-trial-protocol-sele-315455.html 0.6 2026-04-11T03:24:32+08:00 daily https://www.pharmasources.com/industryinsights/takeda-issues-us-recall-of-natpara-315456.html 0.6 2026-06-20T23:14:04+08:00 daily https://www.pharmasources.com/industryinsights/delmar-pharmaceuticals-relocates-headqua-315457.html 0.6 2026-06-21T07:13:04+08:00 daily https://www.pharmasources.com/industryinsights/bnv-denso-establish-new-medical-iot-firm-315458.html 0.6 2026-08-14T13:16:27+08:00 daily https://www.pharmasources.com/industryinsights/hcmed-joins-wuxi-life-science-innovation-315459.html 0.6 2026-07-20T12:54:52+08:00 daily https://www.pharmasources.com/industryinsights/wontechs-holmium-laser-receives-fda-appr-315460.html 0.6 2026-06-21T13:03:31+08:00 daily https://www.pharmasources.com/industryinsights/eisai-launches-antimicrobial-wet-wipes-315461.html 0.6 2026-04-17T00:09:11+08:00 daily https://www.pharmasources.com/industryinsights/speedx-gets-ce-ivd-nod-for-resistanceplu-315462.html 0.6 2026-06-20T19:51:48+08:00 daily https://www.pharmasources.com/industryinsights/thermo-lilly-enter-companion-diagnostic--315463.html 0.6 2026-07-24T09:02:27+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-boehringers-ofev-315464.html 0.6 2026-02-28T15:05:58+08:00 daily https://www.pharmasources.com/industryinsights/two-more-cases-of-eee-virus-confirmed-in-315465.html 0.6 2026-06-20T17:00:19+08:00 daily https://www.pharmasources.com/industryinsights/opioid-maker-purdue-pharma-expected-to-f-315466.html 0.6 2026-02-28T20:44:20+08:00 daily https://www.pharmasources.com/industryinsights/hrt-could-benefit-younger-women-after-hy-315467.html 0.6 2026-06-21T08:59:58+08:00 daily https://www.pharmasources.com/industryinsights/racialethnic-variation-found-in-ed-desti-315468.html 0.6 2026-06-21T11:01:37+08:00 daily https://www.pharmasources.com/industryinsights/treatment-for-very-preterm-infants-may-l-315469.html 0.6 2026-06-22T02:53:42+08:00 daily https://www.pharmasources.com/industryinsights/having-hiv-may-heighten-stroke-risk-315470.html 0.6 2026-06-21T14:56:22+08:00 daily https://www.pharmasources.com/industryinsights/why-weight-gain-often-comes-with-age-315471.html 0.6 2026-06-21T11:48:05+08:00 daily https://www.pharmasources.com/industryinsights/less-tv-more-activity-may-mean-extra-yea-315472.html 0.6 2026-06-20T14:49:01+08:00 daily https://www.pharmasources.com/industryinsights/40-year-study-sees-steady-rise-in-pregna-315473.html 0.6 2026-06-03T04:09:17+08:00 daily https://www.pharmasources.com/industryinsights/lower-systolic-bp-goal-may-cut-risk-for--315474.html 0.6 2026-07-02T17:48:25+08:00 daily https://www.pharmasources.com/industryinsights/retinal-vein-occlusion-linked-to-higher--315475.html 0.6 2026-06-22T06:00:39+08:00 daily https://www.pharmasources.com/industryinsights/model-estimates-effect-of-probiotics-on--315476.html 0.6 2026-06-21T08:00:06+08:00 daily https://www.pharmasources.com/industryinsights/gout-may-up-risk-for-progression-of-chro-315477.html 0.6 2026-06-22T11:12:57+08:00 daily https://www.pharmasources.com/industryinsights/t2dm-risk-reduced-by-75-percent-with-hea-315478.html 0.6 2026-06-20T23:01:41+08:00 daily https://www.pharmasources.com/industryinsights/use-of-pain-reliever-tramadol-may-up-ris-315479.html 0.6 2026-06-20T17:56:23+08:00 daily https://www.pharmasources.com/industryinsights/alternative-viral-delivery-of-gene-thera-315480.html 0.6 2026-08-06T08:01:26+08:00 daily https://www.pharmasources.com/industryinsights/federal-judge-enters-consent-decree-agai-315481.html 0.6 2026-06-20T18:55:49+08:00 daily https://www.pharmasources.com/industryinsights/first-treatment-for-patients-with-rare-l-315482.html 0.6 2026-06-21T10:11:17+08:00 daily https://www.pharmasources.com/industryinsights/new-drug-may-protect-against-memory-loss-315483.html 0.6 2026-06-21T08:00:03+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-fast-track-to-amplyx-for-iv-a-315484.html 0.6 2026-06-20T14:33:02+08:00 daily https://www.pharmasources.com/industryinsights/ridgeback-biotherapeutics-breakthrough-t-315485.html 0.6 2026-08-12T15:23:36+08:00 daily https://www.pharmasources.com/industryinsights/bryostatin-1-study-does-not-meet-primary-315486.html 0.6 2025-12-14T03:40:58+08:00 daily https://www.pharmasources.com/industryinsights/new-data-from-spravato-studies-showed-ra-315487.html 0.6 2026-06-21T11:59:08+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-to-provide-discounted-insul-315488.html 0.6 2026-06-21T10:15:23+08:00 daily https://www.pharmasources.com/industryinsights/ec-expands-label-of-janssens-stelara-to--315489.html 0.6 2026-06-21T15:41:15+08:00 daily https://www.pharmasources.com/industryinsights/ifm-due-signs-immunotherapy-deal-with-no-315490.html 0.6 2026-06-21T04:00:46+08:00 daily https://www.pharmasources.com/industryinsights/sumitomo-dainippon-and-roivant-form-3bn--315491.html 0.6 2026-07-18T09:48:23+08:00 daily https://www.pharmasources.com/industryinsights/nkarta-raises-114m-to-bring-cancer-thera-315492.html 0.6 2026-06-21T08:15:10+08:00 daily https://www.pharmasources.com/industryinsights/kt-corp-unveils-global-epidemic-preventi-315493.html 0.6 2026-06-20T21:55:32+08:00 daily https://www.pharmasources.com/industryinsights/doctor-anywhere-widens-reach-with-new-ag-315494.html 0.6 2026-06-23T21:34:18+08:00 daily https://www.pharmasources.com/industryinsights/insilico-medicine-secures-37m-in-series--315495.html 0.6 2026-06-21T11:05:17+08:00 daily https://www.pharmasources.com/industryinsights/national-centre-for-infectious-diseases--315496.html 0.6 2026-08-02T16:41:44+08:00 daily https://www.pharmasources.com/industryinsights/fda-extends-crada-with-cluepoints-315497.html 0.6 2026-06-21T14:36:14+08:00 daily https://www.pharmasources.com/industryinsights/car-t-for-large-tumors-the-next-frontier-315498.html 0.6 2026-06-21T12:07:44+08:00 daily https://www.pharmasources.com/industryinsights/mallinckrodt-to-sell-cdmo-biovectra-for--315499.html 0.6 2026-06-21T09:49:11+08:00 daily https://www.pharmasources.com/industryinsights/cmab-receives-positive-opinion-following-315500.html 0.6 2026-06-30T01:37:36+08:00 daily https://www.pharmasources.com/industryinsights/irbm-signs-agreement-with-md-anderson-ca-315501.html 0.6 2026-06-20T23:02:43+08:00 daily https://www.pharmasources.com/industryinsights/albemarle-expands-rsm-capabilities-315502.html 0.6 2026-08-15T01:14:20+08:00 daily https://www.pharmasources.com/industryinsights/citryll-lonza-enter-manufacturing-partne-315503.html 0.6 2026-06-21T02:13:50+08:00 daily https://www.pharmasources.com/industryinsights/risk-for-long-term-opioid-use-up-in-hidr-315504.html 0.6 2026-06-21T03:20:09+08:00 daily https://www.pharmasources.com/industryinsights/epa-to-phase-out-chemical-testing-on-mam-315505.html 0.6 2026-06-20T17:14:53+08:00 daily https://www.pharmasources.com/industryinsights/purdue-pharma-tentatively-reaches-settle-315506.html 0.6 2026-08-02T21:56:51+08:00 daily https://www.pharmasources.com/industryinsights/mild-cognitive-impairment-incidence-high-315507.html 0.6 2026-06-22T11:56:18+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-gvoke-glucagon-the-first-re-315508.html 0.6 2026-08-06T00:56:43+08:00 daily https://www.pharmasources.com/industryinsights/vets-with-traumatic-brain-injury-have-hi-315509.html 0.6 2026-06-20T20:06:40+08:00 daily https://www.pharmasources.com/industryinsights/anti-addiction-meds-can-help-teen-opioid-315510.html 0.6 2026-06-21T12:01:10+08:00 daily https://www.pharmasources.com/industryinsights/new-strain-of-strep-causing-cases-of-sca-315511.html 0.6 2025-12-14T04:07:44+08:00 daily https://www.pharmasources.com/industryinsights/full-chemo-doses-may-improve-survival-in-315512.html 0.6 2026-06-24T07:14:26+08:00 daily https://www.pharmasources.com/industryinsights/serum-biomarker-linked-to-brain-atrophy--315513.html 0.6 2026-07-07T04:22:01+08:00 daily https://www.pharmasources.com/industryinsights/mycophenolate-mofetil-does-not-top-mtx-i-315514.html 0.6 2026-06-21T10:03:35+08:00 daily https://www.pharmasources.com/industryinsights/herd-protection-against-oral-hpv-infecti-315515.html 0.6 2026-06-21T08:00:06+08:00 daily https://www.pharmasources.com/industryinsights/california-passes-laws-to-reduce-fake-me-315516.html 0.6 2026-08-09T08:02:16+08:00 daily https://www.pharmasources.com/industryinsights/age-modifies-effects-of-estrogen-therapy-315517.html 0.6 2026-08-07T02:52:27+08:00 daily https://www.pharmasources.com/industryinsights/occasional-napping-linked-to-lower-risk--315518.html 0.6 2026-08-07T02:40:32+08:00 daily https://www.pharmasources.com/industryinsights/greater-height-linked-to-lower-risk-for--315519.html 0.6 2026-08-09T08:25:19+08:00 daily https://www.pharmasources.com/industryinsights/expansion-of-peritoneal-dialysis-feasibl-315520.html 0.6 2026-08-06T23:37:00+08:00 daily https://www.pharmasources.com/industryinsights/metastatic-nsclc-therapy-tepotinib-given-315521.html 0.6 2026-08-06T23:33:16+08:00 daily https://www.pharmasources.com/industryinsights/bacteriostatic-water-recalled-due-to-a-p-315522.html 0.6 2026-08-12T16:28:33+08:00 daily https://www.pharmasources.com/industryinsights/global-lc-ms-market-to-exhibit-cagr-of-6-315523.html 0.6 2026-08-06T23:38:06+08:00 daily https://www.pharmasources.com/industryinsights/scottish-medicines-consortium-approves-k-315524.html 0.6 2026-08-06T23:45:59+08:00 daily https://www.pharmasources.com/industryinsights/microrobot-could-be-used-to-deliver-hype-315525.html 0.6 2026-08-06T23:57:19+08:00 daily https://www.pharmasources.com/industryinsights/fast-track-designation-granted-to-fosman-315526.html 0.6 2026-08-04T14:47:47+08:00 daily https://www.pharmasources.com/industryinsights/jubilant-therapeutics-appoints-president-315527.html 0.6 2026-08-07T01:14:32+08:00 daily https://www.pharmasources.com/industryinsights/advicenne-signs-manufacturing-agreement--315528.html 0.6 2026-08-07T13:18:51+08:00 daily https://www.pharmasources.com/industryinsights/sharps-netherlands-facility-approved-for-315529.html 0.6 2026-08-08T04:30:26+08:00 daily https://www.pharmasources.com/industryinsights/q-biomed-chemveda-form-cancer-collaborat-315530.html 0.6 2026-08-08T07:48:28+08:00 daily https://www.pharmasources.com/industryinsights/cdc-revises-number-of-vaping-linked-lung-315531.html 0.6 2026-08-08T10:10:39+08:00 daily https://www.pharmasources.com/industryinsights/fda-to-assess-first-drug-meant-to-preven-315532.html 0.6 2026-08-08T12:18:55+08:00 daily https://www.pharmasources.com/industryinsights/mci-linked-to-lower-use-of-cardiac-cathe-315533.html 0.6 2026-08-08T14:04:49+08:00 daily https://www.pharmasources.com/industryinsights/zantac-may-contain-small-amounts-of-know-315534.html 0.6 2026-08-08T20:03:05+08:00 daily https://www.pharmasources.com/industryinsights/suicide-rates-increasing-for-male-female-315535.html 0.6 2026-08-09T06:59:20+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-ibsrela-tenapanor-for-the-t-315536.html 0.6 2026-06-27T03:49:22+08:00 daily https://www.pharmasources.com/industryinsights/qualified-pure-nature-products-for-your--315537.html 0.6 2026-06-23T05:02:59+08:00 daily https://www.pharmasources.com/industryinsights/naturalness-and-healthiness-offering-the-315538.html 0.6 2026-07-22T15:00:46+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-nucala-mepolizumab-for-six--315539.html 0.6 2026-08-12T21:55:19+08:00 daily https://www.pharmasources.com/industryinsights/intra-cellular-therapies-provides-lumate-315540.html 0.6 2026-06-21T11:21:30+08:00 daily https://www.pharmasources.com/industryinsights/united-therapeutics-announces-fda-accept-315541.html 0.6 2026-06-21T12:20:56+08:00 daily https://www.pharmasources.com/industryinsights/kidney-transplants-safe-when-donors-had--315542.html 0.6 2026-07-05T04:28:04+08:00 daily https://www.pharmasources.com/industryinsights/is-your-pelvic-pain-a-sign-of-endometrio-315543.html 0.6 2026-06-20T21:02:41+08:00 daily https://www.pharmasources.com/industryinsights/how-to-keep-your-bones-strong-and-preven-315544.html 0.6 2026-08-12T12:49:42+08:00 daily https://www.pharmasources.com/industryinsights/unique-gene-activity-discovered-in-peopl-315545.html 0.6 2026-01-03T07:08:21+08:00 daily https://www.pharmasources.com/industryinsights/prevalence-of-apnea-high-in-individuals--315546.html 0.6 2026-06-21T07:07:04+08:00 daily https://www.pharmasources.com/industryinsights/women-with-heart-attack-do-present-with--315547.html 0.6 2026-06-20T20:51:35+08:00 daily https://www.pharmasources.com/industryinsights/brain-changes-differ-for--amyloid-cerebr-315548.html 0.6 2026-06-21T11:07:19+08:00 daily https://www.pharmasources.com/industryinsights/scientists-use-gene-editing-tool-crispr--315549.html 0.6 2026-06-21T00:16:53+08:00 daily https://www.pharmasources.com/industryinsights/fda-emphasises-need-for-adverse-event-re-315550.html 0.6 2026-06-21T01:46:26+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-regulatory-approval-for-hypog-315551.html 0.6 2026-06-21T01:09:04+08:00 daily https://www.pharmasources.com/industryinsights/germany-imports-largest-ever-shipment-of-315552.html 0.6 2026-06-20T19:54:28+08:00 daily https://www.pharmasources.com/industryinsights/uk-to-launch-seven-data-hubs-to-garner-i-315553.html 0.6 2025-12-14T04:50:51+08:00 daily https://www.pharmasources.com/industryinsights/purdue-reported-to-reach-tentative-agree-315554.html 0.6 2026-06-21T08:16:29+08:00 daily https://www.pharmasources.com/industryinsights/blockchain-technology-in-healthcare-mark-315555.html 0.6 2026-06-21T10:03:10+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-orphan-drug-designation-to-so-315556.html 0.6 2026-07-22T13:48:07+08:00 daily https://www.pharmasources.com/industryinsights/medtronic-novo-nordisk-to-develop-digita-315557.html 0.6 2026-08-05T14:42:02+08:00 daily https://www.pharmasources.com/industryinsights/eisai-biogen-discontinue-clinical-studie-315558.html 0.6 2026-06-23T10:17:46+08:00 daily https://www.pharmasources.com/industryinsights/ntu-designs-molecular-probe-to-track-dis-315559.html 0.6 2026-07-04T13:34:04+08:00 daily https://www.pharmasources.com/industryinsights/novotech-highlights-south-koreas-plans-o-315560.html 0.6 2026-06-21T09:47:18+08:00 daily https://www.pharmasources.com/industryinsights/signant-health-brings-its-econsent-solut-315561.html 0.6 2026-07-10T05:09:11+08:00 daily https://www.pharmasources.com/industryinsights/israels-zebra-inks-pact-with-indias-meds-315562.html 0.6 2026-06-21T06:08:00+08:00 daily https://www.pharmasources.com/industryinsights/cardiac-fibrosis-study-identifies-key-pr-315563.html 0.6 2026-06-20T20:00:35+08:00 daily https://www.pharmasources.com/industryinsights/strekin-ag-completes-patient-recruitment-315564.html 0.6 2026-06-22T05:02:41+08:00 daily https://www.pharmasources.com/industryinsights/shimmer-launches-open-source-initiative--315565.html 0.6 2026-08-09T08:24:53+08:00 daily https://www.pharmasources.com/industryinsights/certara-launches-v82-of-phoenix-pkpd-sim-315566.html 0.6 2026-06-30T14:23:13+08:00 daily https://www.pharmasources.com/industryinsights/astar-jtc-and-science-centre-singapore-o-315567.html 0.6 2026-06-20T22:03:56+08:00 daily https://www.pharmasources.com/industryinsights/apac-lists-in-top-15-nations-with-higher-315568.html 0.6 2026-07-09T11:04:03+08:00 daily https://www.pharmasources.com/industryinsights/china-sxt-pharma-to-establish-rd-for-adv-315569.html 0.6 2026-06-21T11:12:15+08:00 daily https://www.pharmasources.com/industryinsights/pmi-opens-ai-competition-to-develop-impr-315570.html 0.6 2026-06-22T02:58:40+08:00 daily https://www.pharmasources.com/industryinsights/optimized-aed-placement-might-improve-ca-315571.html 0.6 2026-06-21T07:13:03+08:00 daily https://www.pharmasources.com/industryinsights/purdue-files-for-bankruptcy-over-opioid--315572.html 0.6 2026-06-21T14:41:13+08:00 daily https://www.pharmasources.com/industryinsights/new-york-state-to-ban-flavored-e-cigaret-315573.html 0.6 2026-06-21T11:04:12+08:00 daily https://www.pharmasources.com/industryinsights/could-daily-low-dose-aspirin-still-help--315574.html 0.6 2026-08-14T10:56:34+08:00 daily https://www.pharmasources.com/industryinsights/where-womens-health-clinics-close-cervic-315575.html 0.6 2026-06-22T09:55:09+08:00 daily https://www.pharmasources.com/industryinsights/primary-care-faces-challenges-in-caring--315576.html 0.6 2026-06-21T04:52:38+08:00 daily https://www.pharmasources.com/industryinsights/room-for-improvement-found-in-hpv-vaccin-315577.html 0.6 2026-07-30T03:04:38+08:00 daily https://www.pharmasources.com/industryinsights/delaying-treatment-worsens-head-neck-can-315578.html 0.6 2026-04-01T12:51:35+08:00 daily https://www.pharmasources.com/industryinsights/donepezil-ups-risk-for-hospital-admissio-315579.html 0.6 2026-06-22T06:09:42+08:00 daily https://www.pharmasources.com/industryinsights/biopsychosocial-frailty-measure-predicts-315580.html 0.6 2026-06-21T06:18:11+08:00 daily https://www.pharmasources.com/industryinsights/treatment-approved-for-young-children-wi-315581.html 0.6 2026-08-03T10:49:04+08:00 daily https://www.pharmasources.com/industryinsights/ndma-discovered-in-samples-of-ranitidine-315582.html 0.6 2026-06-22T03:43:44+08:00 daily https://www.pharmasources.com/industryinsights/kenya-launches-phased-malaria-vaccine-pi-315583.html 0.6 2026-06-30T22:31:44+08:00 daily https://www.pharmasources.com/industryinsights/gene-targeted-cancer-drugs-slow-release--315584.html 0.6 2026-06-21T02:57:50+08:00 daily https://www.pharmasources.com/industryinsights/roche-presents-new-6-year-ocrevus-ocreli-315585.html 0.6 2026-07-27T16:37:03+08:00 daily https://www.pharmasources.com/industryinsights/abbott-announces-new-data-that-shows-art-315586.html 0.6 2026-06-21T13:09:44+08:00 daily https://www.pharmasources.com/industryinsights/a-promising-treatment-for-an-incurable-d-315587.html 0.6 2026-08-12T15:20:53+08:00 daily https://www.pharmasources.com/industryinsights/ppf-expands-its-investment-in-the-health-315588.html 0.6 2026-06-20T18:59:39+08:00 daily https://www.pharmasources.com/industryinsights/probiogen-licenses-glymaxx-technology-to-315589.html 0.6 2026-08-06T00:11:11+08:00 daily https://www.pharmasources.com/industryinsights/noscendo-reaches-ce-certification-as-key-315590.html 0.6 2026-06-22T10:58:43+08:00 daily https://www.pharmasources.com/industryinsights/seattle-genetics-astellas-announce-fda-g-315591.html 0.6 2026-08-14T23:56:31+08:00 daily https://www.pharmasources.com/industryinsights/darzalex-study-data-show-high-response-r-315592.html 0.6 2026-06-21T20:54:44+08:00 daily https://www.pharmasources.com/industryinsights/gala-therapeutics-receives-fda-breakthro-315593.html 0.6 2026-06-21T22:10:59+08:00 daily https://www.pharmasources.com/industryinsights/eisai-biogen-to-discontinue-elenbecestat-315594.html 0.6 2026-06-21T06:10:49+08:00 daily https://www.pharmasources.com/industryinsights/pertuzumab-trastuzumab-combination-with--315595.html 0.6 2026-06-21T18:10:33+08:00 daily https://www.pharmasources.com/industryinsights/tae-life-sciences-announces-scientific-a-315596.html 0.6 2026-06-21T13:13:13+08:00 daily https://www.pharmasources.com/industryinsights/ai-can-help-scale-up-healthcare-delivery-315597.html 0.6 2026-08-07T14:48:12+08:00 daily https://www.pharmasources.com/industryinsights/saluda-medical-announces-european-commer-315598.html 0.6 2025-12-14T05:41:26+08:00 daily https://www.pharmasources.com/industryinsights/aia-promotes-sleep-sufficiency-and-quali-315599.html 0.6 2026-06-21T07:43:49+08:00 daily https://www.pharmasources.com/industryinsights/covance-unveils-new-rd-center-in-shangha-315600.html 0.6 2026-08-06T13:55:33+08:00 daily https://www.pharmasources.com/industryinsights/astellas-iota-biosciences-enter-into-col-315601.html 0.6 2026-06-22T05:47:57+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-abbott-team-up-to-enhance-diabete-315602.html 0.6 2026-06-21T02:06:46+08:00 daily https://www.pharmasources.com/industryinsights/lipac-huons-ink-licensing-deal-for-bladd-315603.html 0.6 2026-08-07T08:13:47+08:00 daily https://www.pharmasources.com/industryinsights/mitsubishi-tanabe-daiichi-sankyo-tie-all-315604.html 0.6 2026-07-09T19:20:08+08:00 daily https://www.pharmasources.com/industryinsights/sgs-appoints-global-clinical-ops-directo-315605.html 0.6 2026-01-30T23:00:29+08:00 daily https://www.pharmasources.com/industryinsights/cmc-pharmaceuticals-launches-cgmp-lab-se-315606.html 0.6 2026-06-20T23:14:58+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-treatments-for-opioid-abu-315607.html 0.6 2026-06-21T05:49:34+08:00 daily https://www.pharmasources.com/industryinsights/physical-therapy-and-surgery-reduce-mixe-315608.html 0.6 2026-06-22T11:47:47+08:00 daily https://www.pharmasources.com/industryinsights/doubt-over-long-term-use-of-hormone-rx-f-315609.html 0.6 2026-06-22T12:10:04+08:00 daily https://www.pharmasources.com/industryinsights/radiation-rx-might-ease-a-dangerous-irre-315610.html 0.6 2026-06-20T15:58:38+08:00 daily https://www.pharmasources.com/industryinsights/hysterectomy-tied-to-depression-anxiety-315611.html 0.6 2026-07-06T21:48:18+08:00 daily https://www.pharmasources.com/industryinsights/vitamin-d-is-good-for-the-bones-but-what-315612.html 0.6 2026-06-20T16:22:00+08:00 daily https://www.pharmasources.com/industryinsights/prenatal-postnatal-exposures-tied-to-blo-315613.html 0.6 2026-06-20T17:01:19+08:00 daily https://www.pharmasources.com/industryinsights/headache-from-epidural-for-labor-may-up--315614.html 0.6 2026-08-09T21:28:38+08:00 daily https://www.pharmasources.com/industryinsights/high-risk-antibiotic-use-linked-to-hospi-315615.html 0.6 2026-08-07T18:53:11+08:00 daily https://www.pharmasources.com/industryinsights/men-less-knowledgeable-about-hpv-hpv-vac-315616.html 0.6 2026-06-21T16:07:27+08:00 daily https://www.pharmasources.com/industryinsights/combo-antithrombotic-therapy-increases-b-315617.html 0.6 2026-06-21T00:09:54+08:00 daily https://www.pharmasources.com/industryinsights/off-label-ordering-of-systemic-drugs-up--315618.html 0.6 2026-08-06T23:32:34+08:00 daily https://www.pharmasources.com/industryinsights/initiating-empirical-tx-for-sepsis-reduc-315619.html 0.6 2026-08-06T23:48:44+08:00 daily https://www.pharmasources.com/industryinsights/demand-for-containment-facilities-and-ma-315620.html 0.6 2026-08-07T05:31:21+08:00 daily https://www.pharmasources.com/industryinsights/fast-track-designation-given-to-heart-fa-315621.html 0.6 2026-08-06T20:07:40+08:00 daily https://www.pharmasources.com/industryinsights/new-flu-patch-could-lead-to-needle-free--315622.html 0.6 2026-08-06T19:23:13+08:00 daily https://www.pharmasources.com/industryinsights/ema-to-provide-guidance-on-avoiding-nitr-315623.html 0.6 2026-02-28T16:36:56+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-fast-track-designation-for-fa-315624.html 0.6 2026-08-06T23:46:57+08:00 daily https://www.pharmasources.com/industryinsights/fda-takes-first-action-under-new-interna-315625.html 0.6 2026-08-06T23:55:19+08:00 daily https://www.pharmasources.com/industryinsights/polyganics-achieves-positive-3-month-fol-315626.html 0.6 2026-08-07T02:31:01+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-receives-orphan-drug-designatio-315627.html 0.6 2026-08-07T02:36:50+08:00 daily https://www.pharmasources.com/industryinsights/janssen-submits-tremfya-application-to-f-315628.html 0.6 2026-08-09T17:31:42+08:00 daily https://www.pharmasources.com/industryinsights/syqe-signs-pact-with-terrascend-for-medi-315629.html 0.6 2026-06-21T21:00:46+08:00 daily https://www.pharmasources.com/industryinsights/3m-and-mmodal-combine-advanced-technolog-315630.html 0.6 2026-06-21T08:06:01+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-breakthrough-therapy-designat-315631.html 0.6 2026-06-21T12:01:17+08:00 daily https://www.pharmasources.com/industryinsights/medtech-innovator-selects-20-best-in-cla-315632.html 0.6 2026-06-20T16:15:07+08:00 daily https://www.pharmasources.com/industryinsights/ping-an-invests-15m-to-advance-ai-in-hea-315633.html 0.6 2026-08-07T21:44:34+08:00 daily https://www.pharmasources.com/industryinsights/mitsubishi-tanabe-daiichi-sankyo-tie-all-315634.html 0.6 2026-08-09T20:47:37+08:00 daily https://www.pharmasources.com/industryinsights/lipac-huons-ink-licensing-deal-for-bladd-315635.html 0.6 2026-06-21T04:10:55+08:00 daily https://www.pharmasources.com/industryinsights/adalta-secures-licensing-deal-for-i-body-315636.html 0.6 2026-06-21T05:14:54+08:00 daily https://www.pharmasources.com/industryinsights/pse-plans-to-become-part-of-siemens-315637.html 0.6 2026-06-22T05:13:02+08:00 daily https://www.pharmasources.com/industryinsights/avita-medical-receives-us-fda-investigat-315638.html 0.6 2026-06-20T18:54:40+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-priority-review-for-mercks-eb-315639.html 0.6 2026-06-21T11:07:14+08:00 daily https://www.pharmasources.com/industryinsights/seattle-genetics-astellas-gets-usfda-pri-315640.html 0.6 2026-06-23T07:57:59+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-receives-orphan-drug-designatio-315641.html 0.6 2026-07-30T14:28:21+08:00 daily https://www.pharmasources.com/industryinsights/almac-participates-in-global-clinical-su-315642.html 0.6 2026-06-20T20:17:11+08:00 daily https://www.pharmasources.com/industryinsights/3p-biopharmaceuticals-receives-fda-appro-315643.html 0.6 2026-08-13T08:01:05+08:00 daily https://www.pharmasources.com/industryinsights/colorcon-launches-50m-venture-capital-fu-315644.html 0.6 2026-06-23T01:16:23+08:00 daily https://www.pharmasources.com/industryinsights/covance-unveils-new-rd-center-in-shangha-315645.html 0.6 2026-06-21T03:53:39+08:00 daily https://www.pharmasources.com/industryinsights/anemia-in-early-pregnancy-may-harm-child-315646.html 0.6 2026-04-24T08:34:48+08:00 daily https://www.pharmasources.com/industryinsights/126-million-in-us-could-benefit-from-tx--315647.html 0.6 2026-06-20T23:51:05+08:00 daily https://www.pharmasources.com/industryinsights/all-in-one-pill-helps-protect-heart-315648.html 0.6 2026-06-24T02:21:06+08:00 daily https://www.pharmasources.com/industryinsights/tiny-genetic-tweak-may-stop-ebola-virus--315649.html 0.6 2026-06-21T05:02:44+08:00 daily https://www.pharmasources.com/industryinsights/c-section-delivery-might-alter-newborns--315650.html 0.6 2026-06-20T16:55:11+08:00 daily https://www.pharmasources.com/industryinsights/opioid-epidemic-tied-to-doubling-of-dang-315651.html 0.6 2026-08-09T05:41:12+08:00 daily https://www.pharmasources.com/industryinsights/electronic-nose-analysis-may-predict-res-315652.html 0.6 2026-08-09T04:32:14+08:00 daily https://www.pharmasources.com/industryinsights/four-modifiable-risk-factors-tied-to-hyp-315653.html 0.6 2026-08-08T04:35:31+08:00 daily https://www.pharmasources.com/industryinsights/migraines-linked-to-higher-risk-for-deme-315654.html 0.6 2026-08-07T15:07:26+08:00 daily https://www.pharmasources.com/industryinsights/hysterectomy-tied-to-long-term-risk-for--315655.html 0.6 2026-08-07T13:18:44+08:00 daily https://www.pharmasources.com/industryinsights/2002-to-2016-saw-rise-in-drug-abuse-link-315656.html 0.6 2026-08-06T23:47:42+08:00 daily https://www.pharmasources.com/industryinsights/pharmacist-in-ed-cuts-time-to-tx-to-reve-315657.html 0.6 2026-08-06T23:37:22+08:00 daily https://www.pharmasources.com/industryinsights/diabetes-distress-common-at-large-midwes-315658.html 0.6 2026-06-20T16:11:45+08:00 daily https://www.pharmasources.com/industryinsights/aortic-mitral-regurgitation-risk-up-with-315659.html 0.6 2026-08-06T20:08:42+08:00 daily https://www.pharmasources.com/industryinsights/collaborative-oncology-drugs-review-init-315660.html 0.6 2026-07-28T14:18:13+08:00 daily https://www.pharmasources.com/industryinsights/mhra-updates-biologic-quality-guidance-d-315661.html 0.6 2026-08-06T23:32:29+08:00 daily https://www.pharmasources.com/industryinsights/multiple-myeloma-treatment-granted-orpha-315662.html 0.6 2026-08-06T23:37:39+08:00 daily https://www.pharmasources.com/industryinsights/cosentyx-secukinumab-meets-clinical-tria-315663.html 0.6 2026-08-06T23:45:55+08:00 daily https://www.pharmasources.com/industryinsights/alexion-announces-cfo-succession-315664.html 0.6 2026-08-06T23:55:23+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-fast-track-designation-for-me-315665.html 0.6 2026-08-07T00:01:52+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-accelerated-approval-for-pemb-315666.html 0.6 2026-08-07T00:39:44+08:00 daily https://www.pharmasources.com/industryinsights/bookdoc-gears-up-for-further-recognition-315667.html 0.6 2026-08-07T00:52:52+08:00 daily https://www.pharmasources.com/industryinsights/smart-announces-revolutionary-tech-in-ce-315668.html 0.6 2026-06-21T15:39:13+08:00 daily https://www.pharmasources.com/industryinsights/parexel-expands-ph-i-research-capabiliti-315669.html 0.6 2026-08-07T01:06:40+08:00 daily https://www.pharmasources.com/industryinsights/toyobo-to-market-rna-analysis-kit-based--315670.html 0.6 2026-06-21T03:52:51+08:00 daily https://www.pharmasources.com/industryinsights/ping-an-good-doctor-partners-with-govt-o-315671.html 0.6 2026-08-07T06:07:08+08:00 daily https://www.pharmasources.com/industryinsights/ironwood-pharmaceuticals-and-astrazeneca-315672.html 0.6 2026-08-06T23:50:21+08:00 daily https://www.pharmasources.com/industryinsights/ibio-azargen-biotechnologies-expand-mfg--315673.html 0.6 2026-08-06T23:46:47+08:00 daily https://www.pharmasources.com/industryinsights/qps-expands-global-footprint-315674.html 0.6 2026-08-06T23:56:01+08:00 daily https://www.pharmasources.com/industryinsights/cdc-valley-fever-cases-increased-from-20-315675.html 0.6 2026-08-14T19:39:38+08:00 daily https://www.pharmasources.com/industryinsights/rates-of-diabetes-higher-at-lower-bmis-a-315676.html 0.6 2026-06-21T22:01:39+08:00 daily https://www.pharmasources.com/industryinsights/house-speaker-unveils-plan-to-lower-drug-315677.html 0.6 2026-07-01T01:26:54+08:00 daily https://www.pharmasources.com/industryinsights/maker-halts-distribution-of-generic-zant-315678.html 0.6 2026-04-18T00:34:19+08:00 daily https://www.pharmasources.com/industryinsights/cdc-cases-of-vaping-linked-lung-illness--315679.html 0.6 2026-07-17T00:33:02+08:00 daily https://www.pharmasources.com/industryinsights/hysterectomy-procedure-tied-to-worse-can-315680.html 0.6 2026-03-18T08:40:01+08:00 daily https://www.pharmasources.com/industryinsights/opioid-prescriptions-for-eye-surgery-pat-315681.html 0.6 2026-06-21T02:53:32+08:00 daily https://www.pharmasources.com/industryinsights/keeping-blood-sugar-steady-helps-you-liv-315682.html 0.6 2026-08-07T02:18:21+08:00 daily https://www.pharmasources.com/industryinsights/scientists-discover-new-way-fat-harms-yo-315683.html 0.6 2026-08-10T03:48:24+08:00 daily https://www.pharmasources.com/industryinsights/for-people-at-high-risk-evidence-that-ex-315684.html 0.6 2026-08-04T07:25:30+08:00 daily https://www.pharmasources.com/industryinsights/these-diets-helped-women-with-diabetes-c-315685.html 0.6 2026-06-16T09:46:07+08:00 daily https://www.pharmasources.com/industryinsights/increasing-dtp3-coverage-tied-to-drop-in-315686.html 0.6 2026-06-21T12:12:41+08:00 daily https://www.pharmasources.com/industryinsights/few-trauma-patients-assessed-for-effects-315687.html 0.6 2026-08-07T01:04:21+08:00 daily https://www.pharmasources.com/industryinsights/linagliptin-noninferior-for-cv-risk-in-e-315688.html 0.6 2026-06-20T20:02:42+08:00 daily https://www.pharmasources.com/industryinsights/cv-risk-lower-with-metformin-in-t2dm-red-315689.html 0.6 2026-02-15T14:29:56+08:00 daily https://www.pharmasources.com/industryinsights/vaginal-mesh-hysteropexy-no-better-for-u-315690.html 0.6 2026-06-22T09:48:40+08:00 daily https://www.pharmasources.com/industryinsights/frailty-assessment-may-aid-liver-transpl-315691.html 0.6 2026-08-11T22:11:26+08:00 daily https://www.pharmasources.com/industryinsights/astro-issues-guideline-for-radiation-tx--315692.html 0.6 2026-08-04T20:15:33+08:00 daily https://www.pharmasources.com/industryinsights/new-cancer-drugs-approvals-underpinned-b-315693.html 0.6 2026-06-21T05:00:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-biologics-license-applicatio-315694.html 0.6 2026-08-04T20:45:58+08:00 daily https://www.pharmasources.com/industryinsights/hereditary-angioedema-treatment-recommen-315695.html 0.6 2026-06-21T22:26:16+08:00 daily https://www.pharmasources.com/industryinsights/company-sues-fda-over-rejecting-opioids--315696.html 0.6 2026-08-02T07:58:53+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-amends-collaboration-with-ir-315697.html 0.6 2026-08-06T02:58:10+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-combo-drug-to-treat-endomet-315698.html 0.6 2026-06-21T18:55:45+08:00 daily https://www.pharmasources.com/industryinsights/well-rebels-launches-retreats-and-wellne-315699.html 0.6 2026-08-02T19:40:54+08:00 daily https://www.pharmasources.com/industryinsights/certara-launches-hasharc-healthcare-dapp-315700.html 0.6 2026-08-06T07:17:15+08:00 daily https://www.pharmasources.com/industryinsights/wcg-kmr-group-invites-biopharma-companie-315701.html 0.6 2026-08-03T21:28:59+08:00 daily https://www.pharmasources.com/industryinsights/fresenius-medical-care-launches-new-dial-315702.html 0.6 2026-08-09T02:18:35+08:00 daily https://www.pharmasources.com/industryinsights/hong-leong-group-tpg-to-acquire-columbia-315703.html 0.6 2026-08-07T18:18:10+08:00 daily https://www.pharmasources.com/industryinsights/nus-team-develops-anti-cancer-drug-with--315704.html 0.6 2026-08-07T09:39:33+08:00 daily https://www.pharmasources.com/industryinsights/cphi-korea-reports-huge-boom-in-korean-p-315705.html 0.6 2026-08-01T11:40:50+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-launches-health-innovation-h-315706.html 0.6 2026-08-12T20:46:29+08:00 daily https://www.pharmasources.com/industryinsights/aslan-presents-ph2-study-data-for-varlit-315707.html 0.6 2026-08-01T11:13:44+08:00 daily https://www.pharmasources.com/industryinsights/ampac-fine-chemicals-sk-biotek-become-ne-315708.html 0.6 2026-08-01T13:27:08+08:00 daily https://www.pharmasources.com/industryinsights/vetters-chicago-site-wins-award-315709.html 0.6 2026-06-21T04:01:47+08:00 daily https://www.pharmasources.com/industryinsights/pci-unveils-clinical-center-of-excellenc-315710.html 0.6 2026-07-30T16:54:33+08:00 daily https://www.pharmasources.com/industryinsights/colorectal-cancer-mortality-disparities--315711.html 0.6 2026-06-21T15:50:22+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-rybelsus-semaglutide-the-fi-315712.html 0.6 2026-07-29T07:08:09+08:00 daily https://www.pharmasources.com/industryinsights/kidney-donation-linked-to-increased-hype-315713.html 0.6 2026-06-21T16:55:03+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-erleada-apalutamide-for-the-315714.html 0.6 2026-06-21T00:41:30+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-keytruda-pembrolizumab-plus-315715.html 0.6 2026-06-21T11:38:59+08:00 daily https://www.pharmasources.com/industryinsights/vertical-pharmaceuticals-llc-an-osmotica-315716.html 0.6 2026-07-15T23:11:17+08:00 daily https://www.pharmasources.com/industryinsights/cdc-asthma-visit-rates-decreased-from-20-315717.html 0.6 2026-06-21T06:07:57+08:00 daily https://www.pharmasources.com/industryinsights/sertraline-does-not-reduce-depressive-sy-315718.html 0.6 2026-06-21T23:51:50+08:00 daily https://www.pharmasources.com/industryinsights/rate-of-opioid-rx-increasing-for-incisio-315719.html 0.6 2026-06-20T22:54:30+08:00 daily https://www.pharmasources.com/industryinsights/cardiovascular-disease-risk-underestimat-315720.html 0.6 2026-06-20T17:53:33+08:00 daily https://www.pharmasources.com/industryinsights/sglt2-inhibitors-linked-to-lower-risk-fo-315721.html 0.6 2026-08-13T08:02:32+08:00 daily https://www.pharmasources.com/industryinsights/treatment-for-dialysis-patients-with-ckd-315722.html 0.6 2026-07-29T02:47:23+08:00 daily https://www.pharmasources.com/industryinsights/two-lots-of-quinacrine-recalled-due-to-l-315723.html 0.6 2026-08-03T05:52:13+08:00 daily https://www.pharmasources.com/industryinsights/drones-set-to-deliver-drugs-to-remote-pa-315724.html 0.6 2026-08-09T10:30:48+08:00 daily https://www.pharmasources.com/industryinsights/dengue-virus-becoming-resistant-to-vacci-315725.html 0.6 2026-07-28T20:24:15+08:00 daily https://www.pharmasources.com/industryinsights/mimetas-chairman-of-the-board-herbert-he-315726.html 0.6 2026-08-09T12:12:37+08:00 daily https://www.pharmasources.com/industryinsights/schizophrenia-clinical-research-receives-315727.html 0.6 2026-06-21T23:43:35+08:00 daily https://www.pharmasources.com/industryinsights/emmaus-life-sciences-announces-withdrawa-315728.html 0.6 2026-06-20T22:38:28+08:00 daily https://www.pharmasources.com/industryinsights/hovione-announces-successful-end-of-phas-315729.html 0.6 2026-06-22T02:54:45+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-orphan-drug-designation-to-re-315730.html 0.6 2026-06-24T05:51:19+08:00 daily https://www.pharmasources.com/industryinsights/pifeltro-delstrigo-receive-fda-approval--315731.html 0.6 2026-08-13T19:58:23+08:00 daily https://www.pharmasources.com/industryinsights/spruce-biosciences-announces-positive-re-315732.html 0.6 2026-02-28T13:36:26+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2019092-315733.html 0.6 2026-08-09T03:07:10+08:00 daily https://www.pharmasources.com/industryinsights/eisai-mylan-to-promote-anti-cancer-drug--315734.html 0.6 2026-07-22T20:01:27+08:00 daily https://www.pharmasources.com/industryinsights/takeda-receives-ministry-approval-for-de-315735.html 0.6 2026-08-11T03:13:13+08:00 daily https://www.pharmasources.com/industryinsights/luye-medical-cleveland-clinic-to-build-u-315736.html 0.6 2026-08-06T01:56:19+08:00 daily https://www.pharmasources.com/industryinsights/wireless-ultrasound-and-ai-to-auto-detec-315737.html 0.6 2026-06-25T11:54:36+08:00 daily https://www.pharmasources.com/industryinsights/fusionex-and-imu-integrate-big-data-anal-315738.html 0.6 2026-08-09T07:56:24+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-diagnostics-opens-first-research-fa-315739.html 0.6 2026-08-08T10:13:48+08:00 daily https://www.pharmasources.com/industryinsights/eisai-meiji-receive-approval-for-parkins-315740.html 0.6 2026-08-08T07:57:40+08:00 daily https://www.pharmasources.com/industryinsights/kao-named-to-the-dow-jones-sustainabilit-315741.html 0.6 2026-08-07T13:17:18+08:00 daily https://www.pharmasources.com/industryinsights/genscript-partners-with-harvard-to-devel-315742.html 0.6 2026-08-07T12:03:19+08:00 daily https://www.pharmasources.com/industryinsights/pii-to-manufacture-fda-approved-hormone--315743.html 0.6 2026-08-06T23:46:48+08:00 daily https://www.pharmasources.com/industryinsights/common-antidepressants-may-work-in-unexp-315744.html 0.6 2026-08-06T23:38:12+08:00 daily https://www.pharmasources.com/industryinsights/high-intensity-surveillance-of-colorecta-315745.html 0.6 2026-08-06T23:36:16+08:00 daily https://www.pharmasources.com/industryinsights/extinct-human-species-passed-on-powerful-315746.html 0.6 2026-08-06T20:05:27+08:00 daily https://www.pharmasources.com/industryinsights/yo-yoing-blood-pressure-could-be-bad-for-315747.html 0.6 2026-08-06T23:45:04+08:00 daily https://www.pharmasources.com/industryinsights/can-aspirin-help-tackle-some-cancers-315748.html 0.6 2026-08-06T23:48:19+08:00 daily https://www.pharmasources.com/industryinsights/guideline-updated-for-prevention-managem-315749.html 0.6 2026-08-06T23:56:35+08:00 daily https://www.pharmasources.com/industryinsights/higher-mortality-seen-for-male-breast-ca-315750.html 0.6 2026-08-07T00:02:43+08:00 daily https://www.pharmasources.com/industryinsights/higher-fat-mass-may-up-risk-for-major-ad-315751.html 0.6 2026-08-07T00:15:38+08:00 daily https://www.pharmasources.com/industryinsights/dapagliflozin-lowers-risk-for-worsening--315752.html 0.6 2026-08-07T22:36:48+08:00 daily https://www.pharmasources.com/industryinsights/emergency-departments-need-to-up-hiv-tes-315753.html 0.6 2026-06-23T01:59:19+08:00 daily https://www.pharmasources.com/industryinsights/astro-nsaids-may-offer-benefit-to-head-n-315754.html 0.6 2026-06-21T21:00:40+08:00 daily https://www.pharmasources.com/industryinsights/more-aggressive-tx-needed-for-familial-h-315755.html 0.6 2026-06-20T20:55:03+08:00 daily https://www.pharmasources.com/industryinsights/first-oral-glp-1-treatment-for-type-2-di-315756.html 0.6 2026-08-03T14:04:25+08:00 daily https://www.pharmasources.com/industryinsights/partnership-between-the-bp-and-usp-to-be-315757.html 0.6 2026-06-20T17:03:17+08:00 daily https://www.pharmasources.com/industryinsights/drc-announces-plans-to-use-second-ebola--315759.html 0.6 2026-06-20T19:01:35+08:00 daily https://www.pharmasources.com/industryinsights/phoenix-molecular-designs-receives-fda-c-315760.html 0.6 2026-06-20T13:58:04+08:00 daily https://www.pharmasources.com/industryinsights/amydis-awarded-nih-grant-for-cerebral-am-315761.html 0.6 2026-06-21T16:17:32+08:00 daily https://www.pharmasources.com/industryinsights/akcea-announces-ceo-transition-elects-tw-315762.html 0.6 2026-06-20T19:54:36+08:00 daily https://www.pharmasources.com/industryinsights/fda-statement-on-efforts-to-increase-ava-315763.html 0.6 2026-08-13T10:09:51+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-and-inflammasome-to-develop-r-315764.html 0.6 2026-06-21T21:31:06+08:00 daily https://www.pharmasources.com/industryinsights/study-finds-onion-and-garlic-consumption-315765.html 0.6 2026-06-21T13:16:12+08:00 daily https://www.pharmasources.com/industryinsights/powder-flowthe-importance-of-a-sachet-fi-315766.html 0.6 2026-08-08T11:24:33+08:00 daily https://www.pharmasources.com/industryinsights/proteona-oncology-challenge-using-escape-315767.html 0.6 2026-06-21T10:20:45+08:00 daily https://www.pharmasources.com/industryinsights/optima-innovations-to-provide-solutions--315768.html 0.6 2026-03-13T21:59:30+08:00 daily https://www.pharmasources.com/industryinsights/dornier-launches-optivision-for-urology--315769.html 0.6 2026-06-21T11:03:13+08:00 daily https://www.pharmasources.com/industryinsights/researchers-pinpoint-cells-processes-tha-315770.html 0.6 2026-06-20T14:03:13+08:00 daily https://www.pharmasources.com/industryinsights/saudi-ministry-of-health-launches-adaa-h-315771.html 0.6 2026-06-21T07:17:08+08:00 daily https://www.pharmasources.com/industryinsights/biocon-biologics-expands-rd-footprint-315772.html 0.6 2026-06-21T02:46:48+08:00 daily https://www.pharmasources.com/industryinsights/eisai-meiji-receive-approval-for-parkins-315773.html 0.6 2026-07-06T22:11:51+08:00 daily https://www.pharmasources.com/industryinsights/rafael-pharma-expands-ph-3-trial-of-canc-315774.html 0.6 2026-06-21T08:50:26+08:00 daily https://www.pharmasources.com/industryinsights/minerva-catalent-enter-long-term-commerc-315775.html 0.6 2026-07-08T18:41:08+08:00 daily https://www.pharmasources.com/industryinsights/alliance-contract-pharma-adds-2m-liquid--315776.html 0.6 2026-07-05T02:53:55+08:00 daily https://www.pharmasources.com/industryinsights/hovione-reports-successful-end-of-phase--315777.html 0.6 2026-07-07T17:47:40+08:00 daily https://www.pharmasources.com/industryinsights/evotec-takeda-enter-multi-year-drug-disc-315778.html 0.6 2026-04-10T08:47:31+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-jynneos-smallpox-and-monkey-315779.html 0.6 2026-06-22T03:59:38+08:00 daily https://www.pharmasources.com/industryinsights/more-blood-pressure-drugs-recalled-315780.html 0.6 2026-06-21T08:59:56+08:00 daily https://www.pharmasources.com/industryinsights/uspstf-urges-asymptomatic-bacteriuria-sc-315781.html 0.6 2026-06-22T11:02:54+08:00 daily https://www.pharmasources.com/industryinsights/for-seniors-with-t2dm-insulin-use-up-wit-315782.html 0.6 2026-06-21T01:03:46+08:00 daily https://www.pharmasources.com/industryinsights/vitamin-d-deficiency-linked-to-increased-315783.html 0.6 2026-06-22T07:56:41+08:00 daily https://www.pharmasources.com/industryinsights/girls-take-longer-to-recover-from-concus-315784.html 0.6 2026-06-20T16:54:53+08:00 daily https://www.pharmasources.com/industryinsights/vasomotor-symptoms-in-women-tied-to-high-315785.html 0.6 2026-07-01T07:08:30+08:00 daily https://www.pharmasources.com/industryinsights/two-drug-firms-admit-to-colluding-to-kee-315786.html 0.6 2026-06-21T04:57:40+08:00 daily https://www.pharmasources.com/industryinsights/ema-chmp-recommends-seven-medicines-for--315787.html 0.6 2026-08-10T17:15:00+08:00 daily https://www.pharmasources.com/industryinsights/bayer-brigham-and-womens-hospital-and-ma-315788.html 0.6 2026-06-22T15:03:04+08:00 daily https://www.pharmasources.com/industryinsights/leukemia-drug-shows-promise-for-treating-315789.html 0.6 2026-06-21T05:14:56+08:00 daily https://www.pharmasources.com/industryinsights/fda-statement-on-final-guidance-to-advan-315790.html 0.6 2026-08-11T13:05:22+08:00 daily https://www.pharmasources.com/industryinsights/tarsius-announces-fda-acceptance-of-trs0-315791.html 0.6 2026-06-30T13:21:49+08:00 daily https://www.pharmasources.com/industryinsights/ec-grants-orphan-drug-designation-for-ni-315792.html 0.6 2026-08-09T16:05:52+08:00 daily https://www.pharmasources.com/industryinsights/protalix-biotherapeutics-chiesi-complete-315793.html 0.6 2026-07-05T07:57:51+08:00 daily https://www.pharmasources.com/industryinsights/chmp-recommends-astrazenecas-qtrilmet-fo-315794.html 0.6 2026-07-25T08:14:57+08:00 daily https://www.pharmasources.com/industryinsights/omega-therapeutics-launches-with-focus-o-315795.html 0.6 2026-08-12T21:20:30+08:00 daily https://www.pharmasources.com/industryinsights/proteon-therapeutics-to-merge-with-artar-315796.html 0.6 2026-07-08T04:59:28+08:00 daily https://www.pharmasources.com/industryinsights/takeda-and-lundbecks-trintellix-approved-315797.html 0.6 2026-06-21T16:51:36+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-rmat-designation-to-sanbios-c-315798.html 0.6 2026-06-20T17:51:15+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-takedas-takhzyro-in-here-315799.html 0.6 2026-08-06T23:47:40+08:00 daily https://www.pharmasources.com/industryinsights/gsk-gets-positive-chmp-opinion-for-intra-315800.html 0.6 2026-08-06T00:56:49+08:00 daily https://www.pharmasources.com/industryinsights/enesi-pharma-secures-innovate-uk-funding-315801.html 0.6 2026-08-09T07:16:34+08:00 daily https://www.pharmasources.com/industryinsights/countries-must-invest-at-least-1-more-of-315802.html 0.6 2026-08-08T21:34:41+08:00 daily https://www.pharmasources.com/industryinsights/3m-signs-mou-to-launch-infuze--a-program-315803.html 0.6 2026-08-09T20:12:46+08:00 daily https://www.pharmasources.com/industryinsights/noven-announces-appointment-of-dr-naruhi-315804.html 0.6 2026-08-08T17:53:07+08:00 daily https://www.pharmasources.com/industryinsights/nmpa-approves-oral-formulation-of-akynze-315805.html 0.6 2026-08-07T13:15:44+08:00 daily https://www.pharmasources.com/industryinsights/polyu-develops-new-class-of-antibiotic-c-315806.html 0.6 2026-08-07T12:03:18+08:00 daily https://www.pharmasources.com/industryinsights/naidu-foresees-india-as-wellness-capital-315807.html 0.6 2026-08-06T23:55:23+08:00 daily https://www.pharmasources.com/industryinsights/malaysia-hosts-launch-ceremony-of-intern-315808.html 0.6 2026-08-06T23:46:49+08:00 daily https://www.pharmasources.com/industryinsights/guerbet-and-ibm-watson-health-leverage-a-315809.html 0.6 2026-08-07T03:50:05+08:00 daily https://www.pharmasources.com/industryinsights/cryoports-new-shipper-for-advanced-thera-315810.html 0.6 2026-08-06T23:38:12+08:00 daily https://www.pharmasources.com/industryinsights/enesi-gets-innovate-uk-funding-for-asept-315811.html 0.6 2026-08-06T23:46:09+08:00 daily https://www.pharmasources.com/industryinsights/vedolizumab-beats-adalimumab-for-ulcerat-315812.html 0.6 2026-08-06T23:55:04+08:00 daily https://www.pharmasources.com/industryinsights/acog-updates-guidance-on-otc-contracepti-315813.html 0.6 2026-08-07T00:01:17+08:00 daily https://www.pharmasources.com/industryinsights/new-hope-against-a-dizzying-form-of-migr-315814.html 0.6 2026-08-07T00:41:14+08:00 daily https://www.pharmasources.com/industryinsights/why-do-girls-take-longer-than-boys-to-re-315815.html 0.6 2026-08-07T01:14:24+08:00 daily https://www.pharmasources.com/industryinsights/make-all-hormonal-birth-control-availabl-315816.html 0.6 2026-08-10T12:06:22+08:00 daily https://www.pharmasources.com/industryinsights/older-diabetics-may-be-getting-too-much--315817.html 0.6 2026-08-07T01:14:33+08:00 daily https://www.pharmasources.com/industryinsights/incidence-of-hodgkin-lymphoma-up-in-leas-315818.html 0.6 2026-08-07T01:11:03+08:00 daily https://www.pharmasources.com/industryinsights/healthy-dietary-patterns-linked-to-lower-315819.html 0.6 2026-08-07T00:40:52+08:00 daily https://www.pharmasources.com/industryinsights/risk-for-developing-idiopathic-pulmonary-315820.html 0.6 2026-08-07T00:33:50+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-vaccine-for-smallpox-and-mo-315821.html 0.6 2026-08-09T14:34:33+08:00 daily https://www.pharmasources.com/industryinsights/losartan-drug-recall-expanded-to-include-315822.html 0.6 2026-08-07T00:43:03+08:00 daily https://www.pharmasources.com/industryinsights/global-injectable-drug-delivery-market-p-315823.html 0.6 2026-08-07T01:14:25+08:00 daily https://www.pharmasources.com/industryinsights/amgen-announces-positive-results-from-tw-315824.html 0.6 2026-08-07T01:21:33+08:00 daily https://www.pharmasources.com/industryinsights/fda-announces-voluntary-recall-of-sandoz-315825.html 0.6 2026-08-07T01:27:32+08:00 daily https://www.pharmasources.com/industryinsights/nst-doses-first-patient-in-phase-2b-clin-315826.html 0.6 2026-08-07T01:42:41+08:00 daily https://www.pharmasources.com/industryinsights/cumberland-announces-fda-orphan-drug-gra-315827.html 0.6 2026-08-07T01:45:46+08:00 daily https://www.pharmasources.com/industryinsights/phasebio-announces-completion-of-phase-2-315828.html 0.6 2026-08-07T01:52:35+08:00 daily https://www.pharmasources.com/industryinsights/kadimastem-announces-results-of-cohort-a-315829.html 0.6 2026-08-14T10:36:33+08:00 daily https://www.pharmasources.com/industryinsights/linnaeus-announces-fda-clearance-of-ind--315830.html 0.6 2026-08-07T16:09:42+08:00 daily https://www.pharmasources.com/industryinsights/chmp-recommends-biogens-plegridy-and-avo-315831.html 0.6 2026-08-09T07:00:00+08:00 daily https://www.pharmasources.com/industryinsights/bayer-invests-in-joint-research-lab-for--315832.html 0.6 2026-07-16T12:53:46+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-oral-semaglutide-rybelsus-t-315833.html 0.6 2026-06-26T11:01:26+08:00 daily https://www.pharmasources.com/industryinsights/researchers-use-three-drug-combination-t-315834.html 0.6 2026-06-20T21:47:23+08:00 daily https://www.pharmasources.com/industryinsights/eppendorf-significantly-expands-producti-315835.html 0.6 2026-07-12T15:18:23+08:00 daily https://www.pharmasources.com/industryinsights/blue-sail-medical-enters-into-structural-315836.html 0.6 2026-04-01T05:55:28+08:00 daily https://www.pharmasources.com/industryinsights/chinese-startup-carevoice-officially-lau-315837.html 0.6 2026-06-20T14:58:06+08:00 daily https://www.pharmasources.com/industryinsights/agc-biologics-appoints-new-general-manag-315838.html 0.6 2026-06-21T23:12:22+08:00 daily https://www.pharmasources.com/industryinsights/thailand-positions-as-trading-hub-for-la-315839.html 0.6 2026-06-20T14:38:28+08:00 daily https://www.pharmasources.com/industryinsights/ntu-builds-chip-to-analyse-health-of-imm-315840.html 0.6 2026-06-20T20:59:37+08:00 daily https://www.pharmasources.com/industryinsights/thailand-lab-international-stimulating-b-315841.html 0.6 2026-08-13T01:43:19+08:00 daily https://www.pharmasources.com/industryinsights/switzerland-overtakes-germany-as-europes-315842.html 0.6 2026-06-21T10:01:07+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-expands-clinical-trials-ca-315843.html 0.6 2026-07-22T10:59:27+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-collaborates-with-frontier-315844.html 0.6 2026-06-30T12:10:05+08:00 daily https://www.pharmasources.com/industryinsights/gsk-to-make-chickenpox-vaccine-in-russia-315845.html 0.6 2026-06-21T14:38:13+08:00 daily https://www.pharmasources.com/industryinsights/eli-lilly-media-chief-switches-up-market-315846.html 0.6 2026-06-21T12:53:39+08:00 daily https://www.pharmasources.com/industryinsights/roche-spark-deal-review-in-uk-unnerves-m-315847.html 0.6 2026-06-21T03:57:41+08:00 daily https://www.pharmasources.com/industryinsights/novartis-to-put-avexis-into-protective-c-315848.html 0.6 2026-06-20T17:06:23+08:00 daily https://www.pharmasources.com/industryinsights/novartis-sma-gene-therapy-zolgensma-coul-315849.html 0.6 2026-07-17T23:09:30+08:00 daily https://www.pharmasources.com/industryinsights/aurobindo-co-founder-faces-3m-fine-for-i-315850.html 0.6 2026-07-18T22:01:38+08:00 daily https://www.pharmasources.com/industryinsights/servier-faces-courtroom-in-long-running--315851.html 0.6 2026-06-21T13:14:55+08:00 daily https://www.pharmasources.com/industryinsights/biosim-focused-biocon-picks-up-pfizer-rd-315852.html 0.6 2026-06-22T09:07:50+08:00 daily https://www.pharmasources.com/industryinsights/behind-the-curtain-on-lundbecks-alder-bu-315853.html 0.6 2026-07-22T10:12:43+08:00 daily https://www.pharmasources.com/industryinsights/ousted-avexis-execs-doctored-zolgensma-d-315854.html 0.6 2026-06-21T02:00:12+08:00 daily https://www.pharmasources.com/industryinsights/novartis-is-first-to-recall-generic-zant-315855.html 0.6 2026-06-22T11:01:53+08:00 daily https://www.pharmasources.com/industryinsights/novos-rybelsus-check-here-are-the-major--315856.html 0.6 2026-06-23T20:07:50+08:00 daily https://www.pharmasources.com/industryinsights/merck-reimagines-keytruda-patient-suppor-315857.html 0.6 2026-06-20T21:08:42+08:00 daily https://www.pharmasources.com/industryinsights/alnylam-debuts-video-series-to-help-kids-315858.html 0.6 2026-08-13T05:13:06+08:00 daily https://www.pharmasources.com/industryinsights/us-biopharma-ceos-look-outside-for-growt-315859.html 0.6 2026-06-23T01:16:25+08:00 daily https://www.pharmasources.com/industryinsights/abbvies-premium-bid-for-allergan-isnt-en-315860.html 0.6 2026-07-06T23:08:27+08:00 daily https://www.pharmasources.com/industryinsights/novo-prices-oral-rybelsus-on-par-with-in-315861.html 0.6 2026-07-16T19:51:17+08:00 daily https://www.pharmasources.com/industryinsights/troubled-amag-spurns-activists-attempt-t-315862.html 0.6 2026-06-21T01:47:37+08:00 daily https://www.pharmasources.com/industryinsights/torrent-recall-dr-reddys-distribution-ha-315863.html 0.6 2026-08-10T17:21:50+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-wins-fda-green-light-for-ho-315864.html 0.6 2026-08-07T06:07:55+08:00 daily https://www.pharmasources.com/industryinsights/insys-agrees-to-sell-notorious-fentanyl--315865.html 0.6 2026-08-07T00:36:53+08:00 daily https://www.pharmasources.com/industryinsights/darzalex-maker-jj-taps-celebrity-british-315866.html 0.6 2026-08-07T13:17:31+08:00 daily https://www.pharmasources.com/industryinsights/amid-a-political-firestorm-over-pharmas--315867.html 0.6 2026-08-08T07:41:45+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-amps-up-gene-therapy-manufacturin-315868.html 0.6 2026-08-09T07:36:49+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisks-tresiba-misses-main-mark-i-315869.html 0.6 2026-07-05T01:38:26+08:00 daily https://www.pharmasources.com/industryinsights/serum-il-35-levels-tied-to-bone-loss-wit-315870.html 0.6 2026-06-21T16:04:21+08:00 daily https://www.pharmasources.com/industryinsights/many-systemic-lupus-erythematosus-patien-315871.html 0.6 2026-06-21T09:06:11+08:00 daily https://www.pharmasources.com/industryinsights/experimental-genital-herpes-vaccine-show-315872.html 0.6 2026-06-21T21:03:46+08:00 daily https://www.pharmasources.com/industryinsights/more-us-kids-being-diagnosed-with-autism-315873.html 0.6 2026-03-27T16:03:44+08:00 daily https://www.pharmasources.com/industryinsights/health-insurance-premiums-are-soaring-fo-315874.html 0.6 2026-06-21T00:46:43+08:00 daily https://www.pharmasources.com/industryinsights/why-arent-more-stroke-survivors-getting--315875.html 0.6 2026-08-10T09:57:26+08:00 daily https://www.pharmasources.com/industryinsights/oral-health-symptoms-in-seniors-associat-315876.html 0.6 2026-06-20T19:02:35+08:00 daily https://www.pharmasources.com/industryinsights/mohs-micrographic-surgery-may-up-surviva-315877.html 0.6 2026-08-07T08:45:01+08:00 daily https://www.pharmasources.com/industryinsights/severe-adverse-cardiovascular-events-ass-315878.html 0.6 2026-08-09T13:21:18+08:00 daily https://www.pharmasources.com/industryinsights/prostate-cancer-risk-higher-in-men-recei-315879.html 0.6 2026-06-20T22:55:37+08:00 daily https://www.pharmasources.com/industryinsights/primary-care-use-aids-patients-with-diab-315880.html 0.6 2026-06-21T11:17:48+08:00 daily https://www.pharmasources.com/industryinsights/erenumab-migraine-drug-fails-to-meet-nic-315881.html 0.6 2026-03-01T02:15:23+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-voluntarily-recalls-ranitidine-ov-315882.html 0.6 2026-06-20T14:36:56+08:00 daily https://www.pharmasources.com/industryinsights/thermally-stable-chikungunya-vaccine-dev-315883.html 0.6 2026-06-20T21:41:35+08:00 daily https://www.pharmasources.com/industryinsights/cause-of-antibiotic-resistance-identifie-315884.html 0.6 2026-06-21T17:58:20+08:00 daily https://www.pharmasources.com/industryinsights/cheaper-drug-just-as-effective-protectin-315885.html 0.6 2026-06-21T11:21:30+08:00 daily https://www.pharmasources.com/industryinsights/galmed-initiated-study-of-aramchol-in-su-315886.html 0.6 2026-06-21T03:01:43+08:00 daily https://www.pharmasources.com/industryinsights/biolinerx-doses-first-patient-in-solid-t-315887.html 0.6 2026-07-08T06:17:02+08:00 daily https://www.pharmasources.com/industryinsights/ntra-cellular-therapies-announces-progre-315888.html 0.6 2026-07-08T23:00:44+08:00 daily https://www.pharmasources.com/industryinsights/biomarin-submits-cta-in-uk-for-investiga-315889.html 0.6 2026-06-22T05:46:37+08:00 daily https://www.pharmasources.com/industryinsights/springworks-receives-orphan-status-for-n-315890.html 0.6 2026-06-20T14:54:01+08:00 daily https://www.pharmasources.com/industryinsights/gsk-to-invest-120m-to-expand-manufacturi-315891.html 0.6 2026-06-18T07:18:03+08:00 daily https://www.pharmasources.com/industryinsights/us-researchers-develop-car-t-cell-therap-315892.html 0.6 2026-08-07T21:14:27+08:00 daily https://www.pharmasources.com/industryinsights/closing-of-financing-round-and-strengthe-315893.html 0.6 2026-03-25T13:48:08+08:00 daily https://www.pharmasources.com/industryinsights/genewiz-celebrates-opening-of-european-h-315894.html 0.6 2026-06-21T07:45:57+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-donates-vaccines-to-315895.html 0.6 2026-03-21T23:49:22+08:00 daily https://www.pharmasources.com/industryinsights/eisai-to-work-with-tokio-towards-prevent-315896.html 0.6 2026-06-21T07:56:16+08:00 daily https://www.pharmasources.com/industryinsights/fang-chunming-proposes-3-initiatives-to--315897.html 0.6 2026-06-22T05:04:42+08:00 daily https://www.pharmasources.com/industryinsights/biocon-announces-price-reduction-for-ins-315898.html 0.6 2026-06-21T10:55:07+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-with-frontier-bio-to-devel-315899.html 0.6 2026-07-01T22:50:11+08:00 daily https://www.pharmasources.com/industryinsights/philips-highlights-importance-of-early-d-315900.html 0.6 2026-06-20T21:49:28+08:00 daily https://www.pharmasources.com/industryinsights/eisai-fronteo-launch-coroban-prediction--315901.html 0.6 2026-06-21T02:48:43+08:00 daily https://www.pharmasources.com/industryinsights/building-innovation-in-health-private-se-315902.html 0.6 2026-06-20T18:04:24+08:00 daily https://www.pharmasources.com/industryinsights/evolving-world-of-pharma-digital-pills-s-315903.html 0.6 2026-08-07T22:12:52+08:00 daily https://www.pharmasources.com/industryinsights/interview-with-guilin-nuti-ingredients-w-315904.html 0.6 2026-06-12T08:56:03+08:00 daily https://www.pharmasources.com/industryinsights/customers-in-multiple-countries-want-to--315905.html 0.6 2026-06-20T14:56:09+08:00 daily https://www.pharmasources.com/industryinsights/evolving-world-of-pharma-a-smarter-appro-315906.html 0.6 2026-07-08T06:27:12+08:00 daily https://www.pharmasources.com/industryinsights/evolving-world-of-pharma-data-integrity--315907.html 0.6 2026-08-14T08:04:15+08:00 daily https://www.pharmasources.com/industryinsights/haselmeier-signs-an-exclusive-agreement--315908.html 0.6 2025-12-24T00:14:06+08:00 daily https://www.pharmasources.com/industryinsights/cactus-ties-up-with-scholarcy-to-speed-u-315909.html 0.6 2026-06-21T06:15:07+08:00 daily https://www.pharmasources.com/industryinsights/ascletis-appoints-former-novartis-global-315910.html 0.6 2026-06-21T10:13:17+08:00 daily https://www.pharmasources.com/industryinsights/digital-health-to-empower-women-and-agin-315911.html 0.6 2026-08-12T04:59:11+08:00 daily https://www.pharmasources.com/industryinsights/innovent-biologics-announces-a-new-place-315912.html 0.6 2026-08-11T08:02:12+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-biopharma-receives-ind-approval-in-315913.html 0.6 2026-07-30T14:33:00+08:00 daily https://www.pharmasources.com/industryinsights/focusing-on-interior-and-exterior-the-ch-315914.html 0.6 2026-08-06T15:18:36+08:00 daily https://www.pharmasources.com/industryinsights/with-the-approval-of-worlds-first-oral-g-315915.html 0.6 2026-07-06T03:34:32+08:00 daily https://www.pharmasources.com/industryinsights/sales-of-toripalimab-and-sintilimab-both-315916.html 0.6 2026-08-12T05:02:40+08:00 daily https://www.pharmasources.com/industryinsights/shiseido-acquires-leading-skincare-brand-315917.html 0.6 2026-08-08T19:33:39+08:00 daily https://www.pharmasources.com/industryinsights/apacmed-showcases-patient-centric-connec-315918.html 0.6 2026-06-22T02:04:41+08:00 daily https://www.pharmasources.com/industryinsights/mik-japan-launches-new-online-drug-store-315919.html 0.6 2026-06-21T09:14:21+08:00 daily https://www.pharmasources.com/industryinsights/saudi-moh-to-provide-more-accessible-hea-315920.html 0.6 2026-06-22T04:56:38+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-novel-antibody-gets-ind-approval-i-315921.html 0.6 2026-08-03T00:29:38+08:00 daily https://www.pharmasources.com/industryinsights/korean-lab-develops-cosmetics-to-improve-315922.html 0.6 2026-07-01T03:14:24+08:00 daily https://www.pharmasources.com/industryinsights/jj-commits-500m-investment-to-end-tb-hiv-315923.html 0.6 2026-07-24T03:48:08+08:00 daily https://www.pharmasources.com/industryinsights/japanese-ai-startup-secures-429m-in-seri-315924.html 0.6 2026-08-10T19:36:33+08:00 daily https://www.pharmasources.com/industryinsights/rentschler-bio-enhances-collaboration-in-315925.html 0.6 2026-06-22T06:01:40+08:00 daily https://www.pharmasources.com/industryinsights/verita-healthcare-taps-medical-wellness--315926.html 0.6 2026-06-23T07:07:00+08:00 daily https://www.pharmasources.com/industryinsights/cnmpa-approves-agilents-pd-l1-companion--315927.html 0.6 2026-06-20T19:47:19+08:00 daily https://www.pharmasources.com/industryinsights/29th-singapore-pharmacy-congress-aims-ad-315928.html 0.6 2026-07-04T19:59:01+08:00 daily https://www.pharmasources.com/industryinsights/noble-prize-in-medicine-2019-for-us-uk-s-315929.html 0.6 2026-08-13T11:15:37+08:00 daily https://www.pharmasources.com/industryinsights/australia-grants-patent-to-krystal-biote-315930.html 0.6 2026-06-20T20:02:41+08:00 daily https://www.pharmasources.com/industryinsights/nbe-therapeutics-appoints-dr-steffen-hee-315931.html 0.6 2026-06-20T17:16:42+08:00 daily https://www.pharmasources.com/industryinsights/medtech-innovator-announces-finalists-fo-315932.html 0.6 2026-06-21T05:10:50+08:00 daily https://www.pharmasources.com/industryinsights/another-milestone-of-success-for-thailan-315933.html 0.6 2026-06-20T19:51:29+08:00 daily https://www.pharmasources.com/industryinsights/precision-nanosystems-to-launch-the-revo-315934.html 0.6 2026-06-22T05:50:35+08:00 daily https://www.pharmasources.com/industryinsights/bayer-and-riken-establish-partnership-fo-315935.html 0.6 2025-12-11T19:44:44+08:00 daily https://www.pharmasources.com/industryinsights/experts-rally-asia-pacific-for-global-ma-315936.html 0.6 2026-07-07T01:15:24+08:00 daily https://www.pharmasources.com/industryinsights/apacmed-showcases-patient-centric-connec-315937.html 0.6 2026-06-22T07:03:48+08:00 daily https://www.pharmasources.com/industryinsights/chipscreen-novogene-team-up-to-develop-c-315938.html 0.6 2026-06-20T16:06:16+08:00 daily https://www.pharmasources.com/industryinsights/abu-dhabi-partners-with-plug-and-play-to-315939.html 0.6 2026-08-08T00:11:05+08:00 daily https://www.pharmasources.com/industryinsights/ascletis-appoints-new-chief-scientific-o-315940.html 0.6 2026-06-28T14:02:43+08:00 daily https://www.pharmasources.com/industryinsights/phc-kakehashi-partner-for-healthcare-it--315941.html 0.6 2026-06-21T02:59:43+08:00 daily https://www.pharmasources.com/industryinsights/digital-transformation-in-the-pharmaceut-315942.html 0.6 2026-06-21T06:46:58+08:00 daily https://www.pharmasources.com/industryinsights/asian-pharma-companies-prepare-for-russi-315943.html 0.6 2026-06-21T05:15:58+08:00 daily https://www.pharmasources.com/industryinsights/innovations-in-wound-care-to-improve-pat-315944.html 0.6 2026-06-21T11:05:16+08:00 daily https://www.pharmasources.com/industryinsights/true-digital-park-to-propel-digital-econ-315945.html 0.6 2026-06-20T20:11:52+08:00 daily https://www.pharmasources.com/industryinsights/tim-oldham-appointed-as-chief-executive--315946.html 0.6 2026-06-20T23:42:29+08:00 daily https://www.pharmasources.com/industryinsights/breast-cancer-hormone-therapy-has-a-bigg-315947.html 0.6 2026-06-21T08:04:02+08:00 daily https://www.pharmasources.com/industryinsights/precision-diabetes-llc-presents-data-on--315948.html 0.6 2026-06-21T00:00:46+08:00 daily https://www.pharmasources.com/industryinsights/ugentec-and-eurofins-announce-collaborat-315949.html 0.6 2026-06-20T15:52:51+08:00 daily https://www.pharmasources.com/industryinsights/asia-pacific-medical-technology-associat-315950.html 0.6 2026-06-21T10:54:07+08:00 daily https://www.pharmasources.com/industryinsights/perspectum-announces-partnership-with-pr-315951.html 0.6 2026-04-09T06:53:49+08:00 daily https://www.pharmasources.com/industryinsights/fedex-provides-apac-biz-capture-more-glo-315952.html 0.6 2026-06-22T08:26:15+08:00 daily https://www.pharmasources.com/industryinsights/innovent-and-chi-med-expand-global-colla-315953.html 0.6 2026-06-22T00:00:42+08:00 daily https://www.pharmasources.com/industryinsights/smile-direct-club-brings-affordable-dent-315954.html 0.6 2026-06-21T03:54:41+08:00 daily https://www.pharmasources.com/industryinsights/ntu-startup-unveils-robot-with-human-lik-315955.html 0.6 2026-07-08T03:22:38+08:00 daily https://www.pharmasources.com/industryinsights/ctfh-insilico-medicine-enter-al-drug-dis-315956.html 0.6 2026-06-20T23:56:38+08:00 daily https://www.pharmasources.com/industryinsights/shiseido-acquires-leading-skincare-brand-315957.html 0.6 2026-06-21T07:10:02+08:00 daily https://www.pharmasources.com/industryinsights/medtech-innovator-announces-startup-winn-315958.html 0.6 2026-08-10T00:52:22+08:00 daily https://www.pharmasources.com/industryinsights/lifepharma-signs-agreement-with-apotex-315959.html 0.6 2026-02-15T04:06:02+08:00 daily https://www.pharmasources.com/industryinsights/gilead-sciences-submits-nda-to-treat-ra--315960.html 0.6 2026-06-21T07:19:16+08:00 daily https://www.pharmasources.com/industryinsights/true-digital-park-to-propel-digital-econ-315961.html 0.6 2026-06-20T20:16:55+08:00 daily https://www.pharmasources.com/industryinsights/path-breaking-study-reports-high-sensiti-315962.html 0.6 2026-06-21T11:13:39+08:00 daily https://www.pharmasources.com/industryinsights/volition-appoints-dr-phillip-barnes-to-b-315963.html 0.6 2026-03-17T19:43:57+08:00 daily https://www.pharmasources.com/industryinsights/ctfh-and-insilico-medicine-enter-al-drug-315964.html 0.6 2026-07-04T03:17:00+08:00 daily https://www.pharmasources.com/industryinsights/datar-cancer-genetics-announces-positive-315965.html 0.6 2026-06-21T04:10:49+08:00 daily https://www.pharmasources.com/industryinsights/world-thrombosis-day-empowers-people-aro-315966.html 0.6 2026-07-09T12:03:22+08:00 daily https://www.pharmasources.com/industryinsights/clinigen-launches-managed-access-program-315967.html 0.6 2026-07-17T21:16:18+08:00 daily https://www.pharmasources.com/industryinsights/indonesias-largest-single-payer-system-b-315968.html 0.6 2026-06-21T06:16:00+08:00 daily https://www.pharmasources.com/industryinsights/cmab-biopharma-and-bj-bioscience-establi-315969.html 0.6 2026-06-20T20:51:03+08:00 daily https://www.pharmasources.com/industryinsights/kangpu-biopharmaceuticals-successfully-c-315970.html 0.6 2026-08-08T00:04:02+08:00 daily https://www.pharmasources.com/industryinsights/bayer-g4a-partners-with-wellthy-therapeu-315971.html 0.6 2026-08-08T01:17:30+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-apptec-research-service-division-an-315972.html 0.6 2026-07-03T10:19:31+08:00 daily https://www.pharmasources.com/industryinsights/mabplex-lauded-by-frost-sullivan-for-glo-315973.html 0.6 2026-06-22T14:43:08+08:00 daily https://www.pharmasources.com/industryinsights/saudi-ministry-of-health-provides-more-a-315974.html 0.6 2026-08-11T15:43:20+08:00 daily https://www.pharmasources.com/industryinsights/innovent-and-chi-med-expand-global-colla-315975.html 0.6 2026-06-21T11:06:15+08:00 daily https://www.pharmasources.com/industryinsights/ime-medical-electrospinning-appoints-thr-315976.html 0.6 2026-06-20T20:09:40+08:00 daily https://www.pharmasources.com/industryinsights/zeiss-showcases-next-level-eye-care-digi-315977.html 0.6 2026-03-01T03:04:43+08:00 daily https://www.pharmasources.com/industryinsights/natural-extracts-innovated-transformed-a-315978.html 0.6 2026-08-10T05:19:05+08:00 daily https://www.pharmasources.com/industryinsights/focus-on-chemical-and-pharmaceutical-ind-315979.html 0.6 2026-08-07T13:17:42+08:00 daily https://www.pharmasources.com/industryinsights/easy-sourcing-and-free-to-get-the-cphi-c-315980.html 0.6 2026-08-07T22:13:50+08:00 daily https://www.pharmasources.com/industryinsights/better-asthma-care-in-puskesmas-improves-315981.html 0.6 2026-06-20T13:19:35+08:00 daily https://www.pharmasources.com/industryinsights/collaborative-medicinal-development-enro-315982.html 0.6 2026-06-21T23:44:50+08:00 daily https://www.pharmasources.com/industryinsights/medisant-earns-acclaim-from-frost-sulliv-315983.html 0.6 2026-07-01T00:59:49+08:00 daily https://www.pharmasources.com/industryinsights/wontech-receives-fda-clearance-for-hairb-315984.html 0.6 2026-06-23T08:29:00+08:00 daily https://www.pharmasources.com/industryinsights/sta-to-market-sarcoma-drug-in-australia--315985.html 0.6 2026-06-23T07:27:32+08:00 daily https://www.pharmasources.com/industryinsights/admedus-inks-a362m-deal-for-cardiocel-an-315986.html 0.6 2026-06-21T10:40:14+08:00 daily https://www.pharmasources.com/industryinsights/the-global-food-safety-initiative-gfsi-w-315987.html 0.6 2026-06-21T12:58:05+08:00 daily https://www.pharmasources.com/industryinsights/ppf-and-sotio-invest-65-million-in-maver-315988.html 0.6 2026-07-13T01:20:10+08:00 daily https://www.pharmasources.com/industryinsights/short-overview-of-fda-regulations-and-gu-315989.html 0.6 2026-08-06T23:32:08+08:00 daily https://www.pharmasources.com/industryinsights/chinas-first-self-developed-carbon-ion-t-315990.html 0.6 2026-08-08T04:31:38+08:00 daily https://www.pharmasources.com/industryinsights/powder-flow-using-powder-rheology-to-dev-315991.html 0.6 2026-08-14T14:30:25+08:00 daily https://www.pharmasources.com/industryinsights/metgen-earns-acclaim-from-frost-sullivan-315992.html 0.6 2026-08-06T23:56:07+08:00 daily https://www.pharmasources.com/industryinsights/avidity-science-acquires-edstrom-japan-l-315993.html 0.6 2026-08-07T00:02:48+08:00 daily https://www.pharmasources.com/industryinsights/havas-health-you-becomes-first-agency-to-315994.html 0.6 2026-08-06T23:56:16+08:00 daily https://www.pharmasources.com/industryinsights/sirtex-medical-appoints-kevin-r-smith-as-315995.html 0.6 2026-08-06T23:49:33+08:00 daily https://www.pharmasources.com/industryinsights/hepagene-therapeutics-inc-announces-dosi-315996.html 0.6 2026-08-06T23:45:56+08:00 daily https://www.pharmasources.com/industryinsights/curiox-biosystems-achieves-commercialisa-315997.html 0.6 2026-08-06T23:37:42+08:00 daily https://www.pharmasources.com/industryinsights/amarna-therapeutics-raises-10-million-to-315998.html 0.6 2026-08-06T23:37:18+08:00 daily https://www.pharmasources.com/industryinsights/innovent-biologics-announces-positive-up-315999.html 0.6 2026-08-11T08:02:13+08:00 daily https://www.pharmasources.com/industryinsights/getinge-q3-2019-result-continued-growth--316000.html 0.6 2026-08-10T05:17:18+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2019101-316001.html 0.6 2026-08-07T02:36:40+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2019100-316002.html 0.6 2026-07-05T05:32:49+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2019102-316003.html 0.6 2026-08-12T21:41:12+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-stedim-biotech-launches-new-sa-316004.html 0.6 2026-08-09T07:42:53+08:00 daily https://www.pharmasources.com/industryinsights/bd-launches-bd-intevia-1ml-two-step-disp-316005.html 0.6 2026-07-12T09:08:40+08:00 daily https://www.pharmasources.com/industryinsights/apollo-hospitals-unique-initiative-to-pr-316006.html 0.6 2026-06-21T12:48:10+08:00 daily https://www.pharmasources.com/industryinsights/drug-delivery-devices-offering-enhanced--316007.html 0.6 2026-06-20T14:40:25+08:00 daily https://www.pharmasources.com/industryinsights/univercells-applies-modular-laboratory-c-316008.html 0.6 2026-08-08T03:04:04+08:00 daily https://www.pharmasources.com/industryinsights/new-research-on-climate-change-and-the-b-316009.html 0.6 2026-06-21T12:46:46+08:00 daily https://www.pharmasources.com/industryinsights/galderma-launches-online-support-to-empo-316010.html 0.6 2026-06-21T12:49:35+08:00 daily https://www.pharmasources.com/industryinsights/doctor-anywhere-partners-with-viettelpay-316011.html 0.6 2026-06-24T04:59:08+08:00 daily https://www.pharmasources.com/industryinsights/osteoporer-highly-commended-for-its-inno-316012.html 0.6 2026-06-22T03:39:37+08:00 daily https://www.pharmasources.com/industryinsights/tissuecypher-further-validated-to-accura-316013.html 0.6 2026-06-20T22:17:01+08:00 daily https://www.pharmasources.com/industryinsights/western-australia-aims-to-reduce-amputat-316014.html 0.6 2026-06-20T17:16:39+08:00 daily https://www.pharmasources.com/industryinsights/biogx-receives-ce-ivd-mark-for-enhanced--316015.html 0.6 2026-06-22T10:12:53+08:00 daily https://www.pharmasources.com/industryinsights/scality-grows-healthcare-customer-base-a-316016.html 0.6 2026-06-24T00:03:38+08:00 daily https://www.pharmasources.com/industryinsights/zuellig-pharma-enters-into-strategic-par-316017.html 0.6 2026-07-16T09:03:27+08:00 daily https://www.pharmasources.com/industryinsights/ten-points-to-be-watched-in-the-new-edit-316018.html 0.6 2026-08-10T08:49:54+08:00 daily https://www.pharmasources.com/industryinsights/gm-pharm-a-popular-korean-health-functio-316019.html 0.6 2026-07-08T03:24:03+08:00 daily https://www.pharmasources.com/industryinsights/ott-medical-tourism-association-sign-agr-316020.html 0.6 2026-07-08T10:00:46+08:00 daily https://www.pharmasources.com/industryinsights/world-leading-healthcare-company-deploys-316021.html 0.6 2026-08-07T00:07:36+08:00 daily https://www.pharmasources.com/industryinsights/world-first-clinical-trial-commenced-in--316022.html 0.6 2026-03-11T12:14:04+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2019102-316023.html 0.6 2026-06-21T03:42:35+08:00 daily https://www.pharmasources.com/industryinsights/the-approval-of-salubris-teriparatide-is-316024.html 0.6 2026-06-27T20:01:59+08:00 daily https://www.pharmasources.com/industryinsights/world-federation-of-neurology-joins-forc-316025.html 0.6 2026-06-27T11:29:01+08:00 daily https://www.pharmasources.com/industryinsights/biomed-x-completes-alzheimers-disease-re-316026.html 0.6 2026-06-21T12:47:40+08:00 daily https://www.pharmasources.com/industryinsights/bioversys-receives-carb-x-award-of-up-to-316027.html 0.6 2026-06-20T22:15:10+08:00 daily https://www.pharmasources.com/industryinsights/history-of-the-sky-high-priced-imported--316028.html 0.6 2026-08-12T10:33:11+08:00 daily https://www.pharmasources.com/industryinsights/the-injection-consistency-evaluation-may-316029.html 0.6 2026-07-21T15:37:51+08:00 daily https://www.pharmasources.com/industryinsights/the-injection-consistency-evaluation-may-316030.html 0.6 2026-07-15T03:06:57+08:00 daily https://www.pharmasources.com/industryinsights/the-injection-consistency-evaluation-may-316031.html 0.6 2026-04-26T01:47:30+08:00 daily https://www.pharmasources.com/industryinsights/vetter-provides-greater-flexibility-in-s-316032.html 0.6 2026-07-05T00:35:19+08:00 daily https://www.pharmasources.com/industryinsights/tsi-reports-enrollment-of-first-10-patie-316033.html 0.6 2026-08-07T04:23:48+08:00 daily https://www.pharmasources.com/industryinsights/seranovo-enters-into-license-agreement-w-316034.html 0.6 2026-08-07T00:02:55+08:00 daily https://www.pharmasources.com/industryinsights/15-years-of-p-mec-china-driving-global-p-316035.html 0.6 2026-08-07T13:19:35+08:00 daily https://www.pharmasources.com/industryinsights/breaking-news-chinas-humira-biosimilar-p-316036.html 0.6 2026-08-08T07:56:27+08:00 daily https://www.pharmasources.com/industryinsights/ichnos-sciences-announces-completion-of--316037.html 0.6 2026-06-21T23:54:44+08:00 daily https://www.pharmasources.com/industryinsights/c2-pharma-continues-to-expand-api-portfo-316038.html 0.6 2026-08-14T18:50:45+08:00 daily https://www.pharmasources.com/industryinsights/scirhom-initiates-first-in-class-antibod-316039.html 0.6 2026-08-06T22:06:57+08:00 daily https://www.pharmasources.com/industryinsights/china-nmpa-approves-bio-thera-solutions--316040.html 0.6 2026-08-04T06:37:24+08:00 daily https://www.pharmasources.com/industryinsights/application-of-novel-herbal-plant-and-mu-316041.html 0.6 2026-08-06T23:45:41+08:00 daily https://www.pharmasources.com/industryinsights/evolving-world-of-pharma-have-you-given--316042.html 0.6 2026-06-22T07:14:02+08:00 daily https://www.pharmasources.com/industryinsights/omega-3-fatty-acid-enriched-parenteral-n-316043.html 0.6 2026-08-08T14:10:30+08:00 daily https://www.pharmasources.com/industryinsights/the-korea-ginseng-association-announced--316044.html 0.6 2026-08-13T05:32:32+08:00 daily https://www.pharmasources.com/industryinsights/spectrum-therapeutics-partners-with-emer-316045.html 0.6 2026-08-10T12:12:18+08:00 daily https://www.pharmasources.com/industryinsights/akeso-inc-completes-series-d-private-fin-316046.html 0.6 2026-07-18T00:59:32+08:00 daily https://www.pharmasources.com/industryinsights/merck-and-pfizer-provide-update-on-phase-316047.html 0.6 2026-06-20T18:53:37+08:00 daily https://www.pharmasources.com/industryinsights/ortoma-initiates-expansion-with-module-f-316048.html 0.6 2026-07-07T04:45:12+08:00 daily https://www.pharmasources.com/industryinsights/exact-sciences-completes-combination-wit-316049.html 0.6 2026-06-21T10:01:05+08:00 daily https://www.pharmasources.com/industryinsights/abcam-and-brickbio-announce-a-partnershi-316050.html 0.6 2026-06-21T01:05:49+08:00 daily https://www.pharmasources.com/industryinsights/evitria-opens-its-new-head-office-in-sca-316051.html 0.6 2026-07-05T13:31:37+08:00 daily https://www.pharmasources.com/industryinsights/another-anti-pd-l1-monoclonal-antibody-f-316052.html 0.6 2026-06-25T20:35:21+08:00 daily https://www.pharmasources.com/industryinsights/shanghai-green-valleys-class-1-new-drug--316053.html 0.6 2026-06-28T09:12:15+08:00 daily https://www.pharmasources.com/industryinsights/us-food-and-drug-administration-accepts--316054.html 0.6 2026-07-18T17:42:41+08:00 daily https://www.pharmasources.com/industryinsights/directedluck-a-transposase-for-efficient-316055.html 0.6 2026-06-20T14:45:12+08:00 daily https://www.pharmasources.com/industryinsights/ascensia-diabetes-care-celebrates-the-im-316056.html 0.6 2026-06-19T20:23:02+08:00 daily https://www.pharmasources.com/industryinsights/delivering-greater-throughput-and-decrea-316057.html 0.6 2026-06-20T22:06:43+08:00 daily https://www.pharmasources.com/industryinsights/international-diabetes-federation-latest-316058.html 0.6 2026-06-22T01:24:15+08:00 daily https://www.pharmasources.com/industryinsights/china-biologic-reports-financial-results-316059.html 0.6 2026-07-24T04:10:30+08:00 daily https://www.pharmasources.com/industryinsights/volitionrx-limited-announces-third-quart-316060.html 0.6 2026-06-21T09:14:11+08:00 daily https://www.pharmasources.com/industryinsights/powder-flow-the-influence-of-flow-additi-316061.html 0.6 2026-07-23T22:21:17+08:00 daily https://www.pharmasources.com/industryinsights/xinhua-silk-road-yili-launches-yili-futu-316062.html 0.6 2026-07-21T23:41:44+08:00 daily https://www.pharmasources.com/industryinsights/zeus-unveils-high-ratio-fluoropeelz-clea-316063.html 0.6 2026-06-21T02:14:53+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-biopharma-receives-ind-approval-fr-316064.html 0.6 2026-06-21T07:00:53+08:00 daily https://www.pharmasources.com/industryinsights/iherb-enhances-korean-customer-experienc-316065.html 0.6 2026-08-07T03:34:25+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-enhances-its-trusted-s-316066.html 0.6 2026-08-07T03:24:39+08:00 daily https://www.pharmasources.com/industryinsights/111-signs-strategic-partnership-with-hec-316067.html 0.6 2026-08-07T03:02:44+08:00 daily https://www.pharmasources.com/industryinsights/worlds-first-candidate-antibody-treatmen-316068.html 0.6 2026-08-07T02:55:22+08:00 daily https://www.pharmasources.com/industryinsights/memed-wins-25m-award-from-european-innov-316069.html 0.6 2026-08-07T02:51:41+08:00 daily https://www.pharmasources.com/industryinsights/3sbio-selects-verseaus-psgl-1-targeted-a-316070.html 0.6 2026-08-07T03:03:10+08:00 daily https://www.pharmasources.com/industryinsights/bioduro-chooses-scifinder-n-from-cas-to--316071.html 0.6 2026-06-20T18:53:37+08:00 daily https://www.pharmasources.com/industryinsights/china-pharma-holdings-inc-reports-third--316072.html 0.6 2026-07-20T07:59:35+08:00 daily https://www.pharmasources.com/industryinsights/going-conti-in-the-virtual-world-316073.html 0.6 2026-08-05T18:40:27+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-congratulates-tychan-on-y-316075.html 0.6 2026-08-07T18:01:18+08:00 daily https://www.pharmasources.com/industryinsights/curcumin-and-non-alcoholic-fatty-liver-d-316076.html 0.6 2026-08-08T11:12:16+08:00 daily https://www.pharmasources.com/industryinsights/evolving-world-of-pharma-demand-for-biol-316077.html 0.6 2026-07-15T04:40:42+08:00 daily https://www.pharmasources.com/industryinsights/guardant-health-amea-wins-this-years-gro-316081.html 0.6 2026-08-08T00:21:23+08:00 daily https://www.pharmasources.com/industryinsights/curcumin-and-non-alcoholic-fatty-liver-d-316082.html 0.6 2026-08-06T23:54:54+08:00 daily https://www.pharmasources.com/industryinsights/pharma-and-biotech-review-chinese-biopha-316083.html 0.6 2026-07-19T15:54:19+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-vaccines-to-build-a-240-million-man-316084.html 0.6 2026-08-13T11:53:43+08:00 daily https://www.pharmasources.com/industryinsights/submit-ind-safety-reports-to-faers-101-316085.html 0.6 2026-08-07T00:03:35+08:00 daily https://www.pharmasources.com/industryinsights/hub-of-global-pharmaceutical-packaging-s-316086.html 0.6 2026-08-09T02:38:43+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-unveils-positive-results-from-asi-316087.html 0.6 2026-08-09T00:17:19+08:00 daily https://www.pharmasources.com/industryinsights/positive-interim-efficacy-data-from-gdc--316088.html 0.6 2026-08-08T22:01:44+08:00 daily https://www.pharmasources.com/industryinsights/mc2-therapeutics-announces-fda-acceptanc-316089.html 0.6 2026-08-13T00:08:22+08:00 daily https://www.pharmasources.com/industryinsights/halix-celebrates-grand-opening-of-its-st-316090.html 0.6 2026-08-08T17:53:25+08:00 daily https://www.pharmasources.com/industryinsights/vaccitech-provides-update-on-clinical-pr-316091.html 0.6 2026-08-08T15:50:04+08:00 daily https://www.pharmasources.com/industryinsights/heraeus-expands-its-platinum-based-hpapi-316092.html 0.6 2026-06-22T00:00:54+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-novel-treatment-to-target-a-316093.html 0.6 2026-08-08T12:18:39+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-treatment-for-adults-wi-316094.html 0.6 2026-08-13T16:53:11+08:00 daily https://www.pharmasources.com/industryinsights/saint-gobain-completes-second-of-seven-m-316099.html 0.6 2026-08-07T00:42:48+08:00 daily https://www.pharmasources.com/industryinsights/vizient-and-fresenius-kabi-expand-partne-316100.html 0.6 2026-08-07T01:14:26+08:00 daily https://www.pharmasources.com/industryinsights/forging-ahead-about-chinese-pharmaceutic-316118.html 0.6 2026-08-07T00:41:17+08:00 daily https://www.pharmasources.com/industryinsights/evolving-world-of-pharma-making-the-choi-316119.html 0.6 2026-06-21T11:12:20+08:00 daily https://www.pharmasources.com/industryinsights/chinese-autoimmune-disease-drug-market-w-316120.html 0.6 2026-08-07T00:41:40+08:00 daily https://www.pharmasources.com/industryinsights/the-first-bladder-cancer-targeted-therap-316121.html 0.6 2026-08-07T01:21:45+08:00 daily https://www.pharmasources.com/industryinsights/ascletis-successfully-obtained-pharmaceu-316122.html 0.6 2026-08-10T12:15:51+08:00 daily https://www.pharmasources.com/industryinsights/tyvyt-sintilimab-injection-an-innovative-316123.html 0.6 2026-06-20T19:04:26+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2019120-316124.html 0.6 2026-08-07T01:21:50+08:00 daily https://www.pharmasources.com/industryinsights/qbiotics-announces-first-patient-dosed-i-316125.html 0.6 2026-08-10T17:21:50+08:00 daily https://www.pharmasources.com/industryinsights/new-early-breast-cancer-drug-approved-by-316126.html 0.6 2026-06-23T11:49:19+08:00 daily https://www.pharmasources.com/industryinsights/gowan-company-announces-acquisition-of-t-316127.html 0.6 2026-06-27T11:51:12+08:00 daily https://www.pharmasources.com/industryinsights/cmab-biopharma-and-fapon-biopharma-sign--316128.html 0.6 2026-08-07T05:39:35+08:00 daily https://www.pharmasources.com/industryinsights/concord-medical-announces-changes-to-the-316129.html 0.6 2026-08-07T05:37:15+08:00 daily https://www.pharmasources.com/industryinsights/innovent-presents-co-developed-cancer-fi-316130.html 0.6 2026-08-07T05:31:09+08:00 daily https://www.pharmasources.com/industryinsights/innovent-biologics-announces-fda-accepta-316131.html 0.6 2026-08-07T01:11:08+08:00 daily https://www.pharmasources.com/industryinsights/biomed-x-reaches-milestone-in-respirator-316132.html 0.6 2026-08-07T01:19:58+08:00 daily https://www.pharmasources.com/industryinsights/eppendorf-with-new-ceo-dual-leadership-316133.html 0.6 2026-08-07T00:59:19+08:00 daily https://www.pharmasources.com/industryinsights/vedanta-biosciences-gets-carb-x-grant-to-316134.html 0.6 2026-08-07T02:40:46+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-generics-of-novartis-multip-316135.html 0.6 2026-08-10T08:38:57+08:00 daily https://www.pharmasources.com/industryinsights/bc-platforms-to-expand-genotyping-servic-316136.html 0.6 2026-08-07T02:48:59+08:00 daily https://www.pharmasources.com/industryinsights/hitachi-to-provide-cnao-with-proton-ther-316137.html 0.6 2026-06-21T04:19:16+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-mercks-lynparza-approved-in--316138.html 0.6 2026-07-15T08:35:25+08:00 daily https://www.pharmasources.com/industryinsights/novartis-partners-with-amazon-for-digita-316139.html 0.6 2026-08-14T14:18:20+08:00 daily https://www.pharmasources.com/industryinsights/bitbiome-to-analyse-gut-bacteria-related-316140.html 0.6 2026-06-21T06:22:13+08:00 daily https://www.pharmasources.com/industryinsights/biocon-to-unlock-affordable-access-to-in-316141.html 0.6 2026-08-07T09:56:24+08:00 daily https://www.pharmasources.com/industryinsights/bms-orencia-gets-breakthrough-status-in--316142.html 0.6 2026-06-21T07:07:57+08:00 daily https://www.pharmasources.com/industryinsights/hummingbird-bio-raises-19m-in-series-b-r-316143.html 0.6 2026-07-01T05:46:00+08:00 daily https://www.pharmasources.com/industryinsights/imcheck-raises-series-b-funds-to-develop-316144.html 0.6 2026-06-20T18:03:20+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-generic-versions-of-nova-316145.html 0.6 2026-08-13T07:20:43+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-generics-of-gilenya-316146.html 0.6 2026-06-21T03:00:42+08:00 daily https://www.pharmasources.com/industryinsights/investment-in-uk-cell-and-gene-therapy-m-316147.html 0.6 2026-06-20T22:03:46+08:00 daily https://www.pharmasources.com/industryinsights/zotiraciclib-granted-orphan-drug-designa-316148.html 0.6 2026-08-11T10:48:49+08:00 daily https://www.pharmasources.com/industryinsights/environmentally-friendly-pressurised-met-316149.html 0.6 2026-08-03T23:16:31+08:00 daily https://www.pharmasources.com/industryinsights/new-opportunities-for-indian-pharma-indu-316150.html 0.6 2026-08-04T07:46:16+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-vision-announces-new-mon-316151.html 0.6 2026-08-05T17:48:52+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-odd-to-investigational-drug-f-316152.html 0.6 2026-06-27T02:05:21+08:00 daily https://www.pharmasources.com/industryinsights/novartis-hosts-rd-day-316153.html 0.6 2026-08-10T16:12:19+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-atezolizumab-with-nab-pacli-316154.html 0.6 2026-06-20T14:41:13+08:00 daily https://www.pharmasources.com/industryinsights/ciclomed-expands-fosciclopirox-bladder-c-316155.html 0.6 2026-06-20T14:37:09+08:00 daily https://www.pharmasources.com/industryinsights/particle-measuring-systems-announces-dis-316156.html 0.6 2026-06-21T02:13:48+08:00 daily https://www.pharmasources.com/industryinsights/tetra-bio-pharma-receives-odd-for-hepato-316157.html 0.6 2026-06-20T18:56:04+08:00 daily https://www.pharmasources.com/industryinsights/leukemia-lymphoma-squarely-in-sights-of--316158.html 0.6 2025-10-26T22:56:23+08:00 daily https://www.pharmasources.com/industryinsights/first-investigational-drug-therapy-for-l-316159.html 0.6 2026-06-21T16:16:29+08:00 daily https://www.pharmasources.com/industryinsights/the-gut-may-be-involved-in-the-developme-316160.html 0.6 2026-06-21T07:46:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-launches-app-for-health-care-profess-316161.html 0.6 2026-06-28T14:28:01+08:00 daily https://www.pharmasources.com/industryinsights/olaparib-becomes-first-gene-targeted-med-316162.html 0.6 2026-06-23T03:05:06+08:00 daily https://www.pharmasources.com/industryinsights/supreme-court-upholds-kentucky-abortion--316163.html 0.6 2026-05-08T19:01:10+08:00 daily https://www.pharmasources.com/industryinsights/epidarex-exeed-founded-by-epidarex-capit-316164.html 0.6 2026-07-23T18:34:15+08:00 daily https://www.pharmasources.com/industryinsights/darzalex-daratumumab-shows-overall-survi-316165.html 0.6 2026-06-20T20:40:22+08:00 daily https://www.pharmasources.com/industryinsights/xenikos-presents-promising-new-data-from-316166.html 0.6 2026-06-21T11:05:17+08:00 daily https://www.pharmasources.com/industryinsights/aqilion-sells-shareholdings-in-portfolio-316167.html 0.6 2026-06-21T01:48:42+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2019121-316168.html 0.6 2026-08-10T11:05:53+08:00 daily https://www.pharmasources.com/industryinsights/fda-slams-repackager-for-unsupported-dru-316169.html 0.6 2026-06-20T16:56:17+08:00 daily https://www.pharmasources.com/industryinsights/farrer-park-hospital-implements-non-inva-316170.html 0.6 2026-08-08T03:03:08+08:00 daily https://www.pharmasources.com/industryinsights/townsville-hospital-treats-first-austral-316171.html 0.6 2026-06-21T09:15:09+08:00 daily https://www.pharmasources.com/industryinsights/techmah-medical-limacorporate-receive-fi-316172.html 0.6 2026-06-21T04:59:42+08:00 daily https://www.pharmasources.com/industryinsights/gracell-announces-progressive-outcomes-f-316173.html 0.6 2026-08-08T04:03:14+08:00 daily https://www.pharmasources.com/industryinsights/hebron-announces-65-million-private-plac-316174.html 0.6 2026-06-21T12:06:14+08:00 daily https://www.pharmasources.com/industryinsights/publication-of-first-in-human-data-revea-316175.html 0.6 2026-06-21T05:58:56+08:00 daily https://www.pharmasources.com/industryinsights/bj-bioscience-announces-first-patient-do-316176.html 0.6 2026-06-20T18:50:19+08:00 daily https://www.pharmasources.com/industryinsights/carsgen-therapeutics-receives-ind-cleara-316177.html 0.6 2026-07-04T04:24:00+08:00 daily https://www.pharmasources.com/industryinsights/lpg-systems-unveils-a-major-advancement--316178.html 0.6 2026-06-21T07:19:26+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-agrees-to-pay-25bn-for-biotech-fi-316179.html 0.6 2026-08-08T02:03:49+08:00 daily https://www.pharmasources.com/industryinsights/janssen-to-acquire-bermekimabs-rights-fr-316180.html 0.6 2026-06-20T23:17:35+08:00 daily https://www.pharmasources.com/industryinsights/technique-to-manufacture-virus-like-part-316181.html 0.6 2026-08-07T13:08:31+08:00 daily https://www.pharmasources.com/industryinsights/statement-from-the-fda-on-ndma-found-in--316182.html 0.6 2026-06-20T20:54:32+08:00 daily https://www.pharmasources.com/industryinsights/jj-to-provide-200000-ebola-vaccine-regim-316183.html 0.6 2026-06-21T00:15:06+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-orphan-drug-designation-to-ep-316184.html 0.6 2026-06-21T04:56:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-line-of-methotrexate-pr-316185.html 0.6 2026-06-27T22:21:05+08:00 daily https://www.pharmasources.com/industryinsights/astellas-enters-into-definitive-agreemen-316186.html 0.6 2026-06-21T08:55:58+08:00 daily https://www.pharmasources.com/industryinsights/nice-approves-new-tablet-formulation-for-316187.html 0.6 2026-06-20T22:11:07+08:00 daily https://www.pharmasources.com/industryinsights/high-levels-of-pharmaceutical-pollution--316188.html 0.6 2026-06-21T07:52:59+08:00 daily https://www.pharmasources.com/industryinsights/spero-reports-preliminary-findings-from--316189.html 0.6 2026-06-21T12:10:51+08:00 daily https://www.pharmasources.com/industryinsights/moleculin-announces-additional-positive--316190.html 0.6 2026-07-21T00:29:00+08:00 daily https://www.pharmasources.com/industryinsights/huami-corporation-announced-corporate-mi-316191.html 0.6 2026-08-07T12:45:22+08:00 daily https://www.pharmasources.com/industryinsights/fda-requires-additional-testing-of-ranit-316192.html 0.6 2026-06-21T07:14:04+08:00 daily https://www.pharmasources.com/industryinsights/carsgen-therapeutics-receives-ind-cleara-316193.html 0.6 2026-06-21T16:17:32+08:00 daily https://www.pharmasources.com/industryinsights/mayapada-clinic-accomplished-plenary-lev-316194.html 0.6 2026-07-27T23:44:04+08:00 daily https://www.pharmasources.com/industryinsights/ping-an-good-doctor-and-merck-form-strat-316195.html 0.6 2026-07-24T05:06:32+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-orphan-drug-designation-to-ap-316196.html 0.6 2026-06-08T17:55:30+08:00 daily https://www.pharmasources.com/industryinsights/announcement-of-collaborative-research-a-316197.html 0.6 2026-06-23T11:15:50+08:00 daily https://www.pharmasources.com/industryinsights/announcement-of-collaborative-research-a-316198.html 0.6 2026-06-21T12:02:14+08:00 daily https://www.pharmasources.com/industryinsights/accor-releases-thought-leading-white-pap-316199.html 0.6 2026-07-17T07:25:59+08:00 daily https://www.pharmasources.com/industryinsights/korean-ophthalmologist-oh-jungwoo-perfor-316200.html 0.6 2026-06-20T14:21:54+08:00 daily https://www.pharmasources.com/industryinsights/dong-a-st-and-beactica-therapeutics-achi-316201.html 0.6 2026-06-20T14:02:06+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-and-scripps-research-form-drug-de-316202.html 0.6 2026-07-16T20:27:00+08:00 daily https://www.pharmasources.com/industryinsights/vivera-pharma-parexel-ink-clinical-servi-316203.html 0.6 2026-06-21T05:13:52+08:00 daily https://www.pharmasources.com/industryinsights/merck-to-acquire-arqule-in-27bn-deal-316204.html 0.6 2026-07-21T16:42:59+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-partners-with-healx-for-ai-ba-316205.html 0.6 2026-07-19T10:30:57+08:00 daily https://www.pharmasources.com/industryinsights/research-shows-the-pharma-industry-belie-316206.html 0.6 2026-07-25T07:51:30+08:00 daily https://www.pharmasources.com/industryinsights/parexel-adds-experts-to-regulatory-consu-316207.html 0.6 2026-06-20T18:57:52+08:00 daily https://www.pharmasources.com/industryinsights/ema-update-non-eu-metformin-medicines-co-316208.html 0.6 2026-06-21T13:07:41+08:00 daily https://www.pharmasources.com/industryinsights/global-pharma-packaging-market-size-expe-316209.html 0.6 2026-08-13T12:30:09+08:00 daily https://www.pharmasources.com/industryinsights/indian-regulator-asks-states-to-prevent--316210.html 0.6 2026-08-07T05:05:27+08:00 daily https://www.pharmasources.com/industryinsights/medpharm-triples-capacity-at-rtp-site-316211.html 0.6 2026-07-03T16:12:52+08:00 daily https://www.pharmasources.com/industryinsights/ucb-trial-achieves-endpoints-316212.html 0.6 2026-08-07T05:05:50+08:00 daily https://www.pharmasources.com/industryinsights/trovagene-announces-data-showing-ability-316213.html 0.6 2026-08-07T04:57:27+08:00 daily https://www.pharmasources.com/industryinsights/almac-awarded-200000-bmgf-grant-316214.html 0.6 2026-06-20T14:40:18+08:00 daily https://www.pharmasources.com/industryinsights/janssen-announces-initial-results-for-bc-316215.html 0.6 2026-08-13T14:06:41+08:00 daily https://www.pharmasources.com/industryinsights/american-brivision-initiates-next-phase--316216.html 0.6 2026-08-08T03:17:14+08:00 daily https://www.pharmasources.com/industryinsights/biohaven-announces-issuance-of-compositi-316217.html 0.6 2026-07-01T14:02:09+08:00 daily https://www.pharmasources.com/industryinsights/merck-to-acquire-arqule-for-27b-316218.html 0.6 2026-06-21T11:59:09+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-establishes-us-bio-center-316219.html 0.6 2026-06-21T03:58:53+08:00 daily https://www.pharmasources.com/industryinsights/jubilant-biosys-expands-discovery-capabi-316220.html 0.6 2026-06-20T14:43:15+08:00 daily https://www.pharmasources.com/industryinsights/arecor-announces-positive-headline-resul-316221.html 0.6 2026-06-25T07:23:08+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-avsola-316222.html 0.6 2026-08-02T17:14:55+08:00 daily https://www.pharmasources.com/industryinsights/xbiotech-to-sell-anti--il-1-antibody-ber-316223.html 0.6 2026-06-21T01:46:35+08:00 daily https://www.pharmasources.com/industryinsights/kites-yescarta-yields-positive-results-i-316224.html 0.6 2026-06-20T15:54:22+08:00 daily https://www.pharmasources.com/industryinsights/calquence-significantly-prolonged-time-p-316225.html 0.6 2026-08-04T07:57:53+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibbs-liso-cel-meets-key-316226.html 0.6 2026-06-22T06:56:53+08:00 daily https://www.pharmasources.com/industryinsights/limelight-bio-emerges-with-75m-to-develo-316227.html 0.6 2026-06-21T23:02:49+08:00 daily https://www.pharmasources.com/industryinsights/fergenes-phase-3-nmibc-study-of-nadofara-316228.html 0.6 2026-03-12T15:52:32+08:00 daily https://www.pharmasources.com/industryinsights/meitheal-pharmaceuticals-announces-fda-a-316229.html 0.6 2026-06-20T21:04:42+08:00 daily https://www.pharmasources.com/industryinsights/viiv-healthcare-seeks-fda-approval-for-f-316230.html 0.6 2026-08-08T21:48:05+08:00 daily https://www.pharmasources.com/industryinsights/gatehouse-bio-collaborates-with-astrazen-316231.html 0.6 2026-08-14T14:11:07+08:00 daily https://www.pharmasources.com/industryinsights/microcapsules-for-targeted-drug-delivery-316232.html 0.6 2026-08-08T22:08:20+08:00 daily https://www.pharmasources.com/industryinsights/fresh-red-blood-cell-transfusion-no-bett-316233.html 0.6 2026-04-14T23:43:14+08:00 daily https://www.pharmasources.com/industryinsights/bullyings-vicious-circle-harms-mental-he-316234.html 0.6 2026-06-21T08:00:06+08:00 daily https://www.pharmasources.com/industryinsights/e-coli-outbreak-spurs-packaged-salad-war-316235.html 0.6 2026-06-21T01:08:54+08:00 daily https://www.pharmasources.com/industryinsights/correvio-announces-outcome-of-fda-adviso-316236.html 0.6 2026-06-21T06:12:59+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-avsola-infliximab-axxq-a-bi-316237.html 0.6 2026-06-21T23:56:39+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-regeneron-splitting-up-on-praluen-316238.html 0.6 2026-06-21T05:51:17+08:00 daily https://www.pharmasources.com/industryinsights/vetters-occupational-health-management-e-316239.html 0.6 2026-06-20T22:01:06+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-regeneron-to-simplify-antibod-316240.html 0.6 2026-07-23T15:55:26+08:00 daily https://www.pharmasources.com/industryinsights/amneal-pharmaceuticals-to-buy-majority-s-316241.html 0.6 2026-06-21T00:59:45+08:00 daily https://www.pharmasources.com/industryinsights/flagship-pioneering-launches-cellarity-f-316242.html 0.6 2026-06-23T02:57:52+08:00 daily https://www.pharmasources.com/industryinsights/ec-approves-expanded-indication-for-cyst-316243.html 0.6 2026-08-07T05:41:17+08:00 daily https://www.pharmasources.com/industryinsights/consumers-told-not-to-use-drugs-recalled-316244.html 0.6 2026-07-02T15:07:16+08:00 daily https://www.pharmasources.com/industryinsights/multiple-sclerosis-drug-market-predicted-316245.html 0.6 2026-06-20T22:14:27+08:00 daily https://www.pharmasources.com/industryinsights/microcapsules-provide-targeted-chemother-316246.html 0.6 2026-06-21T04:10:53+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-dosed-in-a-phase-1-trial-w-316247.html 0.6 2026-06-22T08:03:48+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-announces-positive-topline-dat-316248.html 0.6 2026-07-05T03:34:39+08:00 daily https://www.pharmasources.com/industryinsights/merck-to-acquire-arqule-316249.html 0.6 2026-06-21T01:14:53+08:00 daily https://www.pharmasources.com/industryinsights/fda-sends-warning-to-companies-for-offer-316250.html 0.6 2026-06-20T18:08:41+08:00 daily https://www.pharmasources.com/industryinsights/curis-announces-positive-data-in-ongoing-316251.html 0.6 2026-03-13T13:19:41+08:00 daily https://www.pharmasources.com/industryinsights/novartis-kymriah-demonstrates-consistent-316252.html 0.6 2026-06-21T04:21:15+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-to-acquire-synthorx-for-25bn-to-s-316253.html 0.6 2026-06-20T22:52:46+08:00 daily https://www.pharmasources.com/industryinsights/incheon-city-envisions-biotech-mecca-by--316254.html 0.6 2026-07-01T19:44:56+08:00 daily https://www.pharmasources.com/industryinsights/novartis-expects-to-sustain-long-term-gr-316255.html 0.6 2026-06-21T06:02:46+08:00 daily https://www.pharmasources.com/industryinsights/over-40-of-antibiotics-could-be-inapprop-316256.html 0.6 2026-06-20T17:44:24+08:00 daily https://www.pharmasources.com/industryinsights/insurance-disparities-idd-in-diagnosis-o-316257.html 0.6 2026-06-21T07:04:58+08:00 daily https://www.pharmasources.com/industryinsights/sabcs-addition-of-tucatinib-ups-survival-316258.html 0.6 2026-06-21T07:04:01+08:00 daily https://www.pharmasources.com/industryinsights/two-drugs-make-inroads-against-aggressiv-316259.html 0.6 2026-06-21T08:59:59+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-aims-to-save-2b-through-job-cuts--316260.html 0.6 2026-06-21T12:01:09+08:00 daily https://www.pharmasources.com/industryinsights/ftc-pumps-the-brakes-on-bayers-elanco-an-316261.html 0.6 2026-07-04T16:18:54+08:00 daily https://www.pharmasources.com/industryinsights/sabcs-roches-perjeta-builds-case-as-her2-316262.html 0.6 2026-06-20T15:12:20+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-joins-unicef-to-fight-child-316263.html 0.6 2026-07-05T06:59:02+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-to-debut-podcast-series-around-va-316264.html 0.6 2026-06-24T10:39:03+08:00 daily https://www.pharmasources.com/industryinsights/tighter-alcohol-laws-might-help-curb-can-316265.html 0.6 2026-06-21T00:54:04+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-to-acquire-synthorx-for-25-b-316266.html 0.6 2026-07-06T20:54:33+08:00 daily https://www.pharmasources.com/industryinsights/breastfeeding-may-bring-added-bonus-for--316267.html 0.6 2026-06-21T01:57:36+08:00 daily https://www.pharmasources.com/industryinsights/for-some-follicular-lymphoma-may-be-cura-316268.html 0.6 2026-06-21T04:56:53+08:00 daily https://www.pharmasources.com/industryinsights/solasia-enters-new-license-alliance-with-316269.html 0.6 2026-06-22T05:46:46+08:00 daily https://www.pharmasources.com/industryinsights/smart-contact-lenses-might-also-monitor--316270.html 0.6 2026-06-20T20:10:41+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-receives-chinese-marketing-n-316271.html 0.6 2026-06-21T23:56:43+08:00 daily https://www.pharmasources.com/industryinsights/cpap-mask-helps-patients-with-mild-obstr-316272.html 0.6 2026-08-08T10:10:45+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-labs-launches-generic-injectio-316273.html 0.6 2026-08-13T02:14:17+08:00 daily https://www.pharmasources.com/industryinsights/type-2-diabetes-more-common-in-patients--316274.html 0.6 2026-08-08T04:33:52+08:00 daily https://www.pharmasources.com/industryinsights/lanxess-signs-sustainable-revolving-cred-316275.html 0.6 2026-08-08T07:55:46+08:00 daily https://www.pharmasources.com/industryinsights/kilitch-drugs-to-set-up-second-green-fie-316276.html 0.6 2026-08-07T13:56:00+08:00 daily https://www.pharmasources.com/industryinsights/bluebird-bio-bristol-myers-multiple-myel-316277.html 0.6 2026-08-07T13:17:21+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-ends-research-in-diabetes-narrows-316278.html 0.6 2026-08-07T03:06:58+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-expands-cell-culture-media-cap-316279.html 0.6 2026-08-11T23:46:00+08:00 daily https://www.pharmasources.com/industryinsights/recipharm-invests-in-inhalation-developm-316280.html 0.6 2026-08-07T02:37:32+08:00 daily https://www.pharmasources.com/industryinsights/powder-flow-characterising-wet-masses-us-316281.html 0.6 2026-07-24T10:10:31+08:00 daily https://www.pharmasources.com/industryinsights/evolving-world-of-pharma-amr-pushing-hea-316282.html 0.6 2026-06-22T16:00:06+08:00 daily https://www.pharmasources.com/industryinsights/hot-list-of-onsite-conferences-at-cphi-p-316283.html 0.6 2026-08-07T02:39:44+08:00 daily https://www.pharmasources.com/industryinsights/sareptas-dmd-therapy-vyondys-53-secures--316284.html 0.6 2026-08-07T02:51:58+08:00 daily https://www.pharmasources.com/industryinsights/amgen-ucbs-evenity-receives-ec-approval--316285.html 0.6 2026-08-09T13:10:07+08:00 daily https://www.pharmasources.com/industryinsights/data-shows-non-inferiority-of-sc-adminis-316286.html 0.6 2026-06-20T20:08:42+08:00 daily https://www.pharmasources.com/industryinsights/almirall-signs-deal-for-iktos-ai-technol-316287.html 0.6 2026-06-21T06:10:09+08:00 daily https://www.pharmasources.com/industryinsights/shionogis-thrombocytopenia-drug-secures--316288.html 0.6 2026-06-20T14:55:05+08:00 daily https://www.pharmasources.com/industryinsights/fda-agrees-to-review-novartis-sbla-of-xo-316289.html 0.6 2026-06-20T15:51:37+08:00 daily https://www.pharmasources.com/industryinsights/novartis-and-forendo-enter-into-tissue-h-316290.html 0.6 2026-08-10T18:03:37+08:00 daily https://www.pharmasources.com/industryinsights/ec-approves-treatment-for-severe-osteopo-316291.html 0.6 2026-07-27T18:15:06+08:00 daily https://www.pharmasources.com/industryinsights/new-drugs-more-likely-to-be-approved-if--316292.html 0.6 2026-06-21T00:46:39+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-announces-it-will-acquire-synthor-316294.html 0.6 2026-08-07T00:40:14+08:00 daily https://www.pharmasources.com/industryinsights/pelosis-drug-pricing-bill-passes-house-o-316296.html 0.6 2026-06-20T13:19:34+08:00 daily https://www.pharmasources.com/industryinsights/psilocybin-study-shows-positive-results--316298.html 0.6 2026-08-04T07:59:58+08:00 daily https://www.pharmasources.com/industryinsights/usmca-to-stabilise-biologic-drug-prices--316299.html 0.6 2026-06-22T08:41:43+08:00 daily https://www.pharmasources.com/industryinsights/fda-issues-warning-letter-for-misreprese-316301.html 0.6 2026-06-20T21:54:34+08:00 daily https://www.pharmasources.com/industryinsights/biomedical-engineers-develop-system-that-316306.html 0.6 2026-06-21T11:44:00+08:00 daily https://www.pharmasources.com/industryinsights/tetra-bio-pharma-requests-meeting-with-f-316307.html 0.6 2026-06-21T21:57:08+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-vistagen-fast-track-designati-316308.html 0.6 2026-02-28T13:55:22+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-accelerated-approval-to-rare--316309.html 0.6 2026-07-03T20:19:46+08:00 daily https://www.pharmasources.com/industryinsights/navigen-announces-fda-clearance-of-ind-a-316310.html 0.6 2026-08-10T07:20:28+08:00 daily https://www.pharmasources.com/industryinsights/nccn-pfizer-announces-funding-for-metast-316311.html 0.6 2026-08-05T20:18:58+08:00 daily https://www.pharmasources.com/industryinsights/orthogrid-systems-receives-fda-510k-clea-316312.html 0.6 2026-07-05T06:04:50+08:00 daily https://www.pharmasources.com/industryinsights/rapt-therapeutics-announces-board-of-dir-316313.html 0.6 2026-06-22T01:44:57+08:00 daily https://www.pharmasources.com/industryinsights/darzalex-shows-overall-survival-benefit--316314.html 0.6 2026-06-21T07:17:07+08:00 daily https://www.pharmasources.com/industryinsights/diasome-announces-new-chairman-of-scient-316315.html 0.6 2026-06-20T14:40:32+08:00 daily https://www.pharmasources.com/industryinsights/giostar-in-process-of-fda-approval-for-t-316316.html 0.6 2026-06-21T12:22:57+08:00 daily https://www.pharmasources.com/industryinsights/eicosis-announces-first-subject-dosed-in-316317.html 0.6 2026-06-21T20:48:46+08:00 daily https://www.pharmasources.com/industryinsights/alkahest-presents-alzheimers-disease-stu-316318.html 0.6 2026-06-21T14:49:18+08:00 daily https://www.pharmasources.com/industryinsights/3m-to-sell-drug-delivery-business-to-alt-316319.html 0.6 2026-04-06T19:59:54+08:00 daily https://www.pharmasources.com/industryinsights/leo-pharmas-tralokinumab-meets-key-endpo-316320.html 0.6 2026-08-09T03:49:23+08:00 daily https://www.pharmasources.com/industryinsights/vedanta-biosciences-initiates-first-in-p-316321.html 0.6 2026-08-07T02:24:36+08:00 daily https://www.pharmasources.com/industryinsights/retrogenix-and-resonant-therapeutics-ann-316322.html 0.6 2026-08-09T11:25:04+08:00 daily https://www.pharmasources.com/industryinsights/ally-bridge-group-leads-more-than-us140--316323.html 0.6 2026-07-11T18:53:22+08:00 daily https://www.pharmasources.com/industryinsights/etectrx-announces-us-fda-clearance-of-no-316324.html 0.6 2026-06-22T11:31:18+08:00 daily https://www.pharmasources.com/industryinsights/at-it-china-2020-to-be-held-alongside-cp-316325.html 0.6 2026-06-22T02:54:37+08:00 daily https://www.pharmasources.com/industryinsights/jlk-inspection-ai-based-medical-firm-lis-316326.html 0.6 2026-08-04T10:50:54+08:00 daily https://www.pharmasources.com/industryinsights/zurich-malaysia-partners-with-doctoronca-316327.html 0.6 2026-06-20T20:49:43+08:00 daily https://www.pharmasources.com/industryinsights/akkad-holdings-asia-and-fks-group-announ-316328.html 0.6 2026-08-13T07:13:34+08:00 daily https://www.pharmasources.com/industryinsights/senhwa-biosciences-reports-positive-phas-316329.html 0.6 2026-08-10T15:18:29+08:00 daily https://www.pharmasources.com/industryinsights/drug-manufacturers-eye-analytical-instru-316330.html 0.6 2026-08-07T01:27:39+08:00 daily https://www.pharmasources.com/industryinsights/united-imagings-artificial-intelligence--316331.html 0.6 2026-08-10T13:09:32+08:00 daily https://www.pharmasources.com/industryinsights/hemocue-ab-the-pioneer-and-global-leader-316332.html 0.6 2026-06-20T23:01:38+08:00 daily https://www.pharmasources.com/industryinsights/world-class-performance-with-assistance--316333.html 0.6 2026-06-21T18:53:51+08:00 daily https://www.pharmasources.com/industryinsights/cstone-completes-registration-filing-for-316334.html 0.6 2026-05-07T05:26:03+08:00 daily https://www.pharmasources.com/industryinsights/mexican-society-of-public-health-smsp-si-316335.html 0.6 2026-06-21T16:17:43+08:00 daily https://www.pharmasources.com/industryinsights/biocon-biologics-symposium-on-100-years--316336.html 0.6 2026-06-30T10:03:31+08:00 daily https://www.pharmasources.com/industryinsights/human-microbiome-market-to-reach-608-bil-316337.html 0.6 2026-06-21T15:56:21+08:00 daily https://www.pharmasources.com/industryinsights/ix-biopharma-reports-on-outcome-of-wafer-316338.html 0.6 2026-06-21T08:53:06+08:00 daily https://www.pharmasources.com/industryinsights/tenth-record-breaking-year-in-a-row-for--316339.html 0.6 2026-07-24T11:11:02+08:00 daily https://www.pharmasources.com/industryinsights/gemvax-announced-phase-ii-results-of-gv1-316340.html 0.6 2026-06-21T04:49:47+08:00 daily https://www.pharmasources.com/industryinsights/xinhua-silk-road-e-china-nanjing-jiangbe-316341.html 0.6 2026-07-23T10:44:39+08:00 daily https://www.pharmasources.com/industryinsights/west-china-hospital-to-build-new-hospita-316342.html 0.6 2026-07-17T02:23:43+08:00 daily https://www.pharmasources.com/industryinsights/cstone-announces-enrollment-target-reach-316343.html 0.6 2026-07-19T13:02:18+08:00 daily https://www.pharmasources.com/industryinsights/at-it-china-2020-to-be-held-alongside-cp-316344.html 0.6 2026-06-21T03:05:41+08:00 daily https://www.pharmasources.com/industryinsights/free-tool-simplifies-cancer-research-316345.html 0.6 2026-06-21T04:48:48+08:00 daily https://www.pharmasources.com/industryinsights/agreement-with-cheplapharm-for-rights-to-316346.html 0.6 2026-06-21T17:46:15+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-accelerated-approval-to-first-316347.html 0.6 2026-06-20T14:22:52+08:00 daily https://www.pharmasources.com/industryinsights/high-tech-method-for-uniquely-targeted-g-316348.html 0.6 2026-08-10T22:59:16+08:00 daily https://www.pharmasources.com/industryinsights/the-new-polymer-can-kill-drug-resistant--316349.html 0.6 2026-06-25T13:03:05+08:00 daily https://www.pharmasources.com/industryinsights/freeman-technology-launches-a-new-websit-316350.html 0.6 2026-06-20T20:49:51+08:00 daily https://www.pharmasources.com/industryinsights/a-vaccine-against-chronic-inflammatory-d-316351.html 0.6 2026-07-05T04:04:29+08:00 daily https://www.pharmasources.com/industryinsights/trastuzumab-deruxtecan-achieved-a-tumour-316352.html 0.6 2026-06-20T23:58:39+08:00 daily https://www.pharmasources.com/industryinsights/new-set-up-for-it-at-bayer-316353.html 0.6 2026-06-20T20:11:44+08:00 daily https://www.pharmasources.com/industryinsights/promethera-closes-series-d-funding-round-316354.html 0.6 2026-06-22T08:01:53+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-receives-chmp-recommendation-for--316355.html 0.6 2026-06-20T14:51:09+08:00 daily https://www.pharmasources.com/industryinsights/viiv-healthcare-seeks-approval-for-child-316356.html 0.6 2026-06-20T13:19:34+08:00 daily https://www.pharmasources.com/industryinsights/report-links-greater-generic-competition-316357.html 0.6 2026-08-04T19:48:20+08:00 daily https://www.pharmasources.com/industryinsights/ema-recommends-five-drugs-for-approval-a-316358.html 0.6 2026-07-30T09:05:28+08:00 daily https://www.pharmasources.com/industryinsights/lilly-opens-randomized-trial-in-treatmen-316359.html 0.6 2026-08-09T07:36:52+08:00 daily https://www.pharmasources.com/industryinsights/avenue-therapeutics-announces-nda-submis-316360.html 0.6 2026-08-08T01:44:12+08:00 daily https://www.pharmasources.com/industryinsights/soligenix-initiates-clinical-trial-of-it-316361.html 0.6 2026-08-08T01:01:44+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2019121-316362.html 0.6 2026-08-07T13:19:14+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-awarded-226-million-by-hhs-to-exp-316363.html 0.6 2026-08-08T03:25:38+08:00 daily https://www.pharmasources.com/industryinsights/amneal-to-acquire-majority-interest-in-a-316364.html 0.6 2026-08-08T04:37:17+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-xcopri-for-partial-onset-se-316365.html 0.6 2026-08-08T07:52:03+08:00 daily https://www.pharmasources.com/industryinsights/novartis-fevipiprant-fails-to-meet-clini-316366.html 0.6 2026-08-09T07:57:00+08:00 daily https://www.pharmasources.com/industryinsights/consuming-ultraprocessed-food-may-up-ris-316367.html 0.6 2026-06-20T14:54:11+08:00 daily https://www.pharmasources.com/industryinsights/opioid-addicted-babies-cost-us-more-than-316368.html 0.6 2026-08-14T01:03:58+08:00 daily https://www.pharmasources.com/industryinsights/many-lung-cancer-patients-receive-meds-t-316369.html 0.6 2026-06-20T16:53:07+08:00 daily https://www.pharmasources.com/industryinsights/inflammatory-bowel-disease-ups-risk-for--316370.html 0.6 2025-10-21T00:20:04+08:00 daily https://www.pharmasources.com/industryinsights/mindfulness-program-may-help-lower-blood-316371.html 0.6 2026-06-21T18:04:25+08:00 daily https://www.pharmasources.com/industryinsights/many-long-term-breast-cancer-survivors-d-316372.html 0.6 2026-07-01T07:37:11+08:00 daily https://www.pharmasources.com/industryinsights/is-az-mercks-lynparza-approvable-in-panc-316373.html 0.6 2026-07-10T02:13:56+08:00 daily https://www.pharmasources.com/industryinsights/ferrer-unloads-another-business-to-focus-316374.html 0.6 2026-08-10T13:35:02+08:00 daily https://www.pharmasources.com/industryinsights/cancer-drug-nilotinib-shows-promise-for--316375.html 0.6 2026-06-21T03:30:21+08:00 daily https://www.pharmasources.com/industryinsights/herbalife-nutrition-study-reveals-asia-p-316376.html 0.6 2026-06-21T19:40:59+08:00 daily https://www.pharmasources.com/industryinsights/cmts-manufacturing-automation-asia-summi-316377.html 0.6 2026-06-28T18:01:49+08:00 daily https://www.pharmasources.com/industryinsights/transthera-biosciences-announces-ind-app-316378.html 0.6 2026-08-10T07:19:25+08:00 daily https://www.pharmasources.com/industryinsights/great-eastern-takaful-berhad-partners-do-316379.html 0.6 2026-06-20T14:53:04+08:00 daily https://www.pharmasources.com/industryinsights/pivotal-dreamm-2-study-demonstrated-a-cl-316380.html 0.6 2026-06-20T21:08:46+08:00 daily https://www.pharmasources.com/industryinsights/utsa-opens-call-for-entries-for-4-millio-316381.html 0.6 2026-06-21T07:45:08+08:00 daily https://www.pharmasources.com/industryinsights/volitionrx-limited-announces-strategic-a-316382.html 0.6 2026-06-19T18:34:30+08:00 daily https://www.pharmasources.com/industryinsights/eli-lillys-earnings-sales-guidance-for-2-316383.html 0.6 2026-06-20T18:22:58+08:00 daily https://www.pharmasources.com/industryinsights/triplet-therapeutics-launches-with-59-mi-316384.html 0.6 2026-07-07T19:03:12+08:00 daily https://www.pharmasources.com/industryinsights/cellestia-biotech-ag-successfully-closes-316385.html 0.6 2026-07-07T10:13:53+08:00 daily https://www.pharmasources.com/industryinsights/tergus-pharma-llc-announces-addition-of--316386.html 0.6 2026-06-20T15:13:28+08:00 daily https://www.pharmasources.com/industryinsights/transthera-biosciences-announces-ind-app-316387.html 0.6 2026-06-21T12:20:45+08:00 daily https://www.pharmasources.com/industryinsights/adial-pharmaceuticals-receives-notice-of-316388.html 0.6 2026-06-21T16:47:08+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-astellas-xtandi-garners-expanded--316389.html 0.6 2026-06-20T19:10:47+08:00 daily https://www.pharmasources.com/industryinsights/midatech-pharma-plc-announces-receipt-of-316390.html 0.6 2026-07-07T07:31:52+08:00 daily https://www.pharmasources.com/industryinsights/charles-river-laboratories-to-acquire-he-316391.html 0.6 2026-07-09T07:36:21+08:00 daily https://www.pharmasources.com/industryinsights/roche-gets-uk-and-us-clearances-for-spar-316392.html 0.6 2026-06-25T06:35:39+08:00 daily https://www.pharmasources.com/industryinsights/drug-approved-which-reduces-risk-of-card-316393.html 0.6 2026-06-21T04:55:09+08:00 daily https://www.pharmasources.com/industryinsights/survey-finds-smaller-enterprises-will-dr-316394.html 0.6 2026-06-08T07:07:13+08:00 daily https://www.pharmasources.com/industryinsights/timetable-reportedly-set-for-national-va-316395.html 0.6 2026-08-05T21:54:10+08:00 daily https://www.pharmasources.com/industryinsights/salarius-receives-fda-fast-track-designa-316396.html 0.6 2026-06-21T11:18:48+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-lilly-provides-upda-316397.html 0.6 2026-07-11T11:38:34+08:00 daily https://www.pharmasources.com/industryinsights/biohaven-achieves-positive-topline-resul-316398.html 0.6 2026-06-23T13:00:53+08:00 daily https://www.pharmasources.com/industryinsights/novartis-will-not-support-further-develo-316399.html 0.6 2026-06-21T08:05:07+08:00 daily https://www.pharmasources.com/industryinsights/aequus-medicom-healthcare-to-jointly-adv-316400.html 0.6 2026-06-21T16:04:20+08:00 daily https://www.pharmasources.com/industryinsights/new-rules-seek-to-increase-organ-transpl-316401.html 0.6 2026-06-21T07:58:56+08:00 daily https://www.pharmasources.com/industryinsights/uspstf-recommends-behavioral-counseling--316402.html 0.6 2026-06-21T04:58:45+08:00 daily https://www.pharmasources.com/industryinsights/why-colds-and-flu-seldom-strike-at-same--316403.html 0.6 2026-06-20T22:19:21+08:00 daily https://www.pharmasources.com/industryinsights/out-of-pocket-costs-for-medicare-recipie-316404.html 0.6 2026-06-21T10:01:15+08:00 daily https://www.pharmasources.com/industryinsights/shedding-pounds-may-shrink-breast-cancer-316405.html 0.6 2026-06-20T19:19:52+08:00 daily https://www.pharmasources.com/industryinsights/sae-rate-higher-with-nilotinib-versus-pl-316406.html 0.6 2026-08-05T18:42:57+08:00 daily https://www.pharmasources.com/industryinsights/anastrozole-tied-to-lasting-reduction-in-316407.html 0.6 2026-08-05T20:22:21+08:00 daily https://www.pharmasources.com/industryinsights/benzodiazepines-with-opioid-agonist-tx-m-316408.html 0.6 2026-06-21T09:06:12+08:00 daily https://www.pharmasources.com/industryinsights/early-regional-anesthesia-effective-for--316409.html 0.6 2026-07-05T18:36:09+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-astellas-xtandi-matches-jjs-erlea-316410.html 0.6 2026-06-21T18:17:48+08:00 daily https://www.pharmasources.com/industryinsights/cellestia-biotech-ag-successfully-closes-316411.html 0.6 2026-06-21T22:12:59+08:00 daily https://www.pharmasources.com/industryinsights/abcam-and-somaserve-announce-comprehensi-316412.html 0.6 2026-06-21T23:14:18+08:00 daily https://www.pharmasources.com/industryinsights/vetters-occupational-health-management-e-316413.html 0.6 2026-06-20T14:50:12+08:00 daily https://www.pharmasources.com/industryinsights/metp-pharma-receives-us-patent-for-drug--316414.html 0.6 2026-06-21T10:02:11+08:00 daily https://www.pharmasources.com/industryinsights/strategies-developed-for-improving-drug--316415.html 0.6 2026-06-20T22:53:34+08:00 daily https://www.pharmasources.com/industryinsights/campaign-calls-for-more-effort-to-combat-316416.html 0.6 2026-06-21T09:09:38+08:00 daily https://www.pharmasources.com/industryinsights/current-statin-use-may-lower-risk-for-le-316417.html 0.6 2026-06-21T07:07:57+08:00 daily https://www.pharmasources.com/industryinsights/holding-intubated-infants-in-icu-found-t-316418.html 0.6 2026-06-22T04:43:50+08:00 daily https://www.pharmasources.com/industryinsights/obesity-mediates-response-to-antiarrhyth-316419.html 0.6 2026-06-21T10:37:55+08:00 daily https://www.pharmasources.com/industryinsights/risk-for-hodgkin-lymphoma-increased-with-316420.html 0.6 2026-06-23T17:47:07+08:00 daily https://www.pharmasources.com/industryinsights/healthesdlife-enlightens-your-healthy-li-316421.html 0.6 2026-06-22T08:52:38+08:00 daily https://www.pharmasources.com/industryinsights/amaris-b-clinic-medical-director-gynecom-316422.html 0.6 2026-08-06T17:52:32+08:00 daily https://www.pharmasources.com/industryinsights/mayapada-healthcare-group-named-indonesi-316423.html 0.6 2026-06-20T23:05:42+08:00 daily https://www.pharmasources.com/industryinsights/ssur-celebrates-20-years-as-a-publicly-t-316424.html 0.6 2026-06-22T00:58:47+08:00 daily https://www.pharmasources.com/industryinsights/dr-jie-jack-li-joins-shanghai-chempartne-316425.html 0.6 2026-06-20T20:22:05+08:00 daily https://www.pharmasources.com/industryinsights/moa-technology-implements-cdd-vault-to-m-316426.html 0.6 2026-06-21T02:44:26+08:00 daily https://www.pharmasources.com/industryinsights/ferring-spinout-fergene-nabs-ipsens-davi-316427.html 0.6 2026-03-11T16:10:06+08:00 daily https://www.pharmasources.com/industryinsights/bc-platforms-partners-with-iqvia-to-exte-316428.html 0.6 2026-06-20T17:14:42+08:00 daily https://www.pharmasources.com/industryinsights/roche-launches-cobas-zika-blood-screenin-316429.html 0.6 2026-06-21T02:05:41+08:00 daily https://www.pharmasources.com/industryinsights/alteogen-enters-into-license-agreement-f-316430.html 0.6 2026-06-21T14:18:47+08:00 daily https://www.pharmasources.com/industryinsights/mit-review-recognises-20-emerging-innova-316431.html 0.6 2026-06-21T22:49:56+08:00 daily https://www.pharmasources.com/industryinsights/roches-ph-iii-cancer-immunotherapy-trial-316432.html 0.6 2026-07-16T23:50:09+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-astellas-xtandi-gets-fda-nod-316433.html 0.6 2026-06-21T01:05:52+08:00 daily https://www.pharmasources.com/industryinsights/nicox-signs-agreement-for-zerviate-in-so-316434.html 0.6 2026-06-23T16:22:32+08:00 daily https://www.pharmasources.com/industryinsights/novoheart-licenses-harvard-technology-to-316435.html 0.6 2026-07-06T22:32:19+08:00 daily https://www.pharmasources.com/industryinsights/addition-of-maintenance-olaparib-slows-a-316436.html 0.6 2026-06-20T20:57:39+08:00 daily https://www.pharmasources.com/industryinsights/fda-to-allow-states-to-import-prescripti-316437.html 0.6 2026-07-04T01:44:49+08:00 daily https://www.pharmasources.com/industryinsights/do-you-know-the-5-symptoms-of-a-heart-at-316438.html 0.6 2026-06-20T20:06:40+08:00 daily https://www.pharmasources.com/industryinsights/heart-risks-in-your-genes-be-sure-to-get-316439.html 0.6 2025-10-21T20:48:56+08:00 daily https://www.pharmasources.com/industryinsights/cannabis-use-disorder-may-up-risk-of-per-316440.html 0.6 2026-07-01T15:43:00+08:00 daily https://www.pharmasources.com/industryinsights/fenfluramine-reduces-convulsive-seizures-316441.html 0.6 2026-06-21T03:02:50+08:00 daily https://www.pharmasources.com/industryinsights/crc-screening-up-for-ages-45-to-49-after-316442.html 0.6 2026-07-27T13:24:06+08:00 daily https://www.pharmasources.com/industryinsights/deep-learning-model-predicts-future-brea-316443.html 0.6 2026-07-20T23:02:15+08:00 daily https://www.pharmasources.com/industryinsights/pregnancy-related-heart-failure-tied-to--316444.html 0.6 2026-06-21T01:39:21+08:00 daily https://www.pharmasources.com/industryinsights/spine-surgery-safely-performed-in-some-v-316445.html 0.6 2026-08-12T00:57:57+08:00 daily https://www.pharmasources.com/industryinsights/triplet-therapeutics-launches-to-focus-o-316446.html 0.6 2026-06-21T06:07:52+08:00 daily https://www.pharmasources.com/industryinsights/cruk-partners-with-vaccitech-on-nsclc-im-316447.html 0.6 2026-06-21T13:02:31+08:00 daily https://www.pharmasources.com/industryinsights/fda-advisory-committee-backs-lynparza-us-316448.html 0.6 2026-03-21T18:15:06+08:00 daily https://www.pharmasources.com/industryinsights/treatment-for-hyperkalaemia-recommended--316449.html 0.6 2026-07-17T18:05:21+08:00 daily https://www.pharmasources.com/industryinsights/ema-releases-findings-from-pharmacovigil-316450.html 0.6 2026-07-15T19:09:55+08:00 daily https://www.pharmasources.com/industryinsights/key-trends-studied-for-diabetes-drug-dev-316451.html 0.6 2026-07-08T20:14:06+08:00 daily https://www.pharmasources.com/industryinsights/dr-stephen-hahn-appointed-as-new-fda-com-316452.html 0.6 2026-06-23T06:32:05+08:00 daily https://www.pharmasources.com/industryinsights/merus-announces-chief-executive-officer--316453.html 0.6 2026-06-20T15:41:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-issues-warning-letter-to-alkermes-316454.html 0.6 2026-08-06T20:00:30+08:00 daily https://www.pharmasources.com/industryinsights/immune-therapeutics-to-acquire-aletheia--316455.html 0.6 2026-08-06T19:25:23+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-receives-ec-approval-of-rinvoq-fo-316456.html 0.6 2026-08-12T03:23:48+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-recalls-all-unexpired-lots-of-i-316457.html 0.6 2026-07-18T15:37:44+08:00 daily https://www.pharmasources.com/industryinsights/t1dm-may-up-progression-of-cac-during-me-316458.html 0.6 2026-08-06T22:08:21+08:00 daily https://www.pharmasources.com/industryinsights/exposure-to-ambient-air-pollution-may-in-316459.html 0.6 2026-08-06T22:20:53+08:00 daily https://www.pharmasources.com/industryinsights/-dimer-test-adjusted-to-clinical-probabi-316460.html 0.6 2026-08-06T22:32:00+08:00 daily https://www.pharmasources.com/industryinsights/2007-to-2014-saw-decrease-in-us-incidenc-316461.html 0.6 2026-08-06T23:32:23+08:00 daily https://www.pharmasources.com/industryinsights/exposure-to-air-pollution-may-up-mortali-316462.html 0.6 2026-08-06T23:47:13+08:00 daily https://www.pharmasources.com/industryinsights/low-dose-aspirin-may-cut-dementia-risk-i-316463.html 0.6 2026-08-06T23:55:40+08:00 daily https://www.pharmasources.com/industryinsights/breastfeeding-may-protect-against-postpa-316464.html 0.6 2026-08-12T15:58:20+08:00 daily https://www.pharmasources.com/industryinsights/antibiotic-exposure-may-be-tied-to-risk--316465.html 0.6 2026-08-14T22:52:12+08:00 daily https://www.pharmasources.com/industryinsights/gabapentin-opioids-a-deadly-duo-fda-316466.html 0.6 2026-08-07T13:17:47+08:00 daily https://www.pharmasources.com/industryinsights/antiretroviral-prescribing-in-pregnancy--316467.html 0.6 2026-08-07T14:28:25+08:00 daily https://www.pharmasources.com/industryinsights/variability-in-lumbar-fusion-surgery-dri-316468.html 0.6 2026-08-08T01:01:27+08:00 daily https://www.pharmasources.com/industryinsights/risk-score-developed-to-help-id-heart-fa-316469.html 0.6 2026-08-08T20:37:26+08:00 daily https://www.pharmasources.com/industryinsights/epizyme-submits-new-drug-application-to--316470.html 0.6 2026-08-08T22:01:41+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-padcev-enfortumab-vedotin-e-316471.html 0.6 2026-08-09T00:10:05+08:00 daily https://www.pharmasources.com/industryinsights/treatment-for-younger-adults-with-crc-im-316472.html 0.6 2026-08-09T01:19:24+08:00 daily https://www.pharmasources.com/industryinsights/menopause-linked-to-increase-in-sleep-on-316473.html 0.6 2026-08-09T04:18:27+08:00 daily https://www.pharmasources.com/industryinsights/how-mercks-desire-for-more-control-becam-316474.html 0.6 2026-08-13T05:45:55+08:00 daily https://www.pharmasources.com/industryinsights/joinn-biologics-nabs-60m-to-use-for-biol-316475.html 0.6 2026-07-31T14:34:01+08:00 daily https://www.pharmasources.com/industryinsights/food-pharma-top-10-key-trends-in-food-20-316476.html 0.6 2026-08-12T17:55:26+08:00 daily https://www.pharmasources.com/industryinsights/ceo-urges-patients-to-get-lillys-help-pa-316477.html 0.6 2026-06-20T17:17:32+08:00 daily https://www.pharmasources.com/industryinsights/old-drug-offers-new-hope-for-children-wi-316478.html 0.6 2026-06-21T08:54:56+08:00 daily https://www.pharmasources.com/industryinsights/filtered-coffee-helps-prevent-type-2-dia-316479.html 0.6 2026-06-27T12:25:25+08:00 daily https://www.pharmasources.com/industryinsights/roche-concludes-acquisition-of-spark-the-316480.html 0.6 2026-06-20T18:00:20+08:00 daily https://www.pharmasources.com/industryinsights/amylyx-pharmaceuticals-announces-amx0035-316481.html 0.6 2026-06-22T00:04:48+08:00 daily https://www.pharmasources.com/industryinsights/ec-grants-orphan-drug-status-to-dicernas-316482.html 0.6 2026-06-20T14:59:06+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-astellas-secure-expanded-fda-appr-316483.html 0.6 2026-04-19T09:35:29+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-closes-deal-with-cheplapharm-316484.html 0.6 2026-08-07T02:46:43+08:00 daily https://www.pharmasources.com/industryinsights/organovo-and-tarveda-therapeutics-announ-316485.html 0.6 2026-06-27T02:42:47+08:00 daily https://www.pharmasources.com/industryinsights/charles-river-laboratories-to-buy-hemaca-316486.html 0.6 2026-06-21T12:49:21+08:00 daily https://www.pharmasources.com/industryinsights/jardiance-phase-3-exercise-ability-studi-316487.html 0.6 2026-08-07T05:25:12+08:00 daily https://www.pharmasources.com/industryinsights/genentech-announces-results-of-imspire15-316488.html 0.6 2026-06-22T01:08:55+08:00 daily https://www.pharmasources.com/industryinsights/fda-advisory-committee-votes-unanimously-316489.html 0.6 2026-06-22T20:03:18+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-mylan-announce-two-future-viatris-316490.html 0.6 2026-08-12T12:36:35+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-german-research-center-for-ai--316491.html 0.6 2026-06-21T08:00:59+08:00 daily https://www.pharmasources.com/industryinsights/agenus-commences-trial-of-next-gen-ctla--316492.html 0.6 2026-06-22T03:56:39+08:00 daily https://www.pharmasources.com/industryinsights/vistagen-baylor-announce-successful-resu-316493.html 0.6 2026-06-26T06:39:26+08:00 daily https://www.pharmasources.com/industryinsights/windmil-announces-collaboration-with-bri-316494.html 0.6 2026-06-20T14:53:05+08:00 daily https://www.pharmasources.com/industryinsights/averitas-announces-snda-filing-for-quten-316495.html 0.6 2026-06-22T11:36:59+08:00 daily https://www.pharmasources.com/industryinsights/speeding-up-review-and-guaranteeing-paym-316496.html 0.6 2026-08-07T01:19:26+08:00 daily https://www.pharmasources.com/industryinsights/top-10-pharmaceutical-products-by-sales--316497.html 0.6 2026-07-28T04:17:25+08:00 daily https://www.pharmasources.com/industryinsights/kyowa-kirin-receives-partial-change-appr-316498.html 0.6 2026-06-23T04:46:04+08:00 daily https://www.pharmasources.com/industryinsights/monopar-therapeutics-inc-announces-full--316499.html 0.6 2026-06-20T17:59:32+08:00 daily https://www.pharmasources.com/industryinsights/new-pneumococcal-vaccine-from-serum-inst-316500.html 0.6 2026-06-20T22:07:40+08:00 daily https://www.pharmasources.com/industryinsights/xoma-announces-closing-of-rights-offerin-316501.html 0.6 2026-06-21T19:46:58+08:00 daily https://www.pharmasources.com/industryinsights/processa-pharmaceuticals-announces-1-for-316502.html 0.6 2026-06-21T09:02:02+08:00 daily https://www.pharmasources.com/industryinsights/neoleukin-therapeutics-announces-closing-316503.html 0.6 2026-07-31T05:57:52+08:00 daily https://www.pharmasources.com/industryinsights/vero-biotech-receives-us-fda-approval-of-316504.html 0.6 2026-04-23T18:47:51+08:00 daily https://www.pharmasources.com/industryinsights/avalon-globocare-partners-with-china-nan-316505.html 0.6 2026-08-09T08:55:49+08:00 daily https://www.pharmasources.com/industryinsights/oncosec-releases-presentation-spotlighti-316506.html 0.6 2026-06-22T09:08:52+08:00 daily https://www.pharmasources.com/industryinsights/beigene-cancer-drug-misses-mark-in-phase-316507.html 0.6 2026-07-06T04:11:47+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-announces-approval-for-ryaltris-316508.html 0.6 2026-06-20T16:52:05+08:00 daily https://www.pharmasources.com/industryinsights/australias-mrcf-leads-88m-funding-for-pa-316509.html 0.6 2026-06-21T18:56:57+08:00 daily https://www.pharmasources.com/industryinsights/terason-anker-biomedical-work-on-diagnos-316510.html 0.6 2026-06-21T06:03:55+08:00 daily https://www.pharmasources.com/industryinsights/merck-signs-crispr-integration-technolog-316511.html 0.6 2026-06-20T19:51:50+08:00 daily https://www.pharmasources.com/industryinsights/takeda-turnstone-biologics-to-develop-no-316512.html 0.6 2026-06-22T04:00:42+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-sells-arimidex-and-casodex-r-316513.html 0.6 2026-08-13T14:27:12+08:00 daily https://www.pharmasources.com/industryinsights/merck-secures-fda-authorisation-for-ebol-316514.html 0.6 2026-07-04T11:32:39+08:00 daily https://www.pharmasources.com/industryinsights/gbt-and-syros-team-up-on-new-therapies-f-316515.html 0.6 2026-02-03T13:26:57+08:00 daily https://www.pharmasources.com/industryinsights/syncona-invests-80m-in-freelines-systemi-316516.html 0.6 2026-04-01T07:11:57+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-astellas-seattle-genetics-b-316517.html 0.6 2026-06-20T19:01:34+08:00 daily https://www.pharmasources.com/industryinsights/vyera-licences-hiv-treatment-from-cytody-316518.html 0.6 2026-06-21T03:49:45+08:00 daily https://www.pharmasources.com/industryinsights/mhra-announces-recall-of-medley-pharma-r-316519.html 0.6 2026-06-21T01:51:43+08:00 daily https://www.pharmasources.com/industryinsights/new-drug-application-submitted-for-first-316520.html 0.6 2026-06-21T06:08:05+08:00 daily https://www.pharmasources.com/industryinsights/lumasiran-drug-achieves-primary-and-seco-316521.html 0.6 2026-06-21T07:16:14+08:00 daily https://www.pharmasources.com/industryinsights/quantum-genomics-initiates-its-trial-in--316522.html 0.6 2026-06-21T10:09:12+08:00 daily https://www.pharmasources.com/industryinsights/elamipretide-study-does-not-meet-primary-316523.html 0.6 2026-08-14T09:21:02+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-divests-arimidex-casodex-rig-316524.html 0.6 2026-06-21T11:19:37+08:00 daily https://www.pharmasources.com/industryinsights/study-confirms-breakthrough-treatment-ca-316525.html 0.6 2026-06-21T04:09:52+08:00 daily https://www.pharmasources.com/industryinsights/rezolute-announces-results-from-ab101-tr-316526.html 0.6 2026-06-21T08:07:09+08:00 daily https://www.pharmasources.com/industryinsights/nabriva-therapeutics-resubmits-nda-for-i-316527.html 0.6 2026-08-03T06:17:19+08:00 daily https://www.pharmasources.com/industryinsights/ionis-licenses-investigational-alzheimer-316528.html 0.6 2026-06-21T03:41:45+08:00 daily https://www.pharmasources.com/industryinsights/gb-sciences-announces-results-from-parki-316529.html 0.6 2026-06-21T06:20:17+08:00 daily https://www.pharmasources.com/industryinsights/amgen-allergan-submit-bla-for-biosimilar-316530.html 0.6 2026-08-10T18:59:24+08:00 daily https://www.pharmasources.com/industryinsights/genmab-curevac-enter-partnership-to-deve-316531.html 0.6 2026-07-25T14:57:05+08:00 daily https://www.pharmasources.com/industryinsights/akcea-therapeutics-announces-new-board-o-316532.html 0.6 2026-06-20T23:01:40+08:00 daily https://www.pharmasources.com/industryinsights/aravive-initiates-trial-of-avb-500-in-pa-316533.html 0.6 2026-06-22T09:54:36+08:00 daily https://www.pharmasources.com/industryinsights/molecular-templates-announces-board-of-d-316534.html 0.6 2026-06-22T12:03:49+08:00 daily https://www.pharmasources.com/industryinsights/the-2nd-chinese-produced-adalimumab-bios-316535.html 0.6 2026-08-14T04:59:16+08:00 daily https://www.pharmasources.com/industryinsights/boston-pharmaceuticals-announces-coo-app-316536.html 0.6 2026-06-22T01:58:37+08:00 daily https://www.pharmasources.com/industryinsights/fda-releases-new-drug-safety-communicati-316537.html 0.6 2026-06-20T16:56:16+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-treatment-option-for-pa-316538.html 0.6 2026-06-20T22:00:39+08:00 daily https://www.pharmasources.com/industryinsights/vitamin-d-supplementation-alone-may-not--316539.html 0.6 2026-07-04T07:19:45+08:00 daily https://www.pharmasources.com/industryinsights/rt-for-dcis-ups-mortality-risk-in-invasi-316540.html 0.6 2026-06-21T03:59:40+08:00 daily https://www.pharmasources.com/industryinsights/anifrolumab-improves-response-at-52-week-316541.html 0.6 2026-06-21T08:06:01+08:00 daily https://www.pharmasources.com/industryinsights/continuing-full-induction-regimen-not-be-316542.html 0.6 2026-06-21T19:45:46+08:00 daily https://www.pharmasources.com/industryinsights/cognitive-symptom-score-from-ehr-predict-316543.html 0.6 2026-06-20T14:48:05+08:00 daily https://www.pharmasources.com/industryinsights/recent-innovations-in-the-field-of-drug--316544.html 0.6 2026-07-23T16:32:22+08:00 daily https://www.pharmasources.com/industryinsights/harvest-in-2019-year-end-with-the-market-316545.html 0.6 2026-06-20T14:56:12+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2019122-316546.html 0.6 2026-06-21T09:04:02+08:00 daily https://www.pharmasources.com/industryinsights/janssens-esketamine-nasal-spray-approved-316547.html 0.6 2026-08-08T02:51:30+08:00 daily https://www.pharmasources.com/industryinsights/forward-science-receives-fda-clearance-f-316548.html 0.6 2026-06-30T20:46:22+08:00 daily https://www.pharmasources.com/industryinsights/sosei-heptares-announces-clinical-start--316549.html 0.6 2026-08-13T06:04:09+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-treatment-for-adults-wi-316550.html 0.6 2026-07-08T06:08:56+08:00 daily https://www.pharmasources.com/industryinsights/concert-pharmaceuticals-successfully-com-316551.html 0.6 2026-06-23T01:31:21+08:00 daily https://www.pharmasources.com/industryinsights/longeveron-completes-enrollment-for-alzh-316552.html 0.6 2026-06-15T19:51:54+08:00 daily https://www.pharmasources.com/industryinsights/cryolife-receives-fda-authorization-to-b-316553.html 0.6 2026-06-21T01:14:59+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-schizophrenia-treatment-316554.html 0.6 2026-06-21T00:03:36+08:00 daily https://www.pharmasources.com/industryinsights/syros-announces-board-of-directors-appoi-316555.html 0.6 2026-06-21T00:01:40+08:00 daily https://www.pharmasources.com/industryinsights/catalyst-biosciences-announces-global-li-316556.html 0.6 2026-06-21T04:01:51+08:00 daily https://www.pharmasources.com/industryinsights/urovant-sciences-initiates-patient-enrol-316557.html 0.6 2026-08-11T17:25:27+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-dayvigo-for-insomnia-316558.html 0.6 2026-07-13T12:58:34+08:00 daily https://www.pharmasources.com/industryinsights/sunovion-announces-fda-filing-acceptance-316559.html 0.6 2026-07-26T06:00:34+08:00 daily https://www.pharmasources.com/industryinsights/sangamo-announces-early-completion-of-tr-316560.html 0.6 2026-01-15T12:40:44+08:00 daily https://www.pharmasources.com/industryinsights/cellect-biotechnology-receives-approval--316561.html 0.6 2026-06-21T21:51:03+08:00 daily https://www.pharmasources.com/industryinsights/diversey-acquires-ahp-intellectual-prope-316562.html 0.6 2026-06-22T11:49:12+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-avatrombopag-orphan-drug-desi-316563.html 0.6 2026-05-04T13:49:42+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-accelerated-approval-to-enfor-316564.html 0.6 2026-08-06T08:59:18+08:00 daily https://www.pharmasources.com/industryinsights/e5-pharma-launches-generic-diazoxide-316565.html 0.6 2026-06-20T19:17:06+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-generics-of-eliquis-316566.html 0.6 2026-08-08T23:20:04+08:00 daily https://www.pharmasources.com/industryinsights/phathom-announces-initiation-of-trial-fo-316567.html 0.6 2026-08-08T21:49:24+08:00 daily https://www.pharmasources.com/industryinsights/gilead-submits-filgotinib-nda-for-rheuma-316568.html 0.6 2026-08-08T20:03:04+08:00 daily https://www.pharmasources.com/industryinsights/theravance-biopharma-and-pfizer-inc-ente-316569.html 0.6 2026-08-08T14:47:29+08:00 daily https://www.pharmasources.com/industryinsights/researchers-identify-immune-suppressing--316570.html 0.6 2026-08-07T13:16:11+08:00 daily https://www.pharmasources.com/industryinsights/biomarker-may-predict-cardiac-risk-in-no-316571.html 0.6 2026-08-14T10:34:00+08:00 daily https://www.pharmasources.com/industryinsights/aspirin-may-no-longer-have-effect-in-pri-316572.html 0.6 2026-08-07T01:14:12+08:00 daily https://www.pharmasources.com/industryinsights/vitamin-d-supplementation-offers-no-bene-316573.html 0.6 2026-08-07T01:21:41+08:00 daily https://www.pharmasources.com/industryinsights/long-working-hours-may-up-risk-for-maske-316574.html 0.6 2026-08-07T02:05:32+08:00 daily https://www.pharmasources.com/industryinsights/age-at-obesity-onset-tied-to-risk-for-ty-316575.html 0.6 2026-08-07T00:42:52+08:00 daily https://www.pharmasources.com/industryinsights/sleep-fragmentation-linked-to-odds-of-mi-316576.html 0.6 2026-08-07T00:41:24+08:00 daily https://www.pharmasources.com/industryinsights/emmaus-life-sciences-announces-update-of-316577.html 0.6 2026-08-07T00:15:39+08:00 daily https://www.pharmasources.com/industryinsights/newlink-genetics-announces-exclusive-wor-316578.html 0.6 2026-08-07T00:02:57+08:00 daily https://www.pharmasources.com/industryinsights/bioasis-completes-bridge-financing-trans-316579.html 0.6 2026-08-12T20:01:43+08:00 daily https://www.pharmasources.com/industryinsights/gilead-and-eisai-enter-into-agreement-in-316580.html 0.6 2026-08-06T23:54:19+08:00 daily https://www.pharmasources.com/industryinsights/alembic-pharmaceuticals-announces-usfda--316581.html 0.6 2026-08-06T23:47:44+08:00 daily https://www.pharmasources.com/industryinsights/westcot-ventures-corp-announces-closing--316582.html 0.6 2026-08-06T21:52:19+08:00 daily https://www.pharmasources.com/industryinsights/ibio-announces-collaboration-with-edgepo-316583.html 0.6 2026-08-06T21:47:29+08:00 daily https://www.pharmasources.com/industryinsights/injection-of-virus-delivered-gene-silenc-316584.html 0.6 2026-08-09T21:04:45+08:00 daily https://www.pharmasources.com/industryinsights/sosei-heptares-announces-nomination-of-a-316585.html 0.6 2026-08-06T23:37:21+08:00 daily https://www.pharmasources.com/industryinsights/briacell-therapeutics-corp-announces-sha-316586.html 0.6 2026-08-14T23:08:32+08:00 daily https://www.pharmasources.com/industryinsights/cel-sci-prices-55-million-underwritten-p-316587.html 0.6 2026-08-06T23:55:58+08:00 daily https://www.pharmasources.com/industryinsights/lineage-cell-therapeutics-enters-into-th-316588.html 0.6 2026-08-12T23:06:29+08:00 daily https://www.pharmasources.com/industryinsights/first-interoperable-automated-insulin-do-316589.html 0.6 2026-06-21T03:06:43+08:00 daily https://www.pharmasources.com/industryinsights/arcus-collaborates-with-genentech-for-tw-316590.html 0.6 2026-08-11T21:18:52+08:00 daily https://www.pharmasources.com/industryinsights/considerable-misunderstanding-surrounds--316591.html 0.6 2026-06-21T02:06:43+08:00 daily https://www.pharmasources.com/industryinsights/prenatal-smoking-raises-risk-for-gestati-316592.html 0.6 2026-06-20T23:04:48+08:00 daily https://www.pharmasources.com/industryinsights/transplant-outcomes-similar-with-lungs-f-316593.html 0.6 2026-08-07T21:42:01+08:00 daily https://www.pharmasources.com/industryinsights/heart-tissue-may-be-harmed-by-heavy-drin-316594.html 0.6 2026-06-21T04:09:52+08:00 daily https://www.pharmasources.com/industryinsights/could-your-indigestion-be-gerd-316595.html 0.6 2026-06-20T19:20:01+08:00 daily https://www.pharmasources.com/industryinsights/kids-microbiome-may-play-key-role-in-ast-316597.html 0.6 2026-08-05T23:22:27+08:00 daily https://www.pharmasources.com/industryinsights/one-third-of-lung-cancer-patients-battle-316598.html 0.6 2026-06-21T03:50:39+08:00 daily https://www.pharmasources.com/industryinsights/could-obesity-alter-a-childs-brain-struc-316599.html 0.6 2026-06-20T15:49:06+08:00 daily https://www.pharmasources.com/industryinsights/focusing-on-cutting-edge-biopharmaceutic-316600.html 0.6 2026-06-26T06:26:01+08:00 daily https://www.pharmasources.com/industryinsights/half-of-patients-on-ppis-for-gerd-still--316601.html 0.6 2026-04-06T07:03:06+08:00 daily https://www.pharmasources.com/industryinsights/obesity-may-up-cardiotoxicity-risk-from--316602.html 0.6 2026-06-29T05:16:25+08:00 daily https://www.pharmasources.com/industryinsights/endocrine-society-releases-hypoglycemia--316603.html 0.6 2026-08-13T02:21:05+08:00 daily https://www.pharmasources.com/industryinsights/vitamin-e-acetate-idd-in-lungs-of-most-v-316604.html 0.6 2026-06-21T19:14:21+08:00 daily https://www.pharmasources.com/industryinsights/astro-issues-recs-for-radiation-tx-of-ba-316605.html 0.6 2026-03-12T22:01:14+08:00 daily https://www.pharmasources.com/industryinsights/healthy-sleep-pattern-may-reduce-risk-fo-316606.html 0.6 2026-06-20T21:01:39+08:00 daily https://www.pharmasources.com/industryinsights/acupuncture-acupressure-may-help-cancer--316607.html 0.6 2026-08-09T08:00:00+08:00 daily https://www.pharmasources.com/industryinsights/ubrogepant-relieves-pain-symptoms-of-acu-316608.html 0.6 2026-08-07T13:17:42+08:00 daily https://www.pharmasources.com/industryinsights/about-one-in-three-in-ed-for-low-back-pa-316609.html 0.6 2026-08-07T20:22:15+08:00 daily https://www.pharmasources.com/industryinsights/pet-helps-tailor-therapy-in-limited-stag-316610.html 0.6 2026-08-07T05:37:03+08:00 daily https://www.pharmasources.com/industryinsights/bc-platforms-closes-15-million-series-c--316611.html 0.6 2026-08-06T23:32:18+08:00 daily https://www.pharmasources.com/industryinsights/vaccitech-oncology-limited-enters-collab-316612.html 0.6 2026-08-06T23:37:17+08:00 daily https://www.pharmasources.com/industryinsights/mc2-therapeutics-announces-positive-top--316613.html 0.6 2026-08-06T23:54:40+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-establishes-scientific-advisor-316614.html 0.6 2026-08-07T13:17:40+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-and-the-german-research-center-316615.html 0.6 2026-08-08T07:57:00+08:00 daily https://www.pharmasources.com/industryinsights/aglaia-oncology-funds-and-sinzer---grant-316616.html 0.6 2026-08-08T21:33:17+08:00 daily https://www.pharmasources.com/industryinsights/new-cardiogenic-shock-staging-system-ids-316617.html 0.6 2026-08-07T13:55:34+08:00 daily https://www.pharmasources.com/industryinsights/allohsct-feasible-after-pd-1-pd-l1-mab-i-316618.html 0.6 2026-08-07T13:17:48+08:00 daily https://www.pharmasources.com/industryinsights/endovascular-avf-for-dialysis-access-sho-316619.html 0.6 2026-08-08T02:37:02+08:00 daily https://www.pharmasources.com/industryinsights/potentially-nephrotoxic-meds-prescribed--316620.html 0.6 2026-08-07T11:21:07+08:00 daily https://www.pharmasources.com/industryinsights/drugs-for-tb-hypertension-and-antacids-a-316621.html 0.6 2026-08-07T10:52:55+08:00 daily https://www.pharmasources.com/industryinsights/aytu-bioscience-and-innovus-pharmaceutic-316622.html 0.6 2026-08-07T06:07:03+08:00 daily https://www.pharmasources.com/industryinsights/bridgebio-stock-up-60-so-far-in-dec-ipo--316623.html 0.6 2026-08-07T00:41:05+08:00 daily https://www.pharmasources.com/industryinsights/taking-certain-vitamins-during-breast-ca-316624.html 0.6 2026-08-07T00:02:36+08:00 daily https://www.pharmasources.com/industryinsights/abeona-announces-closing-of-1035-million-316625.html 0.6 2026-08-06T23:55:55+08:00 daily https://www.pharmasources.com/industryinsights/correvio-receives-fda-complete-response--316626.html 0.6 2026-08-07T03:06:34+08:00 daily https://www.pharmasources.com/industryinsights/lineage-cell-therapeutics-enters-into-th-316627.html 0.6 2026-08-12T17:49:19+08:00 daily https://www.pharmasources.com/industryinsights/als-awareness-project-led-by-an-als-pati-316628.html 0.6 2026-08-07T03:48:40+08:00 daily https://www.pharmasources.com/industryinsights/viva-biotech-awarded-top-10-public-compa-316629.html 0.6 2026-08-07T04:05:06+08:00 daily https://www.pharmasources.com/industryinsights/towa-pharmaceutical-co-ltd-reaches-an-ag-316630.html 0.6 2026-08-10T02:05:30+08:00 daily https://www.pharmasources.com/industryinsights/holmusk-and-nhcs-extend-collaboration-to-316631.html 0.6 2026-06-22T17:02:40+08:00 daily https://www.pharmasources.com/industryinsights/iview-announces-first-patient-treated-in-316632.html 0.6 2026-06-20T18:10:33+08:00 daily https://www.pharmasources.com/industryinsights/neurovive-completes-recruitment-in-the-s-316633.html 0.6 2026-06-21T19:29:42+08:00 daily https://www.pharmasources.com/industryinsights/saluda-medical-results-of-us-evoke-pivot-316634.html 0.6 2026-06-20T16:47:15+08:00 daily https://www.pharmasources.com/industryinsights/chinas-largest-plasmid-and-virus-facilit-316635.html 0.6 2026-06-30T19:35:36+08:00 daily https://www.pharmasources.com/industryinsights/could-you-be-allergic-to-additives-316636.html 0.6 2026-06-30T21:27:20+08:00 daily https://www.pharmasources.com/industryinsights/improved-oral-hygiene-may-cut-risk-for-h-316637.html 0.6 2026-06-21T12:05:44+08:00 daily https://www.pharmasources.com/industryinsights/end-stage-renal-disease-patients-at-high-316638.html 0.6 2026-06-20T23:01:45+08:00 daily https://www.pharmasources.com/industryinsights/palmoplantar-pustulosis-confirmed-as-orp-316639.html 0.6 2026-07-03T04:28:32+08:00 daily https://www.pharmasources.com/industryinsights/non-hdl-cholesterol-levels-linked-to-lon-316640.html 0.6 2026-07-08T21:42:41+08:00 daily https://www.pharmasources.com/industryinsights/permanent-hair-dye-use-linked-to-increas-316641.html 0.6 2026-06-21T13:03:36+08:00 daily https://www.pharmasources.com/industryinsights/first-line-osimertinib-may-up-survival-i-316642.html 0.6 2026-06-26T10:22:07+08:00 daily https://www.pharmasources.com/industryinsights/brachytherapy-treats-skin-cancer-in-elde-316643.html 0.6 2026-07-06T21:14:45+08:00 daily https://www.pharmasources.com/industryinsights/bariatric-surgery-may-raise-risk-for-col-316644.html 0.6 2026-06-21T18:57:45+08:00 daily https://www.pharmasources.com/industryinsights/pharmacist-led-interventions-cut-cardiov-316645.html 0.6 2026-06-21T08:02:01+08:00 daily https://www.pharmasources.com/industryinsights/effects-of-omega-3-fish-oil-mixed-for-ad-316646.html 0.6 2026-08-07T09:02:12+08:00 daily https://www.pharmasources.com/industryinsights/receipt-of-anticoagulant-rx-in-ed-linked-316647.html 0.6 2026-06-21T14:22:41+08:00 daily https://www.pharmasources.com/industryinsights/many-patients-overestimate-the-benefits--316648.html 0.6 2026-06-20T20:48:45+08:00 daily https://www.pharmasources.com/industryinsights/duration-of-diabetes-history-tied-to-hig-316649.html 0.6 2026-06-21T21:05:57+08:00 daily https://www.pharmasources.com/industryinsights/half-of-us-physicians-recommend-compleme-316650.html 0.6 2026-07-09T02:29:09+08:00 daily https://www.pharmasources.com/industryinsights/fewer-cases-of-radiation-induced-xerosto-316651.html 0.6 2026-08-10T11:04:26+08:00 daily https://www.pharmasources.com/industryinsights/purified-cbd-may-help-treat-drug-resista-316652.html 0.6 2026-06-25T03:39:48+08:00 daily https://www.pharmasources.com/industryinsights/access-to-high-cost-targeted-treatments--316653.html 0.6 2026-08-05T21:39:51+08:00 daily https://www.pharmasources.com/industryinsights/single-antidepressant-dose-of-intravenou-316654.html 0.6 2026-08-13T05:51:49+08:00 daily https://www.pharmasources.com/industryinsights/organ-transplant-does-not-worsen-prostat-316655.html 0.6 2026-06-20T20:44:21+08:00 daily https://www.pharmasources.com/industryinsights/breast-cancer-rates-opposite-for-estroge-316656.html 0.6 2026-07-03T23:37:29+08:00 daily https://www.pharmasources.com/industryinsights/incidence-of-nontuberculous-mycobacteria-316657.html 0.6 2026-06-20T15:12:14+08:00 daily https://www.pharmasources.com/industryinsights/evidence-supports-use-of-high-dose-aspir-316658.html 0.6 2026-06-21T02:14:53+08:00 daily https://www.pharmasources.com/industryinsights/mental-health-disorders-may-affect-hip-a-316659.html 0.6 2026-06-21T03:12:54+08:00 daily https://www.pharmasources.com/industryinsights/moderate-physical-activity-tied-to-lower-316660.html 0.6 2026-06-19T13:52:23+08:00 daily https://www.pharmasources.com/industryinsights/factors-predict-adverse-opioid-related-o-316661.html 0.6 2026-06-21T07:00:04+08:00 daily https://www.pharmasources.com/industryinsights/model-may-predict-barrett-esophagus-diag-316662.html 0.6 2026-06-24T19:46:39+08:00 daily https://www.pharmasources.com/industryinsights/results-mixed-for-twice-daily-apbi-in-ea-316663.html 0.6 2026-06-23T22:28:50+08:00 daily https://www.pharmasources.com/industryinsights/frailty-may-worsen-outcomes-in-traumatic-316664.html 0.6 2026-06-20T19:01:35+08:00 daily https://www.pharmasources.com/industryinsights/t2dm-risk-cut-with-weight-loss-even-in-n-316665.html 0.6 2026-06-20T21:54:20+08:00 daily https://www.pharmasources.com/industryinsights/gsks-long-acting-hiv-injectable-hits-fda-316666.html 0.6 2026-08-08T21:02:55+08:00 daily https://www.pharmasources.com/industryinsights/az-daiichi-grab-blockbuster-nod-for-brea-316667.html 0.6 2026-07-25T19:51:40+08:00 daily https://www.pharmasources.com/industryinsights/eisai-preps-for-launch-with-insomnia-med-316668.html 0.6 2026-08-08T02:35:26+08:00 daily https://www.pharmasources.com/industryinsights/psychological-safety-at-work-tied-to-hos-316669.html 0.6 2026-07-02T01:38:10+08:00 daily https://www.pharmasources.com/industryinsights/many-hospitals-fail-to-provide-instructi-316670.html 0.6 2026-06-20T18:00:19+08:00 daily https://www.pharmasources.com/industryinsights/marginal-increase-in-pcp-access-after-ac-316671.html 0.6 2026-06-21T09:13:09+08:00 daily https://www.pharmasources.com/industryinsights/regular-cannabis-use-may-cause-adverse-c-316672.html 0.6 2025-11-10T14:03:23+08:00 daily https://www.pharmasources.com/industryinsights/sleep-disturbances-may-trigger-migraine-316673.html 0.6 2026-01-16T14:46:15+08:00 daily https://www.pharmasources.com/industryinsights/regular-exercise-cuts-odds-for-7-major-c-316674.html 0.6 2026-08-12T14:25:23+08:00 daily https://www.pharmasources.com/industryinsights/could-brain-scans-spot-childrens-mood-at-316675.html 0.6 2026-06-20T22:55:35+08:00 daily https://www.pharmasources.com/industryinsights/older-blood-safe-as-new-blood-for-transf-316676.html 0.6 2026-06-08T19:49:04+08:00 daily https://www.pharmasources.com/industryinsights/intermittent-fasting-diet-could-boost-yo-316677.html 0.6 2026-08-10T15:12:11+08:00 daily https://www.pharmasources.com/industryinsights/fatty-diets-tied-to-leading-cause-of-vis-316678.html 0.6 2026-08-06T22:42:21+08:00 daily https://www.pharmasources.com/industryinsights/car-exhaust-may-up-high-blood-pressure-r-316679.html 0.6 2026-08-09T23:54:40+08:00 daily https://www.pharmasources.com/industryinsights/polygenic-risk-score-more-strongly-linke-316680.html 0.6 2026-08-07T02:05:08+08:00 daily https://www.pharmasources.com/industryinsights/patients-ok-with-use-of-checklist-prior--316681.html 0.6 2026-08-07T01:52:09+08:00 daily https://www.pharmasources.com/industryinsights/survival-up-for-chronic-lymphocytic-leuk-316682.html 0.6 2026-08-07T01:49:06+08:00 daily https://www.pharmasources.com/industryinsights/overdose-relapse-after-buprenorphine-dis-316683.html 0.6 2026-08-07T01:42:47+08:00 daily https://www.pharmasources.com/industryinsights/antioxidant-supplement-use-may-worsen-br-316684.html 0.6 2026-08-07T01:39:33+08:00 daily https://www.pharmasources.com/industryinsights/most-children-do-not-have-positive-resul-316685.html 0.6 2026-08-07T01:27:43+08:00 daily https://www.pharmasources.com/industryinsights/receipt-of-surgery-for-early-nsclc-varie-316686.html 0.6 2026-08-07T01:21:55+08:00 daily https://www.pharmasources.com/industryinsights/obstructive-sleep-apnea-may-be-underdiag-316687.html 0.6 2026-08-08T23:42:20+08:00 daily https://www.pharmasources.com/industryinsights/early-onset-cvd-rate-up-for-children-of--316688.html 0.6 2026-08-07T13:15:30+08:00 daily https://www.pharmasources.com/industryinsights/strength-training-tied-to-less-weight-lo-316689.html 0.6 2026-08-07T13:57:51+08:00 daily https://www.pharmasources.com/industryinsights/refined-carbs-may-up-insomnia-risk-in-po-316690.html 0.6 2026-07-02T18:35:04+08:00 daily https://www.pharmasources.com/industryinsights/hba1c-minimally-adds-to-cvd-risk-predict-316691.html 0.6 2026-06-30T16:13:05+08:00 daily https://www.pharmasources.com/industryinsights/tivozanib-bests-sorafenib-in-metastatic--316692.html 0.6 2026-06-20T19:00:35+08:00 daily https://www.pharmasources.com/industryinsights/achieve-life-sciences-completes-fda-meet-316693.html 0.6 2026-08-14T07:59:31+08:00 daily https://www.pharmasources.com/industryinsights/censa-announces-cnsa-001-met-primary-and-316694.html 0.6 2026-08-08T05:29:25+08:00 daily https://www.pharmasources.com/industryinsights/rafael-expands-cpi-613-trial-316695.html 0.6 2026-06-24T05:35:55+08:00 daily https://www.pharmasources.com/industryinsights/cumberland-receives-fda-approval-for-red-316696.html 0.6 2026-06-21T09:51:24+08:00 daily https://www.pharmasources.com/industryinsights/breckenridge-announces-final-approval-of-316697.html 0.6 2026-08-08T01:41:22+08:00 daily https://www.pharmasources.com/industryinsights/eton-announces-commercial-availability-o-316698.html 0.6 2026-06-20T16:47:17+08:00 daily https://www.pharmasources.com/industryinsights/therapix-biosciences-announces-continued-316699.html 0.6 2026-07-05T13:50:56+08:00 daily https://www.pharmasources.com/industryinsights/mylan-biocon-launch-trastuzumab-biosimil-316700.html 0.6 2026-08-03T03:34:42+08:00 daily https://www.pharmasources.com/industryinsights/orchard-therapeutics-announces-maa-filin-316701.html 0.6 2026-06-22T02:53:55+08:00 daily https://www.pharmasources.com/industryinsights/ose-immunotherapeutics-haliodx-announce--316702.html 0.6 2026-07-27T07:42:11+08:00 daily https://www.pharmasources.com/industryinsights/owp-announces-second-ind-approval-for-la-316703.html 0.6 2026-06-20T14:47:04+08:00 daily https://www.pharmasources.com/industryinsights/marijuana-use-for-ms-tied-to-legal-permi-316704.html 0.6 2026-06-22T04:55:39+08:00 daily https://www.pharmasources.com/industryinsights/depression-may-worsen-qol-in-rheumatoid--316705.html 0.6 2026-06-22T06:00:40+08:00 daily https://www.pharmasources.com/industryinsights/protection-similar-with-single-multiple--316706.html 0.6 2026-06-21T16:04:18+08:00 daily https://www.pharmasources.com/industryinsights/methylmercury-toxicity-found-from-skin-l-316707.html 0.6 2026-06-21T12:12:21+08:00 daily https://www.pharmasources.com/industryinsights/acupuncture-may-ease-a-common-side-effec-316708.html 0.6 2026-08-06T02:17:01+08:00 daily https://www.pharmasources.com/industryinsights/could-one-dose-of-hpv-vaccine-be-enough-316709.html 0.6 2026-06-22T11:40:35+08:00 daily https://www.pharmasources.com/industryinsights/public-insurance-tied-to-lower-cancer-su-316710.html 0.6 2026-06-22T04:00:40+08:00 daily https://www.pharmasources.com/industryinsights/risk-based-approach-could-help-target-pr-316711.html 0.6 2026-06-20T22:52:43+08:00 daily https://www.pharmasources.com/industryinsights/bariatric-surgery-in-teens-may-cut-diabe-316712.html 0.6 2026-06-21T10:48:05+08:00 daily https://www.pharmasources.com/industryinsights/prescribing-practices-can-mitigate-opioi-316713.html 0.6 2026-06-21T09:45:57+08:00 daily https://www.pharmasources.com/industryinsights/liposuction-benefits-women-with-lipedema-316714.html 0.6 2026-08-14T22:09:54+08:00 daily https://www.pharmasources.com/industryinsights/magnesium-inversely-linked-to-risk-for-c-316715.html 0.6 2026-06-20T23:06:45+08:00 daily https://www.pharmasources.com/industryinsights/bmi-survival-linked-in-nsclc-treated-wit-316716.html 0.6 2026-04-06T21:59:47+08:00 daily https://www.pharmasources.com/industryinsights/machine-learning-model-helps-predict-ris-316717.html 0.6 2026-08-08T12:02:52+08:00 daily https://www.pharmasources.com/industryinsights/infertility-risk-increased-for-men-born--316718.html 0.6 2026-06-21T05:46:29+08:00 daily https://www.pharmasources.com/industryinsights/lexicon-completes-safety-review-of-telot-316719.html 0.6 2026-06-21T12:22:05+08:00 daily https://www.pharmasources.com/industryinsights/sk-life-science-announces-ind-applicatio-316720.html 0.6 2026-07-02T23:54:18+08:00 daily https://www.pharmasources.com/industryinsights/sinusonic-clinical-trial-data-shows-safe-316721.html 0.6 2026-06-21T04:56:49+08:00 daily https://www.pharmasources.com/industryinsights/seelos-announces-dosing-of-phase-i-pkpd--316722.html 0.6 2026-06-23T11:57:47+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-divests-rights-to-seroquel-s-316723.html 0.6 2026-06-25T06:43:36+08:00 daily https://www.pharmasources.com/industryinsights/cara-therapeutics-announces-positive-top-316724.html 0.6 2026-07-13T13:53:00+08:00 daily https://www.pharmasources.com/industryinsights/ose-immunotherapeutics-announces-positiv-316725.html 0.6 2026-07-14T10:16:29+08:00 daily https://www.pharmasources.com/industryinsights/evolving-world-of-pharma-focal-points-in-316726.html 0.6 2026-06-21T09:49:02+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-drug-padcev-to-treat-lo-316727.html 0.6 2026-08-11T08:34:45+08:00 daily https://www.pharmasources.com/industryinsights/more-doubt-that-plaques-in-the-brain-cau-316728.html 0.6 2026-06-26T11:41:42+08:00 daily https://www.pharmasources.com/industryinsights/insecticides-tied-to-heart-disease-death-316729.html 0.6 2026-07-19T22:55:47+08:00 daily https://www.pharmasources.com/industryinsights/gastric-sleeve-tied-to-lower-risk-for-su-316730.html 0.6 2026-08-06T19:00:11+08:00 daily https://www.pharmasources.com/industryinsights/high-lipoproteina-is-risk-factor-for-cvd-316731.html 0.6 2026-06-21T21:00:41+08:00 daily https://www.pharmasources.com/industryinsights/poor-diet-contributes-substantially-to-c-316732.html 0.6 2026-07-02T11:04:06+08:00 daily https://www.pharmasources.com/industryinsights/obesity-may-boost-effectiveness-of-a-lun-316733.html 0.6 2026-06-22T02:37:23+08:00 daily https://www.pharmasources.com/industryinsights/samoa-ends-state-of-emergency-over-measl-316734.html 0.6 2026-06-21T08:05:01+08:00 daily https://www.pharmasources.com/industryinsights/intervention-cuts-preoperative-anxiety-i-316735.html 0.6 2026-06-08T21:06:42+08:00 daily https://www.pharmasources.com/industryinsights/yoga-has-positive-effect-on-brain-struct-316736.html 0.6 2026-06-12T01:49:49+08:00 daily https://www.pharmasources.com/industryinsights/number-of-children-with-opioid-poisoning-316737.html 0.6 2026-06-21T01:02:45+08:00 daily https://www.pharmasources.com/industryinsights/multiple-health-benefits-reported-for-in-316738.html 0.6 2026-08-12T12:33:00+08:00 daily https://www.pharmasources.com/industryinsights/inflammation-linked-to-thyroid-dysfuncti-316739.html 0.6 2026-08-10T01:24:12+08:00 daily https://www.pharmasources.com/industryinsights/dense-breast-notifications-may-not-be-ha-316740.html 0.6 2026-08-09T02:38:48+08:00 daily https://www.pharmasources.com/industryinsights/pharmacies-leave-customers-hanging-when--316741.html 0.6 2026-08-08T10:49:59+08:00 daily https://www.pharmasources.com/industryinsights/allergan-scores-year-end-cgrp-nod-for-mi-316742.html 0.6 2026-08-08T05:09:52+08:00 daily https://www.pharmasources.com/industryinsights/intra-cellular-nabs-nod-for-schizophreni-316743.html 0.6 2026-08-07T13:17:15+08:00 daily https://www.pharmasources.com/industryinsights/register-as-visitor-to-cphi-china-2020-316744.html 0.6 2026-08-07T12:03:16+08:00 daily https://www.pharmasources.com/industryinsights/lilly-opens-phase-3-clinical-trial-in-re-316745.html 0.6 2026-08-12T19:12:46+08:00 daily https://www.pharmasources.com/industryinsights/spring-bank-stops-dosing-of-inarigivir-p-316746.html 0.6 2026-08-07T04:22:22+08:00 daily https://www.pharmasources.com/industryinsights/zai-lab-announces-nmpa-approval-of-zejul-316747.html 0.6 2026-08-07T04:07:11+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-acquires-taris-biomedica-316748.html 0.6 2026-08-07T03:55:10+08:00 daily https://www.pharmasources.com/industryinsights/titan-pharmaceuticals-announces-board-of-316749.html 0.6 2026-08-07T03:35:01+08:00 daily https://www.pharmasources.com/industryinsights/fortress-biotech-announces-agreement-wit-316750.html 0.6 2026-08-07T04:04:17+08:00 daily https://www.pharmasources.com/industryinsights/how-are-your-newborns-ears-working-early-316751.html 0.6 2026-06-24T05:39:26+08:00 daily https://www.pharmasources.com/industryinsights/many-drugstores-misinform-on-disposal-of-316752.html 0.6 2026-08-07T01:52:06+08:00 daily https://www.pharmasources.com/industryinsights/patients-often-bring-undetected-superbug-316753.html 0.6 2026-08-07T01:45:44+08:00 daily https://www.pharmasources.com/industryinsights/opioid-meth-habit-particularly-hard-to-b-316754.html 0.6 2026-08-07T23:02:44+08:00 daily https://www.pharmasources.com/industryinsights/stomach-cancer-appears-different-in-youn-316755.html 0.6 2026-06-27T22:43:17+08:00 daily https://www.pharmasources.com/industryinsights/experimental-drug-could-be-new-option-ag-316756.html 0.6 2026-06-21T00:53:49+08:00 daily https://www.pharmasources.com/industryinsights/nurses-can-help-manage-drug-interactions-316757.html 0.6 2026-06-23T13:23:07+08:00 daily https://www.pharmasources.com/industryinsights/frailty-score-may-predict-outcomes-in-mu-316758.html 0.6 2026-06-20T17:02:13+08:00 daily https://www.pharmasources.com/industryinsights/antiepileptic-drug-exposure-low-in-breas-316759.html 0.6 2026-08-13T15:40:24+08:00 daily https://www.pharmasources.com/industryinsights/severity-of-autism-symptoms-may-vary-in--316760.html 0.6 2026-06-21T08:52:16+08:00 daily https://www.pharmasources.com/industryinsights/machine-learning-system-makes-more-alert-316761.html 0.6 2026-06-21T02:12:47+08:00 daily https://www.pharmasources.com/industryinsights/miv-711-no-better-than-placebo-for-pain--316762.html 0.6 2026-06-23T01:02:29+08:00 daily https://www.pharmasources.com/industryinsights/subtle-cognitive-difficulties-may-predic-316763.html 0.6 2026-03-15T09:58:00+08:00 daily https://www.pharmasources.com/industryinsights/study-shows-link-between-atopic-dermatit-316764.html 0.6 2026-08-07T01:06:15+08:00 daily https://www.pharmasources.com/industryinsights/fmri-measures-may-predict-psychiatric-sy-316765.html 0.6 2026-06-20T14:31:05+08:00 daily https://www.pharmasources.com/industryinsights/incidence-of-early-onset-gastric-cancer--316766.html 0.6 2026-06-25T08:21:19+08:00 daily https://www.pharmasources.com/industryinsights/maternal-exposure-to-organic-pollutants--316767.html 0.6 2026-06-21T12:52:21+08:00 daily https://www.pharmasources.com/industryinsights/endoscopic-approaches-feasible-in-surger-316768.html 0.6 2026-04-28T13:52:26+08:00 daily https://www.pharmasources.com/industryinsights/neither-psychotherapy-nor-medications-fa-316769.html 0.6 2025-11-10T10:12:42+08:00 daily https://www.pharmasources.com/industryinsights/cases-of-flu-continue-to-mount-across-am-316770.html 0.6 2026-06-21T11:22:56+08:00 daily https://www.pharmasources.com/industryinsights/breast-density-alerts-might-not-be-helpi-316771.html 0.6 2026-06-20T23:57:36+08:00 daily https://www.pharmasources.com/industryinsights/young-cancer-patients-fare-better-on-pri-316772.html 0.6 2026-06-20T19:11:49+08:00 daily https://www.pharmasources.com/industryinsights/big-advances-made-against-diabetes-in-20-316773.html 0.6 2026-06-21T13:01:59+08:00 daily https://www.pharmasources.com/industryinsights/could-the-family-dog-lower-a-childs-odds-316774.html 0.6 2026-07-02T05:16:33+08:00 daily https://www.pharmasources.com/industryinsights/lynparza-approved-by-fda-to-treat-germli-316775.html 0.6 2026-06-21T11:57:14+08:00 daily https://www.pharmasources.com/industryinsights/who-announces-first-biosimilar-medicine--316776.html 0.6 2026-08-11T11:14:16+08:00 daily https://www.pharmasources.com/industryinsights/intravenous-delivery-of-tb-vaccine-found-316777.html 0.6 2026-06-21T19:17:06+08:00 daily https://www.pharmasources.com/industryinsights/ema-announces-launch-of-collaborative-pi-316778.html 0.6 2026-08-08T01:48:27+08:00 daily https://www.pharmasources.com/industryinsights/novadoz-pharmaceuticals-receives-fda-go--316779.html 0.6 2026-06-23T00:56:31+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-olaparib-for-gbrcam-metasta-316780.html 0.6 2026-06-23T17:28:08+08:00 daily https://www.pharmasources.com/industryinsights/durect-announces-top-line-results-from-p-316781.html 0.6 2026-06-21T14:47:16+08:00 daily https://www.pharmasources.com/industryinsights/adamas-announces-settlement-of-patent-li-316782.html 0.6 2026-07-23T20:54:50+08:00 daily https://www.pharmasources.com/industryinsights/npxe-files-voluntary-chapter-11-316783.html 0.6 2026-06-21T13:15:41+08:00 daily https://www.pharmasources.com/industryinsights/aurobindo-pharma-recalls-mirtazapine-tab-316784.html 0.6 2026-06-22T05:39:43+08:00 daily https://www.pharmasources.com/industryinsights/researchers-determine-how-a-specific-pro-316785.html 0.6 2026-06-16T15:54:43+08:00 daily https://www.pharmasources.com/industryinsights/mental-distress-depression-prevalent-in--316786.html 0.6 2026-06-22T11:51:44+08:00 daily https://www.pharmasources.com/industryinsights/apoa-lrx-found-to-reduce-lipoproteina-le-316787.html 0.6 2026-07-04T03:32:45+08:00 daily https://www.pharmasources.com/industryinsights/guidance-developed-for-providing-quality-316788.html 0.6 2026-06-23T18:23:54+08:00 daily https://www.pharmasources.com/industryinsights/diabetes-mellitus-may-increase-risk-for--316789.html 0.6 2026-06-22T01:08:58+08:00 daily https://www.pharmasources.com/industryinsights/survivors-of-childhood-cancers-at-risk-f-316790.html 0.6 2026-06-20T22:16:58+08:00 daily https://www.pharmasources.com/industryinsights/gene-therapy-may-be-long-term-cure-for-t-316791.html 0.6 2026-02-09T04:22:19+08:00 daily https://www.pharmasources.com/industryinsights/study-might-point-alzheimers-research-in-316792.html 0.6 2026-06-21T12:50:12+08:00 daily https://www.pharmasources.com/industryinsights/nurse-certification-may-promote-evidence-316793.html 0.6 2026-07-05T06:45:06+08:00 daily https://www.pharmasources.com/industryinsights/leisure-time-physical-activity-linked-to-316794.html 0.6 2026-06-22T03:59:45+08:00 daily https://www.pharmasources.com/industryinsights/ai-system-outperforms-radiologists-in-br-316795.html 0.6 2026-03-20T16:52:15+08:00 daily https://www.pharmasources.com/industryinsights/patient-experiences-modestly-worse-after-316796.html 0.6 2026-06-21T09:13:09+08:00 daily https://www.pharmasources.com/industryinsights/abstinence-from-alcohol-cuts-arrhythmia--316797.html 0.6 2026-06-20T22:36:17+08:00 daily https://www.pharmasources.com/industryinsights/tau-pet-signal-predicts-atrophy-in-early-316798.html 0.6 2026-06-22T23:31:41+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-to-lay-off-field-staffers-as-i-316799.html 0.6 2026-06-22T07:49:52+08:00 daily https://www.pharmasources.com/industryinsights/az-mercks-lynparza-lands-fda-nod-in-panc-316800.html 0.6 2026-08-13T01:48:10+08:00 daily https://www.pharmasources.com/industryinsights/mentholated-popsicle-can-help-reduce-pre-316801.html 0.6 2026-07-24T21:03:37+08:00 daily https://www.pharmasources.com/industryinsights/new-workflow-could-improve-imaging-asses-316802.html 0.6 2026-06-21T00:55:43+08:00 daily https://www.pharmasources.com/industryinsights/recall-of-pacemaker-in-nov-2015-was-dela-316803.html 0.6 2026-06-14T14:12:34+08:00 daily https://www.pharmasources.com/industryinsights/111-inc-to-attend-the-jp-morgan-2020-hea-316804.html 0.6 2026-06-21T13:00:37+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-biopharma-announces-dosing-of-firs-316805.html 0.6 2026-06-24T04:48:19+08:00 daily https://www.pharmasources.com/industryinsights/china-sxt-pharmaceuticals-inc-received-n-316806.html 0.6 2026-07-22T22:53:23+08:00 daily https://www.pharmasources.com/industryinsights/huami-corporation-ceo-issues-open-letter-316807.html 0.6 2026-07-22T02:48:40+08:00 daily https://www.pharmasources.com/industryinsights/agritalk-integrates-biotechnology-iot-bi-316808.html 0.6 2026-06-22T01:52:31+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-sta-opens-oligonucleotide-large-sca-316809.html 0.6 2026-08-02T00:54:42+08:00 daily https://www.pharmasources.com/industryinsights/cf-pharmtech-closes-us-90-million-financ-316810.html 0.6 2026-08-03T21:49:12+08:00 daily https://www.pharmasources.com/industryinsights/111-named-316811.html 0.6 2026-08-02T20:34:34+08:00 daily https://www.pharmasources.com/industryinsights/panzhihua-china-creating-a-new-benchmark-316812.html 0.6 2026-07-30T22:51:42+08:00 daily https://www.pharmasources.com/industryinsights/gracell-to-present-at-the-38th-annual-jp-316813.html 0.6 2026-06-21T02:57:42+08:00 daily https://www.pharmasources.com/industryinsights/foresee-x-augment-reality-solution-from--316814.html 0.6 2026-06-21T01:53:33+08:00 daily https://www.pharmasources.com/industryinsights/new-major-order-from-china-316815.html 0.6 2026-07-15T05:10:43+08:00 daily https://www.pharmasources.com/industryinsights/official-launch-of-sino-singapore-biotec-316816.html 0.6 2026-07-19T16:05:34+08:00 daily https://www.pharmasources.com/industryinsights/bridge-biotherapeutics-announces-china-n-316817.html 0.6 2026-07-15T11:35:38+08:00 daily https://www.pharmasources.com/industryinsights/genscript-and-selecxine-enter-into-strat-316818.html 0.6 2026-07-01T23:24:52+08:00 daily https://www.pharmasources.com/industryinsights/the-13th-dongzhi-ejiao-festival-held-in--316819.html 0.6 2026-07-24T06:08:52+08:00 daily https://www.pharmasources.com/industryinsights/onconova-therapeutics-announces-closing--316820.html 0.6 2026-08-10T15:20:19+08:00 daily https://www.pharmasources.com/industryinsights/charles-river-laboratories-completes-the-316821.html 0.6 2026-08-09T09:17:11+08:00 daily https://www.pharmasources.com/industryinsights/leap-therapeutics-and-beigene-announce-e-316822.html 0.6 2026-07-04T04:50:30+08:00 daily https://www.pharmasources.com/industryinsights/azurrx-biopharma-announces-appointment-o-316823.html 0.6 2026-07-02T12:40:21+08:00 daily https://www.pharmasources.com/industryinsights/momenta-pharmaceuticals-announces-cfo-tr-316824.html 0.6 2026-07-02T12:43:15+08:00 daily https://www.pharmasources.com/industryinsights/report-indicates-seasonal-influenza-vacc-316825.html 0.6 2026-07-08T14:02:00+08:00 daily https://www.pharmasources.com/industryinsights/fda-announces-us-recall-of-mirtazapine-t-316826.html 0.6 2026-06-30T21:12:42+08:00 daily https://www.pharmasources.com/industryinsights/nice-issues-draft-guidance-finding-negat-316827.html 0.6 2026-06-21T12:59:27+08:00 daily https://www.pharmasources.com/industryinsights/over-250-drug-list-prices-increased-in-2-316828.html 0.6 2026-08-08T00:33:54+08:00 daily https://www.pharmasources.com/industryinsights/obi-pharma-granted-orphan-drug-designati-316829.html 0.6 2026-08-08T02:02:09+08:00 daily https://www.pharmasources.com/industryinsights/lineage-provides-update-on-opregen-clini-316830.html 0.6 2026-06-21T13:20:03+08:00 daily https://www.pharmasources.com/industryinsights/pulmatrix-announces-agreement-with-lung--316831.html 0.6 2026-06-21T04:57:44+08:00 daily https://www.pharmasources.com/industryinsights/astellas-acquires-xyphos-biosciences-316832.html 0.6 2026-08-07T23:05:40+08:00 daily https://www.pharmasources.com/industryinsights/janssen-completes-acquisition-of-investi-316833.html 0.6 2026-08-10T14:42:39+08:00 daily https://www.pharmasources.com/industryinsights/itacitinib-study-for-treatment-nave-acut-316834.html 0.6 2026-06-20T20:10:43+08:00 daily https://www.pharmasources.com/industryinsights/scientists-find-a-new-use-for-already-kn-316835.html 0.6 2026-06-21T12:15:37+08:00 daily https://www.pharmasources.com/industryinsights/ozone-wood-smoke-raise-odds-of-copd-in-s-316836.html 0.6 2026-06-22T07:48:50+08:00 daily https://www.pharmasources.com/industryinsights/exercise-may-keep-your-brain-healthy-316837.html 0.6 2026-07-01T14:32:56+08:00 daily https://www.pharmasources.com/industryinsights/treating-oral-disease-could-yield-t2dm-r-316838.html 0.6 2026-06-21T13:32:30+08:00 daily https://www.pharmasources.com/industryinsights/routine-hpv-testing-may-be-warranted-for-316839.html 0.6 2026-08-05T16:17:06+08:00 daily https://www.pharmasources.com/industryinsights/donor-heart-acceptance-practices-vary-ac-316840.html 0.6 2026-06-21T16:16:51+08:00 daily https://www.pharmasources.com/industryinsights/severe-hypoglycemia-in-seniors-with-t1dm-316841.html 0.6 2026-06-20T19:20:08+08:00 daily https://www.pharmasources.com/industryinsights/us-saw-big-rise-in-meth-fentanyl-use-in--316842.html 0.6 2026-06-20T20:08:47+08:00 daily https://www.pharmasources.com/industryinsights/ai-beat-humans-in-spotting-breast-tumors-316843.html 0.6 2026-07-09T09:46:15+08:00 daily https://www.pharmasources.com/industryinsights/coffee-consumption-does-not-affect-insul-316844.html 0.6 2026-06-21T20:16:50+08:00 daily https://www.pharmasources.com/industryinsights/new-continuous-glucose-monitor-may-cut-h-316845.html 0.6 2026-08-13T21:39:57+08:00 daily https://www.pharmasources.com/industryinsights/peripheral-nervous-system-events-not-com-316846.html 0.6 2026-08-07T02:19:25+08:00 daily https://www.pharmasources.com/industryinsights/adverse-events-decreased-with-proton-che-316847.html 0.6 2026-08-07T02:22:04+08:00 daily https://www.pharmasources.com/industryinsights/public-policy-recs-updated-for-familial--316848.html 0.6 2026-08-07T02:30:59+08:00 daily https://www.pharmasources.com/industryinsights/cardiorespiratory-fitness-linked-to-gray-316849.html 0.6 2026-08-09T06:58:40+08:00 daily https://www.pharmasources.com/industryinsights/phytomedicine-saffron-in-the-treatment-o-316850.html 0.6 2026-07-05T18:40:07+08:00 daily https://www.pharmasources.com/industryinsights/individualized-pt-can-reduce-incontinenc-316851.html 0.6 2026-08-10T17:23:18+08:00 daily https://www.pharmasources.com/industryinsights/gsk-consolidates-pfizer-consumer-brands--316852.html 0.6 2026-06-22T07:58:49+08:00 daily https://www.pharmasources.com/industryinsights/lab-finds-ndma-in-zantac-can-develop-dur-316853.html 0.6 2026-06-22T10:45:39+08:00 daily https://www.pharmasources.com/industryinsights/the-fda-drug-decisions-to-watch-in-the-f-316854.html 0.6 2026-01-05T08:38:54+08:00 daily https://www.pharmasources.com/industryinsights/chinas-first-innovative-drug-for-alzheim-316855.html 0.6 2026-07-14T07:39:12+08:00 daily https://www.pharmasources.com/industryinsights/happiness-biotech-announces-the-opening--316856.html 0.6 2026-07-25T09:09:40+08:00 daily https://www.pharmasources.com/industryinsights/inovio-provides-update-on-clinical-progr-316857.html 0.6 2026-06-21T07:14:13+08:00 daily https://www.pharmasources.com/industryinsights/antengene-corporation-appoints-former-ce-316858.html 0.6 2026-06-20T19:52:35+08:00 daily https://www.pharmasources.com/industryinsights/12th-consecutive-year-leading-united-sta-316859.html 0.6 2026-06-27T21:33:14+08:00 daily https://www.pharmasources.com/industryinsights/bavencio-significantly-improved-overall--316860.html 0.6 2026-06-21T06:57:56+08:00 daily https://www.pharmasources.com/industryinsights/dr-nalini-rajamannan-comments-on-fda-con-316861.html 0.6 2026-06-23T04:21:21+08:00 daily https://www.pharmasources.com/industryinsights/lianluo-smart-announces-receipt-of-nasda-316862.html 0.6 2026-07-20T01:02:49+08:00 daily https://www.pharmasources.com/industryinsights/carsgen-appoints-yong-fan-as-senior-vice-316863.html 0.6 2026-04-29T03:05:50+08:00 daily https://www.pharmasources.com/industryinsights/abcam-announces-successful-acquisition-o-316864.html 0.6 2026-06-21T06:21:20+08:00 daily https://www.pharmasources.com/industryinsights/gphls-international-headquarters-settle--316865.html 0.6 2026-07-15T11:45:32+08:00 daily https://www.pharmasources.com/industryinsights/nunaps-raises-us42m-to-develop-patient-c-316866.html 0.6 2026-06-21T01:52:39+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-secures-fda-priority-review--316867.html 0.6 2026-06-21T03:10:51+08:00 daily https://www.pharmasources.com/industryinsights/beigene-obtains-certain-rights-for-leap--316868.html 0.6 2026-06-21T01:12:57+08:00 daily https://www.pharmasources.com/industryinsights/true-north-acquires-3-stake-in-biologics-316869.html 0.6 2026-06-20T14:45:00+08:00 daily https://www.pharmasources.com/industryinsights/three-more-companies-raise-their-us-drug-316870.html 0.6 2026-07-05T02:12:01+08:00 daily https://www.pharmasources.com/industryinsights/adopting-new-guidelines-could-get-medici-316871.html 0.6 2026-06-20T19:58:36+08:00 daily https://www.pharmasources.com/industryinsights/first-company-awarded-market-authorisati-316872.html 0.6 2026-06-27T01:45:06+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2020010-316873.html 0.6 2026-06-22T07:56:09+08:00 daily https://www.pharmasources.com/industryinsights/fda-issues-warning-letter-which-highligh-316874.html 0.6 2026-08-11T15:56:42+08:00 daily https://www.pharmasources.com/industryinsights/savara-granted-breakthrough-therapy-desi-316875.html 0.6 2026-06-21T15:12:04+08:00 daily https://www.pharmasources.com/industryinsights/sinovac-announces-approval-of-varicella--316876.html 0.6 2026-07-18T10:03:33+08:00 daily https://www.pharmasources.com/industryinsights/4d-announce-new-study-of-mrx0518-in-panc-316877.html 0.6 2026-06-20T14:47:01+08:00 daily https://www.pharmasources.com/industryinsights/farxiga-granted-fda-priority-review-for--316878.html 0.6 2026-07-16T11:35:54+08:00 daily https://www.pharmasources.com/industryinsights/amgen-commences-strategic-collaboration--316879.html 0.6 2026-06-28T16:47:21+08:00 daily https://www.pharmasources.com/industryinsights/testosterone-supplements-wont-help-most--316880.html 0.6 2026-06-21T13:02:57+08:00 daily https://www.pharmasources.com/industryinsights/laser-based-imaging-ai-may-diagnose-brai-316881.html 0.6 2026-06-21T02:52:01+08:00 daily https://www.pharmasources.com/industryinsights/2014-to-2016-saw-decline-in-us-adults-pr-316882.html 0.6 2026-06-23T01:25:00+08:00 daily https://www.pharmasources.com/industryinsights/2008-to-2015-saw-out-of-pocket-spending--316883.html 0.6 2026-06-21T15:08:54+08:00 daily https://www.pharmasources.com/industryinsights/medical-bookkeeping-costs-us-812-billion-316884.html 0.6 2026-06-30T22:54:58+08:00 daily https://www.pharmasources.com/industryinsights/one-big-roadblock-to-opioid-addiction-tr-316885.html 0.6 2026-08-06T01:51:01+08:00 daily https://www.pharmasources.com/industryinsights/out-of-pocket-medical-costs-average-4500-316886.html 0.6 2026-07-27T23:51:08+08:00 daily https://www.pharmasources.com/industryinsights/many-girls-young-women-getting-unnecessa-316887.html 0.6 2026-06-20T17:59:20+08:00 daily https://www.pharmasources.com/industryinsights/weight-loss-surgery-might-also-lower-ski-316888.html 0.6 2026-06-21T11:07:15+08:00 daily https://www.pharmasources.com/industryinsights/statins-may-do-double-duty-on-heart-dise-316889.html 0.6 2026-06-22T12:11:10+08:00 daily https://www.pharmasources.com/industryinsights/opioid-use-by-teens-a-red-flag-for-other-316890.html 0.6 2026-08-07T13:19:46+08:00 daily https://www.pharmasources.com/industryinsights/one-cycle-be500p-seems-safe-for-high-ris-316891.html 0.6 2026-08-07T02:22:16+08:00 daily https://www.pharmasources.com/industryinsights/study-explores-factors-affecting-glycemi-316892.html 0.6 2026-08-07T01:27:49+08:00 daily https://www.pharmasources.com/industryinsights/allergan-to-fork-over-a-hefty-300m-to-wr-316893.html 0.6 2026-08-07T01:22:05+08:00 daily https://www.pharmasources.com/industryinsights/greater-fort-lauderdale-where-life-scien-316894.html 0.6 2026-08-07T01:14:23+08:00 daily https://www.pharmasources.com/industryinsights/the-top-10-largest-biopharma-ma-deals-in-316895.html 0.6 2026-08-14T22:12:03+08:00 daily https://www.pharmasources.com/industryinsights/important-progresses-of-new-drugs-market-316896.html 0.6 2026-08-07T01:06:45+08:00 daily https://www.pharmasources.com/industryinsights/galen-acquires-nordic-based-poa-pharma-i-316897.html 0.6 2026-08-07T02:30:35+08:00 daily https://www.pharmasources.com/industryinsights/cancer-research-uk-to-fund-bicycles-immu-316898.html 0.6 2026-08-07T02:33:34+08:00 daily https://www.pharmasources.com/industryinsights/tyme-and-eagle-pharmaceuticals-partner-f-316899.html 0.6 2026-08-10T13:10:44+08:00 daily https://www.pharmasources.com/industryinsights/apollomics-buys-aml-programme-rights-in--316900.html 0.6 2026-06-20T15:58:27+08:00 daily https://www.pharmasources.com/industryinsights/mhra-grants-licence-update-for-ipsens-dy-316901.html 0.6 2026-08-11T00:26:55+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-novo-nordisks-fiasp-for-dia-316902.html 0.6 2026-06-21T12:01:19+08:00 daily https://www.pharmasources.com/industryinsights/merck-collaborates-on-small-molecule-inh-316903.html 0.6 2026-06-21T08:05:08+08:00 daily https://www.pharmasources.com/industryinsights/cancer-immunotherapy-market-to-hit-115bn-316904.html 0.6 2026-06-20T22:17:00+08:00 daily https://www.pharmasources.com/industryinsights/the-advance-value-framework-evaluating-t-316905.html 0.6 2026-06-23T19:33:31+08:00 daily https://www.pharmasources.com/industryinsights/project-to-investigate-environmental-imp-316906.html 0.6 2026-06-22T05:56:37+08:00 daily https://www.pharmasources.com/industryinsights/mhra-approves-cerebral-palsy-spasticity--316907.html 0.6 2026-06-22T03:31:32+08:00 daily https://www.pharmasources.com/industryinsights/top-five-pharma-companies-saw-overall-de-316908.html 0.6 2026-06-20T15:30:22+08:00 daily https://www.pharmasources.com/industryinsights/acute-myeloid-leukemia-treatment-receive-316909.html 0.6 2026-07-29T10:52:15+08:00 daily https://www.pharmasources.com/industryinsights/internally-developed-vaccines-reportedly-316910.html 0.6 2026-08-08T01:35:08+08:00 daily https://www.pharmasources.com/industryinsights/astellas-has-announced-its-acquisition-o-316911.html 0.6 2026-08-07T11:48:24+08:00 daily https://www.pharmasources.com/industryinsights/funding-for-ai-in-drug-development-clini-316912.html 0.6 2026-07-07T10:07:28+08:00 daily https://www.pharmasources.com/industryinsights/fda-announces-new-centre-to-improve-comp-316913.html 0.6 2026-06-24T07:38:38+08:00 daily https://www.pharmasources.com/industryinsights/agenus-commences-phase-1-trial-with-agen-316914.html 0.6 2026-06-26T21:50:54+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-pembrolizumab-for-bladder-c-316915.html 0.6 2026-06-30T23:43:45+08:00 daily https://www.pharmasources.com/industryinsights/mirati-announces-executive-management-ch-316916.html 0.6 2026-06-21T10:04:09+08:00 daily https://www.pharmasources.com/industryinsights/connect-biopharma-reports-positive-data--316917.html 0.6 2026-06-20T15:38:22+08:00 daily https://www.pharmasources.com/industryinsights/microcures-awarded-grant-for-therapeutic-316918.html 0.6 2026-06-21T10:11:16+08:00 daily https://www.pharmasources.com/industryinsights/aspirin-appears-to-curb-colorectal-cance-316919.html 0.6 2026-06-21T04:57:43+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-completes-divestmen-316920.html 0.6 2026-06-21T01:39:21+08:00 daily https://www.pharmasources.com/industryinsights/researchers-develop-universal-flu-vaccin-316921.html 0.6 2026-06-20T16:58:19+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-farxiga-gets-fda-priority-r-316922.html 0.6 2026-06-21T04:55:38+08:00 daily https://www.pharmasources.com/industryinsights/veristat-strengthens-its-european-presen-316923.html 0.6 2026-06-22T21:48:47+08:00 daily https://www.pharmasources.com/industryinsights/charles-river-laboratories-wraps-up-380m-316924.html 0.6 2026-06-20T22:05:38+08:00 daily https://www.pharmasources.com/industryinsights/evolving-world-of-pharma-patient-centric-316925.html 0.6 2026-06-25T11:16:23+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-and-almirall-sign-strateg-316926.html 0.6 2026-08-12T19:25:59+08:00 daily https://www.pharmasources.com/industryinsights/alma-a-sisram-medical-company-launches-d-316928.html 0.6 2026-01-16T02:21:07+08:00 daily https://www.pharmasources.com/industryinsights/the-largest-full-marathon-in-chinathe-20-316929.html 0.6 2026-08-03T23:42:08+08:00 daily https://www.pharmasources.com/industryinsights/daewoong-infion-obtained-worlds-first-ha-316930.html 0.6 2026-07-03T18:02:15+08:00 daily https://www.pharmasources.com/industryinsights/publication-of-a-toxicological-study-a-m-316931.html 0.6 2026-08-07T05:01:22+08:00 daily https://www.pharmasources.com/industryinsights/symmetry-surgical-inc-acquires-the-or-co-316932.html 0.6 2026-08-07T04:34:53+08:00 daily https://www.pharmasources.com/industryinsights/waters-corporation-lauded-by-frost-sulli-316933.html 0.6 2026-08-07T04:31:06+08:00 daily https://www.pharmasources.com/industryinsights/transcenta-holding-secures-100-million-s-316934.html 0.6 2026-08-07T04:21:54+08:00 daily https://www.pharmasources.com/industryinsights/former-celgene-chairman-and-ceo-mark-j-a-316935.html 0.6 2026-08-07T04:03:55+08:00 daily https://www.pharmasources.com/industryinsights/connect-biopharma-reports-positive-topli-316936.html 0.6 2026-08-07T04:17:59+08:00 daily https://www.pharmasources.com/industryinsights/cstone-announces-first-patient-dosed-in--316937.html 0.6 2026-06-20T22:15:51+08:00 daily https://www.pharmasources.com/industryinsights/hummingbird-bioscience-publishes-preclin-316938.html 0.6 2026-08-07T04:49:03+08:00 daily https://www.pharmasources.com/industryinsights/innovent-and-sirnaomics-entered-strategi-316939.html 0.6 2026-08-07T13:16:18+08:00 daily https://www.pharmasources.com/industryinsights/rapid-diagnostics-announces-completion-o-316940.html 0.6 2026-08-07T02:46:32+08:00 daily https://www.pharmasources.com/industryinsights/rising-demand-for-iot-enabled-pumps-to-d-316941.html 0.6 2026-08-07T02:40:31+08:00 daily https://www.pharmasources.com/industryinsights/gracell-initiates-investigational-study--316942.html 0.6 2026-08-07T02:30:52+08:00 daily https://www.pharmasources.com/industryinsights/say-no-to-food-allergies-taiwan-china-us-316943.html 0.6 2026-08-07T02:30:43+08:00 daily https://www.pharmasources.com/industryinsights/seneca-biopharma-announces-presentations-316944.html 0.6 2026-08-07T02:36:50+08:00 daily https://www.pharmasources.com/industryinsights/gcam-adds-new-plasma-collection-center-316945.html 0.6 2026-08-07T02:52:03+08:00 daily https://www.pharmasources.com/industryinsights/volitionrx-completes-acquisition-of-octa-316946.html 0.6 2026-08-10T17:34:22+08:00 daily https://www.pharmasources.com/industryinsights/cumberland-extracts-hemp-facility-earns--316947.html 0.6 2026-06-22T06:56:45+08:00 daily https://www.pharmasources.com/industryinsights/jorjin-and-gigabyte-join-forces-to-showc-316948.html 0.6 2025-12-07T08:07:42+08:00 daily https://www.pharmasources.com/industryinsights/led-by-taiwan-china-tech-arena-luftqi-is-316949.html 0.6 2026-07-06T21:04:35+08:00 daily https://www.pharmasources.com/industryinsights/neurobo-pharmaceuticals-and-gemphire-the-316950.html 0.6 2026-08-07T13:22:05+08:00 daily https://www.pharmasources.com/industryinsights/novus-therapeutics-announces-exercise-of-316951.html 0.6 2026-07-17T14:34:52+08:00 daily https://www.pharmasources.com/industryinsights/alphaeon-corporation-completes-reorganiz-316952.html 0.6 2026-08-03T15:40:32+08:00 daily https://www.pharmasources.com/industryinsights/alnylam-initiates-rolling-submission-of--316953.html 0.6 2026-06-22T10:59:52+08:00 daily https://www.pharmasources.com/industryinsights/single-dose-of-antibodies-can-knock-out--316954.html 0.6 2026-08-07T00:40:00+08:00 daily https://www.pharmasources.com/industryinsights/syndax-pharmaceuticals-highlights-2020-c-316955.html 0.6 2026-08-07T00:02:36+08:00 daily https://www.pharmasources.com/industryinsights/janssen-expands-research-development-pre-316956.html 0.6 2026-08-06T23:55:23+08:00 daily https://www.pharmasources.com/industryinsights/anp-technologies-in-partnership-with-ful-316957.html 0.6 2026-08-07T00:02:49+08:00 daily https://www.pharmasources.com/industryinsights/bayer-and-azitra-partner-to-harness-the--316958.html 0.6 2026-08-08T19:41:12+08:00 daily https://www.pharmasources.com/industryinsights/launch-of-anticancer-agent-halaven-in-ch-316959.html 0.6 2026-08-10T12:40:26+08:00 daily https://www.pharmasources.com/industryinsights/recipharm-extends-the-acceptance-period--316960.html 0.6 2026-08-09T16:32:53+08:00 daily https://www.pharmasources.com/industryinsights/bw-therapeutics-announces-opening-of-ser-316961.html 0.6 2026-06-21T00:03:43+08:00 daily https://www.pharmasources.com/industryinsights/blueprint-medicines-secures-fda-approval-316962.html 0.6 2026-06-20T22:56:55+08:00 daily https://www.pharmasources.com/industryinsights/evotec-and-bayer-to-develop-polycystic-o-316963.html 0.6 2026-07-03T02:04:26+08:00 daily https://www.pharmasources.com/industryinsights/aro-biotherapeutics-signs-licensing-agre-316964.html 0.6 2026-06-21T09:15:23+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-astellas-mycamine-supplemen-316965.html 0.6 2026-08-08T08:01:37+08:00 daily https://www.pharmasources.com/industryinsights/altavant-sciences-acquires-onspira-thera-316966.html 0.6 2026-06-20T20:09:39+08:00 daily https://www.pharmasources.com/industryinsights/almirall-signs-option-agreement-to-acqui-316967.html 0.6 2026-06-20T20:20:59+08:00 daily https://www.pharmasources.com/industryinsights/mina-therapeutics-astrazeneca-partner-fo-316968.html 0.6 2026-06-21T12:59:31+08:00 daily https://www.pharmasources.com/industryinsights/t-cell-lymphomas-treatment-trial-update--316969.html 0.6 2026-06-20T17:51:45+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-packaging-equipment-marke-316970.html 0.6 2026-08-03T03:47:06+08:00 daily https://www.pharmasources.com/industryinsights/us-study-investigates-how-medicines-can--316971.html 0.6 2026-08-10T12:38:08+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-ayvakit-the-first-targeted--316972.html 0.6 2026-08-07T12:12:13+08:00 daily https://www.pharmasources.com/industryinsights/governor-of-california-proposes-state-ru-316973.html 0.6 2026-08-07T00:02:39+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-snda-for-candidiasis-treatm-316974.html 0.6 2026-08-07T10:58:08+08:00 daily https://www.pharmasources.com/industryinsights/supply-chain-and-drug-pricing-reform-req-316975.html 0.6 2026-08-08T22:58:33+08:00 daily https://www.pharmasources.com/industryinsights/nanoparticle-gene-therapy-drug-delivery--316976.html 0.6 2026-08-06T23:45:20+08:00 daily https://www.pharmasources.com/industryinsights/nice-argue-for-more-histology-independen-316977.html 0.6 2026-08-06T23:36:00+08:00 daily https://www.pharmasources.com/industryinsights/fda-announces-one-nizatidine-and-two-ran-316978.html 0.6 2026-08-06T23:32:25+08:00 daily https://www.pharmasources.com/industryinsights/tyme-announces-first-patient-dosed-in-me-316979.html 0.6 2026-08-06T22:53:30+08:00 daily https://www.pharmasources.com/industryinsights/mercaptor-announces-epilepsy-preclinical-316980.html 0.6 2026-08-07T06:22:30+08:00 daily https://www.pharmasources.com/industryinsights/aravive-announces-management-changes-316981.html 0.6 2026-08-07T13:17:20+08:00 daily https://www.pharmasources.com/industryinsights/vyome-announces-executive-management-app-316982.html 0.6 2026-08-07T16:15:06+08:00 daily https://www.pharmasources.com/industryinsights/kura-oncology-announces-chief-commercial-316983.html 0.6 2026-08-07T22:00:34+08:00 daily https://www.pharmasources.com/industryinsights/scynexis-announces-positive-results-from-316984.html 0.6 2026-08-08T00:54:00+08:00 daily https://www.pharmasources.com/industryinsights/immunic-licenses-imu-856-from-daiichi-sa-316985.html 0.6 2026-08-09T07:36:48+08:00 daily https://www.pharmasources.com/industryinsights/owp-announces-pre-ind-acknowledgement-pa-316986.html 0.6 2026-06-20T16:00:24+08:00 daily https://www.pharmasources.com/industryinsights/aruvant-receives-fda-rare-pediatric-dise-316987.html 0.6 2026-06-22T10:55:48+08:00 daily https://www.pharmasources.com/industryinsights/3derm-announces-two-fda-breakthrough-dev-316988.html 0.6 2026-08-10T15:13:33+08:00 daily https://www.pharmasources.com/industryinsights/catabasis-duchenne-uk-announce-partnersh-316989.html 0.6 2026-07-07T04:28:56+08:00 daily https://www.pharmasources.com/industryinsights/schrdinger-bayer-collaborate-to-co-devel-316990.html 0.6 2026-08-10T12:25:33+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2020011-316991.html 0.6 2026-06-21T04:18:25+08:00 daily https://www.pharmasources.com/industryinsights/compass-pathways-granted-patent-covering-316992.html 0.6 2026-06-21T19:12:51+08:00 daily https://www.pharmasources.com/industryinsights/111-inc-enters-into-strategic-partnershi-316993.html 0.6 2026-07-29T07:49:30+08:00 daily https://www.pharmasources.com/industryinsights/discover-the-latest-information-and-seiz-316994.html 0.6 2026-06-20T17:59:19+08:00 daily https://www.pharmasources.com/industryinsights/rise-in-pharmaceutical-applications-to-f-316995.html 0.6 2026-06-21T22:56:42+08:00 daily https://www.pharmasources.com/industryinsights/exonate-announces-collaboration-with-jan-316996.html 0.6 2026-08-11T11:12:13+08:00 daily https://www.pharmasources.com/industryinsights/nanoform-appoints-head-of-us-sales-316997.html 0.6 2026-07-02T16:03:55+08:00 daily https://www.pharmasources.com/industryinsights/tyvyt-sintilimab-injection-combined-with-316998.html 0.6 2026-06-20T23:12:50+08:00 daily https://www.pharmasources.com/industryinsights/iovance-biotherapeutics-secures-iov-3001-316999.html 0.6 2026-08-11T20:43:30+08:00 daily https://www.pharmasources.com/industryinsights/neurobo-pharmaceuticals-complete-gemphir-317000.html 0.6 2026-06-26T09:01:54+08:00 daily https://www.pharmasources.com/industryinsights/lilly-to-acquire-dermira-for-approximate-317001.html 0.6 2026-08-10T15:14:30+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-signs-oncology-agreement-with-str-317002.html 0.6 2026-08-07T02:22:11+08:00 daily https://www.pharmasources.com/industryinsights/novartis-and-nhs-partner-to-improve-manu-317003.html 0.6 2026-08-07T01:14:05+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-keytruda-for-patients-with--317004.html 0.6 2025-12-14T18:36:37+08:00 daily https://www.pharmasources.com/industryinsights/ms-treatment-trial-to-compare-stem-cell--317005.html 0.6 2026-08-07T02:36:45+08:00 daily https://www.pharmasources.com/industryinsights/taro-pharmaceuticals-voluntarily-recalls-317006.html 0.6 2026-08-07T02:46:03+08:00 daily https://www.pharmasources.com/industryinsights/nabriva-receives-fda-acknowledgement-of--317007.html 0.6 2026-08-07T02:52:15+08:00 daily https://www.pharmasources.com/industryinsights/bolt-biotherapeutics-announces-scientifi-317008.html 0.6 2026-08-07T02:59:34+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-announces-phase-2-results-for--317009.html 0.6 2026-08-07T13:16:03+08:00 daily https://www.pharmasources.com/industryinsights/mylan-recalls-three-lots-of-nizatidine-c-317010.html 0.6 2026-08-09T06:59:28+08:00 daily https://www.pharmasources.com/industryinsights/wpd-new-discovery-for-cancer-targeting-d-317011.html 0.6 2026-06-20T23:00:46+08:00 daily https://www.pharmasources.com/industryinsights/blueprint-announces-top-line-data-for-pr-317012.html 0.6 2026-06-20T15:00:16+08:00 daily https://www.pharmasources.com/industryinsights/vbi-vaccines-announces-second-pivotal-ph-317013.html 0.6 2026-07-02T18:28:25+08:00 daily https://www.pharmasources.com/industryinsights/empirico-ionis-collaborate-to-develop-an-317014.html 0.6 2026-06-27T22:27:47+08:00 daily https://www.pharmasources.com/industryinsights/amgen-announces-global-diagnostic-collab-317015.html 0.6 2026-06-20T20:59:44+08:00 daily https://www.pharmasources.com/industryinsights/vitamin-b6-leukemias-deadly-addiction-317016.html 0.6 2026-08-14T09:01:58+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-partners-with-enleo-317017.html 0.6 2026-08-04T10:10:18+08:00 daily https://www.pharmasources.com/industryinsights/plant-derived-svc112-hits-cancer-stem-ce-317018.html 0.6 2026-06-23T04:19:35+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-the-first-targeted-therapy--317019.html 0.6 2026-06-08T03:59:21+08:00 daily https://www.pharmasources.com/industryinsights/nuclear-radiologists-outsmart-prostate-c-317020.html 0.6 2026-08-10T19:05:53+08:00 daily https://www.pharmasources.com/industryinsights/bayer-and-exscientia-collaborate-to-leve-317021.html 0.6 2026-07-02T22:48:27+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-valtoco-diazepam-nasal-spra-317022.html 0.6 2026-06-22T02:03:42+08:00 daily https://www.pharmasources.com/industryinsights/gout-incidence-down-with-sglt2-inhibitor-317023.html 0.6 2026-06-23T03:13:05+08:00 daily https://www.pharmasources.com/industryinsights/behavioral-therapy-first-step-for-overac-317024.html 0.6 2026-06-20T15:12:17+08:00 daily https://www.pharmasources.com/industryinsights/physicians-spend-16-minutes-per-encounte-317025.html 0.6 2026-06-21T17:00:25+08:00 daily https://www.pharmasources.com/industryinsights/heart-transplants-from-donors-with-hepat-317026.html 0.6 2026-01-31T06:06:45+08:00 daily https://www.pharmasources.com/industryinsights/low-levels-of-key-blood-cells-could-sign-317027.html 0.6 2026-06-23T07:13:23+08:00 daily https://www.pharmasources.com/industryinsights/morphosys-and-incyte-sign-900m-deal-for--317028.html 0.6 2026-06-21T06:12:54+08:00 daily https://www.pharmasources.com/industryinsights/a-review-of-the-policiesevents-in-2019-317029.html 0.6 2026-06-21T02:55:44+08:00 daily https://www.pharmasources.com/industryinsights/coherus-signs-in-licensing-agreement-for-317030.html 0.6 2026-06-24T14:37:02+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-priority-review-for-astrazene-317031.html 0.6 2026-06-21T03:07:46+08:00 daily https://www.pharmasources.com/industryinsights/az-to-take-100m-hit-from-ending-trial-of-317032.html 0.6 2026-07-29T02:35:02+08:00 daily https://www.pharmasources.com/industryinsights/biodegradable-plastic-packaging-develope-317033.html 0.6 2026-06-22T09:59:42+08:00 daily https://www.pharmasources.com/industryinsights/endo-agrees-opioid-settlement-payment-wi-317034.html 0.6 2026-06-20T17:45:15+08:00 daily https://www.pharmasources.com/industryinsights/life-science-ma-activity-reached-357bn-i-317035.html 0.6 2026-07-04T05:07:15+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-avatrombopag-orphan-drug-desi-317036.html 0.6 2026-08-05T22:15:04+08:00 daily https://www.pharmasources.com/industryinsights/advanced-biomatrix-acquires-hystem-from--317037.html 0.6 2026-06-20T20:10:43+08:00 daily https://www.pharmasources.com/industryinsights/microvention-announces-fda-premarket-app-317038.html 0.6 2026-07-23T15:01:48+08:00 daily https://www.pharmasources.com/industryinsights/presage-receives-fda-clearance-of-first--317039.html 0.6 2026-06-20T21:09:49+08:00 daily https://www.pharmasources.com/industryinsights/biologics-announces-chief-operating-offi-317040.html 0.6 2025-12-03T22:57:51+08:00 daily https://www.pharmasources.com/industryinsights/retrotope-announces-first-dosing-of-rt00-317041.html 0.6 2026-08-07T14:27:42+08:00 daily https://www.pharmasources.com/industryinsights/nurix-therapeutics-sanofi-announce-devel-317042.html 0.6 2026-06-20T17:59:21+08:00 daily https://www.pharmasources.com/industryinsights/bayer-to-commercialise-dars-monthly-cont-317043.html 0.6 2026-06-20T18:16:07+08:00 daily https://www.pharmasources.com/industryinsights/viiv-healthcare-seeks-ema-approval-for-h-317044.html 0.6 2026-06-21T07:23:28+08:00 daily https://www.pharmasources.com/industryinsights/alnylam-initiates-rolling-submission-of--317045.html 0.6 2026-06-20T22:59:34+08:00 daily https://www.pharmasources.com/industryinsights/roche-and-illumina-partner-to-broaden-pa-317046.html 0.6 2026-07-26T12:54:43+08:00 daily https://www.pharmasources.com/industryinsights/exosomes-promote-remarkable-recovery-in--317047.html 0.6 2026-06-22T01:44:52+08:00 daily https://www.pharmasources.com/industryinsights/nonalcoholic-steatohepatitis-will-pose-c-317048.html 0.6 2026-06-20T17:57:32+08:00 daily https://www.pharmasources.com/industryinsights/more-than-half-of-cancer-survivors-dont--317049.html 0.6 2026-06-22T00:54:47+08:00 daily https://www.pharmasources.com/industryinsights/severe-deprivation-in-childhood-has-last-317050.html 0.6 2026-06-21T07:04:55+08:00 daily https://www.pharmasources.com/industryinsights/good-news-for-people-with-persistent-anx-317051.html 0.6 2026-06-08T18:52:17+08:00 daily https://www.pharmasources.com/industryinsights/more-studies-link-vaping-to-asthma-copd-317052.html 0.6 2026-06-22T04:56:40+08:00 daily https://www.pharmasources.com/industryinsights/burnout-could-raise-your-odds-for-a-fib-317053.html 0.6 2026-02-28T15:36:35+08:00 daily https://www.pharmasources.com/industryinsights/2001-to-2016-saw-drop-stall-in-iq-losses-317054.html 0.6 2026-06-21T14:42:11+08:00 daily https://www.pharmasources.com/industryinsights/robotic-surgery-saw-84-fold-increase-fro-317055.html 0.6 2026-07-05T15:22:10+08:00 daily https://www.pharmasources.com/industryinsights/major-cardiovascular-diseases-may-up-lon-317056.html 0.6 2026-06-20T21:01:35+08:00 daily https://www.pharmasources.com/industryinsights/reduction-in-tongue-fat-can-improve-obst-317057.html 0.6 2026-06-20T19:05:39+08:00 daily https://www.pharmasources.com/industryinsights/call-for-application-for-2020-tsinghua-a-317058.html 0.6 2026-06-25T06:12:03+08:00 daily https://www.pharmasources.com/industryinsights/axa-hong-kong-sar-china-launches-the-fir-317059.html 0.6 2026-06-21T05:44:25+08:00 daily https://www.pharmasources.com/industryinsights/medit-responds-to-ongoing-patent-infring-317060.html 0.6 2026-06-22T00:09:55+08:00 daily https://www.pharmasources.com/industryinsights/zap-surgical-brain-tumor-treatments-comm-317061.html 0.6 2026-07-23T23:23:44+08:00 daily https://www.pharmasources.com/industryinsights/innovent-out-licenses-commercial-rights--317062.html 0.6 2026-08-11T06:06:59+08:00 daily https://www.pharmasources.com/industryinsights/genome-company-announces-a-clinical-tria-317063.html 0.6 2026-07-17T21:01:43+08:00 daily https://www.pharmasources.com/industryinsights/evolution-20-prize-unprecedented-10-mill-317064.html 0.6 2026-07-08T20:18:45+08:00 daily https://www.pharmasources.com/industryinsights/mentice-showcases-first-of-its-kind-flex-317065.html 0.6 2026-06-22T01:08:14+08:00 daily https://www.pharmasources.com/industryinsights/volition-develops-a-new-improved-nuq-ass-317066.html 0.6 2026-06-22T07:05:56+08:00 daily https://www.pharmasources.com/industryinsights/takeda-partners-charles-river-to-develop-317067.html 0.6 2026-06-22T05:46:30+08:00 daily https://www.pharmasources.com/industryinsights/hiv-treatment-dovato-dolutegravirlamivud-317068.html 0.6 2026-07-24T14:59:12+08:00 daily https://www.pharmasources.com/industryinsights/global-neoantigen-cancer-vaccine-market--317069.html 0.6 2026-06-20T23:02:42+08:00 daily https://www.pharmasources.com/industryinsights/fda-issues-alert-for-cancer-risk-from-be-317070.html 0.6 2026-06-22T06:04:47+08:00 daily https://www.pharmasources.com/industryinsights/nice-approves-palbociclib-with-fulvestra-317071.html 0.6 2026-06-21T20:42:31+08:00 daily https://www.pharmasources.com/industryinsights/quantum-leap-healthcare-g1-therapeutics--317072.html 0.6 2026-06-22T02:52:56+08:00 daily https://www.pharmasources.com/industryinsights/akcea-ionis-announce-initiation-of-trial-317073.html 0.6 2026-07-06T20:05:10+08:00 daily https://www.pharmasources.com/industryinsights/rockwell-medical-announces-board-of-dire-317074.html 0.6 2026-06-20T23:00:42+08:00 daily https://www.pharmasources.com/industryinsights/taro-issues-voluntary-nationwide-recall--317075.html 0.6 2026-06-21T05:03:45+08:00 daily https://www.pharmasources.com/industryinsights/astellas-completes-acquisition-of-audent-317076.html 0.6 2026-06-21T08:10:08+08:00 daily https://www.pharmasources.com/industryinsights/powder-flow-a-qbd-approach-to-continuous-317077.html 0.6 2026-07-23T20:49:48+08:00 daily https://www.pharmasources.com/industryinsights/lynparza-regulatory-submission-granted-p-317078.html 0.6 2025-12-08T15:07:48+08:00 daily https://www.pharmasources.com/industryinsights/womens-blood-vessels-age-faster-than-men-317079.html 0.6 2026-07-27T13:52:56+08:00 daily https://www.pharmasources.com/industryinsights/2011-to-2017-saw-increase-in-spending-on-317081.html 0.6 2026-06-21T05:01:45+08:00 daily https://www.pharmasources.com/industryinsights/outcomes-superior-for-hm3-lvad-regardles-317082.html 0.6 2026-06-21T01:05:46+08:00 daily https://www.pharmasources.com/industryinsights/weight-control-drug-lorcaserin-may-raise-317083.html 0.6 2026-06-20T19:08:38+08:00 daily https://www.pharmasources.com/industryinsights/hiv-infected-newborns-can-wait-awhile-fo-317084.html 0.6 2026-06-20T14:46:00+08:00 daily https://www.pharmasources.com/industryinsights/surgery-may-add-years-for-patients-with--317085.html 0.6 2026-07-18T07:34:42+08:00 daily https://www.pharmasources.com/industryinsights/universal-flu-vaccine-works-in-mice-317086.html 0.6 2026-06-21T06:05:49+08:00 daily https://www.pharmasources.com/industryinsights/interventions-more-likely-after-rygb-ver-317087.html 0.6 2026-06-20T15:05:21+08:00 daily https://www.pharmasources.com/industryinsights/many-women-have-posttraumatic-stress-aft-317088.html 0.6 2026-08-09T06:59:34+08:00 daily https://www.pharmasources.com/industryinsights/ai-system-can-detect-grade-cancer-in-pro-317089.html 0.6 2026-08-09T01:20:42+08:00 daily https://www.pharmasources.com/industryinsights/maternal-distress-may-affect-brain-devel-317090.html 0.6 2026-08-08T22:52:00+08:00 daily https://www.pharmasources.com/industryinsights/early-treatment-tied-to-faster-concussio-317091.html 0.6 2026-08-08T20:00:51+08:00 daily https://www.pharmasources.com/industryinsights/low-cardiac-troponin-levels-cannot-safel-317092.html 0.6 2026-08-08T17:01:17+08:00 daily https://www.pharmasources.com/industryinsights/few-youths-receive-addiction-treatment-a-317093.html 0.6 2026-08-07T13:17:04+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-and-bayer-enter-into-an-a-317094.html 0.6 2026-08-09T18:04:26+08:00 daily https://www.pharmasources.com/industryinsights/probiogen-and-lava-therapeutics-sign-cel-317095.html 0.6 2026-08-07T12:10:36+08:00 daily https://www.pharmasources.com/industryinsights/velabs-therapeutics-receives-exclusive-l-317096.html 0.6 2026-08-07T02:52:09+08:00 daily https://www.pharmasources.com/industryinsights/polyganics-achieves-ce-mark-certificatio-317097.html 0.6 2026-08-07T13:18:08+08:00 daily https://www.pharmasources.com/industryinsights/probiogen-inks-next-commercial-glymaxx-l-317098.html 0.6 2026-08-07T04:04:05+08:00 daily https://www.pharmasources.com/industryinsights/biomed-x-starts-new-schizophrenia-resear-317099.html 0.6 2026-08-07T03:55:29+08:00 daily https://www.pharmasources.com/industryinsights/china-sxt-pharmaceuticals-inc-announced--317100.html 0.6 2026-08-07T03:33:50+08:00 daily https://www.pharmasources.com/industryinsights/limacorporate-inaugurates-the-new-resear-317101.html 0.6 2026-08-07T03:24:42+08:00 daily https://www.pharmasources.com/industryinsights/every-person-deserves-the-chance-to-live-317102.html 0.6 2026-08-07T03:03:04+08:00 daily https://www.pharmasources.com/industryinsights/fdf-china-to-be-held-in-june-to-boost-ch-317104.html 0.6 2026-08-07T02:52:24+08:00 daily https://www.pharmasources.com/industryinsights/prudential-chooses-img-to-boost-travel-a-317105.html 0.6 2026-06-21T12:12:20+08:00 daily https://www.pharmasources.com/industryinsights/genscript-and-genopis-enter-into-strateg-317106.html 0.6 2026-08-07T03:12:38+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-clovis-rubraca-fast-track-des-317107.html 0.6 2026-08-13T05:33:39+08:00 daily https://www.pharmasources.com/industryinsights/bms-secures-fda-priority-review-for-nscl-317108.html 0.6 2026-06-20T21:13:48+08:00 daily https://www.pharmasources.com/industryinsights/galapagos-expands-fibrosis-research-coll-317109.html 0.6 2026-06-21T07:08:02+08:00 daily https://www.pharmasources.com/industryinsights/nice-requests-more-data-on-keytruda-for--317110.html 0.6 2026-06-20T21:49:30+08:00 daily https://www.pharmasources.com/industryinsights/strengthened-regulatory-systems-are-need-317111.html 0.6 2026-06-21T01:44:46+08:00 daily https://www.pharmasources.com/industryinsights/first-living-robots-called-xenobots-coul-317112.html 0.6 2026-07-04T10:39:59+08:00 daily https://www.pharmasources.com/industryinsights/cyber-security-breaches-at-67-percent-of-317113.html 0.6 2026-06-20T14:00:03+08:00 daily https://www.pharmasources.com/industryinsights/fda-issues-warning-letter-to-health-phar-317114.html 0.6 2026-07-09T08:11:22+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-fast-track-designation-for-he-317115.html 0.6 2026-08-07T12:02:59+08:00 daily https://www.pharmasources.com/industryinsights/aravive-receives-ind-clearance-for-avb-5-317116.html 0.6 2026-08-07T02:30:52+08:00 daily https://www.pharmasources.com/industryinsights/biomarin-to-begin-clinical-trial-with-bm-317117.html 0.6 2026-08-11T20:46:51+08:00 daily https://www.pharmasources.com/industryinsights/compass-granted-patent-of-psilocybin-for-317118.html 0.6 2026-08-07T20:36:42+08:00 daily https://www.pharmasources.com/industryinsights/lannett-announces-fda-approval-of-nda-fo-317119.html 0.6 2026-06-28T11:12:58+08:00 daily https://www.pharmasources.com/industryinsights/phasebio-announces-acquisition-of-novel--317120.html 0.6 2026-08-02T23:07:42+08:00 daily https://www.pharmasources.com/industryinsights/astellas-adaptimmune-sign-deal-to-co-dev-317121.html 0.6 2026-07-02T22:24:31+08:00 daily https://www.pharmasources.com/industryinsights/biomotiv-and-atomwise-sign-ai-partnershi-317122.html 0.6 2026-08-07T16:20:14+08:00 daily https://www.pharmasources.com/industryinsights/edible-security-tag-to-protect-drugs-fro-317123.html 0.6 2026-06-21T17:06:31+08:00 daily https://www.pharmasources.com/industryinsights/researchers-alter-mosquitoes-to-resist-d-317124.html 0.6 2026-04-09T09:50:56+08:00 daily https://www.pharmasources.com/industryinsights/are-doctors-discarding-injured-kidneys-t-317125.html 0.6 2026-06-21T12:16:32+08:00 daily https://www.pharmasources.com/industryinsights/ai-might-help-spot-evaluate-prostate-can-317126.html 0.6 2026-06-20T22:59:37+08:00 daily https://www.pharmasources.com/industryinsights/nerve-stimulation-therapy-could-cut-fibr-317127.html 0.6 2026-04-12T06:32:50+08:00 daily https://www.pharmasources.com/industryinsights/sepsis-associated-with-almost-20-percent-317128.html 0.6 2026-06-22T00:57:47+08:00 daily https://www.pharmasources.com/industryinsights/increasing-vegetable-intake-does-not-slo-317129.html 0.6 2026-06-29T04:23:44+08:00 daily https://www.pharmasources.com/industryinsights/sotio-opens-office-in-basel-switzerland--317130.html 0.6 2026-06-29T10:29:05+08:00 daily https://www.pharmasources.com/industryinsights/biomed-x-starts-new-research-program-in--317131.html 0.6 2026-06-27T16:56:21+08:00 daily https://www.pharmasources.com/industryinsights/apceth-starts-commercial-manufacturing-o-317132.html 0.6 2026-03-14T01:20:54+08:00 daily https://www.pharmasources.com/industryinsights/nbe-therapeutics-closes-usd-22m-series-c-317133.html 0.6 2026-06-21T03:47:45+08:00 daily https://www.pharmasources.com/industryinsights/satisfaction-high-with-mohs-surgery-for--317134.html 0.6 2026-07-01T06:55:08+08:00 daily https://www.pharmasources.com/industryinsights/lack-of-insurance-tied-to-later-stage-of-317135.html 0.6 2026-06-21T05:57:45+08:00 daily https://www.pharmasources.com/industryinsights/happiness-biotech-group-limited-announce-317136.html 0.6 2026-08-07T15:34:35+08:00 daily https://www.pharmasources.com/industryinsights/111-inc-featured-at-38th-annual-jp-morga-317137.html 0.6 2026-07-19T19:59:42+08:00 daily https://www.pharmasources.com/industryinsights/snap-fitness-poised-for-continued-intern-317138.html 0.6 2026-04-27T03:21:36+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-to-acquire-drug-manufactu-317139.html 0.6 2026-05-04T00:10:20+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-secures-fda-expanded-indica-317140.html 0.6 2026-06-21T12:02:13+08:00 daily https://www.pharmasources.com/industryinsights/merck-closes-27bn-acquisition-of-biophar-317141.html 0.6 2026-06-21T06:51:50+08:00 daily https://www.pharmasources.com/industryinsights/dermavant-sells-tapinarof-commercial-rig-317142.html 0.6 2026-06-20T14:29:21+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-olaparib-tablets-for-pla-317143.html 0.6 2026-06-20T22:20:42+08:00 daily https://www.pharmasources.com/industryinsights/uk-accounts-for-12-percent-of-global-cel-317144.html 0.6 2026-06-21T11:49:20+08:00 daily https://www.pharmasources.com/industryinsights/fast-track-designation-granted-to-decomp-317145.html 0.6 2026-06-22T07:09:15+08:00 daily https://www.pharmasources.com/industryinsights/medicine-shortages-should-be-an-industry-317146.html 0.6 2026-06-22T00:44:38+08:00 daily https://www.pharmasources.com/industryinsights/a-review-of-the-chinese-pharmaceutical-p-317147.html 0.6 2026-07-24T09:23:15+08:00 daily https://www.pharmasources.com/industryinsights/fusion-iv-pharmaceuticals-axia-recalls-a-317148.html 0.6 2026-01-04T11:16:52+08:00 daily https://www.pharmasources.com/industryinsights/bosch-packaging-technology-changes-name--317149.html 0.6 2026-06-22T11:55:57+08:00 daily https://www.pharmasources.com/industryinsights/durect-announces-outcome-of-posimir-fda--317150.html 0.6 2026-06-21T05:00:42+08:00 daily https://www.pharmasources.com/industryinsights/neuroptika-announces-enrollment-of-first-317151.html 0.6 2026-07-12T02:14:33+08:00 daily https://www.pharmasources.com/industryinsights/innovation-pharmaceuticals-doses-first-c-317152.html 0.6 2026-06-02T17:24:00+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-indication-for-ozempic--317153.html 0.6 2026-06-14T14:51:33+08:00 daily https://www.pharmasources.com/industryinsights/akero-expands-nash-trial-to-include-coho-317154.html 0.6 2026-08-03T16:27:57+08:00 daily https://www.pharmasources.com/industryinsights/biolinerx-receives-orphan-drug-designati-317155.html 0.6 2026-06-21T12:57:30+08:00 daily https://www.pharmasources.com/industryinsights/fda-statement-on-cardinal-health-surgica-317156.html 0.6 2026-07-16T17:34:55+08:00 daily https://www.pharmasources.com/industryinsights/astellas-adaptimmune-to-co-develop-comme-317157.html 0.6 2026-08-14T15:52:43+08:00 daily https://www.pharmasources.com/industryinsights/ani-announces-fda-approval-of-potassium--317158.html 0.6 2026-08-07T01:42:45+08:00 daily https://www.pharmasources.com/industryinsights/viiv-healthcare-secures-japanese-approva-317159.html 0.6 2026-08-07T01:27:42+08:00 daily https://www.pharmasources.com/industryinsights/twist-bioscience-announces-strategic-col-317160.html 0.6 2026-08-07T01:19:29+08:00 daily https://www.pharmasources.com/industryinsights/b-cells-linked-to-effective-cancer-immun-317161.html 0.6 2026-08-07T01:11:03+08:00 daily https://www.pharmasources.com/industryinsights/how-to-keep-those-blood-vessels-pumping-317162.html 0.6 2026-08-07T00:41:40+08:00 daily https://www.pharmasources.com/industryinsights/just-2-of-patients-who-need-it-get-anti--317163.html 0.6 2026-08-07T00:40:36+08:00 daily https://www.pharmasources.com/industryinsights/roche-her2-adc-enmetrastuzumab-has-been--317164.html 0.6 2026-08-07T00:02:30+08:00 daily https://www.pharmasources.com/industryinsights/do-you-take-warfarin-time-of-day-might-n-317165.html 0.6 2026-08-13T13:11:40+08:00 daily https://www.pharmasources.com/industryinsights/sepsis-causes-far-more-deaths-worldwide--317166.html 0.6 2026-08-07T00:52:45+08:00 daily https://www.pharmasources.com/industryinsights/colorectal-cancer-risk-still-up-in-patie-317167.html 0.6 2026-08-07T00:59:10+08:00 daily https://www.pharmasources.com/industryinsights/lack-of-self-exams-hampers-early-melanom-317168.html 0.6 2026-08-07T13:18:05+08:00 daily https://www.pharmasources.com/industryinsights/hiv-patients-lose-immunity-to-smallpox-d-317169.html 0.6 2026-08-07T13:55:38+08:00 daily https://www.pharmasources.com/industryinsights/heart-transplants-from-hep-c-virus-posit-317170.html 0.6 2026-08-08T03:30:36+08:00 daily https://www.pharmasources.com/industryinsights/many-pelvic-exams-pap-tests-unnecessary--317171.html 0.6 2026-08-09T07:56:31+08:00 daily https://www.pharmasources.com/industryinsights/risk-for-blood-clots-increased-with-picc-317172.html 0.6 2026-06-20T15:55:24+08:00 daily https://www.pharmasources.com/industryinsights/in-hospital-cardiac-arrest-outcomes-simi-317173.html 0.6 2026-06-21T15:03:26+08:00 daily https://www.pharmasources.com/industryinsights/young-adults-who-ever-received-hpv-vacci-317174.html 0.6 2026-08-03T07:55:00+08:00 daily https://www.pharmasources.com/industryinsights/early-antiretroviral-therapy-may-not-ach-317175.html 0.6 2026-06-20T15:50:18+08:00 daily https://www.pharmasources.com/industryinsights/active-lifestyle-may-slow-familial-front-317176.html 0.6 2026-06-21T08:02:05+08:00 daily https://www.pharmasources.com/industryinsights/antipsychotic-initiation-ups-risk-for-he-317177.html 0.6 2026-07-06T23:00:43+08:00 daily https://www.pharmasources.com/industryinsights/recent-years-saw-drop-in-opioid-prescrib-317178.html 0.6 2026-06-22T07:56:44+08:00 daily https://www.pharmasources.com/industryinsights/luspatercept-mitigates-anemia-in-lower-r-317179.html 0.6 2026-06-21T01:46:39+08:00 daily https://www.pharmasources.com/industryinsights/adherence-to-ideal-pathway-in-pregnancy--317180.html 0.6 2026-06-20T15:50:12+08:00 daily https://www.pharmasources.com/industryinsights/clinical-guidelines-developed-for-managi-317181.html 0.6 2026-06-21T01:55:45+08:00 daily https://www.pharmasources.com/industryinsights/four-weeks-of-active-tens-beneficial-for-317182.html 0.6 2026-06-21T13:16:41+08:00 daily https://www.pharmasources.com/industryinsights/tea-drinking-linked-to-reduced-risk-for--317183.html 0.6 2026-06-21T04:12:57+08:00 daily https://www.pharmasources.com/industryinsights/ibd-may-increase-risk-for-adverse-pregna-317184.html 0.6 2026-06-22T00:01:44+08:00 daily https://www.pharmasources.com/industryinsights/metabolic-syndrome-may-up-risk-for-vte-r-317185.html 0.6 2026-06-21T01:55:11+08:00 daily https://www.pharmasources.com/industryinsights/many-with-history-of-anxiety-report-comp-317186.html 0.6 2026-06-21T14:15:45+08:00 daily https://www.pharmasources.com/industryinsights/incidental-lymphopenia-linked-to-increas-317187.html 0.6 2026-06-21T08:52:08+08:00 daily https://www.pharmasources.com/industryinsights/telemedicine-visits-comparable-for-glyce-317188.html 0.6 2026-06-21T04:53:41+08:00 daily https://www.pharmasources.com/industryinsights/mortality-risk-in-oropharynx-cancer-vari-317189.html 0.6 2026-06-21T10:54:09+08:00 daily https://www.pharmasources.com/industryinsights/antipsychotic-use-safer-than-no-use-in-s-317190.html 0.6 2026-06-21T20:46:43+08:00 daily https://www.pharmasources.com/industryinsights/experts-call-for-pediatric-consideration-317191.html 0.6 2026-03-26T22:43:38+08:00 daily https://www.pharmasources.com/industryinsights/coronary-artery-disease-risk-down-in-sur-317192.html 0.6 2026-06-20T21:08:46+08:00 daily https://www.pharmasources.com/industryinsights/folic-acid-zinc-supplements-in-men-no-be-317193.html 0.6 2026-08-05T09:59:00+08:00 daily https://www.pharmasources.com/industryinsights/prevalence-of-buprenorphine-waivered-pre-317194.html 0.6 2026-08-12T05:00:07+08:00 daily https://www.pharmasources.com/industryinsights/bariatric-surgery-may-aid-t2dm-related-o-317195.html 0.6 2026-08-09T21:41:55+08:00 daily https://www.pharmasources.com/industryinsights/neural-tube-defect-prevalence-70-per-100-317196.html 0.6 2026-08-08T12:41:11+08:00 daily https://www.pharmasources.com/industryinsights/total-opioid-overdose-deaths-down-with-m-317197.html 0.6 2026-06-21T22:03:46+08:00 daily https://www.pharmasources.com/industryinsights/high-dose-erythropoietin-no-benefit-for--317198.html 0.6 2026-06-22T12:58:17+08:00 daily https://www.pharmasources.com/industryinsights/smog-may-be-bad-for-your-bones-317199.html 0.6 2026-06-21T07:19:20+08:00 daily https://www.pharmasources.com/industryinsights/worried-about-dementia-check-this-blood--317200.html 0.6 2026-06-21T04:04:55+08:00 daily https://www.pharmasources.com/industryinsights/venus-medtech-announces-the-addition-of--317201.html 0.6 2026-07-03T12:51:39+08:00 daily https://www.pharmasources.com/industryinsights/milk-without-the-cow-turtletree-labs-wor-317202.html 0.6 2026-06-21T01:01:45+08:00 daily https://www.pharmasources.com/industryinsights/kt-and-samsung-medical-center-to-build-5-317203.html 0.6 2026-07-24T12:25:00+08:00 daily https://www.pharmasources.com/industryinsights/china-based-ivy-capital-invests-in-betag-317204.html 0.6 2026-06-29T23:39:30+08:00 daily https://www.pharmasources.com/industryinsights/bridge-biotherapeutics-announces-fda-ind-317205.html 0.6 2026-06-22T03:54:35+08:00 daily https://www.pharmasources.com/industryinsights/qbiotics-receives-first-registration-for-317206.html 0.6 2026-06-22T04:07:57+08:00 daily https://www.pharmasources.com/industryinsights/111-unveils-new-video-on-the-impact-of-c-317207.html 0.6 2026-06-20T14:55:06+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2020121-317208.html 0.6 2026-06-28T01:55:54+08:00 daily https://www.pharmasources.com/industryinsights/labworld-china-2020-is-gearing-up---futu-317209.html 0.6 2026-08-01T16:34:43+08:00 daily https://www.pharmasources.com/industryinsights/numbers-of-drug-approval-by-fda-ema-and--317210.html 0.6 2026-06-17T22:50:12+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-enables-development-of-mu-317211.html 0.6 2026-06-20T20:58:35+08:00 daily https://www.pharmasources.com/industryinsights/global-pharmaceutical-industry-making-ef-317212.html 0.6 2026-07-23T23:39:59+08:00 daily https://www.pharmasources.com/industryinsights/evolving-world-of-pharma-defining-the-pr-317213.html 0.6 2026-06-20T22:52:51+08:00 daily https://www.pharmasources.com/industryinsights/gilead-sciences-statement-on-the-company-317214.html 0.6 2026-06-21T05:05:45+08:00 daily https://www.pharmasources.com/industryinsights/hengruis-class-1-new-drug-fluzoparib-has-317215.html 0.6 2026-06-22T12:46:59+08:00 daily https://www.pharmasources.com/industryinsights/after-apis-carcinogens-ndma-and-ndea-now-317216.html 0.6 2026-07-29T10:12:18+08:00 daily https://www.pharmasources.com/industryinsights/evolving-world-of-pharma-fighting-falsif-317217.html 0.6 2026-06-20T20:49:28+08:00 daily https://www.pharmasources.com/industryinsights/a-comparison-of-the-biosimilar-accessibi-317218.html 0.6 2026-06-20T16:01:19+08:00 daily https://www.pharmasources.com/industryinsights/a-review-of-the-anticancer-drugs-approve-317219.html 0.6 2026-08-10T05:27:52+08:00 daily https://www.pharmasources.com/industryinsights/experimental-antiviral-drug-remdesivir-r-317220.html 0.6 2026-08-03T04:50:14+08:00 daily https://www.pharmasources.com/industryinsights/epidemic-situation-of-the-2019-novel-cor-317221.html 0.6 2026-06-26T02:52:30+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-provides-back-to-work-ope-317222.html 0.6 2026-06-23T21:50:20+08:00 daily https://www.pharmasources.com/industryinsights/battling-the-novel-coronavirus-united-we-317223.html 0.6 2026-05-27T07:49:39+08:00 daily https://www.pharmasources.com/industryinsights/quest-global-strengthens-its-leadership--317224.html 0.6 2026-07-09T03:22:04+08:00 daily https://www.pharmasources.com/industryinsights/111-partners-with-winhealth-to-offer-fre-317225.html 0.6 2026-07-20T00:01:38+08:00 daily https://www.pharmasources.com/industryinsights/sihuan-pharmaceutical-and-hetero-labs-li-317226.html 0.6 2026-08-13T10:44:43+08:00 daily https://www.pharmasources.com/industryinsights/ionpath-launches-research-services-offer-317227.html 0.6 2026-07-01T17:53:58+08:00 daily https://www.pharmasources.com/industryinsights/polyu-develops-the-worlds-most-comprehen-317228.html 0.6 2026-06-20T13:20:40+08:00 daily https://www.pharmasources.com/industryinsights/ping-an-good-doctors-revenue-for-2019-am-317229.html 0.6 2026-08-04T05:58:09+08:00 daily https://www.pharmasources.com/industryinsights/zk-international-group-co-ltd-supplies-p-317230.html 0.6 2026-06-26T15:24:13+08:00 daily https://www.pharmasources.com/industryinsights/with-favorable-policies-the-medical-devi-317231.html 0.6 2026-08-07T20:25:19+08:00 daily https://www.pharmasources.com/industryinsights/genomenon-commended-by-frost-sullivan-fo-317232.html 0.6 2026-06-21T08:18:11+08:00 daily https://www.pharmasources.com/industryinsights/limacorporate-announces-the-successful-c-317233.html 0.6 2026-06-21T07:15:06+08:00 daily https://www.pharmasources.com/industryinsights/2019-novel-coronavirus-driving-surging-d-317234.html 0.6 2026-06-21T18:10:36+08:00 daily https://www.pharmasources.com/industryinsights/major-tobacco-manufacturer-selects-arisg-317235.html 0.6 2026-06-21T13:25:08+08:00 daily https://www.pharmasources.com/industryinsights/amaala-company-announces-a-whos-who-of-i-317236.html 0.6 2026-06-20T23:58:36+08:00 daily https://www.pharmasources.com/industryinsights/vakrangee-to-revolutionize-rural-healthc-317237.html 0.6 2026-06-20T14:41:12+08:00 daily https://www.pharmasources.com/industryinsights/carbiotix-launches-second-generation-dia-317238.html 0.6 2026-06-09T06:42:03+08:00 daily https://www.pharmasources.com/industryinsights/vietnamese-technology-products-join-hand-317239.html 0.6 2026-08-07T15:54:45+08:00 daily https://www.pharmasources.com/industryinsights/fullerton-health-donates-aud50000-to-the-317240.html 0.6 2026-06-21T11:51:05+08:00 daily https://www.pharmasources.com/industryinsights/axa-stands-by-hong-kong-sar-china-front--317241.html 0.6 2026-06-29T17:46:31+08:00 daily https://www.pharmasources.com/industryinsights/with-favorable-policies-the-medical-devi-317242.html 0.6 2026-06-20T21:58:04+08:00 daily https://www.pharmasources.com/industryinsights/luye-pharma-grants-cipla-medpro-exclusiv-317243.html 0.6 2026-08-02T14:37:21+08:00 daily https://www.pharmasources.com/industryinsights/new-model-predicts-near-end-of-new-confi-317244.html 0.6 2026-06-21T11:46:55+08:00 daily https://www.pharmasources.com/industryinsights/condair-study-shows-indoor-humidificatio-317245.html 0.6 2025-12-04T02:46:35+08:00 daily https://www.pharmasources.com/industryinsights/gnc-china-donates-whey-protein-powder-wo-317246.html 0.6 2026-06-29T17:10:51+08:00 daily https://www.pharmasources.com/industryinsights/immuron-reports-diarrhea-no1-health-issu-317247.html 0.6 2026-06-20T18:09:26+08:00 daily https://www.pharmasources.com/industryinsights/lianluo-smart-limited-announces-pricing--317248.html 0.6 2026-08-07T14:15:49+08:00 daily https://www.pharmasources.com/industryinsights/george-clinical-names-james-cheong-chief-317249.html 0.6 2026-08-07T13:55:04+08:00 daily https://www.pharmasources.com/industryinsights/evolving-world-of-pharma-efforts-for-a-c-317250.html 0.6 2026-07-02T14:10:29+08:00 daily https://www.pharmasources.com/industryinsights/sihuan-pharmaceutical-accelerates-produc-317251.html 0.6 2026-08-13T14:22:15+08:00 daily https://www.pharmasources.com/industryinsights/cybernet-announces-worlds-first-antimicr-317252.html 0.6 2026-08-08T22:00:49+08:00 daily https://www.pharmasources.com/industryinsights/the-economic-cost-of-quarantine-317253.html 0.6 2026-07-04T15:04:06+08:00 daily https://www.pharmasources.com/industryinsights/doterra-contributes-financial-and-produc-317254.html 0.6 2026-06-21T16:54:38+08:00 daily https://www.pharmasources.com/industryinsights/dermalog-provides-the-worlds-first-biome-317255.html 0.6 2026-07-06T16:32:56+08:00 daily https://www.pharmasources.com/industryinsights/the-decision-of-the-german-federal-court-317256.html 0.6 2026-06-20T19:56:31+08:00 daily https://www.pharmasources.com/industryinsights/kompa-group-launches-a-12-hour-built-rea-317257.html 0.6 2026-06-21T01:54:34+08:00 daily https://www.pharmasources.com/industryinsights/codagenix-and-serum-institute-of-india-i-317258.html 0.6 2026-08-07T13:20:29+08:00 daily https://www.pharmasources.com/industryinsights/a-summary-and-interpretation-of-the-prog-317259.html 0.6 2026-06-30T07:45:07+08:00 daily https://www.pharmasources.com/industryinsights/a-summary-and-interpretation-of-the-prog-317260.html 0.6 2026-08-09T15:50:30+08:00 daily https://www.pharmasources.com/industryinsights/model-indicates-current-novel-coronaviru-317261.html 0.6 2026-06-21T13:00:32+08:00 daily https://www.pharmasources.com/industryinsights/wat-medicals-study-finds-that-headaterm--317262.html 0.6 2026-06-22T01:08:56+08:00 daily https://www.pharmasources.com/industryinsights/global-cord-blood-corporation-provides-u-317263.html 0.6 2026-08-10T00:45:46+08:00 daily https://www.pharmasources.com/industryinsights/van-don-international-airport-in-quang-n-317264.html 0.6 2026-07-26T11:02:36+08:00 daily https://www.pharmasources.com/industryinsights/new-infections-of-novel-coronavirus-drop-317265.html 0.6 2026-06-21T07:07:57+08:00 daily https://www.pharmasources.com/industryinsights/who-chief-calls-for-solidarity-in-fighti-317266.html 0.6 2026-08-07T10:58:45+08:00 daily https://www.pharmasources.com/industryinsights/center-for-biocide-chemistries-publishes-317267.html 0.6 2026-06-20T20:17:54+08:00 daily https://www.pharmasources.com/industryinsights/the-next-horizon-of-innovations-in-drug--317268.html 0.6 2026-07-06T19:19:32+08:00 daily https://www.pharmasources.com/industryinsights/updates-on-the-novel-coronavirus-outbrea-317269.html 0.6 2026-06-21T14:57:25+08:00 daily https://www.pharmasources.com/industryinsights/interview-chinas-anti-virus-efforts-rema-317270.html 0.6 2026-06-21T01:53:32+08:00 daily https://www.pharmasources.com/industryinsights/xcmg-supports-the-construction-of-multip-317271.html 0.6 2026-08-07T02:16:17+08:00 daily https://www.pharmasources.com/industryinsights/ping-an-good-doctor-issues-2019-sustaina-317272.html 0.6 2026-07-23T17:29:09+08:00 daily https://www.pharmasources.com/industryinsights/a-new-expert-consensus-publication-provi-317273.html 0.6 2026-08-07T00:33:35+08:00 daily https://www.pharmasources.com/industryinsights/singapore-based-novocall-announces-us100-317274.html 0.6 2026-08-07T00:02:19+08:00 daily https://www.pharmasources.com/industryinsights/the-real-cost-of-being-critically-ill-in-317275.html 0.6 2026-08-07T00:40:02+08:00 daily https://www.pharmasources.com/industryinsights/model-indicates-current-novel-coronaviru-317276.html 0.6 2026-08-07T01:14:17+08:00 daily https://www.pharmasources.com/industryinsights/informa-markets-malaysia-hosts-business--317277.html 0.6 2026-08-07T01:21:42+08:00 daily https://www.pharmasources.com/industryinsights/saudi-arabia-sends-support-for-china-to--317278.html 0.6 2026-08-09T21:45:47+08:00 daily https://www.pharmasources.com/industryinsights/global-healthcare-to-soar-above-2-trilli-317279.html 0.6 2026-06-27T06:34:41+08:00 daily https://www.pharmasources.com/industryinsights/sihuan-pharmaceutical-production-approva-317280.html 0.6 2026-08-04T03:36:42+08:00 daily https://www.pharmasources.com/industryinsights/mmi-spa-appoints-ryan-rhodes-as-chief-co-317281.html 0.6 2026-07-03T03:37:55+08:00 daily https://www.pharmasources.com/industryinsights/ascletis-ind-filing-for-its-non-alcoholi-317282.html 0.6 2026-07-23T17:30:00+08:00 daily https://www.pharmasources.com/industryinsights/seegene-launches-kfda-approved-covid-19--317283.html 0.6 2026-08-08T02:57:27+08:00 daily https://www.pharmasources.com/industryinsights/saudi-arabia-sends-support-for-china-to--317284.html 0.6 2026-06-21T02:12:49+08:00 daily https://www.pharmasources.com/industryinsights/nhc-early-diagnosis-and-treatment-brings-317285.html 0.6 2026-06-21T10:18:40+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-subsidiary-wuxi-vaccines--317286.html 0.6 2026-08-12T08:26:44+08:00 daily https://www.pharmasources.com/industryinsights/mankind-should-share-sorrows-when-facing-317287.html 0.6 2026-05-01T13:49:26+08:00 daily https://www.pharmasources.com/industryinsights/chinese-scientist-unite-together-to-tack-317288.html 0.6 2026-07-03T18:39:12+08:00 daily https://www.pharmasources.com/industryinsights/powder-flow-powder-testing-techniques-fo-317289.html 0.6 2026-07-16T17:25:20+08:00 daily https://www.pharmasources.com/industryinsights/powder-flow-powder-testing-techniques-fo-317290.html 0.6 2026-06-25T02:09:06+08:00 daily https://www.pharmasources.com/industryinsights/coronavirus-international-concern-growin-317291.html 0.6 2026-07-07T13:32:19+08:00 daily https://www.pharmasources.com/industryinsights/enterprises-resume-work-and-production-i-317292.html 0.6 2026-07-29T01:10:55+08:00 daily https://www.pharmasources.com/industryinsights/zoomlion-takes-steps-to-combat-the-novel-317293.html 0.6 2026-08-07T15:42:15+08:00 daily https://www.pharmasources.com/industryinsights/nearly-vnd-20-billion-sponsored-by-vingr-317294.html 0.6 2026-06-21T17:02:27+08:00 daily https://www.pharmasources.com/industryinsights/yum-china-stands-with-communities-to-fig-317295.html 0.6 2026-06-21T05:02:46+08:00 daily https://www.pharmasources.com/industryinsights/s-cell-becomes-the-first-in-asia-to-intr-317296.html 0.6 2026-06-21T09:56:00+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-congratulates-immutep-on--317298.html 0.6 2026-07-18T19:47:52+08:00 daily https://www.pharmasources.com/industryinsights/antibody-production-successfully-induced-317299.html 0.6 2026-06-22T22:56:54+08:00 daily https://www.pharmasources.com/industryinsights/which-will-claim-the-real-magic-medicine-317300.html 0.6 2026-06-20T17:17:50+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2020225-317301.html 0.6 2026-08-09T08:17:17+08:00 daily https://www.pharmasources.com/industryinsights/act-continues-to-send-aid-to-various-cou-317302.html 0.6 2026-06-20T17:54:24+08:00 daily https://www.pharmasources.com/industryinsights/index-pharmaceuticals-publishes-mechanis-317303.html 0.6 2026-03-28T03:58:40+08:00 daily https://www.pharmasources.com/industryinsights/manulife-singapore-commits-s1-million-to-317304.html 0.6 2026-06-21T02:49:10+08:00 daily https://www.pharmasources.com/industryinsights/gm-pharm-announces-health-items-for-sale-317305.html 0.6 2026-06-24T01:22:57+08:00 daily https://www.pharmasources.com/industryinsights/those-who-believe-they-have-a-claim-agai-317306.html 0.6 2025-12-20T22:10:26+08:00 daily https://www.pharmasources.com/industryinsights/ascentage-pharma-announces-approval-for--317307.html 0.6 2026-07-21T15:57:15+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-accepts-gsks-snda-application-for-317308.html 0.6 2026-06-20T19:01:36+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-confirms-no-impact-of--317309.html 0.6 2026-07-04T11:34:39+08:00 daily https://www.pharmasources.com/industryinsights/yili-supports-pastures-amid-coronavirus--317310.html 0.6 2026-07-21T12:15:24+08:00 daily https://www.pharmasources.com/industryinsights/emergency-service-from-111-helps-compani-317311.html 0.6 2026-06-20T19:51:34+08:00 daily https://www.pharmasources.com/industryinsights/artisense-group-stated-317312.html 0.6 2026-06-22T02:57:39+08:00 daily https://www.pharmasources.com/industryinsights/brazil-sends-masks-to-help-fight-the-cor-317313.html 0.6 2026-06-22T04:54:40+08:00 daily https://www.pharmasources.com/industryinsights/project-hope-partners-with-united-airlin-317314.html 0.6 2026-06-23T10:06:48+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-and-vir-biotechnology-ann-317315.html 0.6 2026-07-25T20:11:02+08:00 daily https://www.pharmasources.com/industryinsights/precise-efficient-matchmaking-by-cphi-ch-317316.html 0.6 2026-07-23T02:09:24+08:00 daily https://www.pharmasources.com/industryinsights/enso-partners-with-my-life-centre-to-ope-317317.html 0.6 2026-08-07T19:19:17+08:00 daily https://www.pharmasources.com/industryinsights/yola-provides-online-learning-platform-t-317318.html 0.6 2026-08-15T01:21:44+08:00 daily https://www.pharmasources.com/industryinsights/the-animal-health-feed-zone-of-cphi-chin-317319.html 0.6 2026-08-14T09:12:51+08:00 daily https://www.pharmasources.com/industryinsights/kahr-medical-raises-18-million-in-privat-317320.html 0.6 2026-06-20T18:21:58+08:00 daily https://www.pharmasources.com/industryinsights/tripcom-announces-safeguards-for-travele-317321.html 0.6 2026-06-21T08:53:51+08:00 daily https://www.pharmasources.com/industryinsights/new-data-confirms-cardiac-dimensions-car-317322.html 0.6 2026-06-21T11:13:18+08:00 daily https://www.pharmasources.com/industryinsights/clinical-trial-of-ganovo-and-ritonavir-c-317323.html 0.6 2026-07-24T06:45:16+08:00 daily https://www.pharmasources.com/industryinsights/active-motif-clones-sequences-and-expres-317324.html 0.6 2026-06-21T20:56:37+08:00 daily https://www.pharmasources.com/industryinsights/fdacoronavirus-covid-19-supply-chain-upd-317325.html 0.6 2026-06-29T00:53:08+08:00 daily https://www.pharmasources.com/industryinsights/direct-relief-commits-initial-2-million--317326.html 0.6 2026-08-11T13:04:12+08:00 daily https://www.pharmasources.com/industryinsights/jiangsu-hengruis-second-indication-appli-317327.html 0.6 2026-06-21T04:54:37+08:00 daily https://www.pharmasources.com/industryinsights/researchers-worldwide-are-using-berkeley-317328.html 0.6 2025-12-03T11:53:53+08:00 daily https://www.pharmasources.com/industryinsights/xag-robot-joins-drone-fleet-to-initiate--317329.html 0.6 2026-06-20T18:14:01+08:00 daily https://www.pharmasources.com/industryinsights/wuhans-war-on-covid-19-how-china-mobiliz-317330.html 0.6 2026-08-10T02:38:46+08:00 daily https://www.pharmasources.com/industryinsights/ping-an-launches-covid-19-smart-image-re-317331.html 0.6 2026-07-28T12:21:43+08:00 daily https://www.pharmasources.com/industryinsights/lotte-vietnam-shopping-joint-stock-compa-317332.html 0.6 2026-06-21T06:57:55+08:00 daily https://www.pharmasources.com/industryinsights/jlk-inspection-has-announced-signing-of--317333.html 0.6 2026-06-21T12:24:51+08:00 daily https://www.pharmasources.com/industryinsights/lipotrue-sl-and-proya-cooperate-in-devel-317334.html 0.6 2026-07-02T02:16:53+08:00 daily https://www.pharmasources.com/industryinsights/ckgsb-survey-finds-over-60-of-chinese-en-317335.html 0.6 2026-06-20T15:14:33+08:00 daily https://www.pharmasources.com/industryinsights/ping-an-research-on-ai-applications-for--317336.html 0.6 2026-07-02T14:28:15+08:00 daily https://www.pharmasources.com/industryinsights/dermalog-fever-detection-in-operation-at-317337.html 0.6 2026-06-20T15:14:22+08:00 daily https://www.pharmasources.com/industryinsights/china-xiangtai-food-co-ltd-launches-onli-317338.html 0.6 2026-08-07T05:05:29+08:00 daily https://www.pharmasources.com/industryinsights/lianluo-smart-limited-announces-pricing--317339.html 0.6 2026-08-06T23:55:43+08:00 daily https://www.pharmasources.com/industryinsights/tessa-therapeutics-announces-us-fda-rege-317340.html 0.6 2026-08-07T00:01:35+08:00 daily https://www.pharmasources.com/industryinsights/studycat-donates-free-use-of-its-childre-317341.html 0.6 2026-08-07T00:40:10+08:00 daily https://www.pharmasources.com/industryinsights/european-medicines-agency-accepts-submis-317342.html 0.6 2026-08-07T00:59:00+08:00 daily https://www.pharmasources.com/industryinsights/3sbio-makes-investment-in-mpms-100m-onco-317343.html 0.6 2026-08-07T00:52:50+08:00 daily https://www.pharmasources.com/industryinsights/coronavirus-covid-19-update-fda-issues-n-317344.html 0.6 2026-08-07T00:46:30+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn202032-317345.html 0.6 2026-08-07T00:42:19+08:00 daily https://www.pharmasources.com/industryinsights/mydoc-named-2020-singapore-telehealth-co-317346.html 0.6 2026-08-07T13:16:24+08:00 daily https://www.pharmasources.com/industryinsights/firetinas-the-ai-weapon-against-corona-v-317347.html 0.6 2026-08-13T22:21:43+08:00 daily https://www.pharmasources.com/industryinsights/convatec-sharpens-focus-on-asia-pacific--317348.html 0.6 2026-08-07T16:21:00+08:00 daily https://www.pharmasources.com/industryinsights/erbitux-approved-for-first-line-use-in-c-317349.html 0.6 2026-08-08T00:19:06+08:00 daily https://www.pharmasources.com/industryinsights/medix-global-launches-the-mask-of-solida-317350.html 0.6 2026-08-07T12:35:16+08:00 daily https://www.pharmasources.com/industryinsights/sihuan-pharmaceutical-announces-clinical-317351.html 0.6 2026-08-07T12:03:31+08:00 daily https://www.pharmasources.com/industryinsights/luminex-corporation-submits-verigener-ii-317352.html 0.6 2026-08-07T03:48:38+08:00 daily https://www.pharmasources.com/industryinsights/infinitus-moves-to-ensure-a-smooth-retur-317353.html 0.6 2026-08-11T13:13:24+08:00 daily https://www.pharmasources.com/industryinsights/3sbio-makes-investment-in-mpms-100m-onco-317354.html 0.6 2026-08-07T03:12:43+08:00 daily https://www.pharmasources.com/industryinsights/drug-trials-snapshots-317355.html 0.6 2026-08-07T03:03:02+08:00 daily https://www.pharmasources.com/industryinsights/completion-of-study-enrolment-of-impland-317356.html 0.6 2026-08-07T02:52:11+08:00 daily https://www.pharmasources.com/industryinsights/securecell-partners-with-alit-life-scien-317357.html 0.6 2026-08-07T02:45:47+08:00 daily https://www.pharmasources.com/industryinsights/immunos-therapeutics-selects-probiogen-f-317358.html 0.6 2026-08-07T02:40:38+08:00 daily https://www.pharmasources.com/industryinsights/wolfgang-kintzel-to-become-cellbox-solut-317359.html 0.6 2026-08-06T23:36:51+08:00 daily https://www.pharmasources.com/industryinsights/shuwen-biotech-to-offer-breakthrough-pre-317360.html 0.6 2026-08-06T22:21:05+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-introduces-biopat-spectro-to-e-317361.html 0.6 2026-08-06T22:12:30+08:00 daily https://www.pharmasources.com/industryinsights/coronavirus-covid-19-update-fda-and-cdc--317362.html 0.6 2026-08-06T23:33:44+08:00 daily https://www.pharmasources.com/industryinsights/why-the-us-is-flying-in-the-dark-without-317363.html 0.6 2026-08-06T23:36:58+08:00 daily https://www.pharmasources.com/industryinsights/takeda-divests-assets-to-hypera-for-825m-317364.html 0.6 2026-08-07T05:08:21+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-diosynth-expands-gene-therapy-m-317365.html 0.6 2026-08-14T18:40:28+08:00 daily https://www.pharmasources.com/industryinsights/fda-releases-coronavirus-supply-chain-up-317366.html 0.6 2026-08-14T12:58:01+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-cellular-dynamics-opens-ipsc-fa-317367.html 0.6 2026-08-07T04:52:42+08:00 daily https://www.pharmasources.com/industryinsights/gilead-to-acquire-forty-seven-for-49b-317368.html 0.6 2026-08-07T05:05:46+08:00 daily https://www.pharmasources.com/industryinsights/probiogen-immunos-ink-manufacturing-serv-317369.html 0.6 2026-08-07T05:28:29+08:00 daily https://www.pharmasources.com/industryinsights/aragen-appoints-steven-lang-as-vp-biolog-317370.html 0.6 2026-06-21T08:06:00+08:00 daily https://www.pharmasources.com/industryinsights/insilico-opens-subsidiary-in-boston-317371.html 0.6 2026-06-20T14:54:01+08:00 daily https://www.pharmasources.com/industryinsights/novavax-advances-development-of-covid-19-317372.html 0.6 2026-06-22T05:17:55+08:00 daily https://www.pharmasources.com/industryinsights/pistoia-alliances-udm-project-reaches-mi-317373.html 0.6 2026-06-21T10:15:24+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-vir-biotech-partner-to-de-317374.html 0.6 2026-08-09T05:54:47+08:00 daily https://www.pharmasources.com/industryinsights/biohaven-drug-wins-us-fda-approval-for-u-317375.html 0.6 2026-08-07T13:51:00+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-first-generic-version-of-317376.html 0.6 2026-07-05T12:35:20+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-to-pay-119-mn-to-resolve-us-drug--317377.html 0.6 2026-07-10T11:58:14+08:00 daily https://www.pharmasources.com/industryinsights/orphan-drugs-face-uphill-battle-in-2020--317378.html 0.6 2026-07-04T17:51:56+08:00 daily https://www.pharmasources.com/industryinsights/wellcome-trustdbt-india-alliance-confers-317379.html 0.6 2026-06-28T22:46:52+08:00 daily https://www.pharmasources.com/industryinsights/ema-releases-results-from-february-meeti-317380.html 0.6 2026-06-20T20:57:56+08:00 daily https://www.pharmasources.com/industryinsights/technique-to-synthesise-aziridines-devel-317381.html 0.6 2026-06-21T03:05:54+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-advil-dual-action-for-over--317382.html 0.6 2026-06-20T21:12:47+08:00 daily https://www.pharmasources.com/industryinsights/lenalidomide-recommended-for-use-with-ri-317383.html 0.6 2026-06-21T07:12:08+08:00 daily https://www.pharmasources.com/industryinsights/american-health-packaging-voluntarily-re-317384.html 0.6 2026-06-20T20:50:28+08:00 daily https://www.pharmasources.com/industryinsights/fda-sends-warning-letter-to-kvk-tech-man-317385.html 0.6 2026-06-20T18:58:37+08:00 daily https://www.pharmasources.com/industryinsights/global-collaboration-formed-to-develop-n-317386.html 0.6 2026-08-12T23:01:11+08:00 daily https://www.pharmasources.com/industryinsights/takeda-acquires-pvp-biologics-following--317387.html 0.6 2026-06-22T01:56:34+08:00 daily https://www.pharmasources.com/industryinsights/life-arc-invests-1m-in-university-of-cam-317388.html 0.6 2026-06-23T12:19:16+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-sells-hypertension-medicines-317389.html 0.6 2026-06-28T09:16:23+08:00 daily https://www.pharmasources.com/industryinsights/nice-does-not-recommend-polatuzumab-vedo-317390.html 0.6 2026-06-20T22:17:52+08:00 daily https://www.pharmasources.com/industryinsights/coronavirus-deaths-cross-3000-recovery-r-317391.html 0.6 2026-06-21T00:53:48+08:00 daily https://www.pharmasources.com/industryinsights/biogen-and-sangamo-to-develop-neurologic-317392.html 0.6 2026-05-07T22:58:14+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-to-keep-prices-stable-for-potenti-317393.html 0.6 2026-06-22T00:03:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-esperions-non-statin-ldl-c--317394.html 0.6 2026-06-21T15:12:38+08:00 daily https://www.pharmasources.com/industryinsights/novavax-starts-animal-testing-of-coronav-317395.html 0.6 2026-06-21T15:59:26+08:00 daily https://www.pharmasources.com/industryinsights/niaid-began-first-clinical-trial-of-remd-317396.html 0.6 2026-08-09T06:59:20+08:00 daily https://www.pharmasources.com/industryinsights/frost-sullivan-defines-top-femtech-globa-317397.html 0.6 2026-06-08T21:54:56+08:00 daily https://www.pharmasources.com/industryinsights/cromsource-announces-a-significant-miles-317398.html 0.6 2026-06-21T04:01:45+08:00 daily https://www.pharmasources.com/industryinsights/ceo-richard-twomey-leaves-molnlycke-317399.html 0.6 2026-08-05T20:58:11+08:00 daily https://www.pharmasources.com/industryinsights/mimetas-to-launch-assay-ready-product-li-317400.html 0.6 2026-06-07T20:35:13+08:00 daily https://www.pharmasources.com/industryinsights/how-coronavirus-affects-travel-to-eueea--317401.html 0.6 2026-07-04T17:16:06+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-and-stcube-enter-into--317402.html 0.6 2026-08-05T23:01:30+08:00 daily https://www.pharmasources.com/industryinsights/bactiguard-completes-acquisition-of-vigi-317403.html 0.6 2026-06-21T11:21:34+08:00 daily https://www.pharmasources.com/industryinsights/c2-pharma-expands-advisory-board-to-supp-317404.html 0.6 2026-06-20T22:19:02+08:00 daily https://www.pharmasources.com/industryinsights/viroclinics-and-ddl-join-forces-317405.html 0.6 2026-06-20T17:17:37+08:00 daily https://www.pharmasources.com/industryinsights/zpredicta-enters-collaboration-with-labc-317406.html 0.6 2026-06-21T14:38:31+08:00 daily https://www.pharmasources.com/industryinsights/avectas-ccrm-enter-cell-therapy-tie-up-317407.html 0.6 2026-06-21T12:18:35+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-identifies-antiviral-compounds-wi-317408.html 0.6 2026-03-29T10:53:53+08:00 daily https://www.pharmasources.com/industryinsights/exports-of-certain-apis-formulations-put-317409.html 0.6 2026-06-21T22:28:12+08:00 daily https://www.pharmasources.com/industryinsights/sridhar-venkatesh-appointed-as-md-and-vp-317410.html 0.6 2026-07-03T17:04:23+08:00 daily https://www.pharmasources.com/industryinsights/online-pharmacy-valisure-says-tests-show-317411.html 0.6 2026-06-21T02:02:47+08:00 daily https://www.pharmasources.com/industryinsights/new-findings-show-sars-drugs-can-help-tr-317412.html 0.6 2026-06-20T17:01:17+08:00 daily https://www.pharmasources.com/industryinsights/mateon-launches-antiviral-programme-focu-317413.html 0.6 2026-06-20T23:55:45+08:00 daily https://www.pharmasources.com/industryinsights/applied-dna-takis-biotech-design-four-co-317414.html 0.6 2026-04-21T05:33:15+08:00 daily https://www.pharmasources.com/industryinsights/edctp-commits-219m-to-mmv-led-malaria-re-317415.html 0.6 2026-06-21T06:21:19+08:00 daily https://www.pharmasources.com/industryinsights/dynavax-queensland-university-and-cepi-w-317416.html 0.6 2026-06-24T07:44:30+08:00 daily https://www.pharmasources.com/industryinsights/takeda-to-sell-select-non-core-assets-in-317417.html 0.6 2026-07-02T20:55:25+08:00 daily https://www.pharmasources.com/industryinsights/europe-on-high-alert-as-coronavirus-covi-317418.html 0.6 2026-08-03T06:09:05+08:00 daily https://www.pharmasources.com/industryinsights/israeli-researchers-near-covid-19-vaccin-317419.html 0.6 2026-08-13T23:27:43+08:00 daily https://www.pharmasources.com/industryinsights/p2x3-agonist-shows-promise-in-relieving--317420.html 0.6 2026-06-21T02:04:38+08:00 daily https://www.pharmasources.com/industryinsights/mallinckrodt-agrees-to-pay-16bn-to-settl-317421.html 0.6 2026-08-13T22:39:09+08:00 daily https://www.pharmasources.com/industryinsights/bicycle-therapeutics-and-genentech-sign--317422.html 0.6 2026-07-28T08:38:58+08:00 daily https://www.pharmasources.com/industryinsights/stada-agrees-to-buy-15-consumer-healthca-317423.html 0.6 2026-06-21T05:57:47+08:00 daily https://www.pharmasources.com/industryinsights/raman-spectroscopy-and-mass-spectrometry-317424.html 0.6 2026-06-20T14:18:43+08:00 daily https://www.pharmasources.com/industryinsights/nanocarrier-could-revolutionise-chemothe-317425.html 0.6 2026-08-08T01:35:46+08:00 daily https://www.pharmasources.com/industryinsights/coronavirus-rate-in-us-may-suddenly-jump-317426.html 0.6 2026-08-08T02:37:57+08:00 daily https://www.pharmasources.com/industryinsights/gilead-to-acquire-immuno-oncology-compan-317427.html 0.6 2026-08-08T03:25:31+08:00 daily https://www.pharmasources.com/industryinsights/technique-to-stabilise-freeze-dried-cell-317428.html 0.6 2026-08-08T04:36:52+08:00 daily https://www.pharmasources.com/industryinsights/orphan-drug-designations-are-declining-s-317429.html 0.6 2026-08-08T07:38:00+08:00 daily https://www.pharmasources.com/industryinsights/import-restrictions-for-cannabis-based-m-317430.html 0.6 2026-08-08T08:38:43+08:00 daily https://www.pharmasources.com/industryinsights/fda-and-ema-accept-licence-applications--317431.html 0.6 2026-08-08T09:47:14+08:00 daily https://www.pharmasources.com/industryinsights/novartis-launches-review-of-beovu-after--317432.html 0.6 2026-08-09T20:12:24+08:00 daily https://www.pharmasources.com/industryinsights/evolving-world-of-pharma-spray-drying-in-317433.html 0.6 2026-06-27T03:49:11+08:00 daily https://www.pharmasources.com/industryinsights/discovery-could-make-suzuki-miyaura-reac-317434.html 0.6 2026-06-22T12:01:12+08:00 daily https://www.pharmasources.com/industryinsights/oil-and-hydrogel-mix-effective-for-preci-317435.html 0.6 2026-08-07T00:50:45+08:00 daily https://www.pharmasources.com/industryinsights/dry-eye-syndrome-therapies-in-pipeline-s-317436.html 0.6 2026-06-21T01:47:38+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-zejula-snda-application-as-a-317437.html 0.6 2026-04-29T03:21:50+08:00 daily https://www.pharmasources.com/industryinsights/ani-announces-fda-approval-of-memantine--317438.html 0.6 2026-06-21T22:01:41+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-regulatory-submission-for-ta-317439.html 0.6 2026-08-08T15:49:44+08:00 daily https://www.pharmasources.com/industryinsights/kempharm-submits-kp415-nda-to-fda-for-ad-317440.html 0.6 2026-08-08T14:03:02+08:00 daily https://www.pharmasources.com/industryinsights/venclexta-low-dose-cytarabine-combinatio-317441.html 0.6 2026-08-08T12:18:37+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-isatuximab-irfc-for-multipl-317442.html 0.6 2026-07-04T04:07:44+08:00 daily https://www.pharmasources.com/industryinsights/eyepoint-announces-positive-topline-foll-317443.html 0.6 2026-08-08T07:53:42+08:00 daily https://www.pharmasources.com/industryinsights/polypid-announces-start-of-phase-3-clini-317444.html 0.6 2026-08-08T00:39:07+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-completes-divestment-agreeme-317445.html 0.6 2026-08-07T22:35:02+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-potassium-phosphates-inject-317446.html 0.6 2026-08-07T18:15:09+08:00 daily https://www.pharmasources.com/industryinsights/takeda-completes-sale-of-select-otc-and--317447.html 0.6 2026-08-07T13:17:41+08:00 daily https://www.pharmasources.com/industryinsights/halodoc-deploys-more-available-doctors-a-317448.html 0.6 2026-08-07T02:09:51+08:00 daily https://www.pharmasources.com/industryinsights/new-disinfection-spray-from-lipidor-and--317449.html 0.6 2026-08-07T02:04:57+08:00 daily https://www.pharmasources.com/industryinsights/minister-of-tourism-and-creative-economy-317450.html 0.6 2026-08-07T01:51:54+08:00 daily https://www.pharmasources.com/industryinsights/doctoroncall-partners-merchantrade-money-317451.html 0.6 2026-08-07T01:27:28+08:00 daily https://www.pharmasources.com/industryinsights/airports-in-vietnam-apply-special-proces-317452.html 0.6 2026-08-07T01:19:24+08:00 daily https://www.pharmasources.com/industryinsights/innovent-biologics-announces-first-patie-317453.html 0.6 2026-08-07T01:11:17+08:00 daily https://www.pharmasources.com/industryinsights/voluntis-and-bristol-myers-squibb-to-co--317454.html 0.6 2026-06-21T10:59:12+08:00 daily https://www.pharmasources.com/industryinsights/newly-discovered-brain-response-to-obesi-317455.html 0.6 2026-07-24T09:18:31+08:00 daily https://www.pharmasources.com/industryinsights/international-research-partnership-and-e-317456.html 0.6 2026-06-21T11:17:35+08:00 daily https://www.pharmasources.com/industryinsights/amag-pharma-makes-organization-changes-317457.html 0.6 2026-01-31T11:47:20+08:00 daily https://www.pharmasources.com/industryinsights/pharma-packaging-focuses-on-eco-friendly-317458.html 0.6 2026-07-18T15:55:21+08:00 daily https://www.pharmasources.com/industryinsights/milliporesigma-launches-lanexo-317459.html 0.6 2026-06-20T20:50:27+08:00 daily https://www.pharmasources.com/industryinsights/labvantage-bolsters-data-mgmt-capabiliti-317460.html 0.6 2026-07-13T06:19:07+08:00 daily https://www.pharmasources.com/industryinsights/global-travel-vaccine-market---safety-to-317461.html 0.6 2026-06-20T19:55:32+08:00 daily https://www.pharmasources.com/industryinsights/china-approves-use-of-roche-arthritis-dr-317462.html 0.6 2026-08-10T03:10:36+08:00 daily https://www.pharmasources.com/industryinsights/takeda-initiates-development-of-a-plasma-317463.html 0.6 2026-06-21T05:02:44+08:00 daily https://www.pharmasources.com/industryinsights/sharad-tyagi-appointed-as-president-of-o-317464.html 0.6 2026-03-25T17:16:52+08:00 daily https://www.pharmasources.com/industryinsights/strides-receives-us-fda-approval-for-tet-317465.html 0.6 2026-07-04T14:06:34+08:00 daily https://www.pharmasources.com/industryinsights/world-pharma-supplier-india-restricts-ex-317466.html 0.6 2026-06-21T12:12:21+08:00 daily https://www.pharmasources.com/industryinsights/ec-approves-alnylams-givlaari-for-acute--317467.html 0.6 2026-06-21T12:26:53+08:00 daily https://www.pharmasources.com/industryinsights/eli-lilly-expects-no-coronavirus-related-317468.html 0.6 2026-08-10T12:17:58+08:00 daily https://www.pharmasources.com/industryinsights/iktos-and-sri-to-use-ai-for-covid-19-dru-317469.html 0.6 2026-08-07T01:06:37+08:00 daily https://www.pharmasources.com/industryinsights/inovio-pharmaceuticals-set-to-trial-covi-317470.html 0.6 2026-08-10T03:11:12+08:00 daily https://www.pharmasources.com/industryinsights/genentechs-esbriet-gets-fda-breakthrough-317471.html 0.6 2026-06-21T04:49:34+08:00 daily https://www.pharmasources.com/industryinsights/innovations-in-car-t-therapies-in-apac-w-317472.html 0.6 2026-07-26T06:09:47+08:00 daily https://www.pharmasources.com/industryinsights/ema-announces-update-on-nitrosamine-impu-317473.html 0.6 2026-07-30T06:34:05+08:00 daily https://www.pharmasources.com/industryinsights/us-drug-prices-rose-three-times-faster-t-317474.html 0.6 2026-06-21T00:55:45+08:00 daily https://www.pharmasources.com/industryinsights/nccn-astrazeneca-announce-lung-cancer-pr-317475.html 0.6 2026-07-31T01:13:52+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-rare-pediatric-disease-design-317476.html 0.6 2026-06-21T22:03:48+08:00 daily https://www.pharmasources.com/industryinsights/wpd-pharmaceuticals-brain-cancer-drug-re-317477.html 0.6 2026-06-23T00:44:11+08:00 daily https://www.pharmasources.com/industryinsights/biolinerx-announces-notice-of-allowance--317478.html 0.6 2026-06-21T09:04:07+08:00 daily https://www.pharmasources.com/industryinsights/amphastar-receives-fda-approval-for-supp-317479.html 0.6 2026-06-20T17:05:22+08:00 daily https://www.pharmasources.com/industryinsights/merck-kgaa-darmstadt-amcm-cooperate-in-3-317480.html 0.6 2026-06-21T04:44:31+08:00 daily https://www.pharmasources.com/industryinsights/actinium-announces-actimab-a-plus-73-com-317481.html 0.6 2026-07-21T10:47:44+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-neratinib-for-metastatic-he-317482.html 0.6 2026-06-21T18:06:49+08:00 daily https://www.pharmasources.com/industryinsights/halozyme-announces-fda-accepted-bla-for--317483.html 0.6 2026-06-22T06:55:43+08:00 daily https://www.pharmasources.com/industryinsights/amgen-cytokinetics-servier-announce-cont-317484.html 0.6 2026-06-20T19:45:32+08:00 daily https://www.pharmasources.com/industryinsights/oramed-reports-positive-results-in-final-317485.html 0.6 2026-07-19T14:57:54+08:00 daily https://www.pharmasources.com/industryinsights/fda-clears-novalung-for-treatment-of-acu-317486.html 0.6 2026-08-07T18:50:32+08:00 daily https://www.pharmasources.com/industryinsights/akouos-closes-105m-series-b-financing-317487.html 0.6 2026-08-09T19:54:09+08:00 daily https://www.pharmasources.com/industryinsights/ayala-pharmaceuticals-granted-us-fda-fas-317488.html 0.6 2026-06-30T03:36:23+08:00 daily https://www.pharmasources.com/industryinsights/nice-pushes-doptelet-for-pre-surgery-liv-317489.html 0.6 2026-06-20T14:27:25+08:00 daily https://www.pharmasources.com/industryinsights/kbi-names-dirk-lange-ceo-317490.html 0.6 2026-06-07T22:20:19+08:00 daily https://www.pharmasources.com/industryinsights/amicus-opens-philly-coe-317491.html 0.6 2026-06-21T18:59:37+08:00 daily https://www.pharmasources.com/industryinsights/nexelis-to-acquire-immunxperts-317492.html 0.6 2026-08-12T00:33:27+08:00 daily https://www.pharmasources.com/industryinsights/medpharm-completes-fda-inspection-317493.html 0.6 2026-06-20T14:24:35+08:00 daily https://www.pharmasources.com/industryinsights/emergent-strengthens-clinical-ops-317494.html 0.6 2026-07-06T21:29:44+08:00 daily https://www.pharmasources.com/industryinsights/valgenesis-opens-new-offices-317495.html 0.6 2026-08-04T01:07:03+08:00 daily https://www.pharmasources.com/industryinsights/absolute-antibody-launches-flexpress-317496.html 0.6 2026-06-21T07:18:22+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-gsks-advil-dual-action-with-317497.html 0.6 2026-06-20T14:56:15+08:00 daily https://www.pharmasources.com/industryinsights/harbour-biomed-gets-fda-nod-to-begin-cli-317498.html 0.6 2026-06-21T14:50:18+08:00 daily https://www.pharmasources.com/industryinsights/verastem-oncology-announces-new-strategi-317499.html 0.6 2026-07-29T14:47:41+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-babylon-link-up-to-tackle-digesti-317500.html 0.6 2026-07-31T04:17:15+08:00 daily https://www.pharmasources.com/industryinsights/givlaari-approved-in-eu-following-recent-317501.html 0.6 2026-06-21T10:49:08+08:00 daily https://www.pharmasources.com/industryinsights/app-to-determine-risk-of-preterm-birth-d-317502.html 0.6 2026-06-21T11:19:35+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-dosed-in-potential-lymphoe-317503.html 0.6 2026-08-08T09:21:43+08:00 daily https://www.pharmasources.com/industryinsights/chinas-institute-of-materia-medica-partn-317504.html 0.6 2026-06-23T22:01:17+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-sarclisa-for-relapsed-refra-317505.html 0.6 2026-06-21T01:14:56+08:00 daily https://www.pharmasources.com/industryinsights/xpovio-hits-endpoints-in-phase-iii-multi-317506.html 0.6 2026-06-21T05:00:45+08:00 daily https://www.pharmasources.com/industryinsights/keytruda-improves-pfs-in-classical-hodgk-317507.html 0.6 2026-06-20T14:38:52+08:00 daily https://www.pharmasources.com/industryinsights/gw-pharma-regains-sativex-rights-in-uk-317508.html 0.6 2026-06-24T07:49:02+08:00 daily https://www.pharmasources.com/industryinsights/ema-prime-status-granted-to-janssens-inh-317509.html 0.6 2026-06-21T05:10:53+08:00 daily https://www.pharmasources.com/industryinsights/novartis-life-changing-ilaris-set-for-nh-317510.html 0.6 2026-06-21T14:43:14+08:00 daily https://www.pharmasources.com/industryinsights/chmp-recommends-just-two-new-meds-in-feb-317511.html 0.6 2026-06-21T07:55:09+08:00 daily https://www.pharmasources.com/industryinsights/subcutaneous-remsima-launched-in-uk-317512.html 0.6 2026-07-04T11:39:15+08:00 daily https://www.pharmasources.com/industryinsights/trelegy-ellipta-filing-accepted-by-ema-f-317513.html 0.6 2026-06-20T16:11:25+08:00 daily https://www.pharmasources.com/industryinsights/biogen-sangamo-team-up-on-neurological-d-317514.html 0.6 2026-06-21T00:07:39+08:00 daily https://www.pharmasources.com/industryinsights/epivax-accelerates-covid-19-vaccine-deve-317515.html 0.6 2026-06-21T00:02:40+08:00 daily https://www.pharmasources.com/industryinsights/evelo-announces-patent-covering-use-of-p-317516.html 0.6 2026-06-23T17:58:08+08:00 daily https://www.pharmasources.com/industryinsights/american-brivision-first-patient-enrolle-317517.html 0.6 2026-06-21T11:01:09+08:00 daily https://www.pharmasources.com/industryinsights/actinium-announces-first-patient-treated-317518.html 0.6 2026-07-17T09:57:14+08:00 daily https://www.pharmasources.com/industryinsights/fda-strengthens-black-box-warning-for-si-317519.html 0.6 2026-08-03T05:49:45+08:00 daily https://www.pharmasources.com/industryinsights/kura-oncology-receives-fast-track-design-317520.html 0.6 2026-06-30T05:55:51+08:00 daily https://www.pharmasources.com/industryinsights/cma-levels-over-34m-in-fines-for-competi-317521.html 0.6 2026-06-20T16:21:11+08:00 daily https://www.pharmasources.com/industryinsights/thin-film-platform-to-preserve-vaccines--317522.html 0.6 2026-06-20T23:49:51+08:00 daily https://www.pharmasources.com/industryinsights/preventing-spread-of-sars-coronavirus-2--317523.html 0.6 2026-08-08T02:02:33+08:00 daily https://www.pharmasources.com/industryinsights/no-shortage-of-drug-ingredients-for-next-317524.html 0.6 2026-06-20T21:20:07+08:00 daily https://www.pharmasources.com/industryinsights/scientists-from-merck-and-the-walter-and-317525.html 0.6 2026-08-11T14:54:30+08:00 daily https://www.pharmasources.com/industryinsights/amunix-raises-73m-in-series-a-financing--317526.html 0.6 2026-06-22T15:42:39+08:00 daily https://www.pharmasources.com/industryinsights/goclean-by-gocar-malaysia---an-initiativ-317527.html 0.6 2026-06-21T20:15:52+08:00 daily https://www.pharmasources.com/industryinsights/guide-infrared-donates-infrared-fever-sc-317528.html 0.6 2026-07-20T01:02:43+08:00 daily https://www.pharmasources.com/industryinsights/orient-commercial-joint-stock-bank-suppo-317529.html 0.6 2026-06-21T01:58:37+08:00 daily https://www.pharmasources.com/industryinsights/berkeley-lights-launches-t-cell-receptor-317530.html 0.6 2026-01-22T17:28:16+08:00 daily https://www.pharmasources.com/industryinsights/hh-global-enters-partnership-with-gnc-to-317531.html 0.6 2026-06-21T03:04:42+08:00 daily https://www.pharmasources.com/industryinsights/new-thermo-scientific-suretect-pcr-assay-317532.html 0.6 2026-06-20T15:54:31+08:00 daily https://www.pharmasources.com/industryinsights/persona-is-now-available-to-consumers-wo-317533.html 0.6 2026-08-09T15:05:46+08:00 daily https://www.pharmasources.com/industryinsights/sunings-unmanned-logistics-overtakes-the-317534.html 0.6 2026-06-25T10:53:45+08:00 daily https://www.pharmasources.com/industryinsights/qimings-portfolios-fight-the-novel-coron-317535.html 0.6 2026-08-12T01:57:01+08:00 daily https://www.pharmasources.com/industryinsights/msb-viet-nam-announces-relief-measures-f-317536.html 0.6 2026-04-07T23:54:45+08:00 daily https://www.pharmasources.com/industryinsights/tuv-rheinland-emc-testing-laboratory-at--317537.html 0.6 2026-06-28T14:37:36+08:00 daily https://www.pharmasources.com/industryinsights/zuellig-pharma-acquires-alliance-pharma--317538.html 0.6 2026-06-21T10:55:15+08:00 daily https://www.pharmasources.com/industryinsights/farrer-park-hospital-joins-44-hospitals--317539.html 0.6 2026-07-20T03:03:18+08:00 daily https://www.pharmasources.com/industryinsights/syntheticmr-signs-collaboration-agreemen-317540.html 0.6 2026-06-13T14:47:09+08:00 daily https://www.pharmasources.com/industryinsights/science-and-technology-daily-chorus-of-a-317541.html 0.6 2026-06-17T11:32:12+08:00 daily https://www.pharmasources.com/industryinsights/without-innovation-in-ayurveda-we-cant-g-317542.html 0.6 2026-06-20T20:03:36+08:00 daily https://www.pharmasources.com/industryinsights/cryoport-reports-record-revenue-317543.html 0.6 2026-08-14T21:14:57+08:00 daily https://www.pharmasources.com/industryinsights/gram-grows-team-to-serve-new-facility-317544.html 0.6 2026-07-12T14:24:37+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-stcube-ink-cancer-drug-317545.html 0.6 2026-07-15T19:13:24+08:00 daily https://www.pharmasources.com/industryinsights/recipharm-sees-increased-demand-for-chlo-317546.html 0.6 2026-06-22T04:10:53+08:00 daily https://www.pharmasources.com/industryinsights/api-supply-covid-19-industry-update-317547.html 0.6 2026-08-12T09:07:41+08:00 daily https://www.pharmasources.com/industryinsights/research-and-markets-releases-covid-19-c-317548.html 0.6 2026-06-14T22:41:11+08:00 daily https://www.pharmasources.com/industryinsights/vir-biotechnology-and-alnylam-partner-in-317549.html 0.6 2026-08-12T17:04:48+08:00 daily https://www.pharmasources.com/industryinsights/arcturus-therapeutics-partners-with-medi-317550.html 0.6 2026-08-02T08:15:35+08:00 daily https://www.pharmasources.com/industryinsights/orionis-and-novartis-enter-drug-discover-317551.html 0.6 2026-06-21T20:56:38+08:00 daily https://www.pharmasources.com/industryinsights/zydus-saroglitazar-becomes-first-nash-dr-317552.html 0.6 2026-08-03T16:38:32+08:00 daily https://www.pharmasources.com/industryinsights/german-researchers-identify-potential-dr-317553.html 0.6 2026-06-21T20:44:46+08:00 daily https://www.pharmasources.com/industryinsights/epivax-partners-with-uga-researcher-on-c-317554.html 0.6 2026-06-23T00:15:02+08:00 daily https://www.pharmasources.com/industryinsights/35-million-unlicensed-erection-pills-sei-317555.html 0.6 2026-07-03T21:53:46+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-durysta-bimatoprost-implant-317556.html 0.6 2026-06-20T23:00:39+08:00 daily https://www.pharmasources.com/industryinsights/emerade-150-micrograms-auto-injectors-re-317557.html 0.6 2026-06-21T03:40:25+08:00 daily https://www.pharmasources.com/industryinsights/dna-nanostructure-stabilisation-could-en-317558.html 0.6 2026-08-06T02:41:05+08:00 daily https://www.pharmasources.com/industryinsights/online-pharmacy-finds-high-levels-of-ndm-317559.html 0.6 2026-06-22T15:50:46+08:00 daily https://www.pharmasources.com/industryinsights/royalty-pharma-acquires-royalties-on-ent-317560.html 0.6 2026-06-20T14:46:12+08:00 daily https://www.pharmasources.com/industryinsights/novadoz-increases-receives-fda-approval--317561.html 0.6 2026-06-20T15:57:08+08:00 daily https://www.pharmasources.com/industryinsights/hikma-extends-recall-of-ketorolac-tromet-317562.html 0.6 2026-06-21T05:05:46+08:00 daily https://www.pharmasources.com/industryinsights/mologic-receives-financial-award-to-deve-317563.html 0.6 2026-06-20T17:56:19+08:00 daily https://www.pharmasources.com/industryinsights/european-commission-grants-abbvie-market-317564.html 0.6 2026-06-20T14:33:09+08:00 daily https://www.pharmasources.com/industryinsights/individual-response-to-covid-19-as-impor-317565.html 0.6 2026-08-14T22:57:45+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-treatment-for-adults-wi-317566.html 0.6 2026-04-27T13:43:15+08:00 daily https://www.pharmasources.com/industryinsights/imfinzi-cancer-combo-falls-short-in-danu-317567.html 0.6 2026-07-19T07:44:12+08:00 daily https://www.pharmasources.com/industryinsights/200m-mental-health-crisis-services-rolle-317568.html 0.6 2026-06-22T01:48:28+08:00 daily https://www.pharmasources.com/industryinsights/post-surgery-chemo-halves-risk-of-recurr-317569.html 0.6 2026-06-22T09:01:42+08:00 daily https://www.pharmasources.com/industryinsights/inpen-diabetes-management-system-receive-317570.html 0.6 2026-06-20T23:15:55+08:00 daily https://www.pharmasources.com/industryinsights/valoctocogene-roxaparvovec-bla-accepted--317571.html 0.6 2026-08-09T03:58:27+08:00 daily https://www.pharmasources.com/industryinsights/annovis-issued-patent-for-method-of-trea-317572.html 0.6 2026-08-07T05:29:17+08:00 daily https://www.pharmasources.com/industryinsights/palatin-announces-first-patient-enrolled-317573.html 0.6 2026-06-21T00:05:38+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-orphan-drug-designation-for-p-317574.html 0.6 2026-06-21T16:21:11+08:00 daily https://www.pharmasources.com/industryinsights/compugen-announces-triple-combination-st-317575.html 0.6 2026-06-21T19:04:42+08:00 daily https://www.pharmasources.com/industryinsights/heron-receives-fda-extension-of-nda-revi-317576.html 0.6 2026-08-06T01:30:14+08:00 daily https://www.pharmasources.com/industryinsights/reneo-pharmaceuticals-initiates-clinical-317577.html 0.6 2026-06-20T19:17:34+08:00 daily https://www.pharmasources.com/industryinsights/coronavirus-update-fda-and-ftc-warn-seve-317578.html 0.6 2026-06-21T17:52:21+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-diosynth-biotechnologies-appoin-317579.html 0.6 2026-06-21T20:09:56+08:00 daily https://www.pharmasources.com/industryinsights/bora-pharmaceuticals-to-acquire-gsk-miss-317580.html 0.6 2026-06-24T15:24:48+08:00 daily https://www.pharmasources.com/industryinsights/aji-bio-pharma-forms-external-advisory-b-317581.html 0.6 2026-06-21T00:02:43+08:00 daily https://www.pharmasources.com/industryinsights/nanoform-orion-enter-next-gen-drug-devel-317582.html 0.6 2026-08-07T20:34:27+08:00 daily https://www.pharmasources.com/industryinsights/beroni-group-advances-coronavirus-resear-317583.html 0.6 2026-01-18T17:04:00+08:00 daily https://www.pharmasources.com/industryinsights/zydus-xoma-enter-io-agreement-317584.html 0.6 2026-08-14T16:41:25+08:00 daily https://www.pharmasources.com/industryinsights/cel-sci-developing-immunotherapy-to-trea-317585.html 0.6 2026-08-03T02:46:45+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-concludes-sms-pharmas-inspection--317586.html 0.6 2026-06-21T06:12:56+08:00 daily https://www.pharmasources.com/industryinsights/lincoln-pharma-bets-big-on-exports-317587.html 0.6 2026-06-22T03:04:51+08:00 daily https://www.pharmasources.com/industryinsights/divis-laboratories-begins-commercial-pro-317588.html 0.6 2026-06-20T23:58:32+08:00 daily https://www.pharmasources.com/industryinsights/fda-announces-changes-that-will-soon-aff-317589.html 0.6 2026-04-07T16:06:28+08:00 daily https://www.pharmasources.com/industryinsights/development-initiated-for-a-plasma-deriv-317590.html 0.6 2026-06-21T16:06:22+08:00 daily https://www.pharmasources.com/industryinsights/nilvadipine-and-related-drugs-could-slow-317591.html 0.6 2026-06-20T23:01:42+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-isturisa-osilodrostat-treat-317592.html 0.6 2026-04-19T07:09:00+08:00 daily https://www.pharmasources.com/industryinsights/scorpion-derived-proteins-deliver-steroi-317593.html 0.6 2026-06-21T22:55:43+08:00 daily https://www.pharmasources.com/industryinsights/dcat-week-2020-cancelled-amid-covid-19-o-317594.html 0.6 2026-07-19T09:43:04+08:00 daily https://www.pharmasources.com/industryinsights/f2g-receives-orphan-drug-designation-for-317595.html 0.6 2026-08-03T23:53:40+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-bla-for-proposed-biosimilar--317596.html 0.6 2026-06-22T03:09:47+08:00 daily https://www.pharmasources.com/industryinsights/immutep-receives-second-ind-approval-for-317597.html 0.6 2026-06-20T19:00:33+08:00 daily https://www.pharmasources.com/industryinsights/gut-bacteria-can-penetrate-tumors-and-ai-317598.html 0.6 2026-06-20T14:55:07+08:00 daily https://www.pharmasources.com/industryinsights/biocryst-begins-proof-of-concept-trial-i-317599.html 0.6 2026-08-06T05:35:22+08:00 daily https://www.pharmasources.com/industryinsights/breast-cancer-breakthrough-could-end-unn-317600.html 0.6 2026-06-20T20:52:41+08:00 daily https://www.pharmasources.com/industryinsights/eu-marketing-authorisation-change-for-ma-317601.html 0.6 2026-08-06T21:52:39+08:00 daily https://www.pharmasources.com/industryinsights/3000-more-babies-saved-by-nhs-actions-317602.html 0.6 2026-06-20T17:15:06+08:00 daily https://www.pharmasources.com/industryinsights/opdivoyervoy-continues-to-impress-in-kid-317603.html 0.6 2026-06-21T17:56:28+08:00 daily https://www.pharmasources.com/industryinsights/galdermas-investigational-prurigo-nodula-317604.html 0.6 2026-07-07T04:21:26+08:00 daily https://www.pharmasources.com/industryinsights/gsk-immatics-team-up-for-cancer-cell-the-317605.html 0.6 2026-06-21T14:53:16+08:00 daily https://www.pharmasources.com/industryinsights/tevas-austedo-flunks-in-late-stage-paedi-317606.html 0.6 2026-06-21T11:08:19+08:00 daily https://www.pharmasources.com/industryinsights/new-report-highlights-toxic-risk-of-prop-317607.html 0.6 2026-06-21T20:57:37+08:00 daily https://www.pharmasources.com/industryinsights/opdivo-cabiralizumab-combo-falls-short-i-317608.html 0.6 2026-08-10T22:31:52+08:00 daily https://www.pharmasources.com/industryinsights/ngm-bio-announces-positive-preliminary-t-317609.html 0.6 2026-08-10T18:37:30+08:00 daily https://www.pharmasources.com/industryinsights/aravive-announces-dose-escalation-of-avb-317610.html 0.6 2026-06-20T22:19:58+08:00 daily https://www.pharmasources.com/industryinsights/mustang-bio-announces-first-subject-trea-317611.html 0.6 2026-08-09T19:51:44+08:00 daily https://www.pharmasources.com/industryinsights/diasome-announces-positive-results-from--317612.html 0.6 2026-07-13T04:17:40+08:00 daily https://www.pharmasources.com/industryinsights/regulus-therapeutics-reinitiates-rgls432-317613.html 0.6 2026-06-21T09:17:27+08:00 daily https://www.pharmasources.com/industryinsights/oral-vaccines-a-new-drug-development-are-317614.html 0.6 2026-08-04T04:57:52+08:00 daily https://www.pharmasources.com/industryinsights/coronavirus-disease-2019-covid-19-update-317615.html 0.6 2026-07-04T16:39:56+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-completes-weather-tight-s-317616.html 0.6 2026-08-03T13:00:48+08:00 daily https://www.pharmasources.com/industryinsights/interphex-2020-postponed-317617.html 0.6 2026-07-12T22:28:41+08:00 daily https://www.pharmasources.com/industryinsights/qps-assembles-access-restricted-bioanaly-317618.html 0.6 2026-07-21T12:34:34+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-update-fda-foreign-inspections-317619.html 0.6 2026-08-10T15:14:22+08:00 daily https://www.pharmasources.com/industryinsights/fda-inks-research-collaboration-with-ana-317620.html 0.6 2026-08-06T22:08:35+08:00 daily https://www.pharmasources.com/industryinsights/aragen-bioscience-uts-enter-mou-317621.html 0.6 2026-08-06T22:18:58+08:00 daily https://www.pharmasources.com/industryinsights/emergent-biosolutions-novavax-enter-covi-317622.html 0.6 2026-08-07T13:16:30+08:00 daily https://www.pharmasources.com/industryinsights/bourne-partners-emerson-group-form-daybr-317623.html 0.6 2026-01-31T01:06:36+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-clinical-trials-317624.html 0.6 2026-07-05T00:22:13+08:00 daily https://www.pharmasources.com/industryinsights/windmil-therapeutics-and-cognate-bioserv-317625.html 0.6 2026-06-20T18:07:27+08:00 daily https://www.pharmasources.com/industryinsights/pmi-biopharma-solutions-and-nashville-bi-317626.html 0.6 2026-06-23T11:03:52+08:00 daily https://www.pharmasources.com/industryinsights/viiv-healthcare-and-unc-chapel-hill-expa-317627.html 0.6 2026-06-20T20:52:40+08:00 daily https://www.pharmasources.com/industryinsights/numab-closes-236m-series-b-round-led-by--317628.html 0.6 2026-06-21T06:12:21+08:00 daily https://www.pharmasources.com/industryinsights/who-publishes-rd-roadmap-for-coronavirus-317629.html 0.6 2026-06-21T04:00:46+08:00 daily https://www.pharmasources.com/industryinsights/ofev-nintedanib-approved-by-fda-to-treat-317630.html 0.6 2026-06-21T04:00:43+08:00 daily https://www.pharmasources.com/industryinsights/new-production-method-means-rotaxane-cat-317631.html 0.6 2026-04-03T20:58:45+08:00 daily https://www.pharmasources.com/industryinsights/ten-drugs-in-pre-registration-likely-to--317632.html 0.6 2026-08-12T19:56:30+08:00 daily https://www.pharmasources.com/industryinsights/drug-delivery-method-leads-to-sustained--317633.html 0.6 2026-06-21T06:12:57+08:00 daily https://www.pharmasources.com/industryinsights/fda-and-ftc-issue-warning-letters-to-com-317634.html 0.6 2026-08-07T20:48:47+08:00 daily https://www.pharmasources.com/industryinsights/cadent-therapeutics-announces-fda-cleara-317635.html 0.6 2026-06-30T07:32:40+08:00 daily https://www.pharmasources.com/industryinsights/angelini-pharma-acquires-thermacare-from-317636.html 0.6 2026-08-14T17:24:20+08:00 daily https://www.pharmasources.com/industryinsights/pharma-and-biotech-review-treatment-opti-317637.html 0.6 2026-08-10T08:30:49+08:00 daily https://www.pharmasources.com/industryinsights/takeda-provides-update-on-tourmaline-mm2-317638.html 0.6 2026-06-21T15:01:30+08:00 daily https://www.pharmasources.com/industryinsights/mylan-launches-wixela-inhub-317639.html 0.6 2026-07-19T10:31:29+08:00 daily https://www.pharmasources.com/industryinsights/medicinova-to-develop-severe-pneumonia-a-317640.html 0.6 2026-08-10T20:40:12+08:00 daily https://www.pharmasources.com/industryinsights/immune-cells-against-alzheimers-317641.html 0.6 2026-07-16T16:03:04+08:00 daily https://www.pharmasources.com/industryinsights/two-lots-of-phenytoin-oral-suspension-vo-317642.html 0.6 2026-06-22T06:04:42+08:00 daily https://www.pharmasources.com/industryinsights/single-catalyst-could-simplify-biomanufa-317643.html 0.6 2026-07-04T14:15:28+08:00 daily https://www.pharmasources.com/industryinsights/experts-highlight-importance-of-reducing-317644.html 0.6 2026-06-21T06:15:58+08:00 daily https://www.pharmasources.com/industryinsights/mhra-announces-two-medicine-recalls-317645.html 0.6 2026-06-22T01:47:29+08:00 daily https://www.pharmasources.com/industryinsights/supersensitive-smart-material-developed--317646.html 0.6 2026-06-21T11:14:38+08:00 daily https://www.pharmasources.com/industryinsights/biotech-company-promedior-merges-with-ro-317647.html 0.6 2026-08-10T18:04:22+08:00 daily https://www.pharmasources.com/industryinsights/voltaren-approved-for-arthritis-pain-ove-317648.html 0.6 2026-06-26T06:30:52+08:00 daily https://www.pharmasources.com/industryinsights/updated-restrictions-announced-for-multi-317649.html 0.6 2026-06-21T12:53:31+08:00 daily https://www.pharmasources.com/industryinsights/insight-into-2020s-clinical-trials-lands-317650.html 0.6 2026-08-07T23:30:38+08:00 daily https://www.pharmasources.com/industryinsights/adding-natural-extracts-to-medicine-form-317651.html 0.6 2026-06-21T06:11:55+08:00 daily https://www.pharmasources.com/industryinsights/nanoparticle-drug-delivery-could-be-the--317652.html 0.6 2026-06-21T08:01:01+08:00 daily https://www.pharmasources.com/industryinsights/virtual-therapy-services-support-patient-317653.html 0.6 2026-06-20T20:03:38+08:00 daily https://www.pharmasources.com/industryinsights/pharma-and-health-from-ingredients-to-pi-317654.html 0.6 2026-08-07T05:27:47+08:00 daily https://www.pharmasources.com/industryinsights/thermo-scientific-introduces-vanquish-co-317655.html 0.6 2026-06-21T19:52:45+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-completes-biologics-mfg-f-317656.html 0.6 2026-08-13T20:05:33+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-apptec-wuhan-site-resumes-ops-317657.html 0.6 2026-06-23T12:53:46+08:00 daily https://www.pharmasources.com/industryinsights/jj-nsclc-drug-gets-breakthrough-designat-317658.html 0.6 2026-07-04T17:44:09+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-names-corp-development-hea-317659.html 0.6 2026-08-14T21:32:16+08:00 daily https://www.pharmasources.com/industryinsights/lonza-group-strengthens-executive-commit-317660.html 0.6 2026-06-20T14:48:14+08:00 daily https://www.pharmasources.com/industryinsights/mutations-in-plasma-cells-play-a-key-rol-317661.html 0.6 2026-06-21T21:50:50+08:00 daily https://www.pharmasources.com/industryinsights/biocon-mylan-win-patent-litigation-for-i-317662.html 0.6 2026-08-01T03:57:15+08:00 daily https://www.pharmasources.com/industryinsights/tiziana-life-sciences-to-expedite-develo-317663.html 0.6 2026-06-21T23:59:41+08:00 daily https://www.pharmasources.com/industryinsights/eu-addresses-potential-impact-of-covid-1-317664.html 0.6 2026-07-21T09:03:09+08:00 daily https://www.pharmasources.com/industryinsights/serum-institute-plans-covid-19-vaccine-b-317665.html 0.6 2026-06-08T19:50:05+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-postpones-foreign-inspections-ove-317666.html 0.6 2026-06-21T09:05:10+08:00 daily https://www.pharmasources.com/industryinsights/study-finds-median-coronavirus-incubatio-317667.html 0.6 2026-07-05T03:03:24+08:00 daily https://www.pharmasources.com/industryinsights/wellcome-gates-foundation-mastercard-foc-317668.html 0.6 2026-06-21T00:57:54+08:00 daily https://www.pharmasources.com/industryinsights/integral-molecular-to-work-on-coronaviru-317669.html 0.6 2026-06-22T10:57:47+08:00 daily https://www.pharmasources.com/industryinsights/cel-sci-to-develop-covid-19-immunotherap-317670.html 0.6 2026-07-04T02:33:44+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-regeneron-to-assess-kevzara-t-317671.html 0.6 2026-06-21T08:12:05+08:00 daily https://www.pharmasources.com/industryinsights/nicox-broadens-two-agreements-with-ocume-317672.html 0.6 2026-06-28T01:51:39+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-to-test-hiv-drug-for-covid-19-tre-317673.html 0.6 2026-06-20T21:10:43+08:00 daily https://www.pharmasources.com/industryinsights/novavax-secures-cepi-funding-for-covid-1-317674.html 0.6 2026-06-20T15:00:15+08:00 daily https://www.pharmasources.com/industryinsights/second-patient-cured-of-hiv-using-stem-c-317675.html 0.6 2026-06-20T14:51:11+08:00 daily https://www.pharmasources.com/industryinsights/hikma-pharmaceuticals-extends-ketorolac--317676.html 0.6 2026-07-22T16:05:09+08:00 daily https://www.pharmasources.com/industryinsights/star-particles-could-be-the-future-for-t-317677.html 0.6 2026-06-22T12:33:32+08:00 daily https://www.pharmasources.com/industryinsights/almost-400-cell-and-gene-therapies-in-us-317678.html 0.6 2026-06-21T13:12:50+08:00 daily https://www.pharmasources.com/industryinsights/new-hiv-prep-drug-could-derail-efforts-t-317679.html 0.6 2026-07-08T09:45:55+08:00 daily https://www.pharmasources.com/industryinsights/spero-receives-orphan-drug-designation-f-317680.html 0.6 2026-06-21T23:58:45+08:00 daily https://www.pharmasources.com/industryinsights/mallinckrodt-provides-update-on-proposed-317681.html 0.6 2026-06-30T03:22:23+08:00 daily https://www.pharmasources.com/industryinsights/paratek-submits-pre-emergency-use-author-317682.html 0.6 2026-06-22T07:04:50+08:00 daily https://www.pharmasources.com/industryinsights/us-food-and-drug-administration-approves-317683.html 0.6 2026-08-03T04:54:28+08:00 daily https://www.pharmasources.com/industryinsights/kuur-therapeutics-launches-to-develop-an-317684.html 0.6 2026-06-21T13:02:33+08:00 daily https://www.pharmasources.com/industryinsights/kalas-dry-eye-disease-candidate-kpi-121--317685.html 0.6 2026-08-10T14:31:26+08:00 daily https://www.pharmasources.com/industryinsights/mount-sinai-and-harbour-biomed-collabora-317686.html 0.6 2026-06-21T00:40:40+08:00 daily https://www.pharmasources.com/industryinsights/empliciti-revlimid-combo-falls-short-in--317687.html 0.6 2026-06-21T08:02:00+08:00 daily https://www.pharmasources.com/industryinsights/de-122-flops-in-wet-amd-trial-317688.html 0.6 2026-06-21T11:20:35+08:00 daily https://www.pharmasources.com/industryinsights/nice-health-technology-wales-announce-ne-317689.html 0.6 2026-06-20T14:34:21+08:00 daily https://www.pharmasources.com/industryinsights/toxys-raises-2-million-financing-for-glo-317690.html 0.6 2026-08-05T15:47:13+08:00 daily https://www.pharmasources.com/industryinsights/paradigm-shift-in-angiography-kinepict-m-317691.html 0.6 2026-07-15T04:06:31+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-launches-biostat-str-generatio-317692.html 0.6 2026-07-08T19:27:25+08:00 daily https://www.pharmasources.com/industryinsights/china-says-covid-19-peak-is-over-317693.html 0.6 2026-06-21T10:55:56+08:00 daily https://www.pharmasources.com/industryinsights/last-developments-in-epidemic-control-on-317694.html 0.6 2026-04-02T00:54:43+08:00 daily https://www.pharmasources.com/industryinsights/latest-developments-in-epidemic-control--317695.html 0.6 2026-06-21T21:00:45+08:00 daily https://www.pharmasources.com/industryinsights/rapid-diagnosis-test-for-coronavirus-cov-317696.html 0.6 2026-06-29T19:03:49+08:00 daily https://www.pharmasources.com/industryinsights/world-must-work-together-to-defy-the-con-317697.html 0.6 2026-08-12T01:01:26+08:00 daily https://www.pharmasources.com/industryinsights/inovio-receives-new-5-million-grant-to-a-317698.html 0.6 2026-06-22T07:55:44+08:00 daily https://www.pharmasources.com/industryinsights/kuka-lauded-with-frost-sullivans-company-317699.html 0.6 2026-06-21T06:57:55+08:00 daily https://www.pharmasources.com/industryinsights/doo-holding-group-donates-30000-masks-to-317700.html 0.6 2026-06-20T23:00:47+08:00 daily https://www.pharmasources.com/industryinsights/eal-helps-stabilize-global-supply-chain--317701.html 0.6 2026-08-04T20:57:34+08:00 daily https://www.pharmasources.com/industryinsights/111-inc-announces-fourth-quarter-and-fis-317702.html 0.6 2026-07-28T21:45:11+08:00 daily https://www.pharmasources.com/industryinsights/bactiguard-launches-product-that-protect-317703.html 0.6 2026-08-10T16:40:56+08:00 daily https://www.pharmasources.com/industryinsights/global-cord-blood-corporation-reports-fi-317704.html 0.6 2026-08-08T13:11:59+08:00 daily https://www.pharmasources.com/industryinsights/artificial-intelligence-unlocks-gateway--317705.html 0.6 2026-08-08T11:48:43+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-apptec-wuhan-site-resumes-operation-317706.html 0.6 2026-08-08T10:39:41+08:00 daily https://www.pharmasources.com/industryinsights/fullerton-health-indonesia-supports-nati-317707.html 0.6 2026-08-08T01:37:20+08:00 daily https://www.pharmasources.com/industryinsights/concord-medical-welcomes-rmb700-million--317708.html 0.6 2026-08-08T07:56:03+08:00 daily https://www.pharmasources.com/industryinsights/coronavirus-outbreak-solution---world-fi-317709.html 0.6 2026-08-08T08:59:05+08:00 daily https://www.pharmasources.com/industryinsights/international-psoriasis-council-statemen-317710.html 0.6 2026-08-08T10:05:39+08:00 daily https://www.pharmasources.com/industryinsights/hackensack-meridian-healths-center-for-d-317711.html 0.6 2026-06-22T00:05:57+08:00 daily https://www.pharmasources.com/industryinsights/cphi-north-america-reschedules-event-317712.html 0.6 2026-06-21T00:48:54+08:00 daily https://www.pharmasources.com/industryinsights/gates-foundation-establishes-125m-covid--317713.html 0.6 2026-06-20T15:15:31+08:00 daily https://www.pharmasources.com/industryinsights/formulated-solutions-makes-executive-app-317714.html 0.6 2026-06-21T10:15:23+08:00 daily https://www.pharmasources.com/industryinsights/nagase-osaka-university-launch-research--317715.html 0.6 2026-06-20T22:53:44+08:00 daily https://www.pharmasources.com/industryinsights/chime-biologics-supports-covid-19-outbre-317716.html 0.6 2026-06-28T00:54:22+08:00 daily https://www.pharmasources.com/industryinsights/xtalpi-collaborates-with-porton-317717.html 0.6 2026-06-20T16:20:17+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-diosynth-breaks-ground-in-uk-317718.html 0.6 2026-08-07T20:23:57+08:00 daily https://www.pharmasources.com/industryinsights/gs1-us-publishes-blockchain-guidance-317719.html 0.6 2026-07-03T07:02:45+08:00 daily https://www.pharmasources.com/industryinsights/eurofins-offers-coronavirus-testing-serv-317720.html 0.6 2026-07-06T12:50:45+08:00 daily https://www.pharmasources.com/industryinsights/induced-pluripotent-stem-cells-show-succ-317721.html 0.6 2026-08-12T12:59:07+08:00 daily https://www.pharmasources.com/industryinsights/sufficient-medicine-raw-materials-formul-317722.html 0.6 2026-06-13T18:28:24+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-gets-marketing-permission-fo-317723.html 0.6 2026-06-20T17:53:22+08:00 daily https://www.pharmasources.com/industryinsights/centre-to-expedite-clearances-to-bulk-dr-317724.html 0.6 2026-06-21T07:10:00+08:00 daily https://www.pharmasources.com/industryinsights/india-needs-to-get-into-vaccine-producti-317725.html 0.6 2026-08-07T19:24:26+08:00 daily https://www.pharmasources.com/industryinsights/ten-drugs-in-pre-registration-phase-have-317726.html 0.6 2026-08-11T23:55:21+08:00 daily https://www.pharmasources.com/industryinsights/lupin-receives-isrs-certification-8th-ed-317727.html 0.6 2026-06-21T08:05:00+08:00 daily https://www.pharmasources.com/industryinsights/brii-biosciences-to-fund-coronavirus-res-317728.html 0.6 2026-06-12T00:44:49+08:00 daily https://www.pharmasources.com/industryinsights/distributing-hiv-drugs-using-mobile-vans-317729.html 0.6 2026-06-21T10:05:10+08:00 daily https://www.pharmasources.com/industryinsights/flow-cytometry-market-expected-to-reach--317730.html 0.6 2026-07-22T14:59:18+08:00 daily https://www.pharmasources.com/industryinsights/inserm-leads-in-patent-applications-repo-317731.html 0.6 2026-06-21T22:52:44+08:00 daily https://www.pharmasources.com/industryinsights/mhra-issues-medicine-defect-information--317732.html 0.6 2026-06-22T17:38:54+08:00 daily https://www.pharmasources.com/industryinsights/landmark-investment-for-life-sciences-in-317733.html 0.6 2026-07-01T16:42:54+08:00 daily https://www.pharmasources.com/industryinsights/tiziana-developing-tzls-501-as-potential-317734.html 0.6 2026-07-31T14:33:27+08:00 daily https://www.pharmasources.com/industryinsights/ajinomoto-bio-pharma-services-announces--317735.html 0.6 2026-01-06T01:04:47+08:00 daily https://www.pharmasources.com/industryinsights/denovo-biopharma-announces-breakthrough--317736.html 0.6 2026-06-21T15:07:27+08:00 daily https://www.pharmasources.com/industryinsights/bayer-shuts-down-locations-amid-covid-19-317737.html 0.6 2026-06-20T20:53:42+08:00 daily https://www.pharmasources.com/industryinsights/astrea-bioseparations-thermo-fisher-scie-317738.html 0.6 2026-04-17T22:13:36+08:00 daily https://www.pharmasources.com/industryinsights/low-dose-aspirin-linked-to-reduced-liver-317739.html 0.6 2026-06-21T21:54:37+08:00 daily https://www.pharmasources.com/industryinsights/forty-seven-rocket-collaborate-on-new-tr-317740.html 0.6 2026-06-20T17:14:32+08:00 daily https://www.pharmasources.com/industryinsights/silverback-therapeutics-raises-785m-in-o-317741.html 0.6 2026-06-22T09:53:45+08:00 daily https://www.pharmasources.com/industryinsights/ajovy-bags-nice-approval-317742.html 0.6 2026-06-21T20:02:38+08:00 daily https://www.pharmasources.com/industryinsights/setback-for-meddays-md1003-as-drug-fails-317743.html 0.6 2026-06-21T20:15:16+08:00 daily https://www.pharmasources.com/industryinsights/nice-hits-keytruda-with-no-for-urothelia-317744.html 0.6 2026-06-21T03:36:24+08:00 daily https://www.pharmasources.com/industryinsights/new-genetic-test-could-pick-out-high-ris-317745.html 0.6 2026-08-07T05:07:23+08:00 daily https://www.pharmasources.com/industryinsights/thrombocytopenia-patients-set-to-get-mul-317746.html 0.6 2026-08-07T04:57:05+08:00 daily https://www.pharmasources.com/industryinsights/sc-johnson-contributes-1-million-to-cdc--317747.html 0.6 2026-08-07T04:52:52+08:00 daily https://www.pharmasources.com/industryinsights/huawei-powers-thailand-telemedicine-vide-317748.html 0.6 2026-08-07T04:30:59+08:00 daily https://www.pharmasources.com/industryinsights/cphi-to-hold-fiscal-year-2019-earnings-c-317749.html 0.6 2026-08-07T04:22:07+08:00 daily https://www.pharmasources.com/industryinsights/merck-and-pfizer-provide-update-on-phase-317750.html 0.6 2026-08-07T04:06:59+08:00 daily https://www.pharmasources.com/industryinsights/leading-veterinary-diagnostic-company-se-317751.html 0.6 2026-08-07T03:33:54+08:00 daily https://www.pharmasources.com/industryinsights/huami-corporation-reports-fourth-quarter-317752.html 0.6 2026-08-12T20:54:41+08:00 daily https://www.pharmasources.com/industryinsights/doo-holding-group-donates-30000-masks-to-317753.html 0.6 2026-08-07T19:27:20+08:00 daily https://www.pharmasources.com/industryinsights/embracing-the-age-of-innovation-with-chi-317754.html 0.6 2026-08-08T01:01:06+08:00 daily https://www.pharmasources.com/industryinsights/international-psoriasis-council-statemen-317755.html 0.6 2026-08-08T01:35:52+08:00 daily https://www.pharmasources.com/industryinsights/elsevier-gives-full-access-to-its-conten-317756.html 0.6 2026-08-09T06:59:25+08:00 daily https://www.pharmasources.com/industryinsights/yichang-humanwells-class-3-generic-drug--317757.html 0.6 2026-07-06T04:52:28+08:00 daily https://www.pharmasources.com/industryinsights/12m-committed-to-preventable-disease-res-317758.html 0.6 2026-06-24T10:56:02+08:00 daily https://www.pharmasources.com/industryinsights/cediranib-trips-up-in-lynparza-combo-ova-317759.html 0.6 2025-11-14T18:30:57+08:00 daily https://www.pharmasources.com/industryinsights/venclyxto-gains-approval-in-europe-317760.html 0.6 2026-06-21T09:13:11+08:00 daily https://www.pharmasources.com/industryinsights/two-pronged-dna-repair-attack-could-kill-317761.html 0.6 2026-06-21T07:57:14+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-to-develop-tjm2-for-cytokine-relea-317762.html 0.6 2026-03-05T11:10:01+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-fast-track-designation-to-jar-317763.html 0.6 2026-06-21T07:45:58+08:00 daily https://www.pharmasources.com/industryinsights/fda-provides-surgical-mask-gown-conserva-317764.html 0.6 2026-07-18T13:01:39+08:00 daily https://www.pharmasources.com/industryinsights/luminex-provides-update-on-sars-cov-2-va-317765.html 0.6 2026-06-19T06:42:26+08:00 daily https://www.pharmasources.com/industryinsights/beyondspring-files-for-patent-protection-317766.html 0.6 2026-06-22T05:01:41+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-receives-ec-approval-of-venclyxto-317767.html 0.6 2026-06-23T11:28:20+08:00 daily https://www.pharmasources.com/industryinsights/gileads-remdesivir-shows-promise-in-covi-317768.html 0.6 2026-06-24T12:08:39+08:00 daily https://www.pharmasources.com/industryinsights/biogen-vir-enter-covid-19-antibody-allia-317769.html 0.6 2026-06-21T09:49:52+08:00 daily https://www.pharmasources.com/industryinsights/abcellera-lilly-partner-to-develop-antib-317770.html 0.6 2026-06-20T15:14:30+08:00 daily https://www.pharmasources.com/industryinsights/roches-sars-cov-2-test-receives-eua-317771.html 0.6 2026-06-20T22:07:39+08:00 daily https://www.pharmasources.com/industryinsights/advaite-produces-covid-19-rapid-response-317772.html 0.6 2026-08-12T17:07:16+08:00 daily https://www.pharmasources.com/industryinsights/pharmamar-reports-positive-results-for-a-317773.html 0.6 2026-06-20T20:42:21+08:00 daily https://www.pharmasources.com/industryinsights/university-of-california-develops-corona-317774.html 0.6 2026-06-21T15:46:49+08:00 daily https://www.pharmasources.com/industryinsights/satish-reddy-elected-cii-sr-chairman-317775.html 0.6 2026-07-16T03:55:47+08:00 daily https://www.pharmasources.com/industryinsights/zandu-foundation-for-health-care-starts--317776.html 0.6 2026-08-10T03:06:23+08:00 daily https://www.pharmasources.com/industryinsights/alkem-labs-gets-eir-from-us-fda-for-badd-317777.html 0.6 2026-08-07T01:19:39+08:00 daily https://www.pharmasources.com/industryinsights/nurix-raises-120m-financing-to-advance-i-317778.html 0.6 2026-08-07T01:10:38+08:00 daily https://www.pharmasources.com/industryinsights/pluristem-forms-covid-19-drug-developmen-317779.html 0.6 2026-08-07T00:41:02+08:00 daily https://www.pharmasources.com/industryinsights/mallinckrodt-explores-ino-as-potential-c-317780.html 0.6 2026-08-07T00:03:00+08:00 daily https://www.pharmasources.com/industryinsights/india-should-reduce-dependence-on-china--317781.html 0.6 2026-08-12T18:44:42+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-fremanezumab-for-chronic-317782.html 0.6 2026-08-06T23:46:23+08:00 daily https://www.pharmasources.com/industryinsights/new-method-to-probe-molecules-could-impr-317783.html 0.6 2026-08-06T23:37:39+08:00 daily https://www.pharmasources.com/industryinsights/ec-grants-orphan-drug-designation-to-flt-317784.html 0.6 2026-08-07T12:12:44+08:00 daily https://www.pharmasources.com/industryinsights/ema-announces-measures-to-manage-drug-sh-317785.html 0.6 2026-08-07T13:18:52+08:00 daily https://www.pharmasources.com/industryinsights/a-world-premiere-from-erasmus-mc-and-utr-317786.html 0.6 2026-08-09T02:38:44+08:00 daily https://www.pharmasources.com/industryinsights/statins-starve-cancer-cells-to-death-317787.html 0.6 2026-08-09T18:42:07+08:00 daily https://www.pharmasources.com/industryinsights/special-report-highlights-potential-ther-317788.html 0.6 2026-06-20T14:56:09+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-explores-tjm2-in-treating-severe-c-317789.html 0.6 2026-06-20T20:48:39+08:00 daily https://www.pharmasources.com/industryinsights/immunoprecise-uses-polytope-mab-therapy--317790.html 0.6 2026-03-21T03:06:34+08:00 daily https://www.pharmasources.com/industryinsights/inovio-secures-funds-for-delivery-device-317791.html 0.6 2026-06-26T01:56:00+08:00 daily https://www.pharmasources.com/industryinsights/medicago-produces-viable-covid-19-vaccin-317792.html 0.6 2026-06-21T21:01:43+08:00 daily https://www.pharmasources.com/industryinsights/industrial-layout-analysis-of-the-new-ca-317793.html 0.6 2026-08-13T04:15:05+08:00 daily https://www.pharmasources.com/industryinsights/china-sxt-pharmaceuticals-inc-announces--317794.html 0.6 2026-07-20T09:01:07+08:00 daily https://www.pharmasources.com/industryinsights/deuterium-depletion-as-a-possible-new-st-317795.html 0.6 2026-06-29T03:27:22+08:00 daily https://www.pharmasources.com/industryinsights/china-to-further-contribute-to-global-fi-317796.html 0.6 2026-06-20T22:00:38+08:00 daily https://www.pharmasources.com/industryinsights/premier-li-stresses-differentiated-epide-317797.html 0.6 2026-02-28T00:31:47+08:00 daily https://www.pharmasources.com/industryinsights/vice-premier-stresses-scientific-precise-317798.html 0.6 2026-06-21T09:47:52+08:00 daily https://www.pharmasources.com/industryinsights/latest-developments-in-epidemic-control--317799.html 0.6 2026-06-21T19:08:05+08:00 daily https://www.pharmasources.com/industryinsights/xis-article-on-providing-strong-sci-tech-317800.html 0.6 2026-07-06T21:16:40+08:00 daily https://www.pharmasources.com/industryinsights/nippon-paint-and-corning-incorporated-do-317801.html 0.6 2026-07-21T01:01:53+08:00 daily https://www.pharmasources.com/industryinsights/mentice-expands-coronary-product-portfol-317802.html 0.6 2026-06-22T01:49:31+08:00 daily https://www.pharmasources.com/industryinsights/greek-company-solves-the-global-issue-of-317803.html 0.6 2026-08-05T22:45:31+08:00 daily https://www.pharmasources.com/industryinsights/viewsonic-offers-schools-and-universitie-317804.html 0.6 2026-06-20T17:56:48+08:00 daily https://www.pharmasources.com/industryinsights/conducting-clinical-trials-amid-covid-19-317805.html 0.6 2026-06-20T15:35:04+08:00 daily https://www.pharmasources.com/industryinsights/vikor-scientific-to-release-covid-19-tes-317806.html 0.6 2026-06-21T07:46:46+08:00 daily https://www.pharmasources.com/industryinsights/weather-to-play-major-role-in-coronaviru-317807.html 0.6 2026-07-04T14:51:39+08:00 daily https://www.pharmasources.com/industryinsights/biontech-reports-progress-on-covid-19-va-317808.html 0.6 2026-08-08T06:34:42+08:00 daily https://www.pharmasources.com/industryinsights/fda-issues-eua-to-thermo-fisher-317809.html 0.6 2026-06-24T05:50:45+08:00 daily https://www.pharmasources.com/industryinsights/oppi-supports-government-to-address-covi-317810.html 0.6 2026-08-14T17:46:39+08:00 daily https://www.pharmasources.com/industryinsights/cleveland-clinic-researchers-discover-a--317811.html 0.6 2026-07-22T19:58:16+08:00 daily https://www.pharmasources.com/industryinsights/vaccination-is-about-providing-children--317812.html 0.6 2026-06-20T15:14:24+08:00 daily https://www.pharmasources.com/industryinsights/indian-pharma-industry-lauds-moefcc-move-317813.html 0.6 2026-06-22T10:42:47+08:00 daily https://www.pharmasources.com/industryinsights/alembic-pharma-receives-four-observation-317814.html 0.6 2026-06-20T21:05:41+08:00 daily https://www.pharmasources.com/industryinsights/no-shortage-of-apis-and-formulations-in--317815.html 0.6 2026-06-30T03:04:40+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-regeneron-trial-kevzara-to-tr-317816.html 0.6 2026-08-06T18:15:22+08:00 daily https://www.pharmasources.com/industryinsights/enanta-pharmaceuticals-explores-covid-19-317817.html 0.6 2026-06-21T12:57:29+08:00 daily https://www.pharmasources.com/industryinsights/curevac-works-on-mrna-vaccine-for-corona-317818.html 0.6 2026-06-21T01:55:42+08:00 daily https://www.pharmasources.com/industryinsights/jjs-janssen-and-bidmc-team-up-on-covid-1-317819.html 0.6 2026-06-23T01:29:59+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2020317-317820.html 0.6 2026-08-10T03:12:00+08:00 daily https://www.pharmasources.com/industryinsights/ema-begins-safety-review-of-ifosfamide-c-317821.html 0.6 2026-08-10T14:32:30+08:00 daily https://www.pharmasources.com/industryinsights/nice-fails-to-recommend-pembrolizumab-in-317822.html 0.6 2026-06-21T03:53:47+08:00 daily https://www.pharmasources.com/industryinsights/universal-carrier-ink-developed-for-3d-p-317823.html 0.6 2026-06-24T09:14:52+08:00 daily https://www.pharmasources.com/industryinsights/ema-offers-free-advice-to-covid-19-vacci-317824.html 0.6 2026-06-21T09:54:25+08:00 daily https://www.pharmasources.com/industryinsights/fast-track-designation-granted-to-chroni-317825.html 0.6 2026-02-28T15:24:31+08:00 daily https://www.pharmasources.com/industryinsights/agenus-receives-fast-track-designation-f-317826.html 0.6 2026-06-20T19:00:37+08:00 daily https://www.pharmasources.com/industryinsights/fda-issues-emergency-use-authorization-t-317827.html 0.6 2026-06-20T16:53:24+08:00 daily https://www.pharmasources.com/industryinsights/fda-allows-new-york-state-department-of--317828.html 0.6 2026-08-07T22:08:17+08:00 daily https://www.pharmasources.com/industryinsights/exagen-partners-with-sonora-quest-to-off-317829.html 0.6 2026-07-17T02:14:32+08:00 daily https://www.pharmasources.com/industryinsights/new-kind-of-crispr-technology-to-target--317830.html 0.6 2026-08-08T05:21:29+08:00 daily https://www.pharmasources.com/industryinsights/roches-cobas-sars-cov-2-test-to-detect-n-317831.html 0.6 2026-08-07T13:46:41+08:00 daily https://www.pharmasources.com/industryinsights/artugen-therapeutics-announces-first-pat-317832.html 0.6 2026-07-02T13:16:04+08:00 daily https://www.pharmasources.com/industryinsights/fda-clears-first-clinical-study-for-a-po-317833.html 0.6 2026-08-05T10:26:10+08:00 daily https://www.pharmasources.com/industryinsights/risk-of-death-by-stroke-down-24-317834.html 0.6 2026-06-21T09:46:07+08:00 daily https://www.pharmasources.com/industryinsights/pancreas-app-now-available-for-type-i-di-317835.html 0.6 2026-08-11T17:43:54+08:00 daily https://www.pharmasources.com/industryinsights/merck-pfizer-terminate-bavencio-head-and-317836.html 0.6 2026-08-05T14:00:09+08:00 daily https://www.pharmasources.com/industryinsights/biontech-teams-up-with-fosun-pharma-to-t-317837.html 0.6 2026-08-08T01:01:37+08:00 daily https://www.pharmasources.com/industryinsights/quick-look-at-the-anti-epidemic-monoclon-317838.html 0.6 2026-08-12T07:01:27+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-dosed-in-modernas-covid-19-317839.html 0.6 2026-08-03T21:35:38+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-menarini-group-converts-product-317840.html 0.6 2026-06-22T23:06:06+08:00 daily https://www.pharmasources.com/industryinsights/haselmeier-receives-medical-device-maste-317841.html 0.6 2026-08-06T23:51:18+08:00 daily https://www.pharmasources.com/industryinsights/happiness-biotech-begun-production-of-da-317842.html 0.6 2026-07-30T21:43:44+08:00 daily https://www.pharmasources.com/industryinsights/usana-signs-deal-with-professional-new-z-317843.html 0.6 2026-07-16T23:02:14+08:00 daily https://www.pharmasources.com/industryinsights/earth-day-network-announces-shift-to-glo-317844.html 0.6 2026-06-21T02:49:55+08:00 daily https://www.pharmasources.com/industryinsights/west-china-hospital-in-chengdu-donates-c-317845.html 0.6 2026-06-21T05:43:00+08:00 daily https://www.pharmasources.com/industryinsights/efficient-assistance-yitu-ai-assists-wit-317846.html 0.6 2026-07-20T00:01:59+08:00 daily https://www.pharmasources.com/industryinsights/beauty-tourism-is-causing-a-rising-need--317847.html 0.6 2026-06-21T09:14:13+08:00 daily https://www.pharmasources.com/industryinsights/hcc-therapeutic-regimens-rewritten-by-tu-317848.html 0.6 2026-07-21T16:50:12+08:00 daily https://www.pharmasources.com/industryinsights/alembic-pharma-gets-eir-from-us-fda-for--317849.html 0.6 2026-08-12T15:01:26+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-biontech-to-co-develop-potential--317850.html 0.6 2026-08-09T08:00:23+08:00 daily https://www.pharmasources.com/industryinsights/cphi-announces-new-pharma-events-calenda-317851.html 0.6 2026-08-08T17:53:12+08:00 daily https://www.pharmasources.com/industryinsights/lasa-ict-explore-favipiravir-therapy-to--317852.html 0.6 2026-08-10T03:01:32+08:00 daily https://www.pharmasources.com/industryinsights/biohaven-wins-fda-approval-for-nurtec-od-317853.html 0.6 2026-07-04T12:57:36+08:00 daily https://www.pharmasources.com/industryinsights/imfinzis-success-in-es-sclc-not-matched--317854.html 0.6 2026-08-11T20:53:14+08:00 daily https://www.pharmasources.com/industryinsights/moleculin-utmb-evaluate-inhibitors-for-a-317855.html 0.6 2026-06-21T09:43:46+08:00 daily https://www.pharmasources.com/industryinsights/australian-researchers-map-immune-respon-317856.html 0.6 2026-07-19T04:59:05+08:00 daily https://www.pharmasources.com/industryinsights/emphycorp-news-nitric-oxide-is-currently-317857.html 0.6 2026-08-03T07:35:36+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-aprinoia-enter-mab-pac-317858.html 0.6 2026-08-01T08:55:22+08:00 daily https://www.pharmasources.com/industryinsights/xortx-therapeutics-to-assess-xrx-101-for-317859.html 0.6 2026-06-21T22:12:53+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-advances-covid-19-development--317860.html 0.6 2026-06-21T02:58:43+08:00 daily https://www.pharmasources.com/industryinsights/jj-says-no-evidence-darunavir-works-agai-317861.html 0.6 2026-06-20T23:56:35+08:00 daily https://www.pharmasources.com/industryinsights/celltex-to-study-mesenchymal-stem-cells--317862.html 0.6 2026-06-29T05:07:24+08:00 daily https://www.pharmasources.com/industryinsights/marken-opens-new-cold-chain-facility-in--317863.html 0.6 2026-06-21T08:16:15+08:00 daily https://www.pharmasources.com/industryinsights/tetraphase-pharmaceuticals-to-merge-with-317864.html 0.6 2026-06-22T01:50:35+08:00 daily https://www.pharmasources.com/industryinsights/first-us-clinical-trial-of-covid-19-vacc-317865.html 0.6 2026-08-05T10:00:19+08:00 daily https://www.pharmasources.com/industryinsights/biontech-signs-covid-19-vaccine-deals-wi-317866.html 0.6 2026-07-20T23:58:40+08:00 daily https://www.pharmasources.com/industryinsights/evonik-develops-animal-free-fermentation-317867.html 0.6 2026-06-30T15:30:12+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-diosynth-appoints-head-of-nc-op-317868.html 0.6 2026-06-23T09:47:04+08:00 daily https://www.pharmasources.com/industryinsights/fda-updates-coronavirus-policy-317869.html 0.6 2026-06-22T09:10:53+08:00 daily https://www.pharmasources.com/industryinsights/roche-ships-first-400000-covid-19-tests-317870.html 0.6 2026-06-21T12:13:25+08:00 daily https://www.pharmasources.com/industryinsights/eli-lilly-receives-breakthrough-status-f-317871.html 0.6 2026-06-20T21:10:45+08:00 daily https://www.pharmasources.com/industryinsights/cepi-calls-for-2bn-of-funding-for-corona-317872.html 0.6 2026-06-21T15:56:33+08:00 daily https://www.pharmasources.com/industryinsights/new-adaptable-material-could-be-used-as--317873.html 0.6 2026-06-21T03:06:47+08:00 daily https://www.pharmasources.com/industryinsights/court-rules-against-mallinckrodt-ard-llc-317874.html 0.6 2026-06-21T09:13:10+08:00 daily https://www.pharmasources.com/industryinsights/catalent-partners-with-biohaven-on-new-f-317875.html 0.6 2026-08-07T15:37:32+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-accelerated-approval-to-nivol-317876.html 0.6 2026-06-30T23:44:08+08:00 daily https://www.pharmasources.com/industryinsights/imfinzi-confirmed-sustained-overall-surv-317877.html 0.6 2026-06-20T16:21:31+08:00 daily https://www.pharmasources.com/industryinsights/emergent-biosolutions-initiates-developm-317878.html 0.6 2026-06-22T11:52:14+08:00 daily https://www.pharmasources.com/industryinsights/novartis-announces-broad-range-of-initia-317879.html 0.6 2026-07-02T15:45:06+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-the-immune-system-can-fight-bac-317880.html 0.6 2026-06-21T01:54:36+08:00 daily https://www.pharmasources.com/industryinsights/novo-cancels-haemophilia-drug-phase-iii--317881.html 0.6 2026-06-21T13:01:30+08:00 daily https://www.pharmasources.com/industryinsights/new-research-discovers-cells-linked-to-a-317882.html 0.6 2026-08-12T08:23:44+08:00 daily https://www.pharmasources.com/industryinsights/prep-to-be-available-in-england-from-apr-317883.html 0.6 2026-06-28T21:52:19+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccine-developed-by-military-m-317884.html 0.6 2026-06-22T14:39:41+08:00 daily https://www.pharmasources.com/industryinsights/latest-developments-in-epidemic-control--317885.html 0.6 2026-06-22T04:10:53+08:00 daily https://www.pharmasources.com/industryinsights/latest-developments-in-epidemic-control--317886.html 0.6 2026-06-21T16:11:32+08:00 daily https://www.pharmasources.com/industryinsights/research-submit-applications-for-human-t-317887.html 0.6 2026-06-21T11:52:46+08:00 daily https://www.pharmasources.com/industryinsights/vice-premier-demands-orderly-withdrawal--317888.html 0.6 2026-06-22T21:51:43+08:00 daily https://www.pharmasources.com/industryinsights/jnccn-how-to-manage-cancer-care-during-c-317889.html 0.6 2026-08-05T22:15:33+08:00 daily https://www.pharmasources.com/industryinsights/snap-fitness-bringing-free-at-home-worko-317890.html 0.6 2026-06-20T21:18:21+08:00 daily https://www.pharmasources.com/industryinsights/golden-meditechs-associate-cellenkos-foc-317891.html 0.6 2026-06-21T21:10:55+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-board-approves-rs-1700-cr-sha-317892.html 0.6 2026-06-22T20:27:28+08:00 daily https://www.pharmasources.com/industryinsights/lilly-indiana-state-department-of-health-317893.html 0.6 2026-06-22T04:22:50+08:00 daily https://www.pharmasources.com/industryinsights/moderna-leads-coronavirus-vaccine-charge-317894.html 0.6 2026-06-21T21:03:45+08:00 daily https://www.pharmasources.com/industryinsights/study-finds-novel-coronavirus-can-remain-317895.html 0.6 2026-06-21T06:25:19+08:00 daily https://www.pharmasources.com/industryinsights/cellenkos-to-trial-cell-therapy-for-cov--317896.html 0.6 2026-06-21T12:57:28+08:00 daily https://www.pharmasources.com/industryinsights/moleculin-utmb-partner-to-study-wp1122-f-317897.html 0.6 2026-08-06T01:52:00+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-mannkind-pneumagen-conduct-rese-317898.html 0.6 2026-06-21T18:09:30+08:00 daily https://www.pharmasources.com/industryinsights/signpath-relief-explore-drugs-for-covid--317899.html 0.6 2026-06-21T09:04:10+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-identifies-several-antibodies--317900.html 0.6 2026-07-29T16:29:33+08:00 daily https://www.pharmasources.com/industryinsights/chinese-official-says-fujifilms-favipira-317901.html 0.6 2026-06-21T20:54:37+08:00 daily https://www.pharmasources.com/industryinsights/oncoone-launches-with-13m-series-a-fundi-317902.html 0.6 2026-08-14T14:27:26+08:00 daily https://www.pharmasources.com/industryinsights/ose-immunotherapeutics-updates-licensing-317903.html 0.6 2026-08-07T23:41:38+08:00 daily https://www.pharmasources.com/industryinsights/askbio-enters-research-collaboration-wit-317904.html 0.6 2026-07-02T21:37:53+08:00 daily https://www.pharmasources.com/industryinsights/biostem-life-sciences-announces-expansio-317905.html 0.6 2026-07-04T23:36:26+08:00 daily https://www.pharmasources.com/industryinsights/nash-seizing-the-usd40-billion-nash-drug-317906.html 0.6 2026-06-21T08:20:29+08:00 daily https://www.pharmasources.com/industryinsights/altasciences-amador-bioscience-enter-str-317907.html 0.6 2026-04-19T23:58:16+08:00 daily https://www.pharmasources.com/industryinsights/emergent-vaxart-ink-coronavirus-pact-317908.html 0.6 2026-06-20T19:56:51+08:00 daily https://www.pharmasources.com/industryinsights/diatherix-eurofins-launches-sars-cov-2-v-317909.html 0.6 2026-08-11T08:43:24+08:00 daily https://www.pharmasources.com/industryinsights/bormioli-pharma-to-acquire-gcl-pharma-fo-317910.html 0.6 2026-01-03T08:29:21+08:00 daily https://www.pharmasources.com/industryinsights/scientists-propose-method-of-producing-w-317911.html 0.6 2026-06-21T18:20:51+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-label-update-to-sodium-gluc-317912.html 0.6 2026-06-24T07:43:05+08:00 daily https://www.pharmasources.com/industryinsights/clinical-programme-to-evaluate-kevzara-a-317913.html 0.6 2026-08-13T03:56:22+08:00 daily https://www.pharmasources.com/industryinsights/handheld-raman-spectrometer-developed-to-317914.html 0.6 2026-07-02T17:39:20+08:00 daily https://www.pharmasources.com/industryinsights/concizumab-haemophilia-trials-paused-ove-317915.html 0.6 2026-07-10T02:21:19+08:00 daily https://www.pharmasources.com/industryinsights/provention-announces-positive-data-from--317916.html 0.6 2026-07-14T04:03:35+08:00 daily https://www.pharmasources.com/industryinsights/biohavens-verdiperstat-receives-fast-tra-317917.html 0.6 2026-07-03T20:38:21+08:00 daily https://www.pharmasources.com/industryinsights/acelrx-to-acquire-tetraphase-317918.html 0.6 2026-07-19T19:05:42+08:00 daily https://www.pharmasources.com/industryinsights/fda-issues-guidance-for-conducting-covid-317919.html 0.6 2026-06-20T18:02:20+08:00 daily https://www.pharmasources.com/industryinsights/the-covid-19-coronavirus-epidemic-has-a--317920.html 0.6 2026-08-13T20:12:34+08:00 daily https://www.pharmasources.com/industryinsights/oxford-biomedica-to-license-lentivector--317921.html 0.6 2026-06-20T22:07:45+08:00 daily https://www.pharmasources.com/industryinsights/imfinzi-tremelimumab-combo-flunks-sclc-t-317922.html 0.6 2026-07-09T09:47:58+08:00 daily https://www.pharmasources.com/industryinsights/higher-dose-of-gefapixant-hits-endpoints-317923.html 0.6 2026-06-21T02:13:47+08:00 daily https://www.pharmasources.com/industryinsights/jardiance-bags-fda-fast-track-designatio-317924.html 0.6 2026-06-22T19:00:25+08:00 daily https://www.pharmasources.com/industryinsights/contec-launches-virtual-training-tool-se-317925.html 0.6 2026-06-22T01:00:48+08:00 daily https://www.pharmasources.com/industryinsights/chinese-mainland-reports-zero-increase-i-317926.html 0.6 2026-06-18T17:40:05+08:00 daily https://www.pharmasources.com/industryinsights/highlights-of-xis-latest-remarks-on-epid-317927.html 0.6 2026-06-20T22:04:39+08:00 daily https://www.pharmasources.com/industryinsights/vaccine-development-key-to-beating-outbr-317928.html 0.6 2026-06-21T12:00:11+08:00 daily https://www.pharmasources.com/industryinsights/xi-chairs-leadership-meeting-on-epidemic-317929.html 0.6 2026-07-06T11:30:44+08:00 daily https://www.pharmasources.com/industryinsights/fourdesire-launches-tree-planting-campai-317930.html 0.6 2026-06-20T21:55:36+08:00 daily https://www.pharmasources.com/industryinsights/111-launches-free-consultation-services--317931.html 0.6 2025-12-14T02:30:34+08:00 daily https://www.pharmasources.com/industryinsights/hansoh-pharmas-ameile-almonertinib-recei-317932.html 0.6 2026-07-19T00:09:00+08:00 daily https://www.pharmasources.com/industryinsights/glooko-enables-remote-patient-care-at-no-317933.html 0.6 2026-08-06T00:16:29+08:00 daily https://www.pharmasources.com/industryinsights/cii-proposed-action-points-for-strengthe-317934.html 0.6 2026-07-31T16:42:34+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-launches-generic-ziprasidone-m-317935.html 0.6 daily https://www.pharmasources.com/industryinsights/csir-iict-ties-up-with-cipla-to-develop--317936.html 0.6 2026-06-20T22:56:35+08:00 daily https://www.pharmasources.com/industryinsights/whole-genomes-of-coronavirus-from-uk-pat-317937.html 0.6 2026-06-21T12:21:43+08:00 daily https://www.pharmasources.com/industryinsights/coronavirus-covid-19-update-fda-issues-g-317938.html 0.6 2026-08-15T00:42:05+08:00 daily https://www.pharmasources.com/industryinsights/indian-prime-minister-narendra-modi-call-317939.html 0.6 2026-06-20T14:54:09+08:00 daily https://www.pharmasources.com/industryinsights/stanfords-startx-joins-covid-19-response-317940.html 0.6 2026-07-05T00:27:45+08:00 daily https://www.pharmasources.com/industryinsights/imv-to-progress-clinical-development-of--317941.html 0.6 2026-06-22T09:56:41+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-entos-and-takis-to-work-on-sepa-317942.html 0.6 2026-06-22T09:54:40+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-launches-biostat-str-with-biob-317943.html 0.6 2026-08-07T16:20:17+08:00 daily https://www.pharmasources.com/industryinsights/study-finds-covid-19-coronavirus-of-natu-317944.html 0.6 2026-06-21T02:02:50+08:00 daily https://www.pharmasources.com/industryinsights/abbvies-hiv-drug-combo-shows-no-benefit--317945.html 0.6 2026-01-09T06:02:01+08:00 daily https://www.pharmasources.com/industryinsights/cansinobio-synairgen-get-regulatory-appr-317946.html 0.6 2026-02-09T14:18:53+08:00 daily https://www.pharmasources.com/industryinsights/roivant-mateon-to-develop-covid-19-drug--317947.html 0.6 2026-06-21T04:20:23+08:00 daily https://www.pharmasources.com/industryinsights/roche-to-start-phase-iii-trial-of-actemr-317948.html 0.6 2026-06-21T03:03:46+08:00 daily https://www.pharmasources.com/industryinsights/emergent-biosolutions-and-vaxart-partner-317949.html 0.6 2026-03-11T15:36:05+08:00 daily https://www.pharmasources.com/industryinsights/janssen-seeks-fda-approval-for-ponesimod-317950.html 0.6 2026-06-20T23:53:33+08:00 daily https://www.pharmasources.com/industryinsights/novartis-gets-japans-approval-for-zolgen-317951.html 0.6 2026-04-01T04:48:23+08:00 daily https://www.pharmasources.com/industryinsights/novartis-recalls-sandimmune-neoral-blist-317952.html 0.6 2026-06-21T03:10:48+08:00 daily https://www.pharmasources.com/industryinsights/fda-scales-back-domestic-inspections-317953.html 0.6 2026-08-12T10:45:39+08:00 daily https://www.pharmasources.com/industryinsights/abbotts-realtime-sars-cov-2-test-receive-317954.html 0.6 2026-06-20T16:56:11+08:00 daily https://www.pharmasources.com/industryinsights/bright-path-labs-accepted-into-fdas-emer-317956.html 0.6 2026-06-21T03:55:41+08:00 daily https://www.pharmasources.com/industryinsights/us-hhs-seeks-stakeholder-covid-19-counte-317957.html 0.6 2026-06-21T09:41:58+08:00 daily https://www.pharmasources.com/industryinsights/usp-offers-support-for-covid-19-antivira-317958.html 0.6 2026-07-05T12:41:22+08:00 daily https://www.pharmasources.com/industryinsights/ema-issues-statement-on-ibuprofen-report-317959.html 0.6 2026-06-20T18:50:26+08:00 daily https://www.pharmasources.com/industryinsights/novel-thermally-stable-covid-19-vaccine--317960.html 0.6 2026-08-13T05:26:59+08:00 daily https://www.pharmasources.com/industryinsights/professor-gillian-leng-appointed-nice-ch-317961.html 0.6 2026-04-01T02:48:36+08:00 daily https://www.pharmasources.com/industryinsights/harmonised-approach-promoted-for-covid-1-317962.html 0.6 2025-11-17T18:48:24+08:00 daily https://www.pharmasources.com/industryinsights/ec-offers-80m-to-curevac-for-covid-19-va-317963.html 0.6 2026-08-06T12:58:31+08:00 daily https://www.pharmasources.com/industryinsights/univercells-launches-cell-gene-therapy-c-317964.html 0.6 2026-08-02T07:22:44+08:00 daily https://www.pharmasources.com/industryinsights/cellenkos-focuses-on-the-development-of--317965.html 0.6 2026-06-21T09:15:12+08:00 daily https://www.pharmasources.com/industryinsights/biomerica-begins-shipping-samples-of-10--317966.html 0.6 2026-06-21T02:06:43+08:00 daily https://www.pharmasources.com/industryinsights/mylan-ramps-up-us-manufacturing-of-hydro-317967.html 0.6 2026-06-20T16:00:14+08:00 daily https://www.pharmasources.com/industryinsights/provention-bio-provides-pauses-type-1-di-317968.html 0.6 2026-06-21T12:54:06+08:00 daily https://www.pharmasources.com/industryinsights/enlivex-announces-positive-final-safety--317969.html 0.6 2026-06-21T01:11:02+08:00 daily https://www.pharmasources.com/industryinsights/understanding-how-covid-19-affects-child-317970.html 0.6 2026-06-22T11:54:02+08:00 daily https://www.pharmasources.com/industryinsights/free-edc-software-for-non-profit-covid-1-317971.html 0.6 2026-06-21T22:07:47+08:00 daily https://www.pharmasources.com/industryinsights/us-approves-abbott-labs-coronavirus-test-317972.html 0.6 2026-07-07T07:13:57+08:00 daily https://www.pharmasources.com/industryinsights/coronavirus-covid-19-update-fda-focuses--317973.html 0.6 2026-02-28T19:35:55+08:00 daily https://www.pharmasources.com/industryinsights/coronavirus-covid-19-update-fda-continue-317974.html 0.6 2026-07-03T19:44:49+08:00 daily https://www.pharmasources.com/industryinsights/mesa-biotech-to-receive-funding-from-us--317975.html 0.6 2026-06-20T21:37:16+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-treatment-for-pediatric-317976.html 0.6 2026-06-21T07:21:13+08:00 daily https://www.pharmasources.com/industryinsights/all-hubeis-cities-counties-outside-wuhan-317977.html 0.6 2026-06-20T14:42:28+08:00 daily https://www.pharmasources.com/industryinsights/european-and-us-antitrust-authorities-cl-317978.html 0.6 2026-07-03T00:42:21+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-adds-greater-expertise-317979.html 0.6 2026-06-21T02:57:40+08:00 daily https://www.pharmasources.com/industryinsights/ariel-has-lauched-a-series-of-high-quali-317980.html 0.6 2026-06-22T01:06:56+08:00 daily https://www.pharmasources.com/industryinsights/prof-oliver-sartor-joins-claritys-adviso-317981.html 0.6 2026-06-22T12:54:21+08:00 daily https://www.pharmasources.com/industryinsights/federal-circuit-affirms-alfred-e-mann-fo-317982.html 0.6 2026-06-20T14:23:21+08:00 daily https://www.pharmasources.com/industryinsights/zhejiang-hisun-pharmaceutical-co-ltd-fav-317983.html 0.6 2026-08-10T22:42:41+08:00 daily https://www.pharmasources.com/industryinsights/agc-biologics-to-participate-in-virtual--317984.html 0.6 2026-06-21T03:20:18+08:00 daily https://www.pharmasources.com/industryinsights/dcat-week-cancelled-agc-biologics-to-mee-317985.html 0.6 2026-08-07T00:53:26+08:00 daily https://www.pharmasources.com/industryinsights/glucagon-receptor-structures-reveal-g-pr-317986.html 0.6 2026-08-12T00:03:01+08:00 daily https://www.pharmasources.com/industryinsights/zai-lab-announces-financial-results-for--317987.html 0.6 2026-07-25T02:13:33+08:00 daily https://www.pharmasources.com/industryinsights/china-injects-volunteers-with-test-vacci-317988.html 0.6 2026-07-09T08:43:25+08:00 daily https://www.pharmasources.com/industryinsights/mohfw-to-consider-lifting-export-restric-317989.html 0.6 2026-08-09T07:56:48+08:00 daily https://www.pharmasources.com/industryinsights/dgft-allows-pharma-cos-to-continue-expor-317990.html 0.6 2026-08-07T13:15:49+08:00 daily https://www.pharmasources.com/industryinsights/no-scientific-evidence-to-establish-link-317991.html 0.6 2026-08-06T22:28:03+08:00 daily https://www.pharmasources.com/industryinsights/oppi-members-reiterate-commitment-to-add-317992.html 0.6 2026-08-06T22:21:04+08:00 daily https://www.pharmasources.com/industryinsights/state-fda-authorities-initiate-measures--317993.html 0.6 2026-08-06T22:08:18+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-launches-generic-opioid-antago-317994.html 0.6 2026-08-06T21:58:52+08:00 daily https://www.pharmasources.com/industryinsights/ibio-developing-proprietary-covid-19-vac-317995.html 0.6 2026-08-06T21:49:01+08:00 daily https://www.pharmasources.com/industryinsights/cepi-finds-eighth-covid-19-partner-in-in-317996.html 0.6 2026-08-06T22:55:00+08:00 daily https://www.pharmasources.com/industryinsights/eurofins-expands-covid-19-testing-in-eur-317997.html 0.6 2026-08-11T01:50:21+08:00 daily https://www.pharmasources.com/industryinsights/teva-donates-potential-covid-19-treatmen-317998.html 0.6 2026-08-07T00:41:43+08:00 daily https://www.pharmasources.com/industryinsights/mylan-preps-to-meet-potential-covid-19-p-317999.html 0.6 2026-08-14T15:31:51+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-invests-83m-to-expand-microbial-318000.html 0.6 2026-08-07T01:21:40+08:00 daily https://www.pharmasources.com/industryinsights/chempartner-expands-china-ops-318001.html 0.6 2026-08-14T18:28:03+08:00 daily https://www.pharmasources.com/industryinsights/roosterbio-senti-biosciences-partner-on--318002.html 0.6 2026-08-07T01:51:56+08:00 daily https://www.pharmasources.com/industryinsights/univercells-launches-cell-gene-therapy-c-318003.html 0.6 2026-08-07T13:18:57+08:00 daily https://www.pharmasources.com/industryinsights/ridgeback-biotherapeutics-and-drive-to-d-318004.html 0.6 2026-08-09T06:59:18+08:00 daily https://www.pharmasources.com/industryinsights/israel-approves-import-of-generic-of-abb-318005.html 0.6 2026-06-21T14:56:27+08:00 daily https://www.pharmasources.com/industryinsights/merck-signs-drug-development-deal-with-d-318006.html 0.6 2026-06-21T02:58:36+08:00 daily https://www.pharmasources.com/industryinsights/gilead-gets-fda-approval-for-epclusa-to--318007.html 0.6 2026-06-22T08:12:59+08:00 daily https://www.pharmasources.com/industryinsights/indian-prime-minister-narendra-modi-call-318008.html 0.6 2026-06-21T02:58:57+08:00 daily https://www.pharmasources.com/industryinsights/global-operation-identifies-34000-falsif-318009.html 0.6 2026-06-20T15:52:35+08:00 daily https://www.pharmasources.com/industryinsights/technique-to-analyse-optical-parameters--318010.html 0.6 2026-07-02T15:52:20+08:00 daily https://www.pharmasources.com/industryinsights/licence-of-esmya-ulipristal-acetate-susp-318011.html 0.6 2026-07-13T12:56:57+08:00 daily https://www.pharmasources.com/industryinsights/high-density-microarray-patch-could-prov-318012.html 0.6 2026-07-08T12:03:51+08:00 daily https://www.pharmasources.com/industryinsights/study-evaluates-if-siltuximab-benefits-c-318013.html 0.6 2026-07-02T14:59:58+08:00 daily https://www.pharmasources.com/industryinsights/centogene-announces-commencement-of-test-318014.html 0.6 2026-06-27T12:21:32+08:00 daily https://www.pharmasources.com/industryinsights/lynparza-granted-orphan-drug-designation-318015.html 0.6 2026-06-22T13:34:05+08:00 daily https://www.pharmasources.com/industryinsights/roivant-develops-gimsilumab-for-ards-ass-318016.html 0.6 2026-06-22T13:26:23+08:00 daily https://www.pharmasources.com/industryinsights/novartis-receives-approval-from-japanese-318017.html 0.6 2026-08-14T11:21:30+08:00 daily https://www.pharmasources.com/industryinsights/usp-offers-support-for-developers-of-cov-318018.html 0.6 2026-08-08T00:46:43+08:00 daily https://www.pharmasources.com/industryinsights/fda-continues-to-facilitate-development--318019.html 0.6 2026-06-22T00:25:41+08:00 daily https://www.pharmasources.com/industryinsights/roche-initiates-phase-iii-clinical-trial-318020.html 0.6 2026-08-01T23:17:18+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-allergan-megamerger-set-for-may-c-318021.html 0.6 2026-06-20T23:46:26+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-abrocitinib-hits-endpoints-in-la-318022.html 0.6 2026-06-21T01:48:44+08:00 daily https://www.pharmasources.com/industryinsights/vaccitech-and-oxford-university-announce-318023.html 0.6 2026-08-06T14:33:13+08:00 daily https://www.pharmasources.com/industryinsights/ascentage-pharma-announces-first-patient-318024.html 0.6 2026-06-20T15:11:18+08:00 daily https://www.pharmasources.com/industryinsights/drug-registration-approval-granted-for-s-318025.html 0.6 2026-07-15T22:06:26+08:00 daily https://www.pharmasources.com/industryinsights/fpt-donates-2000-quarantine-rooms-and-ca-318026.html 0.6 2026-07-03T17:10:51+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-skema-among-the-first-global-bu-318027.html 0.6 2026-06-23T05:25:39+08:00 daily https://www.pharmasources.com/industryinsights/cedrus-investments-successfully-launched-318028.html 0.6 2026-08-08T01:29:39+08:00 daily https://www.pharmasources.com/industryinsights/cmab-biopharma-resumes-full-scale-operat-318029.html 0.6 2026-07-28T20:58:34+08:00 daily https://www.pharmasources.com/industryinsights/pharma-units-in-ap-telengana-to-be-exemp-318030.html 0.6 2026-06-20T21:07:45+08:00 daily https://www.pharmasources.com/industryinsights/bayer-and-curadev-sign-research-collabor-318031.html 0.6 2026-07-01T06:06:52+08:00 daily https://www.pharmasources.com/industryinsights/cadila-pharmas-kaka-ba-hospital-and-guja-318032.html 0.6 2026-05-07T12:36:55+08:00 daily https://www.pharmasources.com/industryinsights/industry-players-applaud-govts-move-to-b-318033.html 0.6 2026-06-21T01:59:57+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-receives-anda-tentative-approva-318034.html 0.6 2026-06-22T14:30:08+08:00 daily https://www.pharmasources.com/industryinsights/novartis-amneal-apotex-offer-hydroxychlo-318035.html 0.6 2026-06-22T05:05:50+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-junshi-biosciences-olix-pharmac-318036.html 0.6 2026-06-09T12:10:14+08:00 daily https://www.pharmasources.com/industryinsights/university-of-queensland-uq-receives-mor-318037.html 0.6 2026-08-07T05:31:17+08:00 daily https://www.pharmasources.com/industryinsights/gilead-halts-emergency-access-to-remdesi-318038.html 0.6 2026-06-22T10:21:26+08:00 daily https://www.pharmasources.com/industryinsights/mitsubishi-licences-suda-pharmaceuticals-318039.html 0.6 2026-08-08T01:24:26+08:00 daily https://www.pharmasources.com/industryinsights/viiv-healthcare-janssen-get-canadian-app-318040.html 0.6 2026-08-08T21:46:40+08:00 daily https://www.pharmasources.com/industryinsights/aphena-acquires-konsyl-pharma-facility-i-318041.html 0.6 2026-08-07T02:45:42+08:00 daily https://www.pharmasources.com/industryinsights/icon-launches-coronavirus-observatory-318042.html 0.6 2026-08-07T02:41:05+08:00 daily https://www.pharmasources.com/industryinsights/lonza-launches-therapeak-sfaav-medium-318043.html 0.6 2026-08-07T01:14:13+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-update-lilly-clinical-trial-act-318044.html 0.6 2026-08-07T01:11:43+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-lilly-get-complete-response-l-318045.html 0.6 2026-08-07T13:19:15+08:00 daily https://www.pharmasources.com/industryinsights/cns-wpd-pharma-to-develop-coronavirus-ca-318046.html 0.6 2026-08-08T12:28:03+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-scientific-continues-bioph-318047.html 0.6 2026-08-14T06:54:05+08:00 daily https://www.pharmasources.com/industryinsights/fda-provides-access-to-certain-rems-drug-318048.html 0.6 2026-08-08T12:18:37+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-update-fda-issues-eua-for-point-318049.html 0.6 2026-08-08T13:46:52+08:00 daily https://www.pharmasources.com/industryinsights/pii-appoints-sridhar-krishnan-ops-svp-318050.html 0.6 2026-08-08T22:08:05+08:00 daily https://www.pharmasources.com/industryinsights/cabenuva-cabotegravir-and-rilpivirine-gr-318051.html 0.6 2026-08-09T00:31:26+08:00 daily https://www.pharmasources.com/industryinsights/uk-bans-parallel-exporting-of-crucial-me-318052.html 0.6 2026-08-09T02:52:44+08:00 daily https://www.pharmasources.com/industryinsights/researchers-to-trial-sng001-therapeutic--318053.html 0.6 2026-08-09T06:51:43+08:00 daily https://www.pharmasources.com/industryinsights/spiral-vortex-streamlines-delivery-of-na-318054.html 0.6 2026-06-27T04:55:54+08:00 daily https://www.pharmasources.com/industryinsights/cel-sci-university-of-georgia-to-develop-318055.html 0.6 2026-08-08T19:19:58+08:00 daily https://www.pharmasources.com/industryinsights/ctk-biotech-launches-test-kits-for-covid-318056.html 0.6 2026-08-07T14:13:39+08:00 daily https://www.pharmasources.com/industryinsights/novartis-to-donate-up-to-130-million-dos-318057.html 0.6 2026-06-21T02:51:39+08:00 daily https://www.pharmasources.com/industryinsights/fda-provides-update-on-patient-access-to-318058.html 0.6 2026-06-27T01:49:39+08:00 daily https://www.pharmasources.com/industryinsights/celsions-gen-1-immunotherapy-receives-or-318059.html 0.6 2026-07-09T18:41:41+08:00 daily https://www.pharmasources.com/industryinsights/vivli-to-launch-a-portal-for-sharing-dat-318060.html 0.6 2026-06-27T18:55:08+08:00 daily https://www.pharmasources.com/industryinsights/feinstein-institutes-begins-three-clinic-318061.html 0.6 2026-06-20T21:01:40+08:00 daily https://www.pharmasources.com/industryinsights/fda-dismisses-jardiance-for-type-i-diabe-318062.html 0.6 2026-06-21T12:01:18+08:00 daily https://www.pharmasources.com/industryinsights/nhs-enters-major-deal-to-expand-hospital-318063.html 0.6 2026-06-20T17:38:24+08:00 daily https://www.pharmasources.com/industryinsights/fda-oks-gileads-paediatric-hep-c-drug-318064.html 0.6 2026-08-13T06:00:39+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2020324-318065.html 0.6 2026-08-07T04:53:06+08:00 daily https://www.pharmasources.com/industryinsights/powder-flow-influence-of-powder-properti-318066.html 0.6 2026-08-06T07:01:49+08:00 daily https://www.pharmasources.com/industryinsights/codexis-takeda-sign-gene-therapy-collabo-318067.html 0.6 2026-08-07T05:06:09+08:00 daily https://www.pharmasources.com/industryinsights/coronavirus-covid-19-update-fda-takes-ac-318068.html 0.6 2026-08-08T22:32:02+08:00 daily https://www.pharmasources.com/industryinsights/pharma-firm-anges-and-osaka-university-t-318069.html 0.6 2026-06-21T03:05:50+08:00 daily https://www.pharmasources.com/industryinsights/ipca-labs-evaluates-us-market-for-hydrox-318070.html 0.6 2026-06-21T00:07:46+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-divests-vwash-a-female-intimate-318071.html 0.6 2026-06-20T20:55:43+08:00 daily https://www.pharmasources.com/industryinsights/global-biopharmaceutical-industry-pullin-318072.html 0.6 2026-08-05T21:53:55+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-pharma-gets-us-fda-approval-for-318073.html 0.6 2026-07-01T05:25:26+08:00 daily https://www.pharmasources.com/industryinsights/argonauts-advanced-facility-readies-to-c-318074.html 0.6 2026-07-18T03:10:59+08:00 daily https://www.pharmasources.com/industryinsights/wacker-receives-excipient-certification-318075.html 0.6 2026-06-21T04:45:35+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-makes-executive-appointment-318076.html 0.6 2026-08-10T08:16:27+08:00 daily https://www.pharmasources.com/industryinsights/cmab-biopharma-resumes-full-scale-operat-318077.html 0.6 2026-08-07T01:19:35+08:00 daily https://www.pharmasources.com/industryinsights/novartis-publishes-more-positive-data-fo-318078.html 0.6 2026-08-07T01:19:20+08:00 daily https://www.pharmasources.com/industryinsights/hoth-therapeutics-forms-jv-to-develop-co-318079.html 0.6 2026-08-07T03:06:40+08:00 daily https://www.pharmasources.com/industryinsights/genentech-secures-fda-approval-to-trial--318080.html 0.6 2026-08-10T15:11:45+08:00 daily https://www.pharmasources.com/industryinsights/takeda-partners-with-codexis-on-gene-the-318081.html 0.6 2026-06-20T17:14:33+08:00 daily https://www.pharmasources.com/industryinsights/bayer-signs-drug-development-and-licensi-318082.html 0.6 2026-07-01T10:15:43+08:00 daily https://www.pharmasources.com/industryinsights/university-hospitals-among-first-in-nati-318083.html 0.6 2026-06-21T08:01:02+08:00 daily https://www.pharmasources.com/industryinsights/mhra-issues-fmd-over-hms-wholesale-limit-318084.html 0.6 2026-07-05T13:08:25+08:00 daily https://www.pharmasources.com/industryinsights/fda-transitions-to-new-regulatory-pathwa-318085.html 0.6 2026-06-20T17:05:24+08:00 daily https://www.pharmasources.com/industryinsights/anti-malarial-drugs-donated-to-aid-fight-318086.html 0.6 2026-08-14T09:06:00+08:00 daily https://www.pharmasources.com/industryinsights/mass-cytometry-could-reveal-best-cancer--318087.html 0.6 2026-06-21T11:07:14+08:00 daily https://www.pharmasources.com/industryinsights/cma-launches-covid-19-taskforce-to-comba-318088.html 0.6 2026-06-21T16:10:27+08:00 daily https://www.pharmasources.com/industryinsights/cepheid-receives-emergency-use-authoriza-318089.html 0.6 2026-08-06T00:06:01+08:00 daily https://www.pharmasources.com/industryinsights/windtree-to-pursue-clinical-study-of-lun-318090.html 0.6 2026-08-06T13:20:24+08:00 daily https://www.pharmasources.com/industryinsights/samsung-bioepis-announces-fda-approval-o-318091.html 0.6 2026-07-31T04:54:55+08:00 daily https://www.pharmasources.com/industryinsights/fda-alerts-consumers-to-unauthorized-fra-318092.html 0.6 2026-08-06T21:50:30+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-to-donate-9-million-face-mas-318093.html 0.6 2026-06-21T02:46:30+08:00 daily https://www.pharmasources.com/industryinsights/car-macrophages-go-beyond-t-cells-to-fig-318094.html 0.6 2026-06-24T03:41:09+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-covacta-trial-for-ra-drug-a-318095.html 0.6 2026-07-07T15:19:33+08:00 daily https://www.pharmasources.com/industryinsights/viiv-healthcare-secures-canadian-approva-318096.html 0.6 2026-06-25T12:47:59+08:00 daily https://www.pharmasources.com/industryinsights/design-therapeutics-launches-with-45m-to-318097.html 0.6 2026-06-21T00:05:36+08:00 daily https://www.pharmasources.com/industryinsights/venclextavenclyxto-combo-extends-myeloid-318098.html 0.6 2026-07-01T19:56:26+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-gilead-deals-with-overwhelming--318099.html 0.6 2026-06-21T10:22:35+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-nihr-awards-105m-to-six-new-pro-318100.html 0.6 2026-06-21T09:01:09+08:00 daily https://www.pharmasources.com/industryinsights/five-year-zolgensma-data-shows-sma-benef-318101.html 0.6 2026-06-21T07:56:55+08:00 daily https://www.pharmasources.com/industryinsights/immunogenesis-contracts-probiogen-for-de-318102.html 0.6 2026-06-20T23:00:45+08:00 daily https://www.pharmasources.com/industryinsights/evitria-crosses-100-citation-threshold-318103.html 0.6 2026-06-21T21:48:43+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-supports-the-development-of-th-318104.html 0.6 2026-06-21T03:12:51+08:00 daily https://www.pharmasources.com/industryinsights/provinces-told-to-resume-vaccination-ser-318105.html 0.6 2026-07-22T02:47:57+08:00 daily https://www.pharmasources.com/industryinsights/provinces-told-to-resume-vaccination-ser-318106.html 0.6 2026-06-21T14:53:19+08:00 daily https://www.pharmasources.com/industryinsights/chinese-vice-premier-urges-orderly-resto-318107.html 0.6 2026-06-22T14:48:47+08:00 daily https://www.pharmasources.com/industryinsights/leading-group-stay-vigilant-on-virus-ris-318108.html 0.6 2026-06-21T04:47:48+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-patients-must-be-treated-with-d-318109.html 0.6 2026-06-22T00:54:46+08:00 daily https://www.pharmasources.com/industryinsights/china-shares-epidemic-control-experience-318110.html 0.6 2026-08-13T08:56:09+08:00 daily https://www.pharmasources.com/industryinsights/xi-urges-joint-response-to-pandemic-318111.html 0.6 2026-06-20T20:54:12+08:00 daily https://www.pharmasources.com/industryinsights/fda-provides-emergency-use-authorization-318112.html 0.6 2026-06-21T09:28:45+08:00 daily https://www.pharmasources.com/industryinsights/happiness-biotech-announced-breakthrough-318113.html 0.6 2026-06-22T17:22:05+08:00 daily https://www.pharmasources.com/industryinsights/ixlayer-launches-covid-19-clinical-testi-318114.html 0.6 2026-06-23T06:36:48+08:00 daily https://www.pharmasources.com/industryinsights/sinopec-joins-global-fight-against-covid-318115.html 0.6 2026-08-07T05:30:57+08:00 daily https://www.pharmasources.com/industryinsights/pharmaexcipients-china-2020-to-be-held-a-318116.html 0.6 2026-08-10T11:40:39+08:00 daily https://www.pharmasources.com/industryinsights/tepmetko-tepotinib-approved-in-japan-for-318117.html 0.6 2026-08-08T22:41:10+08:00 daily https://www.pharmasources.com/industryinsights/iuiga-sells-3-ply-disposable-face-masks--318118.html 0.6 2026-08-08T20:06:09+08:00 daily https://www.pharmasources.com/industryinsights/bamboo-airways-to-cooperate-with-czech-e-318119.html 0.6 2026-08-07T18:33:53+08:00 daily https://www.pharmasources.com/industryinsights/fotrics-infrared-thermal-imaging-technol-318120.html 0.6 2026-08-08T20:19:20+08:00 daily https://www.pharmasources.com/industryinsights/sun-group-focuses-on-new-developments-du-318121.html 0.6 2026-08-07T12:11:18+08:00 daily https://www.pharmasources.com/industryinsights/sonoscape-shares-its-experience-of-fight-318122.html 0.6 2026-08-08T18:12:30+08:00 daily https://www.pharmasources.com/industryinsights/results-from-first-clinical-study-using--318123.html 0.6 2026-07-31T16:32:45+08:00 daily https://www.pharmasources.com/industryinsights/precision-nanosystems-announces-partners-318124.html 0.6 2026-06-20T15:57:11+08:00 daily https://www.pharmasources.com/industryinsights/realizing-smart-healthcare-with-infortre-318125.html 0.6 2026-06-21T03:05:41+08:00 daily https://www.pharmasources.com/industryinsights/mankind-pharma-shows-support-for-doctors-318126.html 0.6 2026-06-21T07:22:16+08:00 daily https://www.pharmasources.com/industryinsights/bengal-chemicals-can-supply-only-10-lakh-318127.html 0.6 2026-06-20T18:01:29+08:00 daily https://www.pharmasources.com/industryinsights/gilead-requests-retraction-of-orphan-des-318128.html 0.6 2026-06-20T22:00:38+08:00 daily https://www.pharmasources.com/industryinsights/akers-biosciences-licenses-premas-corona-318129.html 0.6 2026-06-21T05:13:00+08:00 daily https://www.pharmasources.com/industryinsights/immunogenesis-probiogen-enter-large-scal-318130.html 0.6 2026-06-21T12:10:22+08:00 daily https://www.pharmasources.com/industryinsights/debiopharm-expands-its-radiopharmaceutic-318131.html 0.6 2026-06-21T08:16:10+08:00 daily https://www.pharmasources.com/industryinsights/avectas-vycellix-enter-next-gen-cell-gen-318132.html 0.6 2026-08-12T11:39:36+08:00 daily https://www.pharmasources.com/industryinsights/forge-roche-enter-antibiotic-alliance-318133.html 0.6 2026-06-20T16:06:17+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-supports-coronavirus-vax-candi-318134.html 0.6 2026-06-20T14:58:08+08:00 daily https://www.pharmasources.com/industryinsights/capsule-delivery-solutions-from-lonza-ph-318135.html 0.6 2026-07-04T15:38:26+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-triggers-20-drop-in-oil-demand-318136.html 0.6 2026-06-20T13:19:37+08:00 daily https://www.pharmasources.com/industryinsights/novavaxs-nanoflu-compares-well-to-fluzon-318137.html 0.6 2026-06-21T12:59:29+08:00 daily https://www.pharmasources.com/industryinsights/telstar-develops-a-new-laboratory-freeze-318138.html 0.6 2026-06-21T07:40:34+08:00 daily https://www.pharmasources.com/industryinsights/india-to-set-up-13bn-pharma-manufacturin-318139.html 0.6 2026-08-08T00:58:31+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-update-eli-lilly-assures-securi-318140.html 0.6 2026-08-09T08:02:36+08:00 daily https://www.pharmasources.com/industryinsights/phase-ib-study-for-oral-amphotericin-b-m-318141.html 0.6 2026-06-20T14:20:11+08:00 daily https://www.pharmasources.com/industryinsights/indian-drug-manufacturing-facility-issue-318142.html 0.6 2026-08-09T16:12:57+08:00 daily https://www.pharmasources.com/industryinsights/fda-hands-boehringer-and-lilly-complete--318143.html 0.6 2026-06-20T15:12:15+08:00 daily https://www.pharmasources.com/industryinsights/ampio-preparing-expanded-access-fda-prot-318144.html 0.6 2026-06-21T06:02:48+08:00 daily https://www.pharmasources.com/industryinsights/wpd-partners-with-cns-on-drug-developmen-318145.html 0.6 2026-04-13T08:46:04+08:00 daily https://www.pharmasources.com/industryinsights/biohaven-to-advance-vazegepant-into-phas-318146.html 0.6 2026-06-20T15:34:19+08:00 daily https://www.pharmasources.com/industryinsights/mesa-biotech-receives-emergency-use-auth-318147.html 0.6 2026-06-23T12:56:48+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-announces-positive-results-from-v-318148.html 0.6 2026-06-21T11:15:23+08:00 daily https://www.pharmasources.com/industryinsights/singapore-modelling-study-estimates-impa-318149.html 0.6 2026-06-21T12:18:39+08:00 daily https://www.pharmasources.com/industryinsights/the-fda-is-facilitating-access-to-conval-318150.html 0.6 2026-08-02T12:03:08+08:00 daily https://www.pharmasources.com/industryinsights/bayer-enlists-curadev-in-sting-antagonis-318151.html 0.6 2026-01-12T09:05:46+08:00 daily https://www.pharmasources.com/industryinsights/hep-c-cases-down-around-70-in-hiv-positi-318152.html 0.6 2026-04-02T04:57:39+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-astrazeneca-to-distribute-masks-318153.html 0.6 2026-07-29T10:03:38+08:00 daily https://www.pharmasources.com/industryinsights/az-to-develop-sirna-with-silence-therapu-318154.html 0.6 2026-06-20T15:10:19+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-uk-clinical-tests-to-start-next-318155.html 0.6 2026-06-21T10:39:43+08:00 daily https://www.pharmasources.com/industryinsights/nhs-data-shows-gap-in-care-for-heart-fai-318156.html 0.6 2026-06-22T12:14:05+08:00 daily https://www.pharmasources.com/industryinsights/beigene-announces-supply-update-for-abra-318158.html 0.6 2026-08-09T09:37:49+08:00 daily https://www.pharmasources.com/industryinsights/most-favor-coronavirus-pandemic-restrict-318159.html 0.6 2026-06-20T18:58:38+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-achieved-remarkable-resul-318160.html 0.6 2026-06-24T01:57:52+08:00 daily https://www.pharmasources.com/industryinsights/cipla-receives-final-approval-for-generi-318161.html 0.6 2026-07-01T19:17:12+08:00 daily https://www.pharmasources.com/industryinsights/nearly-70-drugs-that-may-be-effective-ag-318162.html 0.6 2026-06-21T06:49:49+08:00 daily https://www.pharmasources.com/industryinsights/pharmexcil-asks-dgft-to-allow-exports-fr-318163.html 0.6 2026-08-01T05:33:02+08:00 daily https://www.pharmasources.com/industryinsights/medicago-announces-production-of-a-viabl-318164.html 0.6 2026-02-28T15:33:18+08:00 daily https://www.pharmasources.com/industryinsights/sami-labs-appoints-neeraja-shetty-as-its-318165.html 0.6 2026-08-04T15:13:07+08:00 daily https://www.pharmasources.com/industryinsights/fda-allows-patients-to-use-veros-nitric--318166.html 0.6 2026-06-21T04:04:53+08:00 daily https://www.pharmasources.com/industryinsights/alvotech-dksh-partner-to-bring-biosimila-318167.html 0.6 2026-08-02T16:49:24+08:00 daily https://www.pharmasources.com/industryinsights/spi-pharma-expands-mannogem-mannitol-pro-318168.html 0.6 2026-08-04T06:55:33+08:00 daily https://www.pharmasources.com/industryinsights/gilead-halts-access-to-remdesivir-318169.html 0.6 2026-07-27T07:43:57+08:00 daily https://www.pharmasources.com/industryinsights/sorrento-therapeutics-to-develop-cellula-318170.html 0.6 2026-06-08T17:49:03+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-lokelma-approved-for-hyperk-318171.html 0.6 2026-07-07T00:05:04+08:00 daily https://www.pharmasources.com/industryinsights/xencor-vir-biotechnology-sign-licensing--318172.html 0.6 2026-07-04T21:39:43+08:00 daily https://www.pharmasources.com/industryinsights/mylan-and-gilead-waive-exclusivity-for-p-318173.html 0.6 2026-08-07T10:14:12+08:00 daily https://www.pharmasources.com/industryinsights/grifols-teams-up-with-us-to-test-plasma--318174.html 0.6 2026-06-21T19:06:36+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-and-silence-therapeutics-sig-318175.html 0.6 2026-06-21T13:14:37+08:00 daily https://www.pharmasources.com/industryinsights/jefferies-announces-support-for-new-pre--318176.html 0.6 2026-07-31T15:51:45+08:00 daily https://www.pharmasources.com/industryinsights/chinese-abraxane-supply-expected-to-be-d-318177.html 0.6 2026-08-10T08:30:00+08:00 daily https://www.pharmasources.com/industryinsights/indian-government-ceases-exports-of-ipca-318178.html 0.6 2026-06-22T05:49:36+08:00 daily https://www.pharmasources.com/industryinsights/positive-results-announced-for-acute-mye-318179.html 0.6 2026-07-21T13:44:16+08:00 daily https://www.pharmasources.com/industryinsights/mologic-partners-begin-validation-proces-318180.html 0.6 2026-07-08T16:43:45+08:00 daily https://www.pharmasources.com/industryinsights/ani-files-prior-approval-supplement-for--318181.html 0.6 2026-08-06T22:30:49+08:00 daily https://www.pharmasources.com/industryinsights/codexis-signs-strategic-collaboration-li-318182.html 0.6 2026-06-21T13:06:30+08:00 daily https://www.pharmasources.com/industryinsights/c2-pharma-opens-government-and-research--318183.html 0.6 2026-06-20T23:46:23+08:00 daily https://www.pharmasources.com/industryinsights/novartis-life-sciences-companies-commit--318184.html 0.6 2026-06-20T21:20:55+08:00 daily https://www.pharmasources.com/industryinsights/intra-cellular-therapies-announces-avail-318185.html 0.6 2026-06-22T05:09:56+08:00 daily https://www.pharmasources.com/industryinsights/amgen-and-the-amgen-foundation-commit-up-318186.html 0.6 2026-06-20T20:17:02+08:00 daily https://www.pharmasources.com/industryinsights/roche-response-to-covid-19-pandemic-318187.html 0.6 2026-06-20T22:01:40+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-army-of-volunteers-join-nhs-as--318188.html 0.6 2026-08-08T21:36:11+08:00 daily https://www.pharmasources.com/industryinsights/astellas-cytomx-form-t-cell-engaging-can-318189.html 0.6 2026-07-23T08:04:28+08:00 daily https://www.pharmasources.com/industryinsights/novavax-plans-fda-filing-after-nanoflu-t-318190.html 0.6 2026-06-22T02:57:36+08:00 daily https://www.pharmasources.com/industryinsights/botox-gets-license-update-in-uk-318191.html 0.6 2026-06-20T23:01:41+08:00 daily https://www.pharmasources.com/industryinsights/avexis-zolgensma-gene-therapy-yields-des-318192.html 0.6 2026-06-20T21:55:47+08:00 daily https://www.pharmasources.com/industryinsights/hoth-therapeutics-announces-agreement-to-318193.html 0.6 2026-06-21T22:53:39+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-announces-positive-topline-result-318194.html 0.6 2026-06-21T04:21:09+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-keeping-up-with-the-supply-chai-318195.html 0.6 2026-06-20T21:00:40+08:00 daily https://www.pharmasources.com/industryinsights/nppa-to-ensure-unobstructed-movement-of--318196.html 0.6 2026-08-06T23:37:01+08:00 daily https://www.pharmasources.com/industryinsights/lupin-appoints-ramesh-swaminathan-as-chi-318197.html 0.6 2026-06-20T18:19:58+08:00 daily https://www.pharmasources.com/industryinsights/altasciences-completes-phase-i-study-in--318198.html 0.6 2026-06-21T00:08:52+08:00 daily https://www.pharmasources.com/industryinsights/bioduro-to-develop-covid-19-nanobody-the-318199.html 0.6 2026-08-07T10:22:37+08:00 daily https://www.pharmasources.com/industryinsights/berkshire-sterile-manufacturing-fills-no-318200.html 0.6 2026-06-21T00:52:36+08:00 daily https://www.pharmasources.com/industryinsights/bms-zeposia-wins-approval-for-rms-318201.html 0.6 2026-06-20T19:49:52+08:00 daily https://www.pharmasources.com/industryinsights/bgi-genomics-receives-eua-for-sars-cov-2-318202.html 0.6 2026-06-29T00:11:28+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-appoints-bd-svp-318203.html 0.6 2026-06-20T18:57:34+08:00 daily https://www.pharmasources.com/industryinsights/bionova-scientific-introduces-covid-19-s-318204.html 0.6 2026-06-23T02:37:43+08:00 daily https://www.pharmasources.com/industryinsights/us-researchers-repurpose-blood-clots-dru-318205.html 0.6 2026-06-20T15:10:23+08:00 daily https://www.pharmasources.com/industryinsights/dynavax-teams-up-with-cepi-for-covid-19--318206.html 0.6 2026-06-21T10:08:11+08:00 daily https://www.pharmasources.com/industryinsights/us-overtakes-china-with-largest-number-o-318207.html 0.6 2026-06-20T14:53:09+08:00 daily https://www.pharmasources.com/industryinsights/takeda-enters-rare-disease-alliance-with-318208.html 0.6 2026-08-13T14:12:38+08:00 daily https://www.pharmasources.com/industryinsights/uk-pledges-210m-to-cepi-for-covid-19-vac-318209.html 0.6 2026-06-21T12:09:15+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-translate-bio-to-develop-mrna-318210.html 0.6 2026-04-03T19:27:34+08:00 daily https://www.pharmasources.com/industryinsights/mylan-and-pfizer-delay-upjohn-merger-ami-318211.html 0.6 2026-07-04T15:24:50+08:00 daily https://www.pharmasources.com/industryinsights/novartis-partners-with-life-sciences-com-318212.html 0.6 2026-06-21T05:51:46+08:00 daily https://www.pharmasources.com/industryinsights/over-90-percent-of-medical-marijuana-in--318213.html 0.6 2026-06-21T04:46:41+08:00 daily https://www.pharmasources.com/industryinsights/biopharma-industry-leaders-collaborate-t-318214.html 0.6 2026-06-18T16:37:44+08:00 daily https://www.pharmasources.com/industryinsights/95-percent-of-pharma-industry-concerned--318215.html 0.6 2026-06-22T22:42:59+08:00 daily https://www.pharmasources.com/industryinsights/fda-reports-epipen-auto-injector-errors--318216.html 0.6 2026-06-20T17:05:24+08:00 daily https://www.pharmasources.com/industryinsights/partner-therapeutics-announces-trial-to--318217.html 0.6 2026-04-10T21:05:11+08:00 daily https://www.pharmasources.com/industryinsights/italian-researchers-identify-new-sars-co-318218.html 0.6 2026-06-20T16:15:59+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-supports-development-of-vaccin-318219.html 0.6 2026-06-21T23:45:35+08:00 daily https://www.pharmasources.com/industryinsights/fda-takes-action-to-increase-us-supplies-318220.html 0.6 2026-07-05T00:31:20+08:00 daily https://www.pharmasources.com/industryinsights/mindmed-advances-potential-treatment-for-318221.html 0.6 2026-06-22T10:14:51+08:00 daily https://www.pharmasources.com/industryinsights/clinones-remote-clinical-trial-patient-m-318222.html 0.6 2026-06-24T08:36:30+08:00 daily https://www.pharmasources.com/industryinsights/infinity-gets-fda-fast-track-status-for--318223.html 0.6 2026-08-05T10:00:20+08:00 daily https://www.pharmasources.com/industryinsights/alnylam-pharmaceuticals-and-gen-sign-dis-318224.html 0.6 2026-06-21T04:47:32+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-uk-commits-210m-as-pharmacist-w-318225.html 0.6 2026-07-05T04:51:09+08:00 daily https://www.pharmasources.com/industryinsights/chmp-gives-sanofi-positive-opinion-for-s-318226.html 0.6 2026-06-20T21:03:39+08:00 daily https://www.pharmasources.com/industryinsights/bmj-journal-deems-opioid-dependency-impl-318227.html 0.6 2026-06-20T19:59:32+08:00 daily https://www.pharmasources.com/industryinsights/ema-accepts-arvelles-cenobamate-maa-318228.html 0.6 2026-06-22T12:04:53+08:00 daily https://www.pharmasources.com/industryinsights/takeda-evox-link-up-to-the-tune-of-882m-318229.html 0.6 2026-07-22T20:47:44+08:00 daily https://www.pharmasources.com/industryinsights/china-based-biotech-laekna-acquires-glob-318230.html 0.6 2026-08-09T22:07:37+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-classifies-sun-pharmas-halol-faci-318231.html 0.6 2026-08-10T17:22:03+08:00 daily https://www.pharmasources.com/industryinsights/government-asks-moefcc-to-expedite-clear-318232.html 0.6 2026-06-30T03:31:47+08:00 daily https://www.pharmasources.com/industryinsights/strides-announces-successful-completion--318233.html 0.6 2026-06-20T19:51:29+08:00 daily https://www.pharmasources.com/industryinsights/lupins-inhalation-research-center-florid-318234.html 0.6 2026-08-05T07:27:36+08:00 daily https://www.pharmasources.com/industryinsights/novartis-ceo-says-malaria-drug-is-bigges-318235.html 0.6 2026-06-23T11:15:46+08:00 daily https://www.pharmasources.com/industryinsights/goi-allows-pharmacists-to-deliver-medici-318236.html 0.6 2026-06-20T18:21:51+08:00 daily https://www.pharmasources.com/industryinsights/jj-partners-with-barda-to-commit-1bn-to--318237.html 0.6 2026-06-20T15:52:44+08:00 daily https://www.pharmasources.com/industryinsights/altimmune-and-uab-to-develop-intranasal--318238.html 0.6 2026-06-20T18:14:53+08:00 daily https://www.pharmasources.com/industryinsights/novartis-gets-positive-chmp-opinion-for--318239.html 0.6 2026-07-19T04:03:53+08:00 daily https://www.pharmasources.com/industryinsights/researcher-in-india-designs-potential-co-318240.html 0.6 2026-03-25T14:45:48+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-astrazenecas-imfinzi-for-sm-318241.html 0.6 2026-06-21T00:02:39+08:00 daily https://www.pharmasources.com/industryinsights/moderna-to-pause-certain-clinical-develo-318242.html 0.6 2026-07-04T06:42:14+08:00 daily https://www.pharmasources.com/industryinsights/ema-advises-continued-use-of-hypertensio-318243.html 0.6 2026-06-21T05:09:52+08:00 daily https://www.pharmasources.com/industryinsights/big-pharmas-in-house-manufacturing-impac-318244.html 0.6 2026-08-10T22:01:28+08:00 daily https://www.pharmasources.com/industryinsights/global-trial-to-evaluate-kevzara-sarilum-318245.html 0.6 2026-06-24T12:10:18+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-zeposia-ozanimod-to-treat-r-318246.html 0.6 2026-07-17T04:33:38+08:00 daily https://www.pharmasources.com/industryinsights/committee-for-medicinal-products-for-hum-318247.html 0.6 2026-08-05T20:47:03+08:00 daily https://www.pharmasources.com/industryinsights/fda-issues-emergency-approval-for-anti-m-318248.html 0.6 2026-07-29T08:51:20+08:00 daily https://www.pharmasources.com/industryinsights/eurofins-launches-coronavirus-testing-so-318249.html 0.6 2026-06-08T01:39:48+08:00 daily https://www.pharmasources.com/industryinsights/nafamostat-is-expected-to-prevent-the-tr-318250.html 0.6 2026-06-30T14:17:01+08:00 daily https://www.pharmasources.com/industryinsights/cobra-bio-karolinska-inst-to-develop-cov-318251.html 0.6 2026-08-09T09:43:14+08:00 daily https://www.pharmasources.com/industryinsights/advarra-offers-complimentary-transfer-of-318252.html 0.6 2026-06-21T13:09:43+08:00 daily https://www.pharmasources.com/industryinsights/distek-releases-small-volume-conversion--318253.html 0.6 2026-06-22T07:39:39+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-vero-biotech-expanded-access--318254.html 0.6 2026-06-21T12:24:53+08:00 daily https://www.pharmasources.com/industryinsights/mylan-waives-marketing-exclusivity-in-us-318255.html 0.6 2026-06-21T09:02:00+08:00 daily https://www.pharmasources.com/industryinsights/fda-announces-funding-opportunity-for-re-318256.html 0.6 2026-06-20T18:52:33+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-silence-therapeutics-announc-318257.html 0.6 2026-07-18T05:27:00+08:00 daily https://www.pharmasources.com/industryinsights/berkshire-medical-center-nurses-call-for-318258.html 0.6 2026-06-25T21:27:10+08:00 daily https://www.pharmasources.com/industryinsights/experimental-ai-tool-predicts-which-covi-318259.html 0.6 2026-08-08T03:17:35+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-translate-bio-to-develop-novel-mr-318260.html 0.6 2026-08-03T17:57:38+08:00 daily https://www.pharmasources.com/industryinsights/ema-grants-orphan-drug-designation-to-al-318261.html 0.6 2026-07-30T09:06:29+08:00 daily https://www.pharmasources.com/industryinsights/novartis-life-sciences-firms-collaborate-318262.html 0.6 2026-08-11T04:04:53+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-nice-updates-guideline-as-sanof-318263.html 0.6 2026-08-07T01:53:54+08:00 daily https://www.pharmasources.com/industryinsights/forxiga-successful-in-dapa-hf-heart-fail-318264.html 0.6 2026-06-21T08:03:01+08:00 daily https://www.pharmasources.com/industryinsights/az-recruits-imaginab-in-cd8-immunopet-de-318265.html 0.6 2026-06-21T12:56:30+08:00 daily https://www.pharmasources.com/industryinsights/chmp-backs-eight-new-meds-in-virtual-mar-318266.html 0.6 2026-08-05T21:23:08+08:00 daily https://www.pharmasources.com/industryinsights/sales-of-zai-labs-parp-inhibitor-reachin-318267.html 0.6 2026-08-03T12:48:30+08:00 daily https://www.pharmasources.com/industryinsights/a-wake-up-call-for-one-health-318268.html 0.6 2026-06-21T08:44:46+08:00 daily https://www.pharmasources.com/industryinsights/dgft-defers-track-and-trace-deadline-for-318269.html 0.6 2026-08-04T09:52:00+08:00 daily https://www.pharmasources.com/industryinsights/biocons-insulin-manufacturing-facility-i-318270.html 0.6 2026-06-29T15:27:41+08:00 daily https://www.pharmasources.com/industryinsights/laurus-labs-and-rising-pharma-to-collabo-318271.html 0.6 2026-06-22T04:57:45+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-announces-a-lead-vaccine-318272.html 0.6 2026-06-21T14:55:20+08:00 daily https://www.pharmasources.com/industryinsights/cambrex-appoints-early-stage-development-318273.html 0.6 2026-06-21T12:59:51+08:00 daily https://www.pharmasources.com/industryinsights/coronavirus-consortium-accelerates-immun-318274.html 0.6 2026-06-20T23:00:37+08:00 daily https://www.pharmasources.com/industryinsights/cobra-biologics-joins-covid-19-consortiu-318275.html 0.6 2026-06-21T00:39:26+08:00 daily https://www.pharmasources.com/industryinsights/innovent-alector-enter-oncology-alliance-318276.html 0.6 2026-06-23T12:08:38+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-kalbe-genexine-enter-strategic-pac-318277.html 0.6 2026-04-04T20:49:46+08:00 daily https://www.pharmasources.com/industryinsights/aptorum-and-covar-explore-repurposed-dru-318278.html 0.6 2026-06-21T01:12:56+08:00 daily https://www.pharmasources.com/industryinsights/gigagen-works-on-recombinant-polyclonal--318279.html 0.6 2026-06-21T16:06:23+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-lillys-plaque-psoriasis-dru-318280.html 0.6 2026-06-20T17:01:45+08:00 daily https://www.pharmasources.com/industryinsights/noveome-studies-anti-inflammatory-drug-s-318281.html 0.6 2026-06-21T10:08:10+08:00 daily https://www.pharmasources.com/industryinsights/us-hhs-expedites-development-and-manufac-318282.html 0.6 2026-06-22T04:09:48+08:00 daily https://www.pharmasources.com/industryinsights/us-urges-india-to-lift-export-ban-on-pha-318283.html 0.6 2026-06-21T08:12:07+08:00 daily https://www.pharmasources.com/industryinsights/primmune-selects-sars-cov-2-clinical-can-318284.html 0.6 2026-08-10T23:16:44+08:00 daily https://www.pharmasources.com/industryinsights/ema-warns-consumers-about-falsified-covi-318285.html 0.6 2026-07-16T09:40:17+08:00 daily https://www.pharmasources.com/industryinsights/q-biomed-appoints-head-of-global-regulat-318286.html 0.6 2026-06-20T18:22:04+08:00 daily https://www.pharmasources.com/industryinsights/lilly-sitryx-enter-autoimmune-alliance-318287.html 0.6 2025-12-29T05:26:37+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-appoints-bd-vp-for-cdo-318288.html 0.6 2026-06-21T09:42:58+08:00 daily https://www.pharmasources.com/industryinsights/stem-cell-therapy-shows-efficacy-at-trea-318289.html 0.6 2026-06-21T18:58:12+08:00 daily https://www.pharmasources.com/industryinsights/study-suggests-zolgensma-will-generate-2-318290.html 0.6 2026-07-19T22:59:12+08:00 daily https://www.pharmasources.com/industryinsights/mylan-lupin-announce-positive-chmp-opini-318291.html 0.6 2026-08-05T14:52:08+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-scientific-receives-ce-mar-318292.html 0.6 2026-06-20T16:17:32+08:00 daily https://www.pharmasources.com/industryinsights/luminex-receives-eua-for-nxtag-cov-exten-318293.html 0.6 2026-06-21T06:11:55+08:00 daily https://www.pharmasources.com/industryinsights/altasciences-completes-phase-i-study-on--318294.html 0.6 2026-07-06T22:40:04+08:00 daily https://www.pharmasources.com/industryinsights/relief-therapeutics-neurorx-file-ind-for-318295.html 0.6 2025-11-28T07:38:23+08:00 daily https://www.pharmasources.com/industryinsights/ryvu-therapeutics-receives-orphan-drug-d-318296.html 0.6 2026-06-21T01:07:48+08:00 daily https://www.pharmasources.com/industryinsights/mercks-vericiguat-meets-primary-endpoint-318297.html 0.6 2026-08-11T18:40:50+08:00 daily https://www.pharmasources.com/industryinsights/aveo-oncology-and-biodesix-to-discontinu-318298.html 0.6 2026-07-18T15:17:23+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-imfinzi-for-extensive-stage-318299.html 0.6 2026-06-22T15:10:41+08:00 daily https://www.pharmasources.com/industryinsights/cambrex-appoints-troy-player-as-presiden-318300.html 0.6 2026-06-21T07:49:57+08:00 daily https://www.pharmasources.com/industryinsights/nubeqa-authorised-in-europe-for-certain--318301.html 0.6 2026-06-22T07:02:50+08:00 daily https://www.pharmasources.com/industryinsights/ensifentrine-improves-lung-function-in-c-318302.html 0.6 2026-06-20T19:02:36+08:00 daily https://www.pharmasources.com/industryinsights/brilinta-found-to-reduce-bleeding-vs-dua-318303.html 0.6 2026-06-20T18:12:51+08:00 daily https://www.pharmasources.com/industryinsights/high-incident-cases-of-invasive-pneumoco-318304.html 0.6 2026-06-20T20:49:27+08:00 daily https://www.pharmasources.com/industryinsights/coping-with-covid-19-agi-glaspac-318305.html 0.6 2026-07-23T11:44:23+08:00 daily https://www.pharmasources.com/industryinsights/takeda-appoints-new-country-head-for-ind-318306.html 0.6 2026-06-22T11:57:45+08:00 daily https://www.pharmasources.com/industryinsights/citius-novellus-ink-covid-19-pact-318307.html 0.6 2026-06-21T02:03:42+08:00 daily https://www.pharmasources.com/industryinsights/abbott-to-deploy-rapid-covid-19-test-in--318308.html 0.6 2026-03-30T21:34:22+08:00 daily https://www.pharmasources.com/industryinsights/american-regent-expands-api-ops-318309.html 0.6 2026-08-07T11:07:18+08:00 daily https://www.pharmasources.com/industryinsights/chiral-technologies-names-biz-dev-direct-318310.html 0.6 2026-06-22T09:12:58+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-creates-discovery-research-orga-318311.html 0.6 2026-06-20T17:01:13+08:00 daily https://www.pharmasources.com/industryinsights/evotec-and-ildong-enter-drug-development-318312.html 0.6 2026-06-29T20:00:26+08:00 daily https://www.pharmasources.com/industryinsights/wacker-biosolutions-under-new-leadership-318313.html 0.6 2026-07-04T10:14:26+08:00 daily https://www.pharmasources.com/industryinsights/ritedose-chargepoint-team-up-for-bio-mfg-318314.html 0.6 2026-06-21T22:59:52+08:00 daily https://www.pharmasources.com/industryinsights/bora-strengthens-biz-dev-team-to-support-318315.html 0.6 2026-08-11T07:09:38+08:00 daily https://www.pharmasources.com/industryinsights/rssl-makes-senior-appointment-318316.html 0.6 2026-06-21T01:04:48+08:00 daily https://www.pharmasources.com/industryinsights/akron-biotech-expands-to-second-us-manuf-318317.html 0.6 2026-08-11T17:10:37+08:00 daily https://www.pharmasources.com/industryinsights/exscientia-forms-uk-us-partnership-to-sc-318318.html 0.6 2026-07-16T22:40:32+08:00 daily https://www.pharmasources.com/industryinsights/sorrento-forms-alliance-for-preclinical--318319.html 0.6 2026-06-21T14:35:06+08:00 daily https://www.pharmasources.com/industryinsights/vbi-vaccines-to-develop-pan-coronavirus--318320.html 0.6 2026-06-23T12:58:54+08:00 daily https://www.pharmasources.com/industryinsights/sitryx-signs-potential-880m-drug-develop-318321.html 0.6 2026-07-18T17:46:47+08:00 daily https://www.pharmasources.com/industryinsights/neurimmune-and-ethris-to-develop-mrna-an-318322.html 0.6 2026-06-21T21:43:51+08:00 daily https://www.pharmasources.com/industryinsights/fda-launches-new-programme-to-speed-up-c-318323.html 0.6 2026-06-22T09:10:53+08:00 daily https://www.pharmasources.com/industryinsights/how-to-take-care-of-your-mental-health-d-318324.html 0.6 2026-06-20T18:47:37+08:00 daily https://www.pharmasources.com/industryinsights/accord-to-donate-four-million-tablets-to-318325.html 0.6 2026-08-14T01:37:38+08:00 daily https://www.pharmasources.com/industryinsights/evox-and-takeda-sign-deal-to-collaborate-318326.html 0.6 2026-08-13T14:12:01+08:00 daily https://www.pharmasources.com/industryinsights/fda-and-ema-offer-updates-on-covid-19-tr-318327.html 0.6 2026-04-20T18:32:20+08:00 daily https://www.pharmasources.com/industryinsights/wearable-patch-device-could-provide-an-a-318328.html 0.6 2026-08-13T19:22:16+08:00 daily https://www.pharmasources.com/industryinsights/fibrogenesis-files-expanded-patent-cover-318329.html 0.6 2026-08-11T14:21:58+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2020040-318330.html 0.6 2026-08-07T13:16:05+08:00 daily https://www.pharmasources.com/industryinsights/beckman-coulter-announces-test-developme-318331.html 0.6 2026-08-07T15:24:48+08:00 daily https://www.pharmasources.com/industryinsights/biohaven-achieves-positive-results-in-tr-318332.html 0.6 2026-01-24T19:16:34+08:00 daily https://www.pharmasources.com/industryinsights/chinese-api-industrys-position-becoming--318333.html 0.6 2026-07-30T12:32:19+08:00 daily https://www.pharmasources.com/industryinsights/learning-from-history-a-review-of-produc-318334.html 0.6 2026-07-18T22:35:25+08:00 daily https://www.pharmasources.com/industryinsights/aptorum-to-investigate-use-of-repurposed-318335.html 0.6 2026-08-06T01:48:56+08:00 daily https://www.pharmasources.com/industryinsights/az-licences-movantik-rights-to-redhill-318336.html 0.6 2026-08-11T10:44:16+08:00 daily https://www.pharmasources.com/industryinsights/positive-early-data-from-siltuximab-covi-318337.html 0.6 2026-06-21T01:02:52+08:00 daily https://www.pharmasources.com/industryinsights/nice-publishes-second-set-of-rapid-covid-318338.html 0.6 2026-06-22T02:11:45+08:00 daily https://www.pharmasources.com/industryinsights/ethris-neurimmune-work-on-inhalable-covi-318339.html 0.6 2026-08-07T13:46:57+08:00 daily https://www.pharmasources.com/industryinsights/novel-micro-rna-therapeutic-hits-early-t-318340.html 0.6 2026-06-20T21:59:44+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-submits-application-for-c-318341.html 0.6 2026-06-21T23:09:58+08:00 daily https://www.pharmasources.com/industryinsights/evolving-world-of-pharma-supply-chain-di-318342.html 0.6 2026-07-21T08:02:40+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-calls-for-removal-of-all-ranitidi-318343.html 0.6 2026-08-08T15:45:43+08:00 daily https://www.pharmasources.com/industryinsights/aurobindo-sandoz-call-off-900-million-de-318344.html 0.6 2026-06-21T10:04:12+08:00 daily https://www.pharmasources.com/industryinsights/cipla-announces-completion-of-phase-3-cl-318345.html 0.6 2026-07-29T15:33:18+08:00 daily https://www.pharmasources.com/industryinsights/citius-licences-novellus-stem-cell-thera-318346.html 0.6 2026-04-21T05:54:20+08:00 daily https://www.pharmasources.com/industryinsights/gilead-initiates-two-studies-of-remdesiv-318347.html 0.6 2026-04-27T18:54:13+08:00 daily https://www.pharmasources.com/industryinsights/ema-advises-malaria-drugs-use-for-trials-318348.html 0.6 2026-06-22T03:24:05+08:00 daily https://www.pharmasources.com/industryinsights/novartis-terminates-1bn-sandoz-us-deal-w-318349.html 0.6 2026-06-21T17:14:43+08:00 daily https://www.pharmasources.com/industryinsights/immunitybio-and-microsoft-create-3d-mode-318350.html 0.6 2026-06-20T20:13:55+08:00 daily https://www.pharmasources.com/industryinsights/australias-csiro-starts-first-stage-of-c-318351.html 0.6 2026-06-21T12:08:20+08:00 daily https://www.pharmasources.com/industryinsights/israeli-scientists-begin-animal-testing--318352.html 0.6 2026-06-22T08:04:48+08:00 daily https://www.pharmasources.com/industryinsights/ampio-pharma-to-study-ampion-in-covid-19-318353.html 0.6 2026-06-20T19:07:51+08:00 daily https://www.pharmasources.com/industryinsights/amgen-adaptive-biotech-enter-covid-19-an-318354.html 0.6 2026-07-01T22:36:21+08:00 daily https://www.pharmasources.com/industryinsights/apeiron-biologics-initiates-phase-ii-cov-318355.html 0.6 2026-06-21T05:59:44+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-irvine-scientific-leverages-dis-318356.html 0.6 2026-06-21T13:05:29+08:00 daily https://www.pharmasources.com/industryinsights/paratek-gets-barda-funding-for-nuzyra-su-318357.html 0.6 2026-04-27T15:55:22+08:00 daily https://www.pharmasources.com/industryinsights/ispe-appoints-european-regulatory-adviso-318358.html 0.6 2026-08-06T20:07:25+08:00 daily https://www.pharmasources.com/industryinsights/conducting-clinical-trials-amid-the-covi-318359.html 0.6 2026-08-07T00:59:27+08:00 daily https://www.pharmasources.com/industryinsights/mhra-issues-class-4-medicines-defect-inf-318360.html 0.6 2026-08-07T10:58:24+08:00 daily https://www.pharmasources.com/industryinsights/ema-accepts-marketing-authorisation-appl-318361.html 0.6 2026-08-08T23:31:45+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-announces-lead-vaccine-c-318362.html 0.6 2026-06-21T19:15:49+08:00 daily https://www.pharmasources.com/industryinsights/fda-releases-sars-cov-2-reference-grade--318363.html 0.6 2026-06-21T17:04:25+08:00 daily https://www.pharmasources.com/industryinsights/bosch-developing-covid-19-sars-cov-2-rap-318364.html 0.6 2026-05-28T10:24:14+08:00 daily https://www.pharmasources.com/industryinsights/new-guidelines-on-caring-for-icu-patient-318365.html 0.6 2026-07-04T23:28:13+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-outside-us-treated-in-glob-318366.html 0.6 2026-07-30T23:28:37+08:00 daily https://www.pharmasources.com/industryinsights/tsinghua-and-partners-to-develop-neutral-318367.html 0.6 2026-08-04T03:50:51+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-and-bluebird-bio-su-318368.html 0.6 2026-07-03T03:26:58+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-wins-eu-approval-for-mabthera-bio-318369.html 0.6 2026-06-23T07:18:43+08:00 daily https://www.pharmasources.com/industryinsights/novartis-incyte-to-test-jakavi-for-coron-318370.html 0.6 2026-06-21T01:43:26+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-unveils-new-data-for-dupixent-in--318371.html 0.6 2026-08-06T04:41:12+08:00 daily https://www.pharmasources.com/industryinsights/funding-support-for-community-pharmacy-d-318372.html 0.6 2026-06-20T14:57:05+08:00 daily https://www.pharmasources.com/industryinsights/health-secretary-lays-out-plans-for-1000-318373.html 0.6 2026-07-27T04:46:22+08:00 daily https://www.pharmasources.com/industryinsights/uk-team-close-to-delivering-new-covid-19-318374.html 0.6 2026-06-21T03:59:44+08:00 daily https://www.pharmasources.com/industryinsights/the-impact-of-coronavirus-covid-19-on-gl-318375.html 0.6 2026-08-10T10:11:23+08:00 daily https://www.pharmasources.com/industryinsights/evolving-world-of-pharma-a-framework-for-318376.html 0.6 2026-07-28T12:13:26+08:00 daily https://www.pharmasources.com/industryinsights/pharma-and-health-from-ingredients-to-pi-318377.html 0.6 2026-08-07T02:59:33+08:00 daily https://www.pharmasources.com/industryinsights/fda-provides-updated-guidance-to-address-318378.html 0.6 2026-08-11T07:00:57+08:00 daily https://www.pharmasources.com/industryinsights/china-moves-to-ensure-quality-of-medical-318379.html 0.6 2026-07-19T20:09:41+08:00 daily https://www.pharmasources.com/industryinsights/china-shares-experience-resources-in-glo-318380.html 0.6 2026-06-21T08:53:07+08:00 daily https://www.pharmasources.com/industryinsights/xis-speech-on-epidemic-control-in-hubei--318381.html 0.6 2026-06-21T09:08:17+08:00 daily https://www.pharmasources.com/industryinsights/nation-adds-asymptomatic-cases-to-total-318382.html 0.6 2026-06-22T00:06:50+08:00 daily https://www.pharmasources.com/industryinsights/summary-of-nmpa-approved-novel-coronavir-318383.html 0.6 2026-06-20T14:37:18+08:00 daily https://www.pharmasources.com/industryinsights/premier-li-calls-for-enhanced-guarantee--318384.html 0.6 2025-12-20T22:59:08+08:00 daily https://www.pharmasources.com/industryinsights/vice-premier-stresses-research-on-covid--318385.html 0.6 2026-06-21T04:57:46+08:00 daily https://www.pharmasources.com/industryinsights/great-efforts-made-in-epidemic-control-i-318386.html 0.6 2026-06-20T20:16:56+08:00 daily https://www.pharmasources.com/industryinsights/xi-collective-efforts-key-to-fighting-vi-318387.html 0.6 2026-08-11T03:19:47+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-antibody-test-released-by-ortho-318388.html 0.6 2026-06-21T10:58:06+08:00 daily https://www.pharmasources.com/industryinsights/firmenich-expands-hand-sanitizer-product-318389.html 0.6 2026-07-03T18:38:10+08:00 daily https://www.pharmasources.com/industryinsights/tencent-open-sources-another-ai-powered--318390.html 0.6 2026-08-04T07:01:56+08:00 daily https://www.pharmasources.com/industryinsights/gracell-announces-china-nmpa-acceptance--318391.html 0.6 2026-04-07T05:48:45+08:00 daily https://www.pharmasources.com/industryinsights/vuno-offers-a-suite-of-ai-solutions-in-r-318392.html 0.6 2026-08-03T02:49:05+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-scientific-to-enhance-capa-318393.html 0.6 2026-06-21T13:00:27+08:00 daily https://www.pharmasources.com/industryinsights/lupins-aurangabad-facility-receives-eir--318394.html 0.6 2026-08-04T14:27:59+08:00 daily https://www.pharmasources.com/industryinsights/dsm-completes-acquisition-of-human-milk--318395.html 0.6 2026-06-29T23:14:29+08:00 daily https://www.pharmasources.com/industryinsights/cytovance-promotes-jesse-mccool-to-ceo-318396.html 0.6 2026-06-20T15:58:41+08:00 daily https://www.pharmasources.com/industryinsights/emergent-signs-manufacturing-agreement-w-318397.html 0.6 2025-11-28T09:25:04+08:00 daily https://www.pharmasources.com/industryinsights/pharmaseal-offers-no-cost-support-for-co-318398.html 0.6 2026-07-07T13:59:36+08:00 daily https://www.pharmasources.com/industryinsights/duke-to-expedite-study-of-covid-19-preve-318399.html 0.6 2026-06-20T19:00:40+08:00 daily https://www.pharmasources.com/industryinsights/vir-biotechnology-and-alnylam-expand-all-318400.html 0.6 2026-06-20T22:17:55+08:00 daily https://www.pharmasources.com/industryinsights/flugen-bharat-biotech-and-uwmadison-part-318401.html 0.6 2026-06-20T20:10:42+08:00 daily https://www.pharmasources.com/industryinsights/kite-licences-teneobios-multiple-myeloma-318402.html 0.6 2026-06-20T16:14:25+08:00 daily https://www.pharmasources.com/industryinsights/novartis-and-incyte-to-trial-jakavi-for--318403.html 0.6 2026-06-21T07:01:55+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccine-candidate-yields-promis-318404.html 0.6 2026-06-21T00:04:39+08:00 daily https://www.pharmasources.com/industryinsights/amgen-and-adaptive-biotechnologies-to-de-318405.html 0.6 2026-07-27T16:52:17+08:00 daily https://www.pharmasources.com/industryinsights/apeiron-biologics-gets-regulatory-approv-318406.html 0.6 2026-07-21T11:00:04+08:00 daily https://www.pharmasources.com/industryinsights/global-confirmed-covid-19-cases-exceed-o-318407.html 0.6 2026-06-21T08:51:36+08:00 daily https://www.pharmasources.com/industryinsights/frontage-laboratories-acquires-biotranix-318408.html 0.6 2026-06-21T08:15:17+08:00 daily https://www.pharmasources.com/industryinsights/sai-life-sciences-joins-supply-chain-ini-318409.html 0.6 2026-06-21T12:14:27+08:00 daily https://www.pharmasources.com/industryinsights/cmab-bolsters-executive-team-318410.html 0.6 2026-08-08T00:15:14+08:00 daily https://www.pharmasources.com/industryinsights/cobra-biologics-completes-key-combigene--318411.html 0.6 2026-06-21T03:12:53+08:00 daily https://www.pharmasources.com/industryinsights/francis-crick-institute-and-collaborator-318412.html 0.6 2026-08-12T01:49:41+08:00 daily https://www.pharmasources.com/industryinsights/ema-releases-its-regulatory-strategy-for-318413.html 0.6 2026-06-22T07:59:45+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-recalls-four-lots-of-phytonadi-318414.html 0.6 2026-06-21T10:05:09+08:00 daily https://www.pharmasources.com/industryinsights/influenza-antiviral-avigan-favipiravir-t-318415.html 0.6 2026-06-30T01:51:15+08:00 daily https://www.pharmasources.com/industryinsights/bgi-receives-fda-authorization-for-real--318416.html 0.6 2026-08-11T18:19:37+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-durvalumab-for-extensive-st-318417.html 0.6 2026-06-21T03:46:29+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-additional-treatment-for-ad-318418.html 0.6 2026-07-04T23:15:28+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-therapeutics-summary-of-recentl-318419.html 0.6 2026-08-09T17:38:06+08:00 daily https://www.pharmasources.com/industryinsights/possible-coronavirus-drug-identified-by--318420.html 0.6 2026-06-21T11:19:37+08:00 daily https://www.pharmasources.com/industryinsights/beigene-doses-first-patient-in-phase-1b2-318421.html 0.6 2026-06-26T06:27:52+08:00 daily https://www.pharmasources.com/industryinsights/concert-pharmaceuticals-announces-plans--318422.html 0.6 2026-06-21T15:59:18+08:00 daily https://www.pharmasources.com/industryinsights/nppa-revises-ceiling-price-of-scheduled--318423.html 0.6 2026-06-15T16:05:54+08:00 daily https://www.pharmasources.com/industryinsights/engaging-with-authorities-to-address-cha-318424.html 0.6 2026-08-14T04:07:29+08:00 daily https://www.pharmasources.com/industryinsights/evotec-takeda-enter-long-term-research-a-318425.html 0.6 2026-06-22T03:08:44+08:00 daily https://www.pharmasources.com/industryinsights/bgi-unveils-inflatable-biosafety-lab-for-318426.html 0.6 2026-08-03T16:52:20+08:00 daily https://www.pharmasources.com/industryinsights/zymewire-launches-covidcollaboratorsorg-318427.html 0.6 2026-08-12T17:30:38+08:00 daily https://www.pharmasources.com/industryinsights/lakepharma-offers-covid-19-proteins-to-b-318428.html 0.6 2026-07-06T21:25:08+08:00 daily https://www.pharmasources.com/industryinsights/biosig-acquires-anti-viral-agent-to-trea-318429.html 0.6 2026-06-21T01:59:41+08:00 daily https://www.pharmasources.com/industryinsights/izana-initiates-namilumab-study-in-worse-318430.html 0.6 2026-06-21T11:59:27+08:00 daily https://www.pharmasources.com/industryinsights/akers-premas-progress-covid-19-vax-devel-318431.html 0.6 2026-06-21T11:13:18+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-pharmabcine-enter-anti-318432.html 0.6 2026-07-17T11:10:10+08:00 daily https://www.pharmasources.com/industryinsights/the-fda-approved-drug-ivermectin-inhibit-318433.html 0.6 2026-08-04T11:57:37+08:00 daily https://www.pharmasources.com/industryinsights/xbiotech-and-biobridge-to-develop-plasma-318434.html 0.6 2026-08-06T00:33:57+08:00 daily https://www.pharmasources.com/industryinsights/servier-agrees-to-acquire-symphogen-318435.html 0.6 2026-03-28T01:14:12+08:00 daily https://www.pharmasources.com/industryinsights/gsk-partners-with-innovax-biotech-on-cov-318436.html 0.6 2026-06-22T18:18:28+08:00 daily https://www.pharmasources.com/industryinsights/large-scale-trial-for-coronavirus-drugs--318437.html 0.6 2026-08-05T19:53:13+08:00 daily https://www.pharmasources.com/industryinsights/study-finds-anti-parasitic-drug-could-ki-318438.html 0.6 2026-06-27T16:52:16+08:00 daily https://www.pharmasources.com/industryinsights/pharma-programmes-for-employees-to-volun-318439.html 0.6 2026-06-20T17:47:18+08:00 daily https://www.pharmasources.com/industryinsights/ema-recommendations-on-compassionate-use-318440.html 0.6 2026-08-04T10:56:23+08:00 daily https://www.pharmasources.com/industryinsights/using-fatty-acids-in-oral-formulations-t-318441.html 0.6 2026-06-20T18:21:27+08:00 daily https://www.pharmasources.com/industryinsights/india-to-import-ppe-from-china-in-covid--318442.html 0.6 2026-07-04T22:01:58+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-clinical-research-coalition-to--318443.html 0.6 2026-06-12T15:42:47+08:00 daily https://www.pharmasources.com/industryinsights/fluxergy-submits-request-for-eua-for-one-318444.html 0.6 2026-06-20T19:09:44+08:00 daily https://www.pharmasources.com/industryinsights/usp-offers-hand-sanitizer-toolkit-in-res-318445.html 0.6 2026-06-22T14:30:48+08:00 daily https://www.pharmasources.com/industryinsights/pharmamar-submits-trial-of-aplidin-for-c-318446.html 0.6 2026-06-28T10:45:24+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-announces-divestment-of-mova-318447.html 0.6 2026-08-05T14:36:04+08:00 daily https://www.pharmasources.com/industryinsights/ansun-biopharma-announces-positive-resul-318448.html 0.6 2026-07-24T05:08:30+08:00 daily https://www.pharmasources.com/industryinsights/biomerica-signs-agreements-with-mount-si-318449.html 0.6 2026-06-21T18:51:00+08:00 daily https://www.pharmasources.com/industryinsights/lancaster-academic-sees-positives-in-fir-318450.html 0.6 2026-07-01T10:16:07+08:00 daily https://www.pharmasources.com/industryinsights/trial-drug-can-significantly-block-early-318451.html 0.6 2026-06-20T20:12:01+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-acceleron-get-fda-n-318452.html 0.6 2026-06-21T15:43:21+08:00 daily https://www.pharmasources.com/industryinsights/nice-publishes-four-more-rapid-guideline-318453.html 0.6 2026-06-21T03:36:29+08:00 daily https://www.pharmasources.com/industryinsights/eu-nod-for-novos-diabetes-drug-rybelsus-318454.html 0.6 2026-08-03T11:57:17+08:00 daily https://www.pharmasources.com/industryinsights/gsks-nucala-shows-promise-in-nasal-polyp-318455.html 0.6 2026-06-20T15:00:06+08:00 daily https://www.pharmasources.com/industryinsights/from-china-to-the-world-fosuns-fight-aga-318456.html 0.6 2026-08-03T23:52:30+08:00 daily https://www.pharmasources.com/industryinsights/genscript-probio-and-eutilex-enter-into--318457.html 0.6 2026-06-21T19:03:38+08:00 daily https://www.pharmasources.com/industryinsights/thewavetalk-raises-us2m-318458.html 0.6 2026-07-19T14:56:35+08:00 daily https://www.pharmasources.com/industryinsights/kazias-paxalisib-shows-positive-overall--318459.html 0.6 2026-06-21T19:55:48+08:00 daily https://www.pharmasources.com/industryinsights/cromsource-announces-launch-of-covid-19--318460.html 0.6 2026-06-20T21:36:21+08:00 daily https://www.pharmasources.com/industryinsights/record-breaking-global-mobility-grounded-318461.html 0.6 2026-03-05T13:59:31+08:00 daily https://www.pharmasources.com/industryinsights/prosegur-security-is-managing-critical-i-318462.html 0.6 2026-02-15T14:07:51+08:00 daily https://www.pharmasources.com/industryinsights/winnoz-technology-in-the-fight-against-c-318463.html 0.6 2026-08-09T00:31:26+08:00 daily https://www.pharmasources.com/industryinsights/cgtn-remembering-the-medical-professiona-318464.html 0.6 2026-08-08T22:01:51+08:00 daily https://www.pharmasources.com/industryinsights/mundipharma-donates-betadine-products-to-318465.html 0.6 2026-08-08T20:37:37+08:00 daily https://www.pharmasources.com/industryinsights/deploy-a-management-control-technology-318466.html 0.6 2026-08-08T19:15:35+08:00 daily https://www.pharmasources.com/industryinsights/getinge-to-further-increase-production-c-318467.html 0.6 2026-08-07T13:16:30+08:00 daily https://www.pharmasources.com/industryinsights/inovio-initiates-phase-1-clinical-trial--318468.html 0.6 2026-08-07T03:33:30+08:00 daily https://www.pharmasources.com/industryinsights/nation-to-boost-global-medical-supplies-318469.html 0.6 2026-08-07T03:24:43+08:00 daily https://www.pharmasources.com/industryinsights/virus-testing-along-border-to-get-a-boos-318470.html 0.6 2026-08-07T03:02:57+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2020040-318471.html 0.6 2026-08-06T22:05:47+08:00 daily https://www.pharmasources.com/industryinsights/over-280-units-in-sezs-operational-to-ma-318472.html 0.6 2026-08-07T13:17:16+08:00 daily https://www.pharmasources.com/industryinsights/55-firms-producing-up-to-70000-litres-of-318473.html 0.6 2026-08-08T00:49:14+08:00 daily https://www.pharmasources.com/industryinsights/fdas-ctap-to-expedite-covid-19-counterme-318474.html 0.6 2026-08-14T02:43:07+08:00 daily https://www.pharmasources.com/industryinsights/bioivt-opens-new-blood-donor-center-318476.html 0.6 2026-06-21T18:57:50+08:00 daily https://www.pharmasources.com/industryinsights/sharp-supports-development-of-covid-19-v-318477.html 0.6 2026-06-21T01:06:50+08:00 daily https://www.pharmasources.com/industryinsights/alnylam-and-dicerna-to-develop-liver-dis-318478.html 0.6 2026-08-09T13:06:33+08:00 daily https://www.pharmasources.com/industryinsights/gilead-signs-drug-discovery-deal-with-se-318479.html 0.6 2026-06-21T17:19:37+08:00 daily https://www.pharmasources.com/industryinsights/takeda-teams-up-with-plasma-firms-for-co-318480.html 0.6 2026-06-20T14:56:12+08:00 daily https://www.pharmasources.com/industryinsights/gsk-buys-stake-in-vir-biotechnology-in-s-318481.html 0.6 2026-06-21T11:21:30+08:00 daily https://www.pharmasources.com/industryinsights/drug-supply-chain-disruptions-due-to-cov-318482.html 0.6 2026-08-11T10:05:49+08:00 daily https://www.pharmasources.com/industryinsights/inovio-commences-phase-i-trial-of-dna-va-318483.html 0.6 2026-06-21T01:51:32+08:00 daily https://www.pharmasources.com/industryinsights/cambrex-completes-biopharma-expansion-318484.html 0.6 2026-06-21T07:52:04+08:00 daily https://www.pharmasources.com/industryinsights/almac-offers-expedited-support-for-covid-318485.html 0.6 2026-07-04T03:14:34+08:00 daily https://www.pharmasources.com/industryinsights/orasure-gets-govt-support-to-develop-in--318486.html 0.6 2026-06-20T17:18:48+08:00 daily https://www.pharmasources.com/industryinsights/hope-bio-gets-fda-nod-to-start-first-ste-318487.html 0.6 2026-06-24T13:00:10+08:00 daily https://www.pharmasources.com/industryinsights/applied-biology-to-launch-covid-19-drug--318488.html 0.6 2026-08-11T03:31:14+08:00 daily https://www.pharmasources.com/industryinsights/oncosec-collaborates-with-providence-can-318489.html 0.6 2026-06-22T01:08:56+08:00 daily https://www.pharmasources.com/industryinsights/servier-acquires-cancer-biotech-symphoge-318490.html 0.6 2026-06-27T10:35:53+08:00 daily https://www.pharmasources.com/industryinsights/pharma-sales-to-increasingly-rely-on-vir-318491.html 0.6 2026-07-04T03:31:53+08:00 daily https://www.pharmasources.com/industryinsights/positive-results-from-initial-lopinavir--318492.html 0.6 2026-06-21T17:40:01+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-orphan-drug-designation-to-ph-318493.html 0.6 2026-06-20T21:07:49+08:00 daily https://www.pharmasources.com/industryinsights/limited-supply-of-antimalarial-drugs-may-318494.html 0.6 2026-07-26T03:35:57+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-convalescent-plasma-therapy-sho-318495.html 0.6 2026-06-21T12:21:05+08:00 daily https://www.pharmasources.com/industryinsights/montefiore-einstein-begin-coronavirus-tr-318496.html 0.6 2026-08-09T15:14:32+08:00 daily https://www.pharmasources.com/industryinsights/side-effects-seen-with-use-of-chloroquin-318497.html 0.6 2026-06-22T08:08:59+08:00 daily https://www.pharmasources.com/industryinsights/leica-biosystems-receives-fda-enforcemen-318498.html 0.6 2026-06-21T12:19:43+08:00 daily https://www.pharmasources.com/industryinsights/trxade-group-files-fda-emergency-use-aut-318499.html 0.6 2026-06-21T01:00:43+08:00 daily https://www.pharmasources.com/industryinsights/vanda-initiates-study-of-tradipitant-in--318500.html 0.6 2026-07-29T22:33:24+08:00 daily https://www.pharmasources.com/industryinsights/bd-biogx-announce-fda-emergency-use-auth-318501.html 0.6 2026-06-21T03:57:39+08:00 daily https://www.pharmasources.com/industryinsights/novartis-announces-plan-to-initiate-clin-318502.html 0.6 2026-04-22T04:44:53+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-announces-a-lead-vaccine-318503.html 0.6 2026-06-20T21:02:45+08:00 daily https://www.pharmasources.com/industryinsights/gsks-asthma-drug-nucala-meets-co-primary-318504.html 0.6 2026-08-06T10:31:07+08:00 daily https://www.pharmasources.com/industryinsights/shenogen-enters-into-an-exclusive-licens-318505.html 0.6 2026-08-13T04:59:05+08:00 daily https://www.pharmasources.com/industryinsights/oxford-biomedica-joins-consortium-for-pr-318506.html 0.6 2026-06-22T13:58:56+08:00 daily https://www.pharmasources.com/industryinsights/expanded-eu-approval-for-takedas-alunbri-318507.html 0.6 2026-07-05T05:16:40+08:00 daily https://www.pharmasources.com/industryinsights/vertex-foundation-donates-funds-to-suppo-318508.html 0.6 2026-06-21T10:56:17+08:00 daily https://www.pharmasources.com/industryinsights/roches-atezolizumab-receives-dcgi-approv-318509.html 0.6 2026-06-12T05:57:24+08:00 daily https://www.pharmasources.com/industryinsights/merck-awarded-second-us-patent-for-crisp-318510.html 0.6 2026-08-07T16:09:40+08:00 daily https://www.pharmasources.com/industryinsights/askbio-appoints-chief-business-officer-318511.html 0.6 2026-06-21T01:11:54+08:00 daily https://www.pharmasources.com/industryinsights/leading-biosciences-drug-may-help-critic-318512.html 0.6 2026-02-15T03:47:48+08:00 daily https://www.pharmasources.com/industryinsights/immunologix-expands-translational-scienc-318513.html 0.6 2026-06-20T18:57:32+08:00 daily https://www.pharmasources.com/industryinsights/roche-accelerates-phase-iii-actemra-tria-318514.html 0.6 2026-08-14T08:38:53+08:00 daily https://www.pharmasources.com/industryinsights/luminer-expands-mfg-capacity-in-lakewood-318515.html 0.6 2026-06-21T06:49:02+08:00 daily https://www.pharmasources.com/industryinsights/emerald-bioscience-joins-biosecurity-all-318516.html 0.6 2026-07-18T11:05:07+08:00 daily https://www.pharmasources.com/industryinsights/q-biomed-enters-78m-financial-restructur-318517.html 0.6 2026-06-21T20:54:37+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-zai-lab-enter-strategic-regn19-318518.html 0.6 2026-08-03T14:37:07+08:00 daily https://www.pharmasources.com/industryinsights/recipharms-erdosteine-to-be-tested-for-c-318519.html 0.6 2026-07-10T03:35:24+08:00 daily https://www.pharmasources.com/industryinsights/kedrion-developing-plasma-therapy-for-co-318520.html 0.6 2025-12-20T23:45:20+08:00 daily https://www.pharmasources.com/industryinsights/us-regulator-postpones-decision-on-roche-318521.html 0.6 2026-06-21T06:58:02+08:00 daily https://www.pharmasources.com/industryinsights/fda-authorises-emory-university-to-trial-318522.html 0.6 2026-06-21T13:05:29+08:00 daily https://www.pharmasources.com/industryinsights/university-of-bristol-imophoron-to-test--318523.html 0.6 2026-06-21T08:00:10+08:00 daily https://www.pharmasources.com/industryinsights/oxford-biomedica-joins-consortium-for-co-318524.html 0.6 2026-07-12T08:08:26+08:00 daily https://www.pharmasources.com/industryinsights/indian-immunologicals-griffith-universit-318525.html 0.6 2026-06-20T16:53:11+08:00 daily https://www.pharmasources.com/industryinsights/eu-authorities-agree-new-measures-to-sup-318526.html 0.6 2026-08-11T17:02:38+08:00 daily https://www.pharmasources.com/industryinsights/british-manufacturers-praise-uk-governme-318527.html 0.6 2026-06-21T03:57:00+08:00 daily https://www.pharmasources.com/industryinsights/75-percent-of-nanopharmaceuticals-are-be-318528.html 0.6 2026-06-22T04:02:46+08:00 daily https://www.pharmasources.com/industryinsights/gilead-aims-to-produce-one-million-remde-318529.html 0.6 2026-06-20T21:54:56+08:00 daily https://www.pharmasources.com/industryinsights/uk-and-europe-tackle-false-covid-19-medi-318530.html 0.6 2026-06-20T22:05:39+08:00 daily https://www.pharmasources.com/industryinsights/fda-coordinates-national-effort-to-devel-318531.html 0.6 2026-06-21T09:56:03+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-announces-ind-clearance-to-treat-c-318532.html 0.6 2026-02-26T06:12:52+08:00 daily https://www.pharmasources.com/industryinsights/fate-therapeutics-announces-cancer-immun-318533.html 0.6 2026-06-21T15:00:25+08:00 daily https://www.pharmasources.com/industryinsights/co-diagnostics-receives-fda-emergency-us-318534.html 0.6 2026-08-09T02:52:39+08:00 daily https://www.pharmasources.com/industryinsights/compugen-announces-first-patient-dosed-i-318535.html 0.6 2026-08-09T00:10:15+08:00 daily https://www.pharmasources.com/industryinsights/new-covid-19-at-home-test-with-social-di-318536.html 0.6 2026-08-08T21:48:57+08:00 daily https://www.pharmasources.com/industryinsights/potential-harms-of-chloroquine-hydroxych-318537.html 0.6 2026-08-08T14:04:50+08:00 daily https://www.pharmasources.com/industryinsights/montreal-heart-institute-nyu-grossman-sc-318538.html 0.6 2026-08-08T12:33:06+08:00 daily https://www.pharmasources.com/industryinsights/takeda-gets-eu-approval-for-alunbrig-in--318539.html 0.6 2026-08-06T23:54:00+08:00 daily https://www.pharmasources.com/industryinsights/alnylam-and-dicerna-form-rnai-therapeuti-318540.html 0.6 2026-08-06T23:48:26+08:00 daily https://www.pharmasources.com/industryinsights/cipla-receives-final-approval-for-generi-318541.html 0.6 2026-08-06T23:45:11+08:00 daily https://www.pharmasources.com/industryinsights/biosion-and-zhenge-biotech-sign-global-s-318542.html 0.6 2026-08-13T07:59:33+08:00 daily https://www.pharmasources.com/industryinsights/west-appoints-stewart-campbell-as-vice-p-318543.html 0.6 2026-08-06T23:32:35+08:00 daily https://www.pharmasources.com/industryinsights/granules-india-gets-usfda-approval-for-b-318544.html 0.6 2026-08-06T23:36:53+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-testing-collaboration-astrazene-318545.html 0.6 2026-08-07T05:05:24+08:00 daily https://www.pharmasources.com/industryinsights/emergent-signs-145m-covid-19-barda-deal-318546.html 0.6 2026-08-11T05:59:09+08:00 daily https://www.pharmasources.com/industryinsights/nih-launches-clinical-trial-of-hydroxych-318547.html 0.6 2026-06-21T09:55:23+08:00 daily https://www.pharmasources.com/industryinsights/genscript-probio-eutilex-enter-cancer-co-318548.html 0.6 2026-06-22T09:56:40+08:00 daily https://www.pharmasources.com/industryinsights/avacta-cytiva-collaborate-on-covid-19-ra-318549.html 0.6 2026-06-21T02:50:41+08:00 daily https://www.pharmasources.com/industryinsights/arrakis-roche-ink-multi-billion-dollar-d-318550.html 0.6 2026-08-04T08:35:09+08:00 daily https://www.pharmasources.com/industryinsights/australias-uq-covid-19-vaccine-candidate-318551.html 0.6 2026-06-21T08:53:01+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-begins-efforts-to-identify-a-318552.html 0.6 2026-06-22T07:01:50+08:00 daily https://www.pharmasources.com/industryinsights/oncoimmune-gets-approval-to-trial-cd24fc-318553.html 0.6 2026-06-21T08:07:00+08:00 daily https://www.pharmasources.com/industryinsights/coronavirus-disease-exposure-the-biggest-318554.html 0.6 2026-07-04T00:08:14+08:00 daily https://www.pharmasources.com/industryinsights/ec-approves-nilemdo-bempedoic-acid-for-l-318555.html 0.6 2026-08-08T23:13:50+08:00 daily https://www.pharmasources.com/industryinsights/fda-warns-company-selling-fraudulent-cov-318556.html 0.6 2026-08-09T21:52:15+08:00 daily https://www.pharmasources.com/industryinsights/researchers-develop-nanotechnology-to-cl-318557.html 0.6 2026-08-06T23:45:57+08:00 daily https://www.pharmasources.com/industryinsights/cell-free-cardiac-patch-could-improve-he-318558.html 0.6 2026-08-06T23:55:41+08:00 daily https://www.pharmasources.com/industryinsights/imperial-and-cpi-announce-partnership-to-318559.html 0.6 2026-08-07T13:17:31+08:00 daily https://www.pharmasources.com/industryinsights/akers-biosciences-premas-biotech-announc-318560.html 0.6 2026-08-08T01:01:29+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-encorafenib-cetuximab-combi-318561.html 0.6 2026-08-12T07:32:09+08:00 daily https://www.pharmasources.com/industryinsights/cytovia-macromoltek-to-develop-covid-19--318562.html 0.6 2026-08-09T01:19:48+08:00 daily https://www.pharmasources.com/industryinsights/luminex-receives-emergency-use-authoriza-318563.html 0.6 2026-08-09T02:52:39+08:00 daily https://www.pharmasources.com/industryinsights/kedrion-biopharma-to-develop-plasma-base-318564.html 0.6 2026-08-13T00:08:34+08:00 daily https://www.pharmasources.com/industryinsights/eicosis-ec5026-granted-fast-track-design-318565.html 0.6 2026-06-21T05:12:57+08:00 daily https://www.pharmasources.com/industryinsights/alnylam-seeks-fda-approval-for-lumasiran-318566.html 0.6 2026-06-20T21:59:38+08:00 daily https://www.pharmasources.com/industryinsights/avacta-and-cytiva-team-up-for-covid-19-318567.html 0.6 2026-08-07T05:18:12+08:00 daily https://www.pharmasources.com/industryinsights/tiziana-develops-delivery-tech-for-covid-318568.html 0.6 2026-06-24T21:39:12+08:00 daily https://www.pharmasources.com/industryinsights/circassia-pulls-plug-on-az-agreement-318569.html 0.6 2026-06-23T18:44:21+08:00 daily https://www.pharmasources.com/industryinsights/expanded-eu-approval-for-takedas-alunbri-318570.html 0.6 2026-07-21T16:16:52+08:00 daily https://www.pharmasources.com/industryinsights/alynlam-completes-eu-us-filings-for-luma-318571.html 0.6 2026-01-11T16:50:28+08:00 daily https://www.pharmasources.com/industryinsights/gilead-supersizes-remdesivir-trials-chan-318572.html 0.6 2026-06-21T05:01:43+08:00 daily https://www.pharmasources.com/industryinsights/vaccines-industry-witnesses-essential-de-318573.html 0.6 2026-07-22T17:11:57+08:00 daily https://www.pharmasources.com/industryinsights/study-reveals-immunotherapy-after-chemot-318574.html 0.6 2026-06-21T08:17:14+08:00 daily https://www.pharmasources.com/industryinsights/zydus-receives-tentative-nod-from-usfda--318575.html 0.6 2026-06-10T21:12:25+08:00 daily https://www.pharmasources.com/industryinsights/sesderma-laboratories-communicates-the-e-318576.html 0.6 2026-07-04T11:14:25+08:00 daily https://www.pharmasources.com/industryinsights/aurobindo-pharma-gets-us-fda-nod-for-gen-318577.html 0.6 2026-07-18T04:04:16+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-identifies-lead-coronavirus-drug--318578.html 0.6 2026-06-20T20:53:43+08:00 daily https://www.pharmasources.com/industryinsights/viriom-initiates-phase-2-clinical-study--318579.html 0.6 2026-06-21T23:59:42+08:00 daily https://www.pharmasources.com/industryinsights/affiliate-of-lupus-research-alliance-dev-318580.html 0.6 2026-08-13T21:03:31+08:00 daily https://www.pharmasources.com/industryinsights/ptc-announces-regulatory-update-on-risdi-318581.html 0.6 2026-08-14T15:07:21+08:00 daily https://www.pharmasources.com/industryinsights/avacta-cytiva-collaborating-on-covid-19--318582.html 0.6 2026-07-19T05:01:03+08:00 daily https://www.pharmasources.com/industryinsights/fda-authorizes-blood-purification-device-318583.html 0.6 2026-06-22T08:51:50+08:00 daily https://www.pharmasources.com/industryinsights/biocryst-starts-covid-19-trial-of-broad--318584.html 0.6 2026-06-22T14:35:13+08:00 daily https://www.pharmasources.com/industryinsights/harvard-spins-out-oral-biologic-tech-wit-318585.html 0.6 2026-07-19T21:42:35+08:00 daily https://www.pharmasources.com/industryinsights/takeda-csl-led-plasma-players-band-toget-318586.html 0.6 2026-06-22T17:11:02+08:00 daily https://www.pharmasources.com/industryinsights/how-a-seattle-genetics-cancer-drug-could-318587.html 0.6 2026-06-26T02:33:42+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-finds-covid-19-drug-candidate-plo-318588.html 0.6 2026-07-29T16:38:02+08:00 daily https://www.pharmasources.com/industryinsights/tango-therapeutics-banks-60m-to-push-syn-318589.html 0.6 2026-06-20T19:44:30+08:00 daily https://www.pharmasources.com/industryinsights/keros-upsizes-ipo-raising-96m-for-midpha-318590.html 0.6 2026-08-13T20:56:06+08:00 daily https://www.pharmasources.com/industryinsights/barda-funds-orasures-home-spit-test-for--318591.html 0.6 2026-06-22T06:35:43+08:00 daily https://www.pharmasources.com/industryinsights/chinas-cansino-bio-advances-covid-19-vac-318592.html 0.6 2026-02-15T09:32:43+08:00 daily https://www.pharmasources.com/industryinsights/immune-regulation-ltd-appoints-jonathan--318593.html 0.6 2026-06-21T08:03:00+08:00 daily https://www.pharmasources.com/industryinsights/china-strengthens-epidemic-control-along-318594.html 0.6 2026-08-07T12:08:20+08:00 daily https://www.pharmasources.com/industryinsights/latest-developments-in-epidemic-control--318595.html 0.6 2026-07-16T19:25:17+08:00 daily https://www.pharmasources.com/industryinsights/primary-level-medical-institutions-natio-318596.html 0.6 2026-06-21T10:01:11+08:00 daily https://www.pharmasources.com/industryinsights/the-state-councils-leading-group-for-dee-318597.html 0.6 2026-06-26T18:05:00+08:00 daily https://www.pharmasources.com/industryinsights/thailand-boi-approves-steps-to-ease-covi-318598.html 0.6 2026-07-09T08:43:24+08:00 daily https://www.pharmasources.com/industryinsights/gracell-to-present-the-first-in-human-un-318599.html 0.6 2026-07-02T17:02:48+08:00 daily https://www.pharmasources.com/industryinsights/emeterm-by-wat-medical-an-easy-solution--318600.html 0.6 2026-08-04T11:59:55+08:00 daily https://www.pharmasources.com/industryinsights/seegene-receives-health-canada-approval--318601.html 0.6 2026-06-21T02:00:41+08:00 daily https://www.pharmasources.com/industryinsights/ascletis-receives-ind-approval-for-its-h-318602.html 0.6 2026-07-06T20:20:51+08:00 daily https://www.pharmasources.com/industryinsights/pharmablock-opens-new-chemistry-and-engi-318603.html 0.6 2026-06-22T02:00:59+08:00 daily https://www.pharmasources.com/industryinsights/antengene-corporation-appoints-former-ce-318604.html 0.6 2026-06-23T13:35:56+08:00 daily https://www.pharmasources.com/industryinsights/cyient-receives-iso-13485-quality-certif-318605.html 0.6 2026-07-04T22:35:21+08:00 daily https://www.pharmasources.com/industryinsights/vista-eye-specialist-going-digital-to-ra-318606.html 0.6 2026-06-22T05:05:43+08:00 daily https://www.pharmasources.com/industryinsights/xcmg-exports-special-epidemic-prevention-318607.html 0.6 2026-06-21T06:06:49+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-and-vir-biotechnology--318608.html 0.6 2025-12-03T02:14:45+08:00 daily https://www.pharmasources.com/industryinsights/estonias-public-and-private-sectors-come-318609.html 0.6 2026-06-21T14:47:24+08:00 daily https://www.pharmasources.com/industryinsights/lasa-supergenerics-gets-fda-nod-for-prog-318610.html 0.6 2026-06-22T12:50:01+08:00 daily https://www.pharmasources.com/industryinsights/indian-pharma-industry-best-placed-to-pl-318611.html 0.6 2026-06-21T09:49:09+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-laboratories-announces-the-lau-318612.html 0.6 2026-06-20T20:52:38+08:00 daily https://www.pharmasources.com/industryinsights/computational-methodologies-can-be-effec-318613.html 0.6 2026-07-08T02:45:14+08:00 daily https://www.pharmasources.com/industryinsights/directing-evolution-to-identify-potentia-318614.html 0.6 2026-06-21T15:59:33+08:00 daily https://www.pharmasources.com/industryinsights/lupins-nagpur-facility-receives-eir-from-318615.html 0.6 2026-06-21T10:00:09+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2020041-318616.html 0.6 2026-06-22T00:06:52+08:00 daily https://www.pharmasources.com/industryinsights/lilly-niaid-to-study-baricitinib-in-covi-318617.html 0.6 2026-08-06T20:47:49+08:00 daily https://www.pharmasources.com/industryinsights/ispe-award-honors-new-pfizer-facility-318618.html 0.6 2026-08-06T20:08:59+08:00 daily https://www.pharmasources.com/industryinsights/seneca-completes-stem-cell-manufacturing-318619.html 0.6 2026-08-06T21:54:37+08:00 daily https://www.pharmasources.com/industryinsights/icon-signs-new-service-agreement-with-pf-318620.html 0.6 2026-08-06T22:08:03+08:00 daily https://www.pharmasources.com/industryinsights/cytel-launches-covid-19-clinical-trial-t-318621.html 0.6 2026-08-06T22:19:12+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-advances-battle-against-covid-19--318622.html 0.6 2026-08-06T22:53:24+08:00 daily https://www.pharmasources.com/industryinsights/labcorp-ciox-health-partner-to-create-co-318623.html 0.6 2026-08-06T23:37:18+08:00 daily https://www.pharmasources.com/industryinsights/ibio-expands-covid-19-vaccine-collaborat-318624.html 0.6 2026-08-07T02:41:10+08:00 daily https://www.pharmasources.com/industryinsights/theravance-responds-to-covid-19-pandemic-318625.html 0.6 2026-08-07T03:33:36+08:00 daily https://www.pharmasources.com/industryinsights/marken-expands-clinical-trial-services-318626.html 0.6 2026-08-07T03:55:32+08:00 daily https://www.pharmasources.com/industryinsights/immunomic-partners-epivax-and-pharmajet--318627.html 0.6 2026-08-07T04:04:02+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-astrazenecas-koselugo-to-tr-318628.html 0.6 2026-08-07T04:22:03+08:00 daily https://www.pharmasources.com/industryinsights/vir-selects-samsung-biologics-to-produce-318629.html 0.6 2026-08-09T00:21:08+08:00 daily https://www.pharmasources.com/industryinsights/biohaven-to-proceed-with-intranasal-vaze-318630.html 0.6 2026-08-07T04:36:43+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-suzhou-successfully-passe-318631.html 0.6 2026-08-08T04:30:40+08:00 daily https://www.pharmasources.com/industryinsights/mylan-updates-covid-19-response-318632.html 0.6 2026-06-20T23:43:34+08:00 daily https://www.pharmasources.com/industryinsights/fulcrum-completes-ind-enabling-safety-st-318633.html 0.6 2026-06-20T19:06:42+08:00 daily https://www.pharmasources.com/industryinsights/fast-tracks-testing-of-covid-19-therapie-318634.html 0.6 2026-08-12T10:06:33+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-merck-secure-fda-nod-for-kos-318635.html 0.6 2026-07-28T16:52:49+08:00 daily https://www.pharmasources.com/industryinsights/acceleron-receives-fda-breakthrough-ther-318636.html 0.6 2026-07-04T14:21:55+08:00 daily https://www.pharmasources.com/industryinsights/oncoimmune-receives-fda-approval-for-cov-318637.html 0.6 2026-06-26T20:29:41+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-pfizers-braftovi-plus-cetux-318638.html 0.6 2026-08-05T12:35:21+08:00 daily https://www.pharmasources.com/industryinsights/lilly-to-test-olumiant-ly3127804-against-318639.html 0.6 2026-06-22T08:00:49+08:00 daily https://www.pharmasources.com/industryinsights/nucleus-networks-10-step-guide-to-conduc-318640.html 0.6 2026-07-16T10:00:54+08:00 daily https://www.pharmasources.com/industryinsights/interlink-electronics-quadruples-product-318641.html 0.6 2026-07-07T23:14:49+08:00 daily https://www.pharmasources.com/industryinsights/revolutionary-machine-learning-company-i-318642.html 0.6 2026-06-22T21:29:44+08:00 daily https://www.pharmasources.com/industryinsights/merck-supports-jenner-institute-to-reach-318643.html 0.6 2026-06-21T01:56:37+08:00 daily https://www.pharmasources.com/industryinsights/medit-receives-isoiec-27001-certificatio-318644.html 0.6 2026-06-21T02:58:46+08:00 daily https://www.pharmasources.com/industryinsights/ligandal-is-developing-potential-antidot-318645.html 0.6 2026-04-05T22:50:42+08:00 daily https://www.pharmasources.com/industryinsights/great-minds-from-medtech-gather-at-medte-318647.html 0.6 2026-06-20T14:41:58+08:00 daily https://www.pharmasources.com/industryinsights/dinova-medtech-announces-vivek-y-reddy-m-318648.html 0.6 2026-06-21T20:14:57+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-suzhou-successfully-passe-318649.html 0.6 2026-07-20T19:57:53+08:00 daily https://www.pharmasources.com/industryinsights/vuno-medr-fundus-aitm-receives-mfds-regu-318650.html 0.6 2026-06-21T03:09:52+08:00 daily https://www.pharmasources.com/industryinsights/aitrics-and-cleveland-clinic-collaborate-318651.html 0.6 2026-06-20T17:15:33+08:00 daily https://www.pharmasources.com/industryinsights/orgenesis-to-acquire-tamir-bio-assets-318652.html 0.6 2026-06-20T19:50:54+08:00 daily https://www.pharmasources.com/industryinsights/legacy-pharmaceutical-packaging-expands-318653.html 0.6 2026-06-20T20:20:53+08:00 daily https://www.pharmasources.com/industryinsights/crownbio-appoints-ceo-318654.html 0.6 2026-06-23T09:23:43+08:00 daily https://www.pharmasources.com/industryinsights/aikido-pharma-inks-exclusive-license-for-318655.html 0.6 2026-07-16T00:18:52+08:00 daily https://www.pharmasources.com/industryinsights/jenner-institute-milliporesigma-to-scale-318656.html 0.6 2026-06-21T20:28:49+08:00 daily https://www.pharmasources.com/industryinsights/lupins-mandideep-unit-ii-facility-receiv-318657.html 0.6 2026-07-20T11:54:41+08:00 daily https://www.pharmasources.com/industryinsights/novartis-digital-initiatives-to-create-a-318658.html 0.6 2026-06-20T15:13:20+08:00 daily https://www.pharmasources.com/industryinsights/will-the-industry-sell-covid-19-meds-at--318659.html 0.6 2026-07-04T06:33:10+08:00 daily https://www.pharmasources.com/industryinsights/alnylams-gene-silencing-efforts-get-2-bi-318660.html 0.6 2026-07-09T06:19:04+08:00 daily https://www.pharmasources.com/industryinsights/biocon-and-mylan-launch-fulphila-biosimi-318661.html 0.6 2026-08-10T20:01:05+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-gsk-partner-to-develop-covid--318662.html 0.6 2026-06-20T19:57:51+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-to-trial-calquence-to-treat--318663.html 0.6 2026-07-17T02:06:27+08:00 daily https://www.pharmasources.com/industryinsights/celltrion-identifies-antibody-candidates-318664.html 0.6 2026-06-22T10:51:21+08:00 daily https://www.pharmasources.com/industryinsights/us-researchers-to-study-stem-cell-therap-318665.html 0.6 2026-08-07T00:07:03+08:00 daily https://www.pharmasources.com/industryinsights/ema-task-force-established-to-co-ordinat-318666.html 0.6 2026-08-08T02:25:32+08:00 daily https://www.pharmasources.com/industryinsights/technique-could-enable-biomanufacturing--318667.html 0.6 2026-08-12T10:43:30+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-cytosorb-emergency-use-author-318668.html 0.6 2026-06-21T05:14:53+08:00 daily https://www.pharmasources.com/industryinsights/7-hills-pharma-announces-fda-clearance-o-318669.html 0.6 2026-06-20T20:55:42+08:00 daily https://www.pharmasources.com/industryinsights/lilly-begins-clinical-testing-of-therapi-318670.html 0.6 2026-06-21T08:59:01+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-selumetinib-for-neurofibrom-318671.html 0.6 2026-06-20T16:01:21+08:00 daily https://www.pharmasources.com/industryinsights/bausch-health-initiates-virazole-study-i-318672.html 0.6 2026-06-21T10:02:18+08:00 daily https://www.pharmasources.com/industryinsights/emd-serono-pfizer-receive-breakthrough-t-318673.html 0.6 2026-06-25T10:27:49+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-initiates-calavi-clinical-tr-318674.html 0.6 2026-07-01T12:48:37+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-to-donate-100-million-doses-of-hy-318675.html 0.6 2026-03-21T21:18:53+08:00 daily https://www.pharmasources.com/industryinsights/arrowhead-pharmaceuticals-files-for-regu-318676.html 0.6 2026-06-12T04:56:36+08:00 daily https://www.pharmasources.com/industryinsights/enzychem-lifesciences-announces-filing-o-318677.html 0.6 2026-06-21T06:19:09+08:00 daily https://www.pharmasources.com/industryinsights/genetic-alliance-uk-launches-covid-19-ad-318678.html 0.6 2026-06-20T17:59:20+08:00 daily https://www.pharmasources.com/industryinsights/smc-accepts-four-medicines-for-nhs-use-318679.html 0.6 2026-06-21T05:47:37+08:00 daily https://www.pharmasources.com/industryinsights/govt-streams-14bn-into-public-services-i-318680.html 0.6 2026-07-13T13:13:32+08:00 daily https://www.pharmasources.com/industryinsights/europlx-73-vienna-pharma-partnering-conf-318681.html 0.6 2026-07-09T12:04:38+08:00 daily https://www.pharmasources.com/industryinsights/halix-enters-collaboration-with-the-univ-318682.html 0.6 2026-07-04T21:35:21+08:00 daily https://www.pharmasources.com/industryinsights/one-world-together-at-home-global-specia-318683.html 0.6 2026-07-09T05:03:52+08:00 daily https://www.pharmasources.com/industryinsights/undp-procures-urgent-medical-supplies-fo-318684.html 0.6 2026-07-03T07:18:42+08:00 daily https://www.pharmasources.com/industryinsights/dynata-introduces-interactive-global-cov-318685.html 0.6 2026-06-20T14:48:12+08:00 daily https://www.pharmasources.com/industryinsights/it-tech-packaging-inc-plans-a-production-318686.html 0.6 2026-07-16T10:37:59+08:00 daily https://www.pharmasources.com/industryinsights/china-pharmaceutical-holdings-co-ltd-add-318687.html 0.6 2026-08-11T10:24:11+08:00 daily https://www.pharmasources.com/industryinsights/pascale-cossart-sven-hagstrmer-and-thoma-318688.html 0.6 2026-08-09T21:10:25+08:00 daily https://www.pharmasources.com/industryinsights/ansun-biopharma-enrolls-first-patient-in-318689.html 0.6 2026-08-09T21:54:20+08:00 daily https://www.pharmasources.com/industryinsights/synapse-biomedical-receives-fda-emergenc-318690.html 0.6 2026-08-07T21:27:21+08:00 daily https://www.pharmasources.com/industryinsights/think-city-clear-skies-as-nitrogen-dioxi-318691.html 0.6 2026-08-10T01:00:48+08:00 daily https://www.pharmasources.com/industryinsights/australia-to-test-covid-19-vaccine-318692.html 0.6 2026-06-21T00:00:40+08:00 daily https://www.pharmasources.com/industryinsights/orthos-total-antibody-test-for-covid-19--318693.html 0.6 2026-08-09T23:45:04+08:00 daily https://www.pharmasources.com/industryinsights/lianhua-qingwen-capsule-granule-was-appr-318694.html 0.6 2026-06-21T01:02:46+08:00 daily https://www.pharmasources.com/industryinsights/iceland-provides-a-picture-of-the-early--318695.html 0.6 2026-06-21T02:58:39+08:00 daily https://www.pharmasources.com/industryinsights/updates---china-pharma-holdings-inc-repo-318696.html 0.6 2026-07-23T03:56:25+08:00 daily https://www.pharmasources.com/industryinsights/3d-printed-activat3d-copper-proven-to-ki-318697.html 0.6 2026-08-07T04:57:53+08:00 daily https://www.pharmasources.com/industryinsights/new-clinicall-communicator-app-supports--318698.html 0.6 2026-08-07T04:52:50+08:00 daily https://www.pharmasources.com/industryinsights/chromatic-technologies-scientists-join-f-318699.html 0.6 2026-08-07T04:27:57+08:00 daily https://www.pharmasources.com/industryinsights/zenfold-ventures-takes-equity-stake-in-e-318700.html 0.6 2026-08-07T04:22:20+08:00 daily https://www.pharmasources.com/industryinsights/keystone-expands-capacity-for-vial-syrin-318701.html 0.6 2026-08-07T04:07:03+08:00 daily https://www.pharmasources.com/industryinsights/seikagaku-acquires-dalton-pharma-service-318702.html 0.6 2026-08-08T20:10:02+08:00 daily https://www.pharmasources.com/industryinsights/pharmablock-opens-new-facility-in-zhejia-318703.html 0.6 2026-08-06T22:44:26+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-boosts-production-of-avigan-tab-318704.html 0.6 2026-08-06T22:49:58+08:00 daily https://www.pharmasources.com/industryinsights/medpharm-helps-fight-covid-19-outbreak-318705.html 0.6 2026-08-06T23:33:35+08:00 daily https://www.pharmasources.com/industryinsights/abbott-launches-third-covid-19-test-318706.html 0.6 2026-08-07T06:10:09+08:00 daily https://www.pharmasources.com/industryinsights/centogene-opening-lab-to-increase-covid--318707.html 0.6 2026-08-11T18:36:34+08:00 daily https://www.pharmasources.com/industryinsights/applied-dna-supplies-covid-19-vaccine-ca-318708.html 0.6 2026-07-28T23:31:36+08:00 daily https://www.pharmasources.com/industryinsights/insilico-and-boehringer-to-use-ai-for-dr-318709.html 0.6 2026-07-28T20:41:07+08:00 daily https://www.pharmasources.com/industryinsights/nantkwest-and-immunitybio-work-on-covid--318710.html 0.6 2026-08-07T15:23:40+08:00 daily https://www.pharmasources.com/industryinsights/environmental-monitoring-breaches-at-fac-318711.html 0.6 2026-08-11T15:25:58+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-emergency-use-authorisation-t-318712.html 0.6 2026-08-09T09:54:11+08:00 daily https://www.pharmasources.com/industryinsights/micro-biohybrid-robots-hold-potential-fo-318713.html 0.6 2026-06-21T03:22:31+08:00 daily https://www.pharmasources.com/industryinsights/active-air-sampler-market-to-value-1307--318714.html 0.6 2026-07-09T03:13:49+08:00 daily https://www.pharmasources.com/industryinsights/bd-announces-second-fda-emergency-use-au-318715.html 0.6 2026-06-08T22:01:21+08:00 daily https://www.pharmasources.com/industryinsights/cellectis-appoints-chief-medical-officer-318716.html 0.6 2026-06-21T06:10:51+08:00 daily https://www.pharmasources.com/industryinsights/xylyx-bio-offers-advanced-lung-models-to-318717.html 0.6 2026-06-21T08:06:07+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-initiates-calquence-clinical-318718.html 0.6 2026-06-21T00:56:50+08:00 daily https://www.pharmasources.com/industryinsights/samsung-bioepis-merck-launch-trastuzumab-318719.html 0.6 2026-07-21T07:46:20+08:00 daily https://www.pharmasources.com/industryinsights/hope-biosciences-gets-fda-nod-for-phase--318720.html 0.6 2026-06-08T21:56:33+08:00 daily https://www.pharmasources.com/industryinsights/ridgeback-biotherapeutics-announces-mhra-318721.html 0.6 2026-08-07T23:49:35+08:00 daily https://www.pharmasources.com/industryinsights/healx-links-with-ctf-to-develop-neurofib-318722.html 0.6 2026-06-21T02:58:58+08:00 daily https://www.pharmasources.com/industryinsights/new-transdermal-hrt-spray-rolled-out-in--318723.html 0.6 2026-06-22T07:04:51+08:00 daily https://www.pharmasources.com/industryinsights/india-agrees-to-sell-hydroxychloroquine--318724.html 0.6 2026-06-21T08:01:04+08:00 daily https://www.pharmasources.com/industryinsights/a-dive-into-covid-19-treatment-avenues-318725.html 0.6 2026-06-22T21:35:12+08:00 daily https://www.pharmasources.com/industryinsights/china-approves-two-experimental-coronavi-318726.html 0.6 2026-06-21T00:18:57+08:00 daily https://www.pharmasources.com/industryinsights/mdu-resources-donates-500000-to-support--318727.html 0.6 2026-06-20T23:19:08+08:00 daily https://www.pharmasources.com/industryinsights/heritage-christian-services-launches-cov-318728.html 0.6 2026-06-20T23:58:39+08:00 daily https://www.pharmasources.com/industryinsights/roivant-doses-first-patient-in-pivotal-b-318729.html 0.6 2026-06-22T12:54:06+08:00 daily https://www.pharmasources.com/industryinsights/ncoa-teams-with-airbnb-to-address-social-318730.html 0.6 2026-08-09T08:02:03+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-first-therapy-for-treatm-318731.html 0.6 2026-08-12T13:17:40+08:00 daily https://www.pharmasources.com/industryinsights/curadev-and-bayer-agreement-shows-switch-318732.html 0.6 2026-06-20T15:59:12+08:00 daily https://www.pharmasources.com/industryinsights/biocon-biologics-gets-eir-from-us-fda-fo-318733.html 0.6 2026-06-20T20:00:04+08:00 daily https://www.pharmasources.com/industryinsights/acg-continues-production-to-meet-mission-318734.html 0.6 2026-07-18T03:33:50+08:00 daily https://www.pharmasources.com/industryinsights/bmgf-expands-covid-19-commitment-to-more-318735.html 0.6 2026-06-26T06:31:39+08:00 daily https://www.pharmasources.com/industryinsights/halix-and-university-of-oxford-collabora-318736.html 0.6 2026-07-19T23:48:46+08:00 daily https://www.pharmasources.com/industryinsights/octapharma-supports-new-covid-19-trial-318737.html 0.6 2026-08-09T23:31:40+08:00 daily https://www.pharmasources.com/industryinsights/ppds-aes-biz-launches-patient-transfer-p-318738.html 0.6 2026-08-07T17:12:10+08:00 daily https://www.pharmasources.com/industryinsights/eurofins-genomics-launches-sars-cov-2-pl-318739.html 0.6 2026-06-23T06:05:58+08:00 daily https://www.pharmasources.com/industryinsights/soligenix-licenses-btgs-covaccine-ht-for-318740.html 0.6 2026-08-10T15:13:57+08:00 daily https://www.pharmasources.com/industryinsights/regenerons-bla-for-ebola-cocktail-gets-p-318741.html 0.6 2026-06-26T01:28:41+08:00 daily https://www.pharmasources.com/industryinsights/mayne-pharma-submits-nda-to-fda-for-e4dr-318742.html 0.6 2026-07-01T16:52:07+08:00 daily https://www.pharmasources.com/industryinsights/smc-accepts-janssens-ulcerative-colitis--318743.html 0.6 2026-06-23T04:09:07+08:00 daily https://www.pharmasources.com/industryinsights/high-concern-over-the-spread-of-covid-19-318744.html 0.6 2026-06-20T16:44:19+08:00 daily https://www.pharmasources.com/industryinsights/tscan-and-novartis-partner-to-develop-ca-318745.html 0.6 2026-06-27T00:46:20+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-boosts-production-capacity-for--318746.html 0.6 2026-06-20T14:52:03+08:00 daily https://www.pharmasources.com/industryinsights/are-companies-optimistic-about-growth-pr-318747.html 0.6 2026-06-22T00:56:49+08:00 daily https://www.pharmasources.com/industryinsights/eli-lillys-covid-19-therapies-to-enter-c-318748.html 0.6 2026-07-19T09:16:35+08:00 daily https://www.pharmasources.com/industryinsights/germany-to-lead-aseptic-sampling-market--318749.html 0.6 2026-06-22T01:46:27+08:00 daily https://www.pharmasources.com/industryinsights/novel-cannabinoid-formula-could-be-used--318750.html 0.6 2026-06-20T19:04:36+08:00 daily https://www.pharmasources.com/industryinsights/clinical-trials-for-covid-19-treatments--318751.html 0.6 2026-08-06T11:57:17+08:00 daily https://www.pharmasources.com/industryinsights/roivant-doses-first-patient-in-gimsiluma-318752.html 0.6 2026-06-21T05:07:46+08:00 daily https://www.pharmasources.com/industryinsights/milliporesigma-supports-jenner-institute-318753.html 0.6 2026-06-21T00:13:52+08:00 daily https://www.pharmasources.com/industryinsights/provention-bio-initiates-rolling-submiss-318754.html 0.6 2026-06-21T00:15:49+08:00 daily https://www.pharmasources.com/industryinsights/mylan-board-announces-executive-chairman-318755.html 0.6 2026-08-05T20:52:34+08:00 daily https://www.pharmasources.com/industryinsights/fda-encourages-recovered-patients-to-don-318756.html 0.6 2026-02-28T23:27:41+08:00 daily https://www.pharmasources.com/industryinsights/depression-anxiety-may-be-side-effects-a-318757.html 0.6 2026-08-07T20:37:35+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-steps-up-effort-wit-318758.html 0.6 2026-08-08T22:10:08+08:00 daily https://www.pharmasources.com/industryinsights/your-nose-may-know-more-when-it-comes-to-318759.html 0.6 2026-08-07T14:08:50+08:00 daily https://www.pharmasources.com/industryinsights/sinovac-biotech-to-move-ahead-with-covid-318760.html 0.6 2026-08-08T23:15:45+08:00 daily https://www.pharmasources.com/industryinsights/intensity-therapeutics-signs-clinical-co-318761.html 0.6 2026-06-27T22:42:06+08:00 daily https://www.pharmasources.com/industryinsights/alnylam-receives-fast-track-designation--318762.html 0.6 2026-06-20T22:49:47+08:00 daily https://www.pharmasources.com/industryinsights/researchers-call-for-greater-focus-on-me-318763.html 0.6 2026-07-01T17:27:45+08:00 daily https://www.pharmasources.com/industryinsights/edinburgh-uni-researchers-focus-on-drug--318764.html 0.6 2026-06-20T23:00:42+08:00 daily https://www.pharmasources.com/industryinsights/sir-andrew-witty-to-co-lead-who-covid-19-318765.html 0.6 2026-07-02T17:29:00+08:00 daily https://www.pharmasources.com/industryinsights/aid-groups-ask-uk-gov-to-stop-pharma-pro-318766.html 0.6 2026-06-21T10:43:58+08:00 daily https://www.pharmasources.com/industryinsights/the-old-tcm-to-be-added-the-usage-agains-318767.html 0.6 2026-08-05T04:13:46+08:00 daily https://www.pharmasources.com/industryinsights/wockhardt-receives-us-fda-qualified-infe-318768.html 0.6 2026-07-16T00:40:41+08:00 daily https://www.pharmasources.com/industryinsights/cdsco-instructs-pharma-industry-associat-318769.html 0.6 2026-06-20T18:57:37+08:00 daily https://www.pharmasources.com/industryinsights/cdsco-allows-import-of-covid-19-drugs-wi-318770.html 0.6 2026-07-23T11:01:57+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-pandemic-interferes-with-treatm-318771.html 0.6 2026-06-21T05:52:42+08:00 daily https://www.pharmasources.com/industryinsights/institutional-investors-tell-big-pharma--318772.html 0.6 2026-07-21T11:33:06+08:00 daily https://www.pharmasources.com/industryinsights/cdri-to-sequence-virus-strains-obtained--318773.html 0.6 2026-08-05T11:01:57+08:00 daily https://www.pharmasources.com/industryinsights/chandigarh-based-imtech-to-begin-genome--318774.html 0.6 2026-06-21T17:59:57+08:00 daily https://www.pharmasources.com/industryinsights/no-traces-of-covid-19-virus-found-in-the-318775.html 0.6 2026-07-03T19:24:12+08:00 daily https://www.pharmasources.com/industryinsights/sobi-releases-new-haemophilia-treatment--318776.html 0.6 2026-06-21T06:52:51+08:00 daily https://www.pharmasources.com/industryinsights/us-barda-commits-up-to-483m-for-moderna--318777.html 0.6 2026-06-23T01:26:36+08:00 daily https://www.pharmasources.com/industryinsights/university-of-waterloo-to-develop-nasal--318778.html 0.6 2026-07-08T15:07:39+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-offers-free-90-day-insulin--318779.html 0.6 2026-07-30T16:06:07+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-generic-albuterol-sul-318780.html 0.6 2026-07-28T12:54:02+08:00 daily https://www.pharmasources.com/industryinsights/open-letter-calls-for-uk-government-to-s-318781.html 0.6 2026-06-21T22:27:54+08:00 daily https://www.pharmasources.com/industryinsights/mhra-issues-medicines-defect-information-318782.html 0.6 2026-07-16T07:04:50+08:00 daily https://www.pharmasources.com/industryinsights/production-of-avigan-tablet-favipiravir--318783.html 0.6 2026-07-15T00:19:15+08:00 daily https://www.pharmasources.com/industryinsights/fda-announces-temporary-policy-for-compo-318784.html 0.6 2026-06-20T21:16:52+08:00 daily https://www.pharmasources.com/industryinsights/mindmed-initiates-dosing-in-human-safety-318785.html 0.6 2026-06-21T00:17:03+08:00 daily https://www.pharmasources.com/industryinsights/pressure-biosciences-redshiftbio-combine-318786.html 0.6 2026-06-22T06:06:07+08:00 daily https://www.pharmasources.com/industryinsights/international-laboratories-issues-recall-318787.html 0.6 2026-08-03T00:15:53+08:00 daily https://www.pharmasources.com/industryinsights/cirrusdx-receives-emergency-use-authoriz-318788.html 0.6 2026-06-23T12:02:48+08:00 daily https://www.pharmasources.com/industryinsights/quansys-biosciences-releases-multiplex-h-318789.html 0.6 2026-06-22T07:41:35+08:00 daily https://www.pharmasources.com/industryinsights/halix-enters-covid-19-tie-up-with-univer-318790.html 0.6 2026-08-10T12:15:07+08:00 daily https://www.pharmasources.com/industryinsights/azurrx-delpharm-enter-manufacturing-agre-318791.html 0.6 2026-07-23T07:36:56+08:00 daily https://www.pharmasources.com/industryinsights/evotec-leon-nanodrugs-enter-nanomedicine-318792.html 0.6 2026-08-07T09:07:54+08:00 daily https://www.pharmasources.com/industryinsights/eagle-pharmas-drug-shows-antiviral-activ-318793.html 0.6 2026-06-20T16:00:17+08:00 daily https://www.pharmasources.com/industryinsights/merck-announces-us-launch-of-ontruzant-a-318794.html 0.6 2026-06-21T17:59:43+08:00 daily https://www.pharmasources.com/industryinsights/forma-therapeutics-receives-fda-orphan-d-318795.html 0.6 2026-06-22T12:41:39+08:00 daily https://www.pharmasources.com/industryinsights/novartis-tscan-collaborate-to-develop-tc-318796.html 0.6 2026-06-21T23:51:51+08:00 daily https://www.pharmasources.com/industryinsights/abl-supports-fillfinish-of-covid-19-vacc-318797.html 0.6 2026-07-06T19:51:54+08:00 daily https://www.pharmasources.com/industryinsights/tracelink-launches-digital-supply-chain--318798.html 0.6 2026-06-20T21:35:12+08:00 daily https://www.pharmasources.com/industryinsights/us-clears-first-targeted-treatment-for-c-318799.html 0.6 2026-06-30T03:14:30+08:00 daily https://www.pharmasources.com/industryinsights/ema-confirms-skin-cancer-risk-with-leos--318800.html 0.6 2026-06-20T19:50:21+08:00 daily https://www.pharmasources.com/industryinsights/government-to-extend-coronavirus-testing-318801.html 0.6 2026-08-13T16:16:01+08:00 daily https://www.pharmasources.com/industryinsights/nationwide-launch-for-gp-based-trial-of--318802.html 0.6 2026-06-22T05:00:38+08:00 daily https://www.pharmasources.com/industryinsights/workflow-optimisation-is-a-key-priority--318803.html 0.6 2026-06-21T09:10:08+08:00 daily https://www.pharmasources.com/industryinsights/cphi-and-p-mec-china-to-be-held-in-decem-318804.html 0.6 2026-06-24T22:52:22+08:00 daily https://www.pharmasources.com/industryinsights/giving-highest-priority-to-ensure-uninte-318805.html 0.6 2026-06-23T02:55:51+08:00 daily https://www.pharmasources.com/industryinsights/clinical-trials-on-zinc-usage-initiated--318806.html 0.6 2026-08-07T23:42:38+08:00 daily https://www.pharmasources.com/industryinsights/while-the-market-is-bleeding-pharma-sect-318807.html 0.6 2026-08-14T10:55:28+08:00 daily https://www.pharmasources.com/industryinsights/dbt-and-birac-recommend-16-proposals-for-318808.html 0.6 2026-06-21T14:51:18+08:00 daily https://www.pharmasources.com/industryinsights/best-sellers-among-the-20-chinese-produc-318809.html 0.6 2026-07-18T18:01:42+08:00 daily https://www.pharmasources.com/industryinsights/cphi-p-mec-china-moves-to-december-date--318810.html 0.6 2026-07-19T10:08:00+08:00 daily https://www.pharmasources.com/industryinsights/hdma-highlights-concerns-of-pharma-indus-318811.html 0.6 2025-11-17T06:19:01+08:00 daily https://www.pharmasources.com/industryinsights/strides-receives-usfda-approval-for-fluc-318812.html 0.6 2026-06-22T01:12:59+08:00 daily https://www.pharmasources.com/industryinsights/government-forms-high-level-task-force-f-318813.html 0.6 2026-07-08T02:09:55+08:00 daily https://www.pharmasources.com/industryinsights/a-prospect-of-ranitidine-market-changes--318814.html 0.6 2026-07-21T10:59:24+08:00 daily https://www.pharmasources.com/industryinsights/advarra-acquires-irb-company-inc-318815.html 0.6 2026-06-22T15:42:44+08:00 daily https://www.pharmasources.com/industryinsights/oral-anti-viral-for-covid-19-filed-under-318816.html 0.6 2026-06-29T17:06:30+08:00 daily https://www.pharmasources.com/industryinsights/4d-pharma-begins-phase-ii-covid-19-study-318817.html 0.6 2026-06-21T03:07:43+08:00 daily https://www.pharmasources.com/industryinsights/fda-covid-19-update-318818.html 0.6 2026-06-21T12:05:14+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-update-serological-test-efforts-318819.html 0.6 2026-03-05T06:51:55+08:00 daily https://www.pharmasources.com/industryinsights/wavelength-ups-api-production-for-essent-318820.html 0.6 2026-06-20T21:19:06+08:00 daily https://www.pharmasources.com/industryinsights/gileads-remdesivir-prevents-covid-19-pro-318821.html 0.6 2026-07-01T09:15:41+08:00 daily https://www.pharmasources.com/industryinsights/novartis-expands-ophthalmology-pipeline--318822.html 0.6 2026-07-03T23:36:14+08:00 daily https://www.pharmasources.com/industryinsights/us-nih-to-launch-international-alliance--318823.html 0.6 2026-06-21T07:01:54+08:00 daily https://www.pharmasources.com/industryinsights/incyte-begins-phase-iii-trial-of-ruxolit-318824.html 0.6 2026-06-20T14:57:09+08:00 daily https://www.pharmasources.com/industryinsights/uk-national-priority-covid-19-trial-now--318825.html 0.6 2026-06-20T18:01:21+08:00 daily https://www.pharmasources.com/industryinsights/modified-liposome-nanoparticles-could-be-318826.html 0.6 2026-06-21T00:05:38+08:00 daily https://www.pharmasources.com/industryinsights/ind-submitted-for-opaganib-potential-cov-318827.html 0.6 2026-08-09T14:28:24+08:00 daily https://www.pharmasources.com/industryinsights/china-disclosed-research-data-of-picovac-318828.html 0.6 2026-07-22T20:37:43+08:00 daily https://www.pharmasources.com/industryinsights/sir-andrew-whitty-to-co-lead-who-covid-1-318829.html 0.6 2026-08-06T23:45:37+08:00 daily https://www.pharmasources.com/industryinsights/amneal-recalls-three-nizatidine-lots-due-318830.html 0.6 2026-08-06T23:37:14+08:00 daily https://www.pharmasources.com/industryinsights/pdis-infection-prevention-products-to-be-318831.html 0.6 2026-08-06T23:32:35+08:00 daily https://www.pharmasources.com/industryinsights/stero-biotechs-announces-cbd-steroid-tre-318832.html 0.6 2026-08-06T22:53:32+08:00 daily https://www.pharmasources.com/industryinsights/rutgers-coronavirus-saliva-test-receives-318833.html 0.6 2026-08-06T23:32:23+08:00 daily https://www.pharmasources.com/industryinsights/fresenius-kabi-issues-recall-of-13-lots--318834.html 0.6 2026-08-07T13:15:43+08:00 daily https://www.pharmasources.com/industryinsights/novartis-to-sponsor-trial-of-hydroxychlo-318835.html 0.6 2026-08-09T20:06:15+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-targeted-treatment-fo-318836.html 0.6 2026-08-10T15:18:06+08:00 daily https://www.pharmasources.com/industryinsights/gattefoss-takes-measures-continues-opera-318837.html 0.6 2026-06-20T16:22:06+08:00 daily https://www.pharmasources.com/industryinsights/aptar-requests-eua-for-n95-filtering-fac-318838.html 0.6 2026-06-21T00:56:41+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-treatment-option-for-her2-p-318839.html 0.6 2026-06-21T10:56:05+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2020042-318840.html 0.6 2026-08-07T01:27:54+08:00 daily https://www.pharmasources.com/industryinsights/kidneyintelx-to-predict-major-adverse-ki-318841.html 0.6 2026-08-13T02:09:58+08:00 daily https://www.pharmasources.com/industryinsights/avet-issues-voluntary-recall-of-tetracyc-318842.html 0.6 2026-06-27T04:45:58+08:00 daily https://www.pharmasources.com/industryinsights/all-efforts-are-being-made-to-improve-av-318843.html 0.6 2026-07-03T05:34:33+08:00 daily https://www.pharmasources.com/industryinsights/viravaxx-ag-and-medical-university-of-vi-318844.html 0.6 2026-06-21T03:08:45+08:00 daily https://www.pharmasources.com/industryinsights/pharmastory-aurobindo-pharma-gets-vai-cl-318845.html 0.6 2026-03-24T22:16:33+08:00 daily https://www.pharmasources.com/industryinsights/pills-for-the-good-health-of-pharma-comp-318846.html 0.6 2026-07-20T07:04:11+08:00 daily https://www.pharmasources.com/industryinsights/cipla-donates-rs-25-crores-for-covid-19--318847.html 0.6 2026-06-21T03:17:17+08:00 daily https://www.pharmasources.com/industryinsights/pharmacists-to-maintain-common-flu-sympt-318848.html 0.6 2026-06-24T03:53:37+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-says-opdivo-performs-well--318849.html 0.6 2026-06-21T01:01:43+08:00 daily https://www.pharmasources.com/industryinsights/novartis-to-test-efficacy-of-old-malaria-318850.html 0.6 2026-06-21T12:01:57+08:00 daily https://www.pharmasources.com/industryinsights/csir-backs-development-of-a-drug-for-pat-318851.html 0.6 2026-06-09T21:39:06+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-gives-an-opportunity-to-rethink-318852.html 0.6 2026-08-08T19:49:25+08:00 daily https://www.pharmasources.com/industryinsights/alembic-gets-us-fda-nod-for-generic-opht-318853.html 0.6 2026-08-07T12:42:46+08:00 daily https://www.pharmasources.com/industryinsights/indias-mohfw-seeks-export-ban-of-anti-tb-318854.html 0.6 2026-08-08T20:05:58+08:00 daily https://www.pharmasources.com/industryinsights/pancella-ccrm-collaborate-to-benefit-aca-318855.html 0.6 2026-06-20T20:57:38+08:00 daily https://www.pharmasources.com/industryinsights/micropore-innocore-enter-injectable-drug-318856.html 0.6 2026-08-14T20:46:30+08:00 daily https://www.pharmasources.com/industryinsights/bio-rad-begins-shipping-covid-19-antibod-318857.html 0.6 2026-03-30T21:14:12+08:00 daily https://www.pharmasources.com/industryinsights/cpl-launches-production-of-hand-sanitize-318858.html 0.6 2026-07-17T15:18:26+08:00 daily https://www.pharmasources.com/industryinsights/adc-therapeutics-appoints-jennifer-creel-318859.html 0.6 2026-06-21T09:51:59+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharma-partners-with-niaid-fo-318860.html 0.6 2026-06-20T20:03:42+08:00 daily https://www.pharmasources.com/industryinsights/fda-and-ema-agree-to-review-shorter-infu-318861.html 0.6 2026-08-11T18:17:12+08:00 daily https://www.pharmasources.com/industryinsights/university-of-georgias-covid-19-vaccine--318862.html 0.6 2026-06-28T11:05:51+08:00 daily https://www.pharmasources.com/industryinsights/barda-to-give-moderna-up-to-483-million--318863.html 0.6 2026-06-20T16:50:13+08:00 daily https://www.pharmasources.com/industryinsights/trial-finds-lopinavirritonavir-and-arbid-318864.html 0.6 2026-07-23T08:53:23+08:00 daily https://www.pharmasources.com/industryinsights/cocktail-of-pharmaceuticals-identified-i-318865.html 0.6 2026-06-21T13:07:33+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-pandemic-spurs-cyber-attacks-on-318866.html 0.6 2026-06-20T14:24:39+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-vitrakvi-larotrectinib-f-318867.html 0.6 2026-03-07T10:46:17+08:00 daily https://www.pharmasources.com/industryinsights/ascendis-transcon-pth-shows-promise-in-p-318868.html 0.6 2026-06-20T18:00:22+08:00 daily https://www.pharmasources.com/industryinsights/revive-therapeutics-partners-with-comple-318869.html 0.6 2026-06-20T14:59:06+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-incytes-pemazyre-as-first-t-318870.html 0.6 2026-08-12T23:24:45+08:00 daily https://www.pharmasources.com/industryinsights/seattle-genetics-gets-fda-nod-for-breast-318871.html 0.6 2026-06-21T01:57:37+08:00 daily https://www.pharmasources.com/industryinsights/legochem-biosciences-iksuda-collaborate--318872.html 0.6 2026-07-08T22:06:17+08:00 daily https://www.pharmasources.com/industryinsights/starpharmas-spl7013-shows-significant-ac-318873.html 0.6 2026-06-20T18:45:53+08:00 daily https://www.pharmasources.com/industryinsights/bayer-partners-with-population-health-re-318874.html 0.6 2026-02-09T05:23:01+08:00 daily https://www.pharmasources.com/industryinsights/charity-launches-online-support-services-318875.html 0.6 2026-06-21T23:45:46+08:00 daily https://www.pharmasources.com/industryinsights/novartis-highlights-benefits-of-mayzent--318876.html 0.6 2026-06-21T10:03:14+08:00 daily https://www.pharmasources.com/industryinsights/uk-covid-19-vaccine-to-begin-human-testi-318877.html 0.6 2026-06-21T12:28:19+08:00 daily https://www.pharmasources.com/industryinsights/xian-launches-anti-pandemic-cooperation--318878.html 0.6 2026-07-16T09:50:59+08:00 daily https://www.pharmasources.com/industryinsights/lianghua-qingwen-listed-in-the-novel-cor-318879.html 0.6 2026-07-20T05:03:43+08:00 daily https://www.pharmasources.com/industryinsights/exadel-announces-apperyio-covid-19-virtu-318880.html 0.6 2026-06-17T22:50:38+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-earnings-to-beat-conse-318881.html 0.6 2026-06-21T07:56:14+08:00 daily https://www.pharmasources.com/industryinsights/british-vlogger-stuart-releases-viral-vi-318882.html 0.6 2026-06-26T09:30:26+08:00 daily https://www.pharmasources.com/industryinsights/searefico-group-donating-unique-isolated-318883.html 0.6 2026-08-06T23:43:10+08:00 daily https://www.pharmasources.com/industryinsights/getinge-interim-report-for-january-march-318884.html 0.6 2026-06-21T20:22:57+08:00 daily https://www.pharmasources.com/industryinsights/china-makes-coordinated-efforts-in-covid-318885.html 0.6 2026-08-09T22:34:08+08:00 daily https://www.pharmasources.com/industryinsights/pizza-4ps-donated-meals-to-health-worker-318886.html 0.6 2026-08-09T18:48:17+08:00 daily https://www.pharmasources.com/industryinsights/icon-group-committed-to-uninterrupted-ca-318887.html 0.6 2026-02-09T05:01:41+08:00 daily https://www.pharmasources.com/industryinsights/pharma-and-health-from-ingredients-to-pi-318888.html 0.6 2026-08-07T03:03:45+08:00 daily https://www.pharmasources.com/industryinsights/remdesivir-the-first-experimental-medica-318889.html 0.6 2026-08-10T17:34:36+08:00 daily https://www.pharmasources.com/industryinsights/nash-seizing-opportunities-in-the-untapp-318890.html 0.6 2026-08-07T00:41:08+08:00 daily https://www.pharmasources.com/industryinsights/the-9th-cphi-buyers-sourcing-event-conti-318891.html 0.6 2026-08-04T01:57:30+08:00 daily https://www.pharmasources.com/industryinsights/epimab-biotherapeutics-and-qimr-berghofe-318892.html 0.6 2026-08-07T11:01:03+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-highlighted-vulnerabilities-in--318893.html 0.6 2026-06-20T21:10:57+08:00 daily https://www.pharmasources.com/industryinsights/blood-pressure-drugs-are-in-the-crosshai-318894.html 0.6 2026-06-24T20:54:30+08:00 daily https://www.pharmasources.com/industryinsights/ayush-ministry-modifies-emr-scheme-for-s-318895.html 0.6 2026-06-23T02:17:42+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-therapy-for-triple-nega-318896.html 0.6 2026-06-24T07:33:08+08:00 daily https://www.pharmasources.com/industryinsights/indian-pharmaceutical-firms-will-play-im-318897.html 0.6 2026-06-22T00:00:50+08:00 daily https://www.pharmasources.com/industryinsights/hydroxychloroquine-for-coronavirus-shows-318898.html 0.6 2026-07-09T18:46:21+08:00 daily https://www.pharmasources.com/industryinsights/germany-approves-trials-of-covid-19-vacc-318899.html 0.6 2026-07-15T17:54:18+08:00 daily https://www.pharmasources.com/industryinsights/targovax-valo-tx-to-evaluate-virus-platf-318900.html 0.6 2026-06-22T04:52:36+08:00 daily https://www.pharmasources.com/industryinsights/novartis-kymriah-gets-rmat-designation-318901.html 0.6 2026-06-21T22:44:38+08:00 daily https://www.pharmasources.com/industryinsights/askbio-acquires-brainvectis-318902.html 0.6 2026-06-21T05:59:11+08:00 daily https://www.pharmasources.com/industryinsights/diamond-pharma-services-acquires-pharmac-318903.html 0.6 2026-08-11T09:50:09+08:00 daily https://www.pharmasources.com/industryinsights/q-biomed-mannin-research-accelerate-covi-318904.html 0.6 2026-06-08T08:00:22+08:00 daily https://www.pharmasources.com/industryinsights/pharnext-uhi-to-evaluate-repurposed-drug-318905.html 0.6 2026-06-22T03:53:37+08:00 daily https://www.pharmasources.com/industryinsights/aj-vaccines-secures-who-prequalification-318906.html 0.6 2026-07-24T09:59:11+08:00 daily https://www.pharmasources.com/industryinsights/mit-researchers-in-us-advance-covid-19-v-318907.html 0.6 2026-05-27T16:10:40+08:00 daily https://www.pharmasources.com/industryinsights/lack-of-awareness-among-patients-the-big-318908.html 0.6 2026-06-21T03:14:23+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-rmat-designation-to-novartis--318909.html 0.6 2026-06-21T00:54:39+08:00 daily https://www.pharmasources.com/industryinsights/nih-panel-warns-against-use-of-hydroxych-318910.html 0.6 2026-01-25T11:13:53+08:00 daily https://www.pharmasources.com/industryinsights/real-world-evidence-the-most-impactful-e-318911.html 0.6 2026-06-20T18:47:31+08:00 daily https://www.pharmasources.com/industryinsights/som-biotech-identifies-three-covid-19-dr-318912.html 0.6 2026-06-13T14:44:02+08:00 daily https://www.pharmasources.com/industryinsights/developing-a-covid-19-biosensor-for-fast-318913.html 0.6 2026-06-21T01:03:48+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-imbruvica-ibrutinib-for-tre-318914.html 0.6 2026-06-20T17:15:45+08:00 daily https://www.pharmasources.com/industryinsights/4d-pharma-to-initiate-phase-ii-study-of--318915.html 0.6 2026-06-21T00:01:37+08:00 daily https://www.pharmasources.com/industryinsights/noscendo-closes-series-a-financing-and-l-318916.html 0.6 2026-06-20T23:12:57+08:00 daily https://www.pharmasources.com/industryinsights/vetters-high-performance-is-again-recogn-318917.html 0.6 2026-06-21T20:54:42+08:00 daily https://www.pharmasources.com/industryinsights/synthon-biopharmaceuticals-relaunches-as-318918.html 0.6 2026-06-22T04:02:47+08:00 daily https://www.pharmasources.com/industryinsights/europlx-73-vienna-pharma-partnering-conf-318919.html 0.6 2026-06-30T15:39:23+08:00 daily https://www.pharmasources.com/industryinsights/halix-enters-collaboration-with-the-univ-318920.html 0.6 2026-06-21T07:20:37+08:00 daily https://www.pharmasources.com/industryinsights/powder-flowdeveloping-a-design-space-for-318921.html 0.6 2026-06-21T07:16:10+08:00 daily https://www.pharmasources.com/industryinsights/evolving-world-of-pharma-a-post-pandemic-318922.html 0.6 2026-08-07T22:02:22+08:00 daily https://www.pharmasources.com/industryinsights/jj-strikes-deal-with-emergent-biosolutio-318923.html 0.6 2026-06-21T12:19:40+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-pledges-50-lakh-meals-for-the-n-318924.html 0.6 2025-10-21T21:10:41+08:00 daily https://www.pharmasources.com/industryinsights/gilead-disputes-report-that-its-drug-flo-318925.html 0.6 2026-06-20T17:54:43+08:00 daily https://www.pharmasources.com/industryinsights/alembic-pharma-q4-results-net-profit-up--318926.html 0.6 2026-07-01T01:29:19+08:00 daily https://www.pharmasources.com/industryinsights/stayhappi-pharmacy-to-launch-an-online-p-318927.html 0.6 2026-07-17T23:29:30+08:00 daily https://www.pharmasources.com/industryinsights/government-clarifies-mha-order-no-penalt-318928.html 0.6 2026-06-21T21:48:44+08:00 daily https://www.pharmasources.com/industryinsights/dcgi-instructs-sdcs-to-monitor-supply-an-318929.html 0.6 2026-06-23T19:58:22+08:00 daily https://www.pharmasources.com/industryinsights/catalent-completes-14m-biologics-packagi-318930.html 0.6 2026-07-22T07:32:23+08:00 daily https://www.pharmasources.com/industryinsights/theravance-initiates-study-in-ali-caused-318931.html 0.6 2026-06-20T15:52:29+08:00 daily https://www.pharmasources.com/industryinsights/prothera-takeda-enter-anti-inflammatory--318932.html 0.6 2026-06-21T09:50:56+08:00 daily https://www.pharmasources.com/industryinsights/financial-report-lilly-318933.html 0.6 2026-08-10T10:58:05+08:00 daily https://www.pharmasources.com/industryinsights/imvax-appoints-chief-scientific-officer-318934.html 0.6 2026-06-21T13:14:52+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-diosynth-licenses-oxgenes-aav-s-318935.html 0.6 2026-06-21T18:13:33+08:00 daily https://www.pharmasources.com/industryinsights/griffith-university-and-iil-team-up-to-d-318936.html 0.6 2026-06-23T10:56:51+08:00 daily https://www.pharmasources.com/industryinsights/fresenius-kabi-recalls-13-lots-of-ketoro-318937.html 0.6 2026-06-22T06:52:59+08:00 daily https://www.pharmasources.com/industryinsights/research-focus-should-remain-on-high-qua-318938.html 0.6 2026-08-06T20:07:52+08:00 daily https://www.pharmasources.com/industryinsights/ema-warns-about-side-effects-of-chloroqu-318939.html 0.6 2026-07-05T13:43:17+08:00 daily https://www.pharmasources.com/industryinsights/germany-to-begin-first-clinical-trial-of-318940.html 0.6 2026-08-08T02:24:00+08:00 daily https://www.pharmasources.com/industryinsights/novel-antibody-delivery-method-could-imp-318941.html 0.6 2026-07-15T15:58:07+08:00 daily https://www.pharmasources.com/industryinsights/uk-covid-19-vaccine-candidate-to-be-manu-318942.html 0.6 2026-06-21T05:55:46+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-saint-lukes-mid-america-hear-318943.html 0.6 2026-06-21T09:58:17+08:00 daily https://www.pharmasources.com/industryinsights/first-subject-dosed-in-td-0903-study-for-318944.html 0.6 2026-06-21T10:18:43+08:00 daily https://www.pharmasources.com/industryinsights/fda-authorizes-first-covid-19-at-home-te-318945.html 0.6 2026-06-21T14:21:58+08:00 daily https://www.pharmasources.com/industryinsights/immunic-reports-imu-838-demonstrates-pre-318946.html 0.6 2026-06-21T11:19:34+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-imbruvica-rituximab-combina-318947.html 0.6 2026-06-20T19:20:56+08:00 daily https://www.pharmasources.com/industryinsights/b-braun-medical-issues-recall-of-ceftazi-318948.html 0.6 2026-06-21T02:37:41+08:00 daily https://www.pharmasources.com/industryinsights/fda-update-serological-test-validation-a-318949.html 0.6 2026-08-08T05:07:41+08:00 daily https://www.pharmasources.com/industryinsights/cytosmart-to-donate-100-live-cell-imagin-318950.html 0.6 2026-07-19T01:30:06+08:00 daily https://www.pharmasources.com/industryinsights/medicinova-receives-notice-of-allowance--318951.html 0.6 2026-06-21T21:58:39+08:00 daily https://www.pharmasources.com/industryinsights/aequus-announces-positive-update-on-dry--318952.html 0.6 2026-06-22T10:51:42+08:00 daily https://www.pharmasources.com/industryinsights/emergex-signs-agreement-with-george-maso-318953.html 0.6 2026-06-21T10:59:11+08:00 daily https://www.pharmasources.com/industryinsights/scancell-kicks-off-covid-19-vaccine-deve-318954.html 0.6 2026-08-09T06:59:23+08:00 daily https://www.pharmasources.com/industryinsights/nice-publishes-new-covid-19-guidelines-318955.html 0.6 2026-08-08T08:38:44+08:00 daily https://www.pharmasources.com/industryinsights/us-approves-sanofis-meningococcal-vaccin-318956.html 0.6 2026-08-08T07:33:59+08:00 daily https://www.pharmasources.com/industryinsights/who-prematurely-publishes-remdesivir-res-318957.html 0.6 2026-08-08T04:31:38+08:00 daily https://www.pharmasources.com/industryinsights/industry-lauds-move-to-allow-import-of-d-318959.html 0.6 2026-08-12T02:25:47+08:00 daily https://www.pharmasources.com/industryinsights/trial-of-gileads-potential-coronavirus-t-318960.html 0.6 2026-06-21T10:55:21+08:00 daily https://www.pharmasources.com/industryinsights/getting-smart-with-femtech-take-advantag-318961.html 0.6 2026-06-21T03:00:41+08:00 daily https://www.pharmasources.com/industryinsights/china-approves-third-covid-19-vaccine-fo-318962.html 0.6 2026-07-18T06:04:26+08:00 daily https://www.pharmasources.com/industryinsights/jubilant-life-sciences-contributes-rupee-318963.html 0.6 2026-06-21T13:51:35+08:00 daily https://www.pharmasources.com/industryinsights/ipa-requests-pm-to-allow-pharmacists-to--318964.html 0.6 2026-06-21T02:04:41+08:00 daily https://www.pharmasources.com/industryinsights/iict-laxai-lifesciences-collaborate-for--318965.html 0.6 2026-06-21T04:18:58+08:00 daily https://www.pharmasources.com/industryinsights/state-drug-controllers-asked-to-help-pha-318966.html 0.6 2026-06-20T19:44:24+08:00 daily https://www.pharmasources.com/industryinsights/takeda-to-sell-otc-and-non-core-assets-t-318967.html 0.6 2026-08-07T14:51:14+08:00 daily https://www.pharmasources.com/industryinsights/jj-selects-emergent-biosolutions-for-cov-318968.html 0.6 2026-06-23T19:49:19+08:00 daily https://www.pharmasources.com/industryinsights/gilead-says-leaked-covid-19-trial-data-o-318969.html 0.6 2026-08-11T18:23:15+08:00 daily https://www.pharmasources.com/industryinsights/takeda-offloads-670m-of-european-drugs-a-318970.html 0.6 2026-08-05T20:59:06+08:00 daily https://www.pharmasources.com/industryinsights/fda-cautions-use-of-hydroxychloroquine-c-318971.html 0.6 2026-06-22T06:05:42+08:00 daily https://www.pharmasources.com/industryinsights/cytovance-and-akshaya-enter-vaccine-coll-318972.html 0.6 2026-08-07T06:48:22+08:00 daily https://www.pharmasources.com/industryinsights/ology-bioservices-inks-27m-dod-deal-318973.html 0.6 2026-06-20T21:08:48+08:00 daily https://www.pharmasources.com/industryinsights/cmic-supports-avigan-production-for-pote-318974.html 0.6 2026-06-20T23:01:44+08:00 daily https://www.pharmasources.com/industryinsights/wasdell-acquires-specialist-packaging-su-318975.html 0.6 2026-07-10T02:36:48+08:00 daily https://www.pharmasources.com/industryinsights/lynparza-demonstrated-overall-survival-b-318976.html 0.6 2026-04-17T22:32:19+08:00 daily https://www.pharmasources.com/industryinsights/cns-announces-filing-of-orphan-drug-desi-318977.html 0.6 2026-06-21T06:48:00+08:00 daily https://www.pharmasources.com/industryinsights/hvp-launches-global-initiative-to-accele-318978.html 0.6 2026-08-04T17:22:44+08:00 daily https://www.pharmasources.com/industryinsights/janssen-submits-sbla-for-simponi-aria-fo-318979.html 0.6 2026-06-21T18:10:33+08:00 daily https://www.pharmasources.com/industryinsights/kymriah-receives-fda-regenerative-medici-318980.html 0.6 2026-07-15T22:36:13+08:00 daily https://www.pharmasources.com/industryinsights/fda-reiterates-importance-of-close-patie-318981.html 0.6 2026-07-21T08:18:43+08:00 daily https://www.pharmasources.com/industryinsights/key-nose-cells-identified-as-likely-covi-318982.html 0.6 2026-07-07T12:32:52+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-and-saint-lukes-mid-america--318983.html 0.6 2026-07-02T13:10:37+08:00 daily https://www.pharmasources.com/industryinsights/own-immune-cells-to-target-infectious-di-318984.html 0.6 2026-06-26T12:20:27+08:00 daily https://www.pharmasources.com/industryinsights/bayer-partners-with-population-health-re-318985.html 0.6 2026-06-21T20:39:45+08:00 daily https://www.pharmasources.com/industryinsights/gilead-onko-innate-to-develop-nk-cells-f-318986.html 0.6 2026-06-21T03:06:43+08:00 daily https://www.pharmasources.com/industryinsights/hope-biosciences-announces-third-fda-app-318987.html 0.6 2026-06-22T00:00:43+08:00 daily https://www.pharmasources.com/industryinsights/nexus-pharmaceuticals-announces-approval-318988.html 0.6 2026-06-23T00:53:15+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-gets-ec-approval-fo-318989.html 0.6 2026-06-23T05:09:01+08:00 daily https://www.pharmasources.com/industryinsights/wavelength-pharmaceuticals-expands-suppl-318990.html 0.6 2026-07-24T18:08:47+08:00 daily https://www.pharmasources.com/industryinsights/nice-backs-nhs-use-of-bayers-vitrakvi-vi-318991.html 0.6 2026-01-04T22:01:05+08:00 daily https://www.pharmasources.com/industryinsights/novartis-jakavi-bests-current-therapy-fo-318992.html 0.6 2026-08-06T18:18:53+08:00 daily https://www.pharmasources.com/industryinsights/a-new-indication-of-secukinumab-to-be-ap-318993.html 0.6 2026-08-05T11:21:14+08:00 daily https://www.pharmasources.com/industryinsights/herbal-products-from-cimap-may-boost-imm-318994.html 0.6 2026-05-28T03:16:39+08:00 daily https://www.pharmasources.com/industryinsights/pharma-among-top-domains-of-non-tech-pat-318995.html 0.6 2026-06-21T10:58:08+08:00 daily https://www.pharmasources.com/industryinsights/making-pharma-greener-with-solar-energy-318996.html 0.6 2026-08-06T18:12:43+08:00 daily https://www.pharmasources.com/industryinsights/cdsco-anticipates-low-inventory-of-cardi-318997.html 0.6 2026-06-21T05:59:47+08:00 daily https://www.pharmasources.com/industryinsights/oral-polio-vaccine-can-be-effective-agai-318998.html 0.6 2026-06-21T08:01:04+08:00 daily https://www.pharmasources.com/industryinsights/plans-afoot-to-develop-covid-19-vaccine--318999.html 0.6 2026-06-21T00:13:56+08:00 daily https://www.pharmasources.com/industryinsights/yangtze-river-receiving-another-2-clinic-319000.html 0.6 2026-05-28T04:04:26+08:00 daily https://www.pharmasources.com/industryinsights/a-review-of-the-three-chinese-patent-med-319001.html 0.6 2026-08-14T09:57:50+08:00 daily https://www.pharmasources.com/industryinsights/us-approves-chinese-drug-maker-shanghai--319002.html 0.6 2026-06-26T11:51:21+08:00 daily https://www.pharmasources.com/industryinsights/artes-joins-global-combat-against-corona-319003.html 0.6 2026-06-21T23:37:24+08:00 daily https://www.pharmasources.com/industryinsights/nearly-60-pct-of-imported-covid-19-cases-319004.html 0.6 2026-06-22T01:50:41+08:00 daily https://www.pharmasources.com/industryinsights/nation-works-at-full-capacity-to-supply--319005.html 0.6 2026-04-25T14:53:52+08:00 daily https://www.pharmasources.com/industryinsights/fewer-virus-deaths-due-to-decisive-measu-319006.html 0.6 2026-06-21T08:59:56+08:00 daily https://www.pharmasources.com/industryinsights/experts-call-on-adults-to-take-vaccines--319007.html 0.6 2026-08-06T00:55:29+08:00 daily https://www.pharmasources.com/industryinsights/chinas-inactivated-covid-19-vaccine-ente-319008.html 0.6 2026-08-06T03:02:04+08:00 daily https://www.pharmasources.com/industryinsights/bracco-launches-global-bracco-cares-init-319009.html 0.6 2025-12-28T22:18:21+08:00 daily https://www.pharmasources.com/industryinsights/tsg-announces-acquisition-of-truecoach-319010.html 0.6 2026-06-20T21:12:51+08:00 daily https://www.pharmasources.com/industryinsights/azeus-ensure-business-continuity-with-co-319011.html 0.6 2026-06-22T03:12:53+08:00 daily https://www.pharmasources.com/industryinsights/menarini-silicon-biosystems-explores-new-319012.html 0.6 2026-07-08T16:44:11+08:00 daily https://www.pharmasources.com/industryinsights/global-cord-blood-corporation-provides-f-319013.html 0.6 2026-07-20T08:54:26+08:00 daily https://www.pharmasources.com/industryinsights/carsgen-therapeutics-receives-positive-e-319014.html 0.6 2026-07-05T09:33:36+08:00 daily https://www.pharmasources.com/industryinsights/green-valley-obtains-ind-approval-from-u-319015.html 0.6 2026-07-24T01:16:57+08:00 daily https://www.pharmasources.com/industryinsights/propelling-total-health-program-xcmg-cal-319016.html 0.6 2026-06-20T17:00:21+08:00 daily https://www.pharmasources.com/industryinsights/artes-biotech-to-develop-vlp-sars-cov-2--319017.html 0.6 2026-06-21T22:15:04+08:00 daily https://www.pharmasources.com/industryinsights/cti-biopharma-initiates-phase-iii-pacrit-319018.html 0.6 2026-06-20T19:20:05+08:00 daily https://www.pharmasources.com/industryinsights/romark-initiates-trials-of-nt-300-for-co-319019.html 0.6 2026-07-03T21:20:45+08:00 daily https://www.pharmasources.com/industryinsights/fda-covid-19-update-319020.html 0.6 2026-08-12T00:02:02+08:00 daily https://www.pharmasources.com/industryinsights/valo-tx-working-to-develop-potential-cov-319021.html 0.6 2026-08-12T16:54:40+08:00 daily https://www.pharmasources.com/industryinsights/cro-industry-update-319022.html 0.6 2026-08-14T06:55:39+08:00 daily https://www.pharmasources.com/industryinsights/santhera-cshl-to-investigate-lonodelesta-319023.html 0.6 2026-06-21T02:05:43+08:00 daily https://www.pharmasources.com/industryinsights/agc-biologics-adaptvac-partner-to-develo-319024.html 0.6 2026-06-21T21:55:37+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-sanofi-release-preliminary-pha-319025.html 0.6 2026-08-07T05:56:14+08:00 daily https://www.pharmasources.com/industryinsights/lincoln-pharma-gets-approval-to-manufact-319026.html 0.6 2026-06-20T23:06:44+08:00 daily https://www.pharmasources.com/industryinsights/new-insight-into-genetic-schizophrenia-r-319027.html 0.6 2025-12-11T01:13:32+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-successfully-completes-pf-319028.html 0.6 2026-08-04T16:54:01+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofen-cphicn2020042-319029.html 0.6 2026-08-07T16:15:31+08:00 daily https://www.pharmasources.com/industryinsights/serum-institute-plans-to-price-coronavir-319030.html 0.6 2026-06-21T18:15:38+08:00 daily https://www.pharmasources.com/industryinsights/iit-guwahati-collaborates-with-hester-bi-319031.html 0.6 2026-06-22T01:53:31+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-gets-tentative-usfda-approval-f-319032.html 0.6 2026-06-21T13:03:31+08:00 daily https://www.pharmasources.com/industryinsights/strides-develops-and-commences-export-of-319033.html 0.6 2026-07-05T12:40:01+08:00 daily https://www.pharmasources.com/industryinsights/indias-pharma-capabilities-would-remain--319034.html 0.6 2026-08-07T01:19:30+08:00 daily https://www.pharmasources.com/industryinsights/ayush-ministry-initiates-efforts-to-brin-319035.html 0.6 2026-06-21T00:04:40+08:00 daily https://www.pharmasources.com/industryinsights/biocon-and-mylan-launch-fulphila-biosimi-319036.html 0.6 2026-06-21T18:03:26+08:00 daily https://www.pharmasources.com/industryinsights/marinomed-receives-ffg-funding-to-resear-319037.html 0.6 2026-06-21T23:48:02+08:00 daily https://www.pharmasources.com/industryinsights/bayer-faces-second-investor-reckoning-ov-319038.html 0.6 2026-03-21T20:16:17+08:00 daily https://www.pharmasources.com/industryinsights/novartis-sales-profits-rise-in-first-qua-319039.html 0.6 2026-07-07T13:26:53+08:00 daily https://www.pharmasources.com/industryinsights/natco-pharma-gets-usfda-approval-for-vis-319040.html 0.6 2026-06-21T18:14:42+08:00 daily https://www.pharmasources.com/industryinsights/ayush-ministry-asks-statesuts-to-promote-319041.html 0.6 2026-06-21T06:20:17+08:00 daily https://www.pharmasources.com/industryinsights/dapnat-launch-to-boost-natcos-presence-i-319042.html 0.6 2026-06-22T06:00:45+08:00 daily https://www.pharmasources.com/industryinsights/new-breakthrough-could-help-us-understan-319043.html 0.6 2026-07-04T17:12:01+08:00 daily https://www.pharmasources.com/industryinsights/stevanato-group-collaborates-with-cambri-319044.html 0.6 2026-06-21T10:52:58+08:00 daily https://www.pharmasources.com/industryinsights/medpharm-expands-testing-models-to-targe-319045.html 0.6 2025-12-11T00:54:55+08:00 daily https://www.pharmasources.com/industryinsights/tjoapack-receives-investment-from-ampers-319046.html 0.6 2026-06-20T14:55:07+08:00 daily https://www.pharmasources.com/industryinsights/genalyte-launches-high-speed-covid-19-an-319047.html 0.6 2026-08-05T21:49:29+08:00 daily https://www.pharmasources.com/industryinsights/shiv-nadar-university-develops-molecule--319048.html 0.6 2026-06-20T15:54:28+08:00 daily https://www.pharmasources.com/industryinsights/gujarat-to-try-ayurvedic-drugs-on-select-319049.html 0.6 2026-06-23T07:08:04+08:00 daily https://www.pharmasources.com/industryinsights/labvantage-launches-biobanking-lims-acce-319050.html 0.6 2026-07-16T22:54:03+08:00 daily https://www.pharmasources.com/industryinsights/merck-and-institute-for-systems-biology--319051.html 0.6 2026-06-21T10:17:20+08:00 daily https://www.pharmasources.com/industryinsights/microbial-compound-in-new-fluconazole-fo-319052.html 0.6 2026-06-21T02:05:51+08:00 daily https://www.pharmasources.com/industryinsights/nanohybrid-drug-delivery-vehicle-could-h-319053.html 0.6 2026-06-21T13:13:05+08:00 daily https://www.pharmasources.com/industryinsights/global-manufacturing-fundamental-for-dru-319054.html 0.6 2025-12-29T03:57:02+08:00 daily https://www.pharmasources.com/industryinsights/scientists-double-understanding-of-genet-319055.html 0.6 2026-07-27T08:04:58+08:00 daily https://www.pharmasources.com/industryinsights/syngene-international-converts-lab-into--319056.html 0.6 2026-06-21T17:59:38+08:00 daily https://www.pharmasources.com/industryinsights/british-plastics-federation-releases-gui-319057.html 0.6 2026-07-09T01:34:01+08:00 daily https://www.pharmasources.com/industryinsights/phase-iii-lung-cancer-trial-stopped-earl-319058.html 0.6 2026-06-16T12:36:17+08:00 daily https://www.pharmasources.com/industryinsights/pneumagen-announces-results-from-covid-1-319059.html 0.6 2026-06-20T14:54:06+08:00 daily https://www.pharmasources.com/industryinsights/a-review-of-the-three-chinese-patent-med-319060.html 0.6 2026-08-09T00:51:00+08:00 daily https://www.pharmasources.com/industryinsights/how-fette-compacting-china-supports-the--319061.html 0.6 2026-06-20T14:32:57+08:00 daily https://www.pharmasources.com/industryinsights/financial-report--pfizer-319062.html 0.6 2026-08-14T18:31:45+08:00 daily https://www.pharmasources.com/industryinsights/supernus-acquires-us-worldmeds-cns-portf-319063.html 0.6 2026-08-08T10:55:43+08:00 daily https://www.pharmasources.com/industryinsights/ppd-extends-digital-clinical-trial-capab-319064.html 0.6 2026-06-20T20:06:44+08:00 daily https://www.pharmasources.com/industryinsights/catalent-jj-enter-mfg-pact-for-covid-19--319065.html 0.6 2026-06-20T23:57:37+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-completes-pfs-filling-at--319066.html 0.6 2026-08-08T22:26:58+08:00 daily https://www.pharmasources.com/industryinsights/sesderma-communicates-the-effectiveness--319067.html 0.6 2026-08-07T11:19:44+08:00 daily https://www.pharmasources.com/industryinsights/ai-can-play-a-big-role-in-vaccine-develo-319068.html 0.6 2026-08-11T15:01:06+08:00 daily https://www.pharmasources.com/industryinsights/dcgi-approves-glenmarks-clinical-trials--319069.html 0.6 2026-06-20T21:55:41+08:00 daily https://www.pharmasources.com/industryinsights/lupins-pithampur-unit-1-facility-receive-319070.html 0.6 2026-07-03T17:58:47+08:00 daily https://www.pharmasources.com/industryinsights/technology-has-driven-success-in-pharma--319071.html 0.6 2026-02-28T14:30:04+08:00 daily https://www.pharmasources.com/industryinsights/lupin-receives-tentative-approval-for-ar-319072.html 0.6 2026-02-21T11:14:43+08:00 daily https://www.pharmasources.com/industryinsights/branded-digital-support-for-rheumatoid-a-319073.html 0.6 2026-08-10T03:59:19+08:00 daily https://www.pharmasources.com/industryinsights/university-of-queensland-reports-positiv-319074.html 0.6 2025-12-11T00:51:44+08:00 daily https://www.pharmasources.com/industryinsights/shionogi-works-on-covid-19-therapies-and-319075.html 0.6 2026-06-22T21:52:49+08:00 daily https://www.pharmasources.com/industryinsights/pneumagen-reports-positive-lab-data-of-c-319076.html 0.6 2026-06-20T23:41:22+08:00 daily https://www.pharmasources.com/industryinsights/kamada-and-kedrion-to-develop-immunoglob-319077.html 0.6 2026-06-23T06:04:59+08:00 daily https://www.pharmasources.com/industryinsights/clover-biopharmaceuticals-gets-cepi-fund-319078.html 0.6 2026-06-22T05:51:32+08:00 daily https://www.pharmasources.com/industryinsights/scancell-to-develop-dna-vaccine-candidat-319079.html 0.6 2026-06-20T20:59:42+08:00 daily https://www.pharmasources.com/industryinsights/sanofis-meningococcal-vaccine-menquadfi--319080.html 0.6 2026-07-31T22:08:24+08:00 daily https://www.pharmasources.com/industryinsights/santhera-explores-lonodelestat-to-treat--319081.html 0.6 2026-06-20T23:06:56+08:00 daily https://www.pharmasources.com/industryinsights/merck-signs-covid-19-research-alliance-w-319082.html 0.6 2026-06-21T04:59:51+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-and-oxford-university-partne-319083.html 0.6 2026-06-21T06:02:50+08:00 daily https://www.pharmasources.com/industryinsights/14m-funding-to-support-rapid-covid-19-va-319084.html 0.6 2026-06-21T08:13:31+08:00 daily https://www.pharmasources.com/industryinsights/mers-vaccine-shows-promise-in-clinical-t-319085.html 0.6 2026-06-20T22:52:34+08:00 daily https://www.pharmasources.com/industryinsights/niaid-strategic-plan-for-covid-19-focuse-319086.html 0.6 2026-06-21T08:19:21+08:00 daily https://www.pharmasources.com/industryinsights/researchers-design-first-new-polio-vacci-319087.html 0.6 2026-06-21T05:10:56+08:00 daily https://www.pharmasources.com/industryinsights/fda-sends-two-warnings-to-companies-sell-319088.html 0.6 2026-06-21T03:08:51+08:00 daily https://www.pharmasources.com/industryinsights/who-calls-for-pharma-to-rapidly-distribu-319089.html 0.6 2026-08-10T19:05:59+08:00 daily https://www.pharmasources.com/industryinsights/gilead-announces-primary-endpoints-met-i-319090.html 0.6 2026-06-23T18:17:37+08:00 daily https://www.pharmasources.com/industryinsights/spanish-medicines-agency-authorizes-apli-319091.html 0.6 2026-07-12T12:42:32+08:00 daily https://www.pharmasources.com/industryinsights/romark-initiates-phase-3-clinical-trials-319092.html 0.6 2026-07-04T03:02:46+08:00 daily https://www.pharmasources.com/industryinsights/santhera-cold-spring-harbor-lab-to-inves-319093.html 0.6 2026-08-06T19:34:19+08:00 daily https://www.pharmasources.com/industryinsights/leinco-vanderbilt-university-medical-cen-319094.html 0.6 2026-07-09T11:37:18+08:00 daily https://www.pharmasources.com/industryinsights/bioeclipse-receives-fda-clearance-of-crx-319095.html 0.6 2026-06-21T19:15:50+08:00 daily https://www.pharmasources.com/industryinsights/cti-biopharma-announces-phase-3-pacritin-319096.html 0.6 2026-06-21T21:58:39+08:00 daily https://www.pharmasources.com/industryinsights/aurobindo-pharma-receives-usfda-approval-319097.html 0.6 2026-08-13T09:01:01+08:00 daily https://www.pharmasources.com/industryinsights/pharma-companies-in-apac-shine-during-q1-319098.html 0.6 2026-06-21T14:46:14+08:00 daily https://www.pharmasources.com/industryinsights/laurus-labs-pat-touches-rs-110-crore-in--319099.html 0.6 2026-06-20T16:21:16+08:00 daily https://www.pharmasources.com/industryinsights/valneva-and-pfizer-collaborate-for-lyme--319100.html 0.6 2026-06-20T14:58:06+08:00 daily https://www.pharmasources.com/industryinsights/gilead-granted-eua-for-remdesivir-in-cov-319101.html 0.6 2026-08-07T14:37:07+08:00 daily https://www.pharmasources.com/industryinsights/financial-report---abbvie-319102.html 0.6 2026-08-05T09:03:18+08:00 daily https://www.pharmasources.com/industryinsights/financial-report---amgen-319103.html 0.6 2026-07-24T12:02:00+08:00 daily https://www.pharmasources.com/industryinsights/moderna-signs-ten-year-vaccine-manufactu-319104.html 0.6 2026-04-08T17:02:05+08:00 daily https://www.pharmasources.com/industryinsights/inovio-pharmaceuticals-boosts-covid-19-v-319105.html 0.6 2026-06-20T14:32:02+08:00 daily https://www.pharmasources.com/industryinsights/catalent-appoints-cell-gene-therapy-pres-319106.html 0.6 2026-01-04T14:49:21+08:00 daily https://www.pharmasources.com/industryinsights/zydus-gets-tentative-usfda-approval-for--319107.html 0.6 2026-06-23T17:52:32+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-completes-825m-acquisition-of--319108.html 0.6 2026-07-16T09:19:25+08:00 daily https://www.pharmasources.com/industryinsights/ilc-therapeutics-discovers-novel-potenti-319109.html 0.6 2026-06-20T15:58:44+08:00 daily https://www.pharmasources.com/industryinsights/probiogen-appoints-ceo-319110.html 0.6 2026-06-21T11:04:10+08:00 daily https://www.pharmasources.com/industryinsights/wistar-and-batavia-collaborate-to-manufa-319111.html 0.6 2026-06-21T01:08:51+08:00 daily https://www.pharmasources.com/industryinsights/gemini-bio-helps-support-covid-19-resear-319112.html 0.6 2026-06-21T20:59:36+08:00 daily https://www.pharmasources.com/industryinsights/nppa-allows-six-paracetamol-apis-manufac-319113.html 0.6 2026-06-20T14:40:16+08:00 daily https://www.pharmasources.com/industryinsights/gbrc-signs-mou-with-neuberg-supratech-fo-319114.html 0.6 2026-07-06T13:19:27+08:00 daily https://www.pharmasources.com/industryinsights/cdsco-extends-who-gmpcopp-validity-by-si-319115.html 0.6 2026-06-08T02:10:17+08:00 daily https://www.pharmasources.com/industryinsights/csir-identifies-top-25-drugsdrug-candida-319116.html 0.6 2026-06-21T23:51:06+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-diosynth-biotechnologies-teams--319117.html 0.6 2026-08-07T13:36:10+08:00 daily https://www.pharmasources.com/industryinsights/seastar-to-study-selective-cytopheretic--319118.html 0.6 2026-06-21T01:05:49+08:00 daily https://www.pharmasources.com/industryinsights/eib-cepi-sign-agreement-to-accelerate-in-319119.html 0.6 2026-08-07T00:41:35+08:00 daily https://www.pharmasources.com/industryinsights/proteogenix-announces-a-covid-19-antibod-319120.html 0.6 2026-08-07T02:05:56+08:00 daily https://www.pharmasources.com/industryinsights/trio-pharmaceuticals-ajinomoto-bio-pharm-319121.html 0.6 2026-08-07T02:10:06+08:00 daily https://www.pharmasources.com/industryinsights/novartis-releases-q1-results-updates-cov-319122.html 0.6 2026-08-07T03:05:12+08:00 daily https://www.pharmasources.com/industryinsights/swabs-designed-by-harvard-wyss-institute-319123.html 0.6 2026-08-07T02:22:19+08:00 daily https://www.pharmasources.com/industryinsights/utilising-crispr-could-reduce-contaminat-319124.html 0.6 2026-08-10T17:06:26+08:00 daily https://www.pharmasources.com/industryinsights/uk-vaccine-clinical-trial-outsourcing-ex-319125.html 0.6 2026-08-07T02:33:49+08:00 daily https://www.pharmasources.com/industryinsights/gilead-files-lawsuit-against-us-federal--319126.html 0.6 2026-08-07T02:36:52+08:00 daily https://www.pharmasources.com/industryinsights/new-standards-to-help-remove-foreign-par-319127.html 0.6 2026-08-07T02:39:58+08:00 daily https://www.pharmasources.com/industryinsights/nice-joins-international-collaboratives--319128.html 0.6 2026-08-07T02:45:51+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-dosing-regimen-for-pemb-319129.html 0.6 2026-08-07T13:19:33+08:00 daily https://www.pharmasources.com/industryinsights/cosentyx-gains-fourth-indication-in-eu-f-319130.html 0.6 2026-08-07T16:09:42+08:00 daily https://www.pharmasources.com/industryinsights/eiger-announces-first-covid-19-patients--319131.html 0.6 2026-08-08T17:00:57+08:00 daily https://www.pharmasources.com/industryinsights/convalescent-plasma-trial-begins-as-pote-319132.html 0.6 2026-08-09T09:37:55+08:00 daily https://www.pharmasources.com/industryinsights/fda-issues-emergency-use-authorization-f-319133.html 0.6 2026-06-21T12:59:27+08:00 daily https://www.pharmasources.com/industryinsights/bioinvent-signs-manufacturing-agreement-319134.html 0.6 2026-06-21T17:07:29+08:00 daily https://www.pharmasources.com/industryinsights/quartesian-and-ilikos-form-strategic-par-319135.html 0.6 2026-06-21T04:58:53+08:00 daily https://www.pharmasources.com/industryinsights/applied-biomath-collaborates-with-xilio--319136.html 0.6 2026-06-21T17:14:37+08:00 daily https://www.pharmasources.com/industryinsights/amri-increases-hcq-production-in-us-319137.html 0.6 2026-06-20T22:15:33+08:00 daily https://www.pharmasources.com/industryinsights/cepi-inks-covid-19-vax-pact-with-clover--319138.html 0.6 2026-07-01T21:26:04+08:00 daily https://www.pharmasources.com/industryinsights/kindeva-launches-as-an-independent-compa-319139.html 0.6 2026-07-17T08:33:06+08:00 daily https://www.pharmasources.com/industryinsights/quotient-sciences-cytoagents-form-covid--319140.html 0.6 2026-06-22T07:05:54+08:00 daily https://www.pharmasources.com/industryinsights/arcturus-catalent-partner-to-manufacture-319141.html 0.6 2026-01-30T20:11:53+08:00 daily https://www.pharmasources.com/industryinsights/gujarat-hospitals-to-join-whos-solidarit-319142.html 0.6 2026-08-12T00:05:42+08:00 daily https://www.pharmasources.com/industryinsights/success-of-new-research-projects-crucial-319143.html 0.6 2026-06-21T01:05:53+08:00 daily https://www.pharmasources.com/industryinsights/merck-accelerates-readiness-of-bioproces-319144.html 0.6 2026-07-21T03:29:00+08:00 daily https://www.pharmasources.com/industryinsights/lupin-announces-results-of-phase-3-study-319145.html 0.6 2026-06-15T04:21:30+08:00 daily https://www.pharmasources.com/industryinsights/iict-develops-synthetic-process-for-favi-319146.html 0.6 2026-06-22T02:56:38+08:00 daily https://www.pharmasources.com/industryinsights/aiocd-requests-pm-to-provide-medical-ins-319147.html 0.6 2026-07-19T15:43:19+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-gives-eua-to-roche-for-covid-19-a-319148.html 0.6 2026-08-11T02:34:57+08:00 daily https://www.pharmasources.com/industryinsights/snbncbs-develops-nanomedicine-for-better-319149.html 0.6 2026-06-21T05:55:48+08:00 daily https://www.pharmasources.com/industryinsights/duponts-xivia-xylitol-demonstrates-posit-319150.html 0.6 2026-08-08T01:16:53+08:00 daily https://www.pharmasources.com/industryinsights/premas-biotech-announces-development-of--319151.html 0.6 2025-10-27T09:22:58+08:00 daily https://www.pharmasources.com/industryinsights/researchers-identify-antibody-with-activ-319152.html 0.6 2026-08-03T23:49:11+08:00 daily https://www.pharmasources.com/industryinsights/vaxxel-buys-transgenes-cell-line-to-deve-319153.html 0.6 2026-07-20T04:44:40+08:00 daily https://www.pharmasources.com/industryinsights/canada-provides-1756m-for-abcellera-to-d-319154.html 0.6 2026-06-20T23:55:30+08:00 daily https://www.pharmasources.com/industryinsights/menarini-to-buy-stemline-for-up-to-677-m-319155.html 0.6 2026-06-22T10:01:44+08:00 daily https://www.pharmasources.com/industryinsights/nice-publishes-latest-set-of-covid-19-gu-319156.html 0.6 2026-07-02T01:22:35+08:00 daily https://www.pharmasources.com/industryinsights/gsk-books-19-sales-growth-for-first-quar-319157.html 0.6 2026-06-20T21:10:46+08:00 daily https://www.pharmasources.com/industryinsights/az-delivers-strong-first-quarter-319158.html 0.6 2026-02-04T03:04:45+08:00 daily https://www.pharmasources.com/industryinsights/eli-lilly-junshi-collaborate-to-develop--319159.html 0.6 2026-07-16T07:16:04+08:00 daily https://www.pharmasources.com/industryinsights/junshi-and-eli-lilly-have-reached-a-usd--319160.html 0.6 2026-07-16T06:12:35+08:00 daily https://www.pharmasources.com/industryinsights/cdsco-to-assess-issues-in-the-procuremen-319161.html 0.6 2026-07-17T08:11:59+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-launches-generic-hemophilia-in-319162.html 0.6 2026-06-22T10:53:59+08:00 daily https://www.pharmasources.com/industryinsights/health-ministry-asks-aiocd-to-ensure-ava-319163.html 0.6 2026-06-23T04:34:08+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-farxiga-for-heart-failure-319164.html 0.6 2026-06-23T21:43:52+08:00 daily https://www.pharmasources.com/industryinsights/ajinomoto-bio-pharma-services-announces--319165.html 0.6 2026-07-16T18:25:43+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-says-covid-19-antibody-cocktai-319166.html 0.6 2026-07-04T20:19:28+08:00 daily https://www.pharmasources.com/industryinsights/gileads-anti-viral-remdesivir-may-be-fou-319167.html 0.6 2026-02-28T15:42:59+08:00 daily https://www.pharmasources.com/industryinsights/scientists-to-culture-novel-coronavirus--319168.html 0.6 2026-06-20T19:21:16+08:00 daily https://www.pharmasources.com/industryinsights/chinas-blockchain-backed-recovery-from-c-319169.html 0.6 2026-08-11T18:46:53+08:00 daily https://www.pharmasources.com/industryinsights/us-regulators-permit-abbvieallergan-merg-319170.html 0.6 2026-06-20T13:21:37+08:00 daily https://www.pharmasources.com/industryinsights/lifearc-mrc-create-16m-fund-to-set-up-ge-319171.html 0.6 2026-06-20T14:56:13+08:00 daily https://www.pharmasources.com/industryinsights/chmp-puts-eight-new-medicines-forward-fo-319172.html 0.6 2026-06-21T12:23:09+08:00 daily https://www.pharmasources.com/industryinsights/abbott-launches-covid-19-lab-based-antib-319173.html 0.6 2026-06-23T18:14:24+08:00 daily https://www.pharmasources.com/industryinsights/crescendo-links-with-cruk-to-progress-ca-319174.html 0.6 2026-08-06T20:32:45+08:00 daily https://www.pharmasources.com/industryinsights/jedi-launches-billion-molecules-agains-c-319175.html 0.6 2026-06-23T18:48:38+08:00 daily https://www.pharmasources.com/industryinsights/csl-behring-australia-joins-race-for-cov-319176.html 0.6 2026-07-08T03:13:57+08:00 daily https://www.pharmasources.com/industryinsights/italy-researchers-claim-vaccine-neutrali-319177.html 0.6 2026-02-28T13:16:23+08:00 daily https://www.pharmasources.com/industryinsights/menarini-group-to-buy-stemline-therapeut-319178.html 0.6 2026-06-22T02:07:45+08:00 daily https://www.pharmasources.com/industryinsights/alexion-to-buy-biopharmaceutical-firm-po-319179.html 0.6 2026-06-21T05:35:16+08:00 daily https://www.pharmasources.com/industryinsights/acceleron-receives-prime-designation-fro-319180.html 0.6 2026-06-20T14:55:04+08:00 daily https://www.pharmasources.com/industryinsights/novartis-receives-chmp-positive-opinion--319181.html 0.6 2026-06-29T07:03:55+08:00 daily https://www.pharmasources.com/industryinsights/fda-clears-lpcn-1148-ind-application-for-319182.html 0.6 2026-06-21T08:53:51+08:00 daily https://www.pharmasources.com/industryinsights/centogene-announces-global-expansion-of--319183.html 0.6 2026-06-21T10:06:10+08:00 daily https://www.pharmasources.com/industryinsights/catalent-jj-announce-covid-19-vaccine-ca-319184.html 0.6 2026-06-21T00:53:43+08:00 daily https://www.pharmasources.com/industryinsights/probiogen-ag-appoints-dr-lutz-hilbrich-a-319185.html 0.6 2026-06-21T02:16:57+08:00 daily https://www.pharmasources.com/industryinsights/d-flex-a-new-generation-of-manual-inject-319186.html 0.6 2026-08-08T16:47:20+08:00 daily https://www.pharmasources.com/industryinsights/latest-developments-in-epidemic-control--319187.html 0.6 2026-01-09T23:48:39+08:00 daily https://www.pharmasources.com/industryinsights/no-evidence-mosquitoes-can-pass-coronavi-319188.html 0.6 2026-06-21T06:10:54+08:00 daily https://www.pharmasources.com/industryinsights/beijing-reports-no-new-covid-19-cases-fo-319189.html 0.6 2026-06-21T13:02:29+08:00 daily https://www.pharmasources.com/industryinsights/introducing-univercells-technologies-319190.html 0.6 2026-06-20T17:09:28+08:00 daily https://www.pharmasources.com/industryinsights/about-cphi-p-mec-china-virtual-expo-conn-319191.html 0.6 2026-06-08T23:29:46+08:00 daily https://www.pharmasources.com/industryinsights/quarticai-partners-with-bright-path-labs-319192.html 0.6 2026-06-22T11:57:44+08:00 daily https://www.pharmasources.com/industryinsights/barda-funds-development-of-tangen-biosci-319193.html 0.6 2026-02-12T00:19:53+08:00 daily https://www.pharmasources.com/industryinsights/ftc-clears-abbvies-acquisition-of-allerg-319194.html 0.6 2026-03-14T02:57:23+08:00 daily https://www.pharmasources.com/industryinsights/avrobio-and-magenta-therapeutics-collabo-319195.html 0.6 2026-06-21T00:54:06+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-319196.html 0.6 2026-08-13T14:15:47+08:00 daily https://www.pharmasources.com/industryinsights/agc-biologics-inks-manufacturing-deal-wi-319197.html 0.6 2026-06-21T21:00:43+08:00 daily https://www.pharmasources.com/industryinsights/avantor-launches-single-use-sampling-sol-319198.html 0.6 2026-07-19T06:48:53+08:00 daily https://www.pharmasources.com/industryinsights/hovione-appoints-chief-operating-officer-319199.html 0.6 2026-06-21T15:07:35+08:00 daily https://www.pharmasources.com/industryinsights/open-science-key-to-combat-zoonosis-319200.html 0.6 2026-06-22T12:59:26+08:00 daily https://www.pharmasources.com/industryinsights/usfda-extends-review-of-bristol-myers-ca-319201.html 0.6 2026-08-06T18:40:03+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-targetted-therapy-to--319202.html 0.6 2026-08-11T17:06:26+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-dr-reddys-nda-for-migraine--319203.html 0.6 2025-11-08T14:44:25+08:00 daily https://www.pharmasources.com/industryinsights/alexion-to-buy-portola-pharmaceuticals-f-319204.html 0.6 2026-08-09T06:59:47+08:00 daily https://www.pharmasources.com/industryinsights/tedor-pharma-rhode-island-hospital-in-cl-319205.html 0.6 2026-06-21T12:46:24+08:00 daily https://www.pharmasources.com/industryinsights/njii-launches-biocentriq-cell-gene-thera-319206.html 0.6 2026-01-22T07:43:23+08:00 daily https://www.pharmasources.com/industryinsights/univercells-launches-bioprocess-technolo-319207.html 0.6 2026-07-21T05:58:03+08:00 daily https://www.pharmasources.com/industryinsights/nanoform-awarded-gmp-certification-319208.html 0.6 2026-06-21T12:20:46+08:00 daily https://www.pharmasources.com/industryinsights/merck-names-doina-ionescu-as-uk-and-irel-319209.html 0.6 2026-07-08T16:19:43+08:00 daily https://www.pharmasources.com/industryinsights/manchester-uni-researchers-develop-domes-319210.html 0.6 2026-08-14T13:33:08+08:00 daily https://www.pharmasources.com/industryinsights/nice-joins-international-covid-19-pandem-319211.html 0.6 2026-08-08T02:54:20+08:00 daily https://www.pharmasources.com/industryinsights/imperial-college-london-partners-with-nh-319212.html 0.6 2026-07-04T06:13:14+08:00 daily https://www.pharmasources.com/industryinsights/rebiotix-ferrings-microbiome-based-thera-319213.html 0.6 2026-06-20T22:08:46+08:00 daily https://www.pharmasources.com/industryinsights/speedy-us-approval-for-novartis-tabrecta-319214.html 0.6 2026-06-20T15:00:07+08:00 daily https://www.pharmasources.com/industryinsights/aberdeen-uni-proceeds-with-covid-19-mass-319215.html 0.6 2026-06-20T18:48:22+08:00 daily https://www.pharmasources.com/industryinsights/adare-pharma-acquires-orbis-biosciences-319216.html 0.6 2026-06-21T10:33:38+08:00 daily https://www.pharmasources.com/industryinsights/integral-molecular-develops-test-for-neu-319217.html 0.6 2026-07-09T18:29:06+08:00 daily https://www.pharmasources.com/industryinsights/nyu-langone-to-enroll-patients-in-us-cli-319218.html 0.6 2026-07-10T01:55:32+08:00 daily https://www.pharmasources.com/industryinsights/janssen-receives-fda-approval-of-darzale-319219.html 0.6 2026-02-28T10:28:44+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-oxford-university-announce-a-319220.html 0.6 2026-08-05T15:20:56+08:00 daily https://www.pharmasources.com/industryinsights/novartis-receives-chmp-positive-opinion--319221.html 0.6 2026-08-05T08:52:28+08:00 daily https://www.pharmasources.com/industryinsights/delmar-updates-clinical-trial-of-val-083-319222.html 0.6 2026-06-20T14:41:12+08:00 daily https://www.pharmasources.com/industryinsights/inovio-expands-manufacturing-of-covid-19-319223.html 0.6 2026-08-12T23:36:59+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-closes-acquisition-of-danaher--319224.html 0.6 2026-07-31T15:46:32+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-dosed-with-pfizers-potenti-319225.html 0.6 2026-08-06T00:26:53+08:00 daily https://www.pharmasources.com/industryinsights/ema-initiates-rolling-review-of-remdesiv-319226.html 0.6 2026-07-21T10:09:40+08:00 daily https://www.pharmasources.com/industryinsights/attenuated-diptheria-toxin-developed-by--319227.html 0.6 2026-07-18T16:30:45+08:00 daily https://www.pharmasources.com/industryinsights/cepi-and-european-investment-bank-collab-319228.html 0.6 2026-06-22T01:55:38+08:00 daily https://www.pharmasources.com/industryinsights/government-to-conduct-randomised-control-319229.html 0.6 2026-06-22T07:04:52+08:00 daily https://www.pharmasources.com/industryinsights/gilead-scouting-for-partners-in-india-pa-319230.html 0.6 2026-06-21T09:05:33+08:00 daily https://www.pharmasources.com/industryinsights/researchers-launch-race-to-develop-susta-319231.html 0.6 2026-06-21T08:00:10+08:00 daily https://www.pharmasources.com/industryinsights/dgft-issues-clarification-on-export-rest-319232.html 0.6 2026-03-18T19:48:52+08:00 daily https://www.pharmasources.com/industryinsights/lanxess-robust-in-first-quarter-of-2020--319233.html 0.6 2026-08-13T00:48:56+08:00 daily https://www.pharmasources.com/industryinsights/ema-to-fast-track-development-of-covid-1-319234.html 0.6 2026-08-01T07:14:31+08:00 daily https://www.pharmasources.com/industryinsights/cepi-calls-for-proposals-to-apply-for-co-319235.html 0.6 2026-06-22T06:55:54+08:00 daily https://www.pharmasources.com/industryinsights/chinese-scientists-release-worlds-first--319236.html 0.6 2026-06-21T06:55:00+08:00 daily https://www.pharmasources.com/industryinsights/mrc-and-lifearc-announce-grants-for-gene-319237.html 0.6 2026-08-09T03:45:14+08:00 daily https://www.pharmasources.com/industryinsights/cdmo-pledges-increased-production-of-hyd-319238.html 0.6 2026-08-07T13:18:50+08:00 daily https://www.pharmasources.com/industryinsights/ema-recommends-eight-drugs-for-approval--319239.html 0.6 2026-08-10T09:05:35+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-launches-sars-cov-2-global-319240.html 0.6 2026-08-07T02:52:29+08:00 daily https://www.pharmasources.com/industryinsights/cluepoints-tech-benefits-clinical-studie-319241.html 0.6 2026-08-07T02:40:48+08:00 daily https://www.pharmasources.com/industryinsights/enlivex-initiates-phase-ii-trial-of-allo-319242.html 0.6 2026-08-06T22:21:12+08:00 daily https://www.pharmasources.com/industryinsights/santhera-rutgers-sign-gene-therapy-resea-319243.html 0.6 2026-08-06T22:08:38+08:00 daily https://www.pharmasources.com/industryinsights/biomerica-receives-ce-mark-for-10-minute-319244.html 0.6 2026-08-08T03:20:29+08:00 daily https://www.pharmasources.com/industryinsights/rapid-covid-19-genome-sequencing-aids-ou-319245.html 0.6 2026-08-06T22:54:13+08:00 daily https://www.pharmasources.com/industryinsights/amgen-announces-positive-top-line-result-319246.html 0.6 2026-08-06T23:54:23+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-treatment-for-heart-fai-319247.html 0.6 2026-08-07T00:02:40+08:00 daily https://www.pharmasources.com/industryinsights/magenta-avrobio-to-evaluate-antibody-dru-319248.html 0.6 2026-08-07T00:39:40+08:00 daily https://www.pharmasources.com/industryinsights/indias-csir-proposes-testing-of-sepsis-d-319249.html 0.6 2026-08-07T01:15:18+08:00 daily https://www.pharmasources.com/industryinsights/bicycle-therapeutics-announces-first-pat-319250.html 0.6 2026-08-10T12:36:51+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-biontech-dose-first-participants--319251.html 0.6 2026-08-12T02:51:05+08:00 daily https://www.pharmasources.com/industryinsights/lineage-cell-therapeutics-to-apply-allog-319252.html 0.6 2026-08-07T13:15:30+08:00 daily https://www.pharmasources.com/industryinsights/vir-alnylam-to-develop-vir-2703-rnai-the-319253.html 0.6 2026-08-08T10:39:41+08:00 daily https://www.pharmasources.com/industryinsights/icr-welcomes-new-advanced-prostate-cance-319254.html 0.6 2026-08-08T12:18:52+08:00 daily https://www.pharmasources.com/industryinsights/newron-drops-development-of-sarizotan-in-319255.html 0.6 2026-08-09T03:10:49+08:00 daily https://www.pharmasources.com/industryinsights/sanofiregenerons-libtayo-shows-benefit-i-319256.html 0.6 2026-08-09T06:51:24+08:00 daily https://www.pharmasources.com/industryinsights/arcturus-therapeutics-catalent-announce--319257.html 0.6 2026-06-20T23:04:43+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-for-priority-review-bristol--319258.html 0.6 2026-07-17T23:21:25+08:00 daily https://www.pharmasources.com/industryinsights/vitamin-d-levels-appear-to-play-role-in--319259.html 0.6 2026-06-21T09:01:58+08:00 daily https://www.pharmasources.com/industryinsights/japan-approves-remdesivir-for-use-on-sev-319260.html 0.6 2026-07-22T11:20:30+08:00 daily https://www.pharmasources.com/industryinsights/pharma-industry-witnesses-50-deals-worth-319261.html 0.6 2026-07-30T09:35:27+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-gets-eir-from-usfda-for-srikak-319262.html 0.6 2026-07-05T11:25:30+08:00 daily https://www.pharmasources.com/industryinsights/syntegon-building-on-stable-business-per-319263.html 0.6 2026-08-11T17:53:24+08:00 daily https://www.pharmasources.com/industryinsights/cadila-pharma-shuts-formulations-unit-af-319264.html 0.6 2026-08-07T00:15:37+08:00 daily https://www.pharmasources.com/industryinsights/cphi-pharmasourcescom-member-operation-g-319265.html 0.6 2026-08-07T00:40:45+08:00 daily https://www.pharmasources.com/industryinsights/alcami-makes-senior-leadership-appointme-319268.html 0.6 2026-08-11T18:23:27+08:00 daily https://www.pharmasources.com/industryinsights/catalent-provides-clinical-support-for-c-319269.html 0.6 2026-08-07T01:27:44+08:00 daily https://www.pharmasources.com/industryinsights/inmed-almac-improving-cannabinoid-produc-319270.html 0.6 2026-08-10T15:18:13+08:00 daily https://www.pharmasources.com/industryinsights/bioclinica-launches-covid-19-clinical-en-319271.html 0.6 2026-06-22T06:33:38+08:00 daily https://www.pharmasources.com/industryinsights/medivant-launches-pharma-mfg-ops-in-us-319272.html 0.6 2026-06-21T01:06:51+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-official-tests-positive-after-319273.html 0.6 2026-06-20T20:39:55+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-recalls-its-heart-burn-medicin-319274.html 0.6 2026-07-31T22:12:27+08:00 daily https://www.pharmasources.com/industryinsights/delhi-hc-orders-aiims-to-resume-dispensa-319275.html 0.6 2026-08-07T11:49:14+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-antigen-test-for-rapid-d-319276.html 0.6 2026-06-21T10:02:08+08:00 daily https://www.pharmasources.com/industryinsights/the-us-and-india-are-collaborating-for-t-319277.html 0.6 2026-06-21T14:48:16+08:00 daily https://www.pharmasources.com/industryinsights/pharma-inc-opposes-15-per-cent-covid-19--319278.html 0.6 2026-06-22T05:30:07+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-launches-enzalutamide-to-tr-319279.html 0.6 2026-08-09T08:39:36+08:00 daily https://www.pharmasources.com/industryinsights/new-triple-antiviral-drugs-combo-shows-p-319280.html 0.6 2026-08-02T08:01:10+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-retevmo-for-lung-thyroid-319281.html 0.6 2026-06-22T10:47:58+08:00 daily https://www.pharmasources.com/industryinsights/india-to-send-medicines-to-25-african-co-319282.html 0.6 2026-08-08T23:12:46+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-restricts-indian-pharma-export--319283.html 0.6 2026-08-07T08:34:06+08:00 daily https://www.pharmasources.com/industryinsights/the-carlyle-group-to-acquire-majority-st-319284.html 0.6 2026-07-26T02:09:15+08:00 daily https://www.pharmasources.com/industryinsights/tonix-pharmaceuticals-licences-three-cov-319285.html 0.6 2026-08-05T05:20:35+08:00 daily https://www.pharmasources.com/industryinsights/japanese-regulator-approves-gileads-remd-319286.html 0.6 2026-08-06T23:16:24+08:00 daily https://www.pharmasources.com/industryinsights/multi-arm-multi-stage-clinical-trials-th-319287.html 0.6 2026-08-09T21:16:07+08:00 daily https://www.pharmasources.com/industryinsights/laurent-pharmaceuticals-receives-health--319288.html 0.6 2026-06-21T07:52:10+08:00 daily https://www.pharmasources.com/industryinsights/twist-bioscience-identifies-competitive--319289.html 0.6 2026-06-08T22:22:03+08:00 daily https://www.pharmasources.com/industryinsights/novartis-gets-fda-nod-for-tabrecta-to-tr-319290.html 0.6 2026-08-07T05:30:43+08:00 daily https://www.pharmasources.com/industryinsights/university-of-oxford-sound-pharmaceutica-319291.html 0.6 2026-08-09T00:44:27+08:00 daily https://www.pharmasources.com/industryinsights/ose-immunotherapeutics-announces-covid-1-319292.html 0.6 2026-06-21T12:58:38+08:00 daily https://www.pharmasources.com/industryinsights/evelo-rutgers-rwj-submit-ind-for-study-o-319293.html 0.6 2026-08-10T03:08:43+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-eua-for-cardiac-monitoring-in-319294.html 0.6 2026-04-07T06:32:40+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-accelerated-approval-to-capma-319295.html 0.6 2026-06-20T14:37:17+08:00 daily https://www.pharmasources.com/industryinsights/biodelivery-sciences-appoints-interim-ce-319296.html 0.6 2026-08-09T06:51:22+08:00 daily https://www.pharmasources.com/industryinsights/sterling-begins-hcq-production-in-uk-319297.html 0.6 2026-08-09T02:55:02+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-launches-incucyte-sx5-for-live-319298.html 0.6 2026-08-09T00:10:19+08:00 daily https://www.pharmasources.com/industryinsights/report-says-mmr-vax-campaigns-may-protec-319299.html 0.6 2026-08-07T13:18:45+08:00 daily https://www.pharmasources.com/industryinsights/hcats-apceth-expand-manufacturing-pact-w-319300.html 0.6 2026-08-06T23:33:24+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-ccpm-enter-genetics-research-a-319301.html 0.6 2026-08-09T05:47:39+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-scientific-expands-viral-v-319302.html 0.6 2026-08-06T23:46:58+08:00 daily https://www.pharmasources.com/industryinsights/merck-granted-us-patents-for-foundationa-319303.html 0.6 2026-08-07T13:18:30+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-launches-triple-therapy-inhaler-319304.html 0.6 2026-08-07T16:15:16+08:00 daily https://www.pharmasources.com/industryinsights/hamdard-laboratories-launches-digital-ca-319305.html 0.6 2026-08-08T05:07:08+08:00 daily https://www.pharmasources.com/industryinsights/demand-for-immunity-products-to-be-susta-319306.html 0.6 2026-08-07T20:21:50+08:00 daily https://www.pharmasources.com/industryinsights/wockhardt-q4-results-firm-posts-profit-o-319307.html 0.6 2026-08-07T01:19:34+08:00 daily https://www.pharmasources.com/industryinsights/icmr-teams-up-with-bharat-biotech-to-dev-319308.html 0.6 2026-08-07T01:10:29+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-319309.html 0.6 2026-08-07T01:06:52+08:00 daily https://www.pharmasources.com/industryinsights/dbt-birac-covid-19-research-consortium-r-319310.html 0.6 2026-08-07T01:19:29+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-regains-global-rights-to-bra-319311.html 0.6 2026-08-10T17:34:57+08:00 daily https://www.pharmasources.com/industryinsights/lilly-secures-fda-approval-for-retevmo-t-319312.html 0.6 2026-07-30T12:01:30+08:00 daily https://www.pharmasources.com/industryinsights/sorrento-and-mount-sinai-to-develop-anti-319313.html 0.6 2026-06-20T17:07:20+08:00 daily https://www.pharmasources.com/industryinsights/uks-nice-recommends-roche-breast-cancer--319314.html 0.6 2026-06-20T21:40:25+08:00 daily https://www.pharmasources.com/industryinsights/ftc-accepts-proposal-for-to-abbvie-acqui-319315.html 0.6 2025-11-06T22:09:11+08:00 daily https://www.pharmasources.com/industryinsights/triple-antiviral-drug-combination-shows--319316.html 0.6 2026-04-03T14:49:03+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-tabrecta-for-treatment-of-m-319317.html 0.6 2026-06-21T10:00:03+08:00 daily https://www.pharmasources.com/industryinsights/fda-continues-to-combat-fraudulent-covid-319318.html 0.6 2026-08-02T02:56:28+08:00 daily https://www.pharmasources.com/industryinsights/enlivex-announces-trial-initiation-of-al-319319.html 0.6 2026-06-22T04:54:36+08:00 daily https://www.pharmasources.com/industryinsights/wize-pharma-completes-phase-iv-study-of--319320.html 0.6 2026-06-20T21:17:55+08:00 daily https://www.pharmasources.com/industryinsights/opti-medical-systems-receives-eua-for-op-319321.html 0.6 2026-06-22T10:59:48+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-daiichi-sankyo-get-fda-break-319322.html 0.6 2026-07-22T08:54:41+08:00 daily https://www.pharmasources.com/industryinsights/certara-and-dmtc-announce-research-colla-319323.html 0.6 2026-06-20T13:19:51+08:00 daily https://www.pharmasources.com/industryinsights/zyus-vido-intervac-collaborate-to-develo-319324.html 0.6 2026-08-08T01:05:45+08:00 daily https://www.pharmasources.com/industryinsights/us-nod-for-lynparza-in-hrd-positive-adva-319325.html 0.6 2026-06-21T11:53:37+08:00 daily https://www.pharmasources.com/industryinsights/pm-faces-calls-for-inquiry-into-bame-cov-319326.html 0.6 2026-08-05T19:18:33+08:00 daily https://www.pharmasources.com/industryinsights/new-indication-of-cspc-group-s-butylphth-319327.html 0.6 2026-05-25T14:16:07+08:00 daily https://www.pharmasources.com/industryinsights/beijing-has-67-nucleic-acid-testing-inst-319328.html 0.6 2026-08-09T22:39:04+08:00 daily https://www.pharmasources.com/industryinsights/china-sends-team-to-northeastern-city-wi-319329.html 0.6 2026-08-07T15:20:40+08:00 daily https://www.pharmasources.com/industryinsights/latest-developments-in-epidemic-control--319330.html 0.6 2026-06-22T09:59:38+08:00 daily https://www.pharmasources.com/industryinsights/beijing-taking-steps-to-bolster-control--319331.html 0.6 2026-06-21T02:06:46+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-puts-public-health-gaps-in-focu-319332.html 0.6 2026-06-22T04:11:56+08:00 daily https://www.pharmasources.com/industryinsights/northeast-china-city-raises-covid-19-eme-319333.html 0.6 2026-06-20T14:44:18+08:00 daily https://www.pharmasources.com/industryinsights/smoking-does-not-protect-against-coronav-319334.html 0.6 2026-08-09T04:32:19+08:00 daily https://www.pharmasources.com/industryinsights/second-indication-application-of-novo-no-319335.html 0.6 2026-08-08T12:07:37+08:00 daily https://www.pharmasources.com/industryinsights/gilead-mylan-ink-global-remdesivir-licen-319336.html 0.6 2026-08-08T10:14:37+08:00 daily https://www.pharmasources.com/industryinsights/singota-solutions-collaborates-with-nove-319337.html 0.6 2026-08-08T07:37:58+08:00 daily https://www.pharmasources.com/industryinsights/sorrento-mount-sinai-to-develop-covi-shi-319338.html 0.6 2026-08-08T04:33:27+08:00 daily https://www.pharmasources.com/industryinsights/yourway-and-firma-ink-clinical-supply-pa-319339.html 0.6 2026-08-08T07:37:09+08:00 daily https://www.pharmasources.com/industryinsights/key-biologics-and-astarte-biologics-rebr-319340.html 0.6 2026-08-14T01:00:09+08:00 daily https://www.pharmasources.com/industryinsights/jubilant-life-sciences-and-gilead-sign-a-319341.html 0.6 2026-08-09T04:33:05+08:00 daily https://www.pharmasources.com/industryinsights/noga-therapeutics-and-lonza-to-develop-a-319342.html 0.6 2026-08-07T22:29:17+08:00 daily https://www.pharmasources.com/industryinsights/cipla-enters-into-a-licensing-agreement--319343.html 0.6 2026-06-24T09:34:27+08:00 daily https://www.pharmasources.com/industryinsights/childhood-vaccines-reduce-antibiotic-con-319344.html 0.6 2026-06-22T04:55:37+08:00 daily https://www.pharmasources.com/industryinsights/omniactive-appoints-industry-veteran-jim-319345.html 0.6 2026-06-21T03:04:41+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-initiates-phase-3-clinical-tria-319346.html 0.6 2026-08-11T19:05:59+08:00 daily https://www.pharmasources.com/industryinsights/dyno-therapeutics-launches-with-deals-fr-319347.html 0.6 2026-07-25T14:02:27+08:00 daily https://www.pharmasources.com/industryinsights/cepi-to-provide-up-to-388m-for-novavaxs--319348.html 0.6 2026-06-20T15:01:06+08:00 daily https://www.pharmasources.com/industryinsights/sarepta-and-dyno-therapeutics-will-devel-319349.html 0.6 2026-06-20T18:56:32+08:00 daily https://www.pharmasources.com/industryinsights/tufts-csdd-releases-new-study-319350.html 0.6 2026-08-04T11:51:45+08:00 daily https://www.pharmasources.com/industryinsights/themis-collaborates-with-abl-europe-319351.html 0.6 2026-06-21T06:19:12+08:00 daily https://www.pharmasources.com/industryinsights/junshi-lilly-to-co-develop-antibody-ther-319352.html 0.6 2026-08-10T19:00:07+08:00 daily https://www.pharmasources.com/industryinsights/programme-to-develop-sustainable-cold-ch-319353.html 0.6 2026-08-07T08:36:44+08:00 daily https://www.pharmasources.com/industryinsights/icu-medical-recalls-one-lot-of-lactated--319354.html 0.6 2026-08-08T23:24:46+08:00 daily https://www.pharmasources.com/industryinsights/cepi-invests-384m-in-novavax-covid-19-va-319355.html 0.6 2026-06-21T06:16:00+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-fast-track-designation-for-om-319356.html 0.6 2026-06-20T15:49:25+08:00 daily https://www.pharmasources.com/industryinsights/viracor-eurofins-launches-antibody-tests-319357.html 0.6 2026-06-22T01:55:32+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-hardy-diagnostics-eua-for-cov-319358.html 0.6 2026-06-20T18:17:49+08:00 daily https://www.pharmasources.com/industryinsights/protagonist-announces-phase-2-results-fo-319359.html 0.6 2026-06-12T11:33:18+08:00 daily https://www.pharmasources.com/industryinsights/ultromics-mayo-clinic-collaborate-to-rap-319360.html 0.6 2026-08-10T17:29:01+08:00 daily https://www.pharmasources.com/industryinsights/-319362.html 0.6 2026-07-27T11:25:01+08:00 daily https://www.pharmasources.com/industryinsights/jcyte-signs-ex-us-licensing-deal-with-sa-319363.html 0.6 2026-06-21T15:02:29+08:00 daily https://www.pharmasources.com/industryinsights/ec-approves-subcutaneous-formulation-of--319364.html 0.6 2026-08-14T14:58:20+08:00 daily https://www.pharmasources.com/industryinsights/lilly-receives-us-fda-approval-for-retev-319365.html 0.6 2026-07-10T07:09:54+08:00 daily https://www.pharmasources.com/industryinsights/nice-final-guidance-backs-pfizers-lorviq-319366.html 0.6 2026-06-23T12:12:03+08:00 daily https://www.pharmasources.com/industryinsights/new-partnership-to-sequence-human-genome-319367.html 0.6 2026-06-23T12:57:55+08:00 daily https://www.pharmasources.com/industryinsights/nhs-england-confirms-four-new-icss-319368.html 0.6 2026-06-21T10:16:29+08:00 daily https://www.pharmasources.com/industryinsights/sanofis-sarclisa-cuts-death-risk-in-muti-319369.html 0.6 2026-06-21T06:09:47+08:00 daily https://www.pharmasources.com/industryinsights/nihr-ukri-call-for-new-covid-19-research-319370.html 0.6 2026-08-10T01:24:49+08:00 daily https://www.pharmasources.com/industryinsights/russia-claims-favipiravir-shows-promise--319371.html 0.6 2026-08-10T13:12:04+08:00 daily https://www.pharmasources.com/industryinsights/study-reveals-novel-coronavirus-may-infe-319372.html 0.6 2026-06-29T18:36:10+08:00 daily https://www.pharmasources.com/industryinsights/hp-university-scientists-gets-microsoft--319373.html 0.6 2026-06-20T15:56:39+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-completes-acquisition-of-allergan-319374.html 0.6 2026-06-21T10:04:44+08:00 daily https://www.pharmasources.com/industryinsights/syngene-intl-gains-after-q4-pat-rises-20-319375.html 0.6 2026-07-05T06:19:52+08:00 daily https://www.pharmasources.com/industryinsights/gilead-signs-voluntary-licensing-agreeme-319376.html 0.6 2026-08-03T12:51:54+08:00 daily https://www.pharmasources.com/industryinsights/eu-gmp-certification-for-biocon-biologic-319377.html 0.6 2026-06-21T08:00:04+08:00 daily https://www.pharmasources.com/industryinsights/tau-and-neovii-team-up-to-develop-covid--319378.html 0.6 2026-08-06T18:25:54+08:00 daily https://www.pharmasources.com/industryinsights/fda-fast-tracks-modernas-covid-19-vaccin-319379.html 0.6 2026-06-21T23:57:41+08:00 daily https://www.pharmasources.com/industryinsights/acer-therapeutics-ncats-partner-to-devel-319380.html 0.6 2026-06-27T02:54:11+08:00 daily https://www.pharmasources.com/industryinsights/scientific-leaders-call-for-harmonised-c-319381.html 0.6 2026-06-20T14:58:04+08:00 daily https://www.pharmasources.com/industryinsights/fda-new-drug-approvals-down-16-percent-i-319382.html 0.6 2026-06-20T16:58:17+08:00 daily https://www.pharmasources.com/industryinsights/fairjourney-biologics-joins-forces-with--319383.html 0.6 2026-07-04T00:16:49+08:00 daily https://www.pharmasources.com/industryinsights/catalent-ennaid-therapeutics-ink-covid-1-319384.html 0.6 2026-06-22T03:56:42+08:00 daily https://www.pharmasources.com/industryinsights/biomed-x-launches-rapid-antiviral-respon-319385.html 0.6 2026-07-03T06:49:35+08:00 daily https://www.pharmasources.com/industryinsights/marken-expands-direct-to-patient-service-319386.html 0.6 2026-06-21T20:54:46+08:00 daily https://www.pharmasources.com/industryinsights/ori-biotech-and-cellgenix-collaborate-319387.html 0.6 2026-06-22T07:09:58+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-gets-expanded-eua-for-sars-319388.html 0.6 2026-06-21T06:20:19+08:00 daily https://www.pharmasources.com/industryinsights/skyhawk-therapeutics-merck-expand-rna-al-319389.html 0.6 2026-06-29T13:32:38+08:00 daily https://www.pharmasources.com/industryinsights/parexel-launches-covid-19-risk-mitigatio-319390.html 0.6 2026-06-21T17:57:47+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-recovers-global-rights-to-br-319391.html 0.6 2026-04-01T23:16:10+08:00 daily https://www.pharmasources.com/industryinsights/mylan-to-supply-remdesivir-for-potential-319392.html 0.6 2026-06-29T19:44:23+08:00 daily https://www.pharmasources.com/industryinsights/fda-authorizes-first-covid-19-diagnostic-319393.html 0.6 2026-06-29T06:33:33+08:00 daily https://www.pharmasources.com/industryinsights/usp-launches-trust-accelerated-program-t-319394.html 0.6 2026-06-08T17:29:39+08:00 daily https://www.pharmasources.com/industryinsights/lilly-receives-fda-approval-for-treatmen-319395.html 0.6 2026-08-07T09:59:17+08:00 daily https://www.pharmasources.com/industryinsights/moderna-gets-fda-fast-track-status-for-m-319396.html 0.6 2026-07-09T23:12:24+08:00 daily https://www.pharmasources.com/industryinsights/appili-therapeutics-submits-cta-with-hea-319397.html 0.6 2026-06-20T17:53:17+08:00 daily https://www.pharmasources.com/industryinsights/crispr-therapeutics-and-vertex-pharmaceu-319398.html 0.6 2026-06-21T00:00:37+08:00 daily https://www.pharmasources.com/industryinsights/fda-refuse-to-file-bmsbluebird-bios-car--319399.html 0.6 2026-06-21T08:20:26+08:00 daily https://www.pharmasources.com/industryinsights/scientists-discover-59-repurposing-drug--319400.html 0.6 2026-06-21T06:04:46+08:00 daily https://www.pharmasources.com/industryinsights/nice-backs-use-of-roches-gazyvaro-with-b-319401.html 0.6 2026-06-20T14:55:10+08:00 daily https://www.pharmasources.com/industryinsights/janssens-car-t-shows-100-response-rate-i-319402.html 0.6 2026-08-03T04:46:44+08:00 daily https://www.pharmasources.com/industryinsights/cell-and-gene-therapy-catapult-links-wit-319403.html 0.6 2025-12-28T02:59:18+08:00 daily https://www.pharmasources.com/industryinsights/exyte-and-univercells-technologies-combi-319404.html 0.6 2026-06-21T13:14:55+08:00 daily https://www.pharmasources.com/industryinsights/second-adc-therapeutic-drug-was-approved-319405.html 0.6 2026-07-19T19:42:17+08:00 daily https://www.pharmasources.com/industryinsights/india-calls-upon-g-20-nations-to-ensure--319406.html 0.6 2026-06-21T08:59:03+08:00 daily https://www.pharmasources.com/industryinsights/exyte-and-univercells-join-forces-319407.html 0.6 2026-07-10T18:18:39+08:00 daily https://www.pharmasources.com/industryinsights/cmab-completes-devt-and-mfg-project-for--319408.html 0.6 2026-06-20T21:57:36+08:00 daily https://www.pharmasources.com/industryinsights/vibalogics-to-manufacture-clinical-mater-319409.html 0.6 2026-08-14T20:07:22+08:00 daily https://www.pharmasources.com/industryinsights/sabin-and-reithera-enter-clinical-manufa-319410.html 0.6 2026-06-20T23:53:36+08:00 daily https://www.pharmasources.com/industryinsights/hikal-announces-development-of-favipirav-319411.html 0.6 2026-04-09T18:07:49+08:00 daily https://www.pharmasources.com/industryinsights/clariant-in-india-extends-support-to-loc-319412.html 0.6 2026-04-13T07:28:43+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-says-its-covid-19-vaccine-will-av-319413.html 0.6 2026-06-21T21:04:41+08:00 daily https://www.pharmasources.com/industryinsights/teva-moves-us-court-against-aurobindo-ph-319414.html 0.6 2026-08-07T05:13:35+08:00 daily https://www.pharmasources.com/industryinsights/maharashtra-fda-requests-nppa-to-fix-pri-319415.html 0.6 2026-06-21T12:50:15+08:00 daily https://www.pharmasources.com/industryinsights/health-groups-ask-india-to-rescind-gilea-319416.html 0.6 2026-06-21T20:16:00+08:00 daily https://www.pharmasources.com/industryinsights/coronavirus-vaccine-possible-in-about-a--319417.html 0.6 2026-06-21T02:14:53+08:00 daily https://www.pharmasources.com/industryinsights/merck-registers-an-increase-of-167-per-c-319418.html 0.6 2026-03-13T15:41:35+08:00 daily https://www.pharmasources.com/industryinsights/novalead-pharma-to-conduct-phase-3-trial-319419.html 0.6 2026-06-22T00:42:38+08:00 daily https://www.pharmasources.com/industryinsights/exyte-and-univercells-technologies-to-de-319420.html 0.6 2026-06-22T09:49:36+08:00 daily https://www.pharmasources.com/industryinsights/cytoagents-gets-nih-funding-to-advance-t-319421.html 0.6 2026-06-21T17:08:29+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-and-cdr-life-to-develop-geogr-319422.html 0.6 2026-08-06T02:31:47+08:00 daily https://www.pharmasources.com/industryinsights/us-likely-to-get-first-access-to-sanofis-319423.html 0.6 2026-06-22T05:10:48+08:00 daily https://www.pharmasources.com/industryinsights/doubt-cast-over-avigan-favipiravir-and-d-319424.html 0.6 2026-06-22T22:01:58+08:00 daily https://www.pharmasources.com/industryinsights/mylan-partners-with-gilead-to-manufactur-319425.html 0.6 2026-07-04T07:24:30+08:00 daily https://www.pharmasources.com/industryinsights/obstructive-hypertrophic-cardiomyopathy--319426.html 0.6 2026-06-21T14:13:12+08:00 daily https://www.pharmasources.com/industryinsights/fda-authorizes-first-antigen-test-for-ra-319427.html 0.6 2026-06-22T02:00:52+08:00 daily https://www.pharmasources.com/industryinsights/lynparza-bevacizumab-combination-approve-319428.html 0.6 2026-08-04T17:32:27+08:00 daily https://www.pharmasources.com/industryinsights/abbott-receives-eua-for-covid-19-antibod-319429.html 0.6 2026-08-12T12:06:13+08:00 daily https://www.pharmasources.com/industryinsights/masterpharm-recalls-finasteride-plus-125-319430.html 0.6 2026-06-24T00:16:19+08:00 daily https://www.pharmasources.com/industryinsights/seattle-genetics-gets-approval-of-tukysa-319431.html 0.6 2026-08-12T23:20:37+08:00 daily https://www.pharmasources.com/industryinsights/sanofis-blood-cancer-drug-sarclisa-meets-319432.html 0.6 2026-07-12T09:46:17+08:00 daily https://www.pharmasources.com/industryinsights/ocular-therapeutix-announces-first-patie-319433.html 0.6 2026-06-18T10:43:50+08:00 daily https://www.pharmasources.com/industryinsights/exvastat-wins-36m-euro-grant-for-covid-1-319434.html 0.6 2026-04-21T05:42:48+08:00 daily https://www.pharmasources.com/industryinsights/eu-regulators-approve-takedas-adcetris-f-319435.html 0.6 2026-06-21T23:01:41+08:00 daily https://www.pharmasources.com/industryinsights/sourcing-from-the-heated-marketplace-in--319436.html 0.6 2026-08-14T15:14:02+08:00 daily https://www.pharmasources.com/industryinsights/centogene-appoints-interim-cbo-319437.html 0.6 2026-06-21T21:03:42+08:00 daily https://www.pharmasources.com/industryinsights/vsy-biotech-develops-tr-c-19-candidate-t-319438.html 0.6 2026-06-26T01:03:04+08:00 daily https://www.pharmasources.com/industryinsights/roche-becomes-founding-partner-in-basela-319439.html 0.6 2026-08-11T20:09:48+08:00 daily https://www.pharmasources.com/industryinsights/bangladeshi-doctors-claim-to-have-found--319440.html 0.6 2026-06-21T11:23:38+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-continues-to-disrupt-clinical-t-319441.html 0.6 2026-06-22T14:54:52+08:00 daily https://www.pharmasources.com/industryinsights/cdsco-issues-recommendations-to-lift-exp-319442.html 0.6 2026-06-21T05:16:57+08:00 daily https://www.pharmasources.com/industryinsights/aiims-bhopal-claims-good-results-in-drug-319443.html 0.6 2026-08-07T19:25:34+08:00 daily https://www.pharmasources.com/industryinsights/874-pharma-units-in-gujarat-working-at-8-319444.html 0.6 2026-06-20T15:40:25+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-receives-tentative-us-fda-a-319445.html 0.6 2026-06-21T05:57:22+08:00 daily https://www.pharmasources.com/industryinsights/pmc-to-dispense-homoeopathy-medicine-in--319446.html 0.6 2026-06-21T10:11:15+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-clinical-trials-exhibit-encoura-319447.html 0.6 2026-03-29T00:52:06+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-acquires-northern-b-319448.html 0.6 2026-07-04T22:56:41+08:00 daily https://www.pharmasources.com/industryinsights/tech-mahindra-leverages-ai-to-research-o-319449.html 0.6 2026-07-01T19:42:14+08:00 daily https://www.pharmasources.com/industryinsights/predictive-oncology-joins-race-to-develo-319450.html 0.6 2026-07-19T04:16:26+08:00 daily https://www.pharmasources.com/industryinsights/oxford-universitys-covid-19-vaccine-show-319451.html 0.6 2026-06-29T03:22:44+08:00 daily https://www.pharmasources.com/industryinsights/spartans-covid-19-test-recall-exposes-is-319452.html 0.6 2026-06-20T19:57:51+08:00 daily https://www.pharmasources.com/industryinsights/app-to-help-enrol-covid-19-patients-into-319453.html 0.6 2026-06-22T04:04:48+08:00 daily https://www.pharmasources.com/industryinsights/hkbu-led-research-team-develops-anti-vir-319454.html 0.6 2026-06-20T19:03:40+08:00 daily https://www.pharmasources.com/industryinsights/beyondspring-granted-patent-for-plinabul-319455.html 0.6 2026-08-06T01:44:38+08:00 daily https://www.pharmasources.com/industryinsights/vyriad-to-develop-antibody-test-to-deter-319456.html 0.6 2026-07-27T12:57:38+08:00 daily https://www.pharmasources.com/industryinsights/neurocrine-biosciences-exercises-option--319457.html 0.6 2026-06-23T09:11:06+08:00 daily https://www.pharmasources.com/industryinsights/fda-warns-of-possible-accuracy-concerns--319458.html 0.6 2026-07-18T19:26:16+08:00 daily https://www.pharmasources.com/industryinsights/catalent-ennaid-therapeutics-collaborate-319459.html 0.6 2026-08-05T21:04:15+08:00 daily https://www.pharmasources.com/industryinsights/roche-launches-new-blood-gas-digital-sol-319460.html 0.6 2026-07-05T12:34:19+08:00 daily https://www.pharmasources.com/industryinsights/ergomed-enters-collaboration-with-automa-319461.html 0.6 2026-08-13T12:30:06+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-signs-covid-19-contract-wi-319462.html 0.6 2026-06-21T10:50:12+08:00 daily https://www.pharmasources.com/industryinsights/bluebird-bio-amends-car-t-collaboration--319463.html 0.6 2026-06-21T04:57:42+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-launches-car-t-cell-therapy-platfor-319464.html 0.6 2026-08-07T21:21:22+08:00 daily https://www.pharmasources.com/industryinsights/duke-genscript-astar-enter-covid-19-pact-319465.html 0.6 2026-06-20T15:34:29+08:00 daily https://www.pharmasources.com/industryinsights/pharmacyte-conducts-final-audit-of-mfg-f-319466.html 0.6 2026-07-01T09:45:52+08:00 daily https://www.pharmasources.com/industryinsights/gsk-reports-revenue-growth-at-3-per-cent-319467.html 0.6 2026-06-21T02:05:46+08:00 daily https://www.pharmasources.com/industryinsights/teva-pharm-gets-approval-in-china-for-hu-319468.html 0.6 2026-06-21T12:50:12+08:00 daily https://www.pharmasources.com/industryinsights/gsks-long-acting-injection-beats-truvada-319469.html 0.6 2026-07-04T19:24:49+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-effect-will-boost-infectious-di-319470.html 0.6 2026-07-07T17:09:40+08:00 daily https://www.pharmasources.com/industryinsights/new-research-into-stem-cell-mutations-co-319471.html 0.6 2026-06-22T06:51:54+08:00 daily https://www.pharmasources.com/industryinsights/uk-to-invest-up-to-93-million-pounds-in--319472.html 0.6 2026-06-22T03:12:53+08:00 daily https://www.pharmasources.com/industryinsights/sorrentos-antibody-completely-blocks-cov-319473.html 0.6 2026-02-28T15:22:08+08:00 daily https://www.pharmasources.com/industryinsights/uk-provides-funding-support-for-covid-19-319474.html 0.6 2026-06-21T11:59:10+08:00 daily https://www.pharmasources.com/industryinsights/most-uk-adults-believe-covid-19-vaccines-319475.html 0.6 2026-06-20T21:55:52+08:00 daily https://www.pharmasources.com/industryinsights/ema-recommends-updating-safety-informati-319476.html 0.6 2026-07-11T21:27:31+08:00 daily https://www.pharmasources.com/industryinsights/phase-iib-trial-to-study-hydroxychloroqu-319477.html 0.6 2026-06-21T01:07:58+08:00 daily https://www.pharmasources.com/industryinsights/rhythm-announces-nda-acceptance-for-setm-319478.html 0.6 2026-08-07T01:10:27+08:00 daily https://www.pharmasources.com/industryinsights/potential-anti-sars-cov-2-antibody-able--319479.html 0.6 2026-08-07T01:07:27+08:00 daily https://www.pharmasources.com/industryinsights/adamas-announces-patent-for-gocovri-in-p-319480.html 0.6 2026-08-07T01:14:15+08:00 daily https://www.pharmasources.com/industryinsights/enzychem-initiates-ec-18-study-to-preven-319481.html 0.6 2026-08-07T01:20:01+08:00 daily https://www.pharmasources.com/industryinsights/neuraptive-therapeutics-announces-fda-ha-319482.html 0.6 2026-08-07T01:21:57+08:00 daily https://www.pharmasources.com/industryinsights/takeda-gets-expanded-ec-approval-for-lym-319483.html 0.6 2026-08-10T13:56:11+08:00 daily https://www.pharmasources.com/industryinsights/new-covid-19-guidelines-for-ckd-and-inte-319484.html 0.6 2026-06-22T03:09:48+08:00 daily https://www.pharmasources.com/industryinsights/viiv-hiv-prevention-trial-stopped-early--319485.html 0.6 2026-06-21T19:45:21+08:00 daily https://www.pharmasources.com/industryinsights/azdaiichi-sankyos-enhertu-picks-up-third-319486.html 0.6 2026-08-06T18:47:27+08:00 daily https://www.pharmasources.com/industryinsights/lupin-launches-authorised-generic-versio-319487.html 0.6 2026-08-08T03:16:34+08:00 daily https://www.pharmasources.com/industryinsights/ashwagandha-can-be-effective-preventive--319488.html 0.6 2026-06-21T13:04:29+08:00 daily https://www.pharmasources.com/industryinsights/acg-receives-certification-for-its-clean-319489.html 0.6 2026-06-24T08:43:31+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-product-shortage-and-imba-319490.html 0.6 2026-08-04T01:58:54+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-closes-land-deal-to-build-319491.html 0.6 2026-07-27T09:14:45+08:00 daily https://www.pharmasources.com/industryinsights/ert-launches-virtual-visit-solutions-to--319492.html 0.6 2026-04-28T08:44:31+08:00 daily https://www.pharmasources.com/industryinsights/laurus-labs-receives-usfda-approvals-for-319493.html 0.6 2026-06-20T15:53:26+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-has-made-effective-use-of-data--319494.html 0.6 2026-06-21T11:04:39+08:00 daily https://www.pharmasources.com/industryinsights/premas-biotech-announces-completion-of-v-319495.html 0.6 2026-06-20T14:43:12+08:00 daily https://www.pharmasources.com/industryinsights/lincoln-pharmaceuticals-receives-eu-gmp--319496.html 0.6 2026-06-20T13:58:20+08:00 daily https://www.pharmasources.com/industryinsights/chemistry-experts-develop-small-crystals-319497.html 0.6 2026-07-06T21:11:15+08:00 daily https://www.pharmasources.com/industryinsights/icmra-to-discuss-alignment-on-policy-app-319498.html 0.6 2026-06-22T12:00:52+08:00 daily https://www.pharmasources.com/industryinsights/biocon-biologics-receives-eu-gmp-certifi-319499.html 0.6 2026-06-20T22:35:04+08:00 daily https://www.pharmasources.com/industryinsights/novartis-avexis-gets-ec-conditional-appr-319500.html 0.6 2026-01-31T10:33:11+08:00 daily https://www.pharmasources.com/industryinsights/jj-signs-covid-19-vaccine-manufacturing--319501.html 0.6 2026-06-21T10:05:09+08:00 daily https://www.pharmasources.com/industryinsights/cipla-to-explore-remdesivir-multi-drug-c-319502.html 0.6 2026-06-21T12:59:27+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-gets-breakthrough-status-for-319503.html 0.6 2026-06-21T09:47:36+08:00 daily https://www.pharmasources.com/industryinsights/akers-premas-biotech-announce-successful-319504.html 0.6 2026-06-20T19:01:35+08:00 daily https://www.pharmasources.com/industryinsights/roivant-releases-gimsilumab-trial-update-319505.html 0.6 2026-06-21T02:15:53+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-covid-19-trial-after-succes-319506.html 0.6 2026-04-08T17:26:36+08:00 daily https://www.pharmasources.com/industryinsights/blueprint-medicines-receives-crl-for-ava-319507.html 0.6 2026-06-22T00:43:33+08:00 daily https://www.pharmasources.com/industryinsights/regenerx-joint-venture-announces-neurotr-319508.html 0.6 2026-06-20T18:58:38+08:00 daily https://www.pharmasources.com/industryinsights/ifn-2b-therapy-shows-promise-in-patients-319509.html 0.6 2026-06-22T14:38:47+08:00 daily https://www.pharmasources.com/industryinsights/stem-cells-used-to-replace-neurons-in-pa-319510.html 0.6 2026-08-10T02:35:18+08:00 daily https://www.pharmasources.com/industryinsights/four-uk-cros-announce-collaboration-to-w-319511.html 0.6 2026-06-21T08:58:15+08:00 daily https://www.pharmasources.com/industryinsights/deciphera-gets-fda-nod-for-qinlock-to-tr-319512.html 0.6 2026-07-31T13:17:06+08:00 daily https://www.pharmasources.com/industryinsights/nantkwest-and-immunitybio-to-initiate-a--319513.html 0.6 2026-06-22T03:52:37+08:00 daily https://www.pharmasources.com/industryinsights/ergomed-teams-up-with-automation-anywher-319514.html 0.6 2026-06-20T23:14:54+08:00 daily https://www.pharmasources.com/industryinsights/new-us-nod-for-roches-tecentriq-in-nsclc-319515.html 0.6 2026-08-06T22:59:24+08:00 daily https://www.pharmasources.com/industryinsights/pharmacists-should-have-greater-powers-t-319516.html 0.6 2026-06-21T03:05:45+08:00 daily https://www.pharmasources.com/industryinsights/uks-coronavirus-testing-capacity-has-bee-319517.html 0.6 2026-06-20T18:37:25+08:00 daily https://www.pharmasources.com/industryinsights/inovalon-launches-covid-19-compass-dashb-319518.html 0.6 2026-08-07T15:20:59+08:00 daily https://www.pharmasources.com/industryinsights/rentschler-horizon-ink-cell-line-develop-319519.html 0.6 2026-07-18T11:52:10+08:00 daily https://www.pharmasources.com/industryinsights/triphase-catalent-announce-interim-trph--319520.html 0.6 2025-11-27T04:53:41+08:00 daily https://www.pharmasources.com/industryinsights/selexis-makes-scientific-and-operational-319521.html 0.6 2025-11-27T15:39:29+08:00 daily https://www.pharmasources.com/industryinsights/sharp-acquires-us-pharma-packaging-facil-319522.html 0.6 2026-08-02T21:37:23+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-expands-us-footprint-319523.html 0.6 2026-06-23T13:35:53+08:00 daily https://www.pharmasources.com/industryinsights/oxford-immunotec-releases-the-t-spot-dis-319524.html 0.6 2026-06-20T15:40:34+08:00 daily https://www.pharmasources.com/industryinsights/bharat-biotech-thomas-jefferson-universi-319525.html 0.6 2026-06-21T04:56:45+08:00 daily https://www.pharmasources.com/industryinsights/early-data-on-modernas-covid-19-vaccine--319526.html 0.6 2026-07-04T02:05:40+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-shares-fall-after-report-avigan-319527.html 0.6 2026-06-21T13:08:31+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-mercks-lynparza-gets-us-fda--319528.html 0.6 2026-06-22T16:52:43+08:00 daily https://www.pharmasources.com/industryinsights/dcgi-approves-nintedanib-for-the-treatme-319529.html 0.6 2026-07-25T17:53:10+08:00 daily https://www.pharmasources.com/industryinsights/govt-nod-for-manufacture-of-covid-19-vac-319530.html 0.6 2026-06-22T10:04:47+08:00 daily https://www.pharmasources.com/industryinsights/roche-enters-135m-drug-discovery-deal-wi-319531.html 0.6 2026-07-30T15:41:56+08:00 daily https://www.pharmasources.com/industryinsights/phlow-secures-354m-us-contract-for-drug--319532.html 0.6 2026-06-21T10:35:39+08:00 daily https://www.pharmasources.com/industryinsights/report-reveals-cmos-in-italy-concentrate-319533.html 0.6 2026-07-28T09:34:31+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-priority-review-to-biologics--319534.html 0.6 2026-08-14T22:05:42+08:00 daily https://www.pharmasources.com/industryinsights/fda-collaborations-promote-rigorous-anal-319535.html 0.6 2026-06-20T16:58:19+08:00 daily https://www.pharmasources.com/industryinsights/seelos-receives-rare-pediatric-disease-d-319536.html 0.6 2026-06-21T07:04:56+08:00 daily https://www.pharmasources.com/industryinsights/10x-genomics-becomes-first-one-medical-c-319537.html 0.6 2026-07-03T07:58:20+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-accelerated-approval-to-pomal-319538.html 0.6 2026-06-21T03:58:54+08:00 daily https://www.pharmasources.com/industryinsights/janssen-announces-phase-1-results-for-am-319539.html 0.6 2026-06-21T04:11:52+08:00 daily https://www.pharmasources.com/industryinsights/novartis-firm-avexis-gets-ec-nod-for-zol-319540.html 0.6 2026-06-20T17:07:22+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-genentechs-tecentriq-as-fir-319541.html 0.6 2026-07-02T15:58:56+08:00 daily https://www.pharmasources.com/industryinsights/modernas-covid-19-vaccine-shows-signific-319542.html 0.6 2026-06-21T01:55:43+08:00 daily https://www.pharmasources.com/industryinsights/can-fite-announces-pre-ind-submission-to-319543.html 0.6 2026-06-20T20:05:46+08:00 daily https://www.pharmasources.com/industryinsights/first-uk-healthcare-worker-to-enrol-in-c-319544.html 0.6 2026-07-30T14:56:38+08:00 daily https://www.pharmasources.com/industryinsights/people-with-diabetes-at-higher-risk-of-a-319545.html 0.6 2026-06-21T02:47:56+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-related-delays-to-cancer-treatm-319546.html 0.6 2026-08-05T22:19:05+08:00 daily https://www.pharmasources.com/industryinsights/roche-partners-with-vividion-on-novel-e3-319547.html 0.6 2026-06-08T05:00:04+08:00 daily https://www.pharmasources.com/industryinsights/ranitidine-banned-again-after-being-remo-319548.html 0.6 2026-08-09T18:11:43+08:00 daily https://www.pharmasources.com/industryinsights/breaking-news-the-second-adc-approved-fo-319549.html 0.6 2026-08-06T14:54:56+08:00 daily https://www.pharmasources.com/industryinsights/strides-pharma-q4-results-posts-net-loss-319550.html 0.6 2026-08-09T14:42:37+08:00 daily https://www.pharmasources.com/industryinsights/cipla-receives-final-approval-for-generi-319551.html 0.6 2026-08-07T06:06:59+08:00 daily https://www.pharmasources.com/industryinsights/powder-flow-manufacturing-support-using--319552.html 0.6 2026-08-04T14:53:34+08:00 daily https://www.pharmasources.com/industryinsights/zhejiang-export-commodity-online-fair-eu-319553.html 0.6 2026-08-06T22:49:59+08:00 daily https://www.pharmasources.com/industryinsights/beigenes-zanubrutinib-to-be-approved-in--319554.html 0.6 2026-08-07T12:04:17+08:00 daily https://www.pharmasources.com/industryinsights/fda-fast-track-for-new-vaccine-during-co-319555.html 0.6 2026-07-27T16:57:17+08:00 daily https://www.pharmasources.com/industryinsights/technical-exploration-of-the-blue-ocean--319556.html 0.6 2026-08-07T12:26:00+08:00 daily https://www.pharmasources.com/industryinsights/top-50-drugs-by-sales-to-sample-hospital-319557.html 0.6 2026-08-07T13:16:35+08:00 daily https://www.pharmasources.com/industryinsights/cell-and-gene-therapies-keep-calm-and-ca-319558.html 0.6 2026-06-22T12:12:05+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-gets-1b-from-us-to-deliver-c-319559.html 0.6 2026-08-07T18:15:07+08:00 daily https://www.pharmasources.com/industryinsights/kindred-vaxart-enter-covid-19-vaccine-ma-319560.html 0.6 2026-08-08T21:33:32+08:00 daily https://www.pharmasources.com/industryinsights/airway-therapeutics-and-celonic-enter-co-319561.html 0.6 2026-08-08T22:01:49+08:00 daily https://www.pharmasources.com/industryinsights/rapid-micro-biosystems-expands-testing-p-319562.html 0.6 2026-08-14T06:55:16+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-initiates-phase-3-clinical-tria-319563.html 0.6 2026-08-09T02:52:53+08:00 daily https://www.pharmasources.com/industryinsights/who-pauses-trial-of-hydroxychloroquine-i-319564.html 0.6 2026-08-09T05:41:07+08:00 daily https://www.pharmasources.com/industryinsights/sutro-biopharma-appoints-clinical-develo-319565.html 0.6 2026-08-09T22:16:07+08:00 daily https://www.pharmasources.com/industryinsights/takara-bio-agc-biologics-enter-plasmid-d-319566.html 0.6 2026-06-21T00:01:39+08:00 daily https://www.pharmasources.com/industryinsights/catalent-acquires-clinical-packaging-fac-319567.html 0.6 2026-06-22T04:01:40+08:00 daily https://www.pharmasources.com/industryinsights/uea-research-calls-for-changes-to-pharma-319568.html 0.6 2026-06-20T20:01:34+08:00 daily https://www.pharmasources.com/industryinsights/glaxosmithkline-signs-manufacture-deal-w-319569.html 0.6 2026-06-21T17:51:22+08:00 daily https://www.pharmasources.com/industryinsights/atomwise-leverages-ai-to-explore-broad-s-319570.html 0.6 2026-08-10T08:39:03+08:00 daily https://www.pharmasources.com/industryinsights/beximco-pharma-launches-first-generic-re-319571.html 0.6 2026-06-22T10:44:38+08:00 daily https://www.pharmasources.com/industryinsights/chinas-sinovac-biotech-gets-funding-for--319572.html 0.6 2026-06-21T09:14:09+08:00 daily https://www.pharmasources.com/industryinsights/company-develops-a-covid-19-test-for-use-319573.html 0.6 2026-06-21T07:13:03+08:00 daily https://www.pharmasources.com/industryinsights/two-malaria-vaccine-candidates-show-sign-319574.html 0.6 2026-06-20T21:58:42+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-lynparza-olaparib-for-hrr-m-319575.html 0.6 2026-07-29T18:10:17+08:00 daily https://www.pharmasources.com/industryinsights/the-covid-19-pandemic-and-clinical-trial-319576.html 0.6 2026-06-21T08:08:04+08:00 daily https://www.pharmasources.com/industryinsights/operation-warp-speed-developing-manufact-319577.html 0.6 2026-06-27T15:47:02+08:00 daily https://www.pharmasources.com/industryinsights/fate-announces-ind-application-clearance-319578.html 0.6 2026-06-20T20:03:46+08:00 daily https://www.pharmasources.com/industryinsights/avexis-receives-ec-approval-activates-da-319579.html 0.6 2026-07-04T01:33:12+08:00 daily https://www.pharmasources.com/industryinsights/cipla-receives-final-approval-for-generi-319580.html 0.6 2026-08-09T04:18:23+08:00 daily https://www.pharmasources.com/industryinsights/bevespi-aerosphere-approved-in-china-for-319581.html 0.6 2026-08-12T12:09:47+08:00 daily https://www.pharmasources.com/industryinsights/arch-biopartners-expands-primary-endpoin-319582.html 0.6 2026-06-21T00:03:42+08:00 daily https://www.pharmasources.com/industryinsights/novavax-launches-trial-of-coronavirus-va-319583.html 0.6 2026-07-16T16:50:14+08:00 daily https://www.pharmasources.com/industryinsights/new-us-approval-for-takedas-alunbrig-319584.html 0.6 2026-08-08T08:58:58+08:00 daily https://www.pharmasources.com/industryinsights/chinese-us-scientists-identify-bacterial-319585.html 0.6 2026-08-14T08:11:02+08:00 daily https://www.pharmasources.com/industryinsights/hamdard-plans-clinical-trial-for-immunit-319586.html 0.6 2026-08-08T23:20:05+08:00 daily https://www.pharmasources.com/industryinsights/bachem-lifts-propofol-production-to-247--319587.html 0.6 2026-08-08T22:35:34+08:00 daily https://www.pharmasources.com/industryinsights/project-leader-oxfords-covid-19-vaccine--319588.html 0.6 2026-06-21T03:00:41+08:00 daily https://www.pharmasources.com/industryinsights/new-study-finds-high-doses-of-vitamin-d--319589.html 0.6 2026-08-08T17:01:04+08:00 daily https://www.pharmasources.com/industryinsights/first-covid-19-vaccine-human-trial-finds-319590.html 0.6 2026-08-08T18:26:26+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-to-sell-stake-in-regeneron-319591.html 0.6 2026-08-08T20:01:31+08:00 daily https://www.pharmasources.com/industryinsights/az-links-with-archerdx-to-detect-minimal-319592.html 0.6 2026-08-08T21:48:44+08:00 daily https://www.pharmasources.com/industryinsights/montefiore-einstein-test-new-drug-combo--319593.html 0.6 2026-06-20T15:13:24+08:00 daily https://www.pharmasources.com/industryinsights/merck-to-acquire-themis-319594.html 0.6 2026-08-09T07:56:53+08:00 daily https://www.pharmasources.com/industryinsights/modernas-phase-i-interim-data-of-mrna-12-319595.html 0.6 2026-07-02T16:00:25+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-begins-phase-iii-trial-of-anti--319596.html 0.6 2026-07-17T09:08:07+08:00 daily https://www.pharmasources.com/industryinsights/phenotypic-screening-and-target-based-dr-319597.html 0.6 2026-08-07T00:03:10+08:00 daily https://www.pharmasources.com/industryinsights/accure-therapeutics-launches-with-76m-se-319598.html 0.6 2026-06-21T05:19:00+08:00 daily https://www.pharmasources.com/industryinsights/chi-med-beigene-enter-clinical-collabora-319599.html 0.6 2026-08-12T11:09:29+08:00 daily https://www.pharmasources.com/industryinsights/at-home-covid-19-antibody-tests-expert-o-319600.html 0.6 2026-06-21T03:03:47+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccine-induces-immune-response-319601.html 0.6 2026-06-21T04:46:32+08:00 daily https://www.pharmasources.com/industryinsights/merck-joins-race-to-develop-covid-19-vac-319602.html 0.6 2026-06-20T17:49:24+08:00 daily https://www.pharmasources.com/industryinsights/canadas-usask-reports-positive-preclinic-319603.html 0.6 2026-06-20T23:58:33+08:00 daily https://www.pharmasources.com/industryinsights/vaxine-and-medytox-partner-on-covid-19-v-319604.html 0.6 2026-06-20T22:05:46+08:00 daily https://www.pharmasources.com/industryinsights/adma-biologics-begins-collection-of-covi-319605.html 0.6 2026-06-21T19:17:49+08:00 daily https://www.pharmasources.com/industryinsights/apellis-to-submit-nda-for-pegcetacoplan--319606.html 0.6 2026-06-20T15:52:02+08:00 daily https://www.pharmasources.com/industryinsights/alethia-announces-receipt-of-fda-authori-319607.html 0.6 2026-06-21T23:53:43+08:00 daily https://www.pharmasources.com/industryinsights/cytrx-begins-aldoxorubicin-phase-2-study-319608.html 0.6 2026-06-21T01:10:52+08:00 daily https://www.pharmasources.com/industryinsights/10x-genomics-launches-targeted-gene-expr-319609.html 0.6 2026-06-22T06:02:39+08:00 daily https://www.pharmasources.com/industryinsights/chiesi-receives-fda-approval-for-ferripr-319610.html 0.6 2026-06-22T03:02:39+08:00 daily https://www.pharmasources.com/industryinsights/pathnostics-launches-covid-19-pcr-labora-319611.html 0.6 2026-06-21T03:02:51+08:00 daily https://www.pharmasources.com/industryinsights/dalmia-group-to-start-clinical-trial-for-319612.html 0.6 2026-07-20T00:12:45+08:00 daily https://www.pharmasources.com/industryinsights/study-reveals-distinct-features-of-decea-319613.html 0.6 2026-06-22T01:50:29+08:00 daily https://www.pharmasources.com/industryinsights/sunovion-gets-fda-nod-for-kynmobi-to-tre-319614.html 0.6 2026-06-20T16:10:46+08:00 daily https://www.pharmasources.com/industryinsights/nice-u-turn-backs-roches-tecentriq-for-t-319615.html 0.6 2026-08-10T18:08:36+08:00 daily https://www.pharmasources.com/industryinsights/researchers-investigate-impact-of-lockdo-319616.html 0.6 2026-06-22T22:09:04+08:00 daily https://www.pharmasources.com/industryinsights/algernon-submits-ind-application-with-fd-319617.html 0.6 2026-06-20T20:12:40+08:00 daily https://www.pharmasources.com/industryinsights/antisense-atl1102-final-phase-2-dmd-resu-319618.html 0.6 2026-07-07T05:29:18+08:00 daily https://www.pharmasources.com/industryinsights/gilead-and-galapagos-announce-positive-t-319619.html 0.6 2026-08-12T10:20:36+08:00 daily https://www.pharmasources.com/industryinsights/dst-serb-supports-study-to-identify-stru-319620.html 0.6 2026-08-13T07:28:24+08:00 daily https://www.pharmasources.com/industryinsights/indoco-receives-us-fda-approval-for-succ-319621.html 0.6 2026-06-20T19:13:00+08:00 daily https://www.pharmasources.com/industryinsights/treatment-for-a-form-of-bladder-dysfunct-319622.html 0.6 2026-07-18T01:00:27+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-the-only-drug-in-us-to-t-319623.html 0.6 2026-06-21T13:14:40+08:00 daily https://www.pharmasources.com/industryinsights/biocon-biologics-gets-dcgi-approval-for--319624.html 0.6 2026-06-21T12:23:48+08:00 daily https://www.pharmasources.com/industryinsights/ficci-submits-recommendations-to-governm-319625.html 0.6 2026-06-21T06:00:44+08:00 daily https://www.pharmasources.com/industryinsights/merck-and-ridgeback-bio-collaborate-319626.html 0.6 2026-06-21T00:12:45+08:00 daily https://www.pharmasources.com/industryinsights/ajinomoto-bio-pharma-partners-with-human-319627.html 0.6 2026-06-21T09:01:00+08:00 daily https://www.pharmasources.com/industryinsights/novasep-lysogene-enter-gene-therapy-coll-319628.html 0.6 2026-06-21T20:00:37+08:00 daily https://www.pharmasources.com/industryinsights/gsk-partners-with-samsung-biologics-319629.html 0.6 2026-08-06T14:56:11+08:00 daily https://www.pharmasources.com/industryinsights/novavax-expands-large-scale-global-manuf-319630.html 0.6 2026-06-21T12:56:35+08:00 daily https://www.pharmasources.com/industryinsights/abcellera-raises-105m-for-antibody-drug--319631.html 0.6 2026-08-06T23:45:05+08:00 daily https://www.pharmasources.com/industryinsights/uk-grants-early-access-to-gileads-remdes-319632.html 0.6 2026-08-06T23:36:51+08:00 daily https://www.pharmasources.com/industryinsights/ema-commissions-research-in-preparation--319633.html 0.6 2026-08-06T23:33:22+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-phexxi-vaginal-gel-for-prev-319634.html 0.6 2026-08-06T21:41:08+08:00 daily https://www.pharmasources.com/industryinsights/ispe-announces-new-ceo-and-president-319635.html 0.6 2026-08-06T20:08:43+08:00 daily https://www.pharmasources.com/industryinsights/abbott-releases-interim-study-data-on-id-319636.html 0.6 2026-08-07T12:04:10+08:00 daily https://www.pharmasources.com/industryinsights/montefiore-einstein-scientists-lead-two--319637.html 0.6 2026-08-07T19:28:19+08:00 daily https://www.pharmasources.com/industryinsights/fda-provides-promised-transparency-for-a-319638.html 0.6 2026-08-07T13:16:17+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-ripretinib-for-advanced-gas-319639.html 0.6 2026-08-08T03:08:43+08:00 daily https://www.pharmasources.com/industryinsights/oculis-reports-positive-data-from-ocs-01-319640.html 0.6 2026-08-08T03:45:59+08:00 daily https://www.pharmasources.com/industryinsights/heron-announces-initiation-of-study-of-h-319641.html 0.6 2026-08-08T04:27:59+08:00 daily https://www.pharmasources.com/industryinsights/shionogi-to-buy-tetra-therapeutics-in-50-319642.html 0.6 2026-08-08T07:31:27+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-takedas-alunbrig-for-rar-319643.html 0.6 2026-08-01T12:00:57+08:00 daily https://www.pharmasources.com/industryinsights/novaremed-seeks-fda-nod-for-evaluating-n-319644.html 0.6 2026-08-05T22:38:38+08:00 daily https://www.pharmasources.com/industryinsights/enhertu-granted-orphan-drug-designation--319645.html 0.6 2026-08-01T18:54:16+08:00 daily https://www.pharmasources.com/industryinsights/appili-set-to-evaluate-favipiravir-as-pr-319646.html 0.6 2026-06-21T08:43:45+08:00 daily https://www.pharmasources.com/industryinsights/peer-reviewed-data-shows-remdesivir-for--319647.html 0.6 2026-06-21T03:14:52+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-intends-to-sell-its-equity-invest-319648.html 0.6 2026-08-09T05:41:14+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-launches-social-responsibil-319649.html 0.6 2026-08-09T02:11:01+08:00 daily https://www.pharmasources.com/industryinsights/new-analysis-shows-survival-benefit-of-n-319650.html 0.6 2026-08-07T13:57:46+08:00 daily https://www.pharmasources.com/industryinsights/nice-issues-final-guidance-on-nhs-use-of-319651.html 0.6 2026-08-07T13:15:31+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-asks-five-firms-to-recall-diabete-319652.html 0.6 2026-08-07T01:21:54+08:00 daily https://www.pharmasources.com/industryinsights/sparc-and-sun-pharma-enter-into-license--319653.html 0.6 2026-08-07T13:19:45+08:00 daily https://www.pharmasources.com/industryinsights/novartis-inks-deal-to-make-mass-general--319654.html 0.6 2026-06-22T22:59:56+08:00 daily https://www.pharmasources.com/industryinsights/shilpa-medicare-ibrushil-for-treatment-o-319655.html 0.6 2026-06-13T10:44:03+08:00 daily https://www.pharmasources.com/industryinsights/gsk-says-science-does-not-link-pandemic--319656.html 0.6 2026-06-22T11:49:08+08:00 daily https://www.pharmasources.com/industryinsights/dgft-lifts-export-restrictions-on-parace-319657.html 0.6 2026-02-28T15:34:54+08:00 daily https://www.pharmasources.com/industryinsights/indian-immunologicals-launches-classical-319658.html 0.6 2026-08-10T15:13:28+08:00 daily https://www.pharmasources.com/industryinsights/two-anti-inflammatory-drugs-may-inhibit--319659.html 0.6 2026-08-07T01:14:21+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-reports-59-per-cent-fall-in-c-319660.html 0.6 2026-08-07T01:06:45+08:00 daily https://www.pharmasources.com/industryinsights/mrna-based-vaccine-technology-innovate-a-319661.html 0.6 2026-08-13T19:03:30+08:00 daily https://www.pharmasources.com/industryinsights/gilead-and-arcus-biosciences-partner-to--319662.html 0.6 2026-08-07T00:43:00+08:00 daily https://www.pharmasources.com/industryinsights/biota-biosciences-recalls-cbd-products-319663.html 0.6 2026-08-07T00:40:18+08:00 daily https://www.pharmasources.com/industryinsights/milliporesigma-baylor-college-of-medicin-319664.html 0.6 2026-08-07T00:02:58+08:00 daily https://www.pharmasources.com/industryinsights/novavax-buys-praha-vaccines-for-covid-19-319665.html 0.6 2026-08-06T23:54:51+08:00 daily https://www.pharmasources.com/industryinsights/israeli-scientists-say-gauchers-disease--319666.html 0.6 2026-08-06T22:21:22+08:00 daily https://www.pharmasources.com/industryinsights/experimental-stem-cell-therapy-trial-for-319667.html 0.6 2026-08-06T22:09:15+08:00 daily https://www.pharmasources.com/industryinsights/dose-adjusted-chemotherapy-regimen-effec-319668.html 0.6 2026-08-06T23:37:06+08:00 daily https://www.pharmasources.com/industryinsights/avexis-enters-mfg-pact-for-novel-genetic-319669.html 0.6 2026-08-06T23:46:28+08:00 daily https://www.pharmasources.com/industryinsights/advent-srl-manufactures-13000-doses-of-n-319670.html 0.6 2026-08-11T10:34:12+08:00 daily https://www.pharmasources.com/industryinsights/roche-initiates-phase-iii-trial-in-covid-319671.html 0.6 2026-08-13T18:47:52+08:00 daily https://www.pharmasources.com/industryinsights/almac-receives-grant-to-support-covid-19-319672.html 0.6 2026-08-07T00:21:23+08:00 daily https://www.pharmasources.com/industryinsights/arranta-bio-expands-microbiome-capacity--319673.html 0.6 2026-08-11T16:33:15+08:00 daily https://www.pharmasources.com/industryinsights/lonza-sanquin-reagents-enter-strategic-p-319674.html 0.6 2026-08-07T00:40:49+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-priority-review-of-nucala-for-319675.html 0.6 2026-08-07T01:14:22+08:00 daily https://www.pharmasources.com/industryinsights/phasebio-gets-fda-nod-to-begin-covid-19--319676.html 0.6 2026-08-07T01:19:26+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-opdivo-yervoy-combined-with-319677.html 0.6 2026-08-07T01:27:34+08:00 daily https://www.pharmasources.com/industryinsights/msds-keytruda-doubles-pfs-in-bowel-cance-319678.html 0.6 2026-08-07T03:33:36+08:00 daily https://www.pharmasources.com/industryinsights/puretech-advances-experimental-covid-19--319679.html 0.6 2026-06-21T02:02:47+08:00 daily https://www.pharmasources.com/industryinsights/nice-u-turn-backs-roches-tecentriq-for-s-319680.html 0.6 2026-06-21T05:59:50+08:00 daily https://www.pharmasources.com/industryinsights/researchers-develop-ai-tool-able-to-pred-319681.html 0.6 2026-07-05T13:45:38+08:00 daily https://www.pharmasources.com/industryinsights/old-drugs-for-new-indications-319682.html 0.6 2026-08-10T07:05:07+08:00 daily https://www.pharmasources.com/industryinsights/researchers-decode-neurological-symptoms-319683.html 0.6 2026-06-22T23:28:42+08:00 daily https://www.pharmasources.com/industryinsights/dbt-establishes-four-covid-19-bio-banks-319684.html 0.6 2026-07-30T13:35:17+08:00 daily https://www.pharmasources.com/industryinsights/gilead-seeks-marketing-authorisation-fro-319685.html 0.6 2026-06-21T09:04:05+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-gets-dcgi-nod-for-clinical-tr-319686.html 0.6 2026-08-11T09:07:37+08:00 daily https://www.pharmasources.com/industryinsights/new-vaccine-for-prevention-of-ebola-viru-319687.html 0.6 2026-08-10T05:04:37+08:00 daily https://www.pharmasources.com/industryinsights/eu-plans-permanent-stockpile-of-essentia-319688.html 0.6 2026-06-20T23:01:40+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-says-it-may-consider-exposin-319689.html 0.6 2025-12-12T02:06:46+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-first-drug-to-image-tau--319690.html 0.6 2026-06-21T07:05:59+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-ties-up-with-glass-maker-corning--319691.html 0.6 2026-06-21T12:09:14+08:00 daily https://www.pharmasources.com/industryinsights/gilead-and-arcus-ink-2b-cancer-partnersh-319692.html 0.6 2026-08-07T00:22:11+08:00 daily https://www.pharmasources.com/industryinsights/cordenpharma-moderna-extend-manufacturin-319693.html 0.6 2026-08-06T15:40:16+08:00 daily https://www.pharmasources.com/industryinsights/labcorp-accelerates-adoption-of-decentra-319694.html 0.6 2026-06-22T08:56:38+08:00 daily https://www.pharmasources.com/industryinsights/chimeron-bio-and-ncbid-to-develop-covid--319695.html 0.6 2026-06-21T06:03:19+08:00 daily https://www.pharmasources.com/industryinsights/novartis-avexis-agrees-to-manufacture-us-319696.html 0.6 2026-06-21T05:06:44+08:00 daily https://www.pharmasources.com/industryinsights/gsk-plans-to-produce-one-billion-pandemi-319697.html 0.6 2026-06-20T19:16:56+08:00 daily https://www.pharmasources.com/industryinsights/cdmo-delivers-4000-doses-of-covid-19-vac-319698.html 0.6 2026-06-22T04:02:40+08:00 daily https://www.pharmasources.com/industryinsights/fda-lists-beckman-coulter-rna-extraction-319699.html 0.6 2026-06-21T20:41:27+08:00 daily https://www.pharmasources.com/industryinsights/neurobo-announces-continuation-of-partia-319700.html 0.6 2026-07-20T00:08:48+08:00 daily https://www.pharmasources.com/industryinsights/acella-recalls-thyroid-due-to-super-pote-319701.html 0.6 2026-07-01T08:57:31+08:00 daily https://www.pharmasources.com/industryinsights/parkinsons-therapy-funded-by-njff-receiv-319702.html 0.6 2026-06-22T15:38:32+08:00 daily https://www.pharmasources.com/industryinsights/lonza-sanquin-partner-for-commercializat-319703.html 0.6 2026-06-21T23:09:54+08:00 daily https://www.pharmasources.com/industryinsights/dupixent-eosinophilic-esophagitis-trial--319704.html 0.6 2026-08-14T20:37:21+08:00 daily https://www.pharmasources.com/industryinsights/fda-authorizes-quest-diagnostics-covid-1-319705.html 0.6 2026-06-21T00:14:02+08:00 daily https://www.pharmasources.com/industryinsights/glucocorticoids-are-harmful-in-treating--319706.html 0.6 2026-07-02T21:46:03+08:00 daily https://www.pharmasources.com/industryinsights/roche-initiates-phase-iii-clinical-trial-319707.html 0.6 2026-06-21T09:07:24+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-receives-ec-approva-319708.html 0.6 2026-08-04T08:13:07+08:00 daily https://www.pharmasources.com/industryinsights/tagrisso-shows-unprecedented-disease-fre-319709.html 0.6 2026-06-21T07:12:12+08:00 daily https://www.pharmasources.com/industryinsights/cruk-latus-and-edinburgh-uni-launch-test-319710.html 0.6 2026-03-12T17:38:26+08:00 daily https://www.pharmasources.com/industryinsights/government-launches-coronavirus-test-and-319711.html 0.6 2026-06-20T17:48:45+08:00 daily https://www.pharmasources.com/industryinsights/lupin-q4-net-profit-rises-35-pc-to-rs-39-319712.html 0.6 2026-06-20T21:56:43+08:00 daily https://www.pharmasources.com/industryinsights/2020-zhejiang-export-commodity-online-fa-319713.html 0.6 2026-07-28T20:37:21+08:00 daily https://www.pharmasources.com/industryinsights/highfine-engineering-ltd--virtual-factor-319714.html 0.6 2026-06-21T01:56:39+08:00 daily https://www.pharmasources.com/industryinsights/highfine-engineering-ltd---virtual-facto-319715.html 0.6 2026-07-11T04:25:38+08:00 daily https://www.pharmasources.com/industryinsights/biocons-partner-mylan-receives-favourabl-319716.html 0.6 2026-07-05T13:36:44+08:00 daily https://www.pharmasources.com/industryinsights/nppa-releases-a-list-of-reduced-prices-o-319717.html 0.6 2026-08-08T04:09:34+08:00 daily https://www.pharmasources.com/industryinsights/stempeutics-india-and-novumcella-japan-t-319718.html 0.6 2026-06-21T14:59:24+08:00 daily https://www.pharmasources.com/industryinsights/biogenerics-companies-need-to-focus-on-r-319719.html 0.6 2026-07-01T15:35:47+08:00 daily https://www.pharmasources.com/industryinsights/pharma-leaders-policy-makers-discuss-cov-319720.html 0.6 2026-06-20T22:38:40+08:00 daily https://www.pharmasources.com/industryinsights/celltrion-says-covid-19-drug-shows-drop--319721.html 0.6 2026-08-11T08:06:38+08:00 daily https://www.pharmasources.com/industryinsights/30-countries-launch-initiative-to-share--319722.html 0.6 2026-07-01T07:05:52+08:00 daily https://www.pharmasources.com/industryinsights/new-coronavirus-losing-potency-top-itali-319723.html 0.6 2026-06-20T16:21:39+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-heart-disease-drug-brilinta-319724.html 0.6 2026-07-08T08:23:04+08:00 daily https://www.pharmasources.com/industryinsights/russia-grants-temporary-approval-for-avi-319725.html 0.6 2026-06-21T10:06:13+08:00 daily https://www.pharmasources.com/industryinsights/lilly-abcellera-dose-first-patients-with-319726.html 0.6 2026-06-21T06:19:11+08:00 daily https://www.pharmasources.com/industryinsights/labcorp-launches-new-covid-19-clinical-t-319727.html 0.6 2026-06-21T12:01:17+08:00 daily https://www.pharmasources.com/industryinsights/proteostasis-gets-positive-preclinical-r-319728.html 0.6 2026-01-30T23:43:11+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-cyramza-ramucirumab-for-egf-319729.html 0.6 2026-08-08T17:39:34+08:00 daily https://www.pharmasources.com/industryinsights/60000-doses-of-avifavir-a-covid-19-treat-319730.html 0.6 2026-06-21T12:55:52+08:00 daily https://www.pharmasources.com/industryinsights/junshi-biosciences-merck-partner-on-scch-319731.html 0.6 2026-07-25T08:58:43+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-intellia-expand-crisprcas9-all-319732.html 0.6 2026-06-21T20:47:36+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-apptec-appoints-advanced-therapies--319733.html 0.6 2026-08-07T09:14:28+08:00 daily https://www.pharmasources.com/industryinsights/lonza-and-sanquin-partner-for-commercial-319734.html 0.6 2026-06-21T21:53:54+08:00 daily https://www.pharmasources.com/industryinsights/kisqali-shows-overall-survival-benefit-i-319735.html 0.6 2026-06-22T00:05:08+08:00 daily https://www.pharmasources.com/industryinsights/aerpio-quantum-leap-select-razuprotafib--319736.html 0.6 2026-06-22T00:51:44+08:00 daily https://www.pharmasources.com/industryinsights/relmada-announces-outcome-of-fda-meeting-319737.html 0.6 2026-06-20T16:20:17+08:00 daily https://www.pharmasources.com/industryinsights/durect-announces-positive-topline-data-f-319738.html 0.6 2026-06-20T23:56:34+08:00 daily https://www.pharmasources.com/industryinsights/amivas-announces-fda-approval-of-artesun-319739.html 0.6 2026-06-20T19:09:42+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-brigatinib-for-alk-positive-319740.html 0.6 2026-07-25T14:40:31+08:00 daily https://www.pharmasources.com/industryinsights/roche-to-begin-covid-19-pneumonia-trial--319741.html 0.6 2026-06-21T23:53:44+08:00 daily https://www.pharmasources.com/industryinsights/lynparza-backed-by-chmp-for-brca-mutated-319742.html 0.6 2026-06-21T09:49:02+08:00 daily https://www.pharmasources.com/industryinsights/uk-study-highlights-potential-of-genetic-319743.html 0.6 2026-06-22T18:58:18+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-ibrance-unlikely-to-hit-key-earl-319744.html 0.6 2026-06-21T11:00:17+08:00 daily https://www.pharmasources.com/industryinsights/new-vaccine-for-ebola-among-chmp-recomme-319745.html 0.6 2026-07-17T09:20:08+08:00 daily https://www.pharmasources.com/industryinsights/dockweiler-asia-co-ltd--virtual-factory--319746.html 0.6 2026-08-14T12:57:51+08:00 daily https://www.pharmasources.com/industryinsights/dockweiler-asia-co-ltd---virtual-factory-319747.html 0.6 2026-06-20T22:14:14+08:00 daily https://www.pharmasources.com/industryinsights/cisen-pharmaceutical-coltd--virtual-fact-319748.html 0.6 2026-06-22T16:33:19+08:00 daily https://www.pharmasources.com/industryinsights/cisen-pharmaceutical-coltd---virtual-fac-319749.html 0.6 2026-06-22T06:59:02+08:00 daily https://www.pharmasources.com/industryinsights/gan-lee-pharmaceuticals--virtual-factory-319750.html 0.6 2026-06-22T00:02:46+08:00 daily https://www.pharmasources.com/industryinsights/gan-lee-pharmaceuticals---virtual-factor-319751.html 0.6 2026-08-10T14:32:07+08:00 daily https://www.pharmasources.com/industryinsights/hebei-changshan-biochemical-pharmaceutic-319752.html 0.6 2026-07-05T13:51:23+08:00 daily https://www.pharmasources.com/industryinsights/hebei-changshan-biochemical-pharmaceutic-319753.html 0.6 2026-06-21T05:52:45+08:00 daily https://www.pharmasources.com/industryinsights/hubei-humanwell-pharmaceutical-excipient-319754.html 0.6 2026-08-05T21:24:56+08:00 daily https://www.pharmasources.com/industryinsights/hubei-humanwell-pharmaceutical-excipient-319755.html 0.6 2026-08-11T18:53:50+08:00 daily https://www.pharmasources.com/industryinsights/baoding-shenchen-precision-pump-co-ltd---319756.html 0.6 2026-06-22T11:01:47+08:00 daily https://www.pharmasources.com/industryinsights/baoding-shenchen-precision-pump-co-ltd---319757.html 0.6 2026-06-20T20:01:33+08:00 daily https://www.pharmasources.com/industryinsights/hangzhou-qogori-technology-co-ltd--virtu-319758.html 0.6 2026-06-21T20:57:42+08:00 daily https://www.pharmasources.com/industryinsights/hangzhou-qogori-technology-co-ltd---virt-319759.html 0.6 2026-06-25T12:30:33+08:00 daily https://www.pharmasources.com/industryinsights/jiangyin-yatai-cleaning-equipment-techno-319760.html 0.6 2026-06-23T04:04:12+08:00 daily https://www.pharmasources.com/industryinsights/jiangyin-yatai-cleaning-equipment-techno-319761.html 0.6 2026-06-22T12:47:58+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-guanya-refrigeration-technology-col-319762.html 0.6 2026-06-21T12:21:28+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-guanya-refrigeration-technology-col-319763.html 0.6 2026-07-06T18:49:05+08:00 daily https://www.pharmasources.com/industryinsights/lupin-receives-us-fda-approval-for-melox-319764.html 0.6 2026-07-19T00:42:13+08:00 daily https://www.pharmasources.com/industryinsights/indias-only-certified-tb-bacteria-and-h1-319765.html 0.6 2026-07-06T18:21:45+08:00 daily https://www.pharmasources.com/industryinsights/te-herenga-wakavictoria-university-nz-pr-319766.html 0.6 2026-06-20T19:17:57+08:00 daily https://www.pharmasources.com/industryinsights/indian-pharma-companies-looking-to-lever-319767.html 0.6 2026-04-24T06:16:04+08:00 daily https://www.pharmasources.com/industryinsights/jubilant-life-sciences-posts-rs-26049-cr-319768.html 0.6 2026-08-08T01:23:26+08:00 daily https://www.pharmasources.com/industryinsights/gileads-remdesivir-shows-modest-improvem-319769.html 0.6 2026-06-21T11:13:24+08:00 daily https://www.pharmasources.com/industryinsights/russia-to-roll-out-its-first-approved-co-319770.html 0.6 2026-07-05T17:25:05+08:00 daily https://www.pharmasources.com/industryinsights/psoriasis-digital-landscape-for-patients-319771.html 0.6 2026-07-16T13:24:41+08:00 daily https://www.pharmasources.com/industryinsights/traditional-chinese-medicine-like-a-cup--319772.html 0.6 2026-07-28T21:09:51+08:00 daily https://www.pharmasources.com/industryinsights/strides-receives-usfda-approval-for-tria-319773.html 0.6 2026-06-20T15:46:50+08:00 daily https://www.pharmasources.com/industryinsights/pharma-industry-welcomes-emergency-credi-319774.html 0.6 2026-06-20T20:11:43+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-partners-with-jacobio-pharmaceuti-319775.html 0.6 2026-06-20T14:38:32+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-and-intellia-to-develop-new-ha-319776.html 0.6 2026-08-01T19:30:25+08:00 daily https://www.pharmasources.com/industryinsights/emergent-gets-628m-covid-19-vaccine-manu-319777.html 0.6 2026-01-14T09:10:00+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-unveils-500m-biotech-fund-319778.html 0.6 2026-07-24T15:54:06+08:00 daily https://www.pharmasources.com/industryinsights/catalent-names-charles-lickfold-as-chief-319779.html 0.6 2026-06-22T12:39:01+08:00 daily https://www.pharmasources.com/industryinsights/pci-and-experic-join-forces-in-drug-supp-319780.html 0.6 2026-08-06T20:46:58+08:00 daily https://www.pharmasources.com/industryinsights/milliporesigma-and-baylor-enter-covid-19-319781.html 0.6 2026-06-21T09:50:11+08:00 daily https://www.pharmasources.com/industryinsights/point-biopharma-to-launch-first-us-manuf-319782.html 0.6 2026-02-15T04:08:20+08:00 daily https://www.pharmasources.com/industryinsights/simple-but-effective-an-experimental-nan-319783.html 0.6 2026-02-15T13:58:16+08:00 daily https://www.pharmasources.com/industryinsights/emergent-to-assist-in-production-of-us-c-319784.html 0.6 2026-06-21T10:06:10+08:00 daily https://www.pharmasources.com/industryinsights/mass-spectrometry-identifies-biomarkers--319785.html 0.6 2026-06-21T14:41:17+08:00 daily https://www.pharmasources.com/industryinsights/ajinomoto-bio-pharma-completes-acquisiti-319786.html 0.6 2026-07-12T07:51:30+08:00 daily https://www.pharmasources.com/industryinsights/novartis-announces-new-ofatumumab-data-a-319787.html 0.6 2026-07-21T10:06:46+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-release-results-for-anti-gm-csf-an-319788.html 0.6 2026-08-10T15:16:09+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-treatment-for-bladder-dysfu-319789.html 0.6 2026-08-08T15:51:52+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-nivolumab-plus-ipilimumab-c-319790.html 0.6 2026-08-08T10:49:38+08:00 daily https://www.pharmasources.com/industryinsights/moleculin-provides-update-on-coronavirus-319791.html 0.6 2026-08-07T13:19:41+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-indication-for-astrazen-319792.html 0.6 2026-08-07T01:42:56+08:00 daily https://www.pharmasources.com/industryinsights/imfinzi-shows-sustained-os-benefit-in-fi-319793.html 0.6 2026-08-07T01:27:56+08:00 daily https://www.pharmasources.com/industryinsights/genentech-gets-fda-approval-for-tecentri-319794.html 0.6 2026-08-07T01:21:38+08:00 daily https://www.pharmasources.com/industryinsights/lupin-signs-distribution-agreement-in-eu-319795.html 0.6 2026-08-07T02:32:09+08:00 daily https://www.pharmasources.com/industryinsights/nppa-fixes-retail-prices-for-40-formulat-319796.html 0.6 2026-08-07T02:37:08+08:00 daily https://www.pharmasources.com/industryinsights/lonza-sets-new-goal-to-make-moderna-covi-319797.html 0.6 2026-08-07T02:40:21+08:00 daily https://www.pharmasources.com/industryinsights/nurses-a-barrier-between-patients-and-co-319798.html 0.6 2026-08-07T02:42:57+08:00 daily https://www.pharmasources.com/industryinsights/nppa-issues-draft-guidelines-to-tackle-c-319799.html 0.6 2026-08-07T12:03:13+08:00 daily https://www.pharmasources.com/industryinsights/iit-bhu-to-re-purpose-approved-drugs-fro-319800.html 0.6 2026-08-07T13:17:15+08:00 daily https://www.pharmasources.com/industryinsights/syngene-ties-up-with-himedia-laboratorie-319801.html 0.6 2026-08-07T13:54:40+08:00 daily https://www.pharmasources.com/industryinsights/3d-printing-in-healthcare-healthcare-tre-319802.html 0.6 2026-08-08T01:01:19+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-gets-ec-approval-for-sarclisa-to--319803.html 0.6 2026-08-08T01:44:53+08:00 daily https://www.pharmasources.com/industryinsights/baylor-college-and-texas-childrens-to-ad-319804.html 0.6 2026-02-28T23:26:10+08:00 daily https://www.pharmasources.com/industryinsights/intravacc-and-epivax-to-develop-covid-19-319805.html 0.6 2026-06-20T14:52:05+08:00 daily https://www.pharmasources.com/industryinsights/octapharma-extends-funding-for-covid-19--319806.html 0.6 2026-06-22T13:03:24+08:00 daily https://www.pharmasources.com/industryinsights/fsd-pharma-gets-go-ahead-for-phase-iia-c-319807.html 0.6 2026-06-20T20:59:05+08:00 daily https://www.pharmasources.com/industryinsights/novavax-selects-agc-biologics-to-manufac-319808.html 0.6 2026-06-21T00:54:55+08:00 daily https://www.pharmasources.com/industryinsights/global-regulatory-authorities-covid-19-p-319809.html 0.6 2026-06-21T16:05:22+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-convalescent-plasma-therapy-sho-319810.html 0.6 2026-06-21T05:52:48+08:00 daily https://www.pharmasources.com/industryinsights/seelos-announces-initiation-of-preclinic-319811.html 0.6 2026-06-21T12:14:21+08:00 daily https://www.pharmasources.com/industryinsights/apellis-initiates-study-of-apl-9-in-pati-319812.html 0.6 2026-06-20T20:03:39+08:00 daily https://www.pharmasources.com/industryinsights/arca-announces-ab201-development-program-319813.html 0.6 2026-06-21T20:58:37+08:00 daily https://www.pharmasources.com/industryinsights/fda-provides-new-tool-to-aid-development-319814.html 0.6 2026-06-21T09:10:24+08:00 daily https://www.pharmasources.com/industryinsights/first-do-no-harm---researchers-urge-halt-319815.html 0.6 2026-06-21T10:23:19+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-drug-development-could-benefit--319816.html 0.6 2026-06-23T00:27:20+08:00 daily https://www.pharmasources.com/industryinsights/bayer-to-support-harvard-research-study--319817.html 0.6 2026-06-21T03:58:45+08:00 daily https://www.pharmasources.com/industryinsights/aveo-oncology-announces-fda-acceptance-f-319818.html 0.6 2026-06-21T02:01:37+08:00 daily https://www.pharmasources.com/industryinsights/codiak-biosciences-collaborates-with-rag-319819.html 0.6 2026-07-10T13:43:03+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-dosed-in-bemcentinib-covid-319820.html 0.6 2026-08-14T06:21:46+08:00 daily https://www.pharmasources.com/industryinsights/roches-tecentriqavastin-combo-wins-us-ap-319821.html 0.6 2026-06-21T05:59:49+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-files-rinvoq-for-psoriatic-arthri-319822.html 0.6 2026-06-21T11:12:18+08:00 daily https://www.pharmasources.com/industryinsights/iterum-hit-by-failure-of-anti-infective--319823.html 0.6 2026-06-21T10:42:01+08:00 daily https://www.pharmasources.com/industryinsights/coronavirus-bottleneck-leaves-2m-waiting-319824.html 0.6 2026-06-20T21:09:46+08:00 daily https://www.pharmasources.com/industryinsights/traditional-chinese-medicine-prunella-vu-319825.html 0.6 2026-08-11T22:31:34+08:00 daily https://www.pharmasources.com/industryinsights/pharma-sources-insight-june-2020-your-fr-319826.html 0.6 2026-08-07T00:15:43+08:00 daily https://www.pharmasources.com/industryinsights/novavax-gets-us-defense-funding-for-its--319827.html 0.6 2026-06-21T15:12:32+08:00 daily https://www.pharmasources.com/industryinsights/gavi-to-award-75-million-to-serum-instit-319828.html 0.6 2026-08-06T23:37:38+08:00 daily https://www.pharmasources.com/industryinsights/dalmia-healthcare-starts-clinical-trial--319829.html 0.6 2025-12-20T21:36:43+08:00 daily https://www.pharmasources.com/industryinsights/ncvtc-to-develop-host-directed-antiviral-319830.html 0.6 2026-01-31T10:03:17+08:00 daily https://www.pharmasources.com/industryinsights/lupin-and-mylan-receive-european-marketi-319831.html 0.6 2026-07-14T16:07:51+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-mercks-antibiotic-drug-to-t-319832.html 0.6 2026-08-09T09:10:24+08:00 daily https://www.pharmasources.com/industryinsights/bill-melinda-gates-foundation-pledges-16-319833.html 0.6 2026-06-21T05:56:41+08:00 daily https://www.pharmasources.com/industryinsights/ipa-and-bcg-bring-out-report-on-future-o-319834.html 0.6 2026-06-21T08:00:58+08:00 daily https://www.pharmasources.com/industryinsights/memo-therapeutics-discovers-neutralising-319835.html 0.6 2026-06-21T01:25:43+08:00 daily https://www.pharmasources.com/industryinsights/optimism-over-global-economic-recovery-h-319836.html 0.6 2026-06-22T08:50:40+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-teams-up-with-accent-therape-319837.html 0.6 2026-06-20T17:15:35+08:00 daily https://www.pharmasources.com/industryinsights/agc-biologics-to-produce-covid-19-vaccin-319838.html 0.6 2026-06-22T18:09:08+08:00 daily https://www.pharmasources.com/industryinsights/lilly-launches-phase-i-trial-of-investig-319839.html 0.6 2026-08-11T18:49:39+08:00 daily https://www.pharmasources.com/industryinsights/interim-analysis-indicates-auxora-is-eff-319840.html 0.6 2026-06-24T01:23:05+08:00 daily https://www.pharmasources.com/industryinsights/apotex-issues-recall-of-metformin-hydroc-319841.html 0.6 2026-03-19T09:28:31+08:00 daily https://www.pharmasources.com/industryinsights/proteostasis-announces-in-vitro-data-for-319842.html 0.6 2026-07-04T09:28:16+08:00 daily https://www.pharmasources.com/industryinsights/cti-biopharma-announces-enrollment-of-fi-319843.html 0.6 2026-06-20T21:52:37+08:00 daily https://www.pharmasources.com/industryinsights/bird-rock-bio-files-ind-for-study-of-nim-319844.html 0.6 2026-07-05T16:04:36+08:00 daily https://www.pharmasources.com/industryinsights/biogen-launches-digital-self-help-tool-t-319845.html 0.6 2026-06-20T15:55:31+08:00 daily https://www.pharmasources.com/industryinsights/nice-publishes-final-guidance-backing-te-319846.html 0.6 2026-06-20T15:53:23+08:00 daily https://www.pharmasources.com/industryinsights/eu-nod-for-new-metastatic-colorectal-can-319847.html 0.6 2026-03-28T03:31:52+08:00 daily https://www.pharmasources.com/industryinsights/regulators-expand-review-time-for-novart-319848.html 0.6 2026-08-08T13:48:01+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-announces-positive--319849.html 0.6 2026-06-23T04:13:09+08:00 daily https://www.pharmasources.com/industryinsights/agex-therapeutics-imstem-biotechnology-s-319850.html 0.6 2026-08-14T12:06:16+08:00 daily https://www.pharmasources.com/industryinsights/scientists-aim-gene-targeting-breakthrou-319851.html 0.6 2026-06-22T09:48:45+08:00 daily https://www.pharmasources.com/industryinsights/fsd-pharma-gets-fda-nod-to-design-covid--319852.html 0.6 2026-06-24T01:50:46+08:00 daily https://www.pharmasources.com/industryinsights/polypeptide-group-partners-with-novavax--319853.html 0.6 2026-06-25T03:14:55+08:00 daily https://www.pharmasources.com/industryinsights/agc-biologics-acquires-astrazeneca-facil-319854.html 0.6 2026-08-10T18:04:20+08:00 daily https://www.pharmasources.com/industryinsights/will-the-bottles-be-enough-with-the-mark-319855.html 0.6 2026-08-09T04:54:30+08:00 daily https://www.pharmasources.com/industryinsights/ethypharm-and-rssl-fast-track-medicine-f-319856.html 0.6 2026-04-21T14:15:51+08:00 daily https://www.pharmasources.com/industryinsights/alcami-names-new-ceo-319857.html 0.6 2026-06-21T02:01:37+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-says-covid-19-drug-research-may-319858.html 0.6 2026-03-01T11:51:17+08:00 daily https://www.pharmasources.com/industryinsights/ministry-of-health-publishes-draft-new-d-319859.html 0.6 2026-08-12T00:01:07+08:00 daily https://www.pharmasources.com/industryinsights/maharashtra-to-procure-10000-vials-of-re-319860.html 0.6 2026-06-23T08:58:58+08:00 daily https://www.pharmasources.com/industryinsights/shanghai-junshi-biosciences-starts-human-319861.html 0.6 2026-07-05T13:29:01+08:00 daily https://www.pharmasources.com/industryinsights/the-covid-19-effect-on-pharma-packaging-319862.html 0.6 2026-07-20T01:59:29+08:00 daily https://www.pharmasources.com/industryinsights/meet-and-trade-with-qualified-business-p-319863.html 0.6 2026-07-24T10:10:19+08:00 daily https://www.pharmasources.com/industryinsights/combating-covid-19-with-global-standards-319864.html 0.6 2026-07-02T11:12:47+08:00 daily https://www.pharmasources.com/industryinsights/local-api-production-in-india-for-covid--319865.html 0.6 2026-07-07T12:01:56+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-get-us-fda-approval-for-ata-319866.html 0.6 2026-07-05T19:31:58+08:00 daily https://www.pharmasources.com/industryinsights/anti-tnf-therapies-could-treat-patients--319867.html 0.6 2026-06-22T08:06:53+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-initiates-phase-ii-clinical-t-319868.html 0.6 2026-06-20T15:00:11+08:00 daily https://www.pharmasources.com/industryinsights/australias-csl-says-to-help-fund-make-va-319869.html 0.6 2026-02-15T13:21:57+08:00 daily https://www.pharmasources.com/industryinsights/novavax-awarded-dod-contract-for-covid-1-319870.html 0.6 2026-06-20T22:58:39+08:00 daily https://www.pharmasources.com/industryinsights/mercks-snda-for-recarbrio-wins-fda-appro-319871.html 0.6 2026-08-10T08:02:30+08:00 daily https://www.pharmasources.com/industryinsights/ucb-acquires-engage-therapeutics-for-125-319872.html 0.6 2026-08-06T18:54:47+08:00 daily https://www.pharmasources.com/industryinsights/csl-teams-up-with-cepi-and-uq-for-covid--319873.html 0.6 2026-06-20T23:43:32+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-signs-750m-covid-19-vaccine--319874.html 0.6 2026-06-21T20:54:45+08:00 daily https://www.pharmasources.com/industryinsights/intravacc-forms-alliance-to-develop-intr-319875.html 0.6 2026-06-20T12:12:34+08:00 daily https://www.pharmasources.com/industryinsights/amneal-recalls-metformin-hydrochloride-e-319876.html 0.6 2026-06-20T22:19:04+08:00 daily https://www.pharmasources.com/industryinsights/clinical-ink-implements-covid-19-therapy-319877.html 0.6 2026-06-24T06:50:32+08:00 daily https://www.pharmasources.com/industryinsights/kura-oncology-reports-data-from-tipifarn-319878.html 0.6 2026-06-23T23:40:45+08:00 daily https://www.pharmasources.com/industryinsights/qualigen-releases-fastpack-sars-cov-2-an-319879.html 0.6 2026-06-21T05:00:42+08:00 daily https://www.pharmasources.com/industryinsights/cellenkos-announces-fda-clearance-for-tr-319880.html 0.6 2026-06-21T04:23:42+08:00 daily https://www.pharmasources.com/industryinsights/neurotrope-nih-launch-clinical-trial-of--319881.html 0.6 2026-08-07T02:05:18+08:00 daily https://www.pharmasources.com/industryinsights/calquence-showed-promising-clinical-impr-319882.html 0.6 2026-06-30T20:09:35+08:00 daily https://www.pharmasources.com/industryinsights/janssens-tremfya-delivers-improvement-in-319883.html 0.6 2026-07-17T07:17:10+08:00 daily https://www.pharmasources.com/industryinsights/octapharma-usa-extends-funding-for-covid-319884.html 0.6 2026-07-08T20:55:55+08:00 daily https://www.pharmasources.com/industryinsights/pierre-fabre-gets-ec-nod-for-braftovi-pl-319885.html 0.6 2026-04-13T03:36:06+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-secures-ec-approval-for-sarclisa--319886.html 0.6 2026-06-21T04:11:59+08:00 daily https://www.pharmasources.com/industryinsights/cv-patients-finding-it-harder-to-get-tre-319887.html 0.6 2026-06-20T14:39:13+08:00 daily https://www.pharmasources.com/industryinsights/az-ramps-up-supply-capacity-for-covid-19-319888.html 0.6 2026-07-18T11:08:14+08:00 daily https://www.pharmasources.com/industryinsights/the-lancet-retracts-study-linking-hydrox-319889.html 0.6 2026-08-07T17:17:40+08:00 daily https://www.pharmasources.com/industryinsights/lilly-bags-expanded-eu-approval-for-talt-319890.html 0.6 2026-01-24T13:54:31+08:00 daily https://www.pharmasources.com/industryinsights/hydroxychloroquine-fails-as-postexposure-319892.html 0.6 2026-08-08T14:56:19+08:00 daily https://www.pharmasources.com/industryinsights/study-identifies-potential-approach-to-t-319893.html 0.6 2026-06-21T01:48:45+08:00 daily https://www.pharmasources.com/industryinsights/study-finds-covid-19-convalescent-plasma-319894.html 0.6 2026-08-07T19:48:25+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-signs-lease-for-a-clinica-319895.html 0.6 2026-07-02T21:55:55+08:00 daily https://www.pharmasources.com/industryinsights/ema-to-assess-conditional-authorisation--319896.html 0.6 2026-06-20T20:47:28+08:00 daily https://www.pharmasources.com/industryinsights/csirs-anti-cancer-drug-iiim-290-goes-int-319897.html 0.6 2026-06-26T03:43:10+08:00 daily https://www.pharmasources.com/industryinsights/intravacc-and-versatope-to-develop-unive-319898.html 0.6 2026-08-10T03:01:22+08:00 daily https://www.pharmasources.com/industryinsights/gland-pharma-launches-of-the-first-non-f-319899.html 0.6 2026-08-08T00:49:30+08:00 daily https://www.pharmasources.com/industryinsights/marksons-pharma-voluntarily-recalls-a-ba-319900.html 0.6 2026-08-09T08:00:34+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-grants-lupins-mexiletine-orphan-d-319901.html 0.6 2026-08-09T09:03:08+08:00 daily https://www.pharmasources.com/industryinsights/oxford-biomedica-partners-vmic-for-vacci-319902.html 0.6 2026-06-21T08:12:12+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-and-partners-to-develop-monoclona-319903.html 0.6 2026-07-22T16:51:47+08:00 daily https://www.pharmasources.com/industryinsights/ema-gives-positive-opinion-to-investigat-319904.html 0.6 2026-06-22T02:33:17+08:00 daily https://www.pharmasources.com/industryinsights/potential-cytokine-storm-treatment-ident-319905.html 0.6 2026-06-21T02:12:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-recarbrio-for-treatment-of--319906.html 0.6 2026-06-20T23:04:42+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-takes-next-steps-towards-bro-319907.html 0.6 2026-06-20T14:53:04+08:00 daily https://www.pharmasources.com/industryinsights/sharp-clinical-launches-direct-to-patien-319908.html 0.6 2026-06-20T14:39:15+08:00 daily https://www.pharmasources.com/industryinsights/uq-cepi-and-csl-partner-on-development-a-319909.html 0.6 2026-06-21T02:01:37+08:00 daily https://www.pharmasources.com/industryinsights/vectura-signs-agreement-with-aerami-ther-319910.html 0.6 2026-06-22T11:54:08+08:00 daily https://www.pharmasources.com/industryinsights/tonix-and-fujifilm-enter-covid-19-vax-de-319911.html 0.6 2026-03-21T15:54:18+08:00 daily https://www.pharmasources.com/industryinsights/us-govt-invests-143m-to-scale-up-sio2s-p-319912.html 0.6 2026-06-21T09:14:16+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-update-fda-shares-antibody-test-319913.html 0.6 2026-06-21T04:07:57+08:00 daily https://www.pharmasources.com/industryinsights/nabriva-receives-positive-opinion-for-xe-319914.html 0.6 2026-07-01T15:37:16+08:00 daily https://www.pharmasources.com/industryinsights/immunoprecise-integrated-biotherapeutics-319915.html 0.6 2026-06-21T03:55:53+08:00 daily https://www.pharmasources.com/industryinsights/lilly-receives-fda-approval-of-tauvid-fo-319916.html 0.6 2026-06-20T23:49:34+08:00 daily https://www.pharmasources.com/industryinsights/fda-updates-qa-appendix-of-medical-produ-319917.html 0.6 2026-06-20T19:06:40+08:00 daily https://www.pharmasources.com/industryinsights/beijing-hanlin-hangyu-technology-develop-319918.html 0.6 2026-08-12T09:05:43+08:00 daily https://www.pharmasources.com/industryinsights/beijing-hanlin-hangyu-technology-develop-319919.html 0.6 2026-06-21T12:19:43+08:00 daily https://www.pharmasources.com/industryinsights/omega-bio-tek-launches-a-new-viral-rna-e-319920.html 0.6 2026-08-07T20:43:33+08:00 daily https://www.pharmasources.com/industryinsights/phosphorus-announces-fda-approval-of-at--319921.html 0.6 2026-06-14T02:14:30+08:00 daily https://www.pharmasources.com/industryinsights/yichun-wanshen-pharmaceutical-machinery--319922.html 0.6 2026-06-21T19:18:50+08:00 daily https://www.pharmasources.com/industryinsights/yichun-wanshen-pharmaceutical-machinery--319923.html 0.6 2026-08-08T02:27:47+08:00 daily https://www.pharmasources.com/industryinsights/lilly-announces-start-of-a-phase-1-study-319924.html 0.6 2026-06-22T07:05:57+08:00 daily https://www.pharmasources.com/industryinsights/casi-pharmaceuticals-announces-submissio-319925.html 0.6 2026-06-20T14:57:04+08:00 daily https://www.pharmasources.com/industryinsights/chengde-central-power-electronic-coltd---319926.html 0.6 2026-07-06T23:02:22+08:00 daily https://www.pharmasources.com/industryinsights/chengde-central-power-electronic-coltd---319927.html 0.6 2026-06-21T21:11:55+08:00 daily https://www.pharmasources.com/industryinsights/nobel-prize-winning-scientist-explains-w-319928.html 0.6 2026-06-21T14:42:14+08:00 daily https://www.pharmasources.com/industryinsights/arbor-vita-launches-open-platform-covid--319929.html 0.6 2026-06-21T10:50:07+08:00 daily https://www.pharmasources.com/industryinsights/espac--virtual-factory-tours-319930.html 0.6 2026-06-21T04:57:45+08:00 daily https://www.pharmasources.com/industryinsights/espac---virtual-factory-tours-319931.html 0.6 2026-08-08T01:41:08+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-hands-back-rights-to-oxford-biome-319932.html 0.6 2026-06-20T17:00:11+08:00 daily https://www.pharmasources.com/industryinsights/jiashan-speck-pumps-systemtechnik-co-ltd-319933.html 0.6 2026-08-10T03:50:32+08:00 daily https://www.pharmasources.com/industryinsights/kawasaki-like-syndrome-linked-to-coronav-319934.html 0.6 2026-06-20T14:35:34+08:00 daily https://www.pharmasources.com/industryinsights/jiashan-speck-pumps-systemtechnik-co-ltd-319935.html 0.6 2026-06-21T09:08:05+08:00 daily https://www.pharmasources.com/industryinsights/nice-rejects-sanofis-sarclisa-in-prelimi-319936.html 0.6 2026-08-06T18:09:48+08:00 daily https://www.pharmasources.com/industryinsights/lawa-energy-saving-technologyzhejiangcol-319937.html 0.6 2026-06-09T14:04:37+08:00 daily https://www.pharmasources.com/industryinsights/lawa-energy-saving-technologyzhejiangcol-319938.html 0.6 2026-07-30T15:28:39+08:00 daily https://www.pharmasources.com/industryinsights/eu-lockdowns-saved-more-than-3m-lives-re-319939.html 0.6 2026-07-04T23:31:25+08:00 daily https://www.pharmasources.com/industryinsights/liaoning-chunguang-pharmaceutical-equipm-319940.html 0.6 2026-07-27T05:53:02+08:00 daily https://www.pharmasources.com/industryinsights/liaoning-chunguang-pharmaceutical-equipm-319941.html 0.6 2026-06-20T20:15:50+08:00 daily https://www.pharmasources.com/industryinsights/janssen-gets-ec-approval-for-subcutaneou-319942.html 0.6 2026-06-21T03:09:51+08:00 daily https://www.pharmasources.com/industryinsights/cullinan-oncology-completes-985m-series--319943.html 0.6 2026-06-22T10:24:12+08:00 daily https://www.pharmasources.com/industryinsights/nanjing-jinri-light-industry-technologic-319944.html 0.6 2026-06-27T15:58:29+08:00 daily https://www.pharmasources.com/industryinsights/nanjing-jinri-light-industry-technologic-319945.html 0.6 2026-07-28T04:52:51+08:00 daily https://www.pharmasources.com/industryinsights/shanghai-yuanhuai-industrial-co-ltd--vir-319946.html 0.6 2026-06-21T13:04:37+08:00 daily https://www.pharmasources.com/industryinsights/shanghai-yuanhuai-industrial-co-ltd---vi-319947.html 0.6 2026-06-22T14:36:41+08:00 daily https://www.pharmasources.com/industryinsights/wenzhou-zhonghuan-machinery-equipment-co-319948.html 0.6 2026-06-20T08:47:27+08:00 daily https://www.pharmasources.com/industryinsights/wenzhou-zhonghuan-machinery-equipment-co-319949.html 0.6 2026-06-20T16:49:52+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-lenge-purification-equipment-coltd--319950.html 0.6 2026-06-21T13:00:33+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-lenge-purification-equipment-coltd--319951.html 0.6 2026-06-21T00:40:22+08:00 daily https://www.pharmasources.com/industryinsights/a2a-pharmaceuticals-collaborates-with-la-319952.html 0.6 2026-06-21T08:05:03+08:00 daily https://www.pharmasources.com/industryinsights/altasciences-names-chief-medical-officer-319953.html 0.6 2026-06-20T14:06:05+08:00 daily https://www.pharmasources.com/industryinsights/swiftscale-manufactures-covid-19-antibod-319954.html 0.6 2026-06-21T04:50:39+08:00 daily https://www.pharmasources.com/industryinsights/lilly-and-junshi-biosciences-initiate-ph-319955.html 0.6 2026-07-27T12:23:26+08:00 daily https://www.pharmasources.com/industryinsights/just---evotec-biologics-abl-enter-clinic-319956.html 0.6 2026-08-14T01:07:10+08:00 daily https://www.pharmasources.com/industryinsights/valneva-earns-130m-pfizer-milestone-in-l-319957.html 0.6 2026-06-20T18:58:37+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-agios-pharma-to-co-develop-319958.html 0.6 2026-06-23T14:52:40+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-investing-928m-in-denmark-cdmo--319959.html 0.6 2026-06-21T04:58:57+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-to-open-clinical-mfg-faci-319960.html 0.6 2026-07-19T04:46:46+08:00 daily https://www.pharmasources.com/industryinsights/optima-appoints-cfo-319961.html 0.6 2026-07-05T10:44:14+08:00 daily https://www.pharmasources.com/industryinsights/cipla-acquires-stake-in-goapptiv-319962.html 0.6 2026-08-10T15:13:25+08:00 daily https://www.pharmasources.com/industryinsights/serum-institute-to-invest-100-million-on-319963.html 0.6 2026-08-07T01:51:53+08:00 daily https://www.pharmasources.com/industryinsights/indian-study-may-develop-therapeutics-fo-319964.html 0.6 2026-08-07T01:42:59+08:00 daily https://www.pharmasources.com/industryinsights/abbott-india-q4fy20-performance-hit-by-c-319965.html 0.6 2026-08-07T01:52:18+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-licences-covid-19-antibody-c-319966.html 0.6 2026-08-07T01:58:39+08:00 daily https://www.pharmasources.com/industryinsights/innovent-biologics-enters-drug-developme-319967.html 0.6 2026-08-07T02:04:53+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-to-develop-nafamostat-inh-319968.html 0.6 2026-08-14T17:08:19+08:00 daily https://www.pharmasources.com/industryinsights/ema-recieves-cma-application-for-remdesi-319969.html 0.6 2026-08-07T02:36:33+08:00 daily https://www.pharmasources.com/industryinsights/elevas-drug-candidate-examined-for-use-i-319970.html 0.6 2026-08-07T02:40:59+08:00 daily https://www.pharmasources.com/industryinsights/lynparza-recommended-for-approval-in-eu--319971.html 0.6 2026-08-07T02:51:58+08:00 daily https://www.pharmasources.com/industryinsights/mimivax-survaxm-pembrolizumab-study-open-319972.html 0.6 2026-08-07T03:06:38+08:00 daily https://www.pharmasources.com/industryinsights/relief-therapeutics-neurorx-begin-rlf-10-319973.html 0.6 2026-08-07T03:24:30+08:00 daily https://www.pharmasources.com/industryinsights/shandong-qidu-pharmaceutical-co-ltd--vir-319974.html 0.6 2026-08-07T03:34:18+08:00 daily https://www.pharmasources.com/industryinsights/shandong-qidu-pharmaceutical-co-ltd---vi-319975.html 0.6 2026-08-09T17:58:34+08:00 daily https://www.pharmasources.com/industryinsights/zhejiang-esigma-biotechnology-coltd--vir-319976.html 0.6 2026-08-10T08:55:16+08:00 daily https://www.pharmasources.com/industryinsights/zhejiang-esigma-biotechnology-coltd---vi-319977.html 0.6 2026-07-17T23:34:50+08:00 daily https://www.pharmasources.com/industryinsights/new-consortium-eubopen-will-provide-tool-319978.html 0.6 2026-06-21T23:56:17+08:00 daily https://www.pharmasources.com/industryinsights/bestgrand-biotech-coltd--virtual-factory-319979.html 0.6 2026-08-12T23:19:15+08:00 daily https://www.pharmasources.com/industryinsights/scientists-identify-targets-for-covid-19-319980.html 0.6 2026-07-28T18:17:33+08:00 daily https://www.pharmasources.com/industryinsights/bestgrand-biotech-coltd---virtual-factor-319981.html 0.6 2026-07-30T21:41:58+08:00 daily https://www.pharmasources.com/industryinsights/fujian-fukang-pharmaceutical-coltd--virt-319982.html 0.6 2026-08-07T04:25:19+08:00 daily https://www.pharmasources.com/industryinsights/fujian-fukang-pharmaceutical-coltd---vir-319983.html 0.6 2026-08-07T01:07:09+08:00 daily https://www.pharmasources.com/industryinsights/alnylam-presents-positive-phase-3-result-319984.html 0.6 2026-08-07T00:42:49+08:00 daily https://www.pharmasources.com/industryinsights/liverd-pharma-co-ltd--virtual-factory-to-319985.html 0.6 2026-08-07T00:40:03+08:00 daily https://www.pharmasources.com/industryinsights/liverd-pharma-co-ltd---virtual-factory-t-319986.html 0.6 2026-08-07T00:15:32+08:00 daily https://www.pharmasources.com/industryinsights/north-china-pharmaceutical-group-aino-co-319987.html 0.6 2026-08-07T00:01:50+08:00 daily https://www.pharmasources.com/industryinsights/solenos-drug-misses-key-goal-in-prader-w-319988.html 0.6 2026-08-07T02:40:32+08:00 daily https://www.pharmasources.com/industryinsights/aalto-bio-reagents-announces-it-is-suppl-319989.html 0.6 2026-08-07T00:42:49+08:00 daily https://www.pharmasources.com/industryinsights/north-china-pharmaceutical-group-aino-co-319990.html 0.6 2026-08-07T00:41:27+08:00 daily https://www.pharmasources.com/industryinsights/bridge-womens-center-opens-mobile-pregna-319991.html 0.6 2026-08-07T00:43:03+08:00 daily https://www.pharmasources.com/industryinsights/pharmablock-sciencesnanjinginc--virtual--319992.html 0.6 2026-08-12T16:35:45+08:00 daily https://www.pharmasources.com/industryinsights/panacea-biotec-and-refana-announce-landm-319993.html 0.6 2026-08-07T01:19:31+08:00 daily https://www.pharmasources.com/industryinsights/pharmablock-sciencesnanjinginc---virtual-319994.html 0.6 2026-08-07T01:27:53+08:00 daily https://www.pharmasources.com/industryinsights/reyoung-pharmaceutical-co-ltd--virtual-f-319995.html 0.6 2026-08-07T05:31:13+08:00 daily https://www.pharmasources.com/industryinsights/reyoung-pharmaceutical-co-ltd---virtual--319996.html 0.6 2026-06-15T07:22:14+08:00 daily https://www.pharmasources.com/industryinsights/why-are-children-waiting-so-long-for-new-319997.html 0.6 2026-06-20T14:53:10+08:00 daily https://www.pharmasources.com/industryinsights/africa-pharma-brief-south-africa-restric-319998.html 0.6 2026-08-09T07:48:34+08:00 daily https://www.pharmasources.com/industryinsights/sphinx-scientific-laboratorytianjincoltd-319999.html 0.6 2026-03-03T07:37:28+08:00 daily https://www.pharmasources.com/industryinsights/sphinx-scientific-laboratorytianjincoltd-320000.html 0.6 2026-06-21T20:58:35+08:00 daily https://www.pharmasources.com/industryinsights/yangtze-river-pharmaceutical-group-co-lt-320001.html 0.6 2026-08-06T10:48:52+08:00 daily https://www.pharmasources.com/industryinsights/yangtze-river-pharmaceutical-group-co-lt-320002.html 0.6 2026-06-21T04:01:48+08:00 daily https://www.pharmasources.com/industryinsights/zhejiang-huahai-pharmaceutical-co-ltd--v-320003.html 0.6 2026-08-11T22:25:36+08:00 daily https://www.pharmasources.com/industryinsights/zhejiang-huahai-pharmaceutical-co-ltd----320004.html 0.6 2026-07-15T01:21:44+08:00 daily https://www.pharmasources.com/industryinsights/zhejiang-hengdian-apeloa-imp-exp-co-ltd--320005.html 0.6 2026-06-20T14:36:54+08:00 daily https://www.pharmasources.com/industryinsights/zhejiang-hengdian-apeloa-imp-exp-co-ltd--320006.html 0.6 2026-06-20T15:53:25+08:00 daily https://www.pharmasources.com/industryinsights/zhejiang-langhua-pharmaceutical-co-ltd---320007.html 0.6 2026-08-07T01:19:56+08:00 daily https://www.pharmasources.com/industryinsights/zhejiang-langhua-pharmaceutical-co-ltd---320008.html 0.6 2026-08-07T01:14:31+08:00 daily https://www.pharmasources.com/industryinsights/shandong-huachen-pharmaceutical-coltd--v-320009.html 0.6 2026-08-07T00:59:07+08:00 daily https://www.pharmasources.com/industryinsights/shandong-huachen-pharmaceutical-coltd----320010.html 0.6 2026-08-07T00:40:15+08:00 daily https://www.pharmasources.com/industryinsights/jrs-pharma--virtual-factory-tours-320011.html 0.6 2026-08-07T00:01:51+08:00 daily https://www.pharmasources.com/industryinsights/jrs-pharma---virtual-factory-tours-320012.html 0.6 2026-08-06T23:57:54+08:00 daily https://www.pharmasources.com/industryinsights/stevanato-group--virtual-factory-tours-320013.html 0.6 2026-08-12T09:35:59+08:00 daily https://www.pharmasources.com/industryinsights/stevanato-group---virtual-factory-tours-320014.html 0.6 2026-08-06T23:48:51+08:00 daily https://www.pharmasources.com/industryinsights/government-lifts-export-restrictions-on--320015.html 0.6 2026-08-06T23:54:46+08:00 daily https://www.pharmasources.com/industryinsights/marksans-pharma-recalls-11279-bottles-of-320016.html 0.6 2026-08-07T00:02:44+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-laboratories-completes-acquisi-320017.html 0.6 2026-08-12T04:01:14+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-genmab-enter-750m-antibody-allian-320018.html 0.6 2026-08-07T13:55:32+08:00 daily https://www.pharmasources.com/industryinsights/dyadic-to-develop-cell-lines-for-covid-1-320019.html 0.6 2026-08-09T06:59:07+08:00 daily https://www.pharmasources.com/industryinsights/lonza-and-cellink-join-forces-to-offer-3-320020.html 0.6 2026-08-06T23:58:52+08:00 daily https://www.pharmasources.com/industryinsights/catalent-enters-covid-19-vax-pact-with-s-320021.html 0.6 2026-06-21T00:58:45+08:00 daily https://www.pharmasources.com/industryinsights/panacea-biotec-and-refana-collaborate-fo-320022.html 0.6 2026-08-07T05:05:39+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-commits-928m-to-expand-biologic-320023.html 0.6 2026-08-07T04:56:59+08:00 daily https://www.pharmasources.com/industryinsights/daewoong-finds-niclosamide-effective-aga-320024.html 0.6 2026-08-07T04:36:36+08:00 daily https://www.pharmasources.com/industryinsights/second-of-lillys-covid-19-neutralising-a-320025.html 0.6 2026-08-07T04:27:48+08:00 daily https://www.pharmasources.com/industryinsights/are-thermally-stable-ensilicated-vaccine-320026.html 0.6 2026-08-07T04:16:26+08:00 daily https://www.pharmasources.com/industryinsights/fda-announces-alert-of-amneal-impax-epin-320027.html 0.6 2026-07-10T07:08:51+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-atezolizumab-plus-bevacizum-320028.html 0.6 2026-08-11T14:36:06+08:00 daily https://www.pharmasources.com/industryinsights/fda-clears-ind-for-inkt-cells-to-treat-c-320029.html 0.6 2026-08-09T03:53:30+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-snda-with-priority-review-fo-320030.html 0.6 2026-08-07T03:02:56+08:00 daily https://www.pharmasources.com/industryinsights/junshi-merck-collaborate-on-head-neck-ca-320031.html 0.6 2026-08-07T23:42:16+08:00 daily https://www.pharmasources.com/industryinsights/braeburn-submits-request-for-final-appro-320032.html 0.6 2026-08-07T01:06:46+08:00 daily https://www.pharmasources.com/industryinsights/triccar-releases-results-of-study-of-avl-320033.html 0.6 2026-08-07T00:59:35+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-announces-acceleration-o-320034.html 0.6 2026-08-07T04:39:56+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-mouse-model-will-speed-search-f-320035.html 0.6 2026-08-12T10:35:46+08:00 daily https://www.pharmasources.com/industryinsights/mms-to-support-igy-life-sciences-in-adva-320036.html 0.6 2026-08-07T00:36:33+08:00 daily https://www.pharmasources.com/industryinsights/algotherapeutix-announces-orphan-drug-de-320037.html 0.6 2026-08-07T00:02:48+08:00 daily https://www.pharmasources.com/industryinsights/final-nhs-green-light-for-roches-kadcyla-320038.html 0.6 2026-08-06T23:56:51+08:00 daily https://www.pharmasources.com/industryinsights/eu-expands-reach-of-vertex-cf-drug-kalyd-320039.html 0.6 2026-08-06T23:47:27+08:00 daily https://www.pharmasources.com/industryinsights/nhs-rolls-out-new-online-support-for-dia-320040.html 0.6 2026-08-10T01:15:03+08:00 daily https://www.pharmasources.com/industryinsights/nhs-waiting-lists-could-hit-10m-by-year--320041.html 0.6 2026-08-06T23:32:49+08:00 daily https://www.pharmasources.com/industryinsights/florida-blue-providing-50-million-in-hea-320042.html 0.6 2026-08-06T22:53:24+08:00 daily https://www.pharmasources.com/industryinsights/national-jewish-health-offers-expanded-c-320043.html 0.6 2026-08-06T22:21:06+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-news-of-the-week-june-5th-320044.html 0.6 2026-08-06T22:08:53+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-grants-approval-of-uplizna-to-vie-320045.html 0.6 2026-08-07T13:17:26+08:00 daily https://www.pharmasources.com/industryinsights/biocon-and-mylan-receive-us-fda-approval-320046.html 0.6 2026-08-09T09:06:09+08:00 daily https://www.pharmasources.com/industryinsights/remdesivir-tocilizumab-being-considered--320047.html 0.6 2026-08-08T07:37:12+08:00 daily https://www.pharmasources.com/industryinsights/nipers-should-try-to-establish-national--320048.html 0.6 2026-08-08T10:01:41+08:00 daily https://www.pharmasources.com/industryinsights/european-investment-bank-to-provide-bion-320049.html 0.6 2026-06-21T12:52:18+08:00 daily https://www.pharmasources.com/industryinsights/lupin-receives-us-fdas-approval-for-albe-320050.html 0.6 2026-07-16T16:09:29+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-seeks-fast-review-of-covid-19-pro-320051.html 0.6 2026-06-23T10:16:51+08:00 daily https://www.pharmasources.com/industryinsights/merck-and-10x-genomics-launch-new-option-320052.html 0.6 2026-07-22T10:07:58+08:00 daily https://www.pharmasources.com/industryinsights/shanghai-wanshen-packaging-machinery-co--320053.html 0.6 2026-07-08T22:41:17+08:00 daily https://www.pharmasources.com/industryinsights/shanghai-wanshen-packaging-machinery-co--320054.html 0.6 2026-06-21T05:03:42+08:00 daily https://www.pharmasources.com/industryinsights/jnu-researchers-develop-new-drug-molecul-320055.html 0.6 2026-06-21T09:59:47+08:00 daily https://www.pharmasources.com/industryinsights/which-will-market-the-first-chinese-prod-320056.html 0.6 2026-07-18T00:54:55+08:00 daily https://www.pharmasources.com/industryinsights/lupin-to-approach-usfda-for-reinspection-320057.html 0.6 2026-06-20T14:58:07+08:00 daily https://www.pharmasources.com/industryinsights/regular-dose-of-aspirin-can-lower-risk-o-320058.html 0.6 2026-07-27T14:49:19+08:00 daily https://www.pharmasources.com/industryinsights/remdesivir-tocilizumab-and-cpt-included--320059.html 0.6 2026-08-02T22:41:43+08:00 daily https://www.pharmasources.com/industryinsights/bdr-pharma-urges-regulators-to-expedite--320060.html 0.6 2026-06-21T18:06:26+08:00 daily https://www.pharmasources.com/industryinsights/cancer-cart-therapy-what-are-the-benefit-320061.html 0.6 2026-06-27T08:43:34+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-signs-licensing-agreement-with-320062.html 0.6 2026-06-20T15:40:25+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-presents-clinical-insights-of-320063.html 0.6 2026-04-28T01:38:44+08:00 daily https://www.pharmasources.com/industryinsights/pharma-msmes-ask-government-to-extend-in-320064.html 0.6 2026-08-14T10:07:24+08:00 daily https://www.pharmasources.com/industryinsights/lupin-ties-up-with-omron-healthcare-320065.html 0.6 2026-07-04T09:37:07+08:00 daily https://www.pharmasources.com/industryinsights/naari-completes-acquisition-of-andas-fro-320066.html 0.6 2026-07-18T04:27:44+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-drug-to-treat-infants-and-c-320067.html 0.6 2026-08-13T05:55:40+08:00 daily https://www.pharmasources.com/industryinsights/integrity-bio-announces-newly-validated--320068.html 0.6 2026-08-01T02:33:54+08:00 daily https://www.pharmasources.com/industryinsights/valor-glass-packaging-selected-to-accele-320069.html 0.6 2026-06-22T10:07:03+08:00 daily https://www.pharmasources.com/industryinsights/anthos-lonza-partnership-to-address-thro-320070.html 0.6 2026-06-22T14:04:13+08:00 daily https://www.pharmasources.com/industryinsights/gemini-bio-wins-federal-contract-to-supp-320071.html 0.6 2026-06-21T20:56:36+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-and-emergent-enter-covid-19--320072.html 0.6 2026-06-28T03:38:55+08:00 daily https://www.pharmasources.com/industryinsights/oxford-biomedica-signs-collaboration-agr-320073.html 0.6 2026-06-21T12:05:13+08:00 daily https://www.pharmasources.com/industryinsights/h1-of-june-whats-been-happening-in-pharm-320074.html 0.6 2026-07-01T10:42:01+08:00 daily https://www.pharmasources.com/industryinsights/takeda-to-sell-assets-in-asia-pacific-to-320075.html 0.6 2026-06-21T06:19:09+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-to-acquire-corvidia-therape-320076.html 0.6 2026-08-10T11:44:24+08:00 daily https://www.pharmasources.com/industryinsights/peptidream-and-merck-partner-to-develop--320077.html 0.6 2026-07-19T03:09:28+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-inks-750m-cancer-therapeutics-dea-320078.html 0.6 2026-07-25T07:11:20+08:00 daily https://www.pharmasources.com/industryinsights/biontech-to-receive-up-to-100m-from-eib--320079.html 0.6 2026-08-06T20:26:16+08:00 daily https://www.pharmasources.com/industryinsights/singapore-approves-gileads-remdesivir-to-320080.html 0.6 2026-08-14T15:53:59+08:00 daily https://www.pharmasources.com/industryinsights/panacea-biotec-and-refana-team-up-for-co-320081.html 0.6 2026-06-21T11:56:05+08:00 daily https://www.pharmasources.com/industryinsights/researchers-synthesise-red-blood-cells-w-320082.html 0.6 2026-06-20T20:05:46+08:00 daily https://www.pharmasources.com/industryinsights/shijiazhuang-xinfuda-medical-packaging-c-320083.html 0.6 2026-08-03T10:24:00+08:00 daily https://www.pharmasources.com/industryinsights/study-suggests-current-drug-shortages-in-320084.html 0.6 2026-06-21T11:56:13+08:00 daily https://www.pharmasources.com/industryinsights/shijiazhuang-xinfuda-medical-packaging-c-320085.html 0.6 2026-08-06T22:08:09+08:00 daily https://www.pharmasources.com/industryinsights/who-stresses-need-for-new-treatments-to--320086.html 0.6 2026-08-06T21:54:49+08:00 daily https://www.pharmasources.com/industryinsights/pharma-and-health-from-ingredients-to-pi-320087.html 0.6 2026-08-12T11:30:03+08:00 daily https://www.pharmasources.com/industryinsights/global-excipients-market-predicted-to-gr-320088.html 0.6 2026-08-06T20:01:19+08:00 daily https://www.pharmasources.com/industryinsights/jj-accelerates-clinical-trial-of-investi-320089.html 0.6 2026-08-06T23:47:33+08:00 daily https://www.pharmasources.com/industryinsights/microneedle-system-developed-to-deliver--320090.html 0.6 2026-08-06T23:54:19+08:00 daily https://www.pharmasources.com/industryinsights/novartis-announces-update-on-fda-review--320091.html 0.6 2026-08-06T23:57:56+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-recarbrio-320092.html 0.6 2026-08-07T00:02:30+08:00 daily https://www.pharmasources.com/industryinsights/esperion-announces-commercial-availabili-320093.html 0.6 2026-08-07T03:06:15+08:00 daily https://www.pharmasources.com/industryinsights/american-regent-introduces-estradiol-val-320094.html 0.6 2026-07-06T20:22:30+08:00 daily https://www.pharmasources.com/industryinsights/eleva-drug-candidate-examined-for-use-in-320095.html 0.6 2026-06-21T07:55:11+08:00 daily https://www.pharmasources.com/industryinsights/tvax-biomedical-receives-fast-track-desi-320096.html 0.6 2026-08-09T09:25:45+08:00 daily https://www.pharmasources.com/industryinsights/renovorx-announces-orphan-drug-designati-320097.html 0.6 2026-06-22T18:34:44+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-submits-regulatory-applications-t-320098.html 0.6 2026-06-22T01:01:48+08:00 daily https://www.pharmasources.com/industryinsights/fsd-receives-fda-approval-to-design-tria-320099.html 0.6 2026-08-07T20:01:15+08:00 daily https://www.pharmasources.com/industryinsights/genscript-files-for-eua-of-rapid-sars-co-320100.html 0.6 2026-07-01T16:39:48+08:00 daily https://www.pharmasources.com/industryinsights/vizuri-health-sciences-reorganizes-into--320101.html 0.6 2026-08-06T02:32:23+08:00 daily https://www.pharmasources.com/industryinsights/10-predictions-on-how-covid-19-will-impa-320102.html 0.6 2026-07-23T10:14:41+08:00 daily https://www.pharmasources.com/industryinsights/shaanxi-kingsci-biotechnology-co-ltd--vi-320103.html 0.6 2026-07-31T13:33:20+08:00 daily https://www.pharmasources.com/industryinsights/shaanxi-kingsci-biotechnology-co-ltd---v-320104.html 0.6 2026-08-10T15:13:13+08:00 daily https://www.pharmasources.com/industryinsights/fermenta-biotech-and-indchemie-pledge-vi-320105.html 0.6 2026-08-06T20:01:12+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-and-hikma-enter-into-exclusiv-320106.html 0.6 2026-08-09T21:46:15+08:00 daily https://www.pharmasources.com/industryinsights/moderna-covid-19-vaccine-appears-to-clea-320107.html 0.6 2026-06-21T02:50:01+08:00 daily https://www.pharmasources.com/industryinsights/popular-blood-pressure-medicines-do-not--320108.html 0.6 2026-06-21T00:06:39+08:00 daily https://www.pharmasources.com/industryinsights/centre-clarifies-reasons-for-delay-in-ap-320109.html 0.6 2026-06-21T09:43:00+08:00 daily https://www.pharmasources.com/industryinsights/bontac-bio-engineering-shenzhen-co-ltd---320110.html 0.6 2026-08-04T20:45:55+08:00 daily https://www.pharmasources.com/industryinsights/bontac-bio-engineering-shenzhen-co-ltd---320111.html 0.6 2026-08-05T21:29:18+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-inks-licensing-pact-with-gi-320112.html 0.6 2026-08-09T06:55:54+08:00 daily https://www.pharmasources.com/industryinsights/why-should-india-adopt-iot-for-the-pharm-320113.html 0.6 2026-07-31T13:53:22+08:00 daily https://www.pharmasources.com/industryinsights/lupin-voluntarily-recalls-a-lot-of-diabe-320114.html 0.6 2026-08-03T04:31:22+08:00 daily https://www.pharmasources.com/industryinsights/caplin-steriles-gets-usfda-approval-for--320115.html 0.6 2026-08-02T22:09:36+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-announces-launch-of-colchicine-320116.html 0.6 2026-06-22T12:58:23+08:00 daily https://www.pharmasources.com/industryinsights/pricing-problems-aurobindo-pharma-sun-ph-320117.html 0.6 2026-08-12T11:09:10+08:00 daily https://www.pharmasources.com/industryinsights/pharmabcine-enters-partnership-with-ther-320118.html 0.6 2026-07-30T01:42:50+08:00 daily https://www.pharmasources.com/industryinsights/teva-partners-with-schreiner-medipharm-f-320119.html 0.6 2026-06-24T14:59:46+08:00 daily https://www.pharmasources.com/industryinsights/red-cross-announces-testing-of-all-blood-320120.html 0.6 2026-06-22T06:54:41+08:00 daily https://www.pharmasources.com/industryinsights/mbio-delivers-rapid-cytokine-test-system-320121.html 0.6 2026-08-07T22:52:19+08:00 daily https://www.pharmasources.com/industryinsights/parkway-clinical-laboratories-launches-c-320122.html 0.6 2026-06-22T05:01:38+08:00 daily https://www.pharmasources.com/industryinsights/lilly-begins-a-phase-3-clinical-trial-wi-320123.html 0.6 2026-08-08T01:19:28+08:00 daily https://www.pharmasources.com/industryinsights/insys-smart-automation-china--virtual-fa-320124.html 0.6 2026-06-20T21:56:30+08:00 daily https://www.pharmasources.com/industryinsights/insys-smart-automation-china---virtual-f-320125.html 0.6 2026-07-31T11:05:13+08:00 daily https://www.pharmasources.com/industryinsights/immunic-inc-announces-first-patients-dos-320126.html 0.6 2026-03-19T06:24:15+08:00 daily https://www.pharmasources.com/industryinsights/polyu-collaborates-with-macau-sar-china--320127.html 0.6 2026-05-01T06:13:18+08:00 daily https://www.pharmasources.com/industryinsights/1-in-2-americans-say-covid-19-has-change-320128.html 0.6 2025-12-20T23:02:57+08:00 daily https://www.pharmasources.com/industryinsights/jacobs-to-retrofit-astrazenecas-mfg-faci-320129.html 0.6 2026-08-07T05:34:51+08:00 daily https://www.pharmasources.com/industryinsights/lonza-introduces-capsugel-dbcaps-double--320130.html 0.6 2026-06-20T16:44:01+08:00 daily https://www.pharmasources.com/industryinsights/german-government-dievini-invests-300m-i-320131.html 0.6 2026-06-21T02:02:45+08:00 daily https://www.pharmasources.com/industryinsights/catalent-astrazeneca-ink-mfg-pact-for-co-320132.html 0.6 2026-06-20T22:01:38+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-appoints-new-us-ceo-320133.html 0.6 2026-07-19T13:01:02+08:00 daily https://www.pharmasources.com/industryinsights/ups-healthcare-continues-global-facility-320134.html 0.6 2026-08-14T17:29:13+08:00 daily https://www.pharmasources.com/industryinsights/solvias-completes-agreement-with-investo-320135.html 0.6 2026-06-21T14:58:30+08:00 daily https://www.pharmasources.com/industryinsights/fda-authorizes-next-gen-sequence-test-fo-320136.html 0.6 2026-06-22T10:15:00+08:00 daily https://www.pharmasources.com/industryinsights/grifols-begins-production-of-anti-sars-c-320137.html 0.6 2026-06-21T13:14:37+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-orphan-drug-designation-for-b-320138.html 0.6 2026-06-21T13:03:50+08:00 daily https://www.pharmasources.com/industryinsights/bryologyx-acquires-rights-to-neurotropes-320139.html 0.6 2026-06-21T22:54:41+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-begins-clinical-trials-of-anti-320140.html 0.6 2026-08-09T22:27:33+08:00 daily https://www.pharmasources.com/industryinsights/trial-for-new-ibuprofen-formulation-as-c-320141.html 0.6 2026-08-08T00:08:27+08:00 daily https://www.pharmasources.com/industryinsights/uk-cma-disqualifies-pharma-company-direc-320142.html 0.6 2026-07-10T02:01:08+08:00 daily https://www.pharmasources.com/industryinsights/fda-revokes-authorisation-for-anti-malar-320143.html 0.6 2026-06-20T17:59:22+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-to-develop-covid-19-vacci-320144.html 0.6 2026-05-31T01:01:26+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-viiv-healthcares-tivicay-to-320145.html 0.6 2026-06-22T07:53:55+08:00 daily https://www.pharmasources.com/industryinsights/fda-publicly-shares-antibody-test-perfor-320146.html 0.6 2026-06-22T11:05:10+08:00 daily https://www.pharmasources.com/industryinsights/relief-therapeutics-neurorx-expand-clini-320147.html 0.6 2026-06-20T23:17:56+08:00 daily https://www.pharmasources.com/industryinsights/adamas-announces-fda-filing-acceptance-o-320148.html 0.6 2026-06-21T06:21:22+08:00 daily https://www.pharmasources.com/industryinsights/marksans-recalls-metformin-hydrochloride-320149.html 0.6 2026-06-20T14:37:15+08:00 daily https://www.pharmasources.com/industryinsights/fda-ntia-announce-pilot-program-to-stop--320150.html 0.6 2026-06-21T23:59:42+08:00 daily https://www.pharmasources.com/industryinsights/rakuten-medical-md-anderson-announce-col-320151.html 0.6 2026-08-14T22:56:58+08:00 daily https://www.pharmasources.com/industryinsights/us-expands-scope-of-msds-gardasil-320152.html 0.6 2026-06-20T17:15:27+08:00 daily https://www.pharmasources.com/industryinsights/researchers-to-test-potential-covid-19-t-320153.html 0.6 2026-06-20T22:57:45+08:00 daily https://www.pharmasources.com/industryinsights/nice-backs-rozlytrek-for-subset-of-nsclc-320154.html 0.6 2026-06-23T13:05:23+08:00 daily https://www.pharmasources.com/industryinsights/novo-snaps-up-cardio-renal-group-corvidi-320155.html 0.6 2026-08-10T11:44:25+08:00 daily https://www.pharmasources.com/industryinsights/local-authorities-in-england-get-funding-320156.html 0.6 2026-06-21T21:04:50+08:00 daily https://www.pharmasources.com/industryinsights/nice-rejects-sanofis-cablivi-in-draft-gu-320157.html 0.6 2026-08-05T22:05:06+08:00 daily https://www.pharmasources.com/industryinsights/nhs-accelerates-launch-of-new-radiothera-320158.html 0.6 2026-03-18T01:22:47+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-and-genmab-link-for-oncology-coll-320159.html 0.6 2026-06-20T14:52:03+08:00 daily https://www.pharmasources.com/industryinsights/lilly-signs-up-for-access-to-evox-tech-i-320160.html 0.6 2025-12-13T11:40:08+08:00 daily https://www.pharmasources.com/industryinsights/msds-keytruda-misses-advanced-bladder-ca-320161.html 0.6 2026-06-22T04:12:51+08:00 daily https://www.pharmasources.com/industryinsights/webinar-powder-flow-enhancement-in-batch-320162.html 0.6 2026-06-22T00:25:30+08:00 daily https://www.pharmasources.com/industryinsights/shanghai-iven-pharmatech-engineering-co--320163.html 0.6 2026-06-20T15:55:12+08:00 daily https://www.pharmasources.com/industryinsights/shanghai-iven-pharmatech-engineering-co--320164.html 0.6 2026-07-14T15:27:40+08:00 daily https://www.pharmasources.com/industryinsights/shaanxi-sciphar-natural-products-co-ltd--320165.html 0.6 2026-06-21T17:19:06+08:00 daily https://www.pharmasources.com/industryinsights/shaanxi-sciphar-natural-products-co-ltd--320166.html 0.6 2026-06-21T22:23:56+08:00 daily https://www.pharmasources.com/industryinsights/dexamethasone-low-cost-steroid-drug-can--320167.html 0.6 2026-06-22T04:16:16+08:00 daily https://www.pharmasources.com/industryinsights/pharma-exports-record-sterling-performan-320168.html 0.6 2026-06-21T11:01:13+08:00 daily https://www.pharmasources.com/industryinsights/uk-funds-human-trials-of-imperial-colleg-320169.html 0.6 2026-06-21T06:55:58+08:00 daily https://www.pharmasources.com/industryinsights/curcumin-could-benefit-in-covid-19-treat-320170.html 0.6 2026-06-22T10:55:49+08:00 daily https://www.pharmasources.com/industryinsights/scientists-discover-new-super-potent-hum-320171.html 0.6 2026-06-21T15:53:12+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-final-us-fda-approval--320172.html 0.6 2026-06-22T03:53:39+08:00 daily https://www.pharmasources.com/industryinsights/iamai-requests-government-to-notify-e-ph-320173.html 0.6 2026-06-21T01:52:36+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-revokes-eua-for-chloroquine-and-h-320174.html 0.6 2026-06-24T19:14:56+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-warns-against-co-administration-o-320175.html 0.6 2026-06-20T16:53:26+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-invests-679m-in-two-french-vaccin-320176.html 0.6 2026-06-22T11:00:46+08:00 daily https://www.pharmasources.com/industryinsights/vyripharm-and-regis-sign-off-on-a-master-320177.html 0.6 2026-06-23T17:00:00+08:00 daily https://www.pharmasources.com/industryinsights/chempartner-expands-biologics-capabiliti-320178.html 0.6 2026-08-08T03:27:44+08:00 daily https://www.pharmasources.com/industryinsights/saiba-ag-and-agc-biologics-enter-covid-1-320179.html 0.6 2026-06-30T09:31:13+08:00 daily https://www.pharmasources.com/industryinsights/precise-broad-spectrum-an-overview-of-nt-320180.html 0.6 2026-06-21T04:05:48+08:00 daily https://www.pharmasources.com/industryinsights/3d-printing-in-healthcare-timeline-320181.html 0.6 2026-08-13T16:50:26+08:00 daily https://www.pharmasources.com/industryinsights/tianjin-pharmaceutical-holdings-co-ltd---320182.html 0.6 2026-08-07T10:48:03+08:00 daily https://www.pharmasources.com/industryinsights/tianjin-pharmaceutical-holdings-co-ltd---320183.html 0.6 2026-07-24T23:31:24+08:00 daily https://www.pharmasources.com/industryinsights/germany-to-invest-300m-in-curevacs-mrna--320184.html 0.6 2026-08-12T18:24:08+08:00 daily https://www.pharmasources.com/industryinsights/cell-therapy-expected-to-treat-solid-tum-320185.html 0.6 2026-06-22T07:51:55+08:00 daily https://www.pharmasources.com/industryinsights/the-dark-side-of-anticoagulants-will-a-n-320186.html 0.6 2026-06-21T09:04:06+08:00 daily https://www.pharmasources.com/industryinsights/modelling-the-human-body-a-game-changer--320187.html 0.6 2026-03-08T07:41:31+08:00 daily https://www.pharmasources.com/industryinsights/lilly-begins-study-for-second-potential--320188.html 0.6 2026-06-21T10:48:53+08:00 daily https://www.pharmasources.com/industryinsights/sound-pharma-advances-pivotal-phase-3-cl-320189.html 0.6 2026-06-21T05:07:44+08:00 daily https://www.pharmasources.com/industryinsights/insmed-receives-fda-breakthrough-therapy-320190.html 0.6 2026-06-21T11:03:09+08:00 daily https://www.pharmasources.com/industryinsights/therapeutic-solutions-initiates-500-volu-320191.html 0.6 2026-08-14T11:48:07+08:00 daily https://www.pharmasources.com/industryinsights/trv027-to-be-tested-as-covid-19-illness--320192.html 0.6 2026-06-21T17:12:37+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-rozlytrek-entrectinib-as-320193.html 0.6 2026-06-20T23:04:44+08:00 daily https://www.pharmasources.com/industryinsights/mhra-suspends-covid-19-hydroxychloroquin-320194.html 0.6 2026-06-20T22:58:40+08:00 daily https://www.pharmasources.com/industryinsights/jazz-small-cell-lung-cancer-therapy-wins-320195.html 0.6 2026-06-20T16:56:12+08:00 daily https://www.pharmasources.com/industryinsights/celltrions-infliximab-biosimilar-to-be-t-320196.html 0.6 2026-06-22T06:57:46+08:00 daily https://www.pharmasources.com/industryinsights/nhs-signs-landmark-deal-with-microsoft-320197.html 0.6 2026-06-21T07:14:05+08:00 daily https://www.pharmasources.com/industryinsights/abbvies-venclyxto-shows-promise-as-aml-t-320198.html 0.6 2026-06-21T04:00:46+08:00 daily https://www.pharmasources.com/industryinsights/mps-launch-inquiry-into-uk-asthma-outcom-320199.html 0.6 2026-06-20T21:17:54+08:00 daily https://www.pharmasources.com/industryinsights/the-creative-engagement-group-buys-cormi-320200.html 0.6 2026-06-21T10:10:14+08:00 daily https://www.pharmasources.com/industryinsights/neoimmunetech-receives-fda-orphan-drug-d-320201.html 0.6 2026-08-11T21:40:41+08:00 daily https://www.pharmasources.com/industryinsights/leap-therapeutics-announces-orphan-drug--320202.html 0.6 2026-06-21T15:45:27+08:00 daily https://www.pharmasources.com/industryinsights/clovis-oncology-completes-target-enrollm-320203.html 0.6 2026-08-07T05:34:03+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-announces-positive-top-line-resul-320204.html 0.6 2026-08-07T03:25:02+08:00 daily https://www.pharmasources.com/industryinsights/super-potent-human-antibodies-protect-ag-320205.html 0.6 2026-08-07T04:06:55+08:00 daily https://www.pharmasources.com/industryinsights/up-to-45-percent-of-sars-cov-2-infection-320206.html 0.6 2026-08-07T04:18:53+08:00 daily https://www.pharmasources.com/industryinsights/a-protein-that-helps-to-fight-viruses-ca-320207.html 0.6 2026-08-09T13:10:01+08:00 daily https://www.pharmasources.com/industryinsights/promising-path-found-for-covid-19-therap-320208.html 0.6 2026-06-21T08:54:29+08:00 daily https://www.pharmasources.com/industryinsights/gilead-announces-results-from-phase-3-tr-320209.html 0.6 2026-08-05T20:01:33+08:00 daily https://www.pharmasources.com/industryinsights/pk-hengrui-new-indication-of-mercks-pd-1-320210.html 0.6 2026-07-21T10:04:35+08:00 daily https://www.pharmasources.com/industryinsights/guangxi-gengyuan-flavors-and-fragrances--320211.html 0.6 2026-04-09T11:44:33+08:00 daily https://www.pharmasources.com/industryinsights/guangxi-gengyuan-flavors-and-fragrances--320212.html 0.6 2026-08-09T13:05:11+08:00 daily https://www.pharmasources.com/industryinsights/eu-calls-for-global-alliance-to-buy-covi-320213.html 0.6 2026-08-07T00:02:45+08:00 daily https://www.pharmasources.com/industryinsights/iit-alumni-council-to-partner-with-ict-m-320214.html 0.6 2026-08-06T23:55:29+08:00 daily https://www.pharmasources.com/industryinsights/ict-lasa-succeed-in-favipiravir-drug-syn-320215.html 0.6 2026-08-07T13:18:32+08:00 daily https://www.pharmasources.com/industryinsights/who-moves-to-update-covid-19-guidance-af-320216.html 0.6 2026-08-07T12:27:06+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-novartiss-ilaris-for-act-320217.html 0.6 2026-08-07T11:54:58+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-disruption-of-clinical-trials-s-320218.html 0.6 2026-08-07T11:28:15+08:00 daily https://www.pharmasources.com/industryinsights/curevac-receives-approval-to-initiate-cl-320219.html 0.6 2026-08-07T06:09:44+08:00 daily https://www.pharmasources.com/industryinsights/novavax-adds-two-senior-executives-to-le-320220.html 0.6 2026-08-07T06:03:51+08:00 daily https://www.pharmasources.com/industryinsights/ubiquigent-continues-collaboration-with--320221.html 0.6 2026-08-12T07:21:54+08:00 daily https://www.pharmasources.com/industryinsights/ptc-begins-phase-iiiii-trial-of-ptc299-i-320222.html 0.6 2026-08-07T05:51:48+08:00 daily https://www.pharmasources.com/industryinsights/armata-wins-15m-dod-contract-for-bacteri-320223.html 0.6 2026-08-07T05:49:09+08:00 daily https://www.pharmasources.com/industryinsights/takeda-licences-psychiatry-programmes-to-320224.html 0.6 2026-08-07T05:45:30+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher---patheon--virtual-factory-320225.html 0.6 2026-08-07T05:37:27+08:00 daily https://www.pharmasources.com/industryinsights/uk-approves-dexamethasone-for-covid-19-p-320226.html 0.6 2026-08-07T03:30:30+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher---patheon---virtual-factor-320227.html 0.6 2026-08-07T03:06:21+08:00 daily https://www.pharmasources.com/industryinsights/novo-ventures-gives-the-nod-to-nodtheras-320228.html 0.6 2026-08-12T21:17:57+08:00 daily https://www.pharmasources.com/industryinsights/mhra-suspends-patient-recruitment-to-uk--320229.html 0.6 2026-08-07T02:40:29+08:00 daily https://www.pharmasources.com/industryinsights/edqm-to-provide-covid-19-vaccine-develop-320230.html 0.6 2026-08-06T22:53:25+08:00 daily https://www.pharmasources.com/industryinsights/agios-announces-fda-orphan-drug-designat-320231.html 0.6 2026-08-06T23:32:21+08:00 daily https://www.pharmasources.com/industryinsights/cepheid-announces-development-of-combina-320232.html 0.6 2026-08-06T23:57:38+08:00 daily https://www.pharmasources.com/industryinsights/teva-initiates-recall-of-metformin-hydro-320233.html 0.6 2026-08-13T22:03:09+08:00 daily https://www.pharmasources.com/industryinsights/immunic-announces-fda-allowance-of-imu-8-320234.html 0.6 2026-08-06T22:53:44+08:00 daily https://www.pharmasources.com/industryinsights/opq-issues-the-2019-report-on-the-state--320235.html 0.6 2026-08-06T20:06:39+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-scientific-to-co-develop-g-320236.html 0.6 2026-08-06T22:53:34+08:00 daily https://www.pharmasources.com/industryinsights/nanosponges-could-intercept-coronavirus--320237.html 0.6 2026-08-06T23:47:10+08:00 daily https://www.pharmasources.com/industryinsights/merck-and-pfizers-sglt2-inhibitor-stegla-320238.html 0.6 2026-08-07T13:18:17+08:00 daily https://www.pharmasources.com/industryinsights/sc-formulation-of-darzalex-combination-d-320239.html 0.6 2026-08-08T03:08:41+08:00 daily https://www.pharmasources.com/industryinsights/evgens-sfx-01-selected-for-covid-19-tria-320240.html 0.6 2026-08-09T06:59:27+08:00 daily https://www.pharmasources.com/industryinsights/final-nice-green-light-for-janssens-stel-320241.html 0.6 2026-06-22T23:06:36+08:00 daily https://www.pharmasources.com/industryinsights/gsk-and-ideaya-partner-in-synthetic-leth-320242.html 0.6 2026-06-22T14:39:49+08:00 daily https://www.pharmasources.com/industryinsights/researchers-overdosing-covid-19-patients-320243.html 0.6 2026-06-21T20:46:44+08:00 daily https://www.pharmasources.com/industryinsights/the-medical-face-mask-market-is-expected-320244.html 0.6 2026-06-28T00:08:15+08:00 daily https://www.pharmasources.com/industryinsights/fette-compacting-china-co-ltd--virtual-f-320245.html 0.6 2026-06-21T07:46:42+08:00 daily https://www.pharmasources.com/industryinsights/fette-compacting-china-co-ltd---virtual--320246.html 0.6 2026-07-28T13:10:57+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-receives-anda-approval-for-fing-320247.html 0.6 2026-06-20T23:56:38+08:00 daily https://www.pharmasources.com/industryinsights/umifenovir-gets-dcgi-nod-for-phase-iii-c-320248.html 0.6 2026-06-21T11:13:22+08:00 daily https://www.pharmasources.com/industryinsights/strategic-short-term-measures-needed-on--320249.html 0.6 2026-07-19T23:59:12+08:00 daily https://www.pharmasources.com/industryinsights/optimus-launches-covid-19-drug-favipirav-320250.html 0.6 2026-06-23T04:02:04+08:00 daily https://www.pharmasources.com/industryinsights/roche-partners-with-entero-healthcare-so-320251.html 0.6 2026-08-13T05:47:17+08:00 daily https://www.pharmasources.com/industryinsights/safe-and-effective-vaccination-should-be-320252.html 0.6 2026-07-22T14:53:24+08:00 daily https://www.pharmasources.com/industryinsights/cipla-and-roche-partner-up-to-improve-ac-320253.html 0.6 2026-06-22T01:47:35+08:00 daily https://www.pharmasources.com/industryinsights/double-digit-mcap-growth-in-2019-for-14--320254.html 0.6 2026-07-21T14:49:12+08:00 daily https://www.pharmasources.com/industryinsights/bangladesh-launches-clinical-trial-of-tw-320255.html 0.6 2026-06-22T04:40:47+08:00 daily https://www.pharmasources.com/industryinsights/study-reveals-covid-19-virus-can-cause-c-320256.html 0.6 2026-06-20T22:01:39+08:00 daily https://www.pharmasources.com/industryinsights/export-ban-on-hydroxychloroquine-lifted-320257.html 0.6 2026-06-20T22:02:44+08:00 daily https://www.pharmasources.com/industryinsights/clariant-chemicals-q4-financial-result-s-320258.html 0.6 2026-06-20T22:39:45+08:00 daily https://www.pharmasources.com/industryinsights/fda-issues-eua-to-hymonsars-cov-2-test-k-320259.html 0.6 2026-06-21T01:06:47+08:00 daily https://www.pharmasources.com/industryinsights/bavarian-nordic-to-manufacture-additiona-320260.html 0.6 2026-06-21T06:06:51+08:00 daily https://www.pharmasources.com/industryinsights/calypso-biotech-completes-caly-002-clini-320261.html 0.6 2026-07-01T23:00:05+08:00 daily https://www.pharmasources.com/industryinsights/sharp-expands-commercial-packaging-capab-320262.html 0.6 2026-06-21T06:00:49+08:00 daily https://www.pharmasources.com/industryinsights/cambrex-names-thomas-loewald-as-ceo-320263.html 0.6 2026-06-22T22:10:34+08:00 daily https://www.pharmasources.com/industryinsights/emergent-biosolutions-enters-viral-vecto-320264.html 0.6 2026-06-22T06:02:51+08:00 daily https://www.pharmasources.com/industryinsights/optima-supports-catalent-with-high-speed-320265.html 0.6 2026-07-01T16:43:17+08:00 daily https://www.pharmasources.com/industryinsights/no-one-left-behind-ensuring-covid-19-vac-320266.html 0.6 2026-06-23T10:22:29+08:00 daily https://www.pharmasources.com/industryinsights/tonix-and-southern-research-to-study-imm-320267.html 0.6 2026-06-23T00:34:06+08:00 daily https://www.pharmasources.com/industryinsights/orca-bio-raises-192m-to-support-cell-the-320268.html 0.6 2026-08-14T02:22:48+08:00 daily https://www.pharmasources.com/industryinsights/pds-biotech-and-farmacore-partner-to-dev-320269.html 0.6 2026-06-23T13:59:11+08:00 daily https://www.pharmasources.com/industryinsights/torbay-pharmaceuticals-recalls-two-batch-320270.html 0.6 2026-06-21T03:04:42+08:00 daily https://www.pharmasources.com/industryinsights/sfx01-to-enter-phase-iiiii-trials-to-tes-320271.html 0.6 2026-06-20T22:01:36+08:00 daily https://www.pharmasources.com/industryinsights/generic-remdesivir-may-put-pricing-press-320272.html 0.6 2026-08-05T15:22:38+08:00 daily https://www.pharmasources.com/industryinsights/supernus-completes-acquisition-of-cns-po-320273.html 0.6 2026-08-06T01:33:37+08:00 daily https://www.pharmasources.com/industryinsights/melinta-to-acquire-tetraphase-pharmaceut-320274.html 0.6 2026-07-19T03:54:24+08:00 daily https://www.pharmasources.com/industryinsights/novel-antibody-drug-conjugate-abbv-3373--320275.html 0.6 2026-08-04T14:50:48+08:00 daily https://www.pharmasources.com/industryinsights/hengruis-application-for-new-class-11-dr-320276.html 0.6 2026-08-12T19:40:32+08:00 daily https://www.pharmasources.com/industryinsights/fulcrum-to-evaluate-losmapimod-as-potent-320277.html 0.6 2026-06-21T03:45:33+08:00 daily https://www.pharmasources.com/industryinsights/researchers-identify-potent-antibody-coc-320278.html 0.6 2026-06-21T20:56:41+08:00 daily https://www.pharmasources.com/industryinsights/artificial-intelligence-ai-sector-is-lev-320279.html 0.6 2026-05-31T14:16:43+08:00 daily https://www.pharmasources.com/industryinsights/breakthrough-therapy-for-type-2-immune-i-320280.html 0.6 2026-08-14T11:16:26+08:00 daily https://www.pharmasources.com/industryinsights/cipla-launches-remdesivir-under-brand-na-320281.html 0.6 2026-08-12T20:50:06+08:00 daily https://www.pharmasources.com/industryinsights/maha-govt-plans-to-procure-10000-vials-o-320282.html 0.6 2026-06-21T00:58:42+08:00 daily https://www.pharmasources.com/industryinsights/hetero-announces-launch-of-generic-remde-320283.html 0.6 2026-06-21T15:14:54+08:00 daily https://www.pharmasources.com/industryinsights/unichem-lupin-voluntarily-recall-hyperte-320284.html 0.6 2026-06-20T19:18:08+08:00 daily https://www.pharmasources.com/industryinsights/india-a-global-nutraceutical-hub-in-the--320285.html 0.6 2026-07-19T15:13:46+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-declines-approval-again-for-nabri-320286.html 0.6 2026-08-02T13:40:59+08:00 daily https://www.pharmasources.com/industryinsights/novartis-stops-hcq-trial-against-covid-1-320287.html 0.6 2026-05-31T13:31:34+08:00 daily https://www.pharmasources.com/industryinsights/acute-myeloid-leukaemia-market-to-reach--320288.html 0.6 2026-08-06T00:47:55+08:00 daily https://www.pharmasources.com/industryinsights/piramal-pharma-to-acquire-manufacturing--320289.html 0.6 2026-07-04T13:45:30+08:00 daily https://www.pharmasources.com/industryinsights/network-of-channels-inside-bacterial-com-320290.html 0.6 2026-06-21T10:05:12+08:00 daily https://www.pharmasources.com/industryinsights/mis-c-research-can-give-insights-on-covi-320291.html 0.6 2026-06-20T23:56:36+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-grants-approval-to-ultragenyx-pha-320292.html 0.6 2026-06-20T18:57:49+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-laboratories-launch-abirateron-320293.html 0.6 2026-06-22T12:12:00+08:00 daily https://www.pharmasources.com/industryinsights/cdsco-to-inspect-bdr-pharmas-formulation-320294.html 0.6 2026-06-24T13:15:40+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-set-to-get-manufacturing-and-ma-320295.html 0.6 2026-06-21T07:58:05+08:00 daily https://www.pharmasources.com/industryinsights/aleor-dermaceuticals-gets-us-fda-nod-for-320296.html 0.6 2026-06-20T23:44:51+08:00 daily https://www.pharmasources.com/industryinsights/neurocrine-licenses-seven-takeda-compoun-320297.html 0.6 2026-06-23T14:15:36+08:00 daily https://www.pharmasources.com/industryinsights/opencell-technologies-appoints-ceo-320298.html 0.6 2026-06-16T05:50:46+08:00 daily https://www.pharmasources.com/industryinsights/epizymes-tazverik-secures-fda-approval-t-320299.html 0.6 2026-07-03T16:54:07+08:00 daily https://www.pharmasources.com/industryinsights/alpine-immune-and-abbvie-sign-865m-immun-320300.html 0.6 2026-08-08T12:07:48+08:00 daily https://www.pharmasources.com/industryinsights/cdri-gets-approval-for-phase-iii-trial-o-320301.html 0.6 2026-06-22T05:37:24+08:00 daily https://www.pharmasources.com/industryinsights/clinical-trial-disruption-from-covid-19--320302.html 0.6 2026-05-31T12:13:31+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-commits-to-supply-europe-wit-320303.html 0.6 2026-08-06T14:40:27+08:00 daily https://www.pharmasources.com/industryinsights/nine-in-10-americans-concerned-big-pharm-320304.html 0.6 2026-06-21T10:00:07+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-begins-trials-of-anti-viral-an-320305.html 0.6 2026-08-05T20:59:34+08:00 daily https://www.pharmasources.com/industryinsights/jj-accelerates-covid-19-vaccine-candidat-320306.html 0.6 2026-06-20T20:10:44+08:00 daily https://www.pharmasources.com/industryinsights/impel-neuropharma-announces-positive-res-320307.html 0.6 2026-03-29T14:42:42+08:00 daily https://www.pharmasources.com/industryinsights/vivera-files-first-of-two-us-made-covid--320308.html 0.6 2026-06-21T09:11:14+08:00 daily https://www.pharmasources.com/industryinsights/fda-authorizes-first-next-generation-seq-320309.html 0.6 2026-08-07T12:58:36+08:00 daily https://www.pharmasources.com/industryinsights/bayer-supports-the-challenge-initiative--320310.html 0.6 2026-06-20T20:12:47+08:00 daily https://www.pharmasources.com/industryinsights/mayo-finds-convalescent-plasma-safe-for--320311.html 0.6 2026-06-21T00:17:53+08:00 daily https://www.pharmasources.com/industryinsights/novartis-gets-fda-approval-for-cosentyx--320312.html 0.6 2026-06-21T22:08:58+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisks-am833-shows-early-success--320313.html 0.6 2026-06-21T10:55:26+08:00 daily https://www.pharmasources.com/industryinsights/eu-filing-for-cpps-familial-adenomatous--320314.html 0.6 2026-06-22T07:04:49+08:00 daily https://www.pharmasources.com/industryinsights/abbvies-rinvoq-shows-potential-for-atopi-320315.html 0.6 2026-07-14T09:04:38+08:00 daily https://www.pharmasources.com/industryinsights/uk-launches-worlds-first-subscription-st-320316.html 0.6 2026-07-05T00:12:43+08:00 daily https://www.pharmasources.com/industryinsights/researchers-develop-highly-sensitive-blo-320317.html 0.6 2026-07-06T06:30:26+08:00 daily https://www.pharmasources.com/industryinsights/msdpfizers-diabetes-drug-steglatro-hits--320318.html 0.6 2026-07-02T13:25:11+08:00 daily https://www.pharmasources.com/industryinsights/roches-tecentriq-shows-promise-in-early--320319.html 0.6 2026-07-27T04:13:16+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-pandemic-dramatically-increased-320320.html 0.6 2026-06-21T08:08:03+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-news-of-the-week-june-8th-320321.html 0.6 2026-06-25T05:20:59+08:00 daily https://www.pharmasources.com/industryinsights/catalent-partners-with-viralclear-on-pot-320322.html 0.6 2026-06-21T01:10:58+08:00 daily https://www.pharmasources.com/industryinsights/piramal-acquires-facility-from-gw-labora-320323.html 0.6 2026-06-21T01:59:41+08:00 daily https://www.pharmasources.com/industryinsights/aurobindo-pharma-plans-to-launch-50-60-p-320324.html 0.6 2026-06-12T22:47:04+08:00 daily https://www.pharmasources.com/industryinsights/small-market-cap-companies-more-dependen-320325.html 0.6 2026-08-09T18:09:21+08:00 daily https://www.pharmasources.com/industryinsights/its-time-to-be-more-vigilant-and-quality-320326.html 0.6 2026-08-08T01:44:13+08:00 daily https://www.pharmasources.com/industryinsights/antibody-levels-in-recovered-covid-19-pa-320327.html 0.6 2026-06-22T09:58:46+08:00 daily https://www.pharmasources.com/industryinsights/thai-trials-of-covid-19-vaccine-reach-ma-320328.html 0.6 2026-08-06T08:08:26+08:00 daily https://www.pharmasources.com/industryinsights/intravaccs-experimental-whooping-cough-v-320329.html 0.6 2026-06-21T00:59:43+08:00 daily https://www.pharmasources.com/industryinsights/alembic-pharma-gets-tentative-us-fda-nod-320330.html 0.6 2026-07-03T01:41:31+08:00 daily https://www.pharmasources.com/industryinsights/ipa-launches-a-digital-campaign-to-ensur-320331.html 0.6 2025-11-10T19:10:59+08:00 daily https://www.pharmasources.com/industryinsights/dksh-to-commercialise-seven-generic-form-320332.html 0.6 2026-06-20T19:00:46+08:00 daily https://www.pharmasources.com/industryinsights/chinese-researchers-launch-phase-2-human-320333.html 0.6 2026-06-22T11:37:36+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-regeneron-dupixent-secures-china--320334.html 0.6 2026-08-10T09:01:47+08:00 daily https://www.pharmasources.com/industryinsights/als-global-day-emphasises-need-for-a-cur-320335.html 0.6 2026-08-03T05:12:13+08:00 daily https://www.pharmasources.com/industryinsights/novel-prostate-cancer-drug-formulation-c-320336.html 0.6 2026-06-22T01:51:28+08:00 daily https://www.pharmasources.com/industryinsights/dexamethasone-to-be-available-on-nhs-as--320337.html 0.6 2026-06-23T09:38:23+08:00 daily https://www.pharmasources.com/industryinsights/uk-launches-scheme-to-encourage-developm-320338.html 0.6 2026-06-21T03:58:50+08:00 daily https://www.pharmasources.com/industryinsights/eib-provides-biontech-with-debt-financin-320339.html 0.6 2026-08-05T14:27:43+08:00 daily https://www.pharmasources.com/industryinsights/agios-royalty-pharma-announce-purchase-a-320340.html 0.6 2026-07-06T21:13:46+08:00 daily https://www.pharmasources.com/industryinsights/pfenex-announces-us-commercial-launch-of-320341.html 0.6 2026-06-21T09:15:14+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-therapy-for-rare-diseas-320342.html 0.6 2026-06-20T16:56:15+08:00 daily https://www.pharmasources.com/industryinsights/apple-tree-partners-portfolio-company-co-320343.html 0.6 2026-07-15T18:58:04+08:00 daily https://www.pharmasources.com/industryinsights/interdisciplinary-consortium-receives-gr-320344.html 0.6 2026-08-13T15:48:11+08:00 daily https://www.pharmasources.com/industryinsights/gskclovers-covid-19-vaccine-moves-into-h-320345.html 0.6 2026-07-15T09:14:47+08:00 daily https://www.pharmasources.com/industryinsights/ema-to-consider-expanding-use-of-merckpf-320346.html 0.6 2026-06-22T06:38:35+08:00 daily https://www.pharmasources.com/industryinsights/waldenstrms-macroglobulinemia-drug-bruki-320347.html 0.6 2026-07-13T23:29:24+08:00 daily https://www.pharmasources.com/industryinsights/high-street-pharmacist-check-ups-oversho-320348.html 0.6 2026-06-20T15:11:23+08:00 daily https://www.pharmasources.com/industryinsights/amgen-is-supporting-advancement-of-amg-6-320349.html 0.6 2026-06-20T22:45:40+08:00 daily https://www.pharmasources.com/industryinsights/as-convalescent-plasma-is-authorized-for-320350.html 0.6 2026-08-07T13:55:39+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-news-of-the-week-june15th-320351.html 0.6 2026-08-07T13:19:23+08:00 daily https://www.pharmasources.com/industryinsights/discovering-biotechnology-5-innovations--320352.html 0.6 2026-08-07T02:22:11+08:00 daily https://www.pharmasources.com/industryinsights/aha-international-co-ltd--virtual-factor-320353.html 0.6 2026-06-22T23:04:02+08:00 daily https://www.pharmasources.com/industryinsights/aha-international-co-ltd---virtual-facto-320354.html 0.6 2026-06-21T09:58:09+08:00 daily https://www.pharmasources.com/industryinsights/pharma-and-health-from-ingredients-to-pi-320355.html 0.6 2026-07-19T21:01:29+08:00 daily https://www.pharmasources.com/industryinsights/vaccitech-begins-phase-1-clinical-study--320356.html 0.6 2026-06-28T09:00:14+08:00 daily https://www.pharmasources.com/industryinsights/gilead-targets-remdesivir-supply-for-two-320357.html 0.6 2026-07-04T14:21:21+08:00 daily https://www.pharmasources.com/industryinsights/bayer-close-to-glyphosate-settlement-wor-320358.html 0.6 2026-08-14T14:41:03+08:00 daily https://www.pharmasources.com/industryinsights/inovio-gets-71-million-from-us-defense-d-320359.html 0.6 2026-06-21T04:59:44+08:00 daily https://www.pharmasources.com/industryinsights/trials-with-oxford-covid-19-vaccine-star-320360.html 0.6 2026-06-21T12:13:38+08:00 daily https://www.pharmasources.com/industryinsights/powder-flow-optimising-unit-operations-u-320361.html 0.6 2026-07-09T02:06:52+08:00 daily https://www.pharmasources.com/industryinsights/indian-ancillary-manufacturers-assure-un-320362.html 0.6 2026-06-22T00:17:27+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-eyes-approval-of-covid-19-vaccine-320363.html 0.6 2026-07-08T16:15:30+08:00 daily https://www.pharmasources.com/industryinsights/g1-therapeutics-and-genor-biopharma-sign-320364.html 0.6 2026-06-23T18:59:28+08:00 daily https://www.pharmasources.com/industryinsights/morepen-labs-clocks-double-digit-growth--320365.html 0.6 2026-06-23T20:51:49+08:00 daily https://www.pharmasources.com/industryinsights/cipla-to-price-remdesivir-version-for-co-320366.html 0.6 2026-06-22T13:07:39+08:00 daily https://www.pharmasources.com/industryinsights/honeywell-unveils-aclar-edge-bottles-and-320367.html 0.6 2026-06-21T01:08:48+08:00 daily https://www.pharmasources.com/industryinsights/fresenius-kabi-expands-microvault-packag-320368.html 0.6 2026-07-09T08:39:03+08:00 daily https://www.pharmasources.com/industryinsights/gilead-acquires-stake-in-pionyr-immunoth-320369.html 0.6 2026-06-20T17:32:10+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-daiichi-sankyo-to-co-devel-320370.html 0.6 2026-08-14T09:28:29+08:00 daily https://www.pharmasources.com/industryinsights/gemini-bio-opens-new-cgmp-facility-320371.html 0.6 2026-07-06T21:25:51+08:00 daily https://www.pharmasources.com/industryinsights/sarepta-and-codiak-biosciences-to-develo-320372.html 0.6 2026-06-21T07:01:54+08:00 daily https://www.pharmasources.com/industryinsights/uk-researchers-form-consortium-to-monito-320373.html 0.6 2026-06-20T16:07:35+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-translate-bio-team-up-to-deve-320374.html 0.6 2026-06-21T22:47:40+08:00 daily https://www.pharmasources.com/industryinsights/ruxolitinib-to-be-studied-as-covid-19-tr-320375.html 0.6 2026-08-10T07:19:38+08:00 daily https://www.pharmasources.com/industryinsights/gsk-recalls-three-lots-of-childrens-coug-320376.html 0.6 2026-06-22T12:15:06+08:00 daily https://www.pharmasources.com/industryinsights/lilly-begins-baricitinib-trial-for-hospi-320377.html 0.6 2026-06-21T08:58:59+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-breakthrough-device-designati-320378.html 0.6 2026-06-22T12:57:02+08:00 daily https://www.pharmasources.com/industryinsights/initial-covid-19-infection-rate-may-be-8-320379.html 0.6 2026-06-21T11:55:37+08:00 daily https://www.pharmasources.com/industryinsights/epidarex-capital-closes-life-sciences-ve-320380.html 0.6 2026-06-22T10:49:54+08:00 daily https://www.pharmasources.com/industryinsights/research-charities-warn-of-funding-cuts--320381.html 0.6 2026-06-21T05:58:42+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-to-sell-stake-in-hikma-320382.html 0.6 2026-06-21T18:13:35+08:00 daily https://www.pharmasources.com/industryinsights/new-coronavirus-saliva-test-to-be-triall-320383.html 0.6 2026-06-21T22:41:02+08:00 daily https://www.pharmasources.com/industryinsights/mhra-extends-access-to-santheras-dmd-dru-320384.html 0.6 2026-08-02T18:02:10+08:00 daily https://www.pharmasources.com/industryinsights/a-better-anti-influenza-solution-roches--320385.html 0.6 2026-08-07T06:23:43+08:00 daily https://www.pharmasources.com/industryinsights/the-layout-of-inhalation-formulations-in-320386.html 0.6 2026-07-20T17:54:00+08:00 daily https://www.pharmasources.com/industryinsights/the-layout-of-inhalation-formulations-in-320387.html 0.6 2026-07-22T20:52:56+08:00 daily https://www.pharmasources.com/industryinsights/freeman-technology-news---new-ebook-from-320388.html 0.6 2026-08-09T04:51:50+08:00 daily https://www.pharmasources.com/industryinsights/tonix-pharmaceuticals-and-southern-resea-320389.html 0.6 2026-06-21T10:52:04+08:00 daily https://www.pharmasources.com/industryinsights/bulk-drug-manufacturers-seek-support-fro-320390.html 0.6 2026-07-28T03:33:14+08:00 daily https://www.pharmasources.com/industryinsights/dexamethasone-added-to-covid-19-treatmen-320391.html 0.6 2026-08-08T00:39:24+08:00 daily https://www.pharmasources.com/industryinsights/researchers-identify-six-potential-drug--320392.html 0.6 2026-06-20T15:56:34+08:00 daily https://www.pharmasources.com/industryinsights/carlyle-group-to-acquire-20-per-cent-sta-320393.html 0.6 2026-08-02T10:52:15+08:00 daily https://www.pharmasources.com/industryinsights/lincoln-pharma-posts-net-profit-of-rs-92-320394.html 0.6 2026-06-08T21:20:48+08:00 daily https://www.pharmasources.com/industryinsights/glenmarks-consolidated-revenue-rises-to--320395.html 0.6 2026-07-04T10:50:33+08:00 daily https://www.pharmasources.com/industryinsights/pharma-cos-should-develop-strategies-to--320396.html 0.6 2026-08-12T04:00:39+08:00 daily https://www.pharmasources.com/industryinsights/why-is-there-a-renewed-respect-for-nutra-320397.html 0.6 2026-06-20T16:20:37+08:00 daily https://www.pharmasources.com/industryinsights/honeywell-unveils-aclar-edge-innovative--320398.html 0.6 2026-06-08T22:46:46+08:00 daily https://www.pharmasources.com/industryinsights/teknova-welcomes-stephen-gunstream-as-ce-320399.html 0.6 2026-06-21T06:03:19+08:00 daily https://www.pharmasources.com/industryinsights/india-must-spend-5-per-cent-of-its-gdp-o-320400.html 0.6 2025-11-16T01:27:25+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-grants-approval-of-fintepla-to-zo-320401.html 0.6 2026-06-21T09:03:06+08:00 daily https://www.pharmasources.com/industryinsights/govt-to-announce-regulatory-guidelines-f-320402.html 0.6 2026-06-20T17:05:14+08:00 daily https://www.pharmasources.com/industryinsights/moderna-and-catalent-announce-collaborat-320403.html 0.6 2026-06-21T05:02:43+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-eyes-three-drug-inhaler-oppo-320404.html 0.6 2026-06-21T00:15:02+08:00 daily https://www.pharmasources.com/industryinsights/sosei-abbvie-sign-drug-discovery-deal-wo-320405.html 0.6 2026-06-21T07:12:31+08:00 daily https://www.pharmasources.com/industryinsights/cdsco-asks-industry-to-submit-suggestion-320406.html 0.6 2026-05-28T09:49:35+08:00 daily https://www.pharmasources.com/industryinsights/dupont-achieves-non-gmo-certification-fo-320407.html 0.6 2026-05-28T09:43:32+08:00 daily https://www.pharmasources.com/industryinsights/gilead-to-buy-499-per-cent-stake-in-canc-320408.html 0.6 2026-06-20T22:10:08+08:00 daily https://www.pharmasources.com/industryinsights/take-solutions-appoints-lalit-mahapatra--320409.html 0.6 2026-06-21T01:02:48+08:00 daily https://www.pharmasources.com/industryinsights/edge-pharma-completes-supplier-agreement-320410.html 0.6 2026-08-06T23:32:23+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-translate-bio-expand-vaccine--320411.html 0.6 2026-08-06T23:37:37+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-wako-introduces-pyrostar-es-f-l-320412.html 0.6 2026-08-06T23:45:38+08:00 daily https://www.pharmasources.com/industryinsights/samsung-bioepis-secures-positive-chmp-op-320413.html 0.6 2026-08-06T23:54:49+08:00 daily https://www.pharmasources.com/industryinsights/japans-daiichi-sankyo-in-talks-with-astr-320414.html 0.6 2026-08-07T02:22:05+08:00 daily https://www.pharmasources.com/industryinsights/avalon-globocare-to-develop-intranasal-a-320415.html 0.6 2026-08-07T02:31:10+08:00 daily https://www.pharmasources.com/industryinsights/yumanity-therapeutics-signs-drug-develop-320416.html 0.6 2026-08-07T02:37:00+08:00 daily https://www.pharmasources.com/industryinsights/oxford-covid-19-vaccine-doses-improve-im-320417.html 0.6 2026-08-07T02:40:32+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-fast-track-status-to-neurorxs-320418.html 0.6 2026-08-07T12:03:08+08:00 daily https://www.pharmasources.com/industryinsights/ema-recommends-authorisation-for-remdesi-320419.html 0.6 2026-08-07T13:19:20+08:00 daily https://www.pharmasources.com/industryinsights/emer-cooke-nominated-as-new-ema-executiv-320420.html 0.6 2026-08-07T18:43:39+08:00 daily https://www.pharmasources.com/industryinsights/industry-recommends-changes-in-draft-gui-320421.html 0.6 2026-08-07T22:18:54+08:00 daily https://www.pharmasources.com/industryinsights/over-2000-clinical-trials-currently-unde-320422.html 0.6 2026-08-08T04:35:22+08:00 daily https://www.pharmasources.com/industryinsights/epidyolex-cannabidiol-reclassified-as-sc-320423.html 0.6 2026-08-08T06:16:44+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-dosed-with-covid-19-vaccin-320424.html 0.6 2026-08-08T12:33:18+08:00 daily https://www.pharmasources.com/industryinsights/consortium-established-to-monitor-covid--320425.html 0.6 2026-08-08T14:03:23+08:00 daily https://www.pharmasources.com/industryinsights/arch-biopartners-to-proceed-with-metablo-320426.html 0.6 2026-08-08T20:11:51+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-treatment-for-adult-o-320427.html 0.6 2026-08-10T12:29:52+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-pembrolizumab-for-tmb-h-sol-320428.html 0.6 2026-07-31T06:55:43+08:00 daily https://www.pharmasources.com/industryinsights/diabetes-drug-may-lower-covid-19-death-r-320429.html 0.6 2026-06-20T14:46:20+08:00 daily https://www.pharmasources.com/industryinsights/brazil-signs-agreement-to-produce-astraz-320430.html 0.6 2026-06-20T21:50:31+08:00 daily https://www.pharmasources.com/industryinsights/global-covid-19-fundraising-meeting-rais-320431.html 0.6 2026-06-21T20:14:55+08:00 daily https://www.pharmasources.com/industryinsights/study-identifies-immune-cells-involved-i-320432.html 0.6 2026-08-09T04:07:24+08:00 daily https://www.pharmasources.com/industryinsights/key-pipeline-advancements-to-propel-myel-320433.html 0.6 2026-08-06T08:52:23+08:00 daily https://www.pharmasources.com/industryinsights/nri-professor-discovers-new-therapy-for--320434.html 0.6 2026-06-30T06:05:23+08:00 daily https://www.pharmasources.com/industryinsights/avid-bioservices-names-nicholas-green-as-320435.html 0.6 2026-08-08T03:31:19+08:00 daily https://www.pharmasources.com/industryinsights/fda-revokes-emergency-use-authorization--320436.html 0.6 2026-06-20T14:58:06+08:00 daily https://www.pharmasources.com/industryinsights/aethlon-announces-fda-approval-of-ide-su-320437.html 0.6 2026-06-20T15:08:20+08:00 daily https://www.pharmasources.com/industryinsights/cosentyx-receives-fda-approval-for-new-i-320438.html 0.6 2026-06-21T02:55:44+08:00 daily https://www.pharmasources.com/industryinsights/ptc-announces-the-phase-23-clinical-tria-320439.html 0.6 2026-06-21T02:58:51+08:00 daily https://www.pharmasources.com/industryinsights/fda-warns-four-manufacturers-of-unapprov-320440.html 0.6 2026-06-21T08:09:06+08:00 daily https://www.pharmasources.com/industryinsights/sagimet-announces-positive-results-in-na-320441.html 0.6 2026-06-20T22:56:40+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-accelerated-approval-metastat-320442.html 0.6 2026-06-22T01:55:33+08:00 daily https://www.pharmasources.com/industryinsights/whats-been-happening-in-pharma---updates-320443.html 0.6 2026-06-23T17:40:14+08:00 daily https://www.pharmasources.com/industryinsights/valeo-pharma-receives-fda-approval-for-e-320444.html 0.6 2026-06-21T10:19:33+08:00 daily https://www.pharmasources.com/industryinsights/pharma-packaging-companies-commit-to-sup-320445.html 0.6 2026-06-29T23:50:58+08:00 daily https://www.pharmasources.com/industryinsights/biomerica-files-for-eua-for-its-covid-19-320446.html 0.6 2026-06-23T12:55:51+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-lyumjev-320447.html 0.6 2026-08-12T10:05:01+08:00 daily https://www.pharmasources.com/industryinsights/gsk-covid-19-vaccine-development-collabo-320448.html 0.6 2026-08-11T22:20:36+08:00 daily https://www.pharmasources.com/industryinsights/lilly-begins-worlds-first-study-of-a-pot-320449.html 0.6 2025-11-09T18:59:29+08:00 daily https://www.pharmasources.com/industryinsights/study-is-first-to-identify-potential-the-320450.html 0.6 2026-06-20T14:21:56+08:00 daily https://www.pharmasources.com/industryinsights/novartis-research-shows-technology-talen-320451.html 0.6 2026-06-21T00:14:45+08:00 daily https://www.pharmasources.com/industryinsights/fda-announces-first-of-its-kind-pilot-pr-320452.html 0.6 2026-06-21T04:08:53+08:00 daily https://www.pharmasources.com/industryinsights/ec-clears-new-class-of-anaemia-therapy-320453.html 0.6 2026-06-20T17:51:16+08:00 daily https://www.pharmasources.com/industryinsights/eight-medicines-leap-towards-eu-approval-320454.html 0.6 2026-06-21T22:47:34+08:00 daily https://www.pharmasources.com/industryinsights/msds-keytruda-bags-approval-for-new-skin-320455.html 0.6 2026-07-03T15:01:24+08:00 daily https://www.pharmasources.com/industryinsights/nice-sticks-to-zytiga-rejection-320456.html 0.6 2026-08-07T22:14:04+08:00 daily https://www.pharmasources.com/industryinsights/nihrmrc-fund-new-study-of-potential-gene-320457.html 0.6 2026-06-21T07:58:10+08:00 daily https://www.pharmasources.com/industryinsights/nice-rejects-novartis-mayzent-for-second-320458.html 0.6 2026-06-21T06:04:46+08:00 daily https://www.pharmasources.com/industryinsights/chmp-backs-approval-of-remdesivir-as-cov-320459.html 0.6 2026-06-20T18:49:33+08:00 daily https://www.pharmasources.com/industryinsights/whats-been-happening-in-pharma---updates-320460.html 0.6 2026-06-22T08:23:58+08:00 daily https://www.pharmasources.com/industryinsights/covaxin-from-bharat-biotech-gets-dcgi-ap-320461.html 0.6 2026-06-23T00:03:13+08:00 daily https://www.pharmasources.com/industryinsights/roche-not-yet-meeting-demand-for-molecul-320462.html 0.6 2026-06-21T01:05:55+08:00 daily https://www.pharmasources.com/industryinsights/expect-to-launch-25-products-in-us-this--320463.html 0.6 2026-06-21T12:57:49+08:00 daily https://www.pharmasources.com/industryinsights/chinese-firm-says-coronavirus-vaccine-ca-320464.html 0.6 2026-06-21T13:13:46+08:00 daily https://www.pharmasources.com/industryinsights/cipla-and-boehringer-ingelheim-to-co-mar-320465.html 0.6 2026-08-09T02:52:28+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-receives-japan-mhlw-approval--320466.html 0.6 2026-08-09T00:37:46+08:00 daily https://www.pharmasources.com/industryinsights/re-purposed-drugs-could-reverse-blood-ve-320467.html 0.6 2026-08-08T22:10:37+08:00 daily https://www.pharmasources.com/industryinsights/gilead-sets-covid-19-drug-candidate-remd-320468.html 0.6 2026-08-08T17:53:08+08:00 daily https://www.pharmasources.com/industryinsights/japan-grants-approval-for-gsks-duvroq-to-320469.html 0.6 2026-08-08T15:49:45+08:00 daily https://www.pharmasources.com/industryinsights/brazil-signs-127m-deal-to-manufacture-ox-320470.html 0.6 2026-08-08T14:04:45+08:00 daily https://www.pharmasources.com/industryinsights/common-cancer-treatments-do-not-worsen-c-320471.html 0.6 2026-08-08T03:25:27+08:00 daily https://www.pharmasources.com/industryinsights/nice-does-not-recommend-novartis-siponim-320472.html 0.6 2026-08-07T13:16:09+08:00 daily https://www.pharmasources.com/industryinsights/kymab-wins-uk-court-case-against-regener-320473.html 0.6 2026-08-06T21:58:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-therapy-for-disease-that-ca-320474.html 0.6 2026-08-10T18:06:45+08:00 daily https://www.pharmasources.com/industryinsights/valneva-bavarian-nordic-announce-marketi-320475.html 0.6 2026-08-06T22:53:18+08:00 daily https://www.pharmasources.com/industryinsights/truvian-sciences-introduces-easy-check-c-320476.html 0.6 2026-08-08T20:00:08+08:00 daily https://www.pharmasources.com/industryinsights/mylan-wins-district-court-decision-again-320477.html 0.6 2026-08-07T14:37:26+08:00 daily https://www.pharmasources.com/industryinsights/fda-issues-guidance-for-clinical-trials--320478.html 0.6 2026-08-08T20:36:16+08:00 daily https://www.pharmasources.com/industryinsights/ampio-to-start-first-clinical-trial-in-c-320479.html 0.6 2026-08-07T13:19:05+08:00 daily https://www.pharmasources.com/industryinsights/existing-drugs-can-prevent-sars-cov-2-fr-320480.html 0.6 2026-08-08T02:55:44+08:00 daily https://www.pharmasources.com/industryinsights/us-nod-for-roches-breast-cancer-combo-320481.html 0.6 2026-08-08T03:25:17+08:00 daily https://www.pharmasources.com/industryinsights/cr-uk-calls-on-scottish-gov-to-urgently--320482.html 0.6 2026-08-08T04:36:52+08:00 daily https://www.pharmasources.com/industryinsights/mhra-issues-consent-for-redhill-bioharma-320483.html 0.6 2026-08-08T10:49:47+08:00 daily https://www.pharmasources.com/industryinsights/obesity-linked-to-higher-risk-of-dementi-320484.html 0.6 2026-08-08T15:51:59+08:00 daily https://www.pharmasources.com/industryinsights/successful-eloctaq-bid-should-widen-acce-320485.html 0.6 2026-08-08T17:53:08+08:00 daily https://www.pharmasources.com/industryinsights/breztri-aerosphere-cut-rate-of-copd-exac-320486.html 0.6 2026-08-12T23:10:58+08:00 daily https://www.pharmasources.com/industryinsights/new-consortium-will-monitor-safetyeffica-320487.html 0.6 2026-08-08T21:34:39+08:00 daily https://www.pharmasources.com/industryinsights/imperial-covid-19-vaccine-begins-human-t-320488.html 0.6 2026-08-09T02:39:11+08:00 daily https://www.pharmasources.com/industryinsights/new-13m-national-research-programme-to-e-320489.html 0.6 2026-08-09T05:41:21+08:00 daily https://www.pharmasources.com/industryinsights/theravance-biopharma-doses-first-patient-320490.html 0.6 2026-06-21T07:23:43+08:00 daily https://www.pharmasources.com/industryinsights/beigene-submits-application-for-the-fift-320491.html 0.6 2026-08-01T23:47:45+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-news-of-the-week-june22-2-320492.html 0.6 2026-07-22T21:51:49+08:00 daily https://www.pharmasources.com/industryinsights/scottish-firm-to-trial-t-cells-as-possib-320493.html 0.6 2026-06-21T15:53:14+08:00 daily https://www.pharmasources.com/industryinsights/researchers-identify-drugs-that-may-bloc-320494.html 0.6 2026-06-22T08:53:37+08:00 daily https://www.pharmasources.com/industryinsights/genetics-has-revolutionised-patient-sele-320495.html 0.6 2026-01-31T01:35:34+08:00 daily https://www.pharmasources.com/industryinsights/chinese-researchers-warn-of-new-virus-in-320496.html 0.6 2026-06-21T09:10:10+08:00 daily https://www.pharmasources.com/industryinsights/linagliptin-demonstrates-cardiovascular--320497.html 0.6 2026-06-20T14:39:30+08:00 daily https://www.pharmasources.com/industryinsights/uk-regulator-says-covid-19-prevention-tr-320498.html 0.6 2026-06-21T00:49:00+08:00 daily https://www.pharmasources.com/industryinsights/novartis-global-innovative-sirna-long-ac-320499.html 0.6 2026-08-06T17:43:08+08:00 daily https://www.pharmasources.com/industryinsights/gilead-prices-covid-19-drug-remdesivir-a-320500.html 0.6 2026-06-29T21:44:25+08:00 daily https://www.pharmasources.com/industryinsights/takeda-forms-900m-research-alliance-with-320501.html 0.6 2026-07-09T05:21:38+08:00 daily https://www.pharmasources.com/industryinsights/tiziana-life-sciences-signs-manufacturin-320502.html 0.6 2026-07-06T21:18:07+08:00 daily https://www.pharmasources.com/industryinsights/roches-breast-cancer-drug-phesgo-secures-320503.html 0.6 2026-06-27T02:20:47+08:00 daily https://www.pharmasources.com/industryinsights/first-covid-19-vaccine-clinical-trial-ap-320504.html 0.6 2026-06-21T05:56:46+08:00 daily https://www.pharmasources.com/industryinsights/ajinomoto-bio-pharma-introduces-ajility--320505.html 0.6 2026-06-21T12:12:26+08:00 daily https://www.pharmasources.com/industryinsights/urovant-collaboration-sunovion-pharmaceu-320506.html 0.6 2026-07-08T18:14:33+08:00 daily https://www.pharmasources.com/industryinsights/esperion-daiichi-sankyo-europe-announce--320507.html 0.6 2026-06-21T01:41:24+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-pertuzumab-trastuzumab-hyal-320508.html 0.6 2026-06-20T23:19:06+08:00 daily https://www.pharmasources.com/industryinsights/evelo-biosciences-announces-edp1815-to-a-320509.html 0.6 2026-06-21T01:58:58+08:00 daily https://www.pharmasources.com/industryinsights/fda-to-harness-real-world-data-to-inform-320510.html 0.6 2026-06-20T14:49:10+08:00 daily https://www.pharmasources.com/industryinsights/carlyle-group-to-acquire-20-stake-in-ind-320511.html 0.6 2026-07-20T01:03:58+08:00 daily https://www.pharmasources.com/industryinsights/aadi-bioscience-initiates-rolling-submis-320512.html 0.6 2026-07-30T14:14:28+08:00 daily https://www.pharmasources.com/industryinsights/noxopharm-reports-covid-19-trial-program-320513.html 0.6 2026-06-20T18:59:42+08:00 daily https://www.pharmasources.com/industryinsights/the-second-car-t-therapy-in-china-applie-320514.html 0.6 2026-01-24T04:30:59+08:00 daily https://www.pharmasources.com/industryinsights/whole-town-study-reveals-more-than-40-of-320515.html 0.6 2026-06-21T08:08:06+08:00 daily https://www.pharmasources.com/industryinsights/fda-takes-action-to-help-facilitate-time-320516.html 0.6 2026-06-22T07:46:45+08:00 daily https://www.pharmasources.com/industryinsights/even-in-the-worst-covid-19-cases-the-bod-320517.html 0.6 2026-06-30T03:21:06+08:00 daily https://www.pharmasources.com/industryinsights/cma-imposes-12m-fines-for-price-fixing-i-320518.html 0.6 2026-06-20T20:03:43+08:00 daily https://www.pharmasources.com/industryinsights/vertex-signs-landmark-deal-with-nhs-for--320519.html 0.6 2026-08-10T12:40:16+08:00 daily https://www.pharmasources.com/industryinsights/cambridge-spin-out-pharmenable-raises-18-320520.html 0.6 2026-06-22T09:08:16+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-links-with-sidekickhealth-for-dig-320521.html 0.6 2026-06-22T04:00:43+08:00 daily https://www.pharmasources.com/industryinsights/hoth-therapeutics-announces-sponsored-re-320522.html 0.6 2026-06-20T23:53:31+08:00 daily https://www.pharmasources.com/industryinsights/oncology-venture-out-licenses-clinical-a-320523.html 0.6 2026-06-21T13:02:30+08:00 daily https://www.pharmasources.com/industryinsights/pci-pharma-services-completes-biotech-co-320524.html 0.6 2026-07-15T18:02:08+08:00 daily https://www.pharmasources.com/industryinsights/sotio-appoints-richard-sachse-as-chief-m-320525.html 0.6 2026-03-20T00:06:05+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-grants-orphan-drug-designation-od-320526.html 0.6 2026-08-09T10:03:35+08:00 daily https://www.pharmasources.com/industryinsights/polares-medical-closes-a-40m-financing-t-320527.html 0.6 2026-08-09T05:35:35+08:00 daily https://www.pharmasources.com/industryinsights/biogeneration-ventures-closes-bgv-iv-fun-320528.html 0.6 2026-06-22T11:55:55+08:00 daily https://www.pharmasources.com/industryinsights/first-participant-dosed-in-phase-1-clini-320529.html 0.6 2026-06-21T01:13:57+08:00 daily https://www.pharmasources.com/industryinsights/sotio-presents-new-data-showing-strong-a-320530.html 0.6 2026-06-20T14:31:54+08:00 daily https://www.pharmasources.com/industryinsights/happy-25-years-anniversary-and-a-new-era-320531.html 0.6 2026-03-17T23:37:56+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-biontech-post-positive-data-from--320532.html 0.6 2026-08-12T12:10:22+08:00 daily https://www.pharmasources.com/industryinsights/how-glass-vial-makers-are-girding-to-boo-320533.html 0.6 2026-06-22T09:08:49+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-releases-guidance-for-approval-of-320534.html 0.6 2026-06-21T09:14:13+08:00 daily https://www.pharmasources.com/industryinsights/gmm-pfaudler-acquires-de-dietrich-proces-320535.html 0.6 2026-08-09T06:59:38+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-signs-agreement-with-fujifilm--320536.html 0.6 2026-08-08T04:34:52+08:00 daily https://www.pharmasources.com/industryinsights/big-biopharma-companies-sales-bolstered--320537.html 0.6 2026-08-08T03:46:12+08:00 daily https://www.pharmasources.com/industryinsights/dutch-intravacc-to-in-license-cimcures-i-320538.html 0.6 2026-08-08T03:08:45+08:00 daily https://www.pharmasources.com/industryinsights/emcure-launches-india-first-generic-vers-320539.html 0.6 2026-08-08T15:20:40+08:00 daily https://www.pharmasources.com/industryinsights/inovios-covid-19-vaccine-candidate-shows-320540.html 0.6 2026-08-07T13:15:19+08:00 daily https://www.pharmasources.com/industryinsights/meissa-begins-pre-clinical-studies-of-co-320541.html 0.6 2026-08-06T23:56:05+08:00 daily https://www.pharmasources.com/industryinsights/catalent-completes-purchase-of-teva-take-320542.html 0.6 2026-08-06T23:46:16+08:00 daily https://www.pharmasources.com/industryinsights/bioinvent-pfizer-extend-immunotherapy-re-320543.html 0.6 2026-08-06T23:38:30+08:00 daily https://www.pharmasources.com/industryinsights/vaxart-signs-mou-with-ams-320544.html 0.6 2026-08-06T23:36:32+08:00 daily https://www.pharmasources.com/industryinsights/ibio-receives-ibm-clinical-development-s-320545.html 0.6 2026-08-06T22:05:48+08:00 daily https://www.pharmasources.com/industryinsights/first-covid-19-vaccine-given-green-light-320546.html 0.6 2026-08-07T05:05:21+08:00 daily https://www.pharmasources.com/industryinsights/cbd-could-reduce-behavioural-problems-in-320547.html 0.6 2026-06-14T14:28:26+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-sbla-for-botox-for-neurogeni-320548.html 0.6 2026-06-21T08:06:05+08:00 daily https://www.pharmasources.com/industryinsights/companion-medical-inpen-receives-fda-cle-320549.html 0.6 2026-03-21T18:27:47+08:00 daily https://www.pharmasources.com/industryinsights/praxis-bioresearch-receives-patent-for-p-320550.html 0.6 2026-06-20T17:41:07+08:00 daily https://www.pharmasources.com/industryinsights/therapeutic-solutions-to-use-clinical-st-320551.html 0.6 2026-06-20T23:01:43+08:00 daily https://www.pharmasources.com/industryinsights/palatin-to-develop-potential-treatment-f-320552.html 0.6 2026-06-23T11:59:20+08:00 daily https://www.pharmasources.com/industryinsights/researchers-identify-multiple-molecules--320553.html 0.6 2026-06-20T21:59:45+08:00 daily https://www.pharmasources.com/industryinsights/viiv-selects-projects-for-hivcovid-19-re-320554.html 0.6 2026-07-04T03:23:17+08:00 daily https://www.pharmasources.com/industryinsights/us-approves-bavencio-for-bladder-cancer-320555.html 0.6 2026-06-20T16:01:20+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-gets-ec-approval-for-daurismo-to--320556.html 0.6 2026-06-22T04:00:41+08:00 daily https://www.pharmasources.com/industryinsights/health-canada-approves-phase-2a-covid-19-320557.html 0.6 2026-06-21T14:36:21+08:00 daily https://www.pharmasources.com/industryinsights/nanommune-partners-with-velox-biosystems-320558.html 0.6 2026-08-07T23:00:26+08:00 daily https://www.pharmasources.com/industryinsights/osteolabs-gmbh-provides-further-validati-320559.html 0.6 2026-06-21T22:56:44+08:00 daily https://www.pharmasources.com/industryinsights/avian-solutions-to-provide-discounted-se-320560.html 0.6 2026-06-20T14:22:10+08:00 daily https://www.pharmasources.com/industryinsights/millionpatientscuredcom-is-the-worlds-fi-320561.html 0.6 2026-06-20T18:00:23+08:00 daily https://www.pharmasources.com/industryinsights/kitchens-across-america-trust-eat-cleane-320562.html 0.6 2026-06-21T02:52:59+08:00 daily https://www.pharmasources.com/industryinsights/toptec-the-manufacturer-of-the-air-queen-320563.html 0.6 2026-07-17T16:26:04+08:00 daily https://www.pharmasources.com/industryinsights/insights-into-the-global-ethylene-indust-320564.html 0.6 2026-06-21T04:00:46+08:00 daily https://www.pharmasources.com/industryinsights/59-thought-leaders-present-their-finding-320565.html 0.6 2026-06-21T10:20:30+08:00 daily https://www.pharmasources.com/industryinsights/flowforma-combats-covid-19-business-disr-320566.html 0.6 2026-06-20T22:14:59+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-impact-on-fingerprint-sensor-ma-320567.html 0.6 2026-06-21T01:58:37+08:00 daily https://www.pharmasources.com/industryinsights/gel-battery-market-to-garner-26-bn-globa-320568.html 0.6 2026-08-10T15:43:41+08:00 daily https://www.pharmasources.com/industryinsights/busy-month-of-approvals-a-review-of-onco-320569.html 0.6 2026-08-12T15:54:30+08:00 daily https://www.pharmasources.com/industryinsights/icmr-bharat-biotech-to-expedite-clinical-320570.html 0.6 2026-06-20T22:00:43+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccines-to-enter-late-stage-tr-320571.html 0.6 2026-07-30T02:00:27+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-dcgi-approval-for-huma-320572.html 0.6 2026-06-20T14:43:12+08:00 daily https://www.pharmasources.com/industryinsights/brazil-to-test-sinovacs-potential-vaccin-320573.html 0.6 2026-03-01T01:35:40+08:00 daily https://www.pharmasources.com/industryinsights/mylan-gets-approval-to-make-and-market-r-320574.html 0.6 2026-04-07T19:04:29+08:00 daily https://www.pharmasources.com/industryinsights/alembic-pharma-gets-us-fda-nod-for-gener-320575.html 0.6 2026-06-20T15:33:04+08:00 daily https://www.pharmasources.com/industryinsights/nppa-fixes-retail-prices-for-14-formulat-320576.html 0.6 2026-06-25T08:55:16+08:00 daily https://www.pharmasources.com/industryinsights/intravacc-licences-cimcures-iboost-vacci-320577.html 0.6 2026-06-22T04:56:39+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccine-could-be-approved-and-a-320578.html 0.6 2026-06-21T08:05:03+08:00 daily https://www.pharmasources.com/industryinsights/novartis-agrees-to-pay-678m-to-settle-ki-320579.html 0.6 2026-06-21T06:50:43+08:00 daily https://www.pharmasources.com/industryinsights/janssens-ebola-vaccine-secures-european--320580.html 0.6 2026-08-10T21:44:07+08:00 daily https://www.pharmasources.com/industryinsights/ema-recommends-idefirix-imlinfidase-is-g-320581.html 0.6 2026-06-22T08:56:40+08:00 daily https://www.pharmasources.com/industryinsights/chmp-recommends-cystic-fibrosis-treatmen-320582.html 0.6 2026-06-22T07:07:55+08:00 daily https://www.pharmasources.com/industryinsights/further-billions-pledged-to-ensure-equit-320583.html 0.6 2026-08-12T06:14:14+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-pembrolizumab-for-cutaneous-320584.html 0.6 2026-06-20T23:55:32+08:00 daily https://www.pharmasources.com/industryinsights/linnaeus-announces-clinical-trial-collab-320585.html 0.6 2026-06-21T04:19:30+08:00 daily https://www.pharmasources.com/industryinsights/neurorx-relief-announce-fast-track-desig-320586.html 0.6 2026-06-20T14:49:11+08:00 daily https://www.pharmasources.com/industryinsights/brainstorm-expands-clinical-pipeline-to--320587.html 0.6 2026-04-07T17:06:11+08:00 daily https://www.pharmasources.com/industryinsights/melinta-announces-termination-of-merger--320588.html 0.6 2025-11-11T01:55:32+08:00 daily https://www.pharmasources.com/industryinsights/seelos-announces-initiation-of-preclinic-320589.html 0.6 2026-06-22T02:56:35+08:00 daily https://www.pharmasources.com/industryinsights/virality-diagnostics-antibody-test-wins--320590.html 0.6 2026-06-20T22:14:58+08:00 daily https://www.pharmasources.com/industryinsights/reneo-receives-fda-orphan-drug-designati-320591.html 0.6 2026-06-21T02:59:59+08:00 daily https://www.pharmasources.com/industryinsights/emd-serono-initiates-trial-of-tlr7-8-inh-320592.html 0.6 2026-06-21T01:11:02+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-selinexor-for-relapsedrefra-320593.html 0.6 2026-06-22T01:40:44+08:00 daily https://www.pharmasources.com/industryinsights/ignova-files-patent-application-on-antib-320594.html 0.6 2026-07-02T10:55:57+08:00 daily https://www.pharmasources.com/industryinsights/fulcrum-begins-of-losmapimod-trial-for-h-320595.html 0.6 2026-07-06T21:06:01+08:00 daily https://www.pharmasources.com/industryinsights/newer-variant-of-covid-19-causing-virus--320596.html 0.6 2026-06-21T17:49:15+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-viivs-novel-hiv-treatment-r-320597.html 0.6 2025-12-13T23:33:26+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-regenerons-pull-plug-on-kevzara-c-320598.html 0.6 2026-06-21T07:12:03+08:00 daily https://www.pharmasources.com/industryinsights/partnership-gets-44m-gov-grant-for-bette-320599.html 0.6 2026-06-22T10:04:52+08:00 daily https://www.pharmasources.com/industryinsights/eusa-pharma-bags-us-approval-for-covid-1-320600.html 0.6 2026-06-20T23:54:15+08:00 daily https://www.pharmasources.com/industryinsights/indian-pharma-firms-recall-medications-f-320601.html 0.6 2026-07-31T16:55:28+08:00 daily https://www.pharmasources.com/industryinsights/who-to-discontinue-hydroxycholorquine-tr-320602.html 0.6 2026-06-22T12:50:24+08:00 daily https://www.pharmasources.com/industryinsights/new-covid-19-strain-dominates-global-cas-320603.html 0.6 2026-06-21T02:56:33+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-dapagliflozin-gets-dcgi-nod-320604.html 0.6 2026-08-08T13:21:45+08:00 daily https://www.pharmasources.com/industryinsights/stevioside-can-increase-efficiency-of-ca-320605.html 0.6 2026-06-20T19:59:36+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-sanofi-arthritis-drug-fails-co-320606.html 0.6 2026-06-21T12:14:26+08:00 daily https://www.pharmasources.com/industryinsights/kkr-to-acquire-controlling-stake-in-jb-c-320607.html 0.6 2026-06-21T22:53:42+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-gsks-hiv-drug-for-patien-320608.html 0.6 2026-08-14T22:50:50+08:00 daily https://www.pharmasources.com/industryinsights/russias-rdif-chemrar-to-boost-production-320609.html 0.6 2026-06-20T15:51:34+08:00 daily https://www.pharmasources.com/industryinsights/carlyle-pays-490m-for-20-of-piramal-phar-320610.html 0.6 2026-06-20T17:17:49+08:00 daily https://www.pharmasources.com/industryinsights/symbiosis-secures-125m-of-financing-from-320611.html 0.6 2026-06-22T01:01:49+08:00 daily https://www.pharmasources.com/industryinsights/gram-opens-large-scale-injectable-fillfi-320612.html 0.6 2026-08-10T16:21:46+08:00 daily https://www.pharmasources.com/industryinsights/merck-initiates-first-clinical-trial-of--320613.html 0.6 2026-06-21T00:06:38+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-expands-ds-1062-study-to--320614.html 0.6 2026-06-21T12:08:19+08:00 daily https://www.pharmasources.com/industryinsights/exelixis-initiates-phase-3-trial-of-cabo-320615.html 0.6 2026-06-21T02:18:14+08:00 daily https://www.pharmasources.com/industryinsights/goldfinch-bio-raises-100m-to-develop-the-320616.html 0.6 2026-08-07T05:05:19+08:00 daily https://www.pharmasources.com/industryinsights/oncternal-gets-fda-orphan-drug-designati-320617.html 0.6 2026-08-06T23:37:40+08:00 daily https://www.pharmasources.com/industryinsights/european-pharmacopoeia-publishes-new-cha-320618.html 0.6 2026-08-06T23:33:23+08:00 daily https://www.pharmasources.com/industryinsights/kings-receives-1m-grant-for-mental-healt-320619.html 0.6 2026-08-06T23:36:15+08:00 daily https://www.pharmasources.com/industryinsights/sintilimab-expected-to-break-the-iron-tr-320620.html 0.6 2026-06-21T11:04:10+08:00 daily https://www.pharmasources.com/industryinsights/overseas-marketing-of-fruquintinib-accel-320621.html 0.6 2026-07-21T05:03:17+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-breast-cancer-treatment-tha-320622.html 0.6 2026-06-21T04:58:51+08:00 daily https://www.pharmasources.com/industryinsights/immune-regulation-and-dynport-vaccine-co-320623.html 0.6 2026-06-20T21:14:53+08:00 daily https://www.pharmasources.com/industryinsights/who-halts-hydroxychloroquine-hiv-drugs-i-320624.html 0.6 2026-06-21T12:50:41+08:00 daily https://www.pharmasources.com/industryinsights/zydus-gets-nod-from-cofepris-mexico-to-s-320625.html 0.6 2026-06-20T14:28:08+08:00 daily https://www.pharmasources.com/industryinsights/britain-nears-625-million-sanofigsk-covi-320626.html 0.6 2026-07-02T15:51:21+08:00 daily https://www.pharmasources.com/industryinsights/experts-ask-govt-to-ensure-access-to-rem-320627.html 0.6 2026-08-12T00:19:50+08:00 daily https://www.pharmasources.com/industryinsights/hundreds-of-scientists-say-coronavirus-i-320628.html 0.6 2026-08-09T20:05:47+08:00 daily https://www.pharmasources.com/industryinsights/emergent-to-produce-drug-substance-for-j-320629.html 0.6 2026-08-07T02:04:58+08:00 daily https://www.pharmasources.com/industryinsights/medivir-and-scilifelab-partner-to-identi-320630.html 0.6 2026-08-07T01:51:56+08:00 daily https://www.pharmasources.com/industryinsights/gilead-gets-ec-conditional-approval-for--320631.html 0.6 2026-08-08T22:24:40+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-starts-phase-3-trial-for-coron-320632.html 0.6 2026-08-07T10:07:46+08:00 daily https://www.pharmasources.com/industryinsights/adma-biologics-opens-new-plasma-collecti-320633.html 0.6 2026-08-10T12:32:44+08:00 daily https://www.pharmasources.com/industryinsights/rentschler-biopharma-and-vetter-enter-pa-320634.html 0.6 2026-06-23T12:41:52+08:00 daily https://www.pharmasources.com/industryinsights/sustainable-biomedical-device-promising--320635.html 0.6 2026-08-11T18:47:42+08:00 daily https://www.pharmasources.com/industryinsights/new-next-generation-research-platform-la-320636.html 0.6 2026-05-01T07:11:19+08:00 daily https://www.pharmasources.com/industryinsights/cytocom-announces-successful-fda-meeting-320637.html 0.6 2026-06-22T15:50:48+08:00 daily https://www.pharmasources.com/industryinsights/supernus-sues-apotex-for-infringement-of-320638.html 0.6 2026-07-20T09:03:01+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-therapy-for-dravet-synd-320639.html 0.6 2026-06-20T20:57:40+08:00 daily https://www.pharmasources.com/industryinsights/fda-ec-partner-on-covid-19-response-320640.html 0.6 2026-06-21T06:08:54+08:00 daily https://www.pharmasources.com/industryinsights/lonza-expands-cell-culture-med-portfolio-320641.html 0.6 2026-06-22T06:54:43+08:00 daily https://www.pharmasources.com/industryinsights/novartis-resolves-legacy-fcpa-investigat-320642.html 0.6 2026-03-19T09:59:34+08:00 daily https://www.pharmasources.com/industryinsights/using-epo-against-covid-19-320643.html 0.6 2026-07-19T04:46:28+08:00 daily https://www.pharmasources.com/industryinsights/immune-regulation-teams-with-dynport-on--320644.html 0.6 2026-08-06T02:18:15+08:00 daily https://www.pharmasources.com/industryinsights/uk-study-to-research-long-term-health-im-320645.html 0.6 2026-02-16T15:24:07+08:00 daily https://www.pharmasources.com/industryinsights/kings-researchers-win-1m-grant-for-covid-320646.html 0.6 2026-06-20T16:20:51+08:00 daily https://www.pharmasources.com/industryinsights/nhs-launches-your-covid-recovery-service-320647.html 0.6 2026-06-21T14:51:18+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-panic-spikes-global-demand-for--320648.html 0.6 2026-07-19T06:16:53+08:00 daily https://www.pharmasources.com/industryinsights/assured-bio-labs-receives-aiha-accredita-320649.html 0.6 2026-08-03T05:30:34+08:00 daily https://www.pharmasources.com/industryinsights/in-fight-against-covid-19-csl-behring-be-320650.html 0.6 2026-06-21T00:57:45+08:00 daily https://www.pharmasources.com/industryinsights/mylan-to-launch-desrem-at-rs-4800-per-vi-320651.html 0.6 2026-08-14T17:19:48+08:00 daily https://www.pharmasources.com/industryinsights/curevac-nets-eu-funding-to-ramp-up-vacci-320652.html 0.6 2026-06-21T03:02:47+08:00 daily https://www.pharmasources.com/industryinsights/senhwa-biosciencess-silmitasertib-receiv-320653.html 0.6 2026-07-22T16:49:56+08:00 daily https://www.pharmasources.com/industryinsights/happiness-biotech-announced-receipt-of-n-320654.html 0.6 2026-07-16T17:24:14+08:00 daily https://www.pharmasources.com/industryinsights/genesis-healthcare-co-launched-genelife--320655.html 0.6 2026-06-20T23:16:53+08:00 daily https://www.pharmasources.com/industryinsights/hulf-and-parent-company-saison-informati-320656.html 0.6 2026-08-08T01:13:55+08:00 daily https://www.pharmasources.com/industryinsights/a-breakthrough-in-cancer-treatment-sound-320657.html 0.6 2026-06-21T12:14:21+08:00 daily https://www.pharmasources.com/industryinsights/vista-eye-specialist-wins-health-wellnes-320658.html 0.6 2026-06-21T03:35:25+08:00 daily https://www.pharmasources.com/industryinsights/7-hills-announces-positive-data-on-7hp34-320659.html 0.6 2026-06-21T03:15:52+08:00 daily https://www.pharmasources.com/industryinsights/sgs-initiates-trial-of-potential-covid-1-320660.html 0.6 2026-06-21T02:02:56+08:00 daily https://www.pharmasources.com/industryinsights/vectura-earns-5m-novartis-milestone-for--320661.html 0.6 2026-08-03T11:02:36+08:00 daily https://www.pharmasources.com/industryinsights/lyra-appoints-svp-of-research-and-develo-320662.html 0.6 2026-08-13T23:22:17+08:00 daily https://www.pharmasources.com/industryinsights/lipidor-cadila-sign-agreement-for-phase--320663.html 0.6 2026-06-21T18:02:23+08:00 daily https://www.pharmasources.com/industryinsights/university-of-oxford-selects-axiom-eclin-320664.html 0.6 2026-06-22T05:54:00+08:00 daily https://www.pharmasources.com/industryinsights/novavax-awarded-16b-from-operation-warp--320665.html 0.6 2026-06-22T10:30:23+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-awarded-450m-barda-contract-320666.html 0.6 2026-08-08T23:00:17+08:00 daily https://www.pharmasources.com/industryinsights/csir-seeks-regulatory-nod-for-clinical-t-320667.html 0.6 2026-06-23T04:31:36+08:00 daily https://www.pharmasources.com/industryinsights/at-war-time-speed-china-leads-covid-19-v-320668.html 0.6 2026-06-23T02:17:29+08:00 daily https://www.pharmasources.com/industryinsights/cdsco-asks-drug-controllers-to-take-meas-320669.html 0.6 2026-06-23T05:21:39+08:00 daily https://www.pharmasources.com/industryinsights/jj-drops-tb-drug-price-following-mass-pe-320670.html 0.6 2026-07-08T04:30:42+08:00 daily https://www.pharmasources.com/industryinsights/lipidor-and-cadila-pharma-strike-partner-320671.html 0.6 2026-06-22T00:20:23+08:00 daily https://www.pharmasources.com/industryinsights/caplin-steriles-signs-distribution-agree-320672.html 0.6 2026-06-20T22:57:45+08:00 daily https://www.pharmasources.com/industryinsights/x-ray-structure-analysis-gives-detailed--320673.html 0.6 2025-10-21T05:12:06+08:00 daily https://www.pharmasources.com/industryinsights/new-understanding-of-bacteria-eating-cel-320674.html 0.6 2026-03-20T18:20:58+08:00 daily https://www.pharmasources.com/industryinsights/inflammation-key-to-severe-covid-19-in-h-320675.html 0.6 2026-06-20T18:01:29+08:00 daily https://www.pharmasources.com/industryinsights/who-reviewing-report-urging-new-guidance-320676.html 0.6 2026-06-20T17:03:21+08:00 daily https://www.pharmasources.com/industryinsights/gsk-partners-with-medicago-to-develop-pl-320677.html 0.6 2026-06-22T11:10:57+08:00 daily https://www.pharmasources.com/industryinsights/novavax-receives-16bn-from-us-government-320678.html 0.6 2026-03-24T20:21:46+08:00 daily https://www.pharmasources.com/industryinsights/mylan-gets-approval-for-emergency-use-of-320679.html 0.6 2026-06-21T12:04:16+08:00 daily https://www.pharmasources.com/industryinsights/expanded-access-for-compassionate-use-of-320680.html 0.6 2026-08-11T03:33:32+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-heart-rhythm-devices-fe-320681.html 0.6 2026-06-20T22:56:43+08:00 daily https://www.pharmasources.com/industryinsights/croda-announces-acquisition-of-avanti-po-320682.html 0.6 2026-06-21T22:04:43+08:00 daily https://www.pharmasources.com/industryinsights/revimmune-announces-phase-ii-trial-of-th-320683.html 0.6 2026-07-02T23:52:17+08:00 daily https://www.pharmasources.com/industryinsights/sars-cov-2-igg-antibody-test-receives-fd-320684.html 0.6 2026-08-05T07:07:07+08:00 daily https://www.pharmasources.com/industryinsights/redhill-receives-approval-for-covid-19-p-320685.html 0.6 2026-06-20T20:51:05+08:00 daily https://www.pharmasources.com/industryinsights/cosentyx-gains-positive-chmp-opinion-for-320686.html 0.6 2026-06-21T17:12:32+08:00 daily https://www.pharmasources.com/industryinsights/heron-receives-crl-for-htx-011-for-posto-320687.html 0.6 2026-06-21T09:14:39+08:00 daily https://www.pharmasources.com/industryinsights/remdesivir-can-save-more-lives-where-icu-320688.html 0.6 2026-06-21T09:54:08+08:00 daily https://www.pharmasources.com/industryinsights/novartis-banks-ec-approval-for-enerzair--320689.html 0.6 2026-06-20T19:44:49+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-news-of-the-week-june-29t-320690.html 0.6 2026-07-05T22:39:52+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-news-of-the-week-june-29t-320691.html 0.6 2026-01-05T08:35:44+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-news-of-the-week-june-29t-320692.html 0.6 2026-07-30T01:14:51+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-news-of-the-week-june-29t-320693.html 0.6 2026-06-20T14:55:01+08:00 daily https://www.pharmasources.com/industryinsights/fda-updates-on-hand-sanitizers-with-meth-320694.html 0.6 2026-06-22T08:50:06+08:00 daily https://www.pharmasources.com/industryinsights/fda-updates-and-press-announcements-on-n-320695.html 0.6 2026-07-06T20:06:33+08:00 daily https://www.pharmasources.com/industryinsights/fda-cautions-against-use-of-hydroxychlor-320696.html 0.6 2026-06-25T02:47:53+08:00 daily https://www.pharmasources.com/industryinsights/immune-regulation-ltd-partners-with-dynp-320697.html 0.6 2026-06-21T13:13:47+08:00 daily https://www.pharmasources.com/industryinsights/rentschler-biopharma-and-vetter-team-up--320698.html 0.6 2026-06-22T20:02:03+08:00 daily https://www.pharmasources.com/industryinsights/asieris-received-china-nmpas-approval-to-320699.html 0.6 2026-06-26T07:34:45+08:00 daily https://www.pharmasources.com/industryinsights/frost-sullivan-honors-leading-organizati-320700.html 0.6 2026-08-10T12:39:58+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-nextcode-and-olink-proteomics-annou-320701.html 0.6 2026-08-12T16:44:57+08:00 daily https://www.pharmasources.com/industryinsights/lipidor-signs-agreement-with-cro-for-imp-320702.html 0.6 2026-08-07T00:01:49+08:00 daily https://www.pharmasources.com/industryinsights/sun-life-hong-kong-sar-china-boosts-diab-320703.html 0.6 2026-08-06T23:56:32+08:00 daily https://www.pharmasources.com/industryinsights/rapidly-changing-behaviours-in-2020-are--320704.html 0.6 2026-08-06T23:48:38+08:00 daily https://www.pharmasources.com/industryinsights/turning-point-therapeutics-and-zai-lab-a-320705.html 0.6 2026-08-06T23:45:15+08:00 daily https://www.pharmasources.com/industryinsights/evive-biotech-meets-primary-and-secondar-320706.html 0.6 2026-08-08T12:17:04+08:00 daily https://www.pharmasources.com/industryinsights/ilias-biologics-granted-key-patent-for-e-320707.html 0.6 2026-08-06T23:45:52+08:00 daily https://www.pharmasources.com/industryinsights/cns-pharmaceuticals-completes-api-shipme-320708.html 0.6 2026-08-06T23:48:01+08:00 daily https://www.pharmasources.com/industryinsights/ology-bioservices-wins-department-of-def-320709.html 0.6 2026-08-06T23:57:25+08:00 daily https://www.pharmasources.com/industryinsights/cordenpharma-increases-us-peptide-manufa-320710.html 0.6 2026-08-13T02:55:51+08:00 daily https://www.pharmasources.com/industryinsights/lonza-establishes-center-of-excellence-i-320711.html 0.6 2026-08-07T02:05:05+08:00 daily https://www.pharmasources.com/industryinsights/merck-inks-425m-oncology-deal-with-fogho-320712.html 0.6 2026-08-10T08:34:21+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-civica-rx-partner-to-reduce-medic-320713.html 0.6 2026-06-21T06:16:04+08:00 daily https://www.pharmasources.com/industryinsights/frontage-acquires-acme-bioscience-320714.html 0.6 2026-06-22T05:57:37+08:00 daily https://www.pharmasources.com/industryinsights/cipla-launches-cipremi-likely-to-price-i-320715.html 0.6 2026-06-26T10:49:48+08:00 daily https://www.pharmasources.com/industryinsights/premas-biotech-initiates-triple-antigen--320716.html 0.6 2026-07-01T11:09:46+08:00 daily https://www.pharmasources.com/industryinsights/takeda-launches-ibd-medication-kynteles--320717.html 0.6 2026-07-07T02:58:54+08:00 daily https://www.pharmasources.com/industryinsights/pharma-firms-initiate-steps-to-curb-blac-320718.html 0.6 2026-06-22T15:06:15+08:00 daily https://www.pharmasources.com/industryinsights/doctors-view-antiviral-agents-as-the-mos-320719.html 0.6 2026-07-11T03:41:20+08:00 daily https://www.pharmasources.com/industryinsights/avesthagen-study-may-help-determine-gene-320720.html 0.6 2026-08-06T21:06:11+08:00 daily https://www.pharmasources.com/industryinsights/chinas-sinovac-starts-late-stage-trials--320721.html 0.6 2026-07-17T01:24:10+08:00 daily https://www.pharmasources.com/industryinsights/unichem-labs-gets-us-fda-nod-to-market-m-320722.html 0.6 2026-06-23T12:27:04+08:00 daily https://www.pharmasources.com/industryinsights/healthcare-industry-reports-deals-worth--320723.html 0.6 2026-08-05T09:20:49+08:00 daily https://www.pharmasources.com/industryinsights/serum-institute-of-india-expects-covid-v-320724.html 0.6 2026-06-20T14:51:10+08:00 daily https://www.pharmasources.com/industryinsights/cepi-expands-covid-19-vaccine-alliance-w-320725.html 0.6 2026-07-21T20:37:40+08:00 daily https://www.pharmasources.com/industryinsights/us-awards-450m-contract-to-regeneron-for-320726.html 0.6 2026-06-22T00:09:51+08:00 daily https://www.pharmasources.com/industryinsights/curevac-recieves-75-million-loan-for-vac-320727.html 0.6 2026-06-24T09:54:01+08:00 daily https://www.pharmasources.com/industryinsights/long-acting-injectable-hiv-prep-outperfo-320728.html 0.6 2026-07-11T01:19:10+08:00 daily https://www.pharmasources.com/industryinsights/selumetinib-granted-orphan-drug-designat-320729.html 0.6 2026-08-09T15:10:24+08:00 daily https://www.pharmasources.com/industryinsights/carmine-takeda-collaborate-to-discover-a-320730.html 0.6 2026-07-11T01:30:42+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-keytruda-for-first-line-tre-320731.html 0.6 2026-06-21T12:10:20+08:00 daily https://www.pharmasources.com/industryinsights/inovio-announces-positive-interim-phase--320732.html 0.6 2026-06-20T18:57:38+08:00 daily https://www.pharmasources.com/industryinsights/novartis-receives-positive-chmp-opinion--320733.html 0.6 2026-06-21T12:49:32+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-home-administered-breast-ca-320734.html 0.6 2026-06-22T02:12:03+08:00 daily https://www.pharmasources.com/industryinsights/final-data-on-viivs-cabotegravir-show-im-320735.html 0.6 2026-06-20T22:16:58+08:00 daily https://www.pharmasources.com/industryinsights/new-clinical-trial-platform-launched-to--320736.html 0.6 2026-07-05T13:58:54+08:00 daily https://www.pharmasources.com/industryinsights/gsk-links-with-medicago-to-develop-novel-320737.html 0.6 2026-08-14T13:38:21+08:00 daily https://www.pharmasources.com/industryinsights/eu-nod-for-lynparza-in-pancreatic-cancer-320738.html 0.6 2026-06-20T22:09:42+08:00 daily https://www.pharmasources.com/industryinsights/cr-uk-pairs-with-abcam-320739.html 0.6 2026-06-23T05:07:57+08:00 daily https://www.pharmasources.com/industryinsights/uk-scientists-plead-with-pm-for-charity--320740.html 0.6 2026-08-06T20:47:36+08:00 daily https://www.pharmasources.com/industryinsights/vetter-further-expands-its-development-s-320741.html 0.6 2026-06-22T04:07:53+08:00 daily https://www.pharmasources.com/industryinsights/q-division-bringing-emerging-technology--320742.html 0.6 2026-06-20T17:16:44+08:00 daily https://www.pharmasources.com/industryinsights/laboratory-studies-confirm-betadiner-ant-320743.html 0.6 2026-08-08T00:01:35+08:00 daily https://www.pharmasources.com/industryinsights/frost-sullivan-recognizes-drfirst-for-so-320744.html 0.6 2026-06-21T01:45:32+08:00 daily https://www.pharmasources.com/industryinsights/new-report-reviews-global-hospital-pract-320745.html 0.6 2026-08-07T20:22:57+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-apptec-to-launch-a-special-webinar--320746.html 0.6 2026-06-20T22:52:48+08:00 daily https://www.pharmasources.com/industryinsights/agc-biologics-collaborates-with-molecula-320747.html 0.6 2026-06-26T02:06:31+08:00 daily https://www.pharmasources.com/industryinsights/men-are-discreet-about-their-negative-bo-320748.html 0.6 2025-11-12T19:07:45+08:00 daily https://www.pharmasources.com/industryinsights/innovent-announces-first-patient-dosed-i-320749.html 0.6 2026-08-14T21:04:16+08:00 daily https://www.pharmasources.com/industryinsights/biogen-submits-bla-for-aducanumab-in-alz-320750.html 0.6 2026-07-15T23:11:48+08:00 daily https://www.pharmasources.com/industryinsights/apeiron-maxcyte-enter-licensing-agreemen-320751.html 0.6 2026-06-22T09:05:51+08:00 daily https://www.pharmasources.com/industryinsights/lgc-acquires-the-native-antigen-company-320752.html 0.6 2026-06-22T10:03:39+08:00 daily https://www.pharmasources.com/industryinsights/kymera-sanofi-enter-multi-program-strate-320753.html 0.6 2026-06-21T08:14:13+08:00 daily https://www.pharmasources.com/industryinsights/akcea-therapeutics-appoints-cmo-320754.html 0.6 2026-06-21T10:53:47+08:00 daily https://www.pharmasources.com/industryinsights/orchard-therapeutics-molmed-extend-gene--320755.html 0.6 2026-08-14T13:53:36+08:00 daily https://www.pharmasources.com/industryinsights/agc-biologics-molecular-partners-to-deve-320756.html 0.6 2026-06-21T00:04:40+08:00 daily https://www.pharmasources.com/industryinsights/moderna-signs-deal-with-spains-rovi-to-s-320757.html 0.6 2026-06-20T21:57:42+08:00 daily https://www.pharmasources.com/industryinsights/strides-receives-usfda-approval-for-head-320758.html 0.6 2026-06-20T18:01:27+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-declines-to-approve-merck-and-eis-320759.html 0.6 2026-08-12T16:53:16+08:00 daily https://www.pharmasources.com/industryinsights/coronavirus-tricks-the-body-into-attacki-320760.html 0.6 2026-07-08T20:18:00+08:00 daily https://www.pharmasources.com/industryinsights/gilead-begins-testing-inhalable-form-of--320761.html 0.6 2026-07-27T07:43:56+08:00 daily https://www.pharmasources.com/industryinsights/eu-secures-potential-covid-19-drugs-from-320762.html 0.6 2026-06-21T21:54:41+08:00 daily https://www.pharmasources.com/industryinsights/potential-covid-19-vaccine-not-single-so-320763.html 0.6 2026-06-21T05:30:19+08:00 daily https://www.pharmasources.com/industryinsights/sami-sabinsa-groups-curcumin-c3-complex--320764.html 0.6 2025-12-09T09:23:10+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-partners-with-kymera-in-2bn-prote-320765.html 0.6 2026-08-14T11:51:06+08:00 daily https://www.pharmasources.com/industryinsights/emergent-biosolutions-and-partners-to-de-320766.html 0.6 2026-06-21T16:01:18+08:00 daily https://www.pharmasources.com/industryinsights/russia-approves-r-pharms-coronavir-for-c-320767.html 0.6 2026-06-21T09:02:01+08:00 daily https://www.pharmasources.com/industryinsights/phase-iii-covid-19-antibody-trials-initi-320768.html 0.6 2026-06-21T10:01:06+08:00 daily https://www.pharmasources.com/industryinsights/cervical-dysplasia-treatment-device-appr-320769.html 0.6 2026-07-02T09:31:48+08:00 daily https://www.pharmasources.com/industryinsights/a-new-model-for-enhancing-microparticle--320770.html 0.6 2026-06-23T08:04:04+08:00 daily https://www.pharmasources.com/industryinsights/mediwound-submits-bla-severe-thermal-bur-320771.html 0.6 2025-12-20T23:02:14+08:00 daily https://www.pharmasources.com/industryinsights/abitec-acquires-larodan-ab-research-grad-320772.html 0.6 2026-08-14T02:36:15+08:00 daily https://www.pharmasources.com/industryinsights/ardelyx-submits-nda-for-tenapanor-320773.html 0.6 2026-06-20T20:10:48+08:00 daily https://www.pharmasources.com/industryinsights/mylan-shareholders-approve-proposed-comb-320774.html 0.6 2026-06-21T12:13:20+08:00 daily https://www.pharmasources.com/industryinsights/novartis-receives-approval-for-five-prod-320775.html 0.6 2026-08-07T21:23:25+08:00 daily https://www.pharmasources.com/industryinsights/researchers-call-for-worldwide-biosurvei-320776.html 0.6 2026-06-04T16:54:37+08:00 daily https://www.pharmasources.com/industryinsights/neutralizing-antibodies-in-the-battle-ag-320777.html 0.6 2026-06-21T23:04:52+08:00 daily https://www.pharmasources.com/industryinsights/cma-levies-fines-of-23m-in-pharma-probe-320778.html 0.6 2026-06-20T19:02:44+08:00 daily https://www.pharmasources.com/industryinsights/us-rejects-msdeisais-keytruda-lenvima-co-320779.html 0.6 2026-06-21T06:07:04+08:00 daily https://www.pharmasources.com/industryinsights/gilead-begins-phi-trial-of-inhaled-remde-320780.html 0.6 2026-06-20T15:53:28+08:00 daily https://www.pharmasources.com/industryinsights/uk-researchers-back-use-of-steroid-inhal-320781.html 0.6 2026-06-22T12:15:08+08:00 daily https://www.pharmasources.com/industryinsights/inactivated-virus-vaccines-vs-mrna-vacci-320782.html 0.6 2026-08-07T04:07:20+08:00 daily https://www.pharmasources.com/industryinsights/a-review-of-the-great-journey-of-capecit-320783.html 0.6 2026-08-12T07:13:32+08:00 daily https://www.pharmasources.com/industryinsights/with-up-to-18-first-generics-hansoh-rank-320784.html 0.6 2026-07-15T05:04:13+08:00 daily https://www.pharmasources.com/industryinsights/oriented-by-product-innovation-dongtai-p-320785.html 0.6 2026-08-05T12:52:18+08:00 daily https://www.pharmasources.com/industryinsights/russian-university-completes-clinical-tr-320786.html 0.6 2026-06-21T11:55:07+08:00 daily https://www.pharmasources.com/industryinsights/alembic-pharma-sees-domestic-business-gr-320787.html 0.6 2026-08-12T15:00:12+08:00 daily https://www.pharmasources.com/industryinsights/clariant-chemicals-declares-special-inte-320788.html 0.6 2026-06-21T05:58:59+08:00 daily https://www.pharmasources.com/industryinsights/indiscriminate-use-of-remdesivir-tociliz-320789.html 0.6 2026-07-02T13:34:39+08:00 daily https://www.pharmasources.com/industryinsights/pandemic-exposes-scientific-rift-over-pr-320790.html 0.6 2026-06-20T17:58:18+08:00 daily https://www.pharmasources.com/industryinsights/tuberculosis-vaccine-may-be-limiting-cov-320791.html 0.6 2026-06-21T21:09:46+08:00 daily https://www.pharmasources.com/industryinsights/bill-gates-calls-for-covid-19-meds-to-go-320792.html 0.6 2026-06-20T14:18:53+08:00 daily https://www.pharmasources.com/industryinsights/chinas-cansino-in-talks-for-covid-vaccin-320793.html 0.6 2026-06-26T13:16:56+08:00 daily https://www.pharmasources.com/industryinsights/scientists-focus-on-how-immune-system-t--320794.html 0.6 2026-06-22T02:55:38+08:00 daily https://www.pharmasources.com/industryinsights/gilead-says-remdesivir-reduced-risk-of-d-320795.html 0.6 2026-06-21T01:12:54+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-biontechs-covid-19-vaccine-expect-320796.html 0.6 2026-06-20T22:01:39+08:00 daily https://www.pharmasources.com/industryinsights/no-compromise-on-rigorous-evaluation-for-320797.html 0.6 2026-06-21T04:06:53+08:00 daily https://www.pharmasources.com/industryinsights/ema-finalises-opinion-on-presence-of-nit-320798.html 0.6 2026-06-21T02:55:44+08:00 daily https://www.pharmasources.com/industryinsights/luca-galluzzi-to-succeed-peter-gucher-as-320799.html 0.6 2026-07-23T20:28:48+08:00 daily https://www.pharmasources.com/industryinsights/dcgi-approves-itolizumab-for-restricted--320800.html 0.6 2026-06-21T07:00:55+08:00 daily https://www.pharmasources.com/industryinsights/cadila-pharma-launches-esomeprazole-tabl-320801.html 0.6 2026-06-21T11:13:19+08:00 daily https://www.pharmasources.com/industryinsights/pankajakasthuri-announces-promising-inte-320802.html 0.6 2026-06-20T17:59:18+08:00 daily https://www.pharmasources.com/industryinsights/gujarat-government-to-procure-20000-vial-320803.html 0.6 2026-06-23T00:01:59+08:00 daily https://www.pharmasources.com/industryinsights/international-regulators-align-positions-320804.html 0.6 2026-03-19T23:18:54+08:00 daily https://www.pharmasources.com/industryinsights/panacea-biotec-aims-to-make-1-bn-doses-o-320805.html 0.6 2026-06-21T03:02:48+08:00 daily https://www.pharmasources.com/industryinsights/eu-raises-its-bet-on-blood-plasma-in-sea-320806.html 0.6 2026-06-21T09:58:47+08:00 daily https://www.pharmasources.com/industryinsights/lupin-recalls-diabetes-treatment-drug-in-320807.html 0.6 2026-06-22T06:05:42+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-expanded-use-for-botox-320808.html 0.6 2026-06-21T05:06:46+08:00 daily https://www.pharmasources.com/industryinsights/milliporesigma-opens-m-lab-collaboration-320809.html 0.6 2026-08-14T12:30:23+08:00 daily https://www.pharmasources.com/industryinsights/drugmakers-partner-to-launch-1bn-fund-fo-320810.html 0.6 2026-06-21T06:21:16+08:00 daily https://www.pharmasources.com/industryinsights/approved-covid-19-vaccine-could-be-avail-320811.html 0.6 2026-06-21T08:55:04+08:00 daily https://www.pharmasources.com/industryinsights/altimmune-partners-with-dynport-on-intra-320812.html 0.6 2026-06-20T23:12:53+08:00 daily https://www.pharmasources.com/industryinsights/moderna-teams-up-with-rovi-to-provide-co-320813.html 0.6 2026-06-20T15:46:19+08:00 daily https://www.pharmasources.com/industryinsights/isa-receives-orphan-drug-designation-for-320814.html 0.6 2025-12-04T16:41:17+08:00 daily https://www.pharmasources.com/industryinsights/anivive-initiates-pre-clinical-studies-o-320815.html 0.6 2026-06-20T23:48:31+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-urothelial-carcinoma-mainte-320816.html 0.6 2026-08-08T03:37:31+08:00 daily https://www.pharmasources.com/industryinsights/rhythm-receives-rare-pediatric-disease-d-320817.html 0.6 2026-03-19T22:42:33+08:00 daily https://www.pharmasources.com/industryinsights/federal-circuit-rules-upholds-lower-cour-320818.html 0.6 2026-06-20T17:52:21+08:00 daily https://www.pharmasources.com/industryinsights/technical-ceramics-to-drive-innovative-e-320819.html 0.6 2026-06-20T20:01:51+08:00 daily https://www.pharmasources.com/industryinsights/vela-diagnostics-receives-ce-ivd-approva-320820.html 0.6 2026-06-22T05:14:04+08:00 daily https://www.pharmasources.com/industryinsights/pqe-group-creates-an-internal-research-t-320821.html 0.6 2026-06-21T09:04:00+08:00 daily https://www.pharmasources.com/industryinsights/avatamed-partners-cbmed-in-europe-on-pre-320822.html 0.6 2026-06-21T03:08:53+08:00 daily https://www.pharmasources.com/industryinsights/sinomed-completes-one-year-follow-up-of--320823.html 0.6 2026-07-23T23:20:37+08:00 daily https://www.pharmasources.com/industryinsights/sales-of-cardio-cerebrovascular-products-320824.html 0.6 2026-07-17T03:24:45+08:00 daily https://www.pharmasources.com/industryinsights/institute-for-health-metrics-and-evaluat-320825.html 0.6 2026-03-25T20:28:50+08:00 daily https://www.pharmasources.com/industryinsights/translated-tool-from-nccn-measures-menta-320826.html 0.6 2026-07-03T18:03:11+08:00 daily https://www.pharmasources.com/industryinsights/mallinckrodt-and-terumo-bct-announce-pos-320827.html 0.6 2026-06-21T10:07:16+08:00 daily https://www.pharmasources.com/industryinsights/antengene-appoints-former-celgene-anz-me-320828.html 0.6 2026-06-20T19:08:41+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-biontechs-coronavirus-vaccine-can-320829.html 0.6 2026-07-04T06:38:59+08:00 daily https://www.pharmasources.com/industryinsights/institute-of-life-sciences-odisha-establ-320830.html 0.6 2026-04-18T18:04:15+08:00 daily https://www.pharmasources.com/industryinsights/mumbai-thane-to-get-60-per-cent-of-mahar-320831.html 0.6 2026-06-21T04:59:48+08:00 daily https://www.pharmasources.com/industryinsights/cdsco-extends-consent-to-import-drugs-wi-320832.html 0.6 2026-07-20T12:01:41+08:00 daily https://www.pharmasources.com/industryinsights/inst-scientists-formulate-nanoparticle-t-320833.html 0.6 2026-06-21T10:08:11+08:00 daily https://www.pharmasources.com/industryinsights/viral-dark-matter-exposed-metagenome-dat-320834.html 0.6 2026-08-07T05:28:30+08:00 daily https://www.pharmasources.com/industryinsights/moderna-and-rovi-ink-fill-finish-deal-320835.html 0.6 2026-08-07T05:01:18+08:00 daily https://www.pharmasources.com/industryinsights/viralclear-amri-enter-covid-19-partnersh-320836.html 0.6 2026-08-07T04:50:23+08:00 daily https://www.pharmasources.com/industryinsights/cepi-expands-partnership-with-clover-320837.html 0.6 2026-08-07T04:36:39+08:00 daily https://www.pharmasources.com/industryinsights/mount-sinai-emergent-and-immunotek-form--320838.html 0.6 2026-08-07T04:25:16+08:00 daily https://www.pharmasources.com/industryinsights/oncology-venture-acquires-parp-inhibitor-320839.html 0.6 2026-08-07T04:16:08+08:00 daily https://www.pharmasources.com/industryinsights/gsk-medicago-enter-covid-19-vax-tie-up-320840.html 0.6 2026-08-07T04:04:03+08:00 daily https://www.pharmasources.com/industryinsights/bd-partners-with-us-govt-on-70m-vaccinat-320841.html 0.6 2026-08-07T03:33:38+08:00 daily https://www.pharmasources.com/industryinsights/ovid-angelini-pharma-enter-exclusive-lic-320842.html 0.6 2026-08-07T03:03:26+08:00 daily https://www.pharmasources.com/industryinsights/cobra-biologics-delivers-plasmids-for-co-320843.html 0.6 2026-08-07T02:52:15+08:00 daily https://www.pharmasources.com/industryinsights/eisai-enters-joint-research-alliance-to--320844.html 0.6 2026-08-07T02:40:06+08:00 daily https://www.pharmasources.com/industryinsights/syneos-health-pfizer-ink-new-service-agr-320845.html 0.6 2026-08-07T14:19:25+08:00 daily https://www.pharmasources.com/industryinsights/biocons-drug-itolizumab-gets-approval-to-320846.html 0.6 2026-08-07T02:31:09+08:00 daily https://www.pharmasources.com/industryinsights/australias-tga-approves-remdesivir-as-fi-320847.html 0.6 2026-08-07T02:09:46+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-fast-track-designation-to-two-320848.html 0.6 2026-08-07T02:05:11+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-adcetris-brentuximab-ved-320849.html 0.6 2026-08-07T01:28:11+08:00 daily https://www.pharmasources.com/industryinsights/ema-issues-opinion-on-nitrosamines-in-me-320850.html 0.6 2026-08-07T01:43:14+08:00 daily https://www.pharmasources.com/industryinsights/inhaled-formulation-of-remdesivir-enters-320851.html 0.6 2026-06-20T20:10:51+08:00 daily https://www.pharmasources.com/industryinsights/txa127-enters-multiple-phase-ii-trials-i-320852.html 0.6 2026-08-07T03:24:55+08:00 daily https://www.pharmasources.com/industryinsights/global-distribution-partnership-establis-320853.html 0.6 2026-08-07T03:55:03+08:00 daily https://www.pharmasources.com/industryinsights/biocon-to-launch-drug-for-covid-19-patie-320854.html 0.6 2026-08-07T04:19:02+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-pharma-cuts-price-of-covid-19-d-320855.html 0.6 2026-08-10T05:00:10+08:00 daily https://www.pharmasources.com/industryinsights/clinigens-als-therapy-bags-us-orphan-sta-320856.html 0.6 2026-08-07T04:34:26+08:00 daily https://www.pharmasources.com/industryinsights/experimental-motor-neurone-disease-thera-320857.html 0.6 2026-08-07T05:01:25+08:00 daily https://www.pharmasources.com/industryinsights/bayers-finerenone-hits-targets-in-diabet-320858.html 0.6 2026-08-07T05:28:31+08:00 daily https://www.pharmasources.com/industryinsights/nice-backing-for-takedas-adcetris-for-ra-320859.html 0.6 2026-06-20T18:51:43+08:00 daily https://www.pharmasources.com/industryinsights/us-priority-review-for-az-brilintaaspiri-320860.html 0.6 2026-03-27T23:00:52+08:00 daily https://www.pharmasources.com/industryinsights/uk-report-finds-low-awareness-of-non-mel-320861.html 0.6 2026-06-21T23:58:43+08:00 daily https://www.pharmasources.com/industryinsights/charity-warns-of-catastrophic-effect-of--320862.html 0.6 2026-06-20T23:10:59+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-regeneron-provide-update-on-k-320863.html 0.6 2026-06-20T20:02:36+08:00 daily https://www.pharmasources.com/industryinsights/sotio-announces-first-patient-dosed-in-p-320864.html 0.6 2026-06-20T14:17:05+08:00 daily https://www.pharmasources.com/industryinsights/toxys-appoints-susan-swarte-as-new-non-e-320865.html 0.6 2026-06-20T14:35:55+08:00 daily https://www.pharmasources.com/industryinsights/university-of-toronto-tests-confirm-firs-320866.html 0.6 2026-08-08T12:36:19+08:00 daily https://www.pharmasources.com/industryinsights/fosun-pharma-announces-its-licensed-covi-320867.html 0.6 2026-08-07T13:17:29+08:00 daily https://www.pharmasources.com/industryinsights/ul-helps-advance-vaccination-storage-tec-320868.html 0.6 2026-08-07T01:19:35+08:00 daily https://www.pharmasources.com/industryinsights/venus-medtech-to-partner-with-pi-cardia--320869.html 0.6 2026-08-07T00:59:08+08:00 daily https://www.pharmasources.com/industryinsights/volition-announces-promising-clinical-tr-320870.html 0.6 2026-08-07T13:15:10+08:00 daily https://www.pharmasources.com/industryinsights/invivoscribe-launches-new-division-for-d-320871.html 0.6 2026-08-07T13:55:38+08:00 daily https://www.pharmasources.com/industryinsights/tcl-fight-against-covid-19-alongside-un--320872.html 0.6 2026-08-08T10:50:11+08:00 daily https://www.pharmasources.com/industryinsights/worldremit-partners-with-project-8000-st-320873.html 0.6 2026-08-08T20:37:27+08:00 daily https://www.pharmasources.com/industryinsights/arctic-vision-announces-us32mn-in-series-320874.html 0.6 2026-08-10T17:22:02+08:00 daily https://www.pharmasources.com/industryinsights/revitope-and-junshi-biosciences-enter-in-320875.html 0.6 2026-08-10T08:35:48+08:00 daily https://www.pharmasources.com/industryinsights/zuellig-pharma-appoints-john-graham-as-n-320876.html 0.6 2026-08-07T01:14:23+08:00 daily https://www.pharmasources.com/industryinsights/the-hogo-sleep-system-aims-to-provide-th-320877.html 0.6 2026-06-26T20:01:32+08:00 daily https://www.pharmasources.com/industryinsights/frost-sullivan-reveals-technological-adv-320878.html 0.6 2026-08-07T00:40:25+08:00 daily https://www.pharmasources.com/industryinsights/nthu-research-team-develops-a-rapid-test-320879.html 0.6 2026-08-07T00:03:20+08:00 daily https://www.pharmasources.com/industryinsights/beln-garijo-appointed-as-deputy-ceo-of-m-320880.html 0.6 2026-08-06T23:57:42+08:00 daily https://www.pharmasources.com/industryinsights/fdi-in-pharma-and-related-implications-o-320881.html 0.6 2026-08-11T12:26:39+08:00 daily https://www.pharmasources.com/industryinsights/researchers-find-key-element-in-human-an-320882.html 0.6 2026-08-10T15:19:50+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-laboratories-launch-otc-nicoti-320883.html 0.6 2026-08-07T00:02:36+08:00 daily https://www.pharmasources.com/industryinsights/biocon-presents-key-insights-into-clinic-320884.html 0.6 2026-08-06T23:56:33+08:00 daily https://www.pharmasources.com/industryinsights/biophore-ramps-up-made-in-india-favipira-320885.html 0.6 2026-08-07T03:29:08+08:00 daily https://www.pharmasources.com/industryinsights/bharat-biotech-starts-human-trials-for-c-320886.html 0.6 2026-08-06T23:38:12+08:00 daily https://www.pharmasources.com/industryinsights/operation-warp-speed-to-start-making-cov-320887.html 0.6 2026-08-06T23:34:26+08:00 daily https://www.pharmasources.com/industryinsights/cipla-receives-final-approval-for-generi-320888.html 0.6 2026-08-06T22:31:55+08:00 daily https://www.pharmasources.com/industryinsights/bionova-begins-construction-of-new-manuf-320889.html 0.6 2026-08-06T22:38:01+08:00 daily https://www.pharmasources.com/industryinsights/orgenesis-enters-collaboration-agreement-320890.html 0.6 2026-08-07T19:42:54+08:00 daily https://www.pharmasources.com/industryinsights/luina-bio-and-xing-technologies-partner--320891.html 0.6 2026-08-06T23:32:51+08:00 daily https://www.pharmasources.com/industryinsights/chargepoint-and-steris-collaborate-320892.html 0.6 2026-08-06T23:36:56+08:00 daily https://www.pharmasources.com/industryinsights/uk-researchers-engineer-antibodies-from--320893.html 0.6 2026-08-06T23:46:04+08:00 daily https://www.pharmasources.com/industryinsights/roche-signs-up-to-17bn-cancer-drug-deal--320894.html 0.6 2026-08-06T23:54:18+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-fast-track-status-to-pfizer-a-320895.html 0.6 2026-08-09T09:30:50+08:00 daily https://www.pharmasources.com/industryinsights/amgen-makes-421m-additional-investment-i-320896.html 0.6 2026-08-13T17:58:53+08:00 daily https://www.pharmasources.com/industryinsights/oral-bacteriotherapy-improved-outcomes-i-320897.html 0.6 2026-08-07T00:42:52+08:00 daily https://www.pharmasources.com/industryinsights/report-calls-for-development-of-new-cann-320898.html 0.6 2026-08-07T00:52:51+08:00 daily https://www.pharmasources.com/industryinsights/experimental-motor-neurone-disease-thera-320899.html 0.6 2026-08-07T22:10:16+08:00 daily https://www.pharmasources.com/industryinsights/fda-authorizes-additional-covid-19-combi-320900.html 0.6 2026-08-07T01:14:35+08:00 daily https://www.pharmasources.com/industryinsights/mylan-secures-regulatory-approval-for-re-320901.html 0.6 2026-08-07T01:21:33+08:00 daily https://www.pharmasources.com/industryinsights/several-companies-voluntarily-recall-ext-320902.html 0.6 2026-08-07T01:28:03+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-niaid-begin-regn-cov2-phase-3--320903.html 0.6 2026-08-12T17:55:12+08:00 daily https://www.pharmasources.com/industryinsights/drug-linked-to-45-lower-risk-of-dying-am-320904.html 0.6 2026-08-12T02:22:32+08:00 daily https://www.pharmasources.com/industryinsights/kymera-therapeutics-sanofi-collaborate-t-320905.html 0.6 2026-08-07T19:48:56+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-commits-100m-to-support-developme-320906.html 0.6 2026-06-20T18:02:19+08:00 daily https://www.pharmasources.com/industryinsights/radiotherapy-in-fewer-doses-safe-for-ear-320907.html 0.6 2026-06-20T18:00:24+08:00 daily https://www.pharmasources.com/industryinsights/fda-committee-backs-gsks-multiple-myelom-320908.html 0.6 2026-06-22T08:40:27+08:00 daily https://www.pharmasources.com/industryinsights/study-indicates-lockdown-significantly-r-320909.html 0.6 2026-06-24T09:07:21+08:00 daily https://www.pharmasources.com/industryinsights/tecentriq-misses-mark-in-ovarian-cancer--320910.html 0.6 2026-06-20T23:53:46+08:00 daily https://www.pharmasources.com/industryinsights/prepare-now-for-winter-covid-19-peak-say-320911.html 0.6 2026-06-20T22:37:15+08:00 daily https://www.pharmasources.com/industryinsights/aiocd-requests-government-to-ban-e-pharm-320912.html 0.6 2026-06-20T14:51:14+08:00 daily https://www.pharmasources.com/industryinsights/moderna-phase-1-results-show-coronavirus-320913.html 0.6 2026-06-21T23:08:20+08:00 daily https://www.pharmasources.com/industryinsights/positive-news-on-oxfordastrazeneca-covid-320914.html 0.6 2026-06-24T12:05:45+08:00 daily https://www.pharmasources.com/industryinsights/tifac-releases-report-on-status-issues-t-320915.html 0.6 2026-07-04T14:40:48+08:00 daily https://www.pharmasources.com/industryinsights/gerresheimers-global-pharma-business-dev-320916.html 0.6 2026-06-22T22:12:45+08:00 daily https://www.pharmasources.com/industryinsights/industry-asks-govt-to-take-out-minimum-i-320917.html 0.6 2026-06-21T04:16:58+08:00 daily https://www.pharmasources.com/industryinsights/serum-institute-gets-dcgi-nod-for-pneumo-320918.html 0.6 2026-03-19T08:55:29+08:00 daily https://www.pharmasources.com/industryinsights/hetero-to-supply-60000-vials-of-generic--320919.html 0.6 2026-06-20T20:50:34+08:00 daily https://www.pharmasources.com/industryinsights/zydus-starts-human-trials-of-zycov-d-its-320920.html 0.6 2026-06-28T19:06:43+08:00 daily https://www.pharmasources.com/industryinsights/moderna-expects-to-start-late-stage-covi-320921.html 0.6 2026-06-21T08:57:59+08:00 daily https://www.pharmasources.com/industryinsights/swiftly-waning-covid-19-immunity-poses-v-320922.html 0.6 2026-02-28T15:35:37+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-ties-up-with-iqvia-to-speed--320923.html 0.6 2026-06-20T16:02:27+08:00 daily https://www.pharmasources.com/industryinsights/polpharma-fully-integrates-bioceros-320924.html 0.6 2026-06-21T02:50:20+08:00 daily https://www.pharmasources.com/industryinsights/moleculin-enters-agreement-with-sterling-320925.html 0.6 2026-06-20T14:35:29+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-and-immuneoncia-expand-320926.html 0.6 2026-06-21T09:08:48+08:00 daily https://www.pharmasources.com/industryinsights/cpi-partners-with-excivion-320927.html 0.6 2026-06-22T08:42:41+08:00 daily https://www.pharmasources.com/industryinsights/boston-scientific-considers-sale-of-spec-320928.html 0.6 2026-06-20T21:49:35+08:00 daily https://www.pharmasources.com/industryinsights/hackensack-meridian-partners-with-merck--320929.html 0.6 2026-06-21T11:05:17+08:00 daily https://www.pharmasources.com/industryinsights/study-finds-fenofibrate-may-downgrade-co-320930.html 0.6 2026-06-21T10:11:13+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccine-candidate-gets-green-li-320931.html 0.6 2026-07-09T04:41:53+08:00 daily https://www.pharmasources.com/industryinsights/experimental-covid-19-vaccine-mrna-1273--320932.html 0.6 2026-07-04T15:08:19+08:00 daily https://www.pharmasources.com/industryinsights/tocilizumab-lowers-risk-of-death-for-cri-320933.html 0.6 2026-06-21T19:11:43+08:00 daily https://www.pharmasources.com/industryinsights/adma-biologics-opens-new-adma-biocenters-320934.html 0.6 2026-08-10T20:26:49+08:00 daily https://www.pharmasources.com/industryinsights/7-hills-pharma-announces-positive-data-w-320935.html 0.6 2026-06-20T18:53:00+08:00 daily https://www.pharmasources.com/industryinsights/otonomy-reports-positive-top-line-result-320936.html 0.6 2026-06-21T06:20:26+08:00 daily https://www.pharmasources.com/industryinsights/novartis-receives-ec-approval-for-enerza-320937.html 0.6 2026-08-09T02:35:23+08:00 daily https://www.pharmasources.com/industryinsights/csl-behring-begins-trial-to-evaluate-mon-320938.html 0.6 2026-06-21T05:17:04+08:00 daily https://www.pharmasources.com/industryinsights/rakuten-medical-closes-deal-with-merck-k-320939.html 0.6 2026-07-21T22:03:51+08:00 daily https://www.pharmasources.com/industryinsights/az-unveils-detailed-data-from-thales-tri-320940.html 0.6 2026-06-22T03:09:50+08:00 daily https://www.pharmasources.com/industryinsights/uks-mhra-allows-early-access-to-lumasira-320941.html 0.6 2026-06-20T17:00:12+08:00 daily https://www.pharmasources.com/industryinsights/janssens-tremfya-wins-psoriatic-arthriti-320942.html 0.6 2026-06-21T23:43:42+08:00 daily https://www.pharmasources.com/industryinsights/icrcyclacel-scientists-discover-new-canc-320943.html 0.6 2026-08-10T11:49:41+08:00 daily https://www.pharmasources.com/industryinsights/mindbeauty-launches-upgraded-aa99-reusab-320944.html 0.6 2026-06-20T22:17:59+08:00 daily https://www.pharmasources.com/industryinsights/new-rapid-molecular-test-for-tuberculosi-320945.html 0.6 2026-06-21T23:10:05+08:00 daily https://www.pharmasources.com/industryinsights/harbour-biomed-presented-pre-clinical-da-320946.html 0.6 2026-06-21T18:28:31+08:00 daily https://www.pharmasources.com/industryinsights/getinge-interim-report-january-june-2020-320947.html 0.6 2026-06-20T21:17:10+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-announces-authorization-of-stock-r-320948.html 0.6 2026-06-20T22:00:48+08:00 daily https://www.pharmasources.com/industryinsights/us-institute-of-peace-announces-finalist-320949.html 0.6 2026-06-20T18:05:23+08:00 daily https://www.pharmasources.com/industryinsights/stem-cells-for-everyone-revolutionizing--320950.html 0.6 2026-06-20T16:05:18+08:00 daily https://www.pharmasources.com/industryinsights/terumo-acquires-quirem-medical-to-enhanc-320951.html 0.6 2026-06-21T04:10:50+08:00 daily https://www.pharmasources.com/industryinsights/lam-research-india-donates-funds-to-addr-320952.html 0.6 2026-06-20T22:58:44+08:00 daily https://www.pharmasources.com/industryinsights/jj-in-talks-with-japan-gates-foundation--320953.html 0.6 2026-06-23T02:13:23+08:00 daily https://www.pharmasources.com/industryinsights/worlds-first-phase-iii-clinical-trial-of-320954.html 0.6 2026-06-21T06:17:03+08:00 daily https://www.pharmasources.com/industryinsights/greater-global-cooperation-needed-to-tac-320955.html 0.6 2026-06-21T00:00:36+08:00 daily https://www.pharmasources.com/industryinsights/indian-pharma-industry-can-produce-covid-320956.html 0.6 2026-06-20T19:00:33+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-working-to-restart-on-site-inspec-320957.html 0.6 2026-06-22T12:49:47+08:00 daily https://www.pharmasources.com/industryinsights/cadila-pharma-launches-drug-for-treatmen-320958.html 0.6 2026-04-17T05:31:27+08:00 daily https://www.pharmasources.com/industryinsights/russian-scientists-hail-results-of-covid-320959.html 0.6 2026-06-20T16:00:28+08:00 daily https://www.pharmasources.com/industryinsights/avomeen-appoints-formulation-manufacturi-320960.html 0.6 2026-06-20T23:33:43+08:00 daily https://www.pharmasources.com/industryinsights/ose-immunotherapeutics-receives-grant-to-320961.html 0.6 2026-06-20T21:56:35+08:00 daily https://www.pharmasources.com/industryinsights/novartis-launches-portfolio-of-meds-for--320962.html 0.6 2026-07-30T15:32:47+08:00 daily https://www.pharmasources.com/industryinsights/novilytic-wins-sbir-grant-for-antibody-t-320963.html 0.6 2026-06-20T17:06:46+08:00 daily https://www.pharmasources.com/industryinsights/catalent-humanigen-expand-lenzilumab-ser-320964.html 0.6 2026-06-20T16:09:31+08:00 daily https://www.pharmasources.com/industryinsights/iqvia-partners-with-astrazeneca-320965.html 0.6 2026-06-21T14:53:19+08:00 daily https://www.pharmasources.com/industryinsights/gavi-announces-75-countries-intend-to-jo-320966.html 0.6 2026-06-08T07:33:16+08:00 daily https://www.pharmasources.com/industryinsights/us-researchers-say-heparin-may-neutralis-320967.html 0.6 2026-04-18T22:50:23+08:00 daily https://www.pharmasources.com/industryinsights/novartis-offers-non-profit-medicines-por-320968.html 0.6 2026-02-28T13:20:01+08:00 daily https://www.pharmasources.com/industryinsights/global-antimicrobial-resistance-fund-to--320969.html 0.6 2026-06-21T11:03:17+08:00 daily https://www.pharmasources.com/industryinsights/rotigotine-improves-cognitive-function-i-320970.html 0.6 2026-08-07T16:42:35+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-decitabine-cedazuridine-ora-320971.html 0.6 2026-06-25T06:56:34+08:00 daily https://www.pharmasources.com/industryinsights/cormedix-submits-defencath-new-drug-appl-320972.html 0.6 2026-06-21T23:58:42+08:00 daily https://www.pharmasources.com/industryinsights/palatin-announces-enrollment-reinitiatio-320973.html 0.6 2026-06-22T05:57:37+08:00 daily https://www.pharmasources.com/industryinsights/plex-awarded-nih-grant-to-advance-eye-dr-320974.html 0.6 2026-06-20T19:12:57+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-chugai-pharmaceutical-ente-320975.html 0.6 2026-08-06T10:10:28+08:00 daily https://www.pharmasources.com/industryinsights/pm-to-announce-extra-3bn-or-nhs-320976.html 0.6 2026-06-21T06:19:09+08:00 daily https://www.pharmasources.com/industryinsights/us-committee-backs-terlipressin-approval-320977.html 0.6 2026-06-22T04:41:25+08:00 daily https://www.pharmasources.com/industryinsights/us-fast-tracks-pfizerbiontech-coronaviru-320978.html 0.6 2026-06-24T06:01:10+08:00 daily https://www.pharmasources.com/industryinsights/scientists-uncover-sars-cov-2-specific-t-320979.html 0.6 2026-04-16T20:51:06+08:00 daily https://www.pharmasources.com/industryinsights/common-fda-approved-drug-may-effectively-320980.html 0.6 2026-06-21T12:23:57+08:00 daily https://www.pharmasources.com/industryinsights/ec-approves-new-indication-for-boehringe-320981.html 0.6 2026-07-17T11:38:24+08:00 daily https://www.pharmasources.com/industryinsights/60-degrees-announces-positive-results-of-320982.html 0.6 2026-06-20T16:58:29+08:00 daily https://www.pharmasources.com/industryinsights/seven-indian-pharmaceutical-companies-ra-320983.html 0.6 2026-06-21T21:54:45+08:00 daily https://www.pharmasources.com/industryinsights/dexamethasones-covid-19-benefits-confirm-320984.html 0.6 2026-06-21T01:40:25+08:00 daily https://www.pharmasources.com/industryinsights/indiscriminate-use-led-to-bogus-tocilizu-320985.html 0.6 2026-06-20T15:44:00+08:00 daily https://www.pharmasources.com/industryinsights/golden-moment-for-india-in-key-sectors-i-320986.html 0.6 2026-06-21T06:01:53+08:00 daily https://www.pharmasources.com/industryinsights/aiims-ethics-committee-gives-nod-to-huma-320987.html 0.6 2026-06-22T07:50:43+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-us-fda-nod-to-market-g-320988.html 0.6 2026-06-20T18:04:24+08:00 daily https://www.pharmasources.com/industryinsights/we-are-monitoring-sale-supply-of-medicin-320989.html 0.6 2026-06-20T17:56:18+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-launches-hypertension-awareness-320990.html 0.6 2026-07-17T04:51:20+08:00 daily https://www.pharmasources.com/industryinsights/indore-sez-exports-log-marginal-decline--320991.html 0.6 2026-06-20T15:01:27+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-pushes-up-sales-of-cardiac-anti-320992.html 0.6 2026-06-20T15:58:33+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-plans-to-complete-trials-of-320993.html 0.6 2026-06-22T12:54:13+08:00 daily https://www.pharmasources.com/industryinsights/bharat-biotech-commences-human-trial-of--320994.html 0.6 2026-06-23T14:41:25+08:00 daily https://www.pharmasources.com/industryinsights/pharma-exports-record-10-per-cent-growth-320995.html 0.6 2026-06-21T06:04:44+08:00 daily https://www.pharmasources.com/industryinsights/zydus-receives-approval-from-cofepris-to-320996.html 0.6 2026-06-20T17:00:16+08:00 daily https://www.pharmasources.com/industryinsights/china-gives-the-go-ahead-for-human-trial-320997.html 0.6 2026-07-16T21:11:35+08:00 daily https://www.pharmasources.com/industryinsights/chinas-sinopharm-begins-late-stage-trial-320998.html 0.6 2026-06-30T09:54:49+08:00 daily https://www.pharmasources.com/industryinsights/colorcon-launches-acryl-eze-ii-320999.html 0.6 2026-06-21T00:46:41+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutics-international-announces-gr-321000.html 0.6 2026-06-22T08:55:41+08:00 daily https://www.pharmasources.com/industryinsights/patheon-to-manufacture-fda-approved-nasa-321001.html 0.6 2026-06-21T20:04:43+08:00 daily https://www.pharmasources.com/industryinsights/adagio-therapeutics-launches-with-focus--321002.html 0.6 2026-06-29T07:16:36+08:00 daily https://www.pharmasources.com/industryinsights/tonix-to-focus-on-precision-medicine-app-321003.html 0.6 2026-06-23T08:59:18+08:00 daily https://www.pharmasources.com/industryinsights/novartis-launches-not-for-profit-covid-1-321004.html 0.6 2026-06-22T09:15:09+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-enrolled-in-pafolacianine--321005.html 0.6 2026-08-08T04:47:47+08:00 daily https://www.pharmasources.com/industryinsights/owp-announces-patent-application-for-dul-321006.html 0.6 2026-06-20T16:51:20+08:00 daily https://www.pharmasources.com/industryinsights/mylan-initiates-recall-of-one-lot-of-dap-321007.html 0.6 2026-06-21T16:10:28+08:00 daily https://www.pharmasources.com/industryinsights/txa127-from-constant-therapeutics-tested-321008.html 0.6 2026-06-21T12:55:35+08:00 daily https://www.pharmasources.com/industryinsights/cebina-identifies-common-antihistamine-n-321009.html 0.6 2026-06-21T04:04:45+08:00 daily https://www.pharmasources.com/industryinsights/agc-biologics-molecular-partners-to-deve-321010.html 0.6 2026-06-21T01:47:38+08:00 daily https://www.pharmasources.com/industryinsights/synairgens-sng001-shows-strong-promise-i-321011.html 0.6 2026-06-20T14:48:10+08:00 daily https://www.pharmasources.com/industryinsights/pm-to-announce-extra-3bn-for-nhs-321012.html 0.6 2026-06-21T09:58:52+08:00 daily https://www.pharmasources.com/industryinsights/az-farxiga-fast-tracked-for-heart-failur-321013.html 0.6 2026-06-21T06:18:14+08:00 daily https://www.pharmasources.com/industryinsights/uk-animal-research-dips-34-in-2019-321014.html 0.6 2026-06-21T01:49:26+08:00 daily https://www.pharmasources.com/industryinsights/nice-backing-for-astellas-xospata-321015.html 0.6 2026-06-21T04:10:53+08:00 daily https://www.pharmasources.com/industryinsights/jw-therapeutics-acquires-syracuse-biopha-321016.html 0.6 2026-06-20T20:58:40+08:00 daily https://www.pharmasources.com/industryinsights/phase-scientific-announces-ce-mark-appro-321017.html 0.6 2026-06-21T22:13:20+08:00 daily https://www.pharmasources.com/industryinsights/connect-biopharma-initiates-phase-2-clin-321018.html 0.6 2026-06-21T10:01:21+08:00 daily https://www.pharmasources.com/industryinsights/vitadairy---the-no-1-colostrum-company-i-321019.html 0.6 2026-06-21T06:00:49+08:00 daily https://www.pharmasources.com/industryinsights/singapore-kindness-movement-and-betadine-321020.html 0.6 2026-06-23T12:58:54+08:00 daily https://www.pharmasources.com/industryinsights/new-medical-findings-from-10-year-study--321021.html 0.6 2026-07-02T01:31:25+08:00 daily https://www.pharmasources.com/industryinsights/docquity-partners-with-global-pharma-lea-321022.html 0.6 2026-06-21T13:46:54+08:00 daily https://www.pharmasources.com/industryinsights/meta-analysis-from-biosense-webster-inc--321023.html 0.6 2026-06-21T02:11:55+08:00 daily https://www.pharmasources.com/industryinsights/world-brain-day-2020-moves-to-end-parkin-321024.html 0.6 2026-07-01T22:01:05+08:00 daily https://www.pharmasources.com/industryinsights/bridging-study-in-china-completed-for-na-321025.html 0.6 2026-06-21T18:13:39+08:00 daily https://www.pharmasources.com/industryinsights/antengene-corporation-closes-us97-millio-321026.html 0.6 2026-08-04T09:57:00+08:00 daily https://www.pharmasources.com/industryinsights/unispectral-debuts-industrys-first-mass--321027.html 0.6 2026-06-21T22:05:46+08:00 daily https://www.pharmasources.com/industryinsights/esaote-takes-to-the-track-alongside-duca-321028.html 0.6 2026-06-22T11:09:10+08:00 daily https://www.pharmasources.com/industryinsights/investment-potential-in-africas-pharmace-321029.html 0.6 2026-08-07T19:36:38+08:00 daily https://www.pharmasources.com/industryinsights/discovering-biotechnology-developments-i-321030.html 0.6 2026-08-07T02:30:48+08:00 daily https://www.pharmasources.com/industryinsights/akcea-appoints-svp-global-medical-affair-321031.html 0.6 2026-06-21T01:56:41+08:00 daily https://www.pharmasources.com/industryinsights/gemoab-intellia-enter-cellular-immunothe-321032.html 0.6 2026-06-21T17:50:40+08:00 daily https://www.pharmasources.com/industryinsights/cytocom-acquires-imquest-life-sciences-321033.html 0.6 2026-06-23T00:32:36+08:00 daily https://www.pharmasources.com/industryinsights/grifols-to-acquire-gc-pharmas-plasma-fac-321034.html 0.6 2026-06-21T02:01:50+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-continues-expansion-to-sup-321035.html 0.6 2026-06-20T22:16:52+08:00 daily https://www.pharmasources.com/industryinsights/valneva-to-provide-sars-cov-2-vax-candid-321036.html 0.6 2026-06-21T19:09:42+08:00 daily https://www.pharmasources.com/industryinsights/oxford-university-coronavirus-vaccine-in-321037.html 0.6 2026-07-01T12:31:11+08:00 daily https://www.pharmasources.com/industryinsights/remdesivir-treatment-gains-popularity-in-321038.html 0.6 2026-06-22T11:12:30+08:00 daily https://www.pharmasources.com/industryinsights/mylan-commences-supply-of-remdesivir-in--321039.html 0.6 2026-06-21T19:39:16+08:00 daily https://www.pharmasources.com/industryinsights/cipla-amgen-settle-case-involving-generi-321040.html 0.6 2026-06-21T04:35:30+08:00 daily https://www.pharmasources.com/industryinsights/dcgi-queries-pharma-company-on-its-claim-321041.html 0.6 2026-07-06T20:28:12+08:00 daily https://www.pharmasources.com/industryinsights/russia-to-mass-produce-experimental-covi-321042.html 0.6 2026-06-20T17:53:43+08:00 daily https://www.pharmasources.com/industryinsights/alembic-pharmaceuticals-receives-us-fdas-321043.html 0.6 2026-07-30T01:38:59+08:00 daily https://www.pharmasources.com/industryinsights/chinas-indigenously-developed-covid-19-v-321044.html 0.6 2026-03-27T00:07:01+08:00 daily https://www.pharmasources.com/industryinsights/gsk-to-obtain-10-stake-in-vaccines-maker-321045.html 0.6 2026-06-20T14:43:12+08:00 daily https://www.pharmasources.com/industryinsights/reimbursement-of-telemedicine-services-c-321046.html 0.6 2026-08-03T06:52:59+08:00 daily https://www.pharmasources.com/industryinsights/uk-enters-supply-agreement-for-pfizer-an-321047.html 0.6 2026-03-17T20:22:02+08:00 daily https://www.pharmasources.com/industryinsights/uk-government-secures-early-access-to-90-321048.html 0.6 2026-06-21T07:16:29+08:00 daily https://www.pharmasources.com/industryinsights/inhaled-interferon-beta-therapy-shows-pr-321049.html 0.6 2026-06-20T19:43:18+08:00 daily https://www.pharmasources.com/industryinsights/mylan-fujifilm-kyowa-kirin-biologics-ann-321050.html 0.6 2026-08-07T23:52:01+08:00 daily https://www.pharmasources.com/industryinsights/brilinta-granted-fda-priority-review-321051.html 0.6 2026-06-21T12:10:19+08:00 daily https://www.pharmasources.com/industryinsights/granules-issues-recall-of-metformin-hydr-321052.html 0.6 2026-08-12T22:27:50+08:00 daily https://www.pharmasources.com/industryinsights/beroni-group-to-supply-covid-19-antibody-321053.html 0.6 2026-06-21T12:24:00+08:00 daily https://www.pharmasources.com/industryinsights/assembly-biosciences-announces-fda-fast--321054.html 0.6 2026-06-20T15:02:13+08:00 daily https://www.pharmasources.com/industryinsights/creative-medical-technology-completes-am-321055.html 0.6 2026-06-20T15:56:39+08:00 daily https://www.pharmasources.com/industryinsights/celltrion-begins-covid-19-human-clinical-321056.html 0.6 2026-07-17T16:11:03+08:00 daily https://www.pharmasources.com/industryinsights/brilinta-significantly-reduced-rate-of-c-321057.html 0.6 2026-01-30T08:30:06+08:00 daily https://www.pharmasources.com/industryinsights/bioaegis-therapeutics-receives-approval--321058.html 0.6 2026-06-23T04:55:04+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccine-azd1222-showed-robust-i-321059.html 0.6 2026-06-23T00:12:04+08:00 daily https://www.pharmasources.com/industryinsights/janssenmeiragtx-sight-loss-gene-therapy--321060.html 0.6 2026-07-19T15:31:47+08:00 daily https://www.pharmasources.com/industryinsights/opko-healths-bioreference-laboratories-a-321061.html 0.6 2026-07-13T13:50:20+08:00 daily https://www.pharmasources.com/industryinsights/dcgi-nod-for-jubilants-generic-remdesivi-321062.html 0.6 2026-07-08T12:48:31+08:00 daily https://www.pharmasources.com/industryinsights/shanghai-richjoint-chemical-reagent-co-l-321063.html 0.6 2026-08-13T22:12:50+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-news-of-the-week-july-6th-321064.html 0.6 2026-08-05T02:47:31+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-news-of-the-week-july-6th-321065.html 0.6 2026-07-30T23:36:22+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-news-of-the-week-july-6th-321066.html 0.6 2026-07-23T19:26:05+08:00 daily https://www.pharmasources.com/industryinsights/coming-back-2020-zhejiang-export-commodi-321067.html 0.6 2026-06-29T00:15:49+08:00 daily https://www.pharmasources.com/industryinsights/shanghai-inesa-scientific-instrument-co--321068.html 0.6 2026-06-22T12:17:11+08:00 daily https://www.pharmasources.com/industryinsights/hangzhou-shenshi-energy-conservation-tec-321069.html 0.6 2026-06-21T07:13:05+08:00 daily https://www.pharmasources.com/industryinsights/turbulent-patterns-of-dpp-4-inhibitor-hy-321070.html 0.6 2026-08-01T01:32:29+08:00 daily https://www.pharmasources.com/industryinsights/gemini-bio-launches-moxi-v-321071.html 0.6 2026-06-22T01:46:27+08:00 daily https://www.pharmasources.com/industryinsights/gsk-buys-10-stake-in-german-vaccine-deve-321072.html 0.6 2026-06-21T00:15:54+08:00 daily https://www.pharmasources.com/industryinsights/catalent-expands-clinical-manufacturing--321073.html 0.6 2026-08-06T20:42:15+08:00 daily https://www.pharmasources.com/industryinsights/biogen-to-study-spinraza-in-combination--321074.html 0.6 2026-06-21T05:45:52+08:00 daily https://www.pharmasources.com/industryinsights/wave-of-promising-study-results-raises-h-321075.html 0.6 2026-06-21T02:00:43+08:00 daily https://www.pharmasources.com/industryinsights/six-people-tests-coronavirus-positive-in-321076.html 0.6 2026-06-20T16:06:15+08:00 daily https://www.pharmasources.com/industryinsights/govt-may-allow-30-per-cent-import-of-che-321077.html 0.6 2026-08-07T12:01:09+08:00 daily https://www.pharmasources.com/industryinsights/serum-to-apply-for-local-trials-on-oxfor-321078.html 0.6 2026-06-21T11:13:21+08:00 daily https://www.pharmasources.com/industryinsights/dandong-bettersize-instruments-ltd---exh-321079.html 0.6 2026-06-30T15:49:35+08:00 daily https://www.pharmasources.com/industryinsights/fabiflu-more-affordable-than-other-drugs-321080.html 0.6 2026-07-24T17:33:05+08:00 daily https://www.pharmasources.com/industryinsights/biocon-biologics-and-voluntis-collaborat-321081.html 0.6 2026-06-21T18:52:16+08:00 daily https://www.pharmasources.com/industryinsights/over-158-applications-for-generic-produc-321082.html 0.6 2026-07-15T04:19:30+08:00 daily https://www.pharmasources.com/industryinsights/oxford-covid-19-vaccine-developer-cautio-321083.html 0.6 2026-04-19T01:49:48+08:00 daily https://www.pharmasources.com/industryinsights/baoding-shenchen-precision-pump-co-ltd---321084.html 0.6 2026-08-11T20:33:26+08:00 daily https://www.pharmasources.com/industryinsights/merck-contract-research-firm-irbm-partne-321085.html 0.6 2026-08-10T05:24:40+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-acadias-application-for-deme-321086.html 0.6 2026-06-21T05:13:53+08:00 daily https://www.pharmasources.com/industryinsights/grifols-to-acquire-gc-pharmas-plasma-fra-321087.html 0.6 2026-08-13T12:51:59+08:00 daily https://www.pharmasources.com/industryinsights/uks-sars-cov-2-vaccine-candidate-is-safe-321088.html 0.6 2026-06-21T02:12:47+08:00 daily https://www.pharmasources.com/industryinsights/partnership-to-fight-covid-19-medication-321089.html 0.6 2026-06-22T10:05:47+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccine-safely-induces-immune-r-321090.html 0.6 2026-07-04T11:00:40+08:00 daily https://www.pharmasources.com/industryinsights/ovid-angelini-pharma-announce-agreement--321091.html 0.6 2026-08-06T21:54:18+08:00 daily https://www.pharmasources.com/industryinsights/mydecine-innovations-neuropharm-sign-acq-321092.html 0.6 2026-06-22T06:53:47+08:00 daily https://www.pharmasources.com/industryinsights/tremfya-approved-by-fda-as-selective-int-321093.html 0.6 2026-06-21T14:34:25+08:00 daily https://www.pharmasources.com/industryinsights/enzychem-files-ind-for-phase-2-study-of--321094.html 0.6 2026-06-21T02:15:51+08:00 daily https://www.pharmasources.com/industryinsights/rigel-announces-trial-of-fostamatinib-fo-321095.html 0.6 2026-08-09T06:51:20+08:00 daily https://www.pharmasources.com/industryinsights/gi-supply-receives-fda-clearance-of-firs-321096.html 0.6 2026-08-09T02:52:24+08:00 daily https://www.pharmasources.com/industryinsights/adc-therapeutics-begins-phase-2-portion--321097.html 0.6 2026-08-09T00:38:08+08:00 daily https://www.pharmasources.com/industryinsights/lillys-mirikizumab-superior-to-cosentyx--321098.html 0.6 2026-08-08T03:25:22+08:00 daily https://www.pharmasources.com/industryinsights/trainee-gp-numbers-rise-for-third-year-r-321099.html 0.6 2026-08-08T04:37:51+08:00 daily https://www.pharmasources.com/industryinsights/uclb-apollo-secure-first-licensing-deal--321100.html 0.6 2026-08-09T19:55:33+08:00 daily https://www.pharmasources.com/industryinsights/interim-data-shows-strong-responses-to-a-321101.html 0.6 2026-08-08T02:55:40+08:00 daily https://www.pharmasources.com/industryinsights/childrens-national-hospital-opens-new-he-321102.html 0.6 2026-08-07T15:07:16+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-news-of-the-week-july-13t-321103.html 0.6 2026-08-09T18:00:33+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-news-of-the-week-july-13t-321104.html 0.6 2026-08-07T03:27:34+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-news-of-the-week-july-13t-321105.html 0.6 2026-08-14T16:37:16+08:00 daily https://www.pharmasources.com/industryinsights/piramal-critical-care-medivant-enter-str-321106.html 0.6 2026-08-07T03:55:00+08:00 daily https://www.pharmasources.com/industryinsights/just---evotec-biologics-wins-covid-19-do-321107.html 0.6 2026-06-21T17:08:31+08:00 daily https://www.pharmasources.com/industryinsights/nexelis-acquires-ait-bioscience-321108.html 0.6 2026-06-21T11:16:28+08:00 daily https://www.pharmasources.com/industryinsights/queens-university-awarded-grant-to-resea-321109.html 0.6 2026-06-20T14:36:56+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-announces-top-line-results-from-321110.html 0.6 2026-04-15T11:26:05+08:00 daily https://www.pharmasources.com/industryinsights/govt-issues-notification-on-pli-scheme-w-321111.html 0.6 2026-06-20T16:58:18+08:00 daily https://www.pharmasources.com/industryinsights/cadila-pharma-expands-oncology-portfolio-321112.html 0.6 2026-06-23T02:15:18+08:00 daily https://www.pharmasources.com/industryinsights/fda-extends-enforcement-discretion-polic-321113.html 0.6 2026-06-22T11:00:48+08:00 daily https://www.pharmasources.com/industryinsights/mylan-receives-dcgi-approval-in-india-fo-321114.html 0.6 2026-06-20T22:51:59+08:00 daily https://www.pharmasources.com/industryinsights/brazil-approves-human-trials-for-third-c-321115.html 0.6 2026-08-11T09:11:00+08:00 daily https://www.pharmasources.com/industryinsights/piramal-critical-care-partners-with-medi-321116.html 0.6 2026-06-22T02:37:18+08:00 daily https://www.pharmasources.com/industryinsights/us-inks-195bn-deal-for-pfizer-and-bionte-321117.html 0.6 2026-08-07T11:52:14+08:00 daily https://www.pharmasources.com/industryinsights/bavarian-nordic-licences-covid-19-vaccin-321118.html 0.6 2026-06-21T03:59:51+08:00 daily https://www.pharmasources.com/industryinsights/gilead-to-acquire-stake-in-tizona-therap-321119.html 0.6 2026-06-21T19:06:40+08:00 daily https://www.pharmasources.com/industryinsights/japan-approves-dexamethasone-to-treat-co-321120.html 0.6 2026-07-16T06:27:35+08:00 daily https://www.pharmasources.com/industryinsights/novel-anti-amyloid-drug-ban2401-enters-p-321121.html 0.6 2026-04-14T02:33:01+08:00 daily https://www.pharmasources.com/industryinsights/plant-based-covid-19-vaccine-enters-phas-321122.html 0.6 2026-04-05T01:09:14+08:00 daily https://www.pharmasources.com/industryinsights/orchard-announces-global-license-agreeme-321123.html 0.6 2026-08-05T23:33:45+08:00 daily https://www.pharmasources.com/industryinsights/akebia-begins-investigator-sponsored-vad-321124.html 0.6 2026-06-20T14:44:04+08:00 daily https://www.pharmasources.com/industryinsights/immutep-announces-imp701-antibody-patent-321125.html 0.6 2026-06-24T15:29:46+08:00 daily https://www.pharmasources.com/industryinsights/milliporesigma-invests-20-million-in-new-321126.html 0.6 2026-06-23T23:38:37+08:00 daily https://www.pharmasources.com/industryinsights/hackensack-meridian-cdi-merck-announce-c-321127.html 0.6 2026-08-03T22:49:55+08:00 daily https://www.pharmasources.com/industryinsights/10x-genomics-launches-immune-profiling-p-321128.html 0.6 2026-06-21T06:20:12+08:00 daily https://www.pharmasources.com/industryinsights/novum-expands-services-in-north-america-321129.html 0.6 2026-06-20T19:00:33+08:00 daily https://www.pharmasources.com/industryinsights/end-of-the-line-for-genfits-experimental-321130.html 0.6 2026-07-20T20:55:42+08:00 daily https://www.pharmasources.com/industryinsights/vertex-and-nhs-wales-agree-on-kaftrio-re-321131.html 0.6 2026-08-10T15:15:55+08:00 daily https://www.pharmasources.com/industryinsights/roche-partners-with-jnana-on-slc-transpo-321132.html 0.6 2026-08-07T13:57:43+08:00 daily https://www.pharmasources.com/industryinsights/abbvies-rinvoq-hits-targets-in-atopic-de-321133.html 0.6 2026-08-07T13:19:09+08:00 daily https://www.pharmasources.com/industryinsights/neutralizing-antibodies-isolated-from-co-321134.html 0.6 2026-08-06T23:54:59+08:00 daily https://www.pharmasources.com/industryinsights/bora-adds-four-business-development-dire-321135.html 0.6 2026-08-06T23:48:48+08:00 daily https://www.pharmasources.com/industryinsights/company-implements-labvantage-covid-19-l-321136.html 0.6 2026-08-07T13:16:16+08:00 daily https://www.pharmasources.com/industryinsights/genscript-expands-cdmo-capabilities-321137.html 0.6 2026-08-09T02:39:07+08:00 daily https://www.pharmasources.com/industryinsights/ovid-and-uconn-enter-strategic-research--321138.html 0.6 2026-08-09T04:13:08+08:00 daily https://www.pharmasources.com/industryinsights/us-inks-2b-covid-19-vax-deal-with-pfizer-321139.html 0.6 2026-04-16T03:40:29+08:00 daily https://www.pharmasources.com/industryinsights/dfe-pharma-china-ltd---exhibitor-webinar-321140.html 0.6 2026-06-20T21:56:42+08:00 daily https://www.pharmasources.com/industryinsights/chemwerth-files-its-500th-drug-master-fi-321141.html 0.6 2026-06-20T16:00:09+08:00 daily https://www.pharmasources.com/industryinsights/lupin-receives-us-fdas-tentative-approva-321142.html 0.6 2026-08-07T01:32:05+08:00 daily https://www.pharmasources.com/industryinsights/brinton-pharmaceuticals-gets-dcgis-appro-321143.html 0.6 2026-07-22T18:50:38+08:00 daily https://www.pharmasources.com/industryinsights/pharma-experts-feel-more-drugs-need-pric-321144.html 0.6 2026-07-03T00:16:06+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-us-fda-nod-for-drug-tr-321145.html 0.6 2026-07-28T10:04:57+08:00 daily https://www.pharmasources.com/industryinsights/promise-and-prevention-experts-discuss-t-321146.html 0.6 2026-06-20T15:13:20+08:00 daily https://www.pharmasources.com/industryinsights/us-to-pay-pfizer-biontech-195-billion-fo-321147.html 0.6 2026-06-22T01:08:06+08:00 daily https://www.pharmasources.com/industryinsights/how-the-amr-action-fund-intends-to-suppo-321148.html 0.6 2026-08-14T10:07:28+08:00 daily https://www.pharmasources.com/industryinsights/chinas-sinopharm-says-coronavirus-vaccin-321149.html 0.6 2026-03-01T04:46:39+08:00 daily https://www.pharmasources.com/industryinsights/iqvia-and-jdrf-collaborate-to-improve-un-321150.html 0.6 2026-08-07T23:22:50+08:00 daily https://www.pharmasources.com/industryinsights/syngene-announces-q1-fy21-results-revenu-321151.html 0.6 2026-06-21T19:04:41+08:00 daily https://www.pharmasources.com/industryinsights/maha-fda-files-fir-against-five-people-g-321152.html 0.6 2026-06-22T23:13:12+08:00 daily https://www.pharmasources.com/industryinsights/uk-invests-127m-to-scale-up-covid-19-vac-321153.html 0.6 2026-06-21T01:58:40+08:00 daily https://www.pharmasources.com/industryinsights/researchers-say-newly-identified-antibod-321154.html 0.6 2026-06-22T05:53:31+08:00 daily https://www.pharmasources.com/industryinsights/ema-to-monitor-real-world-use-of-covid-1-321155.html 0.6 2026-06-20T14:04:17+08:00 daily https://www.pharmasources.com/industryinsights/uk-mhra-announces-two-class-2-medicine-r-321156.html 0.6 2026-06-21T06:02:51+08:00 daily https://www.pharmasources.com/industryinsights/bioaegis-receives-approval-to-proceed-wi-321157.html 0.6 2026-04-17T01:01:42+08:00 daily https://www.pharmasources.com/industryinsights/farxiga-granted-fast-track-designation-f-321158.html 0.6 2026-07-16T16:24:05+08:00 daily https://www.pharmasources.com/industryinsights/new-rapid-molecular-test-for-tuberculosi-321159.html 0.6 2026-06-20T15:46:04+08:00 daily https://www.pharmasources.com/industryinsights/oramed-reports-positive-end-of-phase-2-m-321160.html 0.6 2026-06-21T04:50:52+08:00 daily https://www.pharmasources.com/industryinsights/novartis-launches-not-for-profit-portfol-321161.html 0.6 2026-08-10T17:21:48+08:00 daily https://www.pharmasources.com/industryinsights/ucl-start-up-novai-raises-500000-for-ai--321162.html 0.6 2026-08-07T00:01:27+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-more-severe-in-colder-months-re-321163.html 0.6 2026-08-06T23:54:41+08:00 daily https://www.pharmasources.com/industryinsights/acadia-pulls-plug-on-pimavanserin-for-ad-321164.html 0.6 2026-08-06T23:48:17+08:00 daily https://www.pharmasources.com/industryinsights/new-data-shows-steep-rise-in-people-wait-321165.html 0.6 2026-08-06T23:45:39+08:00 daily https://www.pharmasources.com/industryinsights/roche-jnana-sign-multi-target-collaborat-321166.html 0.6 2026-08-06T23:37:28+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-321167.html 0.6 2026-08-06T21:38:10+08:00 daily https://www.pharmasources.com/industryinsights/scientists-decode-how-coronavirus-molecu-321168.html 0.6 2026-08-06T21:58:43+08:00 daily https://www.pharmasources.com/industryinsights/lupin-granules-india-recall-around-971-l-321169.html 0.6 2026-08-06T23:47:19+08:00 daily https://www.pharmasources.com/industryinsights/researchers-identify-21-existing-drugs-t-321170.html 0.6 2026-08-06T23:55:57+08:00 daily https://www.pharmasources.com/industryinsights/why-is-a-romance-burgeoning-between-phar-321171.html 0.6 2026-08-07T13:18:35+08:00 daily https://www.pharmasources.com/industryinsights/serum-institute-seeks-dcgi-nod-for-phase-321172.html 0.6 2026-08-08T07:58:07+08:00 daily https://www.pharmasources.com/industryinsights/us-doj-permits-six-drug-makers-to-share--321173.html 0.6 2026-08-08T10:10:51+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-has-pushed-infectious-disease-d-321174.html 0.6 2026-08-08T12:07:22+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-tecartus-cell-based-gene-th-321175.html 0.6 2026-08-08T13:18:15+08:00 daily https://www.pharmasources.com/industryinsights/dbt-seed-funds-gennova-biopharmaceutical-321176.html 0.6 2026-08-08T14:38:28+08:00 daily https://www.pharmasources.com/industryinsights/jenburkt-pharmaceuticals-second-in-india-321177.html 0.6 2026-08-09T02:38:51+08:00 daily https://www.pharmasources.com/industryinsights/cvd-drugs-prescription-records-high-coug-321178.html 0.6 2026-08-13T18:58:10+08:00 daily https://www.pharmasources.com/industryinsights/biocon-releases-q1fy21-results-revenue-u-321179.html 0.6 2026-06-21T16:13:33+08:00 daily https://www.pharmasources.com/industryinsights/csir-iict-develops-cost-effective-proces-321180.html 0.6 2026-06-20T19:19:55+08:00 daily https://www.pharmasources.com/industryinsights/uk-pledges-100-million-pounds-to-scale-u-321181.html 0.6 2026-06-21T20:02:38+08:00 daily https://www.pharmasources.com/industryinsights/animal-replacement-method-for-vaccine-te-321182.html 0.6 2026-06-21T19:09:42+08:00 daily https://www.pharmasources.com/industryinsights/us-sets-global-benchmark-for-covid-19-va-321183.html 0.6 2026-06-21T20:07:59+08:00 daily https://www.pharmasources.com/industryinsights/sorrento-to-acquire-smartpharm-321184.html 0.6 2026-08-06T07:45:26+08:00 daily https://www.pharmasources.com/industryinsights/novavax-fujifilm-initiate-large-scale-mf-321185.html 0.6 2026-06-22T05:57:37+08:00 daily https://www.pharmasources.com/industryinsights/us-doj-calls-for-increased-covid-19-mono-321186.html 0.6 2026-08-07T11:09:30+08:00 daily https://www.pharmasources.com/industryinsights/dynavax-and-medigen-partner-to-develop-a-321187.html 0.6 2026-06-21T07:00:03+08:00 daily https://www.pharmasources.com/industryinsights/arcturus-agrees-to-supply-potential-covi-321188.html 0.6 2026-06-21T07:15:08+08:00 daily https://www.pharmasources.com/industryinsights/fda-orders-update-of-label-change-for-op-321189.html 0.6 2026-06-20T16:49:36+08:00 daily https://www.pharmasources.com/industryinsights/study-suggests-some-excipients-in-common-321190.html 0.6 2026-06-22T01:52:29+08:00 daily https://www.pharmasources.com/industryinsights/belite-bio-announces-positive-results-fr-321191.html 0.6 2026-08-06T21:33:26+08:00 daily https://www.pharmasources.com/industryinsights/heron-begins-phase-2-clinical-study-of-c-321192.html 0.6 2026-06-21T12:02:13+08:00 daily https://www.pharmasources.com/industryinsights/luminex-receives-eua-for-covid-19-antibo-321193.html 0.6 2026-06-20T17:16:58+08:00 daily https://www.pharmasources.com/industryinsights/amplyx-announces-positive-top-line-data--321194.html 0.6 2026-06-23T08:56:55+08:00 daily https://www.pharmasources.com/industryinsights/fda-issues-first-emergency-authorization-321195.html 0.6 2026-06-24T03:59:12+08:00 daily https://www.pharmasources.com/industryinsights/idorsia-establishes-us-commercial-operat-321196.html 0.6 2026-06-20T21:09:48+08:00 daily https://www.pharmasources.com/industryinsights/people-at-high-risk-of-diabetes-fast-tra-321197.html 0.6 2026-06-21T07:23:46+08:00 daily https://www.pharmasources.com/industryinsights/eleven-medicines-backed-for-eu-approval-321198.html 0.6 2026-08-09T22:00:45+08:00 daily https://www.pharmasources.com/industryinsights/az-copd-therapy-wins-us-approval-321199.html 0.6 2026-06-21T02:07:43+08:00 daily https://www.pharmasources.com/industryinsights/gov-unveils-plans-to-boost-uks-vaccines--321200.html 0.6 2026-06-21T11:03:23+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-321201.html 0.6 2026-07-19T15:46:47+08:00 daily https://www.pharmasources.com/industryinsights/moderna-begins-phase-3-trials-of-its-cov-321202.html 0.6 2026-06-21T04:06:50+08:00 daily https://www.pharmasources.com/industryinsights/pli-scheme-guidelines-evoke-mix-reviews--321203.html 0.6 2026-08-13T03:26:12+08:00 daily https://www.pharmasources.com/industryinsights/sii-enrols-6000-subjects-for-efficacy-tr-321204.html 0.6 2025-10-28T21:02:25+08:00 daily https://www.pharmasources.com/industryinsights/govt-announces-guidelines-to-set-up-park-321205.html 0.6 2026-06-21T08:03:02+08:00 daily https://www.pharmasources.com/industryinsights/hunan-nutramax-inc--exhibitor-webinar-321206.html 0.6 2026-08-08T01:22:44+08:00 daily https://www.pharmasources.com/industryinsights/map-of-ammoniums-journey-may-prevent-inf-321208.html 0.6 2026-06-21T06:14:56+08:00 daily https://www.pharmasources.com/industryinsights/interview-changzhou-golden-bright-pharma-321209.html 0.6 2026-08-12T13:17:38+08:00 daily https://www.pharmasources.com/industryinsights/drl-receives-us-fdas-approval-for-xeglyz-321210.html 0.6 2026-06-21T08:11:04+08:00 daily https://www.pharmasources.com/industryinsights/five-sites-in-india-ready-for-oxford-ast-321211.html 0.6 2026-06-21T10:58:27+08:00 daily https://www.pharmasources.com/industryinsights/number-of-us-covid-19-clinical-trials-su-321212.html 0.6 2026-06-20T22:53:36+08:00 daily https://www.pharmasources.com/industryinsights/us-invests-472mn-more-in-moderna-321213.html 0.6 2026-06-20T14:53:06+08:00 daily https://www.pharmasources.com/industryinsights/lgm-acquires-pharmaceutical-development--321214.html 0.6 2026-06-20T22:02:40+08:00 daily https://www.pharmasources.com/industryinsights/franco-negron-named-ceo-of-apiject-syste-321215.html 0.6 2026-07-14T19:36:47+08:00 daily https://www.pharmasources.com/industryinsights/monoclonal-antibodies---the-challenges-i-321216.html 0.6 2026-08-09T10:22:15+08:00 daily https://www.pharmasources.com/industryinsights/sgs-signs-analytical-testing-agreement-w-321217.html 0.6 2026-08-03T04:49:45+08:00 daily https://www.pharmasources.com/industryinsights/argonaut-expands-capacity-for-covid-19-v-321218.html 0.6 2026-06-22T04:52:35+08:00 daily https://www.pharmasources.com/industryinsights/biocons-itolizumab-fails-to-be-part-of-c-321219.html 0.6 2026-06-13T02:21:05+08:00 daily https://www.pharmasources.com/industryinsights/indivior-to-pay-600m-to-settle-opioid-dr-321220.html 0.6 2026-02-28T20:17:28+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-signs-6bn-worth-cancer-asset-321221.html 0.6 2026-07-10T06:11:35+08:00 daily https://www.pharmasources.com/industryinsights/moderna-to-get-additional-472m-from-bard-321222.html 0.6 2026-07-11T15:57:17+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-and-austrian-government-to-invest-321223.html 0.6 2026-07-24T17:58:01+08:00 daily https://www.pharmasources.com/industryinsights/uk-government-invests-100-million-into-c-321224.html 0.6 2026-06-21T00:12:52+08:00 daily https://www.pharmasources.com/industryinsights/ema-recommends-11-new-medicines-for-appr-321225.html 0.6 2026-08-11T09:05:05+08:00 daily https://www.pharmasources.com/industryinsights/fda-clears-abivertinib-for-safety-effica-321226.html 0.6 2026-08-05T00:01:29+08:00 daily https://www.pharmasources.com/industryinsights/fda-recommends-discussing-naloxone-when--321227.html 0.6 2026-07-04T23:56:26+08:00 daily https://www.pharmasources.com/industryinsights/moderna-announces-start-of-phase-3-cove--321228.html 0.6 2026-08-10T10:13:06+08:00 daily https://www.pharmasources.com/industryinsights/in-vitro-testing-confirms-antiviral-acti-321229.html 0.6 2026-04-30T08:30:32+08:00 daily https://www.pharmasources.com/industryinsights/fresenius-kabi-recalls-two-lots-of-dexme-321230.html 0.6 2026-06-21T04:58:46+08:00 daily https://www.pharmasources.com/industryinsights/prime-status-for-adaptimmunes-synovial-s-321231.html 0.6 2026-06-22T03:14:55+08:00 daily https://www.pharmasources.com/industryinsights/chmp-backs-expanding-scope-of-kyowa-kiri-321232.html 0.6 2026-08-08T01:52:13+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-and-biontech-select-lead-mrna-vac-321233.html 0.6 2026-06-21T10:44:52+08:00 daily https://www.pharmasources.com/industryinsights/gov-unveils-new-anti-obesity-measures-321234.html 0.6 2026-08-12T15:02:49+08:00 daily https://www.pharmasources.com/industryinsights/sobi-to-refile-gamifant-following-chmp-r-321235.html 0.6 2026-08-11T18:24:30+08:00 daily https://www.pharmasources.com/industryinsights/pharma-and-health-from-ingredients-to-pi-321236.html 0.6 2026-07-05T22:37:32+08:00 daily https://www.pharmasources.com/industryinsights/pharma-and-health-from-ingredients-to-pi-321237.html 0.6 2026-07-16T11:18:59+08:00 daily https://www.pharmasources.com/industryinsights/digital-health-clinical-study-published--321238.html 0.6 2026-06-20T14:45:56+08:00 daily https://www.pharmasources.com/industryinsights/mc2-therapeutics-announces-us-food-and-d-321239.html 0.6 2026-06-20T15:55:53+08:00 daily https://www.pharmasources.com/industryinsights/byondis-initiates-phase-ii-study-of-anti-321240.html 0.6 2026-07-22T12:29:45+08:00 daily https://www.pharmasources.com/industryinsights/pharma-industry-thinks-high-risk-groups--321241.html 0.6 2026-06-30T03:45:24+08:00 daily https://www.pharmasources.com/industryinsights/eastman-kodak-to-get-a-765-mn-loan-from--321242.html 0.6 2026-07-16T08:59:11+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-news-of-the-week-july-20t-321243.html 0.6 2026-08-08T22:51:07+08:00 daily https://www.pharmasources.com/industryinsights/researchers-identify-immune-system-varia-321244.html 0.6 2026-07-06T11:52:30+08:00 daily https://www.pharmasources.com/industryinsights/haryana-fda-files-fir-against-foreign-na-321245.html 0.6 2026-07-09T00:03:24+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-news-of-the-week-july-20t-321246.html 0.6 2026-06-20T15:10:26+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-biontech-to-commence-late-stage-s-321247.html 0.6 2026-08-10T18:03:39+08:00 daily https://www.pharmasources.com/industryinsights/the-conundrum-of-usfda-inspections-321248.html 0.6 2026-07-15T06:55:21+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-news-of-the-week-july-20t-321249.html 0.6 2026-08-15T00:10:26+08:00 daily https://www.pharmasources.com/industryinsights/avra-laboratories-gets-cdsco-nod-for-fav-321250.html 0.6 2026-06-21T09:04:00+08:00 daily https://www.pharmasources.com/industryinsights/neubase-therapeutics-appoints-coo-321251.html 0.6 2026-06-23T05:12:44+08:00 daily https://www.pharmasources.com/industryinsights/centogene-molecular-health-partner-to-tr-321252.html 0.6 2026-06-21T17:30:33+08:00 daily https://www.pharmasources.com/industryinsights/abzena-receives-10m-investment-from-bios-321253.html 0.6 2026-06-20T16:05:18+08:00 daily https://www.pharmasources.com/industryinsights/avid-bioservices-argonaut-enter-manufact-321254.html 0.6 2026-06-20T21:18:53+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-partners-with-austria-to-boost-an-321255.html 0.6 2026-08-05T20:13:46+08:00 daily https://www.pharmasources.com/industryinsights/emergent-expands-covid-19-vaccine-manufa-321256.html 0.6 2026-07-07T06:42:54+08:00 daily https://www.pharmasources.com/industryinsights/potential-covid-19-treatment-lam-002a-to-321257.html 0.6 2026-07-16T18:33:43+08:00 daily https://www.pharmasources.com/industryinsights/ema-initiates-review-of-dexamethasone-fo-321258.html 0.6 2026-07-16T21:02:31+08:00 daily https://www.pharmasources.com/industryinsights/luminex-files-eua-for-expanded-nxtag-res-321259.html 0.6 2026-06-22T04:12:48+08:00 daily https://www.pharmasources.com/industryinsights/atai-launches-viridia-life-sciences-to-d-321260.html 0.6 2026-08-07T17:31:01+08:00 daily https://www.pharmasources.com/industryinsights/bd-receives-fda-approval-for-hpv-test-wi-321261.html 0.6 2026-07-10T11:11:04+08:00 daily https://www.pharmasources.com/industryinsights/avacta-provides-update-on-clinical-valid-321262.html 0.6 2026-06-22T05:58:40+08:00 daily https://www.pharmasources.com/industryinsights/grnenthal-averitas-announce-fda-approval-321263.html 0.6 2026-07-01T10:25:41+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-launches-offering-to-facil-321264.html 0.6 2026-06-20T20:57:42+08:00 daily https://www.pharmasources.com/industryinsights/az-farxiga-hits-all-goals-in-chronic-kid-321265.html 0.6 2026-08-08T01:52:39+08:00 daily https://www.pharmasources.com/industryinsights/sanofigsk-sign-deal-with-uk-gov-for-covi-321266.html 0.6 2026-06-22T01:59:33+08:00 daily https://www.pharmasources.com/industryinsights/neoimmunetech-gets-ind-clearance-for-nt--321267.html 0.6 2026-06-21T09:02:04+08:00 daily https://www.pharmasources.com/industryinsights/celltrion-secures-ec-approval-for-remsim-321268.html 0.6 2026-06-21T03:16:56+08:00 daily https://www.pharmasources.com/industryinsights/janssen-gets-chmp-positive-opinion-for-e-321269.html 0.6 2026-02-09T04:33:06+08:00 daily https://www.pharmasources.com/industryinsights/inotrem-gets-clearance-to-launch-phase-2-321270.html 0.6 2026-06-23T18:13:33+08:00 daily https://www.pharmasources.com/industryinsights/dcgi-asks-sii-to-revise-protocol-for-pha-321271.html 0.6 2026-06-20T20:52:34+08:00 daily https://www.pharmasources.com/industryinsights/gsk-pharma-announces-results-for-the-qua-321272.html 0.6 2026-06-20T23:34:23+08:00 daily https://www.pharmasources.com/industryinsights/actemraroactemra-arthritis-drug-from-roc-321273.html 0.6 2026-05-12T16:15:36+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-scientific-strengthens-its-321274.html 0.6 2026-06-21T05:12:08+08:00 daily https://www.pharmasources.com/industryinsights/piramal-pharma-solutions-to-provide-bolt-321275.html 0.6 2026-06-21T14:41:13+08:00 daily https://www.pharmasources.com/industryinsights/hetero-launches-favivir-to-treat-mild-to-321276.html 0.6 2026-06-22T00:05:55+08:00 daily https://www.pharmasources.com/industryinsights/sami-sabinsa-gets-non-gmo-project-verifi-321277.html 0.6 2026-08-08T16:49:07+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-arm-to-acquire-aquinox-pharma-321278.html 0.6 2026-08-08T15:09:58+08:00 daily https://www.pharmasources.com/industryinsights/us-dfc-to-offer-765m-loan-to-support-kod-321279.html 0.6 2026-08-07T13:14:54+08:00 daily https://www.pharmasources.com/industryinsights/health-canada-authorises-remdesivir-as-f-321280.html 0.6 2026-08-09T21:12:24+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-gsk-to-supply-covid-19-vaccin-321281.html 0.6 2026-06-23T14:49:27+08:00 daily https://www.pharmasources.com/industryinsights/wacker-invests-in-amsterdam-site-321282.html 0.6 2026-08-07T00:39:52+08:00 daily https://www.pharmasources.com/industryinsights/jubilant-biosys-merges-with-jubilant-che-321283.html 0.6 2026-08-07T00:02:18+08:00 daily https://www.pharmasources.com/industryinsights/idt-biologika-fills-sars-cov-2-vaccine-c-321284.html 0.6 2026-08-07T00:40:49+08:00 daily https://www.pharmasources.com/industryinsights/catalent-partners-with-gene-editing-comp-321285.html 0.6 2026-08-07T01:10:50+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-diosynth-to-support-covid-19-va-321286.html 0.6 2026-08-14T17:02:44+08:00 daily https://www.pharmasources.com/industryinsights/ec-approves-subcutaneous-formulation-of--321287.html 0.6 2026-07-16T04:48:19+08:00 daily https://www.pharmasources.com/industryinsights/trade-committee-urges-uk-to-ensure-drug--321288.html 0.6 2026-06-18T10:14:16+08:00 daily https://www.pharmasources.com/industryinsights/indena-spa---exhibitor-webinar-321289.html 0.6 2026-06-21T15:16:39+08:00 daily https://www.pharmasources.com/industryinsights/ukri-announces-six-research-initiatives--321290.html 0.6 2026-07-04T09:51:35+08:00 daily https://www.pharmasources.com/industryinsights/ampio-starts-patient-enrollment-in-ampio-321291.html 0.6 2026-06-21T06:02:47+08:00 daily https://www.pharmasources.com/industryinsights/sinoway-industrial-co-ltd---exhibitor-we-321292.html 0.6 2026-07-09T12:28:06+08:00 daily https://www.pharmasources.com/industryinsights/cobomarsen-receives-orphan-drug-designat-321293.html 0.6 2026-07-09T01:14:39+08:00 daily https://www.pharmasources.com/industryinsights/fda-proposes-new-rule-on-reporting-requi-321294.html 0.6 2026-06-20T14:49:09+08:00 daily https://www.pharmasources.com/industryinsights/carisma-announces-fda-clearance-of-ind-a-321295.html 0.6 2026-06-21T08:09:05+08:00 daily https://www.pharmasources.com/industryinsights/myokardia-receives-breakthrough-therapy--321296.html 0.6 2026-06-20T16:59:13+08:00 daily https://www.pharmasources.com/industryinsights/pharmsol-group--exhibitor-webinar-321297.html 0.6 2026-06-21T18:58:33+08:00 daily https://www.pharmasources.com/industryinsights/immunoprotein-impairs-sars-cov-2-321298.html 0.6 2026-06-20T17:59:18+08:00 daily https://www.pharmasources.com/industryinsights/pqe-group---exhibitor-webinar-321299.html 0.6 2026-08-14T01:48:39+08:00 daily https://www.pharmasources.com/industryinsights/experimental-covid-19-vaccine-protects-u-321300.html 0.6 2026-06-30T15:03:07+08:00 daily https://www.pharmasources.com/industryinsights/bioiberica-sau-exhibitor-webinar-321301.html 0.6 2026-08-07T01:19:22+08:00 daily https://www.pharmasources.com/industryinsights/uk-strikes-deal-with-gsk-and-sanofi-for--321302.html 0.6 2026-06-21T12:08:18+08:00 daily https://www.pharmasources.com/industryinsights/beijing-mediking-biopharm-coltd--exhibit-321303.html 0.6 2026-06-21T07:52:20+08:00 daily https://www.pharmasources.com/industryinsights/haryana-fda-seizes-86-remdesivir-vials-t-321304.html 0.6 2026-08-07T21:57:46+08:00 daily https://www.pharmasources.com/industryinsights/advent-international-to-acquire-controll-321305.html 0.6 2026-06-20T13:17:37+08:00 daily https://www.pharmasources.com/industryinsights/empagliflozin-meets-primary-endpoint-in--321306.html 0.6 2026-06-21T13:10:55+08:00 daily https://www.pharmasources.com/industryinsights/biocon-and-voluntis-deal-to-transform-in-321307.html 0.6 2026-08-14T05:55:41+08:00 daily https://www.pharmasources.com/industryinsights/biocon-biologics-to-get-rs-225-cr-from-t-321308.html 0.6 2026-06-20T22:16:52+08:00 daily https://www.pharmasources.com/industryinsights/orion-biotechnology-receives-funding-to--321309.html 0.6 2026-07-17T08:06:25+08:00 daily https://www.pharmasources.com/industryinsights/somalogic-amgen-enter-proteomic-profilin-321310.html 0.6 2026-06-20T17:14:37+08:00 daily https://www.pharmasources.com/industryinsights/pdl-biopharma-sells-noden-pharma-for-483-321311.html 0.6 2026-03-19T08:31:30+08:00 daily https://www.pharmasources.com/industryinsights/moberg-pharma-appoints-chief-medical-off-321312.html 0.6 2026-06-24T00:49:54+08:00 daily https://www.pharmasources.com/industryinsights/inovios-covid-19-dna-vax-effective-in-nh-321313.html 0.6 2026-07-05T13:29:53+08:00 daily https://www.pharmasources.com/industryinsights/roches-phase-iii-trial-of-actemra-in-cov-321314.html 0.6 2026-08-09T16:10:31+08:00 daily https://www.pharmasources.com/industryinsights/sangamo-novartis-partner-to-develop-gene-321315.html 0.6 2026-06-21T05:13:53+08:00 daily https://www.pharmasources.com/industryinsights/jjs-lead-covid-19-vax-candidate-elicits--321316.html 0.6 2026-06-20T16:08:22+08:00 daily https://www.pharmasources.com/industryinsights/avacta-daewoong-expand-affimer-alliance-321317.html 0.6 2026-06-20T22:08:48+08:00 daily https://www.pharmasources.com/industryinsights/cpi-collaborates-with-microfluidx-and-cg-321318.html 0.6 2026-07-20T23:29:08+08:00 daily https://www.pharmasources.com/industryinsights/intravacc-and-celonic-team-up-to-develop-321319.html 0.6 2026-07-17T22:18:30+08:00 daily https://www.pharmasources.com/industryinsights/roche-and-ucb-partner-to-develop-antibod-321320.html 0.6 2026-08-02T02:57:51+08:00 daily https://www.pharmasources.com/industryinsights/hetero-launches-generic-favipiravir-to-t-321321.html 0.6 2026-06-21T01:03:47+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-rapid-antibody-tests-approved-f-321322.html 0.6 2026-06-20T14:44:23+08:00 daily https://www.pharmasources.com/industryinsights/biopharma-increasingly-factoring-sustain-321323.html 0.6 2026-06-20T22:51:51+08:00 daily https://www.pharmasources.com/industryinsights/onconova-submits-application-for-rigoser-321324.html 0.6 2026-06-21T01:06:48+08:00 daily https://www.pharmasources.com/industryinsights/calquence-recommended-for-chmp-approval--321325.html 0.6 2026-07-01T21:39:25+08:00 daily https://www.pharmasources.com/industryinsights/medicinova-announces-sars-cov-2-vaccine--321326.html 0.6 2026-07-19T02:34:04+08:00 daily https://www.pharmasources.com/industryinsights/fda-authorizes-test-for-people-without-k-321327.html 0.6 2026-06-21T08:59:58+08:00 daily https://www.pharmasources.com/industryinsights/immunic-begins-imu-838-oseltamivir-trial-321328.html 0.6 2026-06-20T21:57:34+08:00 daily https://www.pharmasources.com/industryinsights/nirsevimab-shows-promise-for-long-term-r-321329.html 0.6 2026-06-22T14:18:37+08:00 daily https://www.pharmasources.com/industryinsights/gsk-sees-dip-in-second-quarter-sales-321330.html 0.6 2026-06-21T12:04:17+08:00 daily https://www.pharmasources.com/industryinsights/nhs-people-plan-to-address-new-pandemic--321331.html 0.6 2026-06-21T09:56:32+08:00 daily https://www.pharmasources.com/industryinsights/nice-rejects-nhs-funding-for-kyowa-kirin-321332.html 0.6 2026-06-21T22:12:52+08:00 daily https://www.pharmasources.com/industryinsights/nice-backs-bavencio-combo-for-kidney-can-321333.html 0.6 2026-06-20T16:59:16+08:00 daily https://www.pharmasources.com/industryinsights/eu-regulators-approve-novartis-breast-ca-321334.html 0.6 2026-07-04T17:12:48+08:00 daily https://www.pharmasources.com/industryinsights/powder-flow-limitations-of-mathematicall-321335.html 0.6 2026-08-11T15:46:40+08:00 daily https://www.pharmasources.com/industryinsights/russia-readying-for-mass-vaccination-aga-321336.html 0.6 2026-06-21T02:06:27+08:00 daily https://www.pharmasources.com/industryinsights/lupin-recalls-35928-bottles-of-cefdinir--321337.html 0.6 2026-08-10T11:20:47+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-resurgence-expected-in-us-as-he-321338.html 0.6 2026-08-09T13:05:30+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-gsk-to-supply-100-mn-doses-of-cov-321339.html 0.6 2026-08-11T17:10:26+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-tentative-us-fda-appro-321340.html 0.6 2026-08-07T03:03:07+08:00 daily https://www.pharmasources.com/industryinsights/gavis-new-drive-for-covid-19-vaccine-acc-321341.html 0.6 2026-08-07T02:30:29+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-panel-recommends-dcgi-to-permit-321342.html 0.6 2026-08-07T02:21:55+08:00 daily https://www.pharmasources.com/industryinsights/slas-to-issue-manufacturesale-licenses-f-321343.html 0.6 2026-08-07T02:18:31+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-and-biontech-sign-deal-with-japan-321344.html 0.6 2026-08-07T02:05:25+08:00 daily https://www.pharmasources.com/industryinsights/roche-gets-us-fda-approval-for-tecentriq-321345.html 0.6 2026-08-13T10:23:29+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-grants-breakthrough-therapy-desig-321346.html 0.6 2026-08-07T12:13:03+08:00 daily https://www.pharmasources.com/industryinsights/jj-begins-human-trials-of-covid-19-vacci-321347.html 0.6 2026-08-07T13:15:08+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-expands-animal-heal-321348.html 0.6 2026-08-07T19:27:00+08:00 daily https://www.pharmasources.com/industryinsights/policymakers-to-identify-groups-of-peopl-321349.html 0.6 2026-08-08T04:31:09+08:00 daily https://www.pharmasources.com/industryinsights/forge-biologics-completes-series-a-finan-321350.html 0.6 2026-08-08T10:38:53+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-astrazeneca-enter-new-6b--321351.html 0.6 2026-08-10T15:42:20+08:00 daily https://www.pharmasources.com/industryinsights/irisys-to-manufacture-biocorrxs-opioid-u-321352.html 0.6 2026-07-21T01:52:23+08:00 daily https://www.pharmasources.com/industryinsights/sekisui-invests-1893-million-in-biopharm-321353.html 0.6 2026-06-22T13:06:23+08:00 daily https://www.pharmasources.com/industryinsights/celsion-initiates-phase-ii-ovation-2-stu-321354.html 0.6 2026-08-05T19:57:38+08:00 daily https://www.pharmasources.com/industryinsights/imfinzi-recommended-for-approval-by-chmp-321355.html 0.6 2026-08-12T19:56:30+08:00 daily https://www.pharmasources.com/industryinsights/emerald-health-begins-enrollment-for-sys-321356.html 0.6 2026-06-20T18:59:34+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-brexucabtagene-autoleucel-f-321357.html 0.6 2026-06-18T07:56:23+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-expands-globalaccess-progr-321358.html 0.6 2026-06-18T08:13:23+08:00 daily https://www.pharmasources.com/industryinsights/patent-awarded-for-concarlo-developed-th-321359.html 0.6 2026-06-21T04:58:46+08:00 daily https://www.pharmasources.com/industryinsights/us-commits-21bn-for-100-million-sanofi-g-321360.html 0.6 2026-06-23T17:37:13+08:00 daily https://www.pharmasources.com/industryinsights/teva-takeda-joint-venture-divests-certai-321361.html 0.6 2026-06-21T07:19:37+08:00 daily https://www.pharmasources.com/industryinsights/jj-begins-first-trial-of-covid-19-vaccin-321362.html 0.6 2026-06-21T13:46:26+08:00 daily https://www.pharmasources.com/industryinsights/novartis-partners-with-sangamo-on-genomi-321363.html 0.6 2026-08-09T23:54:10+08:00 daily https://www.pharmasources.com/industryinsights/us-invests-over-240-million-into-seven-n-321364.html 0.6 2026-08-06T23:37:09+08:00 daily https://www.pharmasources.com/industryinsights/fda-proposes-four-apis-for-bulk-substanc-321365.html 0.6 2026-08-06T23:33:22+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-avelumab-and-axitinib-to-321366.html 0.6 2026-08-06T21:38:10+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-321367.html 0.6 2026-08-06T20:04:20+08:00 daily https://www.pharmasources.com/industryinsights/vopec-pharma-completes-covid-19-clinical-321368.html 0.6 2026-08-06T22:08:15+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-amgen-and-takeda-jointly-study-im-321369.html 0.6 2026-08-06T22:14:12+08:00 daily https://www.pharmasources.com/industryinsights/study-reveals-macular-degeneration-can-i-321370.html 0.6 2026-08-06T22:20:42+08:00 daily https://www.pharmasources.com/industryinsights/jubilant-life-sciences-launches-jubi-r-f-321371.html 0.6 2026-08-06T23:32:26+08:00 daily https://www.pharmasources.com/industryinsights/hdma-sets-up-two-covid-19-quarantine-cen-321372.html 0.6 2026-08-06T23:36:43+08:00 daily https://www.pharmasources.com/industryinsights/rozlytrek-from-roche-gets-ec-approval-to-321373.html 0.6 2026-08-06T23:45:52+08:00 daily https://www.pharmasources.com/industryinsights/wockhardt-signs-partnership-with-uk-gove-321374.html 0.6 2026-08-07T13:15:57+08:00 daily https://www.pharmasources.com/industryinsights/remdesivir-and-favipiravir-price-regulat-321375.html 0.6 2026-08-08T01:01:11+08:00 daily https://www.pharmasources.com/industryinsights/serum-institute-of-india-gets-dcgi-nod-f-321376.html 0.6 2026-08-08T01:43:51+08:00 daily https://www.pharmasources.com/industryinsights/melinta-therapeutics-appoints-ceo-321377.html 0.6 2026-08-08T04:35:16+08:00 daily https://www.pharmasources.com/industryinsights/pharmabcine-slbio-enter-nsclc-research-p-321378.html 0.6 2026-08-09T06:59:15+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-announces-joint-investment-with-a-321379.html 0.6 2026-06-18T05:10:41+08:00 daily https://www.pharmasources.com/industryinsights/altimmune-and-cdmo-vigene-enter-covid-19-321380.html 0.6 2026-07-08T03:19:56+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-biontech-reach-deal-with-japanese-321381.html 0.6 2026-08-14T14:10:40+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-gsk-selected-for-operation-wa-321382.html 0.6 2026-08-07T16:54:57+08:00 daily https://www.pharmasources.com/industryinsights/emergent-biosolutions-signs-agreement-wi-321383.html 0.6 2026-08-05T12:51:07+08:00 daily https://www.pharmasources.com/industryinsights/ppd-pfizer-ink-new-service-pact-321384.html 0.6 2026-08-08T21:16:20+08:00 daily https://www.pharmasources.com/industryinsights/uk-teams-up-with-wockhardt-for-vaccine-m-321385.html 0.6 2026-08-07T09:02:54+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-and-biontech-to-supply-120-millio-321386.html 0.6 2026-08-09T02:36:45+08:00 daily https://www.pharmasources.com/industryinsights/uk-to-roll-out-covid-19-diagnostic-that--321387.html 0.6 2026-06-24T09:28:52+08:00 daily https://www.pharmasources.com/industryinsights/moderna-initiates-phase-iii-trial-of-cov-321388.html 0.6 2026-06-20T21:41:28+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-epidyolex-for-treatment-of--321389.html 0.6 2026-01-31T10:43:22+08:00 daily https://www.pharmasources.com/industryinsights/global-trial-for-covid-19-vaccine-begins-321390.html 0.6 2026-06-20T20:21:05+08:00 daily https://www.pharmasources.com/industryinsights/promedica-researchers-observe-encouragin-321391.html 0.6 2026-06-20T14:31:34+08:00 daily https://www.pharmasources.com/industryinsights/study-shows-rinvoq-topical-corticosteroi-321392.html 0.6 2026-06-21T00:49:13+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-daiichi-sankyo-announce-coll-321393.html 0.6 2026-06-20T18:05:25+08:00 daily https://www.pharmasources.com/industryinsights/kempharm-receives-of-two-additional-us-p-321394.html 0.6 2026-06-09T15:13:23+08:00 daily https://www.pharmasources.com/industryinsights/self-contained-rapid-adexusdx-covid-19-a-321395.html 0.6 2026-08-07T15:45:46+08:00 daily https://www.pharmasources.com/industryinsights/oxford-biomedica-and-beam-therapeutics-s-321396.html 0.6 2026-08-10T01:15:07+08:00 daily https://www.pharmasources.com/industryinsights/mhra-oks-celltrions-phase-i-trial-of-cov-321397.html 0.6 2026-06-20T14:28:27+08:00 daily https://www.pharmasources.com/industryinsights/uk-firm-starts-research-on-skin-patch-fo-321398.html 0.6 2026-06-22T01:12:01+08:00 daily https://www.pharmasources.com/industryinsights/genmabjanssens-darzalex-combo-hits-the-m-321399.html 0.6 2026-06-23T14:08:31+08:00 daily https://www.pharmasources.com/industryinsights/us-expands-scope-of-janssens-stelara-321400.html 0.6 2026-07-18T11:11:05+08:00 daily https://www.pharmasources.com/industryinsights/immodulon-champalimaud-foundation-team-u-321401.html 0.6 2026-06-20T19:59:35+08:00 daily https://www.pharmasources.com/industryinsights/cosentyx-wins-eu-approval-for-first-line-321402.html 0.6 2026-07-16T08:50:57+08:00 daily https://www.pharmasources.com/industryinsights/uk-and-us-healthcare-workers-report-high-321403.html 0.6 2026-07-07T06:17:59+08:00 daily https://www.pharmasources.com/industryinsights/china-nmpa-accepts-ind-application-for-e-321404.html 0.6 2026-08-07T05:37:13+08:00 daily https://www.pharmasources.com/industryinsights/zhongchao-inc-renews-contract-with-johns-321405.html 0.6 2026-08-07T19:44:00+08:00 daily https://www.pharmasources.com/industryinsights/world-federation-of-hemophilia-wfh-publi-321406.html 0.6 2026-08-07T05:45:33+08:00 daily https://www.pharmasources.com/industryinsights/panchshil-realtys-office-portfolio-first-321407.html 0.6 2026-08-07T05:48:56+08:00 daily https://www.pharmasources.com/industryinsights/axa-hong-kong-sar-china-launches-additio-321408.html 0.6 2026-06-23T10:58:29+08:00 daily https://www.pharmasources.com/industryinsights/adagio-medical-inc-reports-pre-clinical--321409.html 0.6 2026-08-07T12:03:11+08:00 daily https://www.pharmasources.com/industryinsights/amcor-to-report-full-year-2020-results-321410.html 0.6 2026-08-07T13:18:37+08:00 daily https://www.pharmasources.com/industryinsights/macrogen-obtains-europes-ce-ivd-certific-321411.html 0.6 2026-08-07T15:01:45+08:00 daily https://www.pharmasources.com/industryinsights/new-data-independently-confirms-and-exte-321412.html 0.6 2026-08-07T18:30:44+08:00 daily https://www.pharmasources.com/industryinsights/iherb-announces-major-enhancement-to-ihe-321413.html 0.6 2026-08-07T19:39:12+08:00 daily https://www.pharmasources.com/industryinsights/tb-alliance-announces-european-commissio-321414.html 0.6 2026-08-08T07:49:53+08:00 daily https://www.pharmasources.com/industryinsights/pharmabcine-signs-a-research-collaborati-321415.html 0.6 2026-08-08T21:33:29+08:00 daily https://www.pharmasources.com/industryinsights/worlds-first-3d-regenerative-implant-and-321416.html 0.6 2026-08-09T02:39:05+08:00 daily https://www.pharmasources.com/industryinsights/innovent-announces-first-patient-dosed-i-321417.html 0.6 2026-08-06T21:47:20+08:00 daily https://www.pharmasources.com/industryinsights/converge-biotech-launches-vergiflu-favip-321418.html 0.6 2026-06-22T04:53:43+08:00 daily https://www.pharmasources.com/industryinsights/in-the-pharma-industry-technology-has-be-321419.html 0.6 2026-07-21T20:05:59+08:00 daily https://www.pharmasources.com/industryinsights/maha-fda-seizes-15-vials-of-tocilizumab--321420.html 0.6 2026-06-20T18:58:37+08:00 daily https://www.pharmasources.com/industryinsights/kokate-committee-releases-list-of-471-ra-321421.html 0.6 2026-08-13T18:54:01+08:00 daily https://www.pharmasources.com/industryinsights/lupin-gets-tentative-approval-from-us-fd-321422.html 0.6 2026-03-01T06:24:05+08:00 daily https://www.pharmasources.com/industryinsights/manslaughter-charges-on-sanofi-over-epil-321423.html 0.6 2026-04-08T18:33:38+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-launches-generic-favipiravir--321424.html 0.6 2026-06-20T15:47:25+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-spravato-antidepressant--321425.html 0.6 2026-07-01T18:29:46+08:00 daily https://www.pharmasources.com/industryinsights/beroni-group-provides-update-on-covid-19-321426.html 0.6 2026-07-06T08:21:39+08:00 daily https://www.pharmasources.com/industryinsights/cryoport-medipal-partner-on-supply-chain-321427.html 0.6 2026-06-21T05:00:46+08:00 daily https://www.pharmasources.com/industryinsights/partner-therapeutics-wins-35m-dod-contra-321428.html 0.6 2026-06-22T00:59:52+08:00 daily https://www.pharmasources.com/industryinsights/romanco-appoints-joint-managing-director-321429.html 0.6 2026-07-19T16:24:21+08:00 daily https://www.pharmasources.com/industryinsights/sekisui-diagnostics-invests-in-biopharma-321430.html 0.6 2026-07-04T09:29:29+08:00 daily https://www.pharmasources.com/industryinsights/merck-licences-nash-drug-efinopegdutide--321431.html 0.6 2026-08-07T18:45:25+08:00 daily https://www.pharmasources.com/industryinsights/ucb-announces-alzheimers-disease-treatme-321432.html 0.6 2026-03-17T20:45:24+08:00 daily https://www.pharmasources.com/industryinsights/inovio-receives-orphan-drug-designation--321433.html 0.6 2026-08-14T08:38:22+08:00 daily https://www.pharmasources.com/industryinsights/intravacc-celonic-to-develop-and-produce-321434.html 0.6 2026-08-05T23:29:00+08:00 daily https://www.pharmasources.com/industryinsights/truvian-receives-fda-emergency-use-autho-321435.html 0.6 2026-06-23T05:07:55+08:00 daily https://www.pharmasources.com/industryinsights/nabriva-receives-ec-approval-for-xenleta-321436.html 0.6 2026-06-21T18:18:55+08:00 daily https://www.pharmasources.com/industryinsights/gsk-shipping-influenza-vaccine-doses-for-321437.html 0.6 2026-07-17T23:58:38+08:00 daily https://www.pharmasources.com/industryinsights/novartis-car-t-therapy-kymriah-hits-endp-321438.html 0.6 2026-04-09T11:26:44+08:00 daily https://www.pharmasources.com/industryinsights/pharmas-reputation-has-climbed-during-co-321439.html 0.6 2026-08-08T01:33:19+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-forges-licensing-agreement-w-321440.html 0.6 2026-08-11T06:06:42+08:00 daily https://www.pharmasources.com/industryinsights/abzena-appoints-svp-of-san-diego-ops-321441.html 0.6 2026-07-09T13:19:14+08:00 daily https://www.pharmasources.com/industryinsights/nhs-adapts-to-pandemic-with-covid-friend-321442.html 0.6 2026-06-20T16:04:31+08:00 daily https://www.pharmasources.com/industryinsights/abcellera-provides-covid-19-programme-up-321443.html 0.6 2026-06-21T08:05:00+08:00 daily https://www.pharmasources.com/industryinsights/tagrisso-granted-fda-breakthrough-therap-321444.html 0.6 2026-06-20T16:07:24+08:00 daily https://www.pharmasources.com/industryinsights/medicine-suppliers-in-uk-urged-to-stockp-321445.html 0.6 2026-04-15T14:02:05+08:00 daily https://www.pharmasources.com/industryinsights/fda-issues-warning-over-subpotent-and-da-321446.html 0.6 2026-04-08T13:20:58+08:00 daily https://www.pharmasources.com/industryinsights/uk-government-reserves-wockhardt-product-321447.html 0.6 2026-07-06T23:20:46+08:00 daily https://www.pharmasources.com/industryinsights/alkem-launches-favipiravir-under-brand-n-321448.html 0.6 2026-06-22T13:02:21+08:00 daily https://www.pharmasources.com/industryinsights/centre-to-come-up-with-rd-policy-for-pha-321449.html 0.6 2026-06-20T20:12:51+08:00 daily https://www.pharmasources.com/industryinsights/alembic-pharma-receives-usfda-approval-f-321450.html 0.6 2026-06-20T18:16:44+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-completes-dosing-in-phase-i-321451.html 0.6 2026-06-21T10:51:06+08:00 daily https://www.pharmasources.com/industryinsights/lupin-launches-generic-favipiravir-covih-321452.html 0.6 2026-06-21T12:15:28+08:00 daily https://www.pharmasources.com/industryinsights/zenara-pharma-a-biophore-subsidiary-gets-321453.html 0.6 2026-06-22T09:45:38+08:00 daily https://www.pharmasources.com/industryinsights/curevac-appoints-ceo-and-coo-321454.html 0.6 2026-06-26T16:44:53+08:00 daily https://www.pharmasources.com/industryinsights/sri-biosciences-awarded-100m-niaid-contr-321455.html 0.6 2026-06-21T12:21:32+08:00 daily https://www.pharmasources.com/industryinsights/jj-wins-1b-us-contract-for-sars-cov-2-va-321456.html 0.6 2026-06-22T01:53:30+08:00 daily https://www.pharmasources.com/industryinsights/teva-enters-biosimilar-commercialisation-321457.html 0.6 2026-07-18T09:11:19+08:00 daily https://www.pharmasources.com/industryinsights/uk-and-valneva-to-invest-in-coronavirus--321458.html 0.6 2026-08-11T08:48:20+08:00 daily https://www.pharmasources.com/industryinsights/improved-patient-access-seen-as-the-main-321459.html 0.6 2026-07-01T09:12:57+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-to-develop-redxs-drug-for-fi-321460.html 0.6 2026-07-27T15:51:15+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-poll-disrupted-clinical-trials--321461.html 0.6 2026-06-22T07:56:43+08:00 daily https://www.pharmasources.com/industryinsights/tinostamustine-granted-orphan-drug-desig-321462.html 0.6 2026-08-11T18:41:32+08:00 daily https://www.pharmasources.com/industryinsights/commonly-used-treatments-for-chronic-pai-321463.html 0.6 2026-07-24T11:19:43+08:00 daily https://www.pharmasources.com/industryinsights/interleukin-6-inhibitors-improve-outcome-321464.html 0.6 2026-07-19T20:02:19+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-dna-vaccine-targeting-sars-cov--321465.html 0.6 2026-06-21T06:18:20+08:00 daily https://www.pharmasources.com/industryinsights/constant-therapeutics-announces-start-of-321466.html 0.6 2026-06-20T14:50:02+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-announces-positive-phase-3-data-f-321467.html 0.6 2026-08-12T23:00:45+08:00 daily https://www.pharmasources.com/industryinsights/seqirus-begins-shipping-202021-influenza-321468.html 0.6 2026-07-07T06:41:11+08:00 daily https://www.pharmasources.com/industryinsights/direct-biologics-receives-fda-approval-t-321469.html 0.6 2026-07-01T16:56:14+08:00 daily https://www.pharmasources.com/industryinsights/locking-down-shape-shifting-spike-protei-321470.html 0.6 2026-06-28T11:09:20+08:00 daily https://www.pharmasources.com/industryinsights/reviral-secures-fda-fast-track-status-fo-321471.html 0.6 2026-06-30T16:04:17+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-ind-for-pscs-stem-cell-ther-321472.html 0.6 2026-07-06T14:04:47+08:00 daily https://www.pharmasources.com/industryinsights/immunitybios-had5-vaccine-candidate-for--321473.html 0.6 2026-07-08T15:34:02+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-news-of-the-week-cphicn---321474.html 0.6 2026-06-21T05:04:44+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-news-of-the-week-cphicn---321475.html 0.6 2026-07-09T20:56:50+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-news-of-the-week-cphicn---321476.html 0.6 2026-07-12T04:12:02+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-news-of-the-week-cphicn---321477.html 0.6 2026-06-21T20:25:58+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-news-of-the-week-cphicn---321478.html 0.6 2026-07-20T14:55:31+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-news-of-the-week-cphicn---321479.html 0.6 2026-08-13T19:25:34+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-news-of-the-week-cphicn---321480.html 0.6 2026-08-05T22:06:40+08:00 daily https://www.pharmasources.com/industryinsights/farmasino-pharmaceuticalsjiangsu-coltd---321481.html 0.6 2026-06-09T14:36:28+08:00 daily https://www.pharmasources.com/industryinsights/pankajakasthuri-declares-final-clinical--321482.html 0.6 2026-06-28T19:59:17+08:00 daily https://www.pharmasources.com/industryinsights/upskilling-pharma-workforce-to-be-future-321483.html 0.6 2026-07-29T03:10:25+08:00 daily https://www.pharmasources.com/industryinsights/birdo-shanghai-pharmatech-coltd--exhibit-321484.html 0.6 2026-08-07T03:48:45+08:00 daily https://www.pharmasources.com/industryinsights/shandong-runxin-biotechnology-co-ltd--ex-321485.html 0.6 2026-06-21T22:54:47+08:00 daily https://www.pharmasources.com/industryinsights/angel-yeast-coltd---exhibitor-webinar-321486.html 0.6 2026-06-20T18:49:03+08:00 daily https://www.pharmasources.com/industryinsights/shijiazhuang-cready-pharmaceutical-rd-in-321487.html 0.6 2026-08-14T09:23:46+08:00 daily https://www.pharmasources.com/industryinsights/gsk-gets-usfda-approval-for-blenrep-to-t-321488.html 0.6 2026-08-07T01:10:56+08:00 daily https://www.pharmasources.com/industryinsights/lupin-signs-exclusive-distribution-deal--321489.html 0.6 2026-08-07T00:59:21+08:00 daily https://www.pharmasources.com/industryinsights/lupin-concord-receive-us-fda-approval-fo-321490.html 0.6 2026-08-07T00:52:54+08:00 daily https://www.pharmasources.com/industryinsights/hainan-shuangcheng-pharmaceuticals-co-lt-321491.html 0.6 2026-08-07T00:40:05+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-to-launch-fabiflu-400-mg-for-co-321492.html 0.6 2026-08-10T06:29:29+08:00 daily https://www.pharmasources.com/industryinsights/indoco-gets-usfda-approval-for-olanzapin-321493.html 0.6 2026-08-07T06:07:16+08:00 daily https://www.pharmasources.com/industryinsights/fda-finalises-guidance-limited-populatio-321494.html 0.6 2026-08-10T04:55:01+08:00 daily https://www.pharmasources.com/industryinsights/anhui-sunhere-pharmaceutical-excipients--321495.html 0.6 2026-08-03T04:34:55+08:00 daily https://www.pharmasources.com/industryinsights/novavax-signs-deal-with-serum-institute--321496.html 0.6 2026-07-04T09:46:29+08:00 daily https://www.pharmasources.com/industryinsights/jj-signs-pact-with-us-for-100-million-do-321497.html 0.6 2026-06-08T12:56:37+08:00 daily https://www.pharmasources.com/industryinsights/hubei-humanwell-pharmaceutical-excipient-321498.html 0.6 2026-08-13T13:13:46+08:00 daily https://www.pharmasources.com/industryinsights/canada-signs-deals-with-pfizer-moderna-f-321499.html 0.6 2026-06-20T16:14:31+08:00 daily https://www.pharmasources.com/industryinsights/spi-pharma---exhibitor-webinar-321500.html 0.6 2026-07-06T01:44:41+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-signs-first-deal-to-supply-c-321501.html 0.6 2026-08-03T22:50:30+08:00 daily https://www.pharmasources.com/industryinsights/us-seeks-nearly-13bn-from-purdue-pharma--321502.html 0.6 2026-06-20T22:04:39+08:00 daily https://www.pharmasources.com/industryinsights/naturalin-bio-resources-co-ltd--exhibito-321503.html 0.6 2026-08-13T11:23:33+08:00 daily https://www.pharmasources.com/industryinsights/nice-does-not-recommend-chlormethine-gel-321504.html 0.6 2026-07-04T07:03:52+08:00 daily https://www.pharmasources.com/industryinsights/novavax-presents-positive-data-from-phas-321505.html 0.6 2026-06-29T20:38:58+08:00 daily https://www.pharmasources.com/industryinsights/zhejiang-haining-fengming-chlorophyll-co-321506.html 0.6 2026-08-10T14:57:29+08:00 daily https://www.pharmasources.com/industryinsights/rafarma-to-be-acquired-by-r-d-biocogency-321507.html 0.6 2026-06-21T08:57:58+08:00 daily https://www.pharmasources.com/industryinsights/abbott-evaluates-new-device-to-treat-rec-321508.html 0.6 2026-06-21T08:14:19+08:00 daily https://www.pharmasources.com/industryinsights/ferring-recalls-ddavp-nasal-spray-desmop-321509.html 0.6 2026-06-21T10:19:04+08:00 daily https://www.pharmasources.com/industryinsights/bioaegis-therapeutics-initiates-trial-of-321510.html 0.6 2026-06-21T03:02:55+08:00 daily https://www.pharmasources.com/industryinsights/skyherb--exhibitor-webinar-321511.html 0.6 2026-08-12T02:09:18+08:00 daily https://www.pharmasources.com/industryinsights/jj-announces-agreement-with-us-governmen-321512.html 0.6 2026-08-11T10:16:42+08:00 daily https://www.pharmasources.com/industryinsights/beroni-successfully-constructs-purified--321513.html 0.6 2026-06-21T08:56:58+08:00 daily https://www.pharmasources.com/industryinsights/bestgrand-biotech-co-ltd---exhibitor-web-321514.html 0.6 2026-06-22T23:08:11+08:00 daily https://www.pharmasources.com/industryinsights/researchers-says-hydroxychloroquine-coul-321515.html 0.6 2026-06-21T11:08:20+08:00 daily https://www.pharmasources.com/industryinsights/eu-approves-new-indication-for-novartis--321516.html 0.6 2026-08-09T04:17:03+08:00 daily https://www.pharmasources.com/industryinsights/colorcon-asia-pacific-pte-ltd--exhibitor-321517.html 0.6 2026-08-02T10:55:49+08:00 daily https://www.pharmasources.com/industryinsights/second-covid-19-peak-in-the-uk-can-be-av-321518.html 0.6 2026-08-08T05:20:49+08:00 daily https://www.pharmasources.com/industryinsights/ucbs-cimzia-bags-eu-label-extension-321519.html 0.6 2026-08-07T06:20:52+08:00 daily https://www.pharmasources.com/industryinsights/nice-updates-guidance-on-chronic-pain-tr-321520.html 0.6 2026-07-07T10:38:18+08:00 daily https://www.pharmasources.com/industryinsights/novavaxs-covid-19-vaccine-produces-immun-321521.html 0.6 2026-06-20T19:57:36+08:00 daily https://www.pharmasources.com/industryinsights/zhendong-pharm-medpharm-co-ltd--exhibito-321522.html 0.6 2026-08-05T10:31:01+08:00 daily https://www.pharmasources.com/industryinsights/pingyu-yimeikang-plant-technology-co-ltd-321523.html 0.6 2026-08-14T07:48:15+08:00 daily https://www.pharmasources.com/industryinsights/jilin-province-hongjiu-biotech-coltd--ex-321524.html 0.6 2026-06-21T00:16:52+08:00 daily https://www.pharmasources.com/industryinsights/shaanxi-kingsci-biotechnology-coltd--exh-321525.html 0.6 2026-08-03T21:49:13+08:00 daily https://www.pharmasources.com/industryinsights/herblink-biotech-corporation--exhibitor--321526.html 0.6 2026-07-07T14:15:35+08:00 daily https://www.pharmasources.com/industryinsights/seismic-bio-partners-with-twist-bioscien-321527.html 0.6 2026-08-14T13:00:37+08:00 daily https://www.pharmasources.com/industryinsights/gansu-aikon-seabuckthorn-products-coltd--321528.html 0.6 2026-08-12T15:07:13+08:00 daily https://www.pharmasources.com/industryinsights/rlf-100-shown-to-deliver-rapid-recovery--321529.html 0.6 2026-08-06T19:24:12+08:00 daily https://www.pharmasources.com/industryinsights/myr-pharmaceuticals-receives-conditional-321530.html 0.6 2026-08-09T06:51:30+08:00 daily https://www.pharmasources.com/industryinsights/xian-app-chembio-tech-coltd--exhibitor-w-321531.html 0.6 2026-08-08T00:27:57+08:00 daily https://www.pharmasources.com/industryinsights/xian-sanjiang-bio-engineering-co-ltd--ex-321532.html 0.6 2026-08-07T23:39:42+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-signs-manufacturing-pact-wit-321533.html 0.6 2026-08-07T22:35:10+08:00 daily https://www.pharmasources.com/industryinsights/unichem-gets-us-fda-approval-for-toltero-321534.html 0.6 2026-08-07T13:54:37+08:00 daily https://www.pharmasources.com/industryinsights/lyxiaxiaozaotech--exhibitor-webinar-321535.html 0.6 2026-08-11T15:14:41+08:00 daily https://www.pharmasources.com/industryinsights/guangxi-gengyuan-flavors-and-fragrances--321536.html 0.6 2026-08-07T01:19:25+08:00 daily https://www.pharmasources.com/industryinsights/baoding-faithful-industry-coltd---exhibi-321537.html 0.6 2026-08-07T02:29:19+08:00 daily https://www.pharmasources.com/industryinsights/hunan-huakang-biotech-inc--exhibitor-web-321538.html 0.6 2026-08-07T01:27:47+08:00 daily https://www.pharmasources.com/industryinsights/shandong-longchang-animal-health-product-321539.html 0.6 2026-08-07T01:36:37+08:00 daily https://www.pharmasources.com/industryinsights/jinan-pengbo-biotechnology-co-ltd--exhib-321540.html 0.6 2026-08-07T02:04:54+08:00 daily https://www.pharmasources.com/industryinsights/zhejiang-chemvplus-biotech-coltd---exhib-321541.html 0.6 2026-08-13T10:14:33+08:00 daily https://www.pharmasources.com/industryinsights/sichuan-xing-jie-xiang-herb-material-col-321542.html 0.6 2026-08-10T19:02:38+08:00 daily https://www.pharmasources.com/industryinsights/hebei-huarun-pharmacy-co-ltd---exhibitor-321543.html 0.6 2026-08-13T20:25:27+08:00 daily https://www.pharmasources.com/industryinsights/t-fit-unique-insulation-tecnology--exhib-321544.html 0.6 2026-08-07T01:21:38+08:00 daily https://www.pharmasources.com/industryinsights/dockweiler-asia-co-ltd---exhibitor-webin-321545.html 0.6 2026-06-24T05:16:16+08:00 daily https://www.pharmasources.com/industryinsights/fette-compacting-china-coltd--exhibitor--321546.html 0.6 2026-06-21T14:16:39+08:00 daily https://www.pharmasources.com/industryinsights/beijing-sinagel--exhibitor-webinar-321547.html 0.6 2026-08-14T15:22:58+08:00 daily https://www.pharmasources.com/industryinsights/beijing-hanlin-hangyu-technology-develop-321548.html 0.6 2026-08-12T15:27:31+08:00 daily https://www.pharmasources.com/industryinsights/jiangsu-yanxin-environmental-science-tec-321549.html 0.6 2026-08-12T22:11:49+08:00 daily https://www.pharmasources.com/industryinsights/wenzhou-qili-fluid-equipment-coltd---exh-321550.html 0.6 2026-08-12T22:42:51+08:00 daily https://www.pharmasources.com/industryinsights/otc-healthcare-products-a-growth-area-fo-321551.html 0.6 2026-06-21T01:47:53+08:00 daily https://www.pharmasources.com/industryinsights/lupin-sun-pharma-recall-drugs-in-us-mark-321552.html 0.6 2026-06-20T21:06:50+08:00 daily https://www.pharmasources.com/industryinsights/healthcare-industry-reports-95-deals-wor-321553.html 0.6 2026-07-29T02:27:07+08:00 daily https://www.pharmasources.com/industryinsights/russia-to-register-covid-19-vaccine-on-a-321554.html 0.6 2026-06-21T00:49:37+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-signs-agreement-with-gilead-scien-321555.html 0.6 2026-06-22T09:02:43+08:00 daily https://www.pharmasources.com/industryinsights/swiss-parenterals-receives-eu-gmp-approv-321556.html 0.6 2026-06-21T04:05:48+08:00 daily https://www.pharmasources.com/industryinsights/aurobindo-pharma-joins-covid-19-vaccine--321557.html 0.6 2026-05-11T20:41:22+08:00 daily https://www.pharmasources.com/industryinsights/hangzhou-tanvi-filtering-equipment-coltd-321558.html 0.6 2026-08-09T01:55:02+08:00 daily https://www.pharmasources.com/industryinsights/licensing-agreement-deals-decline-in-rar-321559.html 0.6 2026-08-05T09:29:11+08:00 daily https://www.pharmasources.com/industryinsights/shenzhen-bona-pharma-technology-coltd--e-321560.html 0.6 2026-08-14T23:47:56+08:00 daily https://www.pharmasources.com/industryinsights/novateur-ventures-explores-new-strategy--321561.html 0.6 2026-08-09T01:26:34+08:00 daily https://www.pharmasources.com/industryinsights/hilleman-labs-is-developing-a-liquid-for-321562.html 0.6 2026-08-14T10:06:54+08:00 daily https://www.pharmasources.com/industryinsights/xian-global-printing-coltd--exhibitor-we-321563.html 0.6 2026-08-09T05:22:39+08:00 daily https://www.pharmasources.com/industryinsights/caprion-histogenex-and-viroclinics-ddl-a-321564.html 0.6 2026-08-09T03:10:07+08:00 daily https://www.pharmasources.com/industryinsights/dcgi-asks-drug-controllers-to-prevent-sa-321565.html 0.6 2026-08-09T02:32:06+08:00 daily https://www.pharmasources.com/industryinsights/uk-india-experts-drive-to-stop-antibioti-321566.html 0.6 2026-08-07T06:12:08+08:00 daily https://www.pharmasources.com/industryinsights/sichuan-hui-li-industry-co-ltd--exhibito-321567.html 0.6 2026-08-14T15:11:52+08:00 daily https://www.pharmasources.com/industryinsights/sii-gavi-and-bmgf-collaborate-for-covid--321568.html 0.6 2026-08-13T13:50:14+08:00 daily https://www.pharmasources.com/industryinsights/pharma-secretary-urges-closer-cooperatio-321569.html 0.6 2026-08-05T22:49:52+08:00 daily https://www.pharmasources.com/industryinsights/schott-pharmaceutical-systems---exhibito-321570.html 0.6 2026-08-06T15:21:24+08:00 daily https://www.pharmasources.com/industryinsights/acg-appoints-ceo-of-inspection-business-321571.html 0.6 2026-08-06T21:49:33+08:00 daily https://www.pharmasources.com/industryinsights/catalents-harmans-site-approved-to-manuf-321572.html 0.6 2026-07-28T23:29:42+08:00 daily https://www.pharmasources.com/industryinsights/avacta-partners-with-bbi-solutions-321573.html 0.6 2026-06-21T10:18:48+08:00 daily https://www.pharmasources.com/industryinsights/chengdu-jianzhuo-technology-limited-comp-321574.html 0.6 2026-07-28T21:16:38+08:00 daily https://www.pharmasources.com/industryinsights/avid-selected-to-lead-process-developmen-321575.html 0.6 2026-08-03T04:48:21+08:00 daily https://www.pharmasources.com/industryinsights/bormioli-pharma-spa--exhibitor-webinar-321576.html 0.6 2026-08-01T10:01:46+08:00 daily https://www.pharmasources.com/industryinsights/bloomage-biotechnology-corporation-limit-321577.html 0.6 2026-08-13T03:05:06+08:00 daily https://www.pharmasources.com/industryinsights/sharp-acquires-25-stake-in-berkshire-ste-321578.html 0.6 2026-02-06T07:32:57+08:00 daily https://www.pharmasources.com/industryinsights/medipal-holdings-partners-with-cryoport-321579.html 0.6 2026-07-01T03:14:51+08:00 daily https://www.pharmasources.com/industryinsights/zibo-ruiyue-packaging-material-co-ltd--e-321580.html 0.6 2026-06-20T20:15:15+08:00 daily https://www.pharmasources.com/industryinsights/biogen-and-denali-sign-parkinsons-drug-d-321581.html 0.6 2026-06-22T03:06:08+08:00 daily https://www.pharmasources.com/industryinsights/arshine-pharmaceutical-co-limited--exhib-321582.html 0.6 2026-08-15T00:05:52+08:00 daily https://www.pharmasources.com/industryinsights/ningbo-nuobai-pharmaceutical-co-ltd--exh-321583.html 0.6 2026-08-13T01:27:53+08:00 daily https://www.pharmasources.com/industryinsights/heron-shanghai-pharmaceutical-sci-tech-c-321584.html 0.6 2026-06-21T13:03:30+08:00 daily https://www.pharmasources.com/industryinsights/us-president-orders-government-to-buy-dr-321585.html 0.6 2026-06-22T05:45:33+08:00 daily https://www.pharmasources.com/industryinsights/beijing-canny-consulting-inc--exhibitor--321586.html 0.6 2026-08-14T22:11:45+08:00 daily https://www.pharmasources.com/industryinsights/european-commission-approves-novartis-xo-321587.html 0.6 2026-06-20T20:11:43+08:00 daily https://www.pharmasources.com/industryinsights/jiangsu-alpha-pharmaceutical-co-ltd---ex-321588.html 0.6 2026-08-14T08:47:21+08:00 daily https://www.pharmasources.com/industryinsights/prices-of-remdesivir-and-favipiravir-bei-321589.html 0.6 2026-08-06T00:35:21+08:00 daily https://www.pharmasources.com/industryinsights/gan-lee-pharmaceuticals--exhibitor-webin-321590.html 0.6 2026-07-31T01:04:32+08:00 daily https://www.pharmasources.com/industryinsights/chinese-peptide-company--exhibitor-webin-321591.html 0.6 2026-08-09T15:34:45+08:00 daily https://www.pharmasources.com/industryinsights/fda-authorizes-first-tests-that-estimate-321592.html 0.6 2026-08-01T11:14:17+08:00 daily https://www.pharmasources.com/industryinsights/xiamen-amoytop-biotech-co-ltd---exhibito-321593.html 0.6 2026-08-14T22:04:57+08:00 daily https://www.pharmasources.com/industryinsights/kadimastem-reports-positive-interim-resu-321594.html 0.6 2026-08-03T12:55:00+08:00 daily https://www.pharmasources.com/industryinsights/rlf-100-trial-shows-rapid-recovery-from--321595.html 0.6 2026-06-22T11:13:58+08:00 daily https://www.pharmasources.com/industryinsights/shenzhen-jymed-technology-coltd--exhibit-321596.html 0.6 2026-08-14T16:01:25+08:00 daily https://www.pharmasources.com/industryinsights/janssen-announces-approval-of-spravato-f-321597.html 0.6 2026-08-08T03:14:06+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-indication-for-drug-con-321598.html 0.6 2026-02-28T15:31:07+08:00 daily https://www.pharmasources.com/industryinsights/beijing-kawin-technology-share-holding-c-321599.html 0.6 2026-06-20T21:37:16+08:00 daily https://www.pharmasources.com/industryinsights/neutrolis-develops-treatment-targeting-n-321600.html 0.6 2026-08-09T13:05:27+08:00 daily https://www.pharmasources.com/industryinsights/valneva-appoints-chief-medical-officer-321601.html 0.6 2026-08-08T17:21:11+08:00 daily https://www.pharmasources.com/industryinsights/jilin-province-foen-biological-co-ltd----321602.html 0.6 2026-08-07T01:10:56+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-zehui-chemical-coltd---exhibitor-we-321603.html 0.6 2026-08-13T01:40:25+08:00 daily https://www.pharmasources.com/industryinsights/2020-zhejiang-export-commodity-online-fa-321604.html 0.6 2026-08-09T10:43:37+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-321605.html 0.6 2026-08-06T23:57:15+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-laboratories-launches-generic--321606.html 0.6 2026-08-06T20:00:06+08:00 daily https://www.pharmasources.com/industryinsights/iit-mandi-team-compares-disordered-prote-321607.html 0.6 2026-08-06T21:46:05+08:00 daily https://www.pharmasources.com/industryinsights/everest-organics-develops-remdesivir-api-321608.html 0.6 2026-08-07T03:23:25+08:00 daily https://www.pharmasources.com/industryinsights/vav-lipids-gets-written-confirmation-fro-321609.html 0.6 2026-08-06T23:55:11+08:00 daily https://www.pharmasources.com/industryinsights/cansino-to-commence-phase-iii-covid-19-v-321610.html 0.6 2026-08-07T00:03:03+08:00 daily https://www.pharmasources.com/industryinsights/corerx-fully-operational-in-new-product--321611.html 0.6 2026-08-09T20:05:58+08:00 daily https://www.pharmasources.com/industryinsights/novavax-and-serum-institute-of-india-ann-321612.html 0.6 2026-08-08T16:33:05+08:00 daily https://www.pharmasources.com/industryinsights/avacta-collaborates-with-liverpool-schoo-321613.html 0.6 2026-06-22T00:56:46+08:00 daily https://www.pharmasources.com/industryinsights/us-govt-selects-grand-river-aseptic-manu-321614.html 0.6 2026-08-04T19:44:36+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-vaccines-names-jian-dong-as-ceo-321615.html 0.6 2026-08-09T22:14:34+08:00 daily https://www.pharmasources.com/industryinsights/oncogenerix-alpha-capital-to-build-injec-321616.html 0.6 2026-08-13T23:53:21+08:00 daily https://www.pharmasources.com/industryinsights/caprion-histogenex-partners-with-virocli-321617.html 0.6 2026-08-01T02:25:07+08:00 daily https://www.pharmasources.com/industryinsights/gigagen-develops-new-class-of-drugs-to-t-321618.html 0.6 2026-06-22T10:34:29+08:00 daily https://www.pharmasources.com/industryinsights/genentech-secures-fda-approval-for-evrys-321619.html 0.6 2026-06-20T20:17:04+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-signs-multi-year-deal-to-manufact-321620.html 0.6 2026-08-08T02:33:40+08:00 daily https://www.pharmasources.com/industryinsights/novavax-partners-with-takeda-to-develop--321621.html 0.6 2026-07-18T03:43:08+08:00 daily https://www.pharmasources.com/industryinsights/orion-biotechnology-receives-funding-to--321622.html 0.6 2026-06-21T18:09:01+08:00 daily https://www.pharmasources.com/industryinsights/covid-rd-alliance-quantum-leap-healthcar-321623.html 0.6 2026-06-23T21:13:10+08:00 daily https://www.pharmasources.com/industryinsights/fortress-biotech-announces-ema-orphan-dr-321624.html 0.6 2026-06-20T19:08:40+08:00 daily https://www.pharmasources.com/industryinsights/neuroform-atlas-stent-system-granted-an--321625.html 0.6 2026-06-20T18:01:22+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-stelara-for-pediatric-patie-321626.html 0.6 2026-04-17T05:02:16+08:00 daily https://www.pharmasources.com/industryinsights/bio-techne-kantaro-biosciences-to-launch-321627.html 0.6 2026-06-20T14:56:13+08:00 daily https://www.pharmasources.com/industryinsights/roche-post-mixed-results-for-etrolizumab-321628.html 0.6 2026-08-13T15:01:35+08:00 daily https://www.pharmasources.com/industryinsights/opdivoyervoy-improves-survival-in-pleura-321629.html 0.6 2026-06-21T15:52:14+08:00 daily https://www.pharmasources.com/industryinsights/researchers-say-hydroxychloroquine-could-321630.html 0.6 2026-06-20T22:03:50+08:00 daily https://www.pharmasources.com/industryinsights/azs-fasenra-study-confirms-robust-effica-321631.html 0.6 2026-08-11T01:48:44+08:00 daily https://www.pharmasources.com/industryinsights/roche-gets-fda-nod-for-evrysdi-to-treat--321632.html 0.6 2026-03-21T12:20:56+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-astrazeneca-collaborate-t-321633.html 0.6 2026-08-10T15:02:46+08:00 daily https://www.pharmasources.com/industryinsights/viiv-healthcare-gets-fda-expanded-approv-321634.html 0.6 2026-06-21T18:56:40+08:00 daily https://www.pharmasources.com/industryinsights/lorbrena-significantly-improves-progress-321635.html 0.6 2026-08-09T21:06:43+08:00 daily https://www.pharmasources.com/industryinsights/pharmasources-launches-the-export-driven-321636.html 0.6 2026-07-27T05:15:26+08:00 daily https://www.pharmasources.com/industryinsights/orgenesis-to-collaborate-with-educell-to-321637.html 0.6 2026-06-21T03:09:54+08:00 daily https://www.pharmasources.com/industryinsights/success-of-indigenous-covid-19-vaccines--321638.html 0.6 2026-06-21T19:08:55+08:00 daily https://www.pharmasources.com/industryinsights/us-signs-15-bn-deal-with-moderna-for-100-321639.html 0.6 2026-05-29T10:56:51+08:00 daily https://www.pharmasources.com/industryinsights/daewoong-pharma-gets-cdsco-nod-to-test-a-321640.html 0.6 2026-06-24T18:35:10+08:00 daily https://www.pharmasources.com/industryinsights/lupin-launches-zileuton-extended-release-321641.html 0.6 2026-07-30T02:45:20+08:00 daily https://www.pharmasources.com/industryinsights/roche-gets-us-fda-approval-for-evrysdi-t-321642.html 0.6 2026-08-10T18:03:44+08:00 daily https://www.pharmasources.com/industryinsights/gilead-seeks-full-approval-for-remdesivi-321643.html 0.6 2026-06-21T06:15:02+08:00 daily https://www.pharmasources.com/industryinsights/tff-pharmaceuticals-secures-259-million-321644.html 0.6 2026-07-03T14:31:39+08:00 daily https://www.pharmasources.com/industryinsights/bayer-to-acquire-kandy-therapeutics-for--321645.html 0.6 2026-08-13T15:13:02+08:00 daily https://www.pharmasources.com/industryinsights/avacta-appoints-chief-development-office-321646.html 0.6 2026-07-01T09:19:15+08:00 daily https://www.pharmasources.com/industryinsights/agc-biologics-novavax-expand-coronavirus-321647.html 0.6 2026-03-10T08:11:46+08:00 daily https://www.pharmasources.com/industryinsights/financial-report-akorn-321648.html 0.6 2026-06-20T14:39:25+08:00 daily https://www.pharmasources.com/industryinsights/financial-report-abbvie-321649.html 0.6 2026-06-22T10:12:54+08:00 daily https://www.pharmasources.com/industryinsights/financial-report-lilly-321650.html 0.6 2026-08-05T19:25:10+08:00 daily https://www.pharmasources.com/industryinsights/mrna-vaccines-the-most-promising-among-e-321651.html 0.6 2026-06-21T08:20:23+08:00 daily https://www.pharmasources.com/industryinsights/ligand-pharmaceuticals-agrees-to-acquire-321652.html 0.6 2026-06-20T15:48:53+08:00 daily https://www.pharmasources.com/industryinsights/verastem-to-divest-copiktra-rights-to-se-321653.html 0.6 2026-06-21T19:43:38+08:00 daily https://www.pharmasources.com/industryinsights/fda-issues-emergency-use-authorization-t-321654.html 0.6 2026-06-23T06:12:06+08:00 daily https://www.pharmasources.com/industryinsights/pacira-biosciences-announces-fda-accepta-321655.html 0.6 2026-08-10T12:33:13+08:00 daily https://www.pharmasources.com/industryinsights/ptx-announces-contract-with-dod-for-leuk-321656.html 0.6 2026-06-21T11:16:58+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-accelerated-approval-to-tafas-321657.html 0.6 2026-06-23T08:46:32+08:00 daily https://www.pharmasources.com/industryinsights/elios-cancer-vaccine-demonstrates-long-t-321658.html 0.6 2026-06-22T03:32:15+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-inhaled-use-ind-for-rlf-100-f-321659.html 0.6 2026-06-21T07:02:59+08:00 daily https://www.pharmasources.com/industryinsights/randox-recalls-coronavirus-test-kits-aft-321660.html 0.6 2026-06-20T18:21:28+08:00 daily https://www.pharmasources.com/industryinsights/destiny-pharmas-novel-antibiotic-asset-c-321661.html 0.6 2026-06-20T17:14:39+08:00 daily https://www.pharmasources.com/industryinsights/eli-lilly-pieris-collaborate-on-her2-pos-321662.html 0.6 2026-06-21T20:54:42+08:00 daily https://www.pharmasources.com/industryinsights/activity-at-kodak-pharmaceuticals-regard-321663.html 0.6 2026-06-21T07:07:03+08:00 daily https://www.pharmasources.com/industryinsights/licensing-agreement-deals-decline-in-rar-321664.html 0.6 2026-08-05T09:29:13+08:00 daily https://www.pharmasources.com/industryinsights/intranasal-vaccine-made-from-peptide-nan-321665.html 0.6 2026-06-20T14:54:06+08:00 daily https://www.pharmasources.com/industryinsights/what-the-rest-of-the-world-can-learn-fro-321666.html 0.6 2026-06-21T00:41:33+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-lampit-for-the-treatment-321667.html 0.6 2026-06-21T21:41:53+08:00 daily https://www.pharmasources.com/industryinsights/takeda-to-license-novavax-covid-19-vacci-321668.html 0.6 2026-06-21T04:02:46+08:00 daily https://www.pharmasources.com/industryinsights/pharma-units-in-sikkim-affected-by-covid-321669.html 0.6 2026-06-26T21:13:30+08:00 daily https://www.pharmasources.com/industryinsights/stanford-study-reveals-immune-system-dev-321670.html 0.6 2026-07-04T02:32:40+08:00 daily https://www.pharmasources.com/industryinsights/remdesivir-shortage-is-india-is-easing-c-321671.html 0.6 2026-06-21T14:39:09+08:00 daily https://www.pharmasources.com/industryinsights/american-gene-technologies-gets-us-fda-n-321672.html 0.6 2026-06-27T07:33:32+08:00 daily https://www.pharmasources.com/industryinsights/mission-atma-nirbhar-in-pharma-321673.html 0.6 2026-06-20T14:19:19+08:00 daily https://www.pharmasources.com/industryinsights/advent-life-sciences-announces-sale-of-k-321674.html 0.6 2026-08-10T16:01:03+08:00 daily https://www.pharmasources.com/industryinsights/rx-360-expands-audit-program-321675.html 0.6 2026-08-07T14:49:08+08:00 daily https://www.pharmasources.com/industryinsights/financial-report-pfizer-321676.html 0.6 2026-06-23T00:51:18+08:00 daily https://www.pharmasources.com/industryinsights/beroni-signs-agreement-with-cdmo-genscri-321677.html 0.6 2026-06-28T21:23:25+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-expands-footprint-321678.html 0.6 2026-06-23T04:49:07+08:00 daily https://www.pharmasources.com/industryinsights/russia-approves-worlds-first-covid-19-va-321679.html 0.6 2026-06-22T12:52:41+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-blenrep-321680.html 0.6 2026-08-09T05:33:26+08:00 daily https://www.pharmasources.com/industryinsights/ptc-therapeutics-announces-fda-approval--321681.html 0.6 2026-08-08T21:35:06+08:00 daily https://www.pharmasources.com/industryinsights/enlivex-announces-first-patient-dosed-in-321682.html 0.6 2026-06-20T16:50:09+08:00 daily https://www.pharmasources.com/industryinsights/fda-revokes-eua-for-autobio-diagnostics--321683.html 0.6 2026-08-08T17:52:57+08:00 daily https://www.pharmasources.com/industryinsights/fda-posts-additional-postmarket-informat-321684.html 0.6 2026-08-07T14:15:11+08:00 daily https://www.pharmasources.com/industryinsights/precigen-actobio-announces-positive-topl-321685.html 0.6 2026-08-12T13:31:29+08:00 daily https://www.pharmasources.com/industryinsights/demand-for-mental-health-services-to-ris-321686.html 0.6 2026-08-07T12:30:50+08:00 daily https://www.pharmasources.com/industryinsights/bms-opdivo-improves-survival-in-gastric--321687.html 0.6 2026-08-07T12:11:22+08:00 daily https://www.pharmasources.com/industryinsights/two-phase-iii-trials-in-us-to-evaluate-e-321688.html 0.6 2026-08-07T11:43:13+08:00 daily https://www.pharmasources.com/industryinsights/scientists-identify-hundreds-of-drug-can-321689.html 0.6 2026-08-07T06:10:03+08:00 daily https://www.pharmasources.com/industryinsights/only-79-of-americans-considering-getting-321690.html 0.6 2026-06-21T13:09:21+08:00 daily https://www.pharmasources.com/industryinsights/fda-clears-appili-therapeutics-to-expand-321691.html 0.6 2026-08-06T23:55:57+08:00 daily https://www.pharmasources.com/industryinsights/omeros-reports-positive-results-for-nars-321692.html 0.6 2026-08-06T23:37:09+08:00 daily https://www.pharmasources.com/industryinsights/biological-e-signs-tech-transfer-pacts-w-321693.html 0.6 2026-08-06T23:37:03+08:00 daily https://www.pharmasources.com/industryinsights/scientists-leverage-ai-to-find-covid-19--321694.html 0.6 2026-08-13T08:38:18+08:00 daily https://www.pharmasources.com/industryinsights/novavax-announces-collaboration-with-sk--321695.html 0.6 2026-08-06T23:46:20+08:00 daily https://www.pharmasources.com/industryinsights/ajinomoto-bio-pharma-expands-small-molec-321696.html 0.6 2026-08-06T23:56:27+08:00 daily https://www.pharmasources.com/industryinsights/aleor-dermaceuticals-receives-usfda-tent-321697.html 0.6 2026-08-07T13:15:22+08:00 daily https://www.pharmasources.com/industryinsights/msn-laboratories-to-launch-favipiravir-a-321698.html 0.6 2026-08-12T09:57:35+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-viltepso-injection-for-t-321699.html 0.6 2026-08-11T03:45:20+08:00 daily https://www.pharmasources.com/industryinsights/lupin-board-appoints-kbs-anand-and-dr-pu-321700.html 0.6 2026-06-20T22:16:59+08:00 daily https://www.pharmasources.com/industryinsights/argentina-and-mexico-to-make-astrazeneca-321701.html 0.6 2026-06-21T20:05:44+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-launches-remdesivir-at-rs-2-321702.html 0.6 2026-06-21T02:53:41+08:00 daily https://www.pharmasources.com/industryinsights/sequent-scientific-to-sell-stake-in-stri-321703.html 0.6 2026-08-13T19:02:28+08:00 daily https://www.pharmasources.com/industryinsights/cpi-partners-with-perceptive-engineering-321704.html 0.6 2026-06-20T21:17:58+08:00 daily https://www.pharmasources.com/industryinsights/sab-receives-356-miliion-from-us-dod-321705.html 0.6 2026-07-17T08:29:24+08:00 daily https://www.pharmasources.com/industryinsights/genecentric-therapeutics-signs-research--321706.html 0.6 2026-07-21T09:25:21+08:00 daily https://www.pharmasources.com/industryinsights/celleron-licenses-cancer-drug-emactuzuma-321707.html 0.6 2026-08-11T04:00:59+08:00 daily https://www.pharmasources.com/industryinsights/brazils-parana-state-to-produce-russias--321708.html 0.6 2026-04-13T18:50:59+08:00 daily https://www.pharmasources.com/industryinsights/mhra-announces-recall-of-randox-covid-19-321709.html 0.6 2026-06-21T09:01:05+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccines-to-be-monitored-post-m-321710.html 0.6 2026-06-20T21:03:38+08:00 daily https://www.pharmasources.com/industryinsights/amydis-receives-grant-to-accelerate-deve-321711.html 0.6 2026-06-22T08:49:50+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-opioid-for-intravenous--321712.html 0.6 2026-07-12T15:30:09+08:00 daily https://www.pharmasources.com/industryinsights/clearside-biomedical-announces-fda-accep-321713.html 0.6 2026-07-01T20:14:59+08:00 daily https://www.pharmasources.com/industryinsights/helix-receives-eua-for-the-helix-covid-1-321714.html 0.6 2026-06-20T16:51:52+08:00 daily https://www.pharmasources.com/industryinsights/protalix-biotherapeutics-chiesi-global-a-321715.html 0.6 2026-06-21T11:08:16+08:00 daily https://www.pharmasources.com/industryinsights/seelos-receives-fda-may-proceed-notice-t-321716.html 0.6 2026-06-21T09:13:10+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-application-for-self-adminis-321717.html 0.6 2026-06-21T13:08:31+08:00 daily https://www.pharmasources.com/industryinsights/ana-therapeutics-partners-with-quotient--321718.html 0.6 2026-08-02T23:45:22+08:00 daily https://www.pharmasources.com/industryinsights/redhill-and-cosmo-pharmaceuticals-expand-321719.html 0.6 2026-08-05T03:58:06+08:00 daily https://www.pharmasources.com/industryinsights/f2g-raises-608m-to-support-late-stage-an-321720.html 0.6 2026-06-20T19:00:34+08:00 daily https://www.pharmasources.com/industryinsights/celleron-picks-up-discarded-cancer-drug--321721.html 0.6 2026-06-21T04:19:36+08:00 daily https://www.pharmasources.com/industryinsights/sab-begins-phase-1-trial-of-covid-19-the-321722.html 0.6 2026-06-20T21:16:56+08:00 daily https://www.pharmasources.com/industryinsights/preliminary-study-of-300-covid-19-patien-321723.html 0.6 2026-06-21T04:12:55+08:00 daily https://www.pharmasources.com/industryinsights/scientists-ascertain-73-novel-variants-o-321724.html 0.6 2026-07-09T03:52:20+08:00 daily https://www.pharmasources.com/industryinsights/nppa-issues-final-guidelines-to-disconti-321725.html 0.6 2026-06-20T15:54:21+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-enspryng-from-genentech--321726.html 0.6 2026-07-01T05:14:47+08:00 daily https://www.pharmasources.com/industryinsights/russia-begins-production-of-covid-19-vac-321727.html 0.6 2026-06-21T23:09:31+08:00 daily https://www.pharmasources.com/industryinsights/sai-life-sciences-opens-research-technol-321728.html 0.6 2026-06-21T12:05:15+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-disrupted-clinical-trials-with--321729.html 0.6 2026-08-03T16:09:05+08:00 daily https://www.pharmasources.com/industryinsights/government-funded-centre-for-biopharma-a-321730.html 0.6 2026-06-20T16:51:30+08:00 daily https://www.pharmasources.com/industryinsights/uk-signs-deals-with-jj-novavax-for-covid-321731.html 0.6 2026-06-21T10:05:09+08:00 daily https://www.pharmasources.com/industryinsights/lupin-presents-phase-3-data-for-solosec--321732.html 0.6 2026-06-20T21:54:00+08:00 daily https://www.pharmasources.com/industryinsights/atrimed-pharma-claims-breakthrough-in-mo-321733.html 0.6 2026-06-21T09:44:45+08:00 daily https://www.pharmasources.com/industryinsights/lee-pharma-to-launch-favipiravir-under-b-321734.html 0.6 2026-08-09T10:15:36+08:00 daily https://www.pharmasources.com/industryinsights/aurobindo-pharma-expects-phase-i-and-ii--321735.html 0.6 2026-06-21T10:49:01+08:00 daily https://www.pharmasources.com/industryinsights/nppa-sets-up-price-monitoring-and-resour-321736.html 0.6 2026-06-21T10:20:26+08:00 daily https://www.pharmasources.com/industryinsights/ipca-labs-is-setting-up-api-manufacturin-321737.html 0.6 2026-06-22T08:56:40+08:00 daily https://www.pharmasources.com/industryinsights/virus-uses-decoy-strategy-to-evade-immun-321738.html 0.6 2026-06-21T00:17:07+08:00 daily https://www.pharmasources.com/industryinsights/amazon-india-launches-online-pharmacy-se-321739.html 0.6 2026-06-21T01:08:54+08:00 daily https://www.pharmasources.com/industryinsights/phase-iii-trial-to-study-nt-300-as-covid-321740.html 0.6 2026-06-17T03:24:25+08:00 daily https://www.pharmasources.com/industryinsights/bayer-to-acquire-kandy-therapeutics-with-321741.html 0.6 2026-06-21T02:00:40+08:00 daily https://www.pharmasources.com/industryinsights/magventure-receives-fda-clearance-for-oc-321742.html 0.6 2026-06-21T11:12:16+08:00 daily https://www.pharmasources.com/industryinsights/vaccibody-nektar-announce-first-patient--321743.html 0.6 2026-06-21T10:01:08+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-evinacumab-bla-for-hofh-321744.html 0.6 2026-07-24T12:25:18+08:00 daily https://www.pharmasources.com/industryinsights/verrica-licenses-ltx-315-for-dermatologi-321745.html 0.6 2026-06-23T17:58:20+08:00 daily https://www.pharmasources.com/industryinsights/romark-initiates-trial-of-nt-300-for-cov-321746.html 0.6 2026-06-21T01:04:50+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-enrolls-first-patie-321747.html 0.6 2026-06-21T02:44:54+08:00 daily https://www.pharmasources.com/industryinsights/galapagos-signs-deal-with-scipher-for-ib-321748.html 0.6 2026-07-03T01:15:11+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-resumes-late-stage-haemophi-321749.html 0.6 2026-06-21T15:07:36+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-ships-first-doses-of-flu-vac-321750.html 0.6 2026-06-22T05:58:45+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-concludes-agreement-with-the-321751.html 0.6 2026-06-20T21:50:40+08:00 daily https://www.pharmasources.com/industryinsights/global-virus-network-reports-renowned-do-321752.html 0.6 2026-06-20T13:25:00+08:00 daily https://www.pharmasources.com/industryinsights/developments-and-critical-issues-of-covi-321753.html 0.6 2026-07-20T05:00:05+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-321754.html 0.6 2026-06-08T15:27:20+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-records-excellent-interim-321755.html 0.6 2026-07-20T00:01:59+08:00 daily https://www.pharmasources.com/industryinsights/india-in-talks-with-developer-of-russian-321756.html 0.6 2026-06-22T09:15:52+08:00 daily https://www.pharmasources.com/industryinsights/online-pharmacies-urge-government-to-not-321757.html 0.6 2026-06-22T11:50:45+08:00 daily https://www.pharmasources.com/industryinsights/fusion-health-care-launches-favipiravir--321758.html 0.6 2026-06-21T07:03:59+08:00 daily https://www.pharmasources.com/industryinsights/race-to-find-a-viable-vaccine-can-indian-321759.html 0.6 2026-06-21T17:06:25+08:00 daily https://www.pharmasources.com/industryinsights/pharma-industry-requests-government-to-d-321760.html 0.6 2026-06-21T06:56:53+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-appoints-dipankar-bhattacharjee-321761.html 0.6 2026-06-20T15:02:13+08:00 daily https://www.pharmasources.com/industryinsights/biological-e-acquires-akorn-india-321762.html 0.6 2026-06-26T18:46:14+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-to-acquire-principia-biopharma-321763.html 0.6 2026-08-08T00:50:05+08:00 daily https://www.pharmasources.com/industryinsights/indias-cmo-market-is-hotbed-for-global-p-321764.html 0.6 2026-08-04T02:51:30+08:00 daily https://www.pharmasources.com/industryinsights/cansino-gets-covid-19-vaccine-patent-fro-321765.html 0.6 2025-12-05T16:52:41+08:00 daily https://www.pharmasources.com/industryinsights/tff-pharmaceuticals-signs-worldwide-lice-321766.html 0.6 2026-06-21T07:06:02+08:00 daily https://www.pharmasources.com/industryinsights/uk-govt-buys-60-million-doses-of-novavax-321767.html 0.6 2026-06-21T22:05:43+08:00 daily https://www.pharmasources.com/industryinsights/memo-therapeutics-collaborates-with-nort-321768.html 0.6 2026-06-21T14:48:45+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-scientific-signs-cdx-agree-321769.html 0.6 2026-06-26T04:27:30+08:00 daily https://www.pharmasources.com/industryinsights/oses-covid-19-vaccine-shows-promise-in-p-321770.html 0.6 2026-06-20T19:55:38+08:00 daily https://www.pharmasources.com/industryinsights/roche-receives-fda-approval-for-enspryng-321771.html 0.6 2026-08-11T20:03:59+08:00 daily https://www.pharmasources.com/industryinsights/ec-and-uk-sign-agreements-for-covid-19-v-321772.html 0.6 2026-06-20T23:16:57+08:00 daily https://www.pharmasources.com/industryinsights/anixa-ontochem-announce-identification-o-321773.html 0.6 2026-06-21T03:16:57+08:00 daily https://www.pharmasources.com/industryinsights/kaiser-permanente-joins-late-stage-covid-321774.html 0.6 2025-11-30T00:46:23+08:00 daily https://www.pharmasources.com/industryinsights/hoth-therapeutic-submits-ethics-approval-321775.html 0.6 2026-06-21T04:59:48+08:00 daily https://www.pharmasources.com/industryinsights/micurx-commits-funding-for-development-o-321776.html 0.6 2026-06-21T21:58:40+08:00 daily https://www.pharmasources.com/industryinsights/kineta-receives-regulatory-approval-for--321777.html 0.6 2026-07-17T13:31:07+08:00 daily https://www.pharmasources.com/industryinsights/strata-oncology-mirati-announce-partners-321778.html 0.6 2026-06-23T08:00:01+08:00 daily https://www.pharmasources.com/industryinsights/study-confirms-link-between-saba-inhaler-321779.html 0.6 2026-06-25T05:20:45+08:00 daily https://www.pharmasources.com/industryinsights/doctors-express-concern-over-clearing-nh-321780.html 0.6 2026-06-22T11:50:46+08:00 daily https://www.pharmasources.com/industryinsights/nice-publishes-guidance-on-astellas-xosp-321781.html 0.6 2026-06-21T12:11:39+08:00 daily https://www.pharmasources.com/industryinsights/the-end-of-public-health-england-321782.html 0.6 2026-06-22T04:51:33+08:00 daily https://www.pharmasources.com/industryinsights/indian-cmo-market-hotbed-for-private-equ-321783.html 0.6 2026-08-07T03:13:08+08:00 daily https://www.pharmasources.com/industryinsights/severely-ill-covid-19-patients-treated-w-321784.html 0.6 2026-08-07T03:02:56+08:00 daily https://www.pharmasources.com/industryinsights/blade-therapeutics-updates-enrolment-pro-321785.html 0.6 2026-08-07T02:51:54+08:00 daily https://www.pharmasources.com/industryinsights/researchers-design-and-test-protein-that-321786.html 0.6 2026-08-07T02:41:16+08:00 daily https://www.pharmasources.com/industryinsights/ril-buys-majority-stake-in-netmeds-321787.html 0.6 2026-08-09T07:37:32+08:00 daily https://www.pharmasources.com/industryinsights/ai-accelerates-drug-repurposing-to-find--321788.html 0.6 2026-08-02T07:57:36+08:00 daily https://www.pharmasources.com/industryinsights/brazil-regulator-gives-approval-for-huma-321789.html 0.6 2026-06-20T15:46:22+08:00 daily https://www.pharmasources.com/industryinsights/dc-act-1940-should-be-reframed-pharma-st-321790.html 0.6 2026-06-21T14:57:23+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-scientific-continues-to-ex-321791.html 0.6 2026-07-18T02:58:32+08:00 daily https://www.pharmasources.com/industryinsights/pakistan-to-conduct-phase-iii-clinical-t-321792.html 0.6 2026-02-28T23:42:05+08:00 daily https://www.pharmasources.com/industryinsights/care-consortium-launched-to-fast-track-d-321793.html 0.6 2026-06-20T21:01:34+08:00 daily https://www.pharmasources.com/industryinsights/abzena-appoints-senior-director-of-manuf-321794.html 0.6 2026-08-07T12:46:09+08:00 daily https://www.pharmasources.com/industryinsights/swiss-american-cdmo-appears-in-2020-inc--321795.html 0.6 2026-08-09T02:29:50+08:00 daily https://www.pharmasources.com/industryinsights/cobra-produces-master-cell-banks-for-com-321796.html 0.6 2026-08-06T05:56:25+08:00 daily https://www.pharmasources.com/industryinsights/bushu-pharmaceuticals-unveils-major-expa-321797.html 0.6 2026-06-21T19:01:41+08:00 daily https://www.pharmasources.com/industryinsights/evotec-and-novo-nordisk-form-strategic-a-321798.html 0.6 2026-06-22T03:43:47+08:00 daily https://www.pharmasources.com/industryinsights/therapure-signs-manufacturing-deal-with--321799.html 0.6 2026-06-21T05:10:51+08:00 daily https://www.pharmasources.com/industryinsights/liveo-research-expands-pharma-packaging--321800.html 0.6 2026-06-20T21:05:58+08:00 daily https://www.pharmasources.com/industryinsights/cdmo-sai-life-sciences-opens-new-facilit-321801.html 0.6 2026-06-20T18:13:50+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-concludes-agreement-with-ec--321802.html 0.6 2026-08-12T14:16:33+08:00 daily https://www.pharmasources.com/industryinsights/moderna-announces-covid-19-vaccine-suppl-321803.html 0.6 2026-08-14T06:58:14+08:00 daily https://www.pharmasources.com/industryinsights/metastatic-cervical-cancer-treatment-gra-321804.html 0.6 2026-03-21T13:10:40+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-initiation-of-igcs-cannabin-321805.html 0.6 2026-08-09T03:45:31+08:00 daily https://www.pharmasources.com/industryinsights/ligand-to-acquire-pfenex-321806.html 0.6 2026-08-02T20:37:35+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-who-emergency-committee-highlig-321807.html 0.6 2026-08-09T03:46:00+08:00 daily https://www.pharmasources.com/industryinsights/bms-signs-475m-licensing-deal-with-drago-321808.html 0.6 2026-06-20T19:05:39+08:00 daily https://www.pharmasources.com/industryinsights/gilead-and-tango-therapeutics-partner-fo-321809.html 0.6 2026-06-21T02:45:32+08:00 daily https://www.pharmasources.com/industryinsights/researchers-find-three-drugs-on-market-t-321810.html 0.6 2026-06-21T15:55:16+08:00 daily https://www.pharmasources.com/industryinsights/verona-progresses-phii-trial-of-copd-inh-321811.html 0.6 2026-03-29T15:07:40+08:00 daily https://www.pharmasources.com/industryinsights/priority-review-for-imfinzis-less-freque-321812.html 0.6 2026-06-22T00:02:46+08:00 daily https://www.pharmasources.com/industryinsights/gov-announces-expansion-of-uks-ons-covid-321813.html 0.6 2026-07-29T15:14:05+08:00 daily https://www.pharmasources.com/industryinsights/hancock-confirms-replacement-of-public-h-321814.html 0.6 2026-02-09T12:50:41+08:00 daily https://www.pharmasources.com/industryinsights/first-hbv-patient-dosed-in-phase-iia-cli-321815.html 0.6 2026-06-23T10:12:49+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-enzychems-ind-for-trial-of-c-321816.html 0.6 2026-06-20T14:43:08+08:00 daily https://www.pharmasources.com/industryinsights/accelerate-diagnostics-announces-fda-eme-321817.html 0.6 2026-07-18T16:45:33+08:00 daily https://www.pharmasources.com/industryinsights/national-safety-council-covid-19-on-pace-321818.html 0.6 2026-06-20T19:46:38+08:00 daily https://www.pharmasources.com/industryinsights/kimera-labs-files-first-fda-investigatio-321819.html 0.6 2026-07-23T04:28:12+08:00 daily https://www.pharmasources.com/industryinsights/mylan-announces-launch-of-generic-versio-321820.html 0.6 2026-01-20T02:59:00+08:00 daily https://www.pharmasources.com/industryinsights/nppa-rejects-ipa-request-for-upward-pric-321821.html 0.6 2026-06-20T19:02:32+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-gets-dcgi-nod-to-import-and--321822.html 0.6 2026-06-20T13:20:44+08:00 daily https://www.pharmasources.com/industryinsights/zim-labs-in-exclusive-licensing-agreemen-321823.html 0.6 2026-06-22T12:55:09+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-laboratories-launches-avigan-f-321824.html 0.6 2026-06-20T19:45:51+08:00 daily https://www.pharmasources.com/industryinsights/uk-mhra-inspection-of-strides-facility-a-321825.html 0.6 2026-06-20T21:58:37+08:00 daily https://www.pharmasources.com/industryinsights/aiia-and-nisarga-herbs-to-conduct-clinic-321826.html 0.6 2026-06-20T23:57:36+08:00 daily https://www.pharmasources.com/industryinsights/production-applications-of-chinese-new-d-321827.html 0.6 2026-06-26T22:39:54+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-publishes-compliance-policy-for-q-321828.html 0.6 2026-07-09T06:19:21+08:00 daily https://www.pharmasources.com/industryinsights/a-comparison-of-top-ten-best-selling-onc-321829.html 0.6 2026-08-09T09:38:45+08:00 daily https://www.pharmasources.com/industryinsights/who-cautions-against-to-vaccine-national-321830.html 0.6 2026-06-21T01:45:43+08:00 daily https://www.pharmasources.com/industryinsights/emergency-authorisation-for-covid-19-vac-321831.html 0.6 2026-06-21T08:56:57+08:00 daily https://www.pharmasources.com/industryinsights/this-japanese-enterprise-refused-the-ins-321832.html 0.6 2026-08-10T15:14:45+08:00 daily https://www.pharmasources.com/industryinsights/merck-to-establish-13bn-research-hub-in--321833.html 0.6 2026-06-21T05:04:48+08:00 daily https://www.pharmasources.com/industryinsights/australia-signs-deal-for-astrazenecas-co-321834.html 0.6 2026-06-22T02:55:42+08:00 daily https://www.pharmasources.com/industryinsights/eli-lilly-expands-tyvyt-collaboration-wi-321835.html 0.6 2026-06-22T05:01:39+08:00 daily https://www.pharmasources.com/industryinsights/ingenza-achieves-covid-19-vax-milestone-321836.html 0.6 2026-06-21T23:56:06+08:00 daily https://www.pharmasources.com/industryinsights/roche-regeneron-partner-to-increase-glob-321837.html 0.6 2026-06-22T02:14:00+08:00 daily https://www.pharmasources.com/industryinsights/biosymetrics-janssen-enter-ai-prediction-321838.html 0.6 2026-07-16T00:16:29+08:00 daily https://www.pharmasources.com/industryinsights/dietary-supplement-clinical-trials-321839.html 0.6 2026-08-11T07:50:40+08:00 daily https://www.pharmasources.com/industryinsights/fda-issues-eua-to-yale-school-of-public--321840.html 0.6 2026-06-22T06:51:42+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-to-acquire-momenta-321841.html 0.6 2026-07-24T06:33:18+08:00 daily https://www.pharmasources.com/industryinsights/neuroptika-completes-enrollment-of-phase-321842.html 0.6 2026-06-22T04:58:38+08:00 daily https://www.pharmasources.com/industryinsights/agilent-to-invest-150m-for-expansion-of--321843.html 0.6 2026-06-22T11:51:59+08:00 daily https://www.pharmasources.com/industryinsights/gni-group-announces-positive-results-fro-321844.html 0.6 2026-07-23T09:32:48+08:00 daily https://www.pharmasources.com/industryinsights/bold-100-significantly-outperforms-remde-321845.html 0.6 2026-06-21T15:45:12+08:00 daily https://www.pharmasources.com/industryinsights/observational-study-identifies-drug-that-321846.html 0.6 2026-06-22T12:55:09+08:00 daily https://www.pharmasources.com/industryinsights/cuny-med-school-technovax-report-covid-1-321847.html 0.6 2026-07-19T09:57:01+08:00 daily https://www.pharmasources.com/industryinsights/hackensack-meridian-health-observational-321848.html 0.6 2026-06-20T14:57:09+08:00 daily https://www.pharmasources.com/industryinsights/hoth-therapeutics-provides-shareholder-u-321849.html 0.6 2026-07-18T15:54:36+08:00 daily https://www.pharmasources.com/industryinsights/vybe-urgent-care-offers-rapid-covid-19-t-321850.html 0.6 2026-06-22T03:48:46+08:00 daily https://www.pharmasources.com/industryinsights/ampio-provides-update-on-covid-19-clinic-321851.html 0.6 2026-06-21T07:11:14+08:00 daily https://www.pharmasources.com/industryinsights/tradipitant-may-accelerate-recovery-from-321852.html 0.6 2026-03-22T08:23:07+08:00 daily https://www.pharmasources.com/industryinsights/ema-accepts-marketing-application-for-sp-321853.html 0.6 2026-06-20T17:11:02+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-declines-approval-for-gileads-rhe-321854.html 0.6 2026-06-21T15:00:23+08:00 daily https://www.pharmasources.com/industryinsights/researchers-develop-technology-to-see-in-321855.html 0.6 2025-11-29T23:18:34+08:00 daily https://www.pharmasources.com/industryinsights/fda-publishes-revised-mapp-consolidation-321856.html 0.6 2026-06-21T03:56:48+08:00 daily https://www.pharmasources.com/industryinsights/eu-curevac-may-sign-deal-for-225-million-321857.html 0.6 2026-06-20T22:15:58+08:00 daily https://www.pharmasources.com/industryinsights/brinton-pharma-gets-dcgi-nod-for-faviton-321858.html 0.6 2026-06-21T02:05:45+08:00 daily https://www.pharmasources.com/industryinsights/jan-aushadhi-stores-selling-branded-gene-321859.html 0.6 2026-06-21T05:12:58+08:00 daily https://www.pharmasources.com/industryinsights/stempeutics-allogeneic-cell-therapy-gets-321860.html 0.6 2026-06-29T12:34:02+08:00 daily https://www.pharmasources.com/industryinsights/cde-issues-document-to-promote-the-launc-321861.html 0.6 2026-08-04T07:57:41+08:00 daily https://www.pharmasources.com/industryinsights/fda-publishes-temporary-guidance-on-manu-321862.html 0.6 2026-06-20T20:13:52+08:00 daily https://www.pharmasources.com/industryinsights/tetra-bio-pharma-and-dalton-pharma-enter-321863.html 0.6 2026-06-21T10:14:17+08:00 daily https://www.pharmasources.com/industryinsights/oragenics-partners-with-avid-bioservices-321864.html 0.6 2026-06-21T14:42:12+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-diosynth-biotechnologies-breaks-321865.html 0.6 2026-06-21T05:00:42+08:00 daily https://www.pharmasources.com/industryinsights/janone-readies-for-clinical-gmp-manufact-321866.html 0.6 2026-06-21T23:58:44+08:00 daily https://www.pharmasources.com/industryinsights/curevac-and-eu-discuss-advanced-purchase-321867.html 0.6 2026-06-22T01:02:51+08:00 daily https://www.pharmasources.com/industryinsights/agc-biologics-enters-cdmo-partnership-wi-321868.html 0.6 2026-06-21T03:11:50+08:00 daily https://www.pharmasources.com/industryinsights/concerns-over-the-spread-of-covid-19-dec-321869.html 0.6 2026-06-21T09:06:09+08:00 daily https://www.pharmasources.com/industryinsights/roche-teams-up-with-regeneron-on-covid-1-321870.html 0.6 2026-08-10T18:03:40+08:00 daily https://www.pharmasources.com/industryinsights/elicios-lymph-node-targeting-candidate-j-321871.html 0.6 2025-11-29T23:00:50+08:00 daily https://www.pharmasources.com/industryinsights/biomarin-receives-crl-for-valoctocogene--321872.html 0.6 2026-06-21T01:13:59+08:00 daily https://www.pharmasources.com/industryinsights/cannformatics-receives-pilot-study-appro-321873.html 0.6 2026-06-22T11:49:41+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-snda-for-tyvaso-from-united--321874.html 0.6 2026-06-22T07:01:48+08:00 daily https://www.pharmasources.com/industryinsights/imfinzi-granted-fda-priority-review-for--321875.html 0.6 2026-08-02T14:37:24+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-treatment-for-rare-disease--321876.html 0.6 2026-06-20T14:43:13+08:00 daily https://www.pharmasources.com/industryinsights/single-radiotherapy-shot-proves-effectiv-321877.html 0.6 2026-07-13T13:53:02+08:00 daily https://www.pharmasources.com/industryinsights/survey-reveals-britains-welcome-shift-to-321878.html 0.6 2026-07-12T14:10:56+08:00 daily https://www.pharmasources.com/industryinsights/cmos-urge-trusts-to-continue-recruiting--321879.html 0.6 2026-07-01T20:43:07+08:00 daily https://www.pharmasources.com/industryinsights/skin-cancer-deaths-rocket-70-since-the-1-321880.html 0.6 2026-06-27T12:30:57+08:00 daily https://www.pharmasources.com/industryinsights/first-trial-participant-gets-gsks-5-in-1-321881.html 0.6 2026-06-22T10:56:14+08:00 daily https://www.pharmasources.com/industryinsights/us-expand-use-of-janssens-darzalex-321882.html 0.6 2026-06-21T11:14:35+08:00 daily https://www.pharmasources.com/industryinsights/fda-releases-guidance-on-bioavailability-321883.html 0.6 2026-07-17T08:59:56+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-to-acquire-principa-biopharma-for-321884.html 0.6 2026-06-21T12:14:40+08:00 daily https://www.pharmasources.com/industryinsights/arupu-of-u-health-study-finds-self-colle-321885.html 0.6 2026-07-03T13:25:58+08:00 daily https://www.pharmasources.com/industryinsights/kroger-health-announces-covid-19-testing-321886.html 0.6 2026-06-26T13:47:06+08:00 daily https://www.pharmasources.com/industryinsights/co-diagnostics-inc-receives-enhanced-us--321887.html 0.6 2026-07-08T12:11:31+08:00 daily https://www.pharmasources.com/industryinsights/byondis-announces-appointment-of-chief-f-321888.html 0.6 2026-08-08T01:15:22+08:00 daily https://www.pharmasources.com/industryinsights/byondis-initiates-phase-i-study-of-antib-321889.html 0.6 2026-06-08T17:08:33+08:00 daily https://www.pharmasources.com/industryinsights/dutch-saillant-therapeutics-to-develop-g-321890.html 0.6 2026-06-22T07:58:48+08:00 daily https://www.pharmasources.com/industryinsights/a-strong-signal-in-turbulent-times-vette-321891.html 0.6 2026-06-21T09:29:02+08:00 daily https://www.pharmasources.com/industryinsights/intravacc-and-celonic-to-develop-and-pro-321892.html 0.6 2026-06-20T20:01:36+08:00 daily https://www.pharmasources.com/industryinsights/anteotech-develops-high-sensitivity-15-m-321893.html 0.6 2026-06-20T21:16:01+08:00 daily https://www.pharmasources.com/industryinsights/malaysia-detects-10x-infectious-coronavi-321894.html 0.6 2026-08-09T17:54:11+08:00 daily https://www.pharmasources.com/industryinsights/kt-corp-develops-ai-based-covid-19-resea-321895.html 0.6 2026-08-07T02:05:16+08:00 daily https://www.pharmasources.com/industryinsights/singapore-designs-ai-system-to-hand-gest-321896.html 0.6 2026-08-07T01:52:55+08:00 daily https://www.pharmasources.com/industryinsights/preparedness-of-pharma-supply-chains-to--321897.html 0.6 2026-08-07T01:45:43+08:00 daily https://www.pharmasources.com/industryinsights/achiko-extends-covid-19-ecosystem-platfo-321898.html 0.6 2026-08-07T01:42:40+08:00 daily https://www.pharmasources.com/industryinsights/aroas-endoform-gains-validation-to-recru-321899.html 0.6 2026-08-07T01:27:48+08:00 daily https://www.pharmasources.com/industryinsights/mindray-sets-new-standard-for-infusion-s-321900.html 0.6 2026-08-07T01:20:02+08:00 daily https://www.pharmasources.com/industryinsights/nymu-in-taiwan-china-region-of-china-col-321901.html 0.6 2026-08-07T00:59:05+08:00 daily https://www.pharmasources.com/industryinsights/over-617700-covid-19-test-samples-collec-321902.html 0.6 2026-08-07T00:41:42+08:00 daily https://www.pharmasources.com/industryinsights/guideline-cites-incubation-period-of-vir-321903.html 0.6 2026-08-06T23:55:58+08:00 daily https://www.pharmasources.com/industryinsights/xi-extends-greetings-to-countrys-medical-321904.html 0.6 2026-08-06T23:49:04+08:00 daily https://www.pharmasources.com/industryinsights/china-gives-emergency-authorisation-for--321905.html 0.6 2026-08-06T23:48:23+08:00 daily https://www.pharmasources.com/industryinsights/panacea-biotec-terminates-mou-with-refan-321906.html 0.6 2026-08-06T23:55:39+08:00 daily https://www.pharmasources.com/industryinsights/granules-pharma-receives-us-fda-approval-321907.html 0.6 2026-08-07T00:41:06+08:00 daily https://www.pharmasources.com/industryinsights/icmr-developing-portal-for-info-on-covid-321908.html 0.6 2026-08-07T01:14:43+08:00 daily https://www.pharmasources.com/industryinsights/bharat-biotech-gets-green-signal-from-cd-321909.html 0.6 2026-08-10T01:18:00+08:00 daily https://www.pharmasources.com/industryinsights/remdesivir-has-only-marginal-benefit-for-321910.html 0.6 2026-06-21T07:13:05+08:00 daily https://www.pharmasources.com/industryinsights/us-pharma-firm-advanced-penetration-tech-321911.html 0.6 2026-06-21T04:11:51+08:00 daily https://www.pharmasources.com/industryinsights/roll-out-plan-of-sputnik-v-prompts-worri-321912.html 0.6 2026-06-21T01:57:36+08:00 daily https://www.pharmasources.com/industryinsights/40-per-cent-participants-enrolled-for-co-321913.html 0.6 2025-11-29T22:14:29+08:00 daily https://www.pharmasources.com/industryinsights/lupin-recalls-around-561-lakh-pouches-of-321914.html 0.6 2026-06-23T02:11:21+08:00 daily https://www.pharmasources.com/industryinsights/nppa-fixes-retail-prices-of-30-formulati-321915.html 0.6 2026-08-07T19:24:25+08:00 daily https://www.pharmasources.com/industryinsights/research-links-covid-19-to-rise-in-child-321916.html 0.6 2026-01-30T00:48:44+08:00 daily https://www.pharmasources.com/industryinsights/the-cde-issuing-documents-to-promote-the-321917.html 0.6 2026-06-21T04:50:39+08:00 daily https://www.pharmasources.com/industryinsights/inst-mohali-develops-oral-nano-medicines-321918.html 0.6 2026-06-21T14:48:16+08:00 daily https://www.pharmasources.com/industryinsights/strides-gets-usfda-approval-for-ursodiol-321919.html 0.6 2026-08-12T13:38:07+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-novartis-kesimpta-ofatum-321920.html 0.6 2026-06-21T10:00:08+08:00 daily https://www.pharmasources.com/industryinsights/cryoport-to-acquire-cryopdp-321921.html 0.6 2026-06-21T10:04:09+08:00 daily https://www.pharmasources.com/industryinsights/kyprolis-darzalex-combo-approved-for-mul-321922.html 0.6 2026-06-20T16:00:21+08:00 daily https://www.pharmasources.com/industryinsights/fresenius-kabi-introduces-rfid-smart-lab-321923.html 0.6 2026-06-20T23:47:38+08:00 daily https://www.pharmasources.com/industryinsights/a-smarter-pharma-industry-the-key-to-add-321924.html 0.6 2026-08-08T17:38:36+08:00 daily https://www.pharmasources.com/industryinsights/pharma-business-benefits-from-the-shift--321925.html 0.6 2026-08-04T06:41:23+08:00 daily https://www.pharmasources.com/industryinsights/sorrento-to-merge-with-gene-encoded-ther-321926.html 0.6 2026-06-23T02:53:53+08:00 daily https://www.pharmasources.com/industryinsights/curevac-concludes-talks-with-ec-for-covi-321927.html 0.6 2026-06-20T15:05:18+08:00 daily https://www.pharmasources.com/industryinsights/sca-issues-recall-of-heparin-sodium-comp-321928.html 0.6 2026-06-21T04:20:02+08:00 daily https://www.pharmasources.com/industryinsights/preclinical-study-finds-nafamostat-block-321929.html 0.6 2026-06-20T16:49:28+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-label-changes-to-hydrochlor-321930.html 0.6 2026-06-21T09:08:10+08:00 daily https://www.pharmasources.com/industryinsights/zymo-research-granted-ce-ivd-mark-for-qu-321931.html 0.6 2026-06-21T03:06:43+08:00 daily https://www.pharmasources.com/industryinsights/bayshore-issues-voluntary-nationwide-rec-321932.html 0.6 2026-04-23T00:22:17+08:00 daily https://www.pharmasources.com/industryinsights/trials-underway-to-study-covid-19-impact-321933.html 0.6 2026-06-20T20:43:32+08:00 daily https://www.pharmasources.com/industryinsights/intraoperative-radiotherapy-as-effective-321934.html 0.6 2026-06-21T04:14:54+08:00 daily https://www.pharmasources.com/industryinsights/fda-issues-emergency-use-authorization-f-321935.html 0.6 2026-04-20T01:35:33+08:00 daily https://www.pharmasources.com/industryinsights/eu-nod-for-vertex-cf-therapy-kaftrio-321936.html 0.6 2026-08-10T12:18:22+08:00 daily https://www.pharmasources.com/industryinsights/novartis-melanoma-combo-fails-in-phiii-321937.html 0.6 2026-06-21T15:59:26+08:00 daily https://www.pharmasources.com/industryinsights/az-partners-with-renalytixai-in-chronic--321938.html 0.6 2026-06-20T20:38:14+08:00 daily https://www.pharmasources.com/industryinsights/gov-unveils-fund-for-follow-on-care-321939.html 0.6 2026-06-22T00:45:34+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-321940.html 0.6 2026-06-20T22:53:58+08:00 daily https://www.pharmasources.com/industryinsights/novavax-commences-phase-2-clinical-trial-321942.html 0.6 2026-08-03T04:37:29+08:00 daily https://www.pharmasources.com/industryinsights/common-osteoporosis-drugs-can-increase-r-321943.html 0.6 2026-06-20T15:51:39+08:00 daily https://www.pharmasources.com/industryinsights/fda-issues-eua-to-convalescent-plasma-fo-321944.html 0.6 2026-07-08T11:28:40+08:00 daily https://www.pharmasources.com/industryinsights/shilpa-medicare-forays-into-the-otc-segm-321945.html 0.6 2026-06-21T03:56:07+08:00 daily https://www.pharmasources.com/industryinsights/uspto-grants-patent-to-tiziana-for-fully-321946.html 0.6 2026-06-21T02:00:40+08:00 daily https://www.pharmasources.com/industryinsights/jubilant-life-sciences-to-focus-on-opera-321947.html 0.6 2026-06-20T23:06:45+08:00 daily https://www.pharmasources.com/industryinsights/eurofins-expands-chemistry-capacity-321948.html 0.6 2026-06-20T20:01:34+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-romark-facility-in-puerto-r-321949.html 0.6 2026-08-09T18:58:33+08:00 daily https://www.pharmasources.com/industryinsights/catalent-and-astrazeneca-enter-vaccine-m-321950.html 0.6 2026-08-09T07:59:33+08:00 daily https://www.pharmasources.com/industryinsights/fordoz-lupin-enter-injectables-partnersh-321951.html 0.6 2026-07-30T01:30:35+08:00 daily https://www.pharmasources.com/industryinsights/ec-approves-vertexs-kaftrio-plus-ivacaft-321952.html 0.6 2026-08-10T14:46:27+08:00 daily https://www.pharmasources.com/industryinsights/takeda-to-sell-consumer-healthcare-unit--321953.html 0.6 2026-06-22T07:08:54+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-lampit-for-chagas-disease-i-321954.html 0.6 2026-06-20T19:18:55+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccine-candidate-enters-phase--321955.html 0.6 2026-08-07T22:44:23+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-kyprolis-darzalex-combi-321956.html 0.6 2026-07-02T12:30:29+08:00 daily https://www.pharmasources.com/industryinsights/bayshore-voluntarily-recalls-extended-re-321957.html 0.6 2026-07-03T21:05:26+08:00 daily https://www.pharmasources.com/industryinsights/acelrx-announces-an-investigator-initiat-321958.html 0.6 2025-11-29T21:25:48+08:00 daily https://www.pharmasources.com/industryinsights/india-gives-nod-to-cell-therapy-for-crit-321959.html 0.6 2026-08-13T10:13:24+08:00 daily https://www.pharmasources.com/industryinsights/frontida-biopharma-completes-facility-ex-321960.html 0.6 2026-07-01T03:51:26+08:00 daily https://www.pharmasources.com/industryinsights/abcellera-acquires-orthomab-bispecific-p-321961.html 0.6 2026-06-22T09:13:05+08:00 daily https://www.pharmasources.com/industryinsights/biolinerx-achieves-enrolment-target-in-p-321962.html 0.6 2026-06-23T04:04:07+08:00 daily https://www.pharmasources.com/industryinsights/medicure-announces-aggrastat-shows-promi-321963.html 0.6 2026-08-09T06:19:50+08:00 daily https://www.pharmasources.com/industryinsights/bayer-and-informed-data-systems-inc-one--321964.html 0.6 2026-08-09T03:44:58+08:00 daily https://www.pharmasources.com/industryinsights/nasal-vaccine-against-covid-19-prevents--321965.html 0.6 2026-08-09T02:39:13+08:00 daily https://www.pharmasources.com/industryinsights/beckman-coulter-launches-sars-cov-2-igm--321966.html 0.6 2026-08-09T00:17:14+08:00 daily https://www.pharmasources.com/industryinsights/industry-urges-dop-to-expedite-implement-321967.html 0.6 2026-08-08T22:01:06+08:00 daily https://www.pharmasources.com/industryinsights/dusa-to-pay-2075-mn-to-resolve-allegatio-321968.html 0.6 2026-08-07T13:15:40+08:00 daily https://www.pharmasources.com/industryinsights/pharmasourcescom-to-help-propel-the-chin-321969.html 0.6 2026-08-07T02:09:48+08:00 daily https://www.pharmasources.com/industryinsights/govt-may-consider-amendments-in-pli-sche-321970.html 0.6 2026-08-07T02:22:01+08:00 daily https://www.pharmasources.com/industryinsights/amneal-gets-us-fda-approval-for-lidocain-321971.html 0.6 2026-08-07T02:24:59+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-to-acquire-forbius-321972.html 0.6 2026-06-21T23:55:44+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-denies-approval-for-tricidas-veve-321973.html 0.6 2026-08-07T02:33:30+08:00 daily https://www.pharmasources.com/industryinsights/fdc-launches-two-favipiravir-variants-fo-321974.html 0.6 2026-08-07T02:51:56+08:00 daily https://www.pharmasources.com/industryinsights/pharma-psu-bengal-chemicals-produces-519-321975.html 0.6 2026-08-07T03:02:34+08:00 daily https://www.pharmasources.com/industryinsights/govt-may-set-up-mission-covid-suraksha-w-321976.html 0.6 2026-08-07T03:24:58+08:00 daily https://www.pharmasources.com/industryinsights/lupin-gets-us-fda-approval-for-generic-a-321977.html 0.6 2026-08-07T03:55:06+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-covid-19-vaccine-data-may-f-321978.html 0.6 2026-08-07T04:30:56+08:00 daily https://www.pharmasources.com/industryinsights/top-pharma-biopharma-quarterly-results-321979.html 0.6 2026-08-07T04:52:50+08:00 daily https://www.pharmasources.com/industryinsights/maravai-lifesciences-expands-cdmo-capabi-321980.html 0.6 2026-08-07T05:01:19+08:00 daily https://www.pharmasources.com/industryinsights/cryoport-to-acquire-mve-biological-solut-321981.html 0.6 2026-06-22T05:50:41+08:00 daily https://www.pharmasources.com/industryinsights/sutro-biopharma-achieves-merck-kgaa-clin-321982.html 0.6 2026-08-10T19:00:29+08:00 daily https://www.pharmasources.com/industryinsights/translate-bio-sanofi-covid-19-vaccine-el-321983.html 0.6 2026-06-21T03:14:52+08:00 daily https://www.pharmasources.com/industryinsights/kohlberg-and-mubadala-to-buy-controlling-321984.html 0.6 2026-08-09T22:21:00+08:00 daily https://www.pharmasources.com/industryinsights/innovations-brilacidin-shows-promise-in--321985.html 0.6 2026-06-21T04:12:54+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-submits-regulatory-application-to-321986.html 0.6 2026-06-20T14:44:17+08:00 daily https://www.pharmasources.com/industryinsights/regenxbio-announces-fda-clearance-of-ind-321987.html 0.6 2026-06-20T15:59:18+08:00 daily https://www.pharmasources.com/industryinsights/fda-provides-update-on-pooled-sample-tes-321988.html 0.6 2026-08-11T05:53:00+08:00 daily https://www.pharmasources.com/industryinsights/metacrine-announces-met409-receives-fda--321989.html 0.6 2026-08-06T23:46:42+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-nda-filing-for-tepotinib-for-321990.html 0.6 2026-08-04T00:52:28+08:00 daily https://www.pharmasources.com/industryinsights/takeda-signs-deal-with-uk-biotech-engiti-321991.html 0.6 2026-08-06T23:36:27+08:00 daily https://www.pharmasources.com/industryinsights/no-increased-risk-from-covid-19-for-heal-321992.html 0.6 2026-08-06T23:46:31+08:00 daily https://www.pharmasources.com/industryinsights/novartis-cml-drug-hits-phiii-targets-321993.html 0.6 2026-08-06T23:56:33+08:00 daily https://www.pharmasources.com/industryinsights/clinical-research-cut-87-at-peak-of-pand-321994.html 0.6 2026-08-09T13:06:29+08:00 daily https://www.pharmasources.com/industryinsights/az-kicks-off-phi-trial-of-potential-covi-321995.html 0.6 2026-06-21T01:00:46+08:00 daily https://www.pharmasources.com/industryinsights/first-coronavirus-re-infection-reported--321996.html 0.6 2026-06-21T12:00:14+08:00 daily https://www.pharmasources.com/industryinsights/whf-partners-with-az-to-reduce-burden-of-321997.html 0.6 2026-06-21T18:11:39+08:00 daily https://www.pharmasources.com/industryinsights/aggrastat-shows-promise-for-treating-cov-321998.html 0.6 2026-07-03T08:24:14+08:00 daily https://www.pharmasources.com/industryinsights/first-patients-enrolled-in-phase-ii-tria-321999.html 0.6 2026-08-11T22:19:38+08:00 daily https://www.pharmasources.com/industryinsights/collaboration-to-develop-the-worlds-firs-322000.html 0.6 2026-06-20T19:43:22+08:00 daily https://www.pharmasources.com/industryinsights/fda-issues-emergency-use-authorisation-f-322001.html 0.6 2026-06-21T18:20:56+08:00 daily https://www.pharmasources.com/industryinsights/hunan-nutramax-inc---exhibitor-webinar-322002.html 0.6 2026-06-24T11:09:44+08:00 daily https://www.pharmasources.com/industryinsights/hercules-ahr-inhibitor-hp163-blocks-vira-322003.html 0.6 2026-06-21T07:11:00+08:00 daily https://www.pharmasources.com/industryinsights/mc2-therapeutics-announces-collaboration-322004.html 0.6 2026-08-12T23:38:32+08:00 daily https://www.pharmasources.com/industryinsights/new-nasal-gel-evaluated-for-its-protecti-322005.html 0.6 2026-07-06T20:15:13+08:00 daily https://www.pharmasources.com/industryinsights/byondis-initiates-phase-i-study-of-adc-v-322006.html 0.6 2026-06-20T20:20:52+08:00 daily https://www.pharmasources.com/industryinsights/3d-cell-culture-systems-in-cancer-organo-322007.html 0.6 2026-08-07T04:12:57+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccine-candidate-produced-from-322008.html 0.6 2026-08-08T19:39:33+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccine-grown-in-insect-cells-a-322009.html 0.6 2026-06-21T08:05:03+08:00 daily https://www.pharmasources.com/industryinsights/fda-chief-hahn-walks-back-plasma-claims--322010.html 0.6 2026-06-20T20:54:33+08:00 daily https://www.pharmasources.com/industryinsights/in-a-covid-19-twist-pharmas-doc-rep-rela-322011.html 0.6 2026-07-08T19:20:23+08:00 daily https://www.pharmasources.com/industryinsights/is-avoidable-experiment-expenditure-drai-322012.html 0.6 2026-06-22T12:16:14+08:00 daily https://www.pharmasources.com/industryinsights/abbvies-skyrizi-stands-to-gain-as-docs-m-322013.html 0.6 2026-06-21T07:06:59+08:00 daily https://www.pharmasources.com/industryinsights/fda-faces-a-reputation-crisis-amid-trump-322014.html 0.6 2026-01-30T10:43:17+08:00 daily https://www.pharmasources.com/industryinsights/three-things-to-look-for-in-a-patient-as-322015.html 0.6 2026-07-06T23:03:58+08:00 daily https://www.pharmasources.com/industryinsights/novartis-leans-on-state-by-state-strateg-322016.html 0.6 2026-08-10T03:12:26+08:00 daily https://www.pharmasources.com/industryinsights/fiercepharmapoliticsis-the-deep-state-ru-322017.html 0.6 2026-08-07T02:36:50+08:00 daily https://www.pharmasources.com/industryinsights/takeda-to-offload-japan-consumer-health--322018.html 0.6 2026-08-07T02:33:55+08:00 daily https://www.pharmasources.com/industryinsights/fdas-emergency-nod-for-convalescent-plas-322019.html 0.6 2026-08-07T02:30:35+08:00 daily https://www.pharmasources.com/industryinsights/concord-medical-reports-financial-result-322020.html 0.6 2026-08-07T02:18:49+08:00 daily https://www.pharmasources.com/industryinsights/leading-textile-tech-innovators-unite-to-322021.html 0.6 2026-08-07T02:05:10+08:00 daily https://www.pharmasources.com/industryinsights/cspc-pharmaceutical-announces-2020-inter-322022.html 0.6 2026-08-07T01:52:12+08:00 daily https://www.pharmasources.com/industryinsights/sunway-universitys-collaboration-with-ha-322023.html 0.6 2026-08-07T01:46:06+08:00 daily https://www.pharmasources.com/industryinsights/skyherb---exhibitor-webinar-322024.html 0.6 2026-08-07T01:42:52+08:00 daily https://www.pharmasources.com/industryinsights/fda-generally-recognized-as-safe-gras-10-322025.html 0.6 2026-08-14T14:27:31+08:00 daily https://www.pharmasources.com/industryinsights/hunan-huakang-biotech-inc---exhibitor-we-322026.html 0.6 2026-08-07T01:27:51+08:00 daily https://www.pharmasources.com/industryinsights/shaanxi-kingsci-biotechnology-coltd---ex-322027.html 0.6 2026-08-07T01:27:54+08:00 daily https://www.pharmasources.com/industryinsights/jilin-province-hongjiu-biotech-coltd---e-322028.html 0.6 2026-08-09T09:52:21+08:00 daily https://www.pharmasources.com/industryinsights/lyxiaxiaozaotech---exhibitor-webinar-322029.html 0.6 2026-07-03T06:50:08+08:00 daily https://www.pharmasources.com/industryinsights/moderna-informs-covid-19-vaccine-induced-322030.html 0.6 2026-08-14T15:01:58+08:00 daily https://www.pharmasources.com/industryinsights/govt-likely-to-announce-short-term-incen-322031.html 0.6 2026-06-21T03:57:07+08:00 daily https://www.pharmasources.com/industryinsights/intas-gets-dcgi-nod-for-clinical-trials--322032.html 0.6 2026-08-14T08:31:46+08:00 daily https://www.pharmasources.com/industryinsights/iit-guwahati-and-riken-japan-collaborate-322033.html 0.6 2026-06-21T02:59:42+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccines-need-novel-approaches--322034.html 0.6 2026-06-21T02:06:44+08:00 daily https://www.pharmasources.com/industryinsights/us-charges-teva-in-price-fixing-investig-322035.html 0.6 2026-07-24T09:08:41+08:00 daily https://www.pharmasources.com/industryinsights/lupin-and-mylan-launch-nepexto-biosimila-322036.html 0.6 2026-06-21T03:02:55+08:00 daily https://www.pharmasources.com/industryinsights/merck-files-petition-in-us-court-against-322037.html 0.6 2026-07-06T02:05:02+08:00 daily https://www.pharmasources.com/industryinsights/aleor-dermaceuticals-receives-usfda-nod--322038.html 0.6 2026-07-02T14:12:45+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-harvard-university-form-research--322039.html 0.6 2026-06-27T16:10:39+08:00 daily https://www.pharmasources.com/industryinsights/europital-opens-new-site-in-oxford-322040.html 0.6 2026-06-24T02:36:33+08:00 daily https://www.pharmasources.com/industryinsights/engitix-signs-drug-discovery-and-licensi-322041.html 0.6 2026-06-24T10:53:56+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-teams-up-with-harvard-university--322042.html 0.6 2026-06-22T05:47:44+08:00 daily https://www.pharmasources.com/industryinsights/chemomab-receives-eu-orphan-drug-designa-322043.html 0.6 2026-06-08T19:37:14+08:00 daily https://www.pharmasources.com/industryinsights/q-biomed-mannin-announce-gmp-production--322044.html 0.6 2026-06-21T23:07:58+08:00 daily https://www.pharmasources.com/industryinsights/trishula-therapeutics-established-to-adv-322045.html 0.6 2026-06-20T18:01:22+08:00 daily https://www.pharmasources.com/industryinsights/oncolytics-biotech-doses-first-patient-i-322046.html 0.6 2026-06-21T00:19:07+08:00 daily https://www.pharmasources.com/industryinsights/clearside-biomedical-expands-patent-port-322047.html 0.6 2026-06-22T01:55:32+08:00 daily https://www.pharmasources.com/industryinsights/conditional-approval-for-hansas-kidney-t-322048.html 0.6 2026-06-21T23:01:42+08:00 daily https://www.pharmasources.com/industryinsights/scancell-receives-funding-for-covid-19-v-322049.html 0.6 2026-07-19T20:33:03+08:00 daily https://www.pharmasources.com/industryinsights/gsk-bags-eu-approval-for-blenrep-322050.html 0.6 2026-06-20T21:44:24+08:00 daily https://www.pharmasources.com/industryinsights/vertexs-kaftrio-approved-for-use-in-euro-322051.html 0.6 2026-07-12T12:18:10+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-doses-first-patients-in-covi-322052.html 0.6 2026-07-17T23:42:16+08:00 daily https://www.pharmasources.com/industryinsights/blocking-cellular-communication-stops-sa-322053.html 0.6 2026-06-27T01:46:33+08:00 daily https://www.pharmasources.com/industryinsights/73000-scientists-collaborate-over-new-co-322054.html 0.6 2026-01-14T07:46:52+08:00 daily https://www.pharmasources.com/industryinsights/europes-largest-initiative-launches-to-a-322055.html 0.6 2026-06-20T21:10:47+08:00 daily https://www.pharmasources.com/industryinsights/unither-to-acquire-nanjing-ruinian-best-322056.html 0.6 2026-08-03T06:52:16+08:00 daily https://www.pharmasources.com/industryinsights/mapp-biopharma-partners-with-cdmo-avid-b-322057.html 0.6 2026-06-22T05:50:32+08:00 daily https://www.pharmasources.com/industryinsights/symbiosis-appoints-coo-322058.html 0.6 2026-06-20T16:56:13+08:00 daily https://www.pharmasources.com/industryinsights/agc-biologics-completes-ppq-mfg-campaign-322059.html 0.6 2026-06-22T05:59:36+08:00 daily https://www.pharmasources.com/industryinsights/sinovac-signs-agreement-with-bio-farma-i-322060.html 0.6 2025-11-29T19:31:00+08:00 daily https://www.pharmasources.com/industryinsights/acadia-buys-clinical-stage-biotechnology-322061.html 0.6 2026-06-22T12:03:50+08:00 daily https://www.pharmasources.com/industryinsights/odonate-announces-positive-top-line-resu-322062.html 0.6 2026-06-22T07:43:53+08:00 daily https://www.pharmasources.com/industryinsights/focusing-on-new-developments-of-covid-19-322063.html 0.6 2026-07-07T22:55:08+08:00 daily https://www.pharmasources.com/industryinsights/jungs-laboratory-of-immunology-launching-322064.html 0.6 2026-05-27T00:37:07+08:00 daily https://www.pharmasources.com/industryinsights/nccn-meeting-on-blood-cancers-will-be-vi-322065.html 0.6 2026-06-21T20:40:26+08:00 daily https://www.pharmasources.com/industryinsights/sirtex-medical-and-china-grand-pharmaceu-322066.html 0.6 2026-07-11T21:58:29+08:00 daily https://www.pharmasources.com/industryinsights/infinitus-responds-to-covid-19-pandemic--322067.html 0.6 2026-07-23T19:29:24+08:00 daily https://www.pharmasources.com/industryinsights/enrolment-initiated-in-worlds-first-rct--322068.html 0.6 2026-08-09T20:06:06+08:00 daily https://www.pharmasources.com/industryinsights/zeiss-iolmaster-700-software-update-190--322069.html 0.6 2026-08-07T01:10:49+08:00 daily https://www.pharmasources.com/industryinsights/global-virus-network-reports-renowned-do-322070.html 0.6 2026-08-07T00:59:04+08:00 daily https://www.pharmasources.com/industryinsights/innovent-announces-financial-results-for-322071.html 0.6 2026-08-07T00:40:29+08:00 daily https://www.pharmasources.com/industryinsights/tuv-rheinland-india-offers-testing-servi-322072.html 0.6 2026-08-07T00:02:01+08:00 daily https://www.pharmasources.com/industryinsights/digital-international-liver-congress-alc-322073.html 0.6 2026-08-06T23:55:58+08:00 daily https://www.pharmasources.com/industryinsights/indias-proposed-new-agile-pharma-regulat-322074.html 0.6 2026-08-07T06:06:58+08:00 daily https://www.pharmasources.com/industryinsights/dwk-life-sciences-acquires-mller-mller-322075.html 0.6 2026-08-07T11:33:41+08:00 daily https://www.pharmasources.com/industryinsights/premas-biotechs-covid-19-vaccine-candida-322076.html 0.6 2026-08-07T12:00:12+08:00 daily https://www.pharmasources.com/industryinsights/alembic-pharma-gets-tentative-nod-from-u-322077.html 0.6 2026-08-10T14:16:07+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-laboratories-launches-penicill-322078.html 0.6 2026-07-06T22:35:25+08:00 daily https://www.pharmasources.com/industryinsights/markets-for-gvhd-in-five-apac-markets-to-322079.html 0.6 2026-06-20T17:52:19+08:00 daily https://www.pharmasources.com/industryinsights/piramal-pharma-solutions-to-join-hands-w-322080.html 0.6 2026-06-20T21:55:38+08:00 daily https://www.pharmasources.com/industryinsights/processa-pharmaceutical-enters-licensing-322081.html 0.6 2026-06-21T13:03:41+08:00 daily https://www.pharmasources.com/industryinsights/harpoon-therapeutics-appoints-vp-regulat-322082.html 0.6 2026-03-31T14:53:31+08:00 daily https://www.pharmasources.com/industryinsights/vaccitech-receives-uk-grant-to-support-c-322083.html 0.6 2026-06-21T11:51:07+08:00 daily https://www.pharmasources.com/industryinsights/gi-partners-acquires-clinical-ink-322084.html 0.6 2026-06-20T20:58:37+08:00 daily https://www.pharmasources.com/industryinsights/laurent-pharma-initiates-phase-ii-trial--322085.html 0.6 2026-06-20T14:36:34+08:00 daily https://www.pharmasources.com/industryinsights/akers-premas-note-positive-proof-of-conc-322086.html 0.6 2026-04-13T04:34:03+08:00 daily https://www.pharmasources.com/industryinsights/ec-signs-first-covid-19-vaccine-contract-322087.html 0.6 2026-08-07T11:10:57+08:00 daily https://www.pharmasources.com/industryinsights/uqs-covid-19-vaccine-shows-effectiveness-322088.html 0.6 2026-06-20T22:46:53+08:00 daily https://www.pharmasources.com/industryinsights/cassiopea-secures-fda-approval-for-winle-322089.html 0.6 2026-07-30T03:58:46+08:00 daily https://www.pharmasources.com/industryinsights/janone-advances-potential-peripheral-art-322090.html 0.6 2026-08-10T17:33:36+08:00 daily https://www.pharmasources.com/industryinsights/tymes-oncology-research-identifies-poten-322091.html 0.6 2026-08-06T23:33:37+08:00 daily https://www.pharmasources.com/industryinsights/new-york-blood-center-research-confirms--322092.html 0.6 2026-08-10T15:18:23+08:00 daily https://www.pharmasources.com/industryinsights/akers-biosciences-premas-biotech-announc-322093.html 0.6 2026-07-17T05:28:23+08:00 daily https://www.pharmasources.com/industryinsights/fda-removes-amputation-boxed-warning-for-322094.html 0.6 2026-06-22T13:07:29+08:00 daily https://www.pharmasources.com/industryinsights/siemens-perceptive-engineering-pse-join--322095.html 0.6 2026-04-30T20:01:04+08:00 daily https://www.pharmasources.com/industryinsights/ptc-therapeutics-achieves-20m-roche-mile-322096.html 0.6 2026-06-21T16:01:19+08:00 daily https://www.pharmasources.com/industryinsights/parexel-pfizer-extend-long-term-partners-322097.html 0.6 2026-07-16T22:33:54+08:00 daily https://www.pharmasources.com/industryinsights/piramal-to-deliver-integrated-services-t-322098.html 0.6 2026-06-20T16:07:38+08:00 daily https://www.pharmasources.com/industryinsights/us-approves-roches-new-pan-tumour-liquid-322099.html 0.6 2026-08-12T04:36:44+08:00 daily https://www.pharmasources.com/industryinsights/kidney-cancer-charity-slams-nice-rejecti-322100.html 0.6 2026-06-20T21:05:39+08:00 daily https://www.pharmasources.com/industryinsights/nihr-ukri-stream-84m-into-coronavirus-st-322101.html 0.6 2026-06-20T21:06:49+08:00 daily https://www.pharmasources.com/industryinsights/artificial-pancreas-for-type-1-diabetes--322102.html 0.6 2026-07-17T00:38:28+08:00 daily https://www.pharmasources.com/industryinsights/first-patients-dosed-in-gsks-phase-iii-m-322103.html 0.6 2026-06-21T08:12:12+08:00 daily https://www.pharmasources.com/industryinsights/search-for-covid-19-drugs-boosted-by-sar-322104.html 0.6 2026-06-21T01:12:56+08:00 daily https://www.pharmasources.com/industryinsights/researcher-claims-antiviral-medicine-for-322105.html 0.6 2026-06-20T23:03:45+08:00 daily https://www.pharmasources.com/industryinsights/beximco-signs-deal-with-serum-institute--322106.html 0.6 2026-08-06T14:54:31+08:00 daily https://www.pharmasources.com/industryinsights/university-of-sheffield-joins-uk-coronav-322107.html 0.6 2026-06-21T04:13:02+08:00 daily https://www.pharmasources.com/industryinsights/novartis-analysis-shows-inclisiran-lower-322108.html 0.6 2026-08-07T23:39:32+08:00 daily https://www.pharmasources.com/industryinsights/sinovacs-covid-19-vaccine-candidate-get--322109.html 0.6 2026-06-21T14:37:09+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-broadens-eua-for-veklury-remdesiv-322110.html 0.6 2026-06-21T09:41:58+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-harvard-university-collaborate-fo-322111.html 0.6 2026-06-21T08:03:00+08:00 daily https://www.pharmasources.com/industryinsights/cadila-pharma-launches-cadalimab-adalimu-322112.html 0.6 2026-06-20T17:07:22+08:00 daily https://www.pharmasources.com/industryinsights/gardp-and-bugworks-sign-mou-to-develop-a-322113.html 0.6 2026-08-08T03:32:42+08:00 daily https://www.pharmasources.com/industryinsights/gilead-astrazeneca-and-pfizer-may-be-win-322114.html 0.6 2026-07-30T14:10:43+08:00 daily https://www.pharmasources.com/industryinsights/active-ingredient-in-insect-repellent-ma-322115.html 0.6 2026-06-22T12:38:32+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-winlevi-topical-acne-tre-322116.html 0.6 2026-06-21T04:47:30+08:00 daily https://www.pharmasources.com/industryinsights/lsne-expands-aseptic-fill-finish-capabil-322117.html 0.6 2026-06-20T17:08:23+08:00 daily https://www.pharmasources.com/industryinsights/q-biomed-initiates-gmp-production-of-nov-322118.html 0.6 2026-06-21T10:11:11+08:00 daily https://www.pharmasources.com/industryinsights/fda-works-to-mitigate-shortages-of-rifam-322119.html 0.6 2026-08-02T11:38:37+08:00 daily https://www.pharmasources.com/industryinsights/oncosec-announces-initiation-of-astudy-t-322120.html 0.6 2026-06-21T19:53:36+08:00 daily https://www.pharmasources.com/industryinsights/ridgeback-announces-initiation-of-expand-322121.html 0.6 2026-08-07T20:14:42+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharma-announces-positive-rec-322122.html 0.6 2026-08-07T19:33:37+08:00 daily https://www.pharmasources.com/industryinsights/fda-authorizes-first-diagnostic-test-whe-322123.html 0.6 2026-08-07T18:15:09+08:00 daily https://www.pharmasources.com/industryinsights/hackensack-meridian-health-enrolling-ind-322124.html 0.6 2026-08-07T13:17:03+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-to-create-400-jobs-to-support--322125.html 0.6 2026-08-13T16:12:01+08:00 daily https://www.pharmasources.com/industryinsights/study-shows-anticoagulation-therapy-bene-322126.html 0.6 2026-08-06T23:46:13+08:00 daily https://www.pharmasources.com/industryinsights/further-84-million-in-funding-given-to-u-322127.html 0.6 2026-08-06T23:57:09+08:00 daily https://www.pharmasources.com/industryinsights/blenrep-granted-cma-for-relapsed-or-refr-322128.html 0.6 2026-08-05T23:23:19+08:00 daily https://www.pharmasources.com/industryinsights/bayer-invests-in-cancer-therapies-develo-322129.html 0.6 2026-06-22T06:54:41+08:00 daily https://www.pharmasources.com/industryinsights/akers-and-premas-note-positive-proof-of--322130.html 0.6 2026-08-10T15:14:40+08:00 daily https://www.pharmasources.com/industryinsights/hifibio-submits-ind-application-for-sars-322131.html 0.6 2026-08-08T09:47:29+08:00 daily https://www.pharmasources.com/industryinsights/abbotts-fast-5-15-minute-easy-to-use-cov-322132.html 0.6 2026-08-08T08:38:41+08:00 daily https://www.pharmasources.com/industryinsights/empagliflozin-reduced-risk-of-death-and--322133.html 0.6 2026-08-08T07:52:58+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-scientific-officially-open-322134.html 0.6 2026-08-08T04:36:43+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-322135.html 0.6 2026-08-07T13:17:22+08:00 daily https://www.pharmasources.com/industryinsights/nestl-to-acquire-biopharma-company-aimmu-322136.html 0.6 2026-08-07T15:07:08+08:00 daily https://www.pharmasources.com/industryinsights/agilent-supports-customer-laboratories-a-322137.html 0.6 2026-08-10T17:21:58+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-willing-to-give-eua-for-covid-19--322138.html 0.6 2026-08-07T06:01:12+08:00 daily https://www.pharmasources.com/industryinsights/biocon-biologics-and-mylan-launch-semgle-322139.html 0.6 2026-06-21T05:05:50+08:00 daily https://www.pharmasources.com/industryinsights/diabetes-drug-dapagliflozin-shows-benefi-322140.html 0.6 2026-08-04T14:29:06+08:00 daily https://www.pharmasources.com/industryinsights/idorsia-partners-with-syneos-health-322141.html 0.6 2026-07-31T22:36:42+08:00 daily https://www.pharmasources.com/industryinsights/camargo-appoints-commercial-strategy-vp-322142.html 0.6 2026-08-05T07:31:20+08:00 daily https://www.pharmasources.com/industryinsights/sotio-acquires-rights-to-boxr-cell-thera-322143.html 0.6 2026-07-20T07:16:09+08:00 daily https://www.pharmasources.com/industryinsights/fda-clears-spis-ebselen-for-phase-ii-cov-322144.html 0.6 2026-06-22T11:54:44+08:00 daily https://www.pharmasources.com/industryinsights/novavax-to-supply-76m-doses-of-covid-19--322145.html 0.6 2026-07-30T19:58:20+08:00 daily https://www.pharmasources.com/industryinsights/ionis-to-acquire-outstanding-shares-of-a-322146.html 0.6 2026-07-31T06:20:47+08:00 daily https://www.pharmasources.com/industryinsights/leo-pharma-divests-four-medicines-to-che-322147.html 0.6 2026-06-22T05:08:46+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-eua-for-gileads-remdesivir-to-322148.html 0.6 2026-08-08T17:40:35+08:00 daily https://www.pharmasources.com/industryinsights/mylan-biocon-biologics-announce-launch-o-322149.html 0.6 2026-06-20T14:41:28+08:00 daily https://www.pharmasources.com/industryinsights/cormedix-announces-fda-acceptance-of-new-322150.html 0.6 2026-08-01T02:15:23+08:00 daily https://www.pharmasources.com/industryinsights/provention-bio-begins-phase-2-study-of-n-322151.html 0.6 2026-08-15T01:24:36+08:00 daily https://www.pharmasources.com/industryinsights/fda-broadens-eua-for-remdesivir-for-covi-322152.html 0.6 2026-07-30T13:36:14+08:00 daily https://www.pharmasources.com/industryinsights/netzsch-announces-new-northeast-support--322153.html 0.6 2026-08-03T15:42:08+08:00 daily https://www.pharmasources.com/industryinsights/designing-the-messenger-story-of-the-mrn-322154.html 0.6 2026-08-07T00:24:29+08:00 daily https://www.pharmasources.com/industryinsights/advantages-to-using-cros-322155.html 0.6 2026-08-07T00:39:43+08:00 daily https://www.pharmasources.com/industryinsights/hope-for-africa-in-fight-against-rsv-and-322156.html 0.6 2026-08-01T09:58:06+08:00 daily https://www.pharmasources.com/industryinsights/amcor--exhibitor-webinar-322157.html 0.6 2026-06-21T06:10:49+08:00 daily https://www.pharmasources.com/industryinsights/only-drug-inspectors-can-probe-file-firs-322158.html 0.6 2026-08-02T22:45:13+08:00 daily https://www.pharmasources.com/industryinsights/rocket-pharmaceuticals-receives-fda-fast-322159.html 0.6 2026-08-08T03:11:58+08:00 daily https://www.pharmasources.com/industryinsights/treadwell-initiates-expansion-of-cohorts-322160.html 0.6 2026-07-29T00:22:49+08:00 daily https://www.pharmasources.com/industryinsights/beigene-singlomics-sign-licencing-agreem-322161.html 0.6 2026-07-29T02:29:10+08:00 daily https://www.pharmasources.com/industryinsights/novartis-abl001-meets-primary-endpoint-o-322162.html 0.6 2026-08-06T09:43:44+08:00 daily https://www.pharmasources.com/industryinsights/vir-biotechnology-and-gsk-start-phase-23-322163.html 0.6 2026-07-29T02:26:45+08:00 daily https://www.pharmasources.com/industryinsights/mecechem-wuxi-co-ltd---exhibitor-webinar-322164.html 0.6 2026-08-11T09:14:46+08:00 daily https://www.pharmasources.com/industryinsights/guangzhou-bairui-medicine-co-ltd---exhib-322165.html 0.6 2026-08-14T02:28:21+08:00 daily https://www.pharmasources.com/industryinsights/jiangsu-zonta-pharmaceutical-co-ltd---ex-322166.html 0.6 2026-08-01T09:49:17+08:00 daily https://www.pharmasources.com/industryinsights/boai-nky-medical-holdings-ltd---exhibito-322167.html 0.6 2026-07-30T18:49:47+08:00 daily https://www.pharmasources.com/industryinsights/hefei-lifeon-pharmaceutical-coltd---exhi-322168.html 0.6 2026-08-03T19:55:17+08:00 daily https://www.pharmasources.com/industryinsights/shandong-yakang-pharmaceutical-coltd---e-322169.html 0.6 2026-07-29T18:43:12+08:00 daily https://www.pharmasources.com/industryinsights/leadtop-pharmaceutical-machinery-china---322170.html 0.6 2026-08-14T13:36:30+08:00 daily https://www.pharmasources.com/industryinsights/kinglai-group---exhibitor-webinar-322171.html 0.6 2026-08-14T22:41:42+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-pneumatic-technology-research-insti-322172.html 0.6 2026-07-25T15:07:47+08:00 daily https://www.pharmasources.com/industryinsights/hangzhou-qogori-tech-coltd---exhibitor-w-322173.html 0.6 2026-06-28T21:15:01+08:00 daily https://www.pharmasources.com/industryinsights/liaoyang-zhonglian-pharmaceutical-machin-322174.html 0.6 2026-08-14T05:41:37+08:00 daily https://www.pharmasources.com/industryinsights/hebei-first-rubber-medical-technology-co-322175.html 0.6 2026-08-13T07:23:27+08:00 daily https://www.pharmasources.com/industryinsights/aqua-medical-announces-final-82-million--322176.html 0.6 2026-06-27T09:00:49+08:00 daily https://www.pharmasources.com/industryinsights/nestl-plunks-down-21b-to-acquire-aimmune-322177.html 0.6 2026-08-03T03:49:09+08:00 daily https://www.pharmasources.com/industryinsights/fiercepharmapoliticsfda-would-consider-c-322178.html 0.6 2026-08-10T12:37:16+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-backs-mental-health-mission-of-le-322179.html 0.6 2026-03-27T22:41:28+08:00 daily https://www.pharmasources.com/industryinsights/mercks-steglatro-shows-limited-promise-w-322180.html 0.6 2026-08-03T07:22:10+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-farxiga-cuts-kidney-disease-322181.html 0.6 2026-08-01T12:24:30+08:00 daily https://www.pharmasources.com/industryinsights/novartis-entresto-racks-up-a-heart-failu-322182.html 0.6 2026-07-28T20:30:01+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-bms-eliquis-tops-xarelto-vitamin--322183.html 0.6 2026-07-28T21:06:30+08:00 daily https://www.pharmasources.com/industryinsights/sotio-acquires-rights-to-boxr-car-t-plat-322184.html 0.6 2026-08-04T22:09:09+08:00 daily https://www.pharmasources.com/industryinsights/bioversys-announces-chf-19-million-finan-322185.html 0.6 2026-07-29T05:56:28+08:00 daily https://www.pharmasources.com/industryinsights/jiangsu-famacy-glass-coltd---exhibitor-w-322186.html 0.6 2026-08-12T09:43:22+08:00 daily https://www.pharmasources.com/industryinsights/jiangsu-delfu-medical-device-coltd---exh-322187.html 0.6 2026-08-05T05:12:27+08:00 daily https://www.pharmasources.com/industryinsights/shijiazhuang-xinfuda-medicial-packaging--322188.html 0.6 2026-07-31T07:58:24+08:00 daily https://www.pharmasources.com/industryinsights/phillips-medisize--exhibitor-webinar-322189.html 0.6 2026-07-29T22:52:53+08:00 daily https://www.pharmasources.com/industryinsights/schreiner-medipharm---exhibitor-webinar-322190.html 0.6 2026-08-14T08:41:50+08:00 daily https://www.pharmasources.com/industryinsights/zhejiang-yaolian-capsules-coltd---exhibi-322191.html 0.6 2026-08-13T15:49:31+08:00 daily https://www.pharmasources.com/industryinsights/shenzhen-zhijun-medical-pharmaceutical-t-322192.html 0.6 2026-08-14T08:02:54+08:00 daily https://www.pharmasources.com/industryinsights/syncozymes-shanghai-co-ltd---exhibitor-w-322193.html 0.6 2026-08-05T13:24:49+08:00 daily https://www.pharmasources.com/industryinsights/shandong-kexing-bioproductscoltd---exhib-322194.html 0.6 2026-08-09T12:45:57+08:00 daily https://www.pharmasources.com/industryinsights/67-per-cent-experts-to-use-decentralised-322195.html 0.6 2026-07-15T23:23:03+08:00 daily https://www.pharmasources.com/industryinsights/inmune-bio-gets-us-fda-nod-for-phase-ii--322196.html 0.6 2026-08-02T11:39:58+08:00 daily https://www.pharmasources.com/industryinsights/gilead-and-jounce-therapeutics-sign-excl-322197.html 0.6 2026-08-08T19:44:35+08:00 daily https://www.pharmasources.com/industryinsights/eu-approves-astrazenecas-imfinzi-for-tre-322198.html 0.6 2026-08-07T01:14:04+08:00 daily https://www.pharmasources.com/industryinsights/novavax-and-canada-reach-agreement-in-pr-322199.html 0.6 2026-08-07T01:06:48+08:00 daily https://www.pharmasources.com/industryinsights/phase-iii-trials-of-astrazeneca-covid-19-322200.html 0.6 2026-08-07T00:42:46+08:00 daily https://www.pharmasources.com/industryinsights/gsk-vir-biotech-to-test-covid-19-antibod-322201.html 0.6 2026-08-07T00:40:57+08:00 daily https://www.pharmasources.com/industryinsights/luina-bio-expands-322202.html 0.6 2026-08-06T23:57:42+08:00 daily https://www.pharmasources.com/industryinsights/ibio-signs-license-agreement-with-planet-322203.html 0.6 2026-08-06T21:47:12+08:00 daily https://www.pharmasources.com/industryinsights/bilim-pharmaceuticals-ht-presspart-and-h-322204.html 0.6 2026-08-06T23:32:03+08:00 daily https://www.pharmasources.com/industryinsights/dar-bioscience-and-avomeen-form-partners-322205.html 0.6 2026-08-07T00:56:22+08:00 daily https://www.pharmasources.com/industryinsights/kohlberg-and-mubadala-buy-majority-stake-322206.html 0.6 2026-08-07T00:02:57+08:00 daily https://www.pharmasources.com/industryinsights/alcami-trevana-enter-manufacturing-pact-322207.html 0.6 2026-08-15T00:49:21+08:00 daily https://www.pharmasources.com/industryinsights/hjb-and-ansun-biopharma-enter-biologics--322208.html 0.6 2026-08-07T00:52:55+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-priority-review-of-melflufen--322209.html 0.6 2026-08-07T01:14:04+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-automated-insulin-delivery--322210.html 0.6 2026-08-11T20:46:45+08:00 daily https://www.pharmasources.com/industryinsights/innovent-announces-first-subject-dosed-i-322211.html 0.6 2026-07-04T19:53:02+08:00 daily https://www.pharmasources.com/industryinsights/medicinova-announces-development-progres-322212.html 0.6 2026-08-10T08:50:19+08:00 daily https://www.pharmasources.com/industryinsights/mylan-recalls-four-lots-of-amiodarone-hc-322213.html 0.6 2026-06-20T16:36:00+08:00 daily https://www.pharmasources.com/industryinsights/cartesian-initiates-trial-of-cell-therap-322214.html 0.6 2026-06-21T04:06:54+08:00 daily https://www.pharmasources.com/industryinsights/oxford-biomedica-enters-covid-19-vaccine-322215.html 0.6 2026-06-23T20:21:48+08:00 daily https://www.pharmasources.com/industryinsights/kevzara-fails-in-phiii-covid-19-trial-322216.html 0.6 2026-06-23T01:18:21+08:00 daily https://www.pharmasources.com/industryinsights/uk-launch-for-novos-new-diabetes-pill-322217.html 0.6 2026-07-31T19:49:43+08:00 daily https://www.pharmasources.com/industryinsights/phiii-us-trial-for-az-coronavirus-vaccin-322218.html 0.6 2026-08-13T16:29:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-expands-emergency-use-authorisation--322219.html 0.6 2025-11-29T16:33:44+08:00 daily https://www.pharmasources.com/industryinsights/celltrion-receives-korean-mfds-approval--322220.html 0.6 2026-08-06T02:09:17+08:00 daily https://www.pharmasources.com/industryinsights/fsd-pharma-seeks-fda-nod-for-fsd201-phas-322221.html 0.6 2026-06-23T11:03:50+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-provides-update-on-kevzara-sarilu-322222.html 0.6 2026-06-22T01:53:30+08:00 daily https://www.pharmasources.com/industryinsights/improving-fdas-covid-19-vaccine-authoriz-322223.html 0.6 2026-06-23T02:07:24+08:00 daily https://www.pharmasources.com/industryinsights/nw-bio-accelerating-sawston-plant-phase--322224.html 0.6 2026-06-20T14:10:32+08:00 daily https://www.pharmasources.com/industryinsights/animal-studies-for-predicting-drug-toxic-322225.html 0.6 2026-08-08T07:42:12+08:00 daily https://www.pharmasources.com/industryinsights/six-reasons-why-india-is-poised-to-be-a--322226.html 0.6 2026-08-03T07:41:40+08:00 daily https://www.pharmasources.com/industryinsights/arthur-d-little-and-begin-india-launch-i-322227.html 0.6 2026-06-21T14:56:23+08:00 daily https://www.pharmasources.com/industryinsights/abbott-gets-dcgi-approval-for-ivabradine-322228.html 0.6 2026-06-21T08:54:11+08:00 daily https://www.pharmasources.com/industryinsights/lupin-launches-leflunomide-tablets-usp-322229.html 0.6 2026-06-21T12:00:17+08:00 daily https://www.pharmasources.com/industryinsights/biomx-collaborates-with-boehringer-ingel-322230.html 0.6 2026-06-08T19:06:02+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-issues-warning-to-mylan-for-telan-322231.html 0.6 2026-06-22T06:05:45+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-releases-guidance-to-detect-and-p-322232.html 0.6 2026-08-11T20:45:17+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-us-fda-approval-for-ci-322233.html 0.6 2026-07-05T02:32:33+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-onureg-azacitidine-table-322234.html 0.6 2026-08-06T16:27:58+08:00 daily https://www.pharmasources.com/industryinsights/gilead-sciences-signs-agreement-with-jou-322235.html 0.6 2026-08-08T02:32:34+08:00 daily https://www.pharmasources.com/industryinsights/nutriband-acquires-transdermal-and-healt-322236.html 0.6 2026-06-20T23:01:41+08:00 daily https://www.pharmasources.com/industryinsights/which-will-go-further-innovent-or-junshi-322237.html 0.6 2026-08-04T10:06:55+08:00 daily https://www.pharmasources.com/industryinsights/avomeen-dar-partner-to-accelerate-dars-p-322238.html 0.6 2025-11-29T16:13:45+08:00 daily https://www.pharmasources.com/industryinsights/catalent-invests-50m-at-bloomington-faci-322239.html 0.6 2026-06-21T13:01:31+08:00 daily https://www.pharmasources.com/industryinsights/rain-therapeutics-licenses-mdm2-inhibito-322240.html 0.6 2026-08-11T07:51:20+08:00 daily https://www.pharmasources.com/industryinsights/northwest-biotherapeutics-acquires-flask-322241.html 0.6 2026-06-21T06:54:10+08:00 daily https://www.pharmasources.com/industryinsights/trirx-acquires-msd-animal-health-manufac-322242.html 0.6 2026-06-25T19:37:45+08:00 daily https://www.pharmasources.com/industryinsights/micron-progresses-with-clinical-evaluati-322243.html 0.6 2026-06-21T16:56:25+08:00 daily https://www.pharmasources.com/industryinsights/canadian-government-strikes-deals-with-j-322244.html 0.6 2026-08-10T18:39:53+08:00 daily https://www.pharmasources.com/industryinsights/fsd-pharma-applies-to-fda-for-trial-test-322245.html 0.6 2026-07-01T10:37:21+08:00 daily https://www.pharmasources.com/industryinsights/further-clinical-trials-testing-kevzara--322246.html 0.6 2026-08-11T09:49:45+08:00 daily https://www.pharmasources.com/industryinsights/nanoimaging-thermo-fisher-partner-for-cr-322247.html 0.6 2026-04-19T20:41:36+08:00 daily https://www.pharmasources.com/industryinsights/nice-green-light-for-immunotherapy-baven-322248.html 0.6 2026-06-21T05:05:44+08:00 daily https://www.pharmasources.com/industryinsights/roche-to-launch-sars-cov-2-rapid-antigen-322249.html 0.6 2026-06-23T20:54:40+08:00 daily https://www.pharmasources.com/industryinsights/eu-oks-paediatric-use-of-gileads-epclusa-322250.html 0.6 2026-06-21T00:04:39+08:00 daily https://www.pharmasources.com/industryinsights/clear-creek-bio-doses-first-patient-in-c-322251.html 0.6 2026-06-22T11:15:03+08:00 daily https://www.pharmasources.com/industryinsights/omeros-investigational-new-drug-applicat-322252.html 0.6 2026-06-22T13:04:37+08:00 daily https://www.pharmasources.com/industryinsights/orpheris-enrols-first-patients-in-phase--322253.html 0.6 2026-06-20T15:46:53+08:00 daily https://www.pharmasources.com/industryinsights/steroid-found-to-improve-survival-of-cri-322254.html 0.6 2026-05-01T05:44:54+08:00 daily https://www.pharmasources.com/industryinsights/aerpio-and-quantum-leap-announce-first-p-322255.html 0.6 2026-04-18T23:20:58+08:00 daily https://www.pharmasources.com/industryinsights/apiic-signs-mou-with-csir-iict-to-establ-322256.html 0.6 2026-04-14T05:56:33+08:00 daily https://www.pharmasources.com/industryinsights/usfda-approves-prednisone-tablets-from-s-322257.html 0.6 2026-06-30T00:54:28+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-gsk-initiate-phase-12-clinical-tr-322258.html 0.6 2026-07-06T13:06:12+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-usfda-nod-to-market-mi-322259.html 0.6 2026-06-20T15:53:24+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-labs-launch-methylphenidate-hy-322260.html 0.6 2026-06-21T14:59:44+08:00 daily https://www.pharmasources.com/industryinsights/100-public-pharma-and-cmos-took-ppp-covi-322261.html 0.6 2026-08-03T03:46:09+08:00 daily https://www.pharmasources.com/industryinsights/prep-for-covid-19-vaccine-distribution-a-322262.html 0.6 2026-08-04T13:28:06+08:00 daily https://www.pharmasources.com/industryinsights/trirx-finalizes-agreement-with-msd-sante-322263.html 0.6 2026-06-21T07:58:07+08:00 daily https://www.pharmasources.com/industryinsights/swiss-american-cdmo-expands-in-texas-322264.html 0.6 2026-06-21T01:52:05+08:00 daily https://www.pharmasources.com/industryinsights/adma-biologics-launches-covid-19-assay-322265.html 0.6 2026-06-21T01:47:40+08:00 daily https://www.pharmasources.com/industryinsights/stevanato-group-nelson-labs-sign-el-test-322266.html 0.6 2026-06-22T09:12:56+08:00 daily https://www.pharmasources.com/industryinsights/jjs-covid-19-vaccine-prevents-severe-dis-322267.html 0.6 2026-06-21T07:06:59+08:00 daily https://www.pharmasources.com/industryinsights/enesi-pharma-partners-with-adelaide-univ-322268.html 0.6 2026-06-22T01:56:33+08:00 daily https://www.pharmasources.com/industryinsights/who-updates-guidance-on-corticosteroids--322269.html 0.6 2026-06-20T14:44:15+08:00 daily https://www.pharmasources.com/industryinsights/santhera-obtains-exclusive-licence-to-dm-322270.html 0.6 2026-06-20T22:13:59+08:00 daily https://www.pharmasources.com/industryinsights/carlyle-to-acquire-stake-in-chinas-salub-322271.html 0.6 2026-07-24T01:16:42+08:00 daily https://www.pharmasources.com/industryinsights/cenexel-clinical-research-sites-tackle-c-322272.html 0.6 2026-08-13T19:52:11+08:00 daily https://www.pharmasources.com/industryinsights/janssen-to-discontinue-pimodivir-influen-322273.html 0.6 2026-01-03T15:16:34+08:00 daily https://www.pharmasources.com/industryinsights/adma-biologics-launches-covid-19-immunor-322274.html 0.6 2026-06-20T21:00:38+08:00 daily https://www.pharmasources.com/industryinsights/janssen-disappointed-with-second-nice-no-322275.html 0.6 2026-06-21T12:07:12+08:00 daily https://www.pharmasources.com/industryinsights/uk-bladder-cancer-patients-get-early-acc-322276.html 0.6 2026-06-21T19:20:03+08:00 daily https://www.pharmasources.com/industryinsights/immunotherapies-could-target-aggressive--322277.html 0.6 2026-06-20T23:12:54+08:00 daily https://www.pharmasources.com/industryinsights/global-sterility-indicator-market-to-be--322278.html 0.6 2026-08-04T08:06:53+08:00 daily https://www.pharmasources.com/industryinsights/hydrocortisone-steroid-improves-covid-19-322279.html 0.6 2026-06-20T17:51:19+08:00 daily https://www.pharmasources.com/industryinsights/new-collaboration-between-novartis-and-a-322280.html 0.6 2026-08-07T00:47:49+08:00 daily https://www.pharmasources.com/industryinsights/vitamin-d-deficiency-may-raise-risk-of-g-322281.html 0.6 2026-08-07T00:02:54+08:00 daily https://www.pharmasources.com/industryinsights/nanoimaging-services-partners-with-therm-322282.html 0.6 2026-08-06T23:55:24+08:00 daily https://www.pharmasources.com/industryinsights/bharat-biotech-gets-dcgi-nod-for-phase-i-322283.html 0.6 2026-06-21T04:56:43+08:00 daily https://www.pharmasources.com/industryinsights/bppi-records-sales-turnover-of-rs-14659--322284.html 0.6 2026-06-21T02:14:50+08:00 daily https://www.pharmasources.com/industryinsights/nibec-a-dbt-supported-facility-for-viral-322285.html 0.6 2026-06-21T16:17:33+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccine-makers-to-prepare-joint-322286.html 0.6 2026-06-21T03:08:46+08:00 daily https://www.pharmasources.com/industryinsights/marksans-pharma-appoints-dr-meena-rani-s-322287.html 0.6 2026-06-21T03:13:54+08:00 daily https://www.pharmasources.com/industryinsights/lilly-gets-us-fda-nod-for-additional-dos-322288.html 0.6 2026-06-21T01:03:50+08:00 daily https://www.pharmasources.com/industryinsights/roches-genentech-gets-us-fda-approval-fo-322289.html 0.6 2026-08-02T08:04:57+08:00 daily https://www.pharmasources.com/industryinsights/bdr-pharma-to-launch-400-mg-favipiravir--322290.html 0.6 2026-07-09T01:07:50+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-slashes-pharma-production-in-ut-322291.html 0.6 2026-03-17T22:15:47+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-impacted-by-disrupted-clinical-tr-322292.html 0.6 2026-06-21T06:03:53+08:00 daily https://www.pharmasources.com/industryinsights/three-major-deals-contributed-74-per-cen-322293.html 0.6 2026-08-11T18:39:20+08:00 daily https://www.pharmasources.com/industryinsights/curevac-expects-to-produce-covid-19-vacc-322294.html 0.6 2026-06-20T14:48:04+08:00 daily https://www.pharmasources.com/industryinsights/researchers-develop-compound-to-kill-gra-322295.html 0.6 2026-08-09T23:58:11+08:00 daily https://www.pharmasources.com/industryinsights/enesi-pharma-to-develop-zika-virus-vacci-322296.html 0.6 2026-06-24T23:16:35+08:00 daily https://www.pharmasources.com/industryinsights/curevac-to-receive-252m-to-support-covid-322297.html 0.6 2026-08-13T01:13:18+08:00 daily https://www.pharmasources.com/industryinsights/cns-achieves-key-milestones-in-berubicin-322298.html 0.6 2026-04-11T19:03:15+08:00 daily https://www.pharmasources.com/industryinsights/amarna-therapeutics-names-new-ceo-322299.html 0.6 2026-06-21T03:09:47+08:00 daily https://www.pharmasources.com/industryinsights/ppd-lupus-therapeutics-to-support-lupus--322300.html 0.6 2026-07-03T04:08:37+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-i-mab-enter-global-immuno-oncolog-322301.html 0.6 2026-06-22T05:14:16+08:00 daily https://www.pharmasources.com/industryinsights/teva-charged-in-ongoing-criminal-antitru-322302.html 0.6 2026-08-09T15:50:05+08:00 daily https://www.pharmasources.com/industryinsights/abbott-announces-start-of-trial-to-evalu-322303.html 0.6 2026-07-10T02:07:32+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-additional-doses-of-trulici-322304.html 0.6 2026-06-21T17:04:25+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-receives-fda-approval-for-c-322305.html 0.6 2026-08-12T15:46:48+08:00 daily https://www.pharmasources.com/industryinsights/santhera-to-obtain-worldwide-rights-to-v-322306.html 0.6 2026-06-21T11:20:28+08:00 daily https://www.pharmasources.com/industryinsights/amri-selected-to-support-astrazeneca-in--322307.html 0.6 2026-03-17T23:53:17+08:00 daily https://www.pharmasources.com/industryinsights/brevitests-covid-19-igg-antibody-test-re-322308.html 0.6 2026-06-21T06:22:35+08:00 daily https://www.pharmasources.com/industryinsights/akebia-announces-top-line-results-from-v-322309.html 0.6 2026-08-06T00:40:49+08:00 daily https://www.pharmasources.com/industryinsights/intercept-to-cut-25-of-workforce-after-n-322310.html 0.6 2026-06-28T23:19:32+08:00 daily https://www.pharmasources.com/industryinsights/vistagen-reports-positive-new-data-from--322311.html 0.6 2026-06-21T08:14:15+08:00 daily https://www.pharmasources.com/industryinsights/pra-health-sciences-lls-collaborate-on-g-322312.html 0.6 2026-06-22T04:55:43+08:00 daily https://www.pharmasources.com/industryinsights/gsk-establishes-ai-hub-in-london-to-disc-322313.html 0.6 2026-08-11T09:16:13+08:00 daily https://www.pharmasources.com/industryinsights/ema-begins-review-of-dexamethasone-taw-f-322314.html 0.6 2026-06-21T11:57:12+08:00 daily https://www.pharmasources.com/industryinsights/janssens-lead-coronavirus-vaccine-shows--322315.html 0.6 2026-08-09T11:00:39+08:00 daily https://www.pharmasources.com/industryinsights/cr-uk-az-researchers-pioneer-new-antibod-322316.html 0.6 2026-08-07T02:55:25+08:00 daily https://www.pharmasources.com/industryinsights/corticosteroids-boost-survival-rates-for-322317.html 0.6 2026-08-07T02:52:16+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-322318.html 0.6 2026-08-07T02:39:52+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-laboratories-launches-fulvestr-322319.html 0.6 2026-08-07T02:52:01+08:00 daily https://www.pharmasources.com/industryinsights/corona-remedies-picks-up-stake-in-la-cha-322320.html 0.6 2026-08-07T03:03:34+08:00 daily https://www.pharmasources.com/industryinsights/janssen-gets-ec-approval-for-expanded-us-322321.html 0.6 2026-08-09T20:29:22+08:00 daily https://www.pharmasources.com/industryinsights/hamdard-labs-starts-clinical-trials-of-t-322322.html 0.6 2026-08-07T15:47:35+08:00 daily https://www.pharmasources.com/industryinsights/alembic-pharma-gets-tentative-usfda-appr-322323.html 0.6 2026-08-07T04:16:06+08:00 daily https://www.pharmasources.com/industryinsights/unicef-to-pilot-acquisition-distribution-322324.html 0.6 2026-08-07T04:25:14+08:00 daily https://www.pharmasources.com/industryinsights/high-dose-enerzair-breezhaler-further-cu-322325.html 0.6 2026-08-10T08:34:10+08:00 daily https://www.pharmasources.com/industryinsights/genentechs-gavreto-cleared-for-ret-non-s-322326.html 0.6 2026-06-21T08:19:27+08:00 daily https://www.pharmasources.com/industryinsights/gonorrhoea-cases-hit-highest-level-since-322327.html 0.6 2026-07-18T06:46:49+08:00 daily https://www.pharmasources.com/industryinsights/destiny-sporegen-collaborate-on-covid-19-322328.html 0.6 2026-06-20T20:01:33+08:00 daily https://www.pharmasources.com/industryinsights/inhaled-ensifentrine-will-be-assessed-in-322329.html 0.6 2026-06-21T07:58:23+08:00 daily https://www.pharmasources.com/industryinsights/russias-sputnik-v-covid-19-vaccine-safel-322330.html 0.6 2026-05-03T20:25:01+08:00 daily https://www.pharmasources.com/industryinsights/who-says-172-economies-in-talks-for-acce-322331.html 0.6 2026-03-28T00:11:21+08:00 daily https://www.pharmasources.com/industryinsights/uk-to-invest-500-million-in-next-generat-322332.html 0.6 2026-06-21T17:15:41+08:00 daily https://www.pharmasources.com/industryinsights/37-billion-worldwide-hemostasis-diagnost-322333.html 0.6 2026-07-17T17:00:05+08:00 daily https://www.pharmasources.com/industryinsights/octapharma-launches-phase-3-superiority--322334.html 0.6 2026-08-07T23:29:04+08:00 daily https://www.pharmasources.com/industryinsights/kite-hifibio-therapeutics-partner-to-dis-322335.html 0.6 2026-08-07T01:06:43+08:00 daily https://www.pharmasources.com/industryinsights/pharmacyte-biotech-submits-ind-to-fda-fo-322336.html 0.6 2026-08-07T00:59:00+08:00 daily https://www.pharmasources.com/industryinsights/twist-bioscience-announces-potent-sars-c-322337.html 0.6 2026-08-07T00:52:49+08:00 daily https://www.pharmasources.com/industryinsights/nppa-is-readying-mechanism-to-ease-covid-322338.html 0.6 2026-07-05T12:49:18+08:00 daily https://www.pharmasources.com/industryinsights/nine-covid-19-vaccine-makers-sign-safety-322339.html 0.6 2026-06-21T07:57:21+08:00 daily https://www.pharmasources.com/industryinsights/e-pharma-set-to-revolutionise-drug-marke-322340.html 0.6 2026-06-22T03:49:38+08:00 daily https://www.pharmasources.com/industryinsights/takeda-sells-select-non-core-assets-in-e-322341.html 0.6 2026-08-08T03:02:17+08:00 daily https://www.pharmasources.com/industryinsights/india-ramping-up-api-manufacturing-niti--322342.html 0.6 2026-06-22T17:12:21+08:00 daily https://www.pharmasources.com/industryinsights/intravacc-gets-us-niaid-contract-to-deve-322343.html 0.6 2026-06-20T23:56:38+08:00 daily https://www.pharmasources.com/industryinsights/mylan-to-acquire-thrombosis-business-in--322344.html 0.6 2026-06-21T02:03:41+08:00 daily https://www.pharmasources.com/industryinsights/amri-to-provide-sterile-fillfinish-mfg-f-322345.html 0.6 2026-06-21T05:18:06+08:00 daily https://www.pharmasources.com/industryinsights/vibalogics-appoints-global-ceo-to-lead-u-322346.html 0.6 2026-06-22T14:31:37+08:00 daily https://www.pharmasources.com/industryinsights/pharmabcine-signs-cmo-contract-with-bine-322347.html 0.6 2026-06-21T07:55:58+08:00 daily https://www.pharmasources.com/industryinsights/janone-prepares-for-gmp-production-322348.html 0.6 2026-06-21T00:01:35+08:00 daily https://www.pharmasources.com/industryinsights/sharp-bolsters-clinical-trials-services--322349.html 0.6 2026-04-13T17:53:37+08:00 daily https://www.pharmasources.com/industryinsights/exelixis-and-catalent-enter-adc-partners-322350.html 0.6 2026-08-07T17:14:48+08:00 daily https://www.pharmasources.com/industryinsights/avacta-to-launch-sars-cov-2-elisa-lab-te-322351.html 0.6 2026-06-21T00:16:52+08:00 daily https://www.pharmasources.com/industryinsights/grifols-to-acquire-biotech-company-alkah-322352.html 0.6 2026-06-21T09:58:37+08:00 daily https://www.pharmasources.com/industryinsights/australia-enters-12bn-covid-19-vaccine-s-322353.html 0.6 2026-06-21T02:06:42+08:00 daily https://www.pharmasources.com/industryinsights/fda-releases-covid-19-response-at-a-glan-322354.html 0.6 2026-06-21T09:57:32+08:00 daily https://www.pharmasources.com/industryinsights/liminal-biosciences-resubmits-bla-for-ry-322355.html 0.6 2026-06-21T06:09:58+08:00 daily https://www.pharmasources.com/industryinsights/blueprint-announces-fda-approval-of-gavr-322356.html 0.6 2026-06-21T13:16:39+08:00 daily https://www.pharmasources.com/industryinsights/project-als-granted-fda-orphan-drug-desi-322357.html 0.6 2026-06-21T07:02:57+08:00 daily https://www.pharmasources.com/industryinsights/avacta-to-launch-sars-cov-2-elisa-labora-322358.html 0.6 2026-08-12T13:18:40+08:00 daily https://www.pharmasources.com/industryinsights/nice-no-for-pierre-fabres-braftovi-322359.html 0.6 2026-08-13T01:44:24+08:00 daily https://www.pharmasources.com/industryinsights/smc-accepts-14-new-medicines-for-use-by--322360.html 0.6 2026-06-21T14:44:17+08:00 daily https://www.pharmasources.com/industryinsights/verona-begins-pilot-study-of-potential-c-322361.html 0.6 2026-06-20T17:14:52+08:00 daily https://www.pharmasources.com/industryinsights/eu-expands-scope-of-imbruvica-to-include-322362.html 0.6 2026-06-22T02:57:38+08:00 daily https://www.pharmasources.com/industryinsights/asymchem-and-snapdragon-enter-investment-322363.html 0.6 2026-06-21T19:57:35+08:00 daily https://www.pharmasources.com/industryinsights/ema-safety-committee-recommends-withdraw-322364.html 0.6 2026-08-05T09:41:55+08:00 daily https://www.pharmasources.com/industryinsights/ampio-announces-enrolment-completion-for-322365.html 0.6 2026-06-22T10:05:55+08:00 daily https://www.pharmasources.com/industryinsights/small-study-shows-convalescent-plasma-is-322366.html 0.6 2026-06-21T03:05:41+08:00 daily https://www.pharmasources.com/industryinsights/a-new-test-could-identify-covid-19-patie-322367.html 0.6 2026-06-23T08:42:47+08:00 daily https://www.pharmasources.com/industryinsights/dcgi-issues-notice-to-serum-institute-ov-322368.html 0.6 2026-06-21T00:51:50+08:00 daily https://www.pharmasources.com/industryinsights/gsk-gets-us-fda-approval-for-trelegy-ell-322369.html 0.6 2026-08-03T11:24:10+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-tentative-usfda-nod-fo-322370.html 0.6 2026-06-20T20:13:51+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-laboratories-launches-diclofen-322371.html 0.6 2026-07-03T21:26:32+08:00 daily https://www.pharmasources.com/industryinsights/scientists-at-university-of-sheffield-di-322372.html 0.6 2026-06-20T18:10:40+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-laboratories-launches-redyx-re-322373.html 0.6 2026-08-14T20:38:35+08:00 daily https://www.pharmasources.com/industryinsights/neovascularization-inhibitor-sales-will--322374.html 0.6 2026-08-10T03:01:44+08:00 daily https://www.pharmasources.com/industryinsights/cadila-pharma-launches-obetocad-generic--322375.html 0.6 2026-06-21T08:13:08+08:00 daily https://www.pharmasources.com/industryinsights/siro-and-azidus-enter-into-an-alliance-322376.html 0.6 2026-06-20T21:59:39+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-stops-covid-19-vaccine-trial-322377.html 0.6 2026-08-12T03:03:08+08:00 daily https://www.pharmasources.com/industryinsights/anges-brickell-biotech-partner-on-dna-va-322378.html 0.6 2026-07-06T20:53:06+08:00 daily https://www.pharmasources.com/industryinsights/health-highlights-sept-9-2020-322379.html 0.6 2026-08-07T00:46:00+08:00 daily https://www.pharmasources.com/industryinsights/black-diamond-therapeutics-appoints-cmo-322380.html 0.6 2026-06-20T18:59:33+08:00 daily https://www.pharmasources.com/industryinsights/clinical-trial-of-astrazeneca-covid-19-v-322381.html 0.6 2026-08-07T03:34:15+08:00 daily https://www.pharmasources.com/industryinsights/milliporesigma-expands-hpapi-and-adc-mfg-322382.html 0.6 2026-07-02T16:04:08+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-opens-new-bioprocessing-ce-322383.html 0.6 2026-06-25T15:38:17+08:00 daily https://www.pharmasources.com/industryinsights/nkmax-america-partners-with-merck-kgaa-a-322384.html 0.6 2026-07-30T08:54:47+08:00 daily https://www.pharmasources.com/industryinsights/pandemic-threatens-gains-in-reducing-pre-322385.html 0.6 2026-08-10T20:57:53+08:00 daily https://www.pharmasources.com/industryinsights/catalent-invests-130m-in-harmans-gene-th-322386.html 0.6 2026-06-20T14:52:08+08:00 daily https://www.pharmasources.com/industryinsights/more-than-half-a-million-us-children-alr-322387.html 0.6 2026-08-06T18:55:04+08:00 daily https://www.pharmasources.com/industryinsights/grifols-to-acquire-alkahest-for-146m-322388.html 0.6 2026-06-20T14:44:59+08:00 daily https://www.pharmasources.com/industryinsights/weight-gain-pattern-early-in-life-may-af-322389.html 0.6 2026-06-20T19:18:01+08:00 daily https://www.pharmasources.com/industryinsights/cd19-car-t-therapy-manufactured-using-lo-322390.html 0.6 2026-08-08T02:03:25+08:00 daily https://www.pharmasources.com/industryinsights/early-trial-offers-new-hope-for-people-w-322391.html 0.6 2026-06-21T19:16:08+08:00 daily https://www.pharmasources.com/industryinsights/ec-concludes-talks-with-pfizer-biontech--322392.html 0.6 2026-08-11T18:43:06+08:00 daily https://www.pharmasources.com/industryinsights/playing-football-at-young-age-doesnt-slo-322393.html 0.6 2026-06-21T16:06:24+08:00 daily https://www.pharmasources.com/industryinsights/mylan-to-acquire-aspens-thrombosis-busin-322394.html 0.6 2026-07-05T00:23:44+08:00 daily https://www.pharmasources.com/industryinsights/youth-vaping-down-but-still-popular-cdc-322395.html 0.6 2026-06-21T00:58:46+08:00 daily https://www.pharmasources.com/industryinsights/executive-moves-at-lilly-322396.html 0.6 2026-06-21T07:00:02+08:00 daily https://www.pharmasources.com/industryinsights/did-columbus-really-introduce-syphilis-t-322397.html 0.6 2026-06-21T04:18:17+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-qdolo-322398.html 0.6 2026-06-21T06:02:56+08:00 daily https://www.pharmasources.com/industryinsights/lenabasum-study-for-systemic-sclerosis-d-322399.html 0.6 2026-07-12T18:54:10+08:00 daily https://www.pharmasources.com/industryinsights/heron-announces-successful-fda-meeting-f-322400.html 0.6 2026-06-22T13:03:14+08:00 daily https://www.pharmasources.com/industryinsights/nice-turns-down-celgenes-revlimid-as-mul-322401.html 0.6 2026-06-20T14:37:00+08:00 daily https://www.pharmasources.com/industryinsights/nao-calls-for-cross-government-initiativ-322402.html 0.6 2026-06-21T09:17:14+08:00 daily https://www.pharmasources.com/industryinsights/atdbio-and-research-team-win-innovate-uk-322403.html 0.6 2026-06-21T19:01:42+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-gavreto-pralsetinib-for-the-322404.html 0.6 2025-11-13T14:34:03+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-additional-doses-of-trulici-322405.html 0.6 2026-07-29T14:37:24+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccine-tablet-induces-systemic-322406.html 0.6 2026-06-20T16:01:35+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-onureg-azacitidine-tablets--322407.html 0.6 2026-06-20T20:09:46+08:00 daily https://www.pharmasources.com/industryinsights/mirum-pharmaceuticals-initiates-rolling--322408.html 0.6 2026-07-25T07:23:12+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-xaracoll-bupivacaine-hydroc-322409.html 0.6 2026-07-30T09:21:18+08:00 daily https://www.pharmasources.com/industryinsights/cycle-pharmaceuticals-secures-25m-debt-f-322410.html 0.6 2026-06-21T15:00:25+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-evinacumab-biologics-license-322411.html 0.6 2026-06-26T19:46:24+08:00 daily https://www.pharmasources.com/industryinsights/bayers-adempas-meets-primary-endpoint-in-322412.html 0.6 2026-06-21T11:02:07+08:00 daily https://www.pharmasources.com/industryinsights/fennec-pharmaceuticals-receives-complete-322413.html 0.6 2026-08-07T16:23:38+08:00 daily https://www.pharmasources.com/industryinsights/ascentage-pharmas-bcl-2-inhibitor-apg-25-322414.html 0.6 2026-06-20T22:12:52+08:00 daily https://www.pharmasources.com/industryinsights/statement-on-astrazeneca-oxford-sars-cov-322415.html 0.6 2026-07-02T23:23:42+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-and-bluebird-bio-an-322416.html 0.6 2026-03-08T23:14:07+08:00 daily https://www.pharmasources.com/industryinsights/janssen-gets-expanded-ec-nod-for-blood-c-322417.html 0.6 2026-06-20T23:15:55+08:00 daily https://www.pharmasources.com/industryinsights/gilead-submits-new-drug-application-to-u-322418.html 0.6 2026-06-21T16:05:23+08:00 daily https://www.pharmasources.com/industryinsights/apha-hails-hhs-announcement-authorizing--322419.html 0.6 2025-11-10T18:28:32+08:00 daily https://www.pharmasources.com/industryinsights/benepure-pharmaceutical-co-ltd-webinar-322420.html 0.6 2026-08-10T15:10:49+08:00 daily https://www.pharmasources.com/industryinsights/benepure-pharmaceutical-co-ltd-exhibitor-322421.html 0.6 2026-08-14T18:52:39+08:00 daily https://www.pharmasources.com/industryinsights/granules-gets-usfda-nod-for-adhd-drug-de-322422.html 0.6 2026-07-29T08:50:34+08:00 daily https://www.pharmasources.com/industryinsights/ksrpo-asks-government-to-bring-in-centra-322423.html 0.6 2026-06-21T11:21:35+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-and-biontech-to-potentially-suppl-322424.html 0.6 2026-07-15T16:00:28+08:00 daily https://www.pharmasources.com/industryinsights/contact-tracing-inside-infected-cells-of-322425.html 0.6 2026-06-21T05:09:50+08:00 daily https://www.pharmasources.com/industryinsights/sii-pauses-trials-of-covid-19-vaccine-ca-322426.html 0.6 2026-06-30T01:21:18+08:00 daily https://www.pharmasources.com/industryinsights/global-pharmas-two-battles-supply-contin-322427.html 0.6 2026-06-27T04:47:31+08:00 daily https://www.pharmasources.com/industryinsights/informing-payers-and-patients-of-biologi-322428.html 0.6 2026-07-10T10:40:23+08:00 daily https://www.pharmasources.com/industryinsights/cipla-health-forays-into-antifungal-prod-322429.html 0.6 2026-08-07T10:08:57+08:00 daily https://www.pharmasources.com/industryinsights/mercks-gefapixant-45-mg-twice-daily-sign-322430.html 0.6 2026-06-20T18:54:34+08:00 daily https://www.pharmasources.com/industryinsights/cmab-biopharma-and-laekna-therapeutics-c-322431.html 0.6 2026-07-01T08:12:46+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-biontech-inch-closer-to-covid-19--322432.html 0.6 2026-08-12T00:19:41+08:00 daily https://www.pharmasources.com/industryinsights/biopharma-leaders-unite-to-stand-with-sc-322433.html 0.6 2026-06-20T21:54:08+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-announces-that-janssens--322434.html 0.6 2026-04-10T09:37:38+08:00 daily https://www.pharmasources.com/industryinsights/gigagen-initiates-large-scale-manufactur-322435.html 0.6 2026-06-20T22:59:38+08:00 daily https://www.pharmasources.com/industryinsights/amylyx-pharmaceuticals-announces-new-eng-322436.html 0.6 2026-06-21T05:57:40+08:00 daily https://www.pharmasources.com/industryinsights/cobra-biologics-and-combigene-partner-322437.html 0.6 2026-06-22T16:23:24+08:00 daily https://www.pharmasources.com/industryinsights/study-confirms-restaurants-bars-are-covi-322438.html 0.6 2026-06-20T21:09:47+08:00 daily https://www.pharmasources.com/industryinsights/children-use-both-sides-of-the-brain-to--322439.html 0.6 2026-06-24T04:57:16+08:00 daily https://www.pharmasources.com/industryinsights/lipac-oncology-announces-completion-of-l-322440.html 0.6 2026-06-21T01:04:48+08:00 daily https://www.pharmasources.com/industryinsights/how-one-hospital-kept-covid-transmission-322441.html 0.6 2026-06-21T09:38:49+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharmas-opaganib-demonstrates-322442.html 0.6 2026-06-22T07:52:47+08:00 daily https://www.pharmasources.com/industryinsights/cdc-nearly-800-us-children-have-develope-322443.html 0.6 2026-06-21T04:56:44+08:00 daily https://www.pharmasources.com/industryinsights/celularity-doses-first-patient-in-trial--322444.html 0.6 2026-07-29T06:05:13+08:00 daily https://www.pharmasources.com/industryinsights/just-how-reliable-are-covid-19-tests-exp-322445.html 0.6 2026-06-20T22:53:54+08:00 daily https://www.pharmasources.com/industryinsights/small-study-shows-convalescent-plasma-sa-322446.html 0.6 2026-07-03T06:52:53+08:00 daily https://www.pharmasources.com/industryinsights/widespread-avoidance-of-medical-care-fou-322447.html 0.6 2026-06-21T12:19:40+08:00 daily https://www.pharmasources.com/industryinsights/nams-updates-guidance-for-genitourinary--322448.html 0.6 2026-06-22T03:09:46+08:00 daily https://www.pharmasources.com/industryinsights/us-expands-scope-of-trelegy-ellipta-to-i-322449.html 0.6 2026-07-01T19:47:16+08:00 daily https://www.pharmasources.com/industryinsights/eu-review-extended-for-biomarins-gene-th-322450.html 0.6 2026-06-21T07:58:57+08:00 daily https://www.pharmasources.com/industryinsights/middle-high-school-students-mainly-use-f-322451.html 0.6 2026-06-21T14:32:49+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-biontech-could-supply-eu-with-300-322452.html 0.6 2026-07-15T15:41:33+08:00 daily https://www.pharmasources.com/industryinsights/controlled-bp-down-among-us-adults-with--322453.html 0.6 2026-06-20T15:13:22+08:00 daily https://www.pharmasources.com/industryinsights/attc-network-gets-further-investment-of--322454.html 0.6 2026-06-22T22:08:25+08:00 daily https://www.pharmasources.com/industryinsights/russia-to-supply-mexico-with-32-million--322455.html 0.6 2026-06-22T07:21:27+08:00 daily https://www.pharmasources.com/industryinsights/65-million-expansion-to-hpapi-manufactur-322456.html 0.6 2026-06-22T11:49:42+08:00 daily https://www.pharmasources.com/industryinsights/french-authority-orders-444m-fine-on-nov-322457.html 0.6 2026-08-10T17:21:47+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-study-links-strict-social-dista-322458.html 0.6 2026-06-21T21:06:45+08:00 daily https://www.pharmasources.com/industryinsights/health-highlights-sept-10-2020-322459.html 0.6 2026-06-24T00:49:42+08:00 daily https://www.pharmasources.com/industryinsights/sinovac-reports-preliminary-phase-iii-re-322460.html 0.6 2026-06-23T12:14:53+08:00 daily https://www.pharmasources.com/industryinsights/scientists-engineer-dna-based-nanotechno-322461.html 0.6 2026-06-20T16:09:34+08:00 daily https://www.pharmasources.com/industryinsights/exelixis-nbe-join-forces-for-discovery-a-322462.html 0.6 2026-08-07T17:15:06+08:00 daily https://www.pharmasources.com/industryinsights/levodopa-may-improve-vision-in-patients--322463.html 0.6 2026-06-20T20:01:32+08:00 daily https://www.pharmasources.com/industryinsights/3924-million-worldwide-adult-hemoglobino-322464.html 0.6 2026-06-23T03:05:00+08:00 daily https://www.pharmasources.com/industryinsights/mental-health-is-a-growing-concern-for-m-322465.html 0.6 2026-06-20T21:02:40+08:00 daily https://www.pharmasources.com/industryinsights/recursion-raises-239m-and-signs-drug-dis-322466.html 0.6 2026-08-08T01:31:44+08:00 daily https://www.pharmasources.com/industryinsights/one-size-fits-all-medication-approach-do-322467.html 0.6 2026-08-06T20:05:17+08:00 daily https://www.pharmasources.com/industryinsights/penn-researchers-solve-decades-old-mitoc-322468.html 0.6 2026-06-20T16:00:16+08:00 daily https://www.pharmasources.com/industryinsights/bicycle-therapeutics-announces-first-pat-322469.html 0.6 2026-07-13T20:33:04+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccine-doses-could-arrive-in-c-322470.html 0.6 2025-11-01T18:00:43+08:00 daily https://www.pharmasources.com/industryinsights/cbd-oil-for-anxiety-stress-2020-top-15-c-322471.html 0.6 2026-08-07T01:27:46+08:00 daily https://www.pharmasources.com/industryinsights/applied-biology-and-corpometria-institut-322472.html 0.6 2026-06-20T23:15:02+08:00 daily https://www.pharmasources.com/industryinsights/top-20-global-pharma-companies-by-mcap-s-322473.html 0.6 2026-08-13T21:04:35+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-and-biontech-submit-proposal-to-u-322474.html 0.6 2026-08-10T09:14:47+08:00 daily https://www.pharmasources.com/industryinsights/gilead-may-soon-buy-immunomedics-in-deal-322475.html 0.6 2026-08-10T15:14:15+08:00 daily https://www.pharmasources.com/industryinsights/clinical-trials-of-astrazeneca-oxford-co-322476.html 0.6 2026-08-07T01:27:46+08:00 daily https://www.pharmasources.com/industryinsights/covaxin-demonstrates-protective-efficacy-322477.html 0.6 2026-08-07T00:53:23+08:00 daily https://www.pharmasources.com/industryinsights/niis-covid-19-vaccine-candidate-exhibits-322478.html 0.6 2026-08-07T00:59:43+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-and-click-therapeut-322479.html 0.6 2026-08-07T01:06:40+08:00 daily https://www.pharmasources.com/industryinsights/patient-activist-groups-express-relief-o-322480.html 0.6 2026-08-07T01:13:55+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-us-fda-approval-for-do-322481.html 0.6 2026-08-07T05:05:57+08:00 daily https://www.pharmasources.com/industryinsights/schott-ag-appoints-pawan-kumar-shukla-as-322482.html 0.6 2026-08-06T23:57:22+08:00 daily https://www.pharmasources.com/industryinsights/pnb-vesper-gets-dcgi-nod-to-test-proprie-322483.html 0.6 2026-08-06T23:46:33+08:00 daily https://www.pharmasources.com/industryinsights/only-152-cmos-are-equipped-to-manufactur-322484.html 0.6 2026-08-06T23:38:19+08:00 daily https://www.pharmasources.com/industryinsights/junshi-biosciences-gets-us-fda-breakthro-322485.html 0.6 2026-08-06T23:37:30+08:00 daily https://www.pharmasources.com/industryinsights/valneva-wins-dod-contract-for-ixiaro-322486.html 0.6 2026-08-06T23:32:44+08:00 daily https://www.pharmasources.com/industryinsights/ibio-advances-covid-19-vaccine-candidate-322487.html 0.6 2026-08-06T22:53:13+08:00 daily https://www.pharmasources.com/industryinsights/regenxbio-announces-dosing-of-first-pati-322488.html 0.6 2026-08-06T23:32:32+08:00 daily https://www.pharmasources.com/industryinsights/casma-therapeutics-raises-50m-to-support-322489.html 0.6 2026-08-06T23:35:46+08:00 daily https://www.pharmasources.com/industryinsights/22-benefits-of-c-b-d-oil-based-on-academ-322490.html 0.6 2026-08-04T22:59:10+08:00 daily https://www.pharmasources.com/industryinsights/eveliqure-announces-niaid-contract-to-st-322491.html 0.6 2026-08-06T23:46:15+08:00 daily https://www.pharmasources.com/industryinsights/viking-therapeutics-announces-initiation-322492.html 0.6 2026-08-07T02:40:53+08:00 daily https://www.pharmasources.com/industryinsights/intra-cellular-therapies-announces-posit-322493.html 0.6 2026-08-07T02:52:25+08:00 daily https://www.pharmasources.com/industryinsights/fda-announces-efficacy-safety-concerns-w-322494.html 0.6 2026-08-07T06:07:05+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-orphan-drug-designation-for-p-322495.html 0.6 2026-08-07T11:28:57+08:00 daily https://www.pharmasources.com/industryinsights/luminer-appoints-sales-executive-322496.html 0.6 2026-08-07T11:55:22+08:00 daily https://www.pharmasources.com/industryinsights/pii-appoints-head-of-project-management-322497.html 0.6 2026-08-07T13:15:14+08:00 daily https://www.pharmasources.com/industryinsights/nice-backs-portolas-ondexxya-322498.html 0.6 2026-08-08T12:36:37+08:00 daily https://www.pharmasources.com/industryinsights/az-fasenra-shows-benefit-in-chronic-rhin-322499.html 0.6 2026-08-13T18:01:25+08:00 daily https://www.pharmasources.com/industryinsights/research-backs-use-of-liquid-biopsy-for--322500.html 0.6 2026-06-20T19:04:39+08:00 daily https://www.pharmasources.com/industryinsights/nihr-ukri-fund-eight-new-coronavirus-res-322501.html 0.6 2026-07-21T18:01:02+08:00 daily https://www.pharmasources.com/industryinsights/impact-of-covid-19-on-clinical-trials-co-322502.html 0.6 2026-06-23T09:11:55+08:00 daily https://www.pharmasources.com/industryinsights/imfinzi-approved-in-eu-to-treat-extensiv-322503.html 0.6 2026-07-21T14:03:35+08:00 daily https://www.pharmasources.com/industryinsights/genome-analyses-track-sars-cov-2s-early--322504.html 0.6 2026-08-07T05:30:46+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-322505.html 0.6 2026-08-07T01:52:03+08:00 daily https://www.pharmasources.com/industryinsights/msf-urges-government-authorities-to-incl-322506.html 0.6 2026-08-07T01:27:54+08:00 daily https://www.pharmasources.com/industryinsights/kiadis-to-collaborate-with-abigail-wexne-322507.html 0.6 2026-08-07T01:21:40+08:00 daily https://www.pharmasources.com/industryinsights/strides-to-invest-rs-1350-mn-in-24-month-322508.html 0.6 2026-08-10T13:01:42+08:00 daily https://www.pharmasources.com/industryinsights/springworks-therapeutics-in-pact-with-ja-322509.html 0.6 2026-08-07T01:31:34+08:00 daily https://www.pharmasources.com/industryinsights/discord-between-ima-and-msn-labs-over-pr-322510.html 0.6 2026-08-07T01:39:39+08:00 daily https://www.pharmasources.com/industryinsights/saptagir-labs-signs-manufacturing-deal-w-322511.html 0.6 2026-08-07T01:45:52+08:00 daily https://www.pharmasources.com/industryinsights/indoco-gets-usfda-nod-for-apixaban-table-322512.html 0.6 2026-08-07T02:04:55+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-centreone-appoints-general-manage-322513.html 0.6 2026-08-07T02:18:40+08:00 daily https://www.pharmasources.com/industryinsights/sai-offers-enhanced-lab-capabilities-322514.html 0.6 2026-08-07T02:22:00+08:00 daily https://www.pharmasources.com/industryinsights/seattle-genetics-and-merck-partner-322515.html 0.6 2026-08-07T02:24:33+08:00 daily https://www.pharmasources.com/industryinsights/mylan-pays-763m-for-aspens-thrombosis-bu-322516.html 0.6 2026-08-10T13:29:59+08:00 daily https://www.pharmasources.com/industryinsights/vectura-and-monash-university-support-de-322517.html 0.6 2026-06-21T05:16:54+08:00 daily https://www.pharmasources.com/industryinsights/ilc-dover-acquires-solo-containment-322518.html 0.6 2026-06-22T13:06:06+08:00 daily https://www.pharmasources.com/industryinsights/evotec-and-bioaster-partner-322519.html 0.6 2026-06-20T18:57:34+08:00 daily https://www.pharmasources.com/industryinsights/rondo-pak-krber-name-president-322520.html 0.6 2026-06-20T22:54:35+08:00 daily https://www.pharmasources.com/industryinsights/cii-approves-carlyles-acquisition-of-sta-322521.html 0.6 2026-06-22T07:59:46+08:00 daily https://www.pharmasources.com/industryinsights/gilead-agrees-to-acquire-immunomedics-fo-322522.html 0.6 2026-07-17T14:33:14+08:00 daily https://www.pharmasources.com/industryinsights/versatope-awarded-grant-for-novel-c-diff-322523.html 0.6 2026-06-22T14:55:54+08:00 daily https://www.pharmasources.com/industryinsights/ampio-reports-positive-results-for-ampio-322524.html 0.6 2026-06-21T07:38:36+08:00 daily https://www.pharmasources.com/industryinsights/leukemia-lymphoma-society-launches-trial-322525.html 0.6 2026-07-04T18:41:33+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-scientific-opens-new-biopr-322526.html 0.6 2026-06-20T14:20:00+08:00 daily https://www.pharmasources.com/industryinsights/myokardia-doses-first-patient-in-danicam-322527.html 0.6 2026-06-21T18:04:28+08:00 daily https://www.pharmasources.com/industryinsights/direct-biologics-initiates-patient-enrol-322528.html 0.6 2026-06-21T21:55:36+08:00 daily https://www.pharmasources.com/industryinsights/nice-backing-for-az-tagrisso-322529.html 0.6 2026-06-20T19:51:57+08:00 daily https://www.pharmasources.com/industryinsights/phase-i-trial-finds-potential-covid-19-a-322530.html 0.6 2026-06-21T12:38:13+08:00 daily https://www.pharmasources.com/industryinsights/clinical-trial-for-astrazeneca-oxford-co-322531.html 0.6 2026-06-20T18:06:32+08:00 daily https://www.pharmasources.com/industryinsights/which-immune-response-could-cause-a-vacc-322532.html 0.6 2026-06-20T15:09:24+08:00 daily https://www.pharmasources.com/industryinsights/csir-and-aurobindo-pharma-to-collaborate-322533.html 0.6 2026-07-16T16:52:25+08:00 daily https://www.pharmasources.com/industryinsights/industry-urges-government-to-define-impl-322534.html 0.6 2026-08-13T06:23:10+08:00 daily https://www.pharmasources.com/industryinsights/sglt-2-inhibitors-may-primarily-drive-gr-322535.html 0.6 2026-06-21T12:07:20+08:00 daily https://www.pharmasources.com/industryinsights/novavax-expands-deal-with-serum-institut-322536.html 0.6 2026-08-03T04:24:09+08:00 daily https://www.pharmasources.com/industryinsights/why-pharma-industry-needs-to-focus-more--322537.html 0.6 2026-08-07T08:49:42+08:00 daily https://www.pharmasources.com/industryinsights/ema-approves-label-update-for-takedas-hy-322538.html 0.6 2026-07-04T23:04:38+08:00 daily https://www.pharmasources.com/industryinsights/baricitinib-in-combination-with-remdesiv-322539.html 0.6 2026-06-21T10:09:12+08:00 daily https://www.pharmasources.com/industryinsights/uk-researchers-to-test-inhaled-versions--322540.html 0.6 2026-06-20T19:02:46+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-denies-approval-to-mallinckrodt-f-322541.html 0.6 2026-08-07T08:42:15+08:00 daily https://www.pharmasources.com/industryinsights/ansa-raises-funds-for-dna-synthesis-tech-322542.html 0.6 2026-06-20T21:55:39+08:00 daily https://www.pharmasources.com/industryinsights/merck-to-acquire-1bn-equity-stake-in-sea-322543.html 0.6 2026-06-20T20:19:53+08:00 daily https://www.pharmasources.com/industryinsights/valneva-dynavax-enter-covid-19-vax-suppl-322544.html 0.6 2026-03-17T20:49:17+08:00 daily https://www.pharmasources.com/industryinsights/takeda-opens-rd-cell-therapy-mfg-facilit-322545.html 0.6 2026-07-29T17:01:49+08:00 daily https://www.pharmasources.com/industryinsights/biontech-to-receive-german-federal-minis-322546.html 0.6 2026-08-02T18:48:50+08:00 daily https://www.pharmasources.com/industryinsights/rain-therapeutics-appoints-chief-science-322547.html 0.6 2026-06-21T22:56:40+08:00 daily https://www.pharmasources.com/industryinsights/apiject-appoints-cfo-322548.html 0.6 2026-06-20T17:59:18+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccine-trials-resume-in-uk-322549.html 0.6 2026-08-10T17:21:58+08:00 daily https://www.pharmasources.com/industryinsights/aztherapies-doses-first-patient-in-alzt--322550.html 0.6 2026-08-07T03:54:55+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-gavreto-for-metastatic-rear-322551.html 0.6 2026-08-07T03:33:58+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-biontech-propose-expansion-of-piv-322552.html 0.6 2026-08-13T15:40:02+08:00 daily https://www.pharmasources.com/industryinsights/reneo-receives-ema-orphan-drug-designati-322553.html 0.6 2026-08-07T03:12:47+08:00 daily https://www.pharmasources.com/industryinsights/bayer-recursion-collaborate-on-therapies-322554.html 0.6 2026-07-19T11:09:37+08:00 daily https://www.pharmasources.com/industryinsights/a-third-of-uk-doctors-have-treated-covid-322555.html 0.6 2026-08-07T00:53:27+08:00 daily https://www.pharmasources.com/industryinsights/joint-letter-implores-government-to-allo-322556.html 0.6 2026-06-21T10:02:11+08:00 daily https://www.pharmasources.com/industryinsights/msd-partners-with-seattle-genetics-on-tw-322557.html 0.6 2026-06-23T02:59:54+08:00 daily https://www.pharmasources.com/industryinsights/shionogi-launches-novel-antibiotic-fetcr-322558.html 0.6 2026-08-09T07:56:20+08:00 daily https://www.pharmasources.com/industryinsights/valneva-inks-137bn-covid-19-vaccine-supp-322559.html 0.6 2026-08-09T00:31:22+08:00 daily https://www.pharmasources.com/industryinsights/nih-launches-antithrombotics-trials-in-c-322560.html 0.6 2026-08-08T07:58:52+08:00 daily https://www.pharmasources.com/industryinsights/promising-interim-results-from-als-study-322561.html 0.6 2026-08-08T04:34:56+08:00 daily https://www.pharmasources.com/industryinsights/tiny-antibody-component-highly-effective-322562.html 0.6 2026-08-13T00:25:02+08:00 daily https://www.pharmasources.com/industryinsights/experimental-covid-19-drug-shows-promise-322563.html 0.6 2026-08-07T13:19:18+08:00 daily https://www.pharmasources.com/industryinsights/does-c-b-d-oil-really-bring-good-results-322564.html 0.6 2026-06-20T20:21:58+08:00 daily https://www.pharmasources.com/industryinsights/medical-c-b-d-oil-side-effects-and-drug--322565.html 0.6 2026-08-11T17:14:29+08:00 daily https://www.pharmasources.com/industryinsights/univercells-technologies-introduces-the--322566.html 0.6 2026-08-09T22:00:39+08:00 daily https://www.pharmasources.com/industryinsights/top-15-c-b-d-oil-for-anxiety-reviews-322567.html 0.6 2026-08-09T23:49:37+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-news-of-august-pharmasour-322568.html 0.6 2026-06-27T08:55:06+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-news-of-august-pharmasour-322569.html 0.6 2026-08-13T22:29:19+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-news-of-august-pharmasour-322570.html 0.6 2026-05-01T06:35:21+08:00 daily https://www.pharmasources.com/industryinsights/uqc-standardisation-processes-disturb-ph-322571.html 0.6 2026-06-20T22:16:16+08:00 daily https://www.pharmasources.com/industryinsights/serum-institute-receives-dcgi-approval-t-322572.html 0.6 2026-08-03T04:24:06+08:00 daily https://www.pharmasources.com/industryinsights/rdif-and-dr-reddys-to-partner-for-trials-322573.html 0.6 2026-06-20T14:48:07+08:00 daily https://www.pharmasources.com/industryinsights/why-covid-19-presents-a-golden-opportuni-322574.html 0.6 2026-07-06T21:25:16+08:00 daily https://www.pharmasources.com/industryinsights/axon-announces-positive-pre-clinical-res-322575.html 0.6 2026-08-14T07:59:18+08:00 daily https://www.pharmasources.com/industryinsights/reshape-announces-positive-preclinical-r-322576.html 0.6 2026-08-07T20:37:06+08:00 daily https://www.pharmasources.com/industryinsights/janssen-submits-light-chain-amyloidosis--322577.html 0.6 2026-07-24T14:19:24+08:00 daily https://www.pharmasources.com/industryinsights/fasenra-meets-co-primary-endpoints-322578.html 0.6 2026-06-23T06:27:50+08:00 daily https://www.pharmasources.com/industryinsights/zavegepant-receives-authorization-to-pro-322579.html 0.6 2026-06-20T14:46:13+08:00 daily https://www.pharmasources.com/industryinsights/neurosense-announces-encouraging-interim-322580.html 0.6 2026-06-21T11:02:11+08:00 daily https://www.pharmasources.com/industryinsights/fda-clears-ind-application-for-vaxart-or-322581.html 0.6 2026-08-10T11:21:54+08:00 daily https://www.pharmasources.com/industryinsights/lubrizol-supports-womens-health-worldwid-322582.html 0.6 2026-06-22T03:11:52+08:00 daily https://www.pharmasources.com/industryinsights/ensemble-invests-in-phillys-navy-yard-li-322583.html 0.6 2026-07-18T06:47:46+08:00 daily https://www.pharmasources.com/industryinsights/us-researchers-identify-tiny-molecule-to-322584.html 0.6 2026-06-21T16:01:26+08:00 daily https://www.pharmasources.com/industryinsights/germany-awards-750m-to-biontech-and-cure-322585.html 0.6 2026-06-26T19:00:27+08:00 daily https://www.pharmasources.com/industryinsights/phase-iii-trial-to-study-regn-cov2-poten-322586.html 0.6 2026-08-10T17:22:52+08:00 daily https://www.pharmasources.com/industryinsights/oral-covid-19-vaccine-candidate-to-enter-322587.html 0.6 2026-08-08T10:49:58+08:00 daily https://www.pharmasources.com/industryinsights/sleep-apnoea-linked-to-poorer-outcomes-f-322588.html 0.6 2026-08-08T09:47:06+08:00 daily https://www.pharmasources.com/industryinsights/icr-study-combines-precision-medicines-t-322589.html 0.6 2026-08-08T07:37:13+08:00 daily https://www.pharmasources.com/industryinsights/gensight-biologics-seeks-eu-approval-for-322590.html 0.6 2026-08-10T01:30:43+08:00 daily https://www.pharmasources.com/industryinsights/nice-unites-with-global-health-leaders-t-322591.html 0.6 2026-08-08T06:17:00+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-initiates-phase-2-study-o-322592.html 0.6 2026-08-08T08:02:50+08:00 daily https://www.pharmasources.com/industryinsights/hifibio-abl-bio-to-co-develop-hfb30132a--322593.html 0.6 2026-08-08T14:47:12+08:00 daily https://www.pharmasources.com/industryinsights/progress-toward-antiviral-treatments-for-322594.html 0.6 2026-08-11T12:55:58+08:00 daily https://www.pharmasources.com/industryinsights/designed-antiviral-proteins-inhibit-sars-322595.html 0.6 2026-08-06T10:45:51+08:00 daily https://www.pharmasources.com/industryinsights/tridentcare-to-provide-covid-19-testing-322596.html 0.6 2026-06-21T09:12:18+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-signs-development-agre-322597.html 0.6 2026-01-22T13:44:45+08:00 daily https://www.pharmasources.com/industryinsights/acellular-convalescent-plasma-a-cp-and-n-322598.html 0.6 2026-07-06T22:21:17+08:00 daily https://www.pharmasources.com/industryinsights/imvax-appoints-wendy-dicicco-as-new-boar-322599.html 0.6 2026-08-10T12:00:59+08:00 daily https://www.pharmasources.com/industryinsights/lilly-and-amgen-to-collaborate-for-manuf-322600.html 0.6 2026-08-11T00:46:49+08:00 daily https://www.pharmasources.com/industryinsights/moderna-would-seek-eua-in-us-for-covid-1-322601.html 0.6 2026-06-21T03:03:43+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-announces-settlement-of-revlim-322602.html 0.6 2026-06-20T14:48:09+08:00 daily https://www.pharmasources.com/industryinsights/government-plans-a-total-of-10500-janaus-322603.html 0.6 2026-02-28T13:55:20+08:00 daily https://www.pharmasources.com/industryinsights/biontech-to-buy-site-from-novartis-to-bo-322604.html 0.6 2026-06-17T20:15:25+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-launches-otc-olopatadine-hydro-322605.html 0.6 2026-07-25T06:18:04+08:00 daily https://www.pharmasources.com/industryinsights/cdsco-asks-karnataka-drug-controller-to--322606.html 0.6 2026-07-25T06:11:47+08:00 daily https://www.pharmasources.com/industryinsights/sorrento-gets-us-fda-nod-for-phase-1-cli-322607.html 0.6 2026-07-25T06:17:53+08:00 daily https://www.pharmasources.com/industryinsights/palleon-pharmaceuticals-secures-100m-in--322608.html 0.6 2026-07-25T06:20:56+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-acquires-dogma-therapeutics--322609.html 0.6 2026-07-25T06:26:49+08:00 daily https://www.pharmasources.com/industryinsights/moderna-and-vertex-partner-on-gene-editi-322610.html 0.6 2026-08-08T07:08:14+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-dupixent-breakthrough-therapy-322611.html 0.6 2026-07-26T09:12:14+08:00 daily https://www.pharmasources.com/industryinsights/vbl-enrolls-first-patients-in-vb-111-tri-322612.html 0.6 2026-07-25T06:38:56+08:00 daily https://www.pharmasources.com/industryinsights/drug-candidate-glr2007-granted-fda-orpha-322613.html 0.6 2026-07-25T06:41:54+08:00 daily https://www.pharmasources.com/industryinsights/reyvow-c-v-demonstrated-pain-freedom-fro-322614.html 0.6 2026-07-25T06:45:08+08:00 daily https://www.pharmasources.com/industryinsights/lumithera-diopsys-enrolls-of-first-subje-322615.html 0.6 2026-07-25T06:47:49+08:00 daily https://www.pharmasources.com/industryinsights/streck-cell-free-dna-bct-receives-fda-de-322616.html 0.6 2026-07-25T07:00:10+08:00 daily https://www.pharmasources.com/industryinsights/ivd-industry-must-be-supported-in-covid--322617.html 0.6 2026-08-06T00:37:06+08:00 daily https://www.pharmasources.com/industryinsights/novartis-tafinlar-plus-mekinist-shows-lo-322618.html 0.6 2026-07-25T07:09:22+08:00 daily https://www.pharmasources.com/industryinsights/lillys-covid-19-antibody-shows-promise-i-322619.html 0.6 2026-07-25T07:11:57+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-mirati-therapeutics-enter-cli-322620.html 0.6 2026-08-07T03:27:38+08:00 daily https://www.pharmasources.com/industryinsights/biontech-to-acquire-novartis-mfg-site-fo-322621.html 0.6 2026-07-25T07:21:09+08:00 daily https://www.pharmasources.com/industryinsights/vaccinex-merck-collaborate-on-keytruda-c-322622.html 0.6 2026-07-25T12:41:56+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-inks-service-pact-with-322623.html 0.6 2026-07-25T07:29:56+08:00 daily https://www.pharmasources.com/industryinsights/cold-chain-technologies-appoints-ceo-322624.html 0.6 2026-07-25T07:32:53+08:00 daily https://www.pharmasources.com/industryinsights/aprecia-appoints-regulatory-affairs-svp-322625.html 0.6 2026-07-25T07:39:02+08:00 daily https://www.pharmasources.com/industryinsights/t-cells-take-the-lead-in-controlling-sar-322626.html 0.6 2026-06-20T19:00:35+08:00 daily https://www.pharmasources.com/industryinsights/curasen-doses-first-subjects-in-phase-1--322627.html 0.6 2026-06-22T04:40:31+08:00 daily https://www.pharmasources.com/industryinsights/gilead-gets-fda-breakthrough-therapy-sta-322628.html 0.6 2026-07-17T23:32:17+08:00 daily https://www.pharmasources.com/industryinsights/melior-pharmaceuticals-awarded-grant-for-322629.html 0.6 2026-06-22T03:55:40+08:00 daily https://www.pharmasources.com/industryinsights/morphosys-and-i-mab-announce-fda-clearan-322630.html 0.6 2026-07-03T15:09:49+08:00 daily https://www.pharmasources.com/industryinsights/powder-flowunderstanding-the-impact-of-h-322631.html 0.6 2026-06-23T16:04:35+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-in-treatment-in-rhovacs-cl-322632.html 0.6 2026-07-16T12:59:20+08:00 daily https://www.pharmasources.com/industryinsights/dr-steven-yu-joins-chempartner-as-vice-p-322633.html 0.6 2026-06-22T05:00:39+08:00 daily https://www.pharmasources.com/industryinsights/scientists-find-new-drug-that-may-be-abl-322634.html 0.6 2026-07-01T16:45:15+08:00 daily https://www.pharmasources.com/industryinsights/developing-herd-immunity-without-pharma--322635.html 0.6 2026-01-04T12:20:03+08:00 daily https://www.pharmasources.com/industryinsights/lsv-capital-to-invest-70-million-for-ind-322636.html 0.6 2026-06-22T07:00:52+08:00 daily https://www.pharmasources.com/industryinsights/trodelvy-from-immunomedics-extends-survi-322637.html 0.6 2026-07-05T05:29:46+08:00 daily https://www.pharmasources.com/industryinsights/experimental-drug-blocks-covid-19-viral--322638.html 0.6 2026-08-13T21:30:38+08:00 daily https://www.pharmasources.com/industryinsights/future-pharma-policies-will-be-aligned-t-322639.html 0.6 2026-06-26T13:35:53+08:00 daily https://www.pharmasources.com/industryinsights/manjiri-gharat-elected-as-vp-of-fip-for--322640.html 0.6 2026-06-22T08:58:43+08:00 daily https://www.pharmasources.com/industryinsights/s-aparna-appointed-as-secretary-departme-322641.html 0.6 2026-07-07T13:33:01+08:00 daily https://www.pharmasources.com/industryinsights/roche-gets-positive-chmp-opinion-for-tec-322642.html 0.6 2026-06-02T22:06:12+08:00 daily https://www.pharmasources.com/industryinsights/goi-publishes-research-procedure-for-cov-322643.html 0.6 2026-06-22T10:31:52+08:00 daily https://www.pharmasources.com/industryinsights/chmp-advises-approval-for-bristol-myers--322644.html 0.6 2026-08-05T15:17:03+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-us-fda-nod-for-potassi-322645.html 0.6 2026-06-20T20:56:35+08:00 daily https://www.pharmasources.com/industryinsights/indian-pharma-industry-will-be-among-the-322646.html 0.6 2026-07-08T19:22:19+08:00 daily https://www.pharmasources.com/industryinsights/online-offline-pharmacy-collaboration-wi-322647.html 0.6 2026-07-28T12:11:44+08:00 daily https://www.pharmasources.com/industryinsights/medicines-manufacturing-innovation-centr-322648.html 0.6 2026-06-20T15:53:36+08:00 daily https://www.pharmasources.com/industryinsights/alnylam-partners-with-sharp-322649.html 0.6 2026-06-20T17:47:16+08:00 daily https://www.pharmasources.com/industryinsights/russia-authorises-first-covid-19-drug-co-322650.html 0.6 2026-06-20T15:00:19+08:00 daily https://www.pharmasources.com/industryinsights/jj-faces-2bn-insurance-fraud-charges-ove-322651.html 0.6 2026-06-21T17:17:41+08:00 daily https://www.pharmasources.com/industryinsights/biontech-to-acquire-novartis-site-for-co-322652.html 0.6 2026-07-05T10:38:28+08:00 daily https://www.pharmasources.com/industryinsights/fortress-biotech-announces-initiation-of-322653.html 0.6 2026-07-13T07:26:27+08:00 daily https://www.pharmasources.com/industryinsights/baricitinib-remdesivir-trial-reduces-rec-322654.html 0.6 2026-07-03T23:40:10+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-scientific-astrazeneca-to--322655.html 0.6 2026-08-07T22:38:54+08:00 daily https://www.pharmasources.com/industryinsights/springworks-janssen-to-evaluate-nirogace-322656.html 0.6 2026-06-21T01:14:01+08:00 daily https://www.pharmasources.com/industryinsights/schizophrenia-treatment-trial-meets-prim-322657.html 0.6 2026-06-20T14:36:32+08:00 daily https://www.pharmasources.com/industryinsights/novartis-reports-positive-topline-result-322658.html 0.6 2026-08-12T05:05:21+08:00 daily https://www.pharmasources.com/industryinsights/bms-opdivo-wins-new-nice-lung-cancer-bac-322659.html 0.6 2026-06-21T14:51:17+08:00 daily https://www.pharmasources.com/industryinsights/bayers-vitrakvi-shows-long-term-efficacy-322660.html 0.6 2026-06-21T07:16:38+08:00 daily https://www.pharmasources.com/industryinsights/access-to-coronavirus-tests-should-be-to-322661.html 0.6 2026-07-09T12:48:41+08:00 daily https://www.pharmasources.com/industryinsights/nice-u-turn-sees-akceas-waylivra-win-nhs-322662.html 0.6 2026-07-05T12:29:10+08:00 daily https://www.pharmasources.com/industryinsights/smart-biomaterial-drug-delivery-system-c-322663.html 0.6 2026-06-30T16:38:38+08:00 daily https://www.pharmasources.com/industryinsights/viva-biotech-and-synthesis-enters-a-stra-322664.html 0.6 2026-06-25T13:10:58+08:00 daily https://www.pharmasources.com/industryinsights/preparation-products-of-yiling-pharma-ap-322665.html 0.6 2026-07-01T09:50:21+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-322666.html 0.6 2026-06-22T07:00:53+08:00 daily https://www.pharmasources.com/industryinsights/sparc-signs-license-agreement-with-tripo-322667.html 0.6 2026-06-25T12:26:27+08:00 daily https://www.pharmasources.com/industryinsights/arca-biopharma-submits-ind-application-t-322668.html 0.6 2026-06-29T12:24:53+08:00 daily https://www.pharmasources.com/industryinsights/bdr-pharma-launches-80mg-of-enzalutamide-322669.html 0.6 2026-07-04T16:39:26+08:00 daily https://www.pharmasources.com/industryinsights/biolife-solutions-acquires-scisafe-322670.html 0.6 2026-07-10T11:52:24+08:00 daily https://www.pharmasources.com/industryinsights/piramal-opens-solid-oral-dosage-facility-322671.html 0.6 2026-06-20T14:44:06+08:00 daily https://www.pharmasources.com/industryinsights/scenic-biotech-genentech-enter-genetic-m-322672.html 0.6 2026-07-01T22:53:53+08:00 daily https://www.pharmasources.com/industryinsights/pharmabcine-partners-with-samsung-biolog-322673.html 0.6 2026-03-25T19:32:09+08:00 daily https://www.pharmasources.com/industryinsights/viva-biotech-and-synthesis-enter-strateg-322674.html 0.6 2026-06-22T11:57:04+08:00 daily https://www.pharmasources.com/industryinsights/t-knife-catalent-sign-tech-transfer-and--322675.html 0.6 2026-06-21T07:56:14+08:00 daily https://www.pharmasources.com/industryinsights/arca-submits-ind-for-ab201-in-covid-19-322676.html 0.6 2026-06-21T01:01:47+08:00 daily https://www.pharmasources.com/industryinsights/roche-acquires-biotech-firm-inflazome-fo-322677.html 0.6 2026-08-10T14:25:26+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-gsk-agree-to-supply-covid-19--322678.html 0.6 2026-06-21T01:28:54+08:00 daily https://www.pharmasources.com/industryinsights/biontech-to-receive-funding-to-support-c-322679.html 0.6 2026-08-11T09:31:49+08:00 daily https://www.pharmasources.com/industryinsights/ardelyx-announces-nda-acceptance-of-tena-322680.html 0.6 2026-06-21T05:46:36+08:00 daily https://www.pharmasources.com/industryinsights/immunity-pharma-announces-promising-inte-322681.html 0.6 2026-06-21T04:15:54+08:00 daily https://www.pharmasources.com/industryinsights/mylan-pfizer-receive-ec-approval-for-pro-322682.html 0.6 2026-06-09T05:10:19+08:00 daily https://www.pharmasources.com/industryinsights/benevolentais-platform-derived-hypothesi-322683.html 0.6 2026-06-22T07:00:47+08:00 daily https://www.pharmasources.com/industryinsights/supernus-submits-spn-830-nda-for-apomorp-322684.html 0.6 2026-08-06T19:37:16+08:00 daily https://www.pharmasources.com/industryinsights/keytrudalenvima-combo-shows-promise-in-h-322685.html 0.6 2026-07-05T13:37:48+08:00 daily https://www.pharmasources.com/industryinsights/university-of-edinburgh-spinout-cellinta-322686.html 0.6 2025-10-31T14:07:06+08:00 daily https://www.pharmasources.com/industryinsights/lynparza-scores-long-term-benefit-data-i-322687.html 0.6 2026-07-10T06:52:22+08:00 daily https://www.pharmasources.com/industryinsights/chmp-backs-seven-new-meds-in-september-m-322688.html 0.6 2026-06-20T14:27:16+08:00 daily https://www.pharmasources.com/industryinsights/santen-and-us-ophthalmic-company-eyevanc-322689.html 0.6 2026-07-09T09:31:52+08:00 daily https://www.pharmasources.com/industryinsights/uk-prime-minister-visits-the-uk-vaccines-322690.html 0.6 2026-06-21T07:08:05+08:00 daily https://www.pharmasources.com/industryinsights/avelumab-significantly-improves-advanced-322691.html 0.6 2026-06-21T09:51:24+08:00 daily https://www.pharmasources.com/industryinsights/an-overview-of-indian-covid-19-vaccine-s-322692.html 0.6 2026-06-21T23:08:48+08:00 daily https://www.pharmasources.com/industryinsights/hpapi-facility-developed-to-produce-biod-322693.html 0.6 2026-06-18T07:15:44+08:00 daily https://www.pharmasources.com/industryinsights/boost-for-global-response-to-covid-19-as-322694.html 0.6 2026-06-21T22:51:48+08:00 daily https://www.pharmasources.com/industryinsights/researchers-uncover-early-results-about--322695.html 0.6 2026-06-20T14:45:07+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-and-astrazeneca-forge--322696.html 0.6 2026-08-13T23:20:05+08:00 daily https://www.pharmasources.com/industryinsights/ortho-awarded-barda-contract-to-accelera-322697.html 0.6 2026-06-20T14:20:01+08:00 daily https://www.pharmasources.com/industryinsights/harbour-biomed-announces-two-china-nmpa--322698.html 0.6 2026-08-06T08:09:19+08:00 daily https://www.pharmasources.com/industryinsights/serum-institute-starts-manufacturing-cod-322699.html 0.6 2026-08-13T15:38:36+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-launches-ilumya-tildrakizumab-322700.html 0.6 2026-08-07T16:22:07+08:00 daily https://www.pharmasources.com/industryinsights/strides-gets-usfda-approval-for-butalbit-322701.html 0.6 2026-06-20T22:03:47+08:00 daily https://www.pharmasources.com/industryinsights/lupin-launches-divalproex-sodium-er-tabl-322702.html 0.6 2026-08-14T10:46:58+08:00 daily https://www.pharmasources.com/industryinsights/bayer-gets-dcgi-nod-for-intravitreal-afl-322703.html 0.6 2026-06-21T08:55:55+08:00 daily https://www.pharmasources.com/industryinsights/aphena-pharma-invests-21m-in-tennessee-e-322704.html 0.6 2026-06-23T06:09:05+08:00 daily https://www.pharmasources.com/industryinsights/lantern-pharma-and-fox-chase-cancer-cent-322705.html 0.6 2026-06-22T08:02:48+08:00 daily https://www.pharmasources.com/industryinsights/stevanato-group-and-bexson-biomedical-co-322706.html 0.6 2026-06-21T05:51:42+08:00 daily https://www.pharmasources.com/industryinsights/gx-biological-solutions-adds-two-innovat-322707.html 0.6 2026-08-01T10:35:17+08:00 daily https://www.pharmasources.com/industryinsights/metrics-contracts-services-begins-10m-pl-322708.html 0.6 2026-06-20T14:56:13+08:00 daily https://www.pharmasources.com/industryinsights/bausch-health-to-acquire-ophthalmology-a-322709.html 0.6 2026-08-07T04:04:00+08:00 daily https://www.pharmasources.com/industryinsights/arena-announces-first-subject-dosed-etra-322710.html 0.6 2026-08-07T01:52:23+08:00 daily https://www.pharmasources.com/industryinsights/fda-publishes-comparative-performance-da-322711.html 0.6 2026-08-07T12:10:33+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-study-to-investigate-cell-t-322712.html 0.6 2026-08-07T13:18:27+08:00 daily https://www.pharmasources.com/industryinsights/7-hills-pharma-receives-nci-grant-for-im-322713.html 0.6 2026-08-07T18:30:58+08:00 daily https://www.pharmasources.com/industryinsights/mediwound-announces-nexobrid-bla-accepta-322714.html 0.6 2026-08-10T01:21:00+08:00 daily https://www.pharmasources.com/industryinsights/seattle-avm-announces-second-ind-for-avm-322715.html 0.6 2026-08-08T00:09:10+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibbs-opdivo-shows-benef-322716.html 0.6 2026-08-07T01:14:31+08:00 daily https://www.pharmasources.com/industryinsights/gsks-zejula-and-azs-lynparza-leap-toward-322717.html 0.6 2026-08-07T00:42:15+08:00 daily https://www.pharmasources.com/industryinsights/uks-chief-medical-officers-upgrade-coron-322718.html 0.6 2026-08-07T00:02:04+08:00 daily https://www.pharmasources.com/industryinsights/ind-granted-to-ampion-as-covid-19-treatm-322719.html 0.6 2026-08-06T23:56:17+08:00 daily https://www.pharmasources.com/industryinsights/vifor-pharma-group-announces-successful--322720.html 0.6 2026-08-06T23:47:48+08:00 daily https://www.pharmasources.com/industryinsights/padcev-succeeds-in-confirmatory-phase-3--322721.html 0.6 2026-08-06T23:32:52+08:00 daily https://www.pharmasources.com/industryinsights/minoryx-therapeutics-and-sperogenix-ther-322722.html 0.6 2026-08-06T23:36:41+08:00 daily https://www.pharmasources.com/industryinsights/iherb-meeting-increased-worldwide-demand-322723.html 0.6 2026-08-06T23:57:24+08:00 daily https://www.pharmasources.com/industryinsights/vela-diagnostics-sars-cov-2-rt-pcr-test--322724.html 0.6 2026-08-09T01:11:27+08:00 daily https://www.pharmasources.com/industryinsights/sterile-solvent-crystallization-api-syst-322725.html 0.6 2026-08-09T13:22:38+08:00 daily https://www.pharmasources.com/industryinsights/the-impact-of-the-human-genome-project-o-322726.html 0.6 2026-07-31T20:27:07+08:00 daily https://www.pharmasources.com/industryinsights/insights-into-the-oncology-landscape-in--322727.html 0.6 2026-08-11T04:55:23+08:00 daily https://www.pharmasources.com/industryinsights/csir-and-mylan-in-partnership-to-develop-322728.html 0.6 2026-06-20T21:16:56+08:00 daily https://www.pharmasources.com/industryinsights/hester-signs-deal-icar-ivri-for-technolo-322729.html 0.6 2026-07-11T19:40:23+08:00 daily https://www.pharmasources.com/industryinsights/biocon-appoints-anupam-jindal-as-its-cfo-322730.html 0.6 2026-06-20T15:54:31+08:00 daily https://www.pharmasources.com/industryinsights/vivet-pfizer-sign-manufacturing-pact-for-322731.html 0.6 2026-06-30T04:58:02+08:00 daily https://www.pharmasources.com/industryinsights/bharat-biotech-signs-deal-with-washingto-322732.html 0.6 2026-07-10T07:18:30+08:00 daily https://www.pharmasources.com/industryinsights/sperogenix-and-minoryx-enter-exclusive-l-322733.html 0.6 2026-07-27T08:55:59+08:00 daily https://www.pharmasources.com/industryinsights/jj-initiates-phase-iii-ensemble-trial-fo-322734.html 0.6 2026-06-20T23:13:51+08:00 daily https://www.pharmasources.com/industryinsights/parexel-acquires-roam-analytics-nlp-capa-322735.html 0.6 2026-07-13T13:31:13+08:00 daily https://www.pharmasources.com/industryinsights/ers-genomics-appoints-ip-commercial-deve-322736.html 0.6 2026-06-21T04:55:43+08:00 daily https://www.pharmasources.com/industryinsights/dod-selects-pharm-olam-to-support-to-ope-322737.html 0.6 2026-03-19T23:30:10+08:00 daily https://www.pharmasources.com/industryinsights/hovione-to-support-manufacture-of-remdes-322738.html 0.6 2026-06-21T10:45:59+08:00 daily https://www.pharmasources.com/industryinsights/hitachi-chemicals-regenerative-medicine--322739.html 0.6 2026-06-21T19:13:59+08:00 daily https://www.pharmasources.com/industryinsights/europital-launches-as-full-service-cro-322740.html 0.6 2026-07-07T01:23:41+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-gsk-sign-covid-19-vaccine-sup-322741.html 0.6 2026-07-17T07:57:50+08:00 daily https://www.pharmasources.com/industryinsights/permira-to-acquire-german-pharma-firm-ne-322742.html 0.6 2026-06-29T06:38:14+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-to-seek-approval-for-avigan-in--322743.html 0.6 2026-06-20T20:46:22+08:00 daily https://www.pharmasources.com/industryinsights/biontech-to-acquire-gmp-manufacturing-si-322744.html 0.6 2026-08-13T16:37:36+08:00 daily https://www.pharmasources.com/industryinsights/cebina-reports-positive-findings-on-azel-322745.html 0.6 2026-06-22T09:45:45+08:00 daily https://www.pharmasources.com/industryinsights/rigel-announces-nihnhlbi-sponsored-trial-322746.html 0.6 2026-06-21T06:01:49+08:00 daily https://www.pharmasources.com/industryinsights/fda-encourages-use-of-drug-master-files--322747.html 0.6 2026-07-19T06:44:05+08:00 daily https://www.pharmasources.com/industryinsights/menarini-ricerche-announces-dose-escalat-322748.html 0.6 2026-06-21T01:02:49+08:00 daily https://www.pharmasources.com/industryinsights/digital-tech-has-health-benefits-for-dem-322749.html 0.6 2026-08-09T20:47:59+08:00 daily https://www.pharmasources.com/industryinsights/owlstone-medicals-breath-biopsy-test-imp-322750.html 0.6 2026-08-07T01:19:40+08:00 daily https://www.pharmasources.com/industryinsights/vertex-crispr-therapeutics-sickle-cell-g-322751.html 0.6 2026-06-22T07:47:36+08:00 daily https://www.pharmasources.com/industryinsights/serum-institute-of-india-outsourced-manu-322752.html 0.6 2026-07-30T01:38:54+08:00 daily https://www.pharmasources.com/industryinsights/herd-immunity-is-an-impractical-covid-19-322753.html 0.6 2026-06-20T22:52:51+08:00 daily https://www.pharmasources.com/industryinsights/us-expands-covid-19-convalescent-plasma--322754.html 0.6 2026-06-21T05:15:56+08:00 daily https://www.pharmasources.com/industryinsights/sinovac-begins-covid-19-vaccine-candidat-322755.html 0.6 2026-06-20T18:48:27+08:00 daily https://www.pharmasources.com/industryinsights/mercks-keytruda-plus-chemotherapy-meets--322756.html 0.6 2026-06-21T08:03:04+08:00 daily https://www.pharmasources.com/industryinsights/onkure-pfizer-collaborate-to-evaluate-co-322757.html 0.6 2026-06-20T19:11:07+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-signs-strategic-partne-322758.html 0.6 2026-08-07T04:44:25+08:00 daily https://www.pharmasources.com/industryinsights/immvira-announces-us10-million-strategic-322759.html 0.6 2026-08-05T23:55:43+08:00 daily https://www.pharmasources.com/industryinsights/cipla-gets-us-fda-approval-for-dimethyl--322760.html 0.6 2026-08-01T00:19:29+08:00 daily https://www.pharmasources.com/industryinsights/government-asks-statesuts-to-establish-r-322761.html 0.6 2026-06-20T14:47:05+08:00 daily https://www.pharmasources.com/industryinsights/digital-adoption-by-pharma-manufacturers-322762.html 0.6 2026-08-14T21:15:07+08:00 daily https://www.pharmasources.com/industryinsights/kool-ex-partners-with-indospace-to-build-322763.html 0.6 2026-07-05T23:28:24+08:00 daily https://www.pharmasources.com/industryinsights/panacea-biotec-completes-phase-iii-study-322764.html 0.6 2026-07-05T00:26:00+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-receives-tentative-usfda-ap-322765.html 0.6 2026-06-20T21:13:10+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-recalls-metformin-due-to-high-322766.html 0.6 2026-07-17T08:29:14+08:00 daily https://www.pharmasources.com/industryinsights/global-opioid-use-disorder-market-to-rea-322767.html 0.6 2026-06-21T06:23:17+08:00 daily https://www.pharmasources.com/industryinsights/chargepoint-technology-appoints-cfo-322768.html 0.6 2026-06-20T21:21:04+08:00 daily https://www.pharmasources.com/industryinsights/stevanato-group-opens-technology-excelle-322769.html 0.6 2026-06-28T06:32:06+08:00 daily https://www.pharmasources.com/industryinsights/sygnature-discovery-acquires-xenogesis-322770.html 0.6 2026-08-08T10:06:06+08:00 daily https://www.pharmasources.com/industryinsights/algenex-sl-inaugurates-facility-in-spain-322771.html 0.6 2026-06-21T09:13:13+08:00 daily https://www.pharmasources.com/industryinsights/catalent-acquires-new-biologics-facility-322772.html 0.6 2026-06-28T20:04:22+08:00 daily https://www.pharmasources.com/industryinsights/alvotech-and-dksh-extend-biosimilar-part-322773.html 0.6 2026-06-28T12:22:07+08:00 daily https://www.pharmasources.com/industryinsights/rdif-and-chemrar-agree-to-supply-avifavi-322774.html 0.6 2026-06-20T16:48:26+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-priority-review-for-pfizers-x-322775.html 0.6 2026-06-21T19:00:36+08:00 daily https://www.pharmasources.com/industryinsights/novartis-faces-delay-in-expansion-of-sma-322776.html 0.6 2026-06-22T07:52:45+08:00 daily https://www.pharmasources.com/industryinsights/morphosys-i-mab-announce-ind-application-322777.html 0.6 2026-06-22T12:03:54+08:00 daily https://www.pharmasources.com/industryinsights/arca-submits-ind-application-for-ab201-a-322778.html 0.6 2026-06-23T18:19:45+08:00 daily https://www.pharmasources.com/industryinsights/beech-tree-labs-selects-curavit-clinical-322779.html 0.6 2026-06-20T20:46:22+08:00 daily https://www.pharmasources.com/industryinsights/pacira-receives-positive-chmp-opinion-fo-322780.html 0.6 2026-06-21T04:00:46+08:00 daily https://www.pharmasources.com/industryinsights/acella-recalls-two-lots-of-np-thyroid-du-322781.html 0.6 2026-06-21T12:11:23+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-ind-approves-trial-protocol-o-322782.html 0.6 2026-06-21T23:56:11+08:00 daily https://www.pharmasources.com/industryinsights/oncimmune-partners-with-genentech-to-pro-322783.html 0.6 2026-06-21T05:13:52+08:00 daily https://www.pharmasources.com/industryinsights/verona-pharma-launches-late-stage-copd-t-322784.html 0.6 2026-06-22T03:56:48+08:00 daily https://www.pharmasources.com/industryinsights/fda-and-ema-accept-regulatory-submission-322785.html 0.6 2026-08-09T17:55:19+08:00 daily https://www.pharmasources.com/industryinsights/eu-to-receive-300-million-covid-19-vacci-322786.html 0.6 2026-08-08T13:46:53+08:00 daily https://www.pharmasources.com/industryinsights/eua-requested-for-potential-covid-19-res-322787.html 0.6 2026-08-08T12:34:01+08:00 daily https://www.pharmasources.com/industryinsights/global-anti-counterfeit-packaging-market-322788.html 0.6 2026-08-07T13:17:14+08:00 daily https://www.pharmasources.com/industryinsights/cstone-announces-preliminary-results-fro-322789.html 0.6 2026-08-07T12:02:55+08:00 daily https://www.pharmasources.com/industryinsights/neurophth-therapeutics-treatment-of-lebe-322790.html 0.6 2026-08-07T02:31:14+08:00 daily https://www.pharmasources.com/industryinsights/genscript-probio-congratulates-xlifesc-o-322791.html 0.6 2026-08-07T01:27:38+08:00 daily https://www.pharmasources.com/industryinsights/jj-covid-19-vaccine-candidate-yields-str-322792.html 0.6 2026-08-14T15:49:28+08:00 daily https://www.pharmasources.com/industryinsights/usfda-approves-nucala-to-treat-hypereosi-322793.html 0.6 2026-06-22T11:56:51+08:00 daily https://www.pharmasources.com/industryinsights/bacterial-viperins-prove-effective-again-322794.html 0.6 2026-08-14T14:49:15+08:00 daily https://www.pharmasources.com/industryinsights/gilead-gets-approval-for-jyseleca-filgot-322795.html 0.6 2026-08-14T17:52:17+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-launches-dexmedetomidine-hydro-322796.html 0.6 2026-06-30T13:36:16+08:00 daily https://www.pharmasources.com/industryinsights/granules-gets-us-fda-nod-for-otc-naproxe-322797.html 0.6 2026-06-20T15:14:32+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-zydus-cadilas-dimethyl-f-322798.html 0.6 2026-06-20T14:31:51+08:00 daily https://www.pharmasources.com/industryinsights/novavax-begins-late-stage-trial-of-covid-322799.html 0.6 2026-08-13T04:24:14+08:00 daily https://www.pharmasources.com/industryinsights/almac-launches-biologics-testing-service-322800.html 0.6 2026-06-21T11:56:18+08:00 daily https://www.pharmasources.com/industryinsights/bioduro-sunbioduro-sundia-partner-as-new-322801.html 0.6 2026-05-28T12:01:40+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-joins-dfki-to-support-ai-for-a-322802.html 0.6 2026-08-07T00:02:00+08:00 daily https://www.pharmasources.com/industryinsights/novavax-par-sterile-products-enter-covid-322803.html 0.6 2026-08-06T23:48:08+08:00 daily https://www.pharmasources.com/industryinsights/gram-jj-enter-covid-19-vax-manufacturing-322804.html 0.6 2026-08-06T23:45:13+08:00 daily https://www.pharmasources.com/industryinsights/amarna-therapeutics-collaborates-with-sp-322805.html 0.6 2026-08-07T18:40:18+08:00 daily https://www.pharmasources.com/industryinsights/monte-rosa-therapeutics-raises-series-b--322806.html 0.6 2026-08-07T13:16:21+08:00 daily https://www.pharmasources.com/industryinsights/indivior-lays-out-restructuring-plans-to-322807.html 0.6 2026-08-09T04:32:04+08:00 daily https://www.pharmasources.com/industryinsights/perrigo-voluntary-recalls-albuterol-inha-322808.html 0.6 2026-06-21T03:22:08+08:00 daily https://www.pharmasources.com/industryinsights/neomatrix-announces-positive-topline-pha-322809.html 0.6 2026-08-09T13:20:49+08:00 daily https://www.pharmasources.com/industryinsights/fda-takes-actions-to-help-lower-prescrip-322810.html 0.6 2026-06-02T14:10:45+08:00 daily https://www.pharmasources.com/industryinsights/top-line-results-released-from-huntingto-322811.html 0.6 2026-08-09T19:12:49+08:00 daily https://www.pharmasources.com/industryinsights/algenex-opens-facility-with-capacity-to--322812.html 0.6 2026-06-21T09:10:14+08:00 daily https://www.pharmasources.com/industryinsights/ortho-awarded-contract-to-accelerate-ant-322813.html 0.6 2026-06-20T18:03:25+08:00 daily https://www.pharmasources.com/industryinsights/uk-consumers-seeking-advice-from-pharmac-322814.html 0.6 2026-06-20T20:11:52+08:00 daily https://www.pharmasources.com/industryinsights/accord-healthcare-launches-herceptin-bio-322815.html 0.6 2026-06-20T16:59:21+08:00 daily https://www.pharmasources.com/industryinsights/research-finds-25-percent-of-drugs-conta-322816.html 0.6 2026-06-21T12:59:35+08:00 daily https://www.pharmasources.com/industryinsights/micreos-initiates-clinical-trial-to-eval-322817.html 0.6 2026-06-22T06:47:50+08:00 daily https://www.pharmasources.com/industryinsights/adequate-levels-of-vitamin-d-reduces-com-322818.html 0.6 2026-06-20T17:03:19+08:00 daily https://www.pharmasources.com/industryinsights/scientists-trace-severe-covid-19-to-faul-322819.html 0.6 2026-08-10T04:47:54+08:00 daily https://www.pharmasources.com/industryinsights/johns-hopkins-researchers-publish-covid--322820.html 0.6 2026-08-07T07:19:03+08:00 daily https://www.pharmasources.com/industryinsights/cstone-pharmaceuticals-announces-updated-322821.html 0.6 2026-08-09T02:54:51+08:00 daily https://www.pharmasources.com/industryinsights/radius-health-menarini-group-provide-ela-322822.html 0.6 2026-08-07T02:36:48+08:00 daily https://www.pharmasources.com/industryinsights/happiness-biotech-announces-225-million--322823.html 0.6 2026-08-07T23:27:16+08:00 daily https://www.pharmasources.com/industryinsights/indoco-launches-favipiravir-400-mg-table-322824.html 0.6 2026-08-07T02:36:53+08:00 daily https://www.pharmasources.com/industryinsights/preventing-counterfeiting-with-global-id-322825.html 0.6 2026-08-07T02:52:12+08:00 daily https://www.pharmasources.com/industryinsights/who-chief-lauds-indias-assurance-to-shar-322826.html 0.6 2026-08-07T02:55:21+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-launches-dimethyl-fumarate-dr--322827.html 0.6 2026-08-07T03:03:07+08:00 daily https://www.pharmasources.com/industryinsights/csir-announces-shanti-swarup-bhatnagar-p-322828.html 0.6 2026-08-07T03:24:49+08:00 daily https://www.pharmasources.com/industryinsights/the-formula-to-step-up-india-nutra-incs--322829.html 0.6 2026-08-07T03:27:40+08:00 daily https://www.pharmasources.com/industryinsights/importance-of-sublimation-tests-when-fre-322830.html 0.6 2026-08-07T03:55:10+08:00 daily https://www.pharmasources.com/industryinsights/qimings-portfolio-company-zai-lab-lists--322831.html 0.6 2026-08-07T04:22:14+08:00 daily https://www.pharmasources.com/industryinsights/tyvyt-sintilimab-injection-in-combinatio-322832.html 0.6 2026-08-07T04:36:45+08:00 daily https://www.pharmasources.com/industryinsights/preventative-nasal-spray-shown-to-reduce-322833.html 0.6 2026-08-07T05:01:26+08:00 daily https://www.pharmasources.com/industryinsights/inventisbio-announces-147-million-series-322834.html 0.6 2026-08-07T05:45:49+08:00 daily https://www.pharmasources.com/industryinsights/merck-restructures-its-executive-board-322835.html 0.6 2026-08-04T20:02:09+08:00 daily https://www.pharmasources.com/industryinsights/inovio-covid-19-vaccine-trials-on-partia-322836.html 0.6 2026-08-05T23:06:36+08:00 daily https://www.pharmasources.com/industryinsights/centaur-pharma-to-launch-woxheal-diabeti-322837.html 0.6 2026-06-20T18:59:38+08:00 daily https://www.pharmasources.com/industryinsights/lupin-launches-fosaprepitant-for-injecti-322838.html 0.6 2026-06-20T14:57:09+08:00 daily https://www.pharmasources.com/industryinsights/iontas-and-fairjourney-biologics-find-co-322839.html 0.6 2026-06-21T00:47:36+08:00 daily https://www.pharmasources.com/industryinsights/lupin-launches-atorvastatin-calcium-tabl-322840.html 0.6 2026-08-14T05:26:21+08:00 daily https://www.pharmasources.com/industryinsights/iit-delhi-researchers-find-teicoplanin-e-322841.html 0.6 2026-06-21T21:00:41+08:00 daily https://www.pharmasources.com/industryinsights/arranta-bio-establishes-commercial-ready-322842.html 0.6 2026-08-12T16:14:26+08:00 daily https://www.pharmasources.com/industryinsights/fibrogenesis-inks-manufacturing-agreemen-322843.html 0.6 2026-06-20T22:11:06+08:00 daily https://www.pharmasources.com/industryinsights/kymos-and-prolytic-merge-322844.html 0.6 2026-04-29T02:53:47+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-dosed-in-dur-928-study-in--322845.html 0.6 2026-06-21T06:23:30+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-dosed-in-phase-2a-sibofiml-322846.html 0.6 2026-01-18T12:42:50+08:00 daily https://www.pharmasources.com/industryinsights/neurorx-submits-eua-request-for-rlf-100--322847.html 0.6 2026-06-21T07:04:59+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccine-prototype-for-successfu-322848.html 0.6 2026-06-20T22:20:05+08:00 daily https://www.pharmasources.com/industryinsights/avigan-shows-promising-results-in-treatm-322849.html 0.6 2026-06-20T14:33:30+08:00 daily https://www.pharmasources.com/industryinsights/sars-cov-2-rt-pcr-test-v20-granted-autho-322850.html 0.6 2026-06-21T08:17:11+08:00 daily https://www.pharmasources.com/industryinsights/accenture-reveals-data-science-project-f-322851.html 0.6 2026-07-04T14:42:34+08:00 daily https://www.pharmasources.com/industryinsights/abpi-and-efpia-call-for-medicines-priori-322852.html 0.6 2026-06-21T02:16:56+08:00 daily https://www.pharmasources.com/industryinsights/gileads-oral-jak-inhibitor-filgotinib-wi-322853.html 0.6 2026-06-22T02:56:39+08:00 daily https://www.pharmasources.com/industryinsights/first-uk-patient-given-gsks-experimental-322854.html 0.6 2026-06-22T08:39:41+08:00 daily https://www.pharmasources.com/industryinsights/global-hpapi-market-to-grow-at-cagr-of-8-322855.html 0.6 2026-08-11T13:07:42+08:00 daily https://www.pharmasources.com/industryinsights/millendo-therapeutics-initiates-first-in-322856.html 0.6 2026-06-20T23:11:54+08:00 daily https://www.pharmasources.com/industryinsights/anokion-announces-fda-clearance-of-ind-a-322857.html 0.6 2026-07-25T18:22:51+08:00 daily https://www.pharmasources.com/industryinsights/oncoimmunes-saccovid-demonstrates-signif-322858.html 0.6 2026-07-05T00:51:25+08:00 daily https://www.pharmasources.com/industryinsights/eiger-announces-results-of-investigator--322859.html 0.6 2026-06-21T07:55:23+08:00 daily https://www.pharmasources.com/industryinsights/covaxx-initiates-phase-1-clinical-trial--322860.html 0.6 2026-07-06T02:07:05+08:00 daily https://www.pharmasources.com/industryinsights/immunic-inc-announces-results-from-inter-322861.html 0.6 2026-06-21T11:55:10+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-ind-approval-for-phase-ii-cli-322862.html 0.6 2026-06-21T15:58:21+08:00 daily https://www.pharmasources.com/industryinsights/curative-researchers-initiate-research-s-322863.html 0.6 2026-06-21T11:08:17+08:00 daily https://www.pharmasources.com/industryinsights/strong-activation-of-anti-bacterial-t-ce-322864.html 0.6 2026-08-09T17:10:46+08:00 daily https://www.pharmasources.com/industryinsights/large-study-shows-230-times-higher-one-y-322865.html 0.6 2026-04-07T03:28:16+08:00 daily https://www.pharmasources.com/industryinsights/new-study-postoperative-pain-can-be-redu-322866.html 0.6 2026-06-27T19:49:14+08:00 daily https://www.pharmasources.com/industryinsights/new-guidelines-for-maximizing-cures-and--322867.html 0.6 2026-06-25T20:24:45+08:00 daily https://www.pharmasources.com/industryinsights/daewoong-pharmaceutical-announces-koreas-322868.html 0.6 2026-08-10T13:58:21+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-322869.html 0.6 2026-08-08T12:19:29+08:00 daily https://www.pharmasources.com/industryinsights/eton-pharma-gets-us-fda-approval-for-orp-322870.html 0.6 2026-06-20T23:01:43+08:00 daily https://www.pharmasources.com/industryinsights/moderna-publishes-interim-results-from-o-322871.html 0.6 2026-06-20T23:57:37+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-and-cstone-to-collaborate-for-onc-322872.html 0.6 2026-08-08T19:01:03+08:00 daily https://www.pharmasources.com/industryinsights/serum-institute-to-produce-up-to-additio-322873.html 0.6 2026-08-08T20:37:47+08:00 daily https://www.pharmasources.com/industryinsights/oppi-ficci-ipa-come-together-to-highligh-322874.html 0.6 2026-08-10T06:39:52+08:00 daily https://www.pharmasources.com/industryinsights/global-als-market-may-grow-to-104-bn-in--322875.html 0.6 2026-06-22T08:29:13+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-get-usfda-nod-for-xeljanz-tofacit-322876.html 0.6 2026-08-07T20:17:27+08:00 daily https://www.pharmasources.com/industryinsights/rdif-and-trinity-pharma-to-supply-25-mn--322877.html 0.6 2026-06-08T14:10:41+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-concludes-acquisition-of-principi-322878.html 0.6 2026-06-21T11:04:13+08:00 daily https://www.pharmasources.com/industryinsights/bispecific-antibodies-will-mature-after--322879.html 0.6 2026-06-21T07:33:28+08:00 daily https://www.pharmasources.com/industryinsights/prometheus-appoints-cto-322880.html 0.6 2026-07-01T13:37:31+08:00 daily https://www.pharmasources.com/industryinsights/orgenesis-to-acquire-koglio-therapeutics-322881.html 0.6 2026-06-08T19:33:51+08:00 daily https://www.pharmasources.com/industryinsights/sobrera-recipharm-collaborate-to-advance-322882.html 0.6 2026-06-20T15:52:27+08:00 daily https://www.pharmasources.com/industryinsights/catalent-provides-mfg-support-for-nocion-322883.html 0.6 2026-06-21T11:09:11+08:00 daily https://www.pharmasources.com/industryinsights/aji-bio-pharma-dndi-enter-strategic-supp-322884.html 0.6 2026-06-20T14:49:09+08:00 daily https://www.pharmasources.com/industryinsights/xtalpi-raises-318m-to-support-ai-based-d-322885.html 0.6 2026-08-05T15:07:25+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-gets-orphan-drug-and-fast-track-s-322886.html 0.6 2026-08-13T17:25:16+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-drug-to-treat-group-o-322887.html 0.6 2026-06-21T10:01:11+08:00 daily https://www.pharmasources.com/industryinsights/eiger-announces-results-of-study-in-pati-322888.html 0.6 2026-06-21T04:11:52+08:00 daily https://www.pharmasources.com/industryinsights/fda-authorizes-first-point-of-care-antib-322889.html 0.6 2026-05-28T20:26:57+08:00 daily https://www.pharmasources.com/industryinsights/cepheid-receives-eua-for-sars-cov-2-flu--322890.html 0.6 2026-08-11T10:59:20+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-bausch-lomb-alaway-preserva-322891.html 0.6 2026-01-12T16:53:58+08:00 daily https://www.pharmasources.com/industryinsights/astellas-establishes-global-patient-cent-322892.html 0.6 2026-06-28T03:10:43+08:00 daily https://www.pharmasources.com/industryinsights/sosei-heptares-scores-5m-milestone-payme-322893.html 0.6 2026-06-21T03:40:55+08:00 daily https://www.pharmasources.com/industryinsights/novacyt-signs-deal-with-uk-government-fo-322894.html 0.6 2026-07-03T02:11:12+08:00 daily https://www.pharmasources.com/industryinsights/top-six-cros-on-japanese-market-revealed-322895.html 0.6 2026-08-05T20:05:22+08:00 daily https://www.pharmasources.com/industryinsights/positive-results-in-duchenne-muscular-dy-322896.html 0.6 2026-06-22T09:55:52+08:00 daily https://www.pharmasources.com/industryinsights/cdmo-to-conduct-fill-and-finish-manufact-322897.html 0.6 2026-07-30T14:54:49+08:00 daily https://www.pharmasources.com/industryinsights/uk-set-to-produce-70-percent-of-ppe-requ-322898.html 0.6 2026-07-07T01:11:52+08:00 daily https://www.pharmasources.com/industryinsights/older-people-likely-to-be-underrepresent-322899.html 0.6 2025-11-14T11:56:43+08:00 daily https://www.pharmasources.com/industryinsights/lipidor-announces-positive-outcome-of-fe-322900.html 0.6 2026-06-21T05:10:54+08:00 daily https://www.pharmasources.com/industryinsights/taigen-biotechnology-out-licensed-taigex-322901.html 0.6 2026-06-20T19:51:37+08:00 daily https://www.pharmasources.com/industryinsights/experts-laud-dcgi-ruling-to-conduct-phas-322902.html 0.6 2026-08-08T00:49:08+08:00 daily https://www.pharmasources.com/industryinsights/moderna-will-not-enforce-covid-19-vaccin-322903.html 0.6 2026-08-08T03:18:16+08:00 daily https://www.pharmasources.com/industryinsights/hamdard-laboratories-launches-immunity-b-322904.html 0.6 2026-08-07T13:15:51+08:00 daily https://www.pharmasources.com/industryinsights/indian-dose-sites-untapped-ma-opportunit-322905.html 0.6 2026-08-07T01:21:38+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-launches-copd-drug-in-india-322906.html 0.6 2026-08-11T16:03:37+08:00 daily https://www.pharmasources.com/industryinsights/collectively-strengthen-pandemic-respons-322907.html 0.6 2026-08-07T00:40:15+08:00 daily https://www.pharmasources.com/industryinsights/ksrpa-writes-to-dcgi-proposing-amendment-322908.html 0.6 2026-06-22T00:00:44+08:00 daily https://www.pharmasources.com/industryinsights/women-creators-of-genetic-scissors-win-n-322909.html 0.6 2026-06-21T04:19:01+08:00 daily https://www.pharmasources.com/industryinsights/iiit-delhi-offers-life-changing-solution-322910.html 0.6 2026-07-02T22:51:52+08:00 daily https://www.pharmasources.com/industryinsights/majority-of-generic-drug-ingredients-pro-322911.html 0.6 2026-07-04T00:42:24+08:00 daily https://www.pharmasources.com/industryinsights/fda-issues-guidance-on-emergency-use-aut-322912.html 0.6 2026-06-21T19:18:58+08:00 daily https://www.pharmasources.com/industryinsights/msn-group-gets-us-fda-nod-for-dimethyl-f-322913.html 0.6 2026-04-15T18:09:50+08:00 daily https://www.pharmasources.com/industryinsights/chinas-experimental-covid-19-vaccine-app-322914.html 0.6 2026-08-07T09:37:36+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-pharmaceuticals-gets-anda-appro-322915.html 0.6 2026-08-07T05:28:42+08:00 daily https://www.pharmasources.com/industryinsights/marksans-pharma-and-sun-pharma-voluntari-322916.html 0.6 2026-08-07T05:01:29+08:00 daily https://www.pharmasources.com/industryinsights/abzena-invests-60m-into-cgmp-manufacturi-322917.html 0.6 2026-08-07T04:25:12+08:00 daily https://www.pharmasources.com/industryinsights/almac-sciences-appoints-vp-322918.html 0.6 2026-08-07T04:21:52+08:00 daily https://www.pharmasources.com/industryinsights/mapi-pharma-commissions-facility-to-supp-322919.html 0.6 2026-08-12T12:47:44+08:00 daily https://www.pharmasources.com/industryinsights/dwk-life-sciences-partners-with-vmic-322920.html 0.6 2026-07-09T17:17:35+08:00 daily https://www.pharmasources.com/industryinsights/ec-signs-agreement-for-additional-doses--322921.html 0.6 2026-08-07T03:18:44+08:00 daily https://www.pharmasources.com/industryinsights/barda-selects-pharm-olam-for-clinical-tr-322922.html 0.6 2026-08-07T03:07:57+08:00 daily https://www.pharmasources.com/industryinsights/nextpharma-expands-osd-capacity-322923.html 0.6 2026-08-07T02:59:31+08:00 daily https://www.pharmasources.com/industryinsights/eli-lilly-seeks-eua-for-monotherapy-agai-322924.html 0.6 2026-08-07T02:51:44+08:00 daily https://www.pharmasources.com/industryinsights/roche-acquires-enterprise-therapeutics-p-322925.html 0.6 2026-08-07T02:41:03+08:00 daily https://www.pharmasources.com/industryinsights/piramal-pharma-completes-stake-sale-to-c-322926.html 0.6 2026-08-07T02:51:46+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-and-biontech-initiate-rolling-sub-322927.html 0.6 2026-08-07T03:02:56+08:00 daily https://www.pharmasources.com/industryinsights/nvidia-partners-with-gsks-ai-lab-for-dru-322928.html 0.6 2026-08-07T03:33:40+08:00 daily https://www.pharmasources.com/industryinsights/bms-to-acquire-biopharma-firm-myokardia--322929.html 0.6 2026-07-22T11:05:57+08:00 daily https://www.pharmasources.com/industryinsights/bms-opdivo-combo-gets-fda-approval-for-m-322930.html 0.6 2026-08-07T03:55:29+08:00 daily https://www.pharmasources.com/industryinsights/vaccibody-signs-agreement-with-genentech-322931.html 0.6 2026-08-07T04:03:51+08:00 daily https://www.pharmasources.com/industryinsights/owp-announces-ind-approval-for-quetiapin-322932.html 0.6 2026-08-08T18:32:17+08:00 daily https://www.pharmasources.com/industryinsights/kodiak-sciences-treats-first-patients-in-322933.html 0.6 2026-06-21T18:10:30+08:00 daily https://www.pharmasources.com/industryinsights/catalyst-announces-issuance-of-us-patent-322934.html 0.6 2026-06-21T14:52:21+08:00 daily https://www.pharmasources.com/industryinsights/potential-cystic-fibrosis-treatment-does-322935.html 0.6 2026-08-10T14:57:15+08:00 daily https://www.pharmasources.com/industryinsights/moleculin-announces-antiviral-drug-candi-322936.html 0.6 2026-06-21T03:34:22+08:00 daily https://www.pharmasources.com/industryinsights/avacen-announces-completion-of-type-2-di-322937.html 0.6 2026-06-21T08:02:05+08:00 daily https://www.pharmasources.com/industryinsights/amphastar-receives-fda-approval-for-atro-322938.html 0.6 2026-06-26T22:35:32+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccine-trial-resumed-in-japan-322939.html 0.6 2026-08-07T02:27:14+08:00 daily https://www.pharmasources.com/industryinsights/fda-considers-withdrawing-makena-approva-322940.html 0.6 2026-08-07T02:40:12+08:00 daily https://www.pharmasources.com/industryinsights/more-than-apis-indian-pharma-industry-ne-322941.html 0.6 2026-04-17T14:04:42+08:00 daily https://www.pharmasources.com/industryinsights/umifenovir-addition-gives-no-significant-322942.html 0.6 2026-06-22T08:57:41+08:00 daily https://www.pharmasources.com/industryinsights/vir-biotech-research-highlights-mechanis-322943.html 0.6 2026-07-20T19:00:48+08:00 daily https://www.pharmasources.com/industryinsights/axxam-and-fujifilm-cellular-dynamics-ent-322944.html 0.6 2026-06-21T06:13:54+08:00 daily https://www.pharmasources.com/industryinsights/rentschler-biopharma-enters-covid-19-vax-322945.html 0.6 2026-06-21T08:09:05+08:00 daily https://www.pharmasources.com/industryinsights/hhs-funds-development-of-needle-free-vax-322946.html 0.6 2026-06-21T10:53:06+08:00 daily https://www.pharmasources.com/industryinsights/recipharm-arcturus-ink-lunar-cov19-vax-m-322947.html 0.6 2026-07-01T19:42:41+08:00 daily https://www.pharmasources.com/industryinsights/kindred-bio-expands-agreement-with-vaxar-322948.html 0.6 2026-06-21T04:56:45+08:00 daily https://www.pharmasources.com/industryinsights/eisai-enters-joint-development-agreement-322949.html 0.6 2026-07-02T12:10:10+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-drug-using-ajiphase-p-322950.html 0.6 2026-06-21T00:53:52+08:00 daily https://www.pharmasources.com/industryinsights/irisys-signs-contract-with-tff-pharma-322951.html 0.6 2026-06-20T21:17:56+08:00 daily https://www.pharmasources.com/industryinsights/abenza-appoints-svp-and-site-head-322952.html 0.6 2026-08-07T05:39:55+08:00 daily https://www.pharmasources.com/industryinsights/ibrance-palbociclib-fails-trial-for-earl-322953.html 0.6 2026-08-07T05:37:03+08:00 daily https://www.pharmasources.com/industryinsights/ibio-enters-into-agreement-with-safi-bio-322954.html 0.6 2026-08-07T05:33:37+08:00 daily https://www.pharmasources.com/industryinsights/givinostat-from-italfarmaco-gets-fda-rar-322955.html 0.6 2026-06-22T00:56:48+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-awards-six-clinical-trials-resear-322956.html 0.6 2026-04-06T01:42:33+08:00 daily https://www.pharmasources.com/industryinsights/china-joins-covax-initiative-322957.html 0.6 2026-06-21T10:04:10+08:00 daily https://www.pharmasources.com/industryinsights/neuroblastoma-uk-welcomes-advancement-of-322958.html 0.6 2026-06-21T00:14:12+08:00 daily https://www.pharmasources.com/industryinsights/amgen-announces-nhs-collaboration-aiming-322959.html 0.6 2026-06-22T04:51:38+08:00 daily https://www.pharmasources.com/industryinsights/london-universities-join-forces-to-ramp--322960.html 0.6 2026-06-20T20:43:25+08:00 daily https://www.pharmasources.com/industryinsights/european-commission-scores-200-million-d-322961.html 0.6 2026-07-02T18:10:31+08:00 daily https://www.pharmasources.com/industryinsights/charities-unite-to-highlight-pandemics-d-322962.html 0.6 2026-03-18T02:13:17+08:00 daily https://www.pharmasources.com/industryinsights/abpi-calls-on-uk-government-to-create-no-322963.html 0.6 2026-08-12T11:17:41+08:00 daily https://www.pharmasources.com/industryinsights/ema-accepts-filing-for-biogensamsung-bio-322964.html 0.6 2026-07-17T14:30:39+08:00 daily https://www.pharmasources.com/industryinsights/merck-kgaa-out-licenses-osteoarthritis-p-322965.html 0.6 2026-06-20T20:00:39+08:00 daily https://www.pharmasources.com/industryinsights/uk-inks-deal-with-abingdon-health-for-ra-322966.html 0.6 2026-06-20T17:06:27+08:00 daily https://www.pharmasources.com/industryinsights/uni-of-manchester-partners-with-avrobio--322967.html 0.6 2026-02-28T19:35:31+08:00 daily https://www.pharmasources.com/industryinsights/viivs-two-drug-hiv-regimen-demonstrates--322968.html 0.6 2026-08-12T09:18:54+08:00 daily https://www.pharmasources.com/industryinsights/arca-gets-fda-approval-of-ind-for-covid--322969.html 0.6 2026-06-21T09:41:48+08:00 daily https://www.pharmasources.com/industryinsights/fda-broadly-supports-oragenics-pre-ind-d-322970.html 0.6 2026-06-21T00:03:37+08:00 daily https://www.pharmasources.com/industryinsights/scribe-therapeutics-biogen-collaborate-t-322971.html 0.6 2026-03-29T16:13:24+08:00 daily https://www.pharmasources.com/industryinsights/eureka-initiates-trial-to-evaluate-et140-322972.html 0.6 2026-06-21T01:34:41+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-glycomimetics-rare-paediatric-322973.html 0.6 2026-06-21T00:57:46+08:00 daily https://www.pharmasources.com/industryinsights/immunogen-gets-fda-breakthrough-therapy--322974.html 0.6 2026-08-13T01:59:57+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-orphan-drug-designation-to-tw-322975.html 0.6 2026-08-14T14:21:52+08:00 daily https://www.pharmasources.com/industryinsights/trial-testing-anti-coronavirus-hivig-plu-322976.html 0.6 2026-06-20T21:42:26+08:00 daily https://www.pharmasources.com/industryinsights/novecite-to-develop-stem-cell-therapies--322977.html 0.6 2026-08-06T22:02:09+08:00 daily https://www.pharmasources.com/industryinsights/innovent-and-lilly-jointly-announce-the--322978.html 0.6 2026-08-10T23:08:26+08:00 daily https://www.pharmasources.com/industryinsights/helpmesee-launches-revolutionary-technol-322979.html 0.6 2026-07-17T09:29:32+08:00 daily https://www.pharmasources.com/industryinsights/foresee-pharmaceuticals-announces-nda-fo-322980.html 0.6 2026-08-08T10:16:39+08:00 daily https://www.pharmasources.com/industryinsights/mentice-to-acquire-eqip-and-myirlog-322981.html 0.6 2026-07-31T21:37:02+08:00 daily https://www.pharmasources.com/industryinsights/positive-phase-ii-results-for-cns-drug-n-322982.html 0.6 2026-08-05T15:46:59+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-strides-pharma-recall-drugs-i-322983.html 0.6 2026-03-23T18:54:39+08:00 daily https://www.pharmasources.com/industryinsights/occupational-hazard-exposure-risk-are-ke-322984.html 0.6 2026-08-01T03:42:10+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-presents-data-from--322985.html 0.6 2026-07-03T10:25:39+08:00 daily https://www.pharmasources.com/industryinsights/mexico-pays-nearly-160-mn-for-covax-vacc-322986.html 0.6 2026-06-30T05:05:39+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-issues-warning-letter-to-shilpa-m-322987.html 0.6 2026-08-07T02:37:05+08:00 daily https://www.pharmasources.com/industryinsights/mental-health-drugs-market-assessing-the-322988.html 0.6 2026-06-23T06:24:07+08:00 daily https://www.pharmasources.com/industryinsights/bharat-biotech-told-to-provide-phase-ii--322989.html 0.6 2026-06-27T07:23:01+08:00 daily https://www.pharmasources.com/industryinsights/us-astrazeneca-sign-pact-for-covid-19-an-322990.html 0.6 2026-08-09T09:11:16+08:00 daily https://www.pharmasources.com/industryinsights/deal-value-in-the-ma-market-decreased-in-322991.html 0.6 2026-06-30T23:19:58+08:00 daily https://www.pharmasources.com/industryinsights/mental-health-a-challenge-and-an-opportu-322992.html 0.6 2026-07-29T11:10:18+08:00 daily https://www.pharmasources.com/industryinsights/piramal-pharma-announces-completion-of-2-322993.html 0.6 2026-07-30T07:05:04+08:00 daily https://www.pharmasources.com/industryinsights/blue-dart-strengthens-its-temperature-co-322994.html 0.6 2026-08-08T04:24:50+08:00 daily https://www.pharmasources.com/industryinsights/lupin-gets-us-fda-approval-for-dimethyl--322995.html 0.6 2026-08-03T00:26:17+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-india-appoints-vaibhav-karandikar-322996.html 0.6 2026-06-21T03:49:49+08:00 daily https://www.pharmasources.com/industryinsights/jb-chemicals-pharmaceuticals-appoints-ni-322997.html 0.6 2026-06-22T09:59:41+08:00 daily https://www.pharmasources.com/industryinsights/evonik-launches-new-oral-drug-delivery-t-322998.html 0.6 2026-08-09T08:36:31+08:00 daily https://www.pharmasources.com/industryinsights/gt-biopharma-and-cytovance-biologics-exp-322999.html 0.6 2026-08-13T17:25:42+08:00 daily https://www.pharmasources.com/industryinsights/fulcrum-to-initiate-ftx-6058-trial-for-s-323000.html 0.6 2026-08-10T08:32:17+08:00 daily https://www.pharmasources.com/industryinsights/nephron-receives-warning-letter-from-fda-323001.html 0.6 2026-04-28T00:35:22+08:00 daily https://www.pharmasources.com/industryinsights/biomarin-receives-fda-fast-track-designa-323002.html 0.6 2026-08-08T19:03:33+08:00 daily https://www.pharmasources.com/industryinsights/haemonetics-receives-fda-clearance-for-n-323003.html 0.6 2026-07-31T19:53:18+08:00 daily https://www.pharmasources.com/industryinsights/fda-finalizes-guidance-to-encourage-deve-323004.html 0.6 2026-08-06T05:35:37+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-commercial-drug-manuf-323005.html 0.6 2026-08-09T19:06:24+08:00 daily https://www.pharmasources.com/industryinsights/neurotrope-announces-first-patient-dosed-323006.html 0.6 2026-06-22T09:44:40+08:00 daily https://www.pharmasources.com/industryinsights/synthetic-biologics-discontinues-study-o-323007.html 0.6 2026-08-07T13:15:51+08:00 daily https://www.pharmasources.com/industryinsights/aiviva-biopharma-initiates-trial-of-aiv0-323008.html 0.6 2026-06-20T15:46:07+08:00 daily https://www.pharmasources.com/industryinsights/moderna-regains-rsv-vaccine-programme-fr-323009.html 0.6 2026-08-07T03:02:38+08:00 daily https://www.pharmasources.com/industryinsights/takeda-enters-104bn-deal-with-arrowhead--323010.html 0.6 2026-06-22T10:17:03+08:00 daily https://www.pharmasources.com/industryinsights/ema-begins-rolling-review-of-bnt162b2-co-323011.html 0.6 2026-06-21T23:43:42+08:00 daily https://www.pharmasources.com/industryinsights/trial-supports-use-of-fluvoxamine-in-pat-323012.html 0.6 2026-07-31T02:51:39+08:00 daily https://www.pharmasources.com/industryinsights/using-rafts-to-enhance-bioavailability-o-323013.html 0.6 2026-06-21T08:55:02+08:00 daily https://www.pharmasources.com/industryinsights/using-deep-learning-to-predict-drug-meta-323014.html 0.6 2026-06-21T17:32:04+08:00 daily https://www.pharmasources.com/industryinsights/lopinavir-ritonavir-not-an-effective-tre-323015.html 0.6 2026-07-17T01:24:13+08:00 daily https://www.pharmasources.com/industryinsights/immunotherapies-to-treat-cervical-cancer-323016.html 0.6 2026-06-22T07:08:55+08:00 daily https://www.pharmasources.com/industryinsights/gannex-received-us-ind-approval-for-its--323017.html 0.6 2026-08-12T17:31:51+08:00 daily https://www.pharmasources.com/industryinsights/cstone-announces-completion-of-200-milli-323018.html 0.6 2026-07-19T06:03:03+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-long-acting-antibody-laab-combi-323019.html 0.6 2026-07-31T09:40:14+08:00 daily https://www.pharmasources.com/industryinsights/potential-covid-19-vaccines-not-affected-323020.html 0.6 2026-06-20T15:10:24+08:00 daily https://www.pharmasources.com/industryinsights/mask-mandates-shown-to-significantly-red-323021.html 0.6 2026-06-20T22:03:39+08:00 daily https://www.pharmasources.com/industryinsights/avenue-therapeutics-receives-complete-re-323023.html 0.6 2026-08-07T22:13:16+08:00 daily https://www.pharmasources.com/industryinsights/trodelvy-from-immunomedics-gets-us-fda-o-323024.html 0.6 2026-08-04T11:25:52+08:00 daily https://www.pharmasources.com/industryinsights/hitgen-to-acquire-vernalis-for-25-mn-in--323025.html 0.6 2026-08-01T10:06:43+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-grants-orphan-drug-designation-to-323026.html 0.6 2026-08-07T06:57:35+08:00 daily https://www.pharmasources.com/industryinsights/janssen-presents-five-year-data-of-stela-323027.html 0.6 2026-06-21T04:18:05+08:00 daily https://www.pharmasources.com/industryinsights/gannex-receives-us-ind-approval-for-nash-323028.html 0.6 2026-08-09T17:07:26+08:00 daily https://www.pharmasources.com/industryinsights/uk-to-commence-anti-tb-bcg-vaccine-trial-323029.html 0.6 2026-08-08T07:26:30+08:00 daily https://www.pharmasources.com/industryinsights/agc-biologics-appoints-new-gm-of-milan-s-323030.html 0.6 2026-08-11T04:37:05+08:00 daily https://www.pharmasources.com/industryinsights/antengene-wuxi-biologics-ink-innovative--323031.html 0.6 2026-08-13T10:18:20+08:00 daily https://www.pharmasources.com/industryinsights/cambrex-completes-edinburgh-expansion-323032.html 0.6 2026-08-01T00:30:04+08:00 daily https://www.pharmasources.com/industryinsights/mallinckrodt-files-for-bankruptcy-to-res-323033.html 0.6 2026-06-12T11:10:36+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-and-biontech-enter-covid-19-vacci-323034.html 0.6 2026-06-20T14:44:02+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-secures-486m-from-us-for-cov-323035.html 0.6 2026-08-07T04:03:56+08:00 daily https://www.pharmasources.com/industryinsights/arca-announces-ind-application-approval--323036.html 0.6 2026-08-09T04:37:16+08:00 daily https://www.pharmasources.com/industryinsights/lilly-provides-update-on-sars-cov-2-neut-323037.html 0.6 2026-06-21T01:52:52+08:00 daily https://www.pharmasources.com/industryinsights/the-native-antigen-company-launches-rang-323038.html 0.6 2026-07-06T22:48:24+08:00 daily https://www.pharmasources.com/industryinsights/opaganib-covid-19-study-passes-second-in-323039.html 0.6 2026-06-20T14:52:03+08:00 daily https://www.pharmasources.com/industryinsights/abbott-releases-id-now-covid-19-interim--323040.html 0.6 2026-08-14T03:15:49+08:00 daily https://www.pharmasources.com/industryinsights/viiv-posts-positive-long-term-data-for-t-323041.html 0.6 2026-08-07T15:42:27+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-ibrance-flunks-early-breast-canc-323042.html 0.6 2026-07-31T23:19:44+08:00 daily https://www.pharmasources.com/industryinsights/team-enhances-bioavailability-of-simvast-323043.html 0.6 2026-08-02T08:49:11+08:00 daily https://www.pharmasources.com/industryinsights/nice-to-simplify-how-medicines-are-selec-323044.html 0.6 2026-06-21T10:01:07+08:00 daily https://www.pharmasources.com/industryinsights/uk-leads-europe-in-phase-i-and-phase-ii--323045.html 0.6 2026-08-08T15:56:14+08:00 daily https://www.pharmasources.com/industryinsights/total-deaths-recorded-during-the-pandemi-323046.html 0.6 2026-08-09T06:59:31+08:00 daily https://www.pharmasources.com/industryinsights/qynapse-france-and-true-positive-medical-323047.html 0.6 2026-08-07T13:17:20+08:00 daily https://www.pharmasources.com/industryinsights/ai-analysis-can-improve-lung-cancer-dete-323048.html 0.6 2026-08-07T00:40:44+08:00 daily https://www.pharmasources.com/industryinsights/world-thrombosis-day-campaign-shines-spo-323049.html 0.6 2026-08-07T00:02:00+08:00 daily https://www.pharmasources.com/industryinsights/sparc-announces-phase-3-trial-results-of-323050.html 0.6 2026-06-21T17:19:54+08:00 daily https://www.pharmasources.com/industryinsights/sec-asks-cdsco-to-submit-adverse-event-r-323051.html 0.6 2026-06-22T21:51:50+08:00 daily https://www.pharmasources.com/industryinsights/norway-to-distribute-free-covid-19-vacci-323052.html 0.6 2026-06-23T21:39:17+08:00 daily https://www.pharmasources.com/industryinsights/immuneel-hcb-and-idibaps-enter-into-a-co-323053.html 0.6 2026-06-21T09:17:27+08:00 daily https://www.pharmasources.com/industryinsights/vaibhav-karandikar-is-the-new-chief-fina-323054.html 0.6 2026-07-27T05:24:55+08:00 daily https://www.pharmasources.com/industryinsights/jj-covid-19-vaccine-trial-paused-due-to--323055.html 0.6 2026-06-22T18:42:53+08:00 daily https://www.pharmasources.com/industryinsights/rhizen-pharma-curon-biopharma-sign-exclu-323056.html 0.6 2026-06-27T08:45:36+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-clinical-trial-disruption-decli-323057.html 0.6 2026-07-22T01:00:28+08:00 daily https://www.pharmasources.com/industryinsights/cellgenix-expands-facility-323058.html 0.6 2026-08-13T15:06:49+08:00 daily https://www.pharmasources.com/industryinsights/greenwich-lifesciences-completes-manufac-323059.html 0.6 2026-06-20T18:17:55+08:00 daily https://www.pharmasources.com/industryinsights/kindredbio-expands-manufacturing-agreeme-323060.html 0.6 2026-08-14T04:35:28+08:00 daily https://www.pharmasources.com/industryinsights/us-govt-selects-labvantages-lims-323061.html 0.6 2026-07-18T03:32:22+08:00 daily https://www.pharmasources.com/industryinsights/bryologyx-completes-worlds-first-gmp-syn-323062.html 0.6 2026-06-21T08:50:00+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-diosynth-to-manufacture-lilly-c-323063.html 0.6 2026-08-14T11:10:55+08:00 daily https://www.pharmasources.com/industryinsights/sharp-invests-10m-in-biologics-injectabl-323064.html 0.6 2026-06-20T18:57:36+08:00 daily https://www.pharmasources.com/industryinsights/symbiosis-completes-mhra-regulatory-insp-323065.html 0.6 2026-06-21T21:53:47+08:00 daily https://www.pharmasources.com/industryinsights/fdb-approves-argonauts-facility-323066.html 0.6 2026-06-20T20:00:36+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-to-influence-the-outcome-of-bre-323067.html 0.6 2026-08-09T07:23:58+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-enrolled-in-nih-phase-3-tr-323068.html 0.6 2026-06-23T05:11:58+08:00 daily https://www.pharmasources.com/industryinsights/lilly-incyte-release-information-on-bari-323069.html 0.6 2026-06-22T02:52:44+08:00 daily https://www.pharmasources.com/industryinsights/fda-awards-grants-for-rare-diseases-clin-323070.html 0.6 2026-07-16T14:40:12+08:00 daily https://www.pharmasources.com/industryinsights/corbus-announces-restructuring-cuts-work-323071.html 0.6 2026-08-14T17:45:59+08:00 daily https://www.pharmasources.com/industryinsights/rps-calls-for-prevention-of-counterfeit--323072.html 0.6 2026-06-20T22:56:36+08:00 daily https://www.pharmasources.com/industryinsights/uk-biotech-companies-raise-over-1bn-in-r-323073.html 0.6 2026-06-20T14:16:37+08:00 daily https://www.pharmasources.com/industryinsights/sanofis-dupixent-reduces-severe-asthma-a-323074.html 0.6 2026-07-31T19:30:57+08:00 daily https://www.pharmasources.com/industryinsights/bavencio-imbruvica-among-latest-smc-deci-323075.html 0.6 2026-06-20T17:17:30+08:00 daily https://www.pharmasources.com/industryinsights/us-enters-agreement-for-experimental-pro-323076.html 0.6 2026-08-14T01:26:20+08:00 daily https://www.pharmasources.com/industryinsights/can-an-antibody-cocktail-prevent-covid-1-323077.html 0.6 2026-06-21T14:36:12+08:00 daily https://www.pharmasources.com/industryinsights/regenerons-regn-cov2-antibody-cocktail-r-323078.html 0.6 2026-06-21T17:59:28+08:00 daily https://www.pharmasources.com/industryinsights/calls-for-better-integration-of-allied-h-323079.html 0.6 2026-06-21T03:49:36+08:00 daily https://www.pharmasources.com/industryinsights/sk-biopharmaceuticals-ono-pharmaceutical-323080.html 0.6 2026-08-12T01:43:45+08:00 daily https://www.pharmasources.com/industryinsights/kanaph-therapeutics-closes-21m-usd-serie-323081.html 0.6 2026-07-30T11:20:16+08:00 daily https://www.pharmasources.com/industryinsights/biogx-announces-fda-emergency-use-author-323082.html 0.6 2026-08-07T13:18:04+08:00 daily https://www.pharmasources.com/industryinsights/iontas-enters-licensing-agreement-with-b-323083.html 0.6 2026-07-03T02:09:28+08:00 daily https://www.pharmasources.com/industryinsights/dyno-roche-ink-gene-therapy-deal-worth-u-323084.html 0.6 2026-06-22T05:51:36+08:00 daily https://www.pharmasources.com/industryinsights/recipharm-invests-26m-in-kaysersberg-fac-323085.html 0.6 2026-06-30T14:25:42+08:00 daily https://www.pharmasources.com/industryinsights/ppd-to-open-multipurpose-clinical-resear-323086.html 0.6 2026-07-20T05:00:08+08:00 daily https://www.pharmasources.com/industryinsights/momentive-stevanato-partner-to-offer-via-323087.html 0.6 2026-06-21T01:06:53+08:00 daily https://www.pharmasources.com/industryinsights/spi-pharma-appoints-ceo-323088.html 0.6 2026-06-21T11:01:12+08:00 daily https://www.pharmasources.com/industryinsights/lactiga-and-mount-sinai-sign-pact-to-adv-323089.html 0.6 2026-06-20T18:59:34+08:00 daily https://www.pharmasources.com/industryinsights/tsha-102-from-taysha-gets-rare-paediatri-323090.html 0.6 2026-08-09T07:36:44+08:00 daily https://www.pharmasources.com/industryinsights/12-bn-fresh-funding-from-world-bank-for--323091.html 0.6 2026-06-20T23:58:36+08:00 daily https://www.pharmasources.com/industryinsights/hmd-supplies-first-lot-of-56-mn-syringes-323092.html 0.6 2026-06-20T22:07:45+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-launches-nindanib-nintedanib-fo-323093.html 0.6 2026-06-23T05:19:10+08:00 daily https://www.pharmasources.com/industryinsights/remdesivir-alone-or-in-combination-with--323094.html 0.6 2026-06-22T12:54:14+08:00 daily https://www.pharmasources.com/industryinsights/becoming-a-pharma-product-writer-for-pha-323095.html 0.6 2026-06-25T12:38:18+08:00 daily https://www.pharmasources.com/industryinsights/confidence-in-reliability-of-data-regard-323096.html 0.6 2026-06-20T23:01:41+08:00 daily https://www.pharmasources.com/industryinsights/moderna-initiates-rolling-submission-for-323097.html 0.6 2026-06-21T10:57:06+08:00 daily https://www.pharmasources.com/industryinsights/rigel-inova-enrolls-first-patients-in-fo-323098.html 0.6 2026-06-23T01:04:13+08:00 daily https://www.pharmasources.com/industryinsights/apoptosis-targeting-drug-candidates-gran-323099.html 0.6 2026-06-20T19:20:54+08:00 daily https://www.pharmasources.com/industryinsights/beckman-coulter-sars-cov-2-igm-antibody--323100.html 0.6 2026-06-21T10:05:13+08:00 daily https://www.pharmasources.com/industryinsights/lampore-test-for-sars-cov-2-gains-ce-ivd-323101.html 0.6 2026-06-20T16:03:08+08:00 daily https://www.pharmasources.com/industryinsights/fda-advisory-committee-votes-in-support--323102.html 0.6 2026-06-20T22:10:53+08:00 daily https://www.pharmasources.com/industryinsights/bone-therapeutics-showcases-allogeneic-c-323103.html 0.6 2026-06-21T15:13:42+08:00 daily https://www.pharmasources.com/industryinsights/iksuda-therapeutics-exercises-licensing--323104.html 0.6 2026-06-20T17:17:31+08:00 daily https://www.pharmasources.com/industryinsights/redhill-expands-manufacturing-for-covid--323105.html 0.6 2026-06-21T01:52:44+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-dosed-in-covid-19-vaccine--323106.html 0.6 2026-06-21T07:07:00+08:00 daily https://www.pharmasources.com/industryinsights/celltrion-covid-19-antibody-treatment-to-323107.html 0.6 2026-06-21T01:44:27+08:00 daily https://www.pharmasources.com/industryinsights/popular-covid-19-conspiracies-linked-to--323108.html 0.6 2026-06-21T04:17:03+08:00 daily https://www.pharmasources.com/industryinsights/innovent-announces-the-appointment-of-dr-323109.html 0.6 2026-08-14T09:58:46+08:00 daily https://www.pharmasources.com/industryinsights/fondazione-prada-presents-human-brains-a-323110.html 0.6 2026-06-21T01:04:50+08:00 daily https://www.pharmasources.com/industryinsights/2020-zhejiang-export-commodity-online-fa-323111.html 0.6 2026-08-09T14:37:20+08:00 daily https://www.pharmasources.com/industryinsights/the-impact-of-the-uspresidential-electio-323112.html 0.6 2026-08-09T00:17:09+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-authorises-phase-1-trial-of-immun-323113.html 0.6 2026-08-11T18:25:38+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-keytruda-from-merck-for--323114.html 0.6 2026-08-04T07:55:39+08:00 daily https://www.pharmasources.com/industryinsights/russia-approves-second-covid-19-vaccine-323115.html 0.6 2026-07-17T18:09:38+08:00 daily https://www.pharmasources.com/industryinsights/gowda-invites-latam-caribbean-countries--323116.html 0.6 2026-06-20T14:51:06+08:00 daily https://www.pharmasources.com/industryinsights/auravax-therapeutics-partners-with-unive-323117.html 0.6 2026-06-21T07:19:21+08:00 daily https://www.pharmasources.com/industryinsights/faceless-assessment-causes-delay-in-cust-323118.html 0.6 2026-08-07T23:35:07+08:00 daily https://www.pharmasources.com/industryinsights/gsk-to-sell-pozna-manufacturing-site-to--323119.html 0.6 2026-07-06T14:19:44+08:00 daily https://www.pharmasources.com/industryinsights/vigene-biosciences-appoints-coo-323120.html 0.6 2026-06-01T09:52:27+08:00 daily https://www.pharmasources.com/industryinsights/the-discovery-labs-appoints-president-an-323121.html 0.6 2026-06-01T09:43:51+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-to-expand-sterile-filling--323122.html 0.6 2026-06-20T14:46:06+08:00 daily https://www.pharmasources.com/industryinsights/rentschler-biopharma-and-atum-ink-licens-323123.html 0.6 2026-06-20T19:48:52+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharma-ramps-up-manufacturing-323124.html 0.6 2026-06-21T05:01:45+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-regenerons-inmazeb-for-ebol-323125.html 0.6 2026-07-30T15:10:36+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-expands-oncology-partnership--323126.html 0.6 2026-06-20T21:16:58+08:00 daily https://www.pharmasources.com/industryinsights/xenleta-demonstrates-high-efficacy-in-co-323127.html 0.6 2026-06-20T15:51:23+08:00 daily https://www.pharmasources.com/industryinsights/abbott-receives-eua-for-covid-19-igm-ant-323128.html 0.6 2026-06-20T23:00:42+08:00 daily https://www.pharmasources.com/industryinsights/astellas-seagen-announce-positive-result-323129.html 0.6 2026-07-22T10:04:07+08:00 daily https://www.pharmasources.com/industryinsights/biogx-announces-eua-for-extraction-free--323130.html 0.6 2026-06-21T23:49:57+08:00 daily https://www.pharmasources.com/industryinsights/oxular-receives-rare-paediatric-disease--323131.html 0.6 2026-06-21T05:14:57+08:00 daily https://www.pharmasources.com/industryinsights/avenue-therapeutics-receives-complete-re-323132.html 0.6 2026-06-21T10:18:45+08:00 daily https://www.pharmasources.com/industryinsights/nihr-review-identifies-long-term-effects-323133.html 0.6 2026-06-01T09:55:27+08:00 daily https://www.pharmasources.com/industryinsights/roche-signs-deal-with-dyno-therapeutics--323134.html 0.6 2026-06-21T07:55:09+08:00 daily https://www.pharmasources.com/industryinsights/ema-confirms-eligibility-for-submission--323135.html 0.6 2026-07-04T18:32:35+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-novartis-mayzent-on-the--323136.html 0.6 2026-06-28T06:34:43+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-translate-bio-mrna-covid-19-v-323137.html 0.6 2026-08-07T05:58:12+08:00 daily https://www.pharmasources.com/industryinsights/galapagos-and-servier-report-topline-res-323138.html 0.6 2026-07-03T04:38:58+08:00 daily https://www.pharmasources.com/industryinsights/insilico-partners-with-taisho-on-end-to--323139.html 0.6 2026-06-20T15:00:12+08:00 daily https://www.pharmasources.com/industryinsights/111-inc-teams-up-with-huluwa-pharmaceuti-323140.html 0.6 2026-07-21T17:55:56+08:00 daily https://www.pharmasources.com/industryinsights/welltok-addresses-mental-health-crisis-w-323141.html 0.6 2026-08-06T02:03:14+08:00 daily https://www.pharmasources.com/industryinsights/aetion-statement-on-ucsf-led-study-to-in-323142.html 0.6 2026-06-21T00:59:44+08:00 daily https://www.pharmasources.com/industryinsights/brainstorm-announces-financial-results-f-323143.html 0.6 2026-06-21T05:14:54+08:00 daily https://www.pharmasources.com/industryinsights/regulus-therapeutics-announces-first-pat-323144.html 0.6 2026-06-20T13:20:35+08:00 daily https://www.pharmasources.com/industryinsights/eiger-biopharmaceuticals-announces-posit-323145.html 0.6 2026-08-09T09:30:49+08:00 daily https://www.pharmasources.com/industryinsights/beckman-coulter-receives-barda-funding-t-323146.html 0.6 2026-08-08T20:05:14+08:00 daily https://www.pharmasources.com/industryinsights/entrinsic-bioscience-secures-us-patent-g-323147.html 0.6 2026-06-21T07:01:58+08:00 daily https://www.pharmasources.com/industryinsights/prestige-biopharma-drug-gets-positive-em-323148.html 0.6 2026-08-07T13:15:28+08:00 daily https://www.pharmasources.com/industryinsights/serum-india-bharat-biotech-to-test-intra-323149.html 0.6 2026-08-08T00:53:59+08:00 daily https://www.pharmasources.com/industryinsights/aurobindo-pharma-acquires-100-per-cent-s-323150.html 0.6 2026-08-08T10:49:44+08:00 daily https://www.pharmasources.com/industryinsights/vaccine-delivery-system-should-involve-a-323151.html 0.6 2026-08-08T12:07:18+08:00 daily https://www.pharmasources.com/industryinsights/biopharma-companies-more-optimistic-abou-323152.html 0.6 2026-04-05T09:58:32+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-rdif-get-dcgi-nod-for-phase-ii-323153.html 0.6 2026-06-22T21:44:40+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-final-nod-for-ursodiol-323154.html 0.6 2026-06-21T06:12:56+08:00 daily https://www.pharmasources.com/industryinsights/genentech-announces-full-fda-approval-fo-323155.html 0.6 2026-08-13T17:40:56+08:00 daily https://www.pharmasources.com/industryinsights/remdesivir-price-curbs-in-india-make-cov-323156.html 0.6 2026-06-20T20:57:39+08:00 daily https://www.pharmasources.com/industryinsights/nafdac-blacklists-gujarat-pharma-firm-ma-323157.html 0.6 2026-08-05T10:15:17+08:00 daily https://www.pharmasources.com/industryinsights/scientists-to-investigate-arthritis-drug-323158.html 0.6 2026-07-21T02:10:29+08:00 daily https://www.pharmasources.com/industryinsights/vaccine-trials-outside-home-market-will--323159.html 0.6 2026-08-03T21:52:49+08:00 daily https://www.pharmasources.com/industryinsights/aztrazeneca-to-launch-oncology-drug-calq-323160.html 0.6 2026-08-06T12:09:09+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-amantadine-hydrochloride-323161.html 0.6 2026-06-21T06:10:58+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-us-fda-approval-for-fi-323162.html 0.6 2026-06-23T01:53:45+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-to-seek-approval-for-covid-19-vac-323164.html 0.6 2026-06-21T03:57:03+08:00 daily https://www.pharmasources.com/industryinsights/eli-lilly-to-acquire-biotechnology-compa-323165.html 0.6 2026-06-21T13:15:41+08:00 daily https://www.pharmasources.com/industryinsights/neurorx-relief-releases-rlf-100-data-for-323166.html 0.6 2026-06-21T23:51:53+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-dosed-in-trial-of-lns8801--323167.html 0.6 2026-07-22T06:54:17+08:00 daily https://www.pharmasources.com/industryinsights/medigen-dynavax-covid-19-vaccine-receive-323168.html 0.6 2026-06-21T08:00:10+08:00 daily https://www.pharmasources.com/industryinsights/biogx-announces-eua-submission-of-extrac-323169.html 0.6 2026-06-20T16:05:20+08:00 daily https://www.pharmasources.com/industryinsights/moleculin-announces-positive-interim-res-323170.html 0.6 2026-06-21T06:02:49+08:00 daily https://www.pharmasources.com/industryinsights/novellus-licenses-induced-mesenchymal-st-323171.html 0.6 2026-06-22T11:58:05+08:00 daily https://www.pharmasources.com/industryinsights/cqc-assessment-is-a-wake-up-call-to-gove-323172.html 0.6 2026-06-22T03:47:30+08:00 daily https://www.pharmasources.com/industryinsights/janssens-psoriasis-med-tremfya-scores-lo-323173.html 0.6 2026-08-09T05:33:29+08:00 daily https://www.pharmasources.com/industryinsights/astellas-to-acquire-iota-biosciences-fol-323174.html 0.6 2026-08-08T22:02:09+08:00 daily https://www.pharmasources.com/industryinsights/sanofis-sarclisa-bags-nice-recommendatio-323175.html 0.6 2026-08-07T13:17:41+08:00 daily https://www.pharmasources.com/industryinsights/financial-report-johnson-johnson-323176.html 0.6 2026-08-14T15:23:02+08:00 daily https://www.pharmasources.com/industryinsights/touchlight-appoints-ceo-323177.html 0.6 2026-06-11T23:51:57+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-us-govt-enter-486m-covid-19--323178.html 0.6 2026-06-30T17:04:18+08:00 daily https://www.pharmasources.com/industryinsights/sars-cov-2-vaccine-safely-induces-an-imm-323179.html 0.6 2026-08-01T12:51:13+08:00 daily https://www.pharmasources.com/industryinsights/mhra-joins-international-regulatory-cons-323180.html 0.6 2026-06-08T19:53:30+08:00 daily https://www.pharmasources.com/industryinsights/china-natural-resources-inc-announces-ex-323181.html 0.6 2026-06-22T03:54:37+08:00 daily https://www.pharmasources.com/industryinsights/volition-veterinary-diagnostics-developm-323182.html 0.6 2026-07-20T10:27:13+08:00 daily https://www.pharmasources.com/industryinsights/akero-therapeutics-receives-european-med-323183.html 0.6 2026-08-03T03:51:51+08:00 daily https://www.pharmasources.com/industryinsights/bdr-pharma-launches-nintenib-nintedanib--323184.html 0.6 2026-06-22T07:53:43+08:00 daily https://www.pharmasources.com/industryinsights/dpx-covid-19-has-potential-to-improve-du-323185.html 0.6 2026-08-09T21:46:24+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-tentative-usfda-nod-fo-323186.html 0.6 2026-08-08T18:12:48+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-pharma-receives-usfda-approval--323187.html 0.6 2026-08-07T13:16:11+08:00 daily https://www.pharmasources.com/industryinsights/cordenpharma-colorado-completes-highly-p-323188.html 0.6 2026-08-13T00:21:30+08:00 daily https://www.pharmasources.com/industryinsights/incog-biopharma-launches-operations-in-c-323189.html 0.6 2026-08-07T00:21:34+08:00 daily https://www.pharmasources.com/industryinsights/chmp-recommends-astrazenecas-forxiga-for-323190.html 0.6 2026-08-07T00:15:44+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-snda-of-nurtec-odt-for-preve-323191.html 0.6 2026-08-07T00:41:51+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-odd-for-esophageal-gastroesop-323192.html 0.6 2026-08-07T02:58:01+08:00 daily https://www.pharmasources.com/industryinsights/harmony-biosciences-receives-fda-approva-323193.html 0.6 2026-08-07T05:37:17+08:00 daily https://www.pharmasources.com/industryinsights/israeli-ministry-of-health-authorizes-tr-323194.html 0.6 2026-08-07T05:40:22+08:00 daily https://www.pharmasources.com/industryinsights/cyclerion-announces-positive-data-from-c-323195.html 0.6 2026-06-21T19:15:50+08:00 daily https://www.pharmasources.com/industryinsights/abpi-chief-exec-says-no-deal-brexit-is-n-323196.html 0.6 2026-08-07T00:02:59+08:00 daily https://www.pharmasources.com/industryinsights/ten-new-medicines-backed-for-eu-approval-323197.html 0.6 2026-08-06T23:56:40+08:00 daily https://www.pharmasources.com/industryinsights/study-suggests-dolutegravir-is-the-optim-323198.html 0.6 2026-08-06T23:36:01+08:00 daily https://www.pharmasources.com/industryinsights/the-fda-requires-changes-to-nsaid-labell-323199.html 0.6 2026-08-06T23:36:07+08:00 daily https://www.pharmasources.com/industryinsights/telstars-centre-in-the-uk-consolidates-i-323200.html 0.6 2026-08-07T02:39:48+08:00 daily https://www.pharmasources.com/industryinsights/bioanalytical-testing-services-market-to-323201.html 0.6 2026-08-07T02:43:05+08:00 daily https://www.pharmasources.com/industryinsights/niaid-trial-to-identify-potential-covid--323202.html 0.6 2026-08-07T02:48:41+08:00 daily https://www.pharmasources.com/industryinsights/y-mabs-announces-fda-clearance-of-ind-fo-323203.html 0.6 2026-08-10T12:33:32+08:00 daily https://www.pharmasources.com/industryinsights/nih-begins-large-clinical-trial-to-test--323204.html 0.6 2026-04-23T14:18:47+08:00 daily https://www.pharmasources.com/industryinsights/scientists-identify-common-vulnerabiliti-323205.html 0.6 2026-06-20T16:57:20+08:00 daily https://www.pharmasources.com/industryinsights/sihuan-pharmaceutical-invests-in-phase-i-323206.html 0.6 2026-08-09T17:15:55+08:00 daily https://www.pharmasources.com/industryinsights/key-patent-granted-for-isla101-in-brazil-323207.html 0.6 2026-06-22T20:00:59+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-partners-with-bioeleve-323208.html 0.6 2026-08-12T22:46:04+08:00 daily https://www.pharmasources.com/industryinsights/111-inc-teams-up-with-bayer-healthcare-t-323209.html 0.6 2026-06-20T19:01:35+08:00 daily https://www.pharmasources.com/industryinsights/powder-flowpredicting-flow-performance-i-323210.html 0.6 2026-08-08T02:36:49+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccine-delivery-prepping-for-c-323211.html 0.6 2026-06-21T07:47:53+08:00 daily https://www.pharmasources.com/industryinsights/cipla-launches-nintib-nintedanib-to-trea-323212.html 0.6 2026-05-01T01:52:59+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-relaunch-otc-famotidine-tablet-323213.html 0.6 2026-07-24T07:14:50+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-final-us-fda-nod-for-s-323214.html 0.6 2026-06-20T21:18:59+08:00 daily https://www.pharmasources.com/industryinsights/strides-receives-usfda-approval-for-etha-323215.html 0.6 2026-08-10T12:32:56+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-323216.html 0.6 2026-08-06T23:47:52+08:00 daily https://www.pharmasources.com/industryinsights/first-results-of-russian-coronavirus-vac-323217.html 0.6 2026-06-20T16:07:26+08:00 daily https://www.pharmasources.com/industryinsights/bill-melinda-gates-foundation-and-grand--323218.html 0.6 2026-06-21T05:03:44+08:00 daily https://www.pharmasources.com/industryinsights/jsr-life-sciences-expands-european-footp-323219.html 0.6 2026-07-28T19:56:22+08:00 daily https://www.pharmasources.com/industryinsights/cns-pharmaceuticals-completes-us-manufac-323220.html 0.6 2026-08-12T14:35:33+08:00 daily https://www.pharmasources.com/industryinsights/cytocom-and-cleveland-biolabs-merge-323221.html 0.6 2026-06-22T00:11:27+08:00 daily https://www.pharmasources.com/industryinsights/valnevas-chikungunya-vax-granted-prime-d-323222.html 0.6 2026-06-21T21:13:53+08:00 daily https://www.pharmasources.com/industryinsights/cevec-rznomics-ink-license-agreement-for-323223.html 0.6 2026-06-21T12:23:06+08:00 daily https://www.pharmasources.com/industryinsights/mereo-makes-leadership-changes-323224.html 0.6 2026-06-21T10:12:18+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-dinona-partner-on-pote-323225.html 0.6 2026-06-21T13:01:26+08:00 daily https://www.pharmasources.com/industryinsights/endo-international-agrees-to-acquire-bio-323226.html 0.6 2026-06-25T11:59:47+08:00 daily https://www.pharmasources.com/industryinsights/chumakov-center-initiates-covid-19-vacci-323227.html 0.6 2026-06-21T09:14:12+08:00 daily https://www.pharmasources.com/industryinsights/edesa-biotech-gets-fda-approval-for-eb05-323228.html 0.6 2026-03-27T14:43:09+08:00 daily https://www.pharmasources.com/industryinsights/labvantage-awarded-lims-contract-by-walt-323229.html 0.6 2026-07-03T22:33:41+08:00 daily https://www.pharmasources.com/industryinsights/redhill-announces-orphan-drug-designatio-323230.html 0.6 2026-08-08T02:16:54+08:00 daily https://www.pharmasources.com/industryinsights/eiger-announces-positive-results-of-covi-323231.html 0.6 2026-08-04T16:38:51+08:00 daily https://www.pharmasources.com/industryinsights/beckman-coulter-receives-funding-to-vali-323232.html 0.6 2026-06-20T17:41:21+08:00 daily https://www.pharmasources.com/industryinsights/cyclerion-announces-sickle-cell-disease--323233.html 0.6 2026-06-20T18:59:34+08:00 daily https://www.pharmasources.com/industryinsights/zhejiang-quality-apis-industry-shaoxing--323234.html 0.6 2026-06-08T15:27:33+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-review-for-angles-parsortix--323235.html 0.6 2026-08-07T00:49:37+08:00 daily https://www.pharmasources.com/industryinsights/aimmunes-peanut-allergy-med-moves-toward-323236.html 0.6 2026-06-20T22:59:41+08:00 daily https://www.pharmasources.com/industryinsights/azs-tagrisso-scores-priority-review-from-323237.html 0.6 2026-08-03T04:50:09+08:00 daily https://www.pharmasources.com/industryinsights/experts-partner-with-uk-government-for-c-323238.html 0.6 2026-06-20T15:12:22+08:00 daily https://www.pharmasources.com/industryinsights/abbvies-venclexta-granted-full-us-approv-323239.html 0.6 2026-06-20T19:56:32+08:00 daily https://www.pharmasources.com/industryinsights/ucb-acquires-new-campus-to-support-uk-op-323240.html 0.6 2026-06-21T20:45:48+08:00 daily https://www.pharmasources.com/industryinsights/inhaled-antibody-treatment-for-covid-19--323241.html 0.6 2026-06-28T15:16:42+08:00 daily https://www.pharmasources.com/industryinsights/repurposed-drugs-not-effective-treatment-323242.html 0.6 2026-06-22T12:11:10+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-pandemic-to-heighten-sales-of-p-323243.html 0.6 2026-07-18T10:21:04+08:00 daily https://www.pharmasources.com/industryinsights/the-doc-announces-new-rapid-detection-sa-323244.html 0.6 2026-06-20T16:54:12+08:00 daily https://www.pharmasources.com/industryinsights/opko-healths-bioreference-laboratories-l-323245.html 0.6 2026-06-22T03:54:04+08:00 daily https://www.pharmasources.com/industryinsights/one-broken-bone-leads-to-another-warns-i-323246.html 0.6 2026-06-20T18:00:24+08:00 daily https://www.pharmasources.com/industryinsights/nanoform-initiates-gmp-campaign-for-firs-323247.html 0.6 2026-06-20T16:13:38+08:00 daily https://www.pharmasources.com/industryinsights/how-ai-is-redefining-the-pharmaceutical--323248.html 0.6 2026-08-07T00:21:27+08:00 daily https://www.pharmasources.com/industryinsights/aleor-dermaceuticals-gets-usfda-nod-for--323249.html 0.6 2026-06-22T02:59:41+08:00 daily https://www.pharmasources.com/industryinsights/brazil-volunteer-in-astrazeneca-covid-19-323250.html 0.6 2026-06-22T05:02:44+08:00 daily https://www.pharmasources.com/industryinsights/immunitybio-nantkwest-begin-patient-dosi-323251.html 0.6 2026-06-20T15:42:37+08:00 daily https://www.pharmasources.com/industryinsights/aiocd-appeals-to-pm-to-utilise-their-sup-323252.html 0.6 2026-06-21T08:07:07+08:00 daily https://www.pharmasources.com/industryinsights/researchers-find-corticosteroids-combo-i-323253.html 0.6 2026-08-07T12:15:18+08:00 daily https://www.pharmasources.com/industryinsights/gsk-to-begin-final-stage-trials-of-respi-323254.html 0.6 2026-07-27T18:17:32+08:00 daily https://www.pharmasources.com/industryinsights/xeris-pharma-gets-us-fda-fast-track-desi-323255.html 0.6 2026-06-22T02:56:35+08:00 daily https://www.pharmasources.com/industryinsights/alembic-pharmaceuticals-gets-usfda-nod-f-323256.html 0.6 2026-03-08T05:51:15+08:00 daily https://www.pharmasources.com/industryinsights/bdr-pharma-launches-generic-version-of-l-323257.html 0.6 2026-06-20T22:04:36+08:00 daily https://www.pharmasources.com/industryinsights/indias-role-in-global-supply-of-covid-19-323258.html 0.6 2026-06-20T21:01:37+08:00 daily https://www.pharmasources.com/industryinsights/industry-positive-about-cdscos-move-to-d-323259.html 0.6 2026-08-10T13:15:46+08:00 daily https://www.pharmasources.com/industryinsights/roche-canada-to-invest-500m-to-create-50-323260.html 0.6 2026-08-06T22:08:03+08:00 daily https://www.pharmasources.com/industryinsights/metrics-contract-services-expands-busine-323261.html 0.6 2026-08-06T21:58:43+08:00 daily https://www.pharmasources.com/industryinsights/reaction-biology-and-4hf-biotec-collabor-323262.html 0.6 2026-08-14T13:18:19+08:00 daily https://www.pharmasources.com/industryinsights/cdmo-qcl-expands-fill-finish-capabilitie-323263.html 0.6 2026-08-06T22:18:55+08:00 daily https://www.pharmasources.com/industryinsights/lubrizol-expands-partnership-with-the-po-323264.html 0.6 2026-06-22T12:08:27+08:00 daily https://www.pharmasources.com/industryinsights/novartis-branaplam-gets-orphan-drug-desi-323265.html 0.6 2026-06-21T01:13:58+08:00 daily https://www.pharmasources.com/industryinsights/uk-and-hvivo-to-develop-covid-19-human-s-323266.html 0.6 2026-07-12T14:15:51+08:00 daily https://www.pharmasources.com/industryinsights/symvivo-to-develop-covid-19-oral-vaccine-323267.html 0.6 2026-08-05T14:09:28+08:00 daily https://www.pharmasources.com/industryinsights/genalyte-obtains-eua-for-rapid-covid-19--323268.html 0.6 2026-08-06T17:49:01+08:00 daily https://www.pharmasources.com/industryinsights/venclexta-receives-fda-approval-for-aml-323269.html 0.6 2026-08-06T19:01:41+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-dosed-in-rgls4326-trial-fo-323270.html 0.6 2026-07-29T20:34:54+08:00 daily https://www.pharmasources.com/industryinsights/doj-announces-deal-with-purdue-pharma-ci-323271.html 0.6 2026-08-08T13:15:53+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-dosed-in-trial-to-treat-co-323272.html 0.6 2026-06-20T15:47:51+08:00 daily https://www.pharmasources.com/industryinsights/storm-therapeutics-mettl3-inhibitor-move-323273.html 0.6 2026-08-06T00:10:48+08:00 daily https://www.pharmasources.com/industryinsights/pharmings-apds-drug-scores-eu-orphan-sta-323274.html 0.6 2026-08-11T09:16:04+08:00 daily https://www.pharmasources.com/industryinsights/valneva-bags-positive-phase-ii-results-f-323275.html 0.6 2026-06-22T11:58:51+08:00 daily https://www.pharmasources.com/industryinsights/epsilogen-awarded-1m-grant-from-innovate-323276.html 0.6 2026-08-05T19:17:16+08:00 daily https://www.pharmasources.com/industryinsights/asthma-fund-launched-to-support-developm-323277.html 0.6 2026-08-07T02:39:42+08:00 daily https://www.pharmasources.com/industryinsights/new-research-highlights-northern-ireland-323278.html 0.6 2026-06-20T22:58:37+08:00 daily https://www.pharmasources.com/industryinsights/eib-to-support-covid-19-therapy-with-245-323279.html 0.6 2026-07-18T10:58:07+08:00 daily https://www.pharmasources.com/industryinsights/uk-to-establish-human-challenge-studies--323280.html 0.6 2026-06-21T16:04:22+08:00 daily https://www.pharmasources.com/industryinsights/precision-genetics-advances-covid-19-tes-323281.html 0.6 2026-06-21T11:27:32+08:00 daily https://www.pharmasources.com/industryinsights/new-study-finds-covid-19-substantially-r-323282.html 0.6 2026-08-03T13:08:33+08:00 daily https://www.pharmasources.com/industryinsights/poseida-therapeutics-and-tscan-therapeut-323283.html 0.6 2026-08-08T02:49:55+08:00 daily https://www.pharmasources.com/industryinsights/envirotainer-adds-57-more-rap-e2-capacit-323284.html 0.6 2026-08-13T16:57:40+08:00 daily https://www.pharmasources.com/industryinsights/longevity-acquisition-corporation-announ-323285.html 0.6 2026-06-21T22:51:05+08:00 daily https://www.pharmasources.com/industryinsights/sihuan-pharmaceuticals-gabapentin-capsul-323286.html 0.6 2026-07-23T14:14:30+08:00 daily https://www.pharmasources.com/industryinsights/iavi-merck-kgaa-and-serum-institute-part-323287.html 0.6 2026-06-24T01:32:44+08:00 daily https://www.pharmasources.com/industryinsights/uk-to-collaborate-with-oxford-immunotec--323288.html 0.6 2026-08-09T06:51:52+08:00 daily https://www.pharmasources.com/industryinsights/aurobindo-pharma-receives-usfda-approval-323289.html 0.6 2026-08-09T02:37:07+08:00 daily https://www.pharmasources.com/industryinsights/granules-india-gets-us-fda-approval-for--323290.html 0.6 2026-08-09T00:10:29+08:00 daily https://www.pharmasources.com/industryinsights/abec-delivers-process-systems-to-ology-b-323291.html 0.6 2026-08-08T21:48:35+08:00 daily https://www.pharmasources.com/industryinsights/launchworks-cdmo-approved-for-viral-tran-323292.html 0.6 2026-08-08T20:04:47+08:00 daily https://www.pharmasources.com/industryinsights/moderna-completes-enrollment-in-phase-ii-323293.html 0.6 2026-08-08T17:53:14+08:00 daily https://www.pharmasources.com/industryinsights/kamada-signs-supply-agreement-with-israe-323294.html 0.6 2026-08-08T15:51:51+08:00 daily https://www.pharmasources.com/industryinsights/roche-atea-pharma-to-develop-potential-o-323295.html 0.6 2026-08-08T10:10:41+08:00 daily https://www.pharmasources.com/industryinsights/catalent-brainstorm-enter-als-drug-manuf-323296.html 0.6 2026-08-08T07:58:50+08:00 daily https://www.pharmasources.com/industryinsights/eu-signs-contract-with-jj-on-covid-19-va-323297.html 0.6 2026-08-09T00:37:47+08:00 daily https://www.pharmasources.com/industryinsights/purdue-pharma-reaches-agreement-with-doj-323298.html 0.6 2026-06-21T03:17:56+08:00 daily https://www.pharmasources.com/industryinsights/probiogen-heidelberg-pharma-ink-atac-agr-323299.html 0.6 2026-06-21T12:08:26+08:00 daily https://www.pharmasources.com/industryinsights/lonza-expands-capsule-mfg-capacity-323300.html 0.6 2026-06-21T00:03:38+08:00 daily https://www.pharmasources.com/industryinsights/tracelink-launches-serialized-product-in-323301.html 0.6 2026-06-25T03:11:58+08:00 daily https://www.pharmasources.com/industryinsights/aridis-reports-positive-preclinical-effi-323302.html 0.6 2026-06-21T04:21:04+08:00 daily https://www.pharmasources.com/industryinsights/dxterity-announces-new-at-home-covid-19--323303.html 0.6 2026-06-22T19:00:08+08:00 daily https://www.pharmasources.com/industryinsights/catalyst-files-patent-infringement-actio-323304.html 0.6 2026-06-22T12:02:57+08:00 daily https://www.pharmasources.com/industryinsights/affimed-nkmax-america-to-study-egfr-targ-323305.html 0.6 2026-08-05T16:24:40+08:00 daily https://www.pharmasources.com/industryinsights/centogene-receives-eua-for-sars-cov-2-rt-323306.html 0.6 2026-06-20T14:55:05+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-parkinsons-foundation-to-advance--323307.html 0.6 2026-06-22T09:58:40+08:00 daily https://www.pharmasources.com/industryinsights/nanoformed-formulation-of-piroxicam-to-e-323308.html 0.6 2026-06-21T15:01:35+08:00 daily https://www.pharmasources.com/industryinsights/nasal-drug-delivery-technology-market-to-323309.html 0.6 2026-06-21T10:19:37+08:00 daily https://www.pharmasources.com/industryinsights/ema-recommends-10-medicines-for-approval-323310.html 0.6 2026-08-10T23:13:49+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-treatment-for-covid-1-323311.html 0.6 2026-08-12T12:37:16+08:00 daily https://www.pharmasources.com/industryinsights/oxford-covid-19-vaccine-follows-its-prog-323312.html 0.6 2026-07-01T09:57:28+08:00 daily https://www.pharmasources.com/industryinsights/moderna-completes-enrollment-of-phase-3--323313.html 0.6 2026-08-10T10:11:52+08:00 daily https://www.pharmasources.com/industryinsights/study-finds-tocilizumab-improves-surviva-323314.html 0.6 2026-07-07T06:46:04+08:00 daily https://www.pharmasources.com/industryinsights/a-vaccine-project-funded-by-the-federal--323315.html 0.6 2026-06-21T05:04:44+08:00 daily https://www.pharmasources.com/industryinsights/work-to-develop-a-covid-19-vaccine-is-fa-323316.html 0.6 2026-08-08T22:36:25+08:00 daily https://www.pharmasources.com/industryinsights/trippbio-announces-the-completion-of-enr-323317.html 0.6 2026-06-23T00:01:02+08:00 daily https://www.pharmasources.com/industryinsights/amyris-and-the-infectious-disease-resear-323318.html 0.6 2026-04-13T02:06:10+08:00 daily https://www.pharmasources.com/industryinsights/home-state-health-urges-breast-cancer-sc-323319.html 0.6 2026-08-12T12:56:16+08:00 daily https://www.pharmasources.com/industryinsights/tuv-rheinland-announces-the-opening-of-i-323320.html 0.6 2026-08-07T23:45:27+08:00 daily https://www.pharmasources.com/industryinsights/cadi-introduces-lycofertilic---high-pote-323321.html 0.6 2026-08-10T03:22:15+08:00 daily https://www.pharmasources.com/industryinsights/vaccine-verdict-due-by-early-december-an-323322.html 0.6 2026-06-22T09:32:11+08:00 daily https://www.pharmasources.com/industryinsights/mexico-may-not-follow-fda-and-approve-re-323323.html 0.6 2026-06-22T11:49:52+08:00 daily https://www.pharmasources.com/industryinsights/canada-to-invest-up-to-c214-mn-for-rd-of-323324.html 0.6 2026-06-23T14:57:43+08:00 daily https://www.pharmasources.com/industryinsights/e-commerce-will-e-pharmacies-become-the--323325.html 0.6 2026-06-28T11:17:20+08:00 daily https://www.pharmasources.com/industryinsights/generic-aadhaar-to-launch-20-generic-med-323326.html 0.6 2026-07-21T22:37:49+08:00 daily https://www.pharmasources.com/industryinsights/price-monitoring-and-resource-unit-set-u-323327.html 0.6 2026-07-09T15:25:25+08:00 daily https://www.pharmasources.com/industryinsights/bharat-biotech-in-talks-with-many-countr-323328.html 0.6 2026-07-13T11:58:16+08:00 daily https://www.pharmasources.com/industryinsights/pnb-vesper-to-commence-phase-ii-clinical-323329.html 0.6 2026-06-30T08:37:14+08:00 daily https://www.pharmasources.com/industryinsights/second-wave-of-covid-19-vaccines-may-not-323330.html 0.6 2026-06-21T02:03:45+08:00 daily https://www.pharmasources.com/industryinsights/mars-remedies-requests-nafdac-to-remove--323331.html 0.6 2026-06-22T07:50:59+08:00 daily https://www.pharmasources.com/industryinsights/arixa-pharma-to-be-acquired-by-pfizers-h-323332.html 0.6 2026-03-12T08:10:24+08:00 daily https://www.pharmasources.com/industryinsights/covaxin-from-bharat-biotech-gets-dcgi-no-323333.html 0.6 2026-06-21T18:58:47+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-receives-final-approval-fro-323334.html 0.6 2026-07-08T08:54:30+08:00 daily https://www.pharmasources.com/industryinsights/usfda-approves-ind-application-from-reve-323335.html 0.6 2026-02-15T09:16:47+08:00 daily https://www.pharmasources.com/industryinsights/gilead-gets-usfda-approval-for-veklury-r-323336.html 0.6 2026-08-04T00:10:11+08:00 daily https://www.pharmasources.com/industryinsights/launchworks-cdmo-approved-to-provide-vir-323337.html 0.6 2026-06-21T12:57:34+08:00 daily https://www.pharmasources.com/industryinsights/peru-refuses-covid-19-vaccine-purchase-d-323338.html 0.6 2026-06-20T23:58:36+08:00 daily https://www.pharmasources.com/industryinsights/indian-company-dr-reddys-isolates-data-c-323339.html 0.6 2026-06-21T03:09:01+08:00 daily https://www.pharmasources.com/industryinsights/incelldx-to-study-maraviroc-in-covid-19--323340.html 0.6 2026-06-22T03:57:37+08:00 daily https://www.pharmasources.com/industryinsights/retrophin-to-acquire-orphan-technologies-323341.html 0.6 2026-06-20T16:14:00+08:00 daily https://www.pharmasources.com/industryinsights/beroni-group-announces-successful-comple-323342.html 0.6 2026-08-07T05:07:36+08:00 daily https://www.pharmasources.com/industryinsights/gi-supply-gets-fda-clearance-for-submuco-323343.html 0.6 2026-08-07T05:28:29+08:00 daily https://www.pharmasources.com/industryinsights/merck-kgaa-iavi-and-serum-institute-link-323344.html 0.6 2026-06-28T20:35:27+08:00 daily https://www.pharmasources.com/industryinsights/bms-partners-with-sensyne-health-for-rar-323345.html 0.6 2026-08-10T18:03:40+08:00 daily https://www.pharmasources.com/industryinsights/icr-urges-change-as-nice-rejects-keytrud-323346.html 0.6 2026-06-20T20:00:40+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-keytruda-pembrolizumab-f-323347.html 0.6 2026-06-29T08:09:05+08:00 daily https://www.pharmasources.com/industryinsights/aspirin-could-protect-patients-from-seve-323348.html 0.6 2026-06-21T03:55:38+08:00 daily https://www.pharmasources.com/industryinsights/effrx-pharmaceuticals-signs-exclusive-li-323349.html 0.6 2026-08-02T06:01:52+08:00 daily https://www.pharmasources.com/industryinsights/canadas-prime-minister-justin-trudeau-an-323350.html 0.6 2026-08-09T05:05:48+08:00 daily https://www.pharmasources.com/industryinsights/eisai-and-cogstate-expand-agreement-for--323351.html 0.6 2026-08-11T18:50:19+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-heart-changes-raise-death-risk--323352.html 0.6 2026-08-09T00:31:32+08:00 daily https://www.pharmasources.com/industryinsights/alembic-pharma-gets-us-fda-approval-for--323353.html 0.6 2026-08-07T13:17:26+08:00 daily https://www.pharmasources.com/industryinsights/oxford-covid-19-vaccine-trials-produce-r-323354.html 0.6 2026-06-22T10:15:54+08:00 daily https://www.pharmasources.com/industryinsights/south-korea-pharma-celltrions-covid-test-323355.html 0.6 2026-08-06T23:55:44+08:00 daily https://www.pharmasources.com/industryinsights/in-coming-years-ayush-will-be-accepted-a-323356.html 0.6 2026-08-07T05:29:22+08:00 daily https://www.pharmasources.com/industryinsights/aurobindo-pharma-to-divest-natrol-to-new-323357.html 0.6 2026-08-08T07:57:33+08:00 daily https://www.pharmasources.com/industryinsights/3p-biopharmaceuticals-and-spybiotech-ent-323358.html 0.6 2026-08-08T04:35:21+08:00 daily https://www.pharmasources.com/industryinsights/construction-starts-on-the-medicines-man-323359.html 0.6 2026-08-07T13:18:23+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-griffin-completes-investment-in-new-323360.html 0.6 2026-08-07T11:58:17+08:00 daily https://www.pharmasources.com/industryinsights/financial-report-biogen-323361.html 0.6 2026-08-07T11:29:04+08:00 daily https://www.pharmasources.com/industryinsights/cdmo-frontida-strengthens-quality-operat-323362.html 0.6 2026-08-07T01:42:37+08:00 daily https://www.pharmasources.com/industryinsights/ana-therapeutics-initiates-trial-of-oral-323363.html 0.6 2026-08-07T01:19:17+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-gets-fda-approval-to-restart-323364.html 0.6 2026-08-07T01:11:02+08:00 daily https://www.pharmasources.com/industryinsights/bayer-acquires-gene-therapy-specialist-a-323365.html 0.6 2026-08-07T00:41:14+08:00 daily https://www.pharmasources.com/industryinsights/gilead-sciences-acquires-immunomedics-in-323366.html 0.6 2026-08-06T23:54:55+08:00 daily https://www.pharmasources.com/industryinsights/oxeia-initiates-trial-for-oxe103-for-con-323367.html 0.6 2026-08-07T22:35:27+08:00 daily https://www.pharmasources.com/industryinsights/beyond-air-to-initiate-nitric-oxide-lung-323368.html 0.6 2026-08-06T23:47:32+08:00 daily https://www.pharmasources.com/industryinsights/kintara-gcar-execute-agreement-for-val-0-323369.html 0.6 2026-08-09T18:56:24+08:00 daily https://www.pharmasources.com/industryinsights/final-report-confirms-remdesivir-benefit-323370.html 0.6 2026-08-07T10:33:34+08:00 daily https://www.pharmasources.com/industryinsights/ionis-begins-als-clinical-trial-323371.html 0.6 2026-06-22T03:10:51+08:00 daily https://www.pharmasources.com/industryinsights/cannabics-plans-pre-ind-meeting-request--323372.html 0.6 2026-06-12T23:18:43+08:00 daily https://www.pharmasources.com/industryinsights/evgen-scores-full-approval-for-covid-19--323373.html 0.6 2026-08-10T15:15:14+08:00 daily https://www.pharmasources.com/industryinsights/parkinsons-uk-partners-with-ucl-on-phase-323374.html 0.6 2026-08-07T00:59:03+08:00 daily https://www.pharmasources.com/industryinsights/az-presents-new-real-world-chronic-kidne-323375.html 0.6 2026-08-07T00:40:23+08:00 daily https://www.pharmasources.com/industryinsights/first-in-human-trial-to-study-remestemce-323376.html 0.6 2026-08-07T00:02:23+08:00 daily https://www.pharmasources.com/industryinsights/sirnaomics-seals-105m-series-d-financing-323377.html 0.6 2026-08-06T23:56:03+08:00 daily https://www.pharmasources.com/industryinsights/biocanna-announces-a-breakthrough-in-dev-323378.html 0.6 2026-08-07T00:02:31+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-containment-shaped-by-strength--323379.html 0.6 2026-08-07T02:40:45+08:00 daily https://www.pharmasources.com/industryinsights/moderna-announces-supply-agreement-with--323380.html 0.6 2026-08-07T02:43:02+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-prepares-to-resume-phase-323381.html 0.6 2026-06-22T03:54:35+08:00 daily https://www.pharmasources.com/industryinsights/sihuan-pharmaceutical-0460hk-receives-ap-323382.html 0.6 2026-07-22T03:48:36+08:00 daily https://www.pharmasources.com/industryinsights/vechain-renji-hospital-and-dnv-gl-held-s-323383.html 0.6 2026-08-02T17:37:58+08:00 daily https://www.pharmasources.com/industryinsights/orthos-vitros-sars-cov-2-antigen-test-ca-323384.html 0.6 2026-07-03T07:29:40+08:00 daily https://www.pharmasources.com/industryinsights/russia-applies-for-who-emergency-use-tag-323385.html 0.6 2026-08-06T23:46:18+08:00 daily https://www.pharmasources.com/industryinsights/japans-cabinet-approves-plan-for-free-co-323386.html 0.6 2026-08-07T01:27:54+08:00 daily https://www.pharmasources.com/industryinsights/pmi-announces-medicago-to-supply-up-to-7-323387.html 0.6 2026-08-07T02:36:56+08:00 daily https://www.pharmasources.com/industryinsights/torrent-pharma-posts-consolidated-pat-of-323388.html 0.6 2025-12-24T06:16:26+08:00 daily https://www.pharmasources.com/industryinsights/piramal-pharmas-consumer-division-launch-323389.html 0.6 2026-08-13T04:55:36+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-launches-expanded-direct-t-323390.html 0.6 2026-08-06T21:35:06+08:00 daily https://www.pharmasources.com/industryinsights/bioinvent-casi-pharmaceuticals-enter-ant-323391.html 0.6 2026-06-22T11:56:52+08:00 daily https://www.pharmasources.com/industryinsights/financial-report-lilly-323392.html 0.6 2026-08-14T17:19:37+08:00 daily https://www.pharmasources.com/industryinsights/stevanato-group-catalent-partner-to-expe-323393.html 0.6 2026-08-08T19:10:30+08:00 daily https://www.pharmasources.com/industryinsights/immunos-uses-probiogens-pathway-modulato-323394.html 0.6 2026-06-21T02:04:47+08:00 daily https://www.pharmasources.com/industryinsights/regenxbio-achieves-80m-novartis-mileston-323395.html 0.6 2026-07-19T16:36:59+08:00 daily https://www.pharmasources.com/industryinsights/moderna-signs-covid-19-vaccine-supply-de-323396.html 0.6 2026-08-11T16:33:09+08:00 daily https://www.pharmasources.com/industryinsights/aurobindo-pharma-to-sell-us-subsidiary-t-323397.html 0.6 2026-06-22T09:53:53+08:00 daily https://www.pharmasources.com/industryinsights/enlivex-doses-first-two-patients-in-allo-323398.html 0.6 2026-06-21T07:45:46+08:00 daily https://www.pharmasources.com/industryinsights/storm-therapeutics-selects-clinical-cand-323399.html 0.6 2026-06-22T01:03:54+08:00 daily https://www.pharmasources.com/industryinsights/lonza-expands-capsule-manufacturing-capa-323400.html 0.6 2026-08-04T11:57:28+08:00 daily https://www.pharmasources.com/industryinsights/f2g-receives-second-fda-breakthrough-the-323401.html 0.6 2026-06-18T12:33:30+08:00 daily https://www.pharmasources.com/industryinsights/soligenix-announces-sgx301study-continue-323402.html 0.6 2026-03-11T04:38:57+08:00 daily https://www.pharmasources.com/industryinsights/artelo-biosciences-files-patent-on-use-o-323403.html 0.6 2026-06-21T07:40:38+08:00 daily https://www.pharmasources.com/industryinsights/sensyne-health-signs-new-nhs-research-ag-323404.html 0.6 2026-07-02T20:22:24+08:00 daily https://www.pharmasources.com/industryinsights/novartis-rare-renal-disease-candidate-sh-323405.html 0.6 2026-06-21T09:48:02+08:00 daily https://www.pharmasources.com/industryinsights/bayers-nubeqa-wins-nice-prostate-cancer--323406.html 0.6 2026-08-12T10:17:28+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-resumes-us-phase-iii-covid-1-323407.html 0.6 2026-06-22T00:57:50+08:00 daily https://www.pharmasources.com/industryinsights/trial-to-evaluate-oral-nitric-oxide-ther-323408.html 0.6 2026-06-23T16:42:36+08:00 daily https://www.pharmasources.com/industryinsights/pharma-urged-to-review-anti-counterfeiti-323409.html 0.6 2026-08-08T02:39:06+08:00 daily https://www.pharmasources.com/industryinsights/novavax-provides-phase-3-covid-19-vaccin-323410.html 0.6 2026-07-21T11:05:23+08:00 daily https://www.pharmasources.com/industryinsights/russian-application-of-sputnik-v-vaccine-323411.html 0.6 2026-07-22T16:40:54+08:00 daily https://www.pharmasources.com/industryinsights/aprinoia-announces-approval-from-nmpa-to-323412.html 0.6 2026-08-10T11:08:59+08:00 daily https://www.pharmasources.com/industryinsights/molmed-spa-becomes-agc-biologics-spa-fol-323413.html 0.6 2026-08-07T03:11:39+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-323414.html 0.6 2026-06-22T03:58:39+08:00 daily https://www.pharmasources.com/industryinsights/discovering-biotechnology-top-9-chinese--323415.html 0.6 2026-08-08T19:41:07+08:00 daily https://www.pharmasources.com/industryinsights/pharma-and-health-from-ingredients-to-pi-323416.html 0.6 2026-07-30T09:38:23+08:00 daily https://www.pharmasources.com/industryinsights/cipla-launches-elifast-for-covid-19-anti-323417.html 0.6 2026-07-19T17:45:52+08:00 daily https://www.pharmasources.com/industryinsights/antibodies-against-sars-cov-2-wane-over--323418.html 0.6 2026-06-21T12:50:12+08:00 daily https://www.pharmasources.com/industryinsights/abbott-launches-duphalac-bears-in-india-323419.html 0.6 2026-06-21T17:56:52+08:00 daily https://www.pharmasources.com/industryinsights/australias-star-vaccine-maker-not-immune-323420.html 0.6 2026-08-10T17:05:00+08:00 daily https://www.pharmasources.com/industryinsights/financial-report-gilead-323421.html 0.6 2026-06-22T00:51:46+08:00 daily https://www.pharmasources.com/industryinsights/lilly-us-govt-enter-supply-pact-for-baml-323422.html 0.6 2026-06-20T21:59:41+08:00 daily https://www.pharmasources.com/industryinsights/aphena-pharma-completes-7m-facility-expa-323423.html 0.6 2026-06-20T20:51:26+08:00 daily https://www.pharmasources.com/industryinsights/dod-awards-ology-vaccine-manufacturing-c-323424.html 0.6 2026-06-21T00:08:46+08:00 daily https://www.pharmasources.com/industryinsights/valicare-expands-service-portfolio-323425.html 0.6 2026-06-29T15:04:21+08:00 daily https://www.pharmasources.com/industryinsights/sai-life-sciences-to-expand-biology-capa-323426.html 0.6 2026-07-29T21:32:04+08:00 daily https://www.pharmasources.com/industryinsights/dcat-elects-new-president-323427.html 0.6 2026-08-07T02:31:38+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-expands-direct-to-patient--323428.html 0.6 2026-08-07T01:22:29+08:00 daily https://www.pharmasources.com/industryinsights/italy-gives-approval-to-trial-osteoporos-323429.html 0.6 2026-08-07T01:14:29+08:00 daily https://www.pharmasources.com/industryinsights/apellis-enters-drug-development-and-comm-323430.html 0.6 2026-08-07T01:11:43+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-gsk-to-support-covax-with-200-mil-323431.html 0.6 2026-08-07T01:18:51+08:00 daily https://www.pharmasources.com/industryinsights/sotira-finds-preliminary-success-develop-323432.html 0.6 2026-08-10T01:00:48+08:00 daily https://www.pharmasources.com/industryinsights/trippbio-completes-trial-enrollment-to-e-323433.html 0.6 2026-06-22T01:00:50+08:00 daily https://www.pharmasources.com/industryinsights/shylicine-granted-orphan-designation-323434.html 0.6 2026-04-06T09:42:39+08:00 daily https://www.pharmasources.com/industryinsights/biondvax-universal-influenza-vaccine-can-323435.html 0.6 2026-07-06T23:09:45+08:00 daily https://www.pharmasources.com/industryinsights/oxford-start-up-base-genomics-acquired-b-323436.html 0.6 2026-08-12T11:33:15+08:00 daily https://www.pharmasources.com/industryinsights/enhertu-bags-us-priority-review-for-her2-323437.html 0.6 2026-06-20T21:59:51+08:00 daily https://www.pharmasources.com/industryinsights/uks-mhra-starts-rolling-review-of-modern-323438.html 0.6 2026-06-20T23:02:43+08:00 daily https://www.pharmasources.com/industryinsights/clinical-trials-to-study-astrazenecas-co-323439.html 0.6 2026-06-21T10:03:13+08:00 daily https://www.pharmasources.com/industryinsights/hifibio-completes-first-cohort-of-phase--323440.html 0.6 2026-06-20T22:51:50+08:00 daily https://www.pharmasources.com/industryinsights/pathnostics-launches-single-test-to-dete-323441.html 0.6 2026-06-21T11:09:17+08:00 daily https://www.pharmasources.com/industryinsights/ekf-and-kantaro-partner-to-market-quanti-323442.html 0.6 2026-06-22T10:44:45+08:00 daily https://www.pharmasources.com/industryinsights/ampio-begins-phase-1-clinical-trial-of-i-323443.html 0.6 2026-07-15T03:29:35+08:00 daily https://www.pharmasources.com/industryinsights/magnolia-health-urges-breast-cancer-scre-323444.html 0.6 2026-06-21T14:54:39+08:00 daily https://www.pharmasources.com/industryinsights/kroger-health-launches-covid-19-rapid-an-323445.html 0.6 2025-12-22T22:57:17+08:00 daily https://www.pharmasources.com/industryinsights/agena-bioscience-granted-eua-for-high-th-323446.html 0.6 2026-06-21T15:15:42+08:00 daily https://www.pharmasources.com/industryinsights/bc-platforms-announces-partnership-with--323447.html 0.6 2026-06-21T08:49:54+08:00 daily https://www.pharmasources.com/industryinsights/deep-longevity-and-squareone-wellness-pa-323448.html 0.6 2026-08-10T12:03:17+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-expands-global-footpri-323449.html 0.6 2026-08-07T01:27:53+08:00 daily https://www.pharmasources.com/industryinsights/cstone-and-legochem-biosciences-enter-gl-323450.html 0.6 2026-08-07T01:54:42+08:00 daily https://www.pharmasources.com/industryinsights/pharma-sources-insight-october-2020-focu-323451.html 0.6 2026-07-30T13:50:34+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-and-ab2-bio-announce-coll-323452.html 0.6 2026-08-07T01:14:06+08:00 daily https://www.pharmasources.com/industryinsights/who-to-set-up-covid-19-vaccine-insurance-323453.html 0.6 2026-08-07T01:11:33+08:00 daily https://www.pharmasources.com/industryinsights/cabinet-approves-mou-between-india-and-c-323454.html 0.6 2026-08-07T02:41:07+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-tentative-us-fda-appro-323455.html 0.6 2026-08-10T06:21:52+08:00 daily https://www.pharmasources.com/industryinsights/fasenra-eliminated-ocs-in-a-majority-of--323456.html 0.6 2026-08-09T22:12:47+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-receives-tentative-usfda-ap-323457.html 0.6 2026-08-09T23:06:52+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-partners-with-birac-for-sputni-323458.html 0.6 2026-06-22T06:53:47+08:00 daily https://www.pharmasources.com/industryinsights/dop-to-launch-revised-pli-scheme-guideli-323459.html 0.6 2026-06-21T22:54:38+08:00 daily https://www.pharmasources.com/industryinsights/csir-cdri-scientist-dr-satish-mishra-get-323460.html 0.6 2026-06-23T22:23:22+08:00 daily https://www.pharmasources.com/industryinsights/piramal-pharma-to-acquire-navin-fluorine-323461.html 0.6 2026-07-07T18:00:32+08:00 daily https://www.pharmasources.com/industryinsights/syneos-health-agrees-to-acquire-synterac-323462.html 0.6 2026-06-21T02:03:39+08:00 daily https://www.pharmasources.com/industryinsights/ab2-bio-and-wuxi-biologics-enter-collabo-323463.html 0.6 2026-07-14T15:26:30+08:00 daily https://www.pharmasources.com/industryinsights/therapeutaix-expands-rd-network-323464.html 0.6 2026-07-18T04:32:31+08:00 daily https://www.pharmasources.com/industryinsights/financial-report-ppd-323465.html 0.6 2026-06-21T02:14:50+08:00 daily https://www.pharmasources.com/industryinsights/avomeen-names-svp-of-lab-operations-323466.html 0.6 2026-06-21T09:47:58+08:00 daily https://www.pharmasources.com/industryinsights/catalent-to-acquire-bone-therapeutics-ce-323467.html 0.6 2026-03-19T08:48:46+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-symphogen-extend-developme-323468.html 0.6 2026-06-22T03:00:46+08:00 daily https://www.pharmasources.com/industryinsights/barda-reselects-icon-as-preferred-partne-323469.html 0.6 2026-08-09T05:29:07+08:00 daily https://www.pharmasources.com/industryinsights/novartis-and-molecular-partners-collabor-323470.html 0.6 2026-06-20T21:10:45+08:00 daily https://www.pharmasources.com/industryinsights/drug-companies-to-offer-political-donati-323471.html 0.6 2026-08-10T03:12:50+08:00 daily https://www.pharmasources.com/industryinsights/cstone-and-legochem-to-jointly-develop-n-323472.html 0.6 2026-06-22T09:49:57+08:00 daily https://www.pharmasources.com/industryinsights/evoke-eversana-announce-commercial-launc-323473.html 0.6 2026-08-08T07:57:57+08:00 daily https://www.pharmasources.com/industryinsights/nbe-therapeutics-begins-anti-ror1-adc-st-323474.html 0.6 2026-08-08T23:42:34+08:00 daily https://www.pharmasources.com/industryinsights/helix-receives-expanded-eua-for-helix-co-323475.html 0.6 2026-08-10T23:02:03+08:00 daily https://www.pharmasources.com/industryinsights/aeglea-biotherapeutics-announces-orphan--323476.html 0.6 2026-08-08T22:34:55+08:00 daily https://www.pharmasources.com/industryinsights/sqi-diagnostics-updates-clinical-progres-323477.html 0.6 2026-08-07T00:41:38+08:00 daily https://www.pharmasources.com/industryinsights/janssen-submits-snda-for-expanded-use-of-323478.html 0.6 2026-08-07T01:11:18+08:00 daily https://www.pharmasources.com/industryinsights/blood-test-more-predictive-of-ovarian-ca-323479.html 0.6 2026-08-07T01:20:25+08:00 daily https://www.pharmasources.com/industryinsights/bms-collaborates-with-insitro-to-develop-323480.html 0.6 2026-06-30T02:58:13+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-testing-womb-cancer-pati-323481.html 0.6 2026-08-10T13:00:44+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-teams-up-with-msd-to-test-new-onc-323482.html 0.6 2026-06-21T02:16:51+08:00 daily https://www.pharmasources.com/industryinsights/novartis-sets-sights-on-potential-covid--323483.html 0.6 2026-06-23T05:13:07+08:00 daily https://www.pharmasources.com/industryinsights/uk-biotech-consortium-identifies-covid-1-323484.html 0.6 2026-08-11T20:52:17+08:00 daily https://www.pharmasources.com/industryinsights/merck-manuals-shares-what-parents-need-t-323485.html 0.6 2026-06-22T11:50:00+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-priority-review-and-ema-accep-323486.html 0.6 2026-06-20T20:55:48+08:00 daily https://www.pharmasources.com/industryinsights/kala-pharmaceuticals-announces-fda-appro-323487.html 0.6 2026-06-21T17:19:43+08:00 daily https://www.pharmasources.com/industryinsights/aurinia-begins-voclosporin-trial-in-kidn-323488.html 0.6 2026-08-08T21:58:12+08:00 daily https://www.pharmasources.com/industryinsights/ocumension-therapeutics-strengthens-pipe-323489.html 0.6 2026-08-09T03:11:10+08:00 daily https://www.pharmasources.com/industryinsights/avatamed-and-macrogen-sign-mou-on-joint--323490.html 0.6 2026-08-07T13:19:42+08:00 daily https://www.pharmasources.com/industryinsights/agc-biologics-and-horizon-therapeutics-p-323491.html 0.6 2026-08-07T00:39:56+08:00 daily https://www.pharmasources.com/industryinsights/takeda-expands-covid-19-vaccine-supply-i-323492.html 0.6 2026-08-07T00:02:16+08:00 daily https://www.pharmasources.com/industryinsights/uk-mhra-commences-accelerated-review-for-323493.html 0.6 2026-08-07T00:41:14+08:00 daily https://www.pharmasources.com/industryinsights/bharat-biotech-plans-covaxin-launch-in-s-323494.html 0.6 2026-08-07T00:53:17+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-declares-five-year-positive-r-323495.html 0.6 2026-08-13T19:45:04+08:00 daily https://www.pharmasources.com/industryinsights/study-finds-novel-covid-19-antibody-ther-323496.html 0.6 2026-08-10T15:24:59+08:00 daily https://www.pharmasources.com/industryinsights/jj-to-test-covid-19-vaccine-in-youths-ag-323497.html 0.6 2026-06-21T20:50:47+08:00 daily https://www.pharmasources.com/industryinsights/aarti-drugs-to-expand-metformin-capacity-323498.html 0.6 2026-06-21T12:00:18+08:00 daily https://www.pharmasources.com/industryinsights/pharma-industry-appreciates-modification-323499.html 0.6 2026-08-14T10:06:44+08:00 daily https://www.pharmasources.com/industryinsights/form-committees-for-smooth-covid-19-vacc-323500.html 0.6 2026-08-13T21:31:17+08:00 daily https://www.pharmasources.com/industryinsights/appili-therapeutics-to-partner-with-dr-r-323501.html 0.6 2026-06-22T21:54:45+08:00 daily https://www.pharmasources.com/industryinsights/biocon-ranked-among-top-five-biotech-emp-323502.html 0.6 2026-08-12T23:25:54+08:00 daily https://www.pharmasources.com/industryinsights/activists-urge-pharma-companies-to-be-tr-323503.html 0.6 2026-06-22T13:03:05+08:00 daily https://www.pharmasources.com/industryinsights/india-uk-enter-into-new-covid-19-researc-323504.html 0.6 2026-08-05T19:04:35+08:00 daily https://www.pharmasources.com/industryinsights/hivig-is-good-covid-19-treatment-option--323505.html 0.6 2026-06-21T11:03:13+08:00 daily https://www.pharmasources.com/industryinsights/frontida-biopharm-names-steven-roese-as--323506.html 0.6 2026-08-08T21:34:21+08:00 daily https://www.pharmasources.com/industryinsights/moderna-partners-with-takeda-for-covid-1-323507.html 0.6 2026-08-08T20:00:38+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-novo-nordisk-treatment-f-323508.html 0.6 2026-06-20T19:03:36+08:00 daily https://www.pharmasources.com/industryinsights/financial-report-abbvie-323509.html 0.6 2026-08-10T08:00:02+08:00 daily https://www.pharmasources.com/industryinsights/lonza-to-manufacture-astrazenecas-covid--323510.html 0.6 2026-08-07T12:30:38+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-expands-global-footpri-323511.html 0.6 2026-08-07T13:18:07+08:00 daily https://www.pharmasources.com/industryinsights/truvian-to-make-rapid-antibody-testing-m-323512.html 0.6 2026-06-22T13:51:52+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-companion-diagnostic-to-ide-323513.html 0.6 2026-08-08T10:38:32+08:00 daily https://www.pharmasources.com/industryinsights/seelos-announces-patent-for-sls-007-323514.html 0.6 2026-08-08T12:18:43+08:00 daily https://www.pharmasources.com/industryinsights/ampio-begins-phase-trial-of-inhaled-ampi-323515.html 0.6 2026-08-08T22:44:50+08:00 daily https://www.pharmasources.com/industryinsights/nerivio-receives-expanded-indication-to--323516.html 0.6 2026-08-09T00:31:35+08:00 daily https://www.pharmasources.com/industryinsights/vanda-receives-fda-approval-to-proceed-w-323517.html 0.6 2026-08-10T00:13:18+08:00 daily https://www.pharmasources.com/industryinsights/novel-non-opioid-postsurgical-pain-impla-323518.html 0.6 2026-06-20T14:56:13+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-in-human-trial-of-cov-323519.html 0.6 2026-06-21T06:24:31+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-is-threatening-the-uks-medical--323520.html 0.6 2026-08-12T17:05:26+08:00 daily https://www.pharmasources.com/industryinsights/microvascular-dysfunction-in-covid-19-pa-323521.html 0.6 2026-08-07T03:03:01+08:00 daily https://www.pharmasources.com/industryinsights/rdif-and-unio-qumica-file-documents-for--323522.html 0.6 2026-08-07T02:51:43+08:00 daily https://www.pharmasources.com/industryinsights/new-drug-candidate-for-the-treatment-of--323523.html 0.6 2026-08-07T02:45:59+08:00 daily https://www.pharmasources.com/industryinsights/japanese-animal-quarantine-service-confi-323524.html 0.6 2026-08-07T02:05:20+08:00 daily https://www.pharmasources.com/industryinsights/saudi-commission-for-health-specialties--323525.html 0.6 2026-08-07T02:15:39+08:00 daily https://www.pharmasources.com/industryinsights/amgen-appoints-general-manager-mainland--323526.html 0.6 2026-08-09T08:17:30+08:00 daily https://www.pharmasources.com/industryinsights/fusion-pharma-astrazeneca-enter-radiopha-323527.html 0.6 2026-06-20T22:04:39+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-checkpoint-therapeutic-323528.html 0.6 2026-08-06T05:22:24+08:00 daily https://www.pharmasources.com/industryinsights/mylan-appoints-head-of-capital-markets-323529.html 0.6 2026-06-08T21:45:07+08:00 daily https://www.pharmasources.com/industryinsights/minaris-invests-645m-to-expand-cell-and--323530.html 0.6 2026-06-21T12:13:22+08:00 daily https://www.pharmasources.com/industryinsights/ema-accepts-marketing-application-for-bi-323531.html 0.6 2026-06-21T10:02:06+08:00 daily https://www.pharmasources.com/industryinsights/uk-regulator-initiates-rolling-review-of-323532.html 0.6 2026-06-22T04:01:44+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-cases-increase-ahead-of-us-pres-323533.html 0.6 2025-11-14T01:37:56+08:00 daily https://www.pharmasources.com/industryinsights/experts-seek-data-on-remdesivir-and-covi-323534.html 0.6 2026-06-21T10:44:11+08:00 daily https://www.pharmasources.com/industryinsights/cepi-extends-partnership-with-clover-bio-323535.html 0.6 2026-08-08T00:36:57+08:00 daily https://www.pharmasources.com/industryinsights/zydus-to-present-pbc-and-nash-clinical-t-323536.html 0.6 2026-06-20T19:02:31+08:00 daily https://www.pharmasources.com/industryinsights/lonza-appoints-ceo-323537.html 0.6 2026-06-21T15:09:44+08:00 daily https://www.pharmasources.com/industryinsights/reducing-api-dependence-have-we-got-the--323538.html 0.6 2026-06-20T18:53:35+08:00 daily https://www.pharmasources.com/industryinsights/dop-issues-letter-to-pharma-associations-323539.html 0.6 2026-06-20T17:12:38+08:00 daily https://www.pharmasources.com/industryinsights/drug-used-to-treat-opioid-addiction-can--323540.html 0.6 2026-06-21T03:45:37+08:00 daily https://www.pharmasources.com/industryinsights/thermo-king-by-trane-technologies-launch-323541.html 0.6 2026-03-31T21:33:31+08:00 daily https://www.pharmasources.com/industryinsights/new-study-assessing-antibiotics-for-covi-323542.html 0.6 2026-06-23T00:58:26+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-to-buy-kiadis-323543.html 0.6 2026-06-21T19:56:38+08:00 daily https://www.pharmasources.com/industryinsights/mhra-allows-hae-patients-early-access-to-323544.html 0.6 2026-06-22T12:59:44+08:00 daily https://www.pharmasources.com/industryinsights/new-eu-approval-for-gsks-zejula-323545.html 0.6 2026-06-21T20:17:54+08:00 daily https://www.pharmasources.com/industryinsights/perkinelmer-to-acquire-horizon-discovery-323546.html 0.6 2026-08-03T01:48:33+08:00 daily https://www.pharmasources.com/industryinsights/revimmune-advances-new-covid-19-immunoth-323547.html 0.6 2026-07-18T04:58:21+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-named-top-biopharma-company-to-323548.html 0.6 2026-08-08T23:00:20+08:00 daily https://www.pharmasources.com/industryinsights/humanigen-announces-first-patient-dosed--323549.html 0.6 2026-06-21T02:02:48+08:00 daily https://www.pharmasources.com/industryinsights/ultrapotent-covid-19-vaccine-candidate-d-323550.html 0.6 2026-08-08T12:07:38+08:00 daily https://www.pharmasources.com/industryinsights/leading-cell-therapy-company-jw-therapeu-323551.html 0.6 2026-08-08T10:11:43+08:00 daily https://www.pharmasources.com/industryinsights/senhwa-announces-multiple-ind-applicatio-323552.html 0.6 2026-08-08T08:01:03+08:00 daily https://www.pharmasources.com/industryinsights/carsgen-therapeutics-closes-a-usd-186-mi-323553.html 0.6 2026-08-07T13:15:28+08:00 daily https://www.pharmasources.com/industryinsights/chinese-pharma-firms-can-support-africa--323554.html 0.6 2026-08-03T03:50:32+08:00 daily https://www.pharmasources.com/industryinsights/chinese-apis-and-their-role-in-the-world-323557.html 0.6 2026-08-09T02:18:47+08:00 daily https://www.pharmasources.com/industryinsights/pharma-products-worth-rs-358-cr-sold-thr-323558.html 0.6 2026-08-07T00:01:44+08:00 daily https://www.pharmasources.com/industryinsights/romaco-kilian-appoints-stefan-krmer-as-n-323559.html 0.6 2026-08-07T00:40:09+08:00 daily https://www.pharmasources.com/industryinsights/acg-acquires-significant-stake-in-iqgen--323560.html 0.6 2026-08-13T00:14:19+08:00 daily https://www.pharmasources.com/industryinsights/scientists-develop-faster-method-to-dete-323561.html 0.6 2026-08-07T01:21:33+08:00 daily https://www.pharmasources.com/industryinsights/equine-polyclonal-antibodies-have-shown--323562.html 0.6 2026-08-07T01:27:37+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-files-ind-application-for-z-323563.html 0.6 2026-08-07T01:39:50+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-expands-in-china-323564.html 0.6 2026-08-07T01:42:43+08:00 daily https://www.pharmasources.com/industryinsights/reach-separations-expands-nottingham-pre-323565.html 0.6 2026-08-07T13:19:48+08:00 daily https://www.pharmasources.com/industryinsights/eurofins-discovery-collaborates-with-swi-323566.html 0.6 2026-08-09T03:22:26+08:00 daily https://www.pharmasources.com/industryinsights/roche-obtains-ec-approval-for-tecentriqa-323567.html 0.6 2026-08-08T01:01:13+08:00 daily https://www.pharmasources.com/industryinsights/aspen-pharmacare-to-manufacture-covid-19-323568.html 0.6 2025-11-28T10:25:02+08:00 daily https://www.pharmasources.com/industryinsights/brazil-authorises-resumption-of-johnson--323569.html 0.6 2026-06-23T09:01:46+08:00 daily https://www.pharmasources.com/industryinsights/cdmo-minaris-invests-645m-to-expand-oper-323570.html 0.6 2026-06-20T22:48:42+08:00 daily https://www.pharmasources.com/industryinsights/etherna-extends-mrna-production-services-323571.html 0.6 2026-06-20T21:59:37+08:00 daily https://www.pharmasources.com/industryinsights/discovering-biotechnology-trends-in-chin-323572.html 0.6 2026-08-09T17:59:47+08:00 daily https://www.pharmasources.com/industryinsights/novartis-expands-kymriah-manufacturing-f-323573.html 0.6 2026-08-10T18:03:39+08:00 daily https://www.pharmasources.com/industryinsights/atai-announces-neuronasal-completes-pilo-323574.html 0.6 2026-06-21T02:08:43+08:00 daily https://www.pharmasources.com/industryinsights/allergan-announces-positive-phase-3-topl-323575.html 0.6 2026-06-22T05:44:33+08:00 daily https://www.pharmasources.com/industryinsights/syntrix-completes-initial-sx-682-dosing--323576.html 0.6 2026-08-07T01:27:27+08:00 daily https://www.pharmasources.com/industryinsights/rhythm-pharmaceuticals-announces-executi-323577.html 0.6 2026-08-07T01:19:23+08:00 daily https://www.pharmasources.com/industryinsights/agena-bioscience-granted-eua-for-high-th-323578.html 0.6 2026-08-07T01:27:46+08:00 daily https://www.pharmasources.com/industryinsights/oncolytics-biotech-roche-aio-initiate-ga-323579.html 0.6 2026-08-11T22:06:09+08:00 daily https://www.pharmasources.com/industryinsights/aphena-pharma-completes-7m-expansion-323580.html 0.6 2026-08-07T01:42:55+08:00 daily https://www.pharmasources.com/industryinsights/boston-scientific-receives-fda-approval--323581.html 0.6 2026-08-07T01:52:08+08:00 daily https://www.pharmasources.com/industryinsights/agenus-doses-first-covid-19-patient-with-323582.html 0.6 2026-08-07T13:17:35+08:00 daily https://www.pharmasources.com/industryinsights/ema-begins-evaluation-of-filgotinib-for--323583.html 0.6 2026-08-08T07:55:49+08:00 daily https://www.pharmasources.com/industryinsights/oxford-biodynamics-enters-strategic-part-323584.html 0.6 2026-08-08T09:00:19+08:00 daily https://www.pharmasources.com/industryinsights/lilly-incyte-tout-new-baricitinib-data-i-323585.html 0.6 2026-06-22T00:02:48+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisks-saxenda-bags-nice-recommen-323586.html 0.6 2026-08-08T12:18:35+08:00 daily https://www.pharmasources.com/industryinsights/fda-publishes-list-of-essential-medicine-323587.html 0.6 2026-08-10T12:15:57+08:00 daily https://www.pharmasources.com/industryinsights/highly-potent-nanoparticle-covid-19-vacc-323588.html 0.6 2026-06-30T17:15:27+08:00 daily https://www.pharmasources.com/industryinsights/lannett-launches-authorized-generic-of-t-323589.html 0.6 2026-08-10T15:09:42+08:00 daily https://www.pharmasources.com/industryinsights/farrer-park-hospital-garners-2-regional--323590.html 0.6 2026-08-07T00:41:59+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-323591.html 0.6 2026-08-07T00:39:58+08:00 daily https://www.pharmasources.com/industryinsights/nppa-fixes-retail-price-of-new-gen-rabie-323592.html 0.6 2026-08-07T00:33:38+08:00 daily https://www.pharmasources.com/industryinsights/feinstein-institutes-gets-113-million-su-323593.html 0.6 2026-06-20T21:19:06+08:00 daily https://www.pharmasources.com/industryinsights/corona-remedies-to-invest-rs-20-25-cr-fo-323594.html 0.6 2026-08-12T10:17:15+08:00 daily https://www.pharmasources.com/industryinsights/india-and-israel-to-sign-mou-for-coopera-323595.html 0.6 2026-08-13T07:41:59+08:00 daily https://www.pharmasources.com/industryinsights/lasa-gets-environmental-clearance-for-be-323596.html 0.6 2026-08-07T23:46:25+08:00 daily https://www.pharmasources.com/industryinsights/financial-reportmerck-323597.html 0.6 2026-08-04T12:39:56+08:00 daily https://www.pharmasources.com/industryinsights/aptargroup-acquires-assets-of-cohero-hea-323598.html 0.6 2026-08-08T16:54:14+08:00 daily https://www.pharmasources.com/industryinsights/jubilant-radiopharma-sofie-biosciences-i-323599.html 0.6 2026-06-21T11:02:09+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-batl-partner-to-advance-bi-323600.html 0.6 2026-06-20T21:57:36+08:00 daily https://www.pharmasources.com/industryinsights/financial-report-amgen-323601.html 0.6 2026-07-28T10:19:44+08:00 daily https://www.pharmasources.com/industryinsights/sensorion-and-novasep-sign-agreement-323602.html 0.6 2026-08-07T01:42:54+08:00 daily https://www.pharmasources.com/industryinsights/tff-expands-engagement-with-experic-323603.html 0.6 2026-08-07T01:48:58+08:00 daily https://www.pharmasources.com/industryinsights/crown-biosciences-opens-facility-in-chin-323604.html 0.6 2026-08-07T02:05:36+08:00 daily https://www.pharmasources.com/industryinsights/scientists-develop-covid-19-vaccine-cand-323605.html 0.6 2026-08-07T02:09:50+08:00 daily https://www.pharmasources.com/industryinsights/aiims-study-finds-ivermectin-prophylaxis-323606.html 0.6 2026-08-10T15:15:30+08:00 daily https://www.pharmasources.com/industryinsights/humanigen-to-enter-asia-pacific-market-w-323607.html 0.6 2026-06-21T13:04:31+08:00 daily https://www.pharmasources.com/industryinsights/cepi-to-fund-clovers-covid-19-vaccine-de-323608.html 0.6 2026-06-22T15:05:03+08:00 daily https://www.pharmasources.com/industryinsights/financial-report-pfizer-323609.html 0.6 2026-06-21T04:55:37+08:00 daily https://www.pharmasources.com/industryinsights/financial-report-novartis-323610.html 0.6 2026-06-22T09:41:24+08:00 daily https://www.pharmasources.com/industryinsights/fda-announces-potential-for-false-positi-323611.html 0.6 2026-06-21T19:46:44+08:00 daily https://www.pharmasources.com/industryinsights/perkinelmer-to-acquire-cell-engineering--323612.html 0.6 2026-07-02T18:26:06+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-to-sell-atacand-atacand-plus-323613.html 0.6 2026-08-14T20:19:39+08:00 daily https://www.pharmasources.com/industryinsights/nostrum-laboratories-issues-recall-of-me-323614.html 0.6 2026-06-21T06:05:49+08:00 daily https://www.pharmasources.com/industryinsights/sobi-launches-thrombocytopenia-drug-dopt-323615.html 0.6 2026-08-08T19:04:26+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibbs-psoriasis-med-hits-323616.html 0.6 2026-06-21T09:45:48+08:00 daily https://www.pharmasources.com/industryinsights/gw-pharma-begins-recruitment-for-us-base-323617.html 0.6 2026-08-07T12:16:12+08:00 daily https://www.pharmasources.com/industryinsights/mhra-starts-rolling-review-of-azs-corona-323618.html 0.6 2026-07-18T06:17:43+08:00 daily https://www.pharmasources.com/industryinsights/novel-gelatin-microcarrier-developed-to--323619.html 0.6 2026-08-11T18:06:28+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-liraglutide-for-treatmen-323620.html 0.6 2026-07-05T09:17:39+08:00 daily https://www.pharmasources.com/industryinsights/common-osteoporosis-treatments-could-red-323621.html 0.6 2026-06-21T17:49:30+08:00 daily https://www.pharmasources.com/industryinsights/idmc-recommends-modifications-to-regener-323622.html 0.6 2026-06-21T11:19:36+08:00 daily https://www.pharmasources.com/industryinsights/ionis-and-akcea-announce-that-pfizer-ini-323623.html 0.6 2026-08-09T05:38:02+08:00 daily https://www.pharmasources.com/industryinsights/neuraly-gets-fda-clearance-of-inda-to-in-323624.html 0.6 2026-08-07T01:19:43+08:00 daily https://www.pharmasources.com/industryinsights/cancer-treatment-could-be-replicated-for-323625.html 0.6 2026-08-07T00:41:25+08:00 daily https://www.pharmasources.com/industryinsights/scientists-identify-synthetic-mini-antib-323626.html 0.6 2026-08-07T05:19:03+08:00 daily https://www.pharmasources.com/industryinsights/data-for-lillys-bamlanivimab-ly-cov555-i-323627.html 0.6 2026-08-07T00:02:31+08:00 daily https://www.pharmasources.com/industryinsights/tcm-lianhua-qingwens-access-to-russian-m-323628.html 0.6 2026-08-07T00:24:47+08:00 daily https://www.pharmasources.com/industryinsights/skills-and-talents-deficit-poses-biggest-323629.html 0.6 2026-06-20T21:10:43+08:00 daily https://www.pharmasources.com/industryinsights/reassess-your-alternatives-323630.html 0.6 2026-06-20T15:06:27+08:00 daily https://www.pharmasources.com/industryinsights/disappointing-solidarity-results-for-rem-323631.html 0.6 2026-06-21T13:04:34+08:00 daily https://www.pharmasources.com/industryinsights/dr-harsh-vardhan-gives-away-gandhian-you-323632.html 0.6 2026-06-20T22:14:03+08:00 daily https://www.pharmasources.com/industryinsights/covaxin-may-get-launched-in-february-202-323633.html 0.6 2026-06-22T08:19:05+08:00 daily https://www.pharmasources.com/industryinsights/dop-forms-expert-committee-to-identify-i-323634.html 0.6 2026-06-21T04:11:21+08:00 daily https://www.pharmasources.com/industryinsights/schott-kaisha-expands-vial-production-ca-323635.html 0.6 2026-07-02T23:02:09+08:00 daily https://www.pharmasources.com/industryinsights/non-transparency-a-major-bottleneck-in-d-323636.html 0.6 2026-06-22T08:03:49+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-is-driving-more-supplier-redund-323637.html 0.6 2026-07-24T02:29:37+08:00 daily https://www.pharmasources.com/industryinsights/eurofins-cdmo-expands-drug-product-capab-323638.html 0.6 2026-06-03T11:05:59+08:00 daily https://www.pharmasources.com/industryinsights/lonza-opens-facility-for-adc-payload-man-323639.html 0.6 2026-08-10T22:56:24+08:00 daily https://www.pharmasources.com/industryinsights/ec-approves-astrazeneca-and-mercks-lynpa-323640.html 0.6 2026-08-09T14:55:27+08:00 daily https://www.pharmasources.com/industryinsights/aiims-find-ivermectin-prophylaxis-reduce-323641.html 0.6 2026-08-07T02:18:33+08:00 daily https://www.pharmasources.com/industryinsights/australia-to-acquire-40-million-doses-of-323642.html 0.6 2026-08-07T02:05:05+08:00 daily https://www.pharmasources.com/industryinsights/qualigen-receives-positive-pre-ind-respo-323643.html 0.6 2026-08-07T01:43:20+08:00 daily https://www.pharmasources.com/industryinsights/ec-grants-authorization-for-arikayce-lip-323644.html 0.6 2026-08-07T01:19:01+08:00 daily https://www.pharmasources.com/industryinsights/therapeutic-solutions-files-patent-appli-323645.html 0.6 2026-08-07T01:11:19+08:00 daily https://www.pharmasources.com/industryinsights/orasis-initiates-clinical-studies-of-nov-323646.html 0.6 2026-08-07T00:41:17+08:00 daily https://www.pharmasources.com/industryinsights/revision-therapeutics-announces-fda-gran-323647.html 0.6 2026-08-06T23:56:28+08:00 daily https://www.pharmasources.com/industryinsights/novartis-molecular-partners-to-develop-t-323648.html 0.6 2026-08-07T02:40:10+08:00 daily https://www.pharmasources.com/industryinsights/porton-biologics-launches-gene-and-cell--323649.html 0.6 2026-08-07T02:51:58+08:00 daily https://www.pharmasources.com/industryinsights/taysha-gene-therapies-partners-with-cata-323650.html 0.6 2026-06-21T00:54:02+08:00 daily https://www.pharmasources.com/industryinsights/novartis-cosentyx-reduces-synovitis-in-n-323651.html 0.6 2026-07-01T10:17:12+08:00 daily https://www.pharmasources.com/industryinsights/azs-forxiga-wins-eu-approval-for-heart-f-323652.html 0.6 2026-06-20T23:14:58+08:00 daily https://www.pharmasources.com/industryinsights/oncology-development-programme-launches--323653.html 0.6 2026-07-24T12:26:40+08:00 daily https://www.pharmasources.com/industryinsights/nhs-at-a-critical-point-as-covid-19-case-323654.html 0.6 2026-06-23T13:10:06+08:00 daily https://www.pharmasources.com/industryinsights/slow-cmo-revenue-growth-could-impact-us-323655.html 0.6 2026-06-21T23:57:42+08:00 daily https://www.pharmasources.com/industryinsights/pharma-ma-activity-up-17-percent-year-on-323656.html 0.6 2026-07-23T09:12:10+08:00 daily https://www.pharmasources.com/industryinsights/cvncov-covid-19-vaccine-safely-elicits-i-323657.html 0.6 2026-08-11T13:20:41+08:00 daily https://www.pharmasources.com/industryinsights/magnostics-is-co-developing-and-launchin-323658.html 0.6 2026-06-29T14:33:13+08:00 daily https://www.pharmasources.com/industryinsights/prebona-proves-unique-long-term-effect-a-323659.html 0.6 2026-08-09T07:59:41+08:00 daily https://www.pharmasources.com/industryinsights/new-drug-for-gastrointestinal-stromal-tu-323660.html 0.6 2026-08-07T13:17:35+08:00 daily https://www.pharmasources.com/industryinsights/semaglutide-24-mg-injection-demonstrated-323661.html 0.6 2026-08-10T19:03:57+08:00 daily https://www.pharmasources.com/industryinsights/polyactiva-successfully-completes-initia-323662.html 0.6 2026-08-07T02:15:58+08:00 daily https://www.pharmasources.com/industryinsights/trial-in-britain-to-assess-aspirin-as-po-323663.html 0.6 2026-08-07T13:16:04+08:00 daily https://www.pharmasources.com/industryinsights/aiocd-writes-to-ratan-tata-asking-not-to-323664.html 0.6 2026-08-08T17:53:07+08:00 daily https://www.pharmasources.com/industryinsights/healthcare-industry-reports-86-deals-wor-323665.html 0.6 2026-08-08T20:01:05+08:00 daily https://www.pharmasources.com/industryinsights/bharat-biotech-to-manufacture-covaxin-fr-323666.html 0.6 2026-08-08T21:48:25+08:00 daily https://www.pharmasources.com/industryinsights/biocon-biologics-gets-rs-1-125-cr-capita-323667.html 0.6 2026-08-09T00:17:07+08:00 daily https://www.pharmasources.com/industryinsights/humanigen-announces-positive-interim-dat-323668.html 0.6 2026-08-09T03:44:50+08:00 daily https://www.pharmasources.com/industryinsights/ksrpo-urges-abolition-of-dpharm-certific-323669.html 0.6 2026-06-30T21:05:03+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-get-ec-approval-for-323670.html 0.6 2026-07-26T23:37:57+08:00 daily https://www.pharmasources.com/industryinsights/india-is-a-key-market-for-us-it-is-a-pha-323671.html 0.6 2026-08-14T10:06:55+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-scientific-innoforce-to-se-323672.html 0.6 2026-07-23T22:23:08+08:00 daily https://www.pharmasources.com/industryinsights/celltrion-presents-data-for-covid-19-mon-323673.html 0.6 2026-07-06T09:43:07+08:00 daily https://www.pharmasources.com/industryinsights/jubilant-pharma-and-aavis-pharma-launch--323674.html 0.6 2026-06-20T14:27:43+08:00 daily https://www.pharmasources.com/industryinsights/om-pharma-and-astrazeneca-sign-collabora-323675.html 0.6 2026-08-03T02:48:40+08:00 daily https://www.pharmasources.com/industryinsights/amri-named-exclusive-api-supplier-for-re-323676.html 0.6 2026-07-07T17:28:22+08:00 daily https://www.pharmasources.com/industryinsights/argonaut-manufacturing-services-complete-323677.html 0.6 2026-08-08T14:12:33+08:00 daily https://www.pharmasources.com/industryinsights/fareva-expands-sterile-production-capabi-323678.html 0.6 2026-06-20T13:20:38+08:00 daily https://www.pharmasources.com/industryinsights/legacy-pharmaceutical-packaging-adds-fac-323679.html 0.6 2026-07-03T07:14:45+08:00 daily https://www.pharmasources.com/industryinsights/flamma-gilead-continue-mfg-partnership-f-323680.html 0.6 2026-07-06T20:35:37+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-to-continue-patient-recruitmen-323681.html 0.6 2026-06-21T13:03:33+08:00 daily https://www.pharmasources.com/industryinsights/merck-to-acquire-oncology-firm-velosbio--323682.html 0.6 2026-07-21T16:45:03+08:00 daily https://www.pharmasources.com/industryinsights/bangladesh-signs-covid-19-vaccine-deal-w-323683.html 0.6 2026-06-21T01:13:59+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-scientific-extends-collabo-323684.html 0.6 2026-01-03T16:59:01+08:00 daily https://www.pharmasources.com/industryinsights/somalogic-announces-new-collaboration-wi-323685.html 0.6 2026-08-10T09:21:04+08:00 daily https://www.pharmasources.com/industryinsights/boston-scientific-initiates-trial-to-eva-323686.html 0.6 2026-08-07T01:42:58+08:00 daily https://www.pharmasources.com/industryinsights/oncosec-announces-fda-clearance-for-tria-323687.html 0.6 2026-08-07T02:05:27+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-outpatient-trial-demonstrates-r-323688.html 0.6 2026-08-07T21:29:23+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-for-priority-review-libtayo--323689.html 0.6 2026-08-07T01:19:19+08:00 daily https://www.pharmasources.com/industryinsights/open-orphan-announces-25m-influenza-chal-323690.html 0.6 2026-08-07T01:11:02+08:00 daily https://www.pharmasources.com/industryinsights/vertexs-kalydeco-scores-another-label-ex-323691.html 0.6 2026-08-07T00:41:04+08:00 daily https://www.pharmasources.com/industryinsights/nice-backs-abbvies-rinvoq-for-severe-act-323692.html 0.6 2026-06-20T19:53:23+08:00 daily https://www.pharmasources.com/industryinsights/lynparza-scores-two-new-eu-approvals-323693.html 0.6 2026-06-22T11:15:04+08:00 daily https://www.pharmasources.com/industryinsights/care-ga-receives-study-may-proceed-lette-323694.html 0.6 2026-06-22T04:09:49+08:00 daily https://www.pharmasources.com/industryinsights/vuzix-smart-glasses-enables-continuous-r-323695.html 0.6 2026-01-31T05:19:32+08:00 daily https://www.pharmasources.com/industryinsights/xnk-therapeutics-receives-us-orphan-drug-323696.html 0.6 2026-06-21T11:10:24+08:00 daily https://www.pharmasources.com/industryinsights/synact-pharma-announces-positive-interim-323697.html 0.6 2025-12-20T19:56:22+08:00 daily https://www.pharmasources.com/industryinsights/new-research-study-supports-clinical-uti-323698.html 0.6 2025-11-28T12:55:15+08:00 daily https://www.pharmasources.com/industryinsights/inmagene-biopharmaceuticals-closed-21-mi-323699.html 0.6 2026-08-10T06:49:37+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-323700.html 0.6 2026-08-07T03:55:14+08:00 daily https://www.pharmasources.com/industryinsights/impel-neuropharma-submits-nda-for-inp104-323701.html 0.6 2026-08-07T03:48:41+08:00 daily https://www.pharmasources.com/industryinsights/inozyme-pharma-appoints-svp-regulatory-a-323702.html 0.6 2026-08-07T04:04:07+08:00 daily https://www.pharmasources.com/industryinsights/phoremost-oxford-biomedica-enter-car-t-c-323703.html 0.6 2026-08-10T08:16:26+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-biontech-covid-19-vax-candidate-s-323704.html 0.6 2026-08-10T20:09:54+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-presents-preclinical-data-for--323705.html 0.6 2026-08-13T03:47:12+08:00 daily https://www.pharmasources.com/industryinsights/industry-experts-disagree-with-nppas-rem-323706.html 0.6 2026-04-21T15:02:58+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccine-over-90-per-cent-effect-323707.html 0.6 2026-08-05T22:14:21+08:00 daily https://www.pharmasources.com/industryinsights/wellness-forever-raises-rs-13-bn-from-al-323708.html 0.6 2026-06-20T16:58:23+08:00 daily https://www.pharmasources.com/industryinsights/bridge-biotherapeutics-boehringer-ingelh-323709.html 0.6 2026-06-21T21:11:34+08:00 daily https://www.pharmasources.com/industryinsights/alembic-pharma-gets-usfda-tentative-nod--323710.html 0.6 2026-06-29T05:08:39+08:00 daily https://www.pharmasources.com/industryinsights/lupins-somerset-facility-gets-13-observa-323711.html 0.6 2026-08-10T15:15:34+08:00 daily https://www.pharmasources.com/industryinsights/pre-existing-antibodies-may-protect-some-323712.html 0.6 2026-08-07T00:53:16+08:00 daily https://www.pharmasources.com/industryinsights/humanigen-signs-covid-19-therapy-develop-323713.html 0.6 2026-08-07T00:39:50+08:00 daily https://www.pharmasources.com/industryinsights/australia-to-initiate-manufacturing-of-v-323714.html 0.6 2026-08-07T00:03:03+08:00 daily https://www.pharmasources.com/industryinsights/joe-biden-advisers-and-drug-firms-hold-t-323715.html 0.6 2026-08-06T23:55:39+08:00 daily https://www.pharmasources.com/industryinsights/uk-and-eu-agree-on-phased-process-for-no-323716.html 0.6 2026-08-13T09:07:28+08:00 daily https://www.pharmasources.com/industryinsights/us-green-lights-azs-brilinta-to-reduce-r-323717.html 0.6 2026-08-06T23:32:28+08:00 daily https://www.pharmasources.com/industryinsights/new-pricing-models-could-improve-access--323718.html 0.6 2026-08-06T21:59:14+08:00 daily https://www.pharmasources.com/industryinsights/tff-pharmaceuticals-felix-biotechnology--323719.html 0.6 2026-08-07T13:16:48+08:00 daily https://www.pharmasources.com/industryinsights/nanology-enrols-first-patient-in-phase-2-323720.html 0.6 2026-08-07T22:17:49+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-dosed-in-covid-19-trial-wi-323721.html 0.6 2026-08-08T07:56:13+08:00 daily https://www.pharmasources.com/industryinsights/differences-in-remdesivir-efficacy-due-t-323722.html 0.6 2026-08-10T06:48:12+08:00 daily https://www.pharmasources.com/industryinsights/nice-rules-nivolumab-is-not-cost-effecti-323723.html 0.6 2026-06-21T00:01:36+08:00 daily https://www.pharmasources.com/industryinsights/l7-informatics-automates-lab-operations--323724.html 0.6 2026-07-06T05:25:22+08:00 daily https://www.pharmasources.com/industryinsights/llama-nanobodies-could-be-a-powerful-wea-323725.html 0.6 2026-06-21T16:59:19+08:00 daily https://www.pharmasources.com/industryinsights/pre-existing-coronavirus-antibodies-coul-323726.html 0.6 2026-06-21T03:18:02+08:00 daily https://www.pharmasources.com/industryinsights/novartis-provides-update-on-can-covid-tr-323727.html 0.6 2026-07-29T15:56:14+08:00 daily https://www.pharmasources.com/industryinsights/swiss-rockets-ag-announces-the-founding--323728.html 0.6 2026-06-20T22:05:44+08:00 daily https://www.pharmasources.com/industryinsights/insilico-announces-a-multi-target-ai-pow-323729.html 0.6 2026-08-11T22:47:12+08:00 daily https://www.pharmasources.com/industryinsights/farrer-park-hospital-steps-up-prostate-c-323730.html 0.6 2026-07-01T01:58:36+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-reports-phase-1-clinical-trial-dat-323731.html 0.6 2026-08-03T15:42:45+08:00 daily https://www.pharmasources.com/industryinsights/applied-materials-acquires-perceptive-en-323732.html 0.6 2026-08-14T19:09:09+08:00 daily https://www.pharmasources.com/industryinsights/an-opportunity-for-pharmaceuticals-logis-323733.html 0.6 2026-06-21T00:12:16+08:00 daily https://www.pharmasources.com/industryinsights/pioneerspeed-charmingfullysupportallthep-323734.html 0.6 2026-08-14T20:09:01+08:00 daily https://www.pharmasources.com/industryinsights/hiray-pharmaceutical-api-cdmo-and-antivi-323735.html 0.6 2026-08-07T13:56:24+08:00 daily https://www.pharmasources.com/industryinsights/us-to-begin-distribution-of-bamlanivimab-323736.html 0.6 2026-08-08T10:10:38+08:00 daily https://www.pharmasources.com/industryinsights/indian-scientists-working-on-effective-v-323737.html 0.6 2026-08-08T07:55:56+08:00 daily https://www.pharmasources.com/industryinsights/dalmia-healthcare-nod-from-ayush-ministr-323738.html 0.6 2026-08-07T13:16:25+08:00 daily https://www.pharmasources.com/industryinsights/drug-developers-are-interested-in-innova-323739.html 0.6 2026-08-07T01:14:26+08:00 daily https://www.pharmasources.com/industryinsights/abcellera-antibody-gets-us-fda-eua-as-mo-323740.html 0.6 2026-08-07T00:41:24+08:00 daily https://www.pharmasources.com/industryinsights/ease-of-administration-and-dual-protecti-323741.html 0.6 2026-08-07T00:01:44+08:00 daily https://www.pharmasources.com/industryinsights/ypsomed-collaborates-with-schott-and-lon-323742.html 0.6 2026-08-08T08:19:08+08:00 daily https://www.pharmasources.com/industryinsights/rhofed-receives-contract-from-barda-323743.html 0.6 2026-08-06T23:48:18+08:00 daily https://www.pharmasources.com/industryinsights/ac-immune-and-wuxi-biologics-expand-stra-323744.html 0.6 2026-08-06T23:45:51+08:00 daily https://www.pharmasources.com/industryinsights/mercachemsyncom-acquires-admescope-323745.html 0.6 2026-08-06T22:53:24+08:00 daily https://www.pharmasources.com/industryinsights/gilead-bolsters-biologics-capabilities-323746.html 0.6 2026-08-06T23:32:49+08:00 daily https://www.pharmasources.com/industryinsights/novavax-expands-facility-to-support-glob-323747.html 0.6 2026-08-12T09:02:47+08:00 daily https://www.pharmasources.com/industryinsights/immunitybio-reports-positive-data-from-c-323748.html 0.6 2026-08-06T23:46:26+08:00 daily https://www.pharmasources.com/industryinsights/indian-researchers-develop-vaccine-strat-323749.html 0.6 2026-08-06T23:56:01+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-eua-for-lillys-monoclonal-ant-323750.html 0.6 2026-08-07T05:31:26+08:00 daily https://www.pharmasources.com/industryinsights/bridge-biotherapeutics-terminates-collab-323751.html 0.6 2026-08-04T08:52:12+08:00 daily https://www.pharmasources.com/industryinsights/novartis-expands-with-kymriah-manufactur-323752.html 0.6 2026-06-20T17:43:11+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-rafael-pharmaceuticals-orphan-323753.html 0.6 2026-07-07T12:21:42+08:00 daily https://www.pharmasources.com/industryinsights/aivita-biomedical-completes-treatment-of-323754.html 0.6 2026-08-01T09:03:52+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-biontech-announce-covid-19-vaccin-323755.html 0.6 2026-07-17T23:28:04+08:00 daily https://www.pharmasources.com/industryinsights/orphan-drug-designation-granted-for-plas-323756.html 0.6 2026-06-23T11:31:27+08:00 daily https://www.pharmasources.com/industryinsights/exagen-to-evaluate-emergence-of-autoimmu-323757.html 0.6 2026-06-21T12:02:19+08:00 daily https://www.pharmasources.com/industryinsights/biolinerx-announces-positive-results-fro-323758.html 0.6 2026-06-22T11:11:01+08:00 daily https://www.pharmasources.com/industryinsights/uk-study-will-evaluate-aspirin-as-a-pote-323759.html 0.6 2026-06-21T11:02:10+08:00 daily https://www.pharmasources.com/industryinsights/waylivra-tecentriq-and-more-accepted-by--323760.html 0.6 2026-06-21T06:45:42+08:00 daily https://www.pharmasources.com/industryinsights/eu-ok-for-azs-calquence-in-cll-323761.html 0.6 2026-06-20T21:05:49+08:00 daily https://www.pharmasources.com/industryinsights/pharmaron-acquires-absorption-systems-in-323762.html 0.6 2026-06-30T15:36:41+08:00 daily https://www.pharmasources.com/industryinsights/rna-structures-of-coronavirus-reveal-pot-323763.html 0.6 2026-06-21T07:00:00+08:00 daily https://www.pharmasources.com/industryinsights/novavax-covid-19-vaccine-granted-fast-tr-323764.html 0.6 2026-05-02T19:36:57+08:00 daily https://www.pharmasources.com/industryinsights/american-college-of-lifestyle-medicine-l-323765.html 0.6 2026-06-20T22:00:39+08:00 daily https://www.pharmasources.com/industryinsights/cpasstm-sars-cov-2-neutralization-antibo-323766.html 0.6 2026-08-10T03:11:45+08:00 daily https://www.pharmasources.com/industryinsights/holmusk-partners-with-merck-to-help-impr-323767.html 0.6 2026-07-05T13:43:23+08:00 daily https://www.pharmasources.com/industryinsights/innovent-releases-phase-1a-results-of-cd-323768.html 0.6 2026-08-11T05:59:47+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-forced-pharma-to-shuffle-techno-323769.html 0.6 2026-08-08T02:20:51+08:00 daily https://www.pharmasources.com/industryinsights/1600-participants-enrolled-for-phase-iii-323770.html 0.6 2026-04-26T05:44:51+08:00 daily https://www.pharmasources.com/industryinsights/inadequate-cold-chain-infra-may-limit-in-323771.html 0.6 2026-06-21T01:08:51+08:00 daily https://www.pharmasources.com/industryinsights/vor-biopharma-signs-exclusive-license-pa-323772.html 0.6 2026-07-02T20:27:13+08:00 daily https://www.pharmasources.com/industryinsights/industry-appreciate-cabinet-sanction-of--323773.html 0.6 2026-08-14T10:08:03+08:00 daily https://www.pharmasources.com/industryinsights/sputnik-v-vaccine-shows-92-per-cent-effi-323774.html 0.6 2026-02-28T21:37:36+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-pharma-gets-anda-approval-for-t-323775.html 0.6 2026-08-09T23:51:28+08:00 daily https://www.pharmasources.com/industryinsights/schott-glass-india-inaugurates-new-glass-323776.html 0.6 2026-07-26T00:22:11+08:00 daily https://www.pharmasources.com/industryinsights/amu-targets-1000-volunteers-for-phase-ii-323777.html 0.6 2026-06-21T21:57:56+08:00 daily https://www.pharmasources.com/industryinsights/medicagos-covid-19-vaccine-elicits-immun-323778.html 0.6 2026-06-19T21:51:46+08:00 daily https://www.pharmasources.com/industryinsights/novavax-makes-leadership-changes-323779.html 0.6 2026-06-21T12:12:51+08:00 daily https://www.pharmasources.com/industryinsights/aphena-adds-cold-chain-storage-biologics-323780.html 0.6 2026-06-29T23:47:30+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-biontech-to-supply-200m-doses-of--323781.html 0.6 2026-08-07T13:17:58+08:00 daily https://www.pharmasources.com/industryinsights/tcr-therapeutics-elevatebio-expand-tc-21-323782.html 0.6 2026-08-07T12:04:09+08:00 daily https://www.pharmasources.com/industryinsights/altimmune-adds-lonza-as-mfg-partner-for--323783.html 0.6 2026-08-07T11:43:15+08:00 daily https://www.pharmasources.com/industryinsights/cevec-roche-ink-elevecta-technology-lice-323784.html 0.6 2026-08-07T11:21:22+08:00 daily https://www.pharmasources.com/industryinsights/sinovac-gets-authorisation-to-restart-co-323785.html 0.6 2026-08-07T06:09:49+08:00 daily https://www.pharmasources.com/industryinsights/adagio-therapeutics-raises-funding-to-ad-323786.html 0.6 2026-08-06T20:52:26+08:00 daily https://www.pharmasources.com/industryinsights/ispe-names-sanofi-the-2020-facility-of-t-323787.html 0.6 2026-08-06T20:10:40+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-updated-label-for-endari-323788.html 0.6 2026-08-06T23:33:07+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-dosed-in-trodelvy-trial-fo-323789.html 0.6 2026-08-06T23:56:36+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-initiates-study-of-vupanorsen-323790.html 0.6 2026-06-21T13:10:03+08:00 daily https://www.pharmasources.com/industryinsights/israeli-ministry-of-health-authorizes-tr-323791.html 0.6 2026-06-21T10:09:27+08:00 daily https://www.pharmasources.com/industryinsights/senhwa-announces-ind-submissions-for-sil-323792.html 0.6 2026-06-22T11:12:00+08:00 daily https://www.pharmasources.com/industryinsights/mallinckrodt-launches-retrospective-stud-323793.html 0.6 2026-01-11T16:58:13+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-abrocitinib-scores-another-phase-323794.html 0.6 2026-06-29T09:20:11+08:00 daily https://www.pharmasources.com/industryinsights/russian-says-its-sputnik-v-covid-19-vacc-323795.html 0.6 2026-06-20T14:46:12+08:00 daily https://www.pharmasources.com/industryinsights/abbvies-venclyxto-gets-nice-blood-cancer-323796.html 0.6 2026-06-21T08:02:59+08:00 daily https://www.pharmasources.com/industryinsights/amgen-azs-asthma-drug-tezepelumab-scores-323797.html 0.6 2026-08-03T03:18:16+08:00 daily https://www.pharmasources.com/industryinsights/ucb-acquires-gene-therapy-specialist-han-323798.html 0.6 2026-06-21T04:57:45+08:00 daily https://www.pharmasources.com/industryinsights/viivs-long-acting-hiv-drug-beats-standar-323799.html 0.6 2026-06-21T08:01:00+08:00 daily https://www.pharmasources.com/industryinsights/european-commission-approves-contract-wi-323800.html 0.6 2026-03-20T00:22:06+08:00 daily https://www.pharmasources.com/industryinsights/medigen-bluewillow-collaborate-to-develo-323801.html 0.6 2026-06-21T05:16:59+08:00 daily https://www.pharmasources.com/industryinsights/sedor-pharmaceuticals-gets-fda-approval--323802.html 0.6 2026-06-21T02:02:44+08:00 daily https://www.pharmasources.com/industryinsights/lenvima-plus-keytruda-achieves-primary-e-323803.html 0.6 2026-06-20T22:53:33+08:00 daily https://www.pharmasources.com/industryinsights/using-th17-cells-researchers-make-adopti-323804.html 0.6 2026-06-21T04:04:46+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-therapeutics-to-rely-on-large-s-323805.html 0.6 2026-07-05T03:45:27+08:00 daily https://www.pharmasources.com/industryinsights/cstone-pharmaceuticals-announces-chinas--323806.html 0.6 2026-06-20T14:50:09+08:00 daily https://www.pharmasources.com/industryinsights/origimed-and-takeda-announced-partnershi-323807.html 0.6 2026-06-24T23:54:21+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-announces-preclinical-data-on-diff-323808.html 0.6 2026-07-18T01:57:50+08:00 daily https://www.pharmasources.com/industryinsights/gates-foundation-offers-70-mn-additional-323809.html 0.6 2026-06-22T02:33:20+08:00 daily https://www.pharmasources.com/industryinsights/lupins-alliance-partner-concord-gets-usf-323810.html 0.6 2026-06-22T01:48:37+08:00 daily https://www.pharmasources.com/industryinsights/govt-allots-rd-grant-of-rs-900-crores-fo-323811.html 0.6 2026-06-22T15:56:54+08:00 daily https://www.pharmasources.com/industryinsights/amneal-gets-us-fda-approval-for-acyclovi-323812.html 0.6 2026-07-22T04:47:50+08:00 daily https://www.pharmasources.com/industryinsights/zydus-concludes-phase-ii-trials-of-pegyl-323813.html 0.6 2026-06-21T20:07:44+08:00 daily https://www.pharmasources.com/industryinsights/pathoquest-charles-river-expand-strategi-323814.html 0.6 2026-07-02T20:49:36+08:00 daily https://www.pharmasources.com/industryinsights/azurrx-biopharma-partners-with-asymchem-323815.html 0.6 2026-07-09T06:27:20+08:00 daily https://www.pharmasources.com/industryinsights/cytovance-appoints-ceo-323816.html 0.6 2026-08-09T17:07:42+08:00 daily https://www.pharmasources.com/industryinsights/evotec-se-expands-uk-campus-323817.html 0.6 2026-08-05T15:08:46+08:00 daily https://www.pharmasources.com/industryinsights/stelis-biosource-continues-facility-inve-323818.html 0.6 2026-06-20T20:20:59+08:00 daily https://www.pharmasources.com/industryinsights/imcr-and-sii-collaborate-to-develop-nova-323819.html 0.6 2026-06-21T11:12:18+08:00 daily https://www.pharmasources.com/industryinsights/taiho-signs-drug-licensing-deal-with-lun-323820.html 0.6 2026-06-21T01:43:26+08:00 daily https://www.pharmasources.com/industryinsights/forxiga-approved-in-the-eu-for-heart-fai-323821.html 0.6 2026-08-14T08:01:40+08:00 daily https://www.pharmasources.com/industryinsights/cymabay-announces-study-to-evaluate-gpr1-323822.html 0.6 2026-06-21T14:58:23+08:00 daily https://www.pharmasources.com/industryinsights/redhill-receives-patent-allowance-coveri-323823.html 0.6 2026-06-21T10:10:14+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-scientific-announces-colla-323824.html 0.6 2026-06-21T23:43:58+08:00 daily https://www.pharmasources.com/industryinsights/actimab-a-clag-m-trial-for-relapsed-or-r-323825.html 0.6 2026-08-13T23:37:50+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-manufacturers-establish-c-323826.html 0.6 2026-06-20T20:07:42+08:00 daily https://www.pharmasources.com/industryinsights/stem-cell-therapy-trial-for-covid-19-pat-323827.html 0.6 2026-07-06T03:50:08+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-set-to-acquire-emisphere-fo-323828.html 0.6 2026-08-04T23:36:49+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-fast-track-designation-to-nov-323829.html 0.6 2026-06-24T09:29:51+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-emergency-use-authorisation-t-323830.html 0.6 2026-08-07T08:42:19+08:00 daily https://www.pharmasources.com/industryinsights/lack-of-skill-and-talent-biggest-challen-323831.html 0.6 2026-06-22T11:10:55+08:00 daily https://www.pharmasources.com/industryinsights/trial-of-new-hiv-prep-medication-stopped-323832.html 0.6 2026-07-07T23:13:52+08:00 daily https://www.pharmasources.com/industryinsights/use-of-paper-tube-pouch-could-reduce-pla-323833.html 0.6 2026-07-28T19:15:32+08:00 daily https://www.pharmasources.com/industryinsights/jama-reports-fluvoxamine-as-potential-ea-323834.html 0.6 2026-08-06T23:41:04+08:00 daily https://www.pharmasources.com/industryinsights/connect-biopharma-announces-appointment--323835.html 0.6 2026-08-06T23:56:16+08:00 daily https://www.pharmasources.com/industryinsights/asieris-announces-first-patient-administ-323836.html 0.6 2026-08-07T00:03:37+08:00 daily https://www.pharmasources.com/industryinsights/comet-bio-awarded-by-frost-sullivan-for--323837.html 0.6 2026-08-07T00:40:17+08:00 daily https://www.pharmasources.com/industryinsights/fibrogenesis-announces-the-filing-of-its-323838.html 0.6 2026-08-07T01:14:33+08:00 daily https://www.pharmasources.com/industryinsights/bioheng-announced-oral-presentation-of-i-323839.html 0.6 2026-08-07T13:15:23+08:00 daily https://www.pharmasources.com/industryinsights/government-asks-pci-to-respond-to-ksrpos-323840.html 0.6 2026-08-07T04:16:29+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-invests-50-million-euros-in-jeito-323841.html 0.6 2026-08-07T04:28:06+08:00 daily https://www.pharmasources.com/industryinsights/israel-to-enter-into-a-deal-with-pfizer--323842.html 0.6 2026-08-07T04:52:47+08:00 daily https://www.pharmasources.com/industryinsights/natco-gets-us-fda-approval-for-pomalidom-323843.html 0.6 2026-08-10T12:26:37+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-launches-succinylcholine-chlor-323844.html 0.6 2026-07-01T00:52:25+08:00 daily https://www.pharmasources.com/industryinsights/ccrm-mip-partner-to-build-biomanufacturi-323845.html 0.6 2026-08-07T04:28:06+08:00 daily https://www.pharmasources.com/industryinsights/swissmedic-begins-rolling-review-of-mode-323846.html 0.6 2026-08-07T04:37:11+08:00 daily https://www.pharmasources.com/industryinsights/antares-vision-acquires-adents-traceabil-323847.html 0.6 2026-08-07T13:16:02+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-to-acquire-emisphere-techno-323848.html 0.6 2026-08-07T16:22:24+08:00 daily https://www.pharmasources.com/industryinsights/industry-associations-appoint-pwc-as-adv-323849.html 0.6 2026-08-09T06:59:13+08:00 daily https://www.pharmasources.com/industryinsights/study-recommends-steroid-treatment-shoul-323850.html 0.6 2026-06-21T19:06:40+08:00 daily https://www.pharmasources.com/industryinsights/ose-provides-update-on-covid-19-vaccine-323851.html 0.6 2026-08-05T21:50:49+08:00 daily https://www.pharmasources.com/industryinsights/flamma-continues-veklury-partnership-wit-323852.html 0.6 2026-06-21T16:46:17+08:00 daily https://www.pharmasources.com/industryinsights/logan-launches-permeation-barrier-membra-323853.html 0.6 2026-06-20T21:57:34+08:00 daily https://www.pharmasources.com/industryinsights/extension-study-of-vebicorvir-for-chroni-323854.html 0.6 2026-07-28T06:51:14+08:00 daily https://www.pharmasources.com/industryinsights/quansys-biosciences-receives-eua-for-sar-323855.html 0.6 2026-06-20T21:59:38+08:00 daily https://www.pharmasources.com/industryinsights/uni-of-exeter-partners-with-mdc-to-accel-323856.html 0.6 2026-06-20T21:58:35+08:00 daily https://www.pharmasources.com/industryinsights/nihr-establishes-new-patient-recruitment-323857.html 0.6 2026-04-18T20:03:27+08:00 daily https://www.pharmasources.com/industryinsights/eu-secures-300-million-doses-of-biontech-323858.html 0.6 2026-06-21T00:59:45+08:00 daily https://www.pharmasources.com/industryinsights/nice-green-light-for-cablivi-in-rare-blo-323859.html 0.6 2026-06-21T00:59:42+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-new-chemo-free-chronic-l-323860.html 0.6 2026-04-12T23:35:21+08:00 daily https://www.pharmasources.com/industryinsights/calquence-fails-to-prevent-respiratory-f-323861.html 0.6 2026-06-20T15:50:21+08:00 daily https://www.pharmasources.com/industryinsights/packaging-initiative-to-protect-covid-19-323862.html 0.6 2026-06-21T04:51:00+08:00 daily https://www.pharmasources.com/industryinsights/predicine-and-cr-medicon-form-strategic--323863.html 0.6 2026-07-10T02:01:02+08:00 daily https://www.pharmasources.com/industryinsights/medicago-and-gsk-announce-start-of-phase-323864.html 0.6 2026-07-03T12:04:52+08:00 daily https://www.pharmasources.com/industryinsights/fluvoxamine-may-prevent-serious-illness--323865.html 0.6 2026-06-28T23:46:24+08:00 daily https://www.pharmasources.com/industryinsights/neurorx-and-relief-therapeutics-announce-323866.html 0.6 2026-06-30T17:32:36+08:00 daily https://www.pharmasources.com/industryinsights/gilead-sciences-announces-recipients-of--323867.html 0.6 2026-06-10T09:06:41+08:00 daily https://www.pharmasources.com/industryinsights/cytiva-supports-clover-biopharmaceutical-323868.html 0.6 2026-08-07T11:46:45+08:00 daily https://www.pharmasources.com/industryinsights/innovent-announces-the-results-of-the-ph-323869.html 0.6 2026-08-08T21:49:17+08:00 daily https://www.pharmasources.com/industryinsights/ptc-therapeutics-announces-initiation-of-323870.html 0.6 2026-06-21T16:13:31+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-323871.html 0.6 2026-06-21T08:06:00+08:00 daily https://www.pharmasources.com/industryinsights/moderna-pfizer-raise-bar-for-covid-19-va-323872.html 0.6 2026-04-24T01:00:37+08:00 daily https://www.pharmasources.com/industryinsights/vaccine-is-945-per-cent-effective-in-pre-323873.html 0.6 2026-06-21T00:00:40+08:00 daily https://www.pharmasources.com/industryinsights/fall-clause-does-not-apply-on-the-sale-o-323874.html 0.6 2026-06-22T02:34:15+08:00 daily https://www.pharmasources.com/industryinsights/bharat-biotech-commences-phase-iii-trial-323875.html 0.6 2026-06-21T08:00:06+08:00 daily https://www.pharmasources.com/industryinsights/catalent-completes-acquisition-of-bone-t-323876.html 0.6 2026-06-21T17:59:36+08:00 daily https://www.pharmasources.com/industryinsights/lead-pharma-and-roche-enter-collaboratio-323877.html 0.6 2026-06-21T20:59:39+08:00 daily https://www.pharmasources.com/industryinsights/eisai-invests-in-new-packaging-lines-323878.html 0.6 2026-06-21T13:13:06+08:00 daily https://www.pharmasources.com/industryinsights/vibalogics-establishes-us-presence-323879.html 0.6 2026-06-20T21:49:48+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-cellular-dynamics-and-lonza-ent-323880.html 0.6 2026-07-19T06:24:39+08:00 daily https://www.pharmasources.com/industryinsights/indian-firm-biological-e-initiates-clini-323881.html 0.6 2026-06-21T09:03:14+08:00 daily https://www.pharmasources.com/industryinsights/janssen-begins-second-phase-iii-covid-19-323882.html 0.6 2026-08-05T18:22:54+08:00 daily https://www.pharmasources.com/industryinsights/a-collection-of-pharma-sources-insight-2-323883.html 0.6 2026-07-06T23:02:32+08:00 daily https://www.pharmasources.com/industryinsights/uk-study-shows-sng001-aids-in-faster-cov-323884.html 0.6 2026-06-20T20:57:41+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-mercks-keytruda-with-chemot-323885.html 0.6 2026-06-22T07:57:45+08:00 daily https://www.pharmasources.com/industryinsights/canakinumab-study-fails-to-meet-primary--323886.html 0.6 2026-08-07T12:29:06+08:00 daily https://www.pharmasources.com/industryinsights/moderna-covid-19-vaccine-candidate-meets-323887.html 0.6 2026-06-21T22:54:37+08:00 daily https://www.pharmasources.com/industryinsights/care-receives-may-proceed-letter-from-fd-323888.html 0.6 2026-06-21T03:05:42+08:00 daily https://www.pharmasources.com/industryinsights/brilinta-approved-to-reduce-stroke-risk-323889.html 0.6 2026-08-03T21:56:43+08:00 daily https://www.pharmasources.com/industryinsights/mesa-biotech-receives-13-million-from-hh-323890.html 0.6 2026-06-21T19:06:43+08:00 daily https://www.pharmasources.com/industryinsights/nhs-launches-40-long-covid-clinics-323891.html 0.6 2026-07-02T15:46:30+08:00 daily https://www.pharmasources.com/industryinsights/122m-boost-for-coronavirus-genomic-surve-323892.html 0.6 2026-06-20T22:48:41+08:00 daily https://www.pharmasources.com/industryinsights/six-new-medicines-leap-towards-eu-approv-323893.html 0.6 2026-07-21T23:44:54+08:00 daily https://www.pharmasources.com/industryinsights/sagent-pharmaceuticals-launches-phase-2--323894.html 0.6 2026-06-21T11:57:16+08:00 daily https://www.pharmasources.com/industryinsights/fluvoxamine-may-prevent-severe-covid-19--323895.html 0.6 2026-06-24T08:29:03+08:00 daily https://www.pharmasources.com/industryinsights/chmp-recommends-five-medicines-for-appro-323896.html 0.6 2026-06-22T00:45:06+08:00 daily https://www.pharmasources.com/industryinsights/first-covid-19-patient-dosed-in-phase-ii-323897.html 0.6 2026-06-21T10:06:16+08:00 daily https://www.pharmasources.com/industryinsights/hybrid-purifier-removes-host-cell-protei-323898.html 0.6 2026-06-20T17:52:17+08:00 daily https://www.pharmasources.com/industryinsights/trippbio-reports-positive-results-from-i-323899.html 0.6 2026-06-21T10:59:07+08:00 daily https://www.pharmasources.com/industryinsights/united-sewing-automation-producing-usa-s-323900.html 0.6 2026-07-05T06:25:13+08:00 daily https://www.pharmasources.com/industryinsights/cytokine-storms-play-a-limited-role-in-m-323901.html 0.6 2026-06-23T07:05:56+08:00 daily https://www.pharmasources.com/industryinsights/covis-group-completes-acquisition-of-ama-323902.html 0.6 2026-07-29T13:30:17+08:00 daily https://www.pharmasources.com/industryinsights/alterity-announces-approval-of-us-patent-323903.html 0.6 2025-12-20T21:07:13+08:00 daily https://www.pharmasources.com/industryinsights/pharmabcine-to-present-the-final-data-of-323904.html 0.6 2026-08-07T22:56:07+08:00 daily https://www.pharmasources.com/industryinsights/happiness-biotech-starts-offering-kingdo-323905.html 0.6 2026-08-03T23:55:51+08:00 daily https://www.pharmasources.com/industryinsights/harbour-biomed-will-present-results-from-323906.html 0.6 2026-06-21T03:04:55+08:00 daily https://www.pharmasources.com/industryinsights/evolving-world-of-pharma-addressing-bioa-323907.html 0.6 2026-06-22T07:56:46+08:00 daily https://www.pharmasources.com/industryinsights/limitations-of-simple-powder-flow-measur-323908.html 0.6 2026-07-29T18:46:03+08:00 daily https://www.pharmasources.com/industryinsights/ema-begins-rolling-review-of-modernas-co-323909.html 0.6 2026-06-21T00:59:43+08:00 daily https://www.pharmasources.com/industryinsights/foxx-life-sciences-to-open-asia-headquar-323910.html 0.6 2026-03-25T18:06:26+08:00 daily https://www.pharmasources.com/industryinsights/india-china-may-start-producing-sputnik--323911.html 0.6 2026-07-04T00:42:38+08:00 daily https://www.pharmasources.com/industryinsights/t2d-market-will-grow-from-a-total-of-481-323912.html 0.6 2026-07-29T12:07:01+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-to-commence-pilot-delivery-progra-323913.html 0.6 2026-06-21T10:43:56+08:00 daily https://www.pharmasources.com/industryinsights/inovio-to-start-mid-stage-trials-of-its--323914.html 0.6 2026-08-08T00:35:51+08:00 daily https://www.pharmasources.com/industryinsights/syneos-health-appoints-chief-information-323915.html 0.6 2026-08-14T22:20:05+08:00 daily https://www.pharmasources.com/industryinsights/cambrex-expands-api-mfg-capacity-in-char-323916.html 0.6 2026-06-14T16:44:04+08:00 daily https://www.pharmasources.com/industryinsights/curevac-to-ramp-up-mfg-of-covid-19-vax-c-323917.html 0.6 2026-06-21T00:54:44+08:00 daily https://www.pharmasources.com/industryinsights/recipharm-medspray-establish-jv-323918.html 0.6 2026-06-22T08:10:55+08:00 daily https://www.pharmasources.com/industryinsights/onyx-scientific-invests-in-new-facility-323919.html 0.6 2026-08-02T18:10:52+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutics-international-taps-directo-323920.html 0.6 2026-06-20T18:04:22+08:00 daily https://www.pharmasources.com/industryinsights/xoma-earns-2m-takeda-milestone-323921.html 0.6 2026-06-21T03:13:57+08:00 daily https://www.pharmasources.com/industryinsights/lead-pharma-enters-oral-molecules-develo-323922.html 0.6 2026-06-20T17:04:21+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-signs-covid-19-therapy-323923.html 0.6 2026-06-21T08:50:54+08:00 daily https://www.pharmasources.com/industryinsights/genscript-receives-eua-for-sars-cov-2-ne-323924.html 0.6 2026-06-22T09:59:52+08:00 daily https://www.pharmasources.com/industryinsights/phoremost-oxford-biomedica-announce-gene-323925.html 0.6 2026-06-20T21:09:52+08:00 daily https://www.pharmasources.com/industryinsights/pierre-fabre-initiates-trial-for-monoclo-323926.html 0.6 2026-06-22T00:08:50+08:00 daily https://www.pharmasources.com/industryinsights/calquence-approved-in-eu-for-chronic-lym-323927.html 0.6 2026-08-14T15:13:12+08:00 daily https://www.pharmasources.com/industryinsights/immutep-announces-australian-patent-gran-323928.html 0.6 2026-06-23T12:41:58+08:00 daily https://www.pharmasources.com/industryinsights/biomarin-expands-vosoritide-clinical-pro-323929.html 0.6 2026-06-21T00:58:41+08:00 daily https://www.pharmasources.com/industryinsights/new-inquiry-launched-to-assess-impact-of-323930.html 0.6 2026-06-21T20:46:30+08:00 daily https://www.pharmasources.com/industryinsights/gilead-and-novo-nordisks-nash-trial-meet-323931.html 0.6 2026-06-23T01:14:12+08:00 daily https://www.pharmasources.com/industryinsights/uk-strikes-deal-for-five-million-doses-o-323932.html 0.6 2026-06-21T12:12:24+08:00 daily https://www.pharmasources.com/industryinsights/vicore-pharma-recruits-the-first-patient-323933.html 0.6 2026-06-21T01:03:47+08:00 daily https://www.pharmasources.com/industryinsights/lupin-announces-fda-filing-acceptance-of-323934.html 0.6 2026-08-09T06:59:43+08:00 daily https://www.pharmasources.com/industryinsights/microbial-contract-biomanufacturing-mark-323935.html 0.6 2026-08-08T03:25:21+08:00 daily https://www.pharmasources.com/industryinsights/ema-releases-safety-monitoring-plan-for--323936.html 0.6 2026-08-08T18:17:57+08:00 daily https://www.pharmasources.com/industryinsights/who-lists-first-vaccine-for-emergency-us-323937.html 0.6 2026-08-13T03:56:21+08:00 daily https://www.pharmasources.com/industryinsights/late-breaking-study-results-of-the-supre-323938.html 0.6 2026-08-08T21:48:43+08:00 daily https://www.pharmasources.com/industryinsights/foresee-pharmaceuticals-enters-exclusive-323939.html 0.6 2026-08-09T00:10:20+08:00 daily https://www.pharmasources.com/industryinsights/china-pharma-holdings-inc-reports-third--323940.html 0.6 2026-06-27T18:07:59+08:00 daily https://www.pharmasources.com/industryinsights/chmp-adopted-positive-opinion-for-elzonr-323941.html 0.6 2026-05-11T16:11:57+08:00 daily https://www.pharmasources.com/industryinsights/cphi-p-mec-china-2020-adapts-to-customer-323942.html 0.6 2026-08-07T23:50:03+08:00 daily https://www.pharmasources.com/industryinsights/sheffield-university-gets-31-mn-for-tria-323943.html 0.6 2026-06-14T02:07:57+08:00 daily https://www.pharmasources.com/industryinsights/v-krishnakumar-joins-eris-lifesciences-a-323944.html 0.6 2026-08-08T22:36:19+08:00 daily https://www.pharmasources.com/industryinsights/dcgi-asks-state-drug-controllers-to-reca-323945.html 0.6 2026-06-22T00:14:58+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccines-production-driving-con-323946.html 0.6 2026-06-21T11:48:08+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-files-patent-infringement-petitio-323947.html 0.6 2025-11-27T19:57:07+08:00 daily https://www.pharmasources.com/industryinsights/amazon-launches-online-pharmacy-in-the-u-323948.html 0.6 2026-06-29T14:08:26+08:00 daily https://www.pharmasources.com/industryinsights/cipla-signs-licensing-pact-with-multig-f-323949.html 0.6 2026-06-21T13:06:46+08:00 daily https://www.pharmasources.com/industryinsights/coronavac-from-sinovac-triggers-quick-im-323950.html 0.6 2026-06-21T09:40:50+08:00 daily https://www.pharmasources.com/industryinsights/nsrt-to-conduct-phase-ii-trials-of-eflor-323951.html 0.6 2026-06-21T05:11:53+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-biontechs-final-covid-19-vaccine--323952.html 0.6 2026-08-10T18:03:40+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharma-to-initiate-phase-iiii-323953.html 0.6 2026-08-09T06:59:14+08:00 daily https://www.pharmasources.com/industryinsights/bms-acquires-biopharma-firm-myokardia-fo-323954.html 0.6 2026-08-08T07:37:16+08:00 daily https://www.pharmasources.com/industryinsights/sinovacs-coronavac-triggers-quick-immune-323955.html 0.6 2026-08-08T06:16:53+08:00 daily https://www.pharmasources.com/industryinsights/lonza-has-made-additional-investments-in-323956.html 0.6 2026-08-11T11:07:33+08:00 daily https://www.pharmasources.com/industryinsights/cordenpharma-expands-peptide-development-323957.html 0.6 2026-08-08T03:30:36+08:00 daily https://www.pharmasources.com/industryinsights/bionova-scientific-secures-first-client--323958.html 0.6 2026-08-07T13:19:02+08:00 daily https://www.pharmasources.com/industryinsights/almac-gets-grant-from-covid-19-therapeut-323959.html 0.6 2026-08-14T17:34:03+08:00 daily https://www.pharmasources.com/industryinsights/syntegon-opens-new-osd-customer-center-323960.html 0.6 2026-08-14T14:49:18+08:00 daily https://www.pharmasources.com/industryinsights/impel-neuropharma-announces-fda-nda-subm-323961.html 0.6 2026-08-14T14:58:04+08:00 daily https://www.pharmasources.com/industryinsights/cannabics-concludes-pre-clinical-study-o-323962.html 0.6 2026-08-14T15:23:39+08:00 daily https://www.pharmasources.com/industryinsights/viivs-cabotegravir-scores-breakthrough-d-323963.html 0.6 2026-08-14T15:25:43+08:00 daily https://www.pharmasources.com/industryinsights/university-of-oxford-links-up-with-evox--323964.html 0.6 2026-08-14T15:34:36+08:00 daily https://www.pharmasources.com/industryinsights/eu-signs-covid-19-vaccine-deal-with-cure-323965.html 0.6 2026-08-14T15:46:18+08:00 daily https://www.pharmasources.com/industryinsights/azs-brilinta-reduced-rate-of-stroke-and--323966.html 0.6 2026-08-14T15:49:10+08:00 daily https://www.pharmasources.com/industryinsights/drug-safety-research-unit-says-repurpose-323967.html 0.6 2026-08-14T21:17:08+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-is-benefiting-contract-manufact-323968.html 0.6 2026-08-14T21:21:57+08:00 daily https://www.pharmasources.com/industryinsights/lateral-flow-assay-market-set-to-be-wort-323969.html 0.6 2026-08-14T21:25:33+08:00 daily https://www.pharmasources.com/industryinsights/phrma-announces-new-principles-on-clinic-323970.html 0.6 2026-08-14T21:30:54+08:00 daily https://www.pharmasources.com/industryinsights/amylyx-announces-fda-granted-orphan-drug-323971.html 0.6 2026-08-14T21:33:56+08:00 daily https://www.pharmasources.com/industryinsights/eurofins-viracor-diagnostics-launches-co-323972.html 0.6 2026-08-14T21:42:58+08:00 daily https://www.pharmasources.com/industryinsights/research-antibodies-and-reagents-market--323973.html 0.6 2026-08-14T21:45:59+08:00 daily https://www.pharmasources.com/industryinsights/biolinerx-announces-initiation-of-phase--323974.html 0.6 2026-08-14T21:49:24+08:00 daily https://www.pharmasources.com/industryinsights/cuhk-microbiome-immunity-formula-hastens-323975.html 0.6 2026-06-23T12:53:05+08:00 daily https://www.pharmasources.com/industryinsights/asc40-tvb-2640-phase-2-nash-trial-comple-323976.html 0.6 2026-07-23T20:42:47+08:00 daily https://www.pharmasources.com/industryinsights/inex-innovates-igene-laboratory-announce-323977.html 0.6 2026-06-22T12:44:02+08:00 daily https://www.pharmasources.com/industryinsights/olumniant-barcitinab-from-eli-lilly-gets-323978.html 0.6 2026-02-24T15:43:38+08:00 daily https://www.pharmasources.com/industryinsights/covishield-should-be-available-for-publi-323979.html 0.6 2026-06-04T16:19:25+08:00 daily https://www.pharmasources.com/industryinsights/alphamab-applies-for-the-marketing-of-a--323980.html 0.6 2026-07-30T03:04:20+08:00 daily https://www.pharmasources.com/industryinsights/syngene-and-deerfield-discovery-and-deve-323981.html 0.6 2026-06-24T03:47:09+08:00 daily https://www.pharmasources.com/industryinsights/reimagining-the-next-era-of-doctor-engag-323982.html 0.6 2026-06-21T16:58:30+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccine-from-astrazeneca-produc-323983.html 0.6 2026-07-06T15:43:01+08:00 daily https://www.pharmasources.com/industryinsights/injectable-hydrogel-from-spirulina-can-h-323984.html 0.6 2026-06-23T00:07:18+08:00 daily https://www.pharmasources.com/industryinsights/us-uk-and-germany-are-top-manufacturers--323985.html 0.6 2026-08-04T03:50:57+08:00 daily https://www.pharmasources.com/industryinsights/catalent-appoints-open-innovation-biolog-323986.html 0.6 2026-06-21T16:53:21+08:00 daily https://www.pharmasources.com/industryinsights/cue-biopharma-merck-extend-biologics-res-323987.html 0.6 2026-06-20T15:12:17+08:00 daily https://www.pharmasources.com/industryinsights/avantor-opens-new-biorepository-facility-323988.html 0.6 2026-06-21T05:57:45+08:00 daily https://www.pharmasources.com/industryinsights/sgs-plans-to-move-its-clinical-pharmacol-323989.html 0.6 2026-06-20T18:10:25+08:00 daily https://www.pharmasources.com/industryinsights/asahi-kasei-pharma-contracts-probiogen-323990.html 0.6 2026-08-07T02:30:40+08:00 daily https://www.pharmasources.com/industryinsights/fda-to-review-samsung-bioepis-and-biogen-323991.html 0.6 2026-06-21T21:58:40+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-gets-approval-for-phase--323992.html 0.6 2026-06-20T16:07:34+08:00 daily https://www.pharmasources.com/industryinsights/tezepelumab-trial-meets-primary-endpoint-323993.html 0.6 2026-07-23T15:57:37+08:00 daily https://www.pharmasources.com/industryinsights/arena-pharmaceuticals-reports-topline-re-323994.html 0.6 2026-06-22T11:57:45+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-liquid-biopsy-ngs-companion-323995.html 0.6 2026-06-21T10:06:09+08:00 daily https://www.pharmasources.com/industryinsights/collplant-announces-antiviral-agent-prog-323996.html 0.6 2026-06-21T05:08:50+08:00 daily https://www.pharmasources.com/industryinsights/supernus-provides-regulatory-updates-for-323997.html 0.6 2026-08-09T16:11:29+08:00 daily https://www.pharmasources.com/industryinsights/ypsomed-schott-collaborate-with-lonza-to-323998.html 0.6 2026-04-10T00:05:59+08:00 daily https://www.pharmasources.com/industryinsights/cerebral-therapeutics-announces-enrolmen-323999.html 0.6 2026-06-21T19:51:47+08:00 daily https://www.pharmasources.com/industryinsights/lonza-expands-hpapi-capabilities-324000.html 0.6 2026-06-22T18:54:07+08:00 daily https://www.pharmasources.com/industryinsights/novel-antibiotic-recarbrio-has-launched--324001.html 0.6 2026-06-22T05:13:56+08:00 daily https://www.pharmasources.com/industryinsights/multiple-sclerosis-trial-focusing-on-peo-324002.html 0.6 2026-06-10T13:25:56+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-lillys-migraine-med-emga-324003.html 0.6 2026-08-11T18:33:29+08:00 daily https://www.pharmasources.com/industryinsights/pharma-supply-chain-still-highly-vulnera-324004.html 0.6 2026-08-10T08:54:40+08:00 daily https://www.pharmasources.com/industryinsights/cvn058-shows-promise-in-phase-ib-schizop-324005.html 0.6 2026-06-22T11:07:41+08:00 daily https://www.pharmasources.com/industryinsights/edqm-releases-new-guidelines-for-covid-1-324006.html 0.6 2026-08-09T22:07:29+08:00 daily https://www.pharmasources.com/industryinsights/chinese-vaccine-candidate-based-on-inact-324007.html 0.6 2026-08-01T19:54:07+08:00 daily https://www.pharmasources.com/industryinsights/immunological-memory-after-cured-sars-co-324008.html 0.6 2026-04-18T22:00:36+08:00 daily https://www.pharmasources.com/industryinsights/icahn-school-of-medicine-at-mount-sinai--324009.html 0.6 2025-12-18T09:12:25+08:00 daily https://www.pharmasources.com/industryinsights/qimings-portfolio-company-antengene-list-324010.html 0.6 2026-08-08T14:36:45+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharmas-second-covid-19-candi-324011.html 0.6 2026-06-21T02:03:39+08:00 daily https://www.pharmasources.com/industryinsights/covis-group-announces-data-for-ciraparan-324012.html 0.6 2026-06-22T01:52:32+08:00 daily https://www.pharmasources.com/industryinsights/britain-may-approve-covid-19-vaccine-fro-324013.html 0.6 2026-08-03T11:14:32+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-grants-eua-to-monoclonal-antibodi-324014.html 0.6 2026-06-21T08:16:40+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-biontech-covid-19-vaccine-may-cre-324015.html 0.6 2026-06-10T19:41:11+08:00 daily https://www.pharmasources.com/industryinsights/indian-pharma-industry-backbone-of-india-324016.html 0.6 2026-08-06T03:55:41+08:00 daily https://www.pharmasources.com/industryinsights/dop-organises-meeting-with-industry-asso-324017.html 0.6 2026-06-20T20:11:49+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-begins-trials-on-antibody-co-324018.html 0.6 2026-07-24T05:25:10+08:00 daily https://www.pharmasources.com/industryinsights/who-takes-off-remdesivir-from-prequalifi-324019.html 0.6 2026-06-20T16:35:59+08:00 daily https://www.pharmasources.com/industryinsights/ismms-boehringer-ingelheim-to-test-ninte-324020.html 0.6 2026-08-08T01:50:23+08:00 daily https://www.pharmasources.com/industryinsights/cog-uk-consortium-gets-122-mn-for-covid--324021.html 0.6 2026-06-20T23:39:15+08:00 daily https://www.pharmasources.com/industryinsights/sai-life-sciences-opens-representative-o-324022.html 0.6 2026-06-21T07:04:59+08:00 daily https://www.pharmasources.com/industryinsights/frontida-biopharma-appoints-evp-technolo-324023.html 0.6 2026-06-22T06:00:43+08:00 daily https://www.pharmasources.com/industryinsights/august-bioservices-expands-operations-in-324024.html 0.6 2026-07-14T04:43:28+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-partners-with-eli-lill-324025.html 0.6 2026-07-16T08:42:48+08:00 daily https://www.pharmasources.com/industryinsights/pharma-and-health-from-ingredients-to-pi-324026.html 0.6 2026-08-05T15:31:27+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-eua-for-lilly-and-incytes-bar-324027.html 0.6 2026-08-09T15:44:17+08:00 daily https://www.pharmasources.com/industryinsights/2020-zhejiang-export-commodity-online-fa-324028.html 0.6 2026-08-09T04:14:51+08:00 daily https://www.pharmasources.com/industryinsights/roches-arthritis-drug-shows-effectivenes-324029.html 0.6 2026-06-21T17:21:48+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-grants-eua-to-regenerons-antibody-324030.html 0.6 2026-06-21T00:01:37+08:00 daily https://www.pharmasources.com/industryinsights/rafael-pharmaceuticals-receives-fast-tra-324031.html 0.6 2026-06-20T14:26:07+08:00 daily https://www.pharmasources.com/industryinsights/agenus-announces-milestone-payment-from--324032.html 0.6 2026-08-08T12:07:22+08:00 daily https://www.pharmasources.com/industryinsights/inhaled-ampion-advances-to-second-group--324033.html 0.6 2026-08-08T10:49:41+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-scientific-northeastern-un-324034.html 0.6 2026-08-08T09:47:19+08:00 daily https://www.pharmasources.com/industryinsights/advaite-clia-lab-receives-authorization--324035.html 0.6 2026-08-08T07:49:51+08:00 daily https://www.pharmasources.com/industryinsights/university-of-cambridge-announces-agreem-324036.html 0.6 2026-08-07T21:03:22+08:00 daily https://www.pharmasources.com/industryinsights/sosei-heptares-covid-19-programme-advanc-324037.html 0.6 2026-08-07T13:15:21+08:00 daily https://www.pharmasources.com/industryinsights/alnylams-rnai-therapeutic-oxlumo-gets-eu-324038.html 0.6 2026-08-07T03:06:31+08:00 daily https://www.pharmasources.com/industryinsights/novartis-secures-rights-to-mesoblasts-re-324039.html 0.6 2026-08-07T03:24:30+08:00 daily https://www.pharmasources.com/industryinsights/novel-antibiotic-shows-promise-in-phase--324040.html 0.6 2026-08-07T04:27:45+08:00 daily https://www.pharmasources.com/industryinsights/potential-anti-covid-19-nasal-spray-deve-324041.html 0.6 2026-08-07T04:49:17+08:00 daily https://www.pharmasources.com/industryinsights/fda-clears-expanded-access-ind-for-apts--324042.html 0.6 2026-06-23T12:08:44+08:00 daily https://www.pharmasources.com/industryinsights/rilzabrutinib-granted-fda-fast-track-des-324043.html 0.6 2026-08-08T02:17:04+08:00 daily https://www.pharmasources.com/industryinsights/new-peer-reviewed-study-mmr-vaccine-prot-324044.html 0.6 2026-06-20T14:49:11+08:00 daily https://www.pharmasources.com/industryinsights/zymo-research-receives-ce-ivd-mark-for-i-324045.html 0.6 2026-07-04T08:46:27+08:00 daily https://www.pharmasources.com/industryinsights/creation-of-a-research-partnership-betwe-324046.html 0.6 2026-07-01T04:02:04+08:00 daily https://www.pharmasources.com/industryinsights/novel-antioxidant-seen-as-an-effective-s-324047.html 0.6 2026-08-07T05:06:01+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharma-initiates-phase-3-stud-324048.html 0.6 2026-08-07T23:36:22+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-324049.html 0.6 2026-06-20T23:54:54+08:00 daily https://www.pharmasources.com/industryinsights/africa-pharma-brief-new-agency-hopes-to--324050.html 0.6 2026-08-06T23:57:19+08:00 daily https://www.pharmasources.com/industryinsights/vivimed-labs-gets-approval-for-six-produ-324051.html 0.6 2026-06-20T21:51:33+08:00 daily https://www.pharmasources.com/industryinsights/demand-for-repurposed-drugs-to-continue--324052.html 0.6 2026-06-21T08:58:01+08:00 daily https://www.pharmasources.com/industryinsights/strides-receives-usfda-approval-for-pred-324053.html 0.6 2026-06-23T07:01:05+08:00 daily https://www.pharmasources.com/industryinsights/hester-biosciences-nepal-launches-a-live-324054.html 0.6 2026-06-20T16:57:43+08:00 daily https://www.pharmasources.com/industryinsights/successive-drug-launches-will-drive-grow-324055.html 0.6 2026-06-22T06:07:40+08:00 daily https://www.pharmasources.com/industryinsights/fairjourney-biologics-iontas-enter-antib-324056.html 0.6 2026-06-20T22:15:08+08:00 daily https://www.pharmasources.com/industryinsights/govt-of-india-is-committed-to-improvemen-324057.html 0.6 2026-06-21T00:05:40+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-covid-19-vaccine-shows-90-pe-324058.html 0.6 2026-06-09T20:13:08+08:00 daily https://www.pharmasources.com/industryinsights/homegrown-covid-19-vaccine-final-trials--324059.html 0.6 2026-06-20T22:45:12+08:00 daily https://www.pharmasources.com/industryinsights/regenerons-covid-19-antibody-cocktail-ge-324060.html 0.6 2026-07-02T17:41:37+08:00 daily https://www.pharmasources.com/industryinsights/summit-therapeutics-appoints-chief-opera-324061.html 0.6 2026-01-13T21:08:30+08:00 daily https://www.pharmasources.com/industryinsights/amgen-ends-cardio-alliance-with-cytokine-324062.html 0.6 2026-06-21T05:58:51+08:00 daily https://www.pharmasources.com/industryinsights/catalent-blueprint-enter-gavreto-commerc-324063.html 0.6 2026-08-07T08:48:13+08:00 daily https://www.pharmasources.com/industryinsights/arca-biopharmas-ab201-for-covid-19-gets--324064.html 0.6 2026-06-20T23:00:43+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-biontech-submit-eua-request-for-c-324065.html 0.6 2026-08-13T15:57:36+08:00 daily https://www.pharmasources.com/industryinsights/sagent-launches-phase-2-trial-to-evaluat-324066.html 0.6 2026-06-23T11:14:45+08:00 daily https://www.pharmasources.com/industryinsights/inhibrx-announces-positive-interim-resul-324067.html 0.6 2026-06-21T20:03:43+08:00 daily https://www.pharmasources.com/industryinsights/annual-pharma-rd-spending-in-uk-climbed--324068.html 0.6 2026-03-17T22:09:26+08:00 daily https://www.pharmasources.com/industryinsights/lilly-to-collaborate-with-precision-bios-324069.html 0.6 2026-06-23T22:54:49+08:00 daily https://www.pharmasources.com/industryinsights/spending-boost-welcome-but-more-funding--324070.html 0.6 2026-06-21T17:09:32+08:00 daily https://www.pharmasources.com/industryinsights/azoxford-universitys-covid-19-vaccine-sh-324071.html 0.6 2026-08-09T08:01:30+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-starts-covid-19-prevention-t-324072.html 0.6 2026-08-10T17:22:07+08:00 daily https://www.pharmasources.com/industryinsights/uk-and-us-could-administer-first-approve-324073.html 0.6 2026-06-27T10:50:55+08:00 daily https://www.pharmasources.com/industryinsights/adc-therapeutics-secures-fda-priority-re-324074.html 0.6 2026-06-21T03:54:07+08:00 daily https://www.pharmasources.com/industryinsights/zymeworks-gets-ecs-orphan-drug-designati-324075.html 0.6 2026-08-03T22:20:00+08:00 daily https://www.pharmasources.com/industryinsights/arizona-biotech-company-successfully-com-324076.html 0.6 2026-06-21T14:55:21+08:00 daily https://www.pharmasources.com/industryinsights/koru-lifescience-preparing-to-send-drug--324077.html 0.6 2026-06-22T12:12:58+08:00 daily https://www.pharmasources.com/industryinsights/3sbio-inc-received-milestone-payment-of--324078.html 0.6 2026-07-06T10:30:59+08:00 daily https://www.pharmasources.com/industryinsights/tony-blair-institute-and-oracle-launch-a-324079.html 0.6 2026-06-21T07:40:47+08:00 daily https://www.pharmasources.com/industryinsights/gemvax-kael-reports-further-positive-dat-324080.html 0.6 2026-06-22T08:10:53+08:00 daily https://www.pharmasources.com/industryinsights/alembic-pharma-jv-aleor-dermaceuticals-g-324081.html 0.6 2026-08-04T10:53:17+08:00 daily https://www.pharmasources.com/industryinsights/governments-should-work-as-a-team-for-sm-324082.html 0.6 2026-03-24T18:44:34+08:00 daily https://www.pharmasources.com/industryinsights/aiocd-asks-members-to-strengthen-cold-ch-324083.html 0.6 2026-08-11T10:39:28+08:00 daily https://www.pharmasources.com/industryinsights/eu-reaches-supply-deal-with-moderna-for--324084.html 0.6 2026-06-21T13:03:32+08:00 daily https://www.pharmasources.com/industryinsights/micro-labs-launches-anti-diabetic-drug-c-324085.html 0.6 2026-08-13T15:57:37+08:00 daily https://www.pharmasources.com/industryinsights/favipiravir-shows-significant-improvemen-324086.html 0.6 2025-12-12T15:56:47+08:00 daily https://www.pharmasources.com/industryinsights/sheffield-university-pfizer-launch-conso-324087.html 0.6 2026-08-08T16:49:19+08:00 daily https://www.pharmasources.com/industryinsights/companies-should-be-free-to-bid-on-feder-324088.html 0.6 2026-06-21T12:17:30+08:00 daily https://www.pharmasources.com/industryinsights/mesoblast-signs-ards-therapy-development-324089.html 0.6 2026-08-05T07:03:54+08:00 daily https://www.pharmasources.com/industryinsights/merck-agrees-to-buy-biopharma-firm-oncoi-324090.html 0.6 2026-08-10T01:21:07+08:00 daily https://www.pharmasources.com/industryinsights/hifibio-pharmsynthez-and-ibch-sign-covid-324091.html 0.6 2026-08-07T21:39:56+08:00 daily https://www.pharmasources.com/industryinsights/eu-reaches-deal-to-procure-160-million-d-324092.html 0.6 2026-08-09T23:18:51+08:00 daily https://www.pharmasources.com/industryinsights/curevac-and-wacker-sign-contract-for-man-324093.html 0.6 2026-06-08T20:05:28+08:00 daily https://www.pharmasources.com/industryinsights/lonza-and-be-the-match-biotherapies-ente-324094.html 0.6 2026-06-21T13:04:33+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-breaks-ground-on-super-324095.html 0.6 2026-08-08T00:17:13+08:00 daily https://www.pharmasources.com/industryinsights/apiject-systems-approved-for-590-million-324096.html 0.6 2026-06-22T03:01:42+08:00 daily https://www.pharmasources.com/industryinsights/syngene-and-3dc-sign-5-year-collaboratio-324097.html 0.6 2026-06-29T23:54:39+08:00 daily https://www.pharmasources.com/industryinsights/abenza-upgrades-chemistry-gmp-suites-324098.html 0.6 2026-08-07T21:08:25+08:00 daily https://www.pharmasources.com/industryinsights/baxter-invests-50m-to-expand-sterile-fil-324099.html 0.6 2026-06-21T08:47:06+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-covid-19-vaccine-meets-prima-324100.html 0.6 2026-06-22T08:00:14+08:00 daily https://www.pharmasources.com/industryinsights/antares-vision-acquires-assets-of-adents-324101.html 0.6 2026-06-22T07:33:23+08:00 daily https://www.pharmasources.com/industryinsights/lilly-samsung-partner-to-mass-produce-co-324102.html 0.6 2026-07-16T18:05:24+08:00 daily https://www.pharmasources.com/industryinsights/american-regent-announces-ceo-transition-324103.html 0.6 2026-07-04T19:49:49+08:00 daily https://www.pharmasources.com/industryinsights/wize-pharma-announces-positive-results-f-324104.html 0.6 2026-06-21T08:24:28+08:00 daily https://www.pharmasources.com/industryinsights/retrophin-completes-acquisition-of-orpha-324105.html 0.6 2026-06-21T15:47:35+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-pandemic-has-emphasised-existin-324106.html 0.6 2026-06-21T19:00:36+08:00 daily https://www.pharmasources.com/industryinsights/bms-inks-drug-discovery-deal-with-schrdi-324107.html 0.6 2026-08-11T16:58:51+08:00 daily https://www.pharmasources.com/industryinsights/over-half-of-pharmacists-report-that-cov-324108.html 0.6 2026-06-21T03:57:39+08:00 daily https://www.pharmasources.com/industryinsights/gsk-launches-late-stage-study-of-rsv-vac-324109.html 0.6 2026-01-04T01:48:13+08:00 daily https://www.pharmasources.com/industryinsights/sanofis-meningococcal-vaccine-wins-eu-ap-324110.html 0.6 2026-06-21T09:07:08+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-dosing-option-for-azs-i-324111.html 0.6 2026-06-28T15:07:16+08:00 daily https://www.pharmasources.com/industryinsights/amgen-hands-back-heart-failure-programme-324112.html 0.6 2026-06-29T21:43:59+08:00 daily https://www.pharmasources.com/industryinsights/nice-backs-braftovi-for-braf-positive-co-324113.html 0.6 2026-06-21T07:01:55+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-doses-first-participant-in-phase--324114.html 0.6 2026-06-20T19:12:00+08:00 daily https://www.pharmasources.com/industryinsights/clear-creek-bio-doses-first-patient-in-p-324115.html 0.6 2026-08-08T01:00:16+08:00 daily https://www.pharmasources.com/industryinsights/rhovacs-prostate-cancer-drug-candidate-r-324116.html 0.6 2026-07-01T03:08:32+08:00 daily https://www.pharmasources.com/industryinsights/medalliance-announces-successful-complet-324117.html 0.6 2026-06-21T09:47:50+08:00 daily https://www.pharmasources.com/industryinsights/china-biologic-reports-financial-results-324118.html 0.6 2026-07-21T07:04:04+08:00 daily https://www.pharmasources.com/industryinsights/celltrion-concludes-enrolment-for-phase--324119.html 0.6 2026-06-21T09:56:05+08:00 daily https://www.pharmasources.com/industryinsights/cordenpharma-colorado-increases-us-pepti-324120.html 0.6 2026-06-20T14:48:06+08:00 daily https://www.pharmasources.com/industryinsights/iil-to-invest-rs-75-cr-for-viral-antigen-324121.html 0.6 2026-06-21T04:03:48+08:00 daily https://www.pharmasources.com/industryinsights/laurus-labs-forays-into-biotech-acquires-324122.html 0.6 2026-08-06T17:14:06+08:00 daily https://www.pharmasources.com/industryinsights/lupin-launches-tacrolimus-capsules-usp-324123.html 0.6 2026-06-22T01:01:49+08:00 daily https://www.pharmasources.com/industryinsights/roches-xofluza-gets-fda-approval-for-inf-324124.html 0.6 2026-08-03T08:09:46+08:00 daily https://www.pharmasources.com/industryinsights/purdue-pharma-pleads-guilty-to-three-cri-324125.html 0.6 2026-06-20T20:58:38+08:00 daily https://www.pharmasources.com/industryinsights/exagen-gsk-partner-to-raise-lupus-diagno-324126.html 0.6 2026-06-20T19:12:53+08:00 daily https://www.pharmasources.com/industryinsights/plx-pharma-submits-sndas-for-vazalore-324127.html 0.6 2026-08-06T10:53:47+08:00 daily https://www.pharmasources.com/industryinsights/lonza-congratulates-moderna-on-interim-p-324128.html 0.6 2026-06-20T13:27:00+08:00 daily https://www.pharmasources.com/industryinsights/pacira-receives-ec-approval-for-exparel--324129.html 0.6 2026-06-20T21:50:34+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharmas-second-covid-19-candi-324130.html 0.6 2026-08-12T10:26:05+08:00 daily https://www.pharmasources.com/industryinsights/fda-authorizes-covid-19-test-for-self-te-324131.html 0.6 2026-07-04T16:44:46+08:00 daily https://www.pharmasources.com/industryinsights/one-of-the-oldest-vaccines-could-help-co-324132.html 0.6 2026-08-14T06:03:43+08:00 daily https://www.pharmasources.com/industryinsights/new-microneedle-vaccine-shows-promise-in-324133.html 0.6 2026-07-16T09:14:07+08:00 daily https://www.pharmasources.com/industryinsights/sputnik-v-covid-19-vaccine-over-90-perce-324134.html 0.6 2026-06-20T19:58:35+08:00 daily https://www.pharmasources.com/industryinsights/us-pharma-initiates-litigation-challengi-324135.html 0.6 2026-06-27T15:23:17+08:00 daily https://www.pharmasources.com/industryinsights/pelareorep-based-combination-therapy-imp-324136.html 0.6 2026-06-20T21:54:35+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-treatment-for-rare-pa-324137.html 0.6 2026-06-21T10:13:39+08:00 daily https://www.pharmasources.com/industryinsights/government-funding-for-uk-biomedical-inn-324138.html 0.6 2026-07-15T16:07:37+08:00 daily https://www.pharmasources.com/industryinsights/city-of-hope-begins-phase-1-clinical-tri-324139.html 0.6 2026-04-12T19:13:04+08:00 daily https://www.pharmasources.com/industryinsights/the-drug-aprotinin-inhibits-entry-of-sar-324140.html 0.6 2026-06-21T09:01:58+08:00 daily https://www.pharmasources.com/industryinsights/co-diagnostics-jv-cosara-receives-cleara-324141.html 0.6 2026-08-09T22:56:53+08:00 daily https://www.pharmasources.com/industryinsights/kantaro-receives-fda-emergency-use-autho-324142.html 0.6 2026-06-20T22:15:05+08:00 daily https://www.pharmasources.com/industryinsights/captigen-llc-announces-enhanced-covid-19-324143.html 0.6 2026-07-03T07:19:21+08:00 daily https://www.pharmasources.com/industryinsights/approval-of-phase-iii-clinical-trial-of--324144.html 0.6 2026-06-22T01:52:40+08:00 daily https://www.pharmasources.com/industryinsights/senhwa-announces-multiple-ind-applicatio-324145.html 0.6 2026-06-21T10:03:07+08:00 daily https://www.pharmasources.com/industryinsights/the-cost-of-one-dose-of-the-sputnik-v-va-324146.html 0.6 2026-06-20T20:01:38+08:00 daily https://www.pharmasources.com/industryinsights/newcentre-for-medicines-research-cmr-cli-324147.html 0.6 2026-07-05T16:17:38+08:00 daily https://www.pharmasources.com/industryinsights/new-potential-breast-cancer-drugs-identi-324148.html 0.6 2026-07-01T20:45:04+08:00 daily https://www.pharmasources.com/industryinsights/ceo-says-astrazeneca-likely-to-run-new-g-324149.html 0.6 2026-08-10T08:33:19+08:00 daily https://www.pharmasources.com/industryinsights/eu-drugs-watchdog-expects-first-applicat-324150.html 0.6 2026-08-06T14:48:07+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-signs-mou-with-rssdi-to-empo-324151.html 0.6 2026-07-22T18:02:37+08:00 daily https://www.pharmasources.com/industryinsights/gmax-biopharm-looking-to-enter-competiti-324152.html 0.6 2026-08-07T03:04:30+08:00 daily https://www.pharmasources.com/industryinsights/pm-to-visit-serum-institute-of-india-in--324153.html 0.6 2026-08-07T10:37:10+08:00 daily https://www.pharmasources.com/industryinsights/when-and-which-covid-19-vaccines-are-lik-324154.html 0.6 2026-07-30T08:39:02+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-pharma-secures-its-position-in--324155.html 0.6 2026-07-31T16:49:31+08:00 daily https://www.pharmasources.com/industryinsights/abu-dhabi-launches-hope-consortium-for-g-324156.html 0.6 2026-08-09T20:09:12+08:00 daily https://www.pharmasources.com/industryinsights/altimmune-submits-fda-application-for-in-324157.html 0.6 2026-06-21T10:20:23+08:00 daily https://www.pharmasources.com/industryinsights/biontech-fosun-pharma-initiate-covid-19--324158.html 0.6 2026-08-08T01:01:31+08:00 daily https://www.pharmasources.com/industryinsights/covaxx-announces-covid-19-vaccine-purcha-324159.html 0.6 2026-06-20T17:03:14+08:00 daily https://www.pharmasources.com/industryinsights/msf-welcomes-eu-pharmaceutical-strategy--324160.html 0.6 2026-07-21T05:28:29+08:00 daily https://www.pharmasources.com/industryinsights/experts-express-need-for-traceability-of-324161.html 0.6 2026-07-08T20:24:54+08:00 daily https://www.pharmasources.com/industryinsights/nice-backs-use-of-new-treatment-for-mult-324162.html 0.6 2026-06-21T15:50:39+08:00 daily https://www.pharmasources.com/industryinsights/janssens-tremfya-approved-for-active-pso-324163.html 0.6 2026-08-06T09:50:15+08:00 daily https://www.pharmasources.com/industryinsights/mixed-reaction-to-chancellors-spending-r-324164.html 0.6 2026-08-08T18:35:51+08:00 daily https://www.pharmasources.com/industryinsights/ec-announces-new-pharmaceutical-strategy-324165.html 0.6 2026-08-06T04:11:58+08:00 daily https://www.pharmasources.com/industryinsights/trial-to-compare-dexamethasone-and-baric-324166.html 0.6 2026-06-21T16:04:25+08:00 daily https://www.pharmasources.com/industryinsights/ec-approves-opdivo-for-treatment-of-oeso-324167.html 0.6 2026-08-13T19:04:27+08:00 daily https://www.pharmasources.com/industryinsights/apnimed-doses-first-patient-in-phase-2-t-324168.html 0.6 2026-08-07T19:13:17+08:00 daily https://www.pharmasources.com/industryinsights/health-canada-clears-appili-therapeutics-324169.html 0.6 2026-05-31T07:16:44+08:00 daily https://www.pharmasources.com/industryinsights/doctors-use-existing-treatment-earlier-t-324170.html 0.6 2026-07-29T14:50:42+08:00 daily https://www.pharmasources.com/industryinsights/half-of-top-20-global-innovative-pharma--324171.html 0.6 2026-08-14T09:07:14+08:00 daily https://www.pharmasources.com/industryinsights/rdif-and-hetero-agree-to-produce-over-10-324172.html 0.6 2026-07-31T01:26:32+08:00 daily https://www.pharmasources.com/industryinsights/fda-approval-of-provention-bios-teplizum-324173.html 0.6 2026-06-20T16:45:26+08:00 daily https://www.pharmasources.com/industryinsights/amorepacific-develops-an-original-techno-324174.html 0.6 2026-06-21T10:02:07+08:00 daily https://www.pharmasources.com/industryinsights/european-medicines-agency-validates-appl-324175.html 0.6 2026-07-24T02:14:47+08:00 daily https://www.pharmasources.com/industryinsights/haoma-medica-completes-first-in-human-tr-324176.html 0.6 2026-05-31T06:58:39+08:00 daily https://www.pharmasources.com/industryinsights/breakthrough-in-aml-treatment-goldenbiot-324177.html 0.6 2026-07-06T04:47:43+08:00 daily https://www.pharmasources.com/industryinsights/luye-pharma-and-distriphil-enter-exclusi-324178.html 0.6 2026-06-22T12:57:17+08:00 daily https://www.pharmasources.com/industryinsights/global-demand-for-covid-19-products-pres-324179.html 0.6 2026-08-08T01:00:57+08:00 daily https://www.pharmasources.com/industryinsights/unichem-gets-us-fda-approval-for-atenolo-324180.html 0.6 2026-06-20T17:20:48+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-to-acquire-select-anti-allergy-324181.html 0.6 2026-08-03T09:11:26+08:00 daily https://www.pharmasources.com/industryinsights/gufic-biosciences-gets-tigecycline-paten-324182.html 0.6 2026-08-07T02:39:27+08:00 daily https://www.pharmasources.com/industryinsights/modi-visits-key-vaccine-facilities-as-co-324183.html 0.6 2026-05-31T07:28:49+08:00 daily https://www.pharmasources.com/industryinsights/serum-institute-says-in-active-talks-wit-324184.html 0.6 2026-06-21T08:06:05+08:00 daily https://www.pharmasources.com/industryinsights/govt-extends-validity-of-import-licence--324185.html 0.6 2026-06-20T22:58:43+08:00 daily https://www.pharmasources.com/industryinsights/who-says-would-be-highly-speculative-to--324186.html 0.6 2026-08-04T13:33:14+08:00 daily https://www.pharmasources.com/industryinsights/pli-schemes-for-bulk-drugs-and-medical-d-324187.html 0.6 2026-06-21T17:03:26+08:00 daily https://www.pharmasources.com/industryinsights/britain-presses-on-with-astrazeneca-vacc-324188.html 0.6 2026-06-21T04:12:05+08:00 daily https://www.pharmasources.com/industryinsights/russia-to-vaccinate-armed-forces-against-324189.html 0.6 2026-07-06T01:03:09+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccine-distribution-a-daunting-324190.html 0.6 2026-08-06T23:37:47+08:00 daily https://www.pharmasources.com/industryinsights/ema-validates-mercks-application-to-revi-324191.html 0.6 2026-08-06T23:32:49+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-likely-to-conduct-new-global-324192.html 0.6 2026-08-06T23:37:23+08:00 daily https://www.pharmasources.com/industryinsights/bioinvent-signs-monoclonal-antibody-manu-324193.html 0.6 2026-08-06T23:45:39+08:00 daily https://www.pharmasources.com/industryinsights/symkevikalydeco-cleared-for-use-in-young-324194.html 0.6 2026-08-06T23:48:37+08:00 daily https://www.pharmasources.com/industryinsights/eu-to-review-mercks-targeted-lung-cancer-324195.html 0.6 2026-08-07T05:27:52+08:00 daily https://www.pharmasources.com/industryinsights/nice-turns-down-novartis-adakveo-324196.html 0.6 2026-08-09T06:59:42+08:00 daily https://www.pharmasources.com/industryinsights/nhs-to-trial-innovative-cancer-blood-tes-324197.html 0.6 2026-08-08T10:49:39+08:00 daily https://www.pharmasources.com/industryinsights/who-report-suggests-african-countries-ar-324198.html 0.6 2026-08-07T13:18:48+08:00 daily https://www.pharmasources.com/industryinsights/eu-secures-80-million-doses-of-moderna-c-324199.html 0.6 2026-08-06T23:46:07+08:00 daily https://www.pharmasources.com/industryinsights/covaxx-commits-to-deliver-140-million-co-324200.html 0.6 2026-08-06T23:36:21+08:00 daily https://www.pharmasources.com/industryinsights/ec-fines-teva-and-cephalon-605-million-o-324201.html 0.6 2026-08-06T23:33:28+08:00 daily https://www.pharmasources.com/industryinsights/edqm-releases-updated-pharmacopoeial-qua-324202.html 0.6 2026-08-06T22:54:46+08:00 daily https://www.pharmasources.com/industryinsights/fda-defers-approval-of-daxibotulinumtoxi-324203.html 0.6 2026-08-06T23:46:44+08:00 daily https://www.pharmasources.com/industryinsights/predict-cellular-drug-targets-against-co-324204.html 0.6 2026-08-07T05:00:15+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharma-expands-us-based-manuf-324205.html 0.6 2026-08-06T23:56:54+08:00 daily https://www.pharmasources.com/industryinsights/gnc-nmn-anti-aging-products-make-global--324206.html 0.6 2026-06-21T23:12:53+08:00 daily https://www.pharmasources.com/industryinsights/gilead-sciences-pulse-survey-highlights--324207.html 0.6 2026-08-07T00:40:37+08:00 daily https://www.pharmasources.com/industryinsights/eluminex-biosciences-an-ophthalmology-fo-324208.html 0.6 2026-08-07T00:15:28+08:00 daily https://www.pharmasources.com/industryinsights/sedana-medical-submits-market-approval-a-324209.html 0.6 2026-08-07T00:02:03+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-324210.html 0.6 2026-06-14T08:15:09+08:00 daily https://www.pharmasources.com/industryinsights/putting-the-vulnerable-first-could-end-t-324211.html 0.6 2026-08-07T00:39:55+08:00 daily https://www.pharmasources.com/industryinsights/experts-question-continuation-of-covishi-324212.html 0.6 2026-08-07T00:53:01+08:00 daily https://www.pharmasources.com/industryinsights/moderna-announces-vaccine-efficacy-of-94-324213.html 0.6 2026-08-11T05:10:28+08:00 daily https://www.pharmasources.com/industryinsights/eisai-and-wren-therapeutics-to-collabora-324214.html 0.6 2026-08-09T17:57:06+08:00 daily https://www.pharmasources.com/industryinsights/uk-to-procure-additional-two-million-dos-324215.html 0.6 2026-06-21T10:21:23+08:00 daily https://www.pharmasources.com/industryinsights/gilead-sciences-aids-society-of-india-su-324216.html 0.6 2026-08-15T01:09:41+08:00 daily https://www.pharmasources.com/industryinsights/expect-to-commercialise-vaccine-facility-324217.html 0.6 2026-06-22T04:52:37+08:00 daily https://www.pharmasources.com/industryinsights/china-has-highest-pd-1pd-l1-combination--324218.html 0.6 2026-07-19T14:55:17+08:00 daily https://www.pharmasources.com/industryinsights/biogen-and-sage-therapeutics-to-co-devel-324219.html 0.6 2026-08-07T00:40:18+08:00 daily https://www.pharmasources.com/industryinsights/vectura-kinaset-partner-to-develop-asthm-324220.html 0.6 2026-08-07T00:40:07+08:00 daily https://www.pharmasources.com/industryinsights/sgs-initiates-covid-19-clinical-trials-i-324221.html 0.6 2026-08-07T00:57:32+08:00 daily https://www.pharmasources.com/industryinsights/rigel-finalizes-study-design-of-fostamat-324222.html 0.6 2026-06-21T05:00:41+08:00 daily https://www.pharmasources.com/industryinsights/almac-secures-grant-for-remdesivir-manuf-324223.html 0.6 2026-06-22T11:00:18+08:00 daily https://www.pharmasources.com/industryinsights/eicosis-successfully-completes-phase-1a--324224.html 0.6 2026-06-21T00:17:20+08:00 daily https://www.pharmasources.com/industryinsights/ptc-therapeutics-announces-trial-for-hun-324225.html 0.6 2025-11-29T15:49:05+08:00 daily https://www.pharmasources.com/industryinsights/telix-pharmaceuticals-acquires-swiss-ger-324226.html 0.6 2026-08-08T02:53:43+08:00 daily https://www.pharmasources.com/industryinsights/az-sells-rights-to-statin-med-crestor-to-324227.html 0.6 2026-06-21T00:58:43+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-could-cause-long-term-lung-dama-324228.html 0.6 2026-06-21T03:03:39+08:00 daily https://www.pharmasources.com/industryinsights/researchers-warn-pandemic-could-delay-ca-324229.html 0.6 2026-06-20T21:09:47+08:00 daily https://www.pharmasources.com/industryinsights/colchicine-added-to-uks-covid-19-recover-324230.html 0.6 2026-06-20T14:33:44+08:00 daily https://www.pharmasources.com/industryinsights/dupixent-approved-in-eu-for-atopic-derma-324231.html 0.6 2026-06-21T10:07:14+08:00 daily https://www.pharmasources.com/industryinsights/uk-announces-20-million-investment-into--324232.html 0.6 2026-06-20T22:17:53+08:00 daily https://www.pharmasources.com/industryinsights/ema-highlights-link-between-hydroxychlor-324233.html 0.6 2026-08-02T14:33:15+08:00 daily https://www.pharmasources.com/industryinsights/uk-secures-total-of-357-million-doses-of-324234.html 0.6 2026-08-08T08:41:09+08:00 daily https://www.pharmasources.com/industryinsights/agc-biologics-to-expand-biopharmaceutica-324235.html 0.6 2026-08-07T23:52:04+08:00 daily https://www.pharmasources.com/industryinsights/chinas-taiwan-china-based-enterprises-of-324236.html 0.6 2026-08-10T23:50:01+08:00 daily https://www.pharmasources.com/industryinsights/evolving-world-of-pharma-the-importance--324237.html 0.6 2026-06-21T06:07:53+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-and-rdif-begin-clinical-trials-324238.html 0.6 2026-08-08T07:58:17+08:00 daily https://www.pharmasources.com/industryinsights/uk-pm-visits-wockhardt-facility-in-north-324239.html 0.6 2026-08-07T13:56:00+08:00 daily https://www.pharmasources.com/industryinsights/phase-i-pli-scheme-for-bulk-drugs-gets-2-324240.html 0.6 2026-08-07T13:16:14+08:00 daily https://www.pharmasources.com/industryinsights/cdmo-stelis-continues-expansion-324241.html 0.6 2026-08-07T00:53:03+08:00 daily https://www.pharmasources.com/industryinsights/recipharm-inks-covid-19-vax-pact-with-mo-324242.html 0.6 2026-08-07T09:23:07+08:00 daily https://www.pharmasources.com/industryinsights/india-sweden-innovation-day-2020-calls-f-324243.html 0.6 2026-08-07T01:14:30+08:00 daily https://www.pharmasources.com/industryinsights/the-biden-effect-on-india-pharma-inc-324244.html 0.6 2026-06-21T04:01:49+08:00 daily https://www.pharmasources.com/industryinsights/lupin-gets-us-fda-approval-for-penicilla-324245.html 0.6 2026-06-20T17:59:23+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-gets-tentative-approval-from-us-324246.html 0.6 2026-08-02T23:45:47+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-heart-failure-treatment-for-324247.html 0.6 2026-08-05T21:08:18+08:00 daily https://www.pharmasources.com/industryinsights/takeda-sells-select-products-to-celltrio-324248.html 0.6 2026-08-04T23:04:53+08:00 daily https://www.pharmasources.com/industryinsights/camfil-to-build-new-manufacturing-facili-324249.html 0.6 2026-06-07T09:21:21+08:00 daily https://www.pharmasources.com/industryinsights/ampion-study-advances-to-3rd-group-of-co-324250.html 0.6 2026-08-05T00:51:57+08:00 daily https://www.pharmasources.com/industryinsights/elitechgroup-mdx-announces-eua-submissio-324251.html 0.6 2026-08-06T18:01:48+08:00 daily https://www.pharmasources.com/industryinsights/aivita-biomedicals-glioblastoma-trial-sh-324252.html 0.6 2026-08-13T15:05:44+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-biontech-submit-cma-for-covid-19--324253.html 0.6 2026-08-12T11:55:05+08:00 daily https://www.pharmasources.com/industryinsights/neoimmunetech-doses-first-patient-in-cov-324254.html 0.6 2026-06-21T01:05:53+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-to-acquire-select-anti-allergy-324255.html 0.6 2026-08-11T17:21:31+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-covid-19-treatment-fast-track-324256.html 0.6 2026-08-13T02:37:24+08:00 daily https://www.pharmasources.com/industryinsights/survey-finds-64-percent-of-uk-adults-wou-324257.html 0.6 2026-08-14T08:57:02+08:00 daily https://www.pharmasources.com/industryinsights/ema-receives-application-for-conditional-324258.html 0.6 2026-07-31T14:25:14+08:00 daily https://www.pharmasources.com/industryinsights/ema-receives-application-for-conditional-324259.html 0.6 2026-08-03T05:51:48+08:00 daily https://www.pharmasources.com/industryinsights/cameo-expands-partnership-with-red-to-fi-324260.html 0.6 2026-06-20T18:11:31+08:00 daily https://www.pharmasources.com/industryinsights/with-onslaught-of-covid-19-increasing-rd-324261.html 0.6 2026-07-31T16:19:38+08:00 daily https://www.pharmasources.com/industryinsights/ami-expeditionary-healthcare-ami-contrac-324262.html 0.6 2026-06-22T17:40:50+08:00 daily https://www.pharmasources.com/industryinsights/genetworx-labs-launches-new-all-in-one-t-324263.html 0.6 2026-04-06T05:06:33+08:00 daily https://www.pharmasources.com/industryinsights/chinese-authored-reference-book-covid-19-324264.html 0.6 2026-08-07T17:27:36+08:00 daily https://www.pharmasources.com/industryinsights/bora-pharmaceuticals-completes-acquisiti-324265.html 0.6 2026-08-14T17:24:18+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-appoints-leading-immunology-and-he-324266.html 0.6 2026-06-22T00:58:49+08:00 daily https://www.pharmasources.com/industryinsights/alembic-pharma-gets-final-nod-form-us-fd-324267.html 0.6 2026-08-02T19:35:37+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-biontech-can-use-uk-as-test-bed-f-324268.html 0.6 2026-08-13T17:24:15+08:00 daily https://www.pharmasources.com/industryinsights/sec-asks-biocon-to-submit-safety-mortali-324269.html 0.6 2026-08-08T17:50:01+08:00 daily https://www.pharmasources.com/industryinsights/dcgi-finds-no-linkage-between-covishield-324270.html 0.6 2026-08-09T07:56:31+08:00 daily https://www.pharmasources.com/industryinsights/evaluating-pfizer-vaccine-for-possible-l-324271.html 0.6 2026-08-07T13:18:45+08:00 daily https://www.pharmasources.com/industryinsights/rhizen-pharma-gets-usfda-approval-for-ph-324272.html 0.6 2026-08-07T13:18:17+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-biontech-covid-19-vaccine-gets-eu-324273.html 0.6 2026-08-10T18:12:18+08:00 daily https://www.pharmasources.com/industryinsights/divis-laboratories-commence-construction-324274.html 0.6 2026-08-14T10:02:19+08:00 daily https://www.pharmasources.com/industryinsights/genentech-gets-us-fda-nod-for-gavreto-to-324275.html 0.6 2026-08-09T07:56:45+08:00 daily https://www.pharmasources.com/industryinsights/boston-scientific-to-sell-btg-specialty--324276.html 0.6 2026-08-02T16:40:28+08:00 daily https://www.pharmasources.com/industryinsights/ema-initiates-rolling-review-of-janssens-324277.html 0.6 2026-08-02T04:41:07+08:00 daily https://www.pharmasources.com/industryinsights/frontida-biopharm-appoints-chief-financi-324278.html 0.6 2026-08-08T10:40:03+08:00 daily https://www.pharmasources.com/industryinsights/vigeneron-and-wuxi-advanced-therapies-en-324279.html 0.6 2026-08-03T18:36:50+08:00 daily https://www.pharmasources.com/industryinsights/reflect-scientifics-cryometrix-suitable--324280.html 0.6 2026-08-07T13:16:33+08:00 daily https://www.pharmasources.com/industryinsights/sterling-makes-strategic-investment-in-a-324281.html 0.6 2026-08-07T03:54:55+08:00 daily https://www.pharmasources.com/industryinsights/lonza-enters-long-term-bioconjugation-co-324282.html 0.6 2026-08-07T03:33:46+08:00 daily https://www.pharmasources.com/industryinsights/neubase-therapeutics-appoints-chief-scie-324283.html 0.6 2026-08-07T03:03:59+08:00 daily https://www.pharmasources.com/industryinsights/kbi-biopharma-expands-us-ops-324284.html 0.6 2026-08-07T23:33:23+08:00 daily https://www.pharmasources.com/industryinsights/pti-announces-acquisition-of-leak-detect-324285.html 0.6 2026-08-07T13:19:56+08:00 daily https://www.pharmasources.com/industryinsights/biolinerx-initiates-ards-trial-324286.html 0.6 2026-08-07T02:40:51+08:00 daily https://www.pharmasources.com/industryinsights/oramed-initiates-nash-trial-of-oral-insu-324287.html 0.6 2026-08-07T01:31:53+08:00 daily https://www.pharmasources.com/industryinsights/fda-lifts-hold-on-multiple-myeloma-study-324288.html 0.6 2026-08-07T01:28:11+08:00 daily https://www.pharmasources.com/industryinsights/catalyst-receives-fast-track-designation-324289.html 0.6 2026-08-07T22:16:23+08:00 daily https://www.pharmasources.com/industryinsights/vectura-kinaset-therapeutics-set-to-deve-324290.html 0.6 2026-08-07T01:14:31+08:00 daily https://www.pharmasources.com/industryinsights/roches-xolair-gets-us-nod-for-nasal-poly-324291.html 0.6 2026-08-07T00:41:01+08:00 daily https://www.pharmasources.com/industryinsights/bayer-inks-deal-with-blackford-analysis--324292.html 0.6 2026-08-07T06:32:43+08:00 daily https://www.pharmasources.com/industryinsights/phase-iii-trial-to-study-familial-chylom-324293.html 0.6 2026-08-07T00:01:23+08:00 daily https://www.pharmasources.com/industryinsights/who-urges-countries-to-step-up-the-fight-324294.html 0.6 2026-08-07T00:41:37+08:00 daily https://www.pharmasources.com/industryinsights/moderna-applies-for-regulatory-authorisa-324295.html 0.6 2026-08-07T01:14:13+08:00 daily https://www.pharmasources.com/industryinsights/apex-innovative-sciences-pioneers-contin-324296.html 0.6 2026-08-07T13:15:14+08:00 daily https://www.pharmasources.com/industryinsights/pharmacists-ready-to-receive-and-adminis-324297.html 0.6 2026-08-07T01:19:15+08:00 daily https://www.pharmasources.com/industryinsights/seegenes-covid-19fluabrsv-test-with-extr-324298.html 0.6 2026-08-07T01:14:28+08:00 daily https://www.pharmasources.com/industryinsights/ipc-statement-on-sars-cov-2-vaccines-and-324299.html 0.6 2026-08-07T01:10:48+08:00 daily https://www.pharmasources.com/industryinsights/bd-to-invest-12-billion-in-pre-fillable--324300.html 0.6 2026-08-07T00:41:06+08:00 daily https://www.pharmasources.com/industryinsights/regent-pacifics-strategic-partner-receiv-324301.html 0.6 2026-08-07T00:02:29+08:00 daily https://www.pharmasources.com/industryinsights/solutions-for-powder-properties-in-pharm-324302.html 0.6 2026-08-06T23:55:24+08:00 daily https://www.pharmasources.com/industryinsights/inovio-signs-deal-with-japans-kaneka-for-324303.html 0.6 2026-08-07T00:02:41+08:00 daily https://www.pharmasources.com/industryinsights/indian-pharma-driving-excellence-in-qual-324304.html 0.6 2026-08-07T00:41:22+08:00 daily https://www.pharmasources.com/industryinsights/granules-india-gets-us-fda-approval-for--324305.html 0.6 2026-08-06T23:56:08+08:00 daily https://www.pharmasources.com/industryinsights/nppa-extends-revised-ceiling-price-of-he-324306.html 0.6 2026-08-06T20:02:59+08:00 daily https://www.pharmasources.com/industryinsights/fermenta-biotechs-us-subsidiary-acquires-324307.html 0.6 2026-08-06T19:23:18+08:00 daily https://www.pharmasources.com/industryinsights/batavia-biosciences-and-ku-leuven-join-f-324308.html 0.6 2026-06-22T05:01:42+08:00 daily https://www.pharmasources.com/industryinsights/ibio-to-provide-cdmo-services-for-atb-th-324309.html 0.6 2026-08-10T05:16:54+08:00 daily https://www.pharmasources.com/industryinsights/cytovance-expands-partnership-with-natur-324310.html 0.6 2026-06-21T14:51:17+08:00 daily https://www.pharmasources.com/industryinsights/us-buys-additional-650000-doses-of-lilly-324311.html 0.6 2026-06-21T11:08:16+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-rhizen-pharmaceuticals-appl-324312.html 0.6 2026-06-21T00:16:54+08:00 daily https://www.pharmasources.com/industryinsights/dcgi-probe-finds-no-adverse-event-linked-324313.html 0.6 2026-06-22T14:01:29+08:00 daily https://www.pharmasources.com/industryinsights/pionyr-immunotherapeutics-initiates-phas-324314.html 0.6 2026-06-22T16:10:06+08:00 daily https://www.pharmasources.com/industryinsights/neurosense-announces-continuation-of-pos-324315.html 0.6 2026-06-22T05:49:42+08:00 daily https://www.pharmasources.com/industryinsights/samsung-bioepis-biogen-announce-fda-fili-324316.html 0.6 2026-06-21T04:02:48+08:00 daily https://www.pharmasources.com/industryinsights/senhwa-enrolls-first-patient-in-silmitas-324317.html 0.6 2026-06-21T17:57:33+08:00 daily https://www.pharmasources.com/industryinsights/askbio-selecta-biosciences-receive-odd-f-324318.html 0.6 2026-06-28T22:45:53+08:00 daily https://www.pharmasources.com/industryinsights/redhill-to-continue-phase-23-covid-19-st-324319.html 0.6 2026-06-24T13:30:29+08:00 daily https://www.pharmasources.com/industryinsights/janssen-buys-rights-to-hemeras-eye-disea-324320.html 0.6 2026-08-09T04:18:46+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-partners-with-frontier-medicines--324321.html 0.6 2026-08-09T01:21:12+08:00 daily https://www.pharmasources.com/industryinsights/dsru-plans-post-authorisation-study-of-c-324322.html 0.6 2026-08-09T00:32:11+08:00 daily https://www.pharmasources.com/industryinsights/bayer-establishes-new-cell-and-gene-ther-324323.html 0.6 2026-08-08T23:29:59+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccines-may-be-less-effective--324324.html 0.6 2026-08-08T21:33:19+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-fast-track-designation-to-cov-324325.html 0.6 2026-08-07T13:18:10+08:00 daily https://www.pharmasources.com/industryinsights/first-bronchiectasis-patient-dosed-in-ph-324326.html 0.6 2026-08-07T10:53:10+08:00 daily https://www.pharmasources.com/industryinsights/ku-leuven-vaccine-candidate-protects-aga-324327.html 0.6 2026-08-10T17:34:44+08:00 daily https://www.pharmasources.com/industryinsights/nozin-can-help-mitigate-growing-risk-of--324328.html 0.6 2026-06-22T00:53:06+08:00 daily https://www.pharmasources.com/industryinsights/subcutaneously-administered-pd-l1-antibo-324329.html 0.6 2026-06-21T10:04:09+08:00 daily https://www.pharmasources.com/industryinsights/i-peace-inc-obtains-irb-approval-for-pro-324330.html 0.6 2026-08-12T07:10:45+08:00 daily https://www.pharmasources.com/industryinsights/drawbridge-health-partners-with-universi-324331.html 0.6 2026-06-21T00:09:47+08:00 daily https://www.pharmasources.com/industryinsights/inovio-expands-global-manufacturing-cons-324332.html 0.6 2026-06-21T10:03:08+08:00 daily https://www.pharmasources.com/industryinsights/serum-institute-applies-for-eua-for-covi-324333.html 0.6 2026-05-03T06:16:29+08:00 daily https://www.pharmasources.com/industryinsights/career-prospects-in-pharma-in-the-new-no-324334.html 0.6 2026-08-03T17:48:23+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-seeks-eua-for-covid-19-vaccine-in-324335.html 0.6 2026-08-12T10:57:35+08:00 daily https://www.pharmasources.com/industryinsights/aiocd-writes-to-pm-about-possible-shorta-324336.html 0.6 2026-06-22T06:00:43+08:00 daily https://www.pharmasources.com/industryinsights/regenerative-medicine-market-to-reach-16-324337.html 0.6 2026-07-20T23:03:13+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccine-will-not-be-made-mandat-324338.html 0.6 2026-06-21T11:19:32+08:00 daily https://www.pharmasources.com/industryinsights/a-large-basket-of-covid-19-vaccine-candi-324339.html 0.6 2026-07-05T15:14:28+08:00 daily https://www.pharmasources.com/industryinsights/ayush-stakeholders-should-focus-on-rd-fo-324340.html 0.6 2026-06-20T21:07:41+08:00 daily https://www.pharmasources.com/industryinsights/three-big-ticket-deals-contributed-69-pe-324341.html 0.6 2026-06-21T09:55:02+08:00 daily https://www.pharmasources.com/industryinsights/moderna-to-supply-six-million-doses-of-c-324342.html 0.6 2026-07-15T22:56:20+08:00 daily https://www.pharmasources.com/industryinsights/rising-trends-in-combination-drugs-marke-324343.html 0.6 2026-08-09T19:50:05+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccination-drive-will-commence-324344.html 0.6 2026-08-07T18:11:09+08:00 daily https://www.pharmasources.com/industryinsights/zydus-gets-dcgi-approval-to-commence-pha-324345.html 0.6 2026-06-21T10:36:03+08:00 daily https://www.pharmasources.com/industryinsights/indifi-forays-into-pharma-segment-along--324346.html 0.6 2026-06-21T10:01:26+08:00 daily https://www.pharmasources.com/industryinsights/merck-kgaa-signs-deal-with-artios-pharma-324347.html 0.6 2026-08-12T08:22:42+08:00 daily https://www.pharmasources.com/industryinsights/lilly-unitedhealth-to-study-bamlanivimab-324348.html 0.6 2026-06-21T20:49:48+08:00 daily https://www.pharmasources.com/industryinsights/keneka-eurogentec-joins-inovios-global-m-324349.html 0.6 2026-06-21T09:49:52+08:00 daily https://www.pharmasources.com/industryinsights/tubulis-wuxi-biologics-and-wuxi-sta-form-324350.html 0.6 2026-06-20T14:22:04+08:00 daily https://www.pharmasources.com/industryinsights/agc-biologics-expands-copenhagen-facilit-324351.html 0.6 2026-06-20T21:18:55+08:00 daily https://www.pharmasources.com/industryinsights/niaid-study-shows-modernas-covid-19-vacc-324352.html 0.6 2026-06-29T16:38:06+08:00 daily https://www.pharmasources.com/industryinsights/sifi-completes-enrollment-for-acanthamoe-324353.html 0.6 2026-06-21T12:02:11+08:00 daily https://www.pharmasources.com/industryinsights/baricitinib-receives-eua-for-hospitalize-324354.html 0.6 2026-08-13T03:56:20+08:00 daily https://www.pharmasources.com/industryinsights/flowmetric-launches-covid-19-antibody-te-324355.html 0.6 2026-06-21T16:18:43+08:00 daily https://www.pharmasources.com/industryinsights/mount-sinai-boehringer-ingelheim-to-eval-324356.html 0.6 2026-06-21T08:00:05+08:00 daily https://www.pharmasources.com/industryinsights/novartis-set-to-achieve-100-renewable-el-324357.html 0.6 2026-08-07T03:11:55+08:00 daily https://www.pharmasources.com/industryinsights/sosei-heptares-covid-19-program-identifi-324358.html 0.6 2026-06-30T13:55:51+08:00 daily https://www.pharmasources.com/industryinsights/new-study-identifies-challenges-for-covi-324359.html 0.6 2026-06-22T06:52:56+08:00 daily https://www.pharmasources.com/industryinsights/antengene-announces-acceptance-of-ind-ap-324360.html 0.6 2026-06-29T20:13:22+08:00 daily https://www.pharmasources.com/industryinsights/carsgen-therapeutics-presents-updated-mu-324361.html 0.6 2026-06-21T11:10:31+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-accelerates-clinical-development-o-324362.html 0.6 2026-07-15T23:50:00+08:00 daily https://www.pharmasources.com/industryinsights/gracell-biotechnologies-announces-presen-324363.html 0.6 2026-04-10T13:43:01+08:00 daily https://www.pharmasources.com/industryinsights/study-finds-metformin-reduced-covid-19-d-324364.html 0.6 2026-06-21T04:09:55+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-announces-initiation-of--324365.html 0.6 2026-07-27T13:48:16+08:00 daily https://www.pharmasources.com/industryinsights/roche-gets-fda-approval-of-gavreto-in-ad-324366.html 0.6 2026-08-09T19:43:19+08:00 daily https://www.pharmasources.com/industryinsights/appili-announces-dosing-of-first-patient-324367.html 0.6 2026-08-07T01:10:40+08:00 daily https://www.pharmasources.com/industryinsights/bharat-biotech-seeks-eua-for-covaxin-324368.html 0.6 2026-08-07T00:53:04+08:00 daily https://www.pharmasources.com/industryinsights/acg-appoints-dr-marcus-michel-as-new-ceo-324369.html 0.6 2026-08-07T00:59:13+08:00 daily https://www.pharmasources.com/industryinsights/gennext-at-siro-clinpharm-324370.html 0.6 2026-08-07T01:11:05+08:00 daily https://www.pharmasources.com/industryinsights/zydus-announces-phase-i-trials-of-zyil1--324371.html 0.6 2026-08-07T01:18:57+08:00 daily https://www.pharmasources.com/industryinsights/agilent-confers-thought-leader-award-to--324372.html 0.6 2026-08-07T01:21:34+08:00 daily https://www.pharmasources.com/industryinsights/sinovac-get-515-mn-funding-for-covid-19--324373.html 0.6 2026-08-09T07:56:41+08:00 daily https://www.pharmasources.com/industryinsights/bayer-atara-biotherapeutics-to-partner-f-324374.html 0.6 2026-07-01T18:07:19+08:00 daily https://www.pharmasources.com/industryinsights/bora-establishes-first-hq-in-north-ameri-324375.html 0.6 2026-06-21T12:00:13+08:00 daily https://www.pharmasources.com/industryinsights/colorcon-ventures-invests-in-i20-therape-324376.html 0.6 2026-06-20T16:04:30+08:00 daily https://www.pharmasources.com/industryinsights/tjoapack-invests-12m-in-packaging-supply-324377.html 0.6 2026-06-21T04:16:02+08:00 daily https://www.pharmasources.com/industryinsights/imfinzi-approved-in-us-for-less-frequent-324378.html 0.6 2026-08-09T08:01:52+08:00 daily https://www.pharmasources.com/industryinsights/glycostem-initiates-trial-to-evaluate-on-324379.html 0.6 2026-08-08T15:12:09+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-zokinvy-for-hutchinson-gilf-324380.html 0.6 2026-08-07T13:15:41+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharma-initiates-study-of-rhb-324381.html 0.6 2026-08-07T03:06:36+08:00 daily https://www.pharmasources.com/industryinsights/avacta-announces-sars-cov-2-rapid-antige-324382.html 0.6 2026-08-07T00:21:46+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-danyelza-324383.html 0.6 2026-08-07T03:33:26+08:00 daily https://www.pharmasources.com/industryinsights/calquence-shows-long-term-efficacy-and-t-324384.html 0.6 2026-08-07T04:04:04+08:00 daily https://www.pharmasources.com/industryinsights/research-highlights-benefit-of-telemedic-324385.html 0.6 2026-08-10T12:37:47+08:00 daily https://www.pharmasources.com/industryinsights/valneva-fast-tracks-paediatric-developme-324386.html 0.6 2026-06-21T19:56:35+08:00 daily https://www.pharmasources.com/industryinsights/uk-launch-for-vagirux-324387.html 0.6 2026-06-21T02:08:44+08:00 daily https://www.pharmasources.com/industryinsights/janssen-seeks-eu-approval-for-twice-year-324388.html 0.6 2026-06-21T02:33:27+08:00 daily https://www.pharmasources.com/industryinsights/rps-in-discussions-with-government-to-im-324389.html 0.6 2026-06-21T01:07:48+08:00 daily https://www.pharmasources.com/industryinsights/janssen-eyes-us-approval-for-egfr-target-324390.html 0.6 2026-07-16T12:01:26+08:00 daily https://www.pharmasources.com/industryinsights/puretech-launches-phase-ii-long-covid-dr-324391.html 0.6 2026-06-22T08:59:44+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-s-trimer-vaccine-candidates-sho-324392.html 0.6 2026-06-21T08:02:00+08:00 daily https://www.pharmasources.com/industryinsights/axi-cel-highly-effective-in-patients-wit-324393.html 0.6 2026-03-22T16:00:59+08:00 daily https://www.pharmasources.com/industryinsights/hackers-target-covid-19-vaccine-cold-cha-324394.html 0.6 2026-06-20T17:55:24+08:00 daily https://www.pharmasources.com/industryinsights/contributing-to-act-accelerator-could-ge-324395.html 0.6 2026-03-01T01:53:48+08:00 daily https://www.pharmasources.com/industryinsights/first-in-human-universal-car-t-therapy-t-324396.html 0.6 2026-06-21T12:11:36+08:00 daily https://www.pharmasources.com/industryinsights/everlywell-signs-agreement-to-distribute-324397.html 0.6 2026-06-22T05:00:38+08:00 daily https://www.pharmasources.com/industryinsights/innovent-announces-parsaclisib-treatment-324398.html 0.6 2026-08-07T22:31:11+08:00 daily https://www.pharmasources.com/industryinsights/postera-enters-a-multi-year-strategic-pa-324399.html 0.6 2026-01-01T04:54:25+08:00 daily https://www.pharmasources.com/industryinsights/through-strategic-collaboration-with-gen-324400.html 0.6 2026-08-05T23:42:35+08:00 daily https://www.pharmasources.com/industryinsights/inovio-doses-first-subject-in-phase-2-se-324401.html 0.6 2026-08-05T20:31:07+08:00 daily https://www.pharmasources.com/industryinsights/pharma-and-health-from-ingredients-to-pi-324402.html 0.6 2026-08-03T16:46:06+08:00 daily https://www.pharmasources.com/industryinsights/hsmd-seeks-update-from-government-on-pfi-324403.html 0.6 2026-06-20T20:17:07+08:00 daily https://www.pharmasources.com/industryinsights/india-likely-to-approve-authorise-covid--324404.html 0.6 2026-07-06T19:29:16+08:00 daily https://www.pharmasources.com/industryinsights/many-indians-are-sceptical-of-taking-cov-324405.html 0.6 2026-06-23T04:09:07+08:00 daily https://www.pharmasources.com/industryinsights/preparing-the-pharma-sector-for-the-post-324406.html 0.6 2026-06-21T18:00:33+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccines-will-not-be-mandatory--324407.html 0.6 2026-06-22T02:44:35+08:00 daily https://www.pharmasources.com/industryinsights/aesthetic-injectables-market-in-apac-to--324408.html 0.6 2026-08-04T17:57:58+08:00 daily https://www.pharmasources.com/industryinsights/uk-commences-roll-out-of-pfizers-covid-1-324409.html 0.6 2026-08-13T12:32:25+08:00 daily https://www.pharmasources.com/industryinsights/mp-small-scale-drug-manufacturers-associ-324410.html 0.6 2026-06-21T11:04:10+08:00 daily https://www.pharmasources.com/industryinsights/piramal-invests-32m-to-expand-michigan-f-324411.html 0.6 2026-06-08T19:51:45+08:00 daily https://www.pharmasources.com/industryinsights/acg-appoints-new-ceo-324412.html 0.6 2026-06-21T19:00:37+08:00 daily https://www.pharmasources.com/industryinsights/uks-vmic-to-implement-lonzas-moda-em-324413.html 0.6 2026-08-03T13:42:50+08:00 daily https://www.pharmasources.com/industryinsights/halix-astrazeneca-ink-commercial-covid-1-324414.html 0.6 2026-06-21T01:07:47+08:00 daily https://www.pharmasources.com/industryinsights/uk-becomes-first-country-to-initiate-cov-324415.html 0.6 2026-06-22T23:45:04+08:00 daily https://www.pharmasources.com/industryinsights/uk-biobank-unveils-studies-to-measure-ci-324416.html 0.6 2026-06-21T14:07:32+08:00 daily https://www.pharmasources.com/industryinsights/inovio-initiates-dosing-in-phase-ii-segm-324417.html 0.6 2026-08-07T01:14:04+08:00 daily https://www.pharmasources.com/industryinsights/maplight-completes-dosing-in-phase-1-stu-324418.html 0.6 2026-08-07T00:59:24+08:00 daily https://www.pharmasources.com/industryinsights/niaid-selects-metabolon-for-covid-19-stu-324419.html 0.6 2026-08-07T00:43:39+08:00 daily https://www.pharmasources.com/industryinsights/neurelis-completes-pre-ind-meeting-with--324420.html 0.6 2026-08-07T00:53:10+08:00 daily https://www.pharmasources.com/industryinsights/sotira-completes-pre-clinical-testing-fo-324421.html 0.6 2026-08-07T12:03:13+08:00 daily https://www.pharmasources.com/industryinsights/fda-expands-approval-of-influenza-treatm-324422.html 0.6 2026-08-07T13:17:09+08:00 daily https://www.pharmasources.com/industryinsights/potential-treatment-from-arca-for-covid--324423.html 0.6 2026-08-08T00:54:06+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-sangamo-announce-updated-results--324424.html 0.6 2026-08-08T01:44:14+08:00 daily https://www.pharmasources.com/industryinsights/syros-acquires-clinical-stage-drug-candi-324425.html 0.6 2026-08-08T07:44:13+08:00 daily https://www.pharmasources.com/industryinsights/neurogene-announces-ema-grants-orphan-dr-324426.html 0.6 2026-08-08T09:47:25+08:00 daily https://www.pharmasources.com/industryinsights/nice-backs-az-calquence-for-chronic-lymp-324427.html 0.6 2026-08-08T18:13:42+08:00 daily https://www.pharmasources.com/industryinsights/two-medicines-accepted-for-use-by-nhs-sc-324428.html 0.6 2026-07-15T19:53:24+08:00 daily https://www.pharmasources.com/industryinsights/cr-uk-makes-further-cuts-in-covids-wake-324429.html 0.6 2026-06-21T17:04:23+08:00 daily https://www.pharmasources.com/industryinsights/liquid-diagnostics-develops-unique-saliv-324430.html 0.6 2026-06-21T00:56:50+08:00 daily https://www.pharmasources.com/industryinsights/hyundai-bioscience-announced-that-its-co-324431.html 0.6 2026-07-12T12:39:43+08:00 daily https://www.pharmasources.com/industryinsights/top-line-final-data-from-cantrixil-phase-324432.html 0.6 2026-08-10T12:40:14+08:00 daily https://www.pharmasources.com/industryinsights/henlius-adalimumab-biosimilar-approved-b-324433.html 0.6 2026-08-07T04:52:49+08:00 daily https://www.pharmasources.com/industryinsights/mhra-issues-anaphylaxis-warning-for-pfiz-324434.html 0.6 2026-08-07T04:34:00+08:00 daily https://www.pharmasources.com/industryinsights/pharma-industry-seeks-support-from-the-g-324435.html 0.6 2026-08-07T04:21:58+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-to-acquire-labor-dr-324436.html 0.6 2026-08-07T04:16:04+08:00 daily https://www.pharmasources.com/industryinsights/team-of-70-ambassadors-and-high-commissi-324437.html 0.6 2026-08-07T03:55:25+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-announces-secondary-listing-of-324438.html 0.6 2026-08-07T03:34:05+08:00 daily https://www.pharmasources.com/industryinsights/usfda-grants-zydus-fast-track-designatio-324439.html 0.6 2026-08-07T03:02:54+08:00 daily https://www.pharmasources.com/industryinsights/piramal-pharma-solutions-invests-32-mn-i-324440.html 0.6 2026-08-07T02:52:19+08:00 daily https://www.pharmasources.com/industryinsights/pharmacovigilance-during-a-pandemic-324441.html 0.6 2026-08-08T22:03:31+08:00 daily https://www.pharmasources.com/industryinsights/aurobindo-gets-usfda-nod-for-dexmedetomi-324442.html 0.6 2026-08-07T01:27:48+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-staff-back-pfizer-covid-19-vaccin-324443.html 0.6 2026-08-07T01:19:46+08:00 daily https://www.pharmasources.com/industryinsights/health-canada-authorises-pfizer-and-bion-324444.html 0.6 2026-08-07T00:42:47+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-vaccine-shows-efficacy-in-p-324445.html 0.6 2026-08-07T00:41:11+08:00 daily https://www.pharmasources.com/industryinsights/bharat-biotech-to-begin-trial-of-intrana-324446.html 0.6 2026-08-08T00:11:28+08:00 daily https://www.pharmasources.com/industryinsights/recipharm-expands-api-manufacturing-capa-324447.html 0.6 2026-08-06T23:57:04+08:00 daily https://www.pharmasources.com/industryinsights/atbtherapeutics-enters-manufacturing-agr-324448.html 0.6 2026-08-06T23:46:36+08:00 daily https://www.pharmasources.com/industryinsights/initium-therapeutics-launches-antibody-d-324449.html 0.6 2026-08-11T18:38:58+08:00 daily https://www.pharmasources.com/industryinsights/evotec-and-sartorius-partner-with-curexs-324450.html 0.6 2026-08-07T13:17:33+08:00 daily https://www.pharmasources.com/industryinsights/evonik-bolsters-excipients-portfolio-324451.html 0.6 2026-08-09T04:32:07+08:00 daily https://www.pharmasources.com/industryinsights/sesen-bio-enters-mfg-and-supply-partners-324452.html 0.6 2026-08-07T13:19:38+08:00 daily https://www.pharmasources.com/industryinsights/link-medical-acquires-irw-consulting-ab-324453.html 0.6 2026-08-07T02:52:11+08:00 daily https://www.pharmasources.com/industryinsights/vivacelle-bio-receives-award-from-navy-f-324454.html 0.6 2026-06-26T20:46:34+08:00 daily https://www.pharmasources.com/industryinsights/campbell-neurosciences-files-patent-on-q-324455.html 0.6 2026-08-09T19:15:14+08:00 daily https://www.pharmasources.com/industryinsights/upadacitinib-meets-primary-all-ranked-se-324456.html 0.6 2026-06-21T08:58:57+08:00 daily https://www.pharmasources.com/industryinsights/lillys-tirzepatide-reduced-a1c-body-weig-324457.html 0.6 2026-08-08T01:55:18+08:00 daily https://www.pharmasources.com/industryinsights/cepheid-receives-ce-ivd-registration-for-324458.html 0.6 2026-06-22T15:32:52+08:00 daily https://www.pharmasources.com/industryinsights/gileads-car-t-therapy-yescarta-shows-pot-324459.html 0.6 2026-07-06T23:59:22+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-pneumococcal-disease-vaccine-sco-324460.html 0.6 2026-03-12T22:57:53+08:00 daily https://www.pharmasources.com/industryinsights/novartis-signs-ai-ophthalmology-pact-wit-324461.html 0.6 2026-07-01T23:00:13+08:00 daily https://www.pharmasources.com/industryinsights/roche-reveals-new-bispecific-antibody-da-324462.html 0.6 2026-08-07T12:01:54+08:00 daily https://www.pharmasources.com/industryinsights/ema-and-hma-publish-joint-strategy-on-me-324463.html 0.6 2026-07-16T09:10:55+08:00 daily https://www.pharmasources.com/industryinsights/positive-top-line-data-released-for-stud-324464.html 0.6 2026-08-07T05:28:28+08:00 daily https://www.pharmasources.com/industryinsights/european-pharmacopoeia-adopts-a-new-chap-324465.html 0.6 2026-08-06T22:53:22+08:00 daily https://www.pharmasources.com/industryinsights/universal-influenza-vaccine-shows-promis-324466.html 0.6 2026-08-06T23:36:12+08:00 daily https://www.pharmasources.com/industryinsights/amgens-sotorasib-gets-fda-breakthrough-t-324467.html 0.6 2026-08-06T23:46:23+08:00 daily https://www.pharmasources.com/industryinsights/cybin-signs-agreement-to-acquire-adelia--324468.html 0.6 2026-08-06T23:57:08+08:00 daily https://www.pharmasources.com/industryinsights/kazia-to-collaborate-with-pacific-pediat-324469.html 0.6 2026-08-07T00:02:50+08:00 daily https://www.pharmasources.com/industryinsights/stellar-results-from-kintors-gt90001-and-324470.html 0.6 2026-08-07T00:40:31+08:00 daily https://www.pharmasources.com/industryinsights/logistics4pharma-completes-validation-of-324471.html 0.6 2026-08-07T03:03:09+08:00 daily https://www.pharmasources.com/industryinsights/gilead-sciences-to-acquire-myr-gmbh-324472.html 0.6 2026-08-07T03:25:18+08:00 daily https://www.pharmasources.com/industryinsights/moderna-announces-dosing-of-first-adoles-324473.html 0.6 2026-06-22T00:03:44+08:00 daily https://www.pharmasources.com/industryinsights/indian-researchers-find-new-potential-co-324474.html 0.6 2026-07-27T00:37:21+08:00 daily https://www.pharmasources.com/industryinsights/sequent-launches-citramox-la-in-ten-euro-324475.html 0.6 2026-06-20T17:56:41+08:00 daily https://www.pharmasources.com/industryinsights/snowman-logistics-and-spicejet-sign-mou--324476.html 0.6 2026-06-22T10:40:33+08:00 daily https://www.pharmasources.com/industryinsights/biogen-applies-for-approval-of-alzheimer-324477.html 0.6 2026-06-20T18:20:57+08:00 daily https://www.pharmasources.com/industryinsights/arcus-biosciences-and-wuxi-biologics-exp-324478.html 0.6 2026-07-21T02:05:46+08:00 daily https://www.pharmasources.com/industryinsights/torrent-recalls-anagrelide-capsules-usp--324479.html 0.6 2026-06-22T18:42:17+08:00 daily https://www.pharmasources.com/industryinsights/phoenixmd-announces-first-patient-dosed--324480.html 0.6 2026-06-21T18:17:44+08:00 daily https://www.pharmasources.com/industryinsights/oramed-initiates-phase-3-trial-of-oral-i-324481.html 0.6 2026-07-17T14:15:51+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-accelerated-approval-to-naxit-324482.html 0.6 2026-06-20T17:19:28+08:00 daily https://www.pharmasources.com/industryinsights/fda-authorizes-first-direct-to-consumer--324483.html 0.6 2026-06-20T18:18:52+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-drug-to-treat-rare-me-324484.html 0.6 2026-06-08T22:01:13+08:00 daily https://www.pharmasources.com/industryinsights/crescendo-biologics-expands-takeda-colla-324485.html 0.6 2026-05-29T16:13:32+08:00 daily https://www.pharmasources.com/industryinsights/fda-set-to-review-gsks-nucala-for-nasal--324486.html 0.6 2026-07-31T17:03:26+08:00 daily https://www.pharmasources.com/industryinsights/passage-bio-catalent-begin-cgmp-mfg-for--324487.html 0.6 2026-06-20T17:41:25+08:00 daily https://www.pharmasources.com/industryinsights/schreiner-medipharm-joins-doseid-consort-324488.html 0.6 2026-05-29T15:49:36+08:00 daily https://www.pharmasources.com/industryinsights/catalent-appoints-minakuchi-facility-gm-324489.html 0.6 2026-06-30T19:57:39+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-to-acquire-nbe-therapeutics-i-324490.html 0.6 2026-08-14T22:03:27+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-scientific-further-expands-324491.html 0.6 2026-06-20T19:18:02+08:00 daily https://www.pharmasources.com/industryinsights/enhertu-scores-impressive-new-data-in-he-324492.html 0.6 2026-06-21T07:08:04+08:00 daily https://www.pharmasources.com/industryinsights/noncommunicable-diseases-are-leading-cau-324493.html 0.6 2026-07-15T18:01:05+08:00 daily https://www.pharmasources.com/industryinsights/rich-countries-buy-up-majority-of-covid--324494.html 0.6 2026-06-22T02:55:38+08:00 daily https://www.pharmasources.com/industryinsights/biocryst-announces-325m-of-funding-from--324495.html 0.6 2026-06-21T12:21:39+08:00 daily https://www.pharmasources.com/industryinsights/studies-reveal-potential-weaknesses-in-s-324496.html 0.6 2026-08-07T02:21:54+08:00 daily https://www.pharmasources.com/industryinsights/lilly-announces-650000-additional-doses--324497.html 0.6 2026-08-07T00:33:37+08:00 daily https://www.pharmasources.com/industryinsights/oral-drug-blocks-sars-cov-2-transmission-324498.html 0.6 2026-08-07T02:40:31+08:00 daily https://www.pharmasources.com/industryinsights/innovent-announces-first-patient-dosed-i-324499.html 0.6 2026-08-07T00:01:49+08:00 daily https://www.pharmasources.com/industryinsights/antengene-announces-acceptance-of-ind-ap-324500.html 0.6 2026-08-09T04:52:59+08:00 daily https://www.pharmasources.com/industryinsights/global-biosimilars-market-poised-to-grow-324501.html 0.6 2026-08-12T17:02:02+08:00 daily https://www.pharmasources.com/industryinsights/sourcing-bulk-paracetamol-benefits-dosag-324502.html 0.6 2026-08-08T00:23:54+08:00 daily https://www.pharmasources.com/industryinsights/biocon-biologics-mylan-get-chmp-recommen-324503.html 0.6 2026-07-22T16:35:11+08:00 daily https://www.pharmasources.com/industryinsights/scientists-find-five-key-genes-are-linke-324504.html 0.6 2026-06-23T09:08:55+08:00 daily https://www.pharmasources.com/industryinsights/government-calls-tender-for-35-cr-dispos-324505.html 0.6 2026-06-21T04:58:44+08:00 daily https://www.pharmasources.com/industryinsights/covishield-can-be-available-in-first-hal-324506.html 0.6 2026-06-20T22:54:41+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-to-acquire-alexion-324507.html 0.6 2026-07-08T05:43:56+08:00 daily https://www.pharmasources.com/industryinsights/gennovas-mrna-vaccine-candidate-for-covi-324508.html 0.6 2026-08-08T02:05:34+08:00 daily https://www.pharmasources.com/industryinsights/india-prepares-for-600-mn-covid-vaccine--324509.html 0.6 2026-06-20T19:59:40+08:00 daily https://www.pharmasources.com/industryinsights/us-orders-additional-100-mn-doses-of-mod-324510.html 0.6 2026-06-23T01:14:29+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-gives-eua-for-pfizerbiontech-covi-324511.html 0.6 2026-08-12T05:05:22+08:00 daily https://www.pharmasources.com/industryinsights/cdsco-to-identify-and-set-up-two-additio-324512.html 0.6 2026-06-21T05:06:45+08:00 daily https://www.pharmasources.com/industryinsights/cipla-settles-patent-litigation-of-revli-324513.html 0.6 2026-06-21T07:21:18+08:00 daily https://www.pharmasources.com/industryinsights/new-therapies-will-overcome-unmet-needs--324514.html 0.6 2026-08-08T01:13:54+08:00 daily https://www.pharmasources.com/industryinsights/immunitybio-covid-19-vaccine-candidate-s-324515.html 0.6 2026-06-21T00:55:47+08:00 daily https://www.pharmasources.com/industryinsights/alembic-pharma-gets-usfda-final-approval-324516.html 0.6 2026-06-27T11:10:54+08:00 daily https://www.pharmasources.com/industryinsights/australia-invests-ausd-4-mn-for-research-324517.html 0.6 2026-06-21T09:03:09+08:00 daily https://www.pharmasources.com/industryinsights/ipa-to-train-10-lakh-pharmacists-for-cov-324518.html 0.6 2026-06-20T23:52:33+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-gsk-postpone-covid-19-vaccine-324519.html 0.6 2026-06-29T08:45:14+08:00 daily https://www.pharmasources.com/industryinsights/ascentage-selects-pharmablock-as-preferr-324520.html 0.6 2026-07-22T16:14:08+08:00 daily https://www.pharmasources.com/industryinsights/haoma-medica-completes-first-in-human-tr-324521.html 0.6 2026-08-08T05:49:56+08:00 daily https://www.pharmasources.com/industryinsights/ema-validates-application-for-tepotinib--324522.html 0.6 2026-06-20T19:57:11+08:00 daily https://www.pharmasources.com/industryinsights/kantaro-receives-eua-for-semi-quantitati-324523.html 0.6 2026-06-22T11:26:23+08:00 daily https://www.pharmasources.com/industryinsights/albireo-submits-rare-liver-disease-med-o-324524.html 0.6 2026-08-07T04:29:30+08:00 daily https://www.pharmasources.com/industryinsights/cruk-researchers-develop-new-early-stage-324525.html 0.6 2026-08-08T10:39:49+08:00 daily https://www.pharmasources.com/industryinsights/alunbrig-scores-nice-backing-for-alk-pos-324526.html 0.6 2026-08-07T17:15:27+08:00 daily https://www.pharmasources.com/industryinsights/novartis-kisqali-demonstrates-nearly-fiv-324527.html 0.6 2026-08-07T16:16:15+08:00 daily https://www.pharmasources.com/industryinsights/data-from-actt-2-trial-of-baricitinib-in-324528.html 0.6 2026-08-07T15:07:10+08:00 daily https://www.pharmasources.com/industryinsights/tampa-general-hospital-is-preparing-to-a-324529.html 0.6 2026-08-14T01:38:27+08:00 daily https://www.pharmasources.com/industryinsights/molecular-stethoscope-announces-completi-324530.html 0.6 2026-08-10T15:15:00+08:00 daily https://www.pharmasources.com/industryinsights/high-prevalence-of-hospital-malnutrition-324531.html 0.6 2026-06-30T19:42:11+08:00 daily https://www.pharmasources.com/industryinsights/global-respiratory-clinics-market-will-g-324532.html 0.6 2026-08-11T22:11:31+08:00 daily https://www.pharmasources.com/industryinsights/fda-takes-key-action-in-fight-against-co-324533.html 0.6 2026-06-22T05:05:41+08:00 daily https://www.pharmasources.com/industryinsights/us-begins-covid-19-vaccinations-324534.html 0.6 2026-06-23T01:10:17+08:00 daily https://www.pharmasources.com/industryinsights/eqt-makes-28-bn-bid-for-recipharm-324535.html 0.6 2026-06-15T08:59:51+08:00 daily https://www.pharmasources.com/industryinsights/sputnik-v-vaccine-efficacy-is-914-per-ce-324536.html 0.6 2026-06-20T20:04:41+08:00 daily https://www.pharmasources.com/industryinsights/moderna-signs-supply-agreement-with-sing-324537.html 0.6 2026-06-20T17:03:19+08:00 daily https://www.pharmasources.com/industryinsights/himalaya-study-finds-herbal-immunomodula-324538.html 0.6 2026-02-07T17:49:59+08:00 daily https://www.pharmasources.com/industryinsights/ruxolitinib-jakafi-does-not-prevent-comp-324539.html 0.6 2026-08-03T13:10:25+08:00 daily https://www.pharmasources.com/industryinsights/us-begins-transportation-of-covid-19-vac-324540.html 0.6 2026-06-20T19:18:55+08:00 daily https://www.pharmasources.com/industryinsights/bahrain-approves-sinopharms-covid-19-vac-324541.html 0.6 2026-06-08T21:52:18+08:00 daily https://www.pharmasources.com/industryinsights/base10-dna-link-partners-on-research-to--324542.html 0.6 2026-06-20T18:53:50+08:00 daily https://www.pharmasources.com/industryinsights/anixa-ontochem-covid-19-therapy-demonstr-324543.html 0.6 2026-06-20T18:54:39+08:00 daily https://www.pharmasources.com/industryinsights/ptc-therapeutics-initiates-trial-to-eval-324544.html 0.6 2026-07-07T19:29:50+08:00 daily https://www.pharmasources.com/industryinsights/nice-u-turn-on-novartis-migraine-drug-ai-324545.html 0.6 2026-07-24T15:50:26+08:00 daily https://www.pharmasources.com/industryinsights/novartis-cholesterol-med-leqvio-wins-eu--324546.html 0.6 2026-06-26T14:23:09+08:00 daily https://www.pharmasources.com/industryinsights/eu-for-az-copd-maintenance-therapy-324547.html 0.6 2026-06-21T11:03:17+08:00 daily https://www.pharmasources.com/industryinsights/bumper-december-meeting-sees-chmp-recomm-324548.html 0.6 2026-06-21T05:13:52+08:00 daily https://www.pharmasources.com/industryinsights/european-chmp-adopts-positive-opinion-fo-324549.html 0.6 2026-06-21T02:53:41+08:00 daily https://www.pharmasources.com/industryinsights/cpi-scales-up-manufacturing-of-pyocin-s5-324550.html 0.6 2026-06-21T23:09:52+08:00 daily https://www.pharmasources.com/industryinsights/apiject-systems-appoints-general-counsel-324551.html 0.6 2026-06-21T09:05:04+08:00 daily https://www.pharmasources.com/industryinsights/inhalation-cdmo-vectura-expands-hpapi-ca-324552.html 0.6 2026-07-03T15:49:55+08:00 daily https://www.pharmasources.com/industryinsights/the-wasdell-group-earns-iso-13485-certif-324553.html 0.6 2026-06-21T09:08:09+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-emergency-use-authorization-f-324554.html 0.6 2026-02-28T15:34:05+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-to-test-combination-of-azd12-324555.html 0.6 2026-08-08T12:18:40+08:00 daily https://www.pharmasources.com/industryinsights/safety-and-efficacy-data-from-phase-iii--324556.html 0.6 2026-08-08T10:10:49+08:00 daily https://www.pharmasources.com/industryinsights/vaccine-demonstrates-efficacy-against-mu-324557.html 0.6 2026-08-08T07:59:12+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-covid-19-vaccine-data-accessed-i-324558.html 0.6 2026-08-08T04:35:02+08:00 daily https://www.pharmasources.com/industryinsights/genscript-and-innobation-enter-into-the--324559.html 0.6 2026-08-07T20:56:00+08:00 daily https://www.pharmasources.com/industryinsights/harbour-biomed-and-utrecht-university-an-324560.html 0.6 2026-08-07T13:18:59+08:00 daily https://www.pharmasources.com/industryinsights/sunshine-guojian-selects-verseaus-vsig4--324561.html 0.6 2026-08-10T08:20:08+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-added-to-nasdaq-biotechnology-inde-324562.html 0.6 2026-08-10T10:34:25+08:00 daily https://www.pharmasources.com/industryinsights/etruenorth-recruiting-covid-positive-ind-324563.html 0.6 2026-06-21T01:54:46+08:00 daily https://www.pharmasources.com/industryinsights/gilead-galapagos-amend-commercialisation-324564.html 0.6 2026-06-20T22:57:41+08:00 daily https://www.pharmasources.com/industryinsights/cipla-launches-rapid-antigen-detection-t-324565.html 0.6 2026-06-21T13:33:02+08:00 daily https://www.pharmasources.com/industryinsights/countries-must-build-consensus-around-pr-324566.html 0.6 2026-06-22T12:14:02+08:00 daily https://www.pharmasources.com/industryinsights/xentria-gets-us-fda-orphan-drug-designat-324567.html 0.6 2026-08-08T17:24:54+08:00 daily https://www.pharmasources.com/industryinsights/biocon-biologics-signs-mou-with-cssc-in--324568.html 0.6 2026-06-22T15:11:26+08:00 daily https://www.pharmasources.com/industryinsights/loginext-launches-covid-19-vaccine-suppl-324569.html 0.6 2026-06-22T16:11:46+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-expedites-indias-focus-on-innov-324570.html 0.6 2026-08-14T10:06:43+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-nod-for-ocrevus-ocrelizumab-short-324571.html 0.6 2026-06-22T13:03:04+08:00 daily https://www.pharmasources.com/industryinsights/inovio-to-develop-dmab-covid-treatments--324572.html 0.6 2026-06-21T09:13:17+08:00 daily https://www.pharmasources.com/industryinsights/lilly-to-acquire-prevail-therapeutics-in-324573.html 0.6 2026-08-04T11:05:08+08:00 daily https://www.pharmasources.com/industryinsights/draper-kite-ink-strategic-technology-pac-324574.html 0.6 2026-06-21T19:56:50+08:00 daily https://www.pharmasources.com/industryinsights/ergomed-acquires-medsource-324575.html 0.6 2026-06-21T08:53:55+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-expands-clinical-supply-se-324576.html 0.6 2026-06-21T03:00:02+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-report-finds-modernas-covid-19-va-324577.html 0.6 2026-08-03T15:41:51+08:00 daily https://www.pharmasources.com/industryinsights/curevac-initiates-phase-iibiii-trial-of--324578.html 0.6 2026-06-20T15:53:34+08:00 daily https://www.pharmasources.com/industryinsights/eureka-therapeutics-nasal-spray-protects-324579.html 0.6 2026-06-21T03:56:47+08:00 daily https://www.pharmasources.com/industryinsights/iterum-therapeutics-submits-nda-for-oral-324580.html 0.6 2026-07-04T11:33:30+08:00 daily https://www.pharmasources.com/industryinsights/redhills-covid-19-candidate-reduces-ards-324581.html 0.6 2026-06-22T16:52:51+08:00 daily https://www.pharmasources.com/industryinsights/binx-health-receives-eua-authorizing-at--324582.html 0.6 2026-06-20T18:56:54+08:00 daily https://www.pharmasources.com/industryinsights/forxiga-approved-in-japan-for-chronic-he-324583.html 0.6 2026-06-20T20:10:46+08:00 daily https://www.pharmasources.com/industryinsights/regenxbio-doses-first-patient-in-rgx-111-324584.html 0.6 2026-08-05T16:42:39+08:00 daily https://www.pharmasources.com/industryinsights/maplight-therapeutics-receives-grant-for-324585.html 0.6 2026-06-21T04:21:04+08:00 daily https://www.pharmasources.com/industryinsights/new-research-reveals-impact-of-childhood-324586.html 0.6 2026-06-21T06:21:16+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-novartis-wet-amd-drug-be-324587.html 0.6 2026-08-06T13:50:04+08:00 daily https://www.pharmasources.com/industryinsights/novo-holdings-establishes-rare-bleeding--324588.html 0.6 2026-06-21T00:35:22+08:00 daily https://www.pharmasources.com/industryinsights/pandemic-has-made-little-positive-impact-324589.html 0.6 2026-07-15T22:02:05+08:00 daily https://www.pharmasources.com/industryinsights/new-variant-of-coronavirus-identified-in-324590.html 0.6 2026-06-20T21:10:44+08:00 daily https://www.pharmasources.com/industryinsights/green-light-for-uk-trial-of-nasal-corona-324591.html 0.6 2026-06-21T16:58:49+08:00 daily https://www.pharmasources.com/industryinsights/remdesivir-likely-to-be-highly-effective-324592.html 0.6 2026-06-21T14:58:25+08:00 daily https://www.pharmasources.com/industryinsights/ping-an-good-doctor-and-tsumura-china-en-324593.html 0.6 2026-07-15T12:40:40+08:00 daily https://www.pharmasources.com/industryinsights/varian-and-yonsei-cancer-center-yonsei-u-324594.html 0.6 2026-06-21T05:11:50+08:00 daily https://www.pharmasources.com/industryinsights/singlera-genomics-raises-150-million-in--324595.html 0.6 2026-08-13T00:58:47+08:00 daily https://www.pharmasources.com/industryinsights/jk-introduces-online-portal-for-registra-324596.html 0.6 2026-06-21T04:01:44+08:00 daily https://www.pharmasources.com/industryinsights/rise-in-sale-of-heart-and-diabetes-drugs-324597.html 0.6 2026-06-21T02:21:15+08:00 daily https://www.pharmasources.com/industryinsights/british-american-tobaccos-covid-19-vacci-324598.html 0.6 2026-06-21T12:14:49+08:00 daily https://www.pharmasources.com/industryinsights/steer-appoints-subodh-jindal-as-ceo-324599.html 0.6 2026-06-21T06:28:12+08:00 daily https://www.pharmasources.com/industryinsights/be-prepared-to-handle-adverse-events-tha-324600.html 0.6 2026-07-23T17:58:29+08:00 daily https://www.pharmasources.com/industryinsights/gavi-collaborates-with-salesforce-for-co-324601.html 0.6 2026-06-21T11:09:13+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-names-john-rim-as-pres-324602.html 0.6 2026-07-15T18:54:13+08:00 daily https://www.pharmasources.com/industryinsights/aurinia-and-lonza-expand-manufacturing-p-324603.html 0.6 2026-08-03T07:01:03+08:00 daily https://www.pharmasources.com/industryinsights/collaboration-creates-bio-hub-in-norther-324604.html 0.6 2026-06-22T06:07:49+08:00 daily https://www.pharmasources.com/industryinsights/cdmo-cognate-bioservices-teams-up-with-l-324605.html 0.6 2026-08-07T04:52:51+08:00 daily https://www.pharmasources.com/industryinsights/cha-biotech-launches-global-cdmo-biz-324606.html 0.6 2026-06-21T15:57:21+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-initiates-study-of-antisense-324607.html 0.6 2026-08-11T13:58:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-authorizes-antigen-test-as-first-otc-324608.html 0.6 2026-08-09T18:41:07+08:00 daily https://www.pharmasources.com/industryinsights/athira-pharma-initiates-patient-dosing-f-324609.html 0.6 2026-06-20T22:58:37+08:00 daily https://www.pharmasources.com/industryinsights/harmony-biosciences-enrolls-first-patien-324610.html 0.6 2026-06-22T02:48:41+08:00 daily https://www.pharmasources.com/industryinsights/kineta-announces-first-participant-dosed-324611.html 0.6 2026-06-18T03:16:04+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-dosed-in-trial-of-ultra-co-324612.html 0.6 2026-06-21T08:58:01+08:00 daily https://www.pharmasources.com/industryinsights/many-people-may-not-receive-a-covid-19-v-324613.html 0.6 2026-08-06T21:24:51+08:00 daily https://www.pharmasources.com/industryinsights/astrorx-shows-promise-in-early-phase-amy-324614.html 0.6 2026-08-10T08:36:05+08:00 daily https://www.pharmasources.com/industryinsights/abbott-receives-ce-mark-for-covid-19-igg-324615.html 0.6 2026-08-06T23:37:20+08:00 daily https://www.pharmasources.com/industryinsights/class-4-medicines-defect-missing-safety--324616.html 0.6 2026-08-06T23:32:56+08:00 daily https://www.pharmasources.com/industryinsights/valneva-initiates-phase-12-clinical-stud-324617.html 0.6 2026-08-06T23:36:29+08:00 daily https://www.pharmasources.com/industryinsights/update-on-assessment-of-the-biontech-and-324618.html 0.6 2026-08-06T23:45:29+08:00 daily https://www.pharmasources.com/industryinsights/future-uncertainty-hangs-heavy-in-cigna--324619.html 0.6 2026-08-07T05:36:54+08:00 daily https://www.pharmasources.com/industryinsights/i-peace-inc-and-avery-therapeutics-annou-324620.html 0.6 2026-08-10T01:24:47+08:00 daily https://www.pharmasources.com/industryinsights/sos-ltd-announces-strategic-cooperation--324621.html 0.6 2026-07-20T01:02:45+08:00 daily https://www.pharmasources.com/industryinsights/lipidor-signs-cooperation-agreement-with-324622.html 0.6 2026-08-06T02:00:26+08:00 daily https://www.pharmasources.com/industryinsights/acceleron-gets-ec-orphan-designation-for-324623.html 0.6 2026-06-21T01:03:46+08:00 daily https://www.pharmasources.com/industryinsights/sai-life-sciences-to-recruit-over-500-sc-324624.html 0.6 2026-06-23T12:43:22+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-advisory-committee-supports-eua-f-324625.html 0.6 2026-06-27T12:57:48+08:00 daily https://www.pharmasources.com/industryinsights/chlorhexidine-mouthwash-can-kill-novel-c-324626.html 0.6 2026-07-02T18:05:27+08:00 daily https://www.pharmasources.com/industryinsights/natco-launches-rivaroxaban-anticoagulant-324627.html 0.6 2026-06-21T19:18:29+08:00 daily https://www.pharmasources.com/industryinsights/novartis-to-acquire-cadent-therapeutics--324628.html 0.6 2026-06-08T09:24:19+08:00 daily https://www.pharmasources.com/industryinsights/covaxin-is-well-tolerated-with-no-seriou-324629.html 0.6 2026-06-21T15:10:40+08:00 daily https://www.pharmasources.com/industryinsights/india-may-need-18-bn-for-first-phase-of--324630.html 0.6 2026-08-07T21:56:54+08:00 daily https://www.pharmasources.com/industryinsights/biontech-and-fosun-to-supply-100-million-324631.html 0.6 2026-03-24T19:52:27+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-rare-pediatric-disease-desi-324632.html 0.6 2026-06-23T00:55:15+08:00 daily https://www.pharmasources.com/industryinsights/trial-to-assess-pulsed-field-ablation-sy-324633.html 0.6 2026-06-20T14:50:04+08:00 daily https://www.pharmasources.com/industryinsights/fda-authorizes-binaxnow-covid-19-ag-card-324634.html 0.6 2026-06-21T06:02:48+08:00 daily https://www.pharmasources.com/industryinsights/therapeutic-solutions-announces-positive-324635.html 0.6 2026-02-14T23:41:26+08:00 daily https://www.pharmasources.com/industryinsights/codagenix-completes-dosing-for-trial-of--324636.html 0.6 2026-06-20T21:02:40+08:00 daily https://www.pharmasources.com/industryinsights/neurotherapia-completes-ntrx-07-phase-1a-324637.html 0.6 2026-07-01T12:00:28+08:00 daily https://www.pharmasources.com/industryinsights/eusa-pharma-launches-phase-iii-covid-19--324638.html 0.6 2026-06-20T19:17:09+08:00 daily https://www.pharmasources.com/industryinsights/international-consortium-creates-open-pl-324639.html 0.6 2026-08-12T22:18:29+08:00 daily https://www.pharmasources.com/industryinsights/gileads-car-t-therapy-tecartus-authorise-324640.html 0.6 2026-06-18T08:00:00+08:00 daily https://www.pharmasources.com/industryinsights/aptar-csp-increases-capacity-for-active--324641.html 0.6 2026-06-21T00:59:43+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-expands-plasmid-dna-mfg-ca-324642.html 0.6 2026-07-15T16:57:21+08:00 daily https://www.pharmasources.com/industryinsights/passage-bio-invests-in-gene-therapy-manu-324643.html 0.6 2026-06-22T03:49:23+08:00 daily https://www.pharmasources.com/industryinsights/evotec-bms-advance-targeted-protein-degr-324644.html 0.6 2026-06-21T04:59:42+08:00 daily https://www.pharmasources.com/industryinsights/oral-hormone-therapy-found-to-alter-meta-324645.html 0.6 2026-06-22T06:39:28+08:00 daily https://www.pharmasources.com/industryinsights/first-hospitalised-covid-19-patient-dose-324646.html 0.6 2026-06-22T06:00:06+08:00 daily https://www.pharmasources.com/industryinsights/triple-combination-of-therapies-shows-pr-324647.html 0.6 2026-08-06T17:28:43+08:00 daily https://www.pharmasources.com/industryinsights/cn-bio-university-of-melbourne-collabora-324648.html 0.6 2026-02-28T13:19:47+08:00 daily https://www.pharmasources.com/industryinsights/chop-researchers-receive-funding-to-stud-324649.html 0.6 2026-08-07T15:42:12+08:00 daily https://www.pharmasources.com/industryinsights/ace2-protein-protects-against-severe-cov-324650.html 0.6 2026-08-06T22:08:41+08:00 daily https://www.pharmasources.com/industryinsights/antengene-announces-approval-of-ind-appl-324651.html 0.6 2026-08-06T22:20:44+08:00 daily https://www.pharmasources.com/industryinsights/research-on-preventative-nasal-spray-whi-324652.html 0.6 2026-08-10T12:32:18+08:00 daily https://www.pharmasources.com/industryinsights/tessa-therapeutics-appoints-david-mcinty-324653.html 0.6 2026-07-12T12:36:15+08:00 daily https://www.pharmasources.com/industryinsights/open-care-announces-immubio-platform-bas-324654.html 0.6 2026-07-01T21:13:54+08:00 daily https://www.pharmasources.com/industryinsights/nih-sponsored-trials-evaluate-monoclonal-324655.html 0.6 2026-06-20T19:41:33+08:00 daily https://www.pharmasources.com/industryinsights/us-cdc-gives-recommendations-for-covid-1-324656.html 0.6 2026-06-23T13:44:12+08:00 daily https://www.pharmasources.com/industryinsights/shadowfax-to-collaborate-with-spicexpres-324657.html 0.6 2026-07-03T18:53:52+08:00 daily https://www.pharmasources.com/industryinsights/cuts-international-calls-for-second-decl-324658.html 0.6 2026-06-22T10:49:18+08:00 daily https://www.pharmasources.com/industryinsights/oxfordastrazeneca-vaccine-likely-to-get--324659.html 0.6 2026-07-06T19:43:53+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-declines-approval-for-novartis-in-324660.html 0.6 2026-08-11T10:04:23+08:00 daily https://www.pharmasources.com/industryinsights/dun-bradstreet-amex-nominate-neelikon-un-324661.html 0.6 2026-06-22T00:50:44+08:00 daily https://www.pharmasources.com/industryinsights/india-to-make-300-million-sputnik-v-vacc-324662.html 0.6 2026-06-20T18:56:35+08:00 daily https://www.pharmasources.com/industryinsights/covax-alliance-secures-two-billion-doses-324663.html 0.6 2026-06-21T00:40:24+08:00 daily https://www.pharmasources.com/industryinsights/logistics-providers-gear-up-to-ensure-sm-324664.html 0.6 2026-06-21T01:53:39+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-gives-eua-to-modernas-mrna-vaccin-324665.html 0.6 2026-06-21T01:47:39+08:00 daily https://www.pharmasources.com/industryinsights/european-commission-to-purchase-addition-324666.html 0.6 2026-06-21T03:41:29+08:00 daily https://www.pharmasources.com/industryinsights/dop-submits-revised-ptuas-scheme-documen-324667.html 0.6 2026-06-21T06:19:12+08:00 daily https://www.pharmasources.com/industryinsights/lupin-gets-us-fda-approval-for-colesevel-324668.html 0.6 2026-05-02T10:49:07+08:00 daily https://www.pharmasources.com/industryinsights/strides-gets-usfda-nod-for-oxybutynin-ch-324669.html 0.6 2026-06-23T17:02:27+08:00 daily https://www.pharmasources.com/industryinsights/ayush-industry-grew-by-44-per-cent-in-ni-324670.html 0.6 2026-06-21T04:20:28+08:00 daily https://www.pharmasources.com/industryinsights/model-n-to-acquire-deloittes-life-scienc-324671.html 0.6 2026-07-26T06:12:44+08:00 daily https://www.pharmasources.com/industryinsights/icr-scientists-create-3d-protein-structu-324672.html 0.6 2026-06-21T11:00:10+08:00 daily https://www.pharmasources.com/industryinsights/ampion-demonstrates-safety-in-covid-19-p-324673.html 0.6 2026-07-04T09:33:18+08:00 daily https://www.pharmasources.com/industryinsights/apotex-names-new-presdient-chief-executi-324674.html 0.6 2026-06-21T14:46:17+08:00 daily https://www.pharmasources.com/industryinsights/moda-em-paperless-solution-to-be-impleme-324675.html 0.6 2026-06-21T14:46:19+08:00 daily https://www.pharmasources.com/industryinsights/bd-to-invest-in-pre-fillable-syringe-man-324676.html 0.6 2026-07-06T21:10:50+08:00 daily https://www.pharmasources.com/industryinsights/scancell-picks-lead-covid-19-vaccine-can-324677.html 0.6 2026-08-04T18:11:51+08:00 daily https://www.pharmasources.com/industryinsights/gsk-co-leads-investment-in-disease-rebal-324678.html 0.6 2026-06-27T02:46:09+08:00 daily https://www.pharmasources.com/industryinsights/gamma-biosciences-announces-strategic-li-324679.html 0.6 2026-08-10T11:20:08+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-eyes-eu-approval-for-once-w-324680.html 0.6 2026-08-09T22:49:42+08:00 daily https://www.pharmasources.com/industryinsights/nhs-england-invests-10m-in-network-of-lo-324681.html 0.6 2026-06-22T11:11:02+08:00 daily https://www.pharmasources.com/industryinsights/immunemeds-hzvsf-v13-covid-19-clinical-t-324682.html 0.6 2026-07-09T00:29:20+08:00 daily https://www.pharmasources.com/industryinsights/antengene-announces-its-us-partner-karyo-324683.html 0.6 2026-08-02T10:00:26+08:00 daily https://www.pharmasources.com/industryinsights/teijin-pharma-and-transthera-biosciences-324684.html 0.6 2026-06-20T15:31:07+08:00 daily https://www.pharmasources.com/industryinsights/fda-takes-additional-action-in-fight-aga-324685.html 0.6 2026-06-21T21:12:56+08:00 daily https://www.pharmasources.com/industryinsights/vir-biotechnology-and-gsk-announce-start-324686.html 0.6 2026-06-20T18:54:52+08:00 daily https://www.pharmasources.com/industryinsights/neutralizing-antibodies-protect-against--324687.html 0.6 2026-06-21T05:59:45+08:00 daily https://www.pharmasources.com/industryinsights/gsk-gets-fda-nod-for-benlysta-to-treat-a-324688.html 0.6 2026-08-10T09:26:38+08:00 daily https://www.pharmasources.com/industryinsights/merck-reports-positive-results-for-keytr-324689.html 0.6 2026-08-10T18:17:20+08:00 daily https://www.pharmasources.com/industryinsights/neurogene-closes-115m-series-b-financing-324690.html 0.6 2026-08-07T03:33:51+08:00 daily https://www.pharmasources.com/industryinsights/2020-zhejiang-export-commodity-online-fa-324691.html 0.6 2026-08-07T03:03:09+08:00 daily https://www.pharmasources.com/industryinsights/2020-zhejiang-export-commodity-online-fa-324692.html 0.6 2026-07-23T03:57:45+08:00 daily https://www.pharmasources.com/industryinsights/49-per-cent-of-clinical-trial-disruption-324693.html 0.6 2026-08-07T02:45:42+08:00 daily https://www.pharmasources.com/industryinsights/vaccinations-move-to-nursing-homes-as-pa-324694.html 0.6 2026-08-07T02:40:24+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-and-biontech-get-eu-authorisation-324695.html 0.6 2026-08-07T02:33:37+08:00 daily https://www.pharmasources.com/industryinsights/lupin-gets-us-fda-approval-for-rufinamid-324696.html 0.6 2026-08-07T02:31:13+08:00 daily https://www.pharmasources.com/industryinsights/immunitybio-and-nantkwest-announce-merge-324697.html 0.6 2026-08-07T02:22:15+08:00 daily https://www.pharmasources.com/industryinsights/bayer-arogya-finance-join-hands-for-eyle-324698.html 0.6 2026-08-07T02:04:48+08:00 daily https://www.pharmasources.com/industryinsights/takeda-to-divest-select-assets-in-china--324699.html 0.6 2026-08-07T02:10:07+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-pharma-gets-anda-tentative-appr-324700.html 0.6 2026-08-07T02:21:57+08:00 daily https://www.pharmasources.com/industryinsights/sosei-heptares-and-gsk-sign-collaboratio-324701.html 0.6 2026-08-07T02:31:21+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-pharma-india-gets-dcgi-nod-f-324702.html 0.6 2026-08-10T17:22:33+08:00 daily https://www.pharmasources.com/industryinsights/fda-investigates-allergic-reactions-of-p-324703.html 0.6 2026-06-20T14:50:02+08:00 daily https://www.pharmasources.com/industryinsights/uk-identifies-new-sars-cov-2-strain-that-324704.html 0.6 2026-08-09T07:36:53+08:00 daily https://www.pharmasources.com/industryinsights/us-cdc-committee-recommends-modernas-cov-324705.html 0.6 2026-08-08T00:39:05+08:00 daily https://www.pharmasources.com/industryinsights/lonza-expands-conjugation-facility-in-vi-324706.html 0.6 2026-08-07T22:09:50+08:00 daily https://www.pharmasources.com/industryinsights/natoli-engineering-appoints-northeast-se-324707.html 0.6 2026-08-09T03:58:47+08:00 daily https://www.pharmasources.com/industryinsights/sars-cov-2-antigen-test-kit-receives-ce--324708.html 0.6 2026-08-07T06:07:20+08:00 daily https://www.pharmasources.com/industryinsights/aeglea-receives-fda-rare-pediatric-disea-324709.html 0.6 2026-08-08T20:57:17+08:00 daily https://www.pharmasources.com/industryinsights/bioeclipse-initiates-enrollment-in-phase-324710.html 0.6 2026-08-07T01:11:01+08:00 daily https://www.pharmasources.com/industryinsights/novartis-announces-fda-approval-of-xolai-324711.html 0.6 2026-08-09T12:43:14+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-hetlioz-for-nighttime-sleep-324712.html 0.6 2026-08-07T22:22:38+08:00 daily https://www.pharmasources.com/industryinsights/eu-nod-for-first-long-acting-hiv-injecta-324713.html 0.6 2026-06-20T17:14:32+08:00 daily https://www.pharmasources.com/industryinsights/green-light-for-azs-tagrisso-in-early-st-324714.html 0.6 2026-07-19T12:47:11+08:00 daily https://www.pharmasources.com/industryinsights/aimmunes-peanut-allergy-med-palforzia-wi-324715.html 0.6 2026-07-27T09:08:01+08:00 daily https://www.pharmasources.com/industryinsights/roches-faricimab-hits-the-mark-in-diabet-324716.html 0.6 2026-08-10T18:18:29+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-priority-review-to-keytruda-f-324717.html 0.6 2026-06-21T09:17:35+08:00 daily https://www.pharmasources.com/industryinsights/overweight-and-obese-subjects-dosed-with-324718.html 0.6 2026-07-17T23:08:34+08:00 daily https://www.pharmasources.com/industryinsights/ec-orders-additional-80-million-doses-of-324719.html 0.6 2026-07-16T00:11:53+08:00 daily https://www.pharmasources.com/industryinsights/alterity-and-uniquest-partner-to-reverse-324720.html 0.6 2026-06-21T19:13:17+08:00 daily https://www.pharmasources.com/industryinsights/pierre-fabre-selects-agc-biologics-as-cd-324721.html 0.6 2026-06-28T20:14:19+08:00 daily https://www.pharmasources.com/industryinsights/oral-contraceptive-pills-protect-against-324722.html 0.6 2026-06-22T17:09:18+08:00 daily https://www.pharmasources.com/industryinsights/servier-to-acquire-agios-pharmaceuticals-324723.html 0.6 2026-08-07T03:48:43+08:00 daily https://www.pharmasources.com/industryinsights/india-likely-to-approve-astrazeneca-vacc-324724.html 0.6 2026-08-07T03:30:41+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-pharma-and-menarini-enter-into--324725.html 0.6 2026-08-07T03:25:09+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccine-stirs-rare-hesitation-i-324726.html 0.6 2026-08-07T10:19:42+08:00 daily https://www.pharmasources.com/industryinsights/ocugen-and-bharat-biotech-to-co-develop--324727.html 0.6 2026-08-10T13:58:21+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-asthma-drug-benralizumab-ge-324728.html 0.6 2026-08-05T21:16:46+08:00 daily https://www.pharmasources.com/industryinsights/biontech-pfizer-vaccine-heads-to-eu-as-e-324729.html 0.6 2026-06-20T22:16:55+08:00 daily https://www.pharmasources.com/industryinsights/online-search-for-ayurvedic-solutions-go-324730.html 0.6 2026-06-21T03:18:53+08:00 daily https://www.pharmasources.com/industryinsights/redhill-gets-dsmb-recommendation-to-cont-324731.html 0.6 2025-12-05T08:30:26+08:00 daily https://www.pharmasources.com/industryinsights/ajinomoto-bio-pharma-and-revance-therape-324732.html 0.6 2026-06-21T06:08:50+08:00 daily https://www.pharmasources.com/industryinsights/astellas-reports-xospata-azacitidine-com-324733.html 0.6 2026-06-21T04:12:54+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-adjuvant-therapy-for--324734.html 0.6 2026-08-09T02:39:05+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-biontech-receive-chmp-positive-op-324735.html 0.6 2026-08-08T10:10:43+08:00 daily https://www.pharmasources.com/industryinsights/neurotrope-metuchen-announce-merger-comp-324736.html 0.6 2026-08-08T08:02:44+08:00 daily https://www.pharmasources.com/industryinsights/hepcidin-mimetic-candidate-receives-fast-324737.html 0.6 2026-08-07T13:18:09+08:00 daily https://www.pharmasources.com/industryinsights/lilly-to-begin-pragmatic-study-of-bamlan-324738.html 0.6 2026-08-07T12:01:12+08:00 daily https://www.pharmasources.com/industryinsights/eib-launches-50m-africa-pharmaceutical-m-324739.html 0.6 2026-08-07T11:29:22+08:00 daily https://www.pharmasources.com/industryinsights/mhra-approves-polyphors-phase-1-trial-of-324740.html 0.6 2026-08-07T06:06:46+08:00 daily https://www.pharmasources.com/industryinsights/az-amgens-source-trial-misses-primary-en-324741.html 0.6 2026-08-07T11:43:33+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-biontech-win-eu-authorisation-for-324742.html 0.6 2026-08-10T18:03:40+08:00 daily https://www.pharmasources.com/industryinsights/kroger-health-to-provide-covid-19-vaccin-324743.html 0.6 2026-08-07T13:17:53+08:00 daily https://www.pharmasources.com/industryinsights/how-sars-cov-2-interacts-with-cells-324744.html 0.6 2026-08-07T13:54:43+08:00 daily https://www.pharmasources.com/industryinsights/innovent-announces-nmpa-granted-new-indi-324745.html 0.6 2026-08-11T06:10:32+08:00 daily https://www.pharmasources.com/industryinsights/hyundai-bioscience-develops-injection-dr-324746.html 0.6 2026-08-08T10:38:58+08:00 daily https://www.pharmasources.com/industryinsights/transcenta-closes-105-million-in-crossov-324747.html 0.6 2026-08-10T17:22:02+08:00 daily https://www.pharmasources.com/industryinsights/lt1001-naldebainr-an-extended-release-an-324748.html 0.6 2026-08-07T02:37:29+08:00 daily https://www.pharmasources.com/industryinsights/biovaxys-vaccine-platform-stimulates-rob-324749.html 0.6 2026-08-07T02:30:45+08:00 daily https://www.pharmasources.com/industryinsights/gujarat-govt-launches-start-up-ecosystem-324750.html 0.6 2026-08-07T02:30:51+08:00 daily https://www.pharmasources.com/industryinsights/phase-i-clinical-trial-outcome-shows-cov-324751.html 0.6 2026-08-07T02:36:56+08:00 daily https://www.pharmasources.com/industryinsights/us-vaccine-rollouts-next-challenge-verif-324752.html 0.6 2026-08-07T13:16:45+08:00 daily https://www.pharmasources.com/industryinsights/volunteers-in-russias-sputnik-v-vaccine--324753.html 0.6 2026-08-12T14:42:57+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-says-its-vaccine-should-be-e-324754.html 0.6 2026-06-21T19:56:37+08:00 daily https://www.pharmasources.com/industryinsights/scientists-say-uk-strain-unlikely-to-aff-324755.html 0.6 2026-06-21T00:12:49+08:00 daily https://www.pharmasources.com/industryinsights/chinas-cas-covid-19-vaccine-induces-immu-324756.html 0.6 2026-06-21T21:00:44+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-seeks-approval-from-health-can-324757.html 0.6 2026-08-09T01:14:21+08:00 daily https://www.pharmasources.com/industryinsights/f-star-therapeutics-announces-first-pati-324758.html 0.6 2026-08-12T14:24:52+08:00 daily https://www.pharmasources.com/industryinsights/halix-to-provide-large-scale-gmp-manufac-324759.html 0.6 2026-08-09T04:22:19+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-biontech-to-supply-us-with-100-mi-324760.html 0.6 2026-06-21T04:20:03+08:00 daily https://www.pharmasources.com/industryinsights/inovio-doses-first-subject-in-ino-4800-t-324761.html 0.6 2026-06-20T15:00:11+08:00 daily https://www.pharmasources.com/industryinsights/natoli-engineering-announces-northeast-s-324762.html 0.6 2026-06-21T16:43:00+08:00 daily https://www.pharmasources.com/industryinsights/fda-authorizes-covid-19-flu-combination--324763.html 0.6 2026-06-21T22:14:04+08:00 daily https://www.pharmasources.com/industryinsights/eyepoint-reports-positive-results-from-g-324764.html 0.6 2026-03-26T23:04:39+08:00 daily https://www.pharmasources.com/industryinsights/janssen-submits-bla-for-metastatic-lung--324765.html 0.6 2026-08-06T16:57:27+08:00 daily https://www.pharmasources.com/industryinsights/sutro-biopharma-announces-interim-data-o-324766.html 0.6 2026-01-15T23:21:21+08:00 daily https://www.pharmasources.com/industryinsights/gemoab-announces-trial-with-solid-tumor--324767.html 0.6 2026-06-21T00:57:51+08:00 daily https://www.pharmasources.com/industryinsights/fusion-antibodies-queens-university-belf-324768.html 0.6 2026-06-20T17:02:19+08:00 daily https://www.pharmasources.com/industryinsights/therapix-university-of-calgary-to-evalua-324769.html 0.6 2026-06-22T10:15:58+08:00 daily https://www.pharmasources.com/industryinsights/shionogis-novel-antibiotic-added-to-uks--324770.html 0.6 2026-08-07T17:38:08+08:00 daily https://www.pharmasources.com/industryinsights/eu-green-light-for-zogenixs-fintepla-324771.html 0.6 2026-06-21T21:00:44+08:00 daily https://www.pharmasources.com/industryinsights/amo-pharma-launches-late-stage-study-of--324772.html 0.6 2026-06-20T22:19:59+08:00 daily https://www.pharmasources.com/industryinsights/amgen-files-kras-inhibitor-sotorasib-wit-324773.html 0.6 2026-07-10T12:08:30+08:00 daily https://www.pharmasources.com/industryinsights/vicore-pharmas-c21-med-shows-promise-in--324774.html 0.6 2026-07-06T23:01:33+08:00 daily https://www.pharmasources.com/industryinsights/ridgeback-biotherapeutics-ebola-treatmen-324775.html 0.6 2026-06-23T12:42:55+08:00 daily https://www.pharmasources.com/industryinsights/senhwa-biosciences-receives-us-fda-study-324776.html 0.6 2026-07-18T15:39:56+08:00 daily https://www.pharmasources.com/industryinsights/conbercept-new-generation-of-product-for-324777.html 0.6 2026-06-27T11:24:04+08:00 daily https://www.pharmasources.com/industryinsights/china-jo-jo-drugstores-regains-complianc-324778.html 0.6 2026-06-29T11:49:18+08:00 daily https://www.pharmasources.com/industryinsights/serbia-begins-covid-19-vaccination-drive-324779.html 0.6 2026-06-22T19:25:20+08:00 daily https://www.pharmasources.com/industryinsights/mudita-express-cargo-partners-with-spice-324780.html 0.6 2026-04-27T16:11:30+08:00 daily https://www.pharmasources.com/industryinsights/remdesivir-ineffective-against-covid-19--324781.html 0.6 2026-08-08T02:30:23+08:00 daily https://www.pharmasources.com/industryinsights/caplin-steriles-gets-us-fda-approval-for-324782.html 0.6 2026-06-20T19:08:44+08:00 daily https://www.pharmasources.com/industryinsights/spicejet-ties-up-with-gmr-hyderabad-air--324783.html 0.6 2026-06-21T01:52:37+08:00 daily https://www.pharmasources.com/industryinsights/dop-asks-nppa-to-review-verify-bharat-se-324784.html 0.6 2026-08-03T08:54:24+08:00 daily https://www.pharmasources.com/industryinsights/moderna-expects-its-covid-19-vaccine-to--324785.html 0.6 2026-06-21T19:16:55+08:00 daily https://www.pharmasources.com/industryinsights/aurobindo-pharma-to-make-covaxxs-potenti-324786.html 0.6 2026-06-21T06:52:03+08:00 daily https://www.pharmasources.com/industryinsights/argentina-registers-russias-covid-19-vac-324787.html 0.6 2026-06-21T05:14:54+08:00 daily https://www.pharmasources.com/industryinsights/modernas-covid-19-vaccine-obtains-health-324788.html 0.6 2026-06-21T17:13:52+08:00 daily https://www.pharmasources.com/industryinsights/inovio-announces-publication-of-phase-1--324789.html 0.6 2026-06-16T01:08:04+08:00 daily https://www.pharmasources.com/industryinsights/foresee-pharmaceuticals-announces-comple-324790.html 0.6 2026-06-21T01:50:41+08:00 daily https://www.pharmasources.com/industryinsights/neusoft-medical-has-reached-a-strategic--324791.html 0.6 2026-06-21T07:04:58+08:00 daily https://www.pharmasources.com/industryinsights/with-so-many-different-adverse-reactions-324792.html 0.6 2026-08-13T06:52:23+08:00 daily https://www.pharmasources.com/industryinsights/advanced-enzyme-technologies-to-acquire--324793.html 0.6 2026-08-05T05:18:49+08:00 daily https://www.pharmasources.com/industryinsights/india-has-key-role-to-play-in-equitable--324794.html 0.6 2026-06-11T08:19:45+08:00 daily https://www.pharmasources.com/industryinsights/europe-rolls-out-vaccines-against-covid--324795.html 0.6 2026-08-06T10:19:47+08:00 daily https://www.pharmasources.com/industryinsights/open-innovation-in-drug-development-324796.html 0.6 2026-07-09T21:06:54+08:00 daily https://www.pharmasources.com/industryinsights/study-finds-antibodies-target-different--324797.html 0.6 2026-06-22T14:31:28+08:00 daily https://www.pharmasources.com/industryinsights/us-doctor-develops-severe-allergic-react-324798.html 0.6 2026-07-20T06:01:42+08:00 daily https://www.pharmasources.com/industryinsights/vice-president-venkaiah-naidu-meets-bhar-324799.html 0.6 2026-07-13T08:20:24+08:00 daily https://www.pharmasources.com/industryinsights/usfda-defers-action-on-bla-for-avastin-b-324800.html 0.6 2026-08-06T19:56:29+08:00 daily https://www.pharmasources.com/industryinsights/pharma-industry-urges-government-to-exte-324801.html 0.6 2026-06-20T19:52:35+08:00 daily https://www.pharmasources.com/industryinsights/mas-in-biopharma-industry-high-despite-c-324802.html 0.6 2026-08-10T03:50:22+08:00 daily https://www.pharmasources.com/industryinsights/lupin-gets-tentative-approval-from-usfda-324803.html 0.6 2026-08-08T23:06:54+08:00 daily https://www.pharmasources.com/industryinsights/zydus-seeks-approval-for-phase-iii-clini-324804.html 0.6 2026-08-13T05:51:50+08:00 daily https://www.pharmasources.com/industryinsights/soligenix-demonstrates-extended-protecti-324805.html 0.6 2026-08-06T00:14:13+08:00 daily https://www.pharmasources.com/industryinsights/amgen-submits-sotorasib-marketing-author-324806.html 0.6 2026-06-20T14:50:06+08:00 daily https://www.pharmasources.com/industryinsights/tris-pharma-neuraxpharm-announce-partner-324807.html 0.6 2026-06-21T08:57:06+08:00 daily https://www.pharmasources.com/industryinsights/adexusdx-covid-19-antibody-test-filed-fo-324808.html 0.6 2026-06-22T14:36:41+08:00 daily https://www.pharmasources.com/industryinsights/beckman-coulter-launches-high-throughput-324809.html 0.6 2026-06-21T02:05:45+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-hepions-ind-application-for--324810.html 0.6 2026-06-21T21:44:32+08:00 daily https://www.pharmasources.com/industryinsights/first-subject-dosed-with-gannexs-fxr-ago-324811.html 0.6 2026-06-27T17:58:52+08:00 daily https://www.pharmasources.com/industryinsights/innovent-announces-the-nmpa-granted-new--324812.html 0.6 2026-08-06T07:36:36+08:00 daily https://www.pharmasources.com/industryinsights/arctic-vision-obtains-the-first-ind-appr-324813.html 0.6 2026-07-28T04:12:08+08:00 daily https://www.pharmasources.com/industryinsights/111-inc-announces-additional-round-of-ne-324814.html 0.6 2026-08-14T09:59:27+08:00 daily https://www.pharmasources.com/industryinsights/effective-effluent-management-key-to-tac-324815.html 0.6 2026-08-09T21:45:28+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-first-generic-glucagon-i-324816.html 0.6 2026-06-22T10:59:51+08:00 daily https://www.pharmasources.com/industryinsights/lynparza-olaparib-get-three-new-approval-324817.html 0.6 2026-07-29T13:35:52+08:00 daily https://www.pharmasources.com/industryinsights/biocon-launches-tacrolimus-capsules-in-u-324818.html 0.6 2026-08-12T23:43:37+08:00 daily https://www.pharmasources.com/industryinsights/serum-institute-of-india-launches-indige-324819.html 0.6 2026-08-05T12:55:34+08:00 daily https://www.pharmasources.com/industryinsights/spicejet-pluss-sign-mou-for-covid-19-vac-324820.html 0.6 2026-06-21T08:01:58+08:00 daily https://www.pharmasources.com/industryinsights/nasscom-birac-launch-jan-care-challenge--324821.html 0.6 2026-06-20T14:45:04+08:00 daily https://www.pharmasources.com/industryinsights/lupin-launches-meloxicam-capsules-324822.html 0.6 2026-06-21T09:04:31+08:00 daily https://www.pharmasources.com/industryinsights/sec-asks-bharat-serums-to-revise-phase-i-324823.html 0.6 2026-06-22T02:06:50+08:00 daily https://www.pharmasources.com/industryinsights/can-iprs-be-part-of-the-covid-19-solutio-324824.html 0.6 2026-06-21T01:04:47+08:00 daily https://www.pharmasources.com/industryinsights/covaxx-aurobindo-sign-covid-19-vaccine-d-324825.html 0.6 2026-06-21T00:01:36+08:00 daily https://www.pharmasources.com/industryinsights/russia-approves-sputnik-v-covid-19-vacci-324826.html 0.6 2026-06-21T04:02:46+08:00 daily https://www.pharmasources.com/industryinsights/merck-announces-supply-agreement-with-us-324827.html 0.6 2026-06-22T08:50:44+08:00 daily https://www.pharmasources.com/industryinsights/soligenix-announces-15-million-nih-small-324828.html 0.6 2026-06-21T10:04:15+08:00 daily https://www.pharmasources.com/industryinsights/poor-hygiene-in-low-income-countries-to--324829.html 0.6 2026-06-22T00:53:47+08:00 daily https://www.pharmasources.com/industryinsights/optimised-formulation-of-gentamicin-coul-324830.html 0.6 2026-08-02T20:21:10+08:00 daily https://www.pharmasources.com/industryinsights/novotech-health-holdings-appoints-zidong-324831.html 0.6 2026-08-07T05:05:47+08:00 daily https://www.pharmasources.com/industryinsights/concord-medical-announces-divestment-of--324832.html 0.6 2026-08-12T05:54:08+08:00 daily https://www.pharmasources.com/industryinsights/universiti-teknologi-malaysia-community--324833.html 0.6 2026-08-07T02:30:37+08:00 daily https://www.pharmasources.com/industryinsights/novavax-announces-initiation-of-prevent--324834.html 0.6 2026-08-07T02:24:30+08:00 daily https://www.pharmasources.com/industryinsights/a-brief-preview-of-2021-in-the-pharmaceu-324835.html 0.6 2026-08-03T09:55:38+08:00 daily https://www.pharmasources.com/industryinsights/a-brief-overview-of-covid-19-pandemic-in-324836.html 0.6 2026-08-06T23:46:43+08:00 daily https://www.pharmasources.com/industryinsights/vaccines-in-pipeline-will-work-against-t-324837.html 0.6 2026-08-07T04:34:09+08:00 daily https://www.pharmasources.com/industryinsights/cepi-to-help-advance-development-and-man-324838.html 0.6 2026-08-07T05:28:28+08:00 daily https://www.pharmasources.com/industryinsights/dr-harsh-vardhan-nominated-to-the-board--324839.html 0.6 2026-06-20T22:16:05+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-launches-remogliflozin-vildagli-324840.html 0.6 2026-08-09T23:02:54+08:00 daily https://www.pharmasources.com/industryinsights/lupin-launches-mycophenolate-mofetil-tab-324841.html 0.6 2026-07-29T18:28:09+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-and-oxford-made-covid-19-vac-324842.html 0.6 2026-06-22T18:07:10+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-dosed-in-phase-3-registrat-324843.html 0.6 2026-07-04T04:22:14+08:00 daily https://www.pharmasources.com/industryinsights/neurana-announces-top-line-results-from--324844.html 0.6 2026-06-21T01:48:37+08:00 daily https://www.pharmasources.com/industryinsights/united-therapeutics-receives-orphan-drug-324845.html 0.6 2026-06-21T05:16:56+08:00 daily https://www.pharmasources.com/industryinsights/assembly-biosciences-to-wind-down-microb-324846.html 0.6 2026-08-10T00:02:32+08:00 daily https://www.pharmasources.com/industryinsights/chiesi-usa-announces-general-manager-chi-324847.html 0.6 2026-08-07T21:29:40+08:00 daily https://www.pharmasources.com/industryinsights/aivita-biomedical-closes-25-million-fina-324848.html 0.6 2026-02-07T06:07:15+08:00 daily https://www.pharmasources.com/industryinsights/notable-vaccines-against-covid-19-making-324849.html 0.6 2026-08-14T21:36:40+08:00 daily https://www.pharmasources.com/industryinsights/lipocine-announces-update-on-jury-trial--324850.html 0.6 2026-06-08T23:33:41+08:00 daily https://www.pharmasources.com/industryinsights/insilico-enters-into-a-collaboration-wit-324851.html 0.6 2026-07-26T11:56:36+08:00 daily https://www.pharmasources.com/industryinsights/dxy-completes-usd-500-million-financing--324852.html 0.6 2026-07-18T13:00:03+08:00 daily https://www.pharmasources.com/industryinsights/inex-innovates-corotm-real-time-rt-pcr-s-324853.html 0.6 2026-06-20T14:47:05+08:00 daily https://www.pharmasources.com/industryinsights/sustained-cellular-immune-dysregulation--324854.html 0.6 2026-08-07T19:18:00+08:00 daily https://www.pharmasources.com/industryinsights/roche-gets-ec-nod-for-phesgo-to-treat-he-324855.html 0.6 2026-08-07T01:10:50+08:00 daily https://www.pharmasources.com/industryinsights/recipharm-moderna-sign-deal-for-manufact-324856.html 0.6 2026-08-07T00:53:10+08:00 daily https://www.pharmasources.com/industryinsights/sec-meets-to-discuss-eua-applications-fr-324857.html 0.6 2026-08-07T05:30:59+08:00 daily https://www.pharmasources.com/industryinsights/awaiting-indias-approval-for-covishield--324858.html 0.6 2026-06-20T23:01:42+08:00 daily https://www.pharmasources.com/industryinsights/uk-mhra-approves-oxfordastrazeneca-covid-324859.html 0.6 2026-07-05T21:46:28+08:00 daily https://www.pharmasources.com/industryinsights/hmd-completes-order-of-140-mn-kojak-ad-s-324860.html 0.6 2026-08-10T00:38:00+08:00 daily https://www.pharmasources.com/industryinsights/zydus-gets-dcgi-approval-for-saroglitaza-324861.html 0.6 2026-06-20T18:23:08+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-biontech-to-supply-the-eu-with-10-324862.html 0.6 2026-06-21T03:54:47+08:00 daily https://www.pharmasources.com/industryinsights/supernus-announces-positive-results-from-324863.html 0.6 2026-08-09T07:36:45+08:00 daily https://www.pharmasources.com/industryinsights/soterix-medical-expands-clinical-trials--324864.html 0.6 2026-08-07T21:28:23+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-announces-initial-data-from-co-324865.html 0.6 2026-08-07T13:16:30+08:00 daily https://www.pharmasources.com/industryinsights/mologic-receives-ce-mark-approval-for-co-324866.html 0.6 2026-08-07T12:29:46+08:00 daily https://www.pharmasources.com/industryinsights/cara-therapeutics-submits-nda-for-korsuv-324867.html 0.6 2026-08-15T01:30:00+08:00 daily https://www.pharmasources.com/industryinsights/hemoshear-identifies-novel-drug-target-t-324868.html 0.6 2026-08-07T11:51:57+08:00 daily https://www.pharmasources.com/industryinsights/aytu-bioscience-neos-therapeutics-announ-324869.html 0.6 2026-08-09T01:30:52+08:00 daily https://www.pharmasources.com/industryinsights/regenxbio-doses-first-patient-in-rgx-314-324870.html 0.6 2026-08-07T11:55:29+08:00 daily https://www.pharmasources.com/industryinsights/ppf-group-sells-sake-in-nbe-therapeutics-324871.html 0.6 2026-06-25T17:58:29+08:00 daily https://www.pharmasources.com/industryinsights/chmp-recommends-approvals-of-rinvoq-for--324872.html 0.6 2026-08-12T18:51:42+08:00 daily https://www.pharmasources.com/industryinsights/modag-initiates-first-in-patient-phase-1-324873.html 0.6 2026-07-01T10:32:25+08:00 daily https://www.pharmasources.com/industryinsights/biocept-enters-into-laboratory-services--324874.html 0.6 2025-11-29T10:47:15+08:00 daily https://www.pharmasources.com/industryinsights/qynapse-joins-decentralized-trials-resea-324875.html 0.6 2026-06-20T14:32:50+08:00 daily https://www.pharmasources.com/industryinsights/bausch-healths-dexaven-dexamethasone-pho-324876.html 0.6 2026-07-06T22:33:27+08:00 daily https://www.pharmasources.com/industryinsights/centene-completes-acquisition-of-panther-324877.html 0.6 2026-07-05T07:57:10+08:00 daily https://www.pharmasources.com/industryinsights/eurocine-vaccines-has-selected-biovian-a-324878.html 0.6 2026-08-06T18:25:55+08:00 daily https://www.pharmasources.com/industryinsights/winhealth-and-immedica-enter-agreement-g-324879.html 0.6 2026-06-24T05:43:56+08:00 daily https://www.pharmasources.com/industryinsights/modern-chinese-medicine-group-co-ltd-to--324880.html 0.6 2026-08-10T01:18:11+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-dcgi-approval-for-phas-324881.html 0.6 2026-08-07T13:19:38+08:00 daily https://www.pharmasources.com/industryinsights/dcgi-approves-covishield-and-covaxin-for-324882.html 0.6 2026-08-07T15:07:10+08:00 daily https://www.pharmasources.com/industryinsights/nsrt-to-start-phase-ii-trial-of-eflornit-324883.html 0.6 2026-08-14T14:30:41+08:00 daily https://www.pharmasources.com/industryinsights/hmd-gets-who-pqs-certification-for-03-ml-324884.html 0.6 2026-08-07T18:26:33+08:00 daily https://www.pharmasources.com/industryinsights/covaxin-clinical-trials-recruit-23000-su-324885.html 0.6 2026-08-07T19:39:19+08:00 daily https://www.pharmasources.com/industryinsights/sec-recommends-eua-for-covaxin-from-bhar-324886.html 0.6 2026-08-09T06:59:21+08:00 daily https://www.pharmasources.com/industryinsights/lymphoma-drug-pralatrexate-outperforms-r-324887.html 0.6 2026-06-21T09:07:09+08:00 daily https://www.pharmasources.com/industryinsights/virtual-clinical-trials-would-have-a-tre-324888.html 0.6 2026-06-20T22:11:06+08:00 daily https://www.pharmasources.com/industryinsights/wallace-pharma-sets-up-rd-centre-in-goa-324889.html 0.6 2026-07-04T18:47:28+08:00 daily https://www.pharmasources.com/industryinsights/alniche-lifesciences-forays-into-pharma--324890.html 0.6 2026-06-21T03:19:57+08:00 daily https://www.pharmasources.com/industryinsights/cbic-relaxes-rules-for-courier-import-an-324891.html 0.6 2026-06-21T02:06:41+08:00 daily https://www.pharmasources.com/industryinsights/dry-run-for-covid-19-vaccine-roll-out-in-324892.html 0.6 2026-06-21T04:47:30+08:00 daily https://www.pharmasources.com/industryinsights/fdi-in-brownfield-pharma-projects-critic-324893.html 0.6 2026-06-21T11:13:19+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-gets-final-nod-for-tadalafil-ta-324894.html 0.6 2026-08-03T05:53:58+08:00 daily https://www.pharmasources.com/industryinsights/uk-approves-astrazenecas-covid-19-vaccin-324895.html 0.6 2026-08-01T14:06:53+08:00 daily https://www.pharmasources.com/industryinsights/epivax-and-epivax-therapeutics-advance-c-324896.html 0.6 2026-08-07T05:05:55+08:00 daily https://www.pharmasources.com/industryinsights/early-multidrug-covid-19-treatment-can-p-324897.html 0.6 2026-08-07T02:52:01+08:00 daily https://www.pharmasources.com/industryinsights/hoth-therapeutics-announces-production-o-324898.html 0.6 2026-08-07T02:40:07+08:00 daily https://www.pharmasources.com/industryinsights/fyr-diagnostics-partners-with-the-state--324899.html 0.6 2026-08-07T02:31:00+08:00 daily https://www.pharmasources.com/industryinsights/early-treatment-can-stem-the-tide-of-cov-324900.html 0.6 2026-08-07T02:22:13+08:00 daily https://www.pharmasources.com/industryinsights/antengene-submits-nda-for-atg-010-seline-324901.html 0.6 2026-08-07T02:18:42+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharma-announces-positive-top-324902.html 0.6 2026-08-07T02:09:56+08:00 daily https://www.pharmasources.com/industryinsights/immvira-announces-series-c-financing-wit-324903.html 0.6 2026-08-07T20:06:01+08:00 daily https://www.pharmasources.com/industryinsights/new-virtual-screening-strategy-identifie-324904.html 0.6 2026-08-08T03:11:42+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-324905.html 0.6 2026-08-07T23:57:11+08:00 daily https://www.pharmasources.com/industryinsights/mixed-reactions-from-healthcare-experts--324906.html 0.6 2026-08-07T01:06:47+08:00 daily https://www.pharmasources.com/industryinsights/us-may-halve-doses-of-moderna-vaccine-to-324907.html 0.6 2026-08-07T01:14:27+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-starts-phase-ii-trial-of-scd--324908.html 0.6 2026-08-07T01:19:12+08:00 daily https://www.pharmasources.com/industryinsights/tel-aviv-university-develops-novel-lipid-324909.html 0.6 2026-08-07T05:37:18+08:00 daily https://www.pharmasources.com/industryinsights/angelini-pharma-acquires-arvelle-therape-324910.html 0.6 2026-08-10T12:30:14+08:00 daily https://www.pharmasources.com/industryinsights/brazilian-clinics-plans-deal-with-bharat-324911.html 0.6 2026-06-20T14:44:21+08:00 daily https://www.pharmasources.com/industryinsights/drug-activist-group-aidan-raises-concern-324912.html 0.6 2026-08-10T15:14:43+08:00 daily https://www.pharmasources.com/industryinsights/charles-river-labs-acquires-distributed--324913.html 0.6 2026-08-07T02:40:19+08:00 daily https://www.pharmasources.com/industryinsights/agc-biologics-manufactures-orchard-thera-324914.html 0.6 2026-08-07T00:40:30+08:00 daily https://www.pharmasources.com/industryinsights/inovio-advaccine-enter-exclusive-covid-1-324915.html 0.6 2026-08-07T00:43:06+08:00 daily https://www.pharmasources.com/industryinsights/lantern-pharma-launches-adc-program-324916.html 0.6 2026-08-07T01:14:22+08:00 daily https://www.pharmasources.com/industryinsights/oncorus-to-build-gmp-viral-immunotherapy-324917.html 0.6 2026-08-07T02:05:25+08:00 daily https://www.pharmasources.com/industryinsights/aceto-to-acquire-islechem-324918.html 0.6 2026-08-07T02:22:29+08:00 daily https://www.pharmasources.com/industryinsights/atyr-pharma-reports-positive-data-from-p-324919.html 0.6 2026-08-07T02:30:58+08:00 daily https://www.pharmasources.com/industryinsights/the-esperare-foundation-pierre-fabre-to--324920.html 0.6 2026-08-09T01:58:55+08:00 daily https://www.pharmasources.com/industryinsights/codagenix-serum-institute-of-india-annou-324921.html 0.6 2026-08-07T11:06:11+08:00 daily https://www.pharmasources.com/industryinsights/v2act-therapeutics-announces-ind-for-v2a-324922.html 0.6 2026-08-07T03:03:07+08:00 daily https://www.pharmasources.com/industryinsights/palatin-announces-positive-results-from--324923.html 0.6 2026-08-07T03:25:16+08:00 daily https://www.pharmasources.com/industryinsights/european-chmp-adopts-positive-opinion-fo-324924.html 0.6 2026-08-07T03:30:52+08:00 daily https://www.pharmasources.com/industryinsights/brainstorm-announces-nurown-expanded-acc-324925.html 0.6 2026-08-07T13:16:24+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-lorbrena-scores-us-priority-revi-324926.html 0.6 2026-08-08T16:49:03+08:00 daily https://www.pharmasources.com/industryinsights/cruk-scientists-develop-drug-that-target-324927.html 0.6 2026-06-20T16:51:42+08:00 daily https://www.pharmasources.com/industryinsights/janssen-files-egfr-targeting-antibody-am-324928.html 0.6 2026-07-31T09:51:46+08:00 daily https://www.pharmasources.com/industryinsights/first-long-acting-hiv-treatment-approved-324929.html 0.6 2026-07-07T02:40:01+08:00 daily https://www.pharmasources.com/industryinsights/modernas-covid-19-vaccine-is-94-percent--324930.html 0.6 2026-06-21T13:03:32+08:00 daily https://www.pharmasources.com/industryinsights/concerns-raised-over-indias-approval-of--324931.html 0.6 2026-08-05T09:44:42+08:00 daily https://www.pharmasources.com/industryinsights/ampio-provides-update-on-clinical-trials-324932.html 0.6 2026-04-18T04:40:35+08:00 daily https://www.pharmasources.com/industryinsights/nextgen-announce-ground-breaking-clinica-324933.html 0.6 2026-06-21T17:09:27+08:00 daily https://www.pharmasources.com/industryinsights/health-canada-authorizes-cytosorb-for-us-324934.html 0.6 2026-08-10T01:24:47+08:00 daily https://www.pharmasources.com/industryinsights/lui-franciosi-reviewing-the-use-of-glyco-324935.html 0.6 2026-08-07T01:22:17+08:00 daily https://www.pharmasources.com/industryinsights/y-biologics-signed-license-agreement-wit-324936.html 0.6 2026-08-07T17:42:15+08:00 daily https://www.pharmasources.com/industryinsights/antengene-announces-submission-of-ind-ap-324937.html 0.6 2026-08-07T00:43:04+08:00 daily https://www.pharmasources.com/industryinsights/regent-pacific-announces-key-progresses--324938.html 0.6 2026-08-07T00:39:58+08:00 daily https://www.pharmasources.com/industryinsights/happiness-biotech-announces-registered-d-324939.html 0.6 2026-08-07T00:02:47+08:00 daily https://www.pharmasources.com/industryinsights/rolling-out-the-vaccines-324940.html 0.6 2026-08-07T00:02:54+08:00 daily https://www.pharmasources.com/industryinsights/fighting-counterfeiting-requires-a-long--324941.html 0.6 2026-08-07T00:01:50+08:00 daily https://www.pharmasources.com/industryinsights/dr-harsh-vardhan-inaugurates-cepi-centra-324942.html 0.6 2026-06-22T02:46:40+08:00 daily https://www.pharmasources.com/industryinsights/speedy-delivery-of-covid-19-vaccine-a-hu-324943.html 0.6 2026-08-12T18:26:22+08:00 daily https://www.pharmasources.com/industryinsights/sii-bharat-biotech-jointly-pledge-to-wor-324944.html 0.6 2026-08-02T02:40:21+08:00 daily https://www.pharmasources.com/industryinsights/trane-technologies-thermo-king-launches--324945.html 0.6 2026-06-08T17:36:16+08:00 daily https://www.pharmasources.com/industryinsights/bharat-biotech-to-make-700-million-doses-324946.html 0.6 2026-06-21T19:08:49+08:00 daily https://www.pharmasources.com/industryinsights/israel-authorises-import-of-modernas-cov-324947.html 0.6 2026-06-22T10:54:45+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-divests-atacand-commercial-r-324948.html 0.6 2026-08-10T03:26:55+08:00 daily https://www.pharmasources.com/industryinsights/genezen-laboratories-receives-growth-equ-324949.html 0.6 2026-06-20T23:04:44+08:00 daily https://www.pharmasources.com/industryinsights/akston-biosciences-and-lakepharma-enter--324951.html 0.6 2026-08-08T08:48:11+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-to-invest-40m-in-new-facility-324952.html 0.6 2026-08-02T02:57:53+08:00 daily https://www.pharmasources.com/industryinsights/metacrine-reports-positive-results-from--324953.html 0.6 2026-07-10T06:55:45+08:00 daily https://www.pharmasources.com/industryinsights/peripheral-nop-agonist-addressing-chroni-324954.html 0.6 2026-07-11T20:32:51+08:00 daily https://www.pharmasources.com/industryinsights/creative-medical-technology-announces-su-324955.html 0.6 2026-08-10T03:04:10+08:00 daily https://www.pharmasources.com/industryinsights/otonomy-reports-positive-top-line-result-324956.html 0.6 2026-08-07T05:30:59+08:00 daily https://www.pharmasources.com/industryinsights/provention-bio-initiates-first-in-human--324957.html 0.6 2026-08-13T08:01:22+08:00 daily https://www.pharmasources.com/industryinsights/stubli-group-announces-new-ceo-324958.html 0.6 2026-08-06T23:47:01+08:00 daily https://www.pharmasources.com/industryinsights/ema-launches-review-of-bms-opdivo-for-oe-324959.html 0.6 2026-08-06T23:54:53+08:00 daily https://www.pharmasources.com/industryinsights/nice-collaboration-creates-new-route-for-324960.html 0.6 2026-08-07T03:03:13+08:00 daily https://www.pharmasources.com/industryinsights/india-gives-restricted-emergency-use-app-324961.html 0.6 2026-08-10T03:12:51+08:00 daily https://www.pharmasources.com/industryinsights/moderna-in-talks-with-south-korea-to-sup-324962.html 0.6 2026-02-15T13:11:00+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-amphastars-generic-drug--324963.html 0.6 2026-06-20T23:01:41+08:00 daily https://www.pharmasources.com/industryinsights/apex-innovative-sciences-supports-three--324964.html 0.6 2026-06-20T22:03:41+08:00 daily https://www.pharmasources.com/industryinsights/european-commission-approves-first-treat-324965.html 0.6 2026-07-23T15:34:18+08:00 daily https://www.pharmasources.com/industryinsights/novel-covid-19-test-could-significantly--324966.html 0.6 2026-07-09T17:14:35+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-ebanga-ansuvimab-zykl-for-t-324967.html 0.6 2026-08-08T01:16:12+08:00 daily https://www.pharmasources.com/industryinsights/new-resource-for-survivors-from-nccn-hel-324968.html 0.6 2026-06-21T02:10:48+08:00 daily https://www.pharmasources.com/industryinsights/global-cord-blood-announces-nhc-policy-u-324969.html 0.6 2026-08-07T18:18:43+08:00 daily https://www.pharmasources.com/industryinsights/huami-enters-in-definitive-agreement-to--324970.html 0.6 2026-06-26T09:33:43+08:00 daily https://www.pharmasources.com/industryinsights/china-grants-conditional-market-approval-324971.html 0.6 2026-07-31T23:12:23+08:00 daily https://www.pharmasources.com/industryinsights/include-pharma-workforce-in-priority-lis-324972.html 0.6 2026-06-22T11:10:56+08:00 daily https://www.pharmasources.com/industryinsights/the-new-nrdl-becomes-official-many-new-o-324973.html 0.6 2026-07-30T15:17:09+08:00 daily https://www.pharmasources.com/industryinsights/germany-says-does-not-intend-to-delay-se-324974.html 0.6 2026-06-20T22:06:37+08:00 daily https://www.pharmasources.com/industryinsights/lupin-gets-us-fda-approval-for-sulfameth-324975.html 0.6 2026-08-04T00:09:58+08:00 daily https://www.pharmasources.com/industryinsights/ukrainian-firm-applies-to-make-russias-c-324976.html 0.6 2026-06-22T09:12:04+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccine-key-conversation-driver-324977.html 0.6 2026-06-04T13:31:41+08:00 daily https://www.pharmasources.com/industryinsights/indifi-partners-with-retailio-strengthen-324978.html 0.6 2026-07-03T15:31:47+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-applies-for-emergency-use-fo-324979.html 0.6 2026-07-04T13:24:08+08:00 daily https://www.pharmasources.com/industryinsights/australia-brings-forward-covid-19-vaccin-324980.html 0.6 2026-06-21T16:05:22+08:00 daily https://www.pharmasources.com/industryinsights/gmr-hyderabad-and-dubai-airports-sign-mo-324981.html 0.6 2026-06-22T00:58:47+08:00 daily https://www.pharmasources.com/industryinsights/bioclinica-acquires-saliency-324982.html 0.6 2026-06-21T07:59:09+08:00 daily https://www.pharmasources.com/industryinsights/botanical-solution-inc-to-supply-pharma--324983.html 0.6 2026-08-07T03:34:03+08:00 daily https://www.pharmasources.com/industryinsights/parexel-appoints-chief-patient-officer-324984.html 0.6 2026-08-07T01:21:36+08:00 daily https://www.pharmasources.com/industryinsights/brickbio-inks-adc-co-development-deal-324985.html 0.6 2026-08-07T01:42:47+08:00 daily https://www.pharmasources.com/industryinsights/genesis-biotechnology-acquires-statking--324986.html 0.6 2026-08-07T01:45:42+08:00 daily https://www.pharmasources.com/industryinsights/gene-therapy-co-selects-valgenesis-saas--324987.html 0.6 2026-08-07T01:48:56+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-to-acquire-novaseps-chromatogr-324988.html 0.6 2026-08-07T01:52:23+08:00 daily https://www.pharmasources.com/industryinsights/emergex-signs-collaboration-agreement-wi-324989.html 0.6 2026-08-07T02:04:36+08:00 daily https://www.pharmasources.com/industryinsights/colombia-grants-emergency-use-approval-f-324990.html 0.6 2026-08-07T02:19:23+08:00 daily https://www.pharmasources.com/industryinsights/cellid-signs-covid-19-vaccine-research-c-324991.html 0.6 2026-08-07T02:21:53+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-arx788-fast-track-designation-324992.html 0.6 2026-08-07T05:31:15+08:00 daily https://www.pharmasources.com/industryinsights/ose-immunotherapeutics-receives-funding--324993.html 0.6 2026-06-24T04:01:37+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-ind-application-for-brain-c-324994.html 0.6 2026-07-16T20:17:35+08:00 daily https://www.pharmasources.com/industryinsights/chiral-technologies-announces-technology-324995.html 0.6 2026-04-02T06:28:07+08:00 daily https://www.pharmasources.com/industryinsights/natoli-engineering-announces-technical-s-324996.html 0.6 2026-06-22T10:03:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-xpovio-for-multiple-myeloma-324997.html 0.6 2026-06-20T14:44:03+08:00 daily https://www.pharmasources.com/industryinsights/biogen-vigeneron-enter-gene-therapy-coll-324998.html 0.6 2026-06-20T22:59:36+08:00 daily https://www.pharmasources.com/industryinsights/allergy-therapeutics-launches-biomarker--324999.html 0.6 2026-06-20T20:19:07+08:00 daily https://www.pharmasources.com/industryinsights/us-priority-review-for-forxiga-in-chroni-325000.html 0.6 2026-06-22T00:10:03+08:00 daily https://www.pharmasources.com/industryinsights/eu-authorises-intramuscular-administrati-325001.html 0.6 2026-08-08T08:15:41+08:00 daily https://www.pharmasources.com/industryinsights/windtree-announces-first-patient-dosed-i-325002.html 0.6 2026-07-27T07:20:54+08:00 daily https://www.pharmasources.com/industryinsights/seegenes-covid-19-test-with-saliva-sampl-325003.html 0.6 2026-06-21T23:14:02+08:00 daily https://www.pharmasources.com/industryinsights/new-process-for-producing-synthetic-insu-325004.html 0.6 2026-06-22T07:00:51+08:00 daily https://www.pharmasources.com/industryinsights/nice-initiates-new-innovative-licensing--325005.html 0.6 2026-06-21T10:02:09+08:00 daily https://www.pharmasources.com/industryinsights/trial-to-evaluate-monoclonal-antibody-th-325006.html 0.6 2026-08-03T22:58:34+08:00 daily https://www.pharmasources.com/industryinsights/protein-crystallisation-and-crystallogra-325007.html 0.6 2026-08-07T06:59:29+08:00 daily https://www.pharmasources.com/industryinsights/everest-medicines-announces-cta-approval-325008.html 0.6 2026-03-29T14:35:27+08:00 daily https://www.pharmasources.com/industryinsights/everest-medicines-initiates-submission-o-325009.html 0.6 2026-06-20T21:10:46+08:00 daily https://www.pharmasources.com/industryinsights/commerce-secretary-reaffirms-indias-comm-325011.html 0.6 2026-06-21T02:00:42+08:00 daily https://www.pharmasources.com/industryinsights/merck-acquires-germany-based-cdmo-amptec-325012.html 0.6 2026-07-28T00:36:23+08:00 daily https://www.pharmasources.com/industryinsights/lupin-gets-tentative-usfda-nod-for-empag-325013.html 0.6 2026-06-20T17:18:00+08:00 daily https://www.pharmasources.com/industryinsights/private-sector-expresses-willingness-to--325014.html 0.6 2026-04-19T19:08:27+08:00 daily https://www.pharmasources.com/industryinsights/healthcare-industry-records-103-deals-wo-325015.html 0.6 2026-06-21T03:04:41+08:00 daily https://www.pharmasources.com/industryinsights/we-might-need-to-redefine-our-approach-t-325016.html 0.6 2026-06-20T14:13:51+08:00 daily https://www.pharmasources.com/industryinsights/milliporesigma-acquires-amptec-325017.html 0.6 2026-06-21T08:04:59+08:00 daily https://www.pharmasources.com/industryinsights/catalent-divests-blow-fill-seal-sterile--325018.html 0.6 2026-03-01T13:42:33+08:00 daily https://www.pharmasources.com/industryinsights/curevac-and-bayer-join-forces-325019.html 0.6 2026-06-20T15:58:38+08:00 daily https://www.pharmasources.com/industryinsights/innocare-gets-approval-from-nmpa-for-ore-325020.html 0.6 2026-08-03T21:39:28+08:00 daily https://www.pharmasources.com/industryinsights/servier-and-x-chem-enter-drug-discovery--325021.html 0.6 2026-07-03T14:36:09+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-to-invest-2b-in-us-manufacturin-325022.html 0.6 2026-08-09T15:58:58+08:00 daily https://www.pharmasources.com/industryinsights/moderna-covid-19-vaccine-receives-europe-325023.html 0.6 2026-07-02T15:43:59+08:00 daily https://www.pharmasources.com/industryinsights/university-of-glasgow-to-establish-covid-325024.html 0.6 2026-06-20T14:53:01+08:00 daily https://www.pharmasources.com/industryinsights/cure-pharmaceutical-receives-fda-approva-325025.html 0.6 2026-07-31T13:19:17+08:00 daily https://www.pharmasources.com/industryinsights/roche-gets-fda-breakthrough-therapy-stat-325026.html 0.6 2026-06-10T05:12:40+08:00 daily https://www.pharmasources.com/industryinsights/innovent-announces-nmpa-approves-byvasda-325027.html 0.6 2026-08-07T10:55:09+08:00 daily https://www.pharmasources.com/industryinsights/tezepelumab-trial-does-not-meet-primary--325028.html 0.6 2026-06-30T10:47:29+08:00 daily https://www.pharmasources.com/industryinsights/mtpa-announces-initiation-of-open-label--325029.html 0.6 2026-05-31T14:52:35+08:00 daily https://www.pharmasources.com/industryinsights/honeywell-acquires-sparta-systems-325030.html 0.6 2026-08-12T14:19:39+08:00 daily https://www.pharmasources.com/industryinsights/anixa-cleveland-clinic-announce-fda-clea-325031.html 0.6 2026-06-23T06:06:03+08:00 daily https://www.pharmasources.com/industryinsights/skyrizi-bags-positive-psoriatic-arthriti-325032.html 0.6 2026-06-21T00:57:45+08:00 daily https://www.pharmasources.com/industryinsights/the-health-research-authority-launches-f-325033.html 0.6 2026-05-31T15:40:28+08:00 daily https://www.pharmasources.com/industryinsights/foracare-suisse-ag-releases-rapid-covid--325034.html 0.6 2026-06-22T05:07:50+08:00 daily https://www.pharmasources.com/industryinsights/tocilizumab-and-sarilumab-reduce-covid-1-325035.html 0.6 2026-06-20T21:08:42+08:00 daily https://www.pharmasources.com/industryinsights/new-technique-to-grow-crystals-from-nano-325036.html 0.6 2026-06-20T14:22:50+08:00 daily https://www.pharmasources.com/industryinsights/gracell-biotechnologies-announces-pricin-325037.html 0.6 2026-07-18T02:50:23+08:00 daily https://www.pharmasources.com/industryinsights/decode-genetics-monozygous-but-not-ident-325038.html 0.6 2026-06-22T00:16:14+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-in-treatment-in-rhovacs-cl-325039.html 0.6 2026-08-07T21:06:48+08:00 daily https://www.pharmasources.com/industryinsights/dr-david-stamler-appointed-ceo-325040.html 0.6 2026-06-22T00:52:19+08:00 daily https://www.pharmasources.com/industryinsights/kira-pharmaceuticals-announces-535-milli-325041.html 0.6 2026-06-21T05:01:50+08:00 daily https://www.pharmasources.com/industryinsights/iacta-pharmaceuticals-and-pharmaleads-to-325042.html 0.6 2026-08-04T02:51:13+08:00 daily https://www.pharmasources.com/industryinsights/visen-pharmaceuticals-receives-ind-appro-325043.html 0.6 2026-07-04T06:30:29+08:00 daily https://www.pharmasources.com/industryinsights/humanigen-eversana-to-partner-for-launch-325044.html 0.6 2026-08-09T18:58:11+08:00 daily https://www.pharmasources.com/industryinsights/cipla-strides-pharma-recall-drugs-in-the-325045.html 0.6 2026-08-07T21:49:19+08:00 daily https://www.pharmasources.com/industryinsights/china-to-offer-free-covid-19-vaccines-na-325046.html 0.6 2026-06-22T08:40:30+08:00 daily https://www.pharmasources.com/industryinsights/advancing-oncology-325047.html 0.6 2026-08-06T23:57:01+08:00 daily https://www.pharmasources.com/industryinsights/covaxin-trial-participants-death-unrelat-325048.html 0.6 2026-05-31T17:07:55+08:00 daily https://www.pharmasources.com/industryinsights/roll-out-of-covid-19-vaccination-in-indi-325049.html 0.6 2026-06-21T08:55:56+08:00 daily https://www.pharmasources.com/industryinsights/world-awaits-indias-vaccines-watching-ho-325050.html 0.6 2026-08-03T04:20:38+08:00 daily https://www.pharmasources.com/industryinsights/caprion-histogenex-acquires-clinical-log-325051.html 0.6 2026-05-31T17:16:35+08:00 daily https://www.pharmasources.com/industryinsights/biohaven-acquires-remaining-stake-in-kle-325052.html 0.6 2026-08-07T23:02:04+08:00 daily https://www.pharmasources.com/industryinsights/ionis-appoints-clinical-development-evp-325053.html 0.6 2026-06-21T02:10:52+08:00 daily https://www.pharmasources.com/industryinsights/biogen-licenses-cevec-aav-mfg-technology-325054.html 0.6 2026-07-06T21:21:15+08:00 daily https://www.pharmasources.com/industryinsights/dgca-issues-guidelines-to-airlines-for-t-325055.html 0.6 2026-06-08T20:13:06+08:00 daily https://www.pharmasources.com/industryinsights/bharat-biotech-to-start-phase-1-trials-o-325056.html 0.6 2026-06-21T01:02:47+08:00 daily https://www.pharmasources.com/industryinsights/amneal-launches-generic-abiraterone-acet-325057.html 0.6 2026-08-04T02:52:55+08:00 daily https://www.pharmasources.com/industryinsights/drug-pricing-reimbursement-constraints-l-325058.html 0.6 2026-08-03T02:48:59+08:00 daily https://www.pharmasources.com/industryinsights/abu-dhabi-firm-adq-invests-rs-555-crores-325059.html 0.6 2026-08-08T07:47:56+08:00 daily https://www.pharmasources.com/industryinsights/study-suggests-pfizerbiontech-vaccine-ef-325060.html 0.6 2026-08-07T22:00:23+08:00 daily https://www.pharmasources.com/industryinsights/business-optimism-improves-in-december-a-325061.html 0.6 2026-08-07T13:15:19+08:00 daily https://www.pharmasources.com/industryinsights/am-pharma-enrols-first-covid-19-patients-325062.html 0.6 2026-08-07T01:42:42+08:00 daily https://www.pharmasources.com/industryinsights/biohaven-begins-phase-3-troriluzole-tria-325063.html 0.6 2026-08-07T01:39:37+08:00 daily https://www.pharmasources.com/industryinsights/insmed-initiates-arikayce-trial-for-mac--325064.html 0.6 2026-08-07T10:16:43+08:00 daily https://www.pharmasources.com/industryinsights/mei-pharma-announces-expansion-of-zandel-325065.html 0.6 2026-06-21T01:59:38+08:00 daily https://www.pharmasources.com/industryinsights/provention-bio-announces-teplizumab-bla--325066.html 0.6 2026-08-07T01:27:38+08:00 daily https://www.pharmasources.com/industryinsights/harpoon-therapeutics-doses-first-patient-325067.html 0.6 2026-06-21T04:16:26+08:00 daily https://www.pharmasources.com/industryinsights/mhra-review-recommends-discussion-around-325068.html 0.6 2026-06-22T02:40:21+08:00 daily https://www.pharmasources.com/industryinsights/nice-no-for-bms-opdivo-for-head-and-neck-325069.html 0.6 2026-06-21T20:00:36+08:00 daily https://www.pharmasources.com/industryinsights/avidity-biosciences-announces-2021-pipel-325070.html 0.6 2026-06-20T15:11:18+08:00 daily https://www.pharmasources.com/industryinsights/blue-note-therapeutics-partnering-with-p-325071.html 0.6 2026-06-22T14:02:19+08:00 daily https://www.pharmasources.com/industryinsights/value-of-pharmas-ma-deals-remain-high-de-325072.html 0.6 2026-08-12T16:39:27+08:00 daily https://www.pharmasources.com/industryinsights/rapid-microbiology-testing-market-set-to-325073.html 0.6 2026-07-21T00:40:51+08:00 daily https://www.pharmasources.com/industryinsights/collaboration-to-investigate-nasal-drug--325074.html 0.6 2026-06-27T07:56:40+08:00 daily https://www.pharmasources.com/industryinsights/standigm-and-sk-chemicals-repurpose-fda--325075.html 0.6 2026-06-30T16:17:00+08:00 daily https://www.pharmasources.com/industryinsights/kintors-proxalutamide-gt0918-covid-19-cl-325076.html 0.6 2026-06-21T05:06:50+08:00 daily https://www.pharmasources.com/industryinsights/visen-pharmaceuticals-closes-150-million-325077.html 0.6 2026-08-03T06:45:44+08:00 daily https://www.pharmasources.com/industryinsights/an-in-vitro-study-shows-pfizer-biontech--325078.html 0.6 2026-08-13T17:25:03+08:00 daily https://www.pharmasources.com/industryinsights/biosimilars-2020-low-approvals-but-signi-325079.html 0.6 2026-08-01T20:53:22+08:00 daily https://www.pharmasources.com/industryinsights/opportunities-for-africa-in-covid-19-vac-325080.html 0.6 2026-07-24T21:39:08+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-325081.html 0.6 2026-06-21T18:46:24+08:00 daily https://www.pharmasources.com/industryinsights/ta-associates-acquires-stake-in-omniacti-325082.html 0.6 2026-06-21T01:11:52+08:00 daily https://www.pharmasources.com/industryinsights/30-bn-sales-forecast-for-pfizer-biontech-325083.html 0.6 2026-08-03T22:29:03+08:00 daily https://www.pharmasources.com/industryinsights/igba-appoints-sudarshan-jain-as-chair-fo-325084.html 0.6 2026-06-20T20:19:48+08:00 daily https://www.pharmasources.com/industryinsights/sii-receives-purchase-order-from-governm-325085.html 0.6 2026-06-22T05:50:31+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-appoints-vani-manja-325086.html 0.6 2026-06-20T15:13:22+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-laboratories-launches-febuxost-325087.html 0.6 2026-06-21T12:50:33+08:00 daily https://www.pharmasources.com/industryinsights/japan-health-ministry-finds-new-coronavi-325088.html 0.6 2026-06-22T18:57:29+08:00 daily https://www.pharmasources.com/industryinsights/jb-chemicals-gets-anda-approval-from-us--325089.html 0.6 2026-06-21T12:45:18+08:00 daily https://www.pharmasources.com/industryinsights/irisys-receives-nih-contract-for-the-for-325090.html 0.6 2026-06-21T01:11:05+08:00 daily https://www.pharmasources.com/industryinsights/baxter-novavax-ink-sterile-manufacturing-325091.html 0.6 2026-06-20T14:59:07+08:00 daily https://www.pharmasources.com/industryinsights/cyclolab-and-epipharma-form-joint-ventur-325092.html 0.6 2026-08-05T18:30:11+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-diosynth-biotechnologies-begins-325093.html 0.6 2026-06-21T00:08:46+08:00 daily https://www.pharmasources.com/industryinsights/leukocare-starts-operations-in-the-us-325094.html 0.6 2026-06-21T06:57:18+08:00 daily https://www.pharmasources.com/industryinsights/alcami-expands-oral-solid-capabilities-325095.html 0.6 2026-01-15T10:56:28+08:00 daily https://www.pharmasources.com/industryinsights/mogrify-enters-research-collaboration-wi-325096.html 0.6 2026-06-21T03:55:50+08:00 daily https://www.pharmasources.com/industryinsights/abzena-unveils-new-biologics-gmp-manufac-325097.html 0.6 2026-08-06T15:03:38+08:00 daily https://www.pharmasources.com/industryinsights/hdfc-founder-aditya-puri-joins-strides-g-325098.html 0.6 2026-08-09T04:32:30+08:00 daily https://www.pharmasources.com/industryinsights/british-columbia-rejects-health-canada-a-325099.html 0.6 2026-08-07T13:17:25+08:00 daily https://www.pharmasources.com/industryinsights/algeria-registers-russian-sputnik-v-vacc-325100.html 0.6 2026-08-08T14:47:44+08:00 daily https://www.pharmasources.com/industryinsights/university-of-calgary-joins-trial-of-lsa-325101.html 0.6 2026-08-08T20:02:59+08:00 daily https://www.pharmasources.com/industryinsights/ampio-provides-update-on-clinical-trials-325102.html 0.6 2026-08-09T20:48:06+08:00 daily https://www.pharmasources.com/industryinsights/fda-issues-alert-regarding-sars-cov-2-vi-325103.html 0.6 2026-07-05T03:24:13+08:00 daily https://www.pharmasources.com/industryinsights/spinogenix-announces-grant-by-dod-to-adv-325104.html 0.6 2026-06-22T04:07:48+08:00 daily https://www.pharmasources.com/industryinsights/bioniz-announces-positive-fda-meeting-fo-325105.html 0.6 2026-08-07T13:58:12+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-announces-partnersh-325106.html 0.6 2026-06-21T21:16:51+08:00 daily https://www.pharmasources.com/industryinsights/eu-ok-for-roches-oral-flu-treatment-xofl-325107.html 0.6 2026-06-20T15:41:33+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-to-acquire-kymab-for-up-to-145bn-325108.html 0.6 2026-06-20T15:00:19+08:00 daily https://www.pharmasources.com/industryinsights/england-to-launch-rapid-asymptomatic-cov-325109.html 0.6 2026-06-20T14:52:03+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-phase-iii-trial-of-syntheti-325110.html 0.6 2026-08-03T21:34:30+08:00 daily https://www.pharmasources.com/industryinsights/risankizumab-trials-show-higher-clinical-325111.html 0.6 2026-06-21T11:45:07+08:00 daily https://www.pharmasources.com/industryinsights/innovent-announces-nmpa-acceptance-of-a--325112.html 0.6 2026-06-22T12:51:14+08:00 daily https://www.pharmasources.com/industryinsights/gannex-announces-positive-phase-i-clinic-325113.html 0.6 2026-08-10T15:44:00+08:00 daily https://www.pharmasources.com/industryinsights/celularity-and-gx-acquisition-announce-m-325114.html 0.6 2026-07-26T07:46:54+08:00 daily https://www.pharmasources.com/industryinsights/affinivax-secures-226m-in-series-c-finan-325115.html 0.6 2026-06-20T20:02:43+08:00 daily https://www.pharmasources.com/industryinsights/does-your-powder-cake-or-crust-freeman-t-325116.html 0.6 2026-06-21T15:09:38+08:00 daily https://www.pharmasources.com/industryinsights/capricor-lonza-enter-cap-1002-developmen-325117.html 0.6 2026-06-21T08:18:13+08:00 daily https://www.pharmasources.com/industryinsights/varcode-pl-developments-form-strategic-s-325118.html 0.6 2026-06-22T08:17:00+08:00 daily https://www.pharmasources.com/industryinsights/iosbio-inks-exclusive-vax-platform-pact--325119.html 0.6 2026-06-20T21:09:09+08:00 daily https://www.pharmasources.com/industryinsights/adagene-achieves-car-t-collaboration-mil-325120.html 0.6 2026-06-22T11:52:57+08:00 daily https://www.pharmasources.com/industryinsights/hovione-launches-asd-hipros-325121.html 0.6 2026-04-16T05:32:51+08:00 daily https://www.pharmasources.com/industryinsights/parexel-completes-strategic-separation-325122.html 0.6 2026-06-20T17:53:43+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-appoints-president-of-afme-region-325123.html 0.6 2026-06-20T15:14:23+08:00 daily https://www.pharmasources.com/industryinsights/cohbar-niaid-to-assess-cb5064-analogs-fo-325124.html 0.6 2026-06-21T02:16:19+08:00 daily https://www.pharmasources.com/industryinsights/recipients-cannot-choose-between-two-cov-325125.html 0.6 2026-03-27T20:55:11+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-announces-sputnik-v-meets-prim-325126.html 0.6 2026-08-05T22:27:20+08:00 daily https://www.pharmasources.com/industryinsights/precigen-announces-ind-to-begin-study-of-325127.html 0.6 2026-06-26T18:16:58+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-advaite-emergency-use-authori-325128.html 0.6 2026-06-21T13:30:02+08:00 daily https://www.pharmasources.com/industryinsights/radius-health-announces-commercial-agree-325129.html 0.6 2026-06-22T06:56:47+08:00 daily https://www.pharmasources.com/industryinsights/inhibrx-announces-phase-1-dose-escalatio-325130.html 0.6 2026-06-21T12:58:36+08:00 daily https://www.pharmasources.com/industryinsights/precision-dose-recalls-paroex-chlorhexid-325131.html 0.6 2026-06-21T19:05:44+08:00 daily https://www.pharmasources.com/industryinsights/lasa-gets-who-gmp-certificate-for-khed-u-325132.html 0.6 2026-08-06T19:08:19+08:00 daily https://www.pharmasources.com/industryinsights/bharat-biotech-signs-deal-with-precisa-m-325133.html 0.6 2026-06-22T02:40:29+08:00 daily https://www.pharmasources.com/industryinsights/nppa-updates-provisional-list-of-pharma--325134.html 0.6 2026-06-21T04:13:52+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-enara-bio-sign-pact-325135.html 0.6 2026-07-30T12:51:45+08:00 daily https://www.pharmasources.com/industryinsights/biogen-and-apple-partner-on-cognitive-he-325136.html 0.6 2026-03-08T07:05:09+08:00 daily https://www.pharmasources.com/industryinsights/icr-researchers-identify-potential-new-t-325137.html 0.6 2026-07-05T07:23:33+08:00 daily https://www.pharmasources.com/industryinsights/dhsc-publishes-uk-rare-disease-framework-325138.html 0.6 2026-06-21T05:08:46+08:00 daily https://www.pharmasources.com/industryinsights/orthos-vitros-sars-cov-2-antigen-test-fo-325139.html 0.6 2026-06-20T23:17:04+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-advaite-emergency-use-authori-325140.html 0.6 2026-06-21T15:49:13+08:00 daily https://www.pharmasources.com/industryinsights/valeo-pharma-highlights-mdbriefcase-news-325141.html 0.6 2026-08-09T23:54:28+08:00 daily https://www.pharmasources.com/industryinsights/ema-receives-authorisation-application-f-325142.html 0.6 2026-08-12T12:39:13+08:00 daily https://www.pharmasources.com/industryinsights/teva-medincell-announce-positive-results-325143.html 0.6 2026-08-07T04:16:24+08:00 daily https://www.pharmasources.com/industryinsights/inversago-pharma-receives-rare-paediatri-325144.html 0.6 2026-08-07T04:29:01+08:00 daily https://www.pharmasources.com/industryinsights/xencor-md-anderson-enter-collaboration-t-325145.html 0.6 2026-08-07T04:36:39+08:00 daily https://www.pharmasources.com/industryinsights/holmusk-national-healthcare-group-and-in-325146.html 0.6 2026-08-07T05:05:27+08:00 daily https://www.pharmasources.com/industryinsights/ces-2021-taiwan-chinaese-biotech-startup-325147.html 0.6 2026-06-29T08:53:18+08:00 daily https://www.pharmasources.com/industryinsights/new-findings-help-explain-how-covid-19-o-325148.html 0.6 2026-06-20T19:52:31+08:00 daily https://www.pharmasources.com/industryinsights/granules-india-gets-usfda-approval-of-me-325149.html 0.6 2026-07-14T08:43:53+08:00 daily https://www.pharmasources.com/industryinsights/vikas-multicorp-forays-into-pharma-healt-325150.html 0.6 2026-08-07T05:28:00+08:00 daily https://www.pharmasources.com/industryinsights/bharat-biotech-ships-out-covaxin-to-11-c-325151.html 0.6 2026-08-07T01:07:00+08:00 daily https://www.pharmasources.com/industryinsights/four-more-covid-19-vaccines-in-pipeline--325152.html 0.6 2026-08-07T00:59:05+08:00 daily https://www.pharmasources.com/industryinsights/centaur-pharma-to-start-post-marketing-s-325153.html 0.6 2026-08-07T00:53:50+08:00 daily https://www.pharmasources.com/industryinsights/evoq-therapeutics-and-amgen-partner-325154.html 0.6 2026-08-07T00:45:39+08:00 daily https://www.pharmasources.com/industryinsights/almac-sciences-secures-support-from-inve-325155.html 0.6 2026-08-07T00:43:41+08:00 daily https://www.pharmasources.com/industryinsights/catalent-acquires-acordas-inbrija-manufa-325156.html 0.6 2026-08-07T13:18:30+08:00 daily https://www.pharmasources.com/industryinsights/healthcare-sector-could-take-more-than-t-325157.html 0.6 2026-08-07T13:57:23+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-priority-review-of-mercks-pn-325158.html 0.6 2026-08-09T02:38:55+08:00 daily https://www.pharmasources.com/industryinsights/switzerland-authorises-modernas-covid-19-325159.html 0.6 2026-08-09T06:51:38+08:00 daily https://www.pharmasources.com/industryinsights/radius-health-announces-acquisition-of-o-325160.html 0.6 2026-06-20T23:54:00+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharmas-rhb-204-granted-fda-f-325161.html 0.6 2026-08-05T22:11:12+08:00 daily https://www.pharmasources.com/industryinsights/farxiga-granted-priority-review-in-us-fo-325162.html 0.6 2026-07-24T12:33:59+08:00 daily https://www.pharmasources.com/industryinsights/bluerock-sloan-kettering-receive-ind-cle-325163.html 0.6 2026-08-06T11:54:18+08:00 daily https://www.pharmasources.com/industryinsights/adamas-completes-acquisition-of-osmolex--325164.html 0.6 2026-06-21T12:01:13+08:00 daily https://www.pharmasources.com/industryinsights/roches-tecentriqavastin-combo-improves-s-325165.html 0.6 2026-04-14T04:13:51+08:00 daily https://www.pharmasources.com/industryinsights/diurnal-seeks-marketing-authorisation-fo-325166.html 0.6 2026-06-21T11:04:10+08:00 daily https://www.pharmasources.com/industryinsights/eli-lilly-announces-mid-stage-trial-succ-325167.html 0.6 2026-06-21T08:00:08+08:00 daily https://www.pharmasources.com/industryinsights/synairgen-begins-large-scale-trial-of-in-325168.html 0.6 2026-06-21T18:59:44+08:00 daily https://www.pharmasources.com/industryinsights/european-commission-approves-dispersible-325169.html 0.6 2026-08-06T22:49:46+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-dosed-with-covi-vac-an-int-325170.html 0.6 2026-02-25T21:33:41+08:00 daily https://www.pharmasources.com/industryinsights/cytiva-delivers-modular-biologics-factor-325171.html 0.6 2026-06-20T14:24:46+08:00 daily https://www.pharmasources.com/industryinsights/modern-chinese-medicine-group-co-ltd-ann-325172.html 0.6 2026-07-08T17:35:39+08:00 daily https://www.pharmasources.com/industryinsights/caliber-ophthalmics-opens-new-state-of-t-325173.html 0.6 2026-08-09T04:18:25+08:00 daily https://www.pharmasources.com/industryinsights/china-nmpa-grants-approval-for-the-regis-325174.html 0.6 2026-08-09T01:20:37+08:00 daily https://www.pharmasources.com/industryinsights/gsk-vir-biotechnology-to-evaluate-neutra-325175.html 0.6 2026-08-08T23:10:07+08:00 daily https://www.pharmasources.com/industryinsights/rocket-pharmaceuticals-announces-buildou-325176.html 0.6 2026-08-08T21:34:22+08:00 daily https://www.pharmasources.com/industryinsights/beigene-announces-collaboration-with-nov-325177.html 0.6 2026-08-13T07:56:13+08:00 daily https://www.pharmasources.com/industryinsights/gsk-mmv-filing-for-kozenis-in-paediatric-325178.html 0.6 2026-08-14T10:43:25+08:00 daily https://www.pharmasources.com/industryinsights/valneva-in-advanced-discussions-with-eur-325179.html 0.6 2026-06-20T22:58:42+08:00 daily https://www.pharmasources.com/industryinsights/pregnant-lactating-women-should-not-be-g-325180.html 0.6 2026-07-06T02:12:45+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-gets-usfda-nod-for-xalkori-crizot-325181.html 0.6 2026-06-20T13:18:24+08:00 daily https://www.pharmasources.com/industryinsights/halt-bharat-biotechs-covaxin-trial-in-bh-325182.html 0.6 2026-06-21T16:44:38+08:00 daily https://www.pharmasources.com/industryinsights/jan-aushadi-kendras-record-sales-of-rs-4-325183.html 0.6 2026-06-21T03:59:53+08:00 daily https://www.pharmasources.com/industryinsights/teknova-appoints-neal-goodwin-as-cso-325184.html 0.6 2026-07-04T22:09:43+08:00 daily https://www.pharmasources.com/industryinsights/sii-expects-who-emergency-nod-for-astraz-325185.html 0.6 2026-06-22T09:08:51+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-israels-biond-biologics-to-team-u-325186.html 0.6 2026-08-10T13:55:14+08:00 daily https://www.pharmasources.com/industryinsights/osteoporosis-drug-may-halve-repeat-hip-r-325187.html 0.6 2026-07-01T06:00:24+08:00 daily https://www.pharmasources.com/industryinsights/microsoft-cigna-oracle-partner-for-digit-325188.html 0.6 2026-06-22T22:49:45+08:00 daily https://www.pharmasources.com/industryinsights/strides-gets-usfda-approval-for-emtricit-325189.html 0.6 2026-08-09T07:59:46+08:00 daily https://www.pharmasources.com/industryinsights/precision-medicine-group-acquires-projec-325190.html 0.6 2026-08-07T02:15:44+08:00 daily https://www.pharmasources.com/industryinsights/charles-river-partners-with-jade-325191.html 0.6 2026-08-07T02:09:45+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-cabim-get-76m-funding-for-mfg-a-325192.html 0.6 2026-08-07T02:05:06+08:00 daily https://www.pharmasources.com/industryinsights/fresenius-kabi-recalls-ketorolac-trometh-325193.html 0.6 2026-08-07T01:58:36+08:00 daily https://www.pharmasources.com/industryinsights/amydis-announces-successful-completion-o-325194.html 0.6 2026-08-07T02:05:01+08:00 daily https://www.pharmasources.com/industryinsights/abbott-receives-fda-510k-clearance-for-r-325195.html 0.6 2026-08-07T13:16:13+08:00 daily https://www.pharmasources.com/industryinsights/dalcor-announces-launch-of-dalcetrapib-c-325196.html 0.6 2026-08-08T21:48:26+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-orgovyx-for-advanced-prosta-325197.html 0.6 2026-08-09T07:15:50+08:00 daily https://www.pharmasources.com/industryinsights/neurorx-relief-and-quantum-leap-announce-325198.html 0.6 2026-06-21T10:36:49+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-dosed-in-biomarker-guided--325199.html 0.6 2026-06-20T23:00:39+08:00 daily https://www.pharmasources.com/industryinsights/fdas-office-of-generic-drugs-receives-ap-325200.html 0.6 2026-08-05T23:31:45+08:00 daily https://www.pharmasources.com/industryinsights/ideaya-biosciences-submits-ind-applicati-325201.html 0.6 2026-06-22T01:06:53+08:00 daily https://www.pharmasources.com/industryinsights/nhs-england-selects-supermarket-asda-to--325202.html 0.6 2026-07-01T18:12:39+08:00 daily https://www.pharmasources.com/industryinsights/valneva-partners-with-oxford-immunotec-o-325203.html 0.6 2026-06-20T23:58:32+08:00 daily https://www.pharmasources.com/industryinsights/gilead-and-vir-unite-to-find-a-functiona-325204.html 0.6 2026-06-21T06:57:55+08:00 daily https://www.pharmasources.com/industryinsights/uk-could-become-the-worlds-foremost-nati-325205.html 0.6 2026-07-18T10:01:10+08:00 daily https://www.pharmasources.com/industryinsights/biopharma-industry-commits-to-working-wi-325206.html 0.6 2026-06-20T21:00:38+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-antibody-therapy-shows-promise--325207.html 0.6 2026-07-10T01:23:33+08:00 daily https://www.pharmasources.com/industryinsights/antibiotics-market-set-to-generate-reven-325208.html 0.6 2026-07-05T00:05:46+08:00 daily https://www.pharmasources.com/industryinsights/united-immunity-and-xyphos-an-astellas-c-325209.html 0.6 2026-07-03T18:20:27+08:00 daily https://www.pharmasources.com/industryinsights/hyde-engineering-consulting-announces-ap-325210.html 0.6 2026-06-22T15:03:00+08:00 daily https://www.pharmasources.com/industryinsights/nonin-medical-announces-new-full-board-o-325211.html 0.6 2026-06-21T11:18:43+08:00 daily https://www.pharmasources.com/industryinsights/amneal-to-acquire-substantially-all-of-k-325212.html 0.6 2026-06-21T06:02:45+08:00 daily https://www.pharmasources.com/industryinsights/rheincell-therapeutics-achieves-gmp-cert-325213.html 0.6 2026-06-21T06:18:23+08:00 daily https://www.pharmasources.com/industryinsights/using-powder-testing-to-optimise-the-pro-325214.html 0.6 2026-08-13T09:43:50+08:00 daily https://www.pharmasources.com/industryinsights/gamma-biosciences-to-acquire-biomagnetic-325215.html 0.6 2026-06-28T18:06:20+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccine-trials-data-should-be-m-325216.html 0.6 2026-08-07T01:53:33+08:00 daily https://www.pharmasources.com/industryinsights/bayer-examining-if-it-can-help-curevac-w-325217.html 0.6 2026-06-21T00:57:46+08:00 daily https://www.pharmasources.com/industryinsights/alternative-method-to-accelerate-drug-de-325218.html 0.6 2026-07-15T22:14:46+08:00 daily https://www.pharmasources.com/industryinsights/scientists-get-clue-to-origin-of-fluctua-325219.html 0.6 2026-06-21T08:02:03+08:00 daily https://www.pharmasources.com/industryinsights/anvisa-sends-back-request-for-eua-of-spu-325220.html 0.6 2026-06-26T09:16:59+08:00 daily https://www.pharmasources.com/industryinsights/industry-stakeholders-raise-concerns-abo-325221.html 0.6 2026-08-11T08:55:20+08:00 daily https://www.pharmasources.com/industryinsights/india-inoculates-over-191-lakh-people-on-325222.html 0.6 2026-08-14T10:35:14+08:00 daily https://www.pharmasources.com/industryinsights/india-begins-roll-out-of-largest-covid-1-325223.html 0.6 2026-08-09T02:38:48+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccines-expected-to-go-out-to--325224.html 0.6 2026-08-07T15:08:09+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-gets-dcgi-nod-for-phase-3-clin-325225.html 0.6 2026-08-07T23:22:22+08:00 daily https://www.pharmasources.com/industryinsights/jubilant-therapeutics-the-wistar-institu-325226.html 0.6 2026-08-07T13:16:04+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-scientific-acquires-henoge-325227.html 0.6 2026-08-08T00:43:29+08:00 daily https://www.pharmasources.com/industryinsights/teva-launches-generic-vaginal-ring-in-us-325228.html 0.6 2026-08-07T02:40:28+08:00 daily https://www.pharmasources.com/industryinsights/covishield-to-dominate-overall-covid-19--325229.html 0.6 2026-08-07T02:49:11+08:00 daily https://www.pharmasources.com/industryinsights/newamsterdam-pharma-raises-196m-through--325230.html 0.6 2026-08-07T02:59:35+08:00 daily https://www.pharmasources.com/industryinsights/verona-completes-enrolment-in-pilot-stud-325231.html 0.6 2026-08-11T11:48:56+08:00 daily https://www.pharmasources.com/industryinsights/us-breakthrough-designation-for-ligelizu-325232.html 0.6 2026-08-13T00:19:56+08:00 daily https://www.pharmasources.com/industryinsights/nice-backs-gsks-zejula-in-advanced-ovari-325233.html 0.6 2026-08-07T03:33:35+08:00 daily https://www.pharmasources.com/industryinsights/cabozantinib-reduces-tumour-burden-in-ph-325234.html 0.6 2026-08-07T03:55:14+08:00 daily https://www.pharmasources.com/industryinsights/frontage-bolsters-clinical-services-capa-325235.html 0.6 2026-08-07T05:27:56+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-unveils-euroapi-as-name-of-new-eu-325236.html 0.6 2026-06-22T07:25:29+08:00 daily https://www.pharmasources.com/industryinsights/ksq-partners-with-takeda-to-develop-immu-325237.html 0.6 2026-07-03T16:35:47+08:00 daily https://www.pharmasources.com/industryinsights/bayer-announces-fda-accepts-nda-and-gran-325238.html 0.6 2026-06-20T20:05:40+08:00 daily https://www.pharmasources.com/industryinsights/starmed-specialist-centre-partners-prude-325239.html 0.6 2026-06-26T19:29:23+08:00 daily https://www.pharmasources.com/industryinsights/ces-2021-medfluid-develops-first-in-clas-325240.html 0.6 2026-07-18T06:12:40+08:00 daily https://www.pharmasources.com/industryinsights/senhwa-biosciences-presents-positive-cho-325241.html 0.6 2026-06-21T07:00:08+08:00 daily https://www.pharmasources.com/industryinsights/crystal-denlinger-named-chief-scientific-325242.html 0.6 2026-07-04T05:46:04+08:00 daily https://www.pharmasources.com/industryinsights/bayer-transforms-pharma-business-through-325243.html 0.6 2026-06-21T01:06:47+08:00 daily https://www.pharmasources.com/industryinsights/new-england-journal-of-medicine-publishe-325244.html 0.6 2026-06-23T08:38:37+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-325245.html 0.6 2026-06-20T14:46:02+08:00 daily https://www.pharmasources.com/industryinsights/nirsevimab-gets-promising-innovative-med-325246.html 0.6 2026-06-22T03:57:38+08:00 daily https://www.pharmasources.com/industryinsights/indian-firms-interesting-in-procuring-va-325247.html 0.6 2026-08-10T15:10:05+08:00 daily https://www.pharmasources.com/industryinsights/immuneel-sets-up-cell-therapy-developmen-325248.html 0.6 2026-08-08T20:03:16+08:00 daily https://www.pharmasources.com/industryinsights/unfair-distribution-of-covid-19-vaccines-325249.html 0.6 2026-08-08T14:03:21+08:00 daily https://www.pharmasources.com/industryinsights/south-africa-to-get-nine-million-doses-o-325250.html 0.6 2026-08-07T13:17:11+08:00 daily https://www.pharmasources.com/industryinsights/caplin-steriles-jamp-pharma-group-sign-a-325251.html 0.6 2026-08-07T12:12:57+08:00 daily https://www.pharmasources.com/industryinsights/bharat-biotech-factsheet-advises-people--325252.html 0.6 2026-08-07T04:21:59+08:00 daily https://www.pharmasources.com/industryinsights/valeo-pharma-appoints-president-coo-325253.html 0.6 2026-08-07T04:03:58+08:00 daily https://www.pharmasources.com/industryinsights/metrion-lifearc-extend-neuroscience-alli-325254.html 0.6 2026-08-07T03:25:11+08:00 daily https://www.pharmasources.com/industryinsights/grifols-begins-covid-19-plasma-treatment-325255.html 0.6 2026-08-07T03:06:32+08:00 daily https://www.pharmasources.com/industryinsights/janssen-tennor-enter-ntm-research-pact-325256.html 0.6 2026-08-07T02:45:43+08:00 daily https://www.pharmasources.com/industryinsights/cognate-bioservices-announces-major-expa-325257.html 0.6 2026-08-07T02:51:47+08:00 daily https://www.pharmasources.com/industryinsights/bioclinica-partners-with-ikcon-pharma-325258.html 0.6 2026-08-07T03:02:38+08:00 daily https://www.pharmasources.com/industryinsights/pakistan-grants-eua-to-sinopharms-covid--325259.html 0.6 2026-08-07T03:24:46+08:00 daily https://www.pharmasources.com/industryinsights/norway-raises-concern-about-pfizer-covid-325260.html 0.6 2026-08-07T03:31:12+08:00 daily https://www.pharmasources.com/industryinsights/viiv-healthcare-continues-hiv-care-partn-325261.html 0.6 2026-08-07T03:54:57+08:00 daily https://www.pharmasources.com/industryinsights/uk-biotech-ixaka-scores-additional-fundi-325262.html 0.6 2026-08-07T13:16:06+08:00 daily https://www.pharmasources.com/industryinsights/az-daiichi-sankyos-enhertu-wins-us-appro-325263.html 0.6 2026-08-07T15:01:40+08:00 daily https://www.pharmasources.com/industryinsights/trial-to-evaluate-inhaled-covid-19-thera-325264.html 0.6 2026-06-20T19:58:31+08:00 daily https://www.pharmasources.com/industryinsights/us-could-purchase-over-15-million-doses--325265.html 0.6 2026-06-21T07:09:06+08:00 daily https://www.pharmasources.com/industryinsights/pharma-industry-employs-5600-people-in-s-325266.html 0.6 2026-06-20T20:55:43+08:00 daily https://www.pharmasources.com/industryinsights/indevr-launches-vaxarray-measles-and-rub-325267.html 0.6 2026-06-21T06:22:25+08:00 daily https://www.pharmasources.com/industryinsights/neurophth-and-aavnergene-enter-strategic-325268.html 0.6 2026-06-21T11:11:18+08:00 daily https://www.pharmasources.com/industryinsights/innovent-announces-an-out-license-agreem-325269.html 0.6 2026-08-11T05:59:42+08:00 daily https://www.pharmasources.com/industryinsights/oncologist-herbert-loong-joins-george-cl-325270.html 0.6 2026-08-12T16:39:23+08:00 daily https://www.pharmasources.com/industryinsights/cure-genetics-collaborates-with-boehring-325271.html 0.6 2026-03-17T19:10:18+08:00 daily https://www.pharmasources.com/industryinsights/hanmi-pharmaceutical-expects-us-fda-appr-325272.html 0.6 2026-07-28T08:15:23+08:00 daily https://www.pharmasources.com/industryinsights/regent-pacific-group-limited-announces-t-325273.html 0.6 2026-06-21T07:12:04+08:00 daily https://www.pharmasources.com/industryinsights/metformin-use-reduces-risk-of-death-for--325274.html 0.6 2026-06-23T06:06:03+08:00 daily https://www.pharmasources.com/industryinsights/ineos-oxford-university-to-set-up-instit-325275.html 0.6 2026-06-22T01:00:48+08:00 daily https://www.pharmasources.com/industryinsights/serum-institute-issues-factsheet-for-cov-325276.html 0.6 2026-08-03T04:23:22+08:00 daily https://www.pharmasources.com/industryinsights/south-african-variant-of-sars-cov-2-shou-325277.html 0.6 2026-06-21T01:17:59+08:00 daily https://www.pharmasources.com/industryinsights/bharat-biotech-gets-letter-of-comfort-fo-325278.html 0.6 2026-06-21T19:46:38+08:00 daily https://www.pharmasources.com/industryinsights/sahil-munjal-appointed-as-chairman-of-ph-325279.html 0.6 2026-04-06T08:44:22+08:00 daily https://www.pharmasources.com/industryinsights/bone-therapeutics-rigenerand-ink-cell-th-325280.html 0.6 2026-06-21T05:15:57+08:00 daily https://www.pharmasources.com/industryinsights/novaquest-private-equity-acquires-corerx-325281.html 0.6 2026-06-20T20:08:41+08:00 daily https://www.pharmasources.com/industryinsights/js-bio-and-etta-biotech-advancing-partne-325282.html 0.6 2026-07-23T13:18:37+08:00 daily https://www.pharmasources.com/industryinsights/intravacc-completes-project-for-proventi-325283.html 0.6 2026-03-07T10:04:55+08:00 daily https://www.pharmasources.com/industryinsights/lonza-to-exit-pharma-softgels-and-liquid-325284.html 0.6 2026-06-21T23:58:44+08:00 daily https://www.pharmasources.com/industryinsights/syntegra-collaborates-with-us-nih-to-inc-325285.html 0.6 2026-08-07T04:18:03+08:00 daily https://www.pharmasources.com/industryinsights/aruvant-partners-with-lonza-to-manufactu-325286.html 0.6 2026-06-21T05:08:49+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-receives-approval-to-conduct-p-325287.html 0.6 2026-06-21T10:48:13+08:00 daily https://www.pharmasources.com/industryinsights/imfinzi-approved-in-the-eu-for-less-freq-325288.html 0.6 2026-08-07T05:05:17+08:00 daily https://www.pharmasources.com/industryinsights/immunitybio-simulations-give-clue-to-why-325289.html 0.6 2026-08-06T22:53:39+08:00 daily https://www.pharmasources.com/industryinsights/travere-announces-orphan-drug-designatio-325290.html 0.6 2026-08-07T13:18:36+08:00 daily https://www.pharmasources.com/industryinsights/creative-medical-technology-announces-po-325291.html 0.6 2026-08-09T07:56:22+08:00 daily https://www.pharmasources.com/industryinsights/lower-profile-web-intrasaccular-aneurysm-325292.html 0.6 2026-06-20T20:10:41+08:00 daily https://www.pharmasources.com/industryinsights/biohaven-provides-update-on-phase-23-tri-325293.html 0.6 2026-06-24T16:52:44+08:00 daily https://www.pharmasources.com/industryinsights/nostrum-laboratories-expands-recall-of-m-325294.html 0.6 2026-06-20T22:06:38+08:00 daily https://www.pharmasources.com/industryinsights/harpoon-therapeutics-granted-orphan-drug-325296.html 0.6 2026-07-06T19:23:44+08:00 daily https://www.pharmasources.com/industryinsights/with-zero-five-year-recurrences-the-emer-325297.html 0.6 2026-06-22T12:51:25+08:00 daily https://www.pharmasources.com/industryinsights/arup-sequencing-specimens-able-to-detect-325298.html 0.6 2026-06-20T16:07:38+08:00 daily https://www.pharmasources.com/industryinsights/clearside-biomedical-begins-enrollment-f-325299.html 0.6 2026-07-09T14:58:46+08:00 daily https://www.pharmasources.com/industryinsights/how-to-evaluate-the-safety-of-covid-19-v-325300.html 0.6 2026-06-22T08:53:43+08:00 daily https://www.pharmasources.com/industryinsights/biomericas-15-minute-covid-19-antigen-ra-325301.html 0.6 2026-07-05T12:00:01+08:00 daily https://www.pharmasources.com/industryinsights/novartis-expands-oncology-pipeline-with--325302.html 0.6 2026-08-10T13:09:02+08:00 daily https://www.pharmasources.com/industryinsights/gritstone-advances-second-generation-cov-325303.html 0.6 2026-06-26T12:33:04+08:00 daily https://www.pharmasources.com/industryinsights/fda-releases-update-on-otc-monograph-dru-325304.html 0.6 2026-06-25T06:44:12+08:00 daily https://www.pharmasources.com/industryinsights/the-tumor-disappears-after-infection-wit-325305.html 0.6 2026-02-09T09:50:06+08:00 daily https://www.pharmasources.com/industryinsights/invixa-announces-licensing-deal-with-uni-325306.html 0.6 2026-06-20T15:54:19+08:00 daily https://www.pharmasources.com/industryinsights/everyware-and-hedera-hashgraph-enabling--325307.html 0.6 2026-07-25T07:05:01+08:00 daily https://www.pharmasources.com/industryinsights/smc-kicks-of-the-new-year-by-accepting-f-325308.html 0.6 2026-08-13T11:15:15+08:00 daily https://www.pharmasources.com/industryinsights/tecartus-wins-nice-recommendation-for-ma-325309.html 0.6 2026-07-15T16:10:40+08:00 daily https://www.pharmasources.com/industryinsights/scotlands-pharma-sector-sees-increase-in-325310.html 0.6 2026-08-09T18:43:28+08:00 daily https://www.pharmasources.com/industryinsights/dhsc-says-over-four-million-people-have--325311.html 0.6 2026-08-09T08:02:17+08:00 daily https://www.pharmasources.com/industryinsights/new-system-could-deliver-schizophrenia-m-325312.html 0.6 2026-06-09T06:11:12+08:00 daily https://www.pharmasources.com/industryinsights/japan-has-pre-ordered-covid-19-vaccine-d-325313.html 0.6 2026-08-14T11:05:57+08:00 daily https://www.pharmasources.com/industryinsights/optimising-a-panel-for-microbiologic-dia-325314.html 0.6 2026-06-21T00:50:41+08:00 daily https://www.pharmasources.com/industryinsights/jemincare-initiates-phase-i-clinical-tri-325315.html 0.6 2026-08-07T03:13:04+08:00 daily https://www.pharmasources.com/industryinsights/genesis-medtech-collaborates-with-penumb-325316.html 0.6 2026-08-09T16:10:22+08:00 daily https://www.pharmasources.com/industryinsights/sirtex-medical-announces-collaboration-u-325317.html 0.6 2026-08-14T14:31:13+08:00 daily https://www.pharmasources.com/industryinsights/cphi-p-mec-china-gives-a-glimpse-of-the--325318.html 0.6 2026-06-21T17:09:32+08:00 daily https://www.pharmasources.com/industryinsights/remote-patient-monitoring-to-be-most-imp-325319.html 0.6 2026-08-12T10:05:27+08:00 daily https://www.pharmasources.com/industryinsights/ahf-calls-on-govts-public-health-leaders-325320.html 0.6 2026-06-21T00:17:53+08:00 daily https://www.pharmasources.com/industryinsights/bhutan-and-maldives-get-covid-19-vaccine-325321.html 0.6 2026-06-23T15:06:35+08:00 daily https://www.pharmasources.com/industryinsights/cdscos-expert-panel-recommends-approval--325322.html 0.6 2026-07-07T19:55:19+08:00 daily https://www.pharmasources.com/industryinsights/global-biosciences-co-selects-valgenesis-325323.html 0.6 2026-07-05T00:12:34+08:00 daily https://www.pharmasources.com/industryinsights/eisai-appoints-chief-clinical-officer-of-325324.html 0.6 2026-06-30T03:58:09+08:00 daily https://www.pharmasources.com/industryinsights/nexelis-acquires-gsk-vax-lab-in-marburg-325325.html 0.6 2026-06-21T05:59:48+08:00 daily https://www.pharmasources.com/industryinsights/lilly-and-merus-partner-to-develop-t-cel-325326.html 0.6 2026-08-05T18:15:26+08:00 daily https://www.pharmasources.com/industryinsights/orion-biotechnology-project-awarded-gran-325327.html 0.6 2026-06-21T07:16:18+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-fast-track-designation-to-pad-325328.html 0.6 2026-06-21T05:47:57+08:00 daily https://www.pharmasources.com/industryinsights/orchard-therapeutics-announces-otl-200-g-325329.html 0.6 2026-08-06T10:09:04+08:00 daily https://www.pharmasources.com/industryinsights/evoq-announces-license-collaboration-agr-325330.html 0.6 2026-06-22T12:09:03+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-scientific-extends-sars-co-325331.html 0.6 2026-03-25T21:02:48+08:00 daily https://www.pharmasources.com/industryinsights/therapeutic-solutions-announces-positive-325332.html 0.6 2026-04-02T03:02:24+08:00 daily https://www.pharmasources.com/industryinsights/coverified-announces-partnership-with-mi-325333.html 0.6 2026-06-21T00:16:54+08:00 daily https://www.pharmasources.com/industryinsights/takedas-entyvio-sc-and-celltrions-remsim-325334.html 0.6 2026-06-20T23:01:45+08:00 daily https://www.pharmasources.com/industryinsights/amryts-myalepta-scores-nice-backing-for--325335.html 0.6 2026-08-09T06:59:52+08:00 daily https://www.pharmasources.com/industryinsights/conserv-bioscience-to-develop-broad-spec-325336.html 0.6 2026-08-07T13:17:12+08:00 daily https://www.pharmasources.com/industryinsights/enhertu-bags-eu-approval-for-her2-positi-325337.html 0.6 2026-08-07T13:15:33+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnsons-covid-19-vaccine-safely-325338.html 0.6 2026-08-14T02:31:46+08:00 daily https://www.pharmasources.com/industryinsights/blood-test-can-identify-covid-19-patient-325339.html 0.6 2026-08-08T13:11:41+08:00 daily https://www.pharmasources.com/industryinsights/uk-vaccine-supply-chain-workers-to-be-of-325340.html 0.6 2026-08-08T14:39:18+08:00 daily https://www.pharmasources.com/industryinsights/israel-set-to-be-first-country-to-vaccin-325341.html 0.6 2026-08-09T07:56:29+08:00 daily https://www.pharmasources.com/industryinsights/lumiradx-receives-sars-cov-2-antigen-tes-325342.html 0.6 2026-07-26T23:18:21+08:00 daily https://www.pharmasources.com/industryinsights/northway-biotech-opens-new-biopharmaceut-325343.html 0.6 2026-06-21T03:43:32+08:00 daily https://www.pharmasources.com/industryinsights/merck-announces-update-on-the-intrpid-cl-325344.html 0.6 2026-07-02T13:19:22+08:00 daily https://www.pharmasources.com/industryinsights/cytosorbents-announces-approval-of-cytos-325345.html 0.6 2026-08-07T05:46:28+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-has-multiple-faces-325346.html 0.6 2026-08-07T05:40:30+08:00 daily https://www.pharmasources.com/industryinsights/nepal-bangladesh-get-covid-19-vaccine-co-325347.html 0.6 2026-08-07T05:39:39+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-viiv-healthcares-cabenuv-325348.html 0.6 2026-08-07T05:52:41+08:00 daily https://www.pharmasources.com/industryinsights/biocon-biologics-inducts-professor-peter-325349.html 0.6 2026-08-07T12:02:59+08:00 daily https://www.pharmasources.com/industryinsights/five-perish-in-fire-at-sii-pune-facility-325350.html 0.6 2026-08-07T12:25:46+08:00 daily https://www.pharmasources.com/industryinsights/michael-page-india-report-signals-stable-325351.html 0.6 2026-08-07T13:17:19+08:00 daily https://www.pharmasources.com/industryinsights/uae-approves-sputnik-v-covid-19-vaccine--325352.html 0.6 2026-08-08T08:02:35+08:00 daily https://www.pharmasources.com/industryinsights/akron-biotech-octapharma-enter-human-ab--325353.html 0.6 2026-08-08T10:05:38+08:00 daily https://www.pharmasources.com/industryinsights/adamis-submits-ind-application-to-fda-fo-325354.html 0.6 2026-07-04T06:59:31+08:00 daily https://www.pharmasources.com/industryinsights/cross-eu-drug-supply-chain-to-be-most-af-325355.html 0.6 2026-08-08T17:53:36+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-biontech-study-shows-covid-19-vac-325356.html 0.6 2026-06-18T00:03:09+08:00 daily https://www.pharmasources.com/industryinsights/bamlanivimab-reduced-risk-of-covid-19-at-325357.html 0.6 2026-06-21T10:51:25+08:00 daily https://www.pharmasources.com/industryinsights/chiesi-usa-announces-key-promotions-to-b-325358.html 0.6 2026-06-23T06:22:47+08:00 daily https://www.pharmasources.com/industryinsights/sml-genetree-receives-eua-for-ezplex-sar-325359.html 0.6 2026-06-20T21:04:45+08:00 daily https://www.pharmasources.com/industryinsights/therapeutic-solutions-reports-successful-325360.html 0.6 2026-06-12T10:48:37+08:00 daily https://www.pharmasources.com/industryinsights/piramal-inks-clinical-supply-deal-with-t-325361.html 0.6 2026-06-21T18:23:14+08:00 daily https://www.pharmasources.com/industryinsights/recipharm-signs-manufacturing-deal-with--325362.html 0.6 2026-06-21T00:54:02+08:00 daily https://www.pharmasources.com/industryinsights/cdmo-northway-biotech-expands-in-us-325363.html 0.6 2026-07-04T18:08:23+08:00 daily https://www.pharmasources.com/industryinsights/novartis-gsk-team-up-for-36m-genetic-div-325364.html 0.6 2026-08-07T12:20:44+08:00 daily https://www.pharmasources.com/industryinsights/us-approval-for-msds-heart-failure-med-v-325365.html 0.6 2026-06-20T19:51:42+08:00 daily https://www.pharmasources.com/industryinsights/rcp-survey-finds-over-1-in-4-doctors-sou-325366.html 0.6 2026-06-21T06:17:03+08:00 daily https://www.pharmasources.com/industryinsights/nice-publishes-final-guidance-backing-jy-325367.html 0.6 2026-08-02T16:11:19+08:00 daily https://www.pharmasources.com/industryinsights/sanofis-rsv-treatment-nirsevimab-awarded-325368.html 0.6 2026-08-06T19:56:06+08:00 daily https://www.pharmasources.com/industryinsights/emed-announces-partnership-with-the-stat-325369.html 0.6 2026-06-21T23:11:53+08:00 daily https://www.pharmasources.com/industryinsights/aviva-pharmacy-provides-initial-doses-of-325370.html 0.6 2026-06-21T09:57:17+08:00 daily https://www.pharmasources.com/industryinsights/nanoforms-clinical-study-indicates-posit-325371.html 0.6 2026-08-08T03:36:43+08:00 daily https://www.pharmasources.com/industryinsights/elekta-divests-its-stake-in-viewray-325372.html 0.6 2026-07-21T11:31:02+08:00 daily https://www.pharmasources.com/industryinsights/senhwa-announces-the-first-patient-enrol-325373.html 0.6 2026-08-13T14:21:44+08:00 daily https://www.pharmasources.com/industryinsights/clinical-microbiology-to-play-key-role-i-325374.html 0.6 2026-06-28T19:12:08+08:00 daily https://www.pharmasources.com/industryinsights/phase-ii-trial-to-establish-whether-alis-325375.html 0.6 2026-08-07T21:30:08+08:00 daily https://www.pharmasources.com/industryinsights/computational-approach-shows-antibiotic--325376.html 0.6 2026-07-17T18:54:39+08:00 daily https://www.pharmasources.com/industryinsights/obesity-impaired-metabolic-health-and-co-325377.html 0.6 2026-08-06T23:45:41+08:00 daily https://www.pharmasources.com/industryinsights/zydus-desidustat-efficacious-in-treating-325378.html 0.6 2026-08-06T23:38:08+08:00 daily https://www.pharmasources.com/industryinsights/italy-to-take-legal-action-against-pfize-325379.html 0.6 2026-08-06T23:35:52+08:00 daily https://www.pharmasources.com/industryinsights/aurobindo-kapl-kinvan-get-approval-under-325380.html 0.6 2026-08-12T11:00:10+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-us-fda-nod-for-liothyr-325381.html 0.6 2026-08-07T14:21:24+08:00 daily https://www.pharmasources.com/industryinsights/fiocruz-institute-brazil-commences-distr-325382.html 0.6 2026-08-09T20:04:14+08:00 daily https://www.pharmasources.com/industryinsights/ai-to-be-most-disruptive-technology-acro-325383.html 0.6 2026-08-07T21:49:06+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-biontech-announce-agreement-with--325384.html 0.6 2026-08-14T16:05:16+08:00 daily https://www.pharmasources.com/industryinsights/natural-remedies-immunofree-and-reginmun-325385.html 0.6 2026-08-07T05:45:34+08:00 daily https://www.pharmasources.com/industryinsights/alembic-pharma-gets-final-nod-from-usfda-325386.html 0.6 2026-08-07T05:52:09+08:00 daily https://www.pharmasources.com/industryinsights/hamdard-laboratories-launches-twelve-new-325387.html 0.6 2026-08-07T05:58:03+08:00 daily https://www.pharmasources.com/industryinsights/turn-therapeutics-gets-authorisation-for-325388.html 0.6 2026-08-10T12:05:19+08:00 daily https://www.pharmasources.com/industryinsights/fda-publishes-new-guidance-on-protecting-325389.html 0.6 2026-08-07T13:19:18+08:00 daily https://www.pharmasources.com/industryinsights/conserv-bioscience-llnl-to-collaborate-o-325390.html 0.6 2026-08-09T01:26:14+08:00 daily https://www.pharmasources.com/industryinsights/biopharma-companies-announce-formation-o-325391.html 0.6 2026-08-07T02:51:59+08:00 daily https://www.pharmasources.com/industryinsights/jubilant-wistar-institute-to-evaluate-no-325392.html 0.6 2026-08-07T02:40:19+08:00 daily https://www.pharmasources.com/industryinsights/impel-neuropharma-announces-nda-acceptan-325393.html 0.6 2026-08-07T02:31:10+08:00 daily https://www.pharmasources.com/industryinsights/servier-and-mina-therapeutics-ink-neurol-325394.html 0.6 2026-08-07T01:19:45+08:00 daily https://www.pharmasources.com/industryinsights/us-green-light-for-long-acting-hiv-regim-325395.html 0.6 2026-08-07T01:43:03+08:00 daily https://www.pharmasources.com/industryinsights/gileads-veklury-should-be-effective-agai-325396.html 0.6 2026-08-07T01:46:12+08:00 daily https://www.pharmasources.com/industryinsights/nice-no-for-bms-multiple-sclerosis-drug--325397.html 0.6 2026-08-03T07:30:47+08:00 daily https://www.pharmasources.com/industryinsights/european-commission-approves-bavencio-av-325398.html 0.6 2026-06-29T01:48:16+08:00 daily https://www.pharmasources.com/industryinsights/antengene-announces-approval-of-ind-appl-325399.html 0.6 2026-06-22T04:33:19+08:00 daily https://www.pharmasources.com/industryinsights/histoindex-explores-the-clinical-utility-325400.html 0.6 2026-06-20T14:02:16+08:00 daily https://www.pharmasources.com/industryinsights/covax-announces-new-agreement-plans-for--325401.html 0.6 2026-06-22T04:56:37+08:00 daily https://www.pharmasources.com/industryinsights/gavi-to-make-500000-doses-of-ebola-vacci-325402.html 0.6 2026-08-07T03:03:01+08:00 daily https://www.pharmasources.com/industryinsights/agc-biologics-appoints-boulder-site-gm-325403.html 0.6 2026-08-06T23:56:45+08:00 daily https://www.pharmasources.com/industryinsights/lilly-completes-1b-acquisition-of-prevai-325404.html 0.6 2026-08-06T23:47:52+08:00 daily https://www.pharmasources.com/industryinsights/continuus-awarded-693m-dod-grant-325405.html 0.6 2026-07-03T19:49:35+08:00 daily https://www.pharmasources.com/industryinsights/a-review-of-chinese-produced-class-1-new-325406.html 0.6 2026-07-29T07:08:15+08:00 daily https://www.pharmasources.com/industryinsights/nmn-a-star-drug-on-the-way-toward-a-mira-325407.html 0.6 2026-08-07T11:27:30+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-325408.html 0.6 2026-08-06T20:47:58+08:00 daily https://www.pharmasources.com/industryinsights/moderna-believes-its-vaccine-will-protec-325409.html 0.6 2026-06-21T02:52:51+08:00 daily https://www.pharmasources.com/industryinsights/how-is-a-vaccine-engineered-325410.html 0.6 2026-08-06T23:33:52+08:00 daily https://www.pharmasources.com/industryinsights/tata-in-discussion-with-moderna-to-bring-325411.html 0.6 2026-08-06T23:37:37+08:00 daily https://www.pharmasources.com/industryinsights/takeda-named-under-top-employers-in-2021-325412.html 0.6 2026-08-06T23:46:20+08:00 daily https://www.pharmasources.com/industryinsights/strides-get-usfda-nod-for-ursodiol-capsu-325413.html 0.6 2026-08-07T13:17:43+08:00 daily https://www.pharmasources.com/industryinsights/lupin-gets-usfda-approval-for-sevelamer--325414.html 0.6 2026-08-08T22:35:32+08:00 daily https://www.pharmasources.com/industryinsights/australia-approves-pfizer-biontechs-covi-325415.html 0.6 2026-08-09T00:31:38+08:00 daily https://www.pharmasources.com/industryinsights/telemedicine-to-benefit-the-most-from-re-325416.html 0.6 2026-08-09T02:18:48+08:00 daily https://www.pharmasources.com/industryinsights/elasmogen-identifies-potential-vaccine-c-325417.html 0.6 2026-08-09T03:34:15+08:00 daily https://www.pharmasources.com/industryinsights/civica-to-build-an-essential-medicines-m-325418.html 0.6 2026-06-21T02:59:14+08:00 daily https://www.pharmasources.com/industryinsights/humanigen-emergent-enter-covid-19-partne-325419.html 0.6 2026-06-21T17:12:59+08:00 daily https://www.pharmasources.com/industryinsights/samsung-bioepis-opens-new-headquarters-325420.html 0.6 2026-06-26T19:58:36+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-licenses-probiogens-glymaxx-techn-325421.html 0.6 2026-07-01T20:54:50+08:00 daily https://www.pharmasources.com/industryinsights/senhwa-announces-first-patient-enrolled--325422.html 0.6 2026-07-12T07:29:54+08:00 daily https://www.pharmasources.com/industryinsights/antios-completes-phase-1b-clinical-trial-325423.html 0.6 2026-07-13T12:02:51+08:00 daily https://www.pharmasources.com/industryinsights/merck-discontinues-development-of-sars-c-325424.html 0.6 2026-07-22T11:02:20+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-nerivio-for-acute-treatment-325425.html 0.6 2026-06-23T04:05:07+08:00 daily https://www.pharmasources.com/industryinsights/tevogen-bio-secures-funding-from-team-of-325426.html 0.6 2026-06-21T18:20:07+08:00 daily https://www.pharmasources.com/industryinsights/biontech-and-fosun-pharma-receive-author-325427.html 0.6 2026-08-11T14:39:49+08:00 daily https://www.pharmasources.com/industryinsights/vivera-pharmaceuticals-and-burkhan-group-325428.html 0.6 2026-06-21T07:12:07+08:00 daily https://www.pharmasources.com/industryinsights/calquence-tops-imbruvica-in-chronic-lymp-325429.html 0.6 2026-06-23T12:05:42+08:00 daily https://www.pharmasources.com/industryinsights/nhs-covid-19-vaccination-drive-bolstered-325430.html 0.6 2026-08-07T17:59:14+08:00 daily https://www.pharmasources.com/industryinsights/psychiatry-consortium-funds-project-inve-325431.html 0.6 2026-08-08T23:38:22+08:00 daily https://www.pharmasources.com/industryinsights/pharma-sources-insight-january-2021-roll-325432.html 0.6 2026-08-10T05:17:22+08:00 daily https://www.pharmasources.com/industryinsights/increased-heparin-dose-reduces-need-for--325433.html 0.6 2026-06-21T04:58:50+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-new-car-t-cell-therapy-t-325434.html 0.6 2026-08-01T11:50:13+08:00 daily https://www.pharmasources.com/industryinsights/xpro1595-significantly-improves-neurodeg-325435.html 0.6 2026-06-22T12:51:50+08:00 daily https://www.pharmasources.com/industryinsights/voclosporin-approved-by-fda-to-treat-lup-325436.html 0.6 2026-06-21T11:20:26+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-reports-66-increase-in-325437.html 0.6 2026-08-02T16:35:26+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-and-morphosys-announce-first-patie-325438.html 0.6 2026-08-15T01:25:27+08:00 daily https://www.pharmasources.com/industryinsights/biovaxys-announces-initiation-of-cancer--325439.html 0.6 2026-06-21T08:19:12+08:00 daily https://www.pharmasources.com/industryinsights/volitionrx-limited-opens-its-new-manufac-325440.html 0.6 2026-06-21T02:13:49+08:00 daily https://www.pharmasources.com/industryinsights/fda-orange-book-101-325441.html 0.6 2026-06-30T12:45:37+08:00 daily https://www.pharmasources.com/industryinsights/how-to-subscribe-and-keep-pharma-sources-325442.html 0.6 2026-08-08T14:23:01+08:00 daily https://www.pharmasources.com/industryinsights/sheffield-university-gets-16-mn-grant-fr-325443.html 0.6 2026-08-12T20:07:39+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-to-produce-100-million-pfizerbion-325444.html 0.6 2026-06-22T09:40:37+08:00 daily https://www.pharmasources.com/industryinsights/hikma-intends-to-acquire-assets-in-egypt-325445.html 0.6 2026-08-09T06:44:46+08:00 daily https://www.pharmasources.com/industryinsights/misinformation-future-of-work-among-key--325446.html 0.6 2026-08-15T01:43:48+08:00 daily https://www.pharmasources.com/industryinsights/pharma-companies-move-towards-systematic-325447.html 0.6 2026-08-05T22:57:40+08:00 daily https://www.pharmasources.com/industryinsights/supplied-covid-19-vaccines-to-nine-count-325448.html 0.6 2026-08-07T22:39:48+08:00 daily https://www.pharmasources.com/industryinsights/ayush-ministry-issues-advisory-prohibiti-325449.html 0.6 2026-08-05T14:27:56+08:00 daily https://www.pharmasources.com/industryinsights/syntekabio-hanmi-to-co-develop-covid-19--325450.html 0.6 2026-02-26T11:09:30+08:00 daily https://www.pharmasources.com/industryinsights/tessa-receives-prime-designation-from-em-325451.html 0.6 2026-06-22T10:08:56+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-accelerated-approval-to-darza-325452.html 0.6 2026-06-20T23:01:44+08:00 daily https://www.pharmasources.com/industryinsights/elasmogen-announces-panel-of-anti-covid--325453.html 0.6 2026-06-22T01:28:09+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-dosed-in-stp705-study-cuta-325454.html 0.6 2026-06-21T09:12:13+08:00 daily https://www.pharmasources.com/industryinsights/oramed-doses-patients-across-multiple-si-325455.html 0.6 2026-06-21T10:54:15+08:00 daily https://www.pharmasources.com/industryinsights/adare-pharma-solutions-opens-new-small-s-325456.html 0.6 2026-06-21T15:12:11+08:00 daily https://www.pharmasources.com/industryinsights/x-chem-acquires-intellisyn-and-avisyn-325457.html 0.6 2026-06-21T02:54:35+08:00 daily https://www.pharmasources.com/industryinsights/aphenas-21m-cookeville-expansion-nears-c-325458.html 0.6 2026-07-10T15:44:59+08:00 daily https://www.pharmasources.com/industryinsights/biomed-x-janssen-enter-oral-drug-deliver-325459.html 0.6 2026-06-28T12:40:33+08:00 daily https://www.pharmasources.com/industryinsights/care-access-research-astrazeneca-partner-325460.html 0.6 2026-08-12T17:30:15+08:00 daily https://www.pharmasources.com/industryinsights/500-sites-join-inatos-industry-marketpla-325461.html 0.6 2026-06-20T16:55:09+08:00 daily https://www.pharmasources.com/industryinsights/caprion-histogenex-rebrands-as-cellcarta-325462.html 0.6 2026-07-01T23:23:05+08:00 daily https://www.pharmasources.com/industryinsights/promocell-receives-excipact-certificatio-325463.html 0.6 2026-06-20T21:46:32+08:00 daily https://www.pharmasources.com/industryinsights/research-finds-decrease-in-radiotherapy--325464.html 0.6 2026-06-20T16:17:38+08:00 daily https://www.pharmasources.com/industryinsights/keytruda-scores-new-eu-approval-in-color-325465.html 0.6 2026-08-07T23:25:45+08:00 daily https://www.pharmasources.com/industryinsights/wren-therapeutics-raises-124m-in-latest--325466.html 0.6 2026-06-21T09:58:08+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-revlimid-for-newly-diagn-325467.html 0.6 2026-06-21T15:57:15+08:00 daily https://www.pharmasources.com/industryinsights/roches-faricimab-hits-primary-endpoint-i-325468.html 0.6 2026-06-20T19:13:47+08:00 daily https://www.pharmasources.com/industryinsights/abbvies-rinvoq-bags-two-new-eu-approvals-325469.html 0.6 2026-06-21T02:00:38+08:00 daily https://www.pharmasources.com/industryinsights/south-korean-medical-ai-provider-and-pac-325470.html 0.6 2026-06-21T21:54:38+08:00 daily https://www.pharmasources.com/industryinsights/speedy-detection-of-13-cancer-types-usin-325471.html 0.6 2026-06-21T06:08:12+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-national-oncoventure-a-325472.html 0.6 2026-03-28T18:16:44+08:00 daily https://www.pharmasources.com/industryinsights/biocytogen-subsidiary-eucure-biopharma-r-325473.html 0.6 2026-08-11T12:59:49+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-pharma-gets-usfda-approval-for--325474.html 0.6 2026-08-13T10:06:55+08:00 daily https://www.pharmasources.com/industryinsights/more-covid-19-vaccines-will-be-introduce-325475.html 0.6 2026-06-21T09:10:12+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccinations-in-india-china-to--325476.html 0.6 2026-08-11T08:06:36+08:00 daily https://www.pharmasources.com/industryinsights/finished-formulations-from-dr-reddys-wor-325477.html 0.6 2026-06-22T11:41:35+08:00 daily https://www.pharmasources.com/industryinsights/gsk-path-bharat-biotech-sign-product-tra-325478.html 0.6 2026-06-22T06:05:42+08:00 daily https://www.pharmasources.com/industryinsights/unichem-gets-usfda-approval-for-zonisami-325479.html 0.6 2026-06-21T08:04:00+08:00 daily https://www.pharmasources.com/industryinsights/nordic-capital-makes-a-bid-to-purchase-a-325480.html 0.6 2026-08-10T17:21:42+08:00 daily https://www.pharmasources.com/industryinsights/lilly-vir-and-gsk-collaborate-for-trial--325481.html 0.6 2026-08-07T00:39:51+08:00 daily https://www.pharmasources.com/industryinsights/iran-approves-russias-sputnik-v-vaccine--325482.html 0.6 2026-08-07T00:02:54+08:00 daily https://www.pharmasources.com/industryinsights/mundipharma-and-cidaras-rezafungin-gets--325483.html 0.6 2026-08-06T23:54:53+08:00 daily https://www.pharmasources.com/industryinsights/humanetics-receives-us-dod-funding-for-c-325484.html 0.6 2026-08-07T00:03:55+08:00 daily https://www.pharmasources.com/industryinsights/novartis-invests-in-credence-medsystems-325485.html 0.6 2026-08-07T00:41:08+08:00 daily https://www.pharmasources.com/industryinsights/ajinomoto-bio-pharma-humanigen-expand-ma-325486.html 0.6 2026-08-07T01:06:39+08:00 daily https://www.pharmasources.com/industryinsights/almac-expands-global-biologics-testing-s-325487.html 0.6 2026-08-07T22:17:42+08:00 daily https://www.pharmasources.com/industryinsights/ulcerative-colitis-gsk2831781-study-disc-325488.html 0.6 2026-08-09T06:59:40+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-nivolumab-plus-cabozantinib-325489.html 0.6 2026-08-07T02:43:52+08:00 daily https://www.pharmasources.com/industryinsights/oncosec-announces-first-subjects-dosed-i-325490.html 0.6 2026-06-21T01:00:44+08:00 daily https://www.pharmasources.com/industryinsights/harbour-biomeds-batoclimab-hbm9161-recei-325491.html 0.6 2026-07-23T01:59:26+08:00 daily https://www.pharmasources.com/industryinsights/ortho-clinical-diagnostics-announces-pri-325492.html 0.6 2026-08-07T14:15:39+08:00 daily https://www.pharmasources.com/industryinsights/womens-reproductive-healthcare-in-asia-g-325493.html 0.6 2026-08-07T13:57:36+08:00 daily https://www.pharmasources.com/industryinsights/cstone-pharmaceuticals-reports-efficacy--325494.html 0.6 2026-08-08T07:57:49+08:00 daily https://www.pharmasources.com/industryinsights/antengene-announces-the-acceptance-of-at-325495.html 0.6 2026-08-08T09:00:18+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-and-gra-announce-clinically-me-325496.html 0.6 2026-08-09T06:59:05+08:00 daily https://www.pharmasources.com/industryinsights/transnetyx-one-codex-build-strategic-par-325497.html 0.6 2026-06-26T13:43:20+08:00 daily https://www.pharmasources.com/industryinsights/novel-molecules-to-combat-asthma-and-cov-325498.html 0.6 2026-07-02T12:21:21+08:00 daily https://www.pharmasources.com/industryinsights/regen-cov-prevents-symptomatic-covid-19--325499.html 0.6 2026-08-11T07:04:02+08:00 daily https://www.pharmasources.com/industryinsights/igv-001-demonstrates-success-against-gli-325500.html 0.6 2026-06-23T08:00:54+08:00 daily https://www.pharmasources.com/industryinsights/desidustat-prevents-development-of-ards--325501.html 0.6 2026-06-20T23:58:32+08:00 daily https://www.pharmasources.com/industryinsights/dcgi-calls-for-suggestions-from-industry-325502.html 0.6 2026-06-20T15:00:08+08:00 daily https://www.pharmasources.com/industryinsights/novavax-covid-19-vaccine-89-per-cent-eff-325503.html 0.6 2026-06-20T17:56:24+08:00 daily https://www.pharmasources.com/industryinsights/ben-gurion-university-discover-new-drug--325504.html 0.6 2026-06-20T18:11:31+08:00 daily https://www.pharmasources.com/industryinsights/novartis-in-discussions-to-help-produce--325505.html 0.6 2026-06-20T18:50:23+08:00 daily https://www.pharmasources.com/industryinsights/biomedical-molecular-data-firm-elucidata-325506.html 0.6 2026-06-23T05:15:08+08:00 daily https://www.pharmasources.com/industryinsights/sequent-scientific-gets-cep-for-its-gene-325507.html 0.6 2026-03-24T05:54:55+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-grants-orphan-drug-designation-to-325508.html 0.6 2026-06-20T19:19:05+08:00 daily https://www.pharmasources.com/industryinsights/evozyne-takeda-ink-strategic-protein-des-325509.html 0.6 2026-06-21T00:00:35+08:00 daily https://www.pharmasources.com/industryinsights/lonza-launches-cryopreserved-leukopaks-325510.html 0.6 2026-08-08T02:33:55+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-secures-china-approval-for-t-325511.html 0.6 2026-08-06T13:40:17+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-dosed-in-dur-928-study-for-325512.html 0.6 2026-07-10T23:39:51+08:00 daily https://www.pharmasources.com/industryinsights/desidustat-shows-efficacy-safety-treatin-325513.html 0.6 2026-06-20T23:06:44+08:00 daily https://www.pharmasources.com/industryinsights/first-participant-dosed-in-covid-19-vacc-325514.html 0.6 2026-06-22T11:11:10+08:00 daily https://www.pharmasources.com/industryinsights/iterum-therapeutics-announces-nda-for-or-325515.html 0.6 2026-06-21T16:15:34+08:00 daily https://www.pharmasources.com/industryinsights/valneva-begins-covid-vax-production-to-o-325516.html 0.6 2026-02-15T00:48:55+08:00 daily https://www.pharmasources.com/industryinsights/gravity-diagnostics-coordination-with-ke-325517.html 0.6 2026-08-07T14:06:12+08:00 daily https://www.pharmasources.com/industryinsights/ema-begins-review-of-gbts-sickle-cell-tr-325518.html 0.6 2026-06-20T23:50:05+08:00 daily https://www.pharmasources.com/industryinsights/azdaiichi-sankyos-antibody-drug-conjugat-325519.html 0.6 2026-07-31T22:40:53+08:00 daily https://www.pharmasources.com/industryinsights/researchers-identify-existing-drugs-pote-325520.html 0.6 2026-06-20T19:22:30+08:00 daily https://www.pharmasources.com/industryinsights/lillys-antibodies-bamlanivimab-and-etese-325521.html 0.6 2026-08-10T21:41:02+08:00 daily https://www.pharmasources.com/industryinsights/uk-will-offer-its-genomic-expertise-worl-325522.html 0.6 2026-06-21T08:02:00+08:00 daily https://www.pharmasources.com/industryinsights/study-finds-some-antibody-therapies-are--325523.html 0.6 2026-06-22T11:46:33+08:00 daily https://www.pharmasources.com/industryinsights/12-month-below-the-knee-data-with-medall-325524.html 0.6 2026-06-22T11:08:54+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharma-further-expands-opagan-325525.html 0.6 2026-06-26T03:50:16+08:00 daily https://www.pharmasources.com/industryinsights/immunoforges-pf1801-is-designated-as-orp-325526.html 0.6 2026-08-08T08:59:03+08:00 daily https://www.pharmasources.com/industryinsights/clinical-trial-of-proxalutamides-trial-o-325527.html 0.6 2026-08-08T07:59:38+08:00 daily https://www.pharmasources.com/industryinsights/vaccine-delivered-via-skin-scarification-325528.html 0.6 2026-08-07T13:16:14+08:00 daily https://www.pharmasources.com/industryinsights/exothera-expands-range-of-state-of-the-a-325529.html 0.6 2026-08-08T07:54:46+08:00 daily https://www.pharmasources.com/industryinsights/takeda-concludes-sale-of-select-otc-and--325530.html 0.6 2026-08-08T12:18:33+08:00 daily https://www.pharmasources.com/industryinsights/parliamentary-panel-recommends-categoris-325531.html 0.6 2026-08-10T07:06:30+08:00 daily https://www.pharmasources.com/industryinsights/local-court-rejects-cutis-biotechs-trade-325532.html 0.6 2026-07-21T10:57:39+08:00 daily https://www.pharmasources.com/industryinsights/mexico-to-buy-astrazeneca-vaccine-from-i-325533.html 0.6 2026-06-21T12:15:36+08:00 daily https://www.pharmasources.com/industryinsights/over-35-lakh-people-have-received-covid--325534.html 0.6 2026-08-12T01:47:44+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-oxford-covid-19-vaccine-appr-325535.html 0.6 2026-01-31T10:35:42+08:00 daily https://www.pharmasources.com/industryinsights/jjs-covid-19-vaccine-best-used-to-curb-o-325536.html 0.6 2026-08-03T04:26:01+08:00 daily https://www.pharmasources.com/industryinsights/moef-amendment-brings-apis-and-intermedi-325537.html 0.6 2026-06-20T17:15:40+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccines-supply-may-meet-even-e-325538.html 0.6 2026-08-07T05:17:17+08:00 daily https://www.pharmasources.com/industryinsights/mallinckrodt-receives-approval-in-japan--325539.html 0.6 2026-06-22T00:51:03+08:00 daily https://www.pharmasources.com/industryinsights/serum-institute-of-india-seeks-permissio-325540.html 0.6 2026-08-09T04:32:33+08:00 daily https://www.pharmasources.com/industryinsights/mrna-covid-19-vaccine-approvals-likely-t-325541.html 0.6 2026-08-07T13:16:51+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-covid-19-vaccine-gets-eua-i-325542.html 0.6 2026-08-07T02:15:50+08:00 daily https://www.pharmasources.com/industryinsights/cognate-bioservices-nucleus-biologics-fo-325543.html 0.6 2026-08-07T02:05:04+08:00 daily https://www.pharmasources.com/industryinsights/novartis-inks-contract-manufacturing-dea-325544.html 0.6 2026-08-07T01:53:10+08:00 daily https://www.pharmasources.com/industryinsights/sai-life-sciences-expands-capabilities-325545.html 0.6 2026-08-07T01:42:48+08:00 daily https://www.pharmasources.com/industryinsights/meitheal-recalls-cisatracurium-besylate--325546.html 0.6 2026-08-07T01:19:25+08:00 daily https://www.pharmasources.com/industryinsights/omixon-seqonce-announce-extension-to-azu-325547.html 0.6 2026-08-07T01:11:10+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-covid-19-vaccine-recommended-325548.html 0.6 2026-08-07T00:57:30+08:00 daily https://www.pharmasources.com/industryinsights/rigel-awarded-165-million-from-us-depart-325549.html 0.6 2026-06-21T04:12:06+08:00 daily https://www.pharmasources.com/industryinsights/new-study-by-dr-steven-quay-concludes-th-325550.html 0.6 2026-08-07T13:16:05+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-announces-single-shot-ja-325551.html 0.6 2026-08-15T00:31:06+08:00 daily https://www.pharmasources.com/industryinsights/millions-could-benefit-from-genetic-scre-325552.html 0.6 2026-08-09T00:31:23+08:00 daily https://www.pharmasources.com/industryinsights/nhs-has-offered-covid-19-vaccine-to-all--325553.html 0.6 2026-08-09T02:52:35+08:00 daily https://www.pharmasources.com/industryinsights/kesimpta-and-vazkepa-among-latest-chmp-r-325554.html 0.6 2026-08-09T04:34:42+08:00 daily https://www.pharmasources.com/industryinsights/ai-to-be-most-transformative-technology--325555.html 0.6 2026-06-29T16:43:50+08:00 daily https://www.pharmasources.com/industryinsights/cepi-offers-140-million-to-support-resea-325556.html 0.6 2026-07-05T12:28:32+08:00 daily https://www.pharmasources.com/industryinsights/sotorasib-shows-success-against-non-smal-325557.html 0.6 2026-06-30T17:08:06+08:00 daily https://www.pharmasources.com/industryinsights/clover-biopharmaceuticals-announces-publ-325558.html 0.6 2026-06-25T12:58:35+08:00 daily https://www.pharmasources.com/industryinsights/seegene-develops-world-first-covid-19-va-325559.html 0.6 2026-06-21T14:21:42+08:00 daily https://www.pharmasources.com/industryinsights/antengene-announces-collaboration-with-w-325560.html 0.6 2026-08-09T05:50:26+08:00 daily https://www.pharmasources.com/industryinsights/cytiva-acquires-vanrx-pharmasystems-cana-325561.html 0.6 2026-08-08T03:09:00+08:00 daily https://www.pharmasources.com/industryinsights/getting-clinical-trials-back-on-track-325562.html 0.6 2026-06-24T11:50:26+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-325563.html 0.6 2026-08-07T13:16:36+08:00 daily https://www.pharmasources.com/industryinsights/pakistan-receives-first-batch-of-covid-v-325564.html 0.6 2026-08-09T07:56:35+08:00 daily https://www.pharmasources.com/industryinsights/sii-bharat-biotech-welcome-enhanced-focu-325565.html 0.6 2026-07-13T13:22:37+08:00 daily https://www.pharmasources.com/industryinsights/who-led-covid-19-probe-team-in-china-vis-325566.html 0.6 2026-02-09T11:02:46+08:00 daily https://www.pharmasources.com/industryinsights/pharma-sector-reacts-to-union-budget-202-325567.html 0.6 2026-06-20T23:01:42+08:00 daily https://www.pharmasources.com/industryinsights/south-africas-first-covid-19-vaccine-dos-325568.html 0.6 2026-06-21T04:13:15+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-to-supply-9-million-more-vac-325569.html 0.6 2026-07-07T01:36:06+08:00 daily https://www.pharmasources.com/industryinsights/o9-solutions-to-supply-ai-powered-ibp-pl-325570.html 0.6 2026-08-06T03:06:31+08:00 daily https://www.pharmasources.com/industryinsights/granules-india-gets-us-fda-nod-for-potas-325571.html 0.6 2026-08-10T16:34:43+08:00 daily https://www.pharmasources.com/industryinsights/16-chinese-covid-19-vaccines-undergoing--325572.html 0.6 2026-06-22T05:57:40+08:00 daily https://www.pharmasources.com/industryinsights/uk-secures-40-million-doses-of-valneva-c-325573.html 0.6 2026-08-02T02:48:19+08:00 daily https://www.pharmasources.com/industryinsights/lilly-acquires-asahi-kaseis-chronic-pain-325574.html 0.6 2026-08-11T09:22:30+08:00 daily https://www.pharmasources.com/industryinsights/gilead-gritstone-enter-vax-platform-pact-325575.html 0.6 2026-08-10T10:11:35+08:00 daily https://www.pharmasources.com/industryinsights/curevac-rentschler-ramp-up-covid-vax-pro-325576.html 0.6 2026-06-21T06:14:04+08:00 daily https://www.pharmasources.com/industryinsights/recipharm-medspray-launch-resyca-jv-325577.html 0.6 2026-07-07T11:51:43+08:00 daily https://www.pharmasources.com/industryinsights/serum-institute-of-india-plans-clinical--325578.html 0.6 2026-08-08T01:28:11+08:00 daily https://www.pharmasources.com/industryinsights/ge-researchers-begin-in-depth-study-to-u-325579.html 0.6 2026-06-28T14:18:05+08:00 daily https://www.pharmasources.com/industryinsights/ampio-announces-early-positive-data-in-i-325580.html 0.6 2026-06-23T11:19:36+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-morphosys-announce-first-patient-d-325581.html 0.6 2026-06-22T11:55:59+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-to-divest-viela-shareholding-325582.html 0.6 2026-06-22T03:04:11+08:00 daily https://www.pharmasources.com/industryinsights/chiesi-group-receives-ema-for-triple-com-325583.html 0.6 2026-06-21T10:56:08+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisks-sogroya-moves-closer-towar-325584.html 0.6 2026-06-23T10:10:45+08:00 daily https://www.pharmasources.com/industryinsights/eu-approves-chiesis-triple-combination-a-325585.html 0.6 2026-06-21T09:56:01+08:00 daily https://www.pharmasources.com/industryinsights/bayers-xarelto-approved-in-the-uk-325586.html 0.6 2026-08-05T10:26:48+08:00 daily https://www.pharmasources.com/industryinsights/ema-committee-recommends-13-medicines-fo-325587.html 0.6 2026-08-06T07:35:52+08:00 daily https://www.pharmasources.com/industryinsights/kintors-gt20029-ind-for-protac-ar-degrad-325588.html 0.6 2026-08-11T04:58:19+08:00 daily https://www.pharmasources.com/industryinsights/fullerton-health-australia-acquires-wa-b-325589.html 0.6 2026-04-21T05:50:19+08:00 daily https://www.pharmasources.com/industryinsights/dw-healthcare-partners-invests-in-parnel-325590.html 0.6 2026-06-21T14:32:23+08:00 daily https://www.pharmasources.com/industryinsights/ilias-biologics-announces-the-2nd-poc-st-325591.html 0.6 2026-06-20T17:17:33+08:00 daily https://www.pharmasources.com/industryinsights/bayer-to-manufacture-mrna-vaccine-in-ger-325592.html 0.6 2026-06-21T09:06:11+08:00 daily https://www.pharmasources.com/industryinsights/early-functional-sars-cov-2-specific-t-c-325593.html 0.6 2026-06-21T05:53:49+08:00 daily https://www.pharmasources.com/industryinsights/lupin-appoints-mark-d-mcdade-as-new-inde-325594.html 0.6 2026-06-22T06:08:44+08:00 daily https://www.pharmasources.com/industryinsights/neuland-laboratories-q3fy21-consolidated-325595.html 0.6 2026-06-21T09:14:20+08:00 daily https://www.pharmasources.com/industryinsights/free-covid-19-vaccine-for-healthcare-wor-325596.html 0.6 2026-07-06T21:10:52+08:00 daily https://www.pharmasources.com/industryinsights/uk-marks-first-covid-vaccine-milestone-w-325597.html 0.6 2026-08-08T20:12:21+08:00 daily https://www.pharmasources.com/industryinsights/lilly-us-health-systems-partner-to-set-u-325598.html 0.6 2026-07-29T09:11:56+08:00 daily https://www.pharmasources.com/industryinsights/india-allocates-48bn-for-covid-19-vaccin-325599.html 0.6 2026-06-21T17:08:30+08:00 daily https://www.pharmasources.com/industryinsights/cdmo-wuxi-sta-expands-footprint-in-europ-325600.html 0.6 2026-06-29T17:36:25+08:00 daily https://www.pharmasources.com/industryinsights/metrics-contract-services-appoints-vp-of-325601.html 0.6 2026-06-22T03:38:25+08:00 daily https://www.pharmasources.com/industryinsights/redhill-and-cosmo-expand-opaganib-manufa-325602.html 0.6 2026-06-20T23:53:35+08:00 daily https://www.pharmasources.com/industryinsights/frontida-expands-testing-capabilities-325603.html 0.6 2026-07-01T13:34:27+08:00 daily https://www.pharmasources.com/industryinsights/just-evotec-expand-mabs-manufacturing-co-325604.html 0.6 2026-08-14T06:11:31+08:00 daily https://www.pharmasources.com/industryinsights/ajanta-pharma-posts-jump-in-consolidated-325605.html 0.6 2026-07-03T18:03:24+08:00 daily https://www.pharmasources.com/industryinsights/eyepoint-announces-first-patient-dosed-i-325606.html 0.6 2026-06-30T09:22:12+08:00 daily https://www.pharmasources.com/industryinsights/nostrum-expands-recall-metformin-hcl-ext-325607.html 0.6 2026-06-27T12:18:36+08:00 daily https://www.pharmasources.com/industryinsights/vbl-therapeutics-treats-first-patient-in-325608.html 0.6 2026-06-30T08:04:17+08:00 daily https://www.pharmasources.com/industryinsights/agenus-enters-into-clinical-collaboratio-325609.html 0.6 2026-06-22T13:04:21+08:00 daily https://www.pharmasources.com/industryinsights/q-biomeds-uttroside-b-receives-orphan-dr-325610.html 0.6 2026-08-03T04:18:10+08:00 daily https://www.pharmasources.com/industryinsights/visby-medical-speeds-development-of-a-ra-325611.html 0.6 2026-08-03T10:52:31+08:00 daily https://www.pharmasources.com/industryinsights/efficacy-of-sputnik-v-against-covid-19-w-325612.html 0.6 2026-08-06T17:44:56+08:00 daily https://www.pharmasources.com/industryinsights/in-vitro-studies-demonstrate-pfizer-and--325613.html 0.6 2026-06-27T11:20:45+08:00 daily https://www.pharmasources.com/industryinsights/innovent-and-lilly-jointly-announce-the--325614.html 0.6 2026-08-03T20:01:44+08:00 daily https://www.pharmasources.com/industryinsights/ping-an-healthcare-and-technology-compan-325615.html 0.6 2026-08-03T03:46:59+08:00 daily https://www.pharmasources.com/industryinsights/dyadic-and-turtletree-scientific-enter-s-325616.html 0.6 2026-06-27T12:29:33+08:00 daily https://www.pharmasources.com/industryinsights/kira-pharmaceuticals-announces-first-par-325617.html 0.6 2026-06-21T10:58:04+08:00 daily https://www.pharmasources.com/industryinsights/supply-order-for-covishield-vaccine-was--325618.html 0.6 2026-06-25T14:49:50+08:00 daily https://www.pharmasources.com/industryinsights/verity-pharma-and-indias-sii-apply-to-di-325619.html 0.6 2026-08-08T07:44:17+08:00 daily https://www.pharmasources.com/industryinsights/ocugen-bharat-biotech-announce-agreement-325620.html 0.6 2026-08-07T15:07:11+08:00 daily https://www.pharmasources.com/industryinsights/schott-increases-global-sales-and-earnin-325621.html 0.6 2026-08-07T13:15:26+08:00 daily https://www.pharmasources.com/industryinsights/inhaled-hyaluronan-shows-promise-in-copd-325622.html 0.6 2026-08-07T02:51:48+08:00 daily https://www.pharmasources.com/industryinsights/azithromycin-and-doxycycline-of-no-benef-325623.html 0.6 2026-08-07T02:55:47+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-clinical-trials-have-risen-by-6-325624.html 0.6 2026-08-07T03:03:52+08:00 daily https://www.pharmasources.com/industryinsights/ema-initiates-rolling-review-of-regenero-325625.html 0.6 2026-06-20T22:54:44+08:00 daily https://www.pharmasources.com/industryinsights/nih-study-finds-severe-covid-19-during-p-325626.html 0.6 2026-06-21T19:56:40+08:00 daily https://www.pharmasources.com/industryinsights/valera-health-announces-a-38m-round-led--325627.html 0.6 2026-04-28T04:40:15+08:00 daily https://www.pharmasources.com/industryinsights/jazz-pharma-to-buy-gw-pharma-for-72-bill-325628.html 0.6 2026-06-20T18:52:40+08:00 daily https://www.pharmasources.com/industryinsights/the-government-needs-to-notify-the-final-325629.html 0.6 2026-06-25T06:36:12+08:00 daily https://www.pharmasources.com/industryinsights/rajasthan-govt-to-open-500-ayush-wellnes-325630.html 0.6 2026-06-21T12:19:37+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-targets-at-least-2-billion-covid--325631.html 0.6 2026-06-22T16:42:00+08:00 daily https://www.pharmasources.com/industryinsights/new-zealand-approves-covid-19-vaccine-wa-325632.html 0.6 2026-06-21T18:16:38+08:00 daily https://www.pharmasources.com/industryinsights/oxford-kept-covid-19-vaccine-trial-volun-325633.html 0.6 2026-06-30T18:31:16+08:00 daily https://www.pharmasources.com/industryinsights/24-new-drugs-developed-with-researches-a-325634.html 0.6 2026-06-20T22:06:40+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-pharma-receives-us-fda-nod-for--325635.html 0.6 2026-07-29T22:10:14+08:00 daily https://www.pharmasources.com/industryinsights/over-80-people-arrested-in-china-for-smu-325636.html 0.6 2026-06-21T10:00:29+08:00 daily https://www.pharmasources.com/industryinsights/aeterna-zentaris-signs-agreement-to-eval-325637.html 0.6 2026-06-21T08:18:19+08:00 daily https://www.pharmasources.com/industryinsights/mexico-authorises-emergency-use-of-russi-325638.html 0.6 2026-07-03T01:22:33+08:00 daily https://www.pharmasources.com/industryinsights/tizianas-foralumab-suppresses-lung-infla-325639.html 0.6 2026-06-20T19:16:57+08:00 daily https://www.pharmasources.com/industryinsights/ontozry-receives-positive-chmp-opinion-t-325640.html 0.6 2026-07-31T13:21:20+08:00 daily https://www.pharmasources.com/industryinsights/vaccitech-doses-first-patient-in-hbv002--325641.html 0.6 2026-06-21T04:18:16+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharma-announces-positive-dsm-325642.html 0.6 2026-05-05T20:51:28+08:00 daily https://www.pharmasources.com/industryinsights/vaxart-oral-covid-19-vax-tablet-shows-pr-325643.html 0.6 2026-06-21T17:20:46+08:00 daily https://www.pharmasources.com/industryinsights/affimed-roche-explore-afm24-tecentriq-co-325644.html 0.6 2026-06-20T14:40:27+08:00 daily https://www.pharmasources.com/industryinsights/imcyse-pfizer-enter-autoimmune-research--325645.html 0.6 2026-06-20T20:44:31+08:00 daily https://www.pharmasources.com/industryinsights/csafe-global-expands-in-asia-325646.html 0.6 2026-07-04T05:23:25+08:00 daily https://www.pharmasources.com/industryinsights/immunome-abzena-enter-covid-19-antibody--325647.html 0.6 2026-08-07T10:50:04+08:00 daily https://www.pharmasources.com/industryinsights/avid-humanigen-enter-lenzilumab-mfg-agre-325648.html 0.6 2026-06-21T10:58:07+08:00 daily https://www.pharmasources.com/industryinsights/gsk-curevac-enter-new-150m-covid-vax-pac-325649.html 0.6 2026-06-21T06:12:51+08:00 daily https://www.pharmasources.com/industryinsights/element-materials-technology-acquires-av-325650.html 0.6 2026-08-02T16:36:04+08:00 daily https://www.pharmasources.com/industryinsights/quanticate-appoints-chief-operating-offi-325651.html 0.6 2026-06-28T12:03:33+08:00 daily https://www.pharmasources.com/industryinsights/metrics-contract-services-appoints-bd-vp-325652.html 0.6 2026-07-03T20:17:17+08:00 daily https://www.pharmasources.com/industryinsights/exonate-launches-diabetic-macular-oedema-325653.html 0.6 2026-07-08T13:02:15+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-and-ucl-to-collaborate-on-tw-325654.html 0.6 2026-06-21T05:53:41+08:00 daily https://www.pharmasources.com/industryinsights/uk-trial-will-evaluate-safety-of-mixing--325655.html 0.6 2026-07-02T03:43:58+08:00 daily https://www.pharmasources.com/industryinsights/new-analysis-backs-safety-efficacy-of-az-325656.html 0.6 2026-07-27T07:42:20+08:00 daily https://www.pharmasources.com/industryinsights/patients-gain-early-access-to-pfizers-at-325657.html 0.6 2026-06-20T14:44:21+08:00 daily https://www.pharmasources.com/industryinsights/vemlidyr-demonstrates-continued-efficacy-325658.html 0.6 2026-08-11T21:53:52+08:00 daily https://www.pharmasources.com/industryinsights/nccn-gets-personal-about-improving-globa-325659.html 0.6 2026-08-10T05:16:44+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-tepmetko-as-the-first-and-o-325660.html 0.6 2026-08-07T06:07:11+08:00 daily https://www.pharmasources.com/industryinsights/eucure-biopharma-announces-encouraging-a-325661.html 0.6 2026-08-10T12:11:31+08:00 daily https://www.pharmasources.com/industryinsights/more-patients-set-to-benefit-as-kanghong-325662.html 0.6 2026-08-06T17:08:21+08:00 daily https://www.pharmasources.com/industryinsights/pakistan-says-chinas-sinopharm-vaccine-n-325663.html 0.6 2026-06-23T00:03:01+08:00 daily https://www.pharmasources.com/industryinsights/strides-pharma-q3-net-profit-declines-62-325664.html 0.6 2026-06-21T21:47:34+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-has-accelerated-innovation-and--325665.html 0.6 2026-07-24T23:30:58+08:00 daily https://www.pharmasources.com/industryinsights/fdi-india-opening-new-avenues-of-foreign-325666.html 0.6 2026-08-10T15:03:22+08:00 daily https://www.pharmasources.com/industryinsights/malaysia-sets-february-2022-target-to-co-325667.html 0.6 2026-08-10T14:59:45+08:00 daily https://www.pharmasources.com/industryinsights/biocon-biologics-to-offer-its-oncology-b-325668.html 0.6 2026-06-21T09:02:59+08:00 daily https://www.pharmasources.com/industryinsights/recovered-covid-19-patients-may-need-onl-325669.html 0.6 2026-06-21T00:05:38+08:00 daily https://www.pharmasources.com/industryinsights/iit-mandi-led-team-develops-ai-app-to-tr-325670.html 0.6 2026-06-21T12:50:31+08:00 daily https://www.pharmasources.com/industryinsights/zydus-announces-completion-of-phase-i-tr-325671.html 0.6 2026-06-21T14:57:22+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-first-vaccine-dose-cuts-cov-325672.html 0.6 2026-06-20T17:56:21+08:00 daily https://www.pharmasources.com/industryinsights/potential-antiviral-treatment-for-covid--325673.html 0.6 2026-06-20T21:59:36+08:00 daily https://www.pharmasources.com/industryinsights/modernas-covid-19-vaccine-receives-inter-325674.html 0.6 2026-08-10T09:07:19+08:00 daily https://www.pharmasources.com/industryinsights/vaxarts-oral-vaccine-candidate-triggers--325675.html 0.6 2026-08-12T04:57:29+08:00 daily https://www.pharmasources.com/industryinsights/biopharma-manufacturer-hpne-continues-ex-325676.html 0.6 2026-08-09T07:56:35+08:00 daily https://www.pharmasources.com/industryinsights/aardex-group-partners-with-pill-connect-325677.html 0.6 2026-08-08T02:37:50+08:00 daily https://www.pharmasources.com/industryinsights/medpharm-launches-scientific-advisory-co-325678.html 0.6 2026-08-08T01:43:55+08:00 daily https://www.pharmasources.com/industryinsights/cdmo-famar-and-active-biotech-ink-clinic-325679.html 0.6 2026-08-08T01:01:26+08:00 daily https://www.pharmasources.com/industryinsights/catalent-decibel-team-up-for-hearing-los-325680.html 0.6 2026-08-08T01:44:11+08:00 daily https://www.pharmasources.com/industryinsights/sepha-launches-contract-packaging-servic-325681.html 0.6 2026-08-08T07:55:57+08:00 daily https://www.pharmasources.com/industryinsights/wacker-strengthens-biologics-business-325682.html 0.6 2026-08-08T19:01:06+08:00 daily https://www.pharmasources.com/industryinsights/lilly-to-provide-antibody-therapies-at-i-325683.html 0.6 2026-08-09T07:59:41+08:00 daily https://www.pharmasources.com/industryinsights/valneva-begins-manufacturing-of-inactiva-325684.html 0.6 2026-06-24T05:58:58+08:00 daily https://www.pharmasources.com/industryinsights/ose-immunotherapeutics-expands-collabora-325685.html 0.6 2026-06-21T07:20:16+08:00 daily https://www.pharmasources.com/industryinsights/co-diagnostics-completes-eua-submission--325686.html 0.6 2026-06-22T10:59:48+08:00 daily https://www.pharmasources.com/industryinsights/covaxx-announces-phase-2-clinical-trials-325687.html 0.6 2026-06-21T08:09:04+08:00 daily https://www.pharmasources.com/industryinsights/ucbs-bimekizumab-data-in-plaque-psoriasi-325688.html 0.6 2026-06-20T14:56:59+08:00 daily https://www.pharmasources.com/industryinsights/keytruda-recommended-for-routine-nhs-use-325689.html 0.6 2026-04-24T17:46:21+08:00 daily https://www.pharmasources.com/industryinsights/multiple-rolling-reviews-kick-off-for-no-325690.html 0.6 2026-08-08T14:56:40+08:00 daily https://www.pharmasources.com/industryinsights/nice-launches-public-consultation-for-pr-325691.html 0.6 2026-06-21T04:32:05+08:00 daily https://www.pharmasources.com/industryinsights/bms-deucravacitinib-beats-otezla-in-psor-325692.html 0.6 2026-08-10T14:37:11+08:00 daily https://www.pharmasources.com/industryinsights/nice-green-light-for-gsks-nucala-325693.html 0.6 2026-06-21T02:03:42+08:00 daily https://www.pharmasources.com/industryinsights/thomson-x-inks-strategic-partnership-wit-325694.html 0.6 2026-04-19T08:01:38+08:00 daily https://www.pharmasources.com/industryinsights/tcai-physicians-participate-in-clinical--325695.html 0.6 2026-06-21T05:00:46+08:00 daily https://www.pharmasources.com/industryinsights/ihme-extends-covid-19-forecasts-to-june--325696.html 0.6 2026-07-07T05:12:05+08:00 daily https://www.pharmasources.com/industryinsights/health-leaders-urge-public-to-have-sympt-325697.html 0.6 2026-08-10T15:14:26+08:00 daily https://www.pharmasources.com/industryinsights/india-asks-states-to-speed-up-covid-19-v-325698.html 0.6 2026-08-09T14:57:17+08:00 daily https://www.pharmasources.com/industryinsights/india-developing-7-more-covid-vaccines-h-325699.html 0.6 2026-06-21T11:55:11+08:00 daily https://www.pharmasources.com/industryinsights/china-grants-conditional-approval-to-2nd-325700.html 0.6 2026-06-29T12:25:30+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-drops-india-vaccine-application-a-325701.html 0.6 2026-06-21T12:00:12+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-patients-have-higher-risk-of-dy-325702.html 0.6 2026-06-21T18:10:30+08:00 daily https://www.pharmasources.com/industryinsights/china-approves-astrazenecas-forxiga-for--325703.html 0.6 2026-06-22T04:56:44+08:00 daily https://www.pharmasources.com/industryinsights/janssen-seeks-eua-for-covid-19-vaccine-c-325704.html 0.6 2026-06-22T04:13:53+08:00 daily https://www.pharmasources.com/industryinsights/financial-report-lilly-325705.html 0.6 2026-08-05T19:25:16+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-4q-and-fy20-results-325706.html 0.6 2026-07-03T02:30:15+08:00 daily https://www.pharmasources.com/industryinsights/financial-report-roche-325707.html 0.6 2026-08-06T14:26:55+08:00 daily https://www.pharmasources.com/industryinsights/sepha-launches-small-batch-contract-pack-325708.html 0.6 2026-06-20T15:53:29+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-sta-to-buy-swiss-pharma-manufacturi-325709.html 0.6 2026-08-05T22:22:17+08:00 daily https://www.pharmasources.com/industryinsights/curevac-uk-partner-on-vaccines-against-s-325710.html 0.6 2026-07-24T01:23:55+08:00 daily https://www.pharmasources.com/industryinsights/novel-hiv-vaccine-approach-shows-promise-325711.html 0.6 2026-06-29T05:06:59+08:00 daily https://www.pharmasources.com/industryinsights/intranasal-influenza-vaccine-produces-st-325712.html 0.6 2026-06-20T21:19:14+08:00 daily https://www.pharmasources.com/industryinsights/uk-launches-trial-to-study-alternating-c-325713.html 0.6 2026-06-21T19:45:20+08:00 daily https://www.pharmasources.com/industryinsights/2020-the-best-year-for-uk-biotech-invest-325714.html 0.6 2026-06-21T05:35:10+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-beovu-brolucizumab-for-t-325715.html 0.6 2026-07-23T11:58:23+08:00 daily https://www.pharmasources.com/industryinsights/hidroxr-a-proprietary-olive-polyphenols--325716.html 0.6 2026-06-21T16:03:22+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-announces-multiple-clinical-advanc-325717.html 0.6 2026-06-20T23:46:28+08:00 daily https://www.pharmasources.com/industryinsights/roche-announces-the-upcoming-launch-of-t-325718.html 0.6 2026-06-21T22:47:04+08:00 daily https://www.pharmasources.com/industryinsights/analysis-of-the-regulatory-inspection-tr-325719.html 0.6 2026-08-04T17:36:46+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-expects-us-trial-results-in--325720.html 0.6 2026-07-04T15:00:40+08:00 daily https://www.pharmasources.com/industryinsights/pharma-exports-up-1243-per-cent-during-a-325721.html 0.6 2026-06-20T19:57:43+08:00 daily https://www.pharmasources.com/industryinsights/india-sent-56-l-covid-19-vaccines-to-for-325722.html 0.6 2026-07-20T11:29:45+08:00 daily https://www.pharmasources.com/industryinsights/third-phase-will-begin-in-march-and-cove-325723.html 0.6 2026-03-27T20:18:39+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-recalls-36275-cartons-of-test-325724.html 0.6 2026-07-10T06:31:23+08:00 daily https://www.pharmasources.com/industryinsights/healthcare-industry-reported-70-deals-wo-325725.html 0.6 2026-08-05T20:53:48+08:00 daily https://www.pharmasources.com/industryinsights/india-set-to-meet-worlds-70-per-cent-cov-325726.html 0.6 2026-06-20T23:18:14+08:00 daily https://www.pharmasources.com/industryinsights/uk-says-covid-19-booster-and-annual-vacc-325727.html 0.6 2026-06-22T02:07:41+08:00 daily https://www.pharmasources.com/industryinsights/beroni-acquires-majority-interest-in-pen-325728.html 0.6 2026-06-21T01:02:52+08:00 daily https://www.pharmasources.com/industryinsights/chinese-produced-anticancer-drugs-grante-325729.html 0.6 2026-08-04T14:59:40+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-covid-19-vaccine-confirms-10-325730.html 0.6 2026-07-24T16:06:34+08:00 daily https://www.pharmasources.com/industryinsights/viacyte-announces-initiation-of-encapsul-325731.html 0.6 2026-08-07T02:30:50+08:00 daily https://www.pharmasources.com/industryinsights/usp-expands-alcohol-based-hand-sanitizer-325732.html 0.6 2026-08-07T02:24:29+08:00 daily https://www.pharmasources.com/industryinsights/chinese-vaccines-going-global-amid-recei-325733.html 0.6 2026-08-07T02:21:54+08:00 daily https://www.pharmasources.com/industryinsights/fda-announces-alert-of-potential-risks-a-325734.html 0.6 2026-08-07T02:31:08+08:00 daily https://www.pharmasources.com/industryinsights/lands-end-partners-with-iowa-county-heal-325735.html 0.6 2026-08-07T11:22:47+08:00 daily https://www.pharmasources.com/industryinsights/how-sars-cov-2-mutates-to-escape-antibod-325736.html 0.6 2026-08-07T11:55:24+08:00 daily https://www.pharmasources.com/industryinsights/a-novel-drug-device-combination-product--325737.html 0.6 2026-08-07T13:18:07+08:00 daily https://www.pharmasources.com/industryinsights/orpha-labs-ag-initiates-compassionate-us-325738.html 0.6 2026-08-08T03:30:50+08:00 daily https://www.pharmasources.com/industryinsights/inova-appoints-claude-basset-as-chief-pr-325739.html 0.6 2026-06-21T02:53:34+08:00 daily https://www.pharmasources.com/industryinsights/enzymatic-synthesis-of-nmn-greener-and-m-325740.html 0.6 2026-08-14T16:04:07+08:00 daily https://www.pharmasources.com/industryinsights/analysis-of-the-export-market-of-gelatin-325741.html 0.6 2026-08-11T18:27:22+08:00 daily https://www.pharmasources.com/industryinsights/veru-reports-positive-data-from-phase-ii-325742.html 0.6 2026-06-24T19:42:26+08:00 daily https://www.pharmasources.com/industryinsights/fda-casts-doubt-on-clinical-meaningfulne-325743.html 0.6 2026-06-21T09:03:07+08:00 daily https://www.pharmasources.com/industryinsights/rhizen-pharmas-partnered-asset-umbralisi-325744.html 0.6 2026-06-21T09:01:59+08:00 daily https://www.pharmasources.com/industryinsights/bain-capital-cinven-to-acquire-lonza-spe-325745.html 0.6 2026-08-09T12:48:21+08:00 daily https://www.pharmasources.com/industryinsights/881-ongoing-overcharging-cases-worth-rs--325746.html 0.6 2026-06-21T03:06:42+08:00 daily https://www.pharmasources.com/industryinsights/sms-life-sciences-india-gets-dsir-recogn-325747.html 0.6 2026-06-22T14:14:59+08:00 daily https://www.pharmasources.com/industryinsights/indian-pharma-market-expected-to-grow-to-325748.html 0.6 2026-08-09T23:52:04+08:00 daily https://www.pharmasources.com/industryinsights/clinical-data-standards-in-the-era-of-ai-325749.html 0.6 2026-06-22T07:08:54+08:00 daily https://www.pharmasources.com/industryinsights/amri-makes-executive-move-325750.html 0.6 2026-08-08T02:53:24+08:00 daily https://www.pharmasources.com/industryinsights/curevac-rentschler-biopharma-collaborate-325751.html 0.6 2026-08-01T19:54:17+08:00 daily https://www.pharmasources.com/industryinsights/recipharm-and-medspray-complete-joint-ve-325752.html 0.6 2026-06-20T16:38:13+08:00 daily https://www.pharmasources.com/industryinsights/anova-enterprises-acquires-corlexia-clin-325753.html 0.6 2026-06-24T10:44:00+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-jw-therapeutics-form-car-t-325754.html 0.6 2026-04-02T07:32:52+08:00 daily https://www.pharmasources.com/industryinsights/vigene-plans-major-expansion-in-maryland-325755.html 0.6 2026-08-06T02:09:46+08:00 daily https://www.pharmasources.com/industryinsights/cytiva-acquires-canadian-aseptic-filling-325756.html 0.6 2026-07-28T06:47:19+08:00 daily https://www.pharmasources.com/industryinsights/tcg-lifesciences-expands-footprint-to-th-325757.html 0.6 2026-06-21T22:46:45+08:00 daily https://www.pharmasources.com/industryinsights/catalent-trizell-enter-cell-therapy-deal-325758.html 0.6 2026-08-07T23:03:33+08:00 daily https://www.pharmasources.com/industryinsights/paragon-biosciences-expands-cell-and-gen-325759.html 0.6 2026-06-20T17:16:40+08:00 daily https://www.pharmasources.com/industryinsights/merck-and-biontech-to-boost-lipid-supply-325760.html 0.6 2026-07-13T13:26:01+08:00 daily https://www.pharmasources.com/industryinsights/takeda-president-becomes-phrma-board-cha-325761.html 0.6 2026-07-02T11:58:44+08:00 daily https://www.pharmasources.com/industryinsights/new-covid-19-antibody-test-receives-eua-325762.html 0.6 2026-06-26T23:38:24+08:00 daily https://www.pharmasources.com/industryinsights/agenus-announces-positive-preliminary-re-325763.html 0.6 2026-07-06T23:41:11+08:00 daily https://www.pharmasources.com/industryinsights/neurorx-initiates-study-of-inhaled-zyesa-325764.html 0.6 2026-08-09T02:18:56+08:00 daily https://www.pharmasources.com/industryinsights/matrix-collaborates-with-astrazeneca-on--325765.html 0.6 2026-08-09T00:31:39+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-accelerated-approval-to-tepot-325766.html 0.6 2026-08-07T13:15:35+08:00 daily https://www.pharmasources.com/industryinsights/antibiotic-research-uk-calls-for-clear-g-325767.html 0.6 2026-08-09T06:59:12+08:00 daily https://www.pharmasources.com/industryinsights/eu-approves-expanded-use-of-janssens-spr-325768.html 0.6 2026-08-11T15:22:56+08:00 daily https://www.pharmasources.com/industryinsights/the-stroke-association-to-fund-study-inv-325769.html 0.6 2026-06-20T14:44:17+08:00 daily https://www.pharmasources.com/industryinsights/smc-approves-funding-for-four-new-medici-325770.html 0.6 2026-08-11T18:22:33+08:00 daily https://www.pharmasources.com/industryinsights/azs-imfinzi-fails-to-improve-overall-sur-325771.html 0.6 2026-07-27T15:55:47+08:00 daily https://www.pharmasources.com/industryinsights/ons-reveals-covid-19s-impact-on-mental-h-325772.html 0.6 2026-06-22T04:52:36+08:00 daily https://www.pharmasources.com/industryinsights/experiment-showed-that-jemincares-neutra-325773.html 0.6 2026-06-20T14:46:10+08:00 daily https://www.pharmasources.com/industryinsights/innovent-announces-first-patient-dosed-i-325774.html 0.6 2026-08-11T12:17:10+08:00 daily https://www.pharmasources.com/industryinsights/proxima-ventures-and-co-win-ventures-inv-325775.html 0.6 2026-07-01T18:39:41+08:00 daily https://www.pharmasources.com/industryinsights/peginterferon-lambda-accelerates-covid-1-325776.html 0.6 2026-07-06T16:34:21+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-third-gene-therapy-for-larg-325777.html 0.6 2026-06-22T11:00:36+08:00 daily https://www.pharmasources.com/industryinsights/govt-plans-to-shut-down-two-pharma-psus--325778.html 0.6 2026-06-07T23:08:39+08:00 daily https://www.pharmasources.com/industryinsights/abcellera-gets-eua-from-us-fda-for-its-a-325779.html 0.6 2026-08-10T20:51:37+08:00 daily https://www.pharmasources.com/industryinsights/india-says-it-has-no-concerns-about-effi-325780.html 0.6 2026-06-23T03:00:53+08:00 daily https://www.pharmasources.com/industryinsights/india-orders-145-mn-more-covid-19-vaccin-325781.html 0.6 2026-06-21T06:05:46+08:00 daily https://www.pharmasources.com/industryinsights/freeline-modifies-clinical-development-p-325782.html 0.6 2026-06-21T08:00:58+08:00 daily https://www.pharmasources.com/industryinsights/viivs-rukobia-receives-marketing-authori-325783.html 0.6 2026-06-21T05:06:47+08:00 daily https://www.pharmasources.com/industryinsights/neurorx-reports-initial-phase-2b3-study--325784.html 0.6 2026-06-21T10:54:19+08:00 daily https://www.pharmasources.com/industryinsights/lupin-gets-us-fda-nod-for-tavaborole-top-325785.html 0.6 2026-08-06T23:47:30+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-tepmetko-for-metastatic-non-325786.html 0.6 2026-08-11T17:06:28+08:00 daily https://www.pharmasources.com/industryinsights/supernus-resubmits-nda-for-spn-812-for-a-325787.html 0.6 2026-08-09T07:41:32+08:00 daily https://www.pharmasources.com/industryinsights/surface-ophthalmics-announces-first-pati-325788.html 0.6 2026-08-06T23:37:00+08:00 daily https://www.pharmasources.com/industryinsights/imfinzi-trial-does-not-meet-primary-endp-325789.html 0.6 2026-08-07T05:30:51+08:00 daily https://www.pharmasources.com/industryinsights/hackensack-meridian-health-awarded-55-mi-325790.html 0.6 2026-08-07T02:39:57+08:00 daily https://www.pharmasources.com/industryinsights/apotex-recalls-enoxaparin-sodium-injecti-325791.html 0.6 2026-06-22T03:55:41+08:00 daily https://www.pharmasources.com/industryinsights/vaccine-trials-essential-to-evaluate-eff-325792.html 0.6 2026-02-16T13:48:57+08:00 daily https://www.pharmasources.com/industryinsights/jj-to-bring-covid-19-vaccine-to-india-in-325793.html 0.6 2026-06-26T14:37:14+08:00 daily https://www.pharmasources.com/industryinsights/usfda-awards-breakthrough-therapy-design-325794.html 0.6 2026-07-04T03:17:11+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-4q-revenues-up-12-325795.html 0.6 2026-06-20T22:56:56+08:00 daily https://www.pharmasources.com/industryinsights/gilead-4q-revenues-up-26-325796.html 0.6 2026-07-20T23:44:26+08:00 daily https://www.pharmasources.com/industryinsights/lilly-apoints-svp-cfo-325797.html 0.6 2026-06-21T14:43:15+08:00 daily https://www.pharmasources.com/industryinsights/rotachrom-technologies-partners-with-cyc-325798.html 0.6 2026-06-22T01:03:53+08:00 daily https://www.pharmasources.com/industryinsights/quotient-sciences-acquires-arcinova-325799.html 0.6 2026-07-07T21:48:39+08:00 daily https://www.pharmasources.com/industryinsights/lonza-to-divest-specialty-ingredients-bi-325800.html 0.6 2026-07-01T09:36:58+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-bms-car-t-cell-therapy-325801.html 0.6 2026-06-21T12:06:15+08:00 daily https://www.pharmasources.com/industryinsights/bioduro-sundia-appoints-ceo-325802.html 0.6 2026-06-20T22:54:37+08:00 daily https://www.pharmasources.com/industryinsights/erleada-drug-combination-extends-progres-325803.html 0.6 2026-06-21T07:08:59+08:00 daily https://www.pharmasources.com/industryinsights/once-daily-multiple-sclerosis-treatment--325804.html 0.6 2026-06-20T14:24:18+08:00 daily https://www.pharmasources.com/industryinsights/trial-to-assess-astrazenecas-long-acting-325805.html 0.6 2026-08-08T03:29:16+08:00 daily https://www.pharmasources.com/industryinsights/chinese-police-seize-over-3000-fake-covi-325806.html 0.6 2026-06-25T02:14:54+08:00 daily https://www.pharmasources.com/industryinsights/africa-to-receive-first-covid-19-vaccine-325807.html 0.6 2026-06-21T17:54:17+08:00 daily https://www.pharmasources.com/industryinsights/cgtn-cooperation-not-postponed-china-cee-325808.html 0.6 2026-04-17T05:34:05+08:00 daily https://www.pharmasources.com/industryinsights/endpoint-clinical-announces-the-appointm-325809.html 0.6 2026-06-20T15:01:05+08:00 daily https://www.pharmasources.com/industryinsights/alterity-therapeutics-announces-funding--325810.html 0.6 2026-04-19T04:42:47+08:00 daily https://www.pharmasources.com/industryinsights/china-national-medical-products-administ-325811.html 0.6 2026-06-29T16:52:42+08:00 daily https://www.pharmasources.com/industryinsights/neurophth-closes-rmb-400-million-series--325812.html 0.6 2026-07-31T06:57:55+08:00 daily https://www.pharmasources.com/industryinsights/anticancer-drug-may-improve-outcome-for--325813.html 0.6 2026-06-30T12:22:06+08:00 daily https://www.pharmasources.com/industryinsights/biocon-biologics-and-viatris-get-ec-appr-325814.html 0.6 2026-07-27T16:24:16+08:00 daily https://www.pharmasources.com/industryinsights/alembic-pharma-subsidiary-alembic-global-325815.html 0.6 2026-06-20T14:44:25+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccines-worth-rs-338-crores-ex-325816.html 0.6 2026-07-24T19:20:52+08:00 daily https://www.pharmasources.com/industryinsights/pnb-vesper-completes-phase-2-of-clinical-325817.html 0.6 2026-07-24T19:17:48+08:00 daily https://www.pharmasources.com/industryinsights/strides-gets-usfda-approval-for-predniso-325818.html 0.6 2026-07-24T19:14:59+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-gets-us-fda-approval-for-panzyga--325819.html 0.6 2026-07-24T19:08:58+08:00 daily https://www.pharmasources.com/industryinsights/uk-researchers-find-semaglutide-could-be-325820.html 0.6 2026-08-10T23:36:07+08:00 daily https://www.pharmasources.com/industryinsights/study-reveals-how-coronavirus-could-hija-325821.html 0.6 2026-07-24T19:00:01+08:00 daily https://www.pharmasources.com/industryinsights/mrna-covid-19-vaccine-from-sanofi-will-n-325822.html 0.6 2026-07-24T18:50:51+08:00 daily https://www.pharmasources.com/industryinsights/lupin-aurobindo-recall-drugs-in-us-marke-325823.html 0.6 2026-07-24T18:48:13+08:00 daily https://www.pharmasources.com/industryinsights/mexico-gets-astrazeneca-doses-from-india-325824.html 0.6 2026-08-07T12:58:36+08:00 daily https://www.pharmasources.com/industryinsights/s-sridhar-elected-as-president-of-oppi-325825.html 0.6 2026-07-24T18:09:11+08:00 daily https://www.pharmasources.com/industryinsights/lanxess-to-acquire-emerald-kalama-chemic-325826.html 0.6 2026-07-24T18:51:15+08:00 daily https://www.pharmasources.com/industryinsights/18-19-covid-19-vaccine-candidates-in-pip-325827.html 0.6 2026-07-25T03:38:51+08:00 daily https://www.pharmasources.com/industryinsights/biocon-biologics-partners-with-idf-to-im-325828.html 0.6 2026-07-25T03:57:17+08:00 daily https://www.pharmasources.com/industryinsights/nppa-fixes-retail-prices-of-vildagliptin-325829.html 0.6 2026-08-07T11:19:21+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-launches-sutib-sunitinib-capsul-325830.html 0.6 2026-08-08T23:54:11+08:00 daily https://www.pharmasources.com/industryinsights/south-africa-asks-sii-to-take-back-one-m-325831.html 0.6 2026-07-25T04:08:50+08:00 daily https://www.pharmasources.com/industryinsights/research-reveals-pfizer-biontech-covid-1-325832.html 0.6 2026-08-08T01:01:33+08:00 daily https://www.pharmasources.com/industryinsights/bharat-biotech-to-get-genome-valley-exce-325833.html 0.6 2026-07-25T04:24:08+08:00 daily https://www.pharmasources.com/industryinsights/india-to-increase-covid-19-vaccination-s-325834.html 0.6 2026-08-03T01:45:22+08:00 daily https://www.pharmasources.com/industryinsights/lupin-launches-posaconazole-delayed-rele-325835.html 0.6 2026-07-25T04:29:54+08:00 daily https://www.pharmasources.com/industryinsights/granules-india-gets-us-fda-approval-for--325836.html 0.6 2026-08-05T06:09:04+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-launch-capecitabine-tablets-us-325837.html 0.6 2026-06-20T23:53:29+08:00 daily https://www.pharmasources.com/industryinsights/ec-buys-additional-150-mn-doses-of-moder-325838.html 0.6 2026-06-21T02:56:31+08:00 daily https://www.pharmasources.com/industryinsights/antares-vision-acquires-rfxcel-corporati-325839.html 0.6 2026-06-20T23:50:57+08:00 daily https://www.pharmasources.com/industryinsights/novavax-sk-bioscience-expand-vax-pact-325840.html 0.6 2026-06-21T00:15:47+08:00 daily https://www.pharmasources.com/industryinsights/kaneka-eurogentec-expands-capabilities-325841.html 0.6 2026-06-21T09:13:10+08:00 daily https://www.pharmasources.com/industryinsights/charles-river-acquires-cdmo-cognate-bios-325842.html 0.6 2026-06-05T18:30:15+08:00 daily https://www.pharmasources.com/industryinsights/novartis-vet-joins-cdmo-sai-life-science-325843.html 0.6 2026-08-14T01:48:41+08:00 daily https://www.pharmasources.com/industryinsights/centrient-pharmaceuticals-to-acquire-ast-325844.html 0.6 2026-06-22T10:08:49+08:00 daily https://www.pharmasources.com/industryinsights/biomunex-onward-ink-strategic-antibody-d-325845.html 0.6 2026-08-03T22:20:52+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-diosynth-hosts-uk-pm-at-covid-v-325846.html 0.6 2026-06-21T07:07:00+08:00 daily https://www.pharmasources.com/industryinsights/lonza-expands-solid-small-molecule-servi-325847.html 0.6 2026-06-21T02:03:39+08:00 daily https://www.pharmasources.com/industryinsights/gsk-vir-expand-collaboration-for-influen-325848.html 0.6 2026-07-07T00:41:38+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-biontechs-covid-19-vaccine-immuni-325849.html 0.6 2026-06-20T17:22:24+08:00 daily https://www.pharmasources.com/industryinsights/oxford-university-launches-covid-19-vacc-325850.html 0.6 2026-06-21T04:45:30+08:00 daily https://www.pharmasources.com/industryinsights/bharat-biotechs-covaxin-may-provide-covi-325851.html 0.6 2026-06-20T18:01:20+08:00 daily https://www.pharmasources.com/industryinsights/us-judge-orders-bms-sanofi-to-pay-834m-f-325852.html 0.6 2026-06-22T12:09:58+08:00 daily https://www.pharmasources.com/industryinsights/sagent-begins-niaid-sponsored-study-inve-325853.html 0.6 2026-07-09T10:41:58+08:00 daily https://www.pharmasources.com/industryinsights/astellas-seagen-announce-padcev-trial-re-325854.html 0.6 2026-08-07T02:51:56+08:00 daily https://www.pharmasources.com/industryinsights/first-cancer-early-screening-company-lis-325855.html 0.6 2026-08-07T02:40:06+08:00 daily https://www.pharmasources.com/industryinsights/new-nccn-guidelines-analyze-evidence-for-325856.html 0.6 2026-08-15T01:21:45+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharma-announces-first-patien-325857.html 0.6 2026-08-07T02:31:15+08:00 daily https://www.pharmasources.com/industryinsights/joint-feasibility-assessment-of-bionomic-325858.html 0.6 2026-08-07T02:22:07+08:00 daily https://www.pharmasources.com/industryinsights/anixa-biosciences-begins-animal-testing--325859.html 0.6 2026-08-07T12:13:11+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-emergency-use-authorization-f-325860.html 0.6 2026-08-07T13:18:29+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-covid-19-vaccine-authorized--325861.html 0.6 2026-08-09T07:36:45+08:00 daily https://www.pharmasources.com/industryinsights/forge-biologics-announces-multiple-fda-d-325862.html 0.6 2026-06-21T04:08:00+08:00 daily https://www.pharmasources.com/industryinsights/targovax-receives-fast-track-designation-325863.html 0.6 2026-07-31T03:06:46+08:00 daily https://www.pharmasources.com/industryinsights/ben-gurion-researchers-develop-novel-met-325864.html 0.6 2026-08-11T17:09:07+08:00 daily https://www.pharmasources.com/industryinsights/viracta-announces-patent-application-for-325865.html 0.6 2026-06-27T21:33:04+08:00 daily https://www.pharmasources.com/industryinsights/entresto-granted-expanded-indication-in--325866.html 0.6 2026-08-02T16:16:54+08:00 daily https://www.pharmasources.com/industryinsights/ers-genomics-zeclinics-sign-crisprcas9-l-325867.html 0.6 2026-06-30T02:57:26+08:00 daily https://www.pharmasources.com/industryinsights/verrica-announces-fda-filing-acceptance--325868.html 0.6 2026-07-30T15:05:28+08:00 daily https://www.pharmasources.com/industryinsights/astellas-expands-top-management-325869.html 0.6 2026-06-21T23:56:42+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-sotorasib-priority-review-des-325870.html 0.6 2026-06-21T09:37:49+08:00 daily https://www.pharmasources.com/industryinsights/ptc-therapeutics-initiates-second-stage--325871.html 0.6 2026-08-06T01:54:52+08:00 daily https://www.pharmasources.com/industryinsights/janssen-cilag-seeks-ema-authorisation-fo-325872.html 0.6 2026-08-05T18:34:21+08:00 daily https://www.pharmasources.com/industryinsights/cytocom-submits-ind-application-to-condu-325873.html 0.6 2026-04-30T21:19:49+08:00 daily https://www.pharmasources.com/industryinsights/worlds-first-covid-19-human-challenge-st-325874.html 0.6 2026-08-06T20:26:05+08:00 daily https://www.pharmasources.com/industryinsights/fda-clears-altimmunes-ind-application-fo-325875.html 0.6 2026-02-28T23:24:53+08:00 daily https://www.pharmasources.com/industryinsights/uk-expands-covid-19-vaccinations-to-over-325876.html 0.6 2026-07-14T19:29:03+08:00 daily https://www.pharmasources.com/industryinsights/kidney-research-uk-pledges-support-to-ac-325877.html 0.6 2026-06-23T05:03:53+08:00 daily https://www.pharmasources.com/industryinsights/nice-rejects-lillys-verzenios-for-advanc-325878.html 0.6 2026-06-21T04:02:51+08:00 daily https://www.pharmasources.com/industryinsights/curevacs-covid-19-vaccine-begins-rolling-325879.html 0.6 2026-08-04T14:21:44+08:00 daily https://www.pharmasources.com/industryinsights/lifearc-provides-5m-funding-for-covid-19-325880.html 0.6 2026-06-21T11:53:10+08:00 daily https://www.pharmasources.com/industryinsights/mhra-launches-public-consultation-on-rec-325881.html 0.6 2026-06-21T20:50:47+08:00 daily https://www.pharmasources.com/industryinsights/az-daiichi-sankyos-enhertu-scores-approv-325882.html 0.6 2026-06-22T09:13:52+08:00 daily https://www.pharmasources.com/industryinsights/eu-authorises-celltrions-adalimumab-bios-325883.html 0.6 2026-06-21T12:09:15+08:00 daily https://www.pharmasources.com/industryinsights/overuse-of-reliever-medication-for-asthm-325884.html 0.6 2026-06-22T07:52:50+08:00 daily https://www.pharmasources.com/industryinsights/evgen-pharma-recruits-over-100-patients--325885.html 0.6 2026-06-21T13:11:46+08:00 daily https://www.pharmasources.com/industryinsights/uk-government-pledges-185m-for-long-covi-325886.html 0.6 2026-06-20T19:16:49+08:00 daily https://www.pharmasources.com/industryinsights/evox-raises-692m-to-advance-exosome-base-325887.html 0.6 2026-08-07T08:02:45+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-collaborations-could-unlock-the-325888.html 0.6 2026-06-21T07:43:44+08:00 daily https://www.pharmasources.com/industryinsights/therapeutic-proteins-and-oral-vaccines-m-325889.html 0.6 2026-07-14T13:52:39+08:00 daily https://www.pharmasources.com/industryinsights/psychobiotic-ps128-consumption-shows-ben-325890.html 0.6 2026-08-08T21:53:00+08:00 daily https://www.pharmasources.com/industryinsights/sciwind-biosciences-secures-us37-million-325891.html 0.6 2026-08-08T10:56:01+08:00 daily https://www.pharmasources.com/industryinsights/novel-ionic-liquid-enables-uniform-chemo-325892.html 0.6 2026-06-20T18:58:40+08:00 daily https://www.pharmasources.com/industryinsights/february-pharmacovigilance-risk-assessme-325893.html 0.6 2026-04-17T03:53:19+08:00 daily https://www.pharmasources.com/industryinsights/two-new-developments-in-kidney-cancer-tr-325894.html 0.6 2026-06-30T10:25:27+08:00 daily https://www.pharmasources.com/industryinsights/fresenius-kabi-oncology-ltd-to-pay-50mn--325895.html 0.6 2026-07-17T05:43:25+08:00 daily https://www.pharmasources.com/industryinsights/regor-therapeutics-announces-completion--325896.html 0.6 2026-06-22T10:02:19+08:00 daily https://www.pharmasources.com/industryinsights/250mn-europeans-to-be-vaccinated-with-co-325897.html 0.6 2026-06-28T13:40:48+08:00 daily https://www.pharmasources.com/industryinsights/lynparza-crosses-superiority-boundary-fo-325898.html 0.6 2026-08-02T02:32:40+08:00 daily https://www.pharmasources.com/industryinsights/biovaxys-and-bioelpida-sign-term-sheet-f-325899.html 0.6 2026-08-11T09:29:51+08:00 daily https://www.pharmasources.com/industryinsights/bharat-biotech-seeks-approval-for-covid--325900.html 0.6 2026-06-20T20:19:48+08:00 daily https://www.pharmasources.com/industryinsights/aurobindo-pharma-receives-usfda-nod-for--325901.html 0.6 2026-07-16T21:38:14+08:00 daily https://www.pharmasources.com/industryinsights/lupin-gets-us-fda-approval-for-droxidopa-325902.html 0.6 2026-08-10T23:08:52+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-final-nod-from-usfda-f-325903.html 0.6 2026-06-20T18:05:31+08:00 daily https://www.pharmasources.com/industryinsights/unichem-laboratories-gets-usfda-approval-325904.html 0.6 2026-06-14T13:56:37+08:00 daily https://www.pharmasources.com/industryinsights/eli-lilly-enters-into-960-million-deal-w-325905.html 0.6 2026-08-01T03:11:35+08:00 daily https://www.pharmasources.com/industryinsights/researchers-at-iit-madras-pave-way-for-m-325906.html 0.6 2026-06-21T11:14:32+08:00 daily https://www.pharmasources.com/industryinsights/brexit-deal-offers-uk-access-to-research-325907.html 0.6 2026-06-21T11:18:34+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-launch-fluphenazine-hydrochlor-325908.html 0.6 2026-06-22T04:41:22+08:00 daily https://www.pharmasources.com/industryinsights/south-african-variant-may-weaken-vaccine-325909.html 0.6 2026-08-13T02:07:59+08:00 daily https://www.pharmasources.com/industryinsights/eu-launches-vaccine-incubator-to-tackle--325910.html 0.6 2026-06-21T03:01:43+08:00 daily https://www.pharmasources.com/industryinsights/g-con-manufacturing-delivers-installs-po-325911.html 0.6 2026-08-11T04:15:35+08:00 daily https://www.pharmasources.com/industryinsights/eurofins-scientific-acquires-beacon-disc-325912.html 0.6 2026-06-08T17:03:27+08:00 daily https://www.pharmasources.com/industryinsights/antares-vision-agrees-to-acquire-rfxcel--325913.html 0.6 2026-08-07T17:38:12+08:00 daily https://www.pharmasources.com/industryinsights/intravacc-unveils-new-pilot-vaccine-prod-325914.html 0.6 2026-06-21T07:13:03+08:00 daily https://www.pharmasources.com/industryinsights/century-therapeutics-significantly-expan-325915.html 0.6 2026-08-11T15:41:00+08:00 daily https://www.pharmasources.com/industryinsights/redhill-and-cosmo-strengthen-manufacturi-325916.html 0.6 2026-07-05T00:45:35+08:00 daily https://www.pharmasources.com/industryinsights/catalent-aurinia-ink-lupkynis-commercial-325917.html 0.6 2026-06-21T05:11:57+08:00 daily https://www.pharmasources.com/industryinsights/ppd-awarded-us-army-rpa-develop-ptsd-dru-325918.html 0.6 2026-06-21T10:48:09+08:00 daily https://www.pharmasources.com/industryinsights/cascade-chemistry-begins-14m-cgmp-mfg-ca-325919.html 0.6 2026-08-14T17:09:30+08:00 daily https://www.pharmasources.com/industryinsights/wavelength-pharmaceuticals-acquires-majo-325920.html 0.6 2026-08-07T01:02:49+08:00 daily https://www.pharmasources.com/industryinsights/uk-to-pledge-to-share-surplus-covid-19-v-325921.html 0.6 2026-06-20T16:08:32+08:00 daily https://www.pharmasources.com/industryinsights/environmental-sustainability-in-the-phar-325922.html 0.6 2026-07-24T08:12:40+08:00 daily https://www.pharmasources.com/industryinsights/new-study-shows-correlation-between-temp-325923.html 0.6 2026-06-20T23:59:37+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-and-biontech-begin-covid-19-vacci-325924.html 0.6 2026-06-22T07:04:51+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-to-acquire-glaxosmithklines-cepha-325925.html 0.6 2026-08-14T16:46:12+08:00 daily https://www.pharmasources.com/industryinsights/idmc-concluded-lynparza-trial-crossed-su-325926.html 0.6 2026-08-10T12:28:17+08:00 daily https://www.pharmasources.com/industryinsights/metavention-initiates-trial-for-novel-tr-325927.html 0.6 2026-06-27T15:49:16+08:00 daily https://www.pharmasources.com/industryinsights/fibrogenesis-reports-positive-data-in-pa-325928.html 0.6 2026-04-29T01:21:51+08:00 daily https://www.pharmasources.com/industryinsights/novartis-gates-foundation-to-develop-acc-325929.html 0.6 2026-08-12T15:37:14+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-scientific-launches-online-325930.html 0.6 2026-06-21T14:58:24+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-biontech-to-supply-eu-with-200-mi-325931.html 0.6 2026-06-22T12:15:06+08:00 daily https://www.pharmasources.com/industryinsights/roches-vision-loss-therapy-faricimab-ext-325932.html 0.6 2026-06-20T15:14:22+08:00 daily https://www.pharmasources.com/industryinsights/chiesi-launches-pilot-inhaler-recycling--325933.html 0.6 2026-04-08T10:19:03+08:00 daily https://www.pharmasources.com/industryinsights/bluebird-bios-beta-thalassaemia-gene-the-325934.html 0.6 2026-06-21T18:20:09+08:00 daily https://www.pharmasources.com/industryinsights/nhs-to-roll-out-tocilizumab-treatment-fo-325935.html 0.6 2026-03-27T17:08:25+08:00 daily https://www.pharmasources.com/industryinsights/bcg-vaccine-protects-newborns-against-a--325936.html 0.6 2026-06-20T18:07:33+08:00 daily https://www.pharmasources.com/industryinsights/novel-chemotherapeutic-pro-drug-approved-325937.html 0.6 2026-08-08T02:06:49+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-dosed-with-therapeutic-pro-325938.html 0.6 2026-07-04T08:10:36+08:00 daily https://www.pharmasources.com/industryinsights/car-t-therapy-provides-long-lasting-remi-325939.html 0.6 2026-06-22T08:49:44+08:00 daily https://www.pharmasources.com/industryinsights/a-machine-learning-approach-to-finding-t-325940.html 0.6 2026-06-30T16:00:21+08:00 daily https://www.pharmasources.com/industryinsights/neandertal-gene-variants-both-increase-a-325941.html 0.6 2026-06-21T09:10:08+08:00 daily https://www.pharmasources.com/industryinsights/deep-longevity-publishes-article-about-p-325942.html 0.6 2026-08-10T15:18:06+08:00 daily https://www.pharmasources.com/industryinsights/atlas-antibodies-acquires-histocyte-labo-325943.html 0.6 2026-08-07T01:10:51+08:00 daily https://www.pharmasources.com/industryinsights/china-approves-clinical-trials-for-16-in-325944.html 0.6 2026-08-07T01:06:57+08:00 daily https://www.pharmasources.com/industryinsights/serum-institute-of-india-says-prioritisi-325945.html 0.6 2026-08-07T01:14:07+08:00 daily https://www.pharmasources.com/industryinsights/uk-to-provide-covid-19-vaccine-to-all-ad-325946.html 0.6 2026-08-10T04:55:24+08:00 daily https://www.pharmasources.com/industryinsights/world-bank-striving-for-standard-vaccine-325947.html 0.6 2026-08-07T02:40:40+08:00 daily https://www.pharmasources.com/industryinsights/cci-commences-consultation-process-for-p-325948.html 0.6 2026-08-07T02:45:43+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-initiates-process-for-eua-of-s-325949.html 0.6 2026-08-08T03:52:52+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-gets-marketing-approval-for-rya-325950.html 0.6 2026-08-11T16:37:37+08:00 daily https://www.pharmasources.com/industryinsights/serbia-gets-shipment-of-astrazeneca-covi-325951.html 0.6 2026-08-12T06:17:04+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-drug-to-reduce-bone-marrow--325952.html 0.6 2026-06-20T15:55:25+08:00 daily https://www.pharmasources.com/industryinsights/celsion-announces-formation-of-vaccine-a-325953.html 0.6 2026-06-22T13:00:28+08:00 daily https://www.pharmasources.com/industryinsights/xeris-receives-european-commission-appro-325954.html 0.6 2026-06-21T23:57:43+08:00 daily https://www.pharmasources.com/industryinsights/catapult-receives-fda-clearance-of-ind-f-325955.html 0.6 2026-06-21T11:02:11+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-evkeeza-325956.html 0.6 2026-08-08T03:26:32+08:00 daily https://www.pharmasources.com/industryinsights/evonik-announces-partnership-with-bionte-325957.html 0.6 2026-06-22T06:58:50+08:00 daily https://www.pharmasources.com/industryinsights/new-social-media-campaign-launched-to-su-325958.html 0.6 2026-06-21T12:00:12+08:00 daily https://www.pharmasources.com/industryinsights/oxford-university-to-develop-alzheimers--325959.html 0.6 2026-06-21T17:08:30+08:00 daily https://www.pharmasources.com/industryinsights/imu-838-shows-some-clinical-benefit-in-m-325960.html 0.6 2026-07-04T12:24:10+08:00 daily https://www.pharmasources.com/industryinsights/could-a-nasal-spray-prevent-coronavirus--325961.html 0.6 2026-06-28T19:35:58+08:00 daily https://www.pharmasources.com/industryinsights/antibody-response-may-drive-covid-19-out-325962.html 0.6 2026-06-21T02:48:35+08:00 daily https://www.pharmasources.com/industryinsights/gan-lee-announces-new-partnership-with-i-325963.html 0.6 2026-07-31T02:51:49+08:00 daily https://www.pharmasources.com/industryinsights/elekta-establishes-office-in-egypt-to-me-325964.html 0.6 2026-06-21T07:54:23+08:00 daily https://www.pharmasources.com/industryinsights/gannex-announces-positive-clinical-resul-325965.html 0.6 2026-08-02T16:57:31+08:00 daily https://www.pharmasources.com/industryinsights/china-sxt-pharmaceuticals-inc-announces--325966.html 0.6 2026-07-20T11:01:44+08:00 daily https://www.pharmasources.com/industryinsights/onward-therapeutics-makes-a-strategic-in-325967.html 0.6 2026-06-21T00:02:40+08:00 daily https://www.pharmasources.com/industryinsights/bionic-vision-technologies-advances-clin-325968.html 0.6 2026-06-21T13:00:23+08:00 daily https://www.pharmasources.com/industryinsights/gsk-sanofi-begin-new-covid-19-vaccine-st-325969.html 0.6 2026-06-21T03:11:48+08:00 daily https://www.pharmasources.com/industryinsights/dr-rajeev-singh-raghuvanshi-appointed-se-325970.html 0.6 2026-06-21T13:02:31+08:00 daily https://www.pharmasources.com/industryinsights/vivimed-labs-gets-approval-for-one-produ-325971.html 0.6 2026-06-24T03:11:06+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-launch-lansoprazole-dr-orally--325972.html 0.6 2026-07-29T08:11:07+08:00 daily https://www.pharmasources.com/industryinsights/windlas-biotech-mateon-therapeutics-part-325973.html 0.6 2026-07-06T20:14:03+08:00 daily https://www.pharmasources.com/industryinsights/who-agrees-on-compensation-plan-in-case--325974.html 0.6 2026-06-21T07:03:57+08:00 daily https://www.pharmasources.com/industryinsights/fpme-requests-fm-to-continue-section-16--325975.html 0.6 2026-04-13T07:35:51+08:00 daily https://www.pharmasources.com/industryinsights/vaccination-offers-consistent-long-term--325976.html 0.6 2026-08-10T08:49:20+08:00 daily https://www.pharmasources.com/industryinsights/novalgen-and-halix-enter-strategic-partn-325977.html 0.6 2026-08-14T05:25:08+08:00 daily https://www.pharmasources.com/industryinsights/avid-bioservices-begins-phase-2-of-myfor-325978.html 0.6 2026-07-29T18:00:09+08:00 daily https://www.pharmasources.com/industryinsights/russia-grants-approval-to-third-covid-19-325979.html 0.6 2026-06-17T19:20:50+08:00 daily https://www.pharmasources.com/industryinsights/eu-contributes-extra-500m-to-covax-facil-325980.html 0.6 2026-06-22T00:01:44+08:00 daily https://www.pharmasources.com/industryinsights/humacyte-agrees-spac-merger-to-go-public-325981.html 0.6 2026-06-21T07:38:41+08:00 daily https://www.pharmasources.com/industryinsights/novavax-concludes-subject-enrolment-in-c-325982.html 0.6 2026-06-20T21:06:58+08:00 daily https://www.pharmasources.com/industryinsights/anteotechs-anteobind-technology-supports-325983.html 0.6 2026-07-07T00:06:19+08:00 daily https://www.pharmasources.com/industryinsights/blackfynn-builds-therapeutic-pipeline-wi-325984.html 0.6 2026-06-22T08:57:41+08:00 daily https://www.pharmasources.com/industryinsights/cascade-chemistry-initiates-expansion-of-325985.html 0.6 2026-06-14T00:01:31+08:00 daily https://www.pharmasources.com/industryinsights/fda-issues-policies-to-guide-medical-pro-325986.html 0.6 2026-06-21T00:57:49+08:00 daily https://www.pharmasources.com/industryinsights/jj-announces-single-shot-janssen-covid-1-325987.html 0.6 2026-08-06T06:11:59+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-libtayo-325988.html 0.6 2026-08-10T23:49:09+08:00 daily https://www.pharmasources.com/industryinsights/tris-pharma-athena-bioscience-enter-excl-325989.html 0.6 2026-06-20T20:02:05+08:00 daily https://www.pharmasources.com/industryinsights/aevitas-therapeutics-appoints-president--325990.html 0.6 2026-06-21T02:10:54+08:00 daily https://www.pharmasources.com/industryinsights/maxivax-minaris-enter-cell-therapy-mfg-a-325991.html 0.6 2026-06-20T19:46:29+08:00 daily https://www.pharmasources.com/industryinsights/medica-establishes-joint-venture-partner-325992.html 0.6 2026-06-21T11:08:15+08:00 daily https://www.pharmasources.com/industryinsights/onk-therapeutics-enters-collaboration-wi-325993.html 0.6 2026-06-20T23:09:44+08:00 daily https://www.pharmasources.com/industryinsights/nhs-to-open-mental-health-support-hubs-d-325994.html 0.6 2026-06-20T23:04:50+08:00 daily https://www.pharmasources.com/industryinsights/az-withdraws-imfinzi-indication-in-the-u-325995.html 0.6 2026-08-14T03:22:28+08:00 daily https://www.pharmasources.com/industryinsights/uk-grants-marketing-authorisation-to-lan-325996.html 0.6 2026-06-21T04:12:56+08:00 daily https://www.pharmasources.com/industryinsights/new-progress-in-study-on-mechanism-of-li-325997.html 0.6 2026-08-09T04:13:13+08:00 daily https://www.pharmasources.com/industryinsights/molecular-stethoscope-announces-publicat-325998.html 0.6 2026-08-09T03:46:14+08:00 daily https://www.pharmasources.com/industryinsights/the-bcma-car-t-co-developed-by-innovent--325999.html 0.6 2026-08-09T01:21:54+08:00 daily https://www.pharmasources.com/industryinsights/anchordx-completes-usd-40-million-series-326000.html 0.6 2026-08-08T22:51:30+08:00 daily https://www.pharmasources.com/industryinsights/c2-pharma-completes-multiple-regulatory--326001.html 0.6 2026-08-07T02:40:17+08:00 daily https://www.pharmasources.com/industryinsights/opportunities-for-chinauk-trade-in-a-pos-326002.html 0.6 2026-08-07T00:40:07+08:00 daily https://www.pharmasources.com/industryinsights/acg-launches-acg-laboratories-a-process--326003.html 0.6 2026-08-07T13:18:18+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-says-trials-of-modified-vaccines--326004.html 0.6 2026-08-09T07:36:50+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-to-launch-entire-range-of-bri-326005.html 0.6 2026-06-30T07:58:24+08:00 daily https://www.pharmasources.com/industryinsights/indian-pharma-companies-say-they-can-qui-326006.html 0.6 2026-06-22T04:13:19+08:00 daily https://www.pharmasources.com/industryinsights/regulatory-agencies-have-provided-variou-326007.html 0.6 2026-08-03T10:59:42+08:00 daily https://www.pharmasources.com/industryinsights/usfda-denies-application-from-sparc-for--326008.html 0.6 2026-06-21T06:56:57+08:00 daily https://www.pharmasources.com/industryinsights/expiry-and-shelf-life-of-drug-products-326009.html 0.6 2026-08-13T18:58:41+08:00 daily https://www.pharmasources.com/industryinsights/india-sends-first-covid-19-vaccine-shipm-326010.html 0.6 2026-08-13T08:00:33+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-accused-of-bullying-latin-america-326011.html 0.6 2026-06-21T02:51:42+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-biontech-submit-covid-19-vaccine--326012.html 0.6 2026-07-15T21:27:41+08:00 daily https://www.pharmasources.com/industryinsights/astellas-seagen-submit-sblas-for-padcev--326013.html 0.6 2026-07-18T20:09:42+08:00 daily https://www.pharmasources.com/industryinsights/fda-authorizes-everlywells-covid-19-test-326014.html 0.6 2026-06-20T22:19:01+08:00 daily https://www.pharmasources.com/industryinsights/data-safety-monitoring-committee-green-l-326015.html 0.6 2026-03-01T16:46:13+08:00 daily https://www.pharmasources.com/industryinsights/ec-grants-orphan-designation-to-sparsent-326016.html 0.6 2026-07-28T23:46:27+08:00 daily https://www.pharmasources.com/industryinsights/r-ketamine-demonstrates-tolerability-in--326017.html 0.6 2026-06-29T08:00:52+08:00 daily https://www.pharmasources.com/industryinsights/proterixbio-announces-commercial-availab-326018.html 0.6 2026-08-11T13:17:19+08:00 daily https://www.pharmasources.com/industryinsights/zymo-launches-covid-19-sequencing-servic-326019.html 0.6 2026-06-30T17:04:41+08:00 daily https://www.pharmasources.com/industryinsights/molecular-templates-establishes-multi-ta-326020.html 0.6 2026-07-12T13:16:43+08:00 daily https://www.pharmasources.com/industryinsights/aegis-walgreens-announce-expansion-of-co-326021.html 0.6 2026-04-13T22:42:24+08:00 daily https://www.pharmasources.com/industryinsights/genscript-receives-eua-for-use-of-cpass--326022.html 0.6 2026-06-20T20:20:52+08:00 daily https://www.pharmasources.com/industryinsights/university-researcher-analyzes-herbal-su-326023.html 0.6 2026-08-05T20:21:01+08:00 daily https://www.pharmasources.com/industryinsights/glatt-and-aprecia-enter-3d-printing-coll-326024.html 0.6 2026-03-31T10:03:12+08:00 daily https://www.pharmasources.com/industryinsights/catalent-acquires-delphi-genetics-326025.html 0.6 2026-03-27T00:07:02+08:00 daily https://www.pharmasources.com/industryinsights/almac-group-completes-7m-rd-center-326026.html 0.6 2026-06-21T09:55:57+08:00 daily https://www.pharmasources.com/industryinsights/amgen-looks-to-expand-access-to-otezla-i-326027.html 0.6 2026-08-10T20:11:19+08:00 daily https://www.pharmasources.com/industryinsights/uk-sees-a-20-growth-in-the-number-of-adv-326028.html 0.6 2026-06-21T06:43:40+08:00 daily https://www.pharmasources.com/industryinsights/rentschler-biopharma-to-build-cell-and-g-326029.html 0.6 2026-06-21T07:19:17+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisks-semaglutide-cuts-body-weig-326030.html 0.6 2026-06-21T20:08:47+08:00 daily https://www.pharmasources.com/industryinsights/upadacitinib-meets-all-endpoints-in-phas-326031.html 0.6 2026-06-22T11:02:51+08:00 daily https://www.pharmasources.com/industryinsights/fda-issues-new-guidance-for-developers-o-326032.html 0.6 2026-07-02T23:10:42+08:00 daily https://www.pharmasources.com/industryinsights/scientists-repair-spinal-cord-injuries-u-326033.html 0.6 2026-06-22T05:42:31+08:00 daily https://www.pharmasources.com/industryinsights/the-global-smart-syringe-market-should-s-326034.html 0.6 2026-06-21T21:54:51+08:00 daily https://www.pharmasources.com/industryinsights/decodr-app-identifies-unintentional-dna--326035.html 0.6 2026-07-05T01:22:16+08:00 daily https://www.pharmasources.com/industryinsights/additional-positive-interim-results-from-326036.html 0.6 2025-12-02T05:58:21+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-diagnostics-secures-us150-million-s-326037.html 0.6 2026-08-09T00:48:57+08:00 daily https://www.pharmasources.com/industryinsights/antengene-announces-nda-for-atg-010-seli-326038.html 0.6 2026-07-29T17:54:21+08:00 daily https://www.pharmasources.com/industryinsights/ukraine-delegation-visit-bharat-biotechs-326039.html 0.6 2026-06-21T12:58:37+08:00 daily https://www.pharmasources.com/industryinsights/tackling-substandard-and-falsified-medic-326040.html 0.6 2026-07-24T21:44:57+08:00 daily https://www.pharmasources.com/industryinsights/chemical-synthesis-and-bulk-sourcing-of--326041.html 0.6 2026-08-06T12:11:29+08:00 daily https://www.pharmasources.com/industryinsights/cabinet-nod-for-pharma-pli-scheme-326042.html 0.6 2026-06-20T22:58:18+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-expects-eua-in-us-for-covid--326043.html 0.6 2026-08-10T06:02:38+08:00 daily https://www.pharmasources.com/industryinsights/granules-india-gets-usfda-approval-for-o-326044.html 0.6 2026-07-17T05:30:08+08:00 daily https://www.pharmasources.com/industryinsights/strides-gets-usfda-nod-for-ibuprofen-otc-326045.html 0.6 2026-07-02T12:18:14+08:00 daily https://www.pharmasources.com/industryinsights/telangana-government-collaborates-with-c-326046.html 0.6 2026-07-09T10:23:07+08:00 daily https://www.pharmasources.com/industryinsights/celltrion-develops-neutralising-antibody-326047.html 0.6 2026-07-02T21:20:41+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-gets-usfda-approval-for-clindam-326048.html 0.6 2026-07-30T08:44:27+08:00 daily https://www.pharmasources.com/industryinsights/parexel-and-neogenomics-announce-partner-326049.html 0.6 2026-06-23T13:01:01+08:00 daily https://www.pharmasources.com/industryinsights/uk-government-extends-contract-with-wock-326050.html 0.6 2026-07-04T10:18:57+08:00 daily https://www.pharmasources.com/industryinsights/fda-updates-covid-19-variant-guidance-fo-326051.html 0.6 2026-01-14T10:36:41+08:00 daily https://www.pharmasources.com/industryinsights/sinovacs-covid-19-vaccine-gets-approval--326052.html 0.6 2026-04-06T22:27:09+08:00 daily https://www.pharmasources.com/industryinsights/cdc-adds-cetirizine-as-therapy-for-anaph-326053.html 0.6 2026-02-28T13:51:05+08:00 daily https://www.pharmasources.com/industryinsights/ucb-and-microsoft-expand-drug-developmen-326054.html 0.6 2026-08-07T22:31:43+08:00 daily https://www.pharmasources.com/industryinsights/altasciences-contributes-to-vibegron-app-326055.html 0.6 2026-06-21T14:47:18+08:00 daily https://www.pharmasources.com/industryinsights/cyprium-sentynl-therapeutics-ink-asset-p-326056.html 0.6 2026-06-21T05:19:03+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-selects-seven-bridges-to-support--326057.html 0.6 2026-08-10T10:27:52+08:00 daily https://www.pharmasources.com/industryinsights/pwc-joins-medicines-manufacturing-innova-326058.html 0.6 2026-06-21T03:55:53+08:00 daily https://www.pharmasources.com/industryinsights/dynavax-secures-ec-marketing-authorisati-326059.html 0.6 2026-08-09T23:58:25+08:00 daily https://www.pharmasources.com/industryinsights/usfda-grants-ftd-to-efanesoctocog-alfa-f-326060.html 0.6 2026-08-07T01:14:13+08:00 daily https://www.pharmasources.com/industryinsights/otividex-trial-for-mnires-disease-does-n-326061.html 0.6 2026-08-07T00:41:33+08:00 daily https://www.pharmasources.com/industryinsights/intra-cellular-therapies-applies-for-fda-326062.html 0.6 2026-08-07T00:42:49+08:00 daily https://www.pharmasources.com/industryinsights/brainstorm-receives-fda-feedback-on-als--326063.html 0.6 2026-08-07T00:53:06+08:00 daily https://www.pharmasources.com/industryinsights/gala-therapeutics-receives-fda-approval--326064.html 0.6 2026-08-07T01:19:20+08:00 daily https://www.pharmasources.com/industryinsights/exciting-new-covid-19-development-vironi-326065.html 0.6 2026-08-07T01:27:53+08:00 daily https://www.pharmasources.com/industryinsights/ocugens-inherited-retinal-disease-gene-t-326066.html 0.6 2026-08-07T01:31:29+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-partners-with-sirion-to-improve-a-326067.html 0.6 2026-08-10T15:15:22+08:00 daily https://www.pharmasources.com/industryinsights/parkinsons-uk-creates-vivifi-biotech-to--326068.html 0.6 2026-06-21T07:01:55+08:00 daily https://www.pharmasources.com/industryinsights/nhs-england-to-trial-at-home-smear-testi-326069.html 0.6 2026-03-12T18:29:13+08:00 daily https://www.pharmasources.com/industryinsights/synairgens-inhaled-covid-19-treatment-in-326070.html 0.6 2026-03-20T22:52:17+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-gsk-start-phase-ii-study-of-t-326071.html 0.6 2026-08-06T12:54:04+08:00 daily https://www.pharmasources.com/industryinsights/partnership-to-develop-a-microneedle-pat-326072.html 0.6 2026-08-07T00:53:42+08:00 daily https://www.pharmasources.com/industryinsights/patient-dosed-with-first-lassa-fever-vac-326073.html 0.6 2026-03-27T09:41:10+08:00 daily https://www.pharmasources.com/industryinsights/uk-to-revolutionise-oligonucleotide-medi-326074.html 0.6 2026-06-21T07:04:59+08:00 daily https://www.pharmasources.com/industryinsights/scientists-call-for-investment-into-nove-326075.html 0.6 2026-06-22T03:41:33+08:00 daily https://www.pharmasources.com/industryinsights/pax-101-meaningfully-improves-core-sympt-326076.html 0.6 2026-06-21T02:58:43+08:00 daily https://www.pharmasources.com/industryinsights/global-anti-parkinsons-drugs-market-to-b-326077.html 0.6 2026-04-20T20:30:40+08:00 daily https://www.pharmasources.com/industryinsights/new-fdi-world-dental-federation-global-s-326078.html 0.6 2026-06-22T01:46:26+08:00 daily https://www.pharmasources.com/industryinsights/genome-company-and-debiopharm-join-force-326079.html 0.6 2026-06-21T12:54:45+08:00 daily https://www.pharmasources.com/industryinsights/icpa-launches-antibiotic-for-odontogenic-326080.html 0.6 2026-06-20T19:52:31+08:00 daily https://www.pharmasources.com/industryinsights/govt-of-india-gives-india-pharma-innovat-326081.html 0.6 2026-06-20T23:54:34+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-final-us-fda-approval--326082.html 0.6 2026-06-22T10:53:57+08:00 daily https://www.pharmasources.com/industryinsights/researchers-from-iit-madras-identify-alt-326083.html 0.6 2026-08-07T15:07:02+08:00 daily https://www.pharmasources.com/industryinsights/industry-welcomes-pli-20-scheme-awaits-i-326084.html 0.6 2026-08-08T03:25:23+08:00 daily https://www.pharmasources.com/industryinsights/piyush-goyal-asks-pharma-industry-to-str-326085.html 0.6 2026-08-08T04:27:56+08:00 daily https://www.pharmasources.com/industryinsights/fda-finds-jjs-single-dose-covid-19-vacci-326086.html 0.6 2026-08-08T05:07:07+08:00 daily https://www.pharmasources.com/industryinsights/egyptian-drug-authority-approves-sputnik-326087.html 0.6 2026-08-08T07:43:50+08:00 daily https://www.pharmasources.com/industryinsights/ema-begins-review-of-celltrions-antibody-326088.html 0.6 2026-08-08T10:11:03+08:00 daily https://www.pharmasources.com/industryinsights/bayer-reports-steady-2020-performance-de-326089.html 0.6 2026-08-09T06:59:24+08:00 daily https://www.pharmasources.com/industryinsights/high-purity-new-england-bolsters-biophar-326090.html 0.6 2026-06-20T18:54:49+08:00 daily https://www.pharmasources.com/industryinsights/amri-contributes-to-efforts-to-increase--326091.html 0.6 2026-07-17T19:02:29+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-partners-with-medicines-manufactu-326092.html 0.6 2026-08-12T13:48:11+08:00 daily https://www.pharmasources.com/industryinsights/crownbio-jsr-life-sciences-partner-with--326093.html 0.6 2026-06-21T01:58:38+08:00 daily https://www.pharmasources.com/industryinsights/bormioli-opens-new-glass-research-center-326094.html 0.6 2026-08-13T15:14:09+08:00 daily https://www.pharmasources.com/industryinsights/cartesian-initiates-phase-2-clinical-tri-326095.html 0.6 2026-07-08T19:42:48+08:00 daily https://www.pharmasources.com/industryinsights/compugen-expands-collaboration-with-bris-326096.html 0.6 2026-08-07T00:03:05+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharma-announces-planned-expa-326097.html 0.6 2026-08-06T23:55:35+08:00 daily https://www.pharmasources.com/industryinsights/fda-provides-specific-compounded-drug-co-326098.html 0.6 2026-08-06T23:45:13+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-tick-borne-encephalitis-vaccine--326099.html 0.6 2026-08-06T23:36:44+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-invests-in-facility-expansi-326100.html 0.6 2026-08-06T22:31:50+08:00 daily https://www.pharmasources.com/industryinsights/moderna-sends-south-africa-variant-speci-326101.html 0.6 2026-08-09T09:51:05+08:00 daily https://www.pharmasources.com/industryinsights/nhs-commercial-framework-provides-welcom-326102.html 0.6 2026-08-07T03:24:43+08:00 daily https://www.pharmasources.com/industryinsights/zyesami-shows-promise-in-critical-covid--326103.html 0.6 2026-08-10T15:15:53+08:00 daily https://www.pharmasources.com/industryinsights/novel-shows-promise-in-phase-ii-schizoph-326104.html 0.6 2026-08-07T03:24:41+08:00 daily https://www.pharmasources.com/industryinsights/tigermed-supported-and-delivered-clinica-326105.html 0.6 2026-08-07T03:02:40+08:00 daily https://www.pharmasources.com/industryinsights/ide-cel-provides-lasting-remissions-in-m-326106.html 0.6 2026-08-10T12:45:15+08:00 daily https://www.pharmasources.com/industryinsights/vela-diagnostics-adds-two-sars-cov-2-ass-326107.html 0.6 2026-08-06T23:44:53+08:00 daily https://www.pharmasources.com/industryinsights/kyushu-university-confirms-horiuchi-l-fu-326108.html 0.6 2026-08-06T23:36:56+08:00 daily https://www.pharmasources.com/industryinsights/real-world-effectiveness-of-covid-19-vac-326109.html 0.6 2026-08-06T23:45:41+08:00 daily https://www.pharmasources.com/industryinsights/researchers-reveal-genetic-predispositio-326110.html 0.6 2026-08-06T23:48:47+08:00 daily https://www.pharmasources.com/industryinsights/us-gives-eua-jjs-covid-19-vaccine-326111.html 0.6 2026-08-06T23:57:19+08:00 daily https://www.pharmasources.com/industryinsights/hoarding-of-covid-19-vaccines-are-threat-326112.html 0.6 2026-08-10T12:39:54+08:00 daily https://www.pharmasources.com/industryinsights/sales-of-injectable-anti-hiv-therapeutic-326113.html 0.6 2026-07-16T16:59:52+08:00 daily https://www.pharmasources.com/industryinsights/bharat-biotech-signs-supply-deal-with-br-326114.html 0.6 2026-03-18T11:48:48+08:00 daily https://www.pharmasources.com/industryinsights/natco-launches-brivaracetam-tablets-in-i-326115.html 0.6 2026-06-21T00:16:50+08:00 daily https://www.pharmasources.com/industryinsights/amneal-gets-usfda-approval-for-norelgest-326116.html 0.6 2026-06-30T03:16:12+08:00 daily https://www.pharmasources.com/industryinsights/researchers-at-strathclyde-university-st-326117.html 0.6 2026-06-21T10:04:12+08:00 daily https://www.pharmasources.com/industryinsights/biocon-biologics-and-viatris-get-chmp-no-326118.html 0.6 2026-06-22T01:07:55+08:00 daily https://www.pharmasources.com/industryinsights/grace-to-expand-pharma-portfolio-with-al-326119.html 0.6 2026-06-21T02:51:38+08:00 daily https://www.pharmasources.com/industryinsights/panel-finds-efficacy-for-regenerons-rege-326120.html 0.6 2026-08-10T12:56:05+08:00 daily https://www.pharmasources.com/industryinsights/merck-signs-agreement-to-buy-pandion-the-326121.html 0.6 2026-07-23T10:41:51+08:00 daily https://www.pharmasources.com/industryinsights/kura-oncology-receives-fda-breakthrough--326122.html 0.6 2026-07-07T03:57:06+08:00 daily https://www.pharmasources.com/industryinsights/elicio-announces-ind-for-vaccine-targeti-326123.html 0.6 2026-06-21T04:00:02+08:00 daily https://www.pharmasources.com/industryinsights/quest-diagnostics-introduces-new-covid-1-326124.html 0.6 2026-06-22T17:55:50+08:00 daily https://www.pharmasources.com/industryinsights/akero-initiates-phase-2b-harmony-study-o-326125.html 0.6 2026-08-09T06:59:39+08:00 daily https://www.pharmasources.com/industryinsights/spark-therapeutics-appoints-cto-326126.html 0.6 2026-08-07T13:17:59+08:00 daily https://www.pharmasources.com/industryinsights/wayra-ge-healthcare-launch-accelerator-p-326127.html 0.6 2026-08-07T22:48:55+08:00 daily https://www.pharmasources.com/industryinsights/icon-to-acquire-pra-health-sciences-in-1-326128.html 0.6 2026-08-07T13:15:41+08:00 daily https://www.pharmasources.com/industryinsights/gsks-covid-19-antibody-shows-potential-i-326129.html 0.6 2026-06-21T06:50:59+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-routine-funding-for-nova-326130.html 0.6 2026-06-20T23:05:39+08:00 daily https://www.pharmasources.com/industryinsights/ema-issues-its-requirements-for-adapting-326131.html 0.6 2026-08-08T07:33:55+08:00 daily https://www.pharmasources.com/industryinsights/leukine-significantly-improves-lung-func-326132.html 0.6 2026-06-20T22:57:45+08:00 daily https://www.pharmasources.com/industryinsights/treatment-for-rare-duchenne-muscular-dys-326133.html 0.6 2026-06-20T17:14:38+08:00 daily https://www.pharmasources.com/industryinsights/innovent-announces-first-patient-outside-326134.html 0.6 2026-08-11T22:08:47+08:00 daily https://www.pharmasources.com/industryinsights/qilu-pharmaceutical-achieved-staggering--326135.html 0.6 2026-08-14T13:17:14+08:00 daily https://www.pharmasources.com/industryinsights/neutralizing-antibodies-the-specific-dru-326136.html 0.6 2026-08-03T10:57:06+08:00 daily https://www.pharmasources.com/industryinsights/sciwinds-investigational-new-drug-approv-326137.html 0.6 2026-08-14T11:41:48+08:00 daily https://www.pharmasources.com/industryinsights/everest-medicines-announces-selection-as-326138.html 0.6 2026-06-21T18:18:49+08:00 daily https://www.pharmasources.com/industryinsights/avalon-steritech-and-softbank-robotics-g-326139.html 0.6 2026-06-23T06:14:18+08:00 daily https://www.pharmasources.com/industryinsights/arthritis-drugs-may-reduce-mortality-and-326140.html 0.6 2026-06-20T23:20:02+08:00 daily https://www.pharmasources.com/industryinsights/scientific-community-rose-to-occasion-wh-326141.html 0.6 2026-05-05T20:23:30+08:00 daily https://www.pharmasources.com/industryinsights/cipla-gulf-expands-partnership-with-alvo-326142.html 0.6 2026-06-21T09:12:19+08:00 daily https://www.pharmasources.com/industryinsights/liability-for-covid-vaccines-in-india-wh-326143.html 0.6 2026-07-30T10:32:53+08:00 daily https://www.pharmasources.com/industryinsights/jjs-covid-19-shot-gets-cdc-panel-backing-326144.html 0.6 2026-06-21T02:13:47+08:00 daily https://www.pharmasources.com/industryinsights/biocon-biologics-promotes-shreehas-tambe-326145.html 0.6 2026-04-23T18:15:09+08:00 daily https://www.pharmasources.com/industryinsights/fauci-says-of-johnson-johnson-covid-19-v-326146.html 0.6 2026-06-30T22:14:31+08:00 daily https://www.pharmasources.com/industryinsights/israel-to-provide-covid-vaccines-to-sina-326147.html 0.6 2026-03-28T23:55:55+08:00 daily https://www.pharmasources.com/industryinsights/australasian-covid-19-trial-opens-in-ind-326148.html 0.6 2026-08-08T08:33:59+08:00 daily https://www.pharmasources.com/industryinsights/chmp-opinions-ema-refuses-asthma-label-e-326149.html 0.6 2026-08-11T15:42:19+08:00 daily https://www.pharmasources.com/industryinsights/takeda-to-sell-diabetes-products-portfol-326150.html 0.6 2026-07-01T21:01:05+08:00 daily https://www.pharmasources.com/industryinsights/fda-authorises-emergency-use-of-janssens-326151.html 0.6 2026-06-27T15:15:49+08:00 daily https://www.pharmasources.com/industryinsights/partner-therapeutics-inhaled-sargramosti-326152.html 0.6 2026-06-21T16:12:43+08:00 daily https://www.pharmasources.com/industryinsights/reshaping-the-pharmaceutical-supply-chai-326153.html 0.6 2026-06-21T13:45:48+08:00 daily https://www.pharmasources.com/industryinsights/icon-to-acquire-pra-health-sciences-326154.html 0.6 2026-08-07T14:13:47+08:00 daily https://www.pharmasources.com/industryinsights/phlow-corp-and-usp-form-alliance-326155.html 0.6 2026-08-09T01:42:24+08:00 daily https://www.pharmasources.com/industryinsights/arcline-investment-acquires-chargepoint--326156.html 0.6 2026-07-07T05:00:19+08:00 daily https://www.pharmasources.com/industryinsights/cryoport-launches-esg-program-326157.html 0.6 2025-12-16T23:33:36+08:00 daily https://www.pharmasources.com/industryinsights/us-govt-purchases-100k-doses-of-lillys-c-326158.html 0.6 2026-07-04T01:59:44+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-scientific-completes-mesa--326159.html 0.6 2026-07-02T16:32:58+08:00 daily https://www.pharmasources.com/industryinsights/bms-expands-cell-therapy-manufacturing-c-326160.html 0.6 2026-06-03T16:18:26+08:00 daily https://www.pharmasources.com/industryinsights/sinopharm-seeks-eua-for-covid-19-vaccine-326161.html 0.6 2026-06-20T14:33:06+08:00 daily https://www.pharmasources.com/industryinsights/aivita-completes-phase-1-study-of-person-326162.html 0.6 2026-06-21T11:55:08+08:00 daily https://www.pharmasources.com/industryinsights/fda-issues-emergency-use-authorization-f-326163.html 0.6 2026-06-21T01:03:49+08:00 daily https://www.pharmasources.com/industryinsights/humira-receives-fda-approval-to-treat-pe-326164.html 0.6 2026-06-18T07:56:00+08:00 daily https://www.pharmasources.com/industryinsights/genomics-plc-scores-30m-to-expand-patien-326165.html 0.6 2026-04-07T21:35:16+08:00 daily https://www.pharmasources.com/industryinsights/tribunal-upholds-cmas-decision-to-fine-l-326166.html 0.6 2026-08-09T22:51:26+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-nulibry-to-treat-molybdenum-326167.html 0.6 2026-08-08T20:04:47+08:00 daily https://www.pharmasources.com/industryinsights/evrysdi-leads-latest-chmp-recommendation-326168.html 0.6 2026-08-08T17:53:34+08:00 daily https://www.pharmasources.com/industryinsights/tezepelumab-significantly-reduces-exacer-326169.html 0.6 2026-08-12T22:51:24+08:00 daily https://www.pharmasources.com/industryinsights/novel-nanocarrier-enables-targeted-treat-326170.html 0.6 2026-08-07T13:19:32+08:00 daily https://www.pharmasources.com/industryinsights/cipla-receives-final-approval-for-generi-326171.html 0.6 2026-08-09T16:50:28+08:00 daily https://www.pharmasources.com/industryinsights/oscotec-and-beactica-therapeutics-announ-326172.html 0.6 2026-08-07T01:36:31+08:00 daily https://www.pharmasources.com/industryinsights/kazia-licenses-cantrixil-a-clinical-stag-326173.html 0.6 2026-08-07T01:27:30+08:00 daily https://www.pharmasources.com/industryinsights/inovio-announces-positive-results-from-r-326174.html 0.6 2026-08-07T01:21:43+08:00 daily https://www.pharmasources.com/industryinsights/lupin-launches-generic-drug-to-treat-wil-326175.html 0.6 2026-08-07T01:21:45+08:00 daily https://www.pharmasources.com/industryinsights/who-chief-scientist-says-india-exhibited-326176.html 0.6 2026-06-22T04:12:52+08:00 daily https://www.pharmasources.com/industryinsights/dr-ranjit-barshikar-honoured-with-qualit-326177.html 0.6 2026-06-21T21:57:39+08:00 daily https://www.pharmasources.com/industryinsights/how-data-mapping-can-make-distribution-o-326178.html 0.6 2026-07-01T01:11:51+08:00 daily https://www.pharmasources.com/industryinsights/uk-to-receive-10-million-astrazeneca-cov-326179.html 0.6 2026-06-20T22:04:42+08:00 daily https://www.pharmasources.com/industryinsights/biocon-biologics-appoints-susheel-umesh--326180.html 0.6 2026-06-20T19:10:55+08:00 daily https://www.pharmasources.com/industryinsights/chinese-hackers-target-indian-vaccine-ma-326181.html 0.6 2026-08-04T23:49:40+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-oxford-vaccine-reduce-infection-r-326182.html 0.6 2026-06-21T05:03:46+08:00 daily https://www.pharmasources.com/industryinsights/cerecors-antibody-reduces-respiratory-fa-326183.html 0.6 2026-08-07T22:23:39+08:00 daily https://www.pharmasources.com/industryinsights/cruk-teams-up-with-teon-to-trial-first-i-326184.html 0.6 2026-06-20T22:04:38+08:00 daily https://www.pharmasources.com/industryinsights/business-optimism-remains-unchanged-in-f-326185.html 0.6 2026-06-21T03:03:41+08:00 daily https://www.pharmasources.com/industryinsights/who-panel-advises-against-use-of-hydroxy-326186.html 0.6 2026-07-17T18:26:45+08:00 daily https://www.pharmasources.com/industryinsights/veru-to-progress-covid-19-drug-into-phas-326187.html 0.6 2026-06-21T13:05:41+08:00 daily https://www.pharmasources.com/industryinsights/fusion-pharmaceuticals-acquires-ipn-1087-326188.html 0.6 2026-05-12T17:10:18+08:00 daily https://www.pharmasources.com/industryinsights/strata-oncology-unveils-strata-path-tria-326189.html 0.6 2026-06-21T01:05:50+08:00 daily https://www.pharmasources.com/industryinsights/alimentiv-acquires-mcdougall-scientific-326190.html 0.6 2026-06-21T13:05:27+08:00 daily https://www.pharmasources.com/industryinsights/q-biomed-inks-strontium89-supply-pact-326191.html 0.6 2026-06-20T22:29:10+08:00 daily https://www.pharmasources.com/industryinsights/pci-pharma-services-appoints-svp-cfo-326192.html 0.6 2026-06-21T09:06:01+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-opts-to-acquire-mitokinin-326193.html 0.6 2026-06-21T02:43:36+08:00 daily https://www.pharmasources.com/industryinsights/impel-neuropharma-expands-commercial-tea-326194.html 0.6 2026-06-20T21:52:52+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-apptec-completes-oxgene-acquisition-326195.html 0.6 2026-08-09T08:44:57+08:00 daily https://www.pharmasources.com/industryinsights/leukine-trial-in-hospitalized-covid-19-p-326196.html 0.6 2026-06-21T00:07:39+08:00 daily https://www.pharmasources.com/industryinsights/b-braun-receives-fda-approval-for-acetam-326197.html 0.6 2026-03-17T19:55:17+08:00 daily https://www.pharmasources.com/industryinsights/chmp-adopts-positive-opinion-for-evrysdi-326198.html 0.6 2026-06-20T20:47:18+08:00 daily https://www.pharmasources.com/industryinsights/bio-rad-introduces-bio-plex-pro-human-ig-326199.html 0.6 2026-01-01T15:38:49+08:00 daily https://www.pharmasources.com/industryinsights/ers-genomics-signs-crispr-license-agreem-326200.html 0.6 2026-06-22T04:59:41+08:00 daily https://www.pharmasources.com/industryinsights/idorsia-submits-investigational-insomnia-326201.html 0.6 2026-02-15T00:39:22+08:00 daily https://www.pharmasources.com/industryinsights/nhs-prescription-charges-set-to-rise-in--326202.html 0.6 2026-06-20T22:06:39+08:00 daily https://www.pharmasources.com/industryinsights/nice-backs-selective-internal-radiation--326203.html 0.6 2026-08-14T10:02:17+08:00 daily https://www.pharmasources.com/industryinsights/cosentyx-gains-eu-approval-for-new-label-326204.html 0.6 2026-06-21T21:00:44+08:00 daily https://www.pharmasources.com/industryinsights/biotheus-announces-the-closing-of-a-new--326205.html 0.6 2026-07-07T17:56:18+08:00 daily https://www.pharmasources.com/industryinsights/seegenes-latest-covid-19-test-can-simult-326206.html 0.6 2026-06-21T06:09:48+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-gets-full-us-fda-nod-for-lorbrena-326207.html 0.6 2026-08-10T20:15:47+08:00 daily https://www.pharmasources.com/industryinsights/bharat-biotech-announces-phase-iii-resul-326208.html 0.6 2026-06-21T07:20:18+08:00 daily https://www.pharmasources.com/industryinsights/launch-of-generic-brands-for-expensive-o-326209.html 0.6 2026-08-13T12:46:49+08:00 daily https://www.pharmasources.com/industryinsights/gsk-pharma-rolls-out-multilingual-peadia-326210.html 0.6 2026-08-14T17:24:16+08:00 daily https://www.pharmasources.com/industryinsights/aleor-dermaceuticals-gets-usfda-final-no-326211.html 0.6 2026-06-20T20:04:39+08:00 daily https://www.pharmasources.com/industryinsights/merck-to-support-manufacturing-of-johnso-326212.html 0.6 2026-07-06T16:24:17+08:00 daily https://www.pharmasources.com/industryinsights/us-court-rules-in-favour-of-astrazeneca--326213.html 0.6 2026-08-02T23:04:16+08:00 daily https://www.pharmasources.com/industryinsights/nih-pauses-covid-19-convalescent-plasma--326214.html 0.6 2026-06-21T00:39:46+08:00 daily https://www.pharmasources.com/industryinsights/obviohealth-and-redhill-to-begin-remote--326215.html 0.6 2026-06-21T09:12:16+08:00 daily https://www.pharmasources.com/industryinsights/ema-validates-pfizer-and-opkos-somatrogo-326216.html 0.6 2026-06-21T02:59:45+08:00 daily https://www.pharmasources.com/industryinsights/plx-pharma-receives-fda-approval-of-snda-326217.html 0.6 2026-08-03T02:49:07+08:00 daily https://www.pharmasources.com/industryinsights/agios-submits-snda-for-tibsovo-for-idh1--326218.html 0.6 2026-06-20T15:01:09+08:00 daily https://www.pharmasources.com/industryinsights/fda-allows-more-flexible-storage-transpo-326219.html 0.6 2026-08-11T00:44:29+08:00 daily https://www.pharmasources.com/industryinsights/gw-receives-positive-chmp-opinion-for-ep-326220.html 0.6 2026-06-20T22:56:36+08:00 daily https://www.pharmasources.com/industryinsights/vbl-announces-patient-dosing-of-recurren-326221.html 0.6 2026-06-20T23:06:43+08:00 daily https://www.pharmasources.com/industryinsights/fda-authorizes-quidel-quickvue-at-home-c-326222.html 0.6 2026-06-21T01:11:56+08:00 daily https://www.pharmasources.com/industryinsights/matica-biotechnology-breaks-ground-on-ce-326223.html 0.6 2026-06-20T20:01:38+08:00 daily https://www.pharmasources.com/industryinsights/innoforce-and-dmed-enter-development-col-326224.html 0.6 2026-06-21T01:51:32+08:00 daily https://www.pharmasources.com/industryinsights/for-6219-shows-promise-in-phase-i-endome-326225.html 0.6 2026-08-12T18:24:06+08:00 daily https://www.pharmasources.com/industryinsights/positive-effects-of-psychedelic-microdos-326226.html 0.6 2026-05-31T20:19:22+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-treatments-update-hydroxychloro-326227.html 0.6 2026-08-03T05:43:43+08:00 daily https://www.pharmasources.com/industryinsights/first-person-enrolled-in-phase-i-oncolyt-326228.html 0.6 2026-08-14T10:14:47+08:00 daily https://www.pharmasources.com/industryinsights/connected-drug-delivery-devices-market-t-326229.html 0.6 2026-08-08T00:59:10+08:00 daily https://www.pharmasources.com/industryinsights/launch-of-generic-oncology-medications-t-326230.html 0.6 2026-06-21T05:53:04+08:00 daily https://www.pharmasources.com/industryinsights/wellmarkerbio-receives-approval-for-phas-326231.html 0.6 2026-07-03T14:00:02+08:00 daily https://www.pharmasources.com/industryinsights/sciclone-pharmaceuticals-officially-list-326232.html 0.6 2026-08-03T11:00:41+08:00 daily https://www.pharmasources.com/industryinsights/cmab-biopharma-congratulates-partner-inn-326233.html 0.6 2026-08-08T03:16:06+08:00 daily https://www.pharmasources.com/industryinsights/agc-biologics-announces-the-expansion-of-326235.html 0.6 2026-06-29T03:28:03+08:00 daily https://www.pharmasources.com/industryinsights/vaccine-development-software-shows-promi-326236.html 0.6 2026-06-20T19:16:53+08:00 daily https://www.pharmasources.com/industryinsights/nanoparticle-delivered-covid-19-vaccine--326237.html 0.6 2026-06-20T21:14:55+08:00 daily https://www.pharmasources.com/industryinsights/abbott-researchers-find-rare-group-of-pe-326238.html 0.6 2026-05-31T19:22:35+08:00 daily https://www.pharmasources.com/industryinsights/2021-zhejiang-export-commodity-online-fa-326239.html 0.6 2026-08-03T22:54:59+08:00 daily https://www.pharmasources.com/industryinsights/aptamer-group-astrazeneca-extend-collabo-326241.html 0.6 2026-06-20T22:51:58+08:00 daily https://www.pharmasources.com/industryinsights/sii-writes-letter-to-pmo-recommending-re-326242.html 0.6 2026-06-09T16:22:23+08:00 daily https://www.pharmasources.com/industryinsights/ap-drugs-control-administration-asks-dru-326243.html 0.6 2026-08-04T02:44:59+08:00 daily https://www.pharmasources.com/industryinsights/will-fast-track-vaccines-for-coronavirus-326244.html 0.6 2026-07-09T22:50:17+08:00 daily https://www.pharmasources.com/industryinsights/laurus-labs-promoters-sell-52-lakh-equit-326245.html 0.6 2026-06-20T14:51:58+08:00 daily https://www.pharmasources.com/industryinsights/unichem-labs-gets-usfda-approval-for-gua-326246.html 0.6 2026-06-22T00:11:08+08:00 daily https://www.pharmasources.com/industryinsights/vivimed-labs-fdf-facility-in-jeedimetla--326247.html 0.6 2026-06-21T07:01:59+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-has-fast-tracked-digital-transf-326248.html 0.6 2026-05-31T18:49:46+08:00 daily https://www.pharmasources.com/industryinsights/shilpa-medicare-gets-us-fda-tentative-no-326249.html 0.6 2026-06-22T07:57:42+08:00 daily https://www.pharmasources.com/industryinsights/ema-initiates-rolling-review-of-russias--326250.html 0.6 2026-06-21T15:47:10+08:00 daily https://www.pharmasources.com/industryinsights/bharat-biotechs-covid-19-vaccine-shows-i-326251.html 0.6 2026-06-21T11:05:13+08:00 daily https://www.pharmasources.com/industryinsights/nice-rejects-kyowa-kirins-rare-blood-can-326252.html 0.6 2026-07-10T00:35:27+08:00 daily https://www.pharmasources.com/industryinsights/claritas-and-salzman-to-create-nitric-ox-326253.html 0.6 2026-06-20T23:56:40+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-gubra-to-validate-n-326254.html 0.6 2026-07-01T20:29:40+08:00 daily https://www.pharmasources.com/industryinsights/amgen-to-acquire-five-prime-therapeutics-326255.html 0.6 2026-05-31T18:46:36+08:00 daily https://www.pharmasources.com/industryinsights/genesis-drug-discovery-development-acqui-326256.html 0.6 2026-06-20T19:22:01+08:00 daily https://www.pharmasources.com/industryinsights/curevac-novartis-ink-covid-vax-mfg-pact-326257.html 0.6 2026-07-24T01:23:49+08:00 daily https://www.pharmasources.com/industryinsights/moderna-and-ibm-plan-to-collaborate-on-c-326258.html 0.6 2026-08-14T11:24:17+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-treatment-for-molybde-326259.html 0.6 2026-06-21T06:00:47+08:00 daily https://www.pharmasources.com/industryinsights/clearside-biomedical-completes-dosing-in-326260.html 0.6 2026-06-22T01:54:29+08:00 daily https://www.pharmasources.com/industryinsights/chimerix-announces-topline-results-from--326261.html 0.6 2026-06-22T01:56:36+08:00 daily https://www.pharmasources.com/industryinsights/scynexis-announces-positive-results-of-o-326262.html 0.6 2026-08-01T11:10:27+08:00 daily https://www.pharmasources.com/industryinsights/viacyte-gore-to-develop-technologies-tha-326263.html 0.6 2026-08-13T14:52:30+08:00 daily https://www.pharmasources.com/industryinsights/fda-to-review-sanofis-dupixent-in-childr-326264.html 0.6 2026-08-10T10:58:08+08:00 daily https://www.pharmasources.com/industryinsights/lillys-tirzepatide-claims-head-to-head-t-326265.html 0.6 2026-08-10T20:37:45+08:00 daily https://www.pharmasources.com/industryinsights/chancellor-pledges-an-extra-165bn-for-uk-326266.html 0.6 2026-08-12T08:37:16+08:00 daily https://www.pharmasources.com/industryinsights/conserv-bio-partners-with-etherna-on-mrn-326267.html 0.6 2026-08-07T01:06:48+08:00 daily https://www.pharmasources.com/industryinsights/modified-covid-19-vaccines-can-avoid-len-326268.html 0.6 2026-08-07T00:53:20+08:00 daily https://www.pharmasources.com/industryinsights/clinspec-diagnostics-reaches-funding-tar-326269.html 0.6 2026-08-07T00:45:40+08:00 daily https://www.pharmasources.com/industryinsights/elekta-and-iba-strengthen-partnership-to-326270.html 0.6 2026-08-07T00:43:55+08:00 daily https://www.pharmasources.com/industryinsights/oxford-immunotec-submits-emergency-use-a-326271.html 0.6 2026-08-07T00:46:12+08:00 daily https://www.pharmasources.com/industryinsights/mayne-pharma-launches-another-generic-or-326272.html 0.6 2026-08-07T01:00:32+08:00 daily https://www.pharmasources.com/industryinsights/foresee-pharmaceuticals-enters-exclusive-326273.html 0.6 2026-08-07T00:53:53+08:00 daily https://www.pharmasources.com/industryinsights/researchers-discover-sars-cov-2-inhibito-326274.html 0.6 2026-08-07T00:42:57+08:00 daily https://www.pharmasources.com/industryinsights/alniche-has-planned-to-enter-contract-ma-326275.html 0.6 2026-08-07T00:43:06+08:00 daily https://www.pharmasources.com/industryinsights/ck-ranganathan-elected-as-chairman-of-ci-326276.html 0.6 2026-08-07T01:19:37+08:00 daily https://www.pharmasources.com/industryinsights/aarti-speciality-chemicals-gets-approval-326277.html 0.6 2026-08-07T01:21:56+08:00 daily https://www.pharmasources.com/industryinsights/moderna-signs-supply-deal-with-philippin-326278.html 0.6 2026-08-07T01:27:42+08:00 daily https://www.pharmasources.com/industryinsights/healthcare-industry-reported-85-deals-wo-326279.html 0.6 2026-08-07T02:40:47+08:00 daily https://www.pharmasources.com/industryinsights/oxford-study-indicates-astrazenecas-covi-326280.html 0.6 2026-08-07T02:52:10+08:00 daily https://www.pharmasources.com/industryinsights/kite-gets-us-fda-nod-for-yescarta-to-tre-326281.html 0.6 2026-08-07T02:55:22+08:00 daily https://www.pharmasources.com/industryinsights/encourage-members-to-adopt-ipdms-nppa-to-326282.html 0.6 2026-08-10T15:05:16+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-to-acquire-stake-in-wrs-biopr-326283.html 0.6 2026-06-20T22:18:59+08:00 daily https://www.pharmasources.com/industryinsights/windlas-biotech-mateon-therapeutics-laun-326284.html 0.6 2026-06-20T21:54:36+08:00 daily https://www.pharmasources.com/industryinsights/italy-blocks-export-of-250700-astrazenec-326285.html 0.6 2026-06-21T08:16:19+08:00 daily https://www.pharmasources.com/industryinsights/celonic-to-boost-cell-gene-therapy-produ-326286.html 0.6 2026-08-03T04:53:06+08:00 daily https://www.pharmasources.com/industryinsights/pharmaron-acquires-biomanufacturing-site-326287.html 0.6 2026-06-20T14:50:05+08:00 daily https://www.pharmasources.com/industryinsights/aptamer-extends-collaboration-with-astra-326288.html 0.6 2026-08-10T17:30:49+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-breaks-ground-on-major-expansio-326289.html 0.6 2026-08-13T02:55:53+08:00 daily https://www.pharmasources.com/industryinsights/kras---hot-cancer-target-inhibitors-in-d-326290.html 0.6 2026-07-29T14:16:31+08:00 daily https://www.pharmasources.com/industryinsights/kempharm-announces-fda-approval-of-azsta-326291.html 0.6 2026-08-03T18:53:25+08:00 daily https://www.pharmasources.com/industryinsights/neurosense-reports-positive-results-in-a-326292.html 0.6 2026-06-20T20:09:43+08:00 daily https://www.pharmasources.com/industryinsights/exithera-announces-ind-for-ep-7041-trial-326293.html 0.6 2026-08-06T15:53:54+08:00 daily https://www.pharmasources.com/industryinsights/mitokinin-enters-into-purchase-agreement-326294.html 0.6 2026-06-20T18:55:37+08:00 daily https://www.pharmasources.com/industryinsights/luvadaxistat-study-results-did-not-meet--326295.html 0.6 2026-06-21T02:03:37+08:00 daily https://www.pharmasources.com/industryinsights/continuous-manufacturing-part-1-advantag-326296.html 0.6 2026-08-07T03:03:58+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-advances-mass-global-rollout-326297.html 0.6 2026-07-27T15:19:41+08:00 daily https://www.pharmasources.com/industryinsights/nhs-england-agrees-deal-with-novartis-fo-326298.html 0.6 2026-08-11T16:22:26+08:00 daily https://www.pharmasources.com/industryinsights/radiotherapy-responses-may-be-improved-w-326299.html 0.6 2026-06-30T15:22:16+08:00 daily https://www.pharmasources.com/industryinsights/chmp-issues-positive-opinion-for-lillys--326300.html 0.6 2026-06-20T18:49:06+08:00 daily https://www.pharmasources.com/industryinsights/gileads-hiv-therapy-biktarvy-demonstrate-326301.html 0.6 2026-08-09T23:54:42+08:00 daily https://www.pharmasources.com/industryinsights/ivermectin-not-beneficial-to-symptom-res-326302.html 0.6 2026-07-18T09:47:50+08:00 daily https://www.pharmasources.com/industryinsights/ema-and-health-canada-to-make-covid-19-v-326303.html 0.6 2026-08-02T02:48:12+08:00 daily https://www.pharmasources.com/industryinsights/us-closes-enrolment-in-two-covid-19-anti-326304.html 0.6 2026-06-21T11:09:11+08:00 daily https://www.pharmasources.com/industryinsights/experimental-immunotherapy-significantly-326305.html 0.6 2026-06-20T23:59:38+08:00 daily https://www.pharmasources.com/industryinsights/new-partnership-to-explore-potential-bio-326306.html 0.6 2026-01-31T10:00:42+08:00 daily https://www.pharmasources.com/industryinsights/cmab-biopharma-congratulates-partner-jun-326307.html 0.6 2026-08-08T00:51:06+08:00 daily https://www.pharmasources.com/industryinsights/patients-win-when-support-is-personalize-326308.html 0.6 2026-06-21T05:11:50+08:00 daily https://www.pharmasources.com/industryinsights/elekta-wins-lawsuit-against-livian-gmbh-326309.html 0.6 2026-07-05T21:14:04+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-326310.html 0.6 2026-06-21T13:14:34+08:00 daily https://www.pharmasources.com/industryinsights/vaishali-pharma-receives-orders-from-van-326311.html 0.6 2026-06-22T08:54:41+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-covid-19-vaccine-works-against-br-326312.html 0.6 2026-03-01T13:01:55+08:00 daily https://www.pharmasources.com/industryinsights/sii-asks-government-to-intervene-over-im-326313.html 0.6 2026-06-20T17:56:22+08:00 daily https://www.pharmasources.com/industryinsights/is-womens-health-gaining-momentum-326314.html 0.6 2026-08-09T23:51:48+08:00 daily https://www.pharmasources.com/industryinsights/natco-gets-us-fda-nod-for-everolimus-tab-326315.html 0.6 2026-06-24T10:50:20+08:00 daily https://www.pharmasources.com/industryinsights/eu-regulator-advises-caution-on-eua-for--326316.html 0.6 2026-06-21T11:21:26+08:00 daily https://www.pharmasources.com/industryinsights/health-canada-authorises-jjs-covid-19-va-326317.html 0.6 2026-06-20T18:10:27+08:00 daily https://www.pharmasources.com/industryinsights/can-fite-biopharma-enrols-first-patient--326318.html 0.6 2026-08-08T01:02:29+08:00 daily https://www.pharmasources.com/industryinsights/ridgeback-and-merck-report-preliminary-d-326319.html 0.6 2026-06-21T06:52:00+08:00 daily https://www.pharmasources.com/industryinsights/atea-reports-positive-phase-i-data-from--326320.html 0.6 2026-07-03T23:42:49+08:00 daily https://www.pharmasources.com/industryinsights/entod-pharma-launches-freeglaucomatherap-326321.html 0.6 2026-06-30T13:03:21+08:00 daily https://www.pharmasources.com/industryinsights/takeda-secures-global-rights-to-develop--326322.html 0.6 2026-06-21T02:48:39+08:00 daily https://www.pharmasources.com/industryinsights/blueprint-announces-ema-validation-of-ty-326323.html 0.6 2026-07-16T00:29:08+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-lorlatinib-for-metastatic-a-326324.html 0.6 2026-06-21T00:01:43+08:00 daily https://www.pharmasources.com/industryinsights/fulcrum-therapeutics-announces-ceo-trans-326325.html 0.6 2026-06-21T08:58:59+08:00 daily https://www.pharmasources.com/industryinsights/geovax-expands-intellectual-property-por-326326.html 0.6 2026-08-01T11:40:46+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-dupixent-for-review-in-child-326327.html 0.6 2026-06-23T17:41:36+08:00 daily https://www.pharmasources.com/industryinsights/dialectic-receives-fda-clearance-for-lea-326328.html 0.6 2026-06-20T22:14:59+08:00 daily https://www.pharmasources.com/industryinsights/orthos-new-covid-19-total-and-igg-antibo-326329.html 0.6 2026-07-21T04:32:31+08:00 daily https://www.pharmasources.com/industryinsights/vetter-establishes-office-in-china-326330.html 0.6 2026-02-28T13:09:56+08:00 daily https://www.pharmasources.com/industryinsights/cytiva-and-longitude-a-financial-times-c-326331.html 0.6 2026-06-21T13:05:31+08:00 daily https://www.pharmasources.com/industryinsights/winhealth-pharma-and-merz-collaborate-on-326332.html 0.6 2026-08-09T22:44:30+08:00 daily https://www.pharmasources.com/industryinsights/fasn-inhibitor-asc40-demonstrates-positi-326333.html 0.6 2026-08-13T21:00:16+08:00 daily https://www.pharmasources.com/industryinsights/global-covid-19-vaccination-roll-out-cau-326334.html 0.6 2026-06-21T07:34:32+08:00 daily https://www.pharmasources.com/industryinsights/wugen-announces-exclusive-partnership-ag-326335.html 0.6 2026-06-22T10:58:46+08:00 daily https://www.pharmasources.com/industryinsights/indias-covaxin-81-percent-effective-agai-326336.html 0.6 2026-06-22T00:02:45+08:00 daily https://www.pharmasources.com/industryinsights/urine-test-developed-to-diagnose-subclin-326337.html 0.6 2026-08-12T14:34:51+08:00 daily https://www.pharmasources.com/industryinsights/ema-concludes-review-of-lillys-covid-19--326338.html 0.6 2026-08-07T13:16:49+08:00 daily https://www.pharmasources.com/industryinsights/quzyttir-shows-promise-in-preventing-inf-326339.html 0.6 2026-08-07T00:41:15+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-announces-aingle-ahot-ja-326340.html 0.6 2026-08-07T01:14:31+08:00 daily https://www.pharmasources.com/industryinsights/high-purity-new-england-unveils-highly-s-326341.html 0.6 2026-08-10T16:41:05+08:00 daily https://www.pharmasources.com/industryinsights/junshis-anti-pd-1-drug-achieved-sales-of-326342.html 0.6 2026-08-07T01:27:38+08:00 daily https://www.pharmasources.com/industryinsights/a-review-of-the-export-data-of-chinas-pl-326343.html 0.6 2026-08-10T15:13:45+08:00 daily https://www.pharmasources.com/industryinsights/a-review-of-the-current-situation-of-cov-326344.html 0.6 2026-08-07T13:16:17+08:00 daily https://www.pharmasources.com/industryinsights/quad-nations-meet-to-declare-financing-t-326345.html 0.6 2026-06-17T15:56:17+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-booster-shots-more-likely-as-va-326346.html 0.6 2026-07-15T15:41:32+08:00 daily https://www.pharmasources.com/industryinsights/indoco-launches-brinzolamide-ophthalmic--326347.html 0.6 2026-07-15T18:20:37+08:00 daily https://www.pharmasources.com/industryinsights/jubilant-therapeutics-appoints-luca-rast-326348.html 0.6 2026-06-21T01:05:52+08:00 daily https://www.pharmasources.com/industryinsights/lupin-pharma-canada-endoceutics-to-partn-326349.html 0.6 2026-06-20T16:01:28+08:00 daily https://www.pharmasources.com/industryinsights/jubilant-hollisterstier-eli-lilly-enter--326350.html 0.6 2026-06-21T04:03:45+08:00 daily https://www.pharmasources.com/industryinsights/cassava-sciences-enters-drug-supply-agre-326351.html 0.6 2026-06-22T12:12:12+08:00 daily https://www.pharmasources.com/industryinsights/nmpa-accepts-application-for-clinical-tr-326352.html 0.6 2026-06-21T11:07:17+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-tentative-approval-to-generic-326353.html 0.6 2026-08-12T16:36:59+08:00 daily https://www.pharmasources.com/industryinsights/baxter-biopharma-solutions-enters-steril-326354.html 0.6 2026-07-23T17:31:22+08:00 daily https://www.pharmasources.com/industryinsights/arranta-bio-invests-in-new-manufacturing-326355.html 0.6 2026-07-20T23:16:57+08:00 daily https://www.pharmasources.com/industryinsights/cytovance-biologics-offers-licensing-for-326356.html 0.6 2026-06-18T16:24:07+08:00 daily https://www.pharmasources.com/industryinsights/metrics-contract-services-completes-russ-326357.html 0.6 2026-06-23T23:52:27+08:00 daily https://www.pharmasources.com/industryinsights/jubilant-therapeutics-appoints-chief-sci-326358.html 0.6 2026-03-01T04:20:36+08:00 daily https://www.pharmasources.com/industryinsights/sharp-appoints-eu-qualified-person-326359.html 0.6 2026-06-22T17:24:17+08:00 daily https://www.pharmasources.com/industryinsights/iontas-and-fair-journey-biologics-partne-326360.html 0.6 2026-06-22T03:48:42+08:00 daily https://www.pharmasources.com/industryinsights/viriom-chromis-avifavir-reduces-time-to--326361.html 0.6 2026-07-06T05:41:27+08:00 daily https://www.pharmasources.com/industryinsights/novartis-canakinumab-fails-to-meet-prima-326362.html 0.6 2026-06-23T17:37:15+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-accelerated-digital-transformat-326363.html 0.6 2026-08-05T20:43:41+08:00 daily https://www.pharmasources.com/industryinsights/aim-immunotech-initiates-dosing-in-intra-326364.html 0.6 2026-06-21T08:07:02+08:00 daily https://www.pharmasources.com/industryinsights/nih-launches-last-trial-of-anticoagulant-326365.html 0.6 2026-03-12T15:24:17+08:00 daily https://www.pharmasources.com/industryinsights/rokote-laboratories-finland-to-unveil-ne-326366.html 0.6 2026-06-21T06:07:58+08:00 daily https://www.pharmasources.com/industryinsights/us-accuses-russia-of-covid-19-vaccine-di-326367.html 0.6 2026-06-22T19:50:56+08:00 daily https://www.pharmasources.com/industryinsights/roche-to-withdraw-us-indication-for-tece-326368.html 0.6 2026-06-22T13:08:08+08:00 daily https://www.pharmasources.com/industryinsights/bioeclipse-announces-first-patient-dosed-326369.html 0.6 2026-06-21T03:03:15+08:00 daily https://www.pharmasources.com/industryinsights/ema-issues-advice-on-bamlanivimab-alone--326370.html 0.6 2026-06-21T14:57:27+08:00 daily https://www.pharmasources.com/industryinsights/immutep-expands-part-b-of-tacti-002-stud-326371.html 0.6 2026-06-21T07:17:13+08:00 daily https://www.pharmasources.com/industryinsights/oncosynergy-announces-first-patient-trea-326372.html 0.6 2026-08-02T14:43:08+08:00 daily https://www.pharmasources.com/industryinsights/apellis-will-not-peruse-development-of-a-326373.html 0.6 2026-06-21T09:12:24+08:00 daily https://www.pharmasources.com/industryinsights/nice-rejects-azs-lynparza-for-metastatic-326374.html 0.6 2026-08-03T09:04:04+08:00 daily https://www.pharmasources.com/industryinsights/smc-accepts-zolgensma-and-rozlytrek-for--326375.html 0.6 2026-06-23T23:43:49+08:00 daily https://www.pharmasources.com/industryinsights/researchers-identify-early-changes-in-br-326376.html 0.6 2026-06-20T20:11:48+08:00 daily https://www.pharmasources.com/industryinsights/parkinsons-uk-invests-12m-in-drug-design-326377.html 0.6 2026-06-20T20:58:12+08:00 daily https://www.pharmasources.com/industryinsights/arctic-vision-announces-completion-of-ov-326378.html 0.6 2026-08-12T08:33:56+08:00 daily https://www.pharmasources.com/industryinsights/breaking-the-cycle-of-opioid-addiction-a-326379.html 0.6 2026-06-21T13:10:40+08:00 daily https://www.pharmasources.com/industryinsights/genome-and-company-signs-second-clinical-326380.html 0.6 2026-08-10T11:14:44+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-pandemic-has-accelerated-global-326381.html 0.6 2026-08-06T23:08:36+08:00 daily https://www.pharmasources.com/industryinsights/icri-sbsu-dehradun-collaborate-to-advanc-326382.html 0.6 2026-06-21T07:57:59+08:00 daily https://www.pharmasources.com/industryinsights/cepi-plans-100-day-target-for-new-vaccin-326383.html 0.6 2026-06-21T11:23:34+08:00 daily https://www.pharmasources.com/industryinsights/lupin-launches-nitazoxanide-tablets-326384.html 0.6 2026-01-16T02:09:32+08:00 daily https://www.pharmasources.com/industryinsights/scientists-at-iit-madras-identify-energy-326385.html 0.6 2026-06-21T07:03:56+08:00 daily https://www.pharmasources.com/industryinsights/low-patient-accrual-rates-cause-terminat-326386.html 0.6 2026-08-03T15:39:12+08:00 daily https://www.pharmasources.com/industryinsights/lillys-bamlanivimab-plus-etesevimab-cut--326387.html 0.6 2026-06-20T16:08:08+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-interested-in-producing-vaccine-i-326388.html 0.6 2026-08-12T18:55:34+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-pharma-india-gets-dcgi-appro-326389.html 0.6 2026-06-25T15:45:28+08:00 daily https://www.pharmasources.com/industryinsights/melior-pharmaceuticals-to-initiate-trial-326390.html 0.6 2026-06-21T05:07:49+08:00 daily https://www.pharmasources.com/industryinsights/valo-and-immunoscape-identify-peptides-f-326391.html 0.6 2026-06-23T09:18:29+08:00 daily https://www.pharmasources.com/industryinsights/vbi-vaccines-begins-enrolment-in-covid-1-326392.html 0.6 2026-06-20T23:00:56+08:00 daily https://www.pharmasources.com/industryinsights/uk-denies-eu-accusations-of-covid-19-vac-326393.html 0.6 2026-06-20T15:52:38+08:00 daily https://www.pharmasources.com/industryinsights/takeda-exercises-option-to-acquire-maver-326394.html 0.6 2026-08-09T07:00:08+08:00 daily https://www.pharmasources.com/industryinsights/capscanada-launches-liquid-filled-hard-c-326395.html 0.6 2026-08-08T21:49:30+08:00 daily https://www.pharmasources.com/industryinsights/selexis-sa-and-bitt-enter-service-agreem-326396.html 0.6 2026-08-08T15:52:04+08:00 daily https://www.pharmasources.com/industryinsights/altasciences-doubles-size-of-pa-cdmo-fac-326397.html 0.6 2026-08-08T10:10:38+08:00 daily https://www.pharmasources.com/industryinsights/longeveron-expands-enrollment-criteria-f-326398.html 0.6 2026-08-08T08:59:20+08:00 daily https://www.pharmasources.com/industryinsights/quantum-leap-healthcare-discontinues-raz-326399.html 0.6 2026-08-08T07:51:06+08:00 daily https://www.pharmasources.com/industryinsights/abbott-receives-eua-for-pcr-assay-that-d-326400.html 0.6 2026-08-07T13:19:23+08:00 daily https://www.pharmasources.com/industryinsights/biomarin-announces-rmat-designation-gran-326401.html 0.6 2026-08-07T06:07:34+08:00 daily https://www.pharmasources.com/industryinsights/emerald-health-starts-activities-for-ini-326402.html 0.6 2026-08-10T17:21:45+08:00 daily https://www.pharmasources.com/industryinsights/cqc-publishes-new-agreement-with-equalit-326403.html 0.6 2026-08-07T13:17:53+08:00 daily https://www.pharmasources.com/industryinsights/mhra-green-light-for-demerxs-opioid-use--326404.html 0.6 2026-08-07T12:29:50+08:00 daily https://www.pharmasources.com/industryinsights/mhra-authorises-lillys-ret-inhibitor-ret-326405.html 0.6 2026-08-07T12:03:03+08:00 daily https://www.pharmasources.com/industryinsights/researchers-identify-inflammatory-protei-326406.html 0.6 2026-08-07T02:30:39+08:00 daily https://www.pharmasources.com/industryinsights/biotechs-to-test-feasibility-of-a-shelf--326407.html 0.6 2026-08-07T02:21:54+08:00 daily https://www.pharmasources.com/industryinsights/kintor-pharmaceutical-announces-results--326408.html 0.6 2026-08-07T02:18:38+08:00 daily https://www.pharmasources.com/industryinsights/optel-group-on-track-for-record-year-in--326409.html 0.6 2026-08-10T19:48:20+08:00 daily https://www.pharmasources.com/industryinsights/impact-therapeutics-announced-first-pati-326410.html 0.6 2026-08-09T22:56:53+08:00 daily https://www.pharmasources.com/industryinsights/novartis-receives-approval-for-kymriah-t-326411.html 0.6 2026-08-07T01:39:43+08:00 daily https://www.pharmasources.com/industryinsights/plant-extract-varieties-with-great-marke-326412.html 0.6 2026-08-07T01:19:42+08:00 daily https://www.pharmasources.com/industryinsights/jj-gets-positive-chmp-opinion-for-single-326413.html 0.6 2026-08-07T01:19:19+08:00 daily https://www.pharmasources.com/industryinsights/parikh-family-sells-stake-in-zcl-chemica-326414.html 0.6 2026-08-07T13:15:48+08:00 daily https://www.pharmasources.com/industryinsights/covaxin-granted-restricted-eua-326415.html 0.6 2026-08-07T00:41:47+08:00 daily https://www.pharmasources.com/industryinsights/vir-gsk-to-seek-eua-for-covid-19-antibod-326416.html 0.6 2026-08-07T05:05:23+08:00 daily https://www.pharmasources.com/industryinsights/hikma-gsk-stop-talks-over-potential-buyo-326417.html 0.6 2026-06-20T16:07:35+08:00 daily https://www.pharmasources.com/industryinsights/enveric-biosciences-acquires-licence-for-326418.html 0.6 2026-06-21T12:03:42+08:00 daily https://www.pharmasources.com/industryinsights/cepi-and-vbi-to-develop-vaccines-against-326419.html 0.6 2026-07-16T22:21:20+08:00 daily https://www.pharmasources.com/industryinsights/denmark-suspends-azoxford-covid-19-vacci-326420.html 0.6 2026-08-09T18:43:13+08:00 daily https://www.pharmasources.com/industryinsights/ema-approves-fourth-covid-19-vaccine-jjs-326421.html 0.6 2026-06-21T11:18:30+08:00 daily https://www.pharmasources.com/industryinsights/novavaxs-vaccine-shows-greater-efficacy--326422.html 0.6 2026-06-20T23:16:51+08:00 daily https://www.pharmasources.com/industryinsights/niaid-grants-25m-to-12-institutes-for-ba-326423.html 0.6 2026-08-09T07:56:35+08:00 daily https://www.pharmasources.com/industryinsights/breckenridge-receives-anda-approval-for--326424.html 0.6 2026-08-08T19:41:54+08:00 daily https://www.pharmasources.com/industryinsights/pathios-receives-innovate-uk-smart-grant-326425.html 0.6 2026-08-08T17:53:01+08:00 daily https://www.pharmasources.com/industryinsights/pneumagen-announces-neumifil-is-efficaci-326426.html 0.6 2026-08-08T15:52:14+08:00 daily https://www.pharmasources.com/industryinsights/tissuetech-receives-fda-clearance-for-tt-326427.html 0.6 2026-08-08T10:13:46+08:00 daily https://www.pharmasources.com/industryinsights/roche-receives-fda-approval-for-ventana--326428.html 0.6 2026-08-05T11:58:44+08:00 daily https://www.pharmasources.com/industryinsights/fda-authorizes-cue-healths-covid-19-test-326429.html 0.6 2026-08-08T09:47:17+08:00 daily https://www.pharmasources.com/industryinsights/ani-pharmaceuticals-strengthens-cdmo-biz-326430.html 0.6 2026-08-09T05:28:59+08:00 daily https://www.pharmasources.com/industryinsights/phasebio-and-biovectra-enter-into-supply-326431.html 0.6 2026-08-09T06:51:29+08:00 daily https://www.pharmasources.com/industryinsights/dna-production-specialist-touchlight-rai-326432.html 0.6 2026-06-21T08:18:11+08:00 daily https://www.pharmasources.com/industryinsights/gsk-to-leverage-the-cell-and-gene-therap-326433.html 0.6 2026-08-10T09:01:42+08:00 daily https://www.pharmasources.com/industryinsights/nhs-england-breast-cancer-wait-times-are-326434.html 0.6 2026-07-17T18:05:19+08:00 daily https://www.pharmasources.com/industryinsights/new-real-world-evidence-for-pfizerbionte-326435.html 0.6 2026-08-08T00:04:40+08:00 daily https://www.pharmasources.com/industryinsights/nhs-staff-survey-shows-profound-impact-o-326436.html 0.6 2026-07-01T03:35:41+08:00 daily https://www.pharmasources.com/industryinsights/a-single-vaccine-dose-is-sufficient-for--326437.html 0.6 2026-06-21T07:22:16+08:00 daily https://www.pharmasources.com/industryinsights/first-patients-receive-modernas-modified-326438.html 0.6 2026-06-22T07:54:01+08:00 daily https://www.pharmasources.com/industryinsights/maturation-inhibitor-shown-to-be-safe-an-326439.html 0.6 2026-06-21T15:11:49+08:00 daily https://www.pharmasources.com/industryinsights/harbour-biomed-announces-dosing-of-first-326440.html 0.6 2026-08-07T04:56:20+08:00 daily https://www.pharmasources.com/industryinsights/novavax-confirms-high-levels-of-efficacy-326441.html 0.6 2026-08-09T08:01:21+08:00 daily https://www.pharmasources.com/industryinsights/a-large-randomized-clinical-trial-shows--326442.html 0.6 2026-08-07T17:15:22+08:00 daily https://www.pharmasources.com/industryinsights/us-and-eu-kidney-groups-align-for-global-326443.html 0.6 2026-08-07T16:10:40+08:00 daily https://www.pharmasources.com/industryinsights/delonix-bioworks-closes-14-million-serie-326444.html 0.6 2026-08-07T13:17:38+08:00 daily https://www.pharmasources.com/industryinsights/new-compound-targets-enzyme-linked-to-au-326445.html 0.6 2026-08-07T04:16:35+08:00 daily https://www.pharmasources.com/industryinsights/abbott-introduces-neurosphere-virtual-cl-326446.html 0.6 2026-08-07T04:21:58+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-has-created-a-level-playing-fie-326447.html 0.6 2026-08-07T04:52:51+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-dr-reddys-aurobindo-jubilant--326448.html 0.6 2026-08-07T05:01:12+08:00 daily https://www.pharmasources.com/industryinsights/crispr-based-cancer-therapies-likely-to--326449.html 0.6 2026-08-07T12:03:55+08:00 daily https://www.pharmasources.com/industryinsights/agilent-continues-to-focus-on-strategic--326450.html 0.6 2026-08-07T13:15:27+08:00 daily https://www.pharmasources.com/industryinsights/dghs-asks-ksrpo-to-ensure-continuation-o-326451.html 0.6 2026-06-20T15:06:38+08:00 daily https://www.pharmasources.com/industryinsights/antibodies-generated-by-covid-19-vaccine-326452.html 0.6 2026-08-08T07:47:54+08:00 daily https://www.pharmasources.com/industryinsights/quad-pledges-to-supply-billion-doses-of--326453.html 0.6 2026-08-10T23:06:45+08:00 daily https://www.pharmasources.com/industryinsights/jj-single-shot-covid-19-vaccine-gets-eme-326454.html 0.6 2026-08-10T17:22:04+08:00 daily https://www.pharmasources.com/industryinsights/novavax-vaccine-shows-96-per-cent-effica-326455.html 0.6 2026-06-23T11:49:25+08:00 daily https://www.pharmasources.com/industryinsights/abbott-forms-pandemic-defense-coalition-326456.html 0.6 2026-08-08T18:10:34+08:00 daily https://www.pharmasources.com/industryinsights/china-continues-to-lead-high-value-oncol-326457.html 0.6 2026-08-03T12:56:34+08:00 daily https://www.pharmasources.com/industryinsights/rigel-concludes-subject-enrolment-in-nih-326458.html 0.6 2026-08-09T06:59:11+08:00 daily https://www.pharmasources.com/industryinsights/lilly-biolojic-to-develop-antibody-thera-326459.html 0.6 2026-02-28T15:06:53+08:00 daily https://www.pharmasources.com/industryinsights/altimmune-lonza-expand-adcovid-manufactu-326460.html 0.6 2026-06-21T10:04:11+08:00 daily https://www.pharmasources.com/industryinsights/sotera-health-announces-acquisition-of-m-326461.html 0.6 2026-06-21T04:00:47+08:00 daily https://www.pharmasources.com/industryinsights/adaptive-biotechnologies-announces-eua-f-326462.html 0.6 2026-07-08T06:58:16+08:00 daily https://www.pharmasources.com/industryinsights/asceneuron-receives-award-from-alzheimer-326463.html 0.6 2026-07-01T18:32:17+08:00 daily https://www.pharmasources.com/industryinsights/aim-immunotech-begins-dosing-for-intrana-326464.html 0.6 2026-07-05T22:12:04+08:00 daily https://www.pharmasources.com/industryinsights/memverge-analytical-biosciences-accelera-326465.html 0.6 2026-07-16T14:35:10+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-regenerons-libtayo-improves-survi-326466.html 0.6 2026-08-12T13:02:40+08:00 daily https://www.pharmasources.com/industryinsights/cambridge-sleep-sciences-and-parkinsons--326467.html 0.6 2026-07-02T10:12:24+08:00 daily https://www.pharmasources.com/industryinsights/prixa-generali-indonesia-and-lifepack-wo-326468.html 0.6 2026-06-30T14:41:37+08:00 daily https://www.pharmasources.com/industryinsights/supertrans-medical-appoints-australian-p-326469.html 0.6 2026-06-21T17:47:11+08:00 daily https://www.pharmasources.com/industryinsights/update-on-the-safety-of-covid-19-vaccine-326470.html 0.6 2026-06-21T17:33:09+08:00 daily https://www.pharmasources.com/industryinsights/variant-b117-of-covid-19-associated-with-326471.html 0.6 2026-08-06T22:51:18+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-326472.html 0.6 2026-07-13T13:43:51+08:00 daily https://www.pharmasources.com/industryinsights/gilead-merck-sign-pact-to-develop-commer-326473.html 0.6 2026-08-08T11:04:31+08:00 daily https://www.pharmasources.com/industryinsights/univercells-univercells-technologies-and-326474.html 0.6 2026-04-12T09:09:12+08:00 daily https://www.pharmasources.com/industryinsights/no-evidence-of-greater-blood-clot-risk-f-326475.html 0.6 2026-06-21T22:55:41+08:00 daily https://www.pharmasources.com/industryinsights/strides-gets-usfda-approval-for-potassiu-326476.html 0.6 2026-06-21T08:48:55+08:00 daily https://www.pharmasources.com/industryinsights/researchers-reveal-novel-coronavirus-jum-326477.html 0.6 2026-08-13T22:04:12+08:00 daily https://www.pharmasources.com/industryinsights/natco-ventures-into-pheromone-based-tech-326478.html 0.6 2026-07-03T16:24:29+08:00 daily https://www.pharmasources.com/industryinsights/alkem-launches-anti-epileptic-drug-briva-326479.html 0.6 2026-07-02T15:11:00+08:00 daily https://www.pharmasources.com/industryinsights/doctors-keen-to-adopt-novel-biomarkers-f-326480.html 0.6 2026-07-03T15:19:11+08:00 daily https://www.pharmasources.com/industryinsights/eisais-anti-cancer-agent-lenvima-receive-326481.html 0.6 2026-08-04T00:53:43+08:00 daily https://www.pharmasources.com/industryinsights/eu-countries-suspend-use-of-covid-19-vac-326482.html 0.6 2026-06-21T00:02:38+08:00 daily https://www.pharmasources.com/industryinsights/avactas-rapid-antigen-test-confirmed-to--326483.html 0.6 2026-08-07T16:09:59+08:00 daily https://www.pharmasources.com/industryinsights/scisparc-to-commence-pre-clinical-study--326484.html 0.6 2026-08-07T13:16:31+08:00 daily https://www.pharmasources.com/industryinsights/orthos-new-covid-19-total-igg-antibody-t-326485.html 0.6 2026-08-07T18:15:26+08:00 daily https://www.pharmasources.com/industryinsights/adicet-bio-initiates-adi-001-trial-for-b-326486.html 0.6 2026-08-07T22:09:25+08:00 daily https://www.pharmasources.com/industryinsights/4d-molecular-doses-first-patient-in-4d-3-326487.html 0.6 2026-08-08T03:25:26+08:00 daily https://www.pharmasources.com/industryinsights/immutep-secures-second-patent-grant-for--326488.html 0.6 2026-08-08T10:38:53+08:00 daily https://www.pharmasources.com/industryinsights/takeda-and-idt-support-manufacturing-of--326489.html 0.6 2026-08-09T07:57:08+08:00 daily https://www.pharmasources.com/industryinsights/maravai-expands-cdmo-capabilities-throug-326490.html 0.6 2026-06-22T19:02:10+08:00 daily https://www.pharmasources.com/industryinsights/biovaxys-wuxi-biologics-enter-bioproduct-326491.html 0.6 2026-06-28T23:42:08+08:00 daily https://www.pharmasources.com/industryinsights/merck-reports-topline-data-for-bintrafus-326492.html 0.6 2026-06-21T07:20:15+08:00 daily https://www.pharmasources.com/industryinsights/cbc-group-announces-the-appointment-of-r-326493.html 0.6 2026-07-28T12:03:11+08:00 daily https://www.pharmasources.com/industryinsights/microba-life-sciences-partners-with-unil-326494.html 0.6 2026-06-21T09:59:17+08:00 daily https://www.pharmasources.com/industryinsights/aiforia-appoints-swedbank-as-lead-adviso-326495.html 0.6 2026-06-21T00:48:59+08:00 daily https://www.pharmasources.com/industryinsights/first-participants-dosed-in-phase-1-stud-326496.html 0.6 2026-08-11T16:55:47+08:00 daily https://www.pharmasources.com/industryinsights/pharma-is-making-steady-progress-toward--326497.html 0.6 2026-06-21T10:59:12+08:00 daily https://www.pharmasources.com/industryinsights/libtayo-improves-overall-survival-in-adv-326498.html 0.6 2026-07-16T08:45:01+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-packaging-market-to-value-326499.html 0.6 2026-08-03T17:48:14+08:00 daily https://www.pharmasources.com/industryinsights/moderna-commences-trial-of-covid-19-vacc-326500.html 0.6 2026-07-20T09:31:36+08:00 daily https://www.pharmasources.com/industryinsights/mylan-upjohn-merger-as-viatris-provides--326501.html 0.6 2026-06-21T20:56:41+08:00 daily https://www.pharmasources.com/industryinsights/gland-pharma-signs-deal-with-rdif-for-25-326502.html 0.6 2026-06-21T20:15:54+08:00 daily https://www.pharmasources.com/industryinsights/ocugen-intends-to-sell-100-million-doses-326503.html 0.6 2026-06-20T19:20:33+08:00 daily https://www.pharmasources.com/industryinsights/bill-seeking-to-endow-national-importanc-326504.html 0.6 2026-03-20T03:15:44+08:00 daily https://www.pharmasources.com/industryinsights/pharma-msmes-seek-government-interventio-326505.html 0.6 2026-07-24T09:41:19+08:00 daily https://www.pharmasources.com/industryinsights/ampio-reveals-preliminary-positive-resul-326506.html 0.6 2026-06-20T16:00:18+08:00 daily https://www.pharmasources.com/industryinsights/usfda-grants-priority-review-to-mercks-n-326507.html 0.6 2025-12-08T07:45:30+08:00 daily https://www.pharmasources.com/industryinsights/pci-pharma-services-expands-cold-chain-c-326508.html 0.6 2026-07-31T09:58:48+08:00 daily https://www.pharmasources.com/industryinsights/labconnect-expands-johnson-city-facility-326509.html 0.6 2026-07-05T09:03:43+08:00 daily https://www.pharmasources.com/industryinsights/cytocom-gets-fda-clearance-for-phase-ii--326510.html 0.6 2026-06-20T18:05:21+08:00 daily https://www.pharmasources.com/industryinsights/selexis-pandion-enter-antibody-service-a-326511.html 0.6 2026-06-21T14:42:12+08:00 daily https://www.pharmasources.com/industryinsights/tevogen-bio-biocentriq-partner-for-covid-326512.html 0.6 2026-02-28T15:32:02+08:00 daily https://www.pharmasources.com/industryinsights/natera-genentech-initiate-phase-iii-tria-326513.html 0.6 2026-06-20T14:39:01+08:00 daily https://www.pharmasources.com/industryinsights/demerx-receives-mhra-approval-for-dmx-10-326514.html 0.6 2026-06-20T21:10:57+08:00 daily https://www.pharmasources.com/industryinsights/circ-biosciences-announces-orphan-drug-d-326515.html 0.6 2026-06-21T01:52:39+08:00 daily https://www.pharmasources.com/industryinsights/seqonce-announces-azureseq-rt-qpcr-assay-326516.html 0.6 2026-06-21T12:59:27+08:00 daily https://www.pharmasources.com/industryinsights/pcr-biosystems-launches-advanced-bst-pol-326517.html 0.6 2026-08-14T01:48:36+08:00 daily https://www.pharmasources.com/industryinsights/iricor-universit-de-montral-iric-and-val-326518.html 0.6 2026-04-09T15:15:03+08:00 daily https://www.pharmasources.com/industryinsights/further-work-needed-to-develop-nhs-healt-326519.html 0.6 2026-08-07T02:05:46+08:00 daily https://www.pharmasources.com/industryinsights/antiverse-raises-14m-to-bolster-ai-antib-326520.html 0.6 2026-08-13T08:15:55+08:00 daily https://www.pharmasources.com/industryinsights/frontline-charities-sign-open-letter-bac-326521.html 0.6 2026-06-20T23:57:34+08:00 daily https://www.pharmasources.com/industryinsights/caris-life-sciences-study-provides-first-326522.html 0.6 2026-07-29T10:28:58+08:00 daily https://www.pharmasources.com/industryinsights/bluebird-bio-releases-new-data-on-its-ge-326523.html 0.6 2026-07-05T03:56:49+08:00 daily https://www.pharmasources.com/industryinsights/crispr-therapies-could-be-one-of-the-mos-326524.html 0.6 2026-06-23T18:21:00+08:00 daily https://www.pharmasources.com/industryinsights/salbutamol-significantly-increases-cereb-326525.html 0.6 2026-08-03T08:56:56+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-to-launch-rapid-antigen-covid-1-326526.html 0.6 2026-08-10T03:05:50+08:00 daily https://www.pharmasources.com/industryinsights/new-data-demonstrates-nuq-is-effective-i-326527.html 0.6 2026-07-06T08:58:50+08:00 daily https://www.pharmasources.com/industryinsights/biobohemia-released-paper-on-the-discove-326528.html 0.6 2026-06-27T05:11:11+08:00 daily https://www.pharmasources.com/industryinsights/genscript-and-g42-healthcare-announce-co-326529.html 0.6 2026-06-25T00:29:57+08:00 daily https://www.pharmasources.com/industryinsights/cambridge-infinitus-research-centre-made-326530.html 0.6 2026-06-21T05:57:49+08:00 daily https://www.pharmasources.com/industryinsights/edan-announces-2020-annual-results-and-2-326531.html 0.6 2026-08-14T08:32:59+08:00 daily https://www.pharmasources.com/industryinsights/indias-reputation-as-pharmacy-of-world-r-326532.html 0.6 2026-08-09T20:39:22+08:00 daily https://www.pharmasources.com/industryinsights/catalent-expands-partnership-with-jj-326533.html 0.6 2026-06-21T12:17:32+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-to-acquire-manufacturing--326534.html 0.6 2026-06-24T05:39:28+08:00 daily https://www.pharmasources.com/industryinsights/northwest-biotherapeutics-adds-productio-326535.html 0.6 2026-06-20T18:50:32+08:00 daily https://www.pharmasources.com/industryinsights/univercells-technologies-names-ceo-326536.html 0.6 2026-06-29T10:43:15+08:00 daily https://www.pharmasources.com/industryinsights/wdsrx-establishes-national-3pl-presence-326537.html 0.6 2026-06-21T10:01:11+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-and-sana-biotechnology-enter-ce-326538.html 0.6 2026-06-21T01:04:45+08:00 daily https://www.pharmasources.com/industryinsights/tonix-reports-positive-covid-19-vaccine--326539.html 0.6 2026-07-03T03:37:14+08:00 daily https://www.pharmasources.com/industryinsights/the-uk-best-among-countries-dealing-with-326540.html 0.6 2026-07-01T03:08:50+08:00 daily https://www.pharmasources.com/industryinsights/federal-trade-commission-forms-multilate-326541.html 0.6 2026-08-14T21:21:55+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-to-supply-500000-doses-of-co-326542.html 0.6 2026-08-14T21:14:55+08:00 daily https://www.pharmasources.com/industryinsights/aurinia-reports-favourable-assessment-of-326543.html 0.6 2026-08-14T21:06:55+08:00 daily https://www.pharmasources.com/industryinsights/takeda-submits-new-drug-application-for--326544.html 0.6 2026-08-09T06:59:26+08:00 daily https://www.pharmasources.com/industryinsights/usfda-extends-review-period-for-abbvies--326545.html 0.6 2026-08-08T12:36:22+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-tivozanib-for-relapsedrefra-326546.html 0.6 2026-08-07T13:18:33+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-competes-viela-divestment-326547.html 0.6 2026-08-09T02:38:59+08:00 daily https://www.pharmasources.com/industryinsights/denali-announces-fast-track-designation--326548.html 0.6 2026-06-21T09:03:00+08:00 daily https://www.pharmasources.com/industryinsights/bryant-ranch-prepack-recalls-spironolact-326549.html 0.6 2026-06-09T21:54:22+08:00 daily https://www.pharmasources.com/industryinsights/linnaeus-granted-orphan-drug-designation-326550.html 0.6 2026-08-03T19:15:26+08:00 daily https://www.pharmasources.com/industryinsights/codex-dna-releases-synthetic-genomes-for-326551.html 0.6 2026-06-20T14:50:05+08:00 daily https://www.pharmasources.com/industryinsights/hra-pharma-rare-diseases-funds-online-hu-326552.html 0.6 2026-06-20T15:49:27+08:00 daily https://www.pharmasources.com/industryinsights/priority-review-for-merck-cos-belzutifan-326553.html 0.6 2026-07-05T00:37:43+08:00 daily https://www.pharmasources.com/industryinsights/lillys-mirikizumab-hits-primary-endpoint-326554.html 0.6 2026-06-22T15:21:54+08:00 daily https://www.pharmasources.com/industryinsights/gsk-medicago-launch-late-stage-trial-of--326555.html 0.6 2026-06-21T07:19:15+08:00 daily https://www.pharmasources.com/industryinsights/uk-gene-therapy-hub-network-awarded-18m--326556.html 0.6 2026-06-21T05:08:45+08:00 daily https://www.pharmasources.com/industryinsights/gsk-launches-late-stage-study-of-long-ac-326557.html 0.6 2026-06-22T07:01:52+08:00 daily https://www.pharmasources.com/industryinsights/nice-backs-astrazenecas-calquence-for-cl-326558.html 0.6 2026-06-20T19:19:54+08:00 daily https://www.pharmasources.com/industryinsights/uk-approval-for-daiichi-sankyos-choleste-326559.html 0.6 2026-07-24T08:04:10+08:00 daily https://www.pharmasources.com/industryinsights/data-shows-long-term-efficacy-of-tremfya-326560.html 0.6 2026-08-09T09:54:46+08:00 daily https://www.pharmasources.com/industryinsights/drug-eluting-contact-lens-shows-potentia-326561.html 0.6 2026-07-03T09:02:36+08:00 daily https://www.pharmasources.com/industryinsights/vs-01-shows-promise-in-phase-ib-decompen-326562.html 0.6 2026-06-27T08:00:05+08:00 daily https://www.pharmasources.com/industryinsights/aspirin-may-decrease-icu-admission-and-d-326563.html 0.6 2026-06-20T18:01:31+08:00 daily https://www.pharmasources.com/industryinsights/microba-life-sciences-appoints-experienc-326564.html 0.6 2026-08-09T12:49:49+08:00 daily https://www.pharmasources.com/industryinsights/111-inc-enters-into-first-ever-strategic-326565.html 0.6 2026-08-07T01:14:06+08:00 daily https://www.pharmasources.com/industryinsights/ai-and-cloud-to-empower-the-european-tel-326566.html 0.6 2026-08-07T00:40:01+08:00 daily https://www.pharmasources.com/industryinsights/jj-developing-many-next-gen-vaccines-aga-326567.html 0.6 2026-08-07T03:06:21+08:00 daily https://www.pharmasources.com/industryinsights/dsm-launches-digital-awareness-campaign--326568.html 0.6 2026-06-21T20:40:14+08:00 daily https://www.pharmasources.com/industryinsights/gilead-novo-nordisk-expand-nash-clinical-326569.html 0.6 2026-06-21T11:58:07+08:00 daily https://www.pharmasources.com/industryinsights/india-asks-states-to-manage-immunisation-326570.html 0.6 2026-06-21T13:50:30+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-to-acquire-cmab-biopharma-326571.html 0.6 2026-07-24T02:18:45+08:00 daily https://www.pharmasources.com/industryinsights/maha-wants-to-manufacture-covaxin-at-haf-326572.html 0.6 2026-06-21T01:58:38+08:00 daily https://www.pharmasources.com/industryinsights/sii-gets-purchase-order-from-government--326573.html 0.6 2026-06-21T12:11:27+08:00 daily https://www.pharmasources.com/industryinsights/nppa-extends-ceiling-prices-of-heparin-i-326574.html 0.6 2026-07-04T14:48:51+08:00 daily https://www.pharmasources.com/industryinsights/vardhman-health-specialities-forays-into-326575.html 0.6 2026-07-06T21:20:05+08:00 daily https://www.pharmasources.com/industryinsights/stelis-concludes-195-million-series-b-an-326576.html 0.6 2026-08-14T23:16:58+08:00 daily https://www.pharmasources.com/industryinsights/eu-warns-about-tougher-export-control-of-326577.html 0.6 2026-08-05T17:46:01+08:00 daily https://www.pharmasources.com/industryinsights/bayer-wins-best-employer-in-india-award--326578.html 0.6 2026-06-21T09:51:11+08:00 daily https://www.pharmasources.com/industryinsights/spybiotech-licenses-selexis-suretechnolo-326579.html 0.6 2026-06-22T01:50:30+08:00 daily https://www.pharmasources.com/industryinsights/romaco-acquires-ste-tecpharm-326580.html 0.6 2026-08-10T17:33:11+08:00 daily https://www.pharmasources.com/industryinsights/alcami-appoints-patrick-d-walsh-as-chair-326581.html 0.6 2026-08-09T01:20:55+08:00 daily https://www.pharmasources.com/industryinsights/boston-pharmaceuticals-signs-three-year--326582.html 0.6 2026-08-14T15:26:58+08:00 daily https://www.pharmasources.com/industryinsights/philippines-gives-approval-to-sputnik-v--326583.html 0.6 2026-08-08T22:01:48+08:00 daily https://www.pharmasources.com/industryinsights/ema-review-concludes-astrazeneca-covid-1-326584.html 0.6 2026-08-08T23:30:04+08:00 daily https://www.pharmasources.com/industryinsights/merck-adds-assembly-production-unit-in-f-326585.html 0.6 2026-08-09T02:52:38+08:00 daily https://www.pharmasources.com/industryinsights/hoth-therapeutics-and-ucri-to-perform-cr-326586.html 0.6 2026-08-09T04:32:04+08:00 daily https://www.pharmasources.com/industryinsights/lomecel-b-approved-for-compassionate-use-326587.html 0.6 2026-06-22T11:36:45+08:00 daily https://www.pharmasources.com/industryinsights/nuvation-bio-granted-orphan-drug-designa-326588.html 0.6 2026-08-13T15:41:34+08:00 daily https://www.pharmasources.com/industryinsights/harbour-biomed-doses-first-patient-in-ta-326589.html 0.6 2026-07-01T10:39:58+08:00 daily https://www.pharmasources.com/industryinsights/sagent-recalls-phenylephrine-hydrochlori-326590.html 0.6 2026-08-10T17:33:26+08:00 daily https://www.pharmasources.com/industryinsights/getmydna-receives-eua-for-covid-19-test--326591.html 0.6 2026-06-22T13:41:34+08:00 daily https://www.pharmasources.com/industryinsights/beckman-coulter-offers-4high-throughput--326592.html 0.6 2026-06-21T19:54:37+08:00 daily https://www.pharmasources.com/industryinsights/the-shocking-numbers-reveal-an-explosion-326593.html 0.6 2026-06-22T03:06:54+08:00 daily https://www.pharmasources.com/industryinsights/wake-research-earns-recognition-for-nova-326594.html 0.6 2026-06-22T10:56:46+08:00 daily https://www.pharmasources.com/industryinsights/biovaxys-enters-agreement-with-inotiv-to-326595.html 0.6 2026-06-21T12:21:47+08:00 daily https://www.pharmasources.com/industryinsights/eu-authorisation-for-xphytos-rapid-covid-326596.html 0.6 2026-08-08T22:42:40+08:00 daily https://www.pharmasources.com/industryinsights/icrs-resistance-busting-drug-advances-in-326597.html 0.6 2026-08-07T05:19:05+08:00 daily https://www.pharmasources.com/industryinsights/nice-approves-lynparza-plus-avastin-via--326598.html 0.6 2026-07-27T16:26:34+08:00 daily https://www.pharmasources.com/industryinsights/havas-lynx-and-syneos-take-home-most-age-326599.html 0.6 2026-02-28T14:09:31+08:00 daily https://www.pharmasources.com/industryinsights/international-trade-officials-to-review--326600.html 0.6 2026-01-19T07:42:29+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-unveils-strong-perform-326601.html 0.6 2026-08-03T16:46:04+08:00 daily https://www.pharmasources.com/industryinsights/apiject-systems-corp-announces-appointme-326602.html 0.6 2026-06-20T15:13:20+08:00 daily https://www.pharmasources.com/industryinsights/111-inc-announces-fourth-quarter-and-fis-326603.html 0.6 2026-06-20T19:59:35+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-translate-bio-initiate-phase--326604.html 0.6 2026-08-02T18:30:49+08:00 daily https://www.pharmasources.com/industryinsights/leprosy-drug-holds-promise-as-at-home-tr-326605.html 0.6 2026-03-02T03:39:59+08:00 daily https://www.pharmasources.com/industryinsights/analysis-and-policy-review-of-pediatric--326606.html 0.6 2026-07-22T08:53:50+08:00 daily https://www.pharmasources.com/industryinsights/breaking-news-chia-tai-tianqing-to-recei-326607.html 0.6 2026-08-07T02:39:38+08:00 daily https://www.pharmasources.com/industryinsights/new-progress-in-the-hair-loss-prevention-326608.html 0.6 2026-08-07T02:51:47+08:00 daily https://www.pharmasources.com/industryinsights/92-per-cent-decrease-in-uk-covid-19-case-326609.html 0.6 2026-08-05T10:23:37+08:00 daily https://www.pharmasources.com/industryinsights/8-10-months-protection-possible-with-cov-326610.html 0.6 2026-06-20T20:53:39+08:00 daily https://www.pharmasources.com/industryinsights/premas-biotech-oramed-announce-single-do-326611.html 0.6 2026-06-21T08:17:14+08:00 daily https://www.pharmasources.com/industryinsights/nppa-increases-wpi-by-053638-per-cent-in-326612.html 0.6 2026-07-19T05:58:53+08:00 daily https://www.pharmasources.com/industryinsights/cipla-takes-deal-route-with-alvotech-to--326613.html 0.6 2026-06-20T16:53:11+08:00 daily https://www.pharmasources.com/industryinsights/rdif-stelis-biopharma-join-hands-for-200-326614.html 0.6 2026-06-20T23:09:48+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-to-supply-500000-additional--326615.html 0.6 2026-04-20T13:25:18+08:00 daily https://www.pharmasources.com/industryinsights/genopis-renamed-wacker-biotech-us-326616.html 0.6 2026-08-06T00:37:56+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-selects-north-carolina-for-2b-b-326617.html 0.6 2026-08-04T16:06:26+08:00 daily https://www.pharmasources.com/industryinsights/alcami-names-patrick-d-walsh-as-chairman-326618.html 0.6 2026-06-12T01:30:31+08:00 daily https://www.pharmasources.com/industryinsights/mriglobal-research-part-of-first-covid-1-326619.html 0.6 2026-06-18T08:46:58+08:00 daily https://www.pharmasources.com/industryinsights/anima-signs-new-strategic-collaboration--326620.html 0.6 2026-06-21T16:52:31+08:00 daily https://www.pharmasources.com/industryinsights/cansinos-covid-19-vaccine-receives-appro-326621.html 0.6 2026-06-21T22:49:38+08:00 daily https://www.pharmasources.com/industryinsights/fda-warns-of-potential-false-results-wit-326622.html 0.6 2026-08-11T15:28:38+08:00 daily https://www.pharmasources.com/industryinsights/qlhc-concludes-apremilast-not-likely-to--326623.html 0.6 2026-06-20T20:17:55+08:00 daily https://www.pharmasources.com/industryinsights/fda-releases-updated-essure-report-326624.html 0.6 2026-06-23T08:51:37+08:00 daily https://www.pharmasources.com/industryinsights/libtayo-monotherapy-trial-in-advanced-ce-326625.html 0.6 2026-07-21T15:48:12+08:00 daily https://www.pharmasources.com/industryinsights/evrysdi-trial-demonstrates-improvement-o-326626.html 0.6 2026-08-13T21:12:09+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-dosed-in-avatrombopag-stud-326627.html 0.6 2026-06-21T10:58:17+08:00 daily https://www.pharmasources.com/industryinsights/fda-nod-for-kiniksas-arcalyst-in-recurre-326628.html 0.6 2026-06-22T02:07:47+08:00 daily https://www.pharmasources.com/industryinsights/formal-review-of-gp-access-arrangements--326629.html 0.6 2026-06-20T22:05:41+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-kyprolis-triple-combinat-326630.html 0.6 2026-06-21T03:16:00+08:00 daily https://www.pharmasources.com/industryinsights/roches-tecentriq-improves-disease-free-s-326631.html 0.6 2026-06-21T12:21:39+08:00 daily https://www.pharmasources.com/industryinsights/microbiome-biotherapeutic-shows-promise--326632.html 0.6 2026-06-20T15:58:21+08:00 daily https://www.pharmasources.com/industryinsights/new-oral-chronic-lymphocytic-leukaemia-t-326633.html 0.6 2026-06-21T06:57:09+08:00 daily https://www.pharmasources.com/industryinsights/ema-clears-use-of-covid-19-vaccine-astra-326634.html 0.6 2026-08-13T03:57:10+08:00 daily https://www.pharmasources.com/industryinsights/novel-blood-cleansing-device-to-enter-fi-326635.html 0.6 2026-07-13T10:29:20+08:00 daily https://www.pharmasources.com/industryinsights/targeting-a-new-antibody-supersite-key-t-326636.html 0.6 2026-06-20T17:02:17+08:00 daily https://www.pharmasources.com/industryinsights/bharat-biotech-announces-phase-3-results-326637.html 0.6 2026-06-21T19:06:37+08:00 daily https://www.pharmasources.com/industryinsights/who-statement-on-astrazeneca-covid-19-va-326638.html 0.6 2026-06-21T07:25:22+08:00 daily https://www.pharmasources.com/industryinsights/agreement-builds-on-an-earlier-announcem-326639.html 0.6 2026-06-24T20:36:34+08:00 daily https://www.pharmasources.com/industryinsights/chime-biologics-announces-marc-funk-as-n-326640.html 0.6 2026-08-10T19:24:59+08:00 daily https://www.pharmasources.com/industryinsights/everest-medicines-announces-financial-re-326641.html 0.6 2026-08-08T02:43:13+08:00 daily https://www.pharmasources.com/industryinsights/everest-medicines-announces-acceptance-o-326642.html 0.6 2026-07-19T22:00:22+08:00 daily https://www.pharmasources.com/industryinsights/harbour-biomed-announces-dosing-of-first-326643.html 0.6 2026-08-10T11:21:35+08:00 daily https://www.pharmasources.com/industryinsights/innoforce-pharmaceuticals-completes-625m-326644.html 0.6 2026-07-15T21:46:01+08:00 daily https://www.pharmasources.com/industryinsights/curevac-expands-late-stage-trials-of-cov-326645.html 0.6 2026-06-21T12:21:51+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fischer-scientific-collaborates-w-326647.html 0.6 2026-06-29T18:36:36+08:00 daily https://www.pharmasources.com/industryinsights/evotec-takeda-enter-multi-rna-target-all-326648.html 0.6 2026-06-21T21:12:13+08:00 daily https://www.pharmasources.com/industryinsights/rentschler-leukocare-extend-service-offe-326649.html 0.6 2026-06-20T15:53:21+08:00 daily https://www.pharmasources.com/industryinsights/eisai-begins-construction-of-new-injecti-326650.html 0.6 2026-06-21T03:18:17+08:00 daily https://www.pharmasources.com/industryinsights/cybin-to-leverage-catalents-zydis-for-ps-326651.html 0.6 2026-06-21T07:00:05+08:00 daily https://www.pharmasources.com/industryinsights/interval-between-two-doses-of-covishield-326652.html 0.6 2026-06-20T19:01:36+08:00 daily https://www.pharmasources.com/industryinsights/km-biologics-commences-clinical-trial-of-326653.html 0.6 2026-06-21T01:11:00+08:00 daily https://www.pharmasources.com/industryinsights/south-africa-sells-covid-19-vaccines-pro-326654.html 0.6 2026-06-21T10:52:12+08:00 daily https://www.pharmasources.com/industryinsights/rdif-virchow-biotech-sign-agreement-to-p-326655.html 0.6 2026-06-28T20:49:56+08:00 daily https://www.pharmasources.com/industryinsights/new-data-boosts-astrazeneca-covid-19-vac-326656.html 0.6 2026-06-21T12:51:29+08:00 daily https://www.pharmasources.com/industryinsights/researchers-at-iiser-bhopal-nebraska-uni-326657.html 0.6 2026-07-05T22:09:02+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-bausch-health-partner-to-commer-326658.html 0.6 2026-07-18T15:19:35+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-janssens-ponvory-for-rel-326659.html 0.6 2026-08-12T10:44:42+08:00 daily https://www.pharmasources.com/industryinsights/ambrx-gets-orphan-drug-designation-for-g-326660.html 0.6 2026-04-06T23:16:34+08:00 daily https://www.pharmasources.com/industryinsights/pep-therapy-institut-curie-granted-appro-326661.html 0.6 2026-06-30T20:29:36+08:00 daily https://www.pharmasources.com/industryinsights/merck-kgaa-darmstadt-germany-reports-top-326662.html 0.6 2026-06-27T23:15:45+08:00 daily https://www.pharmasources.com/industryinsights/ventyx-doses-first-subject-in-vtx-958-tr-326663.html 0.6 2026-08-10T17:21:56+08:00 daily https://www.pharmasources.com/industryinsights/tilt-biotherapeutics-advances-cancer-imm-326664.html 0.6 2026-08-07T04:36:39+08:00 daily https://www.pharmasources.com/industryinsights/cytocom-receives-ind-for-cyto-205-trial--326665.html 0.6 2026-08-07T04:34:10+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-emergency-use-of-a-non-diag-326666.html 0.6 2026-08-07T00:01:54+08:00 daily https://www.pharmasources.com/industryinsights/pharma-industry-to-spend-45-billion-on-d-326667.html 0.6 2026-08-07T00:40:50+08:00 daily https://www.pharmasources.com/industryinsights/shockwave-announces-joint-venture-in-chi-326668.html 0.6 2026-08-07T13:19:22+08:00 daily https://www.pharmasources.com/industryinsights/eucure-biopharma-announces-breakthrough--326669.html 0.6 2026-08-07T01:22:04+08:00 daily https://www.pharmasources.com/industryinsights/xylonix-reveals-new-drug-compound-for-co-326670.html 0.6 2026-08-07T01:11:01+08:00 daily https://www.pharmasources.com/industryinsights/sirtex-medical-announces-new-sir-spheres-326671.html 0.6 2026-08-12T23:24:13+08:00 daily https://www.pharmasources.com/industryinsights/tavotek-biotherapeutics-announces-comple-326672.html 0.6 2026-08-07T00:39:53+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-gets-usd-40-million-covid-credi-326673.html 0.6 2026-08-07T00:41:52+08:00 daily https://www.pharmasources.com/industryinsights/oxford-astrazeneca-jabs-effective-agains-326674.html 0.6 2026-08-09T02:40:13+08:00 daily https://www.pharmasources.com/industryinsights/bhutan-pm-thanks-modi-for-gift-of-additi-326675.html 0.6 2026-08-07T13:17:31+08:00 daily https://www.pharmasources.com/industryinsights/cipla-therapeutics-and-siga-technologies-326676.html 0.6 2026-08-08T03:25:35+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-pharma-gets-anda-approval-for-d-326677.html 0.6 2026-08-08T04:35:53+08:00 daily https://www.pharmasources.com/industryinsights/sinovacs-covid-19-vaccine-trial-triggers-326678.html 0.6 2026-08-08T06:16:38+08:00 daily https://www.pharmasources.com/industryinsights/komodo-health-secures-220m-in-series-e-f-326679.html 0.6 2026-08-08T07:38:14+08:00 daily https://www.pharmasources.com/industryinsights/us-health-agency-questions-astrazenecas--326680.html 0.6 2026-08-09T07:56:25+08:00 daily https://www.pharmasources.com/industryinsights/ema-advises-against-ivermectin-use-for-c-326681.html 0.6 2026-06-21T13:55:13+08:00 daily https://www.pharmasources.com/industryinsights/bioage-begins-trial-of-oral-inhibitor-to-326682.html 0.6 2026-07-07T13:11:36+08:00 daily https://www.pharmasources.com/industryinsights/roches-antibody-cocktail-lowers-hospital-326683.html 0.6 2026-06-20T20:20:52+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-zealand-pharmas-zegalogue-f-326684.html 0.6 2026-07-03T13:48:30+08:00 daily https://www.pharmasources.com/industryinsights/biocentriq-and-kytopen-enter-cell-therap-326685.html 0.6 2026-06-23T12:09:16+08:00 daily https://www.pharmasources.com/industryinsights/plus-therapeutics-piramal-ink-master-ser-326686.html 0.6 2026-06-20T14:57:11+08:00 daily https://www.pharmasources.com/industryinsights/raybow-pharmaceutical-expands-in-us-326687.html 0.6 2026-06-21T22:50:55+08:00 daily https://www.pharmasources.com/industryinsights/initiative-to-get-covid-19-vaccines-to-p-326688.html 0.6 2026-08-09T17:59:07+08:00 daily https://www.pharmasources.com/industryinsights/one-year-since-fda-validation-of-south-c-326689.html 0.6 2026-08-08T05:08:38+08:00 daily https://www.pharmasources.com/industryinsights/fda-permits-marketing-of-first-sars-cov--326690.html 0.6 2026-08-07T13:17:18+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-326691.html 0.6 2026-08-06T21:58:40+08:00 daily https://www.pharmasources.com/industryinsights/precigen-receives-orphan-drug-designatio-326692.html 0.6 2026-08-06T22:08:48+08:00 daily https://www.pharmasources.com/industryinsights/arise-3-dry-eye-trial-does-not-meet-prim-326693.html 0.6 2026-08-07T21:29:34+08:00 daily https://www.pharmasources.com/industryinsights/sagimet-biosciences-receives-fast-track--326694.html 0.6 2026-08-06T22:31:54+08:00 daily https://www.pharmasources.com/industryinsights/roche-ends-tominersen-study-in-manifest--326695.html 0.6 2026-06-21T11:04:16+08:00 daily https://www.pharmasources.com/industryinsights/researchers-identify-molecular-cookie-cu-326696.html 0.6 2026-08-07T13:17:25+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyo-inks-digital-partnership--326697.html 0.6 2026-08-08T22:51:28+08:00 daily https://www.pharmasources.com/industryinsights/novel-radionuclide-therapy-found-to-be-m-326698.html 0.6 2026-08-09T00:38:10+08:00 daily https://www.pharmasources.com/industryinsights/regen-cov-antibody-cocktail-reduces-hosp-326699.html 0.6 2026-08-09T03:34:09+08:00 daily https://www.pharmasources.com/industryinsights/using-albumin-could-facilitate-vaccinati-326700.html 0.6 2026-08-12T09:40:06+08:00 daily https://www.pharmasources.com/industryinsights/fishawack-health-unveils-an-unrivaled-gl-326701.html 0.6 2026-06-30T17:11:32+08:00 daily https://www.pharmasources.com/industryinsights/forest-hills-lab-is-filing-an-ind-to-ini-326702.html 0.6 2026-07-22T17:14:57+08:00 daily https://www.pharmasources.com/industryinsights/cstone-announces-new-drug-approval-of-ga-326703.html 0.6 2026-07-31T11:57:28+08:00 daily https://www.pharmasources.com/industryinsights/transcenta-announces-appointments-of-dr--326704.html 0.6 2026-08-01T11:59:37+08:00 daily https://www.pharmasources.com/industryinsights/adults-with-obesity-treated-with-semaglu-326705.html 0.6 2026-08-08T18:29:23+08:00 daily https://www.pharmasources.com/industryinsights/hormone-drugs-may-disarm-covid-19-spike--326706.html 0.6 2026-08-06T23:32:59+08:00 daily https://www.pharmasources.com/industryinsights/niaid-statement-on-astrazeneca-vaccine-a-326707.html 0.6 2026-06-20T18:16:44+08:00 daily https://www.pharmasources.com/industryinsights/2020-results-record-high-despite-a-chall-326708.html 0.6 2026-07-01T07:20:07+08:00 daily https://www.pharmasources.com/industryinsights/quantifying-caking-using-the-ft4-powder--326709.html 0.6 2026-07-01T22:17:06+08:00 daily https://www.pharmasources.com/industryinsights/gamma-biosciences-makes-key-management-h-326710.html 0.6 2026-06-20T20:05:46+08:00 daily https://www.pharmasources.com/industryinsights/cyanvac-selects-exothera-for-the-develop-326711.html 0.6 2026-08-04T03:43:43+08:00 daily https://www.pharmasources.com/industryinsights/decentralized-clinical-trials-the-tomorr-326712.html 0.6 2026-08-06T23:36:55+08:00 daily https://www.pharmasources.com/industryinsights/biocentriq-kytopen-enter-cell-therapy-al-326713.html 0.6 2026-06-21T09:13:09+08:00 daily https://www.pharmasources.com/industryinsights/jsr-life-sciences-unveils-corporate-vent-326714.html 0.6 2026-06-21T12:33:18+08:00 daily https://www.pharmasources.com/industryinsights/ppd-clinical-ink-partner-on-near-real-ti-326715.html 0.6 2026-06-20T22:23:09+08:00 daily https://www.pharmasources.com/industryinsights/probiogen-nobelpharma-enter-mfg-agreemen-326716.html 0.6 2026-06-24T07:15:32+08:00 daily https://www.pharmasources.com/industryinsights/china-approves-clinical-trials-for-livzo-326717.html 0.6 2026-08-07T10:20:35+08:00 daily https://www.pharmasources.com/industryinsights/veeda-clinical-research-acquires-stake-i-326718.html 0.6 2026-06-22T10:01:48+08:00 daily https://www.pharmasources.com/industryinsights/acg-launches-acgcaps-ntone-and-acgcaps-t-326719.html 0.6 2026-06-20T14:47:54+08:00 daily https://www.pharmasources.com/industryinsights/brazil-could-approve-russian-coronavirus-326720.html 0.6 2026-06-21T02:58:54+08:00 daily https://www.pharmasources.com/industryinsights/indian-drug-manufacturer-sentenced-to-pa-326721.html 0.6 2026-06-21T11:22:27+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-pharma-gets-anda-approval-for-c-326722.html 0.6 2026-07-26T08:06:21+08:00 daily https://www.pharmasources.com/industryinsights/cipla-board-approves-reappointment-of-um-326723.html 0.6 2026-07-03T04:42:04+08:00 daily https://www.pharmasources.com/industryinsights/india-continues-slow-steady-climb-on-us--326724.html 0.6 2026-07-02T16:09:51+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-reports-positive-bu-326725.html 0.6 2026-08-07T04:53:10+08:00 daily https://www.pharmasources.com/industryinsights/nice-publishes-guideline-for-covid-19-ma-326726.html 0.6 2026-08-07T04:31:32+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-begins-trial-of-oral-antiviral-th-326727.html 0.6 2026-08-07T04:53:05+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-to-sell-anti-inflammatory-drug-po-326728.html 0.6 2026-06-23T23:54:09+08:00 daily https://www.pharmasources.com/industryinsights/the-american-diabetes-association-praise-326729.html 0.6 2026-07-18T10:48:34+08:00 daily https://www.pharmasources.com/industryinsights/clover-biopharmaceuticals-and-dynavax-an-326730.html 0.6 2026-03-20T07:38:33+08:00 daily https://www.pharmasources.com/industryinsights/post-hoc-study-analysis-examines-early-i-326731.html 0.6 2026-06-20T21:57:33+08:00 daily https://www.pharmasources.com/industryinsights/redhill-announces-opaganib-as-compassion-326732.html 0.6 2026-06-21T04:54:50+08:00 daily https://www.pharmasources.com/industryinsights/fda-authorizes-revisions-to-fact-sheets--326733.html 0.6 2026-06-21T04:21:27+08:00 daily https://www.pharmasources.com/industryinsights/anixa-biosciences-moffitt-cancer-center--326734.html 0.6 2026-07-09T05:59:54+08:00 daily https://www.pharmasources.com/industryinsights/report-urges-pharma-companies-to-utilise-326735.html 0.6 2026-06-20T20:07:37+08:00 daily https://www.pharmasources.com/industryinsights/fda-refuses-novo-nordisks-once-weekly-se-326736.html 0.6 2026-08-06T08:54:31+08:00 daily https://www.pharmasources.com/industryinsights/combining-pacritinib-with-sirolimus-base-326737.html 0.6 2026-08-09T06:51:27+08:00 daily https://www.pharmasources.com/industryinsights/isturisa-continues-to-show-promise-in-cu-326738.html 0.6 2026-08-09T03:45:40+08:00 daily https://www.pharmasources.com/industryinsights/fda-sends-warning-to-companies-selling-u-326739.html 0.6 2026-08-07T13:16:57+08:00 daily https://www.pharmasources.com/industryinsights/individual-sars-cov-2-neutralising-antib-326740.html 0.6 2026-08-07T00:24:51+08:00 daily https://www.pharmasources.com/industryinsights/positive-phase-iii-clinical-results-for--326741.html 0.6 2026-08-07T00:39:57+08:00 daily https://www.pharmasources.com/industryinsights/bioheng-biotech-raised-80-million-in-ser-326742.html 0.6 2026-08-07T01:10:51+08:00 daily https://www.pharmasources.com/industryinsights/mabxience-expands-biosimilar-and-cdmo-ma-326743.html 0.6 2026-08-10T20:11:31+08:00 daily https://www.pharmasources.com/industryinsights/cyanvac-and-exothera-enter-covid-19-vacc-326744.html 0.6 2026-08-07T03:03:00+08:00 daily https://www.pharmasources.com/industryinsights/labvantage-solutions-names-mikael-hagstr-326745.html 0.6 2026-08-09T11:05:55+08:00 daily https://www.pharmasources.com/industryinsights/asia-pacific-private-equity-deal-value-h-326746.html 0.6 2026-08-03T06:45:10+08:00 daily https://www.pharmasources.com/industryinsights/india-to-focus-on-domestic-vaccine-deman-326747.html 0.6 2026-07-05T23:27:20+08:00 daily https://www.pharmasources.com/industryinsights/gmr-hyderabad-air-cargo-to-offer-blockch-326748.html 0.6 2026-03-11T20:52:03+08:00 daily https://www.pharmasources.com/industryinsights/animal-research-facility-opens-at-jnu-326749.html 0.6 2026-08-08T12:18:39+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-india-to-sustain-gr-326750.html 0.6 2026-08-08T14:03:07+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-says-covid-19-vaccine-76-per-326751.html 0.6 2026-08-10T10:35:03+08:00 daily https://www.pharmasources.com/industryinsights/bhu-signs-mou-with-ics-for-ganga-godavar-326752.html 0.6 2026-08-07T02:05:19+08:00 daily https://www.pharmasources.com/industryinsights/four-pharma-majors-invest-in-abcd-techno-326753.html 0.6 2026-08-07T01:52:04+08:00 daily https://www.pharmasources.com/industryinsights/govt-set-to-introduce-single-window-clea-326754.html 0.6 2026-08-07T01:27:49+08:00 daily https://www.pharmasources.com/industryinsights/chemotherapy-uptake-to-gradually-decreas-326755.html 0.6 2026-08-07T01:19:21+08:00 daily https://www.pharmasources.com/industryinsights/colombia-approves-jj-covid-19-vaccine-fo-326756.html 0.6 2026-08-07T01:11:09+08:00 daily https://www.pharmasources.com/industryinsights/australian-tga-approves-vertexs-trikafta-326757.html 0.6 2026-08-07T00:40:32+08:00 daily https://www.pharmasources.com/industryinsights/step-pharma-raises-funds-through-series--326758.html 0.6 2026-08-07T00:42:31+08:00 daily https://www.pharmasources.com/industryinsights/ucla-led-study-identifies-potential-drug-326759.html 0.6 2026-08-07T00:53:05+08:00 daily https://www.pharmasources.com/industryinsights/dyadic-and-medytox-to-co-develop-covid-1-326760.html 0.6 2026-08-07T00:57:44+08:00 daily https://www.pharmasources.com/industryinsights/eucure-biopharma-announces-breakthrough--326761.html 0.6 2026-08-07T01:06:34+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-pembrolizumab-for-esophagea-326762.html 0.6 2026-08-07T01:15:27+08:00 daily https://www.pharmasources.com/industryinsights/fda-authorizes-first-machine-learning-ba-326763.html 0.6 2026-08-07T01:21:49+08:00 daily https://www.pharmasources.com/industryinsights/iontas-identifies-novel-sars-cov-2-neutr-326764.html 0.6 2026-08-07T01:27:44+08:00 daily https://www.pharmasources.com/industryinsights/fda-advises-health-care-professionals-no-326765.html 0.6 2026-08-07T01:31:34+08:00 daily https://www.pharmasources.com/industryinsights/relugolix-shows-potential-long-term-bene-326766.html 0.6 2026-08-07T02:05:42+08:00 daily https://www.pharmasources.com/industryinsights/cambridge-start-up-phoremost-raises-33m--326767.html 0.6 2026-08-07T02:18:32+08:00 daily https://www.pharmasources.com/industryinsights/uk-health-security-agency-launches-to-ad-326768.html 0.6 2026-08-10T17:22:23+08:00 daily https://www.pharmasources.com/industryinsights/could-viral-vector-shortages-disrupt-the-326769.html 0.6 2026-06-22T07:02:49+08:00 daily https://www.pharmasources.com/industryinsights/leukine-is-beneficial-to-patients-with-m-326770.html 0.6 2026-06-21T03:20:05+08:00 daily https://www.pharmasources.com/industryinsights/airway-therapeutics-announces-fda-accept-326771.html 0.6 2026-06-20T16:54:13+08:00 daily https://www.pharmasources.com/industryinsights/chime-biologics-announced-the-completion-326772.html 0.6 2026-06-24T06:05:21+08:00 daily https://www.pharmasources.com/industryinsights/amplicore-inc-announces-closing-of-a-suc-326773.html 0.6 2026-06-21T10:59:13+08:00 daily https://www.pharmasources.com/industryinsights/antengene-appoints-kevin-lynch-as-chief--326774.html 0.6 2026-07-29T17:45:09+08:00 daily https://www.pharmasources.com/industryinsights/antengene-appoints-bo-shan-as-chief-scie-326775.html 0.6 2026-08-07T05:02:05+08:00 daily https://www.pharmasources.com/industryinsights/will-covid-19-vaccines-need-to-be-adapte-326776.html 0.6 2026-08-07T04:52:42+08:00 daily https://www.pharmasources.com/industryinsights/ema-approves-biontechs-covid-vax-product-326777.html 0.6 2026-08-07T04:30:48+08:00 daily https://www.pharmasources.com/industryinsights/aenova-expands-sterile-production-capaci-326778.html 0.6 2026-08-07T04:27:54+08:00 daily https://www.pharmasources.com/industryinsights/asymchem-expands-oligonucleotides-mfg-ca-326779.html 0.6 2026-08-10T20:00:21+08:00 daily https://www.pharmasources.com/industryinsights/india-gives-12-million-free-doses-of-ast-326780.html 0.6 2026-08-07T04:16:03+08:00 daily https://www.pharmasources.com/industryinsights/sii-postpones-launch-of-novavax-vaccine--326781.html 0.6 2026-08-07T03:54:50+08:00 daily https://www.pharmasources.com/industryinsights/we-have-supplied-more-vaccines-globally--326782.html 0.6 2026-08-07T03:24:33+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-and-bluebird-bio-ge-326783.html 0.6 2026-08-07T03:12:46+08:00 daily https://www.pharmasources.com/industryinsights/schott-reaches-covid-19-milestone-vials--326784.html 0.6 2026-08-07T03:02:37+08:00 daily https://www.pharmasources.com/industryinsights/natco-pharma-board-okays-acquiring-1-per-326785.html 0.6 2026-08-07T02:48:43+08:00 daily https://www.pharmasources.com/industryinsights/biocon-pharma-joins-hands-with-libbs-far-326786.html 0.6 2026-08-07T02:43:07+08:00 daily https://www.pharmasources.com/industryinsights/russian-president-experienced-slight-sid-326787.html 0.6 2026-08-07T02:36:53+08:00 daily https://www.pharmasources.com/industryinsights/apnimed-raises-funding-to-advance-sleep--326788.html 0.6 2026-08-09T02:52:15+08:00 daily https://www.pharmasources.com/industryinsights/university-team-uses-ai-to-decode-asbest-326789.html 0.6 2026-08-07T03:56:48+08:00 daily https://www.pharmasources.com/industryinsights/fda-panel-votes-against-pfizers-tanezuma-326790.html 0.6 2026-08-08T23:34:32+08:00 daily https://www.pharmasources.com/industryinsights/aptabio-to-initiate-phase-ii-oral-covid--326791.html 0.6 2026-08-10T17:21:40+08:00 daily https://www.pharmasources.com/industryinsights/nih-funded-study-finds-evidence-that-sar-326792.html 0.6 2026-08-08T17:53:17+08:00 daily https://www.pharmasources.com/industryinsights/eli-lilly-stops-distribution-of-bamlaniv-326793.html 0.6 2026-08-10T02:20:38+08:00 daily https://www.pharmasources.com/industryinsights/berg-to-conduct-phase-two-trial-for-glio-326794.html 0.6 2026-08-10T15:57:00+08:00 daily https://www.pharmasources.com/industryinsights/zydus-recalls-acyclovir-sodium-injection-326795.html 0.6 2026-08-08T12:18:44+08:00 daily https://www.pharmasources.com/industryinsights/hoth-announces-positive-preclinical-resu-326796.html 0.6 2026-08-08T10:10:34+08:00 daily https://www.pharmasources.com/industryinsights/fda-warns-companies-illegally-selling-ov-326797.html 0.6 2026-08-08T08:00:21+08:00 daily https://www.pharmasources.com/industryinsights/researchers-identify-new-genetic-clues-f-326798.html 0.6 2026-08-07T17:15:27+08:00 daily https://www.pharmasources.com/industryinsights/cancer-research-uk-launches-new-cancer-t-326799.html 0.6 2026-08-07T16:15:25+08:00 daily https://www.pharmasources.com/industryinsights/ema-accepts-astellasseagens-enfortumab-v-326800.html 0.6 2026-08-07T13:17:12+08:00 daily https://www.pharmasources.com/industryinsights/nhs-england-makes-keytruda-available-for-326801.html 0.6 2026-08-07T02:04:45+08:00 daily https://www.pharmasources.com/industryinsights/machine-learning-used-to-predict-most-ef-326802.html 0.6 2026-08-07T16:38:23+08:00 daily https://www.pharmasources.com/industryinsights/europe-to-lead-growth-in-the-biodegradab-326803.html 0.6 2026-08-09T22:40:33+08:00 daily https://www.pharmasources.com/industryinsights/ema-accepts-regulatory-submission-for-ta-326804.html 0.6 2026-08-07T01:06:40+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-confirms-covid-19-vaccine-ef-326805.html 0.6 2026-04-07T01:58:21+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-announces-advance-purcha-326806.html 0.6 2026-07-21T16:57:06+08:00 daily https://www.pharmasources.com/industryinsights/jacobio-pharma-announces-cny486-million--326807.html 0.6 2026-08-08T13:52:42+08:00 daily https://www.pharmasources.com/industryinsights/henlius-plans-to-file-the-nda-of-novel-a-326808.html 0.6 2026-08-09T19:17:09+08:00 daily https://www.pharmasources.com/industryinsights/foresee-pharmaceuticals-announces-dosing-326809.html 0.6 2026-04-12T19:59:11+08:00 daily https://www.pharmasources.com/industryinsights/saxenda-recommended-for-approval-by-euro-326810.html 0.6 2026-08-03T13:24:11+08:00 daily https://www.pharmasources.com/industryinsights/neurorx-announces-completion-of-data-ana-326811.html 0.6 2026-06-30T13:34:27+08:00 daily https://www.pharmasources.com/industryinsights/jubilant-novavax-enter-covid-19-vaccine--326812.html 0.6 2026-08-14T07:20:43+08:00 daily https://www.pharmasources.com/industryinsights/chime-biologics-expands-cdmo-capabilitie-326813.html 0.6 2026-08-02T23:42:44+08:00 daily https://www.pharmasources.com/industryinsights/bharat-biotech-biovet-sapigen-biologix-e-326814.html 0.6 2026-06-21T20:43:23+08:00 daily https://www.pharmasources.com/industryinsights/kd-pharma-acquires-rohner-ag-manufacturi-326815.html 0.6 2026-06-21T02:57:38+08:00 daily https://www.pharmasources.com/industryinsights/moderna-ships-100-millionth-dose-of-its--326816.html 0.6 2026-06-21T23:57:41+08:00 daily https://www.pharmasources.com/industryinsights/300-per-cent-increase-in-companies-condu-326817.html 0.6 2026-06-21T08:02:02+08:00 daily https://www.pharmasources.com/industryinsights/dcgi-approval-for-sputnik-v-vaccine-expe-326818.html 0.6 2026-06-04T08:00:54+08:00 daily https://www.pharmasources.com/industryinsights/lilly-vir-and-gsk-report-positive-data-f-326819.html 0.6 2026-07-27T22:56:24+08:00 daily https://www.pharmasources.com/industryinsights/humanigens-lenzilumab-improves-survival--326820.html 0.6 2026-06-20T20:47:23+08:00 daily https://www.pharmasources.com/industryinsights/gsk-and-vir-seek-eua-for-monoclonal-anti-326821.html 0.6 2026-06-20T20:08:38+08:00 daily https://www.pharmasources.com/industryinsights/servier-found-guilty-of-deception-and-ma-326822.html 0.6 2026-06-20T16:53:16+08:00 daily https://www.pharmasources.com/industryinsights/batm-develops-molecular-diagnostics-test-326823.html 0.6 2026-06-22T19:02:07+08:00 daily https://www.pharmasources.com/industryinsights/neurorx-announces-zyesami-trial-met-prim-326824.html 0.6 2026-06-21T15:10:46+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-two-octapharma-supplements-326825.html 0.6 2026-06-20T21:02:39+08:00 daily https://www.pharmasources.com/industryinsights/amphastar-receives-fda-approval-for-dext-326826.html 0.6 2026-07-19T23:40:36+08:00 daily https://www.pharmasources.com/industryinsights/biontech-provides-update-on-vaccine-prod-326827.html 0.6 2026-08-06T04:52:33+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-dosed-for-adenoverse-immun-326828.html 0.6 2026-08-06T23:33:24+08:00 daily https://www.pharmasources.com/industryinsights/brainstorm-announces-positive-topline-da-326829.html 0.6 2026-08-06T23:37:36+08:00 daily https://www.pharmasources.com/industryinsights/oramed-initiates-second-phase-3-oral-ins-326830.html 0.6 2026-08-14T20:35:05+08:00 daily https://www.pharmasources.com/industryinsights/chiesi-usa-appoints-vp-of-medical-affair-326831.html 0.6 2026-08-07T12:28:08+08:00 daily https://www.pharmasources.com/industryinsights/new-research-project-aims-to-improve-und-326832.html 0.6 2026-08-07T13:18:32+08:00 daily https://www.pharmasources.com/industryinsights/novartis-uk-signs-digital-partnership-wi-326833.html 0.6 2026-08-07T19:39:22+08:00 daily https://www.pharmasources.com/industryinsights/five-new-meds-recommended-in-march-chmp--326834.html 0.6 2026-06-21T00:51:03+08:00 daily https://www.pharmasources.com/industryinsights/gsk-agrees-to-support-manufacture-of-nov-326835.html 0.6 2026-08-08T17:53:08+08:00 daily https://www.pharmasources.com/industryinsights/inctyes-pemazyre-authorised-in-the-eu-fo-326836.html 0.6 2026-08-08T19:41:42+08:00 daily https://www.pharmasources.com/industryinsights/affamed-therapeutics-announces-completio-326837.html 0.6 2026-08-08T21:34:36+08:00 daily https://www.pharmasources.com/industryinsights/innovent-announced-financial-results-for-326838.html 0.6 2026-08-13T20:42:14+08:00 daily https://www.pharmasources.com/industryinsights/ascletis-announces-investment-escalation-326839.html 0.6 2026-07-24T00:01:40+08:00 daily https://www.pharmasources.com/industryinsights/gemvaxs-highly-promising-phase-ii-alzhei-326840.html 0.6 2026-08-07T19:35:06+08:00 daily https://www.pharmasources.com/industryinsights/turtletree-scientific-and-jsbiosciences--326841.html 0.6 2026-06-22T21:51:15+08:00 daily https://www.pharmasources.com/industryinsights/who-issues-alert-for-falsified-covid-19--326842.html 0.6 2026-07-15T19:15:00+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-aji-bio-pharma-expand-mfg-ag-326843.html 0.6 2026-08-07T00:01:51+08:00 daily https://www.pharmasources.com/industryinsights/gram-attains-eu-gmp-certification-for-co-326844.html 0.6 2026-08-07T00:39:52+08:00 daily https://www.pharmasources.com/industryinsights/ajinomoto-bright-peak-enter-immunocytoki-326845.html 0.6 2026-08-09T17:29:09+08:00 daily https://www.pharmasources.com/industryinsights/curevac-celonic-enter-covid-19-vax-mfg-p-326846.html 0.6 2026-08-07T02:22:24+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-alembic-pharma-recall-drugs-326847.html 0.6 2026-06-20T17:56:35+08:00 daily https://www.pharmasources.com/industryinsights/techinvention-partners-with-eubiologics--326848.html 0.6 2026-06-21T12:22:44+08:00 daily https://www.pharmasources.com/industryinsights/novartis-signs-deal-with-itheranostics-t-326849.html 0.6 2026-06-22T01:39:21+08:00 daily https://www.pharmasources.com/industryinsights/evrysdi-from-roche-gets-ec-nod-as-home-t-326850.html 0.6 2026-06-21T00:01:39+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccines-from-pfizer-moderna-ve-326851.html 0.6 2026-06-21T16:18:36+08:00 daily https://www.pharmasources.com/industryinsights/resumed-clinical-trials-will-grow-gradua-326852.html 0.6 2026-06-20T21:05:39+08:00 daily https://www.pharmasources.com/industryinsights/tiziana-to-commence-trial-of-nasal-covid-326853.html 0.6 2026-06-21T12:54:25+08:00 daily https://www.pharmasources.com/industryinsights/health-canada-approves-tetra-covid-19-dr-326854.html 0.6 2026-08-06T18:52:32+08:00 daily https://www.pharmasources.com/industryinsights/amgen-agrees-to-acquire-biopharmaceutica-326855.html 0.6 2026-06-21T06:22:25+08:00 daily https://www.pharmasources.com/industryinsights/japan-approves-bristol-myers-squibbs-b-c-326856.html 0.6 2026-06-21T19:56:36+08:00 daily https://www.pharmasources.com/industryinsights/ema-validates-gilead-sciences-applicatio-326857.html 0.6 2026-06-22T11:08:54+08:00 daily https://www.pharmasources.com/industryinsights/olive-labs-inc-announces-partnership-wit-326858.html 0.6 2026-06-21T09:04:08+08:00 daily https://www.pharmasources.com/industryinsights/bms-opdivo-plus-lag-3-antibody-relatlima-326859.html 0.6 2026-06-21T02:56:33+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-sobis-kineret-for-first--326860.html 0.6 2026-06-21T11:05:45+08:00 daily https://www.pharmasources.com/industryinsights/nhs-extends-covid-friendly-at-home-cance-326861.html 0.6 2026-06-20T14:41:56+08:00 daily https://www.pharmasources.com/industryinsights/eu-approval-for-new-ai-technology-that-c-326862.html 0.6 2026-06-21T00:48:45+08:00 daily https://www.pharmasources.com/industryinsights/first-ever-award-for-extraordinary-impac-326863.html 0.6 2026-06-22T22:03:53+08:00 daily https://www.pharmasources.com/industryinsights/what-strains-should-be-in-this-years-sea-326864.html 0.6 2026-06-20T22:45:43+08:00 daily https://www.pharmasources.com/industryinsights/immunotherapy-vaccine-shows-promise-in-p-326865.html 0.6 2026-06-21T06:12:58+08:00 daily https://www.pharmasources.com/industryinsights/gracell-biotechnologies-announces-enroll-326866.html 0.6 2026-06-21T14:56:19+08:00 daily https://www.pharmasources.com/industryinsights/biovaxys-files-fda-pre-ind-meeting-reque-326867.html 0.6 2026-06-20T16:00:27+08:00 daily https://www.pharmasources.com/industryinsights/universal-medical-announced-its-2020-ann-326868.html 0.6 2026-06-29T20:50:14+08:00 daily https://www.pharmasources.com/industryinsights/affamed-therapeutics-and-sifi-announce-j-326869.html 0.6 2026-06-22T20:18:38+08:00 daily https://www.pharmasources.com/industryinsights/cstone-announces-china-nmpa-new-drug-app-326870.html 0.6 2026-08-13T22:23:14+08:00 daily https://www.pharmasources.com/industryinsights/increase-in-vaccine-manufacturing-capaci-326871.html 0.6 2026-08-10T11:54:02+08:00 daily https://www.pharmasources.com/industryinsights/evive-biotech-submits-biologics-license--326872.html 0.6 2026-08-07T01:19:30+08:00 daily https://www.pharmasources.com/industryinsights/sk-capital-completes-acquisition-of-bfs--326873.html 0.6 2026-08-07T19:36:45+08:00 daily https://www.pharmasources.com/industryinsights/steriline-delivers-new-manufacturing-lin-326874.html 0.6 2026-08-07T00:40:12+08:00 daily https://www.pharmasources.com/industryinsights/vibalogics-updates-us-leadership-team-326875.html 0.6 2026-08-07T00:03:20+08:00 daily https://www.pharmasources.com/industryinsights/rentschler-biopharma-names-martin-kessle-326876.html 0.6 2026-08-06T23:57:33+08:00 daily https://www.pharmasources.com/industryinsights/there-should-be-a-change-in-sop-paramete-326877.html 0.6 2026-08-06T23:54:35+08:00 daily https://www.pharmasources.com/industryinsights/anvisa-says-covaxin-producing-facility-d-326878.html 0.6 2026-08-12T07:41:51+08:00 daily https://www.pharmasources.com/industryinsights/rossari-biotech-commissions-greenfield-m-326879.html 0.6 2026-08-06T20:06:54+08:00 daily https://www.pharmasources.com/industryinsights/gsk-pharma-board-approves-sale-of-vemgal-326880.html 0.6 2026-08-06T21:48:44+08:00 daily https://www.pharmasources.com/industryinsights/piramal-pharma-to-acquire-100-per-cent-s-326881.html 0.6 2026-08-06T23:56:42+08:00 daily https://www.pharmasources.com/industryinsights/dcgi-extends-shelf-life-of-covishield-do-326882.html 0.6 2026-08-07T00:02:23+08:00 daily https://www.pharmasources.com/industryinsights/mims-research-foundation-is-developing-a-326883.html 0.6 2026-08-07T13:18:49+08:00 daily https://www.pharmasources.com/industryinsights/ec-approves-novartiss-kesimpta-for-relap-326884.html 0.6 2026-08-07T18:43:42+08:00 daily https://www.pharmasources.com/industryinsights/actinium-initiates-patient-enrollment-in-326885.html 0.6 2026-08-09T08:47:13+08:00 daily https://www.pharmasources.com/industryinsights/canadas-national-advisory-committee-on-i-326886.html 0.6 2026-08-08T12:07:27+08:00 daily https://www.pharmasources.com/industryinsights/first-participants-dosed-in-adjuvanted-s-326887.html 0.6 2026-08-08T13:18:09+08:00 daily https://www.pharmasources.com/industryinsights/alembic-recalls-telmisartan-tablets-20-m-326888.html 0.6 2026-08-08T14:38:27+08:00 daily https://www.pharmasources.com/industryinsights/exacis-develops-mrna-engineered-ipsc-der-326889.html 0.6 2026-08-08T20:02:52+08:00 daily https://www.pharmasources.com/industryinsights/fda-green-light-for-sarclisa-combo-in-mu-326890.html 0.6 2026-07-09T01:27:23+08:00 daily https://www.pharmasources.com/industryinsights/cancer-research-in-the-uk-faces-perfect--326891.html 0.6 2026-06-23T09:21:19+08:00 daily https://www.pharmasources.com/industryinsights/opdivo-plus-cabometyx-approved-in-the-eu-326892.html 0.6 2026-06-21T02:04:41+08:00 daily https://www.pharmasources.com/industryinsights/positive-results-for-pfizerbiontechs-cov-326893.html 0.6 2026-06-21T21:06:44+08:00 daily https://www.pharmasources.com/industryinsights/yingli-pharma-announce-promising-topline-326894.html 0.6 2026-07-29T05:29:12+08:00 daily https://www.pharmasources.com/industryinsights/frontier-pharma-and-baystone-group-compl-326895.html 0.6 2026-07-15T08:13:42+08:00 daily https://www.pharmasources.com/industryinsights/alfasigma-its-vein-week-from-5th-to-11th-326896.html 0.6 2026-06-21T11:10:22+08:00 daily https://www.pharmasources.com/industryinsights/ortho-announces-plans-to-accelerate-covi-326897.html 0.6 2026-08-04T21:18:40+08:00 daily https://www.pharmasources.com/industryinsights/iconovo-signs-agreement-with-isr-for-the-326898.html 0.6 2026-06-21T05:17:57+08:00 daily https://www.pharmasources.com/industryinsights/gracell-biotechnologies-signs-agreement--326899.html 0.6 2026-07-09T11:10:21+08:00 daily https://www.pharmasources.com/industryinsights/anti-inflammatory-drug-protects-against--326900.html 0.6 2026-06-21T03:50:35+08:00 daily https://www.pharmasources.com/industryinsights/formulated-solutions-appoints-ray-bodame-326901.html 0.6 2026-06-21T14:47:15+08:00 daily https://www.pharmasources.com/industryinsights/servier-acquires-agios-pharmaceuticals-o-326902.html 0.6 2026-08-09T15:05:28+08:00 daily https://www.pharmasources.com/industryinsights/eloxx-pharmaceuticals-acquires-zikani-th-326903.html 0.6 2026-08-07T01:36:56+08:00 daily https://www.pharmasources.com/industryinsights/lonza-completes-divestment-of-sites-to-n-326904.html 0.6 2026-08-09T17:56:45+08:00 daily https://www.pharmasources.com/industryinsights/eu-asks-india-for-10-million-astrazeneca-326905.html 0.6 2026-06-21T01:02:46+08:00 daily https://www.pharmasources.com/industryinsights/who-recommends-against-ivermectin-for-co-326906.html 0.6 2026-07-24T02:29:37+08:00 daily https://www.pharmasources.com/industryinsights/abcellera-gilead-collaborate-for-new-mul-326907.html 0.6 2026-08-03T23:38:55+08:00 daily https://www.pharmasources.com/industryinsights/dr-sanish-davis-is-the-new-president-of--326908.html 0.6 2026-06-21T13:07:35+08:00 daily https://www.pharmasources.com/industryinsights/aleor-dermaceuticals-gets-usfda-nod-for--326909.html 0.6 2026-08-08T00:13:42+08:00 daily https://www.pharmasources.com/industryinsights/abcd-technologies-buys-6602-per-cent-sta-326910.html 0.6 2026-07-01T22:55:47+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-covid-19-vaccine-safe-efficacious-326911.html 0.6 2026-06-21T04:16:07+08:00 daily https://www.pharmasources.com/industryinsights/takeda-sells-japans-non-core-products-po-326912.html 0.6 2026-07-16T20:09:50+08:00 daily https://www.pharmasources.com/industryinsights/millions-of-jj-covid-19-vaccine-doses-sc-326913.html 0.6 2026-06-21T12:24:08+08:00 daily https://www.pharmasources.com/industryinsights/nih-begins-trial-of-modernas-covid-19-va-326914.html 0.6 2026-06-21T06:01:47+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-and-biontechs-covid-19-vaccine-sh-326915.html 0.6 2026-06-21T06:14:03+08:00 daily https://www.pharmasources.com/industryinsights/usfda-sends-crl-to-mercks-sbla-regarding-326916.html 0.6 2026-06-20T19:58:31+08:00 daily https://www.pharmasources.com/industryinsights/sqi-diagnostics-submits-rali-dx-il-6-sev-326917.html 0.6 2026-07-05T13:35:35+08:00 daily https://www.pharmasources.com/industryinsights/actinium-completes-enrollment-of-second--326918.html 0.6 2026-08-04T07:59:52+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-releases-statement-on-covid--326919.html 0.6 2026-06-21T14:57:23+08:00 daily https://www.pharmasources.com/industryinsights/airway-announces-ind-acceptance-of-at-10-326920.html 0.6 2026-06-20T14:43:17+08:00 daily https://www.pharmasources.com/industryinsights/milestone-enrolls-first-patient-in-rever-326921.html 0.6 2026-07-24T01:04:29+08:00 daily https://www.pharmasources.com/industryinsights/deception-is-not-necessary-for-the-place-326922.html 0.6 2026-06-23T07:58:25+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approved-jemincare-to-initiate-cl-326923.html 0.6 2026-07-06T21:20:34+08:00 daily https://www.pharmasources.com/industryinsights/regent-pacific-receives-hk2496-million-a-326924.html 0.6 2026-08-05T20:09:47+08:00 daily https://www.pharmasources.com/industryinsights/neurophth-announces-ind-approval-by-the--326925.html 0.6 2026-06-20T14:36:54+08:00 daily https://www.pharmasources.com/industryinsights/everest-medicines-announces-china-nmpa-a-326926.html 0.6 2026-06-28T22:41:27+08:00 daily https://www.pharmasources.com/industryinsights/menarini-silicon-biosystems-launches-cel-326927.html 0.6 2026-07-08T16:03:24+08:00 daily https://www.pharmasources.com/industryinsights/b117-variant-of-covid-19-spreading-rapid-326928.html 0.6 2026-06-20T18:04:24+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-326929.html 0.6 2026-06-21T08:55:56+08:00 daily https://www.pharmasources.com/industryinsights/recro-pharma-expands-business-developmen-326930.html 0.6 2026-03-24T04:44:26+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-to-build-new-700m-flu-vaccine-fac-326931.html 0.6 2026-06-23T04:02:03+08:00 daily https://www.pharmasources.com/industryinsights/cordenpharma-enters-alliance-with-nanos--326932.html 0.6 2026-06-20T22:00:37+08:00 daily https://www.pharmasources.com/industryinsights/labvantage-solutions-expands-and-improve-326933.html 0.6 2026-06-21T20:08:48+08:00 daily https://www.pharmasources.com/industryinsights/crystec-launches-new-rd-center-in-china-326934.html 0.6 2026-06-24T17:01:44+08:00 daily https://www.pharmasources.com/industryinsights/charles-river-acquires-retrogenix-326935.html 0.6 2026-07-27T11:05:32+08:00 daily https://www.pharmasources.com/industryinsights/rdif-and-panacea-biotec-partner-to-produ-326936.html 0.6 2026-08-05T18:38:36+08:00 daily https://www.pharmasources.com/industryinsights/amneal-completes-acquisition-of-kashiv-s-326937.html 0.6 2026-08-09T15:01:45+08:00 daily https://www.pharmasources.com/industryinsights/cidara-therapeutics-signs-deal-with-jans-326938.html 0.6 2026-08-13T12:32:24+08:00 daily https://www.pharmasources.com/industryinsights/the-indian-pharma-sector-is-well-poised--326939.html 0.6 2026-08-10T19:32:27+08:00 daily https://www.pharmasources.com/industryinsights/prioritising-who-receives-covid-19-vacci-326940.html 0.6 2026-08-06T17:51:15+08:00 daily https://www.pharmasources.com/industryinsights/zydus-seeks-dcgi-nod-for-pegylated-inter-326941.html 0.6 2026-08-09T07:36:40+08:00 daily https://www.pharmasources.com/industryinsights/us-gives-charge-of-facility-that-botched-326942.html 0.6 2026-08-15T00:57:21+08:00 daily https://www.pharmasources.com/industryinsights/indias-vaccine-endeavour-truly-a-vaccine-326943.html 0.6 2026-08-07T13:18:36+08:00 daily https://www.pharmasources.com/industryinsights/research-identifies-nine-potential-new-c-326944.html 0.6 2026-08-06T20:07:57+08:00 daily https://www.pharmasources.com/industryinsights/the-five-biggest-data-challenges-for-lif-326945.html 0.6 2026-08-06T18:35:39+08:00 daily https://www.pharmasources.com/industryinsights/jj-expands-phase-2a-covid-19-vaccine-tri-326946.html 0.6 2026-08-13T15:57:43+08:00 daily https://www.pharmasources.com/industryinsights/moderna-gets-usfda-nod-for-bigger-vials--326947.html 0.6 2026-01-05T06:31:04+08:00 daily https://www.pharmasources.com/industryinsights/dcgi-expert-committee-allows-clinical-tr-326948.html 0.6 2026-08-05T11:02:47+08:00 daily https://www.pharmasources.com/industryinsights/eu-countries-consent-to-share-covid-19-v-326949.html 0.6 2026-06-21T01:01:47+08:00 daily https://www.pharmasources.com/industryinsights/india-has-not-banned-exports-of-covid-19-326950.html 0.6 2026-08-09T22:45:13+08:00 daily https://www.pharmasources.com/industryinsights/tatva-chintan-pharma-chem-files-for-rs-4-326951.html 0.6 2026-08-13T01:54:14+08:00 daily https://www.pharmasources.com/industryinsights/g-s-krishnan-is-the-new-president-of-abl-326952.html 0.6 2026-07-08T08:27:55+08:00 daily https://www.pharmasources.com/industryinsights/private-genomics-industry-may-be-called--326953.html 0.6 2026-06-20T14:53:08+08:00 daily https://www.pharmasources.com/industryinsights/hungary-issues-gmp-certificate-to-sinoph-326954.html 0.6 2026-08-06T19:59:20+08:00 daily https://www.pharmasources.com/industryinsights/novavax-commences-crossover-arms-in-covi-326955.html 0.6 2026-06-21T02:57:42+08:00 daily https://www.pharmasources.com/industryinsights/abcellera-reports-bamlanivimabs-potency--326956.html 0.6 2026-08-09T05:41:27+08:00 daily https://www.pharmasources.com/industryinsights/antengene-announces-chinas-nmpa-approval-326957.html 0.6 2026-08-09T14:34:18+08:00 daily https://www.pharmasources.com/industryinsights/mitoimmune-received-fda-clearance-of-ind-326958.html 0.6 2026-08-08T03:09:05+08:00 daily https://www.pharmasources.com/industryinsights/brattea-a-leading-renal-denervation-comp-326959.html 0.6 2026-08-08T02:33:06+08:00 daily https://www.pharmasources.com/industryinsights/antengene-announces-nmpa-approval-of-ind-326960.html 0.6 2026-08-08T00:49:36+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-collaborates-with-doctoroncall-to-326961.html 0.6 2026-07-18T02:10:48+08:00 daily https://www.pharmasources.com/industryinsights/n-lorem-foundation-partners-with-ultrage-326962.html 0.6 2026-06-21T15:00:24+08:00 daily https://www.pharmasources.com/industryinsights/rune-labs-announces-formation-of-scienti-326963.html 0.6 2026-06-21T23:09:53+08:00 daily https://www.pharmasources.com/industryinsights/exelixis-announces-us-fda-accepts-invest-326964.html 0.6 2026-06-21T10:06:11+08:00 daily https://www.pharmasources.com/industryinsights/welldoc-and-dexcom-expand-strategic-part-326965.html 0.6 2026-06-23T09:03:44+08:00 daily https://www.pharmasources.com/industryinsights/rare-disease-therapeutics-inc-announces--326966.html 0.6 2026-08-09T06:51:21+08:00 daily https://www.pharmasources.com/industryinsights/a-s-medication-solutions-issues-voluntar-326967.html 0.6 2026-08-09T00:10:11+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-orphan-drug-designation-for-s-326968.html 0.6 2026-08-11T16:55:57+08:00 daily https://www.pharmasources.com/industryinsights/novartis-expands-targeted-radioligand-th-326969.html 0.6 2026-08-13T23:52:43+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-add-on-therapy-for-patients-326970.html 0.6 2026-08-06T23:47:04+08:00 daily https://www.pharmasources.com/industryinsights/syndax-announces-orphan-drug-designation-326971.html 0.6 2026-08-07T13:17:29+08:00 daily https://www.pharmasources.com/industryinsights/twice-weekly-coronavirus-tests-for-all-326972.html 0.6 2026-08-08T04:30:43+08:00 daily https://www.pharmasources.com/industryinsights/thousands-to-benefit-from-five-minute-br-326973.html 0.6 2026-08-11T20:04:44+08:00 daily https://www.pharmasources.com/industryinsights/researchers-link-to-facilitate-cheaper-b-326974.html 0.6 2026-08-06T20:59:09+08:00 daily https://www.pharmasources.com/industryinsights/ec-approval-for-ontozry-326975.html 0.6 2026-06-21T09:03:59+08:00 daily https://www.pharmasources.com/industryinsights/nice-backs-restricted-use-of-ondexxya-326976.html 0.6 2026-06-20T19:20:01+08:00 daily https://www.pharmasources.com/industryinsights/gsk-consumer-healthcare-to-incorporate-p-326977.html 0.6 2026-07-03T04:31:13+08:00 daily https://www.pharmasources.com/industryinsights/valneva-reports-positive-phase-12-data-f-326978.html 0.6 2026-06-20T23:59:37+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-convalescent-plasma-with-greate-326979.html 0.6 2026-06-20T20:58:34+08:00 daily https://www.pharmasources.com/industryinsights/undetected-coronavirus-variant-was-in-at-326980.html 0.6 2026-06-21T15:15:04+08:00 daily https://www.pharmasources.com/industryinsights/innovation-pharma-to-increase-dosing-fre-326981.html 0.6 2026-06-20T14:27:55+08:00 daily https://www.pharmasources.com/industryinsights/anixa-and-ontochem-to-enter-next-stage-o-326982.html 0.6 2026-06-21T06:43:38+08:00 daily https://www.pharmasources.com/industryinsights/miguel-sieler-joins-cedrus-group-as-dire-326983.html 0.6 2026-06-21T05:58:44+08:00 daily https://www.pharmasources.com/industryinsights/bridge-biotherapeutics-announces-initiat-326984.html 0.6 2026-08-08T06:58:30+08:00 daily https://www.pharmasources.com/industryinsights/shanghai-genechem-co-ltd-genechem-announ-326985.html 0.6 2026-07-16T14:40:42+08:00 daily https://www.pharmasources.com/industryinsights/gan-lee-receives-ema-orphan-drug-designa-326986.html 0.6 2026-06-21T10:21:20+08:00 daily https://www.pharmasources.com/industryinsights/india-may-make-available-fewer-vaccines--326987.html 0.6 2026-07-15T19:58:18+08:00 daily https://www.pharmasources.com/industryinsights/novavax-allows-giving-covid-19-vaccine-t-326988.html 0.6 2026-08-05T19:28:46+08:00 daily https://www.pharmasources.com/industryinsights/india-blessed-to-have-a-major-manufactur-326989.html 0.6 2026-07-30T21:59:31+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-326990.html 0.6 2026-07-10T10:13:06+08:00 daily https://www.pharmasources.com/industryinsights/research-identifies-novel-peptoids-with--326991.html 0.6 2026-07-16T19:19:53+08:00 daily https://www.pharmasources.com/industryinsights/new-track-japanese-digital-therapeutics--326992.html 0.6 2026-08-08T01:58:13+08:00 daily https://www.pharmasources.com/industryinsights/legacy-pharma-solutions-appoints-preside-326993.html 0.6 2026-06-21T04:44:32+08:00 daily https://www.pharmasources.com/industryinsights/ani-acquires-branded-products-portfolio--326994.html 0.6 2026-06-22T03:42:21+08:00 daily https://www.pharmasources.com/industryinsights/alkermes-merck-enter-clinical-trial-and--326995.html 0.6 2026-08-07T15:08:02+08:00 daily https://www.pharmasources.com/industryinsights/hitachi-axcelead-to-develop-next-gen-bio-326996.html 0.6 2026-08-12T00:56:40+08:00 daily https://www.pharmasources.com/industryinsights/kindeva-drug-delivery-and-cambridge-heal-326997.html 0.6 2026-06-22T01:58:41+08:00 daily https://www.pharmasources.com/industryinsights/sterling-pharma-solutions-acquires-adc-b-326998.html 0.6 2026-08-12T13:32:03+08:00 daily https://www.pharmasources.com/industryinsights/sound-pharmaceuticals-receives-31m-nih-g-326999.html 0.6 2026-06-21T09:11:17+08:00 daily https://www.pharmasources.com/industryinsights/moleculin-selects-iqvia-biotech-to-advan-327000.html 0.6 2026-08-09T00:23:17+08:00 daily https://www.pharmasources.com/industryinsights/cryoport-acquires-critical-transport-sol-327001.html 0.6 2026-08-07T04:39:16+08:00 daily https://www.pharmasources.com/industryinsights/moderna-catalent-enter-long-term-strateg-327002.html 0.6 2026-08-08T22:05:13+08:00 daily https://www.pharmasources.com/industryinsights/healthcare-industry-reported-119-deals-w-327003.html 0.6 2026-06-20T21:10:47+08:00 daily https://www.pharmasources.com/industryinsights/us-commences-research-on-allergic-reacti-327004.html 0.6 2026-06-27T00:46:29+08:00 daily https://www.pharmasources.com/industryinsights/uk-starts-administering-moderna-vaccine--327005.html 0.6 2026-06-23T04:04:56+08:00 daily https://www.pharmasources.com/industryinsights/novel-pipeline-agents-to-drive-global-ma-327006.html 0.6 2026-06-24T14:36:40+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-launch-generic-sapropterin-dih-327007.html 0.6 2026-06-22T09:58:44+08:00 daily https://www.pharmasources.com/industryinsights/manufacture-of-indian-vaccine-in-russia--327008.html 0.6 2026-06-21T05:05:44+08:00 daily https://www.pharmasources.com/industryinsights/scottish-covid-19-vaccine-shows-strong-i-327009.html 0.6 2026-06-22T00:13:04+08:00 daily https://www.pharmasources.com/industryinsights/siro-clinpharm-partners-with-across-glob-327010.html 0.6 2026-06-22T07:54:42+08:00 daily https://www.pharmasources.com/industryinsights/icosavax-raises-funding-to-advance-rsvhm-327011.html 0.6 2026-06-20T23:58:36+08:00 daily https://www.pharmasources.com/industryinsights/ab-science-and-university-of-chicago-to--327012.html 0.6 2026-06-21T10:10:13+08:00 daily https://www.pharmasources.com/industryinsights/averting-a-second-pandemic-open-medicine-327013.html 0.6 2026-08-06T23:35:18+08:00 daily https://www.pharmasources.com/industryinsights/novartis-uk-announces-further-hrt-patch--327014.html 0.6 2026-03-10T03:43:07+08:00 daily https://www.pharmasources.com/industryinsights/nationwide-launch-for-pioneering-fertili-327015.html 0.6 2026-06-22T08:05:49+08:00 daily https://www.pharmasources.com/industryinsights/artios-novartis-form-cancer-therapies-co-327016.html 0.6 2026-08-05T17:15:59+08:00 daily https://www.pharmasources.com/industryinsights/fund-opens-to-boost-uk-life-sciences-man-327017.html 0.6 2026-08-07T05:28:23+08:00 daily https://www.pharmasources.com/industryinsights/coronavirus-infections-drop-but-r-number-327018.html 0.6 2026-08-07T05:01:23+08:00 daily https://www.pharmasources.com/industryinsights/benefits-of-az-vaccine-outweigh-risks-sa-327019.html 0.6 2026-08-07T04:37:01+08:00 daily https://www.pharmasources.com/industryinsights/new-group-to-tackle-data-governance-and--327020.html 0.6 2026-08-07T04:21:48+08:00 daily https://www.pharmasources.com/industryinsights/thailand-boi-okays-biotech-projects-wort-327021.html 0.6 2026-08-07T03:59:24+08:00 daily https://www.pharmasources.com/industryinsights/clinical-trial-completion-rates-decline--327022.html 0.6 2026-08-07T03:54:57+08:00 daily https://www.pharmasources.com/industryinsights/study-identifies-possible-covid-19-drugs-327023.html 0.6 2026-08-07T03:24:59+08:00 daily https://www.pharmasources.com/industryinsights/merck-kgaa-selects-pras-remote-patient-m-327024.html 0.6 2026-08-02T22:52:31+08:00 daily https://www.pharmasources.com/industryinsights/agilex-biolabs-acquires-tetraq-for-apac--327025.html 0.6 2026-08-07T03:03:25+08:00 daily https://www.pharmasources.com/industryinsights/imvax-appoints-sean-hemingway-chief-oper-327026.html 0.6 2026-08-07T03:24:50+08:00 daily https://www.pharmasources.com/industryinsights/agc-biologics-appoints-jun-takami-gm-of--327027.html 0.6 2026-08-07T13:16:07+08:00 daily https://www.pharmasources.com/industryinsights/otc-drugs-and-e-pharmacies-high-time-for-327028.html 0.6 2026-08-07T13:55:50+08:00 daily https://www.pharmasources.com/industryinsights/hester-signs-deal-with-icar-ivri-for-cla-327029.html 0.6 2026-05-28T07:33:43+08:00 daily https://www.pharmasources.com/industryinsights/covax-has-delivered-vaccines-to-over-100-327030.html 0.6 2026-06-20T19:22:57+08:00 daily https://www.pharmasources.com/industryinsights/ramp-up-remdesivir-manufacturing-to-full-327031.html 0.6 2026-02-10T15:56:24+08:00 daily https://www.pharmasources.com/industryinsights/aleor-dermaceuticals-gets-tentative-usfd-327032.html 0.6 2026-02-15T09:07:42+08:00 daily https://www.pharmasources.com/industryinsights/us-india-lead-in-covid-19-clinical-trial-327033.html 0.6 2026-08-03T04:23:19+08:00 daily https://www.pharmasources.com/industryinsights/gilead-gets-us-fda-nod-for-trodelvy-to-t-327034.html 0.6 2026-07-29T10:14:32+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-final-usfda-nod-for-ma-327035.html 0.6 2026-06-20T14:40:21+08:00 daily https://www.pharmasources.com/industryinsights/cytodyn-and-biomm-enter-leronlimab-suppl-327036.html 0.6 2026-08-05T22:50:46+08:00 daily https://www.pharmasources.com/industryinsights/philippines-halts-use-of-astrazeneca-vac-327037.html 0.6 2026-08-10T21:40:11+08:00 daily https://www.pharmasources.com/industryinsights/aim-immunotech-reports-no-serious-events-327038.html 0.6 2026-04-01T07:14:34+08:00 daily https://www.pharmasources.com/industryinsights/lilly-incyte-report-trial-results-of-bar-327039.html 0.6 2026-08-10T08:32:06+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-presents-applications-to-fda-and--327040.html 0.6 2026-06-21T16:05:22+08:00 daily https://www.pharmasources.com/industryinsights/immunoprecise-launches-tatx-112-candidat-327041.html 0.6 2026-08-07T23:32:20+08:00 daily https://www.pharmasources.com/industryinsights/acadia-pharmaceuticals-receives-complete-327042.html 0.6 2026-08-07T04:49:16+08:00 daily https://www.pharmasources.com/industryinsights/mologics-covid-19-rapid-antigen-self-tes-327043.html 0.6 2026-08-07T05:01:29+08:00 daily https://www.pharmasources.com/industryinsights/achilles-us-ipo-closed-with-proceeds-of--327044.html 0.6 2026-06-21T08:54:54+08:00 daily https://www.pharmasources.com/industryinsights/novartis-bags-eu-uk-licences-for-ms-ther-327045.html 0.6 2026-06-21T08:09:03+08:00 daily https://www.pharmasources.com/industryinsights/global-pharmacovigilance-observatory-to--327046.html 0.6 2026-06-24T16:19:35+08:00 daily https://www.pharmasources.com/industryinsights/cansinobio-announces-approval-for-its-si-327047.html 0.6 2026-08-12T01:51:44+08:00 daily https://www.pharmasources.com/industryinsights/immvira-announces-preclinical-and-clinic-327048.html 0.6 2026-08-07T04:19:06+08:00 daily https://www.pharmasources.com/industryinsights/hyundai-bioscience-leads-in-the-repurpos-327049.html 0.6 2026-08-07T04:07:06+08:00 daily https://www.pharmasources.com/industryinsights/frontage-expands-capabilities-at-its-cli-327050.html 0.6 2026-08-07T04:06:56+08:00 daily https://www.pharmasources.com/industryinsights/ascendia-pharmaceuticals-poised-for-expa-327051.html 0.6 2026-06-21T05:03:49+08:00 daily https://www.pharmasources.com/industryinsights/centre-bans-exports-of-remdesivir-until--327052.html 0.6 2026-08-07T05:01:18+08:00 daily https://www.pharmasources.com/industryinsights/stablepharma-bb-ncipd-partner-to-produce-327053.html 0.6 2026-08-07T05:15:44+08:00 daily https://www.pharmasources.com/industryinsights/solara-active-pharma-and-aurore-life-sci-327054.html 0.6 2026-06-20T16:17:54+08:00 daily https://www.pharmasources.com/industryinsights/natco-gets-tentative-us-fda-approval-for-327055.html 0.6 2026-06-23T11:12:42+08:00 daily https://www.pharmasources.com/industryinsights/virus-therapy-shows-promise-against-inop-327056.html 0.6 2026-06-20T21:41:31+08:00 daily https://www.pharmasources.com/industryinsights/maha-health-minster-asks-centre-to-formu-327057.html 0.6 2026-06-21T11:10:20+08:00 daily https://www.pharmasources.com/industryinsights/biotech-start-up-vaccitech-files-for-us--327058.html 0.6 2026-06-21T01:01:47+08:00 daily https://www.pharmasources.com/industryinsights/iran-in-discussions-with-india-for-secon-327059.html 0.6 2026-06-20T22:05:42+08:00 daily https://www.pharmasources.com/industryinsights/urgent-need-for-disease-modifying-drugs--327060.html 0.6 2026-06-30T21:37:09+08:00 daily https://www.pharmasources.com/industryinsights/sii-is-legally-bound-to-supply-covid-19--327061.html 0.6 2026-08-05T20:51:03+08:00 daily https://www.pharmasources.com/industryinsights/jj-in-discussions-with-indian-regulator--327062.html 0.6 2026-08-07T23:10:29+08:00 daily https://www.pharmasources.com/industryinsights/sii-repays-south-africa-for-covid-19-vac-327063.html 0.6 2026-08-03T09:14:26+08:00 daily https://www.pharmasources.com/industryinsights/remdesivirs-price-must-not-be-more-than--327064.html 0.6 2026-06-20T22:17:53+08:00 daily https://www.pharmasources.com/industryinsights/india-to-assess-side-effects-of-covid-19-327065.html 0.6 2026-06-21T09:14:40+08:00 daily https://www.pharmasources.com/industryinsights/biogen-and-bio-thera-enter-licencing-agr-327066.html 0.6 2026-06-21T16:04:28+08:00 daily https://www.pharmasources.com/industryinsights/claritas-to-expand-covid-19-trial-to-inc-327067.html 0.6 2026-06-21T08:57:57+08:00 daily https://www.pharmasources.com/industryinsights/valenzabio-advances-pipeline-of-antibody-327068.html 0.6 2026-06-21T11:10:23+08:00 daily https://www.pharmasources.com/industryinsights/moderna-highlights-publication-of-antibo-327069.html 0.6 2026-06-21T13:16:07+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-dosing-regimen-for-cetu-327070.html 0.6 2026-08-12T08:50:27+08:00 daily https://www.pharmasources.com/industryinsights/immunitybio-announces-single-prime-had5--327071.html 0.6 2026-06-20T19:05:39+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharmas-phase-23-covid-19-stu-327072.html 0.6 2026-08-05T21:08:04+08:00 daily https://www.pharmasources.com/industryinsights/yiling-pharmaceutical-doubled-its-perfor-327073.html 0.6 2026-07-27T08:33:02+08:00 daily https://www.pharmasources.com/industryinsights/airway-therapeutics-announces-fda-accept-327074.html 0.6 2026-06-20T18:54:42+08:00 daily https://www.pharmasources.com/industryinsights/genscript-parkway-laboratories-and-diagn-327075.html 0.6 2026-06-21T00:41:31+08:00 daily https://www.pharmasources.com/industryinsights/antengene-announces-first-patient-dosed--327076.html 0.6 2026-07-23T00:41:54+08:00 daily https://www.pharmasources.com/industryinsights/gracell-biotechnologies-reports-long-ter-327077.html 0.6 2026-08-01T14:32:55+08:00 daily https://www.pharmasources.com/industryinsights/personalised-cancer-vaccine-safe-and-pot-327078.html 0.6 2026-06-21T17:13:58+08:00 daily https://www.pharmasources.com/industryinsights/global-bioreactor-market-to-value-over-1-327079.html 0.6 2026-06-22T05:15:52+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-327080.html 0.6 2026-08-09T08:57:15+08:00 daily https://www.pharmasources.com/industryinsights/2021-zhejiang-export-commodity-online-fa-327081.html 0.6 2026-08-07T05:31:25+08:00 daily https://www.pharmasources.com/industryinsights/pharmasources-launches-e-trade-season-20-327082.html 0.6 2026-08-12T01:57:21+08:00 daily https://www.pharmasources.com/industryinsights/top-bulk-deflazacort-powder-manufacturer-327083.html 0.6 2026-08-06T22:06:10+08:00 daily https://www.pharmasources.com/industryinsights/everything-you-need-to-know-about-prefil-327084.html 0.6 2026-08-06T21:59:54+08:00 daily https://www.pharmasources.com/industryinsights/lonza-expands-pyrotec-pro-for-endotoxin--327085.html 0.6 2026-08-06T22:13:41+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-invests-in-cutting-edge-vax-produ-327086.html 0.6 2026-08-06T22:21:35+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-acquires-tidal-therapeutics-327087.html 0.6 2026-08-06T22:28:04+08:00 daily https://www.pharmasources.com/industryinsights/lilly-modifies-purchase-agreement-with-u-327088.html 0.6 2026-06-29T07:19:45+08:00 daily https://www.pharmasources.com/industryinsights/gs1-india-elevates-s-swaminathan-as-ceo-327089.html 0.6 2026-07-10T08:35:13+08:00 daily https://www.pharmasources.com/industryinsights/sec-of-cdsco-recommends-approval-to-sput-327090.html 0.6 2026-06-21T14:46:13+08:00 daily https://www.pharmasources.com/industryinsights/china-mulls-combining-covid-19-vaccines--327091.html 0.6 2026-06-22T01:08:53+08:00 daily https://www.pharmasources.com/industryinsights/biocon-pharma-gets-gmp-compliance-certif-327092.html 0.6 2026-06-22T08:13:19+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-c4x-discovery-enter-licensing-327093.html 0.6 2026-06-21T11:02:15+08:00 daily https://www.pharmasources.com/industryinsights/ema-initiates-review-of-jjs-covid-19-vac-327094.html 0.6 2026-06-22T19:05:17+08:00 daily https://www.pharmasources.com/industryinsights/update-on-the-dare-19-phase-iii-trial-fo-327095.html 0.6 2026-06-20T17:51:23+08:00 daily https://www.pharmasources.com/industryinsights/grnenthal-acquires-mestex-ag-and-its-pha-327096.html 0.6 2026-06-21T01:00:48+08:00 daily https://www.pharmasources.com/industryinsights/antibiotic-research-uk-launches-small-re-327097.html 0.6 2026-06-20T16:09:34+08:00 daily https://www.pharmasources.com/industryinsights/experts-call-for-advanced-radiotherapy-f-327098.html 0.6 2026-08-02T22:38:12+08:00 daily https://www.pharmasources.com/industryinsights/inhaled-asthma-drug-accelerates-recovery-327099.html 0.6 2026-06-22T02:51:40+08:00 daily https://www.pharmasources.com/industryinsights/four-medicines-accepted-for-use-by-nhs-s-327100.html 0.6 2026-06-21T03:15:53+08:00 daily https://www.pharmasources.com/industryinsights/us-approval-for-first-ai-device-to-help--327101.html 0.6 2026-06-21T08:57:08+08:00 daily https://www.pharmasources.com/industryinsights/early-promise-for-new-immunotherapy-comb-327102.html 0.6 2026-06-20T14:39:16+08:00 daily https://www.pharmasources.com/industryinsights/nice-no-for-opdivoyervoy-lung-cancer-com-327103.html 0.6 2025-10-19T03:39:52+08:00 daily https://www.pharmasources.com/industryinsights/eu-nod-for-new-formulation-of-biogens-ty-327104.html 0.6 2026-06-22T04:14:50+08:00 daily https://www.pharmasources.com/industryinsights/human-trials-for-worlds-first-ai-designe-327105.html 0.6 2026-06-21T01:00:45+08:00 daily https://www.pharmasources.com/industryinsights/lilly-incytes-olumiant-fails-in-covid-19-327106.html 0.6 2026-06-21T19:07:55+08:00 daily https://www.pharmasources.com/industryinsights/harbour-biomed-presents-novel-antibody-f-327107.html 0.6 2026-08-09T02:39:00+08:00 daily https://www.pharmasources.com/industryinsights/psychobiotic-ps128-improves-mood-and-sle-327108.html 0.6 2026-08-09T11:59:35+08:00 daily https://www.pharmasources.com/industryinsights/alphamab-oncology-presented-clinical-dat-327109.html 0.6 2026-08-07T05:05:43+08:00 daily https://www.pharmasources.com/industryinsights/antengene-presented-preclinical-data-dem-327110.html 0.6 2026-08-07T04:35:00+08:00 daily https://www.pharmasources.com/industryinsights/innovent-and-lilly-release-phase-3-resul-327111.html 0.6 2026-08-12T21:10:44+08:00 daily https://www.pharmasources.com/industryinsights/catalent-biologics-completes-madison-exp-327112.html 0.6 2026-08-07T04:16:28+08:00 daily https://www.pharmasources.com/industryinsights/us-halts-jj-covid-19-vaccine-after-six-w-327113.html 0.6 2026-08-07T04:27:42+08:00 daily https://www.pharmasources.com/industryinsights/low-asthma-patient-adherence-shows-need--327114.html 0.6 2026-08-09T17:34:19+08:00 daily https://www.pharmasources.com/industryinsights/west-pharma-venus-remedies-partner-to-la-327115.html 0.6 2026-07-28T13:59:12+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-survivors-may-face-long-term-co-327116.html 0.6 2026-06-21T09:13:10+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-receives-eua-for-sputnik-v-in--327117.html 0.6 2026-06-21T06:55:14+08:00 daily https://www.pharmasources.com/industryinsights/common-asthma-drug-speeds-up-covid-19-re-327118.html 0.6 2026-06-22T10:34:33+08:00 daily https://www.pharmasources.com/industryinsights/vtv-therapeutics-receives-fda-breakthrou-327119.html 0.6 2026-06-20T20:10:48+08:00 daily https://www.pharmasources.com/industryinsights/akston-biosciences-launches-phase-iii-cl-327120.html 0.6 2026-06-21T05:57:42+08:00 daily https://www.pharmasources.com/industryinsights/waters-and-genovis-collaborate-to-develo-327121.html 0.6 2026-06-20T18:54:50+08:00 daily https://www.pharmasources.com/industryinsights/lindis-biotech-reports-successful-initia-327122.html 0.6 2026-07-17T21:14:02+08:00 daily https://www.pharmasources.com/industryinsights/serimmune-opens-enrollment-for-covid-19--327123.html 0.6 2026-06-21T22:52:52+08:00 daily https://www.pharmasources.com/industryinsights/collaboration-to-encourage-us-adoption-o-327124.html 0.6 2026-08-11T10:29:05+08:00 daily https://www.pharmasources.com/industryinsights/highlights-of-the-emas-drug-safety-commi-327125.html 0.6 2026-07-04T00:33:50+08:00 daily https://www.pharmasources.com/industryinsights/biotech-and-pharma-services-outsourcing--327126.html 0.6 2026-06-21T12:56:48+08:00 daily https://www.pharmasources.com/industryinsights/sinovac-sinopharm-show-safety-efficacy-w-327127.html 0.6 2026-06-21T22:15:00+08:00 daily https://www.pharmasources.com/industryinsights/geneleap-presents-new-preclinical-data-f-327129.html 0.6 2026-08-07T19:43:38+08:00 daily https://www.pharmasources.com/industryinsights/aon-launches-innovative-industry-collabo-327130.html 0.6 2026-06-21T12:54:11+08:00 daily https://www.pharmasources.com/industryinsights/orthos-vitros-sars-cov-2-antigen-test-fo-327131.html 0.6 2026-06-22T09:10:56+08:00 daily https://www.pharmasources.com/industryinsights/molecular-matrix-and-genscript-partner-t-327132.html 0.6 2026-06-20T20:08:43+08:00 daily https://www.pharmasources.com/industryinsights/b117-variant-more-transmissible-does-not-327133.html 0.6 2026-07-28T18:04:52+08:00 daily https://www.pharmasources.com/industryinsights/joint-cdc-and-fda-statement-on-johnson-j-327134.html 0.6 2026-08-13T02:16:00+08:00 daily https://www.pharmasources.com/industryinsights/phase-iii-prevention-trial-showed-subcut-327135.html 0.6 2026-06-20T19:50:38+08:00 daily https://www.pharmasources.com/industryinsights/bioversys-gets-eib-funds-to-address-anti-327136.html 0.6 2026-08-09T01:22:14+08:00 daily https://www.pharmasources.com/industryinsights/microbiologics-expands-virology-services-327137.html 0.6 2026-08-09T00:43:33+08:00 daily https://www.pharmasources.com/industryinsights/atmps-ori-biotech-integrate-digital-plat-327138.html 0.6 2026-06-20T16:59:16+08:00 daily https://www.pharmasources.com/industryinsights/executive-moves-novavax-327139.html 0.6 2026-06-22T11:11:00+08:00 daily https://www.pharmasources.com/industryinsights/albumedix-completes-commercial-scale-mfg-327140.html 0.6 2026-08-13T15:57:41+08:00 daily https://www.pharmasources.com/industryinsights/pfizerbiontechs-vaccine-to-touch-sales-o-327141.html 0.6 2026-08-10T10:45:51+08:00 daily https://www.pharmasources.com/industryinsights/european-commission-to-not-renew-astraze-327142.html 0.6 2026-06-22T11:12:57+08:00 daily https://www.pharmasources.com/industryinsights/ldcs-support-india-south-africas-request-327143.html 0.6 2026-08-09T11:17:41+08:00 daily https://www.pharmasources.com/industryinsights/gilead-gets-us-fda-accelerated-approval--327144.html 0.6 2026-07-22T07:38:02+08:00 daily https://www.pharmasources.com/industryinsights/supply-scarcity-is-delaying-full-scale-p-327145.html 0.6 2026-07-30T21:42:54+08:00 daily https://www.pharmasources.com/industryinsights/cell-and-gene-therapy-the-impact-of-skil-327146.html 0.6 2026-07-08T12:38:14+08:00 daily https://www.pharmasources.com/industryinsights/us-pharma-lobby-reaches-out-to-patients--327147.html 0.6 2026-06-23T04:14:11+08:00 daily https://www.pharmasources.com/industryinsights/niimbl-welcomes-dr-gene-schaefer-as-seni-327148.html 0.6 2026-08-09T08:56:50+08:00 daily https://www.pharmasources.com/industryinsights/noxopharm-files-septic-shock-treatment-p-327149.html 0.6 2026-08-02T14:52:55+08:00 daily https://www.pharmasources.com/industryinsights/need-to-limit-use-of-commonly-used-secur-327150.html 0.6 2026-06-20T14:46:09+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-myovant-begin-dosing-in-relugolix-327151.html 0.6 2026-07-30T09:35:25+08:00 daily https://www.pharmasources.com/industryinsights/gileads-trodelvy-scores-accelerated-appr-327152.html 0.6 2026-08-01T01:32:14+08:00 daily https://www.pharmasources.com/industryinsights/nice-publishes-new-guidance-on-chronic-p-327153.html 0.6 2026-08-11T01:20:54+08:00 daily https://www.pharmasources.com/industryinsights/uk-trial-evaluating-mix-and-match-covid--327154.html 0.6 2026-06-21T11:16:23+08:00 daily https://www.pharmasources.com/industryinsights/novel-natural-killer-cell-engager-therap-327155.html 0.6 2026-07-07T13:27:08+08:00 daily https://www.pharmasources.com/industryinsights/trial-to-assess-anti-cd14-antibody-as-tr-327156.html 0.6 2026-06-20T21:17:57+08:00 daily https://www.pharmasources.com/industryinsights/eu-to-support-novel-antibiotics-with-20--327157.html 0.6 2026-06-22T12:48:52+08:00 daily https://www.pharmasources.com/industryinsights/adlai-nortye-announces-first-patient-dos-327158.html 0.6 2026-06-21T01:10:08+08:00 daily https://www.pharmasources.com/industryinsights/everest-medicines-appoints-jennifer-yang-327159.html 0.6 2026-06-21T11:57:13+08:00 daily https://www.pharmasources.com/industryinsights/kintor-pharmaceutical-and-visum-announce-327160.html 0.6 2026-07-23T11:53:54+08:00 daily https://www.pharmasources.com/industryinsights/gannex-announces-the-first-cohort-dosed--327161.html 0.6 2026-08-08T05:43:56+08:00 daily https://www.pharmasources.com/industryinsights/biovaxys-announces-final-clinical-trial--327162.html 0.6 2026-06-22T10:47:40+08:00 daily https://www.pharmasources.com/industryinsights/moleac-announces-us-fda-approval-of-ind--327163.html 0.6 2026-06-24T11:04:22+08:00 daily https://www.pharmasources.com/industryinsights/massive-fragment-screen-points-way-to-ne-327164.html 0.6 2026-06-20T23:04:45+08:00 daily https://www.pharmasources.com/industryinsights/abenza-chooses-north-carolina-for-new-bi-327165.html 0.6 2026-08-06T18:20:48+08:00 daily https://www.pharmasources.com/industryinsights/catalent-adds-cryogenic-capabilities-at--327166.html 0.6 2026-06-20T15:13:17+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-acquires-ppd-for-174b-327167.html 0.6 2026-07-25T07:13:08+08:00 daily https://www.pharmasources.com/industryinsights/recro-ensysce-expand-development-and-man-327168.html 0.6 2026-07-24T06:40:47+08:00 daily https://www.pharmasources.com/industryinsights/arkema-recruits-dotmatics-as-its-rd-digi-327169.html 0.6 2026-08-08T00:16:31+08:00 daily https://www.pharmasources.com/industryinsights/metrics-names-stephanie-emory-associate--327170.html 0.6 2026-06-30T14:32:53+08:00 daily https://www.pharmasources.com/industryinsights/fda-cdc-calling-to-halt-distribution-of--327171.html 0.6 2026-02-09T16:30:38+08:00 daily https://www.pharmasources.com/industryinsights/google-commits-funds-for-250k-vaccinatio-327172.html 0.6 2026-07-16T16:45:51+08:00 daily https://www.pharmasources.com/industryinsights/working-on-stability-data-on-2-to-8-c-te-327173.html 0.6 2026-08-10T15:14:16+08:00 daily https://www.pharmasources.com/industryinsights/mankind-pharma-seeks-cdsco-approval-for--327174.html 0.6 2026-08-07T03:24:53+08:00 daily https://www.pharmasources.com/industryinsights/puretech-health-reports-increase-in-2020-327175.html 0.6 2026-08-07T03:12:44+08:00 daily https://www.pharmasources.com/industryinsights/tango-therapeutics-to-go-public-with-353-327176.html 0.6 2026-08-07T03:18:45+08:00 daily https://www.pharmasources.com/industryinsights/oxford-university-expands-com-cov2-dose--327177.html 0.6 2026-08-07T03:30:32+08:00 daily https://www.pharmasources.com/industryinsights/post-brexit-point-based-immigration-syst-327178.html 0.6 2026-08-07T03:55:14+08:00 daily https://www.pharmasources.com/industryinsights/alchemab-completes-60m-series-a-funding--327179.html 0.6 2026-08-10T11:58:56+08:00 daily https://www.pharmasources.com/industryinsights/magic-mushroom-compound-psilocybin-shows-327180.html 0.6 2026-06-21T02:16:54+08:00 daily https://www.pharmasources.com/industryinsights/amylyx-pharma-plans-to-file-als-therapy--327181.html 0.6 2026-08-10T23:55:23+08:00 daily https://www.pharmasources.com/industryinsights/gsk-decides-to-halt-mid-stage-feladilima-327182.html 0.6 2026-06-21T08:06:06+08:00 daily https://www.pharmasources.com/industryinsights/rocket-releases-positive-results-from-le-327183.html 0.6 2026-06-21T07:15:10+08:00 daily https://www.pharmasources.com/industryinsights/biologics-cdmo-market-to-double-in-value-327184.html 0.6 2026-08-14T08:57:05+08:00 daily https://www.pharmasources.com/industryinsights/radcliffe-cardiology-launches-new-title--327185.html 0.6 2026-06-20T17:47:18+08:00 daily https://www.pharmasources.com/industryinsights/new-pathway-launched-for-pioneering-life-327186.html 0.6 2026-07-02T15:06:47+08:00 daily https://www.pharmasources.com/industryinsights/kintor-pharmaceutical-announces-ar-prota-327187.html 0.6 2026-06-21T08:08:02+08:00 daily https://www.pharmasources.com/industryinsights/exyte-to-build-dexcoms-first-manufacturi-327188.html 0.6 2026-08-09T02:38:51+08:00 daily https://www.pharmasources.com/industryinsights/lightair-ionflow-fights-the-spread-of-co-327189.html 0.6 2026-08-07T19:40:17+08:00 daily https://www.pharmasources.com/industryinsights/juniper-biologics-announces-the-appointm-327190.html 0.6 2026-08-07T13:16:05+08:00 daily https://www.pharmasources.com/industryinsights/mentice-appoints-pontus-appelqvist-as-vi-327191.html 0.6 2026-08-07T01:27:37+08:00 daily https://www.pharmasources.com/industryinsights/gsk-and-vir-biotechnology-announce-ema-r-327192.html 0.6 2026-08-07T01:21:41+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-expands-at-cambridg-327194.html 0.6 2026-08-07T01:22:08+08:00 daily https://www.pharmasources.com/industryinsights/amgen-completes-five-prime-acquisition-327195.html 0.6 2026-08-10T17:34:49+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-expands-in-the-uk-327196.html 0.6 2026-06-21T12:18:46+08:00 daily https://www.pharmasources.com/industryinsights/indian-pharma-exports-register-18-per-ce-327197.html 0.6 2026-06-20T19:18:09+08:00 daily https://www.pharmasources.com/industryinsights/psus-roped-in-to-ramp-up-covid-19-vaccin-327198.html 0.6 2026-06-23T00:38:13+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-acquires-ppd-a-cro-in-174--327199.html 0.6 2026-08-09T04:18:36+08:00 daily https://www.pharmasources.com/industryinsights/haffkine-bio-pharma-to-target-228-crore--327200.html 0.6 2026-08-09T01:20:42+08:00 daily https://www.pharmasources.com/industryinsights/greater-risk-of-brain-clots-from-covid-1-327201.html 0.6 2026-08-08T23:29:58+08:00 daily https://www.pharmasources.com/industryinsights/chinese-checkpoint-inhibitors-may-drive--327202.html 0.6 2026-08-08T21:33:22+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-receives-us-clearance-of-pro-327203.html 0.6 2026-08-08T04:37:28+08:00 daily https://www.pharmasources.com/industryinsights/evobrutinib-is-the-first-and-only-btk-in-327204.html 0.6 2026-08-10T18:18:09+08:00 daily https://www.pharmasources.com/industryinsights/inovios-covid-19-vaccine-induces-immune--327205.html 0.6 2026-08-13T17:18:19+08:00 daily https://www.pharmasources.com/industryinsights/new-subcutaneous-formulation-of-tysabri--327206.html 0.6 2026-08-07T06:10:05+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-alexions-pnh-treatment-u-327207.html 0.6 2026-08-07T11:01:08+08:00 daily https://www.pharmasources.com/industryinsights/could-precipitation-reduce-the-cost-of-a-327208.html 0.6 2026-08-01T01:10:24+08:00 daily https://www.pharmasources.com/industryinsights/novel-leishmaniasis-vaccine-safely-induc-327209.html 0.6 2026-08-02T07:04:34+08:00 daily https://www.pharmasources.com/industryinsights/nt-300-tablets-show-promise-in-phase-iii-327210.html 0.6 2026-06-21T06:21:26+08:00 daily https://www.pharmasources.com/industryinsights/fda-revokes-emergency-use-authorization--327211.html 0.6 2026-06-20T14:42:09+08:00 daily https://www.pharmasources.com/industryinsights/sars-cov-2-new-findings-on-the-persisten-327212.html 0.6 2026-08-07T09:52:17+08:00 daily https://www.pharmasources.com/industryinsights/transcenta-announced-successful-first-pa-327213.html 0.6 2026-06-22T07:05:59+08:00 daily https://www.pharmasources.com/industryinsights/qilu-pharmaceutical-and-peptron-sign-lic-327214.html 0.6 2026-08-08T03:29:19+08:00 daily https://www.pharmasources.com/industryinsights/kintor-pharmaceuticals-announced-success-327215.html 0.6 2026-08-05T04:51:58+08:00 daily https://www.pharmasources.com/industryinsights/resilience-acquires-ology-bioservices-327216.html 0.6 2026-06-21T08:04:00+08:00 daily https://www.pharmasources.com/industryinsights/rdif-hualan-ink-covid-19-vaccine-deal-327217.html 0.6 2026-08-09T20:50:09+08:00 daily https://www.pharmasources.com/industryinsights/kintor-visum-enter-covid-19-manufacturin-327218.html 0.6 2026-07-24T02:16:46+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-biontech-expand-covid-19-vaccine--327219.html 0.6 2026-08-02T03:13:10+08:00 daily https://www.pharmasources.com/industryinsights/evotec-enters-master-service-agreement-w-327220.html 0.6 2026-08-03T03:17:50+08:00 daily https://www.pharmasources.com/industryinsights/jubilant-pharma-subsidiary-announces-dev-327221.html 0.6 2026-08-06T21:13:42+08:00 daily https://www.pharmasources.com/industryinsights/dachser-shanghai-gets-ceiv-pharma-certif-327222.html 0.6 2026-08-02T07:58:09+08:00 daily https://www.pharmasources.com/industryinsights/indigital-technologies-launches-indigita-327223.html 0.6 2026-08-05T07:24:36+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-alembic-recall-products-in-th-327224.html 0.6 2026-08-07T15:39:07+08:00 daily https://www.pharmasources.com/industryinsights/russias-sputnik-v-covid-19-vaccine-shows-327225.html 0.6 2026-08-02T18:27:52+08:00 daily https://www.pharmasources.com/industryinsights/sinovacs-covid-19-vaccine-prevents-67-sy-327226.html 0.6 2026-06-21T21:02:43+08:00 daily https://www.pharmasources.com/industryinsights/scineuro-and-eli-lilly-sign-exclusive-li-327227.html 0.6 2026-07-29T07:23:33+08:00 daily https://www.pharmasources.com/industryinsights/long-covid-dramatically-increases-cases--327228.html 0.6 2025-12-29T02:00:42+08:00 daily https://www.pharmasources.com/industryinsights/over-the-counter-covid-19-testing-now-av-327229.html 0.6 2026-08-07T16:24:34+08:00 daily https://www.pharmasources.com/industryinsights/agenus-submits-balstilimab-biologics-lic-327230.html 0.6 2026-07-29T05:03:40+08:00 daily https://www.pharmasources.com/industryinsights/jackson-healthcare-saves-only-us-antibio-327231.html 0.6 2026-08-07T04:20:22+08:00 daily https://www.pharmasources.com/industryinsights/astellas-and-seagen-announce-us-fda-acce-327232.html 0.6 2026-08-08T20:56:18+08:00 daily https://www.pharmasources.com/industryinsights/ec-approves-new-sarclisa-indication-327233.html 0.6 2026-06-30T16:30:49+08:00 daily https://www.pharmasources.com/industryinsights/nice-unveils-new-strategy-to-improve-pat-327234.html 0.6 2025-12-28T11:26:42+08:00 daily https://www.pharmasources.com/industryinsights/phico-therapeutics-gains-131m-grant-to-a-327235.html 0.6 2026-07-04T13:35:08+08:00 daily https://www.pharmasources.com/industryinsights/tg-therapeutics-ublituximab-tops-sanofis-327236.html 0.6 2026-06-28T12:45:32+08:00 daily https://www.pharmasources.com/industryinsights/new-advice-on-covid-19-vaccination-for-p-327237.html 0.6 2026-06-28T12:43:49+08:00 daily https://www.pharmasources.com/industryinsights/usp-to-release-922-water-activity-method-327238.html 0.6 2026-08-13T11:12:31+08:00 daily https://www.pharmasources.com/industryinsights/ino-4800-covid-19-vaccine-provides-cross-327239.html 0.6 2026-07-03T11:02:08+08:00 daily https://www.pharmasources.com/industryinsights/prenetics-signs-multi-million-dollar-col-327240.html 0.6 2026-07-07T11:37:41+08:00 daily https://www.pharmasources.com/industryinsights/aacr-2021-immvira-presents-the-preclinic-327241.html 0.6 2026-06-20T21:05:39+08:00 daily https://www.pharmasources.com/industryinsights/abbotts-fast-reliable-and-convenient-cov-327242.html 0.6 2026-06-20T15:10:21+08:00 daily https://www.pharmasources.com/industryinsights/terumo-blood-and-cell-technologies-and-c-327243.html 0.6 2026-06-21T04:13:58+08:00 daily https://www.pharmasources.com/industryinsights/himalaya-therapeutics-announces-appointm-327244.html 0.6 2026-08-11T13:37:35+08:00 daily https://www.pharmasources.com/industryinsights/sirtex-medical-and-blackswan-vascular-in-327245.html 0.6 2026-08-07T02:50:48+08:00 daily https://www.pharmasources.com/industryinsights/patients-who-are-obese-or-overweight-are-327246.html 0.6 2026-07-28T23:33:39+08:00 daily https://www.pharmasources.com/industryinsights/new-covid-19-vaccine-may-offer-broad-pro-327247.html 0.6 2026-07-09T15:11:39+08:00 daily https://www.pharmasources.com/industryinsights/evotec-to-build-second-biologics-mfg-fac-327248.html 0.6 2026-07-30T17:53:52+08:00 daily https://www.pharmasources.com/industryinsights/adare-pharma-names-ludger-roedder-presid-327249.html 0.6 2026-07-28T20:51:14+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-1q-results-327250.html 0.6 2026-07-01T08:01:19+08:00 daily https://www.pharmasources.com/industryinsights/issar-pharma-announces-out-licensing-of--327251.html 0.6 2026-08-03T14:29:22+08:00 daily https://www.pharmasources.com/industryinsights/bharat-biotech-announces-covaxin-capacit-327252.html 0.6 2026-06-20T14:41:24+08:00 daily https://www.pharmasources.com/industryinsights/vav-lifesciences-inks-deal-to-supply-syn-327253.html 0.6 2026-08-08T01:08:56+08:00 daily https://www.pharmasources.com/industryinsights/india-approves-610-million-grant-for-ser-327254.html 0.6 2026-07-30T14:56:59+08:00 daily https://www.pharmasources.com/industryinsights/cansino-biologics-to-start-clinical-tria-327255.html 0.6 2026-08-10T20:13:43+08:00 daily https://www.pharmasources.com/industryinsights/nih-funded-trial-to-assess-repurposed-dr-327256.html 0.6 2026-08-10T16:52:54+08:00 daily https://www.pharmasources.com/industryinsights/gw-pharmaceuticals-receives-european-com-327257.html 0.6 2026-04-23T12:59:52+08:00 daily https://www.pharmasources.com/industryinsights/new-data-for-genentechs-ocrevus-ocrelizu-327258.html 0.6 2026-08-08T12:49:08+08:00 daily https://www.pharmasources.com/industryinsights/advil-to-reduce-plastic-in-over-80-milli-327259.html 0.6 2026-08-07T05:58:08+08:00 daily https://www.pharmasources.com/industryinsights/pacira-biosciences-announces-investment--327260.html 0.6 2026-07-03T21:20:42+08:00 daily https://www.pharmasources.com/industryinsights/breakthrough-designation-granted-for-amg-327261.html 0.6 2026-06-19T09:40:59+08:00 daily https://www.pharmasources.com/industryinsights/enhertu-accepted-via-cancer-drugs-fund-f-327262.html 0.6 2026-08-07T10:45:10+08:00 daily https://www.pharmasources.com/industryinsights/nices-five-year-strategy-sets-a-positive-327263.html 0.6 2026-08-13T09:08:52+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-sterility-testing-market--327264.html 0.6 2026-08-07T03:48:40+08:00 daily https://www.pharmasources.com/industryinsights/novel-blindness-gene-therapy-shows-promi-327265.html 0.6 2026-08-07T03:30:51+08:00 daily https://www.pharmasources.com/industryinsights/genscript-probio-enters-collaboration-wi-327266.html 0.6 2026-08-07T03:25:00+08:00 daily https://www.pharmasources.com/industryinsights/clinical-trial-industry-veteran-paul-mal-327267.html 0.6 2026-08-07T03:06:21+08:00 daily https://www.pharmasources.com/industryinsights/china-biologic-announces-completion-of-g-327268.html 0.6 2026-08-07T02:51:57+08:00 daily https://www.pharmasources.com/industryinsights/transcenta-received-ind-clearance-from-u-327269.html 0.6 2026-08-07T02:39:39+08:00 daily https://www.pharmasources.com/industryinsights/limacorporate-announces-the-first-surger-327270.html 0.6 2026-08-07T02:36:56+08:00 daily https://www.pharmasources.com/industryinsights/biovaxys-and-the-world-ovarian-cancer-co-327271.html 0.6 2026-08-07T02:33:54+08:00 daily https://www.pharmasources.com/industryinsights/where-to-buy-bulk-clobetasol-propionate-327272.html 0.6 2026-08-06T23:33:26+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-327273.html 0.6 2026-08-07T12:03:39+08:00 daily https://www.pharmasources.com/industryinsights/bharat-biotech-icmr-announce-interim-res-327274.html 0.6 2026-08-07T13:16:56+08:00 daily https://www.pharmasources.com/industryinsights/pharma-firms-with-approval-for-projects--327275.html 0.6 2026-08-07T13:55:52+08:00 daily https://www.pharmasources.com/industryinsights/india-to-waive-10-per-cent-import-duty-o-327276.html 0.6 2026-08-07T14:15:30+08:00 daily https://www.pharmasources.com/industryinsights/waters-and-genovis-enter-biopharmaceutic-327277.html 0.6 2026-08-07T15:07:28+08:00 daily https://www.pharmasources.com/industryinsights/frontage-acquires-ocean-ridge-bioscience-327278.html 0.6 2026-02-28T13:19:04+08:00 daily https://www.pharmasources.com/industryinsights/agc-biologics-expands-partnership-with-r-327279.html 0.6 2026-08-07T13:20:06+08:00 daily https://www.pharmasources.com/industryinsights/tracelink-introduces-opus-platform-327280.html 0.6 2026-08-07T04:18:05+08:00 daily https://www.pharmasources.com/industryinsights/reduced-nicotinamide-mononucleotide-nmnh-327281.html 0.6 2026-08-13T08:49:58+08:00 daily https://www.pharmasources.com/industryinsights/increased-patient-empowerment-the-main-b-327282.html 0.6 2026-08-07T04:04:17+08:00 daily https://www.pharmasources.com/industryinsights/janux-therapeutics-raises-funding-to-adv-327283.html 0.6 2026-08-07T04:04:07+08:00 daily https://www.pharmasources.com/industryinsights/moderna-and-israel-sign-new-covid-19-vac-327284.html 0.6 2026-08-07T13:16:17+08:00 daily https://www.pharmasources.com/industryinsights/jj-to-restart-covid-19-vaccine-shipment--327285.html 0.6 2026-08-08T10:50:33+08:00 daily https://www.pharmasources.com/industryinsights/valneva-switches-focus-to-bilateral-disc-327286.html 0.6 2026-08-08T12:19:05+08:00 daily https://www.pharmasources.com/industryinsights/chiesi-group-receives-european-marketing-327287.html 0.6 2026-08-08T13:47:09+08:00 daily https://www.pharmasources.com/industryinsights/gw-pharmas-epidyolex-scores-new-eu-indic-327288.html 0.6 2026-08-07T19:47:05+08:00 daily https://www.pharmasources.com/industryinsights/novartis-ms-therapy-kesimpta-wins-nice-b-327289.html 0.6 2026-08-09T23:41:30+08:00 daily https://www.pharmasources.com/industryinsights/uk-government-launches-search-for-at-hom-327290.html 0.6 2026-06-12T03:53:19+08:00 daily https://www.pharmasources.com/industryinsights/fda-halts-covid-19-vaccine-production-at-327291.html 0.6 2026-07-02T07:40:16+08:00 daily https://www.pharmasources.com/industryinsights/stem-cell-transplantation-may-be-able-to-327292.html 0.6 2026-08-04T21:30:08+08:00 daily https://www.pharmasources.com/industryinsights/ema-confirms-janssen-covid-19-vaccine-be-327293.html 0.6 2026-08-05T16:58:13+08:00 daily https://www.pharmasources.com/industryinsights/baricitinib-enhances-hair-regrowth-for-a-327294.html 0.6 2026-08-11T20:20:36+08:00 daily https://www.pharmasources.com/industryinsights/rdif-and-minapharm-agree-to-produce-over-327295.html 0.6 2026-08-12T04:57:43+08:00 daily https://www.pharmasources.com/industryinsights/tokiwa-phytochemical-co-ltd-announces-ne-327296.html 0.6 2026-05-02T15:19:12+08:00 daily https://www.pharmasources.com/industryinsights/memorandum-of-understanding-signed-betwe-327297.html 0.6 2026-06-21T11:56:05+08:00 daily https://www.pharmasources.com/industryinsights/seegene-to-supply-covid-19-diagnostic-te-327298.html 0.6 2026-06-21T07:11:06+08:00 daily https://www.pharmasources.com/industryinsights/link-medical-strengthens-its-position-in-327299.html 0.6 2026-07-05T00:22:58+08:00 daily https://www.pharmasources.com/industryinsights/top-bulk-griseofulvin-powder-manufacture-327300.html 0.6 2026-08-07T00:42:48+08:00 daily https://www.pharmasources.com/industryinsights/mount-sinai-hospital-in-new-york-joins-r-327301.html 0.6 2026-06-21T09:50:08+08:00 daily https://www.pharmasources.com/industryinsights/ath434-protects-brain-cells-and-improves-327302.html 0.6 2026-07-07T01:26:38+08:00 daily https://www.pharmasources.com/industryinsights/top-hydroxychloroquine-sulfate-api-manuf-327303.html 0.6 2026-08-07T00:03:08+08:00 daily https://www.pharmasources.com/industryinsights/nanoform-aprecia-partner-to-advance-3dp--327304.html 0.6 2026-06-20T16:07:36+08:00 daily https://www.pharmasources.com/industryinsights/kempharm-receives-10m-milestone-for-fda--327305.html 0.6 2026-06-21T08:57:06+08:00 daily https://www.pharmasources.com/industryinsights/valneva-focuses-on-bilateral-discussions-327306.html 0.6 2026-06-21T04:18:07+08:00 daily https://www.pharmasources.com/industryinsights/syneos-medable-partner-for-new-decentral-327307.html 0.6 2026-06-21T03:07:47+08:00 daily https://www.pharmasources.com/industryinsights/csafe-global-appoints-svp-of-technology--327308.html 0.6 2026-06-20T16:53:25+08:00 daily https://www.pharmasources.com/industryinsights/pra-health-sciences-expands-pharmacovigi-327309.html 0.6 2026-08-13T20:12:29+08:00 daily https://www.pharmasources.com/industryinsights/valnevas-inactivated-adjuvanted-covid-19-327310.html 0.6 2026-06-29T15:43:47+08:00 daily https://www.pharmasources.com/industryinsights/in-discussions-with-india-for-vaccine-su-327311.html 0.6 2026-06-21T08:45:43+08:00 daily https://www.pharmasources.com/industryinsights/monoclonal-antibodies-against-covid-19-h-327312.html 0.6 2026-06-21T01:57:00+08:00 daily https://www.pharmasources.com/industryinsights/immuno-oncology-to-be-a-dominant-class-o-327313.html 0.6 2026-06-21T02:11:49+08:00 daily https://www.pharmasources.com/industryinsights/continuous-manufacturing-part-2-industri-327314.html 0.6 2026-08-06T23:55:55+08:00 daily https://www.pharmasources.com/industryinsights/sii-to-sell-astrazeneca-vaccine-to-priva-327315.html 0.6 2026-06-21T00:55:48+08:00 daily https://www.pharmasources.com/industryinsights/efforts-to-ramp-up-production-of-covid-1-327316.html 0.6 2026-06-23T02:53:05+08:00 daily https://www.pharmasources.com/industryinsights/caplin-steriles-gets-usfda-approval-for--327317.html 0.6 2026-07-04T01:16:04+08:00 daily https://www.pharmasources.com/industryinsights/roche-reports-3-increase-in-group-sales--327318.html 0.6 2026-06-30T15:20:20+08:00 daily https://www.pharmasources.com/industryinsights/fda-reports-unsanitary-practices-at-emer-327319.html 0.6 2026-06-21T00:47:34+08:00 daily https://www.pharmasources.com/industryinsights/cost-security-concerns-and-lack-of-integ-327320.html 0.6 2026-06-20T18:57:00+08:00 daily https://www.pharmasources.com/industryinsights/nih-trial-to-evaluate-antibody-therapy-f-327321.html 0.6 2026-06-20T18:54:37+08:00 daily https://www.pharmasources.com/industryinsights/claritas-and-cmax-clinical-sign-agreemen-327322.html 0.6 2026-07-02T03:51:15+08:00 daily https://www.pharmasources.com/industryinsights/fda-continues-important-steps-to-ensure--327323.html 0.6 2026-08-09T07:56:43+08:00 daily https://www.pharmasources.com/industryinsights/start-of-production-in-record-time-evoni-327324.html 0.6 2026-08-08T07:42:02+08:00 daily https://www.pharmasources.com/industryinsights/owp-pharmaceuticals-announces-patent-app-327325.html 0.6 2026-08-07T13:16:12+08:00 daily https://www.pharmasources.com/industryinsights/kempharm-receives-10m-milestone-payment--327326.html 0.6 2026-08-07T04:04:12+08:00 daily https://www.pharmasources.com/industryinsights/new-report-suggests-the-gender-pay-gap-f-327327.html 0.6 2026-08-07T03:55:03+08:00 daily https://www.pharmasources.com/industryinsights/nhs-leaders-warn-of-a-chronic-undersuppl-327328.html 0.6 2026-08-07T03:34:14+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-plans-study-of-oral-semaglu-327329.html 0.6 2026-08-07T02:04:51+08:00 daily https://www.pharmasources.com/industryinsights/continuous-manufacturing-part-3-batch-si-327330.html 0.6 2026-08-13T20:02:41+08:00 daily https://www.pharmasources.com/industryinsights/mhra-authorises-amarins-heart-drug-vazke-327331.html 0.6 2026-08-07T00:41:02+08:00 daily https://www.pharmasources.com/industryinsights/lipidors-subsidiary-emollivet-takes-the--327332.html 0.6 2026-08-13T17:38:43+08:00 daily https://www.pharmasources.com/industryinsights/the-nda-of-the-novel-anti-pd-1-mab-serpl-327333.html 0.6 2026-08-07T14:18:16+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-strives-to-build-a-world-class-biom-327334.html 0.6 2026-08-09T17:08:54+08:00 daily https://www.pharmasources.com/industryinsights/lipidor---update-on-the-companys-phase-i-327335.html 0.6 2026-08-06T23:38:02+08:00 daily https://www.pharmasources.com/industryinsights/updated-results-on-coronavirus-vaccinati-327336.html 0.6 2026-08-06T23:36:19+08:00 daily https://www.pharmasources.com/industryinsights/us-allows-jj-covid-19-vaccine-shots-to-r-327337.html 0.6 2026-08-06T23:36:18+08:00 daily https://www.pharmasources.com/industryinsights/inovio-may-move-covid-19-vaccine-trial-o-327338.html 0.6 2026-07-23T01:19:04+08:00 daily https://www.pharmasources.com/industryinsights/cadila-healthcare-initiates-production-o-327339.html 0.6 2026-07-18T23:58:23+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-eua-from-dcgi-for-hepa-327340.html 0.6 2026-06-21T04:02:47+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-scientifics-amplitude-solu-327341.html 0.6 2026-08-09T04:45:49+08:00 daily https://www.pharmasources.com/industryinsights/jj-covid-19-vaccine-may-be-imported-by-j-327342.html 0.6 2026-06-20T18:45:23+08:00 daily https://www.pharmasources.com/industryinsights/alembic-pharma-gets-usfda-final-approval-327343.html 0.6 2026-07-24T05:58:45+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-final-us-fda-approval--327344.html 0.6 2026-08-07T23:27:03+08:00 daily https://www.pharmasources.com/industryinsights/gland-pharma-gets-us-fda-nod-for-generic-327345.html 0.6 2026-06-21T07:02:56+08:00 daily https://www.pharmasources.com/industryinsights/bora-pharmaceuticals-completes-health-ca-327346.html 0.6 2026-08-08T19:16:25+08:00 daily https://www.pharmasources.com/industryinsights/lonza-to-build-small-molecule-manufactur-327347.html 0.6 2026-08-10T15:16:07+08:00 daily https://www.pharmasources.com/industryinsights/vertex-and-obsidian-partner-to-discover--327348.html 0.6 2026-08-08T03:25:38+08:00 daily https://www.pharmasources.com/industryinsights/emed-expands-access-to-verified-at-home--327349.html 0.6 2026-08-07T13:55:01+08:00 daily https://www.pharmasources.com/industryinsights/associates-of-cape-cod-inc-announces-lau-327350.html 0.6 2026-08-07T13:16:12+08:00 daily https://www.pharmasources.com/industryinsights/jolly-good-and-teijin-pharma-form-a-part-327351.html 0.6 2026-08-07T16:15:16+08:00 daily https://www.pharmasources.com/industryinsights/inovio-planning-for-ex-us-global-phase-3-327352.html 0.6 2026-08-08T03:08:48+08:00 daily https://www.pharmasources.com/industryinsights/ocons-pioneering-iub-ballerine-femtech-a-327353.html 0.6 2026-08-08T07:53:49+08:00 daily https://www.pharmasources.com/industryinsights/towards-a-healthier-old-age-327354.html 0.6 2026-08-06T22:53:49+08:00 daily https://www.pharmasources.com/industryinsights/pancreatic-cancer-market-to-reach-41-bil-327355.html 0.6 2026-08-13T05:56:13+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-gsks-jemperli-for-endometri-327356.html 0.6 2026-08-10T13:10:21+08:00 daily https://www.pharmasources.com/industryinsights/supply-chain-the-pharmaceutical-value-ch-327357.html 0.6 2026-07-20T13:03:05+08:00 daily https://www.pharmasources.com/industryinsights/noxopharms-veyonda-prevents-cytokine-sto-327358.html 0.6 2026-06-24T10:42:48+08:00 daily https://www.pharmasources.com/industryinsights/artificial-intelligence-and-covid-19-vac-327359.html 0.6 2026-08-06T18:35:55+08:00 daily https://www.pharmasources.com/industryinsights/lupin-sun-pharma-jubilant-cadista-recall-327360.html 0.6 2026-08-10T02:20:37+08:00 daily https://www.pharmasources.com/industryinsights/adc-therapeutics-gets-usfda-nod-for-zynl-327361.html 0.6 2026-06-21T11:14:26+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-receives-positive-c-327362.html 0.6 2026-05-23T20:48:54+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-accelerated-approval-to-dosta-327363.html 0.6 2026-06-20T16:38:52+08:00 daily https://www.pharmasources.com/industryinsights/parp-inhibitors-could-exploit-weaknesses-327364.html 0.6 2026-06-21T18:55:38+08:00 daily https://www.pharmasources.com/industryinsights/bms-to-invest-in-new-cell-therapy-manufa-327365.html 0.6 2026-06-22T05:51:30+08:00 daily https://www.pharmasources.com/industryinsights/curevac-swiss-ag-initiates-rolling-submi-327366.html 0.6 2026-06-20T20:21:52+08:00 daily https://www.pharmasources.com/industryinsights/artificial-intelligence-model-predicts-w-327367.html 0.6 2026-06-21T08:07:08+08:00 daily https://www.pharmasources.com/industryinsights/gainhealth-expands-into-the-usd-8-billio-327368.html 0.6 2026-06-23T13:45:15+08:00 daily https://www.pharmasources.com/industryinsights/brief-overview-of-natural-adaptogens-327369.html 0.6 2026-08-06T22:53:40+08:00 daily https://www.pharmasources.com/industryinsights/ronovo-surgical-completes-series-a-finan-327370.html 0.6 2026-06-27T05:03:50+08:00 daily https://www.pharmasources.com/industryinsights/trends-to-watch-out-for-in-the-pharmaceu-327371.html 0.6 2026-07-23T20:50:11+08:00 daily https://www.pharmasources.com/industryinsights/further-woes-for-emergents-bayview-vacci-327372.html 0.6 2026-08-13T10:39:40+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-ravulizumab-for-treatmen-327373.html 0.6 2026-07-23T01:33:52+08:00 daily https://www.pharmasources.com/industryinsights/is-the-compendia-recommended-micro-organ-327374.html 0.6 2026-06-22T00:48:43+08:00 daily https://www.pharmasources.com/industryinsights/first-patients-dosed-with-fasenra-in-thr-327375.html 0.6 2026-06-21T06:05:51+08:00 daily https://www.pharmasources.com/industryinsights/inactivated-covid-19-vaccine-candidate-e-327376.html 0.6 2026-06-20T20:57:41+08:00 daily https://www.pharmasources.com/industryinsights/ema-board-confirms-the-eu-clinical-trial-327377.html 0.6 2026-07-28T22:08:21+08:00 daily https://www.pharmasources.com/industryinsights/antibody-drug-conjugates-understanding-t-327378.html 0.6 2026-08-09T06:51:33+08:00 daily https://www.pharmasources.com/industryinsights/world-lupus-federation-global-survey-of--327379.html 0.6 2026-06-21T10:46:53+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-327380.html 0.6 2026-08-07T04:24:40+08:00 daily https://www.pharmasources.com/industryinsights/south-africa-breaks-ground-in-use-of-ive-327381.html 0.6 2026-06-22T12:07:59+08:00 daily https://www.pharmasources.com/industryinsights/asher-bio-probiogen-ink-development-mfg--327382.html 0.6 2026-06-22T11:09:59+08:00 daily https://www.pharmasources.com/industryinsights/gt-biopharma-appoints-gregory-berk-cmo-327383.html 0.6 2026-06-20T17:34:06+08:00 daily https://www.pharmasources.com/industryinsights/bms-evotec-extend-targeted-protein-degra-327384.html 0.6 2026-08-10T16:24:41+08:00 daily https://www.pharmasources.com/industryinsights/india-should-step-up-vaccination-rate-en-327385.html 0.6 2026-07-18T02:22:07+08:00 daily https://www.pharmasources.com/industryinsights/health-canada-to-review-rolling-submissi-327386.html 0.6 2026-06-29T11:33:35+08:00 daily https://www.pharmasources.com/industryinsights/israel-assesses-myocarditis-cases-linked-327387.html 0.6 2026-07-09T06:19:14+08:00 daily https://www.pharmasources.com/industryinsights/mankind-pharma-to-give-rs-100-cr-to-fami-327388.html 0.6 2026-06-25T18:22:31+08:00 daily https://www.pharmasources.com/industryinsights/glenmarks-ryaltris-nasal-spray-gets-appr-327389.html 0.6 2026-08-07T16:30:21+08:00 daily https://www.pharmasources.com/industryinsights/natco-applies-to-cdsco-for-eua-of-molnup-327390.html 0.6 2026-06-22T04:34:20+08:00 daily https://www.pharmasources.com/industryinsights/future-ready-supply-chains-327391.html 0.6 2026-08-14T05:43:19+08:00 daily https://www.pharmasources.com/industryinsights/biocon-biologics-viatris-get-ec-approval-327392.html 0.6 2026-06-20T17:51:30+08:00 daily https://www.pharmasources.com/industryinsights/ethypharm-establishes-direct-presence-in-327393.html 0.6 2026-08-07T06:07:09+08:00 daily https://www.pharmasources.com/industryinsights/who-90-percent-of-countries-health-servi-327394.html 0.6 2026-07-15T18:35:10+08:00 daily https://www.pharmasources.com/industryinsights/affinity-empowering-is-partnered-with-ov-327395.html 0.6 2026-08-08T20:36:41+08:00 daily https://www.pharmasources.com/industryinsights/positive-topline-results-for-nirsevimab--327396.html 0.6 2026-08-06T10:43:48+08:00 daily https://www.pharmasources.com/industryinsights/bms-deucravacitinib-tops-otezla-in-two-p-327397.html 0.6 2026-06-21T01:24:34+08:00 daily https://www.pharmasources.com/industryinsights/roches-enspryng-leads-latest-chmp-recomm-327398.html 0.6 2026-07-20T16:26:50+08:00 daily https://www.pharmasources.com/industryinsights/new-research-could-allow-bioproduction-o-327399.html 0.6 2026-06-28T10:01:32+08:00 daily https://www.pharmasources.com/industryinsights/adding-vesicles-to-cell-free-gene-expres-327400.html 0.6 2026-03-27T18:24:43+08:00 daily https://www.pharmasources.com/industryinsights/highlights-of-the-emas-human-medicine-co-327401.html 0.6 2026-08-03T09:04:26+08:00 daily https://www.pharmasources.com/industryinsights/bushu-pharmas-collaboration-with-suzuken-327402.html 0.6 2026-06-21T09:04:03+08:00 daily https://www.pharmasources.com/industryinsights/holmusk-acquires-mental-health-analytics-327403.html 0.6 2026-07-07T17:48:07+08:00 daily https://www.pharmasources.com/industryinsights/msig-partners-with-singapore-cancer-soci-327404.html 0.6 2026-06-27T20:44:08+08:00 daily https://www.pharmasources.com/industryinsights/discgenics-completes-patient-enrollment--327405.html 0.6 2026-06-23T01:31:40+08:00 daily https://www.pharmasources.com/industryinsights/ortho-clinical-diagnostics-recognized-wi-327406.html 0.6 2026-08-07T19:11:02+08:00 daily https://www.pharmasources.com/industryinsights/south-africa-breaks-ground-in-use-of-ive-327407.html 0.6 2026-07-03T05:15:40+08:00 daily https://www.pharmasources.com/industryinsights/elektrofi-argenx-enter-collaboration-and-327408.html 0.6 2026-08-07T12:35:21+08:00 daily https://www.pharmasources.com/industryinsights/sharp-expanding-with-third-pennsylvania--327409.html 0.6 2026-08-07T12:12:09+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-tg-therapeutics-expand-327410.html 0.6 2026-06-27T05:22:21+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-invests-in-cell-the-327411.html 0.6 2026-08-06T23:57:29+08:00 daily https://www.pharmasources.com/industryinsights/aceto-acquires-ac-327412.html 0.6 2026-08-06T23:46:19+08:00 daily https://www.pharmasources.com/industryinsights/gilead-sciences-to-support-expansion-of--327413.html 0.6 2026-08-06T23:54:59+08:00 daily https://www.pharmasources.com/industryinsights/msd-signs-voluntary-licensing-agreements-327414.html 0.6 2026-08-07T00:03:07+08:00 daily https://www.pharmasources.com/industryinsights/syngene-extends-research-partnership-wit-327415.html 0.6 2026-08-07T00:40:54+08:00 daily https://www.pharmasources.com/industryinsights/kemwell-biopharma-increases-capacity-for-327416.html 0.6 2026-08-07T01:06:42+08:00 daily https://www.pharmasources.com/industryinsights/ampios-inhaled-drug-lowers-mortality-in--327417.html 0.6 2026-08-10T15:16:14+08:00 daily https://www.pharmasources.com/industryinsights/science-park-merger-creates-uks-largest--327418.html 0.6 2026-08-09T00:42:55+08:00 daily https://www.pharmasources.com/industryinsights/brazils-anvisa-rejects-import-of-russias-327419.html 0.6 2026-08-09T00:38:02+08:00 daily https://www.pharmasources.com/industryinsights/chmp-suggests-astrazeneca-and-mercks-sel-327420.html 0.6 2026-08-10T12:03:14+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-to-manufacture-modernas-covid-19--327421.html 0.6 2026-06-20T14:33:49+08:00 daily https://www.pharmasources.com/industryinsights/dna-script-partners-with-moderna-to-deve-327422.html 0.6 2026-07-02T14:00:12+08:00 daily https://www.pharmasources.com/industryinsights/rps-makes-new-recommendations-for-pharma-327423.html 0.6 2026-06-20T14:49:11+08:00 daily https://www.pharmasources.com/industryinsights/oxford-immunotecs-covid-19-test-to-be-us-327424.html 0.6 2026-06-20T21:12:53+08:00 daily https://www.pharmasources.com/industryinsights/nice-updates-guideline-on-atrial-fibrill-327425.html 0.6 2026-06-20T20:13:46+08:00 daily https://www.pharmasources.com/industryinsights/over-a-quarter-of-uk-adults-have-receive-327426.html 0.6 2026-06-01T05:43:30+08:00 daily https://www.pharmasources.com/industryinsights/how-covid-19-impacted-uk-healthcare-327427.html 0.6 2026-06-01T05:40:34+08:00 daily https://www.pharmasources.com/industryinsights/hepatitis-c-drugs-multiply-effect-of-cov-327428.html 0.6 2026-08-13T06:28:09+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-reports-first-quarter--327429.html 0.6 2026-06-21T19:21:22+08:00 daily https://www.pharmasources.com/industryinsights/gen-incode-announces-major-uk-collaborat-327430.html 0.6 2026-07-27T03:32:57+08:00 daily https://www.pharmasources.com/industryinsights/hmi-group-and-siemens-healthineers-enter-327431.html 0.6 2026-06-21T02:03:18+08:00 daily https://www.pharmasources.com/industryinsights/varian-and-icon-group-partner-to-extend--327432.html 0.6 2026-06-24T00:51:49+08:00 daily https://www.pharmasources.com/industryinsights/himalaya-therapeutics-announces-appointm-327433.html 0.6 2026-08-13T12:34:01+08:00 daily https://www.pharmasources.com/industryinsights/cstone-announces-nmpa-acceptance-of-new--327434.html 0.6 2026-08-06T09:59:29+08:00 daily https://www.pharmasources.com/industryinsights/novel-vaccine-77-percent-effective-in-pr-327435.html 0.6 2026-06-21T10:24:40+08:00 daily https://www.pharmasources.com/industryinsights/ema-and-ecdc-to-collaborate-on-post-mark-327436.html 0.6 2026-08-13T02:20:19+08:00 daily https://www.pharmasources.com/industryinsights/recombinant-bacterial-endotoxin-testing--327437.html 0.6 2026-08-10T19:11:37+08:00 daily https://www.pharmasources.com/industryinsights/precirix-partners-with-evergreen-theragn-327438.html 0.6 2026-06-22T03:00:38+08:00 daily https://www.pharmasources.com/industryinsights/ppd-science-37-partner-to-advance-decent-327439.html 0.6 2026-06-21T02:04:38+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-adma-biologics-increased-iv-327440.html 0.6 2026-06-22T05:11:06+08:00 daily https://www.pharmasources.com/industryinsights/aptar-pharma-nordic-semiconductor-partne-327441.html 0.6 2026-06-21T01:59:34+08:00 daily https://www.pharmasources.com/industryinsights/silo-pharma-enters-joint-venture-with-zy-327442.html 0.6 2026-06-22T01:40:30+08:00 daily https://www.pharmasources.com/industryinsights/introducing-virocell-biologics-327443.html 0.6 2026-06-20T14:17:19+08:00 daily https://www.pharmasources.com/industryinsights/aavantibio-catalent-enter-gene-therapy-a-327444.html 0.6 2026-06-21T19:41:31+08:00 daily https://www.pharmasources.com/industryinsights/charnwood-molecular-plans-significant-ex-327445.html 0.6 2026-08-07T23:12:03+08:00 daily https://www.pharmasources.com/industryinsights/vetter-rentschler-biopharma-advance-stra-327446.html 0.6 2026-06-21T22:11:51+08:00 daily https://www.pharmasources.com/industryinsights/sevoflurane-introduction-uses-and-top-se-327447.html 0.6 2026-07-14T19:45:49+08:00 daily https://www.pharmasources.com/industryinsights/wto-ip-waiver-too-simplistic-global-vacc-327448.html 0.6 2026-06-21T01:06:46+08:00 daily https://www.pharmasources.com/industryinsights/msn-laboratories-launches-favilow-faripi-327449.html 0.6 2026-06-20T16:15:08+08:00 daily https://www.pharmasources.com/industryinsights/morepen-group-gets-100-million-investmen-327450.html 0.6 2026-06-22T08:05:48+08:00 daily https://www.pharmasources.com/industryinsights/pharma-industry-investments-in-blockchai-327451.html 0.6 2026-06-21T03:18:55+08:00 daily https://www.pharmasources.com/industryinsights/eli-lilly-reports-increase-in-first-quar-327452.html 0.6 2026-06-21T00:55:49+08:00 daily https://www.pharmasources.com/industryinsights/triamcinolone-acetonide-cream-specificat-327453.html 0.6 2026-07-22T16:41:08+08:00 daily https://www.pharmasources.com/industryinsights/2021-ispe-facility-of-the-year-awards-wi-327454.html 0.6 2026-06-21T07:00:57+08:00 daily https://www.pharmasources.com/industryinsights/fda-issues-draft-guidance-on-nonclinical-327455.html 0.6 2026-08-13T10:35:48+08:00 daily https://www.pharmasources.com/industryinsights/blue-water-acquisition-merges-with-claru-327456.html 0.6 2026-08-05T11:04:12+08:00 daily https://www.pharmasources.com/industryinsights/ema-prime-status-granted-for-vertex-cris-327457.html 0.6 2026-08-05T14:04:04+08:00 daily https://www.pharmasources.com/industryinsights/ulipristal-acetate-introduction-uses-saf-327458.html 0.6 2026-07-22T19:50:14+08:00 daily https://www.pharmasources.com/industryinsights/tagrisso-moves-closer-towards-eu-approva-327459.html 0.6 2026-06-21T02:15:50+08:00 daily https://www.pharmasources.com/industryinsights/uk-cancer-centre-to-offer-breast-cancer--327460.html 0.6 2026-06-20T20:44:30+08:00 daily https://www.pharmasources.com/industryinsights/chiesis-raxone-recommended-for-use-withi-327461.html 0.6 2026-06-21T08:09:04+08:00 daily https://www.pharmasources.com/industryinsights/list-of-mupirocin-calcium-bulk-powder-ma-327462.html 0.6 2026-06-21T19:18:35+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-dosed-with-dalbavancin-in--327463.html 0.6 2026-08-11T08:05:52+08:00 daily https://www.pharmasources.com/industryinsights/global-pharmacovigilance-market-to-value-327464.html 0.6 2026-08-06T02:49:43+08:00 daily https://www.pharmasources.com/industryinsights/antengene-announces-xpo1-inhibitor-selin-327465.html 0.6 2026-06-21T11:45:54+08:00 daily https://www.pharmasources.com/industryinsights/innovent-announces-first-patient-dosed-i-327466.html 0.6 2026-06-21T20:53:51+08:00 daily https://www.pharmasources.com/industryinsights/alphamab-announced-pd-l1ctla-4-bispecifi-327467.html 0.6 2026-06-25T15:24:07+08:00 daily https://www.pharmasources.com/industryinsights/anchordx-jointly-publishes-clinical-rese-327468.html 0.6 2026-06-20T13:20:41+08:00 daily https://www.pharmasources.com/industryinsights/novaliq-announces-more-than-50-patients--327469.html 0.6 2026-08-06T00:41:35+08:00 daily https://www.pharmasources.com/industryinsights/ert-and-bioclinica-close-merger-creating-327470.html 0.6 2026-06-22T12:09:59+08:00 daily https://www.pharmasources.com/industryinsights/cros-dmed-and-clinipace-merge-to-acceler-327471.html 0.6 2026-06-21T02:16:50+08:00 daily https://www.pharmasources.com/industryinsights/revotek-deploys-its-bioink-technology-to-327472.html 0.6 2026-08-09T06:59:17+08:00 daily https://www.pharmasources.com/industryinsights/biovaxys-broadens-intellectual-property--327473.html 0.6 2026-08-08T23:10:10+08:00 daily https://www.pharmasources.com/industryinsights/grand-river-aseptic-manufacturing-earns--327474.html 0.6 2026-06-20T21:54:40+08:00 daily https://www.pharmasources.com/industryinsights/genscript-launches-research-lentiviral-v-327475.html 0.6 2026-06-23T03:09:04+08:00 daily https://www.pharmasources.com/industryinsights/bushu-pharma-establishes-packaging-cente-327476.html 0.6 2026-08-13T12:19:28+08:00 daily https://www.pharmasources.com/industryinsights/ppd-to-expand-gmp-lab-in-ireland-327477.html 0.6 2026-06-20T16:05:22+08:00 daily https://www.pharmasources.com/industryinsights/catalent-and-stirling-ultracold-enter-co-327478.html 0.6 2026-06-21T01:51:35+08:00 daily https://www.pharmasources.com/industryinsights/adma-receives-fda-approval-for-increased-327479.html 0.6 2026-06-20T21:16:56+08:00 daily https://www.pharmasources.com/industryinsights/lonza-doubles-drug-substance-production--327480.html 0.6 2026-08-04T12:45:53+08:00 daily https://www.pharmasources.com/industryinsights/high-purity-new-england-appoints-chief-s-327481.html 0.6 2026-08-07T03:24:41+08:00 daily https://www.pharmasources.com/industryinsights/precirix-evergreen-ink-clinical-supply-d-327482.html 0.6 2026-08-07T03:34:01+08:00 daily https://www.pharmasources.com/industryinsights/hilco-industrial-acquires-machinery-equi-327483.html 0.6 2026-08-09T07:38:19+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-acquires-amplyx-pharmaceuticals-327484.html 0.6 2026-07-24T23:07:03+08:00 daily https://www.pharmasources.com/industryinsights/covaxin-prices-slashed-from-rs-600-to-rs-327485.html 0.6 2026-06-22T09:14:56+08:00 daily https://www.pharmasources.com/industryinsights/alterity-therapeutics-limited-appendix-4-327486.html 0.6 2026-08-07T13:15:22+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-launches-of-albendazoletablets-327487.html 0.6 2026-04-20T19:26:33+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-announces-upcoming-participation-a-327488.html 0.6 2026-08-06T23:46:34+08:00 daily https://www.pharmasources.com/industryinsights/need-industry-support-to-procure-oxygen--327489.html 0.6 2026-04-17T21:44:03+08:00 daily https://www.pharmasources.com/industryinsights/us-senators-write-to-pfizer-moderna-jj-f-327490.html 0.6 2026-06-21T04:21:10+08:00 daily https://www.pharmasources.com/industryinsights/carbogen-amcis-signs-co-funding-pact-wor-327491.html 0.6 2026-08-12T21:42:22+08:00 daily https://www.pharmasources.com/industryinsights/gsk-reports-decline-in-q1-2021-revenue-d-327492.html 0.6 2026-08-07T02:05:06+08:00 daily https://www.pharmasources.com/industryinsights/south-africa-restarts-inoculation-with-j-327493.html 0.6 2026-08-07T01:52:10+08:00 daily https://www.pharmasources.com/industryinsights/tris-pharma-acquires-park-therapeutics-327494.html 0.6 2026-08-13T14:53:12+08:00 daily https://www.pharmasources.com/industryinsights/artificial-intelligence-helps-ivf-patien-327495.html 0.6 2026-08-06T23:57:45+08:00 daily https://www.pharmasources.com/industryinsights/hyloris-announces-major-commercial-partn-327496.html 0.6 2026-08-07T01:27:31+08:00 daily https://www.pharmasources.com/industryinsights/fda-takes-action-for-failure-to-submit-r-327497.html 0.6 2026-08-07T01:22:21+08:00 daily https://www.pharmasources.com/industryinsights/silence-therapeutics-gets-milestone-paym-327498.html 0.6 2026-08-07T01:28:12+08:00 daily https://www.pharmasources.com/industryinsights/med7-llc-announce-the-completion-of-a-sa-327499.html 0.6 2026-06-21T05:01:41+08:00 daily https://www.pharmasources.com/industryinsights/first-uk-based-clinical-trial-focused-vi-327500.html 0.6 2026-06-21T02:59:54+08:00 daily https://www.pharmasources.com/industryinsights/triple-combo-cystic-fibrosis-therapy-kaf-327501.html 0.6 2026-08-14T15:04:58+08:00 daily https://www.pharmasources.com/industryinsights/daiichi-sankyos-cholesterol-lowering-dru-327502.html 0.6 2026-08-08T12:19:01+08:00 daily https://www.pharmasources.com/industryinsights/uk-based-cro-charnwood-molecular-reveals-327503.html 0.6 2026-08-08T16:57:28+08:00 daily https://www.pharmasources.com/industryinsights/highest-british-business-award-goes-to-c-327504.html 0.6 2026-08-08T08:39:05+08:00 daily https://www.pharmasources.com/industryinsights/100-percent-recovery-rate-for-covid-19-p-327505.html 0.6 2026-08-13T17:07:21+08:00 daily https://www.pharmasources.com/industryinsights/link-medical-expands-its-regulatory-serv-327506.html 0.6 2026-06-21T09:14:09+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-1q-revenues-up-45-driven-by-covid-327507.html 0.6 2026-08-10T17:34:53+08:00 daily https://www.pharmasources.com/industryinsights/biovaxys-inks-deal-with-cdmo-bioelpida-327508.html 0.6 2026-08-10T19:34:23+08:00 daily https://www.pharmasources.com/industryinsights/cellares-expands-cell-therapy-manufactur-327509.html 0.6 2026-06-20T16:05:17+08:00 daily https://www.pharmasources.com/industryinsights/clean-biologics-acquires-biodextris-327510.html 0.6 2026-06-30T17:43:47+08:00 daily https://www.pharmasources.com/industryinsights/exelixis-acquires-gamamabs-oncology-anti-327511.html 0.6 2026-06-20T23:53:30+08:00 daily https://www.pharmasources.com/industryinsights/syneos-komodo-health-expand-data-app-all-327512.html 0.6 2026-06-22T10:20:12+08:00 daily https://www.pharmasources.com/industryinsights/clinical-ink-adds-executives-327513.html 0.6 2026-06-21T22:46:54+08:00 daily https://www.pharmasources.com/industryinsights/moderna-to-increase-global-supply-for-co-327514.html 0.6 2026-06-21T02:01:40+08:00 daily https://www.pharmasources.com/industryinsights/albumedix-extends-research-collaboration-327515.html 0.6 2026-06-21T00:53:46+08:00 daily https://www.pharmasources.com/industryinsights/abcellera-breaks-ground-on-global-hq-in--327516.html 0.6 2026-08-07T16:38:35+08:00 daily https://www.pharmasources.com/industryinsights/nuvox-completes-construction-of-expanded-327517.html 0.6 2026-06-21T05:55:48+08:00 daily https://www.pharmasources.com/industryinsights/ccrm-and-amgen-partner-to-advance-emergi-327518.html 0.6 2026-07-04T16:57:20+08:00 daily https://www.pharmasources.com/industryinsights/gilead-revenues-up-16-in-the-quarter-327519.html 0.6 2026-08-12T13:39:42+08:00 daily https://www.pharmasources.com/industryinsights/abbvies-1q-reveneus-up-51-327520.html 0.6 2026-06-20T19:48:31+08:00 daily https://www.pharmasources.com/industryinsights/amri-adds-rd-and-mfg-solutions-for-orpha-327521.html 0.6 2026-08-12T06:26:02+08:00 daily https://www.pharmasources.com/industryinsights/frontage-laboratories-appoints-executive-327522.html 0.6 2026-06-21T07:55:59+08:00 daily https://www.pharmasources.com/industryinsights/viiv-healthcare-starts-rolling-submissio-327523.html 0.6 2026-06-21T01:57:41+08:00 daily https://www.pharmasources.com/industryinsights/hdt-bio-and-gennova-dose-healthy-subject-327524.html 0.6 2026-06-21T12:10:17+08:00 daily https://www.pharmasources.com/industryinsights/effector-and-qbi-to-study-anti-viral-age-327525.html 0.6 2026-06-21T07:18:34+08:00 daily https://www.pharmasources.com/industryinsights/nih-scientists-identify-small-molecule-c-327526.html 0.6 2026-08-13T23:34:34+08:00 daily https://www.pharmasources.com/industryinsights/moderna-to-supply-covid-19-vaccine-doses-327527.html 0.6 2026-06-21T19:55:16+08:00 daily https://www.pharmasources.com/industryinsights/vaxarts-covid-19-vaccine-shows-cross-cor-327528.html 0.6 2026-06-20T17:01:17+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-astrazenecas-farxiga-for-ch-327529.html 0.6 2026-06-21T06:19:14+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-biontech-seek-cma-expansion-for-c-327530.html 0.6 2026-06-20T15:58:32+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-revenues-increase-i-327531.html 0.6 2026-05-03T05:07:40+08:00 daily https://www.pharmasources.com/industryinsights/o-drug-approved-as-first-line-immunother-327532.html 0.6 2026-06-21T22:53:42+08:00 daily https://www.pharmasources.com/industryinsights/moderna-receives-emergency-use-listing-f-327533.html 0.6 2026-06-21T03:13:51+08:00 daily https://www.pharmasources.com/industryinsights/development-of-anticancer-drugs-for-ferr-327534.html 0.6 2026-08-07T04:49:02+08:00 daily https://www.pharmasources.com/industryinsights/mhra-reports-41-blood-clot-cases-after-u-327535.html 0.6 2026-06-20T19:11:53+08:00 daily https://www.pharmasources.com/industryinsights/mesoblasts-remestemcel-l-lowers-mortalit-327536.html 0.6 2026-07-06T18:20:16+08:00 daily https://www.pharmasources.com/industryinsights/cmos-gain-advantages-of-covid-19-product-327537.html 0.6 2026-06-21T08:02:58+08:00 daily https://www.pharmasources.com/industryinsights/ortho-clinical-diagnostics-launches-quan-327538.html 0.6 2026-04-17T18:53:50+08:00 daily https://www.pharmasources.com/industryinsights/sidbi-launches-shwas-and-arog-schemes-fo-327539.html 0.6 2026-08-13T18:03:26+08:00 daily https://www.pharmasources.com/industryinsights/india-to-import-45-lakh-vials-of-remdesi-327540.html 0.6 2026-06-20T20:55:49+08:00 daily https://www.pharmasources.com/industryinsights/hikma-pharma-get-us-fda-nod-for-higher-d-327541.html 0.6 2026-06-16T12:28:51+08:00 daily https://www.pharmasources.com/industryinsights/pharma-sources-insight-april-2021-toward-327542.html 0.6 2026-07-31T16:56:04+08:00 daily https://www.pharmasources.com/industryinsights/no-more-the-pharmacyvaccine-maker-of-the-327543.html 0.6 2026-06-22T19:51:50+08:00 daily https://www.pharmasources.com/industryinsights/cell-therapy-for-solid-tumors-may-get-ap-327544.html 0.6 2026-06-22T08:01:46+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-announces-arrival-of-first-con-327545.html 0.6 2026-06-20T22:03:43+08:00 daily https://www.pharmasources.com/industryinsights/more-than-78-lakh-covid-vaccine-doses-st-327546.html 0.6 2026-06-20T15:13:18+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-announces-first-quarter-2021-327547.html 0.6 2026-06-21T20:55:44+08:00 daily https://www.pharmasources.com/industryinsights/meissner-announces-award-of-134-million--327548.html 0.6 2026-06-20T14:36:08+08:00 daily https://www.pharmasources.com/industryinsights/iqvia-report-forecasts-global-medicine-s-327549.html 0.6 2026-08-04T22:56:56+08:00 daily https://www.pharmasources.com/industryinsights/uk-buys-another-60-million-doses-of-pfiz-327550.html 0.6 2026-06-20T20:58:40+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-manufacturing-requirements-are--327551.html 0.6 2026-07-15T04:30:36+08:00 daily https://www.pharmasources.com/industryinsights/ema-to-assess-if-olumiant-should-be-auth-327552.html 0.6 2026-06-21T01:58:39+08:00 daily https://www.pharmasources.com/industryinsights/150-million-made-available-for-covid-19--327553.html 0.6 2026-08-14T14:03:35+08:00 daily https://www.pharmasources.com/industryinsights/amcor-begins-consumer-trials-of-recyclab-327554.html 0.6 2026-08-04T07:00:03+08:00 daily https://www.pharmasources.com/industryinsights/himalaya-therapeutics-announces-appointm-327555.html 0.6 2026-08-11T13:37:34+08:00 daily https://www.pharmasources.com/industryinsights/antengene-announces-selinexor-added-to-m-327556.html 0.6 2026-07-21T09:05:04+08:00 daily https://www.pharmasources.com/industryinsights/freshworks-and-plan8-partner-to-develop--327557.html 0.6 2026-06-21T01:13:54+08:00 daily https://www.pharmasources.com/industryinsights/everest-medicines-receives-orphan-drug-d-327558.html 0.6 2026-07-19T09:28:55+08:00 daily https://www.pharmasources.com/industryinsights/hope-medicine-completed-us56-million-in--327559.html 0.6 2026-07-23T18:30:15+08:00 daily https://www.pharmasources.com/industryinsights/165-lakh-vials-of-remdesivir-to-be-alloc-327560.html 0.6 2026-07-31T15:51:09+08:00 daily https://www.pharmasources.com/industryinsights/eli-lilly-accelerates-baricitinibs-avail-327561.html 0.6 2026-06-22T07:59:44+08:00 daily https://www.pharmasources.com/industryinsights/rbi-announces-on-tap-liquidity-window-of-327562.html 0.6 2026-06-22T12:46:57+08:00 daily https://www.pharmasources.com/industryinsights/three-fold-increase-in-remdesivir-produc-327563.html 0.6 2026-06-14T06:31:17+08:00 daily https://www.pharmasources.com/industryinsights/mohfw-issues-guidelines-for-covid-19-vac-327564.html 0.6 2026-07-22T21:39:15+08:00 daily https://www.pharmasources.com/industryinsights/reliable-cold-storage-solutions-to-safeg-327565.html 0.6 2026-05-28T10:04:39+08:00 daily https://www.pharmasources.com/industryinsights/core-one-labs-completes-acquisition-of-a-327566.html 0.6 2026-07-06T02:41:28+08:00 daily https://www.pharmasources.com/industryinsights/serum-institute-of-india-to-make-240-mn--327567.html 0.6 2026-06-21T10:08:10+08:00 daily https://www.pharmasources.com/industryinsights/pil-in-hc-seeks-all-remdesivir-makers-be-327568.html 0.6 2026-07-19T15:45:48+08:00 daily https://www.pharmasources.com/industryinsights/sii-endorses-receiving-rs-1732-crore-for-327569.html 0.6 2026-06-21T05:11:15+08:00 daily https://www.pharmasources.com/industryinsights/safety-issues-over-mass-production-of-co-327570.html 0.6 2026-07-23T05:59:46+08:00 daily https://www.pharmasources.com/industryinsights/centre-has-so-far-provided-over-1654-cro-327571.html 0.6 2026-06-21T10:04:16+08:00 daily https://www.pharmasources.com/industryinsights/natco-receives-emergency-use-approval-fo-327572.html 0.6 2026-06-30T16:22:19+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-in-talks-with-india-over-expedite-327573.html 0.6 2026-08-06T09:07:14+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-launches-ryaltris-az-in-india-327574.html 0.6 2026-07-03T13:39:40+08:00 daily https://www.pharmasources.com/industryinsights/whats-new-on-fda-generic-drugs-forum-202-327575.html 0.6 2026-08-06T20:07:31+08:00 daily https://www.pharmasources.com/industryinsights/acella-pharmaceuticals-issues-voluntary--327576.html 0.6 2026-07-01T05:13:02+08:00 daily https://www.pharmasources.com/industryinsights/amphastar-pharmaceuticals-receives-fda-a-327577.html 0.6 2026-08-08T10:11:49+08:00 daily https://www.pharmasources.com/industryinsights/fda-expands-collaboration-with-cn-bio-to-327578.html 0.6 2026-08-07T13:17:22+08:00 daily https://www.pharmasources.com/industryinsights/lonza-announces-expansion-plans-for-next-327579.html 0.6 2026-08-07T12:03:26+08:00 daily https://www.pharmasources.com/industryinsights/health-canada-approves-pfizer-and-bionte-327580.html 0.6 2026-08-06T23:38:40+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisk-reports-increased-q1-2021-p-327581.html 0.6 2026-08-06T23:45:44+08:00 daily https://www.pharmasources.com/industryinsights/novavax-covid-19-vaccine-provides-cross--327582.html 0.6 2026-08-06T23:47:59+08:00 daily https://www.pharmasources.com/industryinsights/canbridge-signs-license-agreement-with-m-327583.html 0.6 2026-08-10T16:28:32+08:00 daily https://www.pharmasources.com/industryinsights/alchemab-to-collaborate-with-astrazeneca-327584.html 0.6 2026-08-07T00:02:01+08:00 daily https://www.pharmasources.com/industryinsights/preliminary-nice-no-for-mercks-bavencio-327585.html 0.6 2026-08-07T00:40:30+08:00 daily https://www.pharmasources.com/industryinsights/ec-clears-gsks-benlysta-for-lupus-nephri-327586.html 0.6 2026-08-07T00:59:19+08:00 daily https://www.pharmasources.com/industryinsights/us-supports-waiving-ip-for-covid-vaccine-327587.html 0.6 2026-08-07T00:40:58+08:00 daily https://www.pharmasources.com/industryinsights/cumulus-neuroscience-raises-6m-in-dement-327588.html 0.6 2026-08-07T00:01:49+08:00 daily https://www.pharmasources.com/industryinsights/tecentriq-approved-for-first-line-metast-327589.html 0.6 2026-08-07T00:39:56+08:00 daily https://www.pharmasources.com/industryinsights/nice-expands-access-for-sma-drug-spinraz-327590.html 0.6 2026-08-07T01:19:47+08:00 daily https://www.pharmasources.com/industryinsights/uk-bolsters-covid-19-variant-testing-cap-327591.html 0.6 2026-08-09T18:56:25+08:00 daily https://www.pharmasources.com/industryinsights/nhs-rolls-out-3d-heart-scans-to-fast-tra-327592.html 0.6 2026-06-21T12:11:28+08:00 daily https://www.pharmasources.com/industryinsights/researchers-identify-new-genetic-target--327593.html 0.6 2026-06-21T13:07:39+08:00 daily https://www.pharmasources.com/industryinsights/janssen-seeks-eu-approval-for-first-car--327594.html 0.6 2026-06-22T11:03:51+08:00 daily https://www.pharmasources.com/industryinsights/novel-vaccination-regimen-shown-to-be-ef-327595.html 0.6 2026-06-22T00:54:51+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-327596.html 0.6 2026-08-08T01:09:35+08:00 daily https://www.pharmasources.com/industryinsights/charles-river-laboratories-generates-824-327597.html 0.6 2026-06-21T16:54:45+08:00 daily https://www.pharmasources.com/industryinsights/ec-approves-xtandi-for-third-prostate-ca-327598.html 0.6 2026-06-21T03:58:52+08:00 daily https://www.pharmasources.com/industryinsights/nasal-spray-shown-to-be-effective-in-red-327599.html 0.6 2026-06-21T06:50:05+08:00 daily https://www.pharmasources.com/industryinsights/kineret-improves-clinical-outcomes-in-ho-327600.html 0.6 2026-06-21T11:12:21+08:00 daily https://www.pharmasources.com/industryinsights/paediatric-and-adolescent-covid-19-vacci-327601.html 0.6 2026-07-01T08:06:42+08:00 daily https://www.pharmasources.com/industryinsights/hikma-get-us-fda-nod-for-higher-dosage-o-327602.html 0.6 2026-06-21T06:12:54+08:00 daily https://www.pharmasources.com/industryinsights/nexturn-bio-inc-decided-to-invest-in-the-327603.html 0.6 2026-06-20T14:59:08+08:00 daily https://www.pharmasources.com/industryinsights/the-worlds-first-in-class-mirna-therapeu-327604.html 0.6 2026-06-22T05:55:39+08:00 daily https://www.pharmasources.com/industryinsights/novavax-and-gavi-execute-advance-purchas-327605.html 0.6 2026-06-20T21:54:36+08:00 daily https://www.pharmasources.com/industryinsights/hanall-biopharma-reports-first-quarter-2-327606.html 0.6 2026-06-22T12:03:52+08:00 daily https://www.pharmasources.com/industryinsights/darwinhealth-announces-a-research-collab-327607.html 0.6 2026-06-22T01:29:13+08:00 daily https://www.pharmasources.com/industryinsights/aenova-expands-capacity-for-fill-finish--327608.html 0.6 2026-08-07T04:31:01+08:00 daily https://www.pharmasources.com/industryinsights/3p-and-buzzard-pharmaceuticals-enter-can-327609.html 0.6 2026-08-07T04:49:03+08:00 daily https://www.pharmasources.com/industryinsights/agc-biologics-and-oculis-enter-manufactu-327610.html 0.6 2026-08-07T05:07:37+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-adc-therapeutics-zynlonta-327611.html 0.6 2026-06-21T10:55:10+08:00 daily https://www.pharmasources.com/industryinsights/yangtze-river-pharmaceutical-group-selec-327612.html 0.6 2026-07-11T13:33:10+08:00 daily https://www.pharmasources.com/industryinsights/altasciences-acquires-calvert-laboratori-327613.html 0.6 2026-03-17T21:57:37+08:00 daily https://www.pharmasources.com/industryinsights/crown-bioscience-acquires-ocello-327614.html 0.6 2026-03-27T01:16:27+08:00 daily https://www.pharmasources.com/industryinsights/catalent-acquires-commercial-scale-plasm-327615.html 0.6 2026-06-21T11:11:17+08:00 daily https://www.pharmasources.com/industryinsights/vectura-inspira-partner-to-develop-inhal-327616.html 0.6 2026-08-11T16:33:42+08:00 daily https://www.pharmasources.com/industryinsights/richter-helm-triples-cgmp-production-cap-327617.html 0.6 2026-04-14T06:22:00+08:00 daily https://www.pharmasources.com/industryinsights/roches-antibody-cocktail-for-covid-19-ma-327618.html 0.6 2026-08-09T12:38:18+08:00 daily https://www.pharmasources.com/industryinsights/mankind-pharma-collaborates-with-accentu-327619.html 0.6 2026-08-06T22:53:47+08:00 daily https://www.pharmasources.com/industryinsights/pharma-firms-not-providing-mandated-quan-327620.html 0.6 2026-08-06T19:59:43+08:00 daily https://www.pharmasources.com/industryinsights/prashant-nagre-appointed-as-md-of-fermen-327621.html 0.6 2026-08-06T19:23:20+08:00 daily https://www.pharmasources.com/industryinsights/healthcare-industry-reported-77-deals-wo-327622.html 0.6 2026-08-06T20:06:15+08:00 daily https://www.pharmasources.com/industryinsights/russia-authorises-use-of-single-dose-cov-327623.html 0.6 2026-08-06T23:54:11+08:00 daily https://www.pharmasources.com/industryinsights/over-120-countries-back-ip-rights-waiver-327624.html 0.6 2026-08-10T17:34:42+08:00 daily https://www.pharmasources.com/industryinsights/business-optimism-declines-moderately-in-327625.html 0.6 2026-08-10T15:16:28+08:00 daily https://www.pharmasources.com/industryinsights/nih-trial-to-add-trevenas-trv027-for-cov-327626.html 0.6 2026-06-22T11:47:38+08:00 daily https://www.pharmasources.com/industryinsights/revive-therapeutics-ucsf-partner-to-stud-327627.html 0.6 2026-06-21T19:39:15+08:00 daily https://www.pharmasources.com/industryinsights/at-home-coronavirus-pill-to-advance-to-p-327628.html 0.6 2026-06-20T17:11:33+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-and-biontech-initiate-rolling-sub-327629.html 0.6 2026-06-21T04:20:10+08:00 daily https://www.pharmasources.com/industryinsights/astrazenecas-imfinzi-and-tremelimumab-wi-327630.html 0.6 2026-08-01T23:30:55+08:00 daily https://www.pharmasources.com/industryinsights/covid-vaccine-hesitant-consumers-care-ab-327631.html 0.6 2026-07-06T16:10:57+08:00 daily https://www.pharmasources.com/industryinsights/uk-launch-for-progressive-multiple-scler-327632.html 0.6 2026-07-18T03:11:25+08:00 daily https://www.pharmasources.com/industryinsights/az-tagrisso-first-to-win-mhra-approval-u-327633.html 0.6 2026-06-21T18:01:29+08:00 daily https://www.pharmasources.com/industryinsights/novel-cryomicroneedle-patch-successfully-327634.html 0.6 2026-03-05T15:25:47+08:00 daily https://www.pharmasources.com/industryinsights/cell-based-seasonal-influenza-vaccine-sa-327635.html 0.6 2026-07-17T12:13:05+08:00 daily https://www.pharmasources.com/industryinsights/sonelokimab-shows-promise-in-phase-ii-ps-327636.html 0.6 2026-06-20T14:39:12+08:00 daily https://www.pharmasources.com/industryinsights/scientists-show-3d-printed-tablet-porosi-327637.html 0.6 2026-06-22T23:11:13+08:00 daily https://www.pharmasources.com/industryinsights/daewoong-showed-improved-performance-bot-327638.html 0.6 2026-07-07T21:32:56+08:00 daily https://www.pharmasources.com/industryinsights/cellares-raises-82m-to-solve-the-biggest-327639.html 0.6 2026-06-21T02:15:21+08:00 daily https://www.pharmasources.com/industryinsights/carmine-therapeutics-appoints-don-haut-a-327640.html 0.6 2026-08-06T15:58:53+08:00 daily https://www.pharmasources.com/industryinsights/lam-research-commits-1-million-to-battle-327641.html 0.6 2026-06-20T23:54:31+08:00 daily https://www.pharmasources.com/industryinsights/novartis-signs-initial-agreement-to-rese-327642.html 0.6 2026-06-21T05:01:52+08:00 daily https://www.pharmasources.com/industryinsights/large-collaboration-creates-cell-atlas-o-327643.html 0.6 2026-06-20T15:03:17+08:00 daily https://www.pharmasources.com/industryinsights/capa-ivm-a-promising-advance-in-assisted-327644.html 0.6 2026-06-20T23:04:42+08:00 daily https://www.pharmasources.com/industryinsights/hong-kong-sar-china-government-endorses--327645.html 0.6 2026-06-20T13:19:34+08:00 daily https://www.pharmasources.com/industryinsights/new-focus-on-male-factors-critical-for-s-327646.html 0.6 2026-06-21T18:03:24+08:00 daily https://www.pharmasources.com/industryinsights/alebund-pharmaceuticals-raises-60-millio-327647.html 0.6 2026-07-29T09:07:25+08:00 daily https://www.pharmasources.com/industryinsights/cipla-signs-licensing-deal-with-lilly-to-327648.html 0.6 2026-06-21T10:16:27+08:00 daily https://www.pharmasources.com/industryinsights/a-masterstroke-needed-from-the-pm-to-acc-327649.html 0.6 2026-07-07T04:22:03+08:00 daily https://www.pharmasources.com/industryinsights/beyond-the-pandemic-building-collaborati-327650.html 0.6 2026-06-08T21:02:59+08:00 daily https://www.pharmasources.com/industryinsights/tech-transfers-collaborations-materials--327651.html 0.6 2026-06-21T12:13:20+08:00 daily https://www.pharmasources.com/industryinsights/ajanta-pharma-lines-up-capex-of-rs-250-c-327652.html 0.6 2026-06-08T22:43:00+08:00 daily https://www.pharmasources.com/industryinsights/india-will-study-claim-of-sputnik-light--327653.html 0.6 2026-07-18T09:30:31+08:00 daily https://www.pharmasources.com/industryinsights/dcgi-nod-for-anti-covid-19-drug-develope-327654.html 0.6 2026-07-26T12:43:21+08:00 daily https://www.pharmasources.com/industryinsights/biological-e-to-begin-phase-iii-trial-of-327655.html 0.6 2026-06-20T23:14:55+08:00 daily https://www.pharmasources.com/industryinsights/oncotex-sterling-pharma-sign-clinical-mf-327656.html 0.6 2026-06-20T14:26:13+08:00 daily https://www.pharmasources.com/industryinsights/inovios-dna-covid-vax-achieves-positive--327657.html 0.6 2026-05-06T16:00:54+08:00 daily https://www.pharmasources.com/industryinsights/idri-duke-vax-institute-3m-partner-on-ad-327658.html 0.6 2026-06-22T12:59:28+08:00 daily https://www.pharmasources.com/industryinsights/biontech-to-establish-regional-hq-and-mf-327659.html 0.6 2026-06-21T04:18:18+08:00 daily https://www.pharmasources.com/industryinsights/covid-strain-identified-in-india-is-vari-327660.html 0.6 2026-06-22T04:15:55+08:00 daily https://www.pharmasources.com/industryinsights/mankind-pharma-and-anil-kapoor-partner-t-327661.html 0.6 2026-07-02T18:00:43+08:00 daily https://www.pharmasources.com/industryinsights/states-must-ensure-special-teams-to-prev-327662.html 0.6 2026-06-20T17:49:14+08:00 daily https://www.pharmasources.com/industryinsights/bharat-biotech-begins-direct-supply-of-c-327663.html 0.6 2026-06-20T23:07:43+08:00 daily https://www.pharmasources.com/industryinsights/vaccination-is-the-only-long-term-soluti-327664.html 0.6 2026-06-20T20:57:42+08:00 daily https://www.pharmasources.com/industryinsights/vivimed-gets-dghi-nod-to-manufacture-mar-327665.html 0.6 2026-06-20T15:14:25+08:00 daily https://www.pharmasources.com/industryinsights/lilly-signs-licensing-agreements-with-ci-327666.html 0.6 2026-08-10T08:30:04+08:00 daily https://www.pharmasources.com/industryinsights/beigenes-ovarian-cancer-drug-pamiparib-g-327667.html 0.6 2026-07-29T20:23:08+08:00 daily https://www.pharmasources.com/industryinsights/flurotest-provides-clinical-trial-update-327668.html 0.6 2026-08-14T04:13:19+08:00 daily https://www.pharmasources.com/industryinsights/positive-chmp-opinion-for-self-administe-327669.html 0.6 2026-06-20T17:02:17+08:00 daily https://www.pharmasources.com/industryinsights/researchers-find-cd38-targeting-drugs-ma-327670.html 0.6 2026-06-21T01:03:50+08:00 daily https://www.pharmasources.com/industryinsights/who-grants-sinopharms-covid-19-vaccine-e-327671.html 0.6 2026-06-21T22:00:49+08:00 daily https://www.pharmasources.com/industryinsights/azdaiichi-sankyos-datopotamab-deruxtecan-327672.html 0.6 2026-06-21T07:06:00+08:00 daily https://www.pharmasources.com/industryinsights/icmra-and-who-state-clinical-trial-repor-327673.html 0.6 2026-08-09T05:17:44+08:00 daily https://www.pharmasources.com/industryinsights/highlights-of-the-may-2021-pharmacovigil-327674.html 0.6 2026-08-06T19:01:57+08:00 daily https://www.pharmasources.com/industryinsights/atomic-point-contact-significantly-enhan-327675.html 0.6 2026-06-21T10:17:26+08:00 daily https://www.pharmasources.com/industryinsights/novavax-announces-positive-preclinical-d-327676.html 0.6 2026-08-08T03:01:42+08:00 daily https://www.pharmasources.com/industryinsights/researchers-develop-better-way-to-determ-327677.html 0.6 2026-06-21T07:13:15+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-and-biontech-to-provide-covid-19--327678.html 0.6 2026-07-04T02:08:15+08:00 daily https://www.pharmasources.com/industryinsights/lilly-plans-donation-of-covid-19-therapi-327679.html 0.6 2026-06-21T07:20:22+08:00 daily https://www.pharmasources.com/industryinsights/our-immune-systems-blanket-the-sars-cov--327680.html 0.6 2026-04-02T04:44:59+08:00 daily https://www.pharmasources.com/industryinsights/speeding-new-treatments-327681.html 0.6 2026-06-21T08:40:38+08:00 daily https://www.pharmasources.com/industryinsights/using-personalized-medicine-to-avoid-res-327682.html 0.6 2026-08-07T04:33:51+08:00 daily https://www.pharmasources.com/industryinsights/seegenes-germany-subsidiary-supports-the-327683.html 0.6 2026-08-07T04:24:55+08:00 daily https://www.pharmasources.com/industryinsights/dia-imaging-analysis-partners-with-sonos-327684.html 0.6 2026-08-07T02:43:31+08:00 daily https://www.pharmasources.com/industryinsights/gracell-biotechnologies-appoints-seasone-327685.html 0.6 2026-08-07T02:37:06+08:00 daily https://www.pharmasources.com/industryinsights/objective-acuity-announces-successful-pi-327686.html 0.6 2026-08-07T02:52:17+08:00 daily https://www.pharmasources.com/industryinsights/decode-genetics---rounding-off-the-human-327687.html 0.6 2026-08-07T13:16:59+08:00 daily https://www.pharmasources.com/industryinsights/2021-zhejiang-export-commodity-online-fa-327688.html 0.6 2026-08-02T12:47:40+08:00 daily https://www.pharmasources.com/industryinsights/nj-bio-moves-headquarters-to-princeton-n-327689.html 0.6 2026-08-07T22:34:39+08:00 daily https://www.pharmasources.com/industryinsights/enteris-biopharma-completes-expansion-of-327690.html 0.6 2026-06-21T17:07:44+08:00 daily https://www.pharmasources.com/industryinsights/cambrex-expands-analytical-services-capa-327691.html 0.6 2026-06-21T19:13:51+08:00 daily https://www.pharmasources.com/industryinsights/woodstock-sterile-solutions-names-oliver-327692.html 0.6 2026-06-21T22:53:41+08:00 daily https://www.pharmasources.com/industryinsights/virafin-from-zydus-cadila-priced-at-rs-1-327693.html 0.6 2026-06-23T08:01:45+08:00 daily https://www.pharmasources.com/industryinsights/kejriwal-asks-pm-to-share-vaccine-formul-327694.html 0.6 2026-03-11T20:02:45+08:00 daily https://www.pharmasources.com/industryinsights/future-ready-labeling-how-to-thrive-and--327695.html 0.6 2026-08-01T18:53:29+08:00 daily https://www.pharmasources.com/industryinsights/novavax-postpones-timelines-for-covid-19-327696.html 0.6 2026-06-21T06:49:52+08:00 daily https://www.pharmasources.com/industryinsights/india-us-confer-on-collaboration-in-phar-327697.html 0.6 2026-06-21T14:36:36+08:00 daily https://www.pharmasources.com/industryinsights/procurement-norms-for-ministries-of-heal-327698.html 0.6 2026-02-11T16:49:58+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-biontech-get-us-fda-nod-for-emerg-327699.html 0.6 2026-06-22T03:32:24+08:00 daily https://www.pharmasources.com/industryinsights/odisha-to-take-global-tender-route-to-ob-327700.html 0.6 2026-07-02T01:08:31+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-fast-track-designation-to-cer-327701.html 0.6 2026-06-20T20:54:05+08:00 daily https://www.pharmasources.com/industryinsights/abingworth-raises-582m-to-advance-late-s-327702.html 0.6 2026-08-13T20:43:45+08:00 daily https://www.pharmasources.com/industryinsights/inovio-reports-positive-data-from-phase--327703.html 0.6 2026-07-06T16:06:23+08:00 daily https://www.pharmasources.com/industryinsights/navigo-proteins-and-mdimune-enter-into-a-327704.html 0.6 2026-07-01T18:22:33+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-bold-therapeutics-bold-100-an-327705.html 0.6 2026-06-23T20:16:24+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-shareholders-approve-propose-327706.html 0.6 2026-06-20T13:20:40+08:00 daily https://www.pharmasources.com/industryinsights/meenta-announces-partnership-with-mirimu-327707.html 0.6 2026-07-08T08:40:09+08:00 daily https://www.pharmasources.com/industryinsights/new-health-trends-study-by-quest-diagnos-327708.html 0.6 2026-08-10T18:34:17+08:00 daily https://www.pharmasources.com/industryinsights/mhra-approves-label-extension-for-vertex-327709.html 0.6 2026-08-12T20:23:07+08:00 daily https://www.pharmasources.com/industryinsights/phico-therapeutics-raises-7m-to-advance--327710.html 0.6 2026-06-20T21:57:35+08:00 daily https://www.pharmasources.com/industryinsights/smc-endorses-alexions-ultomiris-327711.html 0.6 2026-06-22T07:35:02+08:00 daily https://www.pharmasources.com/industryinsights/mdma-assisted-therapy-successful-in-ptsd-327712.html 0.6 2026-08-07T02:37:27+08:00 daily https://www.pharmasources.com/industryinsights/european-molecular-spectroscopy-market-t-327713.html 0.6 2026-08-10T03:12:26+08:00 daily https://www.pharmasources.com/industryinsights/regent-pacifics-unrealised-gain-in-ventu-327714.html 0.6 2026-06-21T11:58:09+08:00 daily https://www.pharmasources.com/industryinsights/cstone-announces-acceptance-of-new-drug--327715.html 0.6 2026-07-19T07:07:12+08:00 daily https://www.pharmasources.com/industryinsights/seegene-reports-solid-results-in-the-fir-327716.html 0.6 2026-06-20T15:00:04+08:00 daily https://www.pharmasources.com/industryinsights/shaemus-gleason-appointed-executive-vice-327717.html 0.6 2026-08-07T05:05:52+08:00 daily https://www.pharmasources.com/industryinsights/harbour-biomed-announces-dosing-of-first-327718.html 0.6 2026-08-07T01:14:20+08:00 daily https://www.pharmasources.com/industryinsights/new-amsterdam-sciences-appoints-executiv-327719.html 0.6 2026-08-07T00:59:31+08:00 daily https://www.pharmasources.com/industryinsights/hbc-catalent-enter-innovative-softgel-al-327720.html 0.6 2026-08-07T00:40:56+08:00 daily https://www.pharmasources.com/industryinsights/northwest-bio-seeks-gmp-certification-of-327721.html 0.6 2026-08-07T03:34:10+08:00 daily https://www.pharmasources.com/industryinsights/emmes-acquires-orphan-reach-327722.html 0.6 2026-08-06T23:36:08+08:00 daily https://www.pharmasources.com/industryinsights/antares-designs-inspection-solution-for--327723.html 0.6 2026-08-06T23:32:16+08:00 daily https://www.pharmasources.com/industryinsights/angelini-fine-chemicals-invests-in-flow--327724.html 0.6 2026-08-06T23:35:57+08:00 daily https://www.pharmasources.com/industryinsights/parker-bioscience-filtration-expands-cap-327725.html 0.6 2026-08-06T23:46:44+08:00 daily https://www.pharmasources.com/industryinsights/capsida-biotherapeutics-appoints-cmo-327726.html 0.6 2026-08-06T23:54:54+08:00 daily https://www.pharmasources.com/industryinsights/parliamentary-panel-had-recommended-ramp-327727.html 0.6 2026-08-07T00:01:25+08:00 daily https://www.pharmasources.com/industryinsights/govt-in-talks-with-manufacturers-to-ramp-327728.html 0.6 2026-08-07T00:21:30+08:00 daily https://www.pharmasources.com/industryinsights/huma-raises-130-million-financing-to-sca-327729.html 0.6 2026-08-07T00:39:41+08:00 daily https://www.pharmasources.com/industryinsights/multiples-alternate-asset-management-led-327730.html 0.6 2026-08-07T05:05:23+08:00 daily https://www.pharmasources.com/industryinsights/sec-recommends-phase-iiiii-clinical-tria-327731.html 0.6 2026-07-18T17:44:23+08:00 daily https://www.pharmasources.com/industryinsights/growing-opportunities-in-api-manufacturi-327732.html 0.6 2026-08-12T23:12:56+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-launches-ertapenem-for-injecti-327733.html 0.6 2026-06-21T10:03:10+08:00 daily https://www.pharmasources.com/industryinsights/algernons-ifenprodil-lowers-interleukin--327734.html 0.6 2026-08-09T02:15:45+08:00 daily https://www.pharmasources.com/industryinsights/takeda-pharmaceutical-reports-decline-in-327735.html 0.6 2026-08-09T02:28:52+08:00 daily https://www.pharmasources.com/industryinsights/lilly-and-mina-therapeutics-enter-deal-t-327736.html 0.6 2026-08-07T04:56:34+08:00 daily https://www.pharmasources.com/industryinsights/inovios-pan-covid-19-vaccine-candidate-i-327737.html 0.6 2026-08-09T03:01:32+08:00 daily https://www.pharmasources.com/industryinsights/astellas-xtandi-bags-additional-mhra-app-327738.html 0.6 2026-06-21T06:06:54+08:00 daily https://www.pharmasources.com/industryinsights/nice-rejects-pfizers-rare-heart-disease--327739.html 0.6 2026-06-20T19:39:11+08:00 daily https://www.pharmasources.com/industryinsights/new-nhs-legislation-provides-once-in-a-d-327740.html 0.6 2026-06-21T12:49:25+08:00 daily https://www.pharmasources.com/industryinsights/pakistan-approves-zofin-for-compassionat-327741.html 0.6 2026-06-20T23:48:03+08:00 daily https://www.pharmasources.com/industryinsights/gene-therapy-successfully-treats-rare-im-327742.html 0.6 2026-06-21T19:14:11+08:00 daily https://www.pharmasources.com/industryinsights/real-time-bioprocess-raman-analyser-mark-327743.html 0.6 2026-08-08T11:58:58+08:00 daily https://www.pharmasources.com/industryinsights/pregene-and-dr-reddys-announce-license-a-327744.html 0.6 2026-08-08T10:55:15+08:00 daily https://www.pharmasources.com/industryinsights/amorepacific-discovers-skin-barrier-regu-327745.html 0.6 2026-06-21T01:03:48+08:00 daily https://www.pharmasources.com/industryinsights/antengene-announces-ind-approval-in-chin-327746.html 0.6 2026-07-16T09:41:15+08:00 daily https://www.pharmasources.com/industryinsights/initiated-clinical-trial-with-novel-nasa-327747.html 0.6 2026-06-22T05:10:47+08:00 daily https://www.pharmasources.com/industryinsights/sysmex-and-thinkcyte-agree-on-joint-deve-327748.html 0.6 2026-06-30T13:30:35+08:00 daily https://www.pharmasources.com/industryinsights/discover-six-dynamic-trends-to-disrupt-t-327749.html 0.6 2026-06-21T04:20:01+08:00 daily https://www.pharmasources.com/industryinsights/major-differences-in-covid-patient-care--327750.html 0.6 2026-08-08T01:42:18+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-impact-and-recovery-analysis-327751.html 0.6 2026-06-20T16:04:28+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-impact-and-recovery-327752.html 0.6 2026-07-07T00:37:31+08:00 daily https://www.pharmasources.com/industryinsights/novasep-expands-hpapi-manufacturing-capa-327753.html 0.6 2026-07-04T20:12:24+08:00 daily https://www.pharmasources.com/industryinsights/matica-biotech-names-dr-yun-jeong-song-a-327754.html 0.6 2026-08-01T08:03:42+08:00 daily https://www.pharmasources.com/industryinsights/cordenpharma-colorado-continues-expansio-327755.html 0.6 2026-08-10T06:29:04+08:00 daily https://www.pharmasources.com/industryinsights/1mg-collaborates-with-hssc-and-seekify-t-327756.html 0.6 2026-06-21T04:43:41+08:00 daily https://www.pharmasources.com/industryinsights/ntagi-recommends-gap-of-12-16-weeks-betw-327757.html 0.6 2026-06-20T21:07:50+08:00 daily https://www.pharmasources.com/industryinsights/brinton-pharma-triples-production-of-fav-327758.html 0.6 2026-07-04T03:09:27+08:00 daily https://www.pharmasources.com/industryinsights/idma-supports-patent-waiver-for-vaccines-327759.html 0.6 2026-06-21T10:58:09+08:00 daily https://www.pharmasources.com/industryinsights/roche-gives-tocilizumab-worth-over-rs-40-327760.html 0.6 2026-07-28T12:28:43+08:00 daily https://www.pharmasources.com/industryinsights/lilly-signs-licensing-agreements-with-dr-327761.html 0.6 2026-08-07T14:53:41+08:00 daily https://www.pharmasources.com/industryinsights/granules-pledges-16-crore-paracetamol-ta-327762.html 0.6 2026-06-21T11:16:31+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-scientific-pledges-10-mill-327763.html 0.6 2026-06-28T21:04:18+08:00 daily https://www.pharmasources.com/industryinsights/over-two-billion-doses-of-covid-19-vacci-327764.html 0.6 2026-06-22T02:48:38+08:00 daily https://www.pharmasources.com/industryinsights/applying-agile-methodologies-in-cdmos-327765.html 0.6 2026-08-12T06:59:56+08:00 daily https://www.pharmasources.com/industryinsights/sparc-declares-positive-results-from-pha-327766.html 0.6 2026-07-01T02:14:53+08:00 daily https://www.pharmasources.com/industryinsights/cdr-to-acquire-udg-healthcare-for-37bn-327767.html 0.6 2026-06-21T05:57:53+08:00 daily https://www.pharmasources.com/industryinsights/perkinelmer-expands-cell-biology-leaders-327768.html 0.6 2026-06-20T20:47:34+08:00 daily https://www.pharmasources.com/industryinsights/fda-finalizes-guidance-with-internationa-327769.html 0.6 2026-08-03T04:47:56+08:00 daily https://www.pharmasources.com/industryinsights/chiesi-usa-announces-new-organizational--327770.html 0.6 2026-06-21T17:03:23+08:00 daily https://www.pharmasources.com/industryinsights/everything-you-need-to-know-about-ceftio-327771.html 0.6 2026-08-06T23:46:39+08:00 daily https://www.pharmasources.com/industryinsights/abbotts-ai-powered-coronary-imaging-plat-327772.html 0.6 2026-06-21T02:04:37+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisks-weight-loss-drug-semagluti-327773.html 0.6 2026-08-14T10:05:50+08:00 daily https://www.pharmasources.com/industryinsights/nhs-injects-160m-into-elective-accelerat-327774.html 0.6 2026-07-24T12:28:43+08:00 daily https://www.pharmasources.com/industryinsights/bulk-doxycycline-hyclate-api-powder-manu-327775.html 0.6 2026-08-06T21:58:47+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-enrols-first-uk-participant-into--327776.html 0.6 2026-06-20T21:05:41+08:00 daily https://www.pharmasources.com/industryinsights/florfenicol-forms-specifications-uses-an-327777.html 0.6 2026-08-14T06:43:59+08:00 daily https://www.pharmasources.com/industryinsights/cmos-should-invest-in-biologic-api-manuf-327778.html 0.6 2026-08-09T13:27:50+08:00 daily https://www.pharmasources.com/industryinsights/hexamethylenediamine-safety-uses-and-top-327779.html 0.6 2026-08-07T22:57:30+08:00 daily https://www.pharmasources.com/industryinsights/fda-outlines-plan-for-making-inspections-327780.html 0.6 2026-02-28T16:11:36+08:00 daily https://www.pharmasources.com/industryinsights/first-ai-designed-alzheimers-drug-to-ent-327781.html 0.6 2026-08-09T16:13:19+08:00 daily https://www.pharmasources.com/industryinsights/european-pharmacopoeia-adopts-revised-ra-327782.html 0.6 2026-08-07T05:38:03+08:00 daily https://www.pharmasources.com/industryinsights/luye-life-sciences-unveils-cutting-edge--327783.html 0.6 2026-08-09T02:08:10+08:00 daily https://www.pharmasources.com/industryinsights/ibuprofen-uses-manufacturing-process-and-327784.html 0.6 2026-08-06T19:24:49+08:00 daily https://www.pharmasources.com/industryinsights/final-results-of-bioavailability-study-o-327785.html 0.6 2026-08-06T23:20:03+08:00 daily https://www.pharmasources.com/industryinsights/antengene-announces-the-ind-approval-for-327786.html 0.6 2026-08-06T22:53:36+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-and-wuxi-sta-jointly-esta-327787.html 0.6 2026-08-06T22:12:27+08:00 daily https://www.pharmasources.com/industryinsights/transcenta-announces-updated-clinical-da-327788.html 0.6 2026-08-06T22:00:06+08:00 daily https://www.pharmasources.com/industryinsights/antengene-announces-the-completion-of-it-327789.html 0.6 2026-08-07T21:36:57+08:00 daily https://www.pharmasources.com/industryinsights/kanamycin-sulfate-uses-specifications-an-327790.html 0.6 2026-08-06T20:06:21+08:00 daily https://www.pharmasources.com/industryinsights/top-perindopril-erbumine-api-manufacture-327791.html 0.6 2026-08-06T19:23:15+08:00 daily https://www.pharmasources.com/industryinsights/ranolazine-mechanism-of-action-manufactu-327792.html 0.6 2026-08-10T21:52:21+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-treatment-for-adults-wi-327793.html 0.6 2026-06-22T04:54:34+08:00 daily https://www.pharmasources.com/industryinsights/1092-million-worldwide-exosome-research--327794.html 0.6 2026-08-12T11:13:58+08:00 daily https://www.pharmasources.com/industryinsights/researchers-show-how-covid-19-virus-trig-327795.html 0.6 2026-08-06T23:37:13+08:00 daily https://www.pharmasources.com/industryinsights/11-billion-worldwide-metagenomic-sequenc-327796.html 0.6 2026-08-07T13:18:40+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-impact-and-recovery-analysis-cl-327798.html 0.6 2026-07-03T22:27:30+08:00 daily https://www.pharmasources.com/industryinsights/national-safety-council-statement-on-upd-327799.html 0.6 2026-06-22T04:00:41+08:00 daily https://www.pharmasources.com/industryinsights/welltok-helps-close-gaps-in-care-amid-co-327800.html 0.6 2026-06-21T06:01:46+08:00 daily https://www.pharmasources.com/industryinsights/direct-relief-sends-thousands-of-oxygen--327801.html 0.6 2026-06-21T13:15:41+08:00 daily https://www.pharmasources.com/industryinsights/regenxbio-presents-additional-positive-i-327802.html 0.6 2026-06-21T01:02:45+08:00 daily https://www.pharmasources.com/industryinsights/apis-excipients-and-formulation-the-bedr-327803.html 0.6 2026-08-02T15:36:24+08:00 daily https://www.pharmasources.com/industryinsights/avantor-boosts-global-production-of-sing-327804.html 0.6 2026-08-06T23:54:12+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-wuxi-sta-establish-wuxi-x-327805.html 0.6 2026-08-13T02:30:46+08:00 daily https://www.pharmasources.com/industryinsights/beyond-the-box-device-and-packaging-tech-327806.html 0.6 2026-08-08T22:44:45+08:00 daily https://www.pharmasources.com/industryinsights/future-of-pharma-marketing-lies-in-hybri-327807.html 0.6 2026-08-07T00:15:34+08:00 daily https://www.pharmasources.com/industryinsights/second-batch-of-sputnik-v-covid-19-vacci-327808.html 0.6 2026-08-07T00:41:51+08:00 daily https://www.pharmasources.com/industryinsights/gujarat-government-hester-biosciences-an-327809.html 0.6 2026-08-07T01:10:27+08:00 daily https://www.pharmasources.com/industryinsights/plasma-therapy-not-helpful-may-get-remov-327810.html 0.6 2026-08-07T01:19:30+08:00 daily https://www.pharmasources.com/industryinsights/ustr-piyush-goyal-talk-about-vaccine-man-327811.html 0.6 2026-08-07T01:27:59+08:00 daily https://www.pharmasources.com/industryinsights/pmbjks-bppi-ensuring-availability-of-key-327812.html 0.6 2026-08-07T01:42:45+08:00 daily https://www.pharmasources.com/industryinsights/government-to-set-up-national-platform-t-327813.html 0.6 2026-08-09T08:17:39+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-announce-launch-of-sputnik-v-v-327814.html 0.6 2026-03-23T23:30:33+08:00 daily https://www.pharmasources.com/industryinsights/alembic-pharma-gets-usfda-final-nod-for--327815.html 0.6 2026-08-09T01:19:27+08:00 daily https://www.pharmasources.com/industryinsights/uk-nice-rejects-nhs-use-of-ozanimod-for--327816.html 0.6 2026-08-07T16:15:35+08:00 daily https://www.pharmasources.com/industryinsights/labcorp-covid-19-pcr-test-home-collectio-327817.html 0.6 2026-08-06T23:54:11+08:00 daily https://www.pharmasources.com/industryinsights/hi-tech-pharmaceuticals-recalls-lipodren-327818.html 0.6 2026-08-09T06:59:28+08:00 daily https://www.pharmasources.com/industryinsights/japans-ministry-of-health-labour-and-wel-327819.html 0.6 2026-07-04T21:01:10+08:00 daily https://www.pharmasources.com/industryinsights/irish-health-service-hit-with-significan-327820.html 0.6 2026-06-20T14:46:09+08:00 daily https://www.pharmasources.com/industryinsights/biogens-inherited-eye-disease-gene-thera-327821.html 0.6 2026-01-31T10:11:13+08:00 daily https://www.pharmasources.com/industryinsights/keytruda-wins-nice-backing-in-msi-hdmmr--327822.html 0.6 2026-06-20T13:19:22+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-gsks-covid-19-vaccine-achieves-po-327823.html 0.6 2026-07-30T15:41:50+08:00 daily https://www.pharmasources.com/industryinsights/remove-barriers-restricting-the-research-327824.html 0.6 2026-06-21T16:05:21+08:00 daily https://www.pharmasources.com/industryinsights/alzheimers-drug-designed-using-exscienti-327825.html 0.6 2026-07-10T14:09:03+08:00 daily https://www.pharmasources.com/industryinsights/nice-nod-for-bms-opdivo-in-advanced-oeso-327826.html 0.6 2026-06-21T23:44:45+08:00 daily https://www.pharmasources.com/industryinsights/gsk-curevacs-next-gen-covid-19-jab-gener-327827.html 0.6 2026-06-20T17:14:29+08:00 daily https://www.pharmasources.com/industryinsights/everest-medicines-announces-china-nmpa-h-327828.html 0.6 2026-06-21T03:48:23+08:00 daily https://www.pharmasources.com/industryinsights/cynosure-announces-grand-opening-of-stat-327829.html 0.6 2026-06-21T06:55:00+08:00 daily https://www.pharmasources.com/industryinsights/recor-medical-announces-results-from-lan-327830.html 0.6 2026-08-07T14:47:19+08:00 daily https://www.pharmasources.com/industryinsights/affamed-therapeutics-announces-appointme-327831.html 0.6 2026-06-21T09:02:27+08:00 daily https://www.pharmasources.com/industryinsights/antengene-announces-the-completion-of-th-327832.html 0.6 2026-08-06T14:03:39+08:00 daily https://www.pharmasources.com/industryinsights/china-pharma-holdings-inc-reports-33-yoy-327833.html 0.6 2026-07-20T21:01:41+08:00 daily https://www.pharmasources.com/industryinsights/arctic-vision-announces-exclusive-licens-327834.html 0.6 2026-08-09T16:04:57+08:00 daily https://www.pharmasources.com/industryinsights/rd-alliance-for-eye-disease-cell-therapi-327835.html 0.6 2026-06-21T20:45:26+08:00 daily https://www.pharmasources.com/industryinsights/medpharm-expands-formulation-development-327836.html 0.6 2026-06-23T22:01:17+08:00 daily https://www.pharmasources.com/industryinsights/biomedx-extends-collaboration-with-merck-327837.html 0.6 2026-06-22T05:00:40+08:00 daily https://www.pharmasources.com/industryinsights/perkinelmer-acquires-nexcelom-bioscience-327838.html 0.6 2026-06-21T09:12:15+08:00 daily https://www.pharmasources.com/industryinsights/humanigen-selects-chime-biologics-as-man-327839.html 0.6 2026-07-04T06:12:21+08:00 daily https://www.pharmasources.com/industryinsights/zynrelef-anesthetic-receives-fda-approva-327840.html 0.6 2026-08-12T14:18:37+08:00 daily https://www.pharmasources.com/industryinsights/charles-river-to-acquire-vigene-bioscien-327841.html 0.6 2026-06-20T23:47:35+08:00 daily https://www.pharmasources.com/industryinsights/centre-says-over-two-crore-vaccine-doses-327842.html 0.6 2026-08-07T19:26:49+08:00 daily https://www.pharmasources.com/industryinsights/woodfield-distribution-bonne-sant-form-3-327843.html 0.6 2026-06-21T17:19:52+08:00 daily https://www.pharmasources.com/industryinsights/after-setback-sanofi-gsk-reports-success-327844.html 0.6 2026-06-20T19:20:07+08:00 daily https://www.pharmasources.com/industryinsights/sk-biosciences-covid-19-vaccine-plant-in-327845.html 0.6 2026-06-21T23:11:03+08:00 daily https://www.pharmasources.com/industryinsights/drdo-launches-anti-covid-drug-2-dg-327846.html 0.6 2026-06-22T13:05:05+08:00 daily https://www.pharmasources.com/industryinsights/lilly-signs-voluntary-licensing-agreemen-327847.html 0.6 2026-06-23T09:14:57+08:00 daily https://www.pharmasources.com/industryinsights/shilpa-medicare-partners-with-dr-reddys--327848.html 0.6 2026-06-21T15:48:21+08:00 daily https://www.pharmasources.com/industryinsights/appili-to-progress-phase-iii-oral-covid--327849.html 0.6 2026-06-24T00:51:29+08:00 daily https://www.pharmasources.com/industryinsights/pharmaessentia-resubmits-bla-for-polycyt-327850.html 0.6 2026-06-25T17:34:33+08:00 daily https://www.pharmasources.com/industryinsights/aeterna-zentaris-starts-preclinical-deve-327851.html 0.6 2026-06-20T16:41:30+08:00 daily https://www.pharmasources.com/industryinsights/oxford-university-and-oracle-partner-to--327852.html 0.6 2026-06-22T11:03:54+08:00 daily https://www.pharmasources.com/industryinsights/positive-mid-stage-results-for-medicago--327853.html 0.6 2026-06-21T00:58:51+08:00 daily https://www.pharmasources.com/industryinsights/sanofis-dupixent-rapidly-improves-lung-f-327854.html 0.6 2026-07-31T19:31:00+08:00 daily https://www.pharmasources.com/industryinsights/cbd-tablet-significantly-improves-diabet-327855.html 0.6 2026-06-28T20:04:04+08:00 daily https://www.pharmasources.com/industryinsights/trial-to-assess-antimicrobial-nasal-spra-327856.html 0.6 2026-08-11T23:49:00+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-to-donate-200000-vaccine-327857.html 0.6 2026-07-01T02:57:04+08:00 daily https://www.pharmasources.com/industryinsights/novo-nordisks-ziltivekimab-hits-primary--327858.html 0.6 2026-07-06T12:20:25+08:00 daily https://www.pharmasources.com/industryinsights/pandemic-coincided-with-increase-in-ment-327859.html 0.6 2026-06-22T05:56:38+08:00 daily https://www.pharmasources.com/industryinsights/new-harmonised-guidance-for-post-approva-327860.html 0.6 2026-08-09T11:00:36+08:00 daily https://www.pharmasources.com/industryinsights/evinacumab-shows-promise-in-severe-hyper-327861.html 0.6 2026-08-07T00:40:45+08:00 daily https://www.pharmasources.com/industryinsights/atonarp-announces-50m-series-d-financing-327862.html 0.6 2026-08-07T00:02:35+08:00 daily https://www.pharmasources.com/industryinsights/nanoforms-final-clinical-results-confirm-327863.html 0.6 2026-08-07T00:15:28+08:00 daily https://www.pharmasources.com/industryinsights/seegene-signs-exclusive-supply-agreement-327864.html 0.6 2026-08-07T00:18:27+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-accepts-regulatory-submission-for-327865.html 0.6 2026-08-07T02:39:56+08:00 daily https://www.pharmasources.com/industryinsights/mycenax-becomes-taiwan-chinas-first-cdmo-327866.html 0.6 2026-08-07T02:51:46+08:00 daily https://www.pharmasources.com/industryinsights/binx-health-submits-request-for-emergenc-327868.html 0.6 2026-08-09T04:34:39+08:00 daily https://www.pharmasources.com/industryinsights/uruguayan-government-delivers-cold-chain-327869.html 0.6 2026-08-07T22:52:59+08:00 daily https://www.pharmasources.com/industryinsights/ai-supported-predictors-of-cardiac-relat-327870.html 0.6 2026-02-15T00:37:33+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-has-accelerated-workforce-agili-327871.html 0.6 2026-06-22T07:03:50+08:00 daily https://www.pharmasources.com/industryinsights/nibrt-adds-scale-x-carbo-integrated-syst-327872.html 0.6 2026-06-20T22:55:39+08:00 daily https://www.pharmasources.com/industryinsights/gamma-biosciences-acquires-controlling-s-327873.html 0.6 2026-06-21T08:57:03+08:00 daily https://www.pharmasources.com/industryinsights/agricultural-pesticides-market-covid-19--327874.html 0.6 2026-06-21T08:06:02+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-impact-and-recovery-analysis-ru-327875.html 0.6 2026-06-21T02:59:41+08:00 daily https://www.pharmasources.com/industryinsights/drug-repurposing-can-shorten-drug-develo-327876.html 0.6 2026-07-05T04:44:33+08:00 daily https://www.pharmasources.com/industryinsights/gamma-biosciences-acquires-stake-in-miru-327877.html 0.6 2026-08-07T04:25:00+08:00 daily https://www.pharmasources.com/industryinsights/bd-to-build-200m-pfs-mfg-facility-in-spa-327878.html 0.6 2026-08-08T03:29:21+08:00 daily https://www.pharmasources.com/industryinsights/biontech-se-appoints-jens-holstein-as-cf-327879.html 0.6 2026-08-07T00:39:52+08:00 daily https://www.pharmasources.com/industryinsights/centogene-appoints-dr-michael-motz-as-cc-327880.html 0.6 2026-08-07T01:06:48+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-327881.html 0.6 2026-06-21T11:56:13+08:00 daily https://www.pharmasources.com/industryinsights/recro-pharma-astex-enter-drug-developmen-327882.html 0.6 2026-08-11T15:37:11+08:00 daily https://www.pharmasources.com/industryinsights/more-pharma-companies-should-be-permitte-327883.html 0.6 2026-08-07T04:36:45+08:00 daily https://www.pharmasources.com/industryinsights/good-news-in-the-chinese-diabetes-field--327884.html 0.6 2026-08-07T13:16:46+08:00 daily https://www.pharmasources.com/industryinsights/adar-poonawalla-sells-stake-in-panacea-b-327885.html 0.6 2026-08-07T05:01:26+08:00 daily https://www.pharmasources.com/industryinsights/boehringer-ingelheim-allocates-one-milli-327886.html 0.6 2026-08-07T05:07:12+08:00 daily https://www.pharmasources.com/industryinsights/iit-madras-mit-researchers-develop-human-327887.html 0.6 2026-08-08T10:12:02+08:00 daily https://www.pharmasources.com/industryinsights/manufacturing-capacity-of-remdesivir-ram-327888.html 0.6 2026-08-08T10:10:40+08:00 daily https://www.pharmasources.com/industryinsights/ckd-hyperparathyroidism-hyperphosphatemi-327889.html 0.6 2026-08-08T08:39:01+08:00 daily https://www.pharmasources.com/industryinsights/bharat-biotechs-karnataka-facility-will--327890.html 0.6 2026-08-08T07:47:21+08:00 daily https://www.pharmasources.com/industryinsights/overview-of-covid-19-vaccination-in-prog-327891.html 0.6 2026-08-12T13:15:34+08:00 daily https://www.pharmasources.com/industryinsights/pride-of-new-chinese-medicine-icaritin-t-327892.html 0.6 2026-08-06T21:46:57+08:00 daily https://www.pharmasources.com/industryinsights/having-applied-for-ipo-to-hkex-what-to-e-327893.html 0.6 2026-08-06T12:52:23+08:00 daily https://www.pharmasources.com/industryinsights/agenus-and-bms-announce-license-for-anti-327894.html 0.6 2026-06-20T21:16:52+08:00 daily https://www.pharmasources.com/industryinsights/us-supreme-court-denies-sandoz-petition--327895.html 0.6 2026-08-11T00:41:54+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-announces-plans-to-further-streng-327896.html 0.6 2026-08-12T13:37:07+08:00 daily https://www.pharmasources.com/industryinsights/milliporesigma-announces-vectory-as-winn-327897.html 0.6 2026-06-20T21:01:34+08:00 daily https://www.pharmasources.com/industryinsights/janssen-inks-inflammatory-disease-collab-327898.html 0.6 2026-06-20T21:17:05+08:00 daily https://www.pharmasources.com/industryinsights/cross-industry-alliance-launches-to-incr-327899.html 0.6 2026-08-11T23:54:54+08:00 daily https://www.pharmasources.com/industryinsights/nao-report-finds-uk-was-not-as-prepared--327900.html 0.6 2026-06-22T10:37:53+08:00 daily https://www.pharmasources.com/industryinsights/oxford-immunotec-partners-with-uk-covid--327901.html 0.6 2026-06-22T12:33:34+08:00 daily https://www.pharmasources.com/industryinsights/novel-spectroscopy-technique-could-impro-327902.html 0.6 2026-04-18T16:22:34+08:00 daily https://www.pharmasources.com/industryinsights/mrna-covid-19-vaccination-is-immunogenic-327903.html 0.6 2026-06-20T19:51:58+08:00 daily https://www.pharmasources.com/industryinsights/genequantum-raises-hundreds-of-millions--327904.html 0.6 2026-08-10T02:07:58+08:00 daily https://www.pharmasources.com/industryinsights/inteleos-and-dr-smile-medical-group-sign-327905.html 0.6 2026-04-11T08:24:25+08:00 daily https://www.pharmasources.com/industryinsights/dinova-and-metronom-health-an-innovative-327906.html 0.6 2026-08-13T13:52:50+08:00 daily https://www.pharmasources.com/industryinsights/eurofins-discovery-launches-human-immune-327907.html 0.6 2026-08-07T14:50:14+08:00 daily https://www.pharmasources.com/industryinsights/hummingbird-bioscience-raises-us125-mill-327908.html 0.6 2026-06-22T11:09:59+08:00 daily https://www.pharmasources.com/industryinsights/farrer-park-hospital-elevates-cancer-car-327909.html 0.6 2026-06-22T06:58:50+08:00 daily https://www.pharmasources.com/industryinsights/sant-laboratories-and-bioarc-announce-st-327910.html 0.6 2026-06-22T09:09:55+08:00 daily https://www.pharmasources.com/industryinsights/second-generation-covid-19-vaccine-candi-327911.html 0.6 2026-08-07T23:56:00+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-mrna-vaccines-are-immunogenic-i-327912.html 0.6 2026-06-20T14:47:02+08:00 daily https://www.pharmasources.com/industryinsights/beckman-coulter-launches-fully-quantitat-327913.html 0.6 2026-08-07T03:03:59+08:00 daily https://www.pharmasources.com/industryinsights/meijer-offers-10-incentive-to-customers--327914.html 0.6 2026-08-07T02:51:49+08:00 daily https://www.pharmasources.com/industryinsights/product-recalls-expected-to-soar-post-co-327915.html 0.6 2026-08-07T02:39:56+08:00 daily https://www.pharmasources.com/industryinsights/innovating-in-the-viscosity-design-space-327916.html 0.6 2026-07-03T13:58:47+08:00 daily https://www.pharmasources.com/industryinsights/bd-to-build-new-165-million-manufacturin-327917.html 0.6 2026-08-04T00:53:19+08:00 daily https://www.pharmasources.com/industryinsights/sandoz-outlines-european-antibiotic-manu-327918.html 0.6 2026-08-12T13:37:16+08:00 daily https://www.pharmasources.com/industryinsights/fda-receives-hhs-grant-to-expand-cure-id-327919.html 0.6 2026-08-07T05:06:30+08:00 daily https://www.pharmasources.com/industryinsights/overall-benefits-of-ready-to-administer--327920.html 0.6 2026-08-07T00:02:33+08:00 daily https://www.pharmasources.com/industryinsights/cantargia-reports-positive-results-in-on-327921.html 0.6 2026-08-14T15:26:29+08:00 daily https://www.pharmasources.com/industryinsights/brexit-impact-on-uk-pharma-industry-a-mo-327922.html 0.6 2026-08-06T23:45:19+08:00 daily https://www.pharmasources.com/industryinsights/mandos-llc-agrees-to-acquire-adrabetadex-327923.html 0.6 2026-08-14T05:25:30+08:00 daily https://www.pharmasources.com/industryinsights/nextcure-to-present-trials-in-progress-p-327924.html 0.6 2026-06-30T07:32:34+08:00 daily https://www.pharmasources.com/industryinsights/drug-delivery-start-ups-recognize-benefi-327925.html 0.6 2026-08-08T06:19:06+08:00 daily https://www.pharmasources.com/industryinsights/fda-in-brief-fda-authorizes-longer-time--327926.html 0.6 2026-06-20T15:45:56+08:00 daily https://www.pharmasources.com/industryinsights/clovis-oncology-highlights-rubraca-rucap-327927.html 0.6 2026-08-07T04:25:17+08:00 daily https://www.pharmasources.com/industryinsights/univercells-technologies-collaborates-wi-327928.html 0.6 2026-08-10T23:50:11+08:00 daily https://www.pharmasources.com/industryinsights/sharp-appoints-robert-obeirn-to-its-glob-327929.html 0.6 2026-06-20T15:04:24+08:00 daily https://www.pharmasources.com/industryinsights/colorcon-adds-new-containment-suite-in-i-327930.html 0.6 2026-08-08T01:45:25+08:00 daily https://www.pharmasources.com/industryinsights/global-diabetes-therapeutic-market-has-g-327931.html 0.6 2026-07-20T17:56:39+08:00 daily https://www.pharmasources.com/industryinsights/iscr-lauds-clinical-research-stakeholder-327932.html 0.6 2026-06-22T00:57:48+08:00 daily https://www.pharmasources.com/industryinsights/optimus-pharma-gets-dcgi-nod-for-phase-i-327933.html 0.6 2026-06-21T19:09:38+08:00 daily https://www.pharmasources.com/industryinsights/oncopeptides-presents-clinical-abstracts-327934.html 0.6 2026-08-07T13:17:17+08:00 daily https://www.pharmasources.com/industryinsights/goldman-sachs-invests-in-aragen-life-sci-327935.html 0.6 2026-06-21T11:18:40+08:00 daily https://www.pharmasources.com/industryinsights/bdr-pharma-signs-voluntary-licensing-agr-327936.html 0.6 2026-08-03T02:19:57+08:00 daily https://www.pharmasources.com/industryinsights/anupam-rasayan-receives-rs-540-crore-ord-327937.html 0.6 2026-06-22T01:41:59+08:00 daily https://www.pharmasources.com/industryinsights/novasep-to-expand-hpapi-manufacturing-ca-327938.html 0.6 2026-06-20T23:15:14+08:00 daily https://www.pharmasources.com/industryinsights/spanish-study-finds-astrazeneca-vaccine--327939.html 0.6 2026-06-21T12:50:59+08:00 daily https://www.pharmasources.com/industryinsights/american-civil-rights-leader-to-request--327940.html 0.6 2026-06-08T21:41:21+08:00 daily https://www.pharmasources.com/industryinsights/biomed-x-institute-and-merck-extend-coll-327941.html 0.6 2026-06-20T14:54:04+08:00 daily https://www.pharmasources.com/industryinsights/veru-initiates-enrolment-in-phase-iii-tr-327942.html 0.6 2026-06-22T09:06:49+08:00 daily https://www.pharmasources.com/industryinsights/icanomab-announces-a-novel-il-18-signali-327943.html 0.6 2026-06-20T14:57:09+08:00 daily https://www.pharmasources.com/industryinsights/cytodyn-to-seek-regulatory-approval-for--327944.html 0.6 2026-07-06T03:48:44+08:00 daily https://www.pharmasources.com/industryinsights/apeiron-biologics-apn01-selected-for-us--327945.html 0.6 2026-08-07T04:22:02+08:00 daily https://www.pharmasources.com/industryinsights/maxwell-biosciences-develops-a-new-viral-327946.html 0.6 2026-08-07T03:48:44+08:00 daily https://www.pharmasources.com/industryinsights/hpv-vaccination-is-lowering-us-cervical--327947.html 0.6 2026-08-06T23:47:53+08:00 daily https://www.pharmasources.com/industryinsights/as-medicaid-access-expands-so-does-cance-327948.html 0.6 2026-08-10T12:01:25+08:00 daily https://www.pharmasources.com/industryinsights/uk-trial-tests-third-doses-of-covid-19-v-327949.html 0.6 2026-08-07T03:34:04+08:00 daily https://www.pharmasources.com/industryinsights/adamis-pharmaceuticals-resubmits-zimhi-n-327950.html 0.6 2026-06-21T10:17:25+08:00 daily https://www.pharmasources.com/industryinsights/dexpramipexole-could-be-a-promising-trea-327951.html 0.6 2026-08-07T13:16:02+08:00 daily https://www.pharmasources.com/industryinsights/nanomedicine-to-dominate-nanobots-market-327952.html 0.6 2026-08-08T01:01:15+08:00 daily https://www.pharmasources.com/industryinsights/neutralising-antibodies-a-proxy-for-covi-327953.html 0.6 2026-08-08T01:35:57+08:00 daily https://www.pharmasources.com/industryinsights/kintor-announced-1-fda-has-greenlighted--327954.html 0.6 2026-08-12T06:38:22+08:00 daily https://www.pharmasources.com/industryinsights/ascentage-pharma-to-announce-updated-dat-327955.html 0.6 2026-06-20T23:59:38+08:00 daily https://www.pharmasources.com/industryinsights/duality-biologics-completed-90-million-s-327956.html 0.6 2026-07-19T14:58:05+08:00 daily https://www.pharmasources.com/industryinsights/transcenta-announced-the-results-of-the--327957.html 0.6 2026-06-21T13:02:30+08:00 daily https://www.pharmasources.com/industryinsights/world-brain-day-2021-dedicated-to-multip-327958.html 0.6 2026-06-14T18:43:45+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-presents-phase-1-data-on-highly-di-327959.html 0.6 2026-08-03T15:41:34+08:00 daily https://www.pharmasources.com/industryinsights/new-vaccine-platform-two-one-replicon-an-327960.html 0.6 2026-06-21T05:06:43+08:00 daily https://www.pharmasources.com/industryinsights/novartis-reaches-milestone-delivery-of-1-327961.html 0.6 2026-06-20T16:50:12+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-monoclonal-antibodies-reduce-ri-327962.html 0.6 2026-06-15T08:14:57+08:00 daily https://www.pharmasources.com/industryinsights/pharm-olam-is-now-enrolling-uk-volunteer-327963.html 0.6 2026-07-28T22:15:27+08:00 daily https://www.pharmasources.com/industryinsights/global-efforts-to-stop-the-spread-of-cov-327964.html 0.6 2026-06-22T14:21:32+08:00 daily https://www.pharmasources.com/industryinsights/risk-for-post-covid-19-clinical-sequelae-327965.html 0.6 2026-06-20T15:46:43+08:00 daily https://www.pharmasources.com/industryinsights/intensive-bp-lowering-cuts-major-adverse-327966.html 0.6 2026-06-21T04:59:03+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-biontech-to-supply-eu-with-additi-327967.html 0.6 2025-11-30T19:13:20+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-biontech-to-supply-additional-cov-327968.html 0.6 2026-08-14T15:35:57+08:00 daily https://www.pharmasources.com/industryinsights/arecor-lilly-signs-formulation-study-par-327969.html 0.6 2026-06-21T09:49:26+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-ucsf-to-open-cell-therapy--327970.html 0.6 2026-07-04T21:49:02+08:00 daily https://www.pharmasources.com/industryinsights/novartis-announces-delivery-of-one-billi-327971.html 0.6 2026-07-31T07:32:18+08:00 daily https://www.pharmasources.com/industryinsights/bharat-biotech-ramps-up-covaxin-producti-327972.html 0.6 2026-06-21T07:20:19+08:00 daily https://www.pharmasources.com/industryinsights/novartis-cadila-healthcare-lead-digital--327973.html 0.6 2026-08-04T05:56:11+08:00 daily https://www.pharmasources.com/industryinsights/duke-university-researchers-identify-new-327974.html 0.6 2026-06-21T18:07:31+08:00 daily https://www.pharmasources.com/industryinsights/bacteria-viruses-and-fungi-work-as-a-net-327975.html 0.6 2026-06-20T18:58:36+08:00 daily https://www.pharmasources.com/industryinsights/unichem-labs-gets-us-fda-approval-for-am-327976.html 0.6 2026-06-21T05:05:49+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-rdif-in-discussions-on-product-327977.html 0.6 2026-08-07T22:45:48+08:00 daily https://www.pharmasources.com/industryinsights/cipla-launches-viragen-a-covid-19-rt-pcr-327978.html 0.6 2026-06-20T21:49:34+08:00 daily https://www.pharmasources.com/industryinsights/exscientia-signs-12bn-ai-drug-discovery--327979.html 0.6 2026-08-06T11:40:00+08:00 daily https://www.pharmasources.com/industryinsights/fda-publishes-product-specific-guideline-327980.html 0.6 2026-07-27T20:30:10+08:00 daily https://www.pharmasources.com/industryinsights/fda-receives-health-and-human-services-g-327981.html 0.6 2026-06-21T02:15:50+08:00 daily https://www.pharmasources.com/industryinsights/ema-mhra-to-review-vertex-kaftrio-for-ch-327982.html 0.6 2026-06-20T15:10:32+08:00 daily https://www.pharmasources.com/industryinsights/nice-turns-down-janssens-erleada-327983.html 0.6 2026-08-07T00:39:58+08:00 daily https://www.pharmasources.com/industryinsights/many-americans-take-meds-that-weaken-cov-327984.html 0.6 2026-06-20T22:06:43+08:00 daily https://www.pharmasources.com/industryinsights/nhs-patients-with-rare-blood-disorders-g-327985.html 0.6 2026-06-21T04:20:07+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-booster-shots-likely-needed-wit-327986.html 0.6 2026-06-21T04:47:33+08:00 daily https://www.pharmasources.com/industryinsights/scipher-applies-spectra-platform-to-disc-327987.html 0.6 2026-03-16T04:38:50+08:00 daily https://www.pharmasources.com/industryinsights/imbruvica-based-regimens-induce-lasting--327988.html 0.6 2026-06-21T23:54:38+08:00 daily https://www.pharmasources.com/industryinsights/are-covid-19-vaccines-effective-for-immu-327989.html 0.6 2025-11-30T18:44:15+08:00 daily https://www.pharmasources.com/industryinsights/how-computational-analysis-of-a-3d-mucoc-327990.html 0.6 2026-08-03T18:45:58+08:00 daily https://www.pharmasources.com/industryinsights/uk-patients-with-rare-blood-disorders-re-327991.html 0.6 2026-06-21T10:58:05+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-to-provide-fill-and-finish-manufa-327992.html 0.6 2026-07-18T08:52:01+08:00 daily https://www.pharmasources.com/industryinsights/biovaxys-announces-appointment-of-policy-327993.html 0.6 2026-06-25T02:42:20+08:00 daily https://www.pharmasources.com/industryinsights/sterling-pharma-solutions-signs-up-to-ma-327994.html 0.6 2026-07-06T21:41:14+08:00 daily https://www.pharmasources.com/industryinsights/everest-medicines-announces-china-nmpa-h-327995.html 0.6 2026-07-21T07:07:49+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-scores-large-scale-ubl-327996.html 0.6 2025-12-07T04:21:22+08:00 daily https://www.pharmasources.com/industryinsights/european-wellness-and-dongci-join-forces-327997.html 0.6 2026-08-04T04:59:08+08:00 daily https://www.pharmasources.com/industryinsights/drug-rd-innovation-reshaping-manufacturi-327998.html 0.6 2026-08-03T23:54:24+08:00 daily https://www.pharmasources.com/industryinsights/aenova-invests-in-fill-finish-capacity-f-327999.html 0.6 2026-08-05T05:59:42+08:00 daily https://www.pharmasources.com/industryinsights/rogue-antibodies-wreak-havoc-in-severe-c-328000.html 0.6 2025-11-30T18:38:42+08:00 daily https://www.pharmasources.com/industryinsights/why-are-some-covid-19-vaccines-working-b-328001.html 0.6 2026-07-06T13:34:09+08:00 daily https://www.pharmasources.com/industryinsights/moderna-signs-agreement-with-gavi-to-sup-328002.html 0.6 2026-06-21T03:55:41+08:00 daily https://www.pharmasources.com/industryinsights/pharma-ramps-up-innovation-in-response-t-328003.html 0.6 2026-06-23T14:30:31+08:00 daily https://www.pharmasources.com/industryinsights/catalent-buys-belgian-cdmo-to-boost-pdna-328004.html 0.6 2026-06-22T12:03:49+08:00 daily https://www.pharmasources.com/industryinsights/new-moderna-agreement-will-double-vaccin-328005.html 0.6 2026-06-21T09:02:02+08:00 daily https://www.pharmasources.com/industryinsights/phase-3-data-presented-at-ats-2021-show--328006.html 0.6 2026-08-08T02:07:21+08:00 daily https://www.pharmasources.com/industryinsights/affyimmune-therapeutics-aic100-granted-f-328007.html 0.6 2026-06-21T19:16:19+08:00 daily https://www.pharmasources.com/industryinsights/injectafer-receives-fda-approval-for-sin-328008.html 0.6 2026-06-22T11:42:47+08:00 daily https://www.pharmasources.com/industryinsights/puerto-rico-adjusts-travel-measures-remo-328009.html 0.6 2026-06-21T11:01:12+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-and-its-effect-on-mental-health-328010.html 0.6 2026-06-25T21:23:57+08:00 daily https://www.pharmasources.com/industryinsights/empowerdx-at-home-covid-19-testing-kit-r-328011.html 0.6 2026-06-22T21:09:08+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-impact-and-recovery-analysis-fu-328012.html 0.6 2026-08-07T23:02:15+08:00 daily https://www.pharmasources.com/industryinsights/physician-scientist-dr-steven-quay-to-br-328013.html 0.6 2026-08-10T19:19:49+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-targeted-therapy-for--328014.html 0.6 2026-07-01T04:51:33+08:00 daily https://www.pharmasources.com/industryinsights/a-close-insight-into-the-main-applicatio-328015.html 0.6 2026-08-01T10:56:20+08:00 daily https://www.pharmasources.com/industryinsights/premier-research-acquires-camargo-pharma-328016.html 0.6 2026-06-29T22:55:31+08:00 daily https://www.pharmasources.com/industryinsights/argonaut-expands-lyophilization-facility-328017.html 0.6 2026-07-28T23:43:16+08:00 daily https://www.pharmasources.com/industryinsights/resilience-bolsters-canadian-biomanufact-328018.html 0.6 2026-08-07T00:45:03+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-trials-and-tribulations-for-tre-328019.html 0.6 2026-08-02T12:50:58+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccines-highly-effective-again-328020.html 0.6 2026-06-20T16:00:29+08:00 daily https://www.pharmasources.com/industryinsights/paediatric-trials-of-covaxin-are-likely--328021.html 0.6 2026-07-06T21:07:44+08:00 daily https://www.pharmasources.com/industryinsights/moderna-samsung-biologics-sign-agreement-328022.html 0.6 2026-06-08T21:46:36+08:00 daily https://www.pharmasources.com/industryinsights/india-pfizer-discuss-vaccine-deal-seek-t-328023.html 0.6 2026-06-21T09:01:57+08:00 daily https://www.pharmasources.com/industryinsights/msn-laboratories-launches-posaconazole-t-328024.html 0.6 2026-06-20T22:54:38+08:00 daily https://www.pharmasources.com/industryinsights/natco-pharma-gets-usfda-approval-for-len-328025.html 0.6 2026-08-14T21:42:28+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-to-have-long-term-impact-on-glo-328026.html 0.6 2026-06-21T05:02:48+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-recalls-50868-bottles-of-metf-328027.html 0.6 2026-06-21T05:16:01+08:00 daily https://www.pharmasources.com/industryinsights/natco-commences-phase-iii-clinical-trial-328028.html 0.6 2026-06-21T06:42:34+08:00 daily https://www.pharmasources.com/industryinsights/s-korea-approves-modernas-covid-19-vacci-328029.html 0.6 2026-06-21T04:56:54+08:00 daily https://www.pharmasources.com/industryinsights/finding-the-right-experts-and-collaborat-328030.html 0.6 2026-06-23T13:05:10+08:00 daily https://www.pharmasources.com/industryinsights/dishman-carbogen-amcis-announces-results-328031.html 0.6 2026-07-03T03:08:44+08:00 daily https://www.pharmasources.com/industryinsights/biontech-says-vaccine-likely-to-be-effec-328032.html 0.6 2026-06-20T18:08:33+08:00 daily https://www.pharmasources.com/industryinsights/government-working-to-eliminate-shortage-328033.html 0.6 2026-07-03T05:05:51+08:00 daily https://www.pharmasources.com/industryinsights/japan-clinical-trial-of-covid-19-plasma--328034.html 0.6 2026-06-21T20:59:41+08:00 daily https://www.pharmasources.com/industryinsights/morepen-egm-approves-rs-433-crores-inves-328035.html 0.6 2026-06-20T20:10:46+08:00 daily https://www.pharmasources.com/industryinsights/moderna-might-manufacture-covid-19-vacci-328036.html 0.6 2026-08-08T21:23:08+08:00 daily https://www.pharmasources.com/industryinsights/api-market-tested-by-covid-19-but-pandem-328037.html 0.6 2026-08-04T07:57:45+08:00 daily https://www.pharmasources.com/industryinsights/two-astrazeneca-covid-shots-85-90-per-ce-328038.html 0.6 2026-06-22T09:10:53+08:00 daily https://www.pharmasources.com/industryinsights/richter-helm-invests-70m-to-triple-its-p-328039.html 0.6 2026-06-21T19:00:38+08:00 daily https://www.pharmasources.com/industryinsights/hoarse-voice-theres-many-reasons-for-ras-328040.html 0.6 2026-06-21T13:09:52+08:00 daily https://www.pharmasources.com/industryinsights/progress-mixed-in-cancer-prevention-earl-328041.html 0.6 2026-08-05T21:51:40+08:00 daily https://www.pharmasources.com/industryinsights/numab-therapeutics-secures-110m-in-serie-328042.html 0.6 2026-06-21T12:23:58+08:00 daily https://www.pharmasources.com/industryinsights/backyard-poultry-tied-to-salmonella-outb-328043.html 0.6 2026-06-20T15:11:21+08:00 daily https://www.pharmasources.com/industryinsights/gsk-to-sell-stake-in-innoviva-for-392m-328044.html 0.6 2025-12-29T22:33:50+08:00 daily https://www.pharmasources.com/industryinsights/sorrento-gets-brazilian-anvisas-clearanc-328045.html 0.6 2026-06-08T08:01:39+08:00 daily https://www.pharmasources.com/industryinsights/outcomes-worse-when-calling-for-help-wit-328046.html 0.6 2026-07-01T04:47:15+08:00 daily https://www.pharmasources.com/industryinsights/ec-to-procure-18-billion-doses-of-pfizer-328047.html 0.6 2026-08-14T14:13:51+08:00 daily https://www.pharmasources.com/industryinsights/merck-announces-positive-topline-results-328048.html 0.6 2026-06-22T06:40:59+08:00 daily https://www.pharmasources.com/industryinsights/discrimination-may-change-heart-structur-328049.html 0.6 2026-07-04T15:32:08+08:00 daily https://www.pharmasources.com/industryinsights/us-food-drug-administration-grants-prior-328050.html 0.6 2026-06-20T19:18:14+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-covid-19-vaccine-vaxzevria-a-328051.html 0.6 2026-06-21T08:57:01+08:00 daily https://www.pharmasources.com/industryinsights/verantos-and-lundbeck-partner-for-migrai-328052.html 0.6 2026-04-19T07:00:30+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-nivolumab-for-resected-esop-328053.html 0.6 2026-06-20T13:19:44+08:00 daily https://www.pharmasources.com/industryinsights/bioxcel-therapeutics-announces-fda-accep-328054.html 0.6 2026-06-21T07:07:01+08:00 daily https://www.pharmasources.com/industryinsights/genesis-medtech-group-raises-significant-328055.html 0.6 2026-07-31T15:21:12+08:00 daily https://www.pharmasources.com/industryinsights/luye-pharmas-innovative-alzheimers-disea-328056.html 0.6 2026-08-04T02:50:05+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-empaveli-pegcetacoplan-for--328057.html 0.6 2026-07-19T06:23:45+08:00 daily https://www.pharmasources.com/industryinsights/poster-to-highlight-envasarc-pivotal-tri-328058.html 0.6 2026-06-20T23:54:40+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-zynrelef-bupivacaine-and-me-328059.html 0.6 2026-06-20T18:22:02+08:00 daily https://www.pharmasources.com/industryinsights/a-game-changer-covid-19-drug-from-korea--328060.html 0.6 2026-08-10T15:18:23+08:00 daily https://www.pharmasources.com/industryinsights/amgen-announces-tezepelumab-biologics-li-328061.html 0.6 2026-06-20T19:06:49+08:00 daily https://www.pharmasources.com/industryinsights/docusign-the-global-leader-in-document-m-328062.html 0.6 2026-08-07T02:40:21+08:00 daily https://www.pharmasources.com/industryinsights/moderna-and-samsung-biologics-announce-a-328063.html 0.6 2026-08-07T02:36:52+08:00 daily https://www.pharmasources.com/industryinsights/liquidia-resubmits-new-drug-application--328064.html 0.6 2026-08-03T04:49:07+08:00 daily https://www.pharmasources.com/industryinsights/ortho-clinical-diagnostics-simultaneousl-328065.html 0.6 2026-08-07T02:33:42+08:00 daily https://www.pharmasources.com/industryinsights/concord-medical-announces-changes-in-boa-328066.html 0.6 2026-08-07T06:06:53+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-328067.html 0.6 2026-08-07T00:03:02+08:00 daily https://www.pharmasources.com/industryinsights/new-research-identifies-promising-strate-328068.html 0.6 2026-06-21T01:44:27+08:00 daily https://www.pharmasources.com/industryinsights/united-sweepstakes-gives-vaccinated-cust-328069.html 0.6 2026-08-06T21:58:52+08:00 daily https://www.pharmasources.com/industryinsights/social-health-research-center-and-quest--328070.html 0.6 2026-08-06T22:53:44+08:00 daily https://www.pharmasources.com/industryinsights/stemedica-signs-license-agreement-with-p-328071.html 0.6 2026-06-20T20:57:36+08:00 daily https://www.pharmasources.com/industryinsights/cansinobio-receives-european-gmp-certifi-328072.html 0.6 2026-07-23T18:30:51+08:00 daily https://www.pharmasources.com/industryinsights/seegene-introduces-an-exclusive-diagnost-328073.html 0.6 2026-06-20T21:35:11+08:00 daily https://www.pharmasources.com/industryinsights/xeris-to-acquire-strongbridge-biopharma-328074.html 0.6 2026-08-07T00:39:55+08:00 daily https://www.pharmasources.com/industryinsights/sterling-pharma-appoints-stewart-mitchel-328075.html 0.6 2026-08-07T02:41:08+08:00 daily https://www.pharmasources.com/industryinsights/cansino-biologics-gets-ogyi-gmp-certific-328076.html 0.6 2026-06-22T12:56:09+08:00 daily https://www.pharmasources.com/industryinsights/ppd-opens-clinical-research-lab-in-suzho-328077.html 0.6 2026-08-11T05:57:47+08:00 daily https://www.pharmasources.com/industryinsights/biopharma-industry-strives-to-solve-shor-328078.html 0.6 2026-08-05T18:10:10+08:00 daily https://www.pharmasources.com/industryinsights/cadila-healthcare-to-make-around-30-mill-328079.html 0.6 2026-06-21T08:16:14+08:00 daily https://www.pharmasources.com/industryinsights/bal-pharma-launches-balflu-favipiravir-t-328080.html 0.6 2026-07-04T23:06:53+08:00 daily https://www.pharmasources.com/industryinsights/rdif-panacea-biotec-launch-production-of-328081.html 0.6 2026-08-01T17:07:38+08:00 daily https://www.pharmasources.com/industryinsights/link-medical-and-medaffcon-join-forces-i-328082.html 0.6 2026-07-09T03:42:30+08:00 daily https://www.pharmasources.com/industryinsights/cdc-investigating-heart-problems-in-teen-328083.html 0.6 2026-06-22T04:51:33+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-astrazeneca-covid-19-vaccines-eff-328084.html 0.6 2026-03-08T01:27:29+08:00 daily https://www.pharmasources.com/industryinsights/thousands-of-black-fungus-cases-reported-328085.html 0.6 2026-06-21T04:05:46+08:00 daily https://www.pharmasources.com/industryinsights/vivimed-exports-its-first-shipment-famot-328086.html 0.6 2026-08-06T18:25:09+08:00 daily https://www.pharmasources.com/industryinsights/brain-fog-can-linger-with-long-haul-covi-328087.html 0.6 2026-06-21T14:39:14+08:00 daily https://www.pharmasources.com/industryinsights/cipla-to-market-roches-antibody-cocktail-328088.html 0.6 2026-08-03T15:07:49+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-gets-us-fda-nod-for-icatibant-i-328089.html 0.6 2026-06-29T22:50:43+08:00 daily https://www.pharmasources.com/industryinsights/zydus-launches-ujvira-trastuzumab-emtans-328090.html 0.6 2026-06-21T06:53:56+08:00 daily https://www.pharmasources.com/industryinsights/gsk-virs-covid-19-drug-sotrovimab-obtain-328091.html 0.6 2026-06-20T16:56:15+08:00 daily https://www.pharmasources.com/industryinsights/heart-issue-spotted-in-a-few-young-covid-328092.html 0.6 2026-08-08T00:54:47+08:00 daily https://www.pharmasources.com/industryinsights/european-commission-approves-ponvory-----328093.html 0.6 2026-06-20T16:58:27+08:00 daily https://www.pharmasources.com/industryinsights/dicerna-announces-boehringer-ingelheims--328094.html 0.6 2026-04-09T15:31:04+08:00 daily https://www.pharmasources.com/industryinsights/strengthens-investment-in-licensed-mrna--328095.html 0.6 2026-08-06T03:00:18+08:00 daily https://www.pharmasources.com/industryinsights/merck-receives-positive-eu-chmp-opinion--328096.html 0.6 2026-06-21T23:53:45+08:00 daily https://www.pharmasources.com/industryinsights/ajinomoto-bio-pharma-services-expands-fi-328097.html 0.6 2026-08-14T10:58:43+08:00 daily https://www.pharmasources.com/industryinsights/decibel-therapeutics-expands-world-class-328098.html 0.6 2026-06-08T12:46:16+08:00 daily https://www.pharmasources.com/industryinsights/nhs-england-funds-first-national-metasta-328099.html 0.6 2026-06-20T17:15:29+08:00 daily https://www.pharmasources.com/industryinsights/lillys-tirzepatide-achieves-superior-a1c-328100.html 0.6 2026-06-21T07:40:29+08:00 daily https://www.pharmasources.com/industryinsights/chmp-puts-eight-new-medicines-forward-fo-328101.html 0.6 2026-07-05T12:01:03+08:00 daily https://www.pharmasources.com/industryinsights/novavax-to-present-at-international-soci-328102.html 0.6 2026-08-08T12:24:07+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-janssens-rybrevant-328103.html 0.6 2026-08-12T12:35:59+08:00 daily https://www.pharmasources.com/industryinsights/stelara-a-compelling-option-for-the-trea-328104.html 0.6 2026-02-28T16:45:33+08:00 daily https://www.pharmasources.com/industryinsights/global-biopharmaceutical-industry-sees-u-328105.html 0.6 2026-06-20T21:14:55+08:00 daily https://www.pharmasources.com/industryinsights/cdmo-sector-are-the-big-winner-of-the-pa-328106.html 0.6 2026-07-06T23:08:54+08:00 daily https://www.pharmasources.com/industryinsights/bms-opdivoyervoy-improves-long-term-surv-328107.html 0.6 2026-08-03T17:31:43+08:00 daily https://www.pharmasources.com/industryinsights/biogen-partners-with-ginkgo-bioworks-on--328108.html 0.6 2026-06-21T12:26:49+08:00 daily https://www.pharmasources.com/industryinsights/eyemate-system-for-remote-glaucoma-manag-328109.html 0.6 2026-06-27T15:22:16+08:00 daily https://www.pharmasources.com/industryinsights/toxys-and-unilever-enter-agreement-to-fu-328110.html 0.6 2026-06-21T09:08:09+08:00 daily https://www.pharmasources.com/industryinsights/clinical-trial-application-of-asc40-comb-328111.html 0.6 2026-07-31T10:55:06+08:00 daily https://www.pharmasources.com/industryinsights/antengene-appoints-kathryn-gregory-as-vi-328112.html 0.6 2026-06-21T05:59:47+08:00 daily https://www.pharmasources.com/industryinsights/innovent-announces-first-patient-dosed-i-328113.html 0.6 2026-07-18T23:27:50+08:00 daily https://www.pharmasources.com/industryinsights/lifebit-awarded-a-four-year-contract-for-328114.html 0.6 2026-06-21T12:51:46+08:00 daily https://www.pharmasources.com/industryinsights/akesos-penpulimab-monoclonal-antibody-su-328115.html 0.6 2026-08-08T02:43:19+08:00 daily https://www.pharmasources.com/industryinsights/inclusion-is-everything-expanding-divers-328116.html 0.6 2026-06-21T00:55:40+08:00 daily https://www.pharmasources.com/industryinsights/two-products-of-zhaoke-ophthalmology-662-328117.html 0.6 2026-08-06T23:38:00+08:00 daily https://www.pharmasources.com/industryinsights/60-million-doses-of-covid-19-vaccine-adm-328118.html 0.6 2026-07-14T09:01:06+08:00 daily https://www.pharmasources.com/industryinsights/sermo-and-bionical-solutions-partner-to--328119.html 0.6 2026-06-21T10:10:19+08:00 daily https://www.pharmasources.com/industryinsights/elixirgen-therapeutics-announces-dosing--328120.html 0.6 2026-06-27T15:22:13+08:00 daily https://www.pharmasources.com/industryinsights/hex-performance-disrupts-laundry-categor-328121.html 0.6 2026-06-20T20:03:36+08:00 daily https://www.pharmasources.com/industryinsights/target-rwe-covid-19-data-real-world-evid-328122.html 0.6 2026-06-21T20:00:38+08:00 daily https://www.pharmasources.com/industryinsights/linux-foundation-public-health-welcomes--328123.html 0.6 2026-06-22T12:54:52+08:00 daily https://www.pharmasources.com/industryinsights/global-food-enzymes-market-2021-to-2026--328124.html 0.6 2026-06-21T09:01:02+08:00 daily https://www.pharmasources.com/industryinsights/women-ceos-demonstrated-more-inclusive-l-328125.html 0.6 2026-08-09T06:03:33+08:00 daily https://www.pharmasources.com/industryinsights/tiny-dataset-massive-lifeline-for-annovi-328126.html 0.6 2026-08-07T01:39:40+08:00 daily https://www.pharmasources.com/industryinsights/tergus-pharma-opens-new-hq-commercial-ma-328127.html 0.6 2026-08-04T01:58:22+08:00 daily https://www.pharmasources.com/industryinsights/near-infrared-autofluorescence-imaging-d-328128.html 0.6 2026-08-07T01:45:57+08:00 daily https://www.pharmasources.com/industryinsights/avid-bioservices-to-manufacture-zynlonta-328129.html 0.6 2026-07-07T11:45:41+08:00 daily https://www.pharmasources.com/industryinsights/lincoln-pharmaceuticals-reports-2833-per-328130.html 0.6 2026-06-21T05:55:09+08:00 daily https://www.pharmasources.com/industryinsights/iqvia-announces-japac-expansion-of-iqvia-328131.html 0.6 2026-07-20T09:59:08+08:00 daily https://www.pharmasources.com/industryinsights/more-than-2189-crore-vaccine-doses-provi-328132.html 0.6 2026-08-06T22:53:54+08:00 daily https://www.pharmasources.com/industryinsights/vav-life-sciences-ramps-up-production-of-328133.html 0.6 2026-08-06T23:35:44+08:00 daily https://www.pharmasources.com/industryinsights/low-residue-diet-comparable-to-clear-liq-328134.html 0.6 2026-08-11T12:46:47+08:00 daily https://www.pharmasources.com/industryinsights/bharat-biotech-may-begin-paediatric-tria-328135.html 0.6 2026-08-07T05:05:51+08:00 daily https://www.pharmasources.com/industryinsights/liquid-biopsy-exosomal-mirna-panel-predi-328136.html 0.6 2026-08-07T02:05:31+08:00 daily https://www.pharmasources.com/industryinsights/uzbekistan-invites-indian-companies-to-e-328137.html 0.6 2026-07-29T09:52:26+08:00 daily https://www.pharmasources.com/industryinsights/eli-lilly-and-mina-therapeutics-enter-sa-328138.html 0.6 2026-06-29T23:50:35+08:00 daily https://www.pharmasources.com/industryinsights/qimr-berghofer-researchers-create-drugs--328139.html 0.6 2026-08-07T22:54:20+08:00 daily https://www.pharmasources.com/industryinsights/larimar-therapeutics-reports-fda-clinica-328140.html 0.6 2026-08-07T05:07:40+08:00 daily https://www.pharmasources.com/industryinsights/qiagen-partners-with-mirati-therapeutics-328141.html 0.6 2026-08-07T02:18:27+08:00 daily https://www.pharmasources.com/industryinsights/solid-biosciences-to-present-at-upcoming-328142.html 0.6 2026-08-10T13:12:25+08:00 daily https://www.pharmasources.com/industryinsights/travere-therapeutics-provides-regulatory-328143.html 0.6 2026-07-24T11:13:21+08:00 daily https://www.pharmasources.com/industryinsights/duloxetine-cuts-opioid-use-after-total-k-328144.html 0.6 2026-06-21T14:55:32+08:00 daily https://www.pharmasources.com/industryinsights/tg-therapeutics-announces-fda-acceptance-328145.html 0.6 2026-08-08T17:53:09+08:00 daily https://www.pharmasources.com/industryinsights/fda-issues-final-guidance-on-bispecific--328146.html 0.6 2026-06-21T18:09:31+08:00 daily https://www.pharmasources.com/industryinsights/rybrevant-approved-for-nsclc-with-egfr-e-328147.html 0.6 2026-08-08T15:49:46+08:00 daily https://www.pharmasources.com/industryinsights/moderna-covid-19-vaccine-highly-effectiv-328148.html 0.6 2026-08-08T17:53:04+08:00 daily https://www.pharmasources.com/industryinsights/new-nice-guidance-recommends-inducing-wo-328149.html 0.6 2026-07-06T20:11:20+08:00 daily https://www.pharmasources.com/industryinsights/opdivo-plus-yervoy-moves-closer-to-eu-ap-328150.html 0.6 2026-08-09T05:41:22+08:00 daily https://www.pharmasources.com/industryinsights/are-some-foods-super-bitter-to-you-you-m-328151.html 0.6 2026-08-08T20:04:46+08:00 daily https://www.pharmasources.com/industryinsights/takedas-dengue-vaccine-bags-positive-lon-328152.html 0.6 2026-08-07T04:49:19+08:00 daily https://www.pharmasources.com/industryinsights/breakthrough-covid-infections-after-vacc-328153.html 0.6 2026-08-10T08:16:25+08:00 daily https://www.pharmasources.com/industryinsights/ec-approves-ponvory-for-relapsing-ms-328154.html 0.6 2026-08-14T18:15:03+08:00 daily https://www.pharmasources.com/industryinsights/industry-hustling-to-ensure-supply-of-re-328155.html 0.6 2026-06-20T04:50:28+08:00 daily https://www.pharmasources.com/industryinsights/could-covid-19-trigger-chronic-fatigue-s-328156.html 0.6 2026-06-21T00:16:56+08:00 daily https://www.pharmasources.com/industryinsights/novel-implantable-polymer-could-improve--328157.html 0.6 2026-08-07T01:21:58+08:00 daily https://www.pharmasources.com/industryinsights/stem-cell-therapy-shows-promise-in-covid-328158.html 0.6 2026-08-10T23:10:44+08:00 daily https://www.pharmasources.com/industryinsights/novel-raman-spectroscopy-method-enables--328159.html 0.6 2026-08-07T01:31:39+08:00 daily https://www.pharmasources.com/industryinsights/prosit-sole-biotechnology-initiates-firs-328160.html 0.6 2026-08-07T01:52:09+08:00 daily https://www.pharmasources.com/industryinsights/tci-co-ltd-named-as-one-of-asias-fastest-328161.html 0.6 2026-08-02T15:39:34+08:00 daily https://www.pharmasources.com/industryinsights/texas-cardiac-arrhythmia-institute-leade-328162.html 0.6 2026-06-20T18:57:33+08:00 daily https://www.pharmasources.com/industryinsights/sinovant-sciences-and-nabriva-therapeuti-328163.html 0.6 2026-06-21T06:13:56+08:00 daily https://www.pharmasources.com/industryinsights/nanoform-and-celanese-explore-ways-to-en-328164.html 0.6 2026-06-20T21:01:36+08:00 daily https://www.pharmasources.com/industryinsights/viewmind-applauded-by-frost-sullivan-for-328165.html 0.6 2026-06-20T16:55:08+08:00 daily https://www.pharmasources.com/industryinsights/ivf-life-the-first-clinic-group-in-europ-328166.html 0.6 2026-08-13T14:13:02+08:00 daily https://www.pharmasources.com/industryinsights/nearly-half-of-covid-19-patients-left-ho-328167.html 0.6 2026-06-21T09:05:07+08:00 daily https://www.pharmasources.com/industryinsights/european-commission-approves-venclyxto-b-328168.html 0.6 2026-06-20T00:45:59+08:00 daily https://www.pharmasources.com/industryinsights/scholarship-fund-created-for-families-of-328169.html 0.6 2026-06-18T02:49:55+08:00 daily https://www.pharmasources.com/industryinsights/debbies-dream-foundation-publishes-2020--328170.html 0.6 2026-06-22T03:06:42+08:00 daily https://www.pharmasources.com/industryinsights/inhalon-biopharma-receives-7-million-fro-328171.html 0.6 2026-07-10T08:07:17+08:00 daily https://www.pharmasources.com/industryinsights/zogbychildrens-health-defense-poll-sugge-328172.html 0.6 2026-06-20T23:00:38+08:00 daily https://www.pharmasources.com/industryinsights/milliporesigma-accelerates-scale-up-of-l-328173.html 0.6 2026-06-21T17:04:27+08:00 daily https://www.pharmasources.com/industryinsights/covid-response-catalyzes-local-food-syst-328174.html 0.6 2026-06-21T06:57:59+08:00 daily https://www.pharmasources.com/industryinsights/jj-legends-car-t-therapy-cilta-cel-grant-328175.html 0.6 2026-06-24T10:45:56+08:00 daily https://www.pharmasources.com/industryinsights/study-shows-sars-cov-2-variants-unlikely-328176.html 0.6 2026-06-19T21:54:46+08:00 daily https://www.pharmasources.com/industryinsights/gsk-virs-covid-19-antibody-sotrovimab-wi-328177.html 0.6 2026-06-19T19:51:46+08:00 daily https://www.pharmasources.com/industryinsights/cdc-offers-details-on-sars-cov-2-vaccine-328178.html 0.6 2026-06-23T20:08:45+08:00 daily https://www.pharmasources.com/industryinsights/govt-looking-into-securing-part-of-jj-va-328179.html 0.6 2026-06-26T16:01:06+08:00 daily https://www.pharmasources.com/industryinsights/us-officials-say-50-percent-of-american--328180.html 0.6 2026-08-10T06:22:13+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccine-makers-press-countries--328181.html 0.6 2026-06-21T15:48:12+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-myfembree-as-the-first-once-328182.html 0.6 2026-06-21T02:02:56+08:00 daily https://www.pharmasources.com/industryinsights/7-out-of-10-hospitalized-covid-patients--328183.html 0.6 2026-06-01T05:46:30+08:00 daily https://www.pharmasources.com/industryinsights/birth-order-family-size-may-affect-heart-328184.html 0.6 2026-08-10T03:06:41+08:00 daily https://www.pharmasources.com/industryinsights/common-immune-drug-methotrexate-may-hamp-328185.html 0.6 2026-06-20T12:01:55+08:00 daily https://www.pharmasources.com/industryinsights/dyadic-collaborates-with-syngene-to-deve-328186.html 0.6 2026-06-22T00:02:45+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-surprisingly-few-women-may-have-328187.html 0.6 2026-06-20T22:20:14+08:00 daily https://www.pharmasources.com/industryinsights/stevanato-group-corning-partner-on-solut-328188.html 0.6 2026-06-20T20:57:47+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-camcevi-leuprolide-mesylate-328189.html 0.6 2026-08-10T00:12:36+08:00 daily https://www.pharmasources.com/industryinsights/ori-biotech-and-vineti-enter-non-exclusi-328190.html 0.6 2025-10-31T12:59:26+08:00 daily https://www.pharmasources.com/industryinsights/ironwood-pharmaceuticals-announces-agree-328191.html 0.6 2026-08-07T01:37:00+08:00 daily https://www.pharmasources.com/industryinsights/novatek-requalified-as-supplier-for-boeh-328192.html 0.6 2026-06-22T10:07:08+08:00 daily https://www.pharmasources.com/industryinsights/milliporesigma-accelerates-scale-up-of-l-328193.html 0.6 2026-08-09T02:52:11+08:00 daily https://www.pharmasources.com/industryinsights/timber-pharmaceuticals-announces-complet-328194.html 0.6 2026-08-09T11:00:34+08:00 daily https://www.pharmasources.com/industryinsights/cambrex-adds-kilogram-scale-mfg-capabili-328195.html 0.6 2026-08-06T20:40:30+08:00 daily https://www.pharmasources.com/industryinsights/tessol-launches-cold-solutions-for-vacci-328196.html 0.6 2026-06-21T18:31:36+08:00 daily https://www.pharmasources.com/industryinsights/india-might-get-modernas-single-dose-cov-328197.html 0.6 2026-06-21T13:09:41+08:00 daily https://www.pharmasources.com/industryinsights/acg-makes-two-european-appointments-328198.html 0.6 2026-06-19T23:00:53+08:00 daily https://www.pharmasources.com/industryinsights/pharmeasy-announces-merger-with-medlife-328199.html 0.6 2026-06-21T03:15:52+08:00 daily https://www.pharmasources.com/industryinsights/pieris-and-genentech-sign-14bn-respirato-328200.html 0.6 2026-06-20T11:57:57+08:00 daily https://www.pharmasources.com/industryinsights/us-clears-pfizer-myovants-myfembree-for--328201.html 0.6 2025-11-10T11:04:34+08:00 daily https://www.pharmasources.com/industryinsights/study-confirms-longer-term-lung-damage-a-328202.html 0.6 2026-06-21T21:04:40+08:00 daily https://www.pharmasources.com/industryinsights/n-side-launches-production-app-to-optimi-328203.html 0.6 2026-06-21T00:00:42+08:00 daily https://www.pharmasources.com/industryinsights/clean-biologics-buys-cdmo-biodextris-328204.html 0.6 2026-06-22T12:54:20+08:00 daily https://www.pharmasources.com/industryinsights/europe-approves-sk-biosciences-global-co-328205.html 0.6 2026-06-21T03:10:50+08:00 daily https://www.pharmasources.com/industryinsights/janssens-erleada-maintains-quality-of-li-328206.html 0.6 2026-07-28T14:51:31+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-pfizer-myovants-uterine-fib-328207.html 0.6 2026-06-20T17:18:34+08:00 daily https://www.pharmasources.com/industryinsights/gsk-sanofi-launch-late-stage-covid-19-va-328208.html 0.6 2026-06-20T07:04:36+08:00 daily https://www.pharmasources.com/industryinsights/roche-uk-launches-renewable-energy-initi-328209.html 0.6 2026-03-25T21:12:09+08:00 daily https://www.pharmasources.com/industryinsights/abivaxs-abx464-shows-impressive-efficacy-328210.html 0.6 2026-08-11T17:11:08+08:00 daily https://www.pharmasources.com/industryinsights/talquetamab-shows-promise-in-multi-drug--328211.html 0.6 2026-07-28T23:06:51+08:00 daily https://www.pharmasources.com/industryinsights/pegcetacoplan-safe-and-effective-in-paro-328212.html 0.6 2026-07-22T17:52:46+08:00 daily https://www.pharmasources.com/industryinsights/probiogen-and-minapharm-pharmaceuticals--328213.html 0.6 2026-06-21T12:19:45+08:00 daily https://www.pharmasources.com/industryinsights/betagenon-ab-announces-new-ceo-and-new-c-328214.html 0.6 2026-06-21T01:57:43+08:00 daily https://www.pharmasources.com/industryinsights/esco-lifesciences-closes-a-record-settin-328215.html 0.6 2026-07-22T20:57:00+08:00 daily https://www.pharmasources.com/industryinsights/gannex-received-china-ind-approval-of-it-328216.html 0.6 2026-07-31T00:46:45+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-and-oncoc4-establish-excl-328217.html 0.6 2026-08-13T14:53:08+08:00 daily https://www.pharmasources.com/industryinsights/boan-biotech-grants-astrazeneca-exclusiv-328218.html 0.6 2026-07-19T16:56:16+08:00 daily https://www.pharmasources.com/industryinsights/transthera-announces-collaboration-with--328219.html 0.6 2026-08-07T15:40:02+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharma-receives-allowances-fo-328220.html 0.6 2026-06-22T14:48:03+08:00 daily https://www.pharmasources.com/industryinsights/tian-ruixiang-holdings-ltd-signs-insuran-328221.html 0.6 2026-08-06T18:41:22+08:00 daily https://www.pharmasources.com/industryinsights/zai-lab-selects-enpicoms-igx-platform-to-328222.html 0.6 2026-08-07T12:03:15+08:00 daily https://www.pharmasources.com/industryinsights/freeman-technology-news---getting-to-gri-328223.html 0.6 2026-07-22T17:47:09+08:00 daily https://www.pharmasources.com/industryinsights/mimetas-opens-phenotypic-screening-cente-328224.html 0.6 2026-08-08T19:40:12+08:00 daily https://www.pharmasources.com/industryinsights/hovione-and-ibet-form-strategic-collabor-328225.html 0.6 2026-06-20T02:52:07+08:00 daily https://www.pharmasources.com/industryinsights/august-bioservices-expands-us-biopharma--328226.html 0.6 2026-08-13T05:58:41+08:00 daily https://www.pharmasources.com/industryinsights/cryoport-systems-and-cryopdp-jointly-ope-328227.html 0.6 2026-07-16T01:40:05+08:00 daily https://www.pharmasources.com/industryinsights/acg-appoints-senior-executives-in-europe-328228.html 0.6 2026-06-19T23:00:51+08:00 daily https://www.pharmasources.com/industryinsights/the-discovery-labs-signs-lease-with-upen-328229.html 0.6 2026-06-20T02:54:56+08:00 daily https://www.pharmasources.com/industryinsights/carlyle-group-to-acquire-pharma-company--328230.html 0.6 2026-07-24T07:10:37+08:00 daily https://www.pharmasources.com/industryinsights/nikang-therapeutics-secures-200m-in-seri-328231.html 0.6 2026-07-15T23:02:01+08:00 daily https://www.pharmasources.com/industryinsights/poll-evokes-mixed-response-on-the-positi-328232.html 0.6 2026-08-12T05:57:02+08:00 daily https://www.pharmasources.com/industryinsights/us-lawmakers-propose-bill-to-jumpstart-c-328233.html 0.6 2026-06-21T03:44:28+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-explors-coadministration-of-its-2-328234.html 0.6 2026-06-13T10:00:16+08:00 daily https://www.pharmasources.com/industryinsights/dr-steven-hatfill-pandemic-report-single-328235.html 0.6 2026-08-07T01:27:29+08:00 daily https://www.pharmasources.com/industryinsights/aptorum-group-announces-positive-clinica-328236.html 0.6 2026-08-08T01:14:33+08:00 daily https://www.pharmasources.com/industryinsights/wooplus-the-largest-dating-app-for-curvy-328237.html 0.6 2026-08-11T22:20:17+08:00 daily https://www.pharmasources.com/industryinsights/dorian-and-hitgen-announce-research-coll-328238.html 0.6 2026-06-21T14:26:39+08:00 daily https://www.pharmasources.com/industryinsights/neoimmunetech-announces-first-patient-do-328239.html 0.6 2026-04-07T02:12:46+08:00 daily https://www.pharmasources.com/industryinsights/bridging-the-gaps-eases-covid-safety-pro-328240.html 0.6 2026-08-07T01:14:07+08:00 daily https://www.pharmasources.com/industryinsights/verastem-oncology-with-breakthrough-ther-328241.html 0.6 2026-06-21T14:37:12+08:00 daily https://www.pharmasources.com/industryinsights/janssens-phase-1-results-for-teclistamab-328242.html 0.6 2026-06-20T14:59:06+08:00 daily https://www.pharmasources.com/industryinsights/who-won-in-the-covid-19-lockdowns---beve-328243.html 0.6 2026-08-07T01:07:25+08:00 daily https://www.pharmasources.com/industryinsights/moderna-and-aldevron-announce-expanded-p-328244.html 0.6 2026-06-21T22:51:44+08:00 daily https://www.pharmasources.com/industryinsights/as-covid-19-vaccination-rates-rise-groce-328245.html 0.6 2026-08-07T01:14:18+08:00 daily https://www.pharmasources.com/industryinsights/spruce-biosciences-presents-phase-2-data-328246.html 0.6 2026-06-20T19:01:49+08:00 daily https://www.pharmasources.com/industryinsights/docgo-is-partnering-with-barclays-center-328247.html 0.6 2026-08-07T05:36:49+08:00 daily https://www.pharmasources.com/industryinsights/provention-bio-wins-fda-panel-backing-fo-328248.html 0.6 2026-08-07T05:39:40+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccines-may-give-protection-fo-328249.html 0.6 2026-08-07T06:06:53+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-third-covid-19-antibody-tre-328250.html 0.6 2026-08-07T12:03:16+08:00 daily https://www.pharmasources.com/industryinsights/international-society-for-stem-cell-rese-328251.html 0.6 2026-08-07T01:15:27+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-dosed-with-multi-variant-s-328252.html 0.6 2026-06-21T09:08:08+08:00 daily https://www.pharmasources.com/industryinsights/napo-pharmaceuticals-jaguar-healths-subs-328253.html 0.6 2026-08-07T13:17:25+08:00 daily https://www.pharmasources.com/industryinsights/eus-medical-device-regulation-is-now-app-328254.html 0.6 2026-08-10T20:22:36+08:00 daily https://www.pharmasources.com/industryinsights/restrictions-eased-on-use-of-embryos-in--328255.html 0.6 2026-08-08T00:54:18+08:00 daily https://www.pharmasources.com/industryinsights/modernas-covid-19-vaccine-93-percent-eff-328256.html 0.6 2026-08-07T09:19:34+08:00 daily https://www.pharmasources.com/industryinsights/sapience-therapeutics-enters-into-collab-328257.html 0.6 2026-06-21T12:58:29+08:00 daily https://www.pharmasources.com/industryinsights/possible-cause-found-for-rare-blood-clot-328258.html 0.6 2026-06-22T09:58:47+08:00 daily https://www.pharmasources.com/industryinsights/having-ocd-may-triple-a-persons-odds-for-328259.html 0.6 2026-01-13T06:13:13+08:00 daily https://www.pharmasources.com/industryinsights/international-finance-corporation-and-mi-328260.html 0.6 2026-08-08T01:16:16+08:00 daily https://www.pharmasources.com/industryinsights/cstone-announces-the-first-in-class-regi-328261.html 0.6 2026-07-31T22:52:07+08:00 daily https://www.pharmasources.com/industryinsights/affamed-therapeutics-announces-approval--328262.html 0.6 2026-08-11T14:36:30+08:00 daily https://www.pharmasources.com/industryinsights/antengene-announces-first-patient-dosed--328263.html 0.6 2026-08-07T07:36:54+08:00 daily https://www.pharmasources.com/industryinsights/daewoong-first-in-class-prs-inhibitor-fo-328264.html 0.6 2026-08-06T22:17:43+08:00 daily https://www.pharmasources.com/industryinsights/africa-urgently-needs-20-million-second--328265.html 0.6 2026-08-07T17:22:52+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-gsk-initiate-global-phase-3-c-328266.html 0.6 2026-08-08T02:16:53+08:00 daily https://www.pharmasources.com/industryinsights/experimental-treatment-offers-new-hope-a-328267.html 0.6 2026-06-20T07:19:50+08:00 daily https://www.pharmasources.com/industryinsights/disc-medicine-expands-hematology-pipelin-328268.html 0.6 2026-07-31T16:33:14+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccination-now-available-for-p-328269.html 0.6 2026-06-21T08:15:40+08:00 daily https://www.pharmasources.com/industryinsights/merck-kgaa-boosts-lipid-capacity-to-meet-328270.html 0.6 2026-06-22T06:03:44+08:00 daily https://www.pharmasources.com/industryinsights/eddie-gray-appointed-chair-of-antivirals-328271.html 0.6 2026-06-20T00:21:47+08:00 daily https://www.pharmasources.com/industryinsights/cambrex-completes-gmp-manufacturing-expa-328272.html 0.6 2026-06-22T09:55:47+08:00 daily https://www.pharmasources.com/industryinsights/ashwagandha-a-powerful-adaptogen-328273.html 0.6 2026-08-06T19:23:04+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-targeted-therapy-for--328274.html 0.6 2026-06-20T18:08:30+08:00 daily https://www.pharmasources.com/industryinsights/werewolf-therapeutics-appoints-mike-sher-328275.html 0.6 2026-06-08T19:54:46+08:00 daily https://www.pharmasources.com/industryinsights/uae-approves-highly-effective-new-treatm-328276.html 0.6 2026-08-07T15:54:09+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-tracer-that-improves-detect-328277.html 0.6 2026-06-19T17:05:21+08:00 daily https://www.pharmasources.com/industryinsights/poll-finds-herd-immunity-in-us-possible--328278.html 0.6 2026-06-19T19:18:48+08:00 daily https://www.pharmasources.com/industryinsights/many-americans-confused-about-sunscreens-328279.html 0.6 2025-11-10T22:02:36+08:00 daily https://www.pharmasources.com/industryinsights/adare-pharma-expands-executive-leadershi-328280.html 0.6 2026-06-19T22:17:03+08:00 daily https://www.pharmasources.com/industryinsights/beroni-tella-sign-mou-for-cancer-immunot-328281.html 0.6 2026-06-21T07:15:13+08:00 daily https://www.pharmasources.com/industryinsights/will-be-able-to-supply-9-10-crore-doses--328282.html 0.6 2026-06-21T06:05:46+08:00 daily https://www.pharmasources.com/industryinsights/humanigen-seeks-eua-from-usfda-for-lenzi-328283.html 0.6 2025-11-14T00:40:16+08:00 daily https://www.pharmasources.com/industryinsights/iit-hyderabad-is-ready-for-tech-transfer-328284.html 0.6 2026-06-20T07:17:40+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-usfda-approval-for-flu-328285.html 0.6 2026-08-07T21:58:18+08:00 daily https://www.pharmasources.com/industryinsights/the-pharmaceutical-industry-is-proving-i-328286.html 0.6 2026-08-05T06:24:48+08:00 daily https://www.pharmasources.com/industryinsights/120-days-to-make-test-and-release-each-c-328287.html 0.6 2026-08-05T16:49:37+08:00 daily https://www.pharmasources.com/industryinsights/study-reveals-new-dna-vaccine-for-covid--328288.html 0.6 2026-06-19T17:56:21+08:00 daily https://www.pharmasources.com/industryinsights/neuropathic-pain-market-to-reach-252-bil-328289.html 0.6 2026-08-03T22:56:28+08:00 daily https://www.pharmasources.com/industryinsights/iit-mandi-study-reveal-structure-of-nsp1-328290.html 0.6 2026-06-21T14:56:23+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-gives-rights-to-trademark-fo-328291.html 0.6 2026-08-02T23:41:40+08:00 daily https://www.pharmasources.com/industryinsights/merck-launches-synthetic-cholesterol-pro-328292.html 0.6 2026-07-06T17:56:37+08:00 daily https://www.pharmasources.com/industryinsights/a-glimpse-of-the-oncology-drug-treatment-328293.html 0.6 2026-08-12T10:07:11+08:00 daily https://www.pharmasources.com/industryinsights/rdif-unicef-sign-agreement-for-supply-of-328294.html 0.6 2026-08-13T00:13:57+08:00 daily https://www.pharmasources.com/industryinsights/strides-tlc-collaborate-to-launch-black--328295.html 0.6 2025-11-20T07:32:28+08:00 daily https://www.pharmasources.com/industryinsights/qai-launches-accreditation-program-for-b-328296.html 0.6 2026-08-01T21:11:24+08:00 daily https://www.pharmasources.com/industryinsights/with-anlotinib-sold-over-rmb4-billion-in-328297.html 0.6 2026-07-19T21:00:51+08:00 daily https://www.pharmasources.com/industryinsights/significant-adverse-effect-unlikely-with-328298.html 0.6 2026-06-21T06:22:10+08:00 daily https://www.pharmasources.com/industryinsights/bharat-biotech-and-gujarat-covid-vaccine-328299.html 0.6 2026-04-12T23:15:14+08:00 daily https://www.pharmasources.com/industryinsights/bdr-pharma-launches-generic-rucaparib-to-328300.html 0.6 2026-07-02T02:34:57+08:00 daily https://www.pharmasources.com/industryinsights/lupin-announces-achievement-of-key-miles-328301.html 0.6 2026-07-19T06:22:03+08:00 daily https://www.pharmasources.com/industryinsights/zydus-seeks-dcgi-nod-for-clinical-trials-328302.html 0.6 2026-06-20T20:03:40+08:00 daily https://www.pharmasources.com/industryinsights/immune-drug-combination-therapies-for-li-328303.html 0.6 2026-07-19T21:02:05+08:00 daily https://www.pharmasources.com/industryinsights/interview-jiangxi-fangzun-chemical-atten-328304.html 0.6 2026-08-07T01:14:46+08:00 daily https://www.pharmasources.com/industryinsights/immunity-after-covid-19-illness-may-last-328305.html 0.6 2026-07-13T00:16:53+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-lumakras-sotorasib-for-kras-328306.html 0.6 2026-07-15T19:10:41+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-truseltiq-infigratinib-for--328307.html 0.6 2026-07-04T04:01:22+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-pylarify-piflufolastat-f-18-328308.html 0.6 2026-06-24T17:09:59+08:00 daily https://www.pharmasources.com/industryinsights/curevacs-first-generation-covid-19-vacci-328309.html 0.6 2026-06-20T21:50:37+08:00 daily https://www.pharmasources.com/industryinsights/eu-authorises-pfizer-biontech-covid-19-v-328310.html 0.6 2026-06-22T00:51:02+08:00 daily https://www.pharmasources.com/industryinsights/prestige-to-acquire-akorns-consumer-prod-328311.html 0.6 2026-08-14T22:32:09+08:00 daily https://www.pharmasources.com/industryinsights/us-doj-probes-eli-lillys-branchburg-manu-328312.html 0.6 2026-08-05T22:34:10+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-jab-less-effective-but-still-prot-328313.html 0.6 2026-06-19T19:18:53+08:00 daily https://www.pharmasources.com/industryinsights/novartis-and-molecular-partners-commence-328314.html 0.6 2026-08-10T18:03:49+08:00 daily https://www.pharmasources.com/industryinsights/breaking-news-researchers-may-know-the-c-328315.html 0.6 2026-06-20T03:36:48+08:00 daily https://www.pharmasources.com/industryinsights/could-medicinal-cannabis-be-the-answer-t-328316.html 0.6 2026-06-19T14:33:00+08:00 daily https://www.pharmasources.com/industryinsights/anti-pd-l1-monoclonal-antibody-shows-pro-328317.html 0.6 2026-06-19T20:06:41+08:00 daily https://www.pharmasources.com/industryinsights/erleada-improves-survival-without-damagi-328318.html 0.6 2026-06-20T07:18:44+08:00 daily https://www.pharmasources.com/industryinsights/competition-and-markets-authority-invest-328319.html 0.6 2026-07-07T01:04:47+08:00 daily https://www.pharmasources.com/industryinsights/nexturn-bio-inc-acquired-a-50-stake-in-r-328320.html 0.6 2026-06-21T05:03:45+08:00 daily https://www.pharmasources.com/industryinsights/mindray-defines-future-of-imaging-techno-328321.html 0.6 2026-08-07T23:19:28+08:00 daily https://www.pharmasources.com/industryinsights/hummingbird-bioscience-announces-publica-328322.html 0.6 2026-06-14T22:37:11+08:00 daily https://www.pharmasources.com/industryinsights/lab-in-indias-telangana-state-launches-e-328323.html 0.6 2026-06-20T16:51:38+08:00 daily https://www.pharmasources.com/industryinsights/sinovac-biotech-vaccine-effective-in-con-328324.html 0.6 2026-06-23T06:57:20+08:00 daily https://www.pharmasources.com/industryinsights/ireland-could-start-making-pfizer-covid--328325.html 0.6 2026-06-20T16:21:20+08:00 daily https://www.pharmasources.com/industryinsights/telehealth-is-growing-in-use-acceptance--328326.html 0.6 2026-07-09T16:15:55+08:00 daily https://www.pharmasources.com/industryinsights/fda-warns-of-bogus-dietary-supplements-t-328327.html 0.6 2026-06-21T06:57:53+08:00 daily https://www.pharmasources.com/industryinsights/is-it-covid-19-or-seasonal-allergies-328328.html 0.6 2026-06-21T22:12:53+08:00 daily https://www.pharmasources.com/industryinsights/terry-gou-to-bid-for-pfizer-biontech-sho-328329.html 0.6 2026-07-03T14:03:22+08:00 daily https://www.pharmasources.com/industryinsights/four-pharma-firms-get-approval-under-pli-328330.html 0.6 2026-06-21T06:17:05+08:00 daily https://www.pharmasources.com/industryinsights/scientists-identify-drug-that-prevents-m-328331.html 0.6 2026-06-26T08:02:56+08:00 daily https://www.pharmasources.com/industryinsights/generic-pharmasec-signs-distribution-and-328332.html 0.6 2026-06-23T08:19:45+08:00 daily https://www.pharmasources.com/industryinsights/bacthera-receives-manufacturing-licenses-328333.html 0.6 2026-06-30T02:13:49+08:00 daily https://www.pharmasources.com/industryinsights/jb-chemicals-launches-medicated-nicotine-328334.html 0.6 2026-07-10T07:47:23+08:00 daily https://www.pharmasources.com/industryinsights/even-after-us-shift-opponents-resist-cov-328335.html 0.6 2026-06-21T17:05:24+08:00 daily https://www.pharmasources.com/industryinsights/characterisation-of-second-wave-of-covid-328336.html 0.6 2026-06-24T16:53:24+08:00 daily https://www.pharmasources.com/industryinsights/modern-laboratories-to-produce-amphoteri-328337.html 0.6 2026-06-20T09:26:00+08:00 daily https://www.pharmasources.com/industryinsights/cipla-says-close-to-committing-1-billion-328338.html 0.6 2026-06-30T03:23:05+08:00 daily https://www.pharmasources.com/industryinsights/hp-india-jubilant-bhartia-foundation-int-328339.html 0.6 2026-06-21T10:38:31+08:00 daily https://www.pharmasources.com/industryinsights/scientists-discover-a-new-genetic-form-o-328340.html 0.6 2026-06-20T21:53:56+08:00 daily https://www.pharmasources.com/industryinsights/few-cases-of-heart-inflammation-in-big-t-328341.html 0.6 2026-08-08T11:48:40+08:00 daily https://www.pharmasources.com/industryinsights/amgens-lumakras-obtains-early-fda-approv-328342.html 0.6 2026-07-06T23:04:38+08:00 daily https://www.pharmasources.com/industryinsights/fda-authorizes-additional-monoclonal-ant-328343.html 0.6 2026-08-14T11:24:33+08:00 daily https://www.pharmasources.com/industryinsights/due-to-risk-of-serious-liver-injury---fd-328344.html 0.6 2026-08-07T11:23:44+08:00 daily https://www.pharmasources.com/industryinsights/uk-approves-jjs-one-dose-covid-19-vaccin-328345.html 0.6 2026-07-03T23:48:10+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-328346.html 0.6 2026-06-20T21:05:44+08:00 daily https://www.pharmasources.com/industryinsights/nice-green-lights-tremfya-to-treat-activ-328347.html 0.6 2026-06-30T18:24:27+08:00 daily https://www.pharmasources.com/industryinsights/novacyt-disputes-covid-19-testing-contra-328348.html 0.6 2026-05-05T07:15:36+08:00 daily https://www.pharmasources.com/industryinsights/royal-college-of-surgeons-calls-for-crea-328349.html 0.6 2026-08-09T04:32:03+08:00 daily https://www.pharmasources.com/industryinsights/eu-clears-tagrisso-for-early-stage-egfr--328350.html 0.6 2026-08-08T14:47:10+08:00 daily https://www.pharmasources.com/industryinsights/avatamed-sets-up-joint-service-lab-with--328351.html 0.6 2026-08-07T18:44:43+08:00 daily https://www.pharmasources.com/industryinsights/innovent-biologics-and-anheart-therapeut-328352.html 0.6 2026-08-07T13:54:57+08:00 daily https://www.pharmasources.com/industryinsights/pentax-medical-and-vedkang-establish-end-328353.html 0.6 2026-08-07T13:17:10+08:00 daily https://www.pharmasources.com/industryinsights/polyu-develops-biomimetic-nanosheet-for--328354.html 0.6 2026-08-07T12:29:52+08:00 daily https://www.pharmasources.com/industryinsights/rhovac-confirms-forecast---bravac-phase--328355.html 0.6 2026-08-07T13:17:35+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-to-add-mrna-vaccine-dr-328356.html 0.6 2026-08-10T23:56:31+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-impact-and-recovery-analysis-re-328357.html 0.6 2026-08-09T00:17:04+08:00 daily https://www.pharmasources.com/industryinsights/mcare-virtual-care-platform-launches-cov-328358.html 0.6 2026-08-09T01:19:40+08:00 daily https://www.pharmasources.com/industryinsights/nearly-50-residential-communities-help-t-328359.html 0.6 2026-08-09T03:34:15+08:00 daily https://www.pharmasources.com/industryinsights/employee-burnout-up-as-employers-pull-ba-328360.html 0.6 2026-08-09T06:19:53+08:00 daily https://www.pharmasources.com/industryinsights/veeva-commercial-summit-to-spotlight-dig-328361.html 0.6 2026-08-07T21:35:52+08:00 daily https://www.pharmasources.com/industryinsights/xrhealth-announces-xr-augmentedvirtual-r-328362.html 0.6 2026-03-31T23:41:34+08:00 daily https://www.pharmasources.com/industryinsights/techpool-uti-blocks-cytokine-storm-fight-328363.html 0.6 2026-06-21T04:18:01+08:00 daily https://www.pharmasources.com/industryinsights/siegfried-starts-to-ramp-up-production-a-328364.html 0.6 2026-08-07T18:58:40+08:00 daily https://www.pharmasources.com/industryinsights/cdc-updates-covid-19-guidelines-for-summ-328365.html 0.6 2026-06-21T09:58:08+08:00 daily https://www.pharmasources.com/industryinsights/precision-nanosystems-joins-danahers-lif-328366.html 0.6 2026-06-21T06:08:11+08:00 daily https://www.pharmasources.com/industryinsights/asco-incidence-of-cervical-cancer-has-de-328367.html 0.6 2026-06-20T08:15:56+08:00 daily https://www.pharmasources.com/industryinsights/a-new-commitment-for-vaccine-equity-and--328368.html 0.6 2026-06-20T16:00:08+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-lybalvi-olanzapine-and-sami-328369.html 0.6 2026-06-21T08:04:04+08:00 daily https://www.pharmasources.com/industryinsights/stealth-biotherapeutics-receives-orphan--328370.html 0.6 2026-06-21T09:12:16+08:00 daily https://www.pharmasources.com/industryinsights/americans-lung-health-the-poor-suffer-mo-328371.html 0.6 2026-06-22T00:57:54+08:00 daily https://www.pharmasources.com/industryinsights/moderna-announces-agreement-with-thermo--328372.html 0.6 2026-08-08T01:42:01+08:00 daily https://www.pharmasources.com/industryinsights/long-haul-covid-symptoms-getting-vaccine-328373.html 0.6 2026-06-30T14:37:00+08:00 daily https://www.pharmasources.com/industryinsights/us-blood-supply-is-safe-from-coronavirus-328374.html 0.6 2026-06-25T12:37:22+08:00 daily https://www.pharmasources.com/industryinsights/medpharm-opens-new-manufacturing-facilit-328375.html 0.6 2026-06-21T21:52:35+08:00 daily https://www.pharmasources.com/industryinsights/ccrm-enters-regenerative-medicine-partne-328376.html 0.6 2026-06-21T11:57:11+08:00 daily https://www.pharmasources.com/industryinsights/thibault-jonckheere-named-ceo-of-exother-328377.html 0.6 2026-08-09T22:32:32+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-expands-vaccine-manufa-328378.html 0.6 2026-08-09T17:54:40+08:00 daily https://www.pharmasources.com/industryinsights/ipla-seeks-clarity-guidance-from-govt-fo-328379.html 0.6 2026-04-30T08:51:21+08:00 daily https://www.pharmasources.com/industryinsights/sinovac-covid-19-vaccine-gets-who-valida-328380.html 0.6 2026-06-23T04:59:57+08:00 daily https://www.pharmasources.com/industryinsights/key-unmet-needs-in-hnscc-may-be-partly-a-328381.html 0.6 2026-07-16T17:06:04+08:00 daily https://www.pharmasources.com/industryinsights/merck-announces-two-million-euros-as-sup-328382.html 0.6 2026-06-22T08:15:00+08:00 daily https://www.pharmasources.com/industryinsights/omar-sherief-mohammad-appointed-head-ind-328383.html 0.6 2026-06-21T14:49:20+08:00 daily https://www.pharmasources.com/industryinsights/lilly-india-gets-nod-for-restricted-eu-o-328384.html 0.6 2026-08-01T08:30:38+08:00 daily https://www.pharmasources.com/industryinsights/preparing-for-the-third-wave-328385.html 0.6 2026-06-21T01:38:38+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-launches-rufinamide-tablets-usp-328386.html 0.6 2026-06-21T00:13:59+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-alkermes-lybalvi-for-schizo-328387.html 0.6 2026-08-05T18:50:54+08:00 daily https://www.pharmasources.com/industryinsights/low-awareness-of-rare-diseases-increases-328388.html 0.6 2026-06-18T07:56:05+08:00 daily https://www.pharmasources.com/industryinsights/fda-ftc-warn-five-companies-illegally-se-328389.html 0.6 2026-06-19T21:59:42+08:00 daily https://www.pharmasources.com/industryinsights/akorn-to-sell-consumer-health-business-t-328390.html 0.6 2026-06-21T19:00:40+08:00 daily https://www.pharmasources.com/industryinsights/eurofins-awarded-us-government-agreement-328391.html 0.6 2026-08-07T16:15:18+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-expands-production-capacities--328392.html 0.6 2026-06-19T14:48:58+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-an-oral-treatment-for-ad-328393.html 0.6 2026-07-02T13:36:09+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-biohavens-nurtec-odt-first--328394.html 0.6 2026-07-02T19:25:04+08:00 daily https://www.pharmasources.com/industryinsights/roche-canada-announces-collaboration-to--328395.html 0.6 2026-07-03T13:10:25+08:00 daily https://www.pharmasources.com/industryinsights/ec-authorises-diurnals-efmody-for-cah-328396.html 0.6 2026-06-22T01:10:01+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-halts-venglustat-clinical-program-328397.html 0.6 2026-08-07T21:43:39+08:00 daily https://www.pharmasources.com/industryinsights/amgen-and-kyowa-kirin-agree-to-jointly-d-328398.html 0.6 2026-06-20T02:17:35+08:00 daily https://www.pharmasources.com/industryinsights/amoxicillin-trihydrate-api-powder-manufa-328399.html 0.6 2026-06-28T04:13:40+08:00 daily https://www.pharmasources.com/industryinsights/university-of-bradford-to-host-covid-19--328400.html 0.6 2026-06-20T13:22:45+08:00 daily https://www.pharmasources.com/industryinsights/therabody-announces-partnership-with-wor-328401.html 0.6 2026-06-19T21:16:32+08:00 daily https://www.pharmasources.com/industryinsights/cigna-international-survey-finds-percept-328402.html 0.6 2026-08-08T07:32:29+08:00 daily https://www.pharmasources.com/industryinsights/transcenta-announced-completion-of-first-328403.html 0.6 2026-06-21T10:04:10+08:00 daily https://www.pharmasources.com/industryinsights/bridge-biotherapeutics-announces-the-ini-328404.html 0.6 2026-06-20T05:53:14+08:00 daily https://www.pharmasources.com/industryinsights/azithromycin-api-bulk-price-and-manufact-328405.html 0.6 2026-08-06T23:36:35+08:00 daily https://www.pharmasources.com/industryinsights/eucure-biopharma-to-present-findings-fro-328406.html 0.6 2026-06-19T16:19:45+08:00 daily https://www.pharmasources.com/industryinsights/ceftriaxone-sodium-trihydrate-api-price--328407.html 0.6 2026-08-06T23:46:33+08:00 daily https://www.pharmasources.com/industryinsights/puyi-biotechnology-completes-series-b-fi-328408.html 0.6 2026-07-02T03:17:00+08:00 daily https://www.pharmasources.com/industryinsights/daewoong-pharmaceutical-publishes-result-328409.html 0.6 2026-08-01T22:32:34+08:00 daily https://www.pharmasources.com/industryinsights/genscript-probio-and-neoletix-signed-a-l-328410.html 0.6 2026-08-12T00:01:43+08:00 daily https://www.pharmasources.com/industryinsights/biovaxys-and-bioproduction-partner-bio-e-328411.html 0.6 2026-07-08T11:27:51+08:00 daily https://www.pharmasources.com/industryinsights/medical-informatics-corp-commended-by-fr-328412.html 0.6 2026-08-09T07:37:31+08:00 daily https://www.pharmasources.com/industryinsights/neurophth-therapeutics-and-hopstem-biote-328413.html 0.6 2026-08-07T02:51:59+08:00 daily https://www.pharmasources.com/industryinsights/positive-fda-meetings-enable-neuren-to-p-328414.html 0.6 2026-08-07T02:39:39+08:00 daily https://www.pharmasources.com/industryinsights/scripps-research-institute-testing-shows-328415.html 0.6 2026-08-06T23:54:27+08:00 daily https://www.pharmasources.com/industryinsights/l-catterton-leads-40-million-series-b-ro-328416.html 0.6 2026-08-06T23:46:20+08:00 daily https://www.pharmasources.com/industryinsights/amgen-and-kyowa-kirin-to-jointly-develop-328417.html 0.6 2026-08-06T23:35:58+08:00 daily https://www.pharmasources.com/industryinsights/new-development-of-fda-regulations-on-co-328418.html 0.6 2026-08-06T20:07:40+08:00 daily https://www.pharmasources.com/industryinsights/net-health-provides-tips-for-hospitals-r-328419.html 0.6 2026-08-05T21:12:29+08:00 daily https://www.pharmasources.com/industryinsights/anheuser-busch-teams-up-with-the-white-h-328420.html 0.6 2026-06-21T13:00:34+08:00 daily https://www.pharmasources.com/industryinsights/lemi-shine-launches-epa-certified-disinf-328421.html 0.6 2026-06-20T01:00:03+08:00 daily https://www.pharmasources.com/industryinsights/lonza-to-install-new-production-line-at--328422.html 0.6 2026-06-21T03:06:55+08:00 daily https://www.pharmasources.com/industryinsights/genmab-bolt-ink-deal-to-develop-bispecif-328423.html 0.6 2026-07-21T13:03:44+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-expands-portfolio-with-328424.html 0.6 2026-08-10T20:08:50+08:00 daily https://www.pharmasources.com/industryinsights/medpharm-expands-topical-and-transdermal-328425.html 0.6 2026-08-09T04:18:28+08:00 daily https://www.pharmasources.com/industryinsights/houston-methodist-workers-sue-over-covid-328426.html 0.6 2026-08-09T01:19:32+08:00 daily https://www.pharmasources.com/industryinsights/vaccine-protection-may-diminish-need-for-328427.html 0.6 2026-08-08T23:29:59+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-brexafemme-ibrexafungerp-as-328428.html 0.6 2026-08-08T21:54:02+08:00 daily https://www.pharmasources.com/industryinsights/depressive-symptoms-linked-to-rapid-kidn-328429.html 0.6 2026-08-08T10:38:38+08:00 daily https://www.pharmasources.com/industryinsights/aptamer-group-collaborates-with-pinotbio-328430.html 0.6 2026-08-07T02:31:09+08:00 daily https://www.pharmasources.com/industryinsights/recro-expands-capabilities-for-clinical--328431.html 0.6 2026-08-07T07:32:58+08:00 daily https://www.pharmasources.com/industryinsights/asthma-flares-down-among-black-hispanic--328432.html 0.6 2026-08-08T04:35:11+08:00 daily https://www.pharmasources.com/industryinsights/lonza-moderna-expand-covid-vax-mfg-allia-328433.html 0.6 2026-08-08T22:54:06+08:00 daily https://www.pharmasources.com/industryinsights/selexis-sa-appoints-hoffmann-hecht-cbo-328434.html 0.6 2026-08-09T13:43:12+08:00 daily https://www.pharmasources.com/industryinsights/curevac-appoints-chief-development-offic-328435.html 0.6 2026-06-20T17:35:58+08:00 daily https://www.pharmasources.com/industryinsights/ats-guideline-addresses-testing-for-vira-328436.html 0.6 2026-08-08T03:30:54+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-accepts-biologics-license-applica-328437.html 0.6 2026-08-06T05:44:18+08:00 daily https://www.pharmasources.com/industryinsights/nih-starts-trial-assessing-mix-match-cov-328438.html 0.6 2026-08-07T18:44:07+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-ferring-pharmaceuticals-sign--328439.html 0.6 2026-03-08T09:54:17+08:00 daily https://www.pharmasources.com/industryinsights/biological-e-to-produce-providence-thera-328440.html 0.6 2026-06-20T23:19:00+08:00 daily https://www.pharmasources.com/industryinsights/cipla-seeks-clarity-guidance-from-govt-f-328441.html 0.6 2026-08-07T18:00:12+08:00 daily https://www.pharmasources.com/industryinsights/israel-approves-covid-jabs-for-12-15-yea-328442.html 0.6 2026-08-07T13:18:10+08:00 daily https://www.pharmasources.com/industryinsights/first-of-its-kind-study-uses-smartphone--328443.html 0.6 2026-08-07T00:40:50+08:00 daily https://www.pharmasources.com/industryinsights/government-issues-operational-guidelines-328444.html 0.6 2026-08-07T12:45:37+08:00 daily https://www.pharmasources.com/industryinsights/indivumed-launches-the-nravel-ai-platfor-328445.html 0.6 2026-08-07T00:43:46+08:00 daily https://www.pharmasources.com/industryinsights/nordic-capital-acquires-advanz-pharma-fo-328446.html 0.6 2026-06-21T07:13:06+08:00 daily https://www.pharmasources.com/industryinsights/centivax-partners-with-us-nmrc-to-study--328447.html 0.6 2026-06-20T20:17:56+08:00 daily https://www.pharmasources.com/industryinsights/nrx-pharmaceuticals-seeks-fda-eua-for-co-328448.html 0.6 2026-06-20T08:01:59+08:00 daily https://www.pharmasources.com/industryinsights/janssens-myeloma-car-t-therapy-cilta-cel-328449.html 0.6 2026-07-25T20:16:03+08:00 daily https://www.pharmasources.com/industryinsights/cosentyx-approved-to-treat-plaque-psoria-328450.html 0.6 2026-06-21T22:54:39+08:00 daily https://www.pharmasources.com/industryinsights/who-authorises-sinovacs-covid-19-vaccine-328451.html 0.6 2026-06-22T22:55:03+08:00 daily https://www.pharmasources.com/industryinsights/uk-gupta-former-president-of-aspa-and-cm-328452.html 0.6 2026-06-21T10:15:17+08:00 daily https://www.pharmasources.com/industryinsights/first-in-human-universal-flu-vaccine-tri-328453.html 0.6 2026-06-29T16:10:16+08:00 daily https://www.pharmasources.com/industryinsights/novel-automated-production-technique-cou-328454.html 0.6 2026-06-20T17:53:13+08:00 daily https://www.pharmasources.com/industryinsights/ema-recommends-first-covid-19-vaccine-fo-328455.html 0.6 2025-11-13T10:19:15+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-treated-with-potentially-c-328456.html 0.6 2026-02-15T00:35:49+08:00 daily https://www.pharmasources.com/industryinsights/vaccine-slows-loss-of-insulin-production-328457.html 0.6 2026-07-02T23:44:38+08:00 daily https://www.pharmasources.com/industryinsights/uk-approves-janssen-covid-19-vaccine-328458.html 0.6 2026-01-31T00:00:14+08:00 daily https://www.pharmasources.com/industryinsights/grifols-to-provide-korean-red-cross-with-328459.html 0.6 2026-07-04T01:18:38+08:00 daily https://www.pharmasources.com/industryinsights/where-can-you-buy-cephalexin-monohydrate-328460.html 0.6 2026-08-07T00:02:00+08:00 daily https://www.pharmasources.com/industryinsights/clinical-trial-results-of-the-bcma-car-t-328461.html 0.6 2026-06-20T20:12:54+08:00 daily https://www.pharmasources.com/industryinsights/first-patient-dosed-in-qbiotics-msd-clin-328462.html 0.6 2026-08-10T11:17:41+08:00 daily https://www.pharmasources.com/industryinsights/idexx-acquires-ezyvet-328463.html 0.6 2026-08-08T13:04:56+08:00 daily https://www.pharmasources.com/industryinsights/genscript-biotech-and-ligand-pharmaceuti-328464.html 0.6 2026-08-14T20:16:58+08:00 daily https://www.pharmasources.com/industryinsights/dexamethasone-api-bulk-price-and-manufac-328465.html 0.6 2026-08-07T00:40:01+08:00 daily https://www.pharmasources.com/industryinsights/portonbio-announced-strategic-cooperatio-328466.html 0.6 2026-07-06T21:46:21+08:00 daily https://www.pharmasources.com/industryinsights/finasteride-manufacturers-bulk-price-mar-328467.html 0.6 2026-08-10T09:26:55+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-and-kahr-medical-annou-328468.html 0.6 2026-07-19T10:14:50+08:00 daily https://www.pharmasources.com/industryinsights/betagenon-ab-announces-investment-and-co-328469.html 0.6 2026-06-22T07:03:58+08:00 daily https://www.pharmasources.com/industryinsights/fluticasone-propionate-api-price-and-man-328470.html 0.6 2026-08-07T02:31:05+08:00 daily https://www.pharmasources.com/industryinsights/immvira-will-present-the-us-clinical-pha-328471.html 0.6 2026-06-22T12:34:22+08:00 daily https://www.pharmasources.com/industryinsights/glutathione-api-manufacturers-in-china-328472.html 0.6 2026-06-24T12:50:01+08:00 daily https://www.pharmasources.com/industryinsights/where-can-you-find-the-price-of-hydrocor-328473.html 0.6 2026-06-21T13:14:40+08:00 daily https://www.pharmasources.com/industryinsights/where-can-you-find-the-price-of-ivermect-328474.html 0.6 2026-08-14T07:01:34+08:00 daily https://www.pharmasources.com/industryinsights/methylprednisolone-api-manufacturers-in--328475.html 0.6 2026-07-08T02:10:46+08:00 daily https://www.pharmasources.com/industryinsights/paracetamol-api-manufacturers-in-china-328476.html 0.6 2026-08-10T00:06:49+08:00 daily https://www.pharmasources.com/industryinsights/first-antibiotics-used-by-doctors-penici-328477.html 0.6 2026-08-11T11:04:39+08:00 daily https://www.pharmasources.com/industryinsights/spironolactone-active-pharmaceutical-ing-328478.html 0.6 2026-08-14T21:56:30+08:00 daily https://www.pharmasources.com/industryinsights/sucralose-market-size-and-trend-328479.html 0.6 2026-08-13T09:58:58+08:00 daily https://www.pharmasources.com/industryinsights/where-can-you-find-the-price-of-tetracyc-328480.html 0.6 2026-08-07T17:22:51+08:00 daily https://www.pharmasources.com/industryinsights/vitamin-b6-api-manufacturers-in-china-328481.html 0.6 2026-08-14T14:39:58+08:00 daily https://www.pharmasources.com/industryinsights/what-is-the-market-size-of-vitamin-b12-328482.html 0.6 2026-06-27T10:44:15+08:00 daily https://www.pharmasources.com/industryinsights/where-can-you-find-the-price-of-vitamin--328483.html 0.6 2026-08-11T07:04:43+08:00 daily https://www.pharmasources.com/industryinsights/why-the-relaxation-in-lockdowns-is-expec-328484.html 0.6 2026-07-03T08:38:21+08:00 daily https://www.pharmasources.com/industryinsights/aethlon-medical-publishes-case-studies-o-328485.html 0.6 2026-06-20T07:14:41+08:00 daily https://www.pharmasources.com/industryinsights/verifly-digital-wallet-to-be-used-at-us--328486.html 0.6 2026-06-20T00:58:12+08:00 daily https://www.pharmasources.com/industryinsights/global-building-and-road-construction-eq-328487.html 0.6 2026-08-07T03:49:46+08:00 daily https://www.pharmasources.com/industryinsights/zoom-media-partnership-with-kantar-revea-328488.html 0.6 2026-06-19T13:18:58+08:00 daily https://www.pharmasources.com/industryinsights/neo-kuma-sees-early-success-on-psychedel-328489.html 0.6 2026-06-21T08:54:56+08:00 daily https://www.pharmasources.com/industryinsights/new-drug-for-vaginal-yeast-infections-ap-328490.html 0.6 2026-07-17T19:36:56+08:00 daily https://www.pharmasources.com/industryinsights/benefits-of-deep-brain-stimulation-persi-328491.html 0.6 2026-06-23T06:21:53+08:00 daily https://www.pharmasources.com/industryinsights/bms-faces-lawsuit-from-celgene-sharehold-328492.html 0.6 2026-08-08T10:50:13+08:00 daily https://www.pharmasources.com/industryinsights/call-to-action-on-covid-vaccine-access-f-328493.html 0.6 2026-08-07T13:18:04+08:00 daily https://www.pharmasources.com/industryinsights/cpl-completes-successful-virtual-health--328494.html 0.6 2026-08-07T05:30:45+08:00 daily https://www.pharmasources.com/industryinsights/world-leaders-unite-to-commit-to-global--328495.html 0.6 2026-07-07T00:13:01+08:00 daily https://www.pharmasources.com/industryinsights/pharmablock-sciences-partners-with-shouy-328496.html 0.6 2026-07-21T03:05:07+08:00 daily https://www.pharmasources.com/industryinsights/strokes-hitting-covid-patients-are-more--328497.html 0.6 2026-06-21T06:11:53+08:00 daily https://www.pharmasources.com/industryinsights/hhs-launches-first-venture-capital-partn-328498.html 0.6 2026-06-19T19:46:28+08:00 daily https://www.pharmasources.com/industryinsights/biovectra-inc-unveils-new-logo-and-brand-328499.html 0.6 2026-07-06T21:22:54+08:00 daily https://www.pharmasources.com/industryinsights/onyx-scientific-receives-commercial-api--328500.html 0.6 2026-06-21T06:03:49+08:00 daily https://www.pharmasources.com/industryinsights/rain-therapeutics-announces-collaboratio-328501.html 0.6 2026-06-20T14:02:04+08:00 daily https://www.pharmasources.com/industryinsights/alliance-to-zero-founded-for-green-pharm-328502.html 0.6 2026-06-20T22:12:16+08:00 daily https://www.pharmasources.com/industryinsights/early-birds-may-have-extra-buffer-agains-328503.html 0.6 2026-06-20T11:02:49+08:00 daily https://www.pharmasources.com/industryinsights/lupin-launches-generic-version-of-brovan-328504.html 0.6 2026-06-21T06:12:57+08:00 daily https://www.pharmasources.com/industryinsights/ocugen-bharat-biotech-sign-agreement-for-328505.html 0.6 2026-06-22T12:09:57+08:00 daily https://www.pharmasources.com/industryinsights/new-phase-3-data-at-wcpghan-show-long-te-328506.html 0.6 2026-06-19T21:07:50+08:00 daily https://www.pharmasources.com/industryinsights/diagnosed-prevalent-cases-of-systemic-sc-328507.html 0.6 2026-06-21T03:09:48+08:00 daily https://www.pharmasources.com/industryinsights/strongbridge-biopharma-plc-announces-iss-328508.html 0.6 2026-08-12T08:52:33+08:00 daily https://www.pharmasources.com/industryinsights/organon-launches-as-womens-health-compan-328509.html 0.6 2026-07-17T13:43:12+08:00 daily https://www.pharmasources.com/industryinsights/salmonella-outbreak-linked-to-raw-frozen-328510.html 0.6 2026-06-20T21:41:28+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-tentative-us-fda-nod-f-328511.html 0.6 2026-07-24T02:42:20+08:00 daily https://www.pharmasources.com/industryinsights/snowman-logistics-partners-with-dr-reddy-328512.html 0.6 2026-06-21T15:59:19+08:00 daily https://www.pharmasources.com/industryinsights/rheavita-closes-eur-25-million-series-a--328513.html 0.6 2026-06-20T12:18:02+08:00 daily https://www.pharmasources.com/industryinsights/aspa-messe-frankfurt-india-to-organise-a-328514.html 0.6 2026-08-08T14:38:47+08:00 daily https://www.pharmasources.com/industryinsights/innovation-pharma-closes-enrolment-in-ph-328515.html 0.6 2026-08-08T13:18:18+08:00 daily https://www.pharmasources.com/industryinsights/after-editor-in-chiefs-resignation-jama--328516.html 0.6 2026-06-21T18:51:41+08:00 daily https://www.pharmasources.com/industryinsights/could-this-novartis-initiative-finally-c-328517.html 0.6 2026-08-08T12:07:21+08:00 daily https://www.pharmasources.com/industryinsights/moderna-enters-drug-substance-production-328518.html 0.6 2026-08-09T06:59:22+08:00 daily https://www.pharmasources.com/industryinsights/morphosys-to-acquire-constellation-pharm-328519.html 0.6 2026-06-21T11:16:23+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-nda-for-first-potential-trea-328520.html 0.6 2026-06-20T09:08:44+08:00 daily https://www.pharmasources.com/industryinsights/ec-approval-for-opdivo-plus-yervoy-as-fi-328521.html 0.6 2026-08-14T14:51:41+08:00 daily https://www.pharmasources.com/industryinsights/amerisourcebergen-acquires-alliance-heal-328522.html 0.6 2026-06-22T04:59:40+08:00 daily https://www.pharmasources.com/industryinsights/merck-and-sanofis-first-and-only-six-in--328523.html 0.6 2026-07-04T23:04:17+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-accelerated-approval-to-infig-328524.html 0.6 2026-07-03T15:55:31+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-novartis-cosentyx-for-child-328525.html 0.6 2026-08-10T18:03:21+08:00 daily https://www.pharmasources.com/industryinsights/anifrolumab-shows-benefit-in-patients-wi-328526.html 0.6 2026-01-17T05:49:56+08:00 daily https://www.pharmasources.com/industryinsights/paratek-announces-fda-approval-of-nuzyra-328527.html 0.6 2026-07-12T11:15:36+08:00 daily https://www.pharmasources.com/industryinsights/novartis-presents-positive-results-from--328528.html 0.6 2026-08-03T05:27:43+08:00 daily https://www.pharmasources.com/industryinsights/novartis-reports-clinically-relevant-sur-328529.html 0.6 2026-08-11T07:10:04+08:00 daily https://www.pharmasources.com/industryinsights/nice-turns-down-gsks-iv-benlysta-for-sys-328530.html 0.6 2026-06-21T08:03:59+08:00 daily https://www.pharmasources.com/industryinsights/lynparza-shows-promise-in-preventing-can-328531.html 0.6 2026-06-09T18:15:16+08:00 daily https://www.pharmasources.com/industryinsights/indian-variant-of-coronavirus-now-domina-328532.html 0.6 2026-06-20T02:07:05+08:00 daily https://www.pharmasources.com/industryinsights/novartis-car-t-therapy-kymriah-shows-pro-328533.html 0.6 2026-06-21T12:14:27+08:00 daily https://www.pharmasources.com/industryinsights/nice-draft-guidance-does-not-recommend-e-328534.html 0.6 2026-06-25T15:45:03+08:00 daily https://www.pharmasources.com/industryinsights/jjs-tremfya-shows-significant-improvemen-328535.html 0.6 2026-08-07T00:43:15+08:00 daily https://www.pharmasources.com/industryinsights/100-days-mission-landmark-collaboration--328536.html 0.6 2026-08-06T23:55:37+08:00 daily https://www.pharmasources.com/industryinsights/us-begins-testing-mixed-covid-19-vaccine-328537.html 0.6 2026-06-25T18:55:06+08:00 daily https://www.pharmasources.com/industryinsights/risankizumab-induces-deep-remissions-in--328538.html 0.6 2026-06-30T07:15:45+08:00 daily https://www.pharmasources.com/industryinsights/yingli-pharma-announces-presentations-on-328539.html 0.6 2026-08-14T14:52:31+08:00 daily https://www.pharmasources.com/industryinsights/prixa-closes-us3-million-in-additional-f-328540.html 0.6 2026-07-17T16:12:56+08:00 daily https://www.pharmasources.com/industryinsights/antengene-announces-publication-of-abstr-328541.html 0.6 2026-06-23T03:01:57+08:00 daily https://www.pharmasources.com/industryinsights/vela-diagnostics-announces-collaboration-328542.html 0.6 2026-06-30T13:44:36+08:00 daily https://www.pharmasources.com/industryinsights/wcpghan-2021-fish-oil-taken-during-pregn-328543.html 0.6 2025-11-14T22:24:42+08:00 daily https://www.pharmasources.com/industryinsights/the-first-hormone-replacement-therapy-fo-328544.html 0.6 2026-07-19T13:02:29+08:00 daily https://www.pharmasources.com/industryinsights/china-nmpa-approves-micurxs-contezolid-f-328545.html 0.6 2026-07-19T16:56:01+08:00 daily https://www.pharmasources.com/industryinsights/rwdc-industries-appoints-new-chief-finan-328546.html 0.6 2026-06-22T04:48:57+08:00 daily https://www.pharmasources.com/industryinsights/innovent-and-lilly-jointly-announce-the--328547.html 0.6 2026-08-03T17:12:18+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-new-drug-treatment-for-chro-328548.html 0.6 2026-06-21T10:12:24+08:00 daily https://www.pharmasources.com/industryinsights/sotio-presents-positive-biomarker-data-f-328549.html 0.6 2026-06-19T13:23:16+08:00 daily https://www.pharmasources.com/industryinsights/pandemic-inevitably-slows-pharma-ma-acti-328550.html 0.6 2026-08-03T22:54:51+08:00 daily https://www.pharmasources.com/industryinsights/saint-louis-university-successfully-comp-328551.html 0.6 2026-06-30T12:18:20+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-survey-professionals-optimistic-328552.html 0.6 2026-06-21T07:58:59+08:00 daily https://www.pharmasources.com/industryinsights/china-makes-great-efforts-to-contain-cov-328553.html 0.6 2026-06-19T20:44:07+08:00 daily https://www.pharmasources.com/industryinsights/fda-authorizes-lower-1200-mg-intravenous-328554.html 0.6 2026-06-20T04:13:26+08:00 daily https://www.pharmasources.com/industryinsights/tno-study-shows-efficacy-of-corona-canon-328555.html 0.6 2026-08-08T00:54:49+08:00 daily https://www.pharmasources.com/industryinsights/your-doctor-appointments-might-look-diff-328556.html 0.6 2026-06-20T18:04:24+08:00 daily https://www.pharmasources.com/industryinsights/more-radiologists-participating-in-mssp--328557.html 0.6 2026-06-20T15:59:18+08:00 daily https://www.pharmasources.com/industryinsights/neonates-with-acute-seizures-may-be-over-328558.html 0.6 2026-06-20T08:55:48+08:00 daily https://www.pharmasources.com/industryinsights/gluten-intake-not-tied-to-cognition-in-w-328559.html 0.6 2026-08-07T13:16:53+08:00 daily https://www.pharmasources.com/industryinsights/infant-deaths-trigger-recall-of-fisher-p-328560.html 0.6 2026-08-09T07:56:27+08:00 daily https://www.pharmasources.com/industryinsights/newly-approved-lumakras-sotorasib-fights-328561.html 0.6 2026-08-06T03:58:15+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-legally-blind-photographer-over-328562.html 0.6 2026-06-23T11:49:39+08:00 daily https://www.pharmasources.com/industryinsights/vivebiotech-launches-lentiviral-vectors--328563.html 0.6 2026-06-21T10:58:07+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-tembexa-brincidofovir-for-t-328564.html 0.6 2026-03-08T09:42:09+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-wegovy-semaglutide-to-treat-328565.html 0.6 2026-08-06T05:58:18+08:00 daily https://www.pharmasources.com/industryinsights/full-fda-approval-could-drive-covid-19-v-328566.html 0.6 2026-06-20T23:13:56+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-us-trials-for-drug-made-in-taiw-328567.html 0.6 2026-06-20T09:16:48+08:00 daily https://www.pharmasources.com/industryinsights/sinovac-says-a-booster-shot-for-covid-19-328568.html 0.6 2026-06-22T03:54:01+08:00 daily https://www.pharmasources.com/industryinsights/jubilant-hollisterstier-expands-sterile--328569.html 0.6 2026-07-05T09:22:00+08:00 daily https://www.pharmasources.com/industryinsights/phase-ii-clinical-trial-of-niclosamide-d-328570.html 0.6 2026-04-19T22:10:10+08:00 daily https://www.pharmasources.com/industryinsights/argentina-formally-starts-producing-russ-328571.html 0.6 2026-06-20T06:06:12+08:00 daily https://www.pharmasources.com/industryinsights/south-koreas-ip-laws-key-to-expanding-co-328572.html 0.6 2026-06-20T03:58:41+08:00 daily https://www.pharmasources.com/industryinsights/az-delivers-18m-doses-ahead-of-mass-roll-328573.html 0.6 2026-08-08T00:52:54+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-recalls-2980-bottles-of-atorva-328574.html 0.6 2026-06-20T17:34:45+08:00 daily https://www.pharmasources.com/industryinsights/uks-johnson-calls-on-g7-to-vaccinate-wor-328575.html 0.6 2026-06-21T00:58:46+08:00 daily https://www.pharmasources.com/industryinsights/malta-based-company-to-provide-up-to-60--328576.html 0.6 2026-04-17T18:06:17+08:00 daily https://www.pharmasources.com/industryinsights/anvisa-allows-import-of-covaxin-sputnik--328577.html 0.6 2026-05-27T11:19:29+08:00 daily https://www.pharmasources.com/industryinsights/philippines-gets-1-million-more-sinovac--328578.html 0.6 2026-06-21T09:04:05+08:00 daily https://www.pharmasources.com/industryinsights/understanding-molecular-actions-may-be-k-328579.html 0.6 2026-06-20T15:14:23+08:00 daily https://www.pharmasources.com/industryinsights/investigation-of-reports-of-myocarditis--328580.html 0.6 2026-06-19T21:59:49+08:00 daily https://www.pharmasources.com/industryinsights/ethno-pharma-an-opportunity-for-india-328581.html 0.6 2026-04-25T16:19:05+08:00 daily https://www.pharmasources.com/industryinsights/sii-gets-approval-from-dcgi-to-produce-s-328582.html 0.6 2026-06-20T08:10:50+08:00 daily https://www.pharmasources.com/industryinsights/fake-covid-19-vaccines-pose-new-threat-i-328583.html 0.6 2026-06-21T01:33:15+08:00 daily https://www.pharmasources.com/industryinsights/pharma-supply-chain-companies-form-allia-328584.html 0.6 2026-06-21T12:07:21+08:00 daily https://www.pharmasources.com/industryinsights/pfizerbiontech-covid-19-vaccine-approved-328585.html 0.6 2026-08-02T03:13:09+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-cdsco-nod-for-clinical-328586.html 0.6 2026-06-20T19:45:23+08:00 daily https://www.pharmasources.com/industryinsights/us-keen-to-work-with-indian-investigator-328587.html 0.6 2026-06-22T04:14:50+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-partners-with-big-eortc-aft-to-st-328588.html 0.6 2026-06-23T09:16:07+08:00 daily https://www.pharmasources.com/industryinsights/countries-health-partners-deliberate-on--328589.html 0.6 2026-08-03T06:43:39+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-gets-us-fda-approval-for-theoph-328590.html 0.6 2026-03-20T11:33:42+08:00 daily https://www.pharmasources.com/industryinsights/fda-updates-regenerons-covid-19-antibody-328591.html 0.6 2026-06-21T07:03:55+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-covid-19-vaccine-approved-for-ado-328592.html 0.6 2026-08-03T09:46:17+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-faces-64bn-lawsuit-over-ca-328593.html 0.6 2026-06-22T08:49:57+08:00 daily https://www.pharmasources.com/industryinsights/merck-completes-spinoff-of-womens-health-328594.html 0.6 2026-06-22T09:01:45+08:00 daily https://www.pharmasources.com/industryinsights/eurofins-launches-a-new-multiplex-pcr-as-328595.html 0.6 2026-07-20T05:19:12+08:00 daily https://www.pharmasources.com/industryinsights/fda-provides-new-guidance-to-further-enh-328596.html 0.6 2026-08-07T05:06:51+08:00 daily https://www.pharmasources.com/industryinsights/organon-launches-as-new-global-womens-he-328597.html 0.6 2026-08-07T04:52:46+08:00 daily https://www.pharmasources.com/industryinsights/aeterna-zentaris-announces-final-settlem-328598.html 0.6 2026-06-21T12:11:33+08:00 daily https://www.pharmasources.com/industryinsights/nih-researchers-identify-potential-new-a-328599.html 0.6 2026-06-22T13:53:15+08:00 daily https://www.pharmasources.com/industryinsights/how-to-obtain-immune-bovine-milk-to-stre-328600.html 0.6 2026-06-24T06:44:05+08:00 daily https://www.pharmasources.com/industryinsights/new-study-may-help-explain-low-oxygen-le-328601.html 0.6 2026-06-19T20:57:49+08:00 daily https://www.pharmasources.com/industryinsights/elekta-and-philips-deepen-strategic-part-328602.html 0.6 2026-06-26T02:28:27+08:00 daily https://www.pharmasources.com/industryinsights/usana-malaysia-once-again-named-no-1-com-328603.html 0.6 2026-06-23T08:05:02+08:00 daily https://www.pharmasources.com/industryinsights/alphamab-oncology-presents-phase-2-clini-328604.html 0.6 2026-06-21T15:47:12+08:00 daily https://www.pharmasources.com/industryinsights/alphamab-oncology-presents-phase-2-clini-328605.html 0.6 2026-07-17T22:34:51+08:00 daily https://www.pharmasources.com/industryinsights/origincell-therapeutics-presents-positiv-328606.html 0.6 2026-06-21T03:53:45+08:00 daily https://www.pharmasources.com/industryinsights/poster-highlighting-clinical-data-of-kn0-328607.html 0.6 2026-07-30T09:35:03+08:00 daily https://www.pharmasources.com/industryinsights/ascletis-received-china-ind-approval-of--328608.html 0.6 2026-07-26T06:13:44+08:00 daily https://www.pharmasources.com/industryinsights/arctic-vision-announces-exclusive-licens-328609.html 0.6 2026-08-04T13:29:40+08:00 daily https://www.pharmasources.com/industryinsights/innovent-releases-the-phase-iaib-dose-es-328610.html 0.6 2026-08-11T06:07:03+08:00 daily https://www.pharmasources.com/industryinsights/agc-biologics-inks-supply-deal-for-covid-328611.html 0.6 2026-06-20T21:08:43+08:00 daily https://www.pharmasources.com/industryinsights/portonbio-enter-car-t-partnership-with-k-328612.html 0.6 2026-06-22T12:58:04+08:00 daily https://www.pharmasources.com/industryinsights/fusion-to-build-radiopharma-manufacturin-328613.html 0.6 2026-06-20T20:09:39+08:00 daily https://www.pharmasources.com/industryinsights/exelead-helps-manufacture-pfizer-biontec-328614.html 0.6 2026-07-19T23:46:49+08:00 daily https://www.pharmasources.com/industryinsights/lupin-gets-usfda-nod-to-market-generic-h-328615.html 0.6 2026-06-19T22:19:26+08:00 daily https://www.pharmasources.com/industryinsights/csir-and-laxai-life-sciences-begin-phase-328616.html 0.6 2026-06-20T04:39:57+08:00 daily https://www.pharmasources.com/industryinsights/nmpb-and-csir-nbri-sign-mou-for-promotin-328617.html 0.6 2026-06-21T02:02:48+08:00 daily https://www.pharmasources.com/industryinsights/researchers-at-ils-bhubaneshwar-develop--328618.html 0.6 2026-06-20T22:55:45+08:00 daily https://www.pharmasources.com/industryinsights/mcurex-and-samyang-sign-mou-for-mrna-vac-328619.html 0.6 2026-03-01T17:46:43+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccines-show-efficacy-in-adole-328620.html 0.6 2026-06-21T21:18:01+08:00 daily https://www.pharmasources.com/industryinsights/e-pharmacies-could-lead-to-increase-in-d-328621.html 0.6 2026-06-22T09:01:43+08:00 daily https://www.pharmasources.com/industryinsights/serum-institute-obtains-dcgi-nod-to-prod-328622.html 0.6 2026-06-28T02:25:46+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-appoints-aradhana-sarin-as-n-328623.html 0.6 2026-07-16T08:29:59+08:00 daily https://www.pharmasources.com/industryinsights/ortho-regenerative-technologies-receives-328624.html 0.6 2026-08-13T00:47:08+08:00 daily https://www.pharmasources.com/industryinsights/novartis-tislelizumab-meets-primary-endp-328625.html 0.6 2026-07-16T11:09:36+08:00 daily https://www.pharmasources.com/industryinsights/imfinzi-demonstrates-unprecedented-survi-328626.html 0.6 2026-06-21T05:57:52+08:00 daily https://www.pharmasources.com/industryinsights/gsks-pd-1-inhibitor-jemperli-approved-in-328627.html 0.6 2026-06-21T14:50:17+08:00 daily https://www.pharmasources.com/industryinsights/amgens-kras-inhibitor-lumakras-scores-po-328628.html 0.6 2026-08-09T23:06:57+08:00 daily https://www.pharmasources.com/industryinsights/iksuda-therapeutics-raises-47m-to-progre-328629.html 0.6 2026-07-09T12:14:22+08:00 daily https://www.pharmasources.com/industryinsights/mhra-authorises-pfizerbiontechs-covid-19-328630.html 0.6 2026-08-09T01:13:04+08:00 daily https://www.pharmasources.com/industryinsights/tremfya-improves-psoriatic-arthritis-joi-328631.html 0.6 2026-06-30T17:10:21+08:00 daily https://www.pharmasources.com/industryinsights/pharma-supply-companies-form-the-allianc-328632.html 0.6 2026-06-25T12:00:09+08:00 daily https://www.pharmasources.com/industryinsights/tislelizumab-reduces-risk-of-death-by-30-328633.html 0.6 2026-07-01T16:48:13+08:00 daily https://www.pharmasources.com/industryinsights/eu-regulators-release-medicine-demand-fo-328634.html 0.6 2026-06-21T08:06:02+08:00 daily https://www.pharmasources.com/industryinsights/targedys-announces-the-publication-of-th-328635.html 0.6 2026-07-30T07:33:36+08:00 daily https://www.pharmasources.com/industryinsights/2021-zhejiang-export-commodity-online-fa-328636.html 0.6 2026-07-23T22:18:52+08:00 daily https://www.pharmasources.com/industryinsights/onward-therapeutics-signs-an-exclusive-c-328637.html 0.6 2026-06-20T14:42:03+08:00 daily https://www.pharmasources.com/industryinsights/cytiva-opens-experience-and-learning-lab-328638.html 0.6 2026-06-20T13:05:10+08:00 daily https://www.pharmasources.com/industryinsights/cgtn-peng-liyuan-calls-for-global-effort-328639.html 0.6 2026-08-14T10:57:46+08:00 daily https://www.pharmasources.com/industryinsights/innovent-biologics-and-iaso-biotherapeut-328640.html 0.6 2026-06-20T14:48:07+08:00 daily https://www.pharmasources.com/industryinsights/study-of-paxalisib-in-primary-cns-lympho-328641.html 0.6 2026-06-21T00:06:53+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharma-completes-enrollment-o-328642.html 0.6 2026-06-22T07:07:56+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-328643.html 0.6 2026-06-21T08:00:11+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-therapy-for-pediatric-patie-328644.html 0.6 2026-08-12T12:00:02+08:00 daily https://www.pharmasources.com/industryinsights/formulation-development-of-new-chemical--328645.html 0.6 2026-08-06T23:56:10+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-accelerated-approval-for-alzh-328646.html 0.6 2026-06-20T20:35:07+08:00 daily https://www.pharmasources.com/industryinsights/scipher-medicine-and-leading-medical-res-328647.html 0.6 2026-06-21T22:57:42+08:00 daily https://www.pharmasources.com/industryinsights/byondis-announces-positive-topline-resul-328648.html 0.6 2026-06-21T12:54:45+08:00 daily https://www.pharmasources.com/industryinsights/indo-irish-biotech-startup-cygenica-secu-328649.html 0.6 2026-06-20T20:02:35+08:00 daily https://www.pharmasources.com/industryinsights/first-of-its-kind-alzheimers-drug-gains--328650.html 0.6 2026-06-20T21:57:35+08:00 daily https://www.pharmasources.com/industryinsights/kaiser-permanente-joins-white-house-in-e-328651.html 0.6 2026-06-21T07:08:30+08:00 daily https://www.pharmasources.com/industryinsights/the-value-of-measuring-force-and-torque--328652.html 0.6 2026-07-29T21:57:33+08:00 daily https://www.pharmasources.com/industryinsights/science-of-epidemiology-digital-technolo-328653.html 0.6 2026-07-21T05:18:10+08:00 daily https://www.pharmasources.com/industryinsights/empowerpharm-certified-to-manufacture-cb-328654.html 0.6 2026-07-02T01:23:19+08:00 daily https://www.pharmasources.com/industryinsights/fda-okays-pfizers-prevnar-20-pneumococca-328655.html 0.6 2026-08-12T15:48:08+08:00 daily https://www.pharmasources.com/industryinsights/field-trip-health-ltd-applies-to-list-it-328656.html 0.6 2026-08-07T18:36:28+08:00 daily https://www.pharmasources.com/industryinsights/istari-oncology-hires-jamie-iudica-as-ch-328657.html 0.6 2026-08-08T01:51:31+08:00 daily https://www.pharmasources.com/industryinsights/real-world-study-shows-power-of-pfizer-m-328658.html 0.6 2026-06-21T10:10:12+08:00 daily https://www.pharmasources.com/industryinsights/mortality-increased-for-racialethnic-min-328659.html 0.6 2026-06-22T03:54:39+08:00 daily https://www.pharmasources.com/industryinsights/covid-vaccine-effective-for-90-of-cancer-328660.html 0.6 2026-06-21T13:00:35+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccine-patent-rules-reconsider-328661.html 0.6 2026-06-20T22:13:09+08:00 daily https://www.pharmasources.com/industryinsights/india-to-provide-free-covid-19-shots-for-328662.html 0.6 2026-06-22T15:45:38+08:00 daily https://www.pharmasources.com/industryinsights/what-diet-is-most-likely-to-help-ease-cr-328663.html 0.6 2026-06-21T11:02:10+08:00 daily https://www.pharmasources.com/industryinsights/death-rates-are-rising-across-rural-amer-328664.html 0.6 2026-08-07T00:56:03+08:00 daily https://www.pharmasources.com/industryinsights/adhd-meds-may-help-keep-some-kids-from-t-328665.html 0.6 2026-07-01T07:32:52+08:00 daily https://www.pharmasources.com/industryinsights/think-you-can-skip-that-annual-physical--328666.html 0.6 2026-06-20T13:05:13+08:00 daily https://www.pharmasources.com/industryinsights/crestone-joins-antimicrobials-working-gr-328667.html 0.6 2026-06-21T04:51:41+08:00 daily https://www.pharmasources.com/industryinsights/ocuphire-announces-closing-of-15-million-328668.html 0.6 2026-08-10T10:41:09+08:00 daily https://www.pharmasources.com/industryinsights/bioclinica-adds-econsent-to-edc-platform-328669.html 0.6 2026-08-07T01:58:57+08:00 daily https://www.pharmasources.com/industryinsights/aclaris-announces-proposed-public-offeri-328670.html 0.6 2026-06-20T15:03:20+08:00 daily https://www.pharmasources.com/industryinsights/inovio-advaccine-expand-covid-vax-allian-328671.html 0.6 2026-07-16T10:40:53+08:00 daily https://www.pharmasources.com/industryinsights/kiniksa-announces-issuance-of-us-patent--328672.html 0.6 2026-07-14T15:17:10+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-aducanumab-to-treat-alzheim-328673.html 0.6 2026-06-22T08:00:47+08:00 daily https://www.pharmasources.com/industryinsights/common-diabetes-drug-shows-promise-as-tr-328674.html 0.6 2026-06-19T16:18:29+08:00 daily https://www.pharmasources.com/industryinsights/dr-kiran-mazumdar-shaw-donates-rs-5-cror-328675.html 0.6 2026-07-17T00:44:39+08:00 daily https://www.pharmasources.com/industryinsights/pharma-among-top-5-sectors-most-affected-328676.html 0.6 2026-06-24T04:01:30+08:00 daily https://www.pharmasources.com/industryinsights/valeo-pharma-announces-100-million-bough-328677.html 0.6 2026-06-20T14:48:06+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-releases-interim-data-from-pms--328678.html 0.6 2026-07-08T04:13:31+08:00 daily https://www.pharmasources.com/industryinsights/bharat-biotech-gets-15-mn-upfront-from-o-328679.html 0.6 2026-06-22T00:47:31+08:00 daily https://www.pharmasources.com/industryinsights/cygenica-gets-14-million-funding-from-so-328680.html 0.6 2026-08-06T13:13:50+08:00 daily https://www.pharmasources.com/industryinsights/syngene-appoints-sanjeev-sukumaran-as-ch-328681.html 0.6 2026-06-22T07:00:49+08:00 daily https://www.pharmasources.com/industryinsights/biogen-gets-us-fda-accelerated-approval--328682.html 0.6 2026-08-13T07:58:41+08:00 daily https://www.pharmasources.com/industryinsights/arpa-h-bidens-proposed-government-health-328683.html 0.6 2026-06-21T12:26:47+08:00 daily https://www.pharmasources.com/industryinsights/moderna-and-medison-pharma-partner-to-co-328684.html 0.6 2026-06-22T01:48:29+08:00 daily https://www.pharmasources.com/industryinsights/janssen-affiliate-cilag-gmbh-internation-328685.html 0.6 2026-06-23T00:59:07+08:00 daily https://www.pharmasources.com/industryinsights/fda-authorizes-lower-intravenous-and-sub-328686.html 0.6 2026-08-06T16:59:05+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-drug-to-treat-smallpox-328687.html 0.6 2026-06-21T21:12:55+08:00 daily https://www.pharmasources.com/industryinsights/spinogenix-granted-fda-orphan-drug-desig-328688.html 0.6 2026-08-07T05:07:14+08:00 daily https://www.pharmasources.com/industryinsights/akoya-and-astrazeneca-collaborate-on-spa-328689.html 0.6 2026-08-07T05:01:21+08:00 daily https://www.pharmasources.com/industryinsights/aeterna-zentaris-engages-dr-michael-levy-328690.html 0.6 2026-08-07T04:52:48+08:00 daily https://www.pharmasources.com/industryinsights/calquence-demonstrates-fewer-incidences--328691.html 0.6 2026-08-07T04:57:23+08:00 daily https://www.pharmasources.com/industryinsights/novartis-announces-iptacopan-met-primary-328692.html 0.6 2026-08-07T05:13:22+08:00 daily https://www.pharmasources.com/industryinsights/new-research-identifies-single-biomarker-328693.html 0.6 2026-06-21T19:58:41+08:00 daily https://www.pharmasources.com/industryinsights/smc-backs-five-new-medicines-for-nhs-use-328694.html 0.6 2026-06-21T07:53:53+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-tecentriq-for-first-line-328695.html 0.6 2026-06-19T18:18:40+08:00 daily https://www.pharmasources.com/industryinsights/imfinzi-increases-five-year-survival-to--328696.html 0.6 2026-08-03T22:53:41+08:00 daily https://www.pharmasources.com/industryinsights/thermogelling-nanoemulsion-enhances-drug-328697.html 0.6 2026-08-08T15:52:15+08:00 daily https://www.pharmasources.com/industryinsights/chemotherapy-free-combination-shows-pote-328698.html 0.6 2026-08-09T06:59:06+08:00 daily https://www.pharmasources.com/industryinsights/hummingbird-bioscience-and-novogene-ente-328699.html 0.6 2026-08-09T00:37:50+08:00 daily https://www.pharmasources.com/industryinsights/travecta-therapeutics-appoints-charles-s-328700.html 0.6 2026-08-08T22:51:20+08:00 daily https://www.pharmasources.com/industryinsights/livful-and-global-access-diagnostics-ann-328701.html 0.6 2026-08-09T00:39:05+08:00 daily https://www.pharmasources.com/industryinsights/antengenes-partner-karyopharm-therapeuti-328702.html 0.6 2026-08-09T03:45:16+08:00 daily https://www.pharmasources.com/industryinsights/city-of-hope-takes-a-commercial-product--328703.html 0.6 2026-08-09T05:41:00+08:00 daily https://www.pharmasources.com/industryinsights/docgos-rapid-reliable-testing-partners-w-328704.html 0.6 2026-06-21T10:18:57+08:00 daily https://www.pharmasources.com/industryinsights/defense-logistics-market-covid-19-focuse-328705.html 0.6 2026-06-21T04:09:01+08:00 daily https://www.pharmasources.com/industryinsights/usd-331658-billion-growth-expected-in-mo-328706.html 0.6 2026-07-07T00:03:16+08:00 daily https://www.pharmasources.com/industryinsights/video-conferencing-market-size-to-reach--328707.html 0.6 2026-06-20T17:09:38+08:00 daily https://www.pharmasources.com/industryinsights/sp-hinduja-banque-prive-the-desai-founda-328708.html 0.6 2026-06-22T01:05:53+08:00 daily https://www.pharmasources.com/industryinsights/commercial-soft-serve-machines-market-co-328709.html 0.6 2026-08-09T03:45:36+08:00 daily https://www.pharmasources.com/industryinsights/entegris-to-expand-three-life-sciences-m-328710.html 0.6 2026-08-07T13:18:06+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-xdc-and-legochem-biosciences-signed-328711.html 0.6 2026-08-08T07:58:20+08:00 daily https://www.pharmasources.com/industryinsights/what-are-the-benefits-of-covid-19-vaccin-328712.html 0.6 2026-08-07T05:28:22+08:00 daily https://www.pharmasources.com/industryinsights/which-one-of-new-dosage-forms-of-nasal-s-328713.html 0.6 2026-08-06T14:02:42+08:00 daily https://www.pharmasources.com/industryinsights/fda-adcom-roster-shrinks-as-two-quit-ove-328714.html 0.6 2026-08-07T01:14:19+08:00 daily https://www.pharmasources.com/industryinsights/vertex-announces-us-fda-approval-for-tri-328715.html 0.6 2026-08-07T00:40:03+08:00 daily https://www.pharmasources.com/industryinsights/united-nations-urgent-global-action-need-328716.html 0.6 2026-08-07T01:21:36+08:00 daily https://www.pharmasources.com/industryinsights/expiration-date-looming-for-millions-of--328717.html 0.6 2026-06-21T14:18:52+08:00 daily https://www.pharmasources.com/industryinsights/cdr-life-appoints-bjrn-peters-as-chief-b-328718.html 0.6 2026-08-10T03:08:14+08:00 daily https://www.pharmasources.com/industryinsights/vaccinations-more-urgent-as-variant-that-328719.html 0.6 2026-08-08T01:02:12+08:00 daily https://www.pharmasources.com/industryinsights/immune-responses-after-covid-19-vaccinat-328720.html 0.6 2026-08-08T07:37:12+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-covid-vaccine-tied-to-rare-c-328721.html 0.6 2026-08-08T10:14:11+08:00 daily https://www.pharmasources.com/industryinsights/new-treatment-demonstrated-for-people-wi-328722.html 0.6 2026-08-08T12:18:38+08:00 daily https://www.pharmasources.com/industryinsights/new-adaptable-nanoparticle-platform-enab-328723.html 0.6 2026-08-08T14:03:07+08:00 daily https://www.pharmasources.com/industryinsights/catsci-opens-new-dagenham-laboratory-328724.html 0.6 2026-08-07T12:03:14+08:00 daily https://www.pharmasources.com/industryinsights/yourway-breaks-ground-on-major-expansion-328725.html 0.6 2026-08-07T01:13:53+08:00 daily https://www.pharmasources.com/industryinsights/symbiosis-names-jette-cowan-biz-developm-328726.html 0.6 2026-08-11T18:51:08+08:00 daily https://www.pharmasources.com/industryinsights/eubiologics-to-start-phase-two-clinical--328727.html 0.6 2026-08-08T15:49:50+08:00 daily https://www.pharmasources.com/industryinsights/csir-iict-lee-pharma-sign-agreement-to-p-328728.html 0.6 2026-08-07T05:30:46+08:00 daily https://www.pharmasources.com/industryinsights/rockwell-collaborates-with-dr-reddys-for-328729.html 0.6 2026-06-20T02:17:29+08:00 daily https://www.pharmasources.com/industryinsights/research-alliance-corp-i-announces-effec-328730.html 0.6 2026-06-30T11:19:14+08:00 daily https://www.pharmasources.com/industryinsights/lasa-supergenerics-adds-oxyclozanide-to--328731.html 0.6 2026-06-20T20:20:53+08:00 daily https://www.pharmasources.com/industryinsights/vibalogics-invests-an-additional-50-mill-328732.html 0.6 2026-06-21T16:06:30+08:00 daily https://www.pharmasources.com/industryinsights/healthcare-industry-reported-90-deals-wo-328733.html 0.6 2026-06-21T07:51:03+08:00 daily https://www.pharmasources.com/industryinsights/wto-to-start-vaccine-supply-negotiations-328734.html 0.6 2026-06-21T08:00:06+08:00 daily https://www.pharmasources.com/industryinsights/with-doses-at-risk-of-expiration-in-some-328735.html 0.6 2026-06-23T08:12:04+08:00 daily https://www.pharmasources.com/industryinsights/bharat-biotech-facility-in-hyderabad-get-328736.html 0.6 2026-06-23T12:26:52+08:00 daily https://www.pharmasources.com/industryinsights/medicares-penalties-for-poor-quality-dia-328737.html 0.6 2026-06-20T23:55:29+08:00 daily https://www.pharmasources.com/industryinsights/rideshare-apps-could-be-saving-lives-stu-328738.html 0.6 2026-08-07T14:35:03+08:00 daily https://www.pharmasources.com/industryinsights/merck-signs-12bn-supply-deal-with-us-for-328739.html 0.6 2026-04-06T19:18:03+08:00 daily https://www.pharmasources.com/industryinsights/cyxone-appoints-henrik-hang-as-cfo-328740.html 0.6 2026-08-07T13:16:07+08:00 daily https://www.pharmasources.com/industryinsights/indivior-and-aelis-enter-130m-deal-for-c-328741.html 0.6 2026-08-07T13:16:00+08:00 daily https://www.pharmasources.com/industryinsights/scipher-medicine-identifies-new-covid-19-328742.html 0.6 2026-08-08T04:36:44+08:00 daily https://www.pharmasources.com/industryinsights/elicera-therapeutics-new-issue-heavily-o-328743.html 0.6 2026-08-08T08:00:03+08:00 daily https://www.pharmasources.com/industryinsights/dermavant-raises-200m-to-support-tapinar-328744.html 0.6 2026-08-06T15:12:31+08:00 daily https://www.pharmasources.com/industryinsights/concern-over-covid-19-remains-uneven-in--328745.html 0.6 2026-08-09T02:38:54+08:00 daily https://www.pharmasources.com/industryinsights/inovio-expands-partnership-with-advaccin-328746.html 0.6 2026-08-09T04:32:34+08:00 daily https://www.pharmasources.com/industryinsights/bio-thera-solutions-initiates-phase-iii--328747.html 0.6 2026-04-21T03:15:20+08:00 daily https://www.pharmasources.com/industryinsights/niimbl-announces-46m-to-fund-10-new-biop-328748.html 0.6 2026-06-22T04:12:56+08:00 daily https://www.pharmasources.com/industryinsights/cell-and-gene-therapy-catapult-forms-con-328749.html 0.6 2026-06-20T14:44:19+08:00 daily https://www.pharmasources.com/industryinsights/bayer-subsidiary-doses-first-patient-wit-328750.html 0.6 2026-08-09T18:03:39+08:00 daily https://www.pharmasources.com/industryinsights/opdivo-combos-show-os-benefit-in-advance-328751.html 0.6 2026-06-21T07:14:05+08:00 daily https://www.pharmasources.com/industryinsights/3m-worth-of-illegally-sold-meds-and-devi-328752.html 0.6 2026-03-27T10:38:38+08:00 daily https://www.pharmasources.com/industryinsights/astellas-xtandi-bags-nice-approval-in-pr-328753.html 0.6 2026-06-21T08:02:03+08:00 daily https://www.pharmasources.com/industryinsights/amicus-pompe-disease-therapy-joins-early-328754.html 0.6 2026-08-08T00:05:13+08:00 daily https://www.pharmasources.com/industryinsights/no-survival-benefit-from-aspirin-in-covi-328755.html 0.6 2026-06-20T22:59:36+08:00 daily https://www.pharmasources.com/industryinsights/govt-announces-delay-to-gp-data-extracti-328756.html 0.6 2026-08-07T14:16:15+08:00 daily https://www.pharmasources.com/industryinsights/verona-pharma-and-nuance-pharma-announce-328757.html 0.6 2026-08-12T16:22:46+08:00 daily https://www.pharmasources.com/industryinsights/enamine-implements-cdd-vault-to-digitali-328758.html 0.6 2026-06-20T02:54:04+08:00 daily https://www.pharmasources.com/industryinsights/novel-microfluidic-device-could-enhance--328759.html 0.6 2026-08-07T14:08:31+08:00 daily https://www.pharmasources.com/industryinsights/ema-to-assess-whether-covid-19-vaccine-m-328760.html 0.6 2026-06-09T13:33:56+08:00 daily https://www.pharmasources.com/industryinsights/experts-call-for-improved-oversight-to-c-328761.html 0.6 2026-07-04T02:06:59+08:00 daily https://www.pharmasources.com/industryinsights/valneva-completes-phase-3-trial-recruitm-328762.html 0.6 2026-06-29T10:59:17+08:00 daily https://www.pharmasources.com/industryinsights/cdc-covid-19-study-shows-mrna-vaccines-r-328763.html 0.6 2026-08-02T02:50:17+08:00 daily https://www.pharmasources.com/industryinsights/protein-identified-as-new-therapeutic-an-328764.html 0.6 2026-08-09T06:51:37+08:00 daily https://www.pharmasources.com/industryinsights/monoclonal-antibody-prevents-hiv-infecti-328765.html 0.6 2026-08-09T02:40:03+08:00 daily https://www.pharmasources.com/industryinsights/affinity-empowering-launches-operation-e-328766.html 0.6 2026-08-09T05:41:08+08:00 daily https://www.pharmasources.com/industryinsights/new-research-telia-carrier-reveals-spike-328767.html 0.6 2026-06-22T07:57:48+08:00 daily https://www.pharmasources.com/industryinsights/calyx-supports-over-100-covid-19-vaccine-328768.html 0.6 2026-06-21T00:58:43+08:00 daily https://www.pharmasources.com/industryinsights/usd-2081-billion-growth-expected-in-wear-328769.html 0.6 2026-08-06T22:44:54+08:00 daily https://www.pharmasources.com/industryinsights/despite-covid-19-global-financial-wealth-328770.html 0.6 2026-03-17T22:59:07+08:00 daily https://www.pharmasources.com/industryinsights/houston-methodist-suspends-nearly-200-wo-328771.html 0.6 2026-04-11T19:58:23+08:00 daily https://www.pharmasources.com/industryinsights/arsenic-levels-trigger-recall-of-beech-n-328772.html 0.6 2026-07-05T09:46:37+08:00 daily https://www.pharmasources.com/industryinsights/codexis-and-takeda-expand-strategic-coll-328773.html 0.6 2026-06-30T11:06:54+08:00 daily https://www.pharmasources.com/industryinsights/51-billion-effort-to-eradicate-polio-ann-328774.html 0.6 2026-06-21T01:03:51+08:00 daily https://www.pharmasources.com/industryinsights/unitedhealthcare-delays-new-policy-on-em-328775.html 0.6 2026-08-06T23:16:22+08:00 daily https://www.pharmasources.com/industryinsights/us-to-send-500-million-covid-19-vaccine--328776.html 0.6 2026-06-20T02:15:10+08:00 daily https://www.pharmasources.com/industryinsights/america-is-losing-the-war-against-diabet-328777.html 0.6 2026-06-20T13:21:34+08:00 daily https://www.pharmasources.com/industryinsights/laughing-gas-shows-promise-against-tough-328778.html 0.6 2026-08-04T00:55:49+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-why-everyone-should-care-about--328779.html 0.6 2026-06-30T23:44:38+08:00 daily https://www.pharmasources.com/industryinsights/a-real-headache-racism-plays-role-in-mig-328780.html 0.6 2026-08-07T14:15:25+08:00 daily https://www.pharmasources.com/industryinsights/dfe-pharma-becomes-newest-partner-in-the-328781.html 0.6 2026-06-20T14:47:05+08:00 daily https://www.pharmasources.com/industryinsights/biogen-welcomes-nice-announcement-on-ta3-328782.html 0.6 2026-07-17T23:42:13+08:00 daily https://www.pharmasources.com/industryinsights/third-member-of-fda-expert-panel-exits-a-328783.html 0.6 2026-06-21T09:04:00+08:00 daily https://www.pharmasources.com/industryinsights/g7-to-donate-1-billion-covid-19-vaccine--328784.html 0.6 2026-04-21T13:19:28+08:00 daily https://www.pharmasources.com/industryinsights/vaccinated-adults-helps-protect-unvaccin-328785.html 0.6 2026-06-20T14:18:52+08:00 daily https://www.pharmasources.com/industryinsights/kyowa-kirin-new-data-analysis-shows-link-328786.html 0.6 2026-08-09T06:51:39+08:00 daily https://www.pharmasources.com/industryinsights/us-food-and-drug-administration-approves-328787.html 0.6 2026-06-28T21:49:58+08:00 daily https://www.pharmasources.com/industryinsights/abcellera-announces-secondary-private-sa-328788.html 0.6 2026-08-07T13:55:40+08:00 daily https://www.pharmasources.com/industryinsights/lsu-health-new-orleans-study-reports-com-328789.html 0.6 2026-08-09T08:00:04+08:00 daily https://www.pharmasources.com/industryinsights/us-says-it-will-push-covid-vaccine-waive-328790.html 0.6 2026-08-07T17:13:20+08:00 daily https://www.pharmasources.com/industryinsights/entrinsic-bioscience-secures-49-million--328791.html 0.6 2026-08-13T17:08:11+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-cuts-norways-covid-19-vaccine-del-328792.html 0.6 2026-06-21T05:58:59+08:00 daily https://www.pharmasources.com/industryinsights/alkem-launches-perampil-perampanel-table-328793.html 0.6 2026-07-15T17:01:45+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-prevnar-20-pneumococcal-20--328794.html 0.6 2026-06-22T07:01:48+08:00 daily https://www.pharmasources.com/industryinsights/mycovia-pharmaceuticals-submits-new-drug-328795.html 0.6 2026-04-22T00:31:21+08:00 daily https://www.pharmasources.com/industryinsights/emirates-skycargo-expands-pharma-cool-ch-328796.html 0.6 2026-06-08T07:25:12+08:00 daily https://www.pharmasources.com/industryinsights/procell-for-patient-project-to-develop-a-328797.html 0.6 2026-07-02T09:07:51+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-biontech-to-provide-500m-covid-va-328798.html 0.6 2026-08-05T10:22:54+08:00 daily https://www.pharmasources.com/industryinsights/csir-iict-niist-suven-pharma-sign-mou-fo-328799.html 0.6 2026-06-22T01:43:31+08:00 daily https://www.pharmasources.com/industryinsights/mankind-pharma-launches-posaconazole-tab-328800.html 0.6 2026-08-05T14:04:04+08:00 daily https://www.pharmasources.com/industryinsights/the-advent-of-digital-technologies-has-i-328801.html 0.6 2026-06-22T04:08:50+08:00 daily https://www.pharmasources.com/industryinsights/alkem-launches-perampil-perampanel-table-328802.html 0.6 2025-12-11T12:42:44+08:00 daily https://www.pharmasources.com/industryinsights/rockwell-automation-unleashes-new-possib-328803.html 0.6 2026-01-09T10:22:18+08:00 daily https://www.pharmasources.com/industryinsights/meril-gets-icmr-nod-for-covid-19-self-te-328804.html 0.6 2026-07-04T05:14:12+08:00 daily https://www.pharmasources.com/industryinsights/clinical-trials-of-covid-19-vaccines-and-328805.html 0.6 2026-06-21T14:47:21+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-partners-with-caraway-on-parkinso-328806.html 0.6 2026-06-27T09:45:50+08:00 daily https://www.pharmasources.com/industryinsights/viraleze-registered-for-sale-in-covid-ra-328807.html 0.6 2026-06-21T19:18:12+08:00 daily https://www.pharmasources.com/industryinsights/long-lasting-chlorine-dioxide-clo2-aqueo-328808.html 0.6 2026-06-21T04:19:02+08:00 daily https://www.pharmasources.com/industryinsights/yingli-pharma-announces-a-presentation-o-328809.html 0.6 2026-08-07T07:39:08+08:00 daily https://www.pharmasources.com/industryinsights/olipass-expands-scientific-advisory-boar-328810.html 0.6 2026-07-01T03:32:24+08:00 daily https://www.pharmasources.com/industryinsights/vinbrain-and-fit-jointly-release-a-white-328811.html 0.6 2026-06-20T23:54:30+08:00 daily https://www.pharmasources.com/industryinsights/janssen-covid-19-vaccine-can-protect-aga-328812.html 0.6 2026-06-21T07:46:58+08:00 daily https://www.pharmasources.com/industryinsights/cancer-vaccine-shows-promise-in-glioblas-328813.html 0.6 2026-07-05T03:47:47+08:00 daily https://www.pharmasources.com/industryinsights/sanaria-pfspz-cvac-vaccine-75-percent-ef-328814.html 0.6 2026-06-22T23:45:05+08:00 daily https://www.pharmasources.com/industryinsights/prof-ernst-wagner-joins-coriolis-pharmas-328815.html 0.6 2026-06-21T21:15:05+08:00 daily https://www.pharmasources.com/industryinsights/veraxa-biotech-and-quadira-biosciences-e-328816.html 0.6 2026-06-19T18:00:24+08:00 daily https://www.pharmasources.com/industryinsights/biovaxys-receives-positive-fda-response--328817.html 0.6 2026-06-19T22:53:41+08:00 daily https://www.pharmasources.com/industryinsights/novavax-covid-19-vaccine-demonstrates-90-328818.html 0.6 2026-08-08T18:56:53+08:00 daily https://www.pharmasources.com/industryinsights/chinese-biotech-firm-vazyme-to-showcase--328819.html 0.6 2026-08-07T12:34:04+08:00 daily https://www.pharmasources.com/industryinsights/pandemic-life-silver-lining-73-have-impr-328820.html 0.6 2026-08-10T17:34:41+08:00 daily https://www.pharmasources.com/industryinsights/robust-sales-growth-at-indian-pharma-com-328821.html 0.6 2026-08-08T10:13:56+08:00 daily https://www.pharmasources.com/industryinsights/us-food-and-drug-administration-accepts--328822.html 0.6 2026-08-08T10:06:08+08:00 daily https://www.pharmasources.com/industryinsights/pizzie-succeeds-dr-steve-burton-as-presi-328823.html 0.6 2026-06-21T02:54:57+08:00 daily https://www.pharmasources.com/industryinsights/enochian-biosciences-announces-29-millio-328824.html 0.6 2026-08-07T20:39:53+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-xdc-and-legochem-sign-mod-to-make-m-328825.html 0.6 2026-06-22T07:08:50+08:00 daily https://www.pharmasources.com/industryinsights/deep-breath-intelligence-collaborate-wit-328826.html 0.6 2026-06-21T12:59:34+08:00 daily https://www.pharmasources.com/industryinsights/catch-up-vaccinations-for-children-teens-328827.html 0.6 2026-06-22T06:52:55+08:00 daily https://www.pharmasources.com/industryinsights/cellectis-innovation-days-event-highligh-328828.html 0.6 2026-06-22T19:54:00+08:00 daily https://www.pharmasources.com/industryinsights/novavax-covid-19-vaccine-shines-in-lates-328829.html 0.6 2026-06-21T06:55:08+08:00 daily https://www.pharmasources.com/industryinsights/novavax-announces-positive-results-from--328830.html 0.6 2026-06-21T01:13:55+08:00 daily https://www.pharmasources.com/industryinsights/judge-dismisses-lawsuit-over-hospitals-c-328831.html 0.6 2026-06-20T18:04:22+08:00 daily https://www.pharmasources.com/industryinsights/weight-loss-surgeries-used-least-in-us-s-328832.html 0.6 2026-06-08T06:47:30+08:00 daily https://www.pharmasources.com/industryinsights/italys-aifa-approves-using-different-vac-328833.html 0.6 2026-06-23T02:55:20+08:00 daily https://www.pharmasources.com/industryinsights/good-news-bad-news-from-alzheimers-vacci-328834.html 0.6 2026-02-05T02:03:06+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-us-appears-to-lose-ground-in-co-328835.html 0.6 2026-08-10T16:33:01+08:00 daily https://www.pharmasources.com/industryinsights/genincode-eversana-enter-major-us-commer-328836.html 0.6 2026-06-20T14:42:04+08:00 daily https://www.pharmasources.com/industryinsights/most-editors-at-leading-medical-journals-328837.html 0.6 2026-06-21T12:53:55+08:00 daily https://www.pharmasources.com/industryinsights/yposkesi-to-build-second-commercial-biop-328838.html 0.6 2026-06-21T11:00:17+08:00 daily https://www.pharmasources.com/industryinsights/emergent-pledges-fda-improvements-at-tro-328839.html 0.6 2026-06-20T22:57:39+08:00 daily https://www.pharmasources.com/industryinsights/novavax-covid-19-vax-is-90-effective-in--328840.html 0.6 2026-06-22T10:49:43+08:00 daily https://www.pharmasources.com/industryinsights/iteos-therapeutics-gsk-enter-monoclonal--328841.html 0.6 2026-08-07T09:43:04+08:00 daily https://www.pharmasources.com/industryinsights/bd-hits-2-billion-injection-device-miles-328842.html 0.6 2026-07-11T07:30:22+08:00 daily https://www.pharmasources.com/industryinsights/enteris-biopharma-receives-10m-milestone-328843.html 0.6 2026-07-30T20:01:34+08:00 daily https://www.pharmasources.com/industryinsights/nice-approves-first-immunotherapy-combin-328844.html 0.6 2026-04-06T10:06:26+08:00 daily https://www.pharmasources.com/industryinsights/revolo-and-northway-biotech-enter-manufa-328845.html 0.6 2025-12-09T16:40:19+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-xdc-and-legochem-ink-adc-agreement-328846.html 0.6 2026-04-19T19:55:58+08:00 daily https://www.pharmasources.com/industryinsights/rafael-holdings-announces-appointments-t-328847.html 0.6 2026-06-19T16:48:40+08:00 daily https://www.pharmasources.com/industryinsights/vibalogics-expands-manufacturing-capacit-328848.html 0.6 2026-08-12T11:33:22+08:00 daily https://www.pharmasources.com/industryinsights/avalon-globocare-announces-execution-of--328849.html 0.6 2026-07-23T15:33:32+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-ready-to-make-covid-vaccines-for--328850.html 0.6 2026-06-21T04:02:50+08:00 daily https://www.pharmasources.com/industryinsights/ocugen-to-apply-for-full-us-fda-approval-328851.html 0.6 2026-02-26T04:48:24+08:00 daily https://www.pharmasources.com/industryinsights/bharat-biotech-shares-full-research-data-328852.html 0.6 2026-08-11T12:12:29+08:00 daily https://www.pharmasources.com/industryinsights/gossamer-bio-appoints-sandra-milligan-to-328853.html 0.6 2026-06-20T05:05:12+08:00 daily https://www.pharmasources.com/industryinsights/csir-laxai-life-sciences-get-dcgi-nod-fo-328854.html 0.6 2026-06-21T09:03:02+08:00 daily https://www.pharmasources.com/industryinsights/more-and-more-organisations-in-india-und-328855.html 0.6 2026-06-23T12:44:50+08:00 daily https://www.pharmasources.com/industryinsights/bright-minds-biosciences-appoints-new-bo-328856.html 0.6 2026-04-11T18:21:44+08:00 daily https://www.pharmasources.com/industryinsights/ease-supply-of-ingredients-for-making-co-328857.html 0.6 2026-06-20T17:03:16+08:00 daily https://www.pharmasources.com/industryinsights/ama-plan-to-fight-racism-criticized-by-s-328858.html 0.6 2026-06-20T09:54:02+08:00 daily https://www.pharmasources.com/industryinsights/csir-cdri-lucknow-sign-license-deal-with-328859.html 0.6 2026-08-07T12:43:15+08:00 daily https://www.pharmasources.com/industryinsights/lupin-donates-oxygen-generation-plants-i-328860.html 0.6 2026-06-20T19:53:35+08:00 daily https://www.pharmasources.com/industryinsights/biophore-applies-for-dcgi-approval-for-e-328861.html 0.6 2026-08-06T23:30:26+08:00 daily https://www.pharmasources.com/industryinsights/global-oncology-phase-ii-clinical-trials-328862.html 0.6 2026-08-10T03:06:47+08:00 daily https://www.pharmasources.com/industryinsights/ocugen-to-seek-full-approval-for-bharat--328863.html 0.6 2026-08-07T03:25:05+08:00 daily https://www.pharmasources.com/industryinsights/humanigen-starts-rolling-submission-for--328864.html 0.6 2026-08-07T03:02:41+08:00 daily https://www.pharmasources.com/industryinsights/modernas-new-covid-19-vaccine-production-328865.html 0.6 2026-08-07T02:55:16+08:00 daily https://www.pharmasources.com/industryinsights/fda-authorises-jj-covid-19-vaccine-subst-328866.html 0.6 2026-08-07T02:52:12+08:00 daily https://www.pharmasources.com/industryinsights/suzhou-frontera-therapeutics-starts-manu-328867.html 0.6 2026-08-07T02:36:57+08:00 daily https://www.pharmasources.com/industryinsights/concord-medical-officially-opens-new-spe-328868.html 0.6 2026-08-07T02:31:16+08:00 daily https://www.pharmasources.com/industryinsights/tetracore-inc-introduces-first-usda-lice-328869.html 0.6 2026-08-07T22:40:52+08:00 daily https://www.pharmasources.com/industryinsights/immvira-completed-the-first-dosing-for-p-328870.html 0.6 2026-08-09T17:54:07+08:00 daily https://www.pharmasources.com/industryinsights/bridge-biotherapeutics-announces-the-ini-328871.html 0.6 2026-06-20T23:16:57+08:00 daily https://www.pharmasources.com/industryinsights/ascentage-pharma-announces-ind-clearance-328872.html 0.6 2026-06-21T12:01:12+08:00 daily https://www.pharmasources.com/industryinsights/bookdoc-seeks-strategic-partnerships-for-328873.html 0.6 2026-06-21T22:00:41+08:00 daily https://www.pharmasources.com/industryinsights/the-us-fda-approved-ind-application-to-i-328874.html 0.6 2026-08-10T17:13:26+08:00 daily https://www.pharmasources.com/industryinsights/iapps-health-group-a-fin-medtech-company-328875.html 0.6 2026-02-15T09:24:14+08:00 daily https://www.pharmasources.com/industryinsights/innovent-announces-first-overweight-or-o-328876.html 0.6 2026-08-08T16:01:56+08:00 daily https://www.pharmasources.com/industryinsights/hummingbird-bioscience-to-speak-at-2021--328877.html 0.6 2026-08-12T07:20:55+08:00 daily https://www.pharmasources.com/industryinsights/an-omega-3-thats-poison-for-tumors-328878.html 0.6 2026-06-20T21:06:49+08:00 daily https://www.pharmasources.com/industryinsights/scipher-medicine-presents-new-data-at-th-328879.html 0.6 2026-06-19T15:14:51+08:00 daily https://www.pharmasources.com/industryinsights/sermo-acquires-minter-group-to-meet-grow-328880.html 0.6 2026-06-26T06:21:39+08:00 daily https://www.pharmasources.com/industryinsights/why-vaccinated-travelers-should-still-bu-328881.html 0.6 2026-06-21T12:49:37+08:00 daily https://www.pharmasources.com/industryinsights/nineteen-percent-of-asymptomatic-covid-1-328882.html 0.6 2026-06-22T10:56:45+08:00 daily https://www.pharmasources.com/industryinsights/covid-rapid-test-confirms-presence-of-an-328883.html 0.6 2026-06-22T06:25:33+08:00 daily https://www.pharmasources.com/industryinsights/spartan-medical-supports-lukes-wings-and-328884.html 0.6 2026-06-21T05:55:39+08:00 daily https://www.pharmasources.com/industryinsights/telemedicines-emergence-from-the-pandemi-328885.html 0.6 2026-06-21T03:01:48+08:00 daily https://www.pharmasources.com/industryinsights/robert-half-research-points-to-strong-jo-328886.html 0.6 2026-06-21T12:24:47+08:00 daily https://www.pharmasources.com/industryinsights/salix-will-share-trulance-plecanatide-da-328887.html 0.6 2026-08-07T00:59:00+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-328888.html 0.6 2026-06-20T20:53:43+08:00 daily https://www.pharmasources.com/industryinsights/ced-announces-recipients-of-its-2021-dis-328889.html 0.6 2026-06-19T18:16:50+08:00 daily https://www.pharmasources.com/industryinsights/oneamerica-emerges-from-pandemic-year-wi-328890.html 0.6 2026-08-04T09:57:17+08:00 daily https://www.pharmasources.com/industryinsights/nanostring-and-parker-institute-for-canc-328891.html 0.6 2026-08-06T23:55:30+08:00 daily https://www.pharmasources.com/industryinsights/dendreon-pharmaceuticals-establishes-con-328892.html 0.6 2026-06-24T04:53:12+08:00 daily https://www.pharmasources.com/industryinsights/ocugen-and-jubilant-enter-covid-19-vacci-328893.html 0.6 2026-08-07T00:02:15+08:00 daily https://www.pharmasources.com/industryinsights/crispr-capsida-team-up-on-gene-edited-th-328894.html 0.6 2026-08-07T00:39:55+08:00 daily https://www.pharmasources.com/industryinsights/veraxa-and-quadira-enter-adc-development-328895.html 0.6 2026-08-07T02:39:39+08:00 daily https://www.pharmasources.com/industryinsights/researchers-identify-why-covid-19-patien-328896.html 0.6 2026-08-10T12:12:23+08:00 daily https://www.pharmasources.com/industryinsights/sylvia-mcbrinn-joins-board-while-oskar-l-328897.html 0.6 2026-06-21T06:51:13+08:00 daily https://www.pharmasources.com/industryinsights/elanco-exits-manufacturing-sites-328898.html 0.6 2026-08-13T19:03:42+08:00 daily https://www.pharmasources.com/industryinsights/the-bulky-size-of-sars-cov-2-might-make--328899.html 0.6 2026-07-04T05:46:01+08:00 daily https://www.pharmasources.com/industryinsights/mikart-expands-oral-solids-production-ca-328900.html 0.6 2026-06-19T19:52:45+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-gets-tentative-us-fda-appro-328901.html 0.6 2026-06-20T07:06:33+08:00 daily https://www.pharmasources.com/industryinsights/an-emerging-target-for-solid-tumors----c-328902.html 0.6 2026-06-20T02:56:55+08:00 daily https://www.pharmasources.com/industryinsights/no-plans-to-enter-vaccine-production-as--328903.html 0.6 2026-06-21T02:15:51+08:00 daily https://www.pharmasources.com/industryinsights/lupin-gets-uk-marketing-authorisation-fo-328904.html 0.6 2026-06-21T06:11:55+08:00 daily https://www.pharmasources.com/industryinsights/natco-gets-us-fda-approval-for-carfilzom-328905.html 0.6 2026-08-10T10:41:08+08:00 daily https://www.pharmasources.com/industryinsights/lupin-gets-warning-letter-from-us-fda-fo-328906.html 0.6 2026-06-20T15:54:13+08:00 daily https://www.pharmasources.com/industryinsights/training-healthcare-workers-and-pharmaci-328907.html 0.6 2026-06-21T12:57:32+08:00 daily https://www.pharmasources.com/industryinsights/ennaid-therapeutics-partners-with-stride-328908.html 0.6 2026-06-22T02:06:56+08:00 daily https://www.pharmasources.com/industryinsights/senti-bio-signs-lease-agreement-and-begi-328909.html 0.6 2026-06-19T15:09:42+08:00 daily https://www.pharmasources.com/industryinsights/oppi-iapo-nathealth-ipa-searpharm-forum--328910.html 0.6 2026-06-20T19:15:09+08:00 daily https://www.pharmasources.com/industryinsights/avenue-therapeutics-gets-complete-respon-328911.html 0.6 2026-06-21T09:06:13+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-rezipres-ephedrine-hydrochl-328912.html 0.6 2026-07-21T13:58:37+08:00 daily https://www.pharmasources.com/industryinsights/delta-variant-double-risk-of-hospitalisa-328913.html 0.6 2026-06-21T03:14:50+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-launches-tiogiva-tiotropium-bro-328914.html 0.6 2026-08-14T19:01:20+08:00 daily https://www.pharmasources.com/industryinsights/direct-relief-facilitates-donations-of-1-328915.html 0.6 2026-08-05T20:24:57+08:00 daily https://www.pharmasources.com/industryinsights/hifibio-raises-series-d-funds-to-advance-328916.html 0.6 2026-08-12T11:16:07+08:00 daily https://www.pharmasources.com/industryinsights/eton-pharmaceuticals-acquires-us-and-can-328917.html 0.6 2026-08-14T10:27:54+08:00 daily https://www.pharmasources.com/industryinsights/stop-using-innova-sars-cov-2-antigen-rap-328918.html 0.6 2026-06-22T23:59:32+08:00 daily https://www.pharmasources.com/industryinsights/california-lifts-most-covid-19-restricti-328919.html 0.6 2026-06-20T22:54:06+08:00 daily https://www.pharmasources.com/industryinsights/janssen-covid-19-vaccine-shipment-made-w-328920.html 0.6 2026-06-20T20:02:34+08:00 daily https://www.pharmasources.com/industryinsights/fda-takes-steps-to-increase-availability-328921.html 0.6 2026-08-14T15:56:38+08:00 daily https://www.pharmasources.com/industryinsights/changes-to-the-mavyret-product-label-for-328922.html 0.6 2026-07-21T09:57:09+08:00 daily https://www.pharmasources.com/industryinsights/springworks-therapeutics-announces-prese-328923.html 0.6 2026-06-20T14:35:27+08:00 daily https://www.pharmasources.com/industryinsights/moderna-and-tabuk-pharmaceuticals-partne-328924.html 0.6 2026-06-20T15:12:18+08:00 daily https://www.pharmasources.com/industryinsights/new-hybrid-healthcare-agency-stirred-lau-328925.html 0.6 2026-07-05T01:34:04+08:00 daily https://www.pharmasources.com/industryinsights/financial-toxicity-more-prevalent-for-as-328926.html 0.6 2026-06-19T21:57:56+08:00 daily https://www.pharmasources.com/industryinsights/novartis-oral-therapy-iptacopan-shows-pr-328927.html 0.6 2026-06-21T01:12:54+08:00 daily https://www.pharmasources.com/industryinsights/modus-therapeutics-partners-with-imperia-328928.html 0.6 2026-07-18T13:39:48+08:00 daily https://www.pharmasources.com/industryinsights/sars-cov-2-antibodies-identified-before--328929.html 0.6 2026-08-11T17:56:30+08:00 daily https://www.pharmasources.com/industryinsights/mhra-approves-venclyxto-for-newly-diagno-328930.html 0.6 2026-06-21T10:03:11+08:00 daily https://www.pharmasources.com/industryinsights/stressors-of-integrating-work-life-highe-328931.html 0.6 2026-06-20T14:56:09+08:00 daily https://www.pharmasources.com/industryinsights/are-women-absorbing-toxins-from-their-ma-328932.html 0.6 2026-06-24T12:55:58+08:00 daily https://www.pharmasources.com/industryinsights/nice-broadens-access-to-treatments-for-r-328933.html 0.6 2026-06-19T17:19:43+08:00 daily https://www.pharmasources.com/industryinsights/could-a-type-of-statin-raise-dementia-ri-328934.html 0.6 2026-08-06T20:23:55+08:00 daily https://www.pharmasources.com/industryinsights/opdivo-plus-yervoy-scores-nice-backing-f-328935.html 0.6 2026-08-05T18:54:52+08:00 daily https://www.pharmasources.com/industryinsights/third-dose-of-covid-vaccine-boosts-prote-328936.html 0.6 2026-08-08T03:22:47+08:00 daily https://www.pharmasources.com/industryinsights/vertex-crispr-therapeutics-blood-disorde-328937.html 0.6 2026-06-20T20:17:49+08:00 daily https://www.pharmasources.com/industryinsights/nice-to-reassess-kyowa-kirins-poteligeo-328938.html 0.6 2026-06-19T23:51:54+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-misguided-masculinity-keeps-man-328939.html 0.6 2026-06-19T23:10:01+08:00 daily https://www.pharmasources.com/industryinsights/uk-to-donate-100-million-surplus-covid-1-328940.html 0.6 2026-06-21T01:05:49+08:00 daily https://www.pharmasources.com/industryinsights/harbour-biomed-and-dana-farber-cancer-in-328941.html 0.6 2026-06-29T06:26:26+08:00 daily https://www.pharmasources.com/industryinsights/totient-a-viva-biotech-portfolio-company-328942.html 0.6 2026-06-20T23:07:59+08:00 daily https://www.pharmasources.com/industryinsights/medidata-becomes-first-company-to-offer--328943.html 0.6 2026-06-20T08:24:05+08:00 daily https://www.pharmasources.com/industryinsights/doctoroncall-pfizer-and-uob-malaysia-for-328944.html 0.6 2026-06-20T22:15:30+08:00 daily https://www.pharmasources.com/industryinsights/galimedix-accelerating-development-of-it-328945.html 0.6 2026-07-04T20:27:48+08:00 daily https://www.pharmasources.com/industryinsights/frontera-therapeutics-starts-gmp-manufac-328946.html 0.6 2026-08-13T22:53:34+08:00 daily https://www.pharmasources.com/industryinsights/kazia-enters-clinical-collaboration-with-328947.html 0.6 2026-08-13T22:59:10+08:00 daily https://www.pharmasources.com/industryinsights/qynapse-to-present-clinical-results-of-q-328948.html 0.6 2026-06-20T23:57:40+08:00 daily https://www.pharmasources.com/industryinsights/dfe-pharma-joins-uks-leading-initiative--328949.html 0.6 2026-06-20T23:15:50+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-antibody-therapies-safe-and-eff-328950.html 0.6 2025-11-02T00:19:24+08:00 daily https://www.pharmasources.com/industryinsights/comirnaty-covid-19-vaccine-protects-agai-328951.html 0.6 2026-08-13T20:20:50+08:00 daily https://www.pharmasources.com/industryinsights/janssen-covid-19-vaccine-one-regulator-b-328952.html 0.6 2026-07-02T07:39:49+08:00 daily https://www.pharmasources.com/industryinsights/study-identifies-how-covid-19-linked-to--328953.html 0.6 2026-06-21T13:21:39+08:00 daily https://www.pharmasources.com/industryinsights/ampicillin-sodium-apimanufacturers-in-ch-328954.html 0.6 2026-08-08T01:42:20+08:00 daily https://www.pharmasources.com/industryinsights/betamethasone-dipropionate-api-manufactu-328955.html 0.6 2026-06-21T12:59:00+08:00 daily https://www.pharmasources.com/industryinsights/where-can-you-find-the-bulk-price-of-cef-328956.html 0.6 2026-08-13T22:56:14+08:00 daily https://www.pharmasources.com/industryinsights/whats-the-market-size-for-chloramphenico-328957.html 0.6 2026-08-08T22:01:43+08:00 daily https://www.pharmasources.com/industryinsights/clarithromycin-price-and-api-manufacture-328958.html 0.6 2026-08-10T15:14:23+08:00 daily https://www.pharmasources.com/industryinsights/where-can-you-find-the-bulk-price-of-coe-328959.html 0.6 2026-08-14T04:18:16+08:00 daily https://www.pharmasources.com/industryinsights/cortisone-acetate-api-manufacturers-in-c-328960.html 0.6 2026-08-10T22:13:14+08:00 daily https://www.pharmasources.com/industryinsights/what-is-the-difference-between-cytosine--328961.html 0.6 2026-08-14T04:13:36+08:00 daily https://www.pharmasources.com/industryinsights/gentamicin-sulfate-uses-price-and-api-ma-328962.html 0.6 2026-08-07T05:05:57+08:00 daily https://www.pharmasources.com/industryinsights/isotretinoin-brands-price-and-api-manufa-328963.html 0.6 2026-08-07T02:43:09+08:00 daily https://www.pharmasources.com/industryinsights/levodopa-market-size-and-major-suppliers-328964.html 0.6 2026-08-07T02:40:36+08:00 daily https://www.pharmasources.com/industryinsights/levonorgestrel-market-size-and-major-sup-328965.html 0.6 2026-08-09T06:21:58+08:00 daily https://www.pharmasources.com/industryinsights/where-can-you-find-the-price-of-minocycl-328966.html 0.6 2026-08-07T01:13:58+08:00 daily https://www.pharmasources.com/industryinsights/what-is-neomycin-sulphate-what-type-of-b-328967.html 0.6 2026-08-07T01:06:43+08:00 daily https://www.pharmasources.com/industryinsights/praziquantel-usage-price-api-manufacture-328968.html 0.6 2026-08-13T15:33:02+08:00 daily https://www.pharmasources.com/industryinsights/etruenorth-offers-five-tips-for-travel-r-328969.html 0.6 2026-03-17T21:03:13+08:00 daily https://www.pharmasources.com/industryinsights/thermo-scientific-upgrades-ultra-low-tem-328970.html 0.6 2026-07-19T01:36:07+08:00 daily https://www.pharmasources.com/industryinsights/lumen-bioscience-novo-nordisk-enter-meta-328971.html 0.6 2026-07-22T09:33:13+08:00 daily https://www.pharmasources.com/industryinsights/university-of-arkansas-nowdiagnostics-pa-328972.html 0.6 2026-06-21T00:15:49+08:00 daily https://www.pharmasources.com/industryinsights/recro-expands-board-of-directors-328973.html 0.6 2026-08-07T13:20:30+08:00 daily https://www.pharmasources.com/industryinsights/regen-cov-phase-3-trial-meets-primary-ou-328974.html 0.6 2026-08-09T01:21:19+08:00 daily https://www.pharmasources.com/industryinsights/masdar-city-attracts-global-and-regional-328975.html 0.6 2026-08-07T03:55:58+08:00 daily https://www.pharmasources.com/industryinsights/recent-patent-reforms-will-bolster-innov-328976.html 0.6 2026-08-12T09:57:38+08:00 daily https://www.pharmasources.com/industryinsights/csir-iict-anthem-biosciences-partner-to--328977.html 0.6 2026-08-07T03:27:29+08:00 daily https://www.pharmasources.com/industryinsights/health-ministry-who-jss-aher-ipa-and-par-328978.html 0.6 2026-08-07T03:34:49+08:00 daily https://www.pharmasources.com/industryinsights/jubilant-hollisterstier-partners-with-oc-328979.html 0.6 2026-08-09T14:45:56+08:00 daily https://www.pharmasources.com/industryinsights/novartis-cedes-us-operations-for-migrain-328980.html 0.6 2026-08-08T21:48:26+08:00 daily https://www.pharmasources.com/industryinsights/umoja-biopharma-raises-210m-to-develop-c-328981.html 0.6 2026-08-08T20:05:37+08:00 daily https://www.pharmasources.com/industryinsights/monosodium-phosphate-2-hydrate-is-now-av-328982.html 0.6 2026-06-29T20:13:40+08:00 daily https://www.pharmasources.com/industryinsights/rheumatoid-arthritis-accounts-for-189-sh-328983.html 0.6 2026-08-08T15:52:00+08:00 daily https://www.pharmasources.com/industryinsights/nrx-pharmaceuticals-zyesami-yields-posit-328984.html 0.6 2026-08-08T10:10:35+08:00 daily https://www.pharmasources.com/industryinsights/argenx-announces-publication-of-phase-3--328985.html 0.6 2026-08-07T13:17:42+08:00 daily https://www.pharmasources.com/industryinsights/mallinckrodt-obtains-fda-approval-for-st-328986.html 0.6 2026-08-08T07:49:58+08:00 daily https://www.pharmasources.com/industryinsights/vaccine-rollout-across-the-world-does-it-328987.html 0.6 2026-06-21T02:12:47+08:00 daily https://www.pharmasources.com/industryinsights/nih-awards-vibrent-health-contract-to-cr-328988.html 0.6 2026-08-09T03:10:54+08:00 daily https://www.pharmasources.com/industryinsights/storm-chaser-trial-fails-to-meet-primary-328989.html 0.6 2026-08-07T13:19:02+08:00 daily https://www.pharmasources.com/industryinsights/scientists-demonstrate-promising-new-app-328990.html 0.6 2026-08-07T00:40:34+08:00 daily https://www.pharmasources.com/industryinsights/additional-cohorts-to-evaluate-lns8801-i-328991.html 0.6 2026-08-07T00:42:49+08:00 daily https://www.pharmasources.com/industryinsights/dr-paul-burton-joins-moderna-as-chief-me-328992.html 0.6 2026-08-07T01:19:26+08:00 daily https://www.pharmasources.com/industryinsights/influenza-vaccine-and-novavax-covid-19-v-328993.html 0.6 2026-08-07T01:27:48+08:00 daily https://www.pharmasources.com/industryinsights/data-published-in-new-england-journal-of-328994.html 0.6 2026-08-07T06:06:46+08:00 daily https://www.pharmasources.com/industryinsights/jounce-therapeutics-receives-fda-clearan-328995.html 0.6 2026-08-07T13:18:19+08:00 daily https://www.pharmasources.com/industryinsights/circle-pharma-raises-66-million-in-serie-328996.html 0.6 2026-06-19T21:00:46+08:00 daily https://www.pharmasources.com/industryinsights/brazil-to-buy-single-shot-chinese-covid--328997.html 0.6 2026-06-21T01:01:46+08:00 daily https://www.pharmasources.com/industryinsights/ochre-bio-closes-96m-seed-financing-led--328998.html 0.6 2025-12-12T13:20:49+08:00 daily https://www.pharmasources.com/industryinsights/children-with-severe-mis-c-do-better-whe-328999.html 0.6 2026-08-07T21:21:55+08:00 daily https://www.pharmasources.com/industryinsights/chinas-first-mrna-covid-19-vaccine-preps-329000.html 0.6 2026-08-07T15:35:43+08:00 daily https://www.pharmasources.com/industryinsights/boan-biotech-to-start-phase-ii-clinical--329001.html 0.6 2026-08-04T02:51:12+08:00 daily https://www.pharmasources.com/industryinsights/biogens-inherited-eye-disease-gene-thera-329002.html 0.6 2026-08-03T08:04:35+08:00 daily https://www.pharmasources.com/industryinsights/imbruvicavenclyxto-tops-gazyva-plus-chem-329003.html 0.6 2026-06-20T23:57:33+08:00 daily https://www.pharmasources.com/industryinsights/curevac-blames-variants-for-covid-19-vac-329004.html 0.6 2026-06-21T07:43:46+08:00 daily https://www.pharmasources.com/industryinsights/g7-to-share-870-million-doses-of-covid-1-329005.html 0.6 2026-06-20T18:17:51+08:00 daily https://www.pharmasources.com/industryinsights/pharmacovigilance-risk-assessment-commit-329006.html 0.6 2026-05-12T16:17:03+08:00 daily https://www.pharmasources.com/industryinsights/alzheimers-vaccine-shows-promise-in-phas-329007.html 0.6 2026-07-11T21:42:24+08:00 daily https://www.pharmasources.com/industryinsights/new-consortium-to-develop-pat-for-cell-a-329008.html 0.6 2026-06-20T13:19:34+08:00 daily https://www.pharmasources.com/industryinsights/coronavirus-delta-variant-classified-var-329009.html 0.6 2026-04-23T16:44:01+08:00 daily https://www.pharmasources.com/industryinsights/health-canada-to-modernise-its-clinical--329010.html 0.6 2026-08-08T20:00:04+08:00 daily https://www.pharmasources.com/industryinsights/european-union-to-lift-restrictions-on-u-329011.html 0.6 2026-06-20T03:07:52+08:00 daily https://www.pharmasources.com/industryinsights/harbour-biomed-announces-dosing-of-first-329012.html 0.6 2026-08-09T18:55:06+08:00 daily https://www.pharmasources.com/industryinsights/new-york-lifts-pandemic-restrictions-329013.html 0.6 2026-08-07T17:53:49+08:00 daily https://www.pharmasources.com/industryinsights/elekta-radiotherapy-system-designed-for--329014.html 0.6 2026-06-21T13:07:34+08:00 daily https://www.pharmasources.com/industryinsights/for-losing-weight-calorie-counting-tops--329015.html 0.6 2026-07-06T21:42:44+08:00 daily https://www.pharmasources.com/industryinsights/cigna-survey-confirms-mental-health-serv-329016.html 0.6 2026-06-19T18:02:15+08:00 daily https://www.pharmasources.com/industryinsights/innocare-announces-orphan-drug-designati-329017.html 0.6 2026-08-02T11:56:06+08:00 daily https://www.pharmasources.com/industryinsights/spark-aligners-receive-fda-clearance-for-329018.html 0.6 2026-08-13T12:18:22+08:00 daily https://www.pharmasources.com/industryinsights/gannex-announces-positive-topline-result-329019.html 0.6 2026-06-20T20:06:40+08:00 daily https://www.pharmasources.com/industryinsights/proscia-lauded-by-frost-sullivan-for-adv-329020.html 0.6 2026-03-15T10:00:28+08:00 daily https://www.pharmasources.com/industryinsights/zhongchao-inc-partners-with-a-subsidiary-329021.html 0.6 2026-08-13T19:59:01+08:00 daily https://www.pharmasources.com/industryinsights/smic-liver-transplant-programs-ninth-don-329022.html 0.6 2026-06-24T16:51:24+08:00 daily https://www.pharmasources.com/industryinsights/cancer-cells-fight-for-their-footing-by--329023.html 0.6 2026-06-20T20:10:47+08:00 daily https://www.pharmasources.com/industryinsights/us-government-purchases-additional-200-m-329024.html 0.6 2026-08-12T19:39:01+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-a-nasal-antihistamine-for-n-329025.html 0.6 2025-11-27T09:22:14+08:00 daily https://www.pharmasources.com/industryinsights/nference-and-mayo-clinic-study-confirms--329026.html 0.6 2026-08-05T15:45:37+08:00 daily https://www.pharmasources.com/industryinsights/rover-labs-provides-saliva-based-covid-1-329027.html 0.6 2026-06-20T19:45:40+08:00 daily https://www.pharmasources.com/industryinsights/gsma-study-reveals-that-the-gender-gap-i-329028.html 0.6 2026-06-19T14:42:01+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-astepro-allergy-azelastine--329029.html 0.6 2026-06-27T04:47:03+08:00 daily https://www.pharmasources.com/industryinsights/drop-in-havana-covid-19-cases-boosts-hop-329030.html 0.6 2026-06-19T19:54:47+08:00 daily https://www.pharmasources.com/industryinsights/curevacs-covid-19-vaccine-only-47-percen-329031.html 0.6 2026-06-21T06:57:51+08:00 daily https://www.pharmasources.com/industryinsights/red-cross-warns-of-severe-blood-shortage-329032.html 0.6 2026-08-08T01:53:59+08:00 daily https://www.pharmasources.com/industryinsights/athira-pharma-coo-mark-litton-assumes-da-329033.html 0.6 2026-06-19T17:18:37+08:00 daily https://www.pharmasources.com/industryinsights/ahead-of-tokyo-olympics-japan-eases-covi-329034.html 0.6 2026-06-20T02:36:56+08:00 daily https://www.pharmasources.com/industryinsights/alzamend-neuro-announces-closing-of-init-329035.html 0.6 2026-08-04T03:55:35+08:00 daily https://www.pharmasources.com/industryinsights/eu-drug-regulator-records-415-cases-of-p-329036.html 0.6 2026-07-01T06:36:05+08:00 daily https://www.pharmasources.com/industryinsights/us-buys-200-million-extra-moderna-vaccin-329037.html 0.6 2026-03-19T19:00:59+08:00 daily https://www.pharmasources.com/industryinsights/local-pharma-to-begin-phase-2-clinical-t-329038.html 0.6 2025-12-18T00:59:53+08:00 daily https://www.pharmasources.com/industryinsights/pds-biotechnology-corporation-announces--329039.html 0.6 2026-08-03T20:55:13+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-moderna-vaccines-do-no-harm-to-ma-329040.html 0.6 2026-06-20T01:05:04+08:00 daily https://www.pharmasources.com/industryinsights/hand-sanitizer-vapors-can-cause-nausea-d-329041.html 0.6 2026-08-03T12:48:38+08:00 daily https://www.pharmasources.com/industryinsights/us-supreme-court-strikes-down-challenge--329042.html 0.6 2026-06-20T16:04:21+08:00 daily https://www.pharmasources.com/industryinsights/pot-use-may-change-the-teenage-brain-mri-329043.html 0.6 2026-08-10T12:34:22+08:00 daily https://www.pharmasources.com/industryinsights/servier-and-prism-biolab-enter-drug-disc-329044.html 0.6 2026-08-07T00:01:42+08:00 daily https://www.pharmasources.com/industryinsights/mithra-completes-recruitment-of-covid-19-329045.html 0.6 2026-08-06T23:57:14+08:00 daily https://www.pharmasources.com/industryinsights/cytoreason-collaborates-with-sanofi-usin-329046.html 0.6 2026-08-07T00:15:29+08:00 daily https://www.pharmasources.com/industryinsights/risk-of-covid-plummets-21-days-after-fir-329047.html 0.6 2026-08-07T00:15:32+08:00 daily https://www.pharmasources.com/industryinsights/subscribe-now-for-the-pharmasources-e-ne-329048.html 0.6 2026-07-30T10:26:35+08:00 daily https://www.pharmasources.com/industryinsights/immunicum-announces-results-of-directed--329049.html 0.6 2026-08-07T00:02:37+08:00 daily https://www.pharmasources.com/industryinsights/biohaven-appoints-kishen-mehta-to-board--329050.html 0.6 2026-08-06T23:57:04+08:00 daily https://www.pharmasources.com/industryinsights/harrow-health-announces-closing-of-20-mi-329051.html 0.6 2026-08-06T23:46:55+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-accepts-amneals-biologics-license-329052.html 0.6 2026-08-06T23:56:29+08:00 daily https://www.pharmasources.com/industryinsights/kite-and-shoreline-biosciences-enter-par-329053.html 0.6 2026-08-09T22:14:37+08:00 daily https://www.pharmasources.com/industryinsights/govt-is-taking-steps-to-boost-availabili-329054.html 0.6 2026-08-07T13:19:31+08:00 daily https://www.pharmasources.com/industryinsights/lupin-gets-us-fda-approval-for-sevelamer-329055.html 0.6 2026-08-07T15:08:04+08:00 daily https://www.pharmasources.com/industryinsights/pli-scheme-to-help-india-become-aatmanir-329056.html 0.6 2026-08-07T16:15:10+08:00 daily https://www.pharmasources.com/industryinsights/posts-on-social-media-misrepresented-fac-329057.html 0.6 2026-08-08T07:55:05+08:00 daily https://www.pharmasources.com/industryinsights/phdcci-urges-government-to-extend-suppor-329058.html 0.6 2026-08-08T12:18:43+08:00 daily https://www.pharmasources.com/industryinsights/icmr-study-finds-pregnant-postpartum-wom-329059.html 0.6 2026-07-08T22:00:01+08:00 daily https://www.pharmasources.com/industryinsights/avery-dennison-announces-leadership-chan-329060.html 0.6 2026-07-06T21:18:38+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-pandemic-brought-in-a-lot-of-fo-329061.html 0.6 2026-06-20T19:17:56+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-scientific-expands-sars-co-329062.html 0.6 2026-06-20T21:00:50+08:00 daily https://www.pharmasources.com/industryinsights/pai-partners-close-to-acquiring-vaccine--329063.html 0.6 2026-08-07T18:03:18+08:00 daily https://www.pharmasources.com/industryinsights/delta-plus-variant-is-not-yet-classified-329064.html 0.6 2026-06-20T15:02:13+08:00 daily https://www.pharmasources.com/industryinsights/aleor-dermaceuticals-gets-usfda-nod-for--329065.html 0.6 2026-06-21T15:56:42+08:00 daily https://www.pharmasources.com/industryinsights/researchers-in-ireland-identify-the-reas-329066.html 0.6 2026-06-21T01:39:16+08:00 daily https://www.pharmasources.com/industryinsights/kbi-biopharma-am-pharma-enter-manufactur-329067.html 0.6 2026-06-20T14:41:56+08:00 daily https://www.pharmasources.com/industryinsights/horizon-therapeutics-buys-eirgen-manufac-329068.html 0.6 2026-06-21T09:04:03+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-invests-425m-in-flu-vaccine-manuf-329069.html 0.6 2026-08-07T19:40:44+08:00 daily https://www.pharmasources.com/industryinsights/absci-acquires-cell-therapy-company-toti-329070.html 0.6 2026-06-21T08:31:32+08:00 daily https://www.pharmasources.com/industryinsights/australia-recommends-astrazeneca-covid-1-329071.html 0.6 2026-06-20T02:58:59+08:00 daily https://www.pharmasources.com/industryinsights/novartis-prostate-cancer-drug-gets-fda-b-329072.html 0.6 2026-08-14T18:07:06+08:00 daily https://www.pharmasources.com/industryinsights/moderna-and-magenta-partner-to-distribut-329073.html 0.6 2026-08-07T01:13:57+08:00 daily https://www.pharmasources.com/industryinsights/agenus-bla-for-balstilimab-as-treatment--329074.html 0.6 2026-08-07T00:40:48+08:00 daily https://www.pharmasources.com/industryinsights/organon-acquires-alydia-health-329075.html 0.6 2026-08-07T00:01:33+08:00 daily https://www.pharmasources.com/industryinsights/mannkind-and-united-therapeutics-nda-for-329076.html 0.6 2026-08-06T23:55:36+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-avapritinib-for-advanced-sy-329077.html 0.6 2026-08-07T00:01:30+08:00 daily https://www.pharmasources.com/industryinsights/lumen-bioscience-and-novo-nordisk-collab-329078.html 0.6 2026-08-07T00:40:17+08:00 daily https://www.pharmasources.com/industryinsights/danaher-to-acquire-aldevron-from-eqt-for-329079.html 0.6 2026-08-07T00:42:54+08:00 daily https://www.pharmasources.com/industryinsights/new-nice-guidance-supports-shared-decisi-329080.html 0.6 2026-08-07T02:31:04+08:00 daily https://www.pharmasources.com/industryinsights/ontozry-scores-mhra-authorisation-for-fo-329081.html 0.6 2026-08-07T02:38:00+08:00 daily https://www.pharmasources.com/industryinsights/nice-backs-lillys-taltz-for-axial-spondy-329082.html 0.6 2026-06-21T01:13:58+08:00 daily https://www.pharmasources.com/industryinsights/curevacs-covid-19-vaccine-misses-the-mar-329083.html 0.6 2026-06-20T10:17:59+08:00 daily https://www.pharmasources.com/industryinsights/researchers-develop-covid-19-antibody-te-329084.html 0.6 2026-06-21T10:16:40+08:00 daily https://www.pharmasources.com/industryinsights/lilly-plans-head-to-head-migraine-study--329085.html 0.6 2026-08-07T22:52:03+08:00 daily https://www.pharmasources.com/industryinsights/study-demonstrates-safety-and-efficacy-o-329086.html 0.6 2026-06-21T00:55:47+08:00 daily https://www.pharmasources.com/industryinsights/exscientia-expands-translational-capabil-329087.html 0.6 2026-06-20T16:02:16+08:00 daily https://www.pharmasources.com/industryinsights/collaboration-to-develop-an-automated-ca-329088.html 0.6 2026-06-21T02:02:54+08:00 daily https://www.pharmasources.com/industryinsights/chinese-patent-reforms-to-bolster-pharma-329089.html 0.6 2026-08-01T21:40:29+08:00 daily https://www.pharmasources.com/industryinsights/targeted-drug-delivery-enabled-by-geneti-329090.html 0.6 2026-06-23T02:55:53+08:00 daily https://www.pharmasources.com/industryinsights/global-clinical-trials-market-to-value-7-329091.html 0.6 2026-08-03T06:49:48+08:00 daily https://www.pharmasources.com/industryinsights/antibody-cocktail-improves-survival-in-s-329092.html 0.6 2026-08-09T22:07:18+08:00 daily https://www.pharmasources.com/industryinsights/car-t-therapy-achieves-high-remission-ra-329093.html 0.6 2026-08-06T20:57:11+08:00 daily https://www.pharmasources.com/industryinsights/beti-cel-gene-therapy-demonstrates-durab-329094.html 0.6 2026-08-10T15:18:58+08:00 daily https://www.pharmasources.com/industryinsights/innocare-presents-latest-clinical-data-o-329095.html 0.6 2026-06-20T14:51:03+08:00 daily https://www.pharmasources.com/industryinsights/decode-genetics-predicting-the-probabili-329096.html 0.6 2026-08-08T22:03:59+08:00 daily https://www.pharmasources.com/industryinsights/latest-testing-confirms-viraleze-highly--329097.html 0.6 2026-08-09T00:38:46+08:00 daily https://www.pharmasources.com/industryinsights/gilead-sciences-announces-subanalyses-of-329098.html 0.6 2026-08-09T02:39:02+08:00 daily https://www.pharmasources.com/industryinsights/nuevocor-closes-us24m-series-a-financing-329099.html 0.6 2026-08-10T17:21:54+08:00 daily https://www.pharmasources.com/industryinsights/jacobio-announces-first-two-patients-dos-329100.html 0.6 2026-07-05T02:50:29+08:00 daily https://www.pharmasources.com/industryinsights/from-bayer-china-to-ivf-applications-a-s-329101.html 0.6 2026-06-21T13:03:33+08:00 daily https://www.pharmasources.com/industryinsights/a-brief-introduction-about-fda-next-step-329102.html 0.6 2026-08-10T13:15:25+08:00 daily https://www.pharmasources.com/industryinsights/moneygram-announces-completion-of-atm-eq-329103.html 0.6 2026-06-20T21:46:36+08:00 daily https://www.pharmasources.com/industryinsights/the-2021-sco-international-round-table-w-329104.html 0.6 2026-06-30T06:04:57+08:00 daily https://www.pharmasources.com/industryinsights/new-scamadviser-survey-find-28-of-consum-329105.html 0.6 2026-06-21T04:18:16+08:00 daily https://www.pharmasources.com/industryinsights/cannabinoids-the-next-frontier-for-cosme-329106.html 0.6 2026-06-21T00:49:32+08:00 daily https://www.pharmasources.com/industryinsights/women-take-these-key-steps-to-good-urolo-329107.html 0.6 2026-08-11T19:05:11+08:00 daily https://www.pharmasources.com/industryinsights/privacy-concerns-examined-regarding-use--329108.html 0.6 2026-06-21T06:22:23+08:00 daily https://www.pharmasources.com/industryinsights/ascendo-developing-solution-to-rapid-vir-329109.html 0.6 2026-06-15T01:24:25+08:00 daily https://www.pharmasources.com/industryinsights/us-to-spend-32-billion-to-help-develop-a-329110.html 0.6 2026-06-22T04:01:46+08:00 daily https://www.pharmasources.com/industryinsights/tb-outbreak-may-be-linked-to-bone-repair-329111.html 0.6 2026-06-21T09:14:10+08:00 daily https://www.pharmasources.com/industryinsights/european-union-opens-doors-to-american-t-329112.html 0.6 2026-06-20T20:07:40+08:00 daily https://www.pharmasources.com/industryinsights/sickle-cell-plagues-many-black-americans-329113.html 0.6 2026-07-06T01:36:20+08:00 daily https://www.pharmasources.com/industryinsights/australias-first-locally-made-covid-19-m-329114.html 0.6 2026-06-21T00:16:50+08:00 daily https://www.pharmasources.com/industryinsights/on-fathers-day-give-dad-tips-to-keep-hea-329115.html 0.6 2026-06-21T01:58:41+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-at-17-he-received-a-new-heart-b-329116.html 0.6 2026-06-22T09:08:51+08:00 daily https://www.pharmasources.com/industryinsights/jacobio-earns-20m-abbvie-milestone-329117.html 0.6 2026-07-23T19:17:23+08:00 daily https://www.pharmasources.com/industryinsights/bioheng-biotech-received-orphan-drug-des-329118.html 0.6 2026-06-24T06:09:13+08:00 daily https://www.pharmasources.com/industryinsights/eisai-bms-enter-global-anticancer-adc-al-329119.html 0.6 2026-08-07T23:25:28+08:00 daily https://www.pharmasources.com/industryinsights/israel-says-it-sent-completely-normal-va-329120.html 0.6 2026-06-21T07:53:54+08:00 daily https://www.pharmasources.com/industryinsights/solvias-acquires-chemic-labs-329121.html 0.6 2026-06-21T05:15:56+08:00 daily https://www.pharmasources.com/industryinsights/vietnam-receives-500000-sinopharm-covid--329122.html 0.6 2026-06-22T14:52:37+08:00 daily https://www.pharmasources.com/industryinsights/new-products-to-drive-systemic-sclerosis-329123.html 0.6 2026-08-07T21:14:51+08:00 daily https://www.pharmasources.com/industryinsights/venus-remedies-wins-battle-against-scr-p-329124.html 0.6 2026-08-03T14:45:30+08:00 daily https://www.pharmasources.com/industryinsights/study-shows-corticosteroids-may-be-effec-329125.html 0.6 2026-07-02T21:08:19+08:00 daily https://www.pharmasources.com/industryinsights/alkems-st-louis-facility-gets-two-observ-329126.html 0.6 2026-07-16T20:31:26+08:00 daily https://www.pharmasources.com/industryinsights/israeli-scientists-find-promising-target-329127.html 0.6 2026-07-13T09:46:44+08:00 daily https://www.pharmasources.com/industryinsights/cuba-encouraged-by-early-trials-of-homeg-329128.html 0.6 2026-07-02T22:17:27+08:00 daily https://www.pharmasources.com/industryinsights/chinas-sinopharm-covid-19-vaccines-arriv-329129.html 0.6 2026-06-21T03:53:54+08:00 daily https://www.pharmasources.com/industryinsights/urgently-trying-to-work-with-astrazeneca-329130.html 0.6 2026-06-19T17:18:38+08:00 daily https://www.pharmasources.com/industryinsights/putin-says-russia-continues-working-on-n-329131.html 0.6 2026-06-21T12:11:23+08:00 daily https://www.pharmasources.com/industryinsights/china-other-asian-countries-vaccinate-ag-329132.html 0.6 2026-04-21T17:20:57+08:00 daily https://www.pharmasources.com/industryinsights/novartis-cosentyx-wins-nice-backing-for--329133.html 0.6 2026-08-09T05:37:21+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-jak-inhibitor-xeljanz-shows-bene-329134.html 0.6 2026-06-21T08:03:57+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-blueprint-medicines-ayvakit-329135.html 0.6 2026-06-20T00:03:51+08:00 daily https://www.pharmasources.com/industryinsights/researchers-identify-new-drug-class-with-329136.html 0.6 2026-08-07T02:48:03+08:00 daily https://www.pharmasources.com/industryinsights/govt-announces-36m-ai-research-funding-b-329137.html 0.6 2026-08-08T02:45:19+08:00 daily https://www.pharmasources.com/industryinsights/incyte-announces-us-fda-has-extended-the-329138.html 0.6 2026-06-29T08:46:44+08:00 daily https://www.pharmasources.com/industryinsights/adamis-provides-update-on-zimhi-329139.html 0.6 2026-08-09T03:10:56+08:00 daily https://www.pharmasources.com/industryinsights/beyondspring-announces-us-fda-acceptance-329140.html 0.6 2026-08-08T10:11:45+08:00 daily https://www.pharmasources.com/industryinsights/cstone-announces-first-prescriptions-of--329141.html 0.6 2026-08-09T06:59:39+08:00 daily https://www.pharmasources.com/industryinsights/cti-biopharma-announces-acceptance-of-nd-329142.html 0.6 2026-08-08T07:33:44+08:00 daily https://www.pharmasources.com/industryinsights/study-results-of-sintilimab-in-combinati-329143.html 0.6 2026-08-12T16:01:12+08:00 daily https://www.pharmasources.com/industryinsights/ean-congress-covid-19-leads-to-significa-329144.html 0.6 2026-08-08T21:48:37+08:00 daily https://www.pharmasources.com/industryinsights/akebia-and-otsuka-announce-fda-acceptanc-329145.html 0.6 2026-08-09T02:52:44+08:00 daily https://www.pharmasources.com/industryinsights/novavax-announces-positive-data-from-thr-329146.html 0.6 2026-08-09T06:19:56+08:00 daily https://www.pharmasources.com/industryinsights/bioheng-biotech-received-orphan-drug-des-329147.html 0.6 2026-07-27T20:25:28+08:00 daily https://www.pharmasources.com/industryinsights/carsgen-therapeutics-officially-listing--329148.html 0.6 2026-08-06T20:26:28+08:00 daily https://www.pharmasources.com/industryinsights/new-pivotal-data-at-eha-2021-reinforces--329149.html 0.6 2026-08-10T18:49:14+08:00 daily https://www.pharmasources.com/industryinsights/innocare-presents-latest-clinical-data-o-329150.html 0.6 2026-06-20T16:53:38+08:00 daily https://www.pharmasources.com/industryinsights/china-and-india-combat-coronavirus-pande-329151.html 0.6 2026-06-21T04:55:45+08:00 daily https://www.pharmasources.com/industryinsights/acer-therapeutics-plans-clinical-trial-f-329152.html 0.6 2026-06-22T05:09:53+08:00 daily https://www.pharmasources.com/industryinsights/innovent-announces-first-patient-dosed-i-329153.html 0.6 2026-08-04T10:50:58+08:00 daily https://www.pharmasources.com/industryinsights/over-900m-vaccine-doses-given-in-china-329154.html 0.6 2026-06-20T13:19:24+08:00 daily https://www.pharmasources.com/industryinsights/eccogene-announces-the-addition-of-jacqu-329155.html 0.6 2026-06-19T17:45:21+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-welcomes-court-ruling-on-sup-329156.html 0.6 2026-08-03T07:59:16+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccines-pre-prepared-in-syring-329157.html 0.6 2026-06-20T22:17:06+08:00 daily https://www.pharmasources.com/industryinsights/curevac-provides-update-on-phase-2b3-tri-329158.html 0.6 2026-06-21T12:12:21+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-oral-blood-thinning-m-329159.html 0.6 2026-07-06T18:09:36+08:00 daily https://www.pharmasources.com/industryinsights/biotage-launches-new-automated-platform--329160.html 0.6 2026-08-10T10:41:09+08:00 daily https://www.pharmasources.com/industryinsights/coriolis-pharma-expands-its-atmp-develop-329161.html 0.6 2026-08-08T01:12:47+08:00 daily https://www.pharmasources.com/industryinsights/implandatas-breakthrough-eyemate-sc-bios-329162.html 0.6 2026-08-09T00:17:00+08:00 daily https://www.pharmasources.com/industryinsights/ultrasonic-flowmeter-market-to-reach-959-329163.html 0.6 2026-08-08T22:03:04+08:00 daily https://www.pharmasources.com/industryinsights/rritual-superfoods-lists-with-health-foo-329164.html 0.6 2026-08-08T19:41:35+08:00 daily https://www.pharmasources.com/industryinsights/sewa-international-distributes-over-5700-329165.html 0.6 2026-08-08T17:54:05+08:00 daily https://www.pharmasources.com/industryinsights/danaher-to-acquire-aldevron-for-96b-329166.html 0.6 2026-08-08T20:53:55+08:00 daily https://www.pharmasources.com/industryinsights/axe-motivates-guys-to-get-vaxxed-then-ax-329167.html 0.6 2026-08-08T13:46:46+08:00 daily https://www.pharmasources.com/industryinsights/coriolis-pharma-expands-atmp-development-329168.html 0.6 2026-08-08T15:49:49+08:00 daily https://www.pharmasources.com/industryinsights/k-craft-in-times-square-new-york---2021--329169.html 0.6 2026-08-08T12:36:42+08:00 daily https://www.pharmasources.com/industryinsights/recreational-boating-market-to-reach-354-329170.html 0.6 2026-08-07T13:17:43+08:00 daily https://www.pharmasources.com/industryinsights/eupraxia-pharmaceuticals-inc-announces-1-329171.html 0.6 2026-08-07T12:00:11+08:00 daily https://www.pharmasources.com/industryinsights/procaps-group-announces-filing-of-regist-329172.html 0.6 2026-08-07T11:33:47+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-329174.html 0.6 2026-06-20T20:16:04+08:00 daily https://www.pharmasources.com/industryinsights/honeywell-introduces-authentication-tech-329175.html 0.6 2026-07-20T03:17:21+08:00 daily https://www.pharmasources.com/industryinsights/european-commission-approves-jardiance-t-329176.html 0.6 2026-08-12T19:25:51+08:00 daily https://www.pharmasources.com/industryinsights/cadila-pharma-launches-posaconazole-to-t-329177.html 0.6 2026-06-21T05:08:49+08:00 daily https://www.pharmasources.com/industryinsights/bayer-and-zydus-extend-their-jv-for-thre-329178.html 0.6 2026-08-08T19:07:25+08:00 daily https://www.pharmasources.com/industryinsights/sanofis-aubagio-obtains-ec-approval-for--329179.html 0.6 2026-03-01T01:44:46+08:00 daily https://www.pharmasources.com/industryinsights/oryzon-to-present-new-clinical-data-and--329180.html 0.6 2026-06-20T18:17:52+08:00 daily https://www.pharmasources.com/industryinsights/edesa-biotech-to-continue-global-covid-1-329181.html 0.6 2026-06-20T22:54:03+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-dual-antibody-therapies-effecti-329182.html 0.6 2026-06-21T08:06:04+08:00 daily https://www.pharmasources.com/industryinsights/gossamer-bio-promotes-richard-aranda-to--329183.html 0.6 2026-06-23T00:09:28+08:00 daily https://www.pharmasources.com/industryinsights/nurix-therapeutics-appoints-stefani-wolf-329184.html 0.6 2026-07-09T15:07:50+08:00 daily https://www.pharmasources.com/industryinsights/inhibrx-initiates-a-potential-registrati-329185.html 0.6 2026-07-20T06:27:01+08:00 daily https://www.pharmasources.com/industryinsights/kymera-therapeutics-appoints-elaine-caug-329186.html 0.6 2026-06-20T20:56:38+08:00 daily https://www.pharmasources.com/industryinsights/us-approval-for-otc-use-of-bayers-astepr-329187.html 0.6 2026-06-21T09:05:06+08:00 daily https://www.pharmasources.com/industryinsights/russians-threaten-to-sue-over-vaccine-sw-329188.html 0.6 2026-08-06T18:57:25+08:00 daily https://www.pharmasources.com/industryinsights/novartis-radioligand-therapy-granted-us--329189.html 0.6 2026-07-30T15:59:03+08:00 daily https://www.pharmasources.com/industryinsights/novan-announces-closing-of-40-million-pu-329190.html 0.6 2026-08-07T01:15:41+08:00 daily https://www.pharmasources.com/industryinsights/underlying-medical-conditions-up-risk-fo-329191.html 0.6 2026-07-25T06:32:49+08:00 daily https://www.pharmasources.com/industryinsights/gsk-vir-say-final-data-confirm-efficacy--329192.html 0.6 2026-07-25T06:42:16+08:00 daily https://www.pharmasources.com/industryinsights/in-11-states-seniors-low-vaccination-rat-329193.html 0.6 2026-07-25T06:44:51+08:00 daily https://www.pharmasources.com/industryinsights/blood-shortage-causes-surgery-delays-in--329194.html 0.6 2026-07-25T06:48:00+08:00 daily https://www.pharmasources.com/industryinsights/investigation-starts-in-five-states-afte-329195.html 0.6 2026-07-07T00:36:25+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-pradaxa-dabigatran-as-first-329196.html 0.6 2026-08-08T20:05:04+08:00 daily https://www.pharmasources.com/industryinsights/zolgensma-shows-promise-in-presymptomati-329197.html 0.6 2026-07-25T06:53:57+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-should-rare-cases-of-heart-infl-329198.html 0.6 2026-08-08T17:53:31+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccines-highly-effective-again-329199.html 0.6 2026-08-08T10:13:46+08:00 daily https://www.pharmasources.com/industryinsights/collaboration-to-develop-novel-polymer-b-329200.html 0.6 2026-08-08T08:38:40+08:00 daily https://www.pharmasources.com/industryinsights/blame-pandemic-best-way-to-save-relation-329201.html 0.6 2026-08-08T07:45:06+08:00 daily https://www.pharmasources.com/industryinsights/funding-to-support-trial-of-ketamine-in--329202.html 0.6 2026-08-07T13:54:37+08:00 daily https://www.pharmasources.com/industryinsights/not-so-happy-birthdays-parties-helped-sp-329203.html 0.6 2026-08-07T13:19:04+08:00 daily https://www.pharmasources.com/industryinsights/alfasigma-acquires-the-european-license--329204.html 0.6 2026-08-07T05:58:11+08:00 daily https://www.pharmasources.com/industryinsights/european-wellness-advances-clinical-tria-329205.html 0.6 2026-08-07T05:51:49+08:00 daily https://www.pharmasources.com/industryinsights/asieris-announces-first-patient-treated--329206.html 0.6 2026-08-09T10:27:25+08:00 daily https://www.pharmasources.com/industryinsights/indicaidr-covid-19-rapid-antigen-test-ce-329207.html 0.6 2026-08-07T05:39:40+08:00 daily https://www.pharmasources.com/industryinsights/farrer-park-hospital-collaborates-with-s-329208.html 0.6 2026-08-07T05:46:18+08:00 daily https://www.pharmasources.com/industryinsights/innovent-announces-the-approval-of-pemaz-329209.html 0.6 2026-08-07T13:18:22+08:00 daily https://www.pharmasources.com/industryinsights/new-patient-guide-from-nccn-jumpstarts-i-329210.html 0.6 2026-08-08T07:57:41+08:00 daily https://www.pharmasources.com/industryinsights/berry-oncology-partners-with-alibaba-hea-329211.html 0.6 2026-07-19T05:03:30+08:00 daily https://www.pharmasources.com/industryinsights/tian-ruixiang-holdings-ltd-steps-into-he-329212.html 0.6 2026-08-09T06:51:23+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-appoints-international-gastrointes-329213.html 0.6 2026-06-19T16:53:45+08:00 daily https://www.pharmasources.com/industryinsights/the-pressing-need-for-early-detection-of-329214.html 0.6 2026-07-29T02:57:27+08:00 daily https://www.pharmasources.com/industryinsights/duke-nus-and-genscript-announce-notice-o-329215.html 0.6 2026-06-21T11:15:55+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharma-announces-presentation-329216.html 0.6 2025-11-13T21:37:44+08:00 daily https://www.pharmasources.com/industryinsights/hutchmed-announces-nmpa-approval-of-suru-329217.html 0.6 2026-07-23T04:58:08+08:00 daily https://www.pharmasources.com/industryinsights/probiogen-and-lava-therapeutics-nv-sign--329218.html 0.6 2026-06-20T01:04:06+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-and-racism-the-interconnected-p-329219.html 0.6 2026-08-08T00:31:33+08:00 daily https://www.pharmasources.com/industryinsights/iehp-provides-covid-19-vaccine-access-to-329220.html 0.6 2026-06-19T13:19:57+08:00 daily https://www.pharmasources.com/industryinsights/global-scanner-market-report-2021-to-203-329221.html 0.6 2026-06-20T14:44:22+08:00 daily https://www.pharmasources.com/industryinsights/despite-covid-19-and-travel-bans-parator-329222.html 0.6 2026-06-22T17:50:52+08:00 daily https://www.pharmasources.com/industryinsights/cerebrum-brings-cryptographically-verifi-329223.html 0.6 2026-06-21T12:10:25+08:00 daily https://www.pharmasources.com/industryinsights/cellenkos-selects-cryoport-to-support-on-329224.html 0.6 2026-08-06T23:16:01+08:00 daily https://www.pharmasources.com/industryinsights/north-carolina-humanities-covid-19-ameri-329225.html 0.6 2026-07-06T20:06:32+08:00 daily https://www.pharmasources.com/industryinsights/as-pandemic-concerns-fade-76-of-north-am-329226.html 0.6 2026-08-08T02:42:41+08:00 daily https://www.pharmasources.com/industryinsights/bioreference-laboratories-announces-firs-329227.html 0.6 2026-05-06T06:08:40+08:00 daily https://www.pharmasources.com/industryinsights/more-than-800-medicines-are-in-developme-329228.html 0.6 2026-06-19T22:34:24+08:00 daily https://www.pharmasources.com/industryinsights/alzheimers-drug-price-uproar-grows-as-us-329229.html 0.6 2025-11-19T10:22:20+08:00 daily https://www.pharmasources.com/industryinsights/cyteir-therapeutics-announces-closing-of-329230.html 0.6 2026-06-21T20:18:53+08:00 daily https://www.pharmasources.com/industryinsights/novartis-aims-to-bottle-more-than-50-mln-329231.html 0.6 2026-06-19T14:33:04+08:00 daily https://www.pharmasources.com/industryinsights/century-therapeutics-announces-closing-o-329232.html 0.6 2026-07-03T16:46:53+08:00 daily https://www.pharmasources.com/industryinsights/fujitsu-japan-embarks-on-joint-research--329233.html 0.6 2026-06-21T11:13:33+08:00 daily https://www.pharmasources.com/industryinsights/inflectis-bioscience-licenses-rights-to--329234.html 0.6 2026-03-05T07:02:37+08:00 daily https://www.pharmasources.com/industryinsights/enanta-pharmaceuticals-reports-positive--329235.html 0.6 2026-08-02T23:41:36+08:00 daily https://www.pharmasources.com/industryinsights/leo-pharma-announces-european-commission-329236.html 0.6 2026-06-20T11:47:03+08:00 daily https://www.pharmasources.com/industryinsights/us-likely-to-miss-july-4-covid-19-vaccin-329237.html 0.6 2026-05-29T17:40:26+08:00 daily https://www.pharmasources.com/industryinsights/biopharmaceutical-ceo-brussel-meeting-wi-329238.html 0.6 2026-06-07T15:17:29+08:00 daily https://www.pharmasources.com/industryinsights/novavax-statement-on-completion-of-the-n-329239.html 0.6 2026-08-10T07:11:37+08:00 daily https://www.pharmasources.com/industryinsights/memos-reveal-internal-fda-struggle-over--329240.html 0.6 2026-06-20T13:22:27+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-covid-19-vaccine-effective-a-329241.html 0.6 2025-12-30T15:40:52+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccine-coverage-in-us-highest--329242.html 0.6 2026-06-21T10:49:20+08:00 daily https://www.pharmasources.com/industryinsights/fda-oks-first-oral-blood-thinning-medica-329243.html 0.6 2026-07-05T05:33:21+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-deaths-drop-to-new-lows-in-us-w-329244.html 0.6 2026-08-04T01:48:36+08:00 daily https://www.pharmasources.com/industryinsights/medicaid-enrollment-reaches-record-high--329245.html 0.6 2026-06-20T11:10:50+08:00 daily https://www.pharmasources.com/industryinsights/large-increase-seen-in-us-nursing-home-d-329246.html 0.6 2026-07-04T19:51:40+08:00 daily https://www.pharmasources.com/industryinsights/leaded-gas-banned-decades-ago-might-stil-329247.html 0.6 2026-06-21T04:44:28+08:00 daily https://www.pharmasources.com/industryinsights/marijuana-use-tied-to-higher-odds-for-th-329248.html 0.6 2026-07-09T07:39:26+08:00 daily https://www.pharmasources.com/industryinsights/cellenkos-chooses-cryoport-to-support-co-329249.html 0.6 2026-08-09T20:10:28+08:00 daily https://www.pharmasources.com/industryinsights/vectura-incannex-enter-preclinical-servi-329250.html 0.6 2026-06-23T00:11:49+08:00 daily https://www.pharmasources.com/industryinsights/carogen-biocentriq-enter-clinical-manufa-329251.html 0.6 2026-06-20T04:50:24+08:00 daily https://www.pharmasources.com/industryinsights/schreiner-medipharm-plas-tech-partner-on-329252.html 0.6 2026-06-23T06:00:12+08:00 daily https://www.pharmasources.com/industryinsights/iksuda-legochem-expand-adc-alliance-329253.html 0.6 2026-08-07T05:05:49+08:00 daily https://www.pharmasources.com/industryinsights/probiogen-lava-to-develop-cell-lines-for-329254.html 0.6 2026-08-07T02:48:44+08:00 daily https://www.pharmasources.com/industryinsights/syneos-expands-decentralized-trial-capab-329255.html 0.6 2026-08-07T02:41:12+08:00 daily https://www.pharmasources.com/industryinsights/mankind-pharma-launches-justoza-a-dapagl-329256.html 0.6 2026-08-07T02:36:57+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-translate-bio-start-clinical--329257.html 0.6 2026-08-07T02:30:53+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-announces-settlement-of-paten-329258.html 0.6 2026-08-06T23:54:04+08:00 daily https://www.pharmasources.com/industryinsights/researchers-at-hyderabad-university-find-329259.html 0.6 2026-08-07T00:02:37+08:00 daily https://www.pharmasources.com/industryinsights/fujitsu-to-study-covid-19-treatments-usi-329260.html 0.6 2026-08-06T23:55:28+08:00 daily https://www.pharmasources.com/industryinsights/arrowhead-and-horizon-enter-up-to-700m-d-329261.html 0.6 2026-08-06T23:46:22+08:00 daily https://www.pharmasources.com/industryinsights/tonix-to-develop-tnx-102-sl-for-long-cov-329262.html 0.6 2026-08-06T23:37:30+08:00 daily https://www.pharmasources.com/industryinsights/eu-gets-partial-win-in-astrazeneca-covid-329263.html 0.6 2026-08-07T06:07:13+08:00 daily https://www.pharmasources.com/industryinsights/avacta-announces-affidxr-sars-cov-2-anti-329264.html 0.6 2026-08-07T06:10:09+08:00 daily https://www.pharmasources.com/industryinsights/blackstone-life-sciences-cellex-cell-pro-329265.html 0.6 2026-06-19T15:57:10+08:00 daily https://www.pharmasources.com/industryinsights/fda-authorizes-stem-cell-trials-for-park-329266.html 0.6 2026-06-21T03:17:56+08:00 daily https://www.pharmasources.com/industryinsights/koselugo-approved-in-eu-for-children-wit-329267.html 0.6 2026-06-20T22:48:00+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-over-the-counter-nasal-anti-329268.html 0.6 2026-07-01T03:30:30+08:00 daily https://www.pharmasources.com/industryinsights/bristol-myers-squibb-receives-european-c-329269.html 0.6 2026-05-29T05:19:31+08:00 daily https://www.pharmasources.com/industryinsights/mercks-keytruda-met-dual-primary-endpoin-329270.html 0.6 2026-06-20T22:15:54+08:00 daily https://www.pharmasources.com/industryinsights/roche-sars-cov-2-molecular-test-gets-fda-329271.html 0.6 2026-06-21T04:56:48+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-oral-blood-thinner-fo-329272.html 0.6 2026-06-19T20:02:42+08:00 daily https://www.pharmasources.com/industryinsights/european-commission-buys-additional-dose-329273.html 0.6 2026-05-29T04:55:26+08:00 daily https://www.pharmasources.com/industryinsights/nhs-england-announces-extra-funding-for--329274.html 0.6 2026-06-20T04:46:32+08:00 daily https://www.pharmasources.com/industryinsights/abpi-launches-new-patient-advisory-counc-329275.html 0.6 2026-06-22T05:01:39+08:00 daily https://www.pharmasources.com/industryinsights/collaboration-to-develop-ultra-long-acti-329276.html 0.6 2026-06-21T11:14:32+08:00 daily https://www.pharmasources.com/industryinsights/real-world-evidence-confirms-veklury-red-329277.html 0.6 2026-06-21T01:48:29+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-mrna-vaccine-technology-transfe-329278.html 0.6 2026-06-20T17:53:22+08:00 daily https://www.pharmasources.com/industryinsights/senhwa-announces-ind-submission-to-india-329279.html 0.6 2026-06-21T03:03:40+08:00 daily https://www.pharmasources.com/industryinsights/100-billion-live-probiotics-in-a-bottle--329280.html 0.6 2026-08-14T23:08:20+08:00 daily https://www.pharmasources.com/industryinsights/sintilimab-in-combination-with-chemother-329281.html 0.6 2026-08-05T23:55:50+08:00 daily https://www.pharmasources.com/industryinsights/biocytogen-completes-a-new-round-of-fina-329282.html 0.6 2026-08-07T17:44:10+08:00 daily https://www.pharmasources.com/industryinsights/mina-j-bissell-phd-vectorspace-ai-advanc-329283.html 0.6 2026-05-29T04:01:28+08:00 daily https://www.pharmasources.com/industryinsights/phase-iii-clinical-trial-of-biokangtai-c-329284.html 0.6 2026-08-10T08:44:15+08:00 daily https://www.pharmasources.com/industryinsights/insilico-medicine-raises-255-million-in--329285.html 0.6 2026-06-20T20:17:20+08:00 daily https://www.pharmasources.com/industryinsights/eurofins-discovery-and-immunoprecise-ann-329286.html 0.6 2026-07-11T09:53:38+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-healthcare-startup-curative-ach-329287.html 0.6 2026-05-29T03:58:24+08:00 daily https://www.pharmasources.com/industryinsights/cphi-webinar-trends-and-advances-in-pati-329288.html 0.6 2026-06-21T19:56:35+08:00 daily https://www.pharmasources.com/industryinsights/honeywell-survey-reveals-healthier-build-329289.html 0.6 2026-06-21T04:00:47+08:00 daily https://www.pharmasources.com/industryinsights/affinity-empowering-launches-website-to--329290.html 0.6 2026-08-05T20:50:10+08:00 daily https://www.pharmasources.com/industryinsights/survey-reveals-americans-think-theyre-ag-329291.html 0.6 2026-05-29T04:22:26+08:00 daily https://www.pharmasources.com/industryinsights/servicelink-survey-reveals-how-covid-19--329292.html 0.6 2026-06-20T15:56:32+08:00 daily https://www.pharmasources.com/industryinsights/vectura-to-provide-preclinical-support-f-329293.html 0.6 2026-06-20T16:50:21+08:00 daily https://www.pharmasources.com/industryinsights/global-mouse-market-report-2021-to-2030--329294.html 0.6 2026-06-21T17:48:54+08:00 daily https://www.pharmasources.com/industryinsights/statement-following-cdc-acip-meeting-fro-329295.html 0.6 2026-06-20T01:07:05+08:00 daily https://www.pharmasources.com/industryinsights/probiogen-and-lava-therapeutics-sign-cel-329296.html 0.6 2026-06-21T23:37:30+08:00 daily https://www.pharmasources.com/industryinsights/siemens-and-biontech-expand-their-collab-329297.html 0.6 2026-08-14T14:49:06+08:00 daily https://www.pharmasources.com/industryinsights/coriolis-pharma-expands-facilities-for-a-329298.html 0.6 2026-06-20T10:03:37+08:00 daily https://www.pharmasources.com/industryinsights/sahpra-and-the-sinopharm-vaccine-329299.html 0.6 2026-07-20T06:01:58+08:00 daily https://www.pharmasources.com/industryinsights/orion-biotechnology-secures-115m-series--329300.html 0.6 2026-06-20T21:03:40+08:00 daily https://www.pharmasources.com/industryinsights/japan-mulls-approving-astrazeneca-covid--329301.html 0.6 2026-06-20T17:55:41+08:00 daily https://www.pharmasources.com/industryinsights/arcus-says-early-data-for-anti-tigit-dom-329302.html 0.6 2026-06-21T13:04:30+08:00 daily https://www.pharmasources.com/industryinsights/fda-to-add-warning-about-rare-heart-infl-329303.html 0.6 2026-06-21T18:55:38+08:00 daily https://www.pharmasources.com/industryinsights/antibody-therapy-rescues-mice-from-letha-329304.html 0.6 2026-04-12T21:45:59+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-weakly-correlated-with-chilblai-329305.html 0.6 2026-06-20T14:44:25+08:00 daily https://www.pharmasources.com/industryinsights/four-in-10-diabetes-patients-have-kidney-329306.html 0.6 2026-06-20T14:37:19+08:00 daily https://www.pharmasources.com/industryinsights/app-to-monitor-ra-symptoms-does-not-impr-329307.html 0.6 2026-06-20T15:13:17+08:00 daily https://www.pharmasources.com/industryinsights/coronavirus-delta-variant-spreading-rapi-329308.html 0.6 2026-06-22T07:57:50+08:00 daily https://www.pharmasources.com/industryinsights/white-house-says-july-4-vaccination-goal-329309.html 0.6 2026-08-13T03:42:58+08:00 daily https://www.pharmasources.com/industryinsights/c-section-babies-miss-out-on-moms-microb-329310.html 0.6 2026-06-20T00:04:53+08:00 daily https://www.pharmasources.com/industryinsights/study-suggests-covid-vaccine-booster-sho-329311.html 0.6 2026-06-19T17:08:21+08:00 daily https://www.pharmasources.com/industryinsights/pandemic-may-have-created-a-baby-bust-no-329312.html 0.6 2026-06-20T08:40:30+08:00 daily https://www.pharmasources.com/industryinsights/rash-itch-after-covid-vaccine-rare-quick-329313.html 0.6 2026-08-10T15:14:32+08:00 daily https://www.pharmasources.com/industryinsights/senti-bio-invests-in-cell-therapy-manufa-329314.html 0.6 2026-08-07T01:11:14+08:00 daily https://www.pharmasources.com/industryinsights/abcellera-to-build-antibody-manufacturin-329315.html 0.6 2026-08-09T20:20:24+08:00 daily https://www.pharmasources.com/industryinsights/building-authentication-ecosystems-cruci-329316.html 0.6 2026-06-21T01:11:54+08:00 daily https://www.pharmasources.com/industryinsights/piramal-pharma-completes-acquisition-of--329317.html 0.6 2026-06-21T10:21:26+08:00 daily https://www.pharmasources.com/industryinsights/centrient-pharmaceuticals-boosting-stati-329318.html 0.6 2026-08-12T13:37:01+08:00 daily https://www.pharmasources.com/industryinsights/turkish-covid-19-vaccine-starts-phase-ii-329319.html 0.6 2026-06-22T09:59:46+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-laboratories-launches-icosapen-329320.html 0.6 2026-06-22T08:09:57+08:00 daily https://www.pharmasources.com/industryinsights/adroit-biomed-develops-orally-dissolving-329321.html 0.6 2026-06-20T19:58:46+08:00 daily https://www.pharmasources.com/industryinsights/novartis-reveals-long-term-results-for-m-329322.html 0.6 2026-07-31T23:20:01+08:00 daily https://www.pharmasources.com/industryinsights/nhsx-sets-out-new-patient-centred-data-s-329323.html 0.6 2026-06-21T18:47:51+08:00 daily https://www.pharmasources.com/industryinsights/cancer-research-uk-partners-with-aleta-b-329324.html 0.6 2026-06-24T06:30:33+08:00 daily https://www.pharmasources.com/industryinsights/govt-injects-64m-into-clinical-research--329325.html 0.6 2026-06-25T05:48:01+08:00 daily https://www.pharmasources.com/industryinsights/mrna-based-therapeutic-cancer-vaccine-en-329326.html 0.6 2026-06-21T07:58:03+08:00 daily https://www.pharmasources.com/industryinsights/uk-releases-implementation-plan-for-deve-329327.html 0.6 2026-07-05T06:15:52+08:00 daily https://www.pharmasources.com/industryinsights/phase-i-trial-of-mrna-based-influenza-va-329328.html 0.6 2026-06-19T22:15:14+08:00 daily https://www.pharmasources.com/industryinsights/cstone-announces-positive-gavreto-pralse-329329.html 0.6 2026-08-03T23:53:40+08:00 daily https://www.pharmasources.com/industryinsights/endurance-rp-limited-a-new-name-a-new-pe-329330.html 0.6 2026-06-25T10:11:37+08:00 daily https://www.pharmasources.com/industryinsights/alterity-therapeutics-limited-received-e-329331.html 0.6 2026-08-04T09:00:39+08:00 daily https://www.pharmasources.com/industryinsights/novartis-and-hewlett-packard-enterprise--329332.html 0.6 2026-06-20T15:53:25+08:00 daily https://www.pharmasources.com/industryinsights/drug-doubles-down-on-bone-cancer-metasta-329333.html 0.6 2026-08-08T02:55:21+08:00 daily https://www.pharmasources.com/industryinsights/scipher-medicine-announces-prismra-met-p-329334.html 0.6 2026-06-20T21:17:17+08:00 daily https://www.pharmasources.com/industryinsights/deloitte-2021-quality-engineering-report-329335.html 0.6 2026-08-03T09:55:54+08:00 daily https://www.pharmasources.com/industryinsights/how-the-crises-of-2020-underscored-the-v-329336.html 0.6 2026-06-19T20:16:59+08:00 daily https://www.pharmasources.com/industryinsights/global-66-billion-hyperloop-technology-m-329337.html 0.6 2026-07-22T16:55:43+08:00 daily https://www.pharmasources.com/industryinsights/freshworks-named-a-visionary-for-the-sec-329338.html 0.6 2026-08-07T09:47:53+08:00 daily https://www.pharmasources.com/industryinsights/quantum-collaborates-with-supermicro-to--329339.html 0.6 2026-08-09T02:32:14+08:00 daily https://www.pharmasources.com/industryinsights/promethean-to-present-and-exhibit-at-ist-329340.html 0.6 2026-06-21T21:59:51+08:00 daily https://www.pharmasources.com/industryinsights/incyte-announces-outcome-of-fda-oncologi-329341.html 0.6 2026-07-04T02:01:38+08:00 daily https://www.pharmasources.com/industryinsights/medicure-announces-appointment-of-david--329342.html 0.6 2026-06-08T20:02:27+08:00 daily https://www.pharmasources.com/industryinsights/anavex-life-sciences-announces-closing-o-329343.html 0.6 2026-02-15T14:41:10+08:00 daily https://www.pharmasources.com/industryinsights/theravance-biopharma-plans-upcoming-stoc-329344.html 0.6 2026-08-08T12:46:56+08:00 daily https://www.pharmasources.com/industryinsights/parexel-said-to-draw-interest-from-ameri-329345.html 0.6 2026-06-21T01:00:49+08:00 daily https://www.pharmasources.com/industryinsights/theravance-biopharma-announces-proposed--329346.html 0.6 2026-04-23T03:19:03+08:00 daily https://www.pharmasources.com/industryinsights/oncosec-appoints-brian-leuthner-as-inter-329347.html 0.6 2026-01-29T13:09:42+08:00 daily https://www.pharmasources.com/industryinsights/venezuela-receives-first-shipment-of-cub-329348.html 0.6 2026-06-21T10:57:21+08:00 daily https://www.pharmasources.com/industryinsights/hospital-factors-tied-to-greater-covid-1-329349.html 0.6 2026-03-10T05:48:43+08:00 daily https://www.pharmasources.com/industryinsights/adverse-mental-health-symptoms-up-during-329350.html 0.6 2026-06-29T07:12:57+08:00 daily https://www.pharmasources.com/industryinsights/risk-for-dementia-diagnosis-up-for-senio-329351.html 0.6 2026-06-20T18:09:26+08:00 daily https://www.pharmasources.com/industryinsights/morgan-stanley-makes-covid-19-vaccinatio-329352.html 0.6 2026-06-20T17:50:15+08:00 daily https://www.pharmasources.com/industryinsights/us-sends-3-million-jj-covid-19-vaccine-d-329353.html 0.6 2026-06-27T14:27:23+08:00 daily https://www.pharmasources.com/industryinsights/innovative-kidney-donor-voucher-system-i-329354.html 0.6 2026-08-06T06:00:15+08:00 daily https://www.pharmasources.com/industryinsights/lost-sense-of-smell-returns-for-almost-a-329355.html 0.6 2026-06-30T10:44:53+08:00 daily https://www.pharmasources.com/industryinsights/drop-in-life-expectancy-from-covid-much--329356.html 0.6 2026-05-02T09:47:13+08:00 daily https://www.pharmasources.com/industryinsights/potato-chips-fatty-lunches-greatly-raise-329357.html 0.6 2026-06-20T15:53:38+08:00 daily https://www.pharmasources.com/industryinsights/cellpoint-and-lonza-enter-strategic-coll-329358.html 0.6 2026-06-22T05:11:19+08:00 daily https://www.pharmasources.com/industryinsights/chemomab-and-agc-biologics-partner-to-ma-329359.html 0.6 2026-06-21T05:37:25+08:00 daily https://www.pharmasources.com/industryinsights/mankind-pharma-partners-with-bdr-pharma--329360.html 0.6 2026-07-25T16:06:24+08:00 daily https://www.pharmasources.com/industryinsights/dcgi-allows-pnb-vesper-life-science-to-c-329361.html 0.6 2026-06-14T17:48:32+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-receives-tentative-approval-329362.html 0.6 2026-06-20T13:05:29+08:00 daily https://www.pharmasources.com/industryinsights/additional-61120-vials-of-liposomal-amph-329363.html 0.6 2026-07-27T20:59:14+08:00 daily https://www.pharmasources.com/industryinsights/cipla-gets-usfda-nod-for-inhalation-prod-329364.html 0.6 2026-08-13T02:07:31+08:00 daily https://www.pharmasources.com/industryinsights/veeda-clinical-research-receives-growth--329365.html 0.6 2026-06-22T12:03:17+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-receives-tentative-approval-329366.html 0.6 2025-12-30T14:09:49+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-breakthrough-status-to-eisai--329367.html 0.6 2026-08-13T10:22:17+08:00 daily https://www.pharmasources.com/industryinsights/gsk-to-boost-growth-with-consumer-health-329368.html 0.6 2026-06-20T04:04:15+08:00 daily https://www.pharmasources.com/industryinsights/tiziana-and-fhi-clinical-work-on-phase-i-329369.html 0.6 2026-06-20T18:45:30+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-exercises-right-to-acquire-teneoo-329370.html 0.6 2026-06-22T20:46:12+08:00 daily https://www.pharmasources.com/industryinsights/heat-biologics-announces-expansion-of-rd-329371.html 0.6 2026-06-21T01:43:30+08:00 daily https://www.pharmasources.com/industryinsights/dupont-expands-ion-exchange-production-t-329372.html 0.6 2026-08-09T07:36:27+08:00 daily https://www.pharmasources.com/industryinsights/fda-issues-emergency-use-authorization-f-329373.html 0.6 2026-08-07T13:17:44+08:00 daily https://www.pharmasources.com/industryinsights/additional-12mn-to-fund-further-developm-329374.html 0.6 2026-08-07T19:25:57+08:00 daily https://www.pharmasources.com/industryinsights/in-silico-trial-successfully-replicates--329375.html 0.6 2026-08-06T23:36:32+08:00 daily https://www.pharmasources.com/industryinsights/global-api-market-to-value-300-billion-b-329376.html 0.6 2026-08-06T23:38:34+08:00 daily https://www.pharmasources.com/industryinsights/life-whisperer-launches-its-third-global-329377.html 0.6 2026-06-19T16:11:42+08:00 daily https://www.pharmasources.com/industryinsights/lynk-pharmaceuticals-announced-clinical--329378.html 0.6 2026-08-06T23:50:23+08:00 daily https://www.pharmasources.com/industryinsights/research-showed-that-inxmed-fak-inhibito-329379.html 0.6 2026-08-08T23:05:29+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-issues-its-first-annua-329380.html 0.6 2026-08-07T12:12:27+08:00 daily https://www.pharmasources.com/industryinsights/innovent-releases-results-of-a-phase-1-c-329381.html 0.6 2026-08-08T23:47:39+08:00 daily https://www.pharmasources.com/industryinsights/triastek-closes-us-50-million-series-b-f-329382.html 0.6 2026-08-08T07:48:10+08:00 daily https://www.pharmasources.com/industryinsights/licensing-partner-of-shenzhen-chipscreen-329383.html 0.6 2026-08-12T11:29:39+08:00 daily https://www.pharmasources.com/industryinsights/boan-biotech-publishes-research-results--329384.html 0.6 2026-08-08T15:09:44+08:00 daily https://www.pharmasources.com/industryinsights/chinas-first-car-t-cell-therapy-approved-329385.html 0.6 2026-08-07T13:55:43+08:00 daily https://www.pharmasources.com/industryinsights/virus-that-causes-covid-19-can-find-alte-329386.html 0.6 2026-08-07T13:15:18+08:00 daily https://www.pharmasources.com/industryinsights/coronavirus-covid-19-update-fda-authoriz-329387.html 0.6 2026-08-08T03:45:59+08:00 daily https://www.pharmasources.com/industryinsights/cphi-monthly-podcast-ma-strategies-in-th-329388.html 0.6 2026-08-08T04:37:37+08:00 daily https://www.pharmasources.com/industryinsights/britons-can-now-travel-to-the-caribbean--329389.html 0.6 2026-08-08T07:44:37+08:00 daily https://www.pharmasources.com/industryinsights/vinamilk-promotes-healthy-lifestyle-and--329390.html 0.6 2026-08-08T08:39:05+08:00 daily https://www.pharmasources.com/industryinsights/vazyme-brings-covid-19-testing-solutions-329391.html 0.6 2026-08-08T10:01:39+08:00 daily https://www.pharmasources.com/industryinsights/genezen-begins-construction-of-cgmp-lent-329392.html 0.6 2026-08-08T11:08:26+08:00 daily https://www.pharmasources.com/industryinsights/jj-ends-sales-of-opioids-in-the-us-reach-329393.html 0.6 2026-08-08T15:51:50+08:00 daily https://www.pharmasources.com/industryinsights/lillys-surpass-1-results-published-in-th-329394.html 0.6 2026-08-09T03:10:58+08:00 daily https://www.pharmasources.com/industryinsights/rare-disease-drug-101---what-are-the-ben-329395.html 0.6 2026-07-28T04:45:39+08:00 daily https://www.pharmasources.com/industryinsights/the-importance-of-tablet-coating-technol-329396.html 0.6 2026-08-07T13:17:52+08:00 daily https://www.pharmasources.com/industryinsights/boost-for-africas-apis-production-plan-329397.html 0.6 2026-08-09T17:35:16+08:00 daily https://www.pharmasources.com/industryinsights/another-giant-entering-the-tigit-antibod-329398.html 0.6 2026-08-07T18:30:51+08:00 daily https://www.pharmasources.com/industryinsights/da-pag-li-flo-zin-is-well-tolerated-in-h-329399.html 0.6 2026-08-03T15:42:41+08:00 daily https://www.pharmasources.com/industryinsights/trillium-therapeutics-joins-russell-2000-329400.html 0.6 2026-06-21T01:06:47+08:00 daily https://www.pharmasources.com/industryinsights/investigational-2-mg-dose-of-ozempic-sem-329401.html 0.6 2026-07-20T12:01:59+08:00 daily https://www.pharmasources.com/industryinsights/arrowhead-presents-additional-clinical-d-329402.html 0.6 2026-06-22T08:44:38+08:00 daily https://www.pharmasources.com/industryinsights/first-covid-19-variant-vaccine-azd2816-p-329403.html 0.6 2026-07-20T03:14:06+08:00 daily https://www.pharmasources.com/industryinsights/potential-new-car-t-cell-therapy-for-mul-329404.html 0.6 2026-06-19T17:49:12+08:00 daily https://www.pharmasources.com/industryinsights/cancer-biotech-candel-therapeutics-files-329405.html 0.6 2026-07-06T18:06:27+08:00 daily https://www.pharmasources.com/industryinsights/camurus-announces-pdufa-date-for-brixadi-329406.html 0.6 2026-06-21T10:05:09+08:00 daily https://www.pharmasources.com/industryinsights/test-batch-of-the-sputnik-v-vaccine-prod-329407.html 0.6 2026-06-20T18:08:26+08:00 daily https://www.pharmasources.com/industryinsights/intellia-and-regeneron-announce-landmark-329408.html 0.6 2026-08-09T09:05:33+08:00 daily https://www.pharmasources.com/industryinsights/genezen-breaks-ground-on-cgmp-lentiviral-329409.html 0.6 2026-06-21T00:15:59+08:00 daily https://www.pharmasources.com/industryinsights/sanyou-biopharmaceuticals-completes-seri-329410.html 0.6 2026-07-19T19:06:48+08:00 daily https://www.pharmasources.com/industryinsights/novasep-upgrades-api-manufacturing-facil-329411.html 0.6 2026-06-20T22:18:58+08:00 daily https://www.pharmasources.com/industryinsights/hawaii-to-ease-covid-19-rules-for-fully--329412.html 0.6 2026-06-22T15:16:36+08:00 daily https://www.pharmasources.com/industryinsights/catalent-to-acquire-rheincell-therapeuti-329413.html 0.6 2026-08-03T19:54:54+08:00 daily https://www.pharmasources.com/industryinsights/is-the-delta-plus-covid-19-variant-a-new-329414.html 0.6 2026-06-21T19:16:56+08:00 daily https://www.pharmasources.com/industryinsights/lilly-to-seek-fda-approval-for-new-drug--329415.html 0.6 2026-04-17T02:36:12+08:00 daily https://www.pharmasources.com/industryinsights/99-percent-of-new-us-covid-19-hospitaliz-329416.html 0.6 2026-06-20T01:50:21+08:00 daily https://www.pharmasources.com/industryinsights/could-a-dna-blood-test-spot-a-range-of-h-329417.html 0.6 2026-06-20T20:58:54+08:00 daily https://www.pharmasources.com/industryinsights/first-signs-of-ms-may-often-go-undiagnos-329418.html 0.6 2026-08-09T02:22:09+08:00 daily https://www.pharmasources.com/industryinsights/cobra-biologics-combigene-ready-to-start-329419.html 0.6 2026-06-22T05:51:39+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-verkazia-cyclosporine-ophth-329420.html 0.6 2026-08-08T22:38:05+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-halts-distribution-of-anti-smokin-329421.html 0.6 2026-06-21T00:15:27+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-gets-usfda-nod-for-generic-lung-329422.html 0.6 2026-06-24T09:11:59+08:00 daily https://www.pharmasources.com/industryinsights/us-approves-roche-drug-for-emergency-use-329423.html 0.6 2026-06-22T04:13:58+08:00 daily https://www.pharmasources.com/industryinsights/russia-launches-sputnik-light-vaccine-in-329424.html 0.6 2026-06-21T12:10:40+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-says-covid-vaccine-is-highly-effe-329425.html 0.6 2026-07-07T00:43:51+08:00 daily https://www.pharmasources.com/industryinsights/pieris-receives-funding-to-develop-drug--329426.html 0.6 2026-06-20T03:59:19+08:00 daily https://www.pharmasources.com/industryinsights/bms-exercises-option-for-us-licence-of-p-329427.html 0.6 2026-06-22T07:00:46+08:00 daily https://www.pharmasources.com/industryinsights/merck-appoints-michael-klobuchar-chief-s-329428.html 0.6 2026-06-21T13:07:36+08:00 daily https://www.pharmasources.com/industryinsights/over-two-million-people-may-have-had-lon-329429.html 0.6 2026-06-28T03:22:30+08:00 daily https://www.pharmasources.com/industryinsights/scientists-identify-link-between-genetic-329430.html 0.6 2026-06-21T07:43:58+08:00 daily https://www.pharmasources.com/industryinsights/blood-test-can-detect-more-than-50-types-329431.html 0.6 2026-08-06T17:46:25+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-regenerons-libtayo-cleared-for-ba-329432.html 0.6 2026-04-07T03:10:25+08:00 daily https://www.pharmasources.com/industryinsights/collaboration-working-to-promote-health--329433.html 0.6 2026-06-30T04:35:27+08:00 daily https://www.pharmasources.com/industryinsights/ema-human-medicines-committee-meeting-hi-329434.html 0.6 2026-08-09T07:15:38+08:00 daily https://www.pharmasources.com/industryinsights/innocare-announces-breakthrough-therapy--329435.html 0.6 2026-08-07T17:15:11+08:00 daily https://www.pharmasources.com/industryinsights/active8me-announces-new-health-tech-part-329436.html 0.6 2026-08-07T16:21:00+08:00 daily https://www.pharmasources.com/industryinsights/qbiotics-concludes-successful-85-million-329437.html 0.6 2026-08-07T13:14:53+08:00 daily https://www.pharmasources.com/industryinsights/cstone-announces-positive-registrational-329438.html 0.6 2026-08-07T12:07:20+08:00 daily https://www.pharmasources.com/industryinsights/innovent-announces-the-china-nmpa-approv-329439.html 0.6 2026-08-13T01:02:25+08:00 daily https://www.pharmasources.com/industryinsights/world-first-predictive-test-for-diabetic-329440.html 0.6 2026-08-07T13:15:36+08:00 daily https://www.pharmasources.com/industryinsights/happiness-biotech-announces-216-million--329441.html 0.6 2026-08-09T06:59:14+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-announces-china-nmpa-approval-for--329442.html 0.6 2026-08-13T03:19:43+08:00 daily https://www.pharmasources.com/industryinsights/innocare-announces-approval-of-initiatio-329443.html 0.6 2026-06-25T23:30:28+08:00 daily https://www.pharmasources.com/industryinsights/histoindexs-ai-based-digital-pathology-i-329444.html 0.6 2026-06-19T14:59:01+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-329445.html 0.6 2026-06-29T07:37:03+08:00 daily https://www.pharmasources.com/industryinsights/cipherhealth-wins-globee-in-the-16th-ann-329446.html 0.6 2026-06-20T21:56:42+08:00 daily https://www.pharmasources.com/industryinsights/global-financial-centers-unite-in-a-call-329447.html 0.6 2026-07-08T02:34:47+08:00 daily https://www.pharmasources.com/industryinsights/3482-billion-asset-tracking-markets---gl-329448.html 0.6 2026-08-07T04:15:53+08:00 daily https://www.pharmasources.com/industryinsights/marketlab-offers-best-selling-air-saniti-329449.html 0.6 2026-08-10T15:21:44+08:00 daily https://www.pharmasources.com/industryinsights/capital-markets-enter-uncharted-waters-c-329450.html 0.6 2026-08-07T00:40:20+08:00 daily https://www.pharmasources.com/industryinsights/united-states-physician-office-market-re-329451.html 0.6 2026-08-10T17:21:48+08:00 daily https://www.pharmasources.com/industryinsights/analysis-shows-stronger-immunity-by-dela-329452.html 0.6 2026-08-07T00:59:20+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-patients-recover-faster-with-me-329453.html 0.6 2026-08-07T00:53:21+08:00 daily https://www.pharmasources.com/industryinsights/fox-chase-researcher-receives-nih-grant--329454.html 0.6 2026-08-07T00:42:45+08:00 daily https://www.pharmasources.com/industryinsights/junshi-biosciences-sinks-after-us-halts--329455.html 0.6 2026-08-07T00:39:52+08:00 daily https://www.pharmasources.com/industryinsights/kymera-therapeutics-announces-proposed-p-329456.html 0.6 2026-08-07T00:02:09+08:00 daily https://www.pharmasources.com/industryinsights/zentalis-pharmaceuticals-announces-propo-329457.html 0.6 2026-08-06T23:55:28+08:00 daily https://www.pharmasources.com/industryinsights/regenerx-biopharmaceuticals-announces-2--329458.html 0.6 2026-08-06T23:47:56+08:00 daily https://www.pharmasources.com/industryinsights/intellia-therapeutics-announces-proposed-329459.html 0.6 2026-08-07T05:37:33+08:00 daily https://www.pharmasources.com/industryinsights/robotic-platforms-not-superior-for-abdom-329460.html 0.6 2026-08-06T23:55:43+08:00 daily https://www.pharmasources.com/industryinsights/bedside-outside-the-room-case-presentati-329461.html 0.6 2026-08-07T05:46:04+08:00 daily https://www.pharmasources.com/industryinsights/mental-health-conditions-up-in-public-he-329462.html 0.6 2026-08-07T05:51:51+08:00 daily https://www.pharmasources.com/industryinsights/seven-cases-of-guillain-barr-noted-after-329463.html 0.6 2026-08-07T05:58:10+08:00 daily https://www.pharmasources.com/industryinsights/less-than-1-percent-of-covid-19-patients-329464.html 0.6 2026-08-10T12:01:14+08:00 daily https://www.pharmasources.com/industryinsights/could-home-test-for-colon-cancer-mean-a--329465.html 0.6 2026-08-07T03:55:11+08:00 daily https://www.pharmasources.com/industryinsights/juul-to-pay-40-million-in-nc-case-over-v-329466.html 0.6 2026-08-07T03:33:42+08:00 daily https://www.pharmasources.com/industryinsights/high-deductibles-keep-folks-with-chest-p-329467.html 0.6 2026-08-07T00:18:30+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-doctor-thought-high-blood-press-329468.html 0.6 2026-08-07T00:15:32+08:00 daily https://www.pharmasources.com/industryinsights/lillys-donanemab-receives-us-fdas-breakt-329469.html 0.6 2026-08-07T00:02:07+08:00 daily https://www.pharmasources.com/industryinsights/genentechs-actemra-receives-fda-emergenc-329470.html 0.6 2026-08-06T23:56:55+08:00 daily https://www.pharmasources.com/industryinsights/update-on-azd7442-storm-chaser-trial-in--329471.html 0.6 2026-08-07T00:03:02+08:00 daily https://www.pharmasources.com/industryinsights/askbios-gene-therapy-program-gets-fast-t-329472.html 0.6 2026-08-07T00:39:53+08:00 daily https://www.pharmasources.com/industryinsights/lonza-expands-api-development-mfg-facili-329473.html 0.6 2026-08-07T00:43:12+08:00 daily https://www.pharmasources.com/industryinsights/s-korean-consortium-to-produce-russias-s-329474.html 0.6 2026-08-07T13:14:56+08:00 daily https://www.pharmasources.com/industryinsights/patient-access-to-gene-therapies-for-can-329475.html 0.6 2026-08-08T23:20:30+08:00 daily https://www.pharmasources.com/industryinsights/dr-reddys-laboratories-commercially-laun-329476.html 0.6 2026-08-07T05:14:13+08:00 daily https://www.pharmasources.com/industryinsights/ec-approves-chugais-enspryng-for-nmosd-t-329477.html 0.6 2026-08-07T05:01:26+08:00 daily https://www.pharmasources.com/industryinsights/chmp-recommends-approval-of-ucbs-bimzelx-329478.html 0.6 2026-07-21T18:06:21+08:00 daily https://www.pharmasources.com/industryinsights/lillys-tirzepatide-beats-ozempic-in-head-329479.html 0.6 2026-06-21T05:13:00+08:00 daily https://www.pharmasources.com/industryinsights/bms-car-t-therapy-abecma-moves-closer-to-329480.html 0.6 2026-06-30T15:33:14+08:00 daily https://www.pharmasources.com/industryinsights/az-doses-first-participants-with-covid-1-329481.html 0.6 2026-06-20T16:58:14+08:00 daily https://www.pharmasources.com/industryinsights/biovaxys-announces-non-brokered-private--329482.html 0.6 2026-01-04T04:57:30+08:00 daily https://www.pharmasources.com/industryinsights/innovent-announces-license-agreement-wit-329483.html 0.6 2026-07-31T02:35:41+08:00 daily https://www.pharmasources.com/industryinsights/neurophth-announced-the-first-patient-ha-329484.html 0.6 2026-08-08T18:23:43+08:00 daily https://www.pharmasources.com/industryinsights/ilias-biologics-inc-demonstrated-the-the-329485.html 0.6 2026-06-21T01:11:55+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharmas-opaganib-inhibits-cov-329486.html 0.6 2026-08-08T10:38:55+08:00 daily https://www.pharmasources.com/industryinsights/new-late-breaking-data-at-the-american-d-329487.html 0.6 2026-08-07T16:15:13+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccines-have-prevented-72-mill-329488.html 0.6 2026-08-07T13:15:21+08:00 daily https://www.pharmasources.com/industryinsights/global-flower-and-ornamental-plants-mark-329489.html 0.6 2026-08-07T19:27:03+08:00 daily https://www.pharmasources.com/industryinsights/proam-sports-medicine-leads-entertainmen-329490.html 0.6 2026-08-08T09:47:12+08:00 daily https://www.pharmasources.com/industryinsights/yahoo-small-business-finds-only-38-perce-329491.html 0.6 2026-08-09T21:45:29+08:00 daily https://www.pharmasources.com/industryinsights/fostamatinib-selected-for-nih-activ-4-co-329492.html 0.6 2026-06-20T05:57:07+08:00 daily https://www.pharmasources.com/industryinsights/biofriendly-reflects-on-how-the-covid-19-329493.html 0.6 2026-06-21T06:16:00+08:00 daily https://www.pharmasources.com/industryinsights/american-humanes-feed-the-hungry-covid-1-329494.html 0.6 2026-06-21T08:15:55+08:00 daily https://www.pharmasources.com/industryinsights/169-billion-smart-food-logistics-markets-329495.html 0.6 2026-08-11T10:00:28+08:00 daily https://www.pharmasources.com/industryinsights/rdif-sputnik-v-has-demonstrated-978-effi-329496.html 0.6 2026-06-21T04:17:03+08:00 daily https://www.pharmasources.com/industryinsights/human-capital-management-hcm-solutions-m-329497.html 0.6 2026-07-04T03:28:21+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-sta-to-build-second-us-pharma-manuf-329498.html 0.6 2026-08-12T20:25:35+08:00 daily https://www.pharmasources.com/industryinsights/lonza-to-invest-in-mid-scale-api-manufac-329499.html 0.6 2026-08-07T15:20:02+08:00 daily https://www.pharmasources.com/industryinsights/cerevel-surges-on-positive-data-for-cvl--329500.html 0.6 2026-08-09T21:52:20+08:00 daily https://www.pharmasources.com/industryinsights/acurx-pharmaceuticals-announces-closing--329501.html 0.6 2026-08-10T20:58:01+08:00 daily https://www.pharmasources.com/industryinsights/panbela-therapeutics-announces-50-millio-329502.html 0.6 2026-06-22T08:52:41+08:00 daily https://www.pharmasources.com/industryinsights/bioasis-technologies-announces-closing-o-329503.html 0.6 2026-06-21T14:54:29+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-covid-19-vaccine-and-covishi-329504.html 0.6 2026-06-19T22:18:07+08:00 daily https://www.pharmasources.com/industryinsights/study-reveals-mechanisms-of-increased-in-329505.html 0.6 2026-08-06T23:33:15+08:00 daily https://www.pharmasources.com/industryinsights/angion-announces-results-from-the-phase--329506.html 0.6 2026-08-06T23:35:55+08:00 daily https://www.pharmasources.com/industryinsights/reported-cases-of-myocarditis-in-younger-329507.html 0.6 2026-06-16T06:55:14+08:00 daily https://www.pharmasources.com/industryinsights/33-million-persons-of-all-ages-uninsured-329508.html 0.6 2026-08-06T23:57:04+08:00 daily https://www.pharmasources.com/industryinsights/2019-to-2020-saw-drop-in-number-of-birth-329509.html 0.6 2026-08-07T00:01:30+08:00 daily https://www.pharmasources.com/industryinsights/nonpharmacologic-interventions-effective-329510.html 0.6 2026-08-07T02:30:58+08:00 daily https://www.pharmasources.com/industryinsights/walmart-to-offer-low-priced-insulin-329511.html 0.6 2026-08-07T05:28:06+08:00 daily https://www.pharmasources.com/industryinsights/one-third-of-elderly-caregivers-from-gra-329512.html 0.6 2026-06-21T08:16:26+08:00 daily https://www.pharmasources.com/industryinsights/which-blood-sugar-meds-work-best-against-329513.html 0.6 2026-06-30T18:34:36+08:00 daily https://www.pharmasources.com/industryinsights/pandemic-day-care-closures-forced-600000-329514.html 0.6 2026-06-21T11:04:13+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-embraceable-healthy-news-huggin-329515.html 0.6 2026-06-21T10:06:09+08:00 daily https://www.pharmasources.com/industryinsights/fennec-pharmaceuticals-announces-fda-acc-329516.html 0.6 2026-06-20T16:54:08+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-soaanz-torsemide-for-edema--329517.html 0.6 2026-06-24T13:27:41+08:00 daily https://www.pharmasources.com/industryinsights/cmic-and-lokavant-partner-to-deploy-clin-329518.html 0.6 2026-08-01T11:57:12+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-sta-chooses-middletown-delaware-for-329519.html 0.6 2026-07-20T04:05:20+08:00 daily https://www.pharmasources.com/industryinsights/moderna-gets-eua-for-its-covid-19-vaccin-329520.html 0.6 2026-06-20T18:56:39+08:00 daily https://www.pharmasources.com/industryinsights/aragen-expands-discovery-research-pact-w-329521.html 0.6 2026-08-05T19:25:08+08:00 daily https://www.pharmasources.com/industryinsights/cipla-dr-reddys-emcure-sun-pharma-and-to-329522.html 0.6 2026-05-12T16:15:38+08:00 daily https://www.pharmasources.com/industryinsights/cipla-gets-permission-from-dcgi-to-impor-329523.html 0.6 2026-06-21T18:03:29+08:00 daily https://www.pharmasources.com/industryinsights/quadria-capital-led-consortium-acquires--329524.html 0.6 2026-08-12T14:50:25+08:00 daily https://www.pharmasources.com/industryinsights/covishield-approval-to-be-considered-on--329525.html 0.6 2026-07-17T15:31:13+08:00 daily https://www.pharmasources.com/industryinsights/bajaj-healthcare-applies-to-indian-paten-329526.html 0.6 2026-08-10T18:49:45+08:00 daily https://www.pharmasources.com/industryinsights/strides-announces-completion-of-eu-gmp-i-329527.html 0.6 2026-06-19T15:01:05+08:00 daily https://www.pharmasources.com/industryinsights/altimmune-to-discontinue-covid-19-vaccin-329528.html 0.6 2026-08-09T21:41:21+08:00 daily https://www.pharmasources.com/industryinsights/stada-to-acquire-16-consumer-healthcare--329529.html 0.6 2026-08-12T10:13:44+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-appoints-dr-susan-galbraith--329530.html 0.6 2026-08-06T20:05:26+08:00 daily https://www.pharmasources.com/industryinsights/novartis-appoints-rob-kowalski-as-chief--329531.html 0.6 2026-08-06T23:55:38+08:00 daily https://www.pharmasources.com/industryinsights/first-covid-19-variant-vaccine-trial-par-329532.html 0.6 2026-08-10T04:42:54+08:00 daily https://www.pharmasources.com/industryinsights/eurofins-to-acquire-dna-diagnostics-cent-329533.html 0.6 2025-11-28T23:38:30+08:00 daily https://www.pharmasources.com/industryinsights/a-single-dose-of-vaxzevria-induced-immun-329534.html 0.6 2026-08-07T19:39:20+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-plans-400m-investment-in-mrna-vac-329535.html 0.6 2026-08-07T18:30:32+08:00 daily https://www.pharmasources.com/industryinsights/biomarin-resubmits-haemophilia-a-gene-th-329536.html 0.6 2026-08-07T13:19:16+08:00 daily https://www.pharmasources.com/industryinsights/abpi-launches-updated-code-of-practice-329537.html 0.6 2026-06-20T21:15:05+08:00 daily https://www.pharmasources.com/industryinsights/mix-and-match-covid-19-vaccine-study-yie-329538.html 0.6 2026-08-08T07:37:28+08:00 daily https://www.pharmasources.com/industryinsights/clover-and-dynavax-announce-commercial-s-329539.html 0.6 2026-08-08T04:31:21+08:00 daily https://www.pharmasources.com/industryinsights/clover-announces-advance-purchase-agreem-329540.html 0.6 2026-08-07T13:15:11+08:00 daily https://www.pharmasources.com/industryinsights/mentice-appoints-gunilla-andersson-as-ch-329541.html 0.6 2026-08-07T00:40:08+08:00 daily https://www.pharmasources.com/industryinsights/oncusp-therapeutics-commences-operations-329542.html 0.6 2026-08-07T02:41:02+08:00 daily https://www.pharmasources.com/industryinsights/subcutaneously-injected-pd-l1-antibody-e-329543.html 0.6 2026-08-07T02:45:45+08:00 daily https://www.pharmasources.com/industryinsights/gsk-singapore-and-vir-biotechnology-anno-329544.html 0.6 2026-08-11T09:52:27+08:00 daily https://www.pharmasources.com/industryinsights/hanmi-pharmaceutical-finds-new-innovativ-329545.html 0.6 2026-08-10T08:50:04+08:00 daily https://www.pharmasources.com/industryinsights/european-organisation-for-research-and-t-329546.html 0.6 2026-06-22T11:58:47+08:00 daily https://www.pharmasources.com/industryinsights/eight-roads-launches-its-new-us400-milli-329547.html 0.6 2026-06-20T05:32:49+08:00 daily https://www.pharmasources.com/industryinsights/new-accelerate-pheno-landmark-study-vali-329548.html 0.6 2026-06-20T20:01:34+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-diosynth-biotechnologies-to-exp-329549.html 0.6 2026-08-05T18:51:46+08:00 daily https://www.pharmasources.com/industryinsights/graphite-bio-announces-closing-of-upsize-329550.html 0.6 2026-06-20T03:13:17+08:00 daily https://www.pharmasources.com/industryinsights/point-biopharma-debuts-as-publicly-trade-329551.html 0.6 2026-08-04T00:57:42+08:00 daily https://www.pharmasources.com/industryinsights/results-of-biophytis-sara-int-phase-2-tr-329552.html 0.6 2026-06-20T13:13:36+08:00 daily https://www.pharmasources.com/industryinsights/freeline-announces-executive-leadership--329553.html 0.6 2026-06-21T05:58:53+08:00 daily https://www.pharmasources.com/industryinsights/bioasis-technologies-and-oxyrane-uk-ente-329554.html 0.6 2026-06-20T20:03:15+08:00 daily https://www.pharmasources.com/industryinsights/ensysce-biosciences-announces-closing-of-329555.html 0.6 2026-08-03T21:56:05+08:00 daily https://www.pharmasources.com/industryinsights/apellis-beam-ink-base-editing-pact-to-ta-329556.html 0.6 2026-06-21T03:19:01+08:00 daily https://www.pharmasources.com/industryinsights/novavax-publishes-results-of-united-king-329557.html 0.6 2026-06-20T22:45:46+08:00 daily https://www.pharmasources.com/industryinsights/letting-children-catch-covid-may-be-safe-329558.html 0.6 2026-06-23T00:06:04+08:00 daily https://www.pharmasources.com/industryinsights/brazils-anvisa-suspends-covaxin-shots-em-329559.html 0.6 2026-07-07T00:51:22+08:00 daily https://www.pharmasources.com/industryinsights/tenaya-therapeutics-announces-new-appoin-329560.html 0.6 2026-06-21T17:19:10+08:00 daily https://www.pharmasources.com/industryinsights/ada-peds-hospitalization-rates-for-new-o-329561.html 0.6 2026-08-08T10:50:17+08:00 daily https://www.pharmasources.com/industryinsights/only-four-in-10-with-severe-asthma-see-s-329562.html 0.6 2026-06-20T09:11:42+08:00 daily https://www.pharmasources.com/industryinsights/drop-seen-in-physician-work-hours-during-329563.html 0.6 2026-02-10T15:59:48+08:00 daily https://www.pharmasources.com/industryinsights/168-million-undiagnosed-covid-19-cases-i-329564.html 0.6 2026-08-07T06:14:09+08:00 daily https://www.pharmasources.com/industryinsights/most-americans-who-wanted-covid-19-vacci-329565.html 0.6 2025-12-16T03:52:35+08:00 daily https://www.pharmasources.com/industryinsights/more-evidence-spanking-kids-doesnt-work--329566.html 0.6 2026-03-31T14:04:41+08:00 daily https://www.pharmasources.com/industryinsights/drug-may-curb-sluggish-thinking-in-some--329567.html 0.6 2026-08-06T01:45:32+08:00 daily https://www.pharmasources.com/industryinsights/womens-cancer-screenings-plummeted-durin-329568.html 0.6 2026-06-21T03:50:33+08:00 daily https://www.pharmasources.com/industryinsights/cbd-products-gain-following-among-fibrom-329569.html 0.6 2026-06-21T11:10:18+08:00 daily https://www.pharmasources.com/industryinsights/lillys-surpass-2-results-published-in-th-329570.html 0.6 2026-08-14T23:15:07+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-launches-dedicated-mrna-vaccines--329571.html 0.6 2026-08-07T06:07:12+08:00 daily https://www.pharmasources.com/industryinsights/rentschler-expands-complex-antibodies-pr-329572.html 0.6 2026-08-06T20:07:59+08:00 daily https://www.pharmasources.com/industryinsights/curevac-appoints-dr-malte-greune-as-coo-329573.html 0.6 2026-08-07T03:07:10+08:00 daily https://www.pharmasources.com/industryinsights/selexis-kbi-biopharma-immatics-partner-t-329574.html 0.6 2026-08-07T00:53:04+08:00 daily https://www.pharmasources.com/industryinsights/supplied-lipids-for-about-three-lakh-via-329575.html 0.6 2026-08-07T00:58:59+08:00 daily https://www.pharmasources.com/industryinsights/axio-biosolutions-gets-usfda-clearance-f-329576.html 0.6 2026-08-09T07:56:39+08:00 daily https://www.pharmasources.com/industryinsights/lupin-gets-tentative-us-fda-nod-for-dolu-329577.html 0.6 2026-06-20T03:10:15+08:00 daily https://www.pharmasources.com/industryinsights/covaxins-rolling-data-to-start-in-july-w-329578.html 0.6 2026-06-21T05:41:40+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-pharma-india-files-writ-peti-329579.html 0.6 2026-08-08T02:56:37+08:00 daily https://www.pharmasources.com/industryinsights/gilead-seeks-us-approval-for-long-acting-329580.html 0.6 2026-08-07T08:35:43+08:00 daily https://www.pharmasources.com/industryinsights/mhra-approves-paions-ultra-short-acting--329581.html 0.6 2026-06-20T05:01:13+08:00 daily https://www.pharmasources.com/industryinsights/ec-green-light-for-opdivo-plus-yervoy-in-329582.html 0.6 2026-06-08T17:55:57+08:00 daily https://www.pharmasources.com/industryinsights/bluebird-bios-sickle-cell-gene-therapy-g-329583.html 0.6 2026-06-23T05:49:05+08:00 daily https://www.pharmasources.com/industryinsights/extended-dosing-intervals-may-increase-e-329584.html 0.6 2026-08-03T04:24:59+08:00 daily https://www.pharmasources.com/industryinsights/partnership-to-revolutionise-rna-product-329585.html 0.6 2026-06-21T18:52:49+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccine-reduces-severity-length-329586.html 0.6 2026-06-19T17:47:13+08:00 daily https://www.pharmasources.com/industryinsights/indevr-launches-vaxarray-polio-kit-for-f-329587.html 0.6 2026-06-22T09:47:58+08:00 daily https://www.pharmasources.com/industryinsights/joint-commission-international-publishes-329588.html 0.6 2026-07-23T15:33:45+08:00 daily https://www.pharmasources.com/industryinsights/european-wellness-partners-with-chinas-p-329589.html 0.6 2026-06-27T10:13:17+08:00 daily https://www.pharmasources.com/industryinsights/kazia-provides-progress-update-on-paxali-329590.html 0.6 2026-06-22T22:00:50+08:00 daily https://www.pharmasources.com/industryinsights/antheia-announces-73m-series-b-to-commer-329591.html 0.6 2026-08-07T01:19:23+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-component-of-treatment-regi-329592.html 0.6 2026-08-07T01:40:04+08:00 daily https://www.pharmasources.com/industryinsights/global-syringes-market-2021-to-2026---fe-329593.html 0.6 2026-08-09T22:12:11+08:00 daily https://www.pharmasources.com/industryinsights/adhesives-and-sealants-market-growth-cur-329594.html 0.6 2026-08-07T23:22:32+08:00 daily https://www.pharmasources.com/industryinsights/data-center-market-in-china-in-internet--329595.html 0.6 2026-08-09T20:38:26+08:00 daily https://www.pharmasources.com/industryinsights/cmrc-long-term-care-facilities-after-the-329596.html 0.6 2026-08-07T02:18:43+08:00 daily https://www.pharmasources.com/industryinsights/north-america-hydrographic-survey-market-329597.html 0.6 2026-08-07T02:31:12+08:00 daily https://www.pharmasources.com/industryinsights/48-million-worldwide-pmi-foams-industry--329598.html 0.6 2026-08-07T03:33:29+08:00 daily https://www.pharmasources.com/industryinsights/lipidor-licence-agreement-grants-menarin-329599.html 0.6 2026-08-07T01:06:47+08:00 daily https://www.pharmasources.com/industryinsights/zentalis-pharmaceuticals-announces-closi-329600.html 0.6 2026-08-07T00:59:15+08:00 daily https://www.pharmasources.com/industryinsights/oncternal-therapeutics-appoints-pablo-ur-329601.html 0.6 2026-08-07T00:40:09+08:00 daily https://www.pharmasources.com/industryinsights/iconovo-has-completed-a-directed-share-i-329602.html 0.6 2026-08-07T00:15:53+08:00 daily https://www.pharmasources.com/industryinsights/bioasis-announces-the-appointment-of-dav-329603.html 0.6 2026-08-07T00:18:27+08:00 daily https://www.pharmasources.com/industryinsights/caribou-biosciences-files-up-to-100m-ipo-329604.html 0.6 2026-06-21T03:47:37+08:00 daily https://www.pharmasources.com/industryinsights/cidara-therapeutics-provides-leadership--329605.html 0.6 2026-08-07T00:02:05+08:00 daily https://www.pharmasources.com/industryinsights/sqz-biotechnologies-strengthens-board-wi-329606.html 0.6 2026-06-20T21:44:34+08:00 daily https://www.pharmasources.com/industryinsights/denovo-biopharma-in-licenses-late-stage--329607.html 0.6 2026-06-21T01:08:54+08:00 daily https://www.pharmasources.com/industryinsights/krystal-biotech-provides-update-on-the-c-329608.html 0.6 2026-06-20T20:39:32+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-falls-from-americas-no-1-killer-329609.html 0.6 2026-06-21T08:10:11+08:00 daily https://www.pharmasources.com/industryinsights/masks-still-not-needed-for-vaccinated-am-329610.html 0.6 2026-06-21T14:43:17+08:00 daily https://www.pharmasources.com/industryinsights/drug-may-curb-sluggish-thinking-329611.html 0.6 2026-07-05T23:36:44+08:00 daily https://www.pharmasources.com/industryinsights/house-committees-to-investigate-new-alzh-329612.html 0.6 2026-08-10T03:26:24+08:00 daily https://www.pharmasources.com/industryinsights/pets-often-catch-covid-from-owners-study-329613.html 0.6 2026-06-21T05:04:43+08:00 daily https://www.pharmasources.com/industryinsights/aragen-expands-discovery-research-agreem-329614.html 0.6 2026-06-21T02:55:36+08:00 daily https://www.pharmasources.com/industryinsights/pig-study-could-lead-to-gene-therapy-to--329615.html 0.6 2026-06-20T17:15:54+08:00 daily https://www.pharmasources.com/industryinsights/innovent-biologics-signs-license-agreeme-329616.html 0.6 2026-06-30T04:59:30+08:00 daily https://www.pharmasources.com/industryinsights/almac-invests-830m-to-expand-crystalliza-329617.html 0.6 2026-06-21T09:11:26+08:00 daily https://www.pharmasources.com/industryinsights/gene-based-embryo-selection-are-designer-329618.html 0.6 2026-07-28T08:41:42+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-rylaze-for-the-treatment-of-329619.html 0.6 2026-07-20T20:57:02+08:00 daily https://www.pharmasources.com/industryinsights/frontage-to-acquire-quintara-discovery-329620.html 0.6 2026-07-17T22:22:02+08:00 daily https://www.pharmasources.com/industryinsights/waters-corp-expands-collaboration-with-b-329621.html 0.6 2026-06-21T13:07:37+08:00 daily https://www.pharmasources.com/industryinsights/fujifilm-invests-850m-to-expand-biologic-329622.html 0.6 2026-07-31T14:42:35+08:00 daily https://www.pharmasources.com/industryinsights/aspen-to-get-up-to-713m-to-produce-covid-329623.html 0.6 2026-06-19T20:07:48+08:00 daily https://www.pharmasources.com/industryinsights/singapores-gic-to-invest-1bn-in-grifols--329624.html 0.6 2026-06-21T07:18:13+08:00 daily https://www.pharmasources.com/industryinsights/study-finds-drugs-used-to-treat-prostate-329625.html 0.6 2026-06-20T22:15:00+08:00 daily https://www.pharmasources.com/industryinsights/lupin-gets-usfda-approval-of-snda-for-so-329626.html 0.6 2026-08-07T00:52:13+08:00 daily https://www.pharmasources.com/industryinsights/clariant-and-india-glycols-establish-jv--329627.html 0.6 2026-06-22T07:55:02+08:00 daily https://www.pharmasources.com/industryinsights/alembic-pharma-gets-usfda-final-approval-329628.html 0.6 2026-06-19T23:02:56+08:00 daily https://www.pharmasources.com/industryinsights/scientists-identify-new-way-to-target-mu-329629.html 0.6 2026-06-21T07:18:21+08:00 daily https://www.pharmasources.com/industryinsights/zydus-applies-to-dcgi-for-eua-to-launch--329630.html 0.6 2026-07-10T15:27:32+08:00 daily https://www.pharmasources.com/industryinsights/zycov-d-may-find-favour-in-12-18-age-gro-329631.html 0.6 2026-06-23T07:27:21+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-to-pay-230m-to-settle-op-329632.html 0.6 2026-06-30T21:19:29+08:00 daily https://www.pharmasources.com/industryinsights/philip-morris-to-acquire-fertin-pharma-f-329633.html 0.6 2026-07-20T11:59:22+08:00 daily https://www.pharmasources.com/industryinsights/jcvi-recommends-booster-covid-19-jabs-fo-329634.html 0.6 2026-06-20T17:03:16+08:00 daily https://www.pharmasources.com/industryinsights/rinvoq-scores-positive-results-as-a-main-329635.html 0.6 2026-01-30T20:51:59+08:00 daily https://www.pharmasources.com/industryinsights/highest-ever-number-of-hcps-named-on-dis-329636.html 0.6 2026-06-20T18:55:40+08:00 daily https://www.pharmasources.com/industryinsights/msds-keytruda-scores-eu-approval-in-cert-329637.html 0.6 2026-06-21T00:54:47+08:00 daily https://www.pharmasources.com/industryinsights/az-says-mpo-inhibitor-azd4831-shows-prom-329638.html 0.6 2026-08-07T19:29:06+08:00 daily https://www.pharmasources.com/industryinsights/nonacus-partners-with-birmingham-univers-329639.html 0.6 2026-08-06T16:56:50+08:00 daily https://www.pharmasources.com/industryinsights/jazz-pharmas-blood-cancer-therapy-rylaze-329640.html 0.6 2026-06-30T11:43:22+08:00 daily https://www.pharmasources.com/industryinsights/mhra-authorises-diurnals-cah-therapy-efm-329641.html 0.6 2026-06-21T11:01:10+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-qc-market-to-value-9700mn-329642.html 0.6 2026-06-21T16:36:00+08:00 daily https://www.pharmasources.com/industryinsights/novavax-covid-19-vaccine-almost-90-perce-329643.html 0.6 2026-06-20T14:57:06+08:00 daily https://www.pharmasources.com/industryinsights/kingdee-and-bgi-group-signed-a-strategic-329644.html 0.6 2026-07-13T17:45:59+08:00 daily https://www.pharmasources.com/industryinsights/ramesh-subrahmanian-joins-everlife-board-329645.html 0.6 2026-06-24T02:52:29+08:00 daily https://www.pharmasources.com/industryinsights/new-data-on-phase-1-proposed-biosimilar--329646.html 0.6 2026-06-20T22:04:42+08:00 daily https://www.pharmasources.com/industryinsights/chinas-leading-health-insurance-platform-329647.html 0.6 2026-06-23T18:55:14+08:00 daily https://www.pharmasources.com/industryinsights/lipidor-ab-licence-agreement-grants-mena-329648.html 0.6 2026-07-07T03:04:02+08:00 daily https://www.pharmasources.com/industryinsights/korea-national-institute-of-health-knih--329649.html 0.6 2026-08-08T17:52:30+08:00 daily https://www.pharmasources.com/industryinsights/ildong-pharmaceutical-starts-phase-1-stu-329650.html 0.6 2026-08-08T02:53:51+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-announces-multiple-advancements-of-329651.html 0.6 2026-06-25T04:20:26+08:00 daily https://www.pharmasources.com/industryinsights/alterity-therapeutics-granted-a-new-us-p-329652.html 0.6 2026-06-22T12:06:57+08:00 daily https://www.pharmasources.com/industryinsights/mefloquine-a-promising-drug-soldier-in-t-329653.html 0.6 2026-06-22T10:54:50+08:00 daily https://www.pharmasources.com/industryinsights/waterjet-cutting-machine-market-worth-15-329654.html 0.6 2026-08-07T12:35:18+08:00 daily https://www.pharmasources.com/industryinsights/us-job-gains-surge-to-850000-as-business-329655.html 0.6 2026-08-07T13:18:47+08:00 daily https://www.pharmasources.com/industryinsights/eyes-shift-to-the-healthcare-industry-af-329656.html 0.6 2026-08-08T00:53:58+08:00 daily https://www.pharmasources.com/industryinsights/nonprofit-covid-clinic-continues-to-open-329657.html 0.6 2026-08-08T01:44:00+08:00 daily https://www.pharmasources.com/industryinsights/gg56-is-offering-the-covid-19-digital-so-329658.html 0.6 2026-08-10T00:27:24+08:00 daily https://www.pharmasources.com/industryinsights/amgen-to-build-new-assembly-and-final-pa-329659.html 0.6 2026-06-21T08:00:22+08:00 daily https://www.pharmasources.com/industryinsights/arctic-vision-joins-forces-with-the-univ-329660.html 0.6 2026-06-21T03:03:19+08:00 daily https://www.pharmasources.com/industryinsights/more-pharmacies-to-participate-in-c-19-b-329661.html 0.6 2026-06-29T14:32:45+08:00 daily https://www.pharmasources.com/industryinsights/israel-says-negotiating-pfizer-surplus-w-329662.html 0.6 2026-08-14T08:28:15+08:00 daily https://www.pharmasources.com/industryinsights/brazilian-cities-deny-media-reports-that-329663.html 0.6 2026-08-14T09:17:08+08:00 daily https://www.pharmasources.com/industryinsights/bharat-biotech-concludes-final-analysis--329664.html 0.6 2026-06-20T16:57:20+08:00 daily https://www.pharmasources.com/industryinsights/china-us-to-send-covid-19-vaccine-doses--329665.html 0.6 2026-06-22T01:06:57+08:00 daily https://www.pharmasources.com/industryinsights/sahpra-authorises-the-coronavac-vaccine--329666.html 0.6 2026-06-20T14:23:15+08:00 daily https://www.pharmasources.com/industryinsights/us-to-ship-4-million-vaccine-doses-to-in-329667.html 0.6 2026-06-20T12:17:57+08:00 daily https://www.pharmasources.com/industryinsights/uae-approves-moderna-covid-19-vaccine-fo-329668.html 0.6 2026-08-09T07:08:11+08:00 daily https://www.pharmasources.com/industryinsights/large-scale-drug-analysis-reveals-potent-329669.html 0.6 2026-06-19T23:55:03+08:00 daily https://www.pharmasources.com/industryinsights/dermatology-biotech-dermata-therapeutics-329670.html 0.6 2026-06-21T07:13:06+08:00 daily https://www.pharmasources.com/industryinsights/brazil-top-court-gives-nod-for-probe-int-329671.html 0.6 2026-06-22T12:01:10+08:00 daily https://www.pharmasources.com/industryinsights/backyard-fireworks-on-the-4th-rethink-it-329672.html 0.6 2026-07-05T11:56:07+08:00 daily https://www.pharmasources.com/industryinsights/shining-a-light-on-sunscreens-using-suns-329673.html 0.6 2026-06-20T13:12:20+08:00 daily https://www.pharmasources.com/industryinsights/hearing-impairment-tied-to-poorer-physic-329674.html 0.6 2026-06-20T08:22:13+08:00 daily https://www.pharmasources.com/industryinsights/biden-administration-pushes-forward-with-329675.html 0.6 2026-06-20T18:13:43+08:00 daily https://www.pharmasources.com/industryinsights/exercising-with-a-mask-safe-does-not-imp-329676.html 0.6 2026-08-08T17:53:14+08:00 daily https://www.pharmasources.com/industryinsights/jj-vaccine-guards-against-delta-variant--329677.html 0.6 2026-08-08T15:51:53+08:00 daily https://www.pharmasources.com/industryinsights/gap-in-breast-cancer-survival-for-black--329678.html 0.6 2026-08-11T05:09:36+08:00 daily https://www.pharmasources.com/industryinsights/masks-at-the-gym-uncomfortable-but-not-u-329679.html 0.6 2026-08-07T13:16:25+08:00 daily https://www.pharmasources.com/industryinsights/hermes-pharma-announces-spin-out-from-he-329680.html 0.6 2026-08-07T01:21:42+08:00 daily https://www.pharmasources.com/industryinsights/agc-biologics-to-acquire-novartis-facili-329681.html 0.6 2026-08-07T01:14:10+08:00 daily https://www.pharmasources.com/industryinsights/avid-bioservices-appoints-esther-m-alegr-329682.html 0.6 2026-08-07T01:11:03+08:00 daily https://www.pharmasources.com/industryinsights/lonza-finalizes-divestment-of-specialty--329683.html 0.6 2026-08-07T00:53:30+08:00 daily https://www.pharmasources.com/industryinsights/seres-and-nestl-enter-up-to-525m-deal-fo-329684.html 0.6 2026-08-07T00:42:54+08:00 daily https://www.pharmasources.com/industryinsights/unmet-needs-and-opportunities-in-the-cys-329685.html 0.6 2026-08-07T00:40:46+08:00 daily https://www.pharmasources.com/industryinsights/pharmstars-reveals-leading-pharma-compan-329686.html 0.6 2026-08-07T05:06:08+08:00 daily https://www.pharmasources.com/industryinsights/teva-recalls-lot-of-contaminated-topotec-329687.html 0.6 2026-08-07T05:13:43+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-treatment-regimen-for-most--329688.html 0.6 2026-07-16T21:28:52+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-strengthens-cell-and-gene-ther-329689.html 0.6 2026-07-17T07:16:12+08:00 daily https://www.pharmasources.com/industryinsights/recall-of-chantix-due-to-impurity-329690.html 0.6 2026-06-20T23:57:39+08:00 daily https://www.pharmasources.com/industryinsights/ngm-to-focus-on-novel-medicines-for-reti-329691.html 0.6 2026-08-14T10:21:13+08:00 daily https://www.pharmasources.com/industryinsights/merck-provides-update-on-keytruda-indica-329692.html 0.6 2026-08-11T10:01:46+08:00 daily https://www.pharmasources.com/industryinsights/government-allots-funds-from-pmcares-for-329693.html 0.6 2026-06-20T15:13:24+08:00 daily https://www.pharmasources.com/industryinsights/eqt-private-equity-and-goldman-sachs-to--329694.html 0.6 2026-06-21T06:04:47+08:00 daily https://www.pharmasources.com/industryinsights/adroit-biomed-launches-glutone-md-made-f-329695.html 0.6 2026-07-04T13:54:14+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-receives-final-approval-fro-329696.html 0.6 2026-07-04T00:39:42+08:00 daily https://www.pharmasources.com/industryinsights/bharat-biotech-announces-data-from-phase-329697.html 0.6 2026-08-07T02:40:51+08:00 daily https://www.pharmasources.com/industryinsights/opportunities-remain-to-address-unmet-ne-329698.html 0.6 2026-08-08T12:50:51+08:00 daily https://www.pharmasources.com/industryinsights/zim-labs-gets-marketing-authorisation-fo-329699.html 0.6 2026-08-07T00:18:45+08:00 daily https://www.pharmasources.com/industryinsights/impact-of-covid-19-20-on-indian-pharma-i-329700.html 0.6 2026-07-29T14:08:02+08:00 daily https://www.pharmasources.com/industryinsights/laurus-labs-gets-drdo-nod-to-make-and-ma-329701.html 0.6 2026-06-19T21:01:46+08:00 daily https://www.pharmasources.com/industryinsights/first-patients-vaccinated-with-astrazene-329702.html 0.6 2026-07-28T09:57:50+08:00 daily https://www.pharmasources.com/industryinsights/us-grants-new-patent-targeting-major-neu-329703.html 0.6 2026-06-20T15:56:38+08:00 daily https://www.pharmasources.com/industryinsights/novel-covid-19-vaccine-shows-promise-in--329704.html 0.6 2026-06-27T09:14:23+08:00 daily https://www.pharmasources.com/industryinsights/abbisko-and-sperogenix-announce-an-exclu-329705.html 0.6 2026-08-07T20:44:38+08:00 daily https://www.pharmasources.com/industryinsights/tianjin-haihe-media-group-presents-the-s-329706.html 0.6 2026-06-29T05:27:48+08:00 daily https://www.pharmasources.com/industryinsights/transcenta-provides-program-update-for-a-329707.html 0.6 2026-08-06T18:50:07+08:00 daily https://www.pharmasources.com/industryinsights/gsk-and-alector-announce-global-collabor-329708.html 0.6 2026-06-20T21:16:52+08:00 daily https://www.pharmasources.com/industryinsights/topical-jak-inhibitors-becoming-a-major--329709.html 0.6 2026-07-24T00:19:49+08:00 daily https://www.pharmasources.com/industryinsights/biomed-x-and-merck-kgaa-darmstadt-german-329710.html 0.6 2026-04-26T20:36:09+08:00 daily https://www.pharmasources.com/industryinsights/viralgen-opens-expanded-aav-manufacturin-329711.html 0.6 2026-06-22T09:46:20+08:00 daily https://www.pharmasources.com/industryinsights/rdif-test-batch-of-the-sputnik-v-vaccine-329712.html 0.6 2026-07-08T23:58:03+08:00 daily https://www.pharmasources.com/industryinsights/psilera-raises-25-million-with-oversubsc-329713.html 0.6 2026-07-04T11:10:44+08:00 daily https://www.pharmasources.com/industryinsights/moroccos-sothema-to-produce-chinas-sinop-329714.html 0.6 2026-08-08T20:39:58+08:00 daily https://www.pharmasources.com/industryinsights/valneva-to-host-symposium-on-covid-19-an-329715.html 0.6 2025-11-27T03:07:59+08:00 daily https://www.pharmasources.com/industryinsights/rare-disease-biotech-rallybio-files-for--329716.html 0.6 2026-06-20T12:08:46+08:00 daily https://www.pharmasources.com/industryinsights/ultimovacs-announces-review-article-high-329717.html 0.6 2026-06-24T12:00:59+08:00 daily https://www.pharmasources.com/industryinsights/greek-experts-recommend-covid-shots-for--329718.html 0.6 2026-06-19T16:07:13+08:00 daily https://www.pharmasources.com/industryinsights/celltrion-expects-covid-variants-to-fuel-329719.html 0.6 2026-06-21T18:25:02+08:00 daily https://www.pharmasources.com/industryinsights/oncodesign-appoints-aline-aubertin-as-an-329720.html 0.6 2026-06-20T23:02:41+08:00 daily https://www.pharmasources.com/industryinsights/nppa-allows-50-price-hike-for-ibuprofen--329721.html 0.6 2026-06-27T04:49:13+08:00 daily https://www.pharmasources.com/industryinsights/frances-sanofi-expects-covid-vaccine-to--329722.html 0.6 2026-06-21T07:21:42+08:00 daily https://www.pharmasources.com/industryinsights/imugene-says-her-vaxx-cancer-vaccine-ind-329723.html 0.6 2026-08-10T12:01:00+08:00 daily https://www.pharmasources.com/industryinsights/gap-between-covid-jabs-to-be-reduced-to--329724.html 0.6 2026-08-06T22:00:05+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-329725.html 0.6 2026-08-06T21:54:06+08:00 daily https://www.pharmasources.com/industryinsights/ministry-data-said-to-show-pfizer-shot-b-329726.html 0.6 2026-08-06T22:53:50+08:00 daily https://www.pharmasources.com/industryinsights/researchers-find-potential-path-to-a-bro-329727.html 0.6 2026-08-06T23:32:43+08:00 daily https://www.pharmasources.com/industryinsights/allarity-therapeutics-receives-acceptanc-329728.html 0.6 2026-08-06T23:46:36+08:00 daily https://www.pharmasources.com/industryinsights/sales-of-long-acting-immunosuppressants--329729.html 0.6 2026-08-06T23:36:54+08:00 daily https://www.pharmasources.com/industryinsights/indias-covid-crisis-could-spawn-another--329730.html 0.6 2026-08-06T23:57:01+08:00 daily https://www.pharmasources.com/industryinsights/icmr-niced-submits-proposal-to-dbt-for-r-329731.html 0.6 2026-08-07T00:02:11+08:00 daily https://www.pharmasources.com/industryinsights/telehealth-tips-for-helping-kids-with-au-329732.html 0.6 2026-06-20T17:34:47+08:00 daily https://www.pharmasources.com/industryinsights/ignite-life-science-foundation-announces-329733.html 0.6 2026-08-07T00:15:32+08:00 daily https://www.pharmasources.com/industryinsights/too-little-sunlight-vitamin-d-may-raise--329734.html 0.6 2026-06-21T03:20:59+08:00 daily https://www.pharmasources.com/industryinsights/study-finds-rise-in-antibiotic-misuse-in-329735.html 0.6 2026-07-07T20:55:40+08:00 daily https://www.pharmasources.com/industryinsights/pharmeasy-thyrocare-deal-milestone-for-e-329736.html 0.6 2026-07-28T07:09:57+08:00 daily https://www.pharmasources.com/industryinsights/panacea-biotec-gets-license-to-manufactu-329737.html 0.6 2026-06-20T15:14:26+08:00 daily https://www.pharmasources.com/industryinsights/over-600000-covid-19-tests-genomically-s-329738.html 0.6 2026-06-19T16:10:21+08:00 daily https://www.pharmasources.com/industryinsights/ongoing-pharma-productivity-requires-a-f-329739.html 0.6 2026-06-20T14:54:01+08:00 daily https://www.pharmasources.com/industryinsights/diabetes-treatment-pump-trial-begins-in--329740.html 0.6 2026-06-20T20:47:21+08:00 daily https://www.pharmasources.com/industryinsights/2021-zhejiang-export-commodity-online-fa-329741.html 0.6 2026-08-07T02:39:44+08:00 daily https://www.pharmasources.com/industryinsights/clover-biopharmaceuticals-completes-enro-329742.html 0.6 2026-08-07T18:42:49+08:00 daily https://www.pharmasources.com/industryinsights/bora-group-announce-the-rebranding-of-yu-329743.html 0.6 2026-07-24T21:19:29+08:00 daily https://www.pharmasources.com/industryinsights/innovent-and-laekna-therapeutics-enter-a-329744.html 0.6 2026-07-20T12:55:09+08:00 daily https://www.pharmasources.com/industryinsights/antengene-announces-acceptance-of-ind-ap-329745.html 0.6 2026-07-24T10:05:49+08:00 daily https://www.pharmasources.com/industryinsights/south-korean-biotech-y-biologics-and-fre-329746.html 0.6 2026-06-20T13:09:34+08:00 daily https://www.pharmasources.com/industryinsights/everest-medicines-announces-that-spero-t-329747.html 0.6 2026-06-22T02:37:20+08:00 daily https://www.pharmasources.com/industryinsights/cancer-cells-eat-themselves-to-survive-329748.html 0.6 2026-06-20T00:54:27+08:00 daily https://www.pharmasources.com/industryinsights/mimetas-and-roche-enter-into-a-collabora-329749.html 0.6 2026-03-01T21:26:03+08:00 daily https://www.pharmasources.com/industryinsights/eiger-biopharmaceuticals-announces-first-329750.html 0.6 2026-08-13T19:21:30+08:00 daily https://www.pharmasources.com/industryinsights/tipping-the-scales---aduhelms-hefty-pric-329751.html 0.6 2026-06-21T15:42:08+08:00 daily https://www.pharmasources.com/industryinsights/dynavax-and-biological-e-announce-commer-329752.html 0.6 2026-07-20T14:00:57+08:00 daily https://www.pharmasources.com/industryinsights/univercells-technologies-and-vectorbuild-329753.html 0.6 2026-06-21T01:51:35+08:00 daily https://www.pharmasources.com/industryinsights/global-legal-services-market-2020-to-203-329754.html 0.6 2026-08-10T23:33:55+08:00 daily https://www.pharmasources.com/industryinsights/cphi-webinar-how-is-ma-shifting-the-phar-329755.html 0.6 2026-06-24T05:02:30+08:00 daily https://www.pharmasources.com/industryinsights/benzene-market-in-specialty-chemicals-in-329756.html 0.6 2026-06-22T05:02:43+08:00 daily https://www.pharmasources.com/industryinsights/recipharm-selected-to-operate-new-fillfi-329757.html 0.6 2025-12-26T10:30:09+08:00 daily https://www.pharmasources.com/industryinsights/bio-polypropylene-market-post-covid-19-a-329758.html 0.6 2026-08-13T22:54:37+08:00 daily https://www.pharmasources.com/industryinsights/arix-bioscience-plc-team-changes-329759.html 0.6 2026-07-05T08:25:20+08:00 daily https://www.pharmasources.com/industryinsights/codiak-biosciences-announces-the-transit-329760.html 0.6 2026-07-18T13:50:44+08:00 daily https://www.pharmasources.com/industryinsights/ilyas-pharma-to-present-ilp100-accelerat-329761.html 0.6 2026-06-19T21:56:01+08:00 daily https://www.pharmasources.com/industryinsights/xbiotech-announces-dividend-to-holders-o-329762.html 0.6 2026-08-09T04:32:19+08:00 daily https://www.pharmasources.com/industryinsights/structures-discovered-in-brain-cancer-pa-329763.html 0.6 2026-08-07T13:19:06+08:00 daily https://www.pharmasources.com/industryinsights/oncosec-enters-into-a-collaboration-agre-329764.html 0.6 2026-08-07T01:10:55+08:00 daily https://www.pharmasources.com/industryinsights/eloxx-pharmaceuticals-provides-enrollmen-329765.html 0.6 2026-08-11T15:45:13+08:00 daily https://www.pharmasources.com/industryinsights/nrx-pharmaceuticals-announces-initiation-329766.html 0.6 2026-08-07T01:10:50+08:00 daily https://www.pharmasources.com/industryinsights/foresee-announces-potential-new-covid-19-329767.html 0.6 2026-08-07T03:06:16+08:00 daily https://www.pharmasources.com/industryinsights/perrigo-completes-divestiture-of-generic-329768.html 0.6 2026-08-06T22:08:09+08:00 daily https://www.pharmasources.com/industryinsights/standigm-secures-10-m-from-pavilion-capi-329769.html 0.6 2026-08-06T22:20:43+08:00 daily https://www.pharmasources.com/industryinsights/soleno-therapeutics-provides-regulatory--329770.html 0.6 2026-08-06T23:32:59+08:00 daily https://www.pharmasources.com/industryinsights/recommended-therapy-for-low-back-pain-ma-329771.html 0.6 2026-08-06T23:37:05+08:00 daily https://www.pharmasources.com/industryinsights/familial-hereditary-risk-seen-for-hemato-329772.html 0.6 2026-08-10T11:59:38+08:00 daily https://www.pharmasources.com/industryinsights/just-20-states-reached-bidens-july-4-vac-329773.html 0.6 2026-04-11T00:57:41+08:00 daily https://www.pharmasources.com/industryinsights/britain-to-fully-reopen-soon-despite-ris-329774.html 0.6 2026-06-21T00:13:55+08:00 daily https://www.pharmasources.com/industryinsights/cdc-listeria-outbreak-linked-to-precooke-329775.html 0.6 2026-08-08T22:04:26+08:00 daily https://www.pharmasources.com/industryinsights/covid-vaccine-doesnt-infiltrate-breast-m-329776.html 0.6 2026-06-22T16:20:33+08:00 daily https://www.pharmasources.com/industryinsights/people-with-hiv-have-much-higher-risk-fo-329777.html 0.6 2026-06-23T20:48:09+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-smoking-harms-the-brain-raises--329778.html 0.6 2026-08-13T02:01:08+08:00 daily https://www.pharmasources.com/industryinsights/lupin-announces-fda-approval-of-suppleme-329779.html 0.6 2026-06-28T03:38:27+08:00 daily https://www.pharmasources.com/industryinsights/recipharm-to-build-new-fill-finish-facil-329780.html 0.6 2026-07-16T10:30:51+08:00 daily https://www.pharmasources.com/industryinsights/almacs-charnwood-site-receives-iso-certi-329781.html 0.6 2026-06-08T17:14:17+08:00 daily https://www.pharmasources.com/industryinsights/novasep-exelixis-ink-adc-manufacturing-a-329782.html 0.6 2026-08-08T01:29:57+08:00 daily https://www.pharmasources.com/industryinsights/universit-de-paris-and-institut-pasteur--329783.html 0.6 2026-06-20T16:59:13+08:00 daily https://www.pharmasources.com/industryinsights/mankind-partners-with-ace-turtle-for-omn-329784.html 0.6 2026-06-21T16:05:31+08:00 daily https://www.pharmasources.com/industryinsights/rdif-and-morepen-laboratories-announce-t-329785.html 0.6 2026-08-10T15:05:25+08:00 daily https://www.pharmasources.com/industryinsights/niramaya-research-launches-research-indi-329786.html 0.6 2026-06-20T22:50:36+08:00 daily https://www.pharmasources.com/industryinsights/novartis-to-manufacture-anti-cholesterol-329787.html 0.6 2026-08-12T20:16:04+08:00 daily https://www.pharmasources.com/industryinsights/algernon-to-drop-phase-iii-trial-of-ifen-329788.html 0.6 2026-04-26T14:03:57+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-receives-ec-approval-for-39b-329789.html 0.6 2026-07-21T00:08:07+08:00 daily https://www.pharmasources.com/industryinsights/shin-poong-reports-data-of-antimalarial--329790.html 0.6 2026-08-10T04:54:34+08:00 daily https://www.pharmasources.com/industryinsights/newly-introduced-health-and-care-bill-ai-329791.html 0.6 2026-08-09T22:52:32+08:00 daily https://www.pharmasources.com/industryinsights/jardiance-becomes-first-sglt2-inhibitor--329792.html 0.6 2026-06-13T17:46:42+08:00 daily https://www.pharmasources.com/industryinsights/govt-sets-out-ten-year-strategy-for-the--329793.html 0.6 2026-03-29T08:29:51+08:00 daily https://www.pharmasources.com/industryinsights/govt-announces-245m-funding-to-improve-m-329794.html 0.6 2026-06-21T07:59:00+08:00 daily https://www.pharmasources.com/industryinsights/bma-calls-for-some-covid-19-measures-to--329795.html 0.6 2026-07-09T00:18:14+08:00 daily https://www.pharmasources.com/industryinsights/oxford-researchers-launch-hiv-vaccine-tr-329796.html 0.6 2026-07-16T21:34:37+08:00 daily https://www.pharmasources.com/industryinsights/biocytogeneucure-biopharmas-ctla-4-and-c-329797.html 0.6 2026-08-02T14:41:23+08:00 daily https://www.pharmasources.com/industryinsights/cstone-announces-china-nmpa-acceptance-o-329798.html 0.6 2026-08-10T18:00:46+08:00 daily https://www.pharmasources.com/industryinsights/immunogenicity-expert-and-fda-alum-dr-am-329799.html 0.6 2026-06-20T18:01:27+08:00 daily https://www.pharmasources.com/industryinsights/transcenta-announces-nmpa-acceptance-of--329800.html 0.6 2025-11-24T05:35:39+08:00 daily https://www.pharmasources.com/industryinsights/harbour-biomed-reports-positive-topline--329801.html 0.6 2026-07-23T00:49:35+08:00 daily https://www.pharmasources.com/industryinsights/bon-natural-life-limited-announces-land--329802.html 0.6 2026-07-19T19:59:41+08:00 daily https://www.pharmasources.com/industryinsights/bionomics-initiates-phase-2b-attune-stud-329803.html 0.6 2026-06-29T15:27:22+08:00 daily https://www.pharmasources.com/industryinsights/mrna-vaccines-slash-risk-of-covid-19-inf-329804.html 0.6 2026-06-21T00:02:36+08:00 daily https://www.pharmasources.com/industryinsights/novartis-shifts-leqvio-manufacturing-to--329805.html 0.6 2026-08-04T21:22:30+08:00 daily https://www.pharmasources.com/industryinsights/athletico-physical-therapy-opens-in-miss-329806.html 0.6 2026-07-08T06:53:35+08:00 daily https://www.pharmasources.com/industryinsights/leo-pharma-and-x-chem-enter-into-discove-329807.html 0.6 2026-08-07T02:30:42+08:00 daily https://www.pharmasources.com/industryinsights/second-curaleaf-gmp-cannabis-facility-ga-329808.html 0.6 2026-08-07T02:19:19+08:00 daily https://www.pharmasources.com/industryinsights/global-microbiome-markets-report-2021-ma-329809.html 0.6 2026-08-07T02:15:30+08:00 daily https://www.pharmasources.com/industryinsights/jacobs-to-deliver-eastern-busway-allianc-329810.html 0.6 2026-08-07T02:09:45+08:00 daily https://www.pharmasources.com/industryinsights/push-to-talk-over-cellular-market-regist-329811.html 0.6 2026-08-07T02:04:35+08:00 daily https://www.pharmasources.com/industryinsights/tukatech-and-sowtex-create-worlds-first--329812.html 0.6 2026-08-07T01:52:03+08:00 daily https://www.pharmasources.com/industryinsights/parral-reports-tenth-consecutive-quarter-329813.html 0.6 2026-08-07T01:43:45+08:00 daily https://www.pharmasources.com/industryinsights/huons-acquires-marketing-rights-for-sput-329814.html 0.6 2026-08-07T01:27:41+08:00 daily https://www.pharmasources.com/industryinsights/treos-bio-enters-into-clinical-collabora-329815.html 0.6 2026-08-07T01:42:42+08:00 daily https://www.pharmasources.com/industryinsights/vaccine-stocks-skid-as-delta-variant-bec-329816.html 0.6 2026-08-07T01:45:50+08:00 daily https://www.pharmasources.com/industryinsights/mckesson-corporation-enters-agreement-to-329817.html 0.6 2026-08-07T13:15:53+08:00 daily https://www.pharmasources.com/industryinsights/scientists-find-genetic-cause-underlying-329818.html 0.6 2026-08-08T04:37:26+08:00 daily https://www.pharmasources.com/industryinsights/immunotherapy-biotech-hcw-biologics-sets-329819.html 0.6 2026-08-08T15:09:20+08:00 daily https://www.pharmasources.com/industryinsights/phage-display-based-gene-delivery-a-viab-329820.html 0.6 2026-08-08T20:03:00+08:00 daily https://www.pharmasources.com/industryinsights/germany-to-donate-all-remaining-astrazen-329821.html 0.6 2026-08-08T21:48:50+08:00 daily https://www.pharmasources.com/industryinsights/stealth-biotherapeutics-joins-the-rare-d-329822.html 0.6 2026-08-08T23:30:25+08:00 daily https://www.pharmasources.com/industryinsights/us-drugmaker-trevenas-ultra-strong-paink-329823.html 0.6 2026-08-09T01:19:27+08:00 daily https://www.pharmasources.com/industryinsights/absci-strengthens-executive-leadership-t-329824.html 0.6 2026-08-09T02:52:32+08:00 daily https://www.pharmasources.com/industryinsights/past-year-dental-visits-more-frequent-in-329825.html 0.6 2026-08-09T06:51:30+08:00 daily https://www.pharmasources.com/industryinsights/telephone-consults-convenient-effective--329826.html 0.6 2026-06-21T11:56:28+08:00 daily https://www.pharmasources.com/industryinsights/patient-engagement-may-not-drive-return--329827.html 0.6 2026-03-26T22:15:53+08:00 daily https://www.pharmasources.com/industryinsights/delta-variant-now-behind-more-than-50-pe-329828.html 0.6 2026-08-11T12:08:26+08:00 daily https://www.pharmasources.com/industryinsights/blood-shortages-causing-surgery-delays-a-329829.html 0.6 2026-06-21T01:03:47+08:00 daily https://www.pharmasources.com/industryinsights/is-medicare-overspending-costco-prices-m-329830.html 0.6 2026-08-08T01:43:15+08:00 daily https://www.pharmasources.com/industryinsights/language-barriers-keep-25-million-in-us--329831.html 0.6 2026-06-20T11:50:12+08:00 daily https://www.pharmasources.com/industryinsights/gilead-submits-new-drug-application-to-u-329832.html 0.6 2026-08-07T23:12:41+08:00 daily https://www.pharmasources.com/industryinsights/vaxzevria-induced-immunity-for-at-least--329833.html 0.6 2026-08-10T03:48:25+08:00 daily https://www.pharmasources.com/industryinsights/nirsevimab-medley-phase-iiiii-trial-demo-329834.html 0.6 2026-06-23T20:05:22+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-names-new-chief-medical-of-329835.html 0.6 2026-08-06T14:07:09+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-scientific-expands-gene-th-329836.html 0.6 2026-08-09T18:06:13+08:00 daily https://www.pharmasources.com/industryinsights/sri-sanofi-enter-drug-discovery-collabor-329837.html 0.6 2026-08-07T01:10:24+08:00 daily https://www.pharmasources.com/industryinsights/y-biologics-pierre-fabre-enter-immuno-on-329838.html 0.6 2026-08-09T12:47:01+08:00 daily https://www.pharmasources.com/industryinsights/valneva-appoints-ops-svp-329839.html 0.6 2026-06-21T10:59:10+08:00 daily https://www.pharmasources.com/industryinsights/fda-declines-to-approve-provention-bios--329840.html 0.6 2026-06-29T18:40:17+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-to-license-multiple-myeloma-targe-329841.html 0.6 2026-06-20T19:18:03+08:00 daily https://www.pharmasources.com/industryinsights/igba-launches-whitepaper-on-global-gener-329842.html 0.6 2026-08-11T15:10:35+08:00 daily https://www.pharmasources.com/industryinsights/cadila-pharma-hosts-sessions-to-spread-a-329843.html 0.6 2026-01-02T13:57:27+08:00 daily https://www.pharmasources.com/industryinsights/healthcare-industry-reports-106-deals-wo-329844.html 0.6 2026-06-21T13:09:35+08:00 daily https://www.pharmasources.com/industryinsights/research-finds-mutations-aid-epsilon-cor-329845.html 0.6 2026-06-22T12:51:25+08:00 daily https://www.pharmasources.com/industryinsights/protein-spikes-developed-in-labs-consist-329846.html 0.6 2026-06-21T08:11:16+08:00 daily https://www.pharmasources.com/industryinsights/israel-reports-decrease-in-pfizer-vaccin-329847.html 0.6 2026-08-12T03:33:52+08:00 daily https://www.pharmasources.com/industryinsights/il-6-antagonists-reduce-risk-of-death-in-329848.html 0.6 2026-06-15T15:06:27+08:00 daily https://www.pharmasources.com/industryinsights/understanding-your-cleanroom-fungi-is-ke-329849.html 0.6 2026-06-21T12:16:43+08:00 daily https://www.pharmasources.com/industryinsights/mhra-and-health-canada-release-new-clini-329850.html 0.6 2026-07-06T23:23:25+08:00 daily https://www.pharmasources.com/industryinsights/global-sterilisation-monitoring-market-t-329851.html 0.6 2026-04-02T01:08:50+08:00 daily https://www.pharmasources.com/industryinsights/bioshin-expands-senior-leadership-team-s-329852.html 0.6 2026-06-29T03:42:29+08:00 daily https://www.pharmasources.com/industryinsights/just-5-minutes-game-changing-pcr-to-comp-329853.html 0.6 2026-08-09T03:45:04+08:00 daily https://www.pharmasources.com/industryinsights/beato-raises-usd-57-million-in-funding-l-329854.html 0.6 2026-08-08T12:36:14+08:00 daily https://www.pharmasources.com/industryinsights/cstone-announces-updated-results-for-ayv-329855.html 0.6 2026-08-08T01:00:56+08:00 daily https://www.pharmasources.com/industryinsights/otsuka-signs-three-year-collaboration-wi-329856.html 0.6 2026-08-12T13:14:18+08:00 daily https://www.pharmasources.com/industryinsights/ortho-clinical-diagnostics-announces-par-329857.html 0.6 2026-06-22T06:01:07+08:00 daily https://www.pharmasources.com/industryinsights/suvoda-announces-the-expansion-of-its-le-329858.html 0.6 2026-06-22T22:58:01+08:00 daily https://www.pharmasources.com/industryinsights/dmed-clinipace-announces-completion-of-u-329859.html 0.6 2026-06-21T07:22:23+08:00 daily https://www.pharmasources.com/industryinsights/positive-new-data-for-johnson-johnson-si-329860.html 0.6 2026-06-30T22:31:32+08:00 daily https://www.pharmasources.com/industryinsights/eurofins-viracor-invests-in-innovation-w-329861.html 0.6 2026-06-20T05:03:11+08:00 daily https://www.pharmasources.com/industryinsights/study-confirms-that-black-people-are-at--329862.html 0.6 2026-06-20T06:59:33+08:00 daily https://www.pharmasources.com/industryinsights/centers-for-disease-control-and-preventi-329863.html 0.6 2026-07-01T10:00:35+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-impact-and-recovery-analysis-st-329864.html 0.6 2026-07-05T02:15:51+08:00 daily https://www.pharmasources.com/industryinsights/global-automotive-diagnostics-tools-and--329865.html 0.6 2026-08-09T11:39:59+08:00 daily https://www.pharmasources.com/industryinsights/largest-managed-care-psychiatric-practic-329866.html 0.6 2026-06-20T15:09:19+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-doctors-certificates-for-antige-329867.html 0.6 2026-06-21T02:12:47+08:00 daily https://www.pharmasources.com/industryinsights/post-covid-19-erp-software-markets-procu-329868.html 0.6 2026-06-21T04:23:19+08:00 daily https://www.pharmasources.com/industryinsights/the-asset-management-industry-emerged-st-329869.html 0.6 2026-08-05T19:33:32+08:00 daily https://www.pharmasources.com/industryinsights/nearly-all-schools-were-offering-in-pers-329870.html 0.6 2026-06-19T23:01:54+08:00 daily https://www.pharmasources.com/industryinsights/cyclerion-therapeutics-and-beacon-biosig-329871.html 0.6 2026-06-23T02:55:51+08:00 daily https://www.pharmasources.com/industryinsights/us-to-send-500000-pfizer-covid-19-vaccin-329872.html 0.6 2026-03-05T07:17:52+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-plans-to-seek-fda-nod-for-covid-1-329873.html 0.6 2026-06-21T12:00:14+08:00 daily https://www.pharmasources.com/industryinsights/merck-kgaa-appoints-renee-connolly-as-ch-329874.html 0.6 2026-04-07T22:06:15+08:00 daily https://www.pharmasources.com/industryinsights/collaboration-between-abbvie-biogen-and--329875.html 0.6 2026-06-30T09:27:49+08:00 daily https://www.pharmasources.com/industryinsights/purminds-completes-initial-strategic-equ-329876.html 0.6 2026-06-21T09:04:02+08:00 daily https://www.pharmasources.com/industryinsights/zimbabwe-gets-2-million-sinovac-doses-to-329877.html 0.6 2026-06-20T15:55:29+08:00 daily https://www.pharmasources.com/industryinsights/two-dose-covid-19-vaccine-response-works-329878.html 0.6 2026-08-10T08:16:47+08:00 daily https://www.pharmasources.com/industryinsights/venezuela-payment-to-covax-received-afte-329879.html 0.6 2026-08-08T13:46:35+08:00 daily https://www.pharmasources.com/industryinsights/argentina-announces-covid-19-vaccine-sup-329880.html 0.6 2026-08-12T09:10:41+08:00 daily https://www.pharmasources.com/industryinsights/xilis-raises-70-million-series-a-financi-329881.html 0.6 2026-08-08T10:11:02+08:00 daily https://www.pharmasources.com/industryinsights/us-cancer-mortality-rates-down-from-2014-329882.html 0.6 2026-08-08T08:02:34+08:00 daily https://www.pharmasources.com/industryinsights/aduhelm-the-first-fda-approved-therapy-f-329883.html 0.6 2026-08-06T23:56:19+08:00 daily https://www.pharmasources.com/industryinsights/bispecific-antibodies-key-developments-i-329884.html 0.6 2026-08-07T13:15:50+08:00 daily https://www.pharmasources.com/industryinsights/acetaminophen-api-price-and-acetaminophe-329885.html 0.6 2026-08-07T00:24:30+08:00 daily https://www.pharmasources.com/industryinsights/aminophylline-sodium-api-price-and-manuf-329886.html 0.6 2026-08-07T02:40:10+08:00 daily https://www.pharmasources.com/industryinsights/amlodipine-besylate-api-price-and-manufa-329887.html 0.6 2026-07-25T02:16:32+08:00 daily https://www.pharmasources.com/industryinsights/bulk-price-and-chinese-manufacturers-of--329888.html 0.6 2026-08-13T20:24:33+08:00 daily https://www.pharmasources.com/industryinsights/cefdinir-api-market-size-trends-329889.html 0.6 2026-07-29T15:50:22+08:00 daily https://www.pharmasources.com/industryinsights/where-can-you-find-the-bulk-price-of-epl-329890.html 0.6 2026-08-03T16:45:18+08:00 daily https://www.pharmasources.com/industryinsights/erythromycin-thiocyanate-api-bulk-price--329891.html 0.6 2026-08-03T14:45:30+08:00 daily https://www.pharmasources.com/industryinsights/exemestane-api-price-and-manufacturers-i-329892.html 0.6 2026-08-11T11:04:37+08:00 daily https://www.pharmasources.com/industryinsights/levofloxacin-api-price-and-manufacturers-329893.html 0.6 2026-08-12T21:56:38+08:00 daily https://www.pharmasources.com/industryinsights/batavia-to-develop-clinical-process-for--329894.html 0.6 2026-08-08T06:17:06+08:00 daily https://www.pharmasources.com/industryinsights/metformin-hcl-api-market-size-and-manufa-329895.html 0.6 2026-08-07T00:03:37+08:00 daily https://www.pharmasources.com/industryinsights/swiss-government-turns-to-swissfillon-fo-329896.html 0.6 2026-08-08T04:29:48+08:00 daily https://www.pharmasources.com/industryinsights/mifepristone-api-price-and-manufacturers-329897.html 0.6 2026-07-28T23:09:04+08:00 daily https://www.pharmasources.com/industryinsights/lgm-pharma-launches-analytical-services--329898.html 0.6 2026-08-08T03:45:59+08:00 daily https://www.pharmasources.com/industryinsights/vitamin-d3-market-size-and-trend-329899.html 0.6 2026-08-04T04:58:59+08:00 daily https://www.pharmasources.com/industryinsights/purisys-obtains-two-global-iso-certifica-329900.html 0.6 2026-08-07T13:15:12+08:00 daily https://www.pharmasources.com/industryinsights/mankind-pharma-gets-drdo-nod-to-make-and-329901.html 0.6 2026-08-07T00:21:24+08:00 daily https://www.pharmasources.com/industryinsights/global-adult-epilepsy-market-to-reach-83-329902.html 0.6 2026-08-07T00:24:30+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-gsk-get-approval-for-phase-3-covi-329903.html 0.6 2026-08-07T00:33:36+08:00 daily https://www.pharmasources.com/industryinsights/alembic-pharma-gets-usfda-final-nod-for--329904.html 0.6 2026-08-12T05:11:07+08:00 daily https://www.pharmasources.com/industryinsights/regulatory-issues-cause-delay-in-covid-1-329905.html 0.6 2026-06-21T09:06:03+08:00 daily https://www.pharmasources.com/industryinsights/striving-to-increase-vaccine-availabilit-329906.html 0.6 2026-06-20T10:10:42+08:00 daily https://www.pharmasources.com/industryinsights/alembic-pharmaceuticals-gets-usfda-final-329907.html 0.6 2026-06-20T14:57:03+08:00 daily https://www.pharmasources.com/industryinsights/vaxart-and-altesa-enter-licencing-deal-f-329908.html 0.6 2026-07-15T13:09:00+08:00 daily https://www.pharmasources.com/industryinsights/exscientia-receives-15m-gates-foundation-329909.html 0.6 2026-06-21T18:19:48+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-priority-review-to-bla-for-as-329910.html 0.6 2026-07-20T15:34:03+08:00 daily https://www.pharmasources.com/industryinsights/qut-discovers-new-anticoagulant-drug-tar-329911.html 0.6 2026-06-08T21:56:54+08:00 daily https://www.pharmasources.com/industryinsights/kaist-institut-pasteur-researchers-find--329912.html 0.6 2026-06-20T02:00:08+08:00 daily https://www.pharmasources.com/industryinsights/mindmed-announces-partnership-with-datav-329913.html 0.6 2026-06-21T02:11:50+08:00 daily https://www.pharmasources.com/industryinsights/bhl-gets-license-from-defence-research-a-329914.html 0.6 2026-06-19T22:00:54+08:00 daily https://www.pharmasources.com/industryinsights/new-rx-instructions-tighten-use-of-contr-329915.html 0.6 2026-06-22T06:57:46+08:00 daily https://www.pharmasources.com/industryinsights/merck-partners-with-innervia-bioelectron-329916.html 0.6 2026-06-08T02:03:57+08:00 daily https://www.pharmasources.com/industryinsights/pharmacy-exec-behind-meningitis-outbreak-329917.html 0.6 2026-06-21T01:00:42+08:00 daily https://www.pharmasources.com/industryinsights/new-prescribing-instructions-tighten-use-329918.html 0.6 2026-06-19T21:16:12+08:00 daily https://www.pharmasources.com/industryinsights/kuano-raises-1m-to-further-develop-ai-dr-329919.html 0.6 2026-06-20T00:04:50+08:00 daily https://www.pharmasources.com/industryinsights/study-finds-lower-covid-19-infection-pre-329920.html 0.6 2026-08-09T07:56:20+08:00 daily https://www.pharmasources.com/industryinsights/phase-iii-trial-to-assess-pritelivir-as--329921.html 0.6 2026-08-08T18:26:29+08:00 daily https://www.pharmasources.com/industryinsights/first-people-dosed-with-a-quadrivalent-s-329922.html 0.6 2026-08-08T07:44:42+08:00 daily https://www.pharmasources.com/industryinsights/sequanta-and-mission-bio-announce-strate-329923.html 0.6 2026-08-07T13:16:57+08:00 daily https://www.pharmasources.com/industryinsights/innovent-announces-nmpa-acceptance-of-ne-329924.html 0.6 2026-08-11T06:10:45+08:00 daily https://www.pharmasources.com/industryinsights/vaniam-group-llc-announces-european-and--329925.html 0.6 2026-08-07T22:34:42+08:00 daily https://www.pharmasources.com/industryinsights/new-research-highlights-need-for-health--329926.html 0.6 2026-08-08T02:55:43+08:00 daily https://www.pharmasources.com/industryinsights/alpha-tau-and-healthcare-capital-corp-to-329927.html 0.6 2026-08-08T09:52:29+08:00 daily https://www.pharmasources.com/industryinsights/covid-pandemic-heightens-a-lack-of-confi-329928.html 0.6 2026-08-12T22:11:21+08:00 daily https://www.pharmasources.com/industryinsights/with-diversified-car-t-products-in-hand--329929.html 0.6 2026-08-07T13:16:15+08:00 daily https://www.pharmasources.com/industryinsights/ensuring-the-rigor-of-regulatory-science-329930.html 0.6 2026-08-07T03:15:42+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-drug-to-reduce-risk-of-seri-329931.html 0.6 2026-08-07T03:24:35+08:00 daily https://www.pharmasources.com/industryinsights/37-billion-worldwide-network-security-fi-329932.html 0.6 2026-08-07T03:55:07+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-supports-gene-developers-w-329933.html 0.6 2026-08-07T04:16:13+08:00 daily https://www.pharmasources.com/industryinsights/updates-for-the-janssen-and-astrazeneca--329934.html 0.6 2026-08-06T23:45:59+08:00 daily https://www.pharmasources.com/industryinsights/indias-pharmaceutical-industry-disruptio-329935.html 0.6 2026-08-06T23:46:34+08:00 daily https://www.pharmasources.com/industryinsights/animal-extremists-exploit-covid-fears-to-329936.html 0.6 2026-08-07T04:25:19+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-treatment-clinical-landscape-re-329937.html 0.6 2026-08-07T04:34:06+08:00 daily https://www.pharmasources.com/industryinsights/almacs-charnwood-site-achieves-hs-and-en-329938.html 0.6 2026-06-22T12:06:20+08:00 daily https://www.pharmasources.com/industryinsights/immunexpress-presents-data-supporting-se-329939.html 0.6 2026-08-08T03:25:24+08:00 daily https://www.pharmasources.com/industryinsights/cybersecurity-market-with-covid-19-impac-329940.html 0.6 2026-08-08T09:39:22+08:00 daily https://www.pharmasources.com/industryinsights/pbya-subsidiary-disco-learning-media-rei-329941.html 0.6 2026-08-09T05:33:51+08:00 daily https://www.pharmasources.com/industryinsights/kyahn-williamson-joins-telix-to-lead-cor-329942.html 0.6 2026-08-04T05:54:48+08:00 daily https://www.pharmasources.com/industryinsights/australias-delta-outbreak-data-show-vacc-329943.html 0.6 2026-06-21T17:03:23+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-us-health-officials-to-discuss-co-329944.html 0.6 2026-07-24T07:52:42+08:00 daily https://www.pharmasources.com/industryinsights/israel-offers-pfizer-covid-19-vaccine-bo-329945.html 0.6 2026-06-21T01:10:00+08:00 daily https://www.pharmasources.com/industryinsights/president-bidens-executive-order-to-supp-329946.html 0.6 2026-06-25T07:08:22+08:00 daily https://www.pharmasources.com/industryinsights/unvaccinated-belgian-woman-contracted-tw-329947.html 0.6 2026-08-05T13:27:50+08:00 daily https://www.pharmasources.com/industryinsights/sputnik-v-gives-90-protection-against-de-329948.html 0.6 2026-06-20T05:01:14+08:00 daily https://www.pharmasources.com/industryinsights/israeli-co-bonus-biogroup-reports-covid--329949.html 0.6 2026-06-21T11:12:25+08:00 daily https://www.pharmasources.com/industryinsights/overseas-marketing-of-furmonertinib-foll-329950.html 0.6 2026-08-11T05:36:41+08:00 daily https://www.pharmasources.com/industryinsights/release-of-a-novel-domestic-class-1-anti-329951.html 0.6 2026-06-28T04:56:10+08:00 daily https://www.pharmasources.com/industryinsights/good-news-in-the-anti-aantibodies-field--329952.html 0.6 2026-07-09T02:13:52+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-companies-back-to-the-blu-329953.html 0.6 2026-06-22T08:14:17+08:00 daily https://www.pharmasources.com/industryinsights/indonesia-health-workers-to-get-third-va-329954.html 0.6 2026-06-21T00:05:46+08:00 daily https://www.pharmasources.com/industryinsights/japan-releases-study-on-moderna-arm-reac-329955.html 0.6 2026-06-22T04:52:35+08:00 daily https://www.pharmasources.com/industryinsights/omt-skeptical-about-effectiveness-of-jan-329956.html 0.6 2026-06-21T09:06:05+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccines-highly-effective-in-mo-329957.html 0.6 2026-08-07T06:04:15+08:00 daily https://www.pharmasources.com/industryinsights/why-even-the-healthy-need-a-primary-care-329958.html 0.6 2026-08-07T05:58:12+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-kerendia-finerenone-for-the-329959.html 0.6 2026-08-07T05:52:11+08:00 daily https://www.pharmasources.com/industryinsights/cdc-vaccinated-teachers-students-can-ski-329960.html 0.6 2026-08-07T05:39:46+08:00 daily https://www.pharmasources.com/industryinsights/sequanta-mission-bio-enter-strategic-pac-329961.html 0.6 2026-08-07T05:37:07+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-expands-next-gen-novel-oncology-po-329962.html 0.6 2026-08-07T03:12:45+08:00 daily https://www.pharmasources.com/industryinsights/united-states-pharmacopeia-acquires-phar-329963.html 0.6 2026-08-07T03:02:29+08:00 daily https://www.pharmasources.com/industryinsights/who-is-likely-to-decide-on-eul-of-covaxi-329964.html 0.6 2026-08-07T01:51:52+08:00 daily https://www.pharmasources.com/industryinsights/slashed-gst-rates-on-covid-related-items-329965.html 0.6 2026-08-07T01:49:04+08:00 daily https://www.pharmasources.com/industryinsights/bayer-gets-us-fda-nod-for-kerendia-finer-329966.html 0.6 2026-08-07T05:30:58+08:00 daily https://www.pharmasources.com/industryinsights/unichem-labs-gets-tentative-us-fda-appro-329967.html 0.6 2026-08-11T11:08:39+08:00 daily https://www.pharmasources.com/industryinsights/icmr-proposes-clinical-trial-along-with--329968.html 0.6 2026-02-09T08:09:39+08:00 daily https://www.pharmasources.com/industryinsights/study-notes-covid-19-most-likely-caused--329969.html 0.6 2026-06-20T14:57:00+08:00 daily https://www.pharmasources.com/industryinsights/working-with-moderna-to-see-make-its-cov-329970.html 0.6 2026-06-15T13:07:26+08:00 daily https://www.pharmasources.com/industryinsights/microbiome-targeting-treatment-is-set-to-329971.html 0.6 2026-06-27T02:05:49+08:00 daily https://www.pharmasources.com/industryinsights/rubicon-research-acquires-meditabspecial-329972.html 0.6 2026-06-28T08:23:14+08:00 daily https://www.pharmasources.com/industryinsights/sfda-approves-modernas-covid-19-vaccine--329973.html 0.6 2026-06-21T01:03:47+08:00 daily https://www.pharmasources.com/industryinsights/contraceptive-mini-pill-to-be-made-avail-329974.html 0.6 2026-06-30T10:56:33+08:00 daily https://www.pharmasources.com/industryinsights/lilly-and-verge-genomics-partner-to-use--329975.html 0.6 2026-06-30T02:49:58+08:00 daily https://www.pharmasources.com/industryinsights/purdue-pharma-to-pay-45bn-to-settle-opio-329976.html 0.6 2026-08-06T19:26:30+08:00 daily https://www.pharmasources.com/industryinsights/valnevas-chikungunya-virus-vaccine-grant-329977.html 0.6 2026-06-21T01:55:45+08:00 daily https://www.pharmasources.com/industryinsights/survey-finds-kidney-cancer-patients-face-329978.html 0.6 2026-06-21T16:05:22+08:00 daily https://www.pharmasources.com/industryinsights/expanded-access-for-zolgensma-following--329979.html 0.6 2026-06-26T03:50:15+08:00 daily https://www.pharmasources.com/industryinsights/mhra-approves-over-the-counter-contracep-329980.html 0.6 2026-06-21T11:48:06+08:00 daily https://www.pharmasources.com/industryinsights/big-pharma-collaborates-on-free-resource-329981.html 0.6 2026-07-12T19:25:41+08:00 daily https://www.pharmasources.com/industryinsights/long-covid-symptoms-improved-with-neurom-329982.html 0.6 2026-06-22T21:51:44+08:00 daily https://www.pharmasources.com/industryinsights/rabbit-pyrogen-test-to-be-replaced-by-eu-329983.html 0.6 2026-08-06T23:37:49+08:00 daily https://www.pharmasources.com/industryinsights/profoundbio-announces-completion-of-more-329984.html 0.6 2026-08-06T23:46:49+08:00 daily https://www.pharmasources.com/industryinsights/hummingbird-bioscience-and-md-anderson-a-329985.html 0.6 2026-08-06T23:57:00+08:00 daily https://www.pharmasources.com/industryinsights/stem-cell-therapy-company-amniotics-rais-329986.html 0.6 2026-08-12T01:11:12+08:00 daily https://www.pharmasources.com/industryinsights/new-study-demonstrates-significantly-inc-329987.html 0.6 2026-06-19T14:45:02+08:00 daily https://www.pharmasources.com/industryinsights/everest-medicines-announces-strategic-co-329988.html 0.6 2026-07-20T05:04:23+08:00 daily https://www.pharmasources.com/industryinsights/innovent-announces-the-first-patient-dos-329989.html 0.6 2026-08-07T05:05:21+08:00 daily https://www.pharmasources.com/industryinsights/abl-bio-announces-publication-of-preclin-329990.html 0.6 2026-08-03T16:20:46+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-expands-emerging-portfolio-of-next-329991.html 0.6 2026-08-13T15:46:23+08:00 daily https://www.pharmasources.com/industryinsights/clean-interim-safety-review-of-rhovacs-c-329992.html 0.6 2026-08-11T17:20:19+08:00 daily https://www.pharmasources.com/industryinsights/ortho-clinical-diagnostics-quantitative--329993.html 0.6 2026-08-07T03:24:49+08:00 daily https://www.pharmasources.com/industryinsights/bri-deploys-teras-bri-ships-to-provide-v-329994.html 0.6 2026-08-07T03:54:58+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-329995.html 0.6 2026-08-07T04:04:25+08:00 daily https://www.pharmasources.com/industryinsights/lgm-pharma-launches-analytical-and-stabi-329996.html 0.6 2026-08-07T04:22:18+08:00 daily https://www.pharmasources.com/industryinsights/tuition-for-uhnwis-elite-tutoring-compan-329997.html 0.6 2026-08-07T04:28:09+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-expanded-sterilization-and--329998.html 0.6 2026-06-19T14:46:54+08:00 daily https://www.pharmasources.com/industryinsights/new-lightspeed-study-sheds-light-on-impa-329999.html 0.6 2026-08-07T04:57:53+08:00 daily https://www.pharmasources.com/industryinsights/wearing-a-mask-still-matters-the-world-r-330000.html 0.6 2026-08-07T05:07:49+08:00 daily https://www.pharmasources.com/industryinsights/reithera-announces-preliminary-phase-2-d-330001.html 0.6 2026-08-07T05:15:48+08:00 daily https://www.pharmasources.com/industryinsights/medical-disposables-market-revenue-to-su-330002.html 0.6 2026-07-28T06:57:23+08:00 daily https://www.pharmasources.com/industryinsights/biogen-pays-125-million-upfront-for-righ-330003.html 0.6 2026-08-07T13:05:43+08:00 daily https://www.pharmasources.com/industryinsights/aridis-pharmaceuticals-covid-mab-ar-712--330004.html 0.6 2026-06-30T04:45:46+08:00 daily https://www.pharmasources.com/industryinsights/pregnant-women-to-receive-moderna-covid--330005.html 0.6 2026-03-12T13:59:53+08:00 daily https://www.pharmasources.com/industryinsights/documents-for-covaxin-emergency-use-list-330006.html 0.6 2026-06-21T18:00:23+08:00 daily https://www.pharmasources.com/industryinsights/flexion-therapeutics-announces-appointme-330007.html 0.6 2026-08-07T22:33:33+08:00 daily https://www.pharmasources.com/industryinsights/midatech-appoints-dmitry-zamoryakhin-as--330008.html 0.6 2026-06-21T19:15:52+08:00 daily https://www.pharmasources.com/industryinsights/iveric-bio-announces-proposed-offering-o-330009.html 0.6 2026-06-20T20:55:45+08:00 daily https://www.pharmasources.com/industryinsights/clovis-oncology-appoints-ronit-simantov--330010.html 0.6 2026-06-21T04:45:28+08:00 daily https://www.pharmasources.com/industryinsights/fda-adds-guillain-barr-warning-to-jj-cov-330011.html 0.6 2026-06-20T06:52:38+08:00 daily https://www.pharmasources.com/industryinsights/cardiovascular-drugs-do-not-impact-covid-330012.html 0.6 2026-08-10T04:54:56+08:00 daily https://www.pharmasources.com/industryinsights/who-calls-for-global-registry-of-human-g-330013.html 0.6 2026-08-07T03:27:36+08:00 daily https://www.pharmasources.com/industryinsights/fda-head-asks-for-investigation-into-alz-330014.html 0.6 2026-08-07T03:25:17+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-to-meet-with-us-officials-about-c-330015.html 0.6 2026-08-07T03:12:35+08:00 daily https://www.pharmasources.com/industryinsights/flu-shot-might-help-ward-off-severe-covi-330016.html 0.6 2026-08-07T03:02:53+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-how-technology-is-improving-hea-330017.html 0.6 2026-08-07T02:52:04+08:00 daily https://www.pharmasources.com/industryinsights/obese-men-may-have-better-survival-with--330018.html 0.6 2026-08-07T02:40:03+08:00 daily https://www.pharmasources.com/industryinsights/spi-pharma-launches-ultraburst-330019.html 0.6 2026-08-07T00:46:46+08:00 daily https://www.pharmasources.com/industryinsights/amri-becomes-curia-330020.html 0.6 2026-08-07T00:42:41+08:00 daily https://www.pharmasources.com/industryinsights/cigarette-maker-philip-morris-to-buy-vec-330021.html 0.6 2026-08-13T19:00:11+08:00 daily https://www.pharmasources.com/industryinsights/schneider-electric-and-kewaunee-internat-330022.html 0.6 2026-08-07T00:21:23+08:00 daily https://www.pharmasources.com/industryinsights/moderna-signs-supply-pact-with-argentina-330023.html 0.6 2026-08-07T02:52:02+08:00 daily https://www.pharmasources.com/industryinsights/sinovac-signs-agreement-to-supply-corona-330024.html 0.6 2026-06-19T16:00:04+08:00 daily https://www.pharmasources.com/industryinsights/fdc-launches-favipiravir-oral-suspension-330025.html 0.6 2026-08-09T17:30:57+08:00 daily https://www.pharmasources.com/industryinsights/emcure-pharmaceuticals-appoints-naveen-s-330026.html 0.6 2026-08-06T23:37:21+08:00 daily https://www.pharmasources.com/industryinsights/study-finds-nasal-covid-19-vaccine-block-330027.html 0.6 2026-08-11T09:10:11+08:00 daily https://www.pharmasources.com/industryinsights/india-has-huge-resource-material-for-res-330028.html 0.6 2026-04-26T18:12:38+08:00 daily https://www.pharmasources.com/industryinsights/nrx-and-israel-partner-to-advance-covid--330029.html 0.6 2026-03-22T11:46:19+08:00 daily https://www.pharmasources.com/industryinsights/senegal-and-team-europe-to-set-up-covid--330030.html 0.6 2026-07-04T10:26:03+08:00 daily https://www.pharmasources.com/industryinsights/philip-morris-agrees-to-acquire-vectura--330031.html 0.6 2026-08-05T00:34:57+08:00 daily https://www.pharmasources.com/industryinsights/inotiv-acquires-genetic-toxicology-asset-330032.html 0.6 2026-08-05T21:04:26+08:00 daily https://www.pharmasources.com/industryinsights/prothena-and-novo-nordisk-agreement-for--330033.html 0.6 2026-08-08T00:21:27+08:00 daily https://www.pharmasources.com/industryinsights/galapagos-filgotinib-leads-to-rapid-symp-330034.html 0.6 2026-08-08T01:15:41+08:00 daily https://www.pharmasources.com/industryinsights/almost-50000-extra-doctors-needed-in-eng-330035.html 0.6 2026-08-06T23:46:06+08:00 daily https://www.pharmasources.com/industryinsights/phe-study-finds-covid-19-vaccines-highly-330036.html 0.6 2026-08-06T23:47:24+08:00 daily https://www.pharmasources.com/industryinsights/nice-no-for-orchard-therapeutics-gene-th-330037.html 0.6 2026-08-13T08:00:36+08:00 daily https://www.pharmasources.com/industryinsights/cd47-monoclonal-antibody-ak117-completed-330038.html 0.6 2026-07-20T17:56:17+08:00 daily https://www.pharmasources.com/industryinsights/ascletis-announces-dosing-of-the-first-c-330039.html 0.6 2026-08-07T04:48:48+08:00 daily https://www.pharmasources.com/industryinsights/hochuen-medical-raises-tens-of-millions--330040.html 0.6 2026-08-01T00:20:28+08:00 daily https://www.pharmasources.com/industryinsights/servier-and-nymirum-announce-strategic-c-330041.html 0.6 2026-08-08T12:54:09+08:00 daily https://www.pharmasources.com/industryinsights/kintor-pharmaceutical-announced-fda-has--330042.html 0.6 2026-08-09T19:47:39+08:00 daily https://www.pharmasources.com/industryinsights/sciwind-biosciences-appoints-dr-weidong--330043.html 0.6 2026-08-06T20:01:16+08:00 daily https://www.pharmasources.com/industryinsights/artificial-intelligence-could-be-new-blu-330044.html 0.6 2026-08-06T18:36:09+08:00 daily https://www.pharmasources.com/industryinsights/anti-tumor-agent-from-the-intestine-330045.html 0.6 2026-06-23T15:26:26+08:00 daily https://www.pharmasources.com/industryinsights/cure-id-moves-to-automated-data-collecti-330046.html 0.6 2026-06-19T18:16:49+08:00 daily https://www.pharmasources.com/industryinsights/heat-biologics-enters-into-research-lice-330047.html 0.6 2026-06-20T16:50:21+08:00 daily https://www.pharmasources.com/industryinsights/carbon-black-market-featuring-asahi-carb-330048.html 0.6 2026-06-21T22:13:53+08:00 daily https://www.pharmasources.com/industryinsights/intermap-awarded-government-contract-to--330049.html 0.6 2026-01-28T01:09:16+08:00 daily https://www.pharmasources.com/industryinsights/micron-biomedical-initiates-first-ever-m-330050.html 0.6 2026-08-13T07:58:12+08:00 daily https://www.pharmasources.com/industryinsights/outlook-on-the-composite-process-materia-330051.html 0.6 2026-07-27T20:10:01+08:00 daily https://www.pharmasources.com/industryinsights/alzheimers-disease---recent-advances-in--330052.html 0.6 2026-08-09T03:45:17+08:00 daily https://www.pharmasources.com/industryinsights/chemours-breaks-ground-on-93-million-min-330053.html 0.6 2026-06-20T22:59:38+08:00 daily https://www.pharmasources.com/industryinsights/allocating-covid-19-vaccines-based-on-he-330054.html 0.6 2026-06-20T18:58:37+08:00 daily https://www.pharmasources.com/industryinsights/scientists-repurpose-cancer-and-seizure--330055.html 0.6 2026-06-20T22:37:28+08:00 daily https://www.pharmasources.com/industryinsights/imara-announces-launch-of-proposed-publi-330056.html 0.6 2026-05-27T12:28:34+08:00 daily https://www.pharmasources.com/industryinsights/wto-issues-joint-indicative-list-of-crit-330057.html 0.6 2026-06-20T21:11:49+08:00 daily https://www.pharmasources.com/industryinsights/the-scottish-medicines-consortium-recomm-330058.html 0.6 2026-06-22T11:49:44+08:00 daily https://www.pharmasources.com/industryinsights/flu-jab-protects-against-some-of-the-sev-330059.html 0.6 2026-06-23T23:41:04+08:00 daily https://www.pharmasources.com/industryinsights/fox-chase-researchers-find-that-astrocyt-330060.html 0.6 2026-08-08T01:17:35+08:00 daily https://www.pharmasources.com/industryinsights/transcode-therapeutics-inc-announces-clo-330061.html 0.6 2026-06-21T13:02:35+08:00 daily https://www.pharmasources.com/industryinsights/us-officials-say-vaccinated-dont-need-bo-330062.html 0.6 2026-07-17T16:29:12+08:00 daily https://www.pharmasources.com/industryinsights/teen-parent-response-explored-for-cardio-330063.html 0.6 2026-06-21T00:03:38+08:00 daily https://www.pharmasources.com/industryinsights/who-get-covid-19-vaccines-to-poor-nation-330064.html 0.6 2026-06-22T22:57:58+08:00 daily https://www.pharmasources.com/industryinsights/medicare-mulls-coverage-for-controversia-330065.html 0.6 2026-08-11T00:43:48+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-presses-us-scientists-officials-o-330066.html 0.6 2026-06-21T14:57:22+08:00 daily https://www.pharmasources.com/industryinsights/lawsuits-claim-pesticide-caused-harm-to--330067.html 0.6 2026-06-20T00:01:51+08:00 daily https://www.pharmasources.com/industryinsights/whole-grains-every-day-key-to-your-healt-330068.html 0.6 2026-06-24T07:01:29+08:00 daily https://www.pharmasources.com/industryinsights/growing-up-in-lead-contaminated-area-mig-330069.html 0.6 2026-06-20T16:15:43+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-the-challenge-of-diabetes-in-th-330070.html 0.6 2026-01-13T07:17:23+08:00 daily https://www.pharmasources.com/industryinsights/get-covid-19-vaccines-to-poor-nations-in-330071.html 0.6 2026-06-20T20:16:02+08:00 daily https://www.pharmasources.com/industryinsights/catalent-jos-pharmaceuticals-enter-zydis-330072.html 0.6 2026-08-06T16:25:31+08:00 daily https://www.pharmasources.com/industryinsights/bicycle-therapeutics-ionic-pharma-enter--330073.html 0.6 2026-06-29T13:54:08+08:00 daily https://www.pharmasources.com/industryinsights/curia-to-acquire-integrity-bio-330074.html 0.6 2026-06-20T07:04:30+08:00 daily https://www.pharmasources.com/industryinsights/recro-pharma-inks-development-and-mfg-pa-330075.html 0.6 2026-08-06T19:45:00+08:00 daily https://www.pharmasources.com/industryinsights/sii-to-commence-manufacturing-of-sputnik-330076.html 0.6 2026-06-20T00:48:00+08:00 daily https://www.pharmasources.com/industryinsights/lupin-launches-tavaborole-topical-soluti-330077.html 0.6 2026-07-18T11:22:17+08:00 daily https://www.pharmasources.com/industryinsights/serum-institute-to-start-manufacturing-s-330078.html 0.6 2026-06-20T16:56:13+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-adds-new-warning-on-jj-covid-19-v-330079.html 0.6 2026-06-21T23:09:54+08:00 daily https://www.pharmasources.com/industryinsights/shortage-of-sputnik-vs-second-dose-to-de-330080.html 0.6 2026-06-21T11:57:12+08:00 daily https://www.pharmasources.com/industryinsights/abbott-launches-panbio-covid-19-antigen--330081.html 0.6 2026-08-07T10:37:50+08:00 daily https://www.pharmasources.com/industryinsights/sinopharm-and-sinovac-to-deliver-550-mil-330082.html 0.6 2026-06-22T12:58:12+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-accelerated-dosing-in-non-h-330083.html 0.6 2026-08-08T22:46:33+08:00 daily https://www.pharmasources.com/industryinsights/seegene-introduces-new-sars-cov-2-varian-330084.html 0.6 2026-08-07T07:23:58+08:00 daily https://www.pharmasources.com/industryinsights/flowmetric-life-sciences-inc-introduces--330085.html 0.6 2026-08-09T02:54:24+08:00 daily https://www.pharmasources.com/industryinsights/nrx-pharmaceuticals-and-quantum-leap-wit-330086.html 0.6 2026-08-09T22:07:32+08:00 daily https://www.pharmasources.com/industryinsights/quidel-gains-ce-mark-for-combined-covid--330087.html 0.6 2026-08-07T02:52:54+08:00 daily https://www.pharmasources.com/industryinsights/aetion-and-cegedim-expand-real-world-dat-330088.html 0.6 2026-08-07T02:36:48+08:00 daily https://www.pharmasources.com/industryinsights/tecentriq-kesimpta-lead-latest-smc-decis-330089.html 0.6 2026-08-07T02:30:30+08:00 daily https://www.pharmasources.com/industryinsights/new-hope-for-long-covid-blood-tests-afte-330090.html 0.6 2026-08-07T02:22:08+08:00 daily https://www.pharmasources.com/industryinsights/pharmacovigilance-risk-assessment-commit-330091.html 0.6 2026-08-07T02:31:09+08:00 daily https://www.pharmasources.com/industryinsights/who-publishes-recommendations-on-human-g-330092.html 0.6 2026-08-08T14:56:47+08:00 daily https://www.pharmasources.com/industryinsights/a-drop-for-clear-vision-japan-has-surpas-330093.html 0.6 2026-08-07T05:28:14+08:00 daily https://www.pharmasources.com/industryinsights/antengene-submits-new-drug-application-f-330094.html 0.6 2026-08-08T22:55:09+08:00 daily https://www.pharmasources.com/industryinsights/kintor-pharmaceutical-receives-ind-clear-330095.html 0.6 2026-07-20T06:57:19+08:00 daily https://www.pharmasources.com/industryinsights/havas-health-you-network-names-eric-weis-330096.html 0.6 2026-07-12T10:55:32+08:00 daily https://www.pharmasources.com/industryinsights/everest-medicines-announces-strategic-co-330097.html 0.6 2026-06-22T09:48:01+08:00 daily https://www.pharmasources.com/industryinsights/long-covid-more-than-a-quarter-of-covid--330098.html 0.6 2026-06-20T15:10:21+08:00 daily https://www.pharmasources.com/industryinsights/one-shot-of-the-sputnik-v-vaccine-trigge-330099.html 0.6 2026-01-10T10:31:22+08:00 daily https://www.pharmasources.com/industryinsights/curia-to-buy-fellow-cdmo-integrity-bio-330100.html 0.6 2026-08-11T15:55:12+08:00 daily https://www.pharmasources.com/industryinsights/sparx-therapeutics-to-build-first-commer-330101.html 0.6 2026-07-02T03:55:00+08:00 daily https://www.pharmasources.com/industryinsights/diversified-medical-healthcare-acquires--330102.html 0.6 2026-08-10T08:14:07+08:00 daily https://www.pharmasources.com/industryinsights/worldwide-payment-gateways-industry-to-2-330103.html 0.6 2026-06-21T04:56:50+08:00 daily https://www.pharmasources.com/industryinsights/sinovac-biotech-signs-up-to-supply-covax-330104.html 0.6 2026-01-30T18:51:55+08:00 daily https://www.pharmasources.com/industryinsights/direct-biologics-announces-fda-acceptanc-330105.html 0.6 2026-07-05T00:26:41+08:00 daily https://www.pharmasources.com/industryinsights/europe-returns-to-no-1-destination-for-u-330106.html 0.6 2026-08-12T09:03:22+08:00 daily https://www.pharmasources.com/industryinsights/majority-78-say-covid-19-elevated-import-330107.html 0.6 2026-06-20T14:43:13+08:00 daily https://www.pharmasources.com/industryinsights/uc-berkeley-study-reveals-welbehealths-r-330108.html 0.6 2026-06-20T17:15:36+08:00 daily https://www.pharmasources.com/industryinsights/parks-associates-67-of-technology-execut-330109.html 0.6 2026-06-20T20:58:34+08:00 daily https://www.pharmasources.com/industryinsights/dictionarycom-adds-new-words-from-5g-to--330110.html 0.6 2026-06-19T19:17:55+08:00 daily https://www.pharmasources.com/industryinsights/nanodx-announces-licensing-collaboration-330111.html 0.6 2026-08-09T20:06:10+08:00 daily https://www.pharmasources.com/industryinsights/new-data-from-inap-reveals-85-of-it-hiri-330112.html 0.6 2026-06-21T09:49:06+08:00 daily https://www.pharmasources.com/industryinsights/enanta-pharmaceuticals-announces-the-pla-330113.html 0.6 2026-06-21T21:14:55+08:00 daily https://www.pharmasources.com/industryinsights/bioventus-appoints-mary-kay-ladone-to-bo-330114.html 0.6 2026-06-20T22:17:56+08:00 daily https://www.pharmasources.com/industryinsights/delivery-of-pfizer-jabs-to-be-cut-10-in--330115.html 0.6 2026-06-21T01:07:49+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-single-shot-covid-19-vac-330116.html 0.6 2026-08-04T01:44:04+08:00 daily https://www.pharmasources.com/industryinsights/neximmune-strengthens-management-team-wi-330117.html 0.6 2026-06-21T20:56:38+08:00 daily https://www.pharmasources.com/industryinsights/sana-biotechnology-enters-long-term-leas-330118.html 0.6 2026-06-20T18:02:23+08:00 daily https://www.pharmasources.com/industryinsights/galapagos-demonstrates-early-clinical-ac-330119.html 0.6 2026-07-10T07:19:14+08:00 daily https://www.pharmasources.com/industryinsights/ligand-pharmaceuticals-appoints-jennifer-330120.html 0.6 2026-07-01T02:03:56+08:00 daily https://www.pharmasources.com/industryinsights/late-life-cognitive-activity-may-delay-d-330121.html 0.6 2026-08-06T23:36:09+08:00 daily https://www.pharmasources.com/industryinsights/some-hospitalized-covid-19-patients-have-330122.html 0.6 2026-08-06T23:47:06+08:00 daily https://www.pharmasources.com/industryinsights/new-covid-19-cases-doubled-in-us-in-past-330123.html 0.6 2026-08-06T23:55:40+08:00 daily https://www.pharmasources.com/industryinsights/rahul-gupta-to-be-nominated-as-next-us-d-330124.html 0.6 2026-08-10T15:12:40+08:00 daily https://www.pharmasources.com/industryinsights/daicel-chiral-technologies-opens-new-fac-330125.html 0.6 2026-08-11T18:39:49+08:00 daily https://www.pharmasources.com/industryinsights/batavia-manufactures-iavis-lassa-fever-v-330126.html 0.6 2026-06-21T23:31:16+08:00 daily https://www.pharmasources.com/industryinsights/plant-based-soy-rich-diet-studied-in-pos-330127.html 0.6 2026-06-22T05:11:56+08:00 daily https://www.pharmasources.com/industryinsights/busted-ankle-whats-better-a-cast-or-brac-330128.html 0.6 2026-06-27T02:12:42+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-genetic-problem-led-to-a-heart--330129.html 0.6 2026-06-20T00:17:11+08:00 daily https://www.pharmasources.com/industryinsights/us-drug-overdose-deaths-jumped-nearly-30-330130.html 0.6 2026-06-21T05:05:46+08:00 daily https://www.pharmasources.com/industryinsights/alcohol-tied-to-740000-cancer-cases-worl-330131.html 0.6 2026-08-14T02:05:58+08:00 daily https://www.pharmasources.com/industryinsights/tezepelumab-granted-priority-review-by-u-330132.html 0.6 2026-08-08T04:48:30+08:00 daily https://www.pharmasources.com/industryinsights/ashfield-launches-cell-gene-therapy-comm-330133.html 0.6 2026-06-20T13:08:09+08:00 daily https://www.pharmasources.com/industryinsights/curia-to-acquire-us-based-lakepharma-330134.html 0.6 2026-07-01T10:58:15+08:00 daily https://www.pharmasources.com/industryinsights/idifarma-launches-accelerated-pathway-fo-330135.html 0.6 2026-08-12T14:13:17+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccine-doses-administered-in-i-330136.html 0.6 2026-06-20T23:01:37+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccine-market-set-to-reach-195-330137.html 0.6 2026-08-06T17:58:49+08:00 daily https://www.pharmasources.com/industryinsights/2021-is-a-key-year-for-personalised-neoa-330138.html 0.6 2026-06-20T16:56:15+08:00 daily https://www.pharmasources.com/industryinsights/us-claims-it-is-unable-to-send-covid-vac-330139.html 0.6 2026-08-08T03:18:53+08:00 daily https://www.pharmasources.com/industryinsights/govt-exempts-customs-duty-on-imports-of--330140.html 0.6 2026-08-13T03:10:09+08:00 daily https://www.pharmasources.com/industryinsights/kintor-partners-with-fosun-to-market-cov-330141.html 0.6 2026-06-22T04:07:04+08:00 daily https://www.pharmasources.com/industryinsights/lilly-acquires-biotech-firm-protomer-tec-330142.html 0.6 2026-02-25T21:30:24+08:00 daily https://www.pharmasources.com/industryinsights/gene-editing-company-prime-medicine-laun-330143.html 0.6 2026-08-12T05:43:43+08:00 daily https://www.pharmasources.com/industryinsights/zendal-and-iavi-partner-for-tb-vaccine-c-330144.html 0.6 2026-08-11T18:11:52+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-breakthrough-therapy-designat-330145.html 0.6 2026-06-30T19:31:56+08:00 daily https://www.pharmasources.com/industryinsights/kriya-therapeutics-raises-100-million-fo-330146.html 0.6 2026-06-21T01:02:47+08:00 daily https://www.pharmasources.com/industryinsights/two-incelldx-studies-offer-a-model-for-d-330147.html 0.6 2026-06-21T18:10:39+08:00 daily https://www.pharmasources.com/industryinsights/nice-to-develop-guideline-for-rare-blood-330148.html 0.6 2026-06-19T14:28:09+08:00 daily https://www.pharmasources.com/industryinsights/bayers-kerendia-approved-in-the-us-to-sl-330149.html 0.6 2026-06-20T23:15:11+08:00 daily https://www.pharmasources.com/industryinsights/nhs-invests-20m-to-fast-track-measures-f-330150.html 0.6 2026-06-21T09:59:18+08:00 daily https://www.pharmasources.com/industryinsights/az-scores-final-clearance-for-alexion-ac-330151.html 0.6 2026-01-30T19:09:30+08:00 daily https://www.pharmasources.com/industryinsights/new-targeted-gene-therapy-could-reverse--330152.html 0.6 2026-06-21T13:11:37+08:00 daily https://www.pharmasources.com/industryinsights/istar-medical-receives-us-fda-approval-t-330153.html 0.6 2026-06-21T04:00:12+08:00 daily https://www.pharmasources.com/industryinsights/innovation-zed-and-socialdiabetes-announ-330154.html 0.6 2026-06-20T21:08:49+08:00 daily https://www.pharmasources.com/industryinsights/transcenta-announces-first-patient-dosed-330155.html 0.6 2026-07-21T01:03:37+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-innovation-announces-ext-330156.html 0.6 2026-07-14T20:26:18+08:00 daily https://www.pharmasources.com/industryinsights/ascentage-pharma-and-innovent-biologics--330157.html 0.6 2026-07-01T10:51:28+08:00 daily https://www.pharmasources.com/industryinsights/innovent-and-ascentage-pharma-reach-mult-330158.html 0.6 2026-05-21T10:52:17+08:00 daily https://www.pharmasources.com/industryinsights/are-silver-nanoparticles-a-silver-bullet-330159.html 0.6 2026-07-06T23:19:32+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-scientific-opens-plasmid-d-330160.html 0.6 2026-08-04T01:35:09+08:00 daily https://www.pharmasources.com/industryinsights/virtual-shopping-mall-opening-in-central-330161.html 0.6 2026-08-05T16:47:43+08:00 daily https://www.pharmasources.com/industryinsights/the-worldwide-soft-tissue-allografts-ind-330162.html 0.6 2026-08-05T14:43:05+08:00 daily https://www.pharmasources.com/industryinsights/acuityads-provides-q2-2021-update-on-its-330163.html 0.6 2026-06-20T16:19:47+08:00 daily https://www.pharmasources.com/industryinsights/global-nucleic-acid-isolation-and-purifi-330164.html 0.6 2026-06-21T03:37:42+08:00 daily https://www.pharmasources.com/industryinsights/nucor-corporation-will-reduce-greenhouse-330165.html 0.6 2026-02-15T13:09:47+08:00 daily https://www.pharmasources.com/industryinsights/almost-100-of-people-have-antibodies-aft-330166.html 0.6 2026-06-21T06:16:03+08:00 daily https://www.pharmasources.com/industryinsights/viridian-therapeutics-appoints-jennifer--330167.html 0.6 2026-06-21T13:03:34+08:00 daily https://www.pharmasources.com/industryinsights/moderna-to-join-sp-500-shares-jump-after-330168.html 0.6 2026-06-30T22:25:37+08:00 daily https://www.pharmasources.com/industryinsights/trippbio-receives-notice-of-allowance-fr-330169.html 0.6 2026-06-21T09:56:13+08:00 daily https://www.pharmasources.com/industryinsights/chilean-sinovac-trial-leaders-recommend--330170.html 0.6 2026-06-20T18:01:25+08:00 daily https://www.pharmasources.com/industryinsights/corvus-pharmaceuticals-discontinues-phas-330171.html 0.6 2026-06-22T09:51:35+08:00 daily https://www.pharmasources.com/industryinsights/diamedica-therapeutics-elects-two-indust-330172.html 0.6 2026-06-22T04:04:49+08:00 daily https://www.pharmasources.com/industryinsights/common-medication-used-to-reduce-cholest-330173.html 0.6 2026-08-04T12:50:23+08:00 daily https://www.pharmasources.com/industryinsights/piers-morgan-joins-pharnexts-board-of-di-330174.html 0.6 2026-06-21T06:03:49+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-grants-regular-approval-and-expan-330175.html 0.6 2026-06-30T17:14:45+08:00 daily https://www.pharmasources.com/industryinsights/interim-results-from-phase-23-studies-of-330176.html 0.6 2026-06-23T22:17:14+08:00 daily https://www.pharmasources.com/industryinsights/483-percent-of-us-16s-have-had-at-least--330177.html 0.6 2026-08-07T17:36:44+08:00 daily https://www.pharmasources.com/industryinsights/many-states-move-to-ban-vaccine-mandates-330178.html 0.6 2026-08-09T19:05:52+08:00 daily https://www.pharmasources.com/industryinsights/five-neutrogena-and-aveeno-spray-sunscre-330179.html 0.6 2026-06-21T17:00:35+08:00 daily https://www.pharmasources.com/industryinsights/two-major-health-systems-will-not-admini-330180.html 0.6 2026-07-12T03:46:05+08:00 daily https://www.pharmasources.com/industryinsights/chinese-man-hospitalized-with-h5n6-bird--330181.html 0.6 2026-06-21T01:55:41+08:00 daily https://www.pharmasources.com/industryinsights/drowning-deaths-for-us-kids-have-fallen--330182.html 0.6 2026-08-07T04:53:03+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-how-healthy-is-your-neighborhoo-330183.html 0.6 2026-08-07T04:49:07+08:00 daily https://www.pharmasources.com/industryinsights/antibiotic-resistant-pneumonia-is-killin-330184.html 0.6 2026-07-10T11:21:37+08:00 daily https://www.pharmasources.com/industryinsights/mirikizumab-up-regulates-genes-associate-330185.html 0.6 2026-08-07T19:39:13+08:00 daily https://www.pharmasources.com/industryinsights/biogen-and-innocare-announce-license-and-330186.html 0.6 2026-08-10T00:06:10+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-scientific-opens-new-plasm-330187.html 0.6 2026-08-08T01:59:44+08:00 daily https://www.pharmasources.com/industryinsights/ups-healthcare-thread-partner-on-decentr-330188.html 0.6 2026-08-07T05:01:22+08:00 daily https://www.pharmasources.com/industryinsights/medable-opens-emea-hq-in-dublin-330189.html 0.6 2026-08-10T03:12:21+08:00 daily https://www.pharmasources.com/industryinsights/medipharm-labs-receives-canadian-gmp-pha-330190.html 0.6 2026-07-10T12:28:46+08:00 daily https://www.pharmasources.com/industryinsights/rbi-bulletin-calls-for-diversification-o-330191.html 0.6 2026-07-05T19:01:05+08:00 daily https://www.pharmasources.com/industryinsights/trial-reveals-bpal-regimen-for-highly-dr-330192.html 0.6 2026-06-30T17:05:14+08:00 daily https://www.pharmasources.com/industryinsights/aspa-elects-new-governing-body-members-330193.html 0.6 2026-07-05T12:44:54+08:00 daily https://www.pharmasources.com/industryinsights/venus-remedies-forays-into-consumer-heal-330194.html 0.6 2026-07-09T12:50:20+08:00 daily https://www.pharmasources.com/industryinsights/uk-fines-pharma-companies-360-million-fo-330195.html 0.6 2026-03-01T06:33:06+08:00 daily https://www.pharmasources.com/industryinsights/aragen-skyhawk-partner-to-develop-small--330196.html 0.6 2026-06-21T15:08:46+08:00 daily https://www.pharmasources.com/industryinsights/heparin-may-cut-risk-of-severe-disease-a-330197.html 0.6 2026-07-19T02:58:25+08:00 daily https://www.pharmasources.com/industryinsights/ocugen-commences-rolling-submission-of-c-330198.html 0.6 2026-06-21T12:09:20+08:00 daily https://www.pharmasources.com/industryinsights/report-finds-almost-100-of-people-tested-330199.html 0.6 2026-07-10T10:57:58+08:00 daily https://www.pharmasources.com/industryinsights/nices-decision-not-to-approve-zytiga-fru-330200.html 0.6 2026-04-17T04:01:53+08:00 daily https://www.pharmasources.com/industryinsights/galapagos-reports-early-clinical-results-330201.html 0.6 2026-06-20T14:55:05+08:00 daily https://www.pharmasources.com/industryinsights/affinivax-astellas-pneumococcal-vaccine--330202.html 0.6 2026-08-04T21:42:46+08:00 daily https://www.pharmasources.com/industryinsights/mercks-met-inhibitor-tepotinib-gains-pos-330203.html 0.6 2026-06-20T23:56:40+08:00 daily https://www.pharmasources.com/industryinsights/cancer-research-uk-reports-most-successf-330204.html 0.6 2026-04-14T05:19:35+08:00 daily https://www.pharmasources.com/industryinsights/revised-general-chapter-on-chemometric-m-330205.html 0.6 2026-08-06T23:11:47+08:00 daily https://www.pharmasources.com/industryinsights/kintor-pharmaceutical-receives-emergency-330206.html 0.6 2026-06-20T19:18:06+08:00 daily https://www.pharmasources.com/industryinsights/innovent-announces-the-first-patient-dos-330207.html 0.6 2026-08-13T00:28:35+08:00 daily https://www.pharmasources.com/industryinsights/alterity-therapeutics-announces-publicat-330208.html 0.6 2026-08-11T12:16:14+08:00 daily https://www.pharmasources.com/industryinsights/fortacin-receives-strong-positive-result-330209.html 0.6 2026-07-08T19:34:16+08:00 daily https://www.pharmasources.com/industryinsights/collaboration-between-abbvie-biogen-and--330210.html 0.6 2026-08-12T12:25:51+08:00 daily https://www.pharmasources.com/industryinsights/catalent-enters-cbd-anaesthetic-product--330211.html 0.6 2026-06-21T02:40:11+08:00 daily https://www.pharmasources.com/industryinsights/svmhs-helps-vaccinate-indigenous-populat-330212.html 0.6 2026-06-21T05:56:30+08:00 daily https://www.pharmasources.com/industryinsights/to-combat-covid-19-vaccine-hesitancy-in--330213.html 0.6 2026-06-24T22:12:14+08:00 daily https://www.pharmasources.com/industryinsights/yemen-to-get-more-covid-19-vaccines-by-e-330214.html 0.6 2026-08-08T03:19:44+08:00 daily https://www.pharmasources.com/industryinsights/british-ministers-decide-against-mass-va-330215.html 0.6 2026-06-30T07:03:17+08:00 daily https://www.pharmasources.com/industryinsights/make-summer-camp-safe-for-your-child-wit-330216.html 0.6 2026-08-09T11:54:47+08:00 daily https://www.pharmasources.com/industryinsights/cdc-advisers-to-discuss-third-covid-19-v-330217.html 0.6 2026-06-20T14:36:08+08:00 daily https://www.pharmasources.com/industryinsights/canada-may-open-borders-to-fully-vaccina-330218.html 0.6 2026-08-09T12:47:53+08:00 daily https://www.pharmasources.com/industryinsights/fda-to-prioritize-full-approval-for-pfiz-330219.html 0.6 2026-08-07T02:40:22+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-rezurock-belumosudil-for-th-330220.html 0.6 2026-08-07T02:36:48+08:00 daily https://www.pharmasources.com/industryinsights/curtana-and-catalent-enter-brain-cancer--330221.html 0.6 2026-08-10T06:16:35+08:00 daily https://www.pharmasources.com/industryinsights/gentibio-forge-biologics-ink-development-330222.html 0.6 2026-08-07T02:22:05+08:00 daily https://www.pharmasources.com/industryinsights/vibalogics-advances-growth-with-leadersh-330223.html 0.6 2026-08-07T00:41:04+08:00 daily https://www.pharmasources.com/industryinsights/cro-charnwood-molecular-expands-capabili-330224.html 0.6 2026-06-21T08:00:11+08:00 daily https://www.pharmasources.com/industryinsights/recipharm-invests-in-fill-finish-capacit-330225.html 0.6 2026-05-31T09:16:27+08:00 daily https://www.pharmasources.com/industryinsights/india-tops-in-number-of-unvaccinated-und-330226.html 0.6 2026-06-21T12:57:29+08:00 daily https://www.pharmasources.com/industryinsights/lonza-extends-collaboration-with-biophar-330227.html 0.6 2026-07-20T09:46:10+08:00 daily https://www.pharmasources.com/industryinsights/celltrions-monoclonal-antibody-treatment-330228.html 0.6 2026-06-20T17:05:23+08:00 daily https://www.pharmasources.com/industryinsights/heat-tolerant-covid-19-vaccine-from-iisc-330229.html 0.6 2026-05-31T09:04:26+08:00 daily https://www.pharmasources.com/industryinsights/ocugen-seeks-approval-for-covaxin-in-can-330230.html 0.6 2026-06-21T08:16:18+08:00 daily https://www.pharmasources.com/industryinsights/ai-big-data-will-continue-to-disrupt-pha-330231.html 0.6 2026-06-20T08:08:38+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-biontechs-covid-19-vaccine-receiv-330232.html 0.6 2026-07-01T02:57:53+08:00 daily https://www.pharmasources.com/industryinsights/ipsen-and-irlab-sign-363m-deal-for-parki-330233.html 0.6 2026-07-01T07:53:06+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-to-invest-18bn-to-expand-facil-330234.html 0.6 2026-06-21T03:14:51+08:00 daily https://www.pharmasources.com/industryinsights/gc-labcell-and-gc-cell-merge-330235.html 0.6 2026-06-23T14:52:34+08:00 daily https://www.pharmasources.com/industryinsights/fda-vote-on-roxadustat-in-anemia-of-chro-330236.html 0.6 2026-05-31T09:13:35+08:00 daily https://www.pharmasources.com/industryinsights/lonza-extends-collaboration-for-monoclon-330237.html 0.6 2026-06-20T08:16:15+08:00 daily https://www.pharmasources.com/industryinsights/ledaga-recommended-by-nice-for-rare-type-330238.html 0.6 2026-06-22T02:57:43+08:00 daily https://www.pharmasources.com/industryinsights/reacta-biotech-raises-29m-to-scale-up-fo-330239.html 0.6 2026-07-04T03:46:35+08:00 daily https://www.pharmasources.com/industryinsights/dsru-says-more-research-needed-to-unders-330240.html 0.6 2026-06-21T04:02:47+08:00 daily https://www.pharmasources.com/industryinsights/most-comprehensive-flu-vaccination-progr-330241.html 0.6 2026-06-21T20:03:41+08:00 daily https://www.pharmasources.com/industryinsights/parkinsons-uk-implements-cdd-vault-to-ma-330242.html 0.6 2026-06-21T09:03:04+08:00 daily https://www.pharmasources.com/industryinsights/yishengbio-announces-pika-recombinant-co-330243.html 0.6 2026-07-24T03:12:45+08:00 daily https://www.pharmasources.com/industryinsights/bioelectronica-announces-hypercell-expan-330244.html 0.6 2026-08-09T07:37:46+08:00 daily https://www.pharmasources.com/industryinsights/immvira-launches-pilot-scale-production--330245.html 0.6 2026-07-01T00:50:57+08:00 daily https://www.pharmasources.com/industryinsights/merck-gets-us-fda-nod-of-adult-pneumococ-330246.html 0.6 2026-06-20T08:22:40+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-330247.html 0.6 2026-06-21T01:14:01+08:00 daily https://www.pharmasources.com/industryinsights/mirimus-inc-announces-publication-of-res-330248.html 0.6 2026-06-21T08:00:02+08:00 daily https://www.pharmasources.com/industryinsights/new-study-reveals-63-of-healthcare-provi-330249.html 0.6 2026-08-07T20:09:37+08:00 daily https://www.pharmasources.com/industryinsights/taffix-blocks-the-delta-variant-of-sars--330250.html 0.6 2026-07-02T21:19:42+08:00 daily https://www.pharmasources.com/industryinsights/cityzenith-and-safelythrive-digital-twin-330251.html 0.6 2025-10-20T20:34:35+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharma-announces-last-patient-330252.html 0.6 2026-06-21T01:00:52+08:00 daily https://www.pharmasources.com/industryinsights/nrx-pharmaceuticals-presents-evidence-zy-330253.html 0.6 2026-06-22T12:35:11+08:00 daily https://www.pharmasources.com/industryinsights/arcus-cmo-moving-to-gilead-to-head-clini-330254.html 0.6 2026-06-20T21:58:38+08:00 daily https://www.pharmasources.com/industryinsights/novel-autoantibody-adds-fuel-to-covid-19-330255.html 0.6 2026-06-20T15:47:08+08:00 daily https://www.pharmasources.com/industryinsights/study-shows-why-second-dose-of-covid-19--330256.html 0.6 2026-06-20T23:14:18+08:00 daily https://www.pharmasources.com/industryinsights/immunic-inc-announces-closing-of-450-mil-330257.html 0.6 2026-08-09T21:22:35+08:00 daily https://www.pharmasources.com/industryinsights/bial-and-medis-entered-into-a-partnershi-330258.html 0.6 2026-06-20T11:58:00+08:00 daily https://www.pharmasources.com/industryinsights/cytokinetics-announces-proposed-public-o-330259.html 0.6 2026-08-06T23:36:44+08:00 daily https://www.pharmasources.com/industryinsights/atreca-appoints-stacey-ma-and-stephen-br-330260.html 0.6 2026-08-06T23:45:56+08:00 daily https://www.pharmasources.com/industryinsights/a-small-molecule-induces-readthrough-of--330261.html 0.6 2026-08-06T23:55:05+08:00 daily https://www.pharmasources.com/industryinsights/chinas-kangtai-biological-partners-with--330262.html 0.6 2026-08-07T00:02:16+08:00 daily https://www.pharmasources.com/industryinsights/statement-on-offering-covid-19-vaccines--330263.html 0.6 2026-08-07T00:40:39+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-at-risk-children-to-be-offered--330264.html 0.6 2026-08-07T00:42:51+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-fexinidazole-as-the-first-a-330265.html 0.6 2026-08-07T01:10:33+08:00 daily https://www.pharmasources.com/industryinsights/ash-suggests-not-using-outpatient-thromb-330266.html 0.6 2026-08-07T02:40:05+08:00 daily https://www.pharmasources.com/industryinsights/us-surgeon-general-backs-local-mask-mand-330267.html 0.6 2026-08-07T02:52:40+08:00 daily https://www.pharmasources.com/industryinsights/court-blocks-lifting-of-covid-19-restric-330268.html 0.6 2026-08-07T02:59:32+08:00 daily https://www.pharmasources.com/industryinsights/canada-surpasses-us-covid-19-vaccination-330269.html 0.6 2026-08-07T03:07:59+08:00 daily https://www.pharmasources.com/industryinsights/monkeypox-case-confirmed-in-us-resident--330270.html 0.6 2026-08-07T03:12:35+08:00 daily https://www.pharmasources.com/industryinsights/pediatricians-group-all-school-kids-staf-330271.html 0.6 2026-08-10T04:48:10+08:00 daily https://www.pharmasources.com/industryinsights/coffee-wont-upset-your-heartbeat-it-migh-330272.html 0.6 2026-06-21T18:54:13+08:00 daily https://www.pharmasources.com/industryinsights/boris-johnson-to-self-isolate-after-coro-330273.html 0.6 2026-06-21T10:00:05+08:00 daily https://www.pharmasources.com/industryinsights/aquestive-therapeutics-announces-fda-acc-330274.html 0.6 2026-07-01T03:21:17+08:00 daily https://www.pharmasources.com/industryinsights/status-on-fda-advisory-committee-vote-on-330275.html 0.6 2026-06-21T11:02:10+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-vaxneuvance-pneumococcal-15-330276.html 0.6 2026-06-19T14:38:44+08:00 daily https://www.pharmasources.com/industryinsights/dfe-pharma-expands-portfolio-with-launch-330277.html 0.6 2026-03-08T19:21:33+08:00 daily https://www.pharmasources.com/industryinsights/lonza-cn-bio-partner-on-prevalidated-hep-330278.html 0.6 2026-06-20T23:54:32+08:00 daily https://www.pharmasources.com/industryinsights/calyx-opens-us-hq-near-research-triangle-330279.html 0.6 2026-08-14T11:56:56+08:00 daily https://www.pharmasources.com/industryinsights/biontech-to-acquire-kites-tcr-cell-thera-330280.html 0.6 2026-06-21T17:55:22+08:00 daily https://www.pharmasources.com/industryinsights/centre-to-buy-covishield-and-covaxin-at--330281.html 0.6 2026-07-18T06:09:20+08:00 daily https://www.pharmasources.com/industryinsights/pharma-industrys-digital-maturity-has-ac-330282.html 0.6 2026-07-28T02:54:34+08:00 daily https://www.pharmasources.com/industryinsights/digital-transformation-pharmas-pivot-for-330283.html 0.6 2026-08-10T15:15:46+08:00 daily https://www.pharmasources.com/industryinsights/altem-technologies-and-cellink-partner-t-330284.html 0.6 2026-08-08T17:53:15+08:00 daily https://www.pharmasources.com/industryinsights/uk-to-launch-research-studies-to-develop-330285.html 0.6 2026-08-08T15:52:12+08:00 daily https://www.pharmasources.com/industryinsights/gsk-to-build-549m-biotech-hub-in-stevena-330286.html 0.6 2026-08-08T10:51:02+08:00 daily https://www.pharmasources.com/industryinsights/imfinzi-approved-in-china-for-small-cell-330287.html 0.6 2026-08-07T13:16:48+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-belumosudil-for-graft-versu-330288.html 0.6 2026-08-07T04:33:44+08:00 daily https://www.pharmasources.com/industryinsights/fda-update-on-chantix-with-nitrosamine-i-330289.html 0.6 2026-08-07T05:01:17+08:00 daily https://www.pharmasources.com/industryinsights/ai-and-big-data-will-continue-to-disrupt-330290.html 0.6 2026-08-12T11:26:58+08:00 daily https://www.pharmasources.com/industryinsights/lam-research-funds-the-expansion-of-crit-330291.html 0.6 2026-07-09T08:39:28+08:00 daily https://www.pharmasources.com/industryinsights/novotech-joins-decentralized-trials-rese-330292.html 0.6 2026-01-31T10:10:19+08:00 daily https://www.pharmasources.com/industryinsights/digital-new-deal-startups-gain-global-at-330293.html 0.6 2026-08-07T11:36:57+08:00 daily https://www.pharmasources.com/industryinsights/within-weeks-of-first-covid-19-outbreak--330294.html 0.6 2026-07-08T16:22:57+08:00 daily https://www.pharmasources.com/industryinsights/ai-startup-lunit-secures-investment-from-330295.html 0.6 2026-08-14T07:59:03+08:00 daily https://www.pharmasources.com/industryinsights/on-world-brain-day-join-wfn-msif-to-stop-330296.html 0.6 2026-06-22T02:55:36+08:00 daily https://www.pharmasources.com/industryinsights/parexel-commended-by-frost-sullivan-for--330297.html 0.6 2026-06-08T17:27:55+08:00 daily https://www.pharmasources.com/industryinsights/decode-genetics---new-study-on-inheritan-330298.html 0.6 2026-06-20T17:52:20+08:00 daily https://www.pharmasources.com/industryinsights/ascentage-pharma-establishes-cooperative-330299.html 0.6 2026-08-07T10:48:27+08:00 daily https://www.pharmasources.com/industryinsights/frontier-biotechnologies-first-long-acti-330300.html 0.6 2026-07-20T08:59:46+08:00 daily https://www.pharmasources.com/industryinsights/centre-provides-over-42-crore-vaccine-do-330301.html 0.6 2026-06-22T02:14:12+08:00 daily https://www.pharmasources.com/industryinsights/eisai-biogens-lecanemab-gets-breakthroug-330302.html 0.6 2026-07-20T08:03:40+08:00 daily https://www.pharmasources.com/industryinsights/exevir-mithra-cdmo-enter-manufacturing-c-330303.html 0.6 2026-06-21T14:49:20+08:00 daily https://www.pharmasources.com/industryinsights/evergreen-expands-alpha-radiopharmaceuti-330304.html 0.6 2026-06-21T22:57:48+08:00 daily https://www.pharmasources.com/industryinsights/intravaccs-inactivated-polio-vaccine-out-330305.html 0.6 2026-07-20T17:57:41+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-kineta-enter-developme-330306.html 0.6 2026-06-20T22:17:57+08:00 daily https://www.pharmasources.com/industryinsights/steriline-supplies-shilpa-medicare-with--330307.html 0.6 2026-06-21T11:00:17+08:00 daily https://www.pharmasources.com/industryinsights/skyepharma-bolsters-data-integrity-capab-330308.html 0.6 2026-08-07T23:23:28+08:00 daily https://www.pharmasources.com/industryinsights/chugai-pharma-obtains-regulatory-approva-330309.html 0.6 2026-06-21T04:58:46+08:00 daily https://www.pharmasources.com/industryinsights/new-data-for-roches-hemlibra-reinforce-s-330310.html 0.6 2026-07-23T02:07:34+08:00 daily https://www.pharmasources.com/industryinsights/adma-biologics-completes-fda-manufacturi-330311.html 0.6 2026-01-14T11:27:16+08:00 daily https://www.pharmasources.com/industryinsights/partners-group-to-acquire-pharmathen-fro-330312.html 0.6 2026-08-07T12:51:24+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-expands-its-voluntary-recall-of-c-330313.html 0.6 2026-07-22T08:52:46+08:00 daily https://www.pharmasources.com/industryinsights/novartis-pledges-10-year-commitment-with-330314.html 0.6 2026-06-20T10:57:58+08:00 daily https://www.pharmasources.com/industryinsights/sps-fill-finish-system-chosen-by-nib-rt--330315.html 0.6 2026-07-31T17:36:26+08:00 daily https://www.pharmasources.com/industryinsights/celltrion-says-its-covid-19-antibody-sho-330316.html 0.6 2026-05-06T08:45:33+08:00 daily https://www.pharmasources.com/industryinsights/eu-approval-for-self-administered-crysvi-330317.html 0.6 2026-06-20T14:44:19+08:00 daily https://www.pharmasources.com/industryinsights/marketplace-launched-to-speed-up-global--330318.html 0.6 2026-06-22T17:03:07+08:00 daily https://www.pharmasources.com/industryinsights/almost-70-of-doctors-say-covid-19-vaccin-330319.html 0.6 2026-06-22T21:55:47+08:00 daily https://www.pharmasources.com/industryinsights/new-advice-issued-on-covid-19-vaccinatio-330320.html 0.6 2026-04-02T03:15:19+08:00 daily https://www.pharmasources.com/industryinsights/synthetic-biology-startup-allozymes-rais-330321.html 0.6 2026-08-05T11:04:07+08:00 daily https://www.pharmasources.com/industryinsights/direct-biologics-announces-fda-approval--330322.html 0.6 2026-08-09T11:18:14+08:00 daily https://www.pharmasources.com/industryinsights/exoflo-from-direct-biologics-fulfills-ur-330323.html 0.6 2026-08-07T03:55:22+08:00 daily https://www.pharmasources.com/industryinsights/oriciro-announces-1-billion-series-b-fin-330324.html 0.6 2026-08-07T21:55:38+08:00 daily https://www.pharmasources.com/industryinsights/terumo-and-umcu-strengthen-their-partner-330325.html 0.6 2026-08-09T03:08:11+08:00 daily https://www.pharmasources.com/industryinsights/skyepharma-selects-veratrak-platform-to--330326.html 0.6 2026-08-07T03:02:43+08:00 daily https://www.pharmasources.com/industryinsights/interaxon-partners-with-celri-health-to--330327.html 0.6 2026-08-07T02:52:05+08:00 daily https://www.pharmasources.com/industryinsights/everest-medicines-announces-strategic-co-330328.html 0.6 2026-08-07T02:45:38+08:00 daily https://www.pharmasources.com/industryinsights/harbour-biomed-appoints-yingying-chen-ph-330329.html 0.6 2026-08-07T02:41:42+08:00 daily https://www.pharmasources.com/industryinsights/sherpa-healthcare-partners-announces-the-330330.html 0.6 2026-08-06T23:36:33+08:00 daily https://www.pharmasources.com/industryinsights/genfleet-therapeutics-and-insilico-medic-330331.html 0.6 2026-08-06T23:45:39+08:00 daily https://www.pharmasources.com/industryinsights/cdsco-grants-permission-to-three-private-330332.html 0.6 2026-08-06T23:48:12+08:00 daily https://www.pharmasources.com/industryinsights/affinity-empowering-and-eurofins-clinica-330333.html 0.6 2026-08-06T23:56:04+08:00 daily https://www.pharmasources.com/industryinsights/debtcom-poll-well-spend-more-preparing-f-330334.html 0.6 2026-08-07T00:01:52+08:00 daily https://www.pharmasources.com/industryinsights/imago-biosciences-inc-announces-closing--330335.html 0.6 2026-08-07T06:09:46+08:00 daily https://www.pharmasources.com/industryinsights/global-edtech-and-accessibility-company--330336.html 0.6 2026-08-07T11:01:29+08:00 daily https://www.pharmasources.com/industryinsights/gc-pharma-partners-with-speragen-to-deve-330337.html 0.6 2026-08-07T11:28:18+08:00 daily https://www.pharmasources.com/industryinsights/japan-becomes-first-country-to-approve-r-330338.html 0.6 2026-08-07T13:16:15+08:00 daily https://www.pharmasources.com/industryinsights/lumos-pharma-announces-clinical-updates-330339.html 0.6 2026-08-08T14:47:17+08:00 daily https://www.pharmasources.com/industryinsights/gho-capital-announces-final-close-of-fun-330340.html 0.6 2026-08-08T21:33:24+08:00 daily https://www.pharmasources.com/industryinsights/sars-cov-2-achilles-heel-of-viral-rna-330341.html 0.6 2026-08-08T23:10:04+08:00 daily https://www.pharmasources.com/industryinsights/albireo-wins-back-to-back-us-eu-nods-for-330342.html 0.6 2026-08-09T01:21:24+08:00 daily https://www.pharmasources.com/industryinsights/takeda-data-at-isth-2021-highlight-the-b-330343.html 0.6 2026-08-09T03:45:24+08:00 daily https://www.pharmasources.com/industryinsights/one-dose-of-jj-vaccine-is-ineffective-ag-330344.html 0.6 2026-08-10T15:13:43+08:00 daily https://www.pharmasources.com/industryinsights/delta-variant-behind-more-than-80-of-us--330345.html 0.6 2026-08-07T18:50:53+08:00 daily https://www.pharmasources.com/industryinsights/elevar-therapeutics-announces-ceo-transi-330346.html 0.6 2026-08-05T12:22:42+08:00 daily https://www.pharmasources.com/industryinsights/erasca-announces-closing-of-initial-publ-330347.html 0.6 2026-06-22T10:10:52+08:00 daily https://www.pharmasources.com/industryinsights/sars-cov-2-vaccines-effectively-prevent--330348.html 0.6 2026-06-21T03:00:40+08:00 daily https://www.pharmasources.com/industryinsights/patients-of-female-doctors-have-lower-in-330349.html 0.6 2026-02-28T13:21:42+08:00 daily https://www.pharmasources.com/industryinsights/federal-court-backs-covid-19-vaccine-man-330350.html 0.6 2026-08-07T04:15:10+08:00 daily https://www.pharmasources.com/industryinsights/canada-to-welcome-fully-vaccinated-ameri-330351.html 0.6 2026-06-21T10:55:07+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-bylvay-odevixibat-for-the-t-330352.html 0.6 2026-06-27T08:19:21+08:00 daily https://www.pharmasources.com/industryinsights/severe-covid-in-kids-rare-but-brain-issu-330353.html 0.6 2026-06-19T16:05:13+08:00 daily https://www.pharmasources.com/industryinsights/statin-users-may-have-added-protection-a-330354.html 0.6 2026-06-20T02:02:14+08:00 daily https://www.pharmasources.com/industryinsights/double-trouble-wildfire-smoke-could-boos-330355.html 0.6 2026-06-21T08:08:03+08:00 daily https://www.pharmasources.com/industryinsights/could-menopausal-hormone-therapy-reduce--330356.html 0.6 2026-06-23T07:21:07+08:00 daily https://www.pharmasources.com/industryinsights/provention-bio-receives-complete-respons-330357.html 0.6 2026-02-28T19:33:04+08:00 daily https://www.pharmasources.com/industryinsights/vetters-new-clinical-manufacturing-site--330358.html 0.6 2026-08-09T05:38:10+08:00 daily https://www.pharmasources.com/industryinsights/minaris-will-be-the-commercial-manufactu-330359.html 0.6 2026-01-14T02:10:28+08:00 daily https://www.pharmasources.com/industryinsights/organicell-announces-fda-approval-of-ind-330360.html 0.6 2026-08-04T18:21:35+08:00 daily https://www.pharmasources.com/industryinsights/catalent-plans-100-million-biologics-man-330361.html 0.6 2026-06-21T03:10:48+08:00 daily https://www.pharmasources.com/industryinsights/mirimus-inc-forms-strategic-collaboratio-330362.html 0.6 2026-08-02T16:28:40+08:00 daily https://www.pharmasources.com/industryinsights/study-shows-smithnephews-regeneten-bioin-330363.html 0.6 2026-08-10T15:16:14+08:00 daily https://www.pharmasources.com/industryinsights/biontech-to-purchase-kite-manufacturing--330364.html 0.6 2026-06-19T14:58:04+08:00 daily https://www.pharmasources.com/industryinsights/swelling-demand-for-functional-ingredien-330365.html 0.6 2026-06-21T16:07:25+08:00 daily https://www.pharmasources.com/industryinsights/samsung-biologics-and-kineta-strike-canc-330366.html 0.6 2026-07-25T08:50:50+08:00 daily https://www.pharmasources.com/industryinsights/tripactions-selects-salt-security-to-pro-330367.html 0.6 2026-07-25T08:42:09+08:00 daily https://www.pharmasources.com/industryinsights/ligand-partner-jazz-pharmaceuticals-laun-330368.html 0.6 2026-08-03T18:51:04+08:00 daily https://www.pharmasources.com/industryinsights/tracon-pharmaceuticals-announces-10-mill-330369.html 0.6 2026-08-08T18:53:22+08:00 daily https://www.pharmasources.com/industryinsights/nanopharm-and-leyden-labs-announce-agree-330370.html 0.6 2026-08-07T03:46:52+08:00 daily https://www.pharmasources.com/industryinsights/two-doses-of-pfizer-astrazeneca-shots-ef-330371.html 0.6 2026-08-08T19:42:25+08:00 daily https://www.pharmasources.com/industryinsights/comcor-study-analysis-of-the-effectivene-330372.html 0.6 2026-07-25T08:05:55+08:00 daily https://www.pharmasources.com/industryinsights/magenta-slips-after-fda-hold-on-early-st-330373.html 0.6 2026-08-05T08:11:12+08:00 daily https://www.pharmasources.com/industryinsights/toward-one-drug-to-treat-all-coronavirus-330374.html 0.6 2026-07-25T08:00:17+08:00 daily https://www.pharmasources.com/industryinsights/noxxon-pharma-enters-second-clinical-col-330375.html 0.6 2026-07-25T07:56:58+08:00 daily https://www.pharmasources.com/industryinsights/slu-researchers-begin-enrolling-particip-330376.html 0.6 2026-07-25T07:53:47+08:00 daily https://www.pharmasources.com/industryinsights/erytech-confirms-plans-to-submit-bla-for-330377.html 0.6 2026-08-04T11:55:04+08:00 daily https://www.pharmasources.com/industryinsights/pm-wants-review-of-astrazeneca-age-advic-330378.html 0.6 2026-07-25T07:48:12+08:00 daily https://www.pharmasources.com/industryinsights/inveniai-announces-successful-completion-330379.html 0.6 2026-07-25T07:44:58+08:00 daily https://www.pharmasources.com/industryinsights/startups-join-csl-moderna-in-local-mrna--330380.html 0.6 2026-07-25T07:38:55+08:00 daily https://www.pharmasources.com/industryinsights/no-increase-in-risk-with-dapagliflozin-i-330381.html 0.6 2026-07-25T07:32:58+08:00 daily https://www.pharmasources.com/industryinsights/in-a-first-for-the-continent-pfizer-covi-330382.html 0.6 2026-08-13T05:24:42+08:00 daily https://www.pharmasources.com/industryinsights/prior-statin-use-linked-to-reduced-risk--330383.html 0.6 2026-07-25T07:32:50+08:00 daily https://www.pharmasources.com/industryinsights/prep-hiv-prevention-pills-to-be-free-for-330384.html 0.6 2026-08-12T14:01:26+08:00 daily https://www.pharmasources.com/industryinsights/1-in-20-cases-of-dementia-occurs-in-peop-330385.html 0.6 2026-08-07T10:11:22+08:00 daily https://www.pharmasources.com/industryinsights/eating-meat-raises-risk-of-heart-disease-330386.html 0.6 2026-08-09T02:58:40+08:00 daily https://www.pharmasources.com/industryinsights/secret-weapon-why-the-2nd-dose-of-pfizer-330387.html 0.6 2026-06-29T23:42:26+08:00 daily https://www.pharmasources.com/industryinsights/japan-first-to-approve-roches-ronapreve--330388.html 0.6 2026-07-03T19:13:49+08:00 daily https://www.pharmasources.com/industryinsights/tcr2-therapeutics-appoints-chief-technic-330389.html 0.6 2026-08-07T13:18:37+08:00 daily https://www.pharmasources.com/industryinsights/aptar-csps-activ-film-technology-protect-330390.html 0.6 2026-08-07T12:38:00+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-scientific-launches-herace-330391.html 0.6 2025-12-08T07:21:39+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-biontech-partner-with-biovac-for--330392.html 0.6 2026-08-08T03:37:05+08:00 daily https://www.pharmasources.com/industryinsights/catalent-plans-100m-expansion-of-biologi-330393.html 0.6 2026-08-08T01:49:09+08:00 daily https://www.pharmasources.com/industryinsights/vetters-new-clinical-mfg-site-now-fully--330394.html 0.6 2026-08-07T11:22:42+08:00 daily https://www.pharmasources.com/industryinsights/askbios-gene-therapy-gets-fast-track-330395.html 0.6 2026-08-07T04:52:40+08:00 daily https://www.pharmasources.com/industryinsights/ema-grants-orphan-drug-designation-to-sa-330396.html 0.6 2026-08-07T04:48:58+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-btd-for-venclexta-in-combinat-330397.html 0.6 2026-08-09T10:52:15+08:00 daily https://www.pharmasources.com/industryinsights/former-fda-adviser-calls-for-wider-probe-330398.html 0.6 2026-08-07T04:27:52+08:00 daily https://www.pharmasources.com/industryinsights/new-york-drug-distributors-reach-118-bil-330399.html 0.6 2026-08-07T04:07:00+08:00 daily https://www.pharmasources.com/industryinsights/eu-begins-real-time-review-of-sanofi-gsk-330400.html 0.6 2026-08-07T04:28:03+08:00 daily https://www.pharmasources.com/industryinsights/centre-allows-research-on-ayush-medicine-330401.html 0.6 2026-08-10T11:58:26+08:00 daily https://www.pharmasources.com/industryinsights/takeda-expands-covid-19-vaccine-supply-d-330402.html 0.6 2026-06-19T20:46:46+08:00 daily https://www.pharmasources.com/industryinsights/akston-biosciences-to-supply-seppics-adj-330403.html 0.6 2026-08-14T05:41:14+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-expands-recall-to-twelve-lots-of--330404.html 0.6 2026-06-21T02:46:32+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-drug-for-severe-itching-in--330405.html 0.6 2026-06-29T14:50:44+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-completes-acquisition-of-ale-330406.html 0.6 2026-07-24T06:40:48+08:00 daily https://www.pharmasources.com/industryinsights/fda-expands-indication-for-prograf-for-l-330407.html 0.6 2026-06-20T06:18:38+08:00 daily https://www.pharmasources.com/industryinsights/myovant-gedeon-richters-uterine-fibroids-330408.html 0.6 2026-01-31T01:36:45+08:00 daily https://www.pharmasources.com/industryinsights/govt-reveals-new-strategy-to-improve-sup-330409.html 0.6 2026-06-22T10:45:51+08:00 daily https://www.pharmasources.com/industryinsights/orbit-discovery-raises-76m-to-boost-pept-330410.html 0.6 2026-06-11T21:18:52+08:00 daily https://www.pharmasources.com/industryinsights/nhs-england-unveils-new-innovative-medic-330411.html 0.6 2026-06-22T07:58:47+08:00 daily https://www.pharmasources.com/industryinsights/intas-enters-into-an-exclusive-license-a-330412.html 0.6 2026-06-28T07:46:45+08:00 daily https://www.pharmasources.com/industryinsights/menarini-asia-pacific-strengthens-mens-h-330413.html 0.6 2026-08-13T09:32:45+08:00 daily https://www.pharmasources.com/industryinsights/antengene-announces-the-approval-by-huma-330414.html 0.6 2026-08-10T17:19:33+08:00 daily https://www.pharmasources.com/industryinsights/joysbios-covid-19-rapid-tests-detect-new-330415.html 0.6 2026-08-07T19:28:32+08:00 daily https://www.pharmasources.com/industryinsights/china-nmpa-approves-phase-iii-clinical-t-330416.html 0.6 2026-08-06T06:54:08+08:00 daily https://www.pharmasources.com/industryinsights/kazia-calls-for-increased-focus-on-brain-330417.html 0.6 2026-06-21T02:51:36+08:00 daily https://www.pharmasources.com/industryinsights/arcscan-inc-signs-definitive-agreement-f-330418.html 0.6 2026-08-09T23:54:36+08:00 daily https://www.pharmasources.com/industryinsights/ascentage-pharmas-mdm2-p53-inhibitor-apg-330419.html 0.6 2026-08-05T00:24:05+08:00 daily https://www.pharmasources.com/industryinsights/2021-a-pivotal-year-for-personalised-neo-330420.html 0.6 2026-06-24T17:54:26+08:00 daily https://www.pharmasources.com/industryinsights/lilly-to-acquire-biotech-company-protome-330421.html 0.6 2026-06-21T12:10:40+08:00 daily https://www.pharmasources.com/industryinsights/take-your-best-shot-which-sars-cov-2-vac-330422.html 0.6 2026-07-06T23:23:54+08:00 daily https://www.pharmasources.com/industryinsights/study-shows-why-second-dose-of-covid-19--330423.html 0.6 2026-06-21T21:00:45+08:00 daily https://www.pharmasources.com/industryinsights/national-survey-finds-increased-interest-330424.html 0.6 2026-06-22T00:59:56+08:00 daily https://www.pharmasources.com/industryinsights/inhalon-collaborates-with-celltrion-inc--330425.html 0.6 2026-06-22T10:14:51+08:00 daily https://www.pharmasources.com/industryinsights/volitions-nuq-nets-assay-demonstrates-pr-330426.html 0.6 2026-06-21T19:54:05+08:00 daily https://www.pharmasources.com/industryinsights/study-by-providence-researchers-suggest--330427.html 0.6 2026-06-20T22:06:41+08:00 daily https://www.pharmasources.com/industryinsights/medical-center-hospital-of-odessa-partne-330429.html 0.6 2026-07-06T10:57:27+08:00 daily https://www.pharmasources.com/industryinsights/hcw-biologics-inc-announces-closing-of-5-330430.html 0.6 2026-07-01T14:28:30+08:00 daily https://www.pharmasources.com/industryinsights/japan-mulls-asking-pfizer-to-speed-up-co-330431.html 0.6 2026-08-07T05:29:16+08:00 daily https://www.pharmasources.com/industryinsights/ribon-therapeutics-announces-publication-330432.html 0.6 2026-08-10T18:12:55+08:00 daily https://www.pharmasources.com/industryinsights/aptamer-group-and-wuxi-apptec-research-s-330433.html 0.6 2026-08-09T03:32:15+08:00 daily https://www.pharmasources.com/industryinsights/fresenius-medical-care-north-america-ann-330434.html 0.6 2026-07-17T17:27:05+08:00 daily https://www.pharmasources.com/industryinsights/tga-approves-pfizer-covid-19-vaccine-for-330435.html 0.6 2026-07-05T08:04:09+08:00 daily https://www.pharmasources.com/industryinsights/rare-disease-biotech-rallybio-sets-terms-330436.html 0.6 2026-07-06T08:01:20+08:00 daily https://www.pharmasources.com/industryinsights/acticor-biotech-announces-the-completion-330437.html 0.6 2026-07-08T19:21:34+08:00 daily https://www.pharmasources.com/industryinsights/azurrx-biopharma-announces-30-million-bo-330438.html 0.6 2026-06-21T08:07:07+08:00 daily https://www.pharmasources.com/industryinsights/vaccine-biotech-icosavax-sets-terms-for--330439.html 0.6 2026-06-21T12:01:09+08:00 daily https://www.pharmasources.com/industryinsights/guidelines-updated-for-treatment-of-sexu-330440.html 0.6 2026-08-13T22:18:07+08:00 daily https://www.pharmasources.com/industryinsights/as-olympics-begin-tokyo-posts-highest-nu-330441.html 0.6 2026-07-02T14:38:17+08:00 daily https://www.pharmasources.com/industryinsights/biden-says-full-approval-for-covid-19-va-330442.html 0.6 2026-06-21T06:57:55+08:00 daily https://www.pharmasources.com/industryinsights/chinese-btk-inhibitor-orelabrutinib-gone-330443.html 0.6 2026-08-04T04:59:07+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-oral-medicine----a-link-to-be-f-330444.html 0.6 2026-08-04T02:51:12+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharmas-smo-inhibitor-sonidegib-at-1-330445.html 0.6 2026-08-14T23:36:35+08:00 daily https://www.pharmasources.com/industryinsights/muffins-recalled-for-possible-listeria-c-330446.html 0.6 2026-03-21T22:35:00+08:00 daily https://www.pharmasources.com/industryinsights/even-at-same-hospital-black-patients-fac-330447.html 0.6 2026-06-21T17:58:23+08:00 daily https://www.pharmasources.com/industryinsights/empty-stadiums-covid-fears-how-will-it-a-330448.html 0.6 2026-06-22T03:49:09+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-7-day-olds-skin-felt-cold-she-w-330449.html 0.6 2026-06-21T03:10:57+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-octapharmas-octagam-10-for--330450.html 0.6 2026-08-11T13:00:49+08:00 daily https://www.pharmasources.com/industryinsights/anthos-therapeutics-novel-factor-xi-inhi-330451.html 0.6 2025-12-15T12:58:32+08:00 daily https://www.pharmasources.com/industryinsights/vertex-initiates-phase-2-clinical-trial--330452.html 0.6 2026-08-04T03:52:15+08:00 daily https://www.pharmasources.com/industryinsights/gsk-announces-positive-headline-results--330453.html 0.6 2026-06-20T00:15:29+08:00 daily https://www.pharmasources.com/industryinsights/catalent-biologics-launches-gpex-lightni-330454.html 0.6 2026-08-10T11:39:30+08:00 daily https://www.pharmasources.com/industryinsights/marvel-biotechnology-begins-cgmp-manufac-330455.html 0.6 2026-06-21T05:15:55+08:00 daily https://www.pharmasources.com/industryinsights/calyx-expands-us-presence-in-response-to-330456.html 0.6 2026-08-09T07:36:57+08:00 daily https://www.pharmasources.com/industryinsights/cognizant-agrees-to-acquire-tqs-integrat-330457.html 0.6 2026-08-07T04:16:04+08:00 daily https://www.pharmasources.com/industryinsights/minaris-and-bluebird-bio-enter-manufactu-330458.html 0.6 2026-08-07T03:55:11+08:00 daily https://www.pharmasources.com/industryinsights/nanopharm-leyden-labs-to-develop-nasal-s-330459.html 0.6 2026-08-14T14:51:03+08:00 daily https://www.pharmasources.com/industryinsights/aptamer-and-wuxi-apptec-form-research-pa-330460.html 0.6 2026-08-07T10:45:23+08:00 daily https://www.pharmasources.com/industryinsights/spectronrx-receives-nuclear-materials-li-330461.html 0.6 2026-08-07T02:48:45+08:00 daily https://www.pharmasources.com/industryinsights/premier-research-acquires-health-decisio-330462.html 0.6 2026-08-07T02:52:12+08:00 daily https://www.pharmasources.com/industryinsights/financial-report-roche-1h-results-330463.html 0.6 2026-08-07T03:03:50+08:00 daily https://www.pharmasources.com/industryinsights/recro-pharma-appoints-erica-raether-as-v-330464.html 0.6 2026-08-07T03:15:58+08:00 daily https://www.pharmasources.com/industryinsights/sulfamethoxazole-api-price-and-manufactu-330465.html 0.6 2026-08-08T07:54:05+08:00 daily https://www.pharmasources.com/industryinsights/intas-enters-into-agreement-with-meiji-a-330466.html 0.6 2026-08-10T07:15:07+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-receives-tentative-approval-330467.html 0.6 2026-08-07T04:36:45+08:00 daily https://www.pharmasources.com/industryinsights/granules-pharmaceuticals-clears-us-fda-a-330468.html 0.6 2026-08-07T04:25:03+08:00 daily https://www.pharmasources.com/industryinsights/inositol-api-market-size-trends-and-manu-330469.html 0.6 2026-07-08T18:21:32+08:00 daily https://www.pharmasources.com/industryinsights/rossari-to-acquire-tristar-intermediates-330470.html 0.6 2026-08-06T20:06:21+08:00 daily https://www.pharmasources.com/industryinsights/pag-to-acquire-control-of-acme-formulati-330471.html 0.6 2026-08-06T22:08:31+08:00 daily https://www.pharmasources.com/industryinsights/biocon-q1fy22-revenue-at-rs-1808-crores--330472.html 0.6 2026-08-06T23:57:00+08:00 daily https://www.pharmasources.com/industryinsights/vitamin-e-api-trends-and-manufacturers-330473.html 0.6 2026-08-14T21:22:12+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-carcinoma-treatment-330474.html 0.6 2026-08-07T02:30:48+08:00 daily https://www.pharmasources.com/industryinsights/archimicas-14-million-manufacturing-expa-330475.html 0.6 2026-08-13T13:58:54+08:00 daily https://www.pharmasources.com/industryinsights/what-is-vitamin-a-vitamin-a-forms-and-sp-330476.html 0.6 2026-08-13T04:15:56+08:00 daily https://www.pharmasources.com/industryinsights/albireos-bylvay-approved-in-eu-and-us-fo-330477.html 0.6 2026-08-09T00:16:57+08:00 daily https://www.pharmasources.com/industryinsights/msd-bayers-heart-failure-med-verquvo-gai-330478.html 0.6 2026-08-09T00:17:00+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-incytes-pemazyre-for-rar-330479.html 0.6 2026-08-08T21:34:43+08:00 daily https://www.pharmasources.com/industryinsights/innovations-drug-shows-antiviral-activit-330480.html 0.6 2026-08-13T15:35:29+08:00 daily https://www.pharmasources.com/industryinsights/norgine-bv-and-us-worldmeds-enter-into-e-330481.html 0.6 2026-06-20T11:07:47+08:00 daily https://www.pharmasources.com/industryinsights/texas-cardiac-arrhythmia-institute-leade-330482.html 0.6 2026-07-29T20:04:05+08:00 daily https://www.pharmasources.com/industryinsights/fda-provides-necessary-guidance-for-biov-330483.html 0.6 2026-06-20T10:56:22+08:00 daily https://www.pharmasources.com/industryinsights/ortho-clinical-diagnostics-announces-lau-330484.html 0.6 2026-06-29T23:37:28+08:00 daily https://www.pharmasources.com/industryinsights/novartis-bayer-and-boehringer-ingelheim--330485.html 0.6 2026-08-12T04:16:26+08:00 daily https://www.pharmasources.com/industryinsights/antibiotics-may-help-to-treat-melanoma-330486.html 0.6 2026-06-22T12:42:55+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-reports-271-increase-in--330487.html 0.6 2026-06-20T16:00:18+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-concludes-alexion-acquisitio-330488.html 0.6 2026-06-29T17:40:35+08:00 daily https://www.pharmasources.com/industryinsights/capsida-biotherapeutics-opens-facility-i-330489.html 0.6 2026-08-08T12:41:34+08:00 daily https://www.pharmasources.com/industryinsights/eisai-mercks-drug-combo-approved-for-adv-330490.html 0.6 2026-06-21T09:59:40+08:00 daily https://www.pharmasources.com/industryinsights/us-govt-buys-additional-200m-doses-of-pf-330491.html 0.6 2026-06-20T13:01:05+08:00 daily https://www.pharmasources.com/industryinsights/tessols-greatest-contribution-has-been-i-330492.html 0.6 2026-07-04T13:06:14+08:00 daily https://www.pharmasources.com/industryinsights/arvinas-and-pfizer-enter-up-to-24bn-deal-330493.html 0.6 2026-08-14T11:51:21+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccine-market-set-to-reach-195-330494.html 0.6 2026-08-08T10:04:27+08:00 daily https://www.pharmasources.com/industryinsights/roche-records-8-increase-in-group-sales--330495.html 0.6 2026-08-04T03:39:41+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-pediatric-type-2-diabetes-t-330496.html 0.6 2026-06-29T16:34:49+08:00 daily https://www.pharmasources.com/industryinsights/nice-phe-publish-new-antimicrobial-presc-330497.html 0.6 2026-08-07T05:15:50+08:00 daily https://www.pharmasources.com/industryinsights/new-plans-to-improve-patient-access-to-m-330498.html 0.6 2026-08-07T05:05:26+08:00 daily https://www.pharmasources.com/industryinsights/seres-ulcerative-colitis-candidate-misse-330499.html 0.6 2026-06-29T17:46:26+08:00 daily https://www.pharmasources.com/industryinsights/az-says-its-covid-19-vaccine-protects-ag-330500.html 0.6 2026-08-07T03:03:41+08:00 daily https://www.pharmasources.com/industryinsights/etherna-immunotherapies-joins-forces-wit-330501.html 0.6 2026-06-21T02:49:42+08:00 daily https://www.pharmasources.com/industryinsights/cgtn-think-tank-releases-an-analytical-r-330502.html 0.6 2026-08-07T00:24:26+08:00 daily https://www.pharmasources.com/industryinsights/cigna-study-shows-improvement-in-vaccine-330503.html 0.6 2026-08-07T00:41:42+08:00 daily https://www.pharmasources.com/industryinsights/antengene-and-its-partners-publish-precl-330504.html 0.6 2026-08-07T00:45:43+08:00 daily https://www.pharmasources.com/industryinsights/innovent-announces-the-first-patient-dos-330505.html 0.6 2026-08-09T12:43:12+08:00 daily https://www.pharmasources.com/industryinsights/the-global-self-care-federation-highligh-330506.html 0.6 2026-06-20T02:44:58+08:00 daily https://www.pharmasources.com/industryinsights/japan-becomes-first-country-to-approve-r-330507.html 0.6 2026-06-21T09:56:06+08:00 daily https://www.pharmasources.com/industryinsights/metrion-biosciences-appoints-nick-foster-330508.html 0.6 2026-06-19T21:10:15+08:00 daily https://www.pharmasources.com/industryinsights/catalent-launches-new-optidose-design-so-330509.html 0.6 2026-06-21T11:59:14+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-receives-manufacturing-li-330510.html 0.6 2026-08-04T11:55:43+08:00 daily https://www.pharmasources.com/industryinsights/wcg-acquires-eclinical-provider-verasci-330511.html 0.6 2026-06-19T11:15:56+08:00 daily https://www.pharmasources.com/industryinsights/bdr-pharmaceuticals-announces-license-ag-330512.html 0.6 2026-08-09T03:12:08+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-and-cassiopea-spa-sign-licens-330513.html 0.6 2026-08-14T14:08:11+08:00 daily https://www.pharmasources.com/industryinsights/dop-amends-drugs-prices-control-order-20-330514.html 0.6 2026-08-08T13:11:46+08:00 daily https://www.pharmasources.com/industryinsights/only-marginal-difference-in-purchase-pri-330515.html 0.6 2026-08-08T11:48:39+08:00 daily https://www.pharmasources.com/industryinsights/chiefai-launches-pay-as-you-go-ai-platfo-330516.html 0.6 2026-08-08T13:11:42+08:00 daily https://www.pharmasources.com/industryinsights/ema-committee-recommends-modernas-covid--330517.html 0.6 2026-08-08T14:38:30+08:00 daily https://www.pharmasources.com/industryinsights/omnicell-to-acquire-fds-amplicare-330518.html 0.6 2026-08-08T20:03:02+08:00 daily https://www.pharmasources.com/industryinsights/shingrix-approved-for-shingles-preventio-330519.html 0.6 2026-08-04T19:39:12+08:00 daily https://www.pharmasources.com/industryinsights/four-drug-combo-therapy-shows-benefit-fo-330520.html 0.6 2026-08-07T11:43:17+08:00 daily https://www.pharmasources.com/industryinsights/researchers-find-extending-the-time-betw-330521.html 0.6 2026-08-09T03:12:17+08:00 daily https://www.pharmasources.com/industryinsights/chmp-recommends-expanded-use-for-alexion-330522.html 0.6 2026-08-07T06:06:43+08:00 daily https://www.pharmasources.com/industryinsights/emas-human-medicine-committee-chmp-meeti-330523.html 0.6 2026-08-07T04:25:01+08:00 daily https://www.pharmasources.com/industryinsights/cytiva-and-pall-corporation-investing-15-330524.html 0.6 2026-08-07T19:56:03+08:00 daily https://www.pharmasources.com/industryinsights/liscure-biosciences-announces-know-how-l-330525.html 0.6 2026-08-07T03:55:00+08:00 daily https://www.pharmasources.com/industryinsights/beckman-coulter-to-distribute-bnp-cardia-330526.html 0.6 2026-08-07T03:27:51+08:00 daily https://www.pharmasources.com/industryinsights/hbm-presents-phase-i-data-on-next-genera-330527.html 0.6 2026-08-07T03:18:45+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-received-commercial-manuf-330528.html 0.6 2026-08-07T03:03:04+08:00 daily https://www.pharmasources.com/industryinsights/hummingbird-bioscience-appoints-renowned-330529.html 0.6 2026-08-07T02:51:59+08:00 daily https://www.pharmasources.com/industryinsights/advantages-of-intranasal-vaccination-aga-330530.html 0.6 2026-08-07T03:02:42+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-330531.html 0.6 2026-08-07T03:07:56+08:00 daily https://www.pharmasources.com/industryinsights/mayo-clinic-and-nference-study-links-pre-330532.html 0.6 2026-08-07T06:09:59+08:00 daily https://www.pharmasources.com/industryinsights/valenzabio-partners-with-probiogen-to-ma-330533.html 0.6 2026-08-09T07:36:16+08:00 daily https://www.pharmasources.com/industryinsights/pandemic-and-transformative-technologies-330534.html 0.6 2026-06-21T07:46:39+08:00 daily https://www.pharmasources.com/industryinsights/startup-tech-company-helping-austin-rest-330535.html 0.6 2026-06-21T17:46:35+08:00 daily https://www.pharmasources.com/industryinsights/california-family-physicians-support-cov-330536.html 0.6 2026-06-22T00:54:50+08:00 daily https://www.pharmasources.com/industryinsights/arrow-reports-133-million-in-q2-net-inco-330537.html 0.6 2026-06-21T05:05:49+08:00 daily https://www.pharmasources.com/industryinsights/ixensor-levels-up-pixotest-covid-19-ag-t-330538.html 0.6 2026-06-21T04:22:45+08:00 daily https://www.pharmasources.com/industryinsights/opteev-launches-the-first-ever-plug-in-a-330539.html 0.6 2026-08-09T11:31:13+08:00 daily https://www.pharmasources.com/industryinsights/new-strategy-for-drug-design-keeping-cop-330540.html 0.6 2026-06-21T00:50:49+08:00 daily https://www.pharmasources.com/industryinsights/second-covid-19-mrna-vaccine-dose-found--330541.html 0.6 2026-07-28T00:53:02+08:00 daily https://www.pharmasources.com/industryinsights/arena-pharmaceuticals-and-aristea-therap-330542.html 0.6 2026-06-24T10:03:28+08:00 daily https://www.pharmasources.com/industryinsights/caribou-biosciences-announces-closing-of-330543.html 0.6 2026-08-07T00:42:53+08:00 daily https://www.pharmasources.com/industryinsights/sol-gel-technologies-announces-fda-appro-330544.html 0.6 2026-08-07T00:40:28+08:00 daily https://www.pharmasources.com/industryinsights/cybin-announces-overnight-marketed-publi-330545.html 0.6 2026-08-07T00:02:44+08:00 daily https://www.pharmasources.com/industryinsights/iggenix-announces-25m-in-series-a1-fundi-330546.html 0.6 2026-08-07T02:31:10+08:00 daily https://www.pharmasources.com/industryinsights/azurrx-biopharma-announces-closing-of-57-330547.html 0.6 2026-08-07T02:51:50+08:00 daily https://www.pharmasources.com/industryinsights/aristea-completes-63-million-series-b-fi-330548.html 0.6 2026-08-07T03:06:54+08:00 daily https://www.pharmasources.com/industryinsights/abzena-and-bioxpress-therapeutics-announ-330549.html 0.6 2026-08-10T02:56:08+08:00 daily https://www.pharmasources.com/industryinsights/despite-reopening-britain-sees-six-strai-330550.html 0.6 2026-08-07T03:30:36+08:00 daily https://www.pharmasources.com/industryinsights/new-breakthrough-to-help-immune-systems--330551.html 0.6 2026-08-14T20:00:25+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-moderna-to-expand-vaccine-studies-330552.html 0.6 2026-08-07T16:14:22+08:00 daily https://www.pharmasources.com/industryinsights/federal-state-agencies-begin-to-mandate--330553.html 0.6 2026-07-07T12:22:48+08:00 daily https://www.pharmasources.com/industryinsights/cdc-to-advise-return-to-masks-indoors-fo-330554.html 0.6 2026-06-19T16:52:34+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-twyneo-tretinoin-and-benzoy-330555.html 0.6 2026-06-21T12:56:47+08:00 daily https://www.pharmasources.com/industryinsights/long-covid-may-qualify-as-a-disability-b-330556.html 0.6 2026-08-10T03:01:31+08:00 daily https://www.pharmasources.com/industryinsights/could-heavy-marijuana-use-be-driving-ris-330557.html 0.6 2026-08-06T23:44:52+08:00 daily https://www.pharmasources.com/industryinsights/severe-covid-for-people-under-45-whos-mo-330558.html 0.6 2026-08-06T23:38:34+08:00 daily https://www.pharmasources.com/industryinsights/iterum-therapeutics-receives-complete-re-330559.html 0.6 2026-08-06T23:45:36+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-braeburns-new-drug-applicati-330560.html 0.6 2026-08-06T23:48:51+08:00 daily https://www.pharmasources.com/industryinsights/grifols-expands-activity-in-africa-330561.html 0.6 2026-08-06T23:55:45+08:00 daily https://www.pharmasources.com/industryinsights/aavantibio-aldevron-form-gene-therapy-pa-330562.html 0.6 2026-08-07T00:03:27+08:00 daily https://www.pharmasources.com/industryinsights/alloy-therapeutics-echo-investment-capit-330563.html 0.6 2026-08-07T04:34:01+08:00 daily https://www.pharmasources.com/industryinsights/capsida-unveils-next-generation-gene-the-330564.html 0.6 2026-08-10T12:12:08+08:00 daily https://www.pharmasources.com/industryinsights/biocon-biologics-and-adagio-therapeutics-330565.html 0.6 2026-06-20T22:55:47+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-shingrix-to-prevent-shin-330566.html 0.6 2026-07-29T00:27:44+08:00 daily https://www.pharmasources.com/industryinsights/dyadic-and-rubic-to-develop-covid-19-vac-330567.html 0.6 2026-06-21T00:51:59+08:00 daily https://www.pharmasources.com/industryinsights/the-use-of-robotics-in-pharmaceutical-ma-330568.html 0.6 2026-08-01T16:51:20+08:00 daily https://www.pharmasources.com/industryinsights/perkinelmer-agrees-to-acquire-antibody-m-330569.html 0.6 2026-08-06T19:02:07+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-and-regeneron-to-research-de-330570.html 0.6 2026-07-24T06:41:05+08:00 daily https://www.pharmasources.com/industryinsights/10x-genomics-signs-patent-agreement-with-330571.html 0.6 2026-08-02T06:01:07+08:00 daily https://www.pharmasources.com/industryinsights/organon-and-obseva-agree-to-develop-and--330572.html 0.6 2026-08-12T11:02:16+08:00 daily https://www.pharmasources.com/industryinsights/biontech-update-on-sustainable-solutions-330573.html 0.6 2026-06-21T08:56:00+08:00 daily https://www.pharmasources.com/industryinsights/nice-publishes-new-draft-guideline-cover-330574.html 0.6 2026-08-07T11:28:58+08:00 daily https://www.pharmasources.com/industryinsights/eu-backs-approval-of-modernas-covid-19-v-330575.html 0.6 2026-07-20T13:19:32+08:00 daily https://www.pharmasources.com/industryinsights/organon-and-obseva-to-collaborate-on-pre-330576.html 0.6 2026-08-03T14:33:04+08:00 daily https://www.pharmasources.com/industryinsights/biontech-to-develop-a-mrna-based-malaria-330577.html 0.6 2026-08-10T10:12:06+08:00 daily https://www.pharmasources.com/industryinsights/regulators-call-for-clinical-research-to-330578.html 0.6 2026-06-22T00:43:12+08:00 daily https://www.pharmasources.com/industryinsights/jj-to-pay-up-to-5bn-in-us-opioid-settlem-330579.html 0.6 2026-08-05T00:16:10+08:00 daily https://www.pharmasources.com/industryinsights/bayer-appoints-head-of-research-and-earl-330580.html 0.6 2026-06-20T13:08:06+08:00 daily https://www.pharmasources.com/industryinsights/cuhk-develops-a-novel-faecal-test-that-c-330581.html 0.6 2026-06-21T03:02:49+08:00 daily https://www.pharmasources.com/industryinsights/kintor-pharmaceutical-announces-dosing-o-330582.html 0.6 2026-07-24T06:11:14+08:00 daily https://www.pharmasources.com/industryinsights/venus-medtech-appoints-professor-martin--330583.html 0.6 2026-06-19T20:58:48+08:00 daily https://www.pharmasources.com/industryinsights/india-based-medtel-receives-investment-t-330584.html 0.6 2026-06-22T10:58:46+08:00 daily https://www.pharmasources.com/industryinsights/more-than-half-of-singaporeans-unaware-o-330585.html 0.6 2026-06-20T16:38:33+08:00 daily https://www.pharmasources.com/industryinsights/gilead-sciences-announces-launch-of-asia-330586.html 0.6 2026-06-21T04:12:03+08:00 daily https://www.pharmasources.com/industryinsights/ascletis-announces-completion-of-149-pat-330587.html 0.6 2026-07-26T09:55:08+08:00 daily https://www.pharmasources.com/industryinsights/zepp-health-invests-24m-to-lead-neuro42s-330588.html 0.6 2026-06-23T21:19:27+08:00 daily https://www.pharmasources.com/industryinsights/global-dementia-cases-forecasted-to-trip-330589.html 0.6 2026-03-01T03:59:48+08:00 daily https://www.pharmasources.com/industryinsights/deep-longevity-repurposes-a-blood-aging--330590.html 0.6 2026-06-22T10:53:54+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-announces-preliminary-proposal-for-330591.html 0.6 2026-07-20T06:03:15+08:00 daily https://www.pharmasources.com/industryinsights/facemydoc-announces-official-partnership-330592.html 0.6 2026-06-21T05:55:40+08:00 daily https://www.pharmasources.com/industryinsights/viraleze-spl7013-virucidal-9999-against--330593.html 0.6 2026-08-09T02:57:28+08:00 daily https://www.pharmasources.com/industryinsights/new-mountain-capital-to-acquire-flexan-330594.html 0.6 2026-06-21T21:45:50+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-interchangeable-biosi-330595.html 0.6 2026-06-24T07:34:54+08:00 daily https://www.pharmasources.com/industryinsights/us-needs-to-look-differently-at-public-h-330596.html 0.6 2026-07-08T05:51:14+08:00 daily https://www.pharmasources.com/industryinsights/metriopharm-selected-by-european-commiss-330597.html 0.6 2026-06-22T11:42:13+08:00 daily https://www.pharmasources.com/industryinsights/easysend-partners-with-pscu-to-swiftly-d-330598.html 0.6 2026-08-07T22:41:29+08:00 daily https://www.pharmasources.com/industryinsights/rhythm-pharmaceuticals-announces-collabo-330599.html 0.6 2026-07-04T20:42:07+08:00 daily https://www.pharmasources.com/industryinsights/mink-therapeutics-announces-confidential-330600.html 0.6 2026-08-05T22:13:32+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-interchangeable-status-to-via-330601.html 0.6 2026-08-10T12:13:46+08:00 daily https://www.pharmasources.com/industryinsights/heron-therapeutics-announces-publication-330602.html 0.6 2026-08-07T01:42:47+08:00 daily https://www.pharmasources.com/industryinsights/novita-pharmaceuticals-and-china-resourc-330603.html 0.6 2026-08-12T19:04:04+08:00 daily https://www.pharmasources.com/industryinsights/protagonist-therapeutics-announces-amend-330604.html 0.6 2026-08-14T04:38:34+08:00 daily https://www.pharmasources.com/industryinsights/lindy-durrant-appointed-ceo-of-scancell-330605.html 0.6 2026-08-07T01:18:53+08:00 daily https://www.pharmasources.com/industryinsights/xeris-pharmaceuticals-announces-executiv-330606.html 0.6 2026-08-07T01:10:48+08:00 daily https://www.pharmasources.com/industryinsights/data-show-steady-drop-off-in-protection--330607.html 0.6 2026-08-07T00:41:07+08:00 daily https://www.pharmasources.com/industryinsights/hmnc-brain-health-raises-eur-9-million-330608.html 0.6 2026-08-06T23:54:28+08:00 daily https://www.pharmasources.com/industryinsights/deep-genomics-raises-180m-in-series-c-fi-330609.html 0.6 2026-08-07T02:30:54+08:00 daily https://www.pharmasources.com/industryinsights/kriya-therapeutics-completes-renovation--330610.html 0.6 2026-08-07T02:34:33+08:00 daily https://www.pharmasources.com/industryinsights/ring-therapeutics-raises-117-million-in--330611.html 0.6 2026-08-07T02:52:07+08:00 daily https://www.pharmasources.com/industryinsights/m6p-therapeutics-presented-data-on-m041--330612.html 0.6 2026-08-07T03:03:15+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-says-third-shot-of-vaccine-boosts-330613.html 0.6 2026-08-09T22:09:57+08:00 daily https://www.pharmasources.com/industryinsights/depression-suicide-concerns-up-among-tee-330614.html 0.6 2026-06-26T09:59:00+08:00 daily https://www.pharmasources.com/industryinsights/dod-not-protecting-service-members-from--330615.html 0.6 2026-03-20T17:05:31+08:00 daily https://www.pharmasources.com/industryinsights/vaccinated-americans-can-soon-visit-the--330616.html 0.6 2026-06-21T13:01:27+08:00 daily https://www.pharmasources.com/industryinsights/moderate-drinking-may-be-heart-healthy-330617.html 0.6 2026-06-24T10:49:50+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-find-your-way-back-to-the-gym-s-330618.html 0.6 2026-06-21T03:02:45+08:00 daily https://www.pharmasources.com/industryinsights/mycovia-pharmaceuticals-announces-us-fda-330619.html 0.6 2026-07-31T12:06:14+08:00 daily https://www.pharmasources.com/industryinsights/dalvance-dalbavancin-receives-fda-approv-330620.html 0.6 2026-06-20T16:00:24+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-keytruda-pembrolizumab-plus-330621.html 0.6 2026-08-09T06:59:25+08:00 daily https://www.pharmasources.com/industryinsights/ardelyx-provides-regulatory-update-on-ne-330622.html 0.6 2026-08-08T18:18:37+08:00 daily https://www.pharmasources.com/industryinsights/satsuma-pharmaceuticals-announces-first--330623.html 0.6 2026-08-07T13:17:13+08:00 daily https://www.pharmasources.com/industryinsights/johnson-johnson-statement-on-us-fda-appr-330624.html 0.6 2026-08-07T01:10:46+08:00 daily https://www.pharmasources.com/industryinsights/amgen-to-acquire-teneobio-for-900m-330625.html 0.6 2026-08-07T00:41:13+08:00 daily https://www.pharmasources.com/industryinsights/almac-thread-to-integrate-technologies-f-330626.html 0.6 2026-08-07T00:01:32+08:00 daily https://www.pharmasources.com/industryinsights/lantern-pharma-reacquires-irofulven-from-330627.html 0.6 2026-08-06T23:56:33+08:00 daily https://www.pharmasources.com/industryinsights/immunogenesis-opens-research-lab-adds-ke-330628.html 0.6 2026-08-07T00:02:08+08:00 daily https://www.pharmasources.com/industryinsights/valenzabio-probiogen-enter-cell-line-pac-330629.html 0.6 2026-08-07T02:30:58+08:00 daily https://www.pharmasources.com/industryinsights/cerba-research-wins-nih-contract-for-cen-330630.html 0.6 2026-08-07T02:36:33+08:00 daily https://www.pharmasources.com/industryinsights/role-of-pharmacovigilance-in-innovating--330631.html 0.6 2026-08-07T02:43:21+08:00 daily https://www.pharmasources.com/industryinsights/emcure-pharma-appoints-four-new-director-330632.html 0.6 2026-08-10T04:42:57+08:00 daily https://www.pharmasources.com/industryinsights/alembic-pharma-q1-net-profit-declines-to-330633.html 0.6 2026-08-06T23:47:18+08:00 daily https://www.pharmasources.com/industryinsights/high-commissioner-of-india-visits-wockha-330634.html 0.6 2026-08-06T23:54:54+08:00 daily https://www.pharmasources.com/industryinsights/gsk-and-vir-enter-supply-deal-with-europ-330635.html 0.6 2026-08-07T00:41:03+08:00 daily https://www.pharmasources.com/industryinsights/abbvie-and-calico-extend-partnership-on--330636.html 0.6 2026-08-07T03:34:27+08:00 daily https://www.pharmasources.com/industryinsights/hypertension-study-suggests-arbs-should--330637.html 0.6 2026-08-07T03:55:04+08:00 daily https://www.pharmasources.com/industryinsights/vaxzevria-and-mrna-covid-19-vaccines-sho-330638.html 0.6 2026-08-07T03:58:57+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-pancreatic-cancer-treatment-o-330639.html 0.6 2026-08-07T04:16:03+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-breast-cancer-treatment-330640.html 0.6 2026-08-14T04:47:28+08:00 daily https://www.pharmasources.com/industryinsights/hutchmed-and-astrazeneca-begin-phase-ii--330641.html 0.6 2026-08-11T15:49:39+08:00 daily https://www.pharmasources.com/industryinsights/early-data-shows-cansinobios-inhaled-cov-330642.html 0.6 2026-08-04T06:59:52+08:00 daily https://www.pharmasources.com/industryinsights/study-shows-azs-covid-19-jab-did-not-inc-330643.html 0.6 2026-06-20T06:07:17+08:00 daily https://www.pharmasources.com/industryinsights/ac-immune-acquires-parkinsons-disease-va-330644.html 0.6 2026-06-20T16:55:08+08:00 daily https://www.pharmasources.com/industryinsights/genomic-sequencing-is-a-potential-key-to-330645.html 0.6 2026-06-21T11:05:13+08:00 daily https://www.pharmasources.com/industryinsights/british-generics-manufacturers-call-for--330646.html 0.6 2026-08-11T04:11:07+08:00 daily https://www.pharmasources.com/industryinsights/vaxzevria-has-similar-safety-profile-to--330647.html 0.6 2026-03-24T20:42:36+08:00 daily https://www.pharmasources.com/industryinsights/collaboration-to-enable-standardisation--330648.html 0.6 2026-06-23T01:48:25+08:00 daily https://www.pharmasources.com/industryinsights/hanall-biopharma-reports-second-quarter--330649.html 0.6 2026-07-23T09:30:03+08:00 daily https://www.pharmasources.com/industryinsights/everest-medicines-receives-pediatric-and-330650.html 0.6 2026-06-20T06:22:59+08:00 daily https://www.pharmasources.com/industryinsights/daewoong-pharmaceutical-announces-camost-330651.html 0.6 2026-08-07T05:31:01+08:00 daily https://www.pharmasources.com/industryinsights/transcenta-announces-orphan-drug-designa-330652.html 0.6 2026-08-07T02:04:52+08:00 daily https://www.pharmasources.com/industryinsights/ascentage-pharma-announces-another-miles-330653.html 0.6 2026-08-07T01:52:02+08:00 daily https://www.pharmasources.com/industryinsights/hemanext-partners-with-sickle-cell-101-t-330654.html 0.6 2026-08-07T01:42:46+08:00 daily https://www.pharmasources.com/industryinsights/clarity-commences-cu-64cu-67-sar-bispsma-330655.html 0.6 2026-08-07T01:39:39+08:00 daily https://www.pharmasources.com/industryinsights/sasakawa-leprosy-hansens-disease-initiat-330656.html 0.6 2026-08-07T01:27:52+08:00 daily https://www.pharmasources.com/industryinsights/fortacin-receives-extremely-encouraging--330657.html 0.6 2026-08-07T01:19:55+08:00 daily https://www.pharmasources.com/industryinsights/genscript-announces-notice-of-allowance--330658.html 0.6 2026-08-12T13:39:35+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-announces-ind-acceptance-for-phase-330659.html 0.6 2026-08-07T01:42:48+08:00 daily https://www.pharmasources.com/industryinsights/eccogene-announces-completed-first-in-hu-330660.html 0.6 2026-08-07T01:45:39+08:00 daily https://www.pharmasources.com/industryinsights/scipher-medicine-increases-patient-acces-330661.html 0.6 2026-08-07T01:52:25+08:00 daily https://www.pharmasources.com/industryinsights/diversification-and-addition-of-capabili-330662.html 0.6 2026-08-07T02:04:57+08:00 daily https://www.pharmasources.com/industryinsights/what-a-post-pandemic-advertising-market--330663.html 0.6 2026-08-14T17:34:25+08:00 daily https://www.pharmasources.com/industryinsights/v-digital-services-climbs-higher-in-denv-330664.html 0.6 2026-08-10T13:33:13+08:00 daily https://www.pharmasources.com/industryinsights/swedish-company-zandcell-offers-russia-7-330665.html 0.6 2026-08-07T04:49:26+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-associated-with-long-term-cogni-330666.html 0.6 2026-06-20T13:17:35+08:00 daily https://www.pharmasources.com/industryinsights/gsk-announces-fda-approval-for-nucala-me-330667.html 0.6 2026-08-07T04:21:51+08:00 daily https://www.pharmasources.com/industryinsights/igm-biosciences-appoints-chris-takimoto--330668.html 0.6 2026-08-07T04:12:12+08:00 daily https://www.pharmasources.com/industryinsights/cytrx-announces-director-election-result-330669.html 0.6 2026-08-07T03:55:04+08:00 daily https://www.pharmasources.com/industryinsights/miravo-healthcare-ireland-enters-into-su-330670.html 0.6 2026-08-07T03:33:33+08:00 daily https://www.pharmasources.com/industryinsights/alnylam-and-peptidream-enter-into-collab-330671.html 0.6 2026-08-07T03:20:05+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-biosimilar-insulin-pr-330672.html 0.6 2026-08-10T12:13:42+08:00 daily https://www.pharmasources.com/industryinsights/cdc-now-says-vaccinated-should-be-tested-330673.html 0.6 2026-08-07T05:37:30+08:00 daily https://www.pharmasources.com/industryinsights/mississippi-health-system-buckles-under--330674.html 0.6 2026-08-07T05:52:05+08:00 daily https://www.pharmasources.com/industryinsights/mccormick-recalls-seasonings-over-salmon-330675.html 0.6 2026-08-07T05:57:56+08:00 daily https://www.pharmasources.com/industryinsights/global-dementia-cases-projected-to-top-1-330676.html 0.6 2026-08-07T06:03:53+08:00 daily https://www.pharmasources.com/industryinsights/type-2-diabetes-in-teens-can-bring-dange-330677.html 0.6 2026-08-07T11:21:29+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-deaths-related-to-irregular-hea-330678.html 0.6 2026-08-07T12:00:00+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-she-had-a-baby-then-emergency-h-330679.html 0.6 2026-08-07T12:18:38+08:00 daily https://www.pharmasources.com/industryinsights/new-data-presented-on-the-safety-and-eff-330680.html 0.6 2026-08-07T13:17:23+08:00 daily https://www.pharmasources.com/industryinsights/incyte-provides-regulatory-update-on-ret-330681.html 0.6 2026-08-08T10:40:00+08:00 daily https://www.pharmasources.com/industryinsights/vaxzevria-is-highly-effective-after-one--330682.html 0.6 2026-08-07T13:18:34+08:00 daily https://www.pharmasources.com/industryinsights/rec-biotechnology-went-to-hong-kong-sar--330683.html 0.6 2026-08-07T04:30:49+08:00 daily https://www.pharmasources.com/industryinsights/jjs-2q-pharma-sales-up-17-330684.html 0.6 2026-08-08T02:52:30+08:00 daily https://www.pharmasources.com/industryinsights/pfizers-2q-revenues-up-92-330685.html 0.6 2026-08-13T19:47:47+08:00 daily https://www.pharmasources.com/industryinsights/cellcan-and-ccrm-partner-to-launch-catti-330686.html 0.6 2026-08-07T03:06:27+08:00 daily https://www.pharmasources.com/industryinsights/regeneron-investing-nearly-2b-in-tarryto-330687.html 0.6 2026-08-07T23:14:40+08:00 daily https://www.pharmasources.com/industryinsights/nexus-pharmaceuticals-opens-state-of-the-330688.html 0.6 2026-08-09T22:09:51+08:00 daily https://www.pharmasources.com/industryinsights/celanese-opens-pharma-drug-delivery-feas-330689.html 0.6 2026-08-10T12:59:55+08:00 daily https://www.pharmasources.com/industryinsights/akston-biosciences-seppic-ink-commercial-330690.html 0.6 2026-08-07T00:40:31+08:00 daily https://www.pharmasources.com/industryinsights/abzena-bioxpress-therapeutics-enter-bios-330691.html 0.6 2026-08-06T23:58:00+08:00 daily https://www.pharmasources.com/industryinsights/cocktail-covid-19-neutralizing-antibody--330692.html 0.6 2026-08-07T02:48:35+08:00 daily https://www.pharmasources.com/industryinsights/sca-pharma-names-scott-luce-as-ceo-330693.html 0.6 2026-08-12T11:23:35+08:00 daily https://www.pharmasources.com/industryinsights/sterling-pharma-solutions-appoints-ian-b-330694.html 0.6 2026-08-06T23:46:31+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-application-for-roches-faric-330695.html 0.6 2026-08-06T23:38:06+08:00 daily https://www.pharmasources.com/industryinsights/new-progress-of-potential-specific-drugs-330696.html 0.6 2026-08-07T02:42:57+08:00 daily https://www.pharmasources.com/industryinsights/white-paper-calls-for-action-on-amr-330697.html 0.6 2026-08-06T23:36:10+08:00 daily https://www.pharmasources.com/industryinsights/agricultural-machinery-market-in-india-p-330698.html 0.6 2026-08-06T23:38:08+08:00 daily https://www.pharmasources.com/industryinsights/nppa-fixes-ceiling-prices-of-355-medicin-330699.html 0.6 2026-08-06T23:41:49+08:00 daily https://www.pharmasources.com/industryinsights/monterey-car-week-celebrates-post-covid--330700.html 0.6 2026-08-06T23:45:27+08:00 daily https://www.pharmasources.com/industryinsights/private-equity-firms-acquiring-top-cmos--330701.html 0.6 2026-08-07T13:15:53+08:00 daily https://www.pharmasources.com/industryinsights/biocon-biologics-and-viatris-receive-us--330702.html 0.6 2026-01-31T10:06:15+08:00 daily https://www.pharmasources.com/industryinsights/covishield-gives-93-per-cent-protection--330703.html 0.6 2026-08-07T02:37:10+08:00 daily https://www.pharmasources.com/industryinsights/after-suspending-eua-request-brazil-now--330704.html 0.6 2026-08-07T02:31:10+08:00 daily https://www.pharmasources.com/industryinsights/pharma-sources-insight-august-2021-new-m-330705.html 0.6 2026-07-16T12:57:42+08:00 daily https://www.pharmasources.com/industryinsights/fda-expands-eua-for-lilly-incytes-barici-330706.html 0.6 2026-08-07T02:22:12+08:00 daily https://www.pharmasources.com/industryinsights/calico-and-abbvie-google-backed-partners-330707.html 0.6 2026-08-07T00:01:51+08:00 daily https://www.pharmasources.com/industryinsights/deep-genomics-raises-180m-to-advance-dru-330708.html 0.6 2026-08-06T23:55:56+08:00 daily https://www.pharmasources.com/industryinsights/fda-authorizes-new-standalone-treatment--330709.html 0.6 2026-08-06T23:47:50+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-biosimilar-interchangeable--330710.html 0.6 2026-07-25T15:06:31+08:00 daily https://www.pharmasources.com/industryinsights/rho-granted-extension-by-niaid-to-study--330711.html 0.6 2026-08-08T13:51:25+08:00 daily https://www.pharmasources.com/industryinsights/panaxia-axionovo-gmbh-to-market-cannabis-330712.html 0.6 2026-08-07T02:40:03+08:00 daily https://www.pharmasources.com/industryinsights/ipsen-to-collaborate-with-bakx-therapeut-330713.html 0.6 2026-08-07T02:52:16+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-regenerons-dupixent-wins-positive-330714.html 0.6 2026-08-07T03:02:35+08:00 daily https://www.pharmasources.com/industryinsights/macomics-secures-424m-to-accelerate-macr-330715.html 0.6 2026-08-07T03:24:54+08:00 daily https://www.pharmasources.com/industryinsights/new-study-provides-insight-into-the-phar-330716.html 0.6 2026-08-07T13:17:52+08:00 daily https://www.pharmasources.com/industryinsights/ec-healthcare-and-prenetics-form-strateg-330717.html 0.6 2026-08-07T03:33:40+08:00 daily https://www.pharmasources.com/industryinsights/clinirx-becomes-a-medidata-rave-edc-accr-330718.html 0.6 2026-08-07T03:24:53+08:00 daily https://www.pharmasources.com/industryinsights/dhl-express-delivers-us-donation-of-15m--330719.html 0.6 2026-04-19T01:27:38+08:00 daily https://www.pharmasources.com/industryinsights/neukio-biotherapeutics-completed-its-40m-330720.html 0.6 2026-08-10T11:57:07+08:00 daily https://www.pharmasources.com/industryinsights/bon-natural-life-limited-breaks-ground-o-330721.html 0.6 2026-07-20T02:02:56+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-announces-authorization-of-a-renew-330722.html 0.6 2026-07-17T08:18:41+08:00 daily https://www.pharmasources.com/industryinsights/mgi-australia-demo-lab-opens-to-support--330723.html 0.6 2026-06-30T00:51:01+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-first-interchangeable-biosi-330724.html 0.6 2026-08-14T19:41:09+08:00 daily https://www.pharmasources.com/industryinsights/over-100mn-in-fines-for-pharma-firms-hik-330725.html 0.6 2026-08-07T05:15:51+08:00 daily https://www.pharmasources.com/industryinsights/alzheimers-treatment-lowers-tau-by-nearl-330726.html 0.6 2026-08-07T05:01:19+08:00 daily https://www.pharmasources.com/industryinsights/as-delta-variant-surges-medicomp-systems-330727.html 0.6 2026-06-22T03:12:55+08:00 daily https://www.pharmasources.com/industryinsights/qps-supports-covid-19-vaccine-developmen-330728.html 0.6 2026-08-07T13:16:54+08:00 daily https://www.pharmasources.com/industryinsights/cytosorbents-completes-its-mission-10000-330729.html 0.6 2026-08-08T05:07:30+08:00 daily https://www.pharmasources.com/industryinsights/peach-state-health-plan-and-morehouse-sc-330730.html 0.6 2026-08-07T04:52:45+08:00 daily https://www.pharmasources.com/industryinsights/ut-southwestern-finds-crucial-new-molecu-330731.html 0.6 2026-08-07T04:34:03+08:00 daily https://www.pharmasources.com/industryinsights/veklury-drives-2q-growth-for-gilead-330732.html 0.6 2026-08-07T02:40:37+08:00 daily https://www.pharmasources.com/industryinsights/abbvies-2q-revenue-up-34-330733.html 0.6 2026-08-06T23:45:24+08:00 daily https://www.pharmasources.com/industryinsights/bms-2q-revenues-up-16-330734.html 0.6 2026-08-12T08:20:08+08:00 daily https://www.pharmasources.com/industryinsights/russias-global-vaccine-ambitions-stumble-330735.html 0.6 2026-08-06T23:56:47+08:00 daily https://www.pharmasources.com/industryinsights/multiple-myeloma-patients-display-weaken-330736.html 0.6 2026-08-07T13:18:00+08:00 daily https://www.pharmasources.com/industryinsights/janssens-uptravi-iv-fda-approved-for-pah-330737.html 0.6 2026-08-07T00:02:09+08:00 daily https://www.pharmasources.com/industryinsights/antengene-announces-the-approval-of-firs-330738.html 0.6 2026-08-07T18:15:12+08:00 daily https://www.pharmasources.com/industryinsights/first-batches-of-the-sputnik-v-vaccine-p-330739.html 0.6 2026-08-08T07:53:14+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-and-moderna-raise-prices-for-its--330740.html 0.6 2026-08-08T22:44:48+08:00 daily https://www.pharmasources.com/industryinsights/taiwan-china-starts-study-on-efficacy-of-330741.html 0.6 2026-08-14T23:22:56+08:00 daily https://www.pharmasources.com/industryinsights/uk-scientists-believe-it-is-almost-certa-330742.html 0.6 2026-06-21T04:08:50+08:00 daily https://www.pharmasources.com/industryinsights/us-approval-of-covid-19-shots-could-boos-330743.html 0.6 2026-08-10T10:41:49+08:00 daily https://www.pharmasources.com/industryinsights/sputnik-v-vaccine-production-in-india-to-330744.html 0.6 2026-08-08T13:11:40+08:00 daily https://www.pharmasources.com/industryinsights/pm-cambodians-to-receive-astrazeneca-3rd-330745.html 0.6 2026-08-08T11:48:37+08:00 daily https://www.pharmasources.com/industryinsights/research-body-recommends-covid-19-drug-330746.html 0.6 2026-08-08T10:39:42+08:00 daily https://www.pharmasources.com/industryinsights/saudi-study-documents-safety-of-astrazen-330747.html 0.6 2026-08-08T06:16:59+08:00 daily https://www.pharmasources.com/industryinsights/take-this-refresher-on-skin-safety-in-su-330748.html 0.6 2026-08-08T04:31:30+08:00 daily https://www.pharmasources.com/industryinsights/all-sunglasses-not-equal-when-it-comes-t-330749.html 0.6 2026-08-08T01:28:41+08:00 daily https://www.pharmasources.com/industryinsights/uptravi-selexipag-receives-fda-approval--330750.html 0.6 2026-08-06T23:55:41+08:00 daily https://www.pharmasources.com/industryinsights/affordable-care-act-had-limited-effects--330751.html 0.6 2026-08-06T23:47:09+08:00 daily https://www.pharmasources.com/industryinsights/biden-reverses-trump-policy-limiting-us--330752.html 0.6 2026-08-07T23:46:03+08:00 daily https://www.pharmasources.com/industryinsights/provincetown-outbreak-shows-delta-can-sp-330753.html 0.6 2026-08-06T23:45:29+08:00 daily https://www.pharmasources.com/industryinsights/israel-offers-covid-19-booster-shots-to--330754.html 0.6 2026-08-10T11:20:12+08:00 daily https://www.pharmasources.com/industryinsights/deaths-from-alzheimers-far-more-common-i-330755.html 0.6 2026-06-20T12:01:45+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-expanded-botox-onabotulinum-330756.html 0.6 2026-08-07T03:34:03+08:00 daily https://www.pharmasources.com/industryinsights/lilly-releases-donanemab-data-that-demon-330757.html 0.6 2026-08-08T23:30:53+08:00 daily https://www.pharmasources.com/industryinsights/fda-broadens-existing-emergency-use-of-l-330758.html 0.6 2026-06-21T08:54:15+08:00 daily https://www.pharmasources.com/industryinsights/global-cell-gene-therapy-mfg-market-coul-330759.html 0.6 2026-08-04T22:48:27+08:00 daily https://www.pharmasources.com/industryinsights/covishield-single-dose-efficacy-drops-af-330760.html 0.6 2026-07-04T18:58:53+08:00 daily https://www.pharmasources.com/industryinsights/sun-pharma-releases-q1fy22-results-330761.html 0.6 2026-06-21T16:00:20+08:00 daily https://www.pharmasources.com/industryinsights/zydus-cadila-receives-final-approval-fro-330762.html 0.6 2026-06-21T12:07:13+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-and-sputnik-v-combination-sh-330763.html 0.6 2026-06-20T13:09:21+08:00 daily https://www.pharmasources.com/industryinsights/how-paperless-vaccine-passport-can-becom-330764.html 0.6 2026-06-21T01:53:37+08:00 daily https://www.pharmasources.com/industryinsights/lupins-generic-health-acquires-southern--330765.html 0.6 2026-08-09T05:33:08+08:00 daily https://www.pharmasources.com/industryinsights/cii-to-work-with-serum-institute-of-indi-330766.html 0.6 2026-08-11T19:20:50+08:00 daily https://www.pharmasources.com/industryinsights/ispe-publishes-ispe-apq-guide-management-330767.html 0.6 2026-08-06T20:03:30+08:00 daily https://www.pharmasources.com/industryinsights/alkem-laboratories-says-us-fda-inspectio-330768.html 0.6 2026-08-06T21:58:34+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-eua-for-regenerons-antibody-c-330769.html 0.6 2026-08-08T00:14:31+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-reports-124-sales-growth-in-q2-20-330770.html 0.6 2026-08-07T04:36:47+08:00 daily https://www.pharmasources.com/industryinsights/takeda-and-frazier-to-launch-hillevax-fo-330771.html 0.6 2026-08-07T04:49:01+08:00 daily https://www.pharmasources.com/industryinsights/astellas-and-minovia-therapeutics-to-col-330772.html 0.6 2026-07-29T18:29:11+08:00 daily https://www.pharmasources.com/industryinsights/keiferx-receives-fda-acceptance-of-inves-330773.html 0.6 2026-07-30T12:07:08+08:00 daily https://www.pharmasources.com/industryinsights/marker-therapeutics-announces-opening-of-330774.html 0.6 2026-08-05T10:51:09+08:00 daily https://www.pharmasources.com/industryinsights/integral-molecular-launches-transgene-pr-330775.html 0.6 2026-08-04T23:54:30+08:00 daily https://www.pharmasources.com/industryinsights/nice-publishes-rapid-guideline-on-rare-b-330776.html 0.6 2026-06-30T12:22:15+08:00 daily https://www.pharmasources.com/industryinsights/gsks-nucala-approved-to-treat-chronic-rh-330777.html 0.6 2026-08-07T22:28:13+08:00 daily https://www.pharmasources.com/industryinsights/uk-genomics-market-valued-at-over-5bn-ac-330778.html 0.6 2026-06-21T15:07:35+08:00 daily https://www.pharmasources.com/industryinsights/gps-call-for-rescue-plan-to-save-general-330779.html 0.6 2026-07-31T00:09:22+08:00 daily https://www.pharmasources.com/industryinsights/hummingbird-bioscience-announces-uk-mhra-330780.html 0.6 2026-06-20T12:19:03+08:00 daily https://www.pharmasources.com/industryinsights/biokangtai-covid-19-vaccine-approved-for-330781.html 0.6 2026-08-03T11:56:17+08:00 daily https://www.pharmasources.com/industryinsights/servier-announces-positive-topline-data--330782.html 0.6 2026-08-09T06:59:17+08:00 daily https://www.pharmasources.com/industryinsights/luye-pharma-enters-distribution-agreemen-330783.html 0.6 2026-08-05T08:34:40+08:00 daily https://www.pharmasources.com/industryinsights/rey-announces-10-million-in-new-series-a-330784.html 0.6 2026-08-04T12:26:48+08:00 daily https://www.pharmasources.com/industryinsights/china-jo-jo-drugstores-completes-redomic-330785.html 0.6 2026-06-21T00:49:46+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-announces-ind-approval-by-fda-to-i-330786.html 0.6 2026-08-06T23:45:33+08:00 daily https://www.pharmasources.com/industryinsights/thinking-impaired-in-60-of-covid-19-surv-330787.html 0.6 2026-07-01T07:24:44+08:00 daily https://www.pharmasources.com/industryinsights/camostat-cuts-recovery-time-in-half-for--330788.html 0.6 2026-08-06T23:32:38+08:00 daily https://www.pharmasources.com/industryinsights/project-worth-31mn-to-develop-advanced-c-330789.html 0.6 2026-08-06T22:54:46+08:00 daily https://www.pharmasources.com/industryinsights/roches-evrysdi-significantly-improves-li-330790.html 0.6 2026-08-07T04:30:51+08:00 daily https://www.pharmasources.com/industryinsights/biomed-x-institute-today-announces-two-n-330791.html 0.6 2026-08-07T04:57:03+08:00 daily https://www.pharmasources.com/industryinsights/nfl-alumni-health-partners-with-cdc-to-t-330792.html 0.6 2026-06-24T10:59:20+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-330793.html 0.6 2026-06-23T11:01:44+08:00 daily https://www.pharmasources.com/industryinsights/sartorius-extends-its-cell-culture-media-330794.html 0.6 2026-06-22T05:13:49+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-offers-to-buy-us-mrna-partner-tra-330795.html 0.6 2026-07-27T15:03:22+08:00 daily https://www.pharmasources.com/industryinsights/nuvalent-announces-closing-of-upsized-in-330796.html 0.6 2026-07-20T22:14:40+08:00 daily https://www.pharmasources.com/industryinsights/existing-drug-is-shown-to-inhibit-virus--330797.html 0.6 2026-06-21T17:54:21+08:00 daily https://www.pharmasources.com/industryinsights/fate-therapeutics-announces-treatment-of-330798.html 0.6 2026-07-30T02:31:49+08:00 daily https://www.pharmasources.com/industryinsights/avidity-biosciences-announces-proposed-p-330799.html 0.6 2026-06-22T07:47:38+08:00 daily https://www.pharmasources.com/industryinsights/inventiva-announces-the-implementation-o-330800.html 0.6 2026-06-21T01:16:00+08:00 daily https://www.pharmasources.com/industryinsights/pharmacyte-biotech-announces-uplist-to-t-330801.html 0.6 2026-08-07T23:57:00+08:00 daily https://www.pharmasources.com/industryinsights/oyster-point-pharma-announces-new-chairp-330802.html 0.6 2026-07-22T05:51:13+08:00 daily https://www.pharmasources.com/industryinsights/icosavax-announces-closing-of-initial-pu-330803.html 0.6 2026-06-20T23:15:51+08:00 daily https://www.pharmasources.com/industryinsights/arcutis-announces-additions-to-its-inves-330804.html 0.6 2026-08-07T03:18:56+08:00 daily https://www.pharmasources.com/industryinsights/rallybio-corporation-announces-closing-o-330805.html 0.6 2026-08-13T01:55:03+08:00 daily https://www.pharmasources.com/industryinsights/new-data-show-the-power-of-covid-19-vacc-330806.html 0.6 2026-08-01T13:34:16+08:00 daily https://www.pharmasources.com/industryinsights/florida-sees-record-number-of-covid-19-c-330807.html 0.6 2026-08-09T10:32:12+08:00 daily https://www.pharmasources.com/industryinsights/troubling-rise-seen-in-both-covid-19-rsv-330808.html 0.6 2026-08-07T23:15:20+08:00 daily https://www.pharmasources.com/industryinsights/protective-factors-can-reduce-vaping-in--330809.html 0.6 2026-08-10T11:57:44+08:00 daily https://www.pharmasources.com/industryinsights/higher-midlife-net-worth-tied-to-greater-330810.html 0.6 2026-07-11T05:35:35+08:00 daily https://www.pharmasources.com/industryinsights/how-did-the-pandemic-affect-cancer-clini-330811.html 0.6 2026-08-07T13:36:12+08:00 daily https://www.pharmasources.com/industryinsights/parents-pot-smoking-means-more-colds-flu-330812.html 0.6 2026-08-05T15:46:34+08:00 daily https://www.pharmasources.com/industryinsights/after-nearly-9-million-pfizer-shots-for--330813.html 0.6 2026-08-09T15:05:32+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-dangers-of-life-threatening-sec-330814.html 0.6 2026-08-07T04:53:02+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-saphnelo-anifrolumab-for-mo-330815.html 0.6 2026-08-12T18:31:00+08:00 daily https://www.pharmasources.com/industryinsights/bharat-biotechs-rotavac-5d-receives-who--330816.html 0.6 2026-08-10T23:40:05+08:00 daily https://www.pharmasources.com/industryinsights/glenmark-inks-agreement-with-sanotize-to-330817.html 0.6 2026-08-07T23:08:54+08:00 daily https://www.pharmasources.com/industryinsights/achieving-aatmanirbharta-in-apis-are-we--330818.html 0.6 2026-08-07T03:33:33+08:00 daily https://www.pharmasources.com/industryinsights/india-and-uk-to-conduct-clinical-trials--330819.html 0.6 2026-08-06T20:01:58+08:00 daily https://www.pharmasources.com/industryinsights/takeda-and-frazier-healthcare-partners-c-330820.html 0.6 2026-08-12T12:57:33+08:00 daily https://www.pharmasources.com/industryinsights/abbvies-net-revenues-rise-339-in-q2-2021-330821.html 0.6 2026-08-06T23:38:05+08:00 daily https://www.pharmasources.com/industryinsights/celltrion-gets-priority-review-in-canada-330822.html 0.6 2026-08-06T23:45:38+08:00 daily https://www.pharmasources.com/industryinsights/more-than-85-million-covid-vaccines-admi-330823.html 0.6 2026-08-06T23:47:56+08:00 daily https://www.pharmasources.com/industryinsights/ucbs-bimekizumab-issued-nice-recommendat-330824.html 0.6 2026-08-06T23:54:22+08:00 daily https://www.pharmasources.com/industryinsights/ec-approves-bms-opdivo-as-adjuvant-treat-330825.html 0.6 2026-08-07T06:10:09+08:00 daily https://www.pharmasources.com/industryinsights/azs-saphnelo-scores-us-approval-for-syst-330826.html 0.6 2026-08-12T10:07:08+08:00 daily https://www.pharmasources.com/industryinsights/tcm-lianhua-qingwen-shows-stable-in-vitr-330827.html 0.6 2026-06-28T02:58:40+08:00 daily https://www.pharmasources.com/industryinsights/nanoform-and-boehringer-ingelheim-execut-330828.html 0.6 2026-08-03T16:47:47+08:00 daily https://www.pharmasources.com/industryinsights/jacobio-announces-first-patient-dosed-in-330829.html 0.6 2026-08-12T12:16:26+08:00 daily https://www.pharmasources.com/industryinsights/cstone-announces-positive-registrational-330830.html 0.6 2026-06-28T16:47:18+08:00 daily https://www.pharmasources.com/industryinsights/insilico-medicine-and-westlake-pharma-an-330831.html 0.6 2026-06-19T16:04:13+08:00 daily https://www.pharmasources.com/industryinsights/cardinal-health-completes-sale-of-cordis-330832.html 0.6 2026-06-20T05:13:24+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-biologics-biosafety-testing-facilit-330833.html 0.6 2026-07-26T09:16:10+08:00 daily https://www.pharmasources.com/industryinsights/happiness-biotech-announced-financial-re-330834.html 0.6 2026-07-24T00:17:14+08:00 daily https://www.pharmasources.com/industryinsights/bionomics-announces-plans-to-conduct-us--330835.html 0.6 2026-08-07T04:21:55+08:00 daily https://www.pharmasources.com/industryinsights/electrophysiology-frontiers-announces-ap-330836.html 0.6 2026-08-07T03:56:09+08:00 daily https://www.pharmasources.com/industryinsights/nice-approves-cost-comparison-fast-track-330837.html 0.6 2026-08-07T03:27:32+08:00 daily https://www.pharmasources.com/industryinsights/fda-approve-emergency-use-of-regen-covtm-330838.html 0.6 2026-08-07T03:12:48+08:00 daily https://www.pharmasources.com/industryinsights/lbps-may-offer-hope-to-ibs-patients-in-t-330839.html 0.6 2026-08-05T14:18:49+08:00 daily https://www.pharmasources.com/industryinsights/biden-administration-to-support-resilien-330840.html 0.6 2026-08-07T03:25:34+08:00 daily https://www.pharmasources.com/industryinsights/cosmetics-packaging-needs-to-respond-to--330841.html 0.6 2026-08-07T03:55:28+08:00 daily https://www.pharmasources.com/industryinsights/affinity-empowering-to-offer-no-cost-cov-330842.html 0.6 2026-08-07T04:07:22+08:00 daily https://www.pharmasources.com/industryinsights/vironaire-donates-200-medical-grade-hepa-330843.html 0.6 2026-06-21T01:38:15+08:00 daily https://www.pharmasources.com/industryinsights/tech-transfer-a-many-layered-artform-tha-330844.html 0.6 2026-06-20T14:06:17+08:00 daily https://www.pharmasources.com/industryinsights/worldwide-hematopoietic-stem-cell-transp-330845.html 0.6 2026-06-21T09:11:10+08:00 daily https://www.pharmasources.com/industryinsights/vanda-pharmaceuticals-closes-enrollment--330846.html 0.6 2026-06-21T20:59:35+08:00 daily https://www.pharmasources.com/industryinsights/helen-hovenga-joins-telix-as-chief-peopl-330847.html 0.6 2026-06-21T07:51:56+08:00 daily https://www.pharmasources.com/industryinsights/immuneering-announces-closing-of-its-ups-330848.html 0.6 2026-06-21T04:02:55+08:00 daily https://www.pharmasources.com/industryinsights/rethinking-remdesivir-330849.html 0.6 2026-08-08T18:47:09+08:00 daily https://www.pharmasources.com/industryinsights/tenaya-therapeutics-announces-closing-of-330850.html 0.6 2026-06-21T10:55:31+08:00 daily https://www.pharmasources.com/industryinsights/sinovacs-covid-19-vaccine-585-effective--330851.html 0.6 2026-06-09T19:36:32+08:00 daily https://www.pharmasources.com/industryinsights/rupture-disc-market-in-industrial-machin-330852.html 0.6 2026-08-09T11:05:12+08:00 daily https://www.pharmasources.com/industryinsights/ardelyx-receives-complete-response-lette-330853.html 0.6 2026-08-11T15:47:19+08:00 daily https://www.pharmasources.com/industryinsights/aap-provides-guidance-for-follow-up-care-330854.html 0.6 2026-08-10T17:34:26+08:00 daily https://www.pharmasources.com/industryinsights/for-us-teens-most-adverse-events-to-covi-330855.html 0.6 2026-06-20T23:52:34+08:00 daily https://www.pharmasources.com/industryinsights/exposure-to-flu-like-illness-in-doctors--330856.html 0.6 2026-08-09T12:47:53+08:00 daily https://www.pharmasources.com/industryinsights/indiana-university-covid-19-vaccine-mand-330857.html 0.6 2026-08-07T04:25:48+08:00 daily https://www.pharmasources.com/industryinsights/nyc-becomes-first-to-require-vaccination-330858.html 0.6 2026-08-07T04:16:06+08:00 daily https://www.pharmasources.com/industryinsights/hrt-could-raise-odds-for-asthma-330859.html 0.6 2026-08-07T03:59:15+08:00 daily https://www.pharmasources.com/industryinsights/the-bigger-the-city-the-lower-the-depres-330860.html 0.6 2026-08-07T03:48:58+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-bob-odenkirks-small-heart-attac-330861.html 0.6 2026-08-07T03:24:57+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-sta-completes-acquisition-of-bms-ma-330862.html 0.6 2026-08-09T00:40:28+08:00 daily https://www.pharmasources.com/industryinsights/dispersol-catalent-enter-manufacturing-c-330863.html 0.6 2026-08-07T03:18:46+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-grants-priority-review-to-roches--330864.html 0.6 2026-07-08T21:10:11+08:00 daily https://www.pharmasources.com/industryinsights/not-independent-but-more-inter-dependent-330865.html 0.6 2026-08-07T00:15:31+08:00 daily https://www.pharmasources.com/industryinsights/jj-committed-to-bring-its-covid-jab-to-i-330866.html 0.6 2026-08-07T00:02:49+08:00 daily https://www.pharmasources.com/industryinsights/uae-rolls-out-sinopharm-covid-19-vaccine-330867.html 0.6 2026-08-06T23:56:49+08:00 daily https://www.pharmasources.com/industryinsights/lilly-incytes-baricitinib-lowers-mortali-330868.html 0.6 2026-08-06T23:46:10+08:00 daily https://www.pharmasources.com/industryinsights/ipsen-and-exicure-to-develop-therapies-f-330869.html 0.6 2026-08-06T23:37:32+08:00 daily https://www.pharmasources.com/industryinsights/novartis-announces-new-phase-3-study-for-330870.html 0.6 2026-08-06T23:46:26+08:00 daily https://www.pharmasources.com/industryinsights/mindmed-joins-digital-medicine-society-t-330871.html 0.6 2026-08-10T15:09:04+08:00 daily https://www.pharmasources.com/industryinsights/lumosa-therapeutics-announces-positive-r-330872.html 0.6 2026-08-07T15:39:37+08:00 daily https://www.pharmasources.com/industryinsights/saphnelo-approved-in-us-for-moderate-to--330873.html 0.6 2026-08-13T08:52:54+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-to-acquire-mrna-therapies-develop-330874.html 0.6 2026-06-22T09:46:30+08:00 daily https://www.pharmasources.com/industryinsights/columbia-clinic-signed-a-cooperation-agr-330875.html 0.6 2026-07-18T11:03:41+08:00 daily https://www.pharmasources.com/industryinsights/clarivateacquiresbioinfogate-reinforcing-330876.html 0.6 2026-07-03T05:43:24+08:00 daily https://www.pharmasources.com/industryinsights/open-health-acquires-spirit-330877.html 0.6 2026-06-21T18:10:36+08:00 daily https://www.pharmasources.com/industryinsights/navifus-begins-fus-combined-with-radioth-330878.html 0.6 2026-05-29T08:55:43+08:00 daily https://www.pharmasources.com/industryinsights/tiens-group-will-become-a-global-partici-330879.html 0.6 2026-07-04T10:18:32+08:00 daily https://www.pharmasources.com/industryinsights/varigard-technologies-proven-to-prevent--330880.html 0.6 2026-06-22T08:08:00+08:00 daily https://www.pharmasources.com/industryinsights/yuyu-pharma-signs-exclusive-distribution-330881.html 0.6 2026-07-23T11:44:11+08:00 daily https://www.pharmasources.com/industryinsights/clinical-trial-affirms-covidth-diagnosti-330882.html 0.6 2026-06-22T05:06:45+08:00 daily https://www.pharmasources.com/industryinsights/111-inc-enters-into-strategic-cooperatio-330883.html 0.6 2026-06-23T15:46:48+08:00 daily https://www.pharmasources.com/industryinsights/coller-capital-and-ping-an-overseas-hold-330884.html 0.6 2026-07-20T05:00:27+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-reveals-1554-billion-in-reve-330885.html 0.6 2026-07-29T15:21:45+08:00 daily https://www.pharmasources.com/industryinsights/gsk-reports-81-billion-in-q2-sales-330886.html 0.6 2026-07-27T22:33:56+08:00 daily https://www.pharmasources.com/industryinsights/lilly-and-incytes-baricitinib-reduced-de-330887.html 0.6 2026-06-21T02:55:40+08:00 daily https://www.pharmasources.com/industryinsights/usa-medical-llc-announces-free-48-hour-c-330888.html 0.6 2026-05-29T07:16:35+08:00 daily https://www.pharmasources.com/industryinsights/fda-authorizes-regen-cov-monoclonal-anti-330889.html 0.6 2026-08-01T23:45:26+08:00 daily https://www.pharmasources.com/industryinsights/dispersol-signs-up-catalent-for-manufact-330890.html 0.6 2026-06-21T12:06:25+08:00 daily https://www.pharmasources.com/industryinsights/blis-reveals-new-interactive-dashboard-t-330891.html 0.6 2026-05-29T06:55:30+08:00 daily https://www.pharmasources.com/industryinsights/bio-technes-rnascope-technology-aids-in--330892.html 0.6 2026-06-22T00:57:45+08:00 daily https://www.pharmasources.com/industryinsights/wuxi-sta-completes-acquisition-of-its-fi-330893.html 0.6 2026-06-21T10:07:11+08:00 daily https://www.pharmasources.com/industryinsights/miller-school-research-reveals-that-flu--330894.html 0.6 2026-07-09T22:44:20+08:00 daily https://www.pharmasources.com/industryinsights/maia-biotechnology-announces-additions-t-330895.html 0.6 2026-07-04T19:59:14+08:00 daily https://www.pharmasources.com/industryinsights/full-dose-blood-thinners-reduce-the-need-330896.html 0.6 2026-06-28T10:40:24+08:00 daily https://www.pharmasources.com/industryinsights/alpha-healthcare-acquisition-corp-sets-a-330897.html 0.6 2026-06-23T13:38:10+08:00 daily https://www.pharmasources.com/industryinsights/xinthera-closes-50m-series-b-financing-330898.html 0.6 2026-07-23T07:01:42+08:00 daily https://www.pharmasources.com/industryinsights/new-england-journal-of-medicine-publishe-330899.html 0.6 2026-06-21T08:04:59+08:00 daily https://www.pharmasources.com/industryinsights/combination-of-the-first-component-of-sp-330900.html 0.6 2026-08-07T19:42:54+08:00 daily https://www.pharmasources.com/industryinsights/adamis-announces-agreement-to-sell-porti-330901.html 0.6 2026-06-21T08:15:46+08:00 daily https://www.pharmasources.com/industryinsights/complete-response-letter-received-from-f-330902.html 0.6 2026-08-08T01:08:19+08:00 daily https://www.pharmasources.com/industryinsights/digital-publishing-market-to-grow-by-usd-330903.html 0.6 2026-06-23T13:38:42+08:00 daily https://www.pharmasources.com/industryinsights/disposable-respiratory-masks-market-2021-330904.html 0.6 2026-06-27T11:48:49+08:00 daily https://www.pharmasources.com/industryinsights/who-slams-covid-19-booster-shots-in-weal-330905.html 0.6 2026-08-05T22:25:52+08:00 daily https://www.pharmasources.com/industryinsights/regen-cov-authorized-for-postexposure-pr-330906.html 0.6 2026-07-08T13:47:41+08:00 daily https://www.pharmasources.com/industryinsights/full-approval-of-pfizer-covid-19-vaccine-330907.html 0.6 2026-07-13T11:23:58+08:00 daily https://www.pharmasources.com/industryinsights/wuhan-tests-all-residents-as-delta-varia-330908.html 0.6 2026-06-20T21:12:50+08:00 daily https://www.pharmasources.com/industryinsights/biden-offers-covid-19-vaccines-to-migran-330909.html 0.6 2026-06-21T21:01:39+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-she-couldnt-put-up-her-arms-on--330910.html 0.6 2026-06-21T17:01:24+08:00 daily https://www.pharmasources.com/industryinsights/time-to-rethink-suicide-warnings-on-labe-330911.html 0.6 2026-06-20T05:19:32+08:00 daily https://www.pharmasources.com/industryinsights/spinosad-powder-manufacturers-in-china-330912.html 0.6 2026-08-10T08:15:39+08:00 daily https://www.pharmasources.com/industryinsights/vitamin-b1-api-manufacturers-in-china-330913.html 0.6 2026-08-06T21:23:04+08:00 daily https://www.pharmasources.com/industryinsights/catalent-completes-rheincell-therapeutic-330914.html 0.6 2026-06-21T14:15:38+08:00 daily https://www.pharmasources.com/industryinsights/syneos-health-aetion-partner-on-regulato-330915.html 0.6 2026-06-21T20:50:37+08:00 daily https://www.pharmasources.com/industryinsights/biomed-x-janssen-begin-autoimmunity-and--330916.html 0.6 2026-06-21T07:01:54+08:00 daily https://www.pharmasources.com/industryinsights/pii-to-offer-wests-daikyo-crystal-zenith-330917.html 0.6 2026-08-06T16:47:05+08:00 daily https://www.pharmasources.com/industryinsights/bms-completes-sale-of-couvet-site-to-wux-330918.html 0.6 2026-06-20T15:10:22+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-to-acquire-translate-bio-for-32b-330919.html 0.6 2026-08-03T22:54:46+08:00 daily https://www.pharmasources.com/industryinsights/syngene-appoints-two-senior-leaders-in-u-330920.html 0.6 2026-07-09T19:20:34+08:00 daily https://www.pharmasources.com/industryinsights/alkem-laboratories-launches-ibuprofen-fa-330921.html 0.6 2026-08-07T02:48:58+08:00 daily https://www.pharmasources.com/industryinsights/government-releases-national-clinical-ma-330922.html 0.6 2026-08-07T02:40:04+08:00 daily https://www.pharmasources.com/industryinsights/centre-increases-supply-of-essential-dru-330923.html 0.6 2026-08-07T02:52:22+08:00 daily https://www.pharmasources.com/industryinsights/government-imports-apis-worth-rs-28529-c-330924.html 0.6 2026-08-07T13:18:00+08:00 daily https://www.pharmasources.com/industryinsights/monthly-production-capacity-of-covishiel-330925.html 0.6 2026-08-08T03:25:21+08:00 daily https://www.pharmasources.com/industryinsights/bayer-to-acquire-vividion-for-15bn-to-bo-330926.html 0.6 2026-08-08T04:28:01+08:00 daily https://www.pharmasources.com/industryinsights/nrx-and-mannkind-to-develop-zyesami-inha-330927.html 0.6 2026-08-08T05:07:35+08:00 daily https://www.pharmasources.com/industryinsights/amgen-to-set-up-550m-manufacturing-plant-330928.html 0.6 2026-08-08T07:47:45+08:00 daily https://www.pharmasources.com/industryinsights/biontech-acquires-kites-neoantigen-tcr-c-330929.html 0.6 2026-08-08T08:59:01+08:00 daily https://www.pharmasources.com/industryinsights/biodelivery-sciences-to-acquire-us-and-c-330930.html 0.6 2026-08-08T10:10:52+08:00 daily https://www.pharmasources.com/industryinsights/ortho-clinical-diagnostics-expands-covid-330931.html 0.6 2026-08-07T13:58:07+08:00 daily https://www.pharmasources.com/industryinsights/berry-oncology-completes-series-b1-fundi-330932.html 0.6 2026-08-07T13:19:47+08:00 daily https://www.pharmasources.com/industryinsights/china-pharmas-candesartan-hypertension-p-330933.html 0.6 2026-08-07T18:15:14+08:00 daily https://www.pharmasources.com/industryinsights/insilico-medicine-and-usynova-announce-s-330934.html 0.6 2026-08-08T04:29:58+08:00 daily https://www.pharmasources.com/industryinsights/pharmaxis-cancer-drug-decreases-tumour-b-330935.html 0.6 2026-08-08T06:16:52+08:00 daily https://www.pharmasources.com/industryinsights/cuhk-discovers-children-with-autism-have-330936.html 0.6 2026-08-09T01:20:34+08:00 daily https://www.pharmasources.com/industryinsights/kyowa-pharmaceutical-industry-co-ltd-par-330937.html 0.6 2026-06-19T21:17:15+08:00 daily https://www.pharmasources.com/industryinsights/inmagene-and-kissei-enter-into-an-exclus-330938.html 0.6 2026-07-23T14:36:13+08:00 daily https://www.pharmasources.com/industryinsights/everest-medicines-announces-approval-of--330939.html 0.6 2026-02-15T13:23:05+08:00 daily https://www.pharmasources.com/industryinsights/abl-bio-receives-ind-approval-for-phase--330940.html 0.6 2026-06-21T09:06:10+08:00 daily https://www.pharmasources.com/industryinsights/novavax-and-european-commission-finalize-330941.html 0.6 2026-06-21T04:14:54+08:00 daily https://www.pharmasources.com/industryinsights/alterity-therapeutics-announces-new-us-p-330942.html 0.6 2026-06-30T02:04:46+08:00 daily https://www.pharmasources.com/industryinsights/insilico-medicine-announces-the-preclini-330943.html 0.6 2025-10-26T19:49:01+08:00 daily https://www.pharmasources.com/industryinsights/stemedica-opens-enrollment-in-phase-ii-c-330944.html 0.6 2026-06-22T10:58:48+08:00 daily https://www.pharmasources.com/industryinsights/educational-robot-market-to-reach-us-332-330945.html 0.6 2026-08-07T04:52:43+08:00 daily https://www.pharmasources.com/industryinsights/centene-announces-additional-actions-to--330946.html 0.6 2026-08-07T23:19:15+08:00 daily https://www.pharmasources.com/industryinsights/drug-research-and-development-of-targeti-330947.html 0.6 2026-08-09T00:10:04+08:00 daily https://www.pharmasources.com/industryinsights/how-much-do-you-know-about-fighting-aids-330948.html 0.6 2026-08-08T21:33:26+08:00 daily https://www.pharmasources.com/industryinsights/new-breakthrough-in-the-therapy-of-hemop-330949.html 0.6 2026-08-14T14:29:12+08:00 daily https://www.pharmasources.com/industryinsights/oravax-to-present-keynote-talk-on-oral-c-330950.html 0.6 2026-08-07T04:24:50+08:00 daily https://www.pharmasources.com/industryinsights/kroger-health-teams-up-with-lyft-to-prov-330951.html 0.6 2026-08-07T16:51:46+08:00 daily https://www.pharmasources.com/industryinsights/aprea-therapeutics-announces-a-partial-c-330952.html 0.6 2026-08-07T03:55:06+08:00 daily https://www.pharmasources.com/industryinsights/athersys-and-healios-kk-announce-advance-330953.html 0.6 2026-08-07T03:30:44+08:00 daily https://www.pharmasources.com/industryinsights/ryoichi-tanaka-joins-telix-japan-as-coo-330954.html 0.6 2026-08-07T03:18:54+08:00 daily https://www.pharmasources.com/industryinsights/ocular-therapeutix-announces-termination-330955.html 0.6 2026-08-07T14:38:32+08:00 daily https://www.pharmasources.com/industryinsights/indias-panacea-biotec-to-make-up-to-25-m-330956.html 0.6 2026-08-08T19:20:04+08:00 daily https://www.pharmasources.com/industryinsights/formycon-and-bioeq-announce-submission-o-330957.html 0.6 2026-08-07T04:12:20+08:00 daily https://www.pharmasources.com/industryinsights/springworks-therapeutics-announces-phase-330958.html 0.6 2026-08-07T04:30:52+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-announces-positive-top-line-resul-330959.html 0.6 2026-08-10T22:01:21+08:00 daily https://www.pharmasources.com/industryinsights/fda-accepts-application-for-genentechs-f-330960.html 0.6 2026-08-07T05:01:42+08:00 daily https://www.pharmasources.com/industryinsights/poorer-motor-function-in-seniors-linked--330961.html 0.6 2026-06-14T19:39:07+08:00 daily https://www.pharmasources.com/industryinsights/moderna-vaccines-protection-does-not-wan-330962.html 0.6 2026-06-21T00:02:38+08:00 daily https://www.pharmasources.com/industryinsights/smartphone-only-internet-tied-to-lower-p-330963.html 0.6 2026-06-21T05:15:55+08:00 daily https://www.pharmasources.com/industryinsights/record-number-of-covid-19-hospitalizatio-330964.html 0.6 2026-06-21T04:00:49+08:00 daily https://www.pharmasources.com/industryinsights/largest-operator-of-nursing-homes-in-us--330965.html 0.6 2026-06-21T16:56:22+08:00 daily https://www.pharmasources.com/industryinsights/car-t-cell-immunotherapy-rids-woman-of-t-330966.html 0.6 2026-07-04T01:13:16+08:00 daily https://www.pharmasources.com/industryinsights/two-thirds-of-mild-covid-cases-leave-lon-330967.html 0.6 2026-04-05T07:38:36+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-are-figs-good-for-you-get-the-w-330968.html 0.6 2026-08-06T17:45:19+08:00 daily https://www.pharmasources.com/industryinsights/biden-administration-plans-to-require-va-330969.html 0.6 2026-08-06T16:10:30+08:00 daily https://www.pharmasources.com/industryinsights/marinus-pharmaceuticals-submits-new-drug-330970.html 0.6 2026-08-06T14:21:24+08:00 daily https://www.pharmasources.com/industryinsights/metrics-contract-services-expands-its-fa-330971.html 0.6 2026-08-08T22:37:38+08:00 daily https://www.pharmasources.com/industryinsights/takeda-breaks-ground-on-new-manufacturin-330972.html 0.6 2026-06-09T01:46:30+08:00 daily https://www.pharmasources.com/industryinsights/purdue-university-us-pharmacopeia-launch-330973.html 0.6 2026-06-21T02:05:43+08:00 daily https://www.pharmasources.com/industryinsights/sio2-materials-science-receives-64-milli-330974.html 0.6 2026-06-19T17:04:18+08:00 daily https://www.pharmasources.com/industryinsights/amgen-investing-550m-in-new-biomanufactu-330975.html 0.6 2026-08-06T11:50:07+08:00 daily https://www.pharmasources.com/industryinsights/novavax-and-european-commission-finalise-330976.html 0.6 2026-06-20T16:00:23+08:00 daily https://www.pharmasources.com/industryinsights/alembic-pharmaceuticals-gets-usfda-appro-330977.html 0.6 2026-06-27T19:01:56+08:00 daily https://www.pharmasources.com/industryinsights/clarivateacquires-analytics-solutions-pr-330978.html 0.6 2026-07-29T21:08:05+08:00 daily https://www.pharmasources.com/industryinsights/product-list-of-nanjing-foreign-economic-330979.html 0.6 2026-08-14T03:51:22+08:00 daily https://www.pharmasources.com/industryinsights/covaxin-receives-gmp-certificate-from-hu-330980.html 0.6 2026-08-11T10:49:19+08:00 daily https://www.pharmasources.com/industryinsights/lanxess-completes-acquisition-of-emerald-330981.html 0.6 2026-08-12T12:59:31+08:00 daily https://www.pharmasources.com/industryinsights/product-list-of-nanjing-foreign-economic-330982.html 0.6 2026-08-06T20:51:58+08:00 daily https://www.pharmasources.com/industryinsights/clintex-cti-launches-cti-oem-blockchain--330983.html 0.6 2026-08-09T13:16:55+08:00 daily https://www.pharmasources.com/industryinsights/acg-films-foils-and-danapak-flexibles-as-330984.html 0.6 2026-08-03T04:11:48+08:00 daily https://www.pharmasources.com/industryinsights/nih-trial-closes-enrolment-for-brii-bios-330985.html 0.6 2026-06-21T06:08:48+08:00 daily https://www.pharmasources.com/industryinsights/mymd-pharmaceuticals-lead-compound-mymd--330986.html 0.6 2026-06-21T04:08:57+08:00 daily https://www.pharmasources.com/industryinsights/akston-biosciences-doses-first-subjects--330987.html 0.6 2026-08-08T13:32:34+08:00 daily https://www.pharmasources.com/industryinsights/kite-and-appia-bio-announce-collaboratio-330988.html 0.6 2026-08-04T05:31:14+08:00 daily https://www.pharmasources.com/industryinsights/report-finds-reducing-primary-care-antib-330989.html 0.6 2026-08-08T13:24:36+08:00 daily https://www.pharmasources.com/industryinsights/positive-phase-iii-results-for-valnevas--330990.html 0.6 2026-08-07T05:06:37+08:00 daily https://www.pharmasources.com/industryinsights/bms-withdraws-istodax-as-a-treatment-for-330991.html 0.6 2026-06-21T06:06:47+08:00 daily https://www.pharmasources.com/industryinsights/16--and-17-year-olds-should-receive-firs-330992.html 0.6 2026-07-16T08:02:06+08:00 daily https://www.pharmasources.com/industryinsights/govt-launches-study-on-covid-19-vaccine--330993.html 0.6 2026-06-24T23:27:35+08:00 daily https://www.pharmasources.com/industryinsights/cma-fines-advanz-over-excessive-and-unfa-330994.html 0.6 2026-08-09T23:13:35+08:00 daily https://www.pharmasources.com/industryinsights/nice-pens-two-year-collaboration-with-th-330995.html 0.6 2026-04-14T10:06:11+08:00 daily https://www.pharmasources.com/industryinsights/mhra-approves-opdivo-plus-yervoy-for-unr-330996.html 0.6 2026-08-08T13:20:53+08:00 daily https://www.pharmasources.com/industryinsights/uk-trial-to-assess-sativex-for-the-treat-330997.html 0.6 2026-07-31T14:23:07+08:00 daily https://www.pharmasources.com/industryinsights/long-covid-rare-in-children-kcl-study-fi-330998.html 0.6 2026-06-20T17:57:21+08:00 daily https://www.pharmasources.com/industryinsights/ori-capitals-portfolio-company-pillar-re-330999.html 0.6 2026-08-03T05:56:58+08:00 daily https://www.pharmasources.com/industryinsights/penpulimab-monoclonal-antibody-pd-1-obta-331000.html 0.6 2026-08-06T11:27:09+08:00 daily https://www.pharmasources.com/industryinsights/updated-overall-survival-data-and-biomar-331001.html 0.6 2026-07-28T20:02:34+08:00 daily https://www.pharmasources.com/industryinsights/novavax-and-serum-institute-of-india-ann-331002.html 0.6 2026-08-06T17:33:44+08:00 daily https://www.pharmasources.com/industryinsights/global-api-cdmo-market-to-value-almost-1-331003.html 0.6 2026-07-19T12:58:44+08:00 daily https://www.pharmasources.com/industryinsights/remetinostat-shows-promise-as-a-bcc-trea-331004.html 0.6 2026-07-29T00:25:02+08:00 daily https://www.pharmasources.com/industryinsights/ritlecitinib-improves-scalp-hair-regrowt-331005.html 0.6 2026-07-30T17:55:26+08:00 daily https://www.pharmasources.com/industryinsights/blood-thinners-reduce-need-for-organ-sup-331006.html 0.6 2026-08-03T01:46:37+08:00 daily https://www.pharmasources.com/industryinsights/biogen-announces-results-from-phase-iiib-331007.html 0.6 2026-07-30T22:37:28+08:00 daily https://www.pharmasources.com/industryinsights/navifus-begins-clinical-trial-for-brain--331008.html 0.6 2026-08-01T05:03:35+08:00 daily https://www.pharmasources.com/industryinsights/fda-fast-track-designation-given-to-mrna-331009.html 0.6 2026-08-10T04:00:53+08:00 daily https://www.pharmasources.com/industryinsights/understanding-limitations-of-microbial-d-331010.html 0.6 2026-08-02T14:28:27+08:00 daily https://www.pharmasources.com/industryinsights/measuring-the-flow-properties-of-consoli-331011.html 0.6 2026-08-12T16:11:00+08:00 daily https://www.pharmasources.com/industryinsights/syngene-adds-senior-leadership-in-the-us-331012.html 0.6 2026-06-21T03:07:45+08:00 daily https://www.pharmasources.com/industryinsights/gram-expands-footprint-with-new-finishin-331013.html 0.6 2026-08-14T02:24:41+08:00 daily https://www.pharmasources.com/industryinsights/bd-and-certest-biotec-announce-ce-mark-f-331014.html 0.6 2026-08-06T03:12:13+08:00 daily https://www.pharmasources.com/industryinsights/traveling-with-purpose-in-post-covid-env-331015.html 0.6 2026-06-21T08:20:16+08:00 daily https://www.pharmasources.com/industryinsights/global-hydrogen-generators-market-to-rea-331016.html 0.6 2026-06-22T08:17:22+08:00 daily https://www.pharmasources.com/industryinsights/diversifying-supply-chains-does-usmca-of-331017.html 0.6 2026-08-04T00:33:19+08:00 daily https://www.pharmasources.com/industryinsights/first-responders-childrens-foundation-pa-331018.html 0.6 2026-08-05T13:27:03+08:00 daily https://www.pharmasources.com/industryinsights/three-lakes-foundation-lung-foundation-a-331019.html 0.6 2026-08-05T22:33:37+08:00 daily https://www.pharmasources.com/industryinsights/botswana-astrazeneca-vaccines-arrives-in-331020.html 0.6 2026-08-14T02:15:32+08:00 daily https://www.pharmasources.com/industryinsights/additional-covid-19-treatment-for-austra-331021.html 0.6 2026-08-06T23:13:04+08:00 daily https://www.pharmasources.com/industryinsights/israeli-survey-finds-3rd-pfizer-vaccine--331022.html 0.6 2026-06-21T05:16:07+08:00 daily https://www.pharmasources.com/industryinsights/mix-of-covishield-covaxin-yields-better--331023.html 0.6 2026-07-30T13:41:02+08:00 daily https://www.pharmasources.com/industryinsights/hopeful-of-launching-covovax-for-adults--331024.html 0.6 2026-08-03T19:43:41+08:00 daily https://www.pharmasources.com/industryinsights/india-approves-jj-vaccine-no-delivery-ti-331025.html 0.6 2026-07-31T16:40:44+08:00 daily https://www.pharmasources.com/industryinsights/potential-drug-against-covid-19-found-am-331026.html 0.6 2026-07-03T17:32:43+08:00 daily https://www.pharmasources.com/industryinsights/philip-morris-heats-up-race-for-vectura--331027.html 0.6 2026-07-29T22:30:25+08:00 daily https://www.pharmasources.com/industryinsights/fda-to-allow-export-of-certain-lots-of-a-331028.html 0.6 2026-08-12T12:58:37+08:00 daily https://www.pharmasources.com/industryinsights/japan-studying-giving-third-covid-19-sho-331029.html 0.6 2025-11-20T00:02:42+08:00 daily https://www.pharmasources.com/industryinsights/jcvi-largely-opposed-to-covid-vaccinatio-331030.html 0.6 2026-08-02T02:35:48+08:00 daily https://www.pharmasources.com/industryinsights/6-tips-on-getting-back-to-your-regular-d-331031.html 0.6 2026-06-20T14:32:41+08:00 daily https://www.pharmasources.com/industryinsights/keeping-classrooms-safe-for-kids-with-as-331032.html 0.6 2026-06-21T03:15:58+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-nexviazyme-avalglucosidase--331033.html 0.6 2026-08-05T00:33:44+08:00 daily https://www.pharmasources.com/industryinsights/white-house-outlines-effort-to-vaccinate-331034.html 0.6 2026-06-21T09:59:09+08:00 daily https://www.pharmasources.com/industryinsights/many-parents-do-not-plan-to-vaccinate-yo-331035.html 0.6 2026-06-20T15:49:05+08:00 daily https://www.pharmasources.com/industryinsights/all-health-care-long-term-care-workers-i-331036.html 0.6 2026-06-20T00:20:01+08:00 daily https://www.pharmasources.com/industryinsights/novavax-seeks-approval-for-vaccine-in-ne-331037.html 0.6 2026-06-21T04:55:40+08:00 daily https://www.pharmasources.com/industryinsights/at-home-saliva-test-can-spot-covid-varia-331038.html 0.6 2026-06-21T00:15:53+08:00 daily https://www.pharmasources.com/industryinsights/is-the-delta-variant-hitting-kids-harder-331039.html 0.6 2026-08-02T15:35:07+08:00 daily https://www.pharmasources.com/industryinsights/stelis-biopharma-appoints-mark-womack-as-331040.html 0.6 2026-08-03T05:52:02+08:00 daily https://www.pharmasources.com/industryinsights/trirx-completes-acquisition-of-elanco-an-331041.html 0.6 2026-08-07T05:43:54+08:00 daily https://www.pharmasources.com/industryinsights/metrics-contract-services-expands-facili-331042.html 0.6 2026-08-09T03:13:05+08:00 daily https://www.pharmasources.com/industryinsights/researchers-find-potential-drug-against--331043.html 0.6 2026-06-21T12:52:21+08:00 daily https://www.pharmasources.com/industryinsights/us-fda-approves-nexviazyme-for-late-onse-331044.html 0.6 2026-07-01T23:33:02+08:00 daily https://www.pharmasources.com/industryinsights/pharma-cos-foray-into-digital-healthcare-331045.html 0.6 2026-08-13T09:46:57+08:00 daily https://www.pharmasources.com/industryinsights/jj-single-dose-covid-19-vaccine-gets-app-331046.html 0.6 2026-05-03T08:34:43+08:00 daily https://www.pharmasources.com/industryinsights/government-increases-jak-storeowners-inc-331047.html 0.6 2026-06-20T16:17:45+08:00 daily https://www.pharmasources.com/industryinsights/facility-augmentation-of-bharat-biotech--331048.html 0.6 2026-06-20T14:47:56+08:00 daily https://www.pharmasources.com/industryinsights/from-hiv-to-covid-19-the-role-of-liposom-331049.html 0.6 2026-06-21T17:08:26+08:00 daily https://www.pharmasources.com/industryinsights/strides-pharma-science-to-acquire-endos--331050.html 0.6 2026-08-06T22:43:12+08:00 daily https://www.pharmasources.com/industryinsights/pharma-industry-reports-75-deals-worth-2-331051.html 0.6 2026-08-06T22:31:46+08:00 daily https://www.pharmasources.com/industryinsights/covaxin-subjected-to-over-200-quality-co-331052.html 0.6 2026-08-06T23:47:27+08:00 daily https://www.pharmasources.com/industryinsights/cipla-q1-net-profit-rises-25-per-cent-to-331053.html 0.6 2026-08-06T23:56:18+08:00 daily https://www.pharmasources.com/industryinsights/india-authorises-jjs-covid-19-vaccine-fo-331054.html 0.6 2026-08-07T00:01:36+08:00 daily https://www.pharmasources.com/industryinsights/moderna-records-44bn-total-revenue-in-q2-331055.html 0.6 2026-08-09T23:34:31+08:00 daily https://www.pharmasources.com/industryinsights/kite-and-appia-bio-to-develop-allogeneic-331056.html 0.6 2026-08-08T07:52:43+08:00 daily https://www.pharmasources.com/industryinsights/phase-2-trials-from-akston-covid-19-vacc-331057.html 0.6 2026-08-09T15:00:07+08:00 daily https://www.pharmasources.com/industryinsights/ortho-clinical-diagnostics-expands-covid-331058.html 0.6 2026-06-21T20:48:33+08:00 daily https://www.pharmasources.com/industryinsights/sanofi-and-regenerons-libtayo-trial-stop-331059.html 0.6 2026-08-09T01:21:03+08:00 daily https://www.pharmasources.com/industryinsights/sierra-oncology-licenses-myelofibrosis-c-331060.html 0.6 2026-08-08T23:10:06+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-flynn-accused-of-charging-the-nhs-331061.html 0.6 2026-08-08T07:54:44+08:00 daily https://www.pharmasources.com/industryinsights/azs-forxiga-gains-ec-mhra-approvals-for--331062.html 0.6 2026-08-07T13:17:24+08:00 daily https://www.pharmasources.com/industryinsights/interim-trial-data-for-ucbs-bimekizumab--331063.html 0.6 2026-08-07T12:03:21+08:00 daily https://www.pharmasources.com/industryinsights/enhertu-improves-progression-free-surviv-331064.html 0.6 2026-08-13T11:27:03+08:00 daily https://www.pharmasources.com/industryinsights/sas-and-biomrieux-join-forces-to-fight-a-331065.html 0.6 2026-08-07T13:19:41+08:00 daily https://www.pharmasources.com/industryinsights/despite-strain-of-pandemic-americans-spe-331066.html 0.6 2026-08-07T23:45:32+08:00 daily https://www.pharmasources.com/industryinsights/hearts-of-athletes-research-study-launch-331067.html 0.6 2026-06-21T00:19:19+08:00 daily https://www.pharmasources.com/industryinsights/global-toothpaste-market-to-reach-176-bi-331068.html 0.6 2026-06-21T12:09:20+08:00 daily https://www.pharmasources.com/industryinsights/creative-medical-technology-holdings-ann-331069.html 0.6 2026-06-21T04:54:38+08:00 daily https://www.pharmasources.com/industryinsights/qiagen-and-oncxerna-therapeutics-sign-li-331070.html 0.6 2026-06-22T09:00:41+08:00 daily https://www.pharmasources.com/industryinsights/therapeuticsmd-appoints-hugh-odowd-as-pr-331071.html 0.6 2026-06-21T04:01:54+08:00 daily https://www.pharmasources.com/industryinsights/coronavirus-test-kits-market-in-north-am-331072.html 0.6 2026-06-20T18:04:24+08:00 daily https://www.pharmasources.com/industryinsights/inovio-focused-on-launching-global-covid-331073.html 0.6 2026-06-21T07:23:37+08:00 daily https://www.pharmasources.com/industryinsights/kaleido-biosciences-announces-new-chairp-331074.html 0.6 2026-06-20T14:40:46+08:00 daily https://www.pharmasources.com/industryinsights/exicure-provides-interim-results-from-on-331075.html 0.6 2026-06-29T17:56:25+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-331076.html 0.6 2026-06-20T01:01:03+08:00 daily https://www.pharmasources.com/industryinsights/immviras-mvr-t3011-obtained-nmpas-approv-331077.html 0.6 2026-06-20T19:00:36+08:00 daily https://www.pharmasources.com/industryinsights/gsk-files-for-licensure-of-priorix-mmr-v-331078.html 0.6 2026-08-04T10:54:28+08:00 daily https://www.pharmasources.com/industryinsights/fibrobiologics-announces-inaugural-board-331079.html 0.6 2026-02-09T08:57:04+08:00 daily https://www.pharmasources.com/industryinsights/innovent-announces-the-establishment-of--331080.html 0.6 2026-06-21T12:55:21+08:00 daily https://www.pharmasources.com/industryinsights/china-nmpa-approves-phase-ii-clinical-tr-331081.html 0.6 2026-08-03T05:45:39+08:00 daily https://www.pharmasources.com/industryinsights/spectrum-pharmaceuticals-receives-comple-331082.html 0.6 2026-08-10T08:16:40+08:00 daily https://www.pharmasources.com/industryinsights/antengene-and-mindrank-ai-enter-into-col-331083.html 0.6 2026-08-04T10:54:03+08:00 daily https://www.pharmasources.com/industryinsights/life-sciences-contribution-to-the-us-dig-331084.html 0.6 2026-08-08T18:12:30+08:00 daily https://www.pharmasources.com/industryinsights/biontechs-2q-revenue-soars-331085.html 0.6 2026-08-08T17:01:03+08:00 daily https://www.pharmasources.com/industryinsights/biolife-solutions-acquires-sexton-biotec-331086.html 0.6 2026-08-07T13:15:59+08:00 daily https://www.pharmasources.com/industryinsights/frontage-opens-new-lab-facility-in-exton-331087.html 0.6 2026-08-07T04:27:43+08:00 daily https://www.pharmasources.com/industryinsights/nppa-fixes-retail-prices-for-six-formula-331088.html 0.6 2026-08-08T11:59:06+08:00 daily https://www.pharmasources.com/industryinsights/icmr-says-covaxin-covishield-combination-331089.html 0.6 2026-06-21T19:48:37+08:00 daily https://www.pharmasources.com/industryinsights/eqrx-signs-18bn-merger-deal-with-cm-life-331090.html 0.6 2026-08-07T23:57:28+08:00 daily https://www.pharmasources.com/industryinsights/fdb-launches-clinical-decision-support-a-331091.html 0.6 2026-06-20T01:52:24+08:00 daily https://www.pharmasources.com/industryinsights/forxiga-approved-in-eu-to-treat-chronic--331092.html 0.6 2026-06-22T10:01:42+08:00 daily https://www.pharmasources.com/industryinsights/bavarian-nordic-reports-initial-results--331093.html 0.6 2026-06-22T01:07:54+08:00 daily https://www.pharmasources.com/industryinsights/goodrx-and-boehringer-ingelheim-announce-331094.html 0.6 2026-07-08T09:32:29+08:00 daily https://www.pharmasources.com/industryinsights/polivy-with-r-chp-significantly-improves-331095.html 0.6 2026-08-02T14:39:29+08:00 daily https://www.pharmasources.com/industryinsights/pharmacovigilance-risk-assessment-commit-331096.html 0.6 2026-06-22T12:08:06+08:00 daily https://www.pharmasources.com/industryinsights/libtayo-with-chemotherapy-trial-stopped--331097.html 0.6 2026-07-04T16:01:16+08:00 daily https://www.pharmasources.com/industryinsights/lancaster-university-intranasal-vaccine--331098.html 0.6 2026-06-20T13:58:02+08:00 daily https://www.pharmasources.com/industryinsights/sars-cov-2-reinfection-more-likely-in-un-331099.html 0.6 2026-06-22T03:04:51+08:00 daily https://www.pharmasources.com/industryinsights/decline-in-mental-health-seen-in-college-331100.html 0.6 2026-06-20T16:17:19+08:00 daily https://www.pharmasources.com/industryinsights/female-surgeons-face-increased-fertility-331101.html 0.6 2026-06-21T23:08:48+08:00 daily https://www.pharmasources.com/industryinsights/european-union-passes-us-in-covid-19-vac-331102.html 0.6 2026-08-10T15:11:46+08:00 daily https://www.pharmasources.com/industryinsights/all-amazon-workers-must-wear-masks--331103.html 0.6 2026-08-07T02:39:41+08:00 daily https://www.pharmasources.com/industryinsights/pandemic-has-depression-anxiety-rates-am-331104.html 0.6 2026-08-10T17:21:45+08:00 daily https://www.pharmasources.com/industryinsights/the-delta-variant-the-vaccinated-one-exp-331105.html 0.6 2026-06-21T12:57:26+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-how-a-doctors-presence-may-alte-331106.html 0.6 2026-06-20T22:52:44+08:00 daily https://www.pharmasources.com/industryinsights/telemedicine-may-not-work-for-speech-voi-331107.html 0.6 2026-08-13T21:34:29+08:00 daily https://www.pharmasources.com/industryinsights/trevi-therapeutics-announces-additions-t-331108.html 0.6 2026-06-21T18:10:28+08:00 daily https://www.pharmasources.com/industryinsights/current-director-theo-melas-kyriazi-appo-331109.html 0.6 2026-06-21T09:46:24+08:00 daily https://www.pharmasources.com/industryinsights/dymicron-names-gunther-peeters-as-senior-331110.html 0.6 2026-01-18T12:57:17+08:00 daily https://www.pharmasources.com/industryinsights/orizuru-therapeutics-launches-operations-331111.html 0.6 2026-08-09T18:55:45+08:00 daily https://www.pharmasources.com/industryinsights/img-appoints-steve-paraboschi-as-chief-e-331112.html 0.6 2026-06-20T08:06:45+08:00 daily https://www.pharmasources.com/industryinsights/yishengbio-announces-pika-recombinant-co-331113.html 0.6 2026-06-21T13:00:27+08:00 daily https://www.pharmasources.com/industryinsights/antibodies-to-sars-cov-2-remain-stable-o-331114.html 0.6 2026-06-20T16:04:33+08:00 daily https://www.pharmasources.com/industryinsights/veraxa-biotech-and-indivumed-cooperate-o-331115.html 0.6 2026-08-03T15:40:16+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-patient-needs-and-sustainabilit-331116.html 0.6 2026-06-21T12:05:13+08:00 daily https://www.pharmasources.com/industryinsights/xoma-announces-heather-l-franklin-joins--331117.html 0.6 2026-08-09T07:36:29+08:00 daily https://www.pharmasources.com/industryinsights/3rd-covid-shot-highly-potent-in-israels--331118.html 0.6 2026-08-09T01:14:00+08:00 daily https://www.pharmasources.com/industryinsights/pandemic-spurs-banks-ai-adoption-for-aml-331119.html 0.6 2026-08-08T04:35:03+08:00 daily https://www.pharmasources.com/industryinsights/fulcrum-therapeutics-announces-proposed--331120.html 0.6 2026-08-08T22:23:23+08:00 daily https://www.pharmasources.com/industryinsights/assisted-living-locators-celebrates-nati-331121.html 0.6 2026-08-09T04:40:29+08:00 daily https://www.pharmasources.com/industryinsights/new-research-50-of-us-adults-did-not-rec-331122.html 0.6 2026-06-20T10:57:03+08:00 daily https://www.pharmasources.com/industryinsights/cardinal-health-partners-with-abbott-and-331123.html 0.6 2026-06-20T17:56:17+08:00 daily https://www.pharmasources.com/industryinsights/with-american-rescue-plan-funding-arrivi-331124.html 0.6 2026-06-20T21:39:17+08:00 daily https://www.pharmasources.com/industryinsights/ashford-regains-compliance-with-nyse-ame-331125.html 0.6 2026-06-30T08:59:59+08:00 daily https://www.pharmasources.com/industryinsights/vecna-technologies-launches-healthpass-m-331126.html 0.6 2026-06-21T07:15:14+08:00 daily https://www.pharmasources.com/industryinsights/nikola-expands-sales-and-service-dealer--331127.html 0.6 2026-06-20T21:54:38+08:00 daily https://www.pharmasources.com/industryinsights/monthly-covid-19-hospitalization-rates-p-331128.html 0.6 2026-06-21T12:05:16+08:00 daily https://www.pharmasources.com/industryinsights/consumption-of-ultraprocessed-food-up-am-331129.html 0.6 2026-06-21T11:58:20+08:00 daily https://www.pharmasources.com/industryinsights/lung-cancer-screening-rates-mainly-uncha-331130.html 0.6 2026-06-21T06:57:53+08:00 daily https://www.pharmasources.com/industryinsights/enzyme-replacement-therapy-approved-for--331131.html 0.6 2026-08-06T22:35:37+08:00 daily https://www.pharmasources.com/industryinsights/cdc-fourth-case-of-melioidosis-found-in--331132.html 0.6 2026-06-21T17:01:23+08:00 daily https://www.pharmasources.com/industryinsights/a-second-closet-for-some-lgbtq-seniors-e-331133.html 0.6 2026-08-06T22:38:27+08:00 daily https://www.pharmasources.com/industryinsights/incomplete-polyp-removal-during-colonosc-331134.html 0.6 2026-06-20T23:50:53+08:00 daily https://www.pharmasources.com/industryinsights/christina-applegate-announces-she-has-mu-331135.html 0.6 2026-08-09T05:41:18+08:00 daily https://www.pharmasources.com/industryinsights/us-kids-are-eating-more-ultraprocessed-f-331136.html 0.6 2026-08-11T04:55:40+08:00 daily https://www.pharmasources.com/industryinsights/chinese-mainland-reports-108-new-locally-331137.html 0.6 2026-08-07T13:16:46+08:00 daily https://www.pharmasources.com/industryinsights/veraxa-biotech-and-indivumed-to-jointly--331138.html 0.6 2026-08-07T11:33:53+08:00 daily https://www.pharmasources.com/industryinsights/catalent-edenbridge-pharma-enter-zydis-f-331139.html 0.6 2026-08-07T06:06:48+08:00 daily https://www.pharmasources.com/industryinsights/alcami-appoints-timothy-compton-chief-bu-331140.html 0.6 2026-08-07T11:29:19+08:00 daily https://www.pharmasources.com/industryinsights/metrics-appoints-senior-director-scienti-331141.html 0.6 2026-08-07T11:57:21+08:00 daily https://www.pharmasources.com/industryinsights/kyowa-bora-pharmaceuticals-enter-mfg-pac-331142.html 0.6 2026-08-07T12:18:39+08:00 daily https://www.pharmasources.com/industryinsights/lincoln-pharmaceuticals-reports-standalo-331143.html 0.6 2026-08-07T13:17:15+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-indias-q1-net-profit-decline-331144.html 0.6 2026-08-08T05:08:44+08:00 daily https://www.pharmasources.com/industryinsights/biontech-says-repeats-of-its-covid-19-va-331145.html 0.6 2026-08-09T12:48:27+08:00 daily https://www.pharmasources.com/industryinsights/philip-morris-international-acquires-oti-331146.html 0.6 2026-08-07T00:42:44+08:00 daily https://www.pharmasources.com/industryinsights/seagen-and-remegen-enter-up-to-26bn-deal-331147.html 0.6 2026-07-22T11:35:31+08:00 daily https://www.pharmasources.com/industryinsights/inovio-to-commence-covid-19-vaccine-prim-331148.html 0.6 2026-08-03T19:49:58+08:00 daily https://www.pharmasources.com/industryinsights/adma-biologics-announces-commercial-avai-331149.html 0.6 2026-08-09T06:51:24+08:00 daily https://www.pharmasources.com/industryinsights/q-biomed-signs-distribution-agreement-wi-331150.html 0.6 2026-08-09T02:38:51+08:00 daily https://www.pharmasources.com/industryinsights/mindmed-appoints-dr-robert-dworkin-to-sc-331151.html 0.6 2026-08-09T00:17:17+08:00 daily https://www.pharmasources.com/industryinsights/stand-up-to-cancer-and-jazz-pharmaceutic-331152.html 0.6 2026-08-08T23:10:07+08:00 daily https://www.pharmasources.com/industryinsights/santen-and-sydnexis-partner-on-childhood-331153.html 0.6 2026-08-07T13:18:05+08:00 daily https://www.pharmasources.com/industryinsights/uk-approval-for-epidyolex-to-treat-seizu-331154.html 0.6 2026-08-06T23:45:08+08:00 daily https://www.pharmasources.com/industryinsights/smc-approves-bavencio-for-bladder-cancer-331155.html 0.6 2026-08-06T23:35:46+08:00 daily https://www.pharmasources.com/industryinsights/maniac-robots-could-deliver-drugs-direct-331156.html 0.6 2026-08-06T23:45:46+08:00 daily https://www.pharmasources.com/industryinsights/cell-line-development-services-market-to-331157.html 0.6 2026-07-18T04:36:54+08:00 daily https://www.pharmasources.com/industryinsights/immviras-mvr-t3011-iv-completed-first-do-331158.html 0.6 2026-08-07T12:28:46+08:00 daily https://www.pharmasources.com/industryinsights/innocare-announces-approval-of-phase-ii--331159.html 0.6 2026-08-07T11:56:12+08:00 daily https://www.pharmasources.com/industryinsights/indicaidtm-covid-19-rapid-antigen-test-r-331160.html 0.6 2026-08-07T11:33:50+08:00 daily https://www.pharmasources.com/industryinsights/belief-biomeds-gene-therapy-for-hemophil-331161.html 0.6 2026-08-13T17:32:43+08:00 daily https://www.pharmasources.com/industryinsights/popular-products-and-suppliers-at-pharma-331162.html 0.6 2026-08-12T16:14:36+08:00 daily https://www.pharmasources.com/industryinsights/precision-nanosystems-announces-plans-to-331163.html 0.6 2026-08-07T11:33:18+08:00 daily https://www.pharmasources.com/industryinsights/evotec-opens-cgmp-manufacturing-facility-331164.html 0.6 2026-08-07T13:15:32+08:00 daily https://www.pharmasources.com/industryinsights/new-at-home-finger-prick-test-helps-peop-331165.html 0.6 2026-08-07T03:02:40+08:00 daily https://www.pharmasources.com/industryinsights/aldevron-ginkgo-bioworks-partner-on-mrna-331166.html 0.6 2026-08-07T04:25:04+08:00 daily https://www.pharmasources.com/industryinsights/recro-eyes-expansion-to-full-service-cdm-331167.html 0.6 2026-08-07T02:52:20+08:00 daily https://www.pharmasources.com/industryinsights/lumen-bioscience-google-partner-to-apply-331168.html 0.6 2026-08-07T02:41:01+08:00 daily https://www.pharmasources.com/industryinsights/texas-childrens-hospital-announces-covid-331169.html 0.6 2026-08-07T02:40:47+08:00 daily https://www.pharmasources.com/industryinsights/almac-pila-pharma-enter-api-manufacturin-331170.html 0.6 2026-08-06T23:45:14+08:00 daily https://www.pharmasources.com/industryinsights/soundbar-market-2021-2025-covid-19-impac-331171.html 0.6 2026-08-07T02:48:35+08:00 daily https://www.pharmasources.com/industryinsights/antibody-levels-predictive-of-modernas-v-331172.html 0.6 2026-08-07T02:45:43+08:00 daily https://www.pharmasources.com/industryinsights/moderna-to-build-mrna-vaccine-manufactur-331173.html 0.6 2026-08-07T03:02:37+08:00 daily https://www.pharmasources.com/industryinsights/bioiq-approaches-milestone-of-one-millio-331174.html 0.6 2026-08-10T13:12:38+08:00 daily https://www.pharmasources.com/industryinsights/introduction-of-fda-regulatory-education-331175.html 0.6 2026-07-28T07:02:39+08:00 daily https://www.pharmasources.com/industryinsights/world-first-covid-vaccine-booster-random-331176.html 0.6 2026-06-30T23:01:02+08:00 daily https://www.pharmasources.com/industryinsights/us-clears-keytruda-lenvima-combo-in-firs-331177.html 0.6 2026-06-20T22:02:44+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-reports-positive-interim-analysis--331178.html 0.6 2026-06-19T17:53:17+08:00 daily https://www.pharmasources.com/industryinsights/japans-top-home-security-company-secom-i-331179.html 0.6 2026-08-07T05:01:21+08:00 daily https://www.pharmasources.com/industryinsights/elderly-chileans-line-up-for-booster-jab-331180.html 0.6 2026-08-07T04:49:04+08:00 daily https://www.pharmasources.com/industryinsights/eyegate-announces-closing-of-1075-millio-331181.html 0.6 2026-08-07T04:24:47+08:00 daily https://www.pharmasources.com/industryinsights/age-restrictions-on-astrazeneca-shot-hav-331182.html 0.6 2026-08-07T04:57:01+08:00 daily https://www.pharmasources.com/industryinsights/antibody-cocktail-therapy-may-cover-more-331183.html 0.6 2026-06-19T18:18:44+08:00 daily https://www.pharmasources.com/industryinsights/centre-approves-bharat-biotechs-ankleshw-331184.html 0.6 2026-08-07T05:07:30+08:00 daily https://www.pharmasources.com/industryinsights/nppa-puts-cap-on-trade-margin-of-42-non--331185.html 0.6 2026-06-21T06:07:53+08:00 daily https://www.pharmasources.com/industryinsights/global-travel-management-services-market-331186.html 0.6 2025-11-27T09:46:49+08:00 daily https://www.pharmasources.com/industryinsights/nih-launches-study-of-third-covid-19-vac-331187.html 0.6 2026-06-21T05:01:42+08:00 daily https://www.pharmasources.com/industryinsights/mercks-keytruda-receives-fda-priority-re-331188.html 0.6 2026-08-06T12:27:04+08:00 daily https://www.pharmasources.com/industryinsights/azurrx-expands-trial-of-drug-for-covid-1-331189.html 0.6 2026-05-06T11:34:33+08:00 daily https://www.pharmasources.com/industryinsights/motorsport-market-from-auto-parts-equipm-331190.html 0.6 2026-06-21T06:13:55+08:00 daily https://www.pharmasources.com/industryinsights/american-injectables-hires-new-leadershi-331191.html 0.6 2026-08-04T03:58:48+08:00 daily https://www.pharmasources.com/industryinsights/vensica-therapeutics-partners-with-merz-331192.html 0.6 2026-08-10T12:05:56+08:00 daily https://www.pharmasources.com/industryinsights/update-on-us-regulatory-review-of-roxadu-331193.html 0.6 2026-08-07T03:03:20+08:00 daily https://www.pharmasources.com/industryinsights/takeda-takes-the-lead-on-finchs-ulcerati-331194.html 0.6 2026-08-06T22:20:45+08:00 daily https://www.pharmasources.com/industryinsights/new-joint-venture-aims-to-open-funding-o-331195.html 0.6 2026-08-06T22:54:29+08:00 daily https://www.pharmasources.com/industryinsights/bluebird-bio-re-evaluates-gene-therapy-s-331196.html 0.6 2026-06-09T11:53:58+08:00 daily https://www.pharmasources.com/industryinsights/mhra-nod-for-janssens-relapsing-multiple-331197.html 0.6 2026-08-07T13:16:39+08:00 daily https://www.pharmasources.com/industryinsights/cell-and-gene-therapy-manufacturing-serv-331198.html 0.6 2026-08-08T10:40:49+08:00 daily https://www.pharmasources.com/industryinsights/parkinsons-disease-market-sales-to-reach-331199.html 0.6 2026-08-08T15:51:51+08:00 daily https://www.pharmasources.com/industryinsights/cali-biosciences-initiates-phase-2b-stud-331200.html 0.6 2026-08-08T17:53:07+08:00 daily https://www.pharmasources.com/industryinsights/ukm-collaborated-in-an-international-stu-331201.html 0.6 2026-08-08T20:37:27+08:00 daily https://www.pharmasources.com/industryinsights/innovent-announces-ibi306-anti-pcsk-9-an-331202.html 0.6 2026-08-10T11:57:07+08:00 daily https://www.pharmasources.com/industryinsights/lynk-pharmaceuticals-announced-first-pat-331203.html 0.6 2026-08-12T11:59:35+08:00 daily https://www.pharmasources.com/industryinsights/terumo-blood-and-cell-technologies-and-p-331204.html 0.6 2026-08-03T11:59:10+08:00 daily https://www.pharmasources.com/industryinsights/the-former-director-of-the-center-for-dr-331205.html 0.6 2026-06-21T15:16:59+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccine-safe-recommended-for-pr-331206.html 0.6 2026-07-17T23:06:11+08:00 daily https://www.pharmasources.com/industryinsights/americans-have-high-trust-in-health-care-331207.html 0.6 2026-03-28T19:55:45+08:00 daily https://www.pharmasources.com/industryinsights/new-tighter-covid-19-rules-coming-for-or-331208.html 0.6 2026-06-24T07:07:33+08:00 daily https://www.pharmasources.com/industryinsights/us-sees-big-spike-in-covid-19-vaccinatio-331209.html 0.6 2026-04-04T16:54:55+08:00 daily https://www.pharmasources.com/industryinsights/experts-demand-that-biden-do-more-to-dis-331210.html 0.6 2026-06-19T20:38:40+08:00 daily https://www.pharmasources.com/industryinsights/covid-vaccine-safe-recommended-for-pregn-331211.html 0.6 2026-06-21T02:13:48+08:00 daily https://www.pharmasources.com/industryinsights/breaded-raw-chicken-recalled-in-multi-st-331212.html 0.6 2026-06-20T10:14:46+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-shot-may-help-fight-covid-variant-331213.html 0.6 2026-07-04T11:59:22+08:00 daily https://www.pharmasources.com/industryinsights/preemie-babies-more-vulnerable-to-autism-331214.html 0.6 2026-06-22T10:03:43+08:00 daily https://www.pharmasources.com/industryinsights/fibrogen-receives-complete-response-lett-331215.html 0.6 2026-08-06T02:51:26+08:00 daily https://www.pharmasources.com/industryinsights/fda-grants-first-of-its-kind-indication--331216.html 0.6 2026-06-21T12:10:22+08:00 daily https://www.pharmasources.com/industryinsights/aok-baden-wrttemberg-initiates-innovativ-331217.html 0.6 2026-06-20T17:07:22+08:00 daily https://www.pharmasources.com/industryinsights/nobelpharma-signs-a-license-agreement-fo-331218.html 0.6 2026-08-09T07:03:00+08:00 daily https://www.pharmasources.com/industryinsights/diacarta-receives-ceivd-for-its-new-covi-331219.html 0.6 2026-07-16T20:26:40+08:00 daily https://www.pharmasources.com/industryinsights/digital-pathology-market-worth-us-189240-331220.html 0.6 2026-08-13T17:27:22+08:00 daily https://www.pharmasources.com/industryinsights/real-estate---the-most-preferred-asset-c-331221.html 0.6 2026-06-21T00:59:45+08:00 daily https://www.pharmasources.com/industryinsights/newspaper-advertising-markets-covid-19-i-331222.html 0.6 2026-06-21T04:04:46+08:00 daily https://www.pharmasources.com/industryinsights/as-delta-variant-spreads-most-parents-wo-331223.html 0.6 2026-06-21T02:11:22+08:00 daily https://www.pharmasources.com/industryinsights/global-data-visualization-applications-m-331224.html 0.6 2026-06-22T08:08:59+08:00 daily https://www.pharmasources.com/industryinsights/moderna-announces-new-study-showing-its--331225.html 0.6 2026-07-23T15:04:10+08:00 daily https://www.pharmasources.com/industryinsights/1173-cases-of-domestic-arboviral-disease-331226.html 0.6 2026-06-22T12:59:36+08:00 daily https://www.pharmasources.com/industryinsights/physical-activity-linked-to-lower-mortal-331227.html 0.6 2026-06-20T20:12:51+08:00 daily https://www.pharmasources.com/industryinsights/all-hhs-health-care-workers-must-now-get-331228.html 0.6 2026-08-10T17:21:47+08:00 daily https://www.pharmasources.com/industryinsights/moderna-vaccine-may-shield-more-against--331229.html 0.6 2026-08-07T01:11:02+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccines-now-mandatory-for-cali-331230.html 0.6 2026-08-07T00:53:03+08:00 daily https://www.pharmasources.com/industryinsights/covid-vaccine-in-pregnancy-means-healthi-331231.html 0.6 2026-08-07T00:42:58+08:00 daily https://www.pharmasources.com/industryinsights/some-diabetes-meds-might-also-lower-alzh-331232.html 0.6 2026-08-07T00:41:31+08:00 daily https://www.pharmasources.com/industryinsights/the-growth-of-e-pharmacies-in-india-331233.html 0.6 2026-08-06T23:56:12+08:00 daily https://www.pharmasources.com/industryinsights/kamlesh-kumar-pant-appointed-as-chairman-331234.html 0.6 2026-08-06T23:48:35+08:00 daily https://www.pharmasources.com/industryinsights/india-lags-behind-in-terms-of-commercial-331235.html 0.6 2026-08-06T23:54:02+08:00 daily https://www.pharmasources.com/industryinsights/cadila-healthcares-net-profit-rises-29-p-331236.html 0.6 2026-06-20T16:06:36+08:00 daily https://www.pharmasources.com/industryinsights/cdsco-approves-study-on-mixing-of-covaxi-331237.html 0.6 2026-06-20T21:57:35+08:00 daily https://www.pharmasources.com/industryinsights/discovery-life-sciences-appoints-cell-ge-331238.html 0.6 2026-06-20T04:26:17+08:00 daily https://www.pharmasources.com/industryinsights/lonza-sheba-medical-center-leverage-coco-331239.html 0.6 2026-07-16T05:41:05+08:00 daily https://www.pharmasources.com/industryinsights/nobelpharma-signs-license-agreement-to-u-331240.html 0.6 2026-07-17T18:05:20+08:00 daily https://www.pharmasources.com/industryinsights/rentschler-biopharma-breaks-ground-at-us-331241.html 0.6 2026-06-13T05:33:41+08:00 daily https://www.pharmasources.com/industryinsights/ben-gurion-university-researchers-to-dev-331242.html 0.6 2026-06-19T21:00:00+08:00 daily https://www.pharmasources.com/industryinsights/sen-jam-pharmaceutical-partners-with-duk-331243.html 0.6 2026-06-22T12:11:06+08:00 daily https://www.pharmasources.com/industryinsights/uk-regulators-recall-batches-of-sartan-d-331244.html 0.6 2026-08-10T10:12:27+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-keytruda-plus-lenvima-for-a-331245.html 0.6 2026-06-20T11:56:49+08:00 daily https://www.pharmasources.com/industryinsights/further-clinical-trial-planned-for-valne-331246.html 0.6 2026-06-21T04:55:46+08:00 daily https://www.pharmasources.com/industryinsights/us-rejects-az-and-fibrogens-anaemia-drug-331247.html 0.6 2026-07-09T12:22:48+08:00 daily https://www.pharmasources.com/industryinsights/nice-recommends-eli-lillys-breast-cancer-331248.html 0.6 2026-08-11T12:03:19+08:00 daily https://www.pharmasources.com/industryinsights/mhra-approves-for-epidyolex-cannabidiol--331249.html 0.6 2026-06-28T19:48:16+08:00 daily https://www.pharmasources.com/industryinsights/third-covid-19-vaccine-dose-could-improv-331250.html 0.6 2026-06-23T11:25:03+08:00 daily https://www.pharmasources.com/industryinsights/monoclonal-antibody-prevents-malaria-in--331251.html 0.6 2026-06-20T15:57:13+08:00 daily https://www.pharmasources.com/industryinsights/a3p-biomedical-ab-fast-track-publication-331252.html 0.6 2026-07-18T23:33:07+08:00 daily https://www.pharmasources.com/industryinsights/diabetes-treatment-lowers-promarkerd-ris-331253.html 0.6 2026-07-04T01:39:19+08:00 daily https://www.pharmasources.com/industryinsights/problems-in-thinking-and-attention-linke-331254.html 0.6 2026-06-30T08:23:52+08:00 daily https://www.pharmasources.com/industryinsights/a-protein-based-covid-19-vaccine-that-mi-331255.html 0.6 2026-06-25T14:56:28+08:00 daily https://www.pharmasources.com/industryinsights/fidelity-health-services-sets-to-venture-331256.html 0.6 2026-08-09T06:59:33+08:00 daily https://www.pharmasources.com/industryinsights/syngene-expands-biopharma-manufacturing--331257.html 0.6 2026-08-08T19:41:38+08:00 daily https://www.pharmasources.com/industryinsights/gentibio-raises-157m-to-develop-treg-the-331258.html 0.6 2026-08-08T21:48:52+08:00 daily https://www.pharmasources.com/industryinsights/per-catalinas-cpg-shopper-insights-ongoi-331259.html 0.6 2026-08-14T20:51:02+08:00 daily https://www.pharmasources.com/industryinsights/global-spa-services-market-2021-to-2026--331260.html 0.6 2026-08-09T12:48:39+08:00 daily https://www.pharmasources.com/industryinsights/rigel-pharmaceuticals-provides-update-on-331261.html 0.6 2026-06-21T20:21:42+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-robots-market-to-exceed-u-331262.html 0.6 2026-08-03T06:48:44+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-gelatin-markets-covid-19--331263.html 0.6 2026-07-20T05:02:58+08:00 daily https://www.pharmasources.com/industryinsights/coronavirus-covid-19-update-fda-authoriz-331264.html 0.6 2026-06-29T16:07:51+08:00 daily https://www.pharmasources.com/industryinsights/sinovac-to-apply-for-clinical-trial-of-d-331265.html 0.6 2026-08-03T12:51:53+08:00 daily https://www.pharmasources.com/industryinsights/s-korea-urges-rapid-vaccine-supply-durin-331266.html 0.6 2026-06-23T11:53:45+08:00 daily https://www.pharmasources.com/industryinsights/serbia-authorizes-third-shot-of-covid-19-331267.html 0.6 2026-06-27T12:26:13+08:00 daily https://www.pharmasources.com/industryinsights/all-young-people-aged-16-and-17-in-engla-331268.html 0.6 2026-08-05T22:35:54+08:00 daily https://www.pharmasources.com/industryinsights/satellos-and-ico-announce-completion-of--331269.html 0.6 2026-08-13T06:44:05+08:00 daily https://www.pharmasources.com/industryinsights/uk-donated-covid-19-vaccine-doses-reach--331270.html 0.6 2026-07-16T00:30:30+08:00 daily https://www.pharmasources.com/industryinsights/australia-purchases-pfizer-vaccines-from-331271.html 0.6 2026-07-04T21:49:41+08:00 daily https://www.pharmasources.com/industryinsights/swedish-researchers-planning-to-hold-cov-331272.html 0.6 2026-06-22T05:22:55+08:00 daily https://www.pharmasources.com/industryinsights/bio-firms-raising-alert-over-vaccine-tec-331273.html 0.6 2026-06-24T02:55:48+08:00 daily https://www.pharmasources.com/industryinsights/foxwayne-aerami-therapeutics-spac-deal-s-331274.html 0.6 2026-06-23T03:12:21+08:00 daily https://www.pharmasources.com/industryinsights/enlivex-after-review-of-phase-ii-data-is-331275.html 0.6 2026-06-24T02:45:35+08:00 daily https://www.pharmasources.com/industryinsights/merck-canada-initiates-rolling-submissio-331276.html 0.6 2026-06-21T04:30:18+08:00 daily https://www.pharmasources.com/industryinsights/the-securities-and-exchange-commission-d-331277.html 0.6 2026-06-30T22:21:02+08:00 daily https://www.pharmasources.com/industryinsights/get-your-kids-on-a-school-ready-sleep-sc-331278.html 0.6 2026-08-09T02:19:19+08:00 daily https://www.pharmasources.com/industryinsights/achilles-tendon-injures-are-rising---her-331279.html 0.6 2026-08-09T00:32:06+08:00 daily https://www.pharmasources.com/industryinsights/xywav-gets-fda-approval-to-treat-rare-sl-331280.html 0.6 2026-08-07T13:17:34+08:00 daily https://www.pharmasources.com/industryinsights/health-coaching-change-in-early-life-car-331281.html 0.6 2026-08-07T12:35:18+08:00 daily https://www.pharmasources.com/industryinsights/wildfires-may-amplify-effect-of-pm-expos-331282.html 0.6 2026-08-07T13:18:59+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-outbreak-reported-on-carnival-c-331283.html 0.6 2026-08-07T16:21:06+08:00 daily https://www.pharmasources.com/industryinsights/odds-for-an-eating-disorder-may-vary-by--331284.html 0.6 2026-06-22T13:12:31+08:00 daily https://www.pharmasources.com/industryinsights/keep-asthma-under-control-to-avoid-worse-331285.html 0.6 2026-06-27T09:04:22+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-welireg-belzutifan-for-the--331286.html 0.6 2026-08-09T13:05:49+08:00 daily https://www.pharmasources.com/industryinsights/jazz-pharmaceuticals-announces-us-fda-ap-331287.html 0.6 2026-08-06T22:00:30+08:00 daily https://www.pharmasources.com/industryinsights/new-capacity-helps-eliminate-bottleneck--331288.html 0.6 2026-08-06T22:08:22+08:00 daily https://www.pharmasources.com/industryinsights/fixed-wireless-access-has-become-a-brigh-331289.html 0.6 2026-08-06T22:53:57+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-intensifies-college-students-ne-331290.html 0.6 2026-08-06T23:47:14+08:00 daily https://www.pharmasources.com/industryinsights/137-million-american-adults-53-to-travel-331291.html 0.6 2026-08-06T23:55:43+08:00 daily https://www.pharmasources.com/industryinsights/steelcase-teams-up-with-kontrol-technolo-331292.html 0.6 2026-08-07T00:03:03+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-331293.html 0.6 2026-08-07T00:40:15+08:00 daily https://www.pharmasources.com/industryinsights/avidity-biosciences-enters-into-collabor-331294.html 0.6 2026-08-07T01:10:41+08:00 daily https://www.pharmasources.com/industryinsights/clarivate-announces-expiration-of-its-pr-331295.html 0.6 2026-08-07T01:19:23+08:00 daily https://www.pharmasources.com/industryinsights/oric-pharmaceuticals-appoints-steven-l-h-331296.html 0.6 2026-08-14T08:55:58+08:00 daily https://www.pharmasources.com/industryinsights/fulcrum-therapeutics-announces-closing-o-331297.html 0.6 2026-08-07T01:19:29+08:00 daily https://www.pharmasources.com/industryinsights/a-million-israelis-get-third-dose-with-e-331298.html 0.6 2026-08-10T09:04:47+08:00 daily https://www.pharmasources.com/industryinsights/acupuncture-alleviates-chronic-prostatit-331299.html 0.6 2026-08-04T11:52:52+08:00 daily https://www.pharmasources.com/industryinsights/scholar-rock-appoints-caryn-parlavecchio-331300.html 0.6 2026-08-07T05:28:40+08:00 daily https://www.pharmasources.com/industryinsights/dexamethasone-underused-for-adults-hospi-331301.html 0.6 2026-06-30T05:27:12+08:00 daily https://www.pharmasources.com/industryinsights/clovis-oncology-announces-renewal-of-at--331302.html 0.6 2026-08-07T05:28:18+08:00 daily https://www.pharmasources.com/industryinsights/exposure-to-prenatal-antipsychotics-seem-331303.html 0.6 2026-08-03T19:54:22+08:00 daily https://www.pharmasources.com/industryinsights/age-ethnicity-tied-to-less-follow-up-car-331304.html 0.6 2026-06-23T10:20:15+08:00 daily https://www.pharmasources.com/industryinsights/canada-to-mandate-covid-19-vaccines-for--331305.html 0.6 2026-06-24T20:25:14+08:00 daily https://www.pharmasources.com/industryinsights/sit-all-day-for-work-simple-step-can-cut-331306.html 0.6 2026-06-23T16:37:25+08:00 daily https://www.pharmasources.com/industryinsights/four-teachers-in-same-florida-county-die-331307.html 0.6 2026-06-25T06:29:17+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-healthy-hearts-and-brains-get-t-331308.html 0.6 2026-06-22T13:15:31+08:00 daily https://www.pharmasources.com/industryinsights/online-outraged-facebook-likes-stoke-the-331309.html 0.6 2026-06-22T15:17:46+08:00 daily https://www.pharmasources.com/industryinsights/worldwide-premium-denim-jeans-industry-t-331310.html 0.6 2026-06-21T04:25:31+08:00 daily https://www.pharmasources.com/industryinsights/immixbio-announces-galit-lahav-of-harvar-331311.html 0.6 2026-06-24T19:30:22+08:00 daily https://www.pharmasources.com/industryinsights/american-academy-of-ophthalmology-applau-331312.html 0.6 2026-07-08T18:39:05+08:00 daily https://www.pharmasources.com/industryinsights/uk-authorises-modernas-covid-19-vaccine--331313.html 0.6 2026-08-08T09:25:21+08:00 daily https://www.pharmasources.com/industryinsights/gsks-jemperli-scores-fda-nod-for-mismatc-331314.html 0.6 2026-08-13T16:37:25+08:00 daily https://www.pharmasources.com/industryinsights/who-says-some-data-may-suggest-increased-331315.html 0.6 2026-06-24T18:30:34+08:00 daily https://www.pharmasources.com/industryinsights/nih-hamster-study-evaluates-airborne-and-331316.html 0.6 2026-08-13T07:49:23+08:00 daily https://www.pharmasources.com/industryinsights/5-interesting-facts-about-the-worlds-hot-331317.html 0.6 2026-06-23T02:17:37+08:00 daily https://www.pharmasources.com/industryinsights/survey-finds-hybrid-work-will-vary-by-ci-331318.html 0.6 2026-06-22T16:09:26+08:00 daily https://www.pharmasources.com/industryinsights/mercys-virtual-covid-care-home-provides--331319.html 0.6 2026-06-21T13:17:05+08:00 daily https://www.pharmasources.com/industryinsights/medivolve-reports-236-increase-in-weekly-331320.html 0.6 2026-06-24T07:54:06+08:00 daily https://www.pharmasources.com/industryinsights/top-four-mistakes-to-avoid-when-booking--331321.html 0.6 2026-06-21T17:20:08+08:00 daily https://www.pharmasources.com/industryinsights/revive-therapeutics-signs-exclusive-worl-331322.html 0.6 2026-08-09T07:33:14+08:00 daily https://www.pharmasources.com/industryinsights/arthrosi-establishes-joint-venture-in-ch-331323.html 0.6 2026-08-07T02:48:44+08:00 daily https://www.pharmasources.com/industryinsights/promis-neurosciences-announces-us15-mill-331324.html 0.6 2026-08-07T02:40:50+08:00 daily https://www.pharmasources.com/industryinsights/researchers-to-create-new-breathing-lung-331325.html 0.6 2026-08-06T23:50:29+08:00 daily https://www.pharmasources.com/industryinsights/maia-biotechnology-appoints-joseph-f-mcg-331326.html 0.6 2026-08-06T23:48:27+08:00 daily https://www.pharmasources.com/industryinsights/south-african-activists-slam-jj-for-expo-331327.html 0.6 2026-08-10T23:22:34+08:00 daily https://www.pharmasources.com/industryinsights/marinus-pharmaceuticals-reports-topline--331328.html 0.6 2026-08-06T22:21:25+08:00 daily https://www.pharmasources.com/industryinsights/avanti-expands-recall-of-frozen-shrimp-f-331329.html 0.6 2026-08-06T23:47:32+08:00 daily https://www.pharmasources.com/industryinsights/pharma-sources-insight-august-2021-from--331330.html 0.6 2026-08-08T05:55:10+08:00 daily https://www.pharmasources.com/industryinsights/flu-vaccine-may-protect-against-adverse--331331.html 0.6 2026-08-07T05:31:04+08:00 daily https://www.pharmasources.com/industryinsights/doctors-more-likely-to-test-for-conditio-331332.html 0.6 2026-06-22T01:16:04+08:00 daily https://www.pharmasources.com/industryinsights/child-injuries-deaths-spur-recall-of-10--331333.html 0.6 2026-06-24T18:38:43+08:00 daily https://www.pharmasources.com/industryinsights/us-national-park-service-issues-mask-man-331334.html 0.6 2026-06-20T19:33:32+08:00 daily https://www.pharmasources.com/industryinsights/race-based-disparities-in-americans-heal-331335.html 0.6 2026-06-22T12:21:43+08:00 daily https://www.pharmasources.com/industryinsights/dexamethasone-can-help-the-sickest-covid-331336.html 0.6 2026-07-17T14:06:34+08:00 daily https://www.pharmasources.com/industryinsights/lyme-disease-can-wreak-havoc-on-mental-h-331337.html 0.6 2026-08-11T18:12:55+08:00 daily https://www.pharmasources.com/industryinsights/20-best-selling-drugs-in-the-world-by-20-331338.html 0.6 2026-08-10T05:17:04+08:00 daily https://www.pharmasources.com/industryinsights/biotage-expands-production-capacity-to-e-331339.html 0.6 2026-07-09T02:48:26+08:00 daily https://www.pharmasources.com/industryinsights/array-it-desktop-support-team-serves-mon-331340.html 0.6 2026-06-27T05:52:18+08:00 daily https://www.pharmasources.com/industryinsights/tikun-olam-cannbit-and-wavelength-strike-331341.html 0.6 2026-08-13T22:46:17+08:00 daily https://www.pharmasources.com/industryinsights/therapeutic-solutions-international-iden-331342.html 0.6 2026-06-23T23:00:09+08:00 daily https://www.pharmasources.com/industryinsights/pbs-biotech-secures-10-million-to-expand-331343.html 0.6 2026-06-23T09:16:23+08:00 daily https://www.pharmasources.com/industryinsights/taking-the-fight-against-covid-19-global-331344.html 0.6 2026-06-23T09:25:45+08:00 daily https://www.pharmasources.com/industryinsights/global-fitness-tracker-market-research-r-331345.html 0.6 2026-06-25T12:13:27+08:00 daily https://www.pharmasources.com/industryinsights/integral-moleculars-extensive-collection-331346.html 0.6 2026-08-13T00:21:32+08:00 daily https://www.pharmasources.com/industryinsights/digbi-health-protects-teachers-by-reduci-331347.html 0.6 2026-06-23T09:29:21+08:00 daily https://www.pharmasources.com/industryinsights/captura-biopharma-secures-50-million-inv-331348.html 0.6 2026-06-23T07:29:15+08:00 daily https://www.pharmasources.com/industryinsights/govt-to-focus-on-buying-pfizer-moderna-o-331349.html 0.6 2026-06-23T00:23:42+08:00 daily https://www.pharmasources.com/industryinsights/kempharm-appoints-tamara-a-seymour-to-bo-331350.html 0.6 2026-07-06T05:37:44+08:00 daily https://www.pharmasources.com/industryinsights/koreas-messaging-around-astrazeneca-vacc-331351.html 0.6 2026-06-24T12:49:59+08:00 daily https://www.pharmasources.com/industryinsights/nih-study-shows-no-significant-benefit-o-331352.html 0.6 2026-06-25T07:25:50+08:00 daily https://www.pharmasources.com/industryinsights/paratek-pharmaceuticals-announces-fda-or-331353.html 0.6 2026-06-21T23:22:29+08:00 daily https://www.pharmasources.com/industryinsights/lilly-boehringers-jardiance-bags-fda-app-331354.html 0.6 2026-06-26T17:14:03+08:00 daily https://www.pharmasources.com/industryinsights/lundbeck-trims-full-year-sales-outlook-a-331355.html 0.6 2026-06-24T12:12:16+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-booster-shots-for-all-americans-331356.html 0.6 2026-06-22T03:29:23+08:00 daily https://www.pharmasources.com/industryinsights/dexamethasone-studied-for-treatment-of-h-331357.html 0.6 2026-06-26T23:10:21+08:00 daily https://www.pharmasources.com/industryinsights/recall-of-philips-breathing-machines-aff-331358.html 0.6 2026-06-20T20:10:44+08:00 daily https://www.pharmasources.com/industryinsights/tsa-extends-mask-mandate-for-us-traveler-331359.html 0.6 2026-06-23T05:20:18+08:00 daily https://www.pharmasources.com/industryinsights/cannabis-use-lower-in-cancer-survivors-t-331360.html 0.6 2026-06-24T13:19:12+08:00 daily https://www.pharmasources.com/industryinsights/texas-governor-has-breakthrough-covid-in-331361.html 0.6 2026-06-27T04:18:35+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-new-genetic-tech-can-fight-inhe-331362.html 0.6 2026-06-21T23:16:40+08:00 daily https://www.pharmasources.com/industryinsights/dangerous-diabetes-tied-to-pregnancy-is--331363.html 0.6 2026-06-23T22:44:42+08:00 daily https://www.pharmasources.com/industryinsights/global-air-mattress-and-beds-market-to-r-331364.html 0.6 2026-06-29T16:02:08+08:00 daily https://www.pharmasources.com/industryinsights/us-economy-again-limited-by-covid-and-su-331365.html 0.6 2026-06-23T11:27:17+08:00 daily https://www.pharmasources.com/industryinsights/cardiac-rehabilitation-market-to-grow-by-331366.html 0.6 2026-06-23T21:51:11+08:00 daily https://www.pharmasources.com/industryinsights/affinity-empowering-enrolls-first-progra-331367.html 0.6 2026-06-22T05:00:41+08:00 daily https://www.pharmasources.com/industryinsights/memrise-launches-free-return-to-travel-l-331368.html 0.6 2026-06-22T00:47:58+08:00 daily https://www.pharmasources.com/industryinsights/physician-views-the-covid-19-vaccine-out-331369.html 0.6 2026-06-23T16:02:48+08:00 daily https://www.pharmasources.com/industryinsights/changing-of-the-guard-at-jj-as-joaquin-d-331370.html 0.6 2026-06-22T22:07:05+08:00 daily https://www.pharmasources.com/industryinsights/fate-therapeutics-announces-positive-int-331371.html 0.6 2026-07-13T04:05:45+08:00 daily https://www.pharmasources.com/industryinsights/geovax-presents-covid-19-vaccine-data-at-331372.html 0.6 2026-06-26T14:15:06+08:00 daily https://www.pharmasources.com/industryinsights/marker-therapeutics-awarded-131-million--331373.html 0.6 2026-06-23T14:02:47+08:00 daily https://www.pharmasources.com/industryinsights/sorrento-announces-its-lead-protein-base-331374.html 0.6 2026-06-21T18:55:44+08:00 daily https://www.pharmasources.com/industryinsights/vaxart-announces-creation-of-new-scienti-331375.html 0.6 2026-08-07T13:18:00+08:00 daily https://www.pharmasources.com/industryinsights/vtx-801-receives-us-fda-fast-track-desig-331376.html 0.6 2026-08-08T12:36:42+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-and-biontech-announce-submission--331377.html 0.6 2026-08-08T13:46:48+08:00 daily https://www.pharmasources.com/industryinsights/second-generation-mrna-covid-19-vaccine--331378.html 0.6 2026-08-08T20:02:56+08:00 daily https://www.pharmasources.com/industryinsights/statement-on-boosting-with-the-johnson-j-331379.html 0.6 2026-08-08T21:48:46+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-ticovac-tick-borne-encephal-331380.html 0.6 2026-08-09T05:34:16+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-vaccine-effectiveness-down-agai-331381.html 0.6 2025-12-05T14:16:07+08:00 daily https://www.pharmasources.com/industryinsights/fda-stop-using-eco-med-ultrasound-gels-l-331382.html 0.6 2026-08-09T03:45:16+08:00 daily https://www.pharmasources.com/industryinsights/biden-puts-pressure-on-nursing-homes-to--331383.html 0.6 2026-08-07T18:27:06+08:00 daily https://www.pharmasources.com/industryinsights/pesticide-to-be-banned-over-ties-to-neur-331384.html 0.6 2026-08-07T17:22:28+08:00 daily https://www.pharmasources.com/industryinsights/family-behind-oxycontin-denies-any-respo-331385.html 0.6 2026-08-07T13:17:38+08:00 daily https://www.pharmasources.com/industryinsights/neuro-surprise-some-brain-skills-might-i-331386.html 0.6 2026-08-07T12:03:54+08:00 daily https://www.pharmasources.com/industryinsights/early-us-vaccine-rollout-saved-140000-li-331387.html 0.6 2026-08-07T11:29:45+08:00 daily https://www.pharmasources.com/industryinsights/even-delta-variant-cant-evade-vaccine-li-331388.html 0.6 2026-08-07T06:06:49+08:00 daily https://www.pharmasources.com/industryinsights/common-pesticide-to-be-banned-over-links-331389.html 0.6 2026-08-07T01:10:48+08:00 daily https://www.pharmasources.com/industryinsights/the-pharmaceutical-company-licenses-in-t-331390.html 0.6 2026-08-07T04:04:01+08:00 daily https://www.pharmasources.com/industryinsights/will-exo-cd24-the-new-drug-from-israeli--331391.html 0.6 2026-08-07T04:25:10+08:00 daily https://www.pharmasources.com/industryinsights/penpulimab-the-fifth-chinese-pd-1-monocl-331392.html 0.6 2026-08-07T03:19:01+08:00 daily https://www.pharmasources.com/industryinsights/curia-lays-out-plans-to-expand-complex-a-331393.html 0.6 2026-08-07T00:42:52+08:00 daily https://www.pharmasources.com/industryinsights/cphi-monthly-podcast-the-opportunities-a-331394.html 0.6 2026-08-07T00:39:39+08:00 daily https://www.pharmasources.com/industryinsights/us-clears-bms-opdivo-as-first-adjuvant-t-331395.html 0.6 2026-08-07T13:15:08+08:00 daily https://www.pharmasources.com/industryinsights/geovax-labs-shares-jump-after-presenting-331396.html 0.6 2026-08-07T00:40:45+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-biontechs-covid-19-vaccine-on-bri-331397.html 0.6 2026-08-08T20:43:51+08:00 daily https://www.pharmasources.com/industryinsights/editas-medicine-presents-data-on-new-sle-331398.html 0.6 2026-08-07T05:01:21+08:00 daily https://www.pharmasources.com/industryinsights/south-korea-to-get-more-moderna-covid-sh-331399.html 0.6 2026-08-07T05:28:36+08:00 daily https://www.pharmasources.com/industryinsights/oncology-biotech-tyra-biosciences-files--331400.html 0.6 2026-06-21T19:20:52+08:00 daily https://www.pharmasources.com/industryinsights/uk-scientists-look-at-reducing-boosters--331401.html 0.6 2026-06-21T19:21:31+08:00 daily https://www.pharmasources.com/industryinsights/leslie-a-brun-resigns-from-merck-board-o-331402.html 0.6 2026-06-23T02:18:02+08:00 daily https://www.pharmasources.com/industryinsights/bonus-biogroup-receives-approval-to-expa-331403.html 0.6 2026-06-23T12:00:00+08:00 daily https://www.pharmasources.com/industryinsights/xeljanz-tofacitinib-citrate-receives-mar-331404.html 0.6 2026-06-28T11:10:52+08:00 daily https://www.pharmasources.com/industryinsights/vividion-therapeutics-officially-withdra-331405.html 0.6 2026-08-08T02:28:13+08:00 daily https://www.pharmasources.com/industryinsights/cuba-grants-emergency-approval-to-second-331406.html 0.6 2026-07-10T12:40:05+08:00 daily https://www.pharmasources.com/industryinsights/spotting-the-signs-of-deadly-melanoma-sk-331407.html 0.6 2026-06-29T00:31:38+08:00 daily https://www.pharmasources.com/industryinsights/tga-provisionally-approves-glaxosmithkli-331408.html 0.6 2026-07-27T16:41:01+08:00 daily https://www.pharmasources.com/industryinsights/want-that-healthy-skin-glow-these-foods--331409.html 0.6 2026-06-29T15:28:34+08:00 daily https://www.pharmasources.com/industryinsights/decision-on-jj-covid-19-vaccine-booster--331410.html 0.6 2026-06-19T16:09:21+08:00 daily https://www.pharmasources.com/industryinsights/long-haul-covid-19-may-affect-two-of-thr-331411.html 0.6 2026-06-27T04:20:21+08:00 daily https://www.pharmasources.com/industryinsights/risk-for-myocarditis-in-young-who-get-mo-331412.html 0.6 2026-06-28T13:01:27+08:00 daily https://www.pharmasources.com/industryinsights/regional-stroke-triage-by-ems-ups-endova-331413.html 0.6 2026-06-22T19:21:18+08:00 daily https://www.pharmasources.com/industryinsights/delta-variant-has-americans-stress-level-331414.html 0.6 2026-06-28T11:43:10+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-after-three-strokes-he-overhear-331415.html 0.6 2026-06-23T05:21:27+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-331416.html 0.6 2026-06-27T09:53:59+08:00 daily https://www.pharmasources.com/industryinsights/europe-garage-doors-market-report-2021-2-331417.html 0.6 2026-06-23T16:03:43+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-biontech-shot-becomes-first-covid-331418.html 0.6 2026-06-22T15:08:28+08:00 daily https://www.pharmasources.com/industryinsights/medigen-vaccine-biologics-announces-laun-331419.html 0.6 2026-06-21T17:22:59+08:00 daily https://www.pharmasources.com/industryinsights/remarkable-agility-331420.html 0.6 2026-08-04T03:56:26+08:00 daily https://www.pharmasources.com/industryinsights/global-contract-logistics-markets-report-331421.html 0.6 2026-08-02T18:34:48+08:00 daily https://www.pharmasources.com/industryinsights/wellcare-of-new-jersey-announces-actions-331422.html 0.6 2026-06-22T08:02:47+08:00 daily https://www.pharmasources.com/industryinsights/us-clears-cara-vifors-korsuva-to-treat-i-331423.html 0.6 2026-08-14T13:33:41+08:00 daily https://www.pharmasources.com/industryinsights/connect-biopharma-hires-general-counsel--331424.html 0.6 2026-08-07T00:02:37+08:00 daily https://www.pharmasources.com/industryinsights/disc-medicine-appoints-will-savage-as-ch-331425.html 0.6 2026-08-09T10:32:22+08:00 daily https://www.pharmasources.com/industryinsights/morphic-therapeutic-appoints-nisha-nanda-331426.html 0.6 2026-08-08T21:33:14+08:00 daily https://www.pharmasources.com/industryinsights/pharmacyte-biotech-announces-closing-of--331427.html 0.6 2026-08-07T13:16:57+08:00 daily https://www.pharmasources.com/industryinsights/privo-technologies-awarded-3m-nidcr-nih--331428.html 0.6 2026-08-06T20:06:24+08:00 daily https://www.pharmasources.com/industryinsights/vaccine-approval-important-step-forward--331429.html 0.6 2026-08-06T19:23:31+08:00 daily https://www.pharmasources.com/industryinsights/united-biomedical-seeks-appeal-after-eua-331430.html 0.6 2026-08-06T20:06:16+08:00 daily https://www.pharmasources.com/industryinsights/sinopharm-executive-suggests-vaccinated--331431.html 0.6 2026-08-06T21:38:15+08:00 daily https://www.pharmasources.com/industryinsights/ptc-therapeutics-announces-waylivra-appr-331432.html 0.6 2026-08-07T03:03:10+08:00 daily https://www.pharmasources.com/industryinsights/jj-theravances-izencitinib-fails-phase-i-331433.html 0.6 2026-08-07T03:12:40+08:00 daily https://www.pharmasources.com/industryinsights/neuvogen-appoints-mark-w-frohlich-to-its-331434.html 0.6 2026-08-07T03:25:39+08:00 daily https://www.pharmasources.com/industryinsights/theravance-biopharma-inc-announces-top-l-331435.html 0.6 2026-08-10T01:24:02+08:00 daily https://www.pharmasources.com/industryinsights/most-parents-plan-to-send-children-to-in-331436.html 0.6 2026-08-09T01:20:41+08:00 daily https://www.pharmasources.com/industryinsights/among-persons-with-hiv-more-finish-short-331437.html 0.6 2026-08-08T20:54:18+08:00 daily https://www.pharmasources.com/industryinsights/stop-using-ivermectin-veterinary-drug-to-331438.html 0.6 2026-08-09T03:44:48+08:00 daily https://www.pharmasources.com/industryinsights/pentagon-to-make-covid-19-vaccination-ma-331439.html 0.6 2026-08-11T08:36:25+08:00 daily https://www.pharmasources.com/industryinsights/israeli-study-shows-pfizer-booster-gives-331440.html 0.6 2026-06-21T13:27:11+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-comirnaty-pfizer-biontech-c-331441.html 0.6 2026-07-22T11:26:06+08:00 daily https://www.pharmasources.com/industryinsights/study-gives-hope-for-dream-vaccine-again-331442.html 0.6 2026-06-22T09:33:37+08:00 daily https://www.pharmasources.com/industryinsights/rising-number-of-us-cardiac-arrests-tied-331443.html 0.6 2026-06-21T08:51:58+08:00 daily https://www.pharmasources.com/industryinsights/little-change-in-number-of-uninsured-in--331444.html 0.6 2026-06-24T15:37:34+08:00 daily https://www.pharmasources.com/industryinsights/advancing-generic-drug-development-trans-331445.html 0.6 2026-08-11T17:16:24+08:00 daily https://www.pharmasources.com/industryinsights/biogenes-and-fyonibio-combine-their-scie-331446.html 0.6 2026-06-21T15:31:23+08:00 daily https://www.pharmasources.com/industryinsights/medicines-manufacturing-innovation-centr-331447.html 0.6 2026-06-25T01:00:01+08:00 daily https://www.pharmasources.com/industryinsights/360converge-releases-free-texting-soluti-331448.html 0.6 2026-06-22T06:10:59+08:00 daily https://www.pharmasources.com/industryinsights/eom-pharmaceuticals-announces-first-pati-331449.html 0.6 2026-06-28T01:23:51+08:00 daily https://www.pharmasources.com/industryinsights/sports-mouthguard-market-worth-us-495890-331450.html 0.6 2026-06-22T14:15:56+08:00 daily https://www.pharmasources.com/industryinsights/sterilization-services-market-to-garner--331451.html 0.6 2026-06-22T17:23:38+08:00 daily https://www.pharmasources.com/industryinsights/medivolve-announces-new-covid-19-testing-331452.html 0.6 2026-06-25T11:08:07+08:00 daily https://www.pharmasources.com/industryinsights/disposable-gloves-market-in-europe-covid-331453.html 0.6 2026-06-23T12:24:26+08:00 daily https://www.pharmasources.com/industryinsights/fsd-pharma-announces-termination-of-fsd--331454.html 0.6 2026-06-30T05:50:52+08:00 daily https://www.pharmasources.com/industryinsights/dementia-research-that-moves-us-forward--331455.html 0.6 2026-06-22T09:23:21+08:00 daily https://www.pharmasources.com/industryinsights/adamis-appoints-david-c-benedicto-as-cfo-331456.html 0.6 2026-08-09T06:59:58+08:00 daily https://www.pharmasources.com/industryinsights/abbvies-rinvoq-cleared-in-eu-for-atopic--331457.html 0.6 2026-06-24T17:33:53+08:00 daily https://www.pharmasources.com/industryinsights/rafael-holdings-announces-closing-of-104-331458.html 0.6 2026-08-08T16:49:25+08:00 daily https://www.pharmasources.com/industryinsights/navega-therapeutics-expands-its-scientif-331459.html 0.6 2026-08-08T15:12:36+08:00 daily https://www.pharmasources.com/industryinsights/new-study-to-test-third-covid-19-vaccine-331460.html 0.6 2026-08-08T10:50:02+08:00 daily https://www.pharmasources.com/industryinsights/pfizer-ceo-says-covid-19-vaccine-resista-331461.html 0.6 2026-08-08T09:47:26+08:00 daily https://www.pharmasources.com/industryinsights/when-could-moderna-jj-covid-19-vaccines--331462.html 0.6 2026-08-08T07:37:31+08:00 daily https://www.pharmasources.com/industryinsights/us-data-show-rising-breakthrough-infecti-331463.html 0.6 2026-08-08T06:17:10+08:00 daily https://www.pharmasources.com/industryinsights/lillys-lebrikizumab-significantly-improv-331464.html 0.6 2026-08-08T04:34:11+08:00 daily https://www.pharmasources.com/industryinsights/sutro-biopharma-announces-stro-002-fda-f-331465.html 0.6 2026-08-08T03:25:26+08:00 daily https://www.pharmasources.com/industryinsights/oramed-reaches-25-enrollment-in-its-seco-331466.html 0.6 2026-08-07T13:16:15+08:00 daily https://www.pharmasources.com/industryinsights/axsome-therapeutics-provides-update-on-t-331467.html 0.6 2026-08-12T19:56:28+08:00 daily https://www.pharmasources.com/industryinsights/xeris-pharmaceuticals-announces-approval-331468.html 0.6 2026-08-07T01:10:46+08:00 daily https://www.pharmasources.com/industryinsights/can-you-exercise-your-a-fib-away-331469.html 0.6 2026-08-08T23:55:57+08:00 daily https://www.pharmasources.com/industryinsights/a-little-wine-certain-foods-could-help-k-331470.html 0.6 2026-06-21T16:23:24+08:00 daily https://www.pharmasources.com/industryinsights/2001-to-2017-saw-increase-in-prevalence--331471.html 0.6 2026-07-03T00:11:42+08:00 daily https://www.pharmasources.com/industryinsights/more-than-10-percent-of-adults-missed-he-331472.html 0.6 2026-08-07T05:05:42+08:00 daily https://www.pharmasources.com/industryinsights/why-water-is-key-to-your-hearts-health-331473.html 0.6 2026-08-06T23:56:52+08:00 daily https://www.pharmasources.com/industryinsights/salmonella-illness-in-17-states-tied-to--331474.html 0.6 2026-08-06T23:48:07+08:00 daily https://www.pharmasources.com/industryinsights/fda-warns-against-off-label-use-of-pfize-331475.html 0.6 2026-08-06T23:55:09+08:00 daily https://www.pharmasources.com/industryinsights/alcohol-use-down-nicotine-use-up-for-tee-331476.html 0.6 2026-08-07T03:06:07+08:00 daily https://www.pharmasources.com/industryinsights/a-brief-discussion-on-roxadustat-in-the--331477.html 0.6 2026-08-06T22:54:18+08:00 daily https://www.pharmasources.com/industryinsights/national-college-student-survey-finds-st-331478.html 0.6 2026-08-07T04:52:46+08:00 daily https://www.pharmasources.com/industryinsights/anixa-biosciences-covid-19-compounds-exp-331479.html 0.6 2026-08-07T05:07:13+08:00 daily https://www.pharmasources.com/industryinsights/current-sampling-resistance-market-to-ex-331480.html 0.6 2026-06-24T13:37:40+08:00 daily https://www.pharmasources.com/industryinsights/knoetic-launches-with-18m-accel-led-seri-331481.html 0.6 2026-07-01T09:40:45+08:00 daily https://www.pharmasources.com/industryinsights/sterile-manufacturing-annex-1-amendments-331482.html 0.6 2026-08-08T19:07:41+08:00 daily https://www.pharmasources.com/industryinsights/increase-in-use-of-superabsorbent-gel-to-331483.html 0.6 2026-07-01T08:42:00+08:00 daily https://www.pharmasources.com/industryinsights/recipharm-expands-its-analytical-service-331484.html 0.6 2026-07-01T00:27:27+08:00 daily https://www.pharmasources.com/industryinsights/protective-coatings-market-worth-178-bil-331485.html 0.6 2026-07-09T04:49:16+08:00 daily https://www.pharmasources.com/industryinsights/signature-biologics-opens-additional-man-331486.html 0.6 2026-06-22T03:24:35+08:00 daily https://www.pharmasources.com/industryinsights/enzene-biosciences-ltd-obtains-marketing-331487.html 0.6 2026-06-23T10:28:56+08:00 daily https://www.pharmasources.com/industryinsights/merck-kgaa-darmstadt-germany-announces-c-331488.html 0.6 2026-06-28T12:55:22+08:00 daily https://www.pharmasources.com/industryinsights/novarock-biotherapeutics-announces-exclu-331489.html 0.6 2026-08-13T10:56:41+08:00 daily https://www.pharmasources.com/industryinsights/heart-inflammation-risk-boosted-slightly-331490.html 0.6 2026-08-07T05:30:44+08:00 daily https://www.pharmasources.com/industryinsights/servier-announces-fda-approval-of-tibsov-331491.html 0.6 2026-08-08T09:55:17+08:00 daily https://www.pharmasources.com/industryinsights/us-clears-ascendis-once-weekly-paediatri-331492.html 0.6 2026-08-12T12:12:48+08:00 daily https://www.pharmasources.com/industryinsights/exelixis-announces-partner-takeda-and-on-331493.html 0.6 2026-08-07T03:56:06+08:00 daily https://www.pharmasources.com/industryinsights/biocryst-announces-acceptance-of-regulat-331494.html 0.6 2026-06-21T15:24:52+08:00 daily https://www.pharmasources.com/industryinsights/an-existing-drug-opens-new-possibilities-331495.html 0.6 2026-08-07T04:18:56+08:00 daily https://www.pharmasources.com/industryinsights/inmune-bio-inc-announces-biomarker-data--331496.html 0.6 2026-08-07T04:24:48+08:00 daily https://www.pharmasources.com/industryinsights/known-medicine-raises-72-million-seed-ro-331497.html 0.6 2026-08-07T05:37:01+08:00 daily https://www.pharmasources.com/industryinsights/ibio-expands-immuno-oncology-pipeline-in-331498.html 0.6 2026-08-09T19:42:04+08:00 daily https://www.pharmasources.com/industryinsights/covid-booster-shots-raise-protection-aga-331499.html 0.6 2026-07-10T02:07:13+08:00 daily https://www.pharmasources.com/industryinsights/rubryc-therapeutics-announces-series-a2--331500.html 0.6 2026-08-06T21:47:13+08:00 daily https://www.pharmasources.com/industryinsights/sars-cov-2-vaccine-effectiveness-66-perc-331501.html 0.6 2026-08-07T06:10:03+08:00 daily https://www.pharmasources.com/industryinsights/rates-of-obesity-weight-gain-up-for-tran-331502.html 0.6 2026-08-07T11:34:05+08:00 daily https://www.pharmasources.com/industryinsights/jj-says-booster-shot-ups-immune-response-331503.html 0.6 2026-08-09T19:48:12+08:00 daily https://www.pharmasources.com/industryinsights/pentagon-says-troops-must-start-lining-u-331504.html 0.6 2026-08-07T00:00:36+08:00 daily https://www.pharmasources.com/industryinsights/long-covid-big-bills-grim-legacy-of-even-331505.html 0.6 2026-06-24T08:51:23+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-despite-progress-black-patients-331506.html 0.6 2026-08-09T13:09:39+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-cardiac-arrest-program-may-impr-331507.html 0.6 2026-08-07T00:59:05+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-skytrofa-lonapegsomatropin--331508.html 0.6 2026-08-07T00:53:29+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-korsuva-difelikefalin-injec-331509.html 0.6 2026-08-07T00:41:07+08:00 daily https://www.pharmasources.com/industryinsights/agios-announces-fda-acceptance-and-prior-331510.html 0.6 2026-08-06T23:55:57+08:00 daily https://www.pharmasources.com/industryinsights/colombia-says-welcome-back-to-all-cruise-331511.html 0.6 2026-08-06T23:48:10+08:00 daily https://www.pharmasources.com/industryinsights/lotte-hotelsresorts-ready-for-global-tra-331512.html 0.6 2026-08-06T23:45:25+08:00 daily https://www.pharmasources.com/industryinsights/inovio-receives-authorization-to-conduct-331513.html 0.6 2026-08-06T23:37:53+08:00 daily https://www.pharmasources.com/industryinsights/puro-airs-aurora-uv-air-fan-proven-99976-331514.html 0.6 2026-08-06T23:46:02+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharmas-opaganib-demonstrates-331515.html 0.6 2026-06-22T19:22:51+08:00 daily https://www.pharmasources.com/industryinsights/electric-vehicle-sourcing-and-procuremen-331516.html 0.6 2026-06-27T03:08:51+08:00 daily https://www.pharmasources.com/industryinsights/oasmia-appoints-head-of-clinical-develop-331517.html 0.6 2026-06-23T23:07:25+08:00 daily https://www.pharmasources.com/industryinsights/cytodyn-appoints-seenu-srinivasan-as-exe-331518.html 0.6 2026-06-27T06:24:07+08:00 daily https://www.pharmasources.com/industryinsights/wockhardt-and-jemincare-partner-for-nove-331519.html 0.6 2026-06-29T17:29:28+08:00 daily https://www.pharmasources.com/industryinsights/first-danish-doses-delivered-through-cov-331520.html 0.6 2026-06-22T20:42:42+08:00 daily https://www.pharmasources.com/industryinsights/sorrento-exercises-exclusive-option-agre-331521.html 0.6 2026-06-21T13:28:49+08:00 daily https://www.pharmasources.com/industryinsights/us-ships-more-than-2-mln-more-covid-vacc-331522.html 0.6 2026-06-27T04:20:27+08:00 daily https://www.pharmasources.com/industryinsights/incyte-and-morphosys-announce-the-europe-331523.html 0.6 2026-08-14T13:08:35+08:00 daily https://www.pharmasources.com/industryinsights/ontada-signs-strategic-agreement-with-me-331524.html 0.6 2026-06-22T12:15:28+08:00 daily https://www.pharmasources.com/industryinsights/airway-therapeutics-announces-first-pati-331525.html 0.6 2026-06-25T12:41:00+08:00 daily https://www.pharmasources.com/industryinsights/humacyte-announces-successful-closing-of-331526.html 0.6 2026-06-27T08:48:59+08:00 daily https://www.pharmasources.com/industryinsights/bolt-biotherapeutics-and-innovent-biolog-331527.html 0.6 2026-06-28T01:50:12+08:00 daily https://www.pharmasources.com/industryinsights/aadi-bioscience-announces-closing-of-mer-331528.html 0.6 2026-06-22T15:13:27+08:00 daily https://www.pharmasources.com/industryinsights/2019-to-2020-saw-increase-in-benzodiazep-331529.html 0.6 2026-08-07T19:52:55+08:00 daily https://www.pharmasources.com/industryinsights/reading-clinic-visit-notes-benefits-olde-331530.html 0.6 2026-06-27T01:51:44+08:00 daily https://www.pharmasources.com/industryinsights/record-high-covid-19-cases-and-deaths-re-331531.html 0.6 2026-06-24T23:37:41+08:00 daily https://www.pharmasources.com/industryinsights/learning-environment-issues-tied-to-medi-331532.html 0.6 2026-08-07T01:10:49+08:00 daily https://www.pharmasources.com/industryinsights/who-team-says-search-for-coronavirus-ori-331533.html 0.6 2026-08-07T00:40:39+08:00 daily https://www.pharmasources.com/industryinsights/fatal-ods-from-illicit-tranquilizers-jum-331534.html 0.6 2026-08-07T00:36:33+08:00 daily https://www.pharmasources.com/industryinsights/a-third-of-americans-were-infected-with--331535.html 0.6 2026-08-07T00:02:51+08:00 daily https://www.pharmasources.com/industryinsights/could-electrode-pulses-cut-back-leg-pain-331536.html 0.6 2026-08-06T23:56:39+08:00 daily https://www.pharmasources.com/industryinsights/aha-news-he-got-help-fast-for-his-stroke-331537.html 0.6 2026-08-06T23:35:58+08:00 daily https://www.pharmasources.com/industryinsights/universal-medical-announces-2021-interim-331538.html 0.6 2026-07-27T10:23:42+08:00 daily https://www.pharmasources.com/industryinsights/high-value-molecules-going-off-patent-fr-331539.html 0.6 2026-07-25T11:09:39+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-331540.html 0.6 2026-08-06T22:09:08+08:00 daily https://www.pharmasources.com/industryinsights/medicinal-value-and-supply-and-demand-st-331541.html 0.6 2026-06-24T17:18:17+08:00 daily https://www.pharmasources.com/industryinsights/akeso-inc-has-made-positive-progress-on--331542.html 0.6 2026-08-11T22:46:44+08:00 daily https://www.pharmasources.com/industryinsights/application-status-and-market-prospect-o-331543.html 0.6 2026-08-10T15:08:14+08:00 daily https://www.pharmasources.com/industryinsights/film-coating-manufacturers-in-china-331544.html 0.6 2026-08-06T22:07:57+08:00 daily https://www.pharmasources.com/industryinsights/aloe-vera-extract-manufacturers-in-china-331545.html 0.6 2026-08-06T21:54:06+08:00 daily https://www.pharmasources.com/industryinsights/hua-medicine-announces-2020-interim-resu-331546.html 0.6 2026-08-06T23:54:26+08:00 daily https://www.pharmasources.com/industryinsights/sihuan-pharmaceutical0460hk-respond-to-t-331547.html 0.6 2026-08-06T23:32:20+08:00 daily https://www.pharmasources.com/industryinsights/eisai-and-fuji-yakuhin-conclude-license--331548.html 0.6 2026-08-06T23:33:14+08:00 daily https://www.pharmasources.com/industryinsights/major-new-study-reveals-that-half-of-all-331549.html 0.6 2026-08-10T02:15:14+08:00 daily https://www.pharmasources.com/industryinsights/jw-therapeutics-announces-nmpa-approval--331550.html 0.6 2026-08-06T23:48:42+08:00 daily https://www.pharmasources.com/industryinsights/neuexcell-therapeutics-and-spark-therape-331551.html 0.6 2026-08-06T23:45:39+08:00 daily https://www.pharmasources.com/industryinsights/ai-startup-complycube-sees-staggering-50-331552.html 0.6 2026-08-06T23:54:53+08:00 daily https://www.pharmasources.com/industryinsights/jubilant-biosys-limited-announces-the-ap-331554.html 0.6 2026-08-06T23:58:19+08:00 daily https://www.pharmasources.com/industryinsights/mim-software-inc-announces-ai-segmentati-331555.html 0.6 2026-08-07T00:41:27+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-331556.html 0.6 2026-06-24T18:31:32+08:00 daily https://www.pharmasources.com/industryinsights/madison-street-capital-awarded-distresse-331557.html 0.6 2026-08-12T10:35:03+08:00 daily https://www.pharmasources.com/industryinsights/new-study-from-strategyr-highlights-a-17-331559.html 0.6 2026-06-23T04:24:56+08:00 daily https://www.pharmasources.com/industryinsights/adlai-nortye-announces-first-patient-dos-331560.html 0.6 2026-06-30T20:37:01+08:00 daily https://www.pharmasources.com/industryinsights/yiling-pharmaceuticals-yishen-yangxin-an-331561.html 0.6 2026-06-24T06:48:06+08:00 daily https://www.pharmasources.com/industryinsights/bactiguard-appoints-new-ceo-331562.html 0.6 2026-08-07T03:33:50+08:00 daily https://www.pharmasources.com/industryinsights/nccn-shares-latest-expert-recommendation-331563.html 0.6 2026-06-22T10:10:54+08:00 daily https://www.pharmasources.com/industryinsights/novel-excipient-review-pilot-program-331564.html 0.6 2026-08-07T03:25:09+08:00 daily https://www.pharmasources.com/industryinsights/emerging-regional-markets-show-promise-a-331565.html 0.6 2026-08-07T03:33:51+08:00 daily https://www.pharmasources.com/industryinsights/icis-top-100-chemical-companies-ranking--331568.html 0.6 2026-08-07T11:22:40+08:00 daily https://www.pharmasources.com/industryinsights/where-are-the-oral-covid-19-vaccines-sta-331569.html 0.6 2026-08-07T02:22:13+08:00 daily https://www.pharmasources.com/industryinsights/wclc-2021-mini-oral---ascentage-pharma-a-331570.html 0.6 2026-07-23T06:22:46+08:00 daily https://www.pharmasources.com/industryinsights/cstone-presents-registrational-bridging--331571.html 0.6 2026-08-07T10:52:50+08:00 daily https://www.pharmasources.com/industryinsights/haemalogix-raises-10-million-to-advance--331572.html 0.6 2026-08-07T06:09:54+08:00 daily https://www.pharmasources.com/industryinsights/retrobrain-announces-strategic-cooperati-331573.html 0.6 2026-08-09T12:55:33+08:00 daily https://www.pharmasources.com/industryinsights/more-than-77-of-nations-population-vacci-331574.html 0.6 2026-06-24T18:30:45+08:00 daily https://www.pharmasources.com/industryinsights/cphi-monthly-podcast-selecting-the-right-331575.html 0.6 2026-08-10T17:21:56+08:00 daily https://www.pharmasources.com/industryinsights/how-africa-vaccine-production-would-boos-331576.html 0.6 2026-08-10T12:34:03+08:00 daily https://www.pharmasources.com/industryinsights/whiz-gambit-now-available-across-emea-331577.html 0.6 2026-08-09T15:04:46+08:00 daily https://www.pharmasources.com/industryinsights/diacarta-receives-ceivd-for-its-new-covi-331578.html 0.6 2026-08-09T18:00:24+08:00 daily https://www.pharmasources.com/industryinsights/nature-scientific-reports-publishes-nove-331579.html 0.6 2026-08-07T03:30:42+08:00 daily https://www.pharmasources.com/industryinsights/sleefs-aids-community-and-youth-amid-cov-331580.html 0.6 2026-08-07T03:18:49+08:00 daily https://www.pharmasources.com/industryinsights/animal-communicator-nancy-mello-helps-no-331581.html 0.6 2026-08-07T03:02:57+08:00 daily https://www.pharmasources.com/industryinsights/joint-statement-from-the-american-board--331582.html 0.6 2026-06-23T09:27:38+08:00 daily https://www.pharmasources.com/industryinsights/room-for-specialists-and-one-stop-shops--331583.html 0.6 2026-08-07T06:06:43+08:00 daily https://www.pharmasources.com/industryinsights/cadence-education-announces-covid-19-vac-331584.html 0.6 2026-07-08T13:59:58+08:00 daily https://www.pharmasources.com/industryinsights/clover-biopharmaceuticals-receives-pharm-331585.html 0.6 2026-08-09T00:52:08+08:00 daily https://www.pharmasources.com/industryinsights/research-and-application-status-of-kojic-331586.html 0.6 2026-08-08T01:33:21+08:00 daily https://www.pharmasources.com/industryinsights/with-the-transaction-exceeding-300-milli-331587.html 0.6 2026-08-13T20:40:44+08:00 daily https://www.pharmasources.com/industryinsights/a-new-target-in-adc-nectin-4-331588.html 0.6 2026-08-07T00:40:51+08:00 daily https://www.pharmasources.com/industryinsights/supported-by-capital-the-application-of--331589.html 0.6 2026-08-08T01:05:32+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-331590.html 0.6 2026-06-23T06:20:56+08:00 daily https://www.pharmasources.com/industryinsights/american-board-of-medical-specialties-su-331591.html 0.6 2026-08-07T00:43:08+08:00 daily https://www.pharmasources.com/industryinsights/austin-doctors-appear-in-national-video--331592.html 0.6 2026-06-23T06:28:50+08:00 daily https://www.pharmasources.com/industryinsights/biovaxys-bioproduction-partner-wuxi-biol-331593.html 0.6 2026-08-06T03:21:03+08:00 daily https://www.pharmasources.com/industryinsights/jemincare-group-has-completed-the-phase--331594.html 0.6 2026-08-10T14:14:12+08:00 daily https://www.pharmasources.com/industryinsights/gates-foundations-annual-goalkeepers-rep-331595.html 0.6 2026-06-22T02:11:27+08:00 daily https://www.pharmasources.com/industryinsights/chinese-mainland-reports-22-new-locally--331596.html 0.6 2026-07-05T02:46:38+08:00 daily https://www.pharmasources.com/industryinsights/seminar-held-to-boost-drug-regulatory-co-331597.html 0.6 2026-07-28T17:46:15+08:00 daily https://www.pharmasources.com/industryinsights/eleva-reaches-industrial-production-scal-331598.html 0.6 2026-08-06T16:11:12+08:00 daily https://www.pharmasources.com/industryinsights/xinhua-silk-road-2021-international-bozh-331599.html 0.6 2026-08-06T13:39:30+08:00 daily https://www.pharmasources.com/industryinsights/cstone-presents-updated-data-from-regist-331600.html 0.6 2026-08-03T20:51:42+08:00 daily https://www.pharmasources.com/industryinsights/ambrisentan-api-price-and-manufacturers--331601.html 0.6 2026-08-13T21:48:31+08:00 daily https://www.pharmasources.com/industryinsights/wolf-berry-extract-api-manufacturers-in--331602.html 0.6 2026-08-10T05:48:00+08:00 daily https://www.pharmasources.com/industryinsights/redhill-biopharma-reports-top-line-data--331603.html 0.6 2026-08-08T11:56:55+08:00 daily https://www.pharmasources.com/industryinsights/calcimedica-reports-topline-data-from-th-331604.html 0.6 2026-08-07T02:53:04+08:00 daily https://www.pharmasources.com/industryinsights/affinity-empowering-is-prepared-to-imple-331605.html 0.6 2026-07-30T01:42:30+08:00 daily https://www.pharmasources.com/industryinsights/igene-laboratory-donates-25000-sars-cov--331606.html 0.6 2026-08-12T08:30:10+08:00 daily https://www.pharmasources.com/industryinsights/cstone-received-china-nmpa-ind-approval--331607.html 0.6 2026-07-31T18:36:16+08:00 daily https://www.pharmasources.com/industryinsights/peijia-medical-announces-first-patient-i-331608.html 0.6 2026-08-05T19:18:28+08:00 daily https://www.pharmasources.com/industryinsights/almost-75-of-doctors-say-they-have-seen--331609.html 0.6 2026-08-06T21:47:25+08:00 daily https://www.pharmasources.com/industryinsights/6th-china-asean-summit-for-drug-developm-331610.html 0.6 2026-07-22T01:50:35+08:00 daily https://www.pharmasources.com/industryinsights/anti-money-laundering-aml-software-marke-331611.html 0.6 2026-07-09T12:01:26+08:00 daily https://www.pharmasources.com/industryinsights/hot-melt-glue-gun-market-71513-million-b-331612.html 0.6 2026-06-25T01:30:29+08:00 daily https://www.pharmasources.com/industryinsights/lilly-to-supply-388000-doses-of-etesevim-331613.html 0.6 2026-06-27T05:08:54+08:00 daily https://www.pharmasources.com/industryinsights/pr-newswires-2021-healthcare-media-pitch-331614.html 0.6 2026-08-06T23:35:59+08:00 daily https://www.pharmasources.com/industryinsights/genequantum-announces-two-key-leadership-331615.html 0.6 2026-08-06T21:59:02+08:00 daily https://www.pharmasources.com/industryinsights/allianz-partners-expands-its-digital-hea-331616.html 0.6 2026-08-06T23:47:13+08:00 daily https://www.pharmasources.com/industryinsights/catalent-boosts-nutraceuticals-market-pr-331617.html 0.6 2026-08-07T22:11:21+08:00 daily https://www.pharmasources.com/industryinsights/agc-biologics-to-increase-capacity-for-p-331618.html 0.6 2026-08-08T03:01:44+08:00 daily https://www.pharmasources.com/industryinsights/premier-li-stresses-professional-ethics--331619.html 0.6 2026-06-23T20:38:13+08:00 daily https://www.pharmasources.com/industryinsights/chinese-mainland-reports-50-new-locally--331620.html 0.6 2026-08-09T22:52:47+08:00 daily https://www.pharmasources.com/industryinsights/therapeutic-solutions-international-iden-331621.html 0.6 2026-06-24T05:54:58+08:00 daily https://www.pharmasources.com/industryinsights/liver-disease-patients-struggle-with-hea-331622.html 0.6 2026-06-24T15:36:45+08:00 daily https://www.pharmasources.com/industryinsights/survey-finds-satellite-internet-essentia-331623.html 0.6 2026-06-22T03:17:32+08:00 daily https://www.pharmasources.com/industryinsights/astrea-bioseparations-makes-critical-inf-331624.html 0.6 2026-08-08T22:51:30+08:00 daily https://www.pharmasources.com/industryinsights/micro-coils-market-83630-million-by-2028-331625.html 0.6 2026-06-20T14:33:03+08:00 daily https://www.pharmasources.com/industryinsights/analysis-on-the-construction-of-sustaina-331626.html 0.6 2026-08-08T02:45:43+08:00 daily https://www.pharmasources.com/industryinsights/small-molecule-and-great-potential-oral--331627.html 0.6 2026-07-28T09:13:11+08:00 daily https://www.pharmasources.com/industryinsights/new-progress-of-key-chinese-covid-19-dru-331628.html 0.6 2026-08-13T20:55:17+08:00 daily https://www.pharmasources.com/industryinsights/terumo-celebrates-100th-anniversary-of-c-331629.html 0.6 2026-06-29T16:44:50+08:00 daily https://www.pharmasources.com/industryinsights/vieworks-to-showcase-its-complete-dental-331630.html 0.6 2026-07-31T23:37:33+08:00 daily https://www.pharmasources.com/industryinsights/new-suppliers-new-session---2021-jiangxi-331631.html 0.6 2026-08-08T04:29:57+08:00 daily https://www.pharmasources.com/industryinsights/do-we-still-need-animal-testing-331632.html 0.6 2026-06-20T14:42:05+08:00 daily https://www.pharmasources.com/industryinsights/global-hand-saw-blades-market-to-reach-5-331633.html 0.6 2026-08-05T03:30:52+08:00 daily https://www.pharmasources.com/industryinsights/new-test-shows-if-your-covid-vaccine-is--331634.html 0.6 2026-08-01T03:28:39+08:00 daily https://www.pharmasources.com/industryinsights/urotronic-inc-announces-completion-of-th-331635.html 0.6 2026-08-09T11:38:26+08:00 daily https://www.pharmasources.com/industryinsights/dr-ivan-puah-sees-an-increasing-number-o-331636.html 0.6 2026-06-26T22:27:00+08:00 daily https://www.pharmasources.com/industryinsights/bactiguard-completes-a-directed-new-shar-331637.html 0.6 2026-08-07T05:05:56+08:00 daily https://www.pharmasources.com/industryinsights/vetters-contribution-to-climate-protecti-331638.html 0.6 2026-08-07T00:40:37+08:00 daily https://www.pharmasources.com/industryinsights/pureos-bioventures-expands-the-team-by-t-331639.html 0.6 2026-08-07T00:02:42+08:00 daily https://www.pharmasources.com/industryinsights/fresenius-kabi-invests-in-pre-filled-syr-331640.html 0.6 2026-08-06T23:55:29+08:00 daily https://www.pharmasources.com/industryinsights/fda-in-brief-fda-posts-an-initial-batch--331641.html 0.6 2026-08-07T00:01:35+08:00 daily https://www.pharmasources.com/industryinsights/changing-landscape-of-pharma-market-in-c-331642.html 0.6 2026-08-06T10:55:56+08:00 daily https://www.pharmasources.com/industryinsights/what-is-sea-buckthorn-seed-oil-331643.html 0.6 2026-08-08T20:37:40+08:00 daily https://www.pharmasources.com/industryinsights/some-oral-membrane-products-on-the-marke-331644.html 0.6 2026-08-15T00:10:54+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-331645.html 0.6 2026-08-10T11:57:20+08:00 daily https://www.pharmasources.com/industryinsights/affinity-empowering-enrolls-first-school-331646.html 0.6 2026-06-22T17:34:05+08:00 daily https://www.pharmasources.com/industryinsights/inovio-receives-regulatory-authorization-331647.html 0.6 2026-08-04T05:58:17+08:00 daily https://www.pharmasources.com/industryinsights/sweetch-enters-strategic-partnership-wit-331648.html 0.6 2026-06-23T23:45:55+08:00 daily https://www.pharmasources.com/industryinsights/innovent-announces-nmpa-acceptance-of-a--331649.html 0.6 2026-08-11T06:10:28+08:00 daily https://www.pharmasources.com/industryinsights/ascentage-pharmas-mdm2-p53-inhibitor-alr-331650.html 0.6 2026-07-19T18:57:00+08:00 daily https://www.pharmasources.com/industryinsights/abcellera-and-everest-medicines-announce-331651.html 0.6 2026-08-04T02:40:51+08:00 daily https://www.pharmasources.com/industryinsights/bd-completes-study-investigating-perform-331652.html 0.6 2026-08-03T04:52:06+08:00 daily https://www.pharmasources.com/industryinsights/new-survey-provides-insights-into-drinki-331653.html 0.6 2026-06-25T12:33:39+08:00 daily https://www.pharmasources.com/industryinsights/codagenix-announces-safety-and-immunogen-331654.html 0.6 2026-08-06T15:32:50+08:00 daily https://www.pharmasources.com/industryinsights/model-medicines-announces-preclinical-da-331655.html 0.6 2026-07-01T11:32:29+08:00 daily https://www.pharmasources.com/industryinsights/new-drug-application-for-cadonilimab-pd--331656.html 0.6 2026-07-28T13:52:31+08:00 daily https://www.pharmasources.com/industryinsights/results-from-novavax-nanoflu-influenza-v-331657.html 0.6 2026-08-10T23:43:13+08:00 daily https://www.pharmasources.com/industryinsights/innovent-announces-first-patient-dosed-i-331658.html 0.6 2026-08-11T15:11:16+08:00 daily https://www.pharmasources.com/industryinsights/recipients-of-the-novo-nordisk-prize-pla-331659.html 0.6 2026-07-09T01:40:41+08:00 daily https://www.pharmasources.com/industryinsights/host-genetic-backgrounds-underlie-variab-331660.html 0.6 2026-07-19T07:57:13+08:00 daily https://www.pharmasources.com/industryinsights/more-americans-see-cybercrime-as-threat--331661.html 0.6 2026-06-21T07:23:45+08:00 daily https://www.pharmasources.com/industryinsights/clean-cells-to-invest-13-million-to-crea-331662.html 0.6 2026-06-21T02:17:55+08:00 daily https://www.pharmasources.com/industryinsights/angel-yeast-enhances-overall-wellbeing-a-331663.html 0.6 2026-07-20T11:07:04+08:00 daily https://www.pharmasources.com/industryinsights/post-covid-19-procurement-report-on-digi-331664.html 0.6 2026-06-27T01:02:56+08:00 daily https://www.pharmasources.com/industryinsights/everest-medicines-announces-approval-of--331665.html 0.6 2026-07-30T20:48:26+08:00 daily https://www.pharmasources.com/industryinsights/gamma-biosciences-makes-strategic-invest-331666.html 0.6 2026-08-09T01:20:44+08:00 daily https://www.pharmasources.com/industryinsights/bantys-dr-richard-tytus-discusses-how-to-331667.html 0.6 2026-06-21T20:22:27+08:00 daily https://www.pharmasources.com/industryinsights/-120-bn-growth-in-cannabis-testing-marke-331668.html 0.6 2026-06-22T12:36:49+08:00 daily https://www.pharmasources.com/industryinsights/report-accuses-covid-vaccine-makers-of-p-331669.html 0.6 2026-06-22T20:24:09+08:00 daily https://www.pharmasources.com/industryinsights/an-update-on-sunscreen-requirements-the--331670.html 0.6 2026-08-11T16:00:14+08:00 daily https://www.pharmasources.com/industryinsights/vice-premier-urges-efforts-to-curb-covid-331671.html 0.6 2026-06-22T00:14:25+08:00 daily https://www.pharmasources.com/industryinsights/chinese-mainland-reports-30-new-locally--331672.html 0.6 2026-06-23T12:27:41+08:00 daily https://www.pharmasources.com/industryinsights/boan-biotech-to-present-the-pre-clinical-331673.html 0.6 2026-08-07T18:11:57+08:00 daily https://www.pharmasources.com/industryinsights/global-25-billion-last-mile-food-and-gro-331674.html 0.6 2026-06-22T19:22:56+08:00 daily https://www.pharmasources.com/industryinsights/ezz-moves-closer-to-breakthrough-with-wo-331675.html 0.6 2026-06-23T08:53:31+08:00 daily https://www.pharmasources.com/industryinsights/novavax-and-serum-institute-of-india-ann-331676.html 0.6 2026-08-12T09:02:43+08:00 daily https://www.pharmasources.com/industryinsights/lead-horizon-how-travelers-in-austria-ga-331677.html 0.6 2026-08-06T21:56:25+08:00 daily https://www.pharmasources.com/industryinsights/transcenta-received-ind-clearance-from-n-331678.html 0.6 2026-08-10T14:46:04+08:00 daily https://www.pharmasources.com/industryinsights/kintor-pharma-announces-brazils-anvisa-a-331679.html 0.6 2026-06-30T04:40:22+08:00 daily https://www.pharmasources.com/industryinsights/genscript-probio-and-askgene-enter-into--331680.html 0.6 2026-08-11T15:13:14+08:00 daily https://www.pharmasources.com/industryinsights/c-o-r-r-e-c-t-i-o-n----phoxbio-331681.html 0.6 2026-06-23T20:37:17+08:00 daily https://www.pharmasources.com/industryinsights/innovent-and-anheart-announce-interim-da-331682.html 0.6 2026-08-11T15:07:22+08:00 daily https://www.pharmasources.com/industryinsights/lion-tcr-announces-fda-ind-clearance-for-331683.html 0.6 2026-08-14T14:19:03+08:00 daily https://www.pharmasources.com/industryinsights/biovaxys-prepares-for-groundbreaking-stu-331684.html 0.6 2026-08-06T23:56:26+08:00 daily https://www.pharmasources.com/industryinsights/astrazeneca-and-oncoshot-establish-strat-331685.html 0.6 2026-08-07T00:41:39+08:00 daily https://www.pharmasources.com/industryinsights/zymo-research-receives-ce-ivd-mark-for-i-331686.html 0.6 2026-08-07T00:59:32+08:00 daily https://www.pharmasources.com/industryinsights/innovent-and-union-therapeutics-enter-in-331687.html 0.6 2026-08-06T10:11:40+08:00 daily https://www.pharmasources.com/industryinsights/brii-bio-appoints-coy-stout-as-senior-vi-331688.html 0.6 2026-06-27T16:48:54+08:00 daily https://www.pharmasources.com/industryinsights/harbour-biomed-announces-dosing-of-first-331689.html 0.6 2026-07-19T22:00:17+08:00 daily https://www.pharmasources.com/industryinsights/cgbio-to-introduce-ai-empowered-robotic--331690.html 0.6 2026-08-03T22:50:26+08:00 daily https://www.pharmasources.com/industryinsights/jw-therapeutics-announces-ind-approval-f-331691.html 0.6 2026-06-27T11:50:28+08:00 daily https://www.pharmasources.com/industryinsights/senhwa-announces-acceptance-of-early-pos-331692.html 0.6 2026-06-23T11:26:39+08:00 daily https://www.pharmasources.com/industryinsights/cyanvac-and-blue-lake-biotechnology-anno-331693.html 0.6 2026-08-08T15:14:02+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-331694.html 0.6 2026-08-10T07:15:33+08:00 daily https://www.pharmasources.com/industryinsights/nrx-pharmaceuticals-announces-improved-s-331695.html 0.6 2026-06-21T22:24:44+08:00 daily https://www.pharmasources.com/industryinsights/operation-hope-launches-helping-hand-fun-331696.html 0.6 2026-06-21T12:58:39+08:00 daily https://www.pharmasources.com/industryinsights/salix-will-share-relistor-methylnaltrexo-331697.html 0.6 2026-06-24T18:44:41+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-scientific-unveils-new-cli-331698.html 0.6 2026-08-09T10:31:23+08:00 daily https://www.pharmasources.com/industryinsights/soligenix-announces-accelerated-publicat-331699.html 0.6 2026-06-21T21:21:48+08:00 daily https://www.pharmasources.com/industryinsights/clearmask-introduces-worlds-first-ce-mar-331700.html 0.6 2026-08-08T20:47:09+08:00 daily https://www.pharmasources.com/industryinsights/innovent-releases-preliminary-results-of-331701.html 0.6 2026-08-03T13:10:37+08:00 daily https://www.pharmasources.com/industryinsights/heart-experts-call-for-millions-to-benef-331702.html 0.6 2026-08-07T03:24:53+08:00 daily https://www.pharmasources.com/industryinsights/chinese-mainland-reports-13-new-locally--331703.html 0.6 2026-08-07T16:16:02+08:00 daily https://www.pharmasources.com/industryinsights/biovaxys-begins-toxicity-study-ahead-of--331704.html 0.6 2026-08-07T02:41:03+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-announces-acceptance-of-ind-applic-331705.html 0.6 2026-08-14T17:48:26+08:00 daily https://www.pharmasources.com/industryinsights/hikma-boosts-us-injectables-business-wit-331706.html 0.6 2026-08-07T03:03:19+08:00 daily https://www.pharmasources.com/industryinsights/parks-associates-adoption-of-smart-tvs-a-331707.html 0.6 2026-08-07T03:15:49+08:00 daily https://www.pharmasources.com/industryinsights/pulmotects-positive-topline-results-for--331708.html 0.6 2026-08-07T03:33:31+08:00 daily https://www.pharmasources.com/industryinsights/thermo-fisher-scientific-continues-suppo-331709.html 0.6 2026-08-09T18:38:51+08:00 daily https://www.pharmasources.com/industryinsights/st-lukes-achieves-vaccine-mandate-goal-331710.html 0.6 2026-06-26T19:18:04+08:00 daily https://www.pharmasources.com/industryinsights/genfleet-and-innovent-starts-first-in-hu-331711.html 0.6 2026-07-20T12:59:36+08:00 daily https://www.pharmasources.com/industryinsights/innovent-announces-the-first-patient-dos-331712.html 0.6 2026-07-25T04:03:50+08:00 daily https://www.pharmasources.com/industryinsights/recbio-and-rhegen-signed-an-mrna-vaccine-331713.html 0.6 2026-06-30T08:21:49+08:00 daily https://www.pharmasources.com/industryinsights/everest-medicines-initiates-submission-o-331714.html 0.6 2026-06-21T19:25:50+08:00 daily https://www.pharmasources.com/industryinsights/survey-82-of-americans-scared-that-suppl-331715.html 0.6 2026-06-23T11:16:48+08:00 daily https://www.pharmasources.com/industryinsights/covid-swings-pendulum-back-to-traditiona-331716.html 0.6 2026-08-09T08:01:03+08:00 daily https://www.pharmasources.com/industryinsights/from-pegan-diet-to-functional-medicine-a-331717.html 0.6 2026-07-18T15:57:23+08:00 daily https://www.pharmasources.com/industryinsights/has-covid-been-injecting-cash-into-pharm-331718.html 0.6 2026-08-07T01:47:44+08:00 daily https://www.pharmasources.com/industryinsights/quantum-computing-in-pharma-331719.html 0.6 2026-08-03T17:32:19+08:00 daily https://www.pharmasources.com/industryinsights/global-paraffin-wax-market-procurement-i-331720.html 0.6 2026-06-21T06:22:42+08:00 daily https://www.pharmasources.com/industryinsights/inhalon-doses-first-patient-in-phase-1-s-331721.html 0.6 2026-06-27T01:29:40+08:00 daily https://www.pharmasources.com/industryinsights/pandemic-reality-makes-flu-shots-a-must-331722.html 0.6 2026-06-22T00:20:43+08:00 daily https://www.pharmasources.com/industryinsights/cstone-presents-research-data-of-cs5001--331723.html 0.6 2026-06-27T20:44:36+08:00 daily https://www.pharmasources.com/industryinsights/debiopharm-and-dexa-medica-launch-tripto-331724.html 0.6 2026-07-23T21:30:47+08:00 daily https://www.pharmasources.com/industryinsights/ascensia-diabetes-care-launches-the-this-331725.html 0.6 2026-06-22T11:23:30+08:00 daily https://www.pharmasources.com/industryinsights/navigo-proteins-gmbh-announces-extension-331726.html 0.6 2026-06-26T13:10:41+08:00 daily https://www.pharmasources.com/industryinsights/brii-bio-initiates-submission-of-emergen-331727.html 0.6 2026-06-22T16:21:29+08:00 daily https://www.pharmasources.com/industryinsights/my-dental-key-democratizing-dental-educa-331728.html 0.6 2026-06-22T09:49:44+08:00 daily https://www.pharmasources.com/industryinsights/viraleze-antiviral-nasal-spray-launched--331729.html 0.6 2026-08-07T05:10:39+08:00 daily https://www.pharmasources.com/industryinsights/bismaleimide-monomer-market-to-reach-us--331730.html 0.6 2026-06-21T15:24:27+08:00 daily https://www.pharmasources.com/industryinsights/one-third-of-plastic-protective-packagin-331731.html 0.6 2026-06-27T00:45:44+08:00 daily https://www.pharmasources.com/industryinsights/pharmapack-2021-pre-filled-syringe-techn-331732.html 0.6 2026-07-05T04:09:49+08:00 daily https://www.pharmasources.com/industryinsights/cder-conversation-novel-excipient-review-331733.html 0.6 2026-08-07T03:34:56+08:00 daily https://www.pharmasources.com/industryinsights/advanced-computing-in-pharma-3-reasons-w-331734.html 0.6 2026-08-02T19:28:59+08:00 daily https://www.pharmasources.com/industryinsights/forge-biologics-to-provide-cdmo-support--331735.html 0.6 2026-08-10T15:12:08+08:00 daily https://www.pharmasources.com/industryinsights/18-month-below-the-knee-data-with-medall-331737.html 0.6 2026-07-18T10:29:29+08:00 daily https://www.pharmasources.com/industryinsights/kintor-pharma-announces-china-nmpa-appro-331738.html 0.6 2026-07-23T00:53:52+08:00 daily https://www.pharmasources.com/industryinsights/breakthrough-for-medtech-pioneer-syntell-331739.html 0.6 2026-08-08T00:39:06+08:00 daily https://www.pharmasources.com/industryinsights/worldwide-human-papillomavirus-testing-i-331740.html 0.6 2026-06-22T23:19:48+08:00 daily https://www.pharmasources.com/industryinsights/amplo-biotechnology-closes-series-seed-f-331741.html 0.6 2026-08-01T10:23:16+08:00 daily https://www.pharmasources.com/industryinsights/vuno-signs-another-deal-with-samsung-ele-331742.html 0.6 2026-08-07T11:33:50+08:00 daily https://www.pharmasources.com/industryinsights/bico-launches-the-snest-a-high-throughpu-331743.html 0.6 2026-08-13T08:58:39+08:00 daily https://www.pharmasources.com/industryinsights/kazia-therapeutics-to-present-at-ld-micr-331744.html 0.6 2026-08-10T00:55:35+08:00 daily https://www.pharmasources.com/industryinsights/luciole-pharmaceuticals-and-cyclica-anno-331745.html 0.6 2026-08-09T11:44:54+08:00 daily https://www.pharmasources.com/industryinsights/rhovac-retains-international-investment--331746.html 0.6 2026-08-10T00:51:52+08:00 daily https://www.pharmasources.com/industryinsights/inovio-expands-innovate-phase-3-for-ino--331747.html 0.6 2026-06-24T19:43:03+08:00 daily https://www.pharmasources.com/industryinsights/chinese-mainland-reports-25-new-imported-331749.html 0.6 2026-07-08T10:30:09+08:00 daily https://www.pharmasources.com/industryinsights/ascletis-announces-results-of-the-phase--331750.html 0.6 2026-07-17T21:57:25+08:00 daily https://www.pharmasources.com/industryinsights/sciwind-biosciences-completes-70-million-331751.html 0.6 2026-07-23T03:54:34+08:00 daily https://www.pharmasources.com/industryinsights/twist-alliance-pan-cancer-methylation-pa-331752.html 0.6 2026-08-05T15:44:55+08:00 daily https://www.pharmasources.com/industryinsights/sirtex-medical-and-china-grand-pharmaceu-331753.html 0.6 2026-08-09T13:05:50+08:00 daily https://www.pharmasources.com/industryinsights/cgm-lab-software-modernizes-healthcare-i-331754.html 0.6 2026-08-09T04:13:23+08:00 daily https://www.pharmasources.com/industryinsights/eleva-enters-clinical-development-of-dif-331755.html 0.6 2026-08-10T06:22:58+08:00 daily https://www.pharmasources.com/industryinsights/nearly-2219b-covid-19-vaccine-doses-admi-331756.html 0.6 2026-06-24T02:38:36+08:00 daily https://www.pharmasources.com/industryinsights/neoplex-tm-hpv29-detection-a-new-molecul-331757.html 0.6 2026-08-11T04:44:25+08:00 daily https://www.pharmasources.com/industryinsights/aethlon-medical-announces-peer-reviewed--331759.html 0.6 2026-08-13T04:54:00+08:00 daily https://www.pharmasources.com/industryinsights/inovio-announces-online-preprint-publica-331760.html 0.6 2026-06-23T04:31:36+08:00 daily https://www.pharmasources.com/industryinsights/world-liquid-biopsy-markets-report-2021--331761.html 0.6 2026-06-23T12:20:34+08:00 daily https://www.pharmasources.com/industryinsights/itutors-virtual-quarantine-classroom-off-331762.html 0.6 2026-08-07T01:27:58+08:00 daily https://www.pharmasources.com/industryinsights/chop-led-study-finds-healthy-newborns-ha-331763.html 0.6 2026-08-07T04:25:04+08:00 daily https://www.pharmasources.com/industryinsights/new-dymax-mdr-1040-m-autoclave-resistant-331764.html 0.6 2026-08-07T04:30:54+08:00 daily https://www.pharmasources.com/industryinsights/more-community-healthcare-needed-in-covi-331765.html 0.6 2026-08-07T04:57:09+08:00 daily https://www.pharmasources.com/industryinsights/emmaus-life-sciences-acquires-key-intell-331766.html 0.6 2026-08-07T05:08:12+08:00 daily https://www.pharmasources.com/industryinsights/gilead-sciences-partners-with-the-intern-331767.html 0.6 2026-06-21T18:24:41+08:00 daily https://www.pharmasources.com/industryinsights/aum-biosciences-announces-closing-of-usd-331768.html 0.6 2026-06-21T22:18:30+08:00 daily https://www.pharmasources.com/industryinsights/how-much-money-do-pharmaceutical-compani-331769.html 0.6 2026-08-10T00:04:20+08:00 daily https://www.pharmasources.com/industryinsights/edheroes-global-movement-is-expanding-to-331770.html 0.6 2026-08-07T23:32:47+08:00 daily https://www.pharmasources.com/industryinsights/channeladvisor-announces-2021-e-commerce-331771.html 0.6 2026-06-24T01:49:24+08:00 daily https://www.pharmasources.com/industryinsights/domestic-travel-near-full-recovery-ont-s-331772.html 0.6 2026-06-22T14:44:00+08:00 daily https://www.pharmasources.com/industryinsights/neurobo-pharmaceuticals-announces-positi-331773.html 0.6 2026-08-09T04:34:51+08:00 daily https://www.pharmasources.com/industryinsights/over-50-of-hospitals-will-accelerate-dig-331774.html 0.6 2026-08-08T14:47:15+08:00 daily https://www.pharmasources.com/industryinsights/new-information-from-nccn-on-most-common-331775.html 0.6 2026-08-07T13:17:02+08:00 daily https://www.pharmasources.com/industryinsights/one-shot-sputnik-light-vaccine-first-com-331776.html 0.6 2026-08-14T11:01:27+08:00 daily https://www.pharmasources.com/industryinsights/gannex-announces-clinical-and-preclinica-331777.html 0.6 2026-06-24T04:37:59+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-advances-late-stage-development-of-331778.html 0.6 2026-08-14T06:26:48+08:00 daily https://www.pharmasources.com/industryinsights/survey-finds-industry-taking-action-to-a-331779.html 0.6 2026-06-21T22:03:48+08:00 daily https://www.pharmasources.com/industryinsights/automotive-infotainment-os-market-record-331780.html 0.6 2026-08-08T13:11:58+08:00 daily https://www.pharmasources.com/industryinsights/panamas-greatest-post-pandemic-challenge-331781.html 0.6 2026-08-09T07:56:27+08:00 daily https://www.pharmasources.com/industryinsights/cellumed-and-artes-sign-development-and--331782.html 0.6 2026-08-06T05:59:38+08:00 daily https://www.pharmasources.com/industryinsights/bd-launches-plunger-stopper-in-partnersh-331783.html 0.6 2026-08-08T10:05:23+08:00 daily https://www.pharmasources.com/industryinsights/everest-organics-starts-api-production-f-331784.html 0.6 2026-08-07T04:57:24+08:00 daily https://www.pharmasources.com/industryinsights/interim-results-of-a-pioneering-combinat-331785.html 0.6 2026-07-16T21:36:34+08:00 daily https://www.pharmasources.com/industryinsights/gan-lee-pharmaceuticals-concludes-phase--331786.html 0.6 2026-08-07T12:30:03+08:00 daily https://www.pharmasources.com/industryinsights/akeso-is-rapidly-advancing-the-phase-ii--331787.html 0.6 2026-08-07T12:10:19+08:00 daily https://www.pharmasources.com/industryinsights/antengene-to-present-data-of-its-pd-l14--331788.html 0.6 2026-08-07T04:52:45+08:00 daily https://www.pharmasources.com/industryinsights/progress-of-research-on-key-covid-19-tre-331789.html 0.6 2026-07-08T14:44:31+08:00 daily https://www.pharmasources.com/industryinsights/alphamab-oncology-completed-enrollment-i-331790.html 0.6 2026-08-07T04:28:12+08:00 daily https://www.pharmasources.com/industryinsights/innovent-announces-orient-31-a-phase-3-s-331791.html 0.6 2026-08-07T04:16:09+08:00 daily https://www.pharmasources.com/industryinsights/cellorigin-secured-a-new-round-of-invest-331792.html 0.6 2026-08-07T03:54:53+08:00 daily https://www.pharmasources.com/industryinsights/phase-ii-data-of-medigen-covid-19-vaccin-331793.html 0.6 2026-08-07T04:22:15+08:00 daily https://www.pharmasources.com/industryinsights/aft-launches-nz-made-100-natural-90-recy-331794.html 0.6 2026-08-07T04:24:58+08:00 daily https://www.pharmasources.com/industryinsights/covid-19-battering-healthcare-workers-wi-331795.html 0.6 2026-08-06T21:47:24+08:00 daily https://www.pharmasources.com/industryinsights/gara-group-files-lawsuit-against-holista-331796.html 0.6 2026-08-07T05:05:34+08:00 daily https://www.pharmasources.com/industryinsights/gv20-oncotherapy-completes-series-b-fina-331797.html 0.6 2026-08-07T23:53:51+08:00 daily https://www.pharmasources.com/industryinsights/nanoform-convenes-egm-to-elect-jeanne-th-331798.html 0.6 2026-06-23T00:29:50+08:00 daily https://www.pharmasources.com/industryinsights/osim-enters-into-virtual-reality-with-th-331799.html 0.6 2026-06-21T20:29:45+08:00 daily https://www.pharmasources.com/industryinsights/mentice-receives-order-of-total-sek-70-m-331800.html 0.6 2026-06-22T01:03:49+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-331801.html 0.6 2026-08-07T04:04:06+08:00 daily https://www.pharmasources.com/industryinsights/nearly-half-of-american-workers-purchase-331802.html 0.6 2026-06-21T17:22:48+08:00 daily https://www.pharmasources.com/industryinsights/affinity-empowering-enrolls-first-organi-331803.html 0.6 2026-06-23T06:57:56+08:00 daily https://www.pharmasources.com/industryinsights/fda-authorizes-new-saliva-sample-collect-331804.html 0.6 2026-06-21T17:33:37+08:00 daily https://www.pharmasources.com/industryinsights/innocare-announces-approval-of-clinical--331805.html 0.6 2026-08-05T15:39:53+08:00 daily https://www.pharmasources.com/industryinsights/carb-x-funds-the-3rd-round-of-debiopharm-331806.html 0.6 2026-06-23T04:28:21+08:00 daily https://www.pharmasources.com/industryinsights/prenetics-to-be-the-exclusive-rt-pcr-cov-331807.html 0.6 2026-08-07T03:02:59+08:00 daily https://www.pharmasources.com/industryinsights/the-journal-of-medicinal-chemistry-publi-331808.html 0.6 2026-08-10T15:57:26+08:00 daily https://www.pharmasources.com/industryinsights/professor-carl-june-the-pioneer-of-car-t-331809.html 0.6 2026-06-20T15:19:50+08:00 daily https://www.pharmasources.com/industryinsights/bigo-live-continues-its-partnership-with-331810.html 0.6 2026-08-06T23:45:26+08:00 daily https://www.pharmasources.com/industryinsights/force-of-nature-launches-epa-registered--331811.html 0.6 2026-08-06T23:36:23+08:00 daily https://www.pharmasources.com/industryinsights/valued-to-be-103-billion-by-2026-instrum-331812.html 0.6 2026-08-06T21:54:31+08:00 daily https://www.pharmasources.com/industryinsights/cellbox-solutions-introduces-cbs-natural-331813.html 0.6 2026-08-06T21:03:11+08:00 daily https://www.pharmasources.com/industryinsights/ophthalmic-company-implandata-awarded-as-331814.html 0.6 2026-08-06T22:53:40+08:00 daily https://www.pharmasources.com/industryinsights/fda-declines-approval-of-united-therapeu-331815.html 0.6 2026-08-06T22:53:21+08:00 daily https://www.pharmasources.com/industryinsights/bridge-biotherapeutics-announces-initiat-331816.html 0.6 2026-08-06T23:23:13+08:00 daily https://www.pharmasources.com/industryinsights/alterity-therapeutics-announces-expanded-331817.html 0.6 2026-08-06T23:37:21+08:00 daily https://www.pharmasources.com/industryinsights/mot-hennessy-breaks-new-ground-for-innov-331818.html 0.6 2026-08-14T18:50:34+08:00 daily https://www.pharmasources.com/industryinsights/harbour-biomed-announces-dosing-of-first-331819.html 0.6 2026-08-14T11:01:19+08:00 daily https://www.pharmasources.com/industryinsights/chinese-mainland-reports-9-locally-trasm-331820.html 0.6 2026-06-21T22:24:10+08:00 daily https://www.pharmasources.com/industryinsights/fda-approves-naloxone-injection-to-count-331821.html 0.6 2026-08-13T23:35:42+08:00 daily https://www.pharmasources.com/industryinsights/quest-diagnostics-to-provide-k-12-school-331822.html 0.6 2026-07-01T19:13:58+08:00 daily https://www.pharmasources.com/industryinsights/scientific-reports-revealing-early-promi-331823.html 0.6 2026-06-21T08:18:12+08:00 daily https://www.pharmasources.com/industryinsights/vice-premier-stresses-accelerating-covid-331824.html 0.6 2026-06-22T23:23:48+08:00 daily https://www.pharmasources.com/industryinsights/chinese-mainland-reports-17-locally-tran-331825.html 0.6 2026-08-07T05:07:32+08:00 daily https://www.pharmasources.com/industryinsights/novavax-defends-covid-19-vaccine-manufac-331826.html 0.6 2026-08-07T04:52:38+08:00 daily https://www.pharmasources.com/industryinsights/fda-misses-approval-target-dates-after-p-331827.html 0.6 2026-08-07T04:49:05+08:00 daily https://www.pharmasources.com/industryinsights/matica-bio-and-sartorius-form-large-scal-331828.html 0.6 2026-08-07T04:22:02+08:00 daily https://www.pharmasources.com/industryinsights/advancing-generic-drug-development-to-ap-331829.html 0.6 2026-08-10T08:43:01+08:00 daily https://www.pharmasources.com/industryinsights/ind-application-for-phase-iii-clinical-s-331830.html 0.6 2026-08-08T20:01:08+08:00 daily https://www.pharmasources.com/industryinsights/red-ginsengs-possible-covid-19-vaccine-a-331831.html 0.6 2026-06-29T14:51:41+08:00 daily https://www.pharmasources.com/industryinsights/facebook-instagram-telegram-are-go-to-si-331832.html 0.6 2026-08-07T03:03:14+08:00 daily https://www.pharmasources.com/industryinsights/fda-selects-aetion-evidence-platform-to--331833.html 0.6 2026-08-07T02:52:41+08:00 daily https://www.pharmasources.com/industryinsights/inovio-announces-collaboration-with-colo-331834.html 0.6 2026-08-07T02:55:20+08:00 daily https://www.pharmasources.com/industryinsights/affinity-empowering-enrolls-three-kentuc-331835.html 0.6 2026-08-07T03:03:16+08:00 daily https://www.pharmasources.com/industryinsights/chinese-mainland-reports-13-locally-tran-331836.html 0.6 2026-08-07T05:07:16+08:00 daily https://www.pharmasources.com/industryinsights/xtrava-health-receives-emergency-use-aut-331837.html 0.6 2026-08-07T13:17:03+08:00 daily https://www.pharmasources.com/industryinsights/akeso-is-rapidly-advancing-the-clinical--331838.html 0.6 2026-08-07T02:05:00+08:00 daily https://www.pharmasources.com/industryinsights/kintor-pharma-announces-pd-l1tgf--dual-t-331839.html 0.6 2026-08-07T01:52:00+08:00 daily https://www.pharmasources.com/industryinsights/educating-children-about-good-hygiene-is-331840.html 0.6 2026-08-07T00:39:43+08:00 daily https://www.pharmasources.com/industryinsights/luoxin-pharmaceutical-signs-licensing-ag-331841.html 0.6 2026-08-08T21:53:00+08:00 daily https://www.pharmasources.com/industryinsights/emergency-physicians-we-must-address-vac-331842.html 0.6 2026-08-12T00:47:36+08:00 daily https://www.pharmasources.com/industryinsights/nmpa-releases-2nd-group-of-key-projects--331843.html 0.6 2026-06-29T19:37:05+08:00 daily https://www.pharmasources.com/industryinsights/phlow-receives-approval-to-join-barda-cd-331844.html 0.6 2026-08-09T12:42:47+08:00 daily https://www.pharmasources.com/industryinsights/new-breakthrough-in-epilepsy-drug-first--331845.html 0.6 2026-08-03T15:46:12+08:00 daily https://www.pharmasources.com/industryinsights/alcami-to-manufacture-pharmathers-propri-331846.html 0.6 2026-07-09T12:10:42+08:00 daily https://www.pharmasources.com/industryinsights/josip-heit-comments-on-the-current-situa-331847.html 0.6 2026-06-24T00:08:31+08:00 daily https://www.pharmasources.com/industryinsights/nccn-works-with-polish-health-leaders-to-331848.html 0.6 2026-08-05T20:48:28+08:00 daily https://www.pharmasources.com/industryinsights/i-mab-expands-us-footprint-with-new-rd-s-331849.html 0.6 2026-06-21T17:32:03+08:00 daily https://www.pharmasources.com/industryinsights/new-distributor-in-the-us-for-lightair-331850.html 0.6 2026-06-22T15:20:42+08:00 daily https://www.pharmasources.com/industryinsights/red-ginseng-acts-as-a-potential-vaccine--331851.html 0.6 2026-07-23T18:25:13+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-331852.html 0.6 2026-06-22T07:20:36+08:00 daily https://www.pharmasources.com/industryinsights/copilot-chief-operating-officer-charles--331853.html 0.6 2026-06-27T22:53:24+08:00 daily https://www.pharmasources.com/industryinsights/pandemic-driven-changes-in-pharma-here-t-331854.html 0.6 2026-06-22T00:19:26+08:00 daily https://www.pharmasources.com/industryinsights/steel-grating-market-size-1387-bn-by-202-331855.html 0.6 2026-06-24T04:33:58+08:00 daily https://www.pharmasources.com/industryinsights/vice-premier-demands-no-relaxation-of-an-331856.html 0.6 2026-06-21T16:36:17+08:00 daily https://www.pharmasources.com/industryinsights/chinese-mainland-reports-35-locally-tran-331857.html 0.6 2026-06-21T07:32:50+08:00 daily https://www.pharmasources.com/industryinsights/angel-pharmaceuticals-announces-approval-331858.html 0.6 2026-07-15T03:56:10+08:00 daily https://www.pharmasources.com/industryinsights/scn9a-antisense-pain-killer-olp-1002-mov-331859.html 0.6 2026-08-05T23:27:43+08:00 daily https://www.pharmasources.com/industryinsights/gc-group-strengthens-sustainable-growth--331860.html 0.6 2026-06-22T13:12:48+08:00 daily https://www.pharmasources.com/industryinsights/kontron-launches-a-new-35-single-board-c-331861.html 0.6 2026-06-22T03:27:45+08:00 daily https://www.pharmasources.com/industryinsights/credio-inc-partners-with-tablet-command--331862.html 0.6 2026-08-08T22:04:12+08:00 daily https://www.pharmasources.com/industryinsights/global-medical-electrodes-market-2021-to-331863.html 0.6 2026-06-22T08:24:11+08:00 daily https://www.pharmasources.com/industryinsights/global-ionic-liquids-market-research-rep-331864.html 0.6 2026-08-07T13:17:45+08:00 daily https://www.pharmasources.com/industryinsights/qa-covid-19-booster-shots-331865.html 0.6 2026-08-08T04:29:52+08:00 daily https://www.pharmasources.com/industryinsights/vaccination-of-young-children-begins-aro-331866.html 0.6 2026-08-09T06:59:50+08:00 daily https://www.pharmasources.com/industryinsights/chinese-mainland-reports-29-locally-tran-331867.html 0.6 2026-06-29T01:38:24+08:00 daily https://www.pharmasources.com/industryinsights/api-supply-chain-needs-to-address-future-331868.html 0.6 2026-08-04T07:00:34+08:00 daily https://www.pharmasources.com/industryinsights/medigens-mvc-cov1901-selected-for-who-co-331869.html 0.6 2026-06-23T00:23:47+08:00 daily https://www.pharmasources.com/industryinsights/introducing-prodigy-for-improved-peptide-331870.html 0.6 2026-06-23T08:32:45+08:00 daily https://www.pharmasources.com/industryinsights/qilian-international-holding-group-limit-331871.html 0.6 2026-08-12T00:57:12+08:00 daily https://www.pharmasources.com/industryinsights/analysis-on-the-layout-of-innovative-dru-331872.html 0.6 2026-08-04T04:59:01+08:00 daily https://www.pharmasources.com/industryinsights/catalent-embarks-on-230m-viral-vector-ex-331873.html 0.6 2026-07-22T07:32:19+08:00 daily https://www.pharmasources.com/industryinsights/global-sports-nutrition-market-research--331874.html 0.6 2026-06-21T16:35:49+08:00 daily https://www.pharmasources.com/industryinsights/conning-consumer-and-investor-demand-sig-331875.html 0.6 2026-06-28T18:46:51+08:00 daily https://www.pharmasources.com/industryinsights/chinese-mainland-reports-50-locally-tran-331876.html 0.6 2026-07-04T23:50:22+08:00 daily https://www.pharmasources.com/industryinsights/innovent-and-neocura-announce-strategic--331877.html 0.6 2026-08-07T00:41:09+08:00 daily https://www.pharmasources.com/industryinsights/mallinckrodt-and-terumo-blood-and-cell-t-331878.html 0.6 2026-08-01T09:50:49+08:00 daily https://www.pharmasources.com/industryinsights/merck-allows-poor-nations-to-make-covid--331879.html 0.6 2026-08-07T00:02:26+08:00 daily https://www.pharmasources.com/industryinsights/waters-and-sartorius-enter-bioprocessing-331880.html 0.6 2026-08-10T09:58:36+08:00 daily https://www.pharmasources.com/industryinsights/cyanvac-eyes-fundraise-for-parainfluenza-331881.html 0.6 2026-08-07T00:52:52+08:00 daily https://www.pharmasources.com/industryinsights/news-sec-ms-a-powerful-tool-for-adc-anal-331882.html 0.6 2026-08-11T09:39:40+08:00 daily https://www.pharmasources.com/industryinsights/review-of-covaxin-underway-expect-a-reco-331883.html 0.6 2026-08-12T07:18:36+08:00 daily https://www.pharmasources.com/industryinsights/fda-fast-track-designation-for-nemvaleuk-331884.html 0.6 2026-08-09T06:59:41+08:00 daily https://www.pharmasources.com/industryinsights/horse-hyperimmune-antibody-may-help-the--331885.html 0.6 2026-06-22T06:11:53+08:00 daily https://www.pharmasources.com/industryinsights/ec-approves-mercks-keytruda-and-chemothe-331886.html 0.6 2026-06-29T15:23:16+08:00 daily https://www.pharmasources.com/industryinsights/launch-of-seegenes-starlet-aios-all-in-o-331887.html 0.6 2026-07-21T21:15:00+08:00 daily https://www.pharmasources.com/industryinsights/frontier-biotechnologies-long-acting-inj-331888.html 0.6 2026-08-02T01:30:48+08:00 daily https://www.pharmasources.com/industryinsights/adagene-establishes-collaboration-for-cl-331889.html 0.6 2026-06-26T20:51:43+08:00 daily https://www.pharmasources.com/industryinsights/novavax-files-for-authorization-of-its-c-331890.html 0.6 2026-08-12T09:03:27+08:00 daily https://www.pharmasources.com/industryinsights/european-wellness-collaborates-with-heid-331891.html 0.6 2026-08-09T07:37:50+08:00 daily https://www.pharmasources.com/industryinsights/immunocompromised-may-need-fourth-covid--331892.html 0.6 2026-08-07T00:02:26+08:00 daily https://www.pharmasources.com/industryinsights/lithium-ion-battery-recycling-market-to--331893.html 0.6 2026-08-06T23:55:51+08:00 daily https://www.pharmasources.com/industryinsights/nexe-launches-its-highly-anticipated-keu-331894.html 0.6 2026-08-06T23:47:12+08:00 daily https://www.pharmasources.com/industryinsights/fda-holds-workshop-to-discuss-the-safe-u-331895.html 0.6 2026-08-06T23:36:56+08:00 daily https://www.pharmasources.com/industryinsights/qa-covid-19-vaccine-shots-for-children-331896.html 0.6 2026-08-06T23:45:37+08:00 daily https://www.pharmasources.com/industryinsights/thrombolytic-science-granted-us-patent-o-331897.html 0.6 2026-08-06T23:55:46+08:00 daily https://www.pharmasources.com/industryinsights/gtp-bioways-to-galvanise-cdmo-position-i-331898.html 0.6 2026-08-11T20:11:30+08:00 daily https://www.pharmasources.com/industryinsights/alexandre-pasini-appointed-chief-operati-331899.html 0.6 2026-08-06T22:20:52+08:00 daily https://www.pharmasources.com/industryinsights/alphamab-oncology-announces-first-patien-331900.html 0.6 2026-08-03T08:54:53+08:00 daily https://www.pharmasources.com/industryinsights/hanmi-science-consortium-drives-ambitiou-331901.html 0.6 2026-06-21T21:16:04+08:00 daily https://www.pharmasources.com/industryinsights/immunoforge-inc-receives-us-fda-odd-for--331902.html 0.6 2026-06-23T14:56:54+08:00 daily https://www.pharmasources.com/industryinsights/nearly-59000-meatpacking-workers-caught--331903.html 0.6 2026-06-21T16:27:03+08:00 daily https://www.pharmasources.com/industryinsights/bharat-biotechs-us-partner-ocugen-files--331904.html 0.6 2026-06-21T09:17:17+08:00 daily https://www.pharmasources.com/industryinsights/milliporesigma-launches-new-tech-and-exp-331905.html 0.6 2026-06-24T12:06:14+08:00 daily https://www.pharmasources.com/industryinsights/fda-joins-bespoke-gene-therapy-consortiu-331906.html 0.6 2026-08-04T04:56:53+08:00 daily https://www.pharmasources.com/industryinsights/merck-and-mpp-sign-licence-deal-for-oral-331907.html 0.6 2026-08-06T10:14:07+08:00 daily https://www.pharmasources.com/industryinsights/fda-nih-and-15-private-organizations-joi-331908.html 0.6 2026-08-04T20:54:27+08:00 daily https://www.pharmasources.com/industryinsights/cdc-unanimously-recommends-johnson-johns-331909.html 0.6 2026-08-14T01:31:48+08:00 daily https://www.pharmasources.com/industryinsights/teva-modag-to-develop-drug-candidates-fo-331910.html 0.6 2026-08-07T05:37:20+08:00 daily https://www.pharmasources.com/industryinsights/trillium-therapeutics-receives-final-cou-331911.html 0.6 2026-08-07T02:30:57+08:00 daily https://www.pharmasources.com/industryinsights/impact-therapeutics-announced-atr-inhibi-331912.html 0.6 2026-08-07T02:18:35+08:00 daily https://www.pharmasources.com/industryinsights/chinese-developed-new-drug-exploits-the--331913.html 0.6 2026-08-13T09:01:39+08:00 daily https://www.pharmasources.com/industryinsights/pharmaceutical-companies-have-been-engag-331914.html 0.6 2026-08-08T10:24:40+08:00 daily https://www.pharmasources.com/industryinsights/the-production-application-of-first-seco-331915.html 0.6 2026-08-07T01:14:06+08:00 daily https://www.pharmasources.com/industryinsights/florida-receives-43m-to-help-rehabs-like-331916.html 0.6 2026-08-07T02:09:48+08:00 daily https://www.pharmasources.com/industryinsights/global-car-t-therapy-pipeline-report-202-331917.html 0.6 2026-08-07T02:18:39+08:00 daily https://www.pharmasources.com/industryinsights/akebia-announces-otsukas-submission-of-i-331918.html 0.6 2026-08-07T02:31:11+08:00 daily https://www.pharmasources.com/industryinsights/hpv-shots-expected-to-benefit-world-331919.html 0.6 2026-08-07T02:36:37+08:00 daily https://www.pharmasources.com/industryinsights/achedaway-releases-a-cupping-therapy-gam-331920.html 0.6 2026-08-10T07:17:44+08:00 daily https://www.pharmasources.com/industryinsights/suzhou-ribo-life-science-co-ltd-adopts-a-331921.html 0.6 2026-08-12T12:53:38+08:00 daily https://www.pharmasources.com/industryinsights/antengene-receives-fda-approval-of-ind-f-331922.html 0.6 2026-08-07T02:22:00+08:00 daily https://www.pharmasources.com/industryinsights/gannex-announces-us-ind-approval-of-asc4-331923.html 0.6 2026-08-07T02:05:22+08:00 daily https://www.pharmasources.com/industryinsights/farrer-park-hospital-introduced-actinium-331924.html 0.6 2026-08-07T00:59:33+08:00 daily https://www.pharmasources.com/industryinsights/novavax-files-for-provisional-approval-o-331925.html 0.6 2026-08-07T13:15:32+08:00 daily https://www.pharmasources.com/industryinsights/kol-views-preview-abbvies-abbv-951-works-331926.html 0.6 2026-08-08T10:38:38+08:00 daily https://www.pharmasources.com/industryinsights/india-committed-to-supplying-covid-19-va-331927.html 0.6 2026-08-14T10:03:31+08:00 daily https://www.pharmasources.com/industryinsights/cipla-health-develops-povidone-iodine-ba-331928.html 0.6 2026-08-09T00:26:54+08:00 daily https://www.pharmasources.com/industryinsights/inceptor-bio-acquires-arranta-bios-gaine-331929.html 0.6 2026-06-28T19:29:56+08:00 daily https://www.pharmasources.com/industryinsights/gilead-and-merck-collaborate-for-breast--331930.html 0.6 2026-06-24T07:51:16+08:00 daily https://www.pharmasources.com/industryinsights/merck-recalls-cubicin-injection-due-to-p-331931.html 0.6 2026-06-22T11:12:01+08:00 daily https://www.pharmasources.com/industryinsights/needle-free-covid-19-vaccine-shows-promi-331932.html 0.6 2026-06-24T05:35:04+08:00 daily https://www.pharmasources.com/industryinsights/reasons-for-the-rise-of-chemical-interme-331933.html 0.6 2026-08-07T19:37:04+08:00 daily https://www.pharmasources.com/industryinsights/urgent-sourcing-needs-ofpharmasourcescom-331934.html 0.6 2026-08-07T01:06:46+08:00 daily https://www.pharmasources.com/industryinsights/what-are-fine-chemical-intermediates-331935.html 0.6 2026-06-25T05:52:46+08:00 daily https://www.pharmasources.com/industryinsights/the-advantages-of-drop-pill-equipment-an-331936.html 0.6 2026-08-10T16:17:38+08:00 daily https://www.pharmasources.com/industryinsights/what-are-the-main-systems-of-the-laborat-331937.html 0.6 2026-08-07T00:40:17+08:00 daily https://www.pharmasources.com/industryinsights/commonly-used-laboratory-pill-dropping-m-331938.html 0.6 2026-08-13T14:46:41+08:00 daily https://www.pharmasources.com/industryinsights/customized-production-process-of-pharma--331939.html 0.6 2026-08-07T05:53:14+08:00 daily https://www.pharmasources.com/industryinsights/what-is-the-future-development-direction-331940.html 0.6 2026-08-13T00:58:29+08:00 daily https://www.pharmasources.com/industryinsights/what-are-pharma-intermediates-and-how-ar-331941.html 0.6 2026-08-07T04:25:10+08:00 daily https://www.pharmasources.com/industryinsights/what-are-pesticide-intermediates-what-ar-331942.html 0.6 2026-08-07T06:29:24+08:00 daily https://www.pharmasources.com/industryinsights/what-are-the-differences-between-pharma--331943.html 0.6 2026-08-10T08:32:10+08:00 daily https://www.pharmasources.com/industryinsights/what-are-the-advantages-of-herbal-extrac-331944.html 0.6 2026-08-07T03:33:58+08:00 daily https://www.pharmasources.com/industryinsights/the-advantages-of-herbal-extraction-equi-331945.html 0.6 2026-08-06T23:36:43+08:00 daily https://www.pharmasources.com/industryinsights/working-principles-and-characteristics-o-331946.html 0.6 2026-08-07T04:20:32+08:00 daily